Citrus Sinensis ID: 004097
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | 2.2.26 [Sep-21-2011] | |||||||
| P32361 | 1115 | Serine/threonine-protein | yes | no | 0.509 | 0.353 | 0.354 | 5e-81 | |
| Q09499 | 967 | Serine/threonine-protein | yes | no | 0.489 | 0.391 | 0.399 | 7e-80 | |
| O94537 | 1072 | Serine/threonine-protein | yes | no | 0.573 | 0.414 | 0.334 | 2e-73 | |
| Q55GJ2 | 984 | Probable serine/threonine | yes | no | 0.515 | 0.405 | 0.366 | 9e-73 | |
| Q76MJ5 | 926 | Serine/threonine-protein | yes | no | 0.501 | 0.419 | 0.351 | 1e-70 | |
| Q9EQY0 | 977 | Serine/threonine-protein | yes | no | 0.496 | 0.393 | 0.329 | 6e-68 | |
| O75460 | 977 | Serine/threonine-protein | no | no | 0.493 | 0.390 | 0.330 | 1e-67 | |
| Q9Z2E3 | 911 | Serine/threonine-protein | no | no | 0.496 | 0.421 | 0.334 | 2e-67 | |
| Q55DJ9 | 1505 | Probable serine/threonine | no | no | 0.494 | 0.254 | 0.298 | 1e-45 | |
| Q559A2 | 1431 | Probable serine/threonine | no | no | 0.494 | 0.267 | 0.299 | 5e-43 |
| >sp|P32361|IRE1_YEAST Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=IRE1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 302 bits (774), Expect = 5e-81, Method: Compositional matrix adjust.
Identities = 169/477 (35%), Positives = 256/477 (53%), Gaps = 83/477 (17%)
Query: 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 402
+ LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN++
Sbjct: 670 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 729
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R+Y E+ F+Y++LE C +L DL+ E N +++ L E P+
Sbjct: 730 RYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYN----PI-- 775
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK-- 520
+ R I SG++HLH + +IHRDLKPQN+L+S F A
Sbjct: 776 -------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 816
Query: 521 ---------LSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG------------ 558
+SD G+ K+L S N G+SGW+APE L +
Sbjct: 817 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQCQVETEHS 876
Query: 559 -------------------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--- 596
R TR+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++
Sbjct: 877 SSRHTVVSSDSFYDPFTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 936
Query: 597 ---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 653
+ K L I EA DL ++++D +P RP A VL HP FW +L FL VSDR
Sbjct: 937 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDR 996
Query: 654 VELEDRESDSKLLRALE-GIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 712
+E+E+R+ S LL + G V +G W K + F++N+ RYR+Y + DLLR +R
Sbjct: 997 LEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALR 1056
Query: 713 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 769
NK +HF +LP+DI EL+G P+GFY+YF+ RFP LLI VY ++ +++ +++
Sbjct: 1057 NKYHHFMDLPEDIAELMGPVPDGFYDYFTKRFPNLLIGVYMIVKENLSDDQILREFL 1113
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices HAC1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 3EC: .EC: 1EC: .EC: 2EC: 6EC: .EC: - |
| >sp|Q09499|IRE1_CAEEL Serine/threonine-protein kinase/endoribonuclease ire-1 OS=Caenorhabditis elegans GN=ire-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 7e-80, Method: Compositional matrix adjust.
Identities = 171/428 (39%), Positives = 246/428 (57%), Gaps = 49/428 (11%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412
+ G GTVV G ++GR VAVKR+V A +E L SD HP+++R++ +ESD
Sbjct: 524 LGTGCEGTVVYRGTFDGREVAVKRVVSEFVKFAHREADLLRESDTHPHVIRYFCMESDSQ 583
Query: 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472
F YL+LE C SLND + EQ KE N V I L +M+ D
Sbjct: 584 FRYLALELCIASLNDYV--------EQ---KEVQQN----VTIALRDIMKQATD------ 622
Query: 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKR 529
GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR
Sbjct: 623 -----------------GLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKR 665
Query: 530 LQGDMSCLTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 587
+Q + +++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S
Sbjct: 666 VQPGKNSISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKS 725
Query: 588 FERDANIVKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644
R ANIV L + + + A DL + +L+ P R A VLNHPFFWT++ RL
Sbjct: 726 LHRQANIVNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRL 785
Query: 645 SFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNV 704
++ DVSDRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +V
Sbjct: 786 AYFSDVSDRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSV 843
Query: 705 RDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEV 764
RDLLR +RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE V
Sbjct: 844 RDLLRAMRNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAV 902
Query: 765 FHKYVTND 772
F +Y ++D
Sbjct: 903 FKRYYSDD 910
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices xbp-1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Unfolded protein response (UPR) transcripional activation by ire-1, as well as translational attenuation by pek-1 in a complementary pathway, maintains ER homeostasis. Ire-1 and pek-1 are redundant genes that control a pathway essential for larval development and survival. Caenorhabditis elegans (taxid: 6239) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O94537|PPK4_SCHPO Serine/threonine-protein kinase ppk4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 172/514 (33%), Positives = 270/514 (52%), Gaps = 70/514 (13%)
Query: 287 RPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKL 346
+ + +N T +NI+ + K TD L + K L +I + + L
Sbjct: 596 QASFEQNQTLDILSENIVEIQDK--STDPLQKSLDSSLKSHLPEATVIQNTDGSVTVNSL 653
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 406
V+ + I GS+GT+V G YE R VAVKR++ +D+A +EI L SD HPNIVR+Y
Sbjct: 654 TVYPEVIGYGSHGTIVYRGVYEDREVAVKRVLMEFYDLASREITLLQQSDNHPNIVRYYC 713
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ F+Y+ +E C C+L+DLI E+ A +
Sbjct: 714 KQKSDQFLYIVIELCKCNLSDLI--------EKPIAYD---------------------- 743
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-------FCA 519
+L+K S L+ + I G+SHLH + L+HRDLKPQN+L+ + S A
Sbjct: 744 -DLFK-----SIDLVSLLYQIAFGVSHLHSLDLVHRDLKPQNILLVVNNSPNLSKTRVRA 797
Query: 520 KLSDMGISKRLQGDMSCLTQNAT--GYGSSGWQAPEQL------------LQGRQTR--- 562
+SD G+SK+L + S L +N T GS GW++PE L ++ R+ R
Sbjct: 798 LISDFGLSKKLDFNQSSL-RNTTFEAAGSYGWRSPEILSGSLSQQSKEIQVKTREGRIRQ 856
Query: 563 ---AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFT 615
A D+F+LGCI ++ +TGG HP+G ++ + NI+K L ++ + E A DL
Sbjct: 857 ASHATDIFALGCIFYYTLTGGMHPFGSHYDCEGNILKGNYCLVHLQSLGECGVLAADLIE 916
Query: 616 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 675
++ P RP + VLNHP FW +L FL DVSDR E+E+R+ S LL+ LE +
Sbjct: 917 DMIAFEPSKRPTIEVVLNHPLFWDYAKKLDFLIDVSDRFEVEERDPPSPLLQMLENNSKS 976
Query: 676 ALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEG 735
+ W + + ++N+G+YR+Y + D+LRV+RNK +H+++LP+ ++ +LG P+G
Sbjct: 977 VIGENWTTCLHSSLVDNLGKYRKYDGSKILDILRVLRNKRHHYQDLPESVRRVLGDLPDG 1036
Query: 736 FYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 769
F +YF +FP LL+ Y+++ E F +Y+
Sbjct: 1037 FTSYFVEKFPMLLLHCYHLVKDVLYEESQFKRYL 1070
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GJ2|IREA_DICDI Probable serine/threonine-protein kinase ireA OS=Dictyostelium discoideum GN=ireA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (703), Expect = 9e-73, Method: Compositional matrix adjust.
Identities = 162/442 (36%), Positives = 249/442 (56%), Gaps = 43/442 (9%)
Query: 342 RIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 400
+IGKL ++ NK + GS GT+V EG EGR VAVKR++ A +E+ LI SD+H N
Sbjct: 569 KIGKLEIITNKILGTGSCGTIVYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTN 628
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+VR+Y E D +F+YL++ C SL+ +YV + Q++ + S +
Sbjct: 629 VVRYYAKEEDDEFIYLAISFCQKSLD--MYV-QQTLSLQISPTDSPS------------I 673
Query: 461 MENTKDIELWKANGHPSAQLL------KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
+ + N + + Q++ ++ ++ GL HLH + ++HRD+KP NVLI D
Sbjct: 674 QSSNNNGNGNNGNNNNNNQIIIDNKTKQMILELFKGLEHLHSLNIVHRDIKPHNVLI--D 731
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 572
+ K+SDMG+ K L D LT + S GWQ P + L G R T+ +D+FSLGC+
Sbjct: 732 PNNRVKISDMGLGKLLDNDDQSLTFTS---DSHGWQ-PAEYLNGTNRNTKKVDIFSLGCV 787
Query: 573 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
+++ +TG HP+G + R+ N++K + D+ ++H+P+ L ++ P+ RP +
Sbjct: 788 VYYLLTGA-HPFGHRYNREKNVLKGKFDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECI 846
Query: 633 NHPFFWTADTRLSFLRDVSDRVELE------DRESDSKLLRALEGIALVALNGKWDEKME 686
NHPFFW +LSFL SD +E E + E DS + +G +G W K++
Sbjct: 847 NHPFFWEVHKKLSFLVAASDYLEFEKPTSPLNLEIDSHVDLVTDG------SGDWWLKID 900
Query: 687 TKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPK 746
I+NIGRYR+Y ++RDLLRVIRNK NH+R+L + Q LG P+GF+NYF +FP+
Sbjct: 901 QVLIDNIGRYRKYNGKSIRDLLRVIRNKFNHYRDLSPEEQTCLGILPDGFFNYFDLKFPQ 960
Query: 747 LLIEVYNVIFTYCKGEEVFHKY 768
L I Y I K ++ F +Y
Sbjct: 961 LFIVTYLFILKNLKNDQYFVQY 982
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q76MJ5|ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 155/441 (35%), Positives = 233/441 (52%), Gaps = 53/441 (12%)
Query: 343 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 401
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 515 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 574
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R++ E F Y++LE C SL + + N L EV
Sbjct: 575 LRYFCTERGPQFHYIALELCRASLQEYVE----------NPDLDRGGLEPEV-------- 616
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC--- 518
V + ++SGL+HLH + ++HRDLKP N+LI+ S
Sbjct: 617 ---------------------VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGR 655
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQG-RQTRAIDLFSLGCILFF 575
LSD G+ K+L + ++ G+ GW APE QLL T A+D+FS GC+ ++
Sbjct: 656 VVLSDFGLCKKLPAGRCSFSLHSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYY 715
Query: 576 CITGGKHPYGESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNV 631
++GG HP+G+S R ANI+ L L E + + V DL +L P P RP A V
Sbjct: 716 VLSGGSHPFGDSLYRQANILTGAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQV 775
Query: 632 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 691
L HPFFW+ +L F +DVSD +E E + L+RALE + W E +
Sbjct: 776 LAHPFFWSRAKQLQFFQDVSDWLEKESEQE--PLVRALEAGGCAVVRDNWHEHISMPLQT 833
Query: 692 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 751
++ ++R YK +VRDLLR +RNK +H+RELP ++++ LG P+GF YF+ RFP+LL+
Sbjct: 834 DLRKFRSYKGTSVRDLLRAVRNKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHT 893
Query: 752 YNVIFTYCKGEEVFHKYVTND 772
+ + + C E +F Y D
Sbjct: 894 HRAMRS-CASESLFLPYYPPD 913
|
Induces translational repression through 28S ribosomal RNA cleavage in response to ER stress. Pro-apoptotic. Appears to play no role in the unfolded-protein response, unlike closely related proteins. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus GN=Ern1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 144/437 (32%), Positives = 231/437 (52%), Gaps = 53/437 (12%)
Query: 343 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 401
+GK+ K++ G+ GT+V +G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYKGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R++ E D+ F Y+++E C +L + + EQ
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQEYV--------------EQ---------------- 655
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 518
K H + + + SGL+HLH + ++HRDLKP N+L+S +
Sbjct: 656 ---------KDFAHLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIK 706
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 575
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYY 766
Query: 576 CITGGKHPYGESFERDANIV--KDRKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNV 631
I+ G HP+G+S +R ANI+ D F + + + +L +++ +P RP A++V
Sbjct: 767 VISEGNHPFGKSLQRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHV 826
Query: 632 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 691
L HPFFW+ + +L F +DVSDR+E E D ++R LE + W E +
Sbjct: 827 LKHPFFWSLEKQLQFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMDWRENITVPLQT 884
Query: 692 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 751
++ ++R YK +VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL
Sbjct: 885 DLRKFRTYKGGSVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHT 944
Query: 752 YNVIFTYCKGEEVFHKY 768
Y + C+ E +F Y
Sbjct: 945 YQAM-ELCRHERLFQTY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O75460|ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 145/439 (33%), Positives = 229/439 (52%), Gaps = 57/439 (12%)
Query: 343 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 401
+GK+ K++ G+ GT+V G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 518
H + + + + SGL+HLH + ++HRDLKP N+LIS +
Sbjct: 659 ------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK 706
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 575
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 766
Query: 576 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPE------AVDLFTRLLDPNPDLRPKAQ 629
I+ G HP+G+S +R ANI+ L + PE A +L +++ +P RP A+
Sbjct: 767 VISEGSHPFGKSLQRQANILLGACSLDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAK 824
Query: 630 NVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKF 689
+VL HPFFW+ + +L F +DVSDR+E E D +++ LE + W E +
Sbjct: 825 HVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKMDWRENITVPL 882
Query: 690 IENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLI 749
++ ++R YK +VRDLLR +RNK +H+RELP +++E LGS P+ F YF+ RFP LL
Sbjct: 883 QTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLA 942
Query: 750 EVYNVIFTYCKGEEVFHKY 768
Y + C E +F Y
Sbjct: 943 HTYRAM-ELCSHERLFQPY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus GN=Ern2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 146/436 (33%), Positives = 228/436 (52%), Gaps = 52/436 (11%)
Query: 343 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 401
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 503 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 562
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R++ E F Y++LE C SL + +
Sbjct: 563 LRYFCTEHGPQFHYIALELCQASLQEYV-------------------------------- 590
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK- 520
+ D++ W + V + ++SGL+HLH + ++HRDLKP N+L++ S
Sbjct: 591 -ESPDLDRW------GLEPTTVLQQMMSGLAHLHSLHIVHRDLKPANILMAGPDSQGQGR 643
Query: 521 --LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQGRQTRAIDLFSLGCILFFC 576
+SD G+ K+L + ++ G+ GW APE QL T A+D+FS GC+ ++
Sbjct: 644 VVISDFGLCKKLPVGRCSFSLHSGIPGTEGWMAPELLQLPPDSPTSAVDIFSAGCVFYYV 703
Query: 577 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFTRLLDPNPDLRPKAQNVL 632
++GG HP+GES R ANI+ L ++ A+DL +L P RP A VL
Sbjct: 704 LSGGSHPFGESLYRQANILSGDPCLAQLQEETHDKVVALDLVRAMLSLLPQDRPSAGWVL 763
Query: 633 NHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIEN 692
HP FW+ L F +DVSD +E E + L+ ALE + + W + + +
Sbjct: 764 AHPLFWSRAKELQFFQDVSDWLEKEPDQG--PLVSALEAGSYKVVREDWHKHISAPLQAD 821
Query: 693 IGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVY 752
+ R+R YK +VRDLLR +RNK +H+RELP ++++ LG P GF YF+ RFP+LL+ +
Sbjct: 822 LKRFRSYKGTSVRDLLRAMRNKKHHYRELPAEVRQTLGQLPAGFIQYFTQRFPRLLLHTH 881
Query: 753 NVIFTYCKGEEVFHKY 768
+ T C E +F Y
Sbjct: 882 RAMRT-CASESLFLPY 896
|
Role in expression of the DDIT3 transcription factor, required for the unfolded-protein response, growth arrest and apoptosis. Has no effect on 28S ribosomal RNA cleavage, unlike the corresponding human protein. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q55DJ9|IRLD_DICDI Probable serine/threonine-protein kinase irlD OS=Dictyostelium discoideum GN=irlD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (470), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 139/465 (29%), Positives = 225/465 (48%), Gaps = 82/465 (17%)
Query: 343 IGKLVVFNKE---IAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLIA--SD 396
IGK K+ I +GSNGT+V +G + R VA+K++ K + + KEI+ LI +
Sbjct: 1047 IGKFKFSRKDEFIIGRGSNGTLVFKGIWNDRIPVAIKQMHKAFNPLISKEIEVLITLTNK 1106
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
NIVR+ E D FVYL L C SL +L+ K+ + NL++
Sbjct: 1107 NCNNIVRYIDQEEDDMFVYLGLTLCNGSLQNLV------------EKDLEINLISTSNNE 1154
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
+ I +LL++ +DIV G+ LH+ G++H DL P+N+LI D+
Sbjct: 1155 NNNNNKLKNFI-------GSELRLLELIKDIVYGIQFLHQQGIVHNDLNPRNILIKDDRF 1207
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
+SD+G+SK T +A G G+ E LL+ R+T+++D+FS+GCILF+
Sbjct: 1208 I---ISDLGLSKMEVTSSYSFTMHAPT-GQEGFHPAEVLLEKRKTKSVDIFSMGCILFYL 1263
Query: 577 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+TGG+HP+G+ F R ANI+ D+ L ++H A DL ++++ N RP +N+L HPF
Sbjct: 1264 MTGGQHPFGDKFFRMANILTDKPILEPLKHNLVACDLISQMISKNESDRPTTENILLHPF 1323
Query: 637 FWTADTRLSFLRDVSDRVELEDRESDSKLLRAL------EGIALVA---LNGKWDEKMET 687
FW + ++ F+ + + + SKL + + +G+ + L+ W++ ++
Sbjct: 1324 FWNHEKKVKFIDASLNLFKDSNGLFTSKLNKLINQFQDTDGVNTTSTPFLSKPWNQLIDP 1383
Query: 688 KFIENIG-------------------------RYRRYKYDNVRDLLRVIRNKSNHFRELP 722
IE+I ++ Y Y V+DL+R IRN H +E
Sbjct: 1384 TLIEHITNKQNQLSGGSSIGNNNNNSLTLSGKKFYFYDYSQVKDLVRCIRNTIQHHKE-- 1441
Query: 723 QDIQELLGSHP---------------EGFYNYFSCRFPKLLIEVY 752
IQ L+ P E +YF + P LL+ +Y
Sbjct: 1442 --IQRLISQSPSSSNKQEVLDCLESQELVLSYFEEKVPDLLLFLY 1484
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q559A2|IRLA_DICDI Probable serine/threonine-protein kinase irlA OS=Dictyostelium discoideum GN=irlA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 133/444 (29%), Positives = 221/444 (49%), Gaps = 61/444 (13%)
Query: 350 NKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLI--ASDQHPNIVRWYG 406
N I +GSNGT+V G + R VAVK++ K + KEI+ LI S+ N++R+
Sbjct: 990 NNIIGRGSNGTLVFRGIWNDRIPVAVKQMQKAFNPHISKEIEVLIRLTSNNCSNMIRYID 1049
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
E DQ FVYL L C SL DL+ S ++E + E+ + + EN +
Sbjct: 1050 QEEDQLFVYLGLTLCEESLQDLME--SKRYKEFI---EKTTTTNITTTFNNNIIDENLYE 1104
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
++L + +D+++G++ LH ++H DL P+N+L+ K +SD+G+
Sbjct: 1105 -----------QRILSLFKDVINGINFLHCQDIVHNDLNPRNILVHKGNFV---ISDLGL 1150
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
SK +Q + S N G G+ E L + R+T+++D+FSLGCILF+ +T G+HP+G
Sbjct: 1151 SK-MQVETSYSFTNNAPTGQEGYHPIEVLQEKRKTKSVDIFSLGCILFYLLTNGQHPFGN 1209
Query: 587 S-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS 645
+ R ANIV D+ DL ++ A+DL ++ + RP +LNHP FW+ + ++
Sbjct: 1210 NKLLRVANIVYDKPDLEPLKFNAPALDLVRLMISQDEKKRPTIDTILNHPLFWSTNEKIK 1269
Query: 646 FLRDVSDRVELED--RESDSKLLRALEGI---ALVALNGKWDEKMETKFIENIGRYRR-- 698
F + ++ + + SKLL + ++ L+ W++ ++ I+++
Sbjct: 1270 FYESSLNLLKDPNNSQSKHSKLLNYYQNDNSGGVLFLSKPWNQIIDPFLIDHVENNNNNN 1329
Query: 699 -----------------YKYDNVRDLLRVIRNKSNHFRELPQDI--QELLGSHPEGFYN- 738
Y+YD VRDL+R IRN H +++ + I Q+ L + F N
Sbjct: 1330 NNNNNNKQNSKKLAIVAYQYDQVRDLVRCIRNSLVHHKDILRSITQQQNLPPSSKEFAND 1389
Query: 739 ----------YFSCRFPKLLIEVY 752
YF C+FP LL +Y
Sbjct: 1390 CLKSQESVLLYFECKFPDLLFHLY 1413
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | ||||||
| 225457602 | 925 | PREDICTED: uncharacterized protein LOC10 | 0.957 | 0.801 | 0.554 | 0.0 | |
| 297745578 | 827 | unnamed protein product [Vitis vinifera] | 0.881 | 0.824 | 0.551 | 0.0 | |
| 224086074 | 496 | predicted protein [Populus trichocarpa] | 0.638 | 0.995 | 0.728 | 0.0 | |
| 225438442 | 957 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.777 | 0.514 | 0.0 | |
| 224074275 | 822 | predicted protein [Populus trichocarpa] | 0.936 | 0.881 | 0.508 | 0.0 | |
| 10177897 | 939 | unnamed protein product [Arabidopsis tha | 0.945 | 0.779 | 0.487 | 0.0 | |
| 297808453 | 871 | hypothetical protein ARALYDRAFT_489300 [ | 0.921 | 0.818 | 0.480 | 0.0 | |
| 255561453 | 911 | kinase, putative [Ricinus communis] gi|2 | 0.961 | 0.816 | 0.495 | 0.0 | |
| 15277137 | 881 | Ire1 homolog-1 [Arabidopsis thaliana] | 0.945 | 0.830 | 0.482 | 0.0 | |
| 18420784 | 881 | protein inositol requiring 1-1 [Arabidop | 0.945 | 0.830 | 0.483 | 0.0 |
| >gi|225457602|ref|XP_002272934.1| PREDICTED: uncharacterized protein LOC100247854 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/810 (55%), Positives = 559/810 (69%), Gaps = 69/810 (8%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEEL 61
PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GFQSDE ++ + EEL
Sbjct: 138 PYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGFQSDEENPILSREEIEEL 196
Query: 62 VESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYH 121
+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD +A F+C
Sbjct: 197 IEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADIEAVFQC----------- 245
Query: 122 FNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSL----------PEFLSVIGKVA-- 169
G+E+G + + D+ES P H Q ASVYR+R+ SL P+ L + ++
Sbjct: 246 --PGTEIGSEYMSDIES--PLHCQTRASVYRIREPSLLDSFPMHDRLPKTLPAVEVLSLP 301
Query: 170 --------------------------GWISLPGSSQNSLLGPVDR-NSPLFLPDKVDRPP 202
+SLP S SL PV R P L +P
Sbjct: 302 ASEPKSHSLLDSFPMHDRLPKALPAVEVLSLPASEPKSLSQPVGRLPGPHHLGQ--GKPL 359
Query: 203 LALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSK 262
LALP +E TL + GG SE++ + I+ + L I+GF+ Y
Sbjct: 360 LALPLSEG----TLSVHGGDASEMD----IMSIVSDNIEKLGIWAAPLLFIVGFIIYQFF 411
Query: 263 QVKSKKQNEEHITKT-GI-PKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 320
V+ ++ +K GI PKKKK+R+ N+N ++EK I +ESKV + +GLS +
Sbjct: 412 AVREPGKSRPKDSKVQGISPKKKKARKSVINKNNASNEKRHGNISHESKVADNNGLSQVE 471
Query: 321 GNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT 380
N K L L D V R+IGK++V KEIAKGSNGT+VLEG Y+GR VAVKRLV+T
Sbjct: 472 RNEIKLELNSNSLADVHVGERKIGKMLVSKKEIAKGSNGTIVLEGIYDGRPVAVKRLVRT 531
Query: 381 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 440
HHDVALKEIQNLIASDQHPNIVRW+GVE DQDFVYLSLERC CSL+DLIY+ S S ++QL
Sbjct: 532 HHDVALKEIQNLIASDQHPNIVRWHGVEYDQDFVYLSLERCNCSLSDLIYLCSDS-QDQL 590
Query: 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500
++ DSN+LNE +RL +M+ KD ELWK NG+PS QLLK+ RD+VSGL+HLHE+G+I
Sbjct: 591 VNQDWDSNILNEYIVRLHSIMDPNKDFELWKTNGYPSPQLLKLMRDVVSGLAHLHELGII 650
Query: 501 HRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR 559
HRDLKPQN+LI K KS AKLSDMGISKRL GDMS LT + TGYGSSGWQAPEQL GR
Sbjct: 651 HRDLKPQNILIIIKGKSLSAKLSDMGISKRLLGDMSSLTHHGTGYGSSGWQAPEQLRHGR 710
Query: 560 QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 619
QTRA+DLFSLGC+LFFC+TGGKHPYG++ ERD NIV +RKDLFL+E+IPEAVDLF+ LL+
Sbjct: 711 QTRAVDLFSLGCVLFFCLTGGKHPYGDNLERDVNIVNNRKDLFLIENIPEAVDLFSLLLE 770
Query: 620 PNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNG 679
P+PDLRPKA +VL+HPFFW+++ RLSFLRDVSDRVELEDRE++S+LL+ LE I +ALNG
Sbjct: 771 PDPDLRPKAMDVLHHPFFWSSEMRLSFLRDVSDRVELEDRENESQLLKQLESIGTLALNG 830
Query: 680 KWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNY 739
KWDEKME FI NIGRYRRYK+D+VRDLLRVIRNK NH+RELP DIQE+LG PEGF Y
Sbjct: 831 KWDEKMEGAFINNIGRYRRYKFDSVRDLLRVIRNKLNHYRELPSDIQEILGPVPEGFNLY 890
Query: 740 FSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 769
FS RFP+ LIEVY VI T+C+ EE F KY+
Sbjct: 891 FSSRFPRFLIEVYKVIHTHCREEEFFQKYI 920
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745578|emb|CBI40743.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/771 (55%), Positives = 525/771 (68%), Gaps = 89/771 (11%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEEL 61
PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GFQSDE ++ + EEL
Sbjct: 138 PYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGFQSDEENPILSREEIEEL 196
Query: 62 VESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYH 121
+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD +A F+C
Sbjct: 197 IEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADIEAVFQC----------- 245
Query: 122 FNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNS 181
G+E+G + + D+ES L C T+ S +G+ LPG
Sbjct: 246 --PGTEIGSEYMSDIESPLHCQTRA----------------SPVGR------LPGPHH-- 279
Query: 182 LLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQ 241
LG +P LALP +E TL + GG SE++ + I+
Sbjct: 280 -LGQ-------------GKPLLALPLSEG----TLSVHGGDASEMD----IMSIVSDNIE 317
Query: 242 SFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKKKKSRRPGYNRNTTNSEK 299
+ L I+GF+ Y V+ ++ +K GI PKKKK+R+ N+N ++EK
Sbjct: 318 KLGIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKKKKARKSVINKNNASNEK 377
Query: 300 MQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNG 359
I +ESKV + +GLS + N K L L D V R+IGK++V KEIAKGSNG
Sbjct: 378 RHGNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERKIGKMLVSKKEIAKGSNG 437
Query: 360 TVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419
T+VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIVRW+GVE DQDFVYLSLE
Sbjct: 438 TIVLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIVRWHGVEYDQDFVYLSLE 497
Query: 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 479
RC CSL+DLIY+ S S ++QL D ELWK NG+PS Q
Sbjct: 498 RCNCSLSDLIYLCSDS-QDQL-------------------------DFELWKTNGYPSPQ 531
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLT 538
LLK+ RD+VSGL+HLHE+G+IHRDLKPQN+LI K KS AKLSDMGISKRL GDMS LT
Sbjct: 532 LLKLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKLSDMGISKRLLGDMSSLT 591
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
+ TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGKHPYG++ ERD NIV +R
Sbjct: 592 HHGTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGKHPYGDNLERDVNIVNNR 651
Query: 599 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELED 658
KDLFL+E+IPEAVDLF+ LL+P+PDLRPKA +VL+HPFFW+++ RLSFLRDVSDRVELED
Sbjct: 652 KDLFLIENIPEAVDLFSLLLEPDPDLRPKAMDVLHHPFFWSSEMRLSFLRDVSDRVELED 711
Query: 659 RESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHF 718
RE++S+LL+ LE I +ALNGKWDEKME FI NIGRYRRYK+D+VRDLLRVIRNK NH+
Sbjct: 712 RENESQLLKQLESIGTLALNGKWDEKMEGAFINNIGRYRRYKFDSVRDLLRVIRNKLNHY 771
Query: 719 RELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 769
RELP DIQE+LG PEGF YFS RFP+ LIEVY VI T+C+ EE F KY+
Sbjct: 772 RELPSDIQEILGPVPEGFNLYFSSRFPRFLIEVYKVIHTHCREEEFFQKYI 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086074|ref|XP_002307805.1| predicted protein [Populus trichocarpa] gi|222857254|gb|EEE94801.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/494 (72%), Positives = 424/494 (85%)
Query: 279 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRV 338
+PKKKK+RR G N++ N+ K Q + +SKVGE + L+ + + K LLTFTD +D RV
Sbjct: 1 MPKKKKNRRSGNNKSNPNNLKNQKYLSLQSKVGEINELTRVERDERKLLLTFTDHVDGRV 60
Query: 339 DGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQH 398
DGRRIGKL+V NKEIAKGSNGTVVLEG Y+GR VAVKRLV++HHDVALKEIQNLIASDQH
Sbjct: 61 DGRRIGKLLVSNKEIAKGSNGTVVLEGIYDGRHVAVKRLVQSHHDVALKEIQNLIASDQH 120
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
PNIVRWYGVE DQDFVYL+LERCTCSLNDLIYV S SF+ Q+ +K+ DSN L E +RL
Sbjct: 121 PNIVRWYGVEYDQDFVYLALERCTCSLNDLIYVNSESFQNQIPSKDMDSNRLPEYMVRLH 180
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
+ E+ +++ELWKANG+PS QLLK+ RD+VSGL+HLHE+G++HRD+KPQNVLI +KSFC
Sbjct: 181 SMPEHNRNVELWKANGYPSVQLLKLMRDVVSGLAHLHELGIVHRDMKPQNVLIISEKSFC 240
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
AKLSDMGISKRL GDMS LTQ+ TGYGSSGWQAPEQLL GRQTRA+DLFSLGC+LFFCIT
Sbjct: 241 AKLSDMGISKRLLGDMSSLTQHPTGYGSSGWQAPEQLLHGRQTRALDLFSLGCVLFFCIT 300
Query: 579 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638
GGKHP+G++ ERD NIV DRKDLFLVE+IPEA+DLFT LLDP+P+ RPKAQ VLNHP FW
Sbjct: 301 GGKHPFGDNIERDVNIVNDRKDLFLVENIPEALDLFTCLLDPDPEKRPKAQEVLNHPLFW 360
Query: 639 TADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRR 698
T++ RLSFL+DVSDRVELEDRE+ S+LL LE A +ALNGKWDEKME FI NIGRYRR
Sbjct: 361 TSEKRLSFLQDVSDRVELEDRENASELLDTLESTATMALNGKWDEKMEAAFINNIGRYRR 420
Query: 699 YKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTY 758
YK+D++RDLLRVIRNKS+H+RELPQ+I+ELLGSHPEGF +YFS RFPKLLIEVY VI+ Y
Sbjct: 421 YKFDSIRDLLRVIRNKSHHYRELPQEIKELLGSHPEGFESYFSRRFPKLLIEVYKVIYRY 480
Query: 759 CKGEEVFHKYVTND 772
CK EE F KY+ ++
Sbjct: 481 CKEEEFFRKYIDSN 494
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438442|ref|XP_002275036.1| PREDICTED: uncharacterized protein LOC100249111 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/802 (51%), Positives = 525/802 (65%), Gaps = 58/802 (7%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEEL 61
P++S+DGGV LG+ +T+VFL++ K+G+++ +Y S TP S++ + VV EE
Sbjct: 175 PHVSEDGGVILGSKQTTVFLLNAKTGKLIHSYRSLESPPTP--LSNKEESVVHDKDIEEW 232
Query: 62 VESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYH 121
V+SG NL + +YI RTDY LQS +Q S +VLWN+ A+ A F CQ FS
Sbjct: 233 VDSGSTNLNIVEPRLYITRTDYSLQSFAQGSDKVLWNMTVAEIGAAFLCQGTENLFSRPP 292
Query: 122 FNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPE------FLSVIGKVAGWISLP 175
N G ELG + D E LPC Q A VYR R +++ E L + + P
Sbjct: 293 LNLGCELGPEYNCDFEMPLPC--QSKAVVYRYRGHTMLEPFPRHDRLQEAHQEDRLLLQP 350
Query: 176 GSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS-------------TETEIPWTLGMP--- 219
+ P D P +P+ + LPS ++E L P
Sbjct: 351 NIDKTLDFHPQDMMLPAVVPNHM------LPSEPKDEISLNFQDNNDSEAVLPLSPPKIK 404
Query: 220 GGSVSEINKKHAFVEGFR-----SYIQSFIVLFIAL--------CPIIGFLFYHSKQVKS 266
+S+ N + + +G S + S IV + L P+ G +KQ
Sbjct: 405 NSGISDQNVQMPYNDGLSMFSGGSILFSLIVFIVILLVSVIYCCTPVAGEQGEMNKQPND 464
Query: 267 KKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKF 326
N +P KK+ R N ++ +K ++++ +E+K DG +HI + +
Sbjct: 465 SDSN-------SVPSKKRKIRKSAKNNISSGKKDEHVL-SENK----DGSAHIASDNSPW 512
Query: 327 LLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL 386
L L+D +GR +GKL V N IAKGSNGT+VLEG +EGRSVAVKRLV+ HHDVA
Sbjct: 513 L-NLNGLVDGDTNGRIVGKLFVSNIVIAKGSNGTIVLEGIHEGRSVAVKRLVRAHHDVAF 571
Query: 387 KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQD 446
KEIQNLIASD+HPNIVRWYGVE DQDFVYLSLERCTCSLNDL+ + S S + + +Q
Sbjct: 572 KEIQNLIASDRHPNIVRWYGVEYDQDFVYLSLERCTCSLNDLLQIHSNSSQNPGFSMDQA 631
Query: 447 SNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506
+ + E RI+L V +DI+LWK+NG+PS+ LL + RD+VSGL HLH++G+IHRDLKP
Sbjct: 632 TKAMMEYRIQLDSVKCIVQDIKLWKSNGYPSSVLLSLMRDVVSGLVHLHDLGIIHRDLKP 691
Query: 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566
QNVLI K+KS CAKLSDMGISKRL GDMS L +ATGYGSSGWQAPEQLL GRQTRA+DL
Sbjct: 692 QNVLIIKEKSLCAKLSDMGISKRLVGDMSSLGHHATGYGSSGWQAPEQLLHGRQTRAVDL 751
Query: 567 FSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 626
FSLGCILF CITGG+HP+G+ ERD NIVK++ DLFLVE IPEA+DLF RLLDP P+LRP
Sbjct: 752 FSLGCILFSCITGGRHPFGDPLERDVNIVKNKPDLFLVEFIPEALDLFARLLDPKPELRP 811
Query: 627 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKME 686
KA VL HP FW+++ RLSFLRD SDRVELEDRES+S +L+ALEG A AL GKW+EKME
Sbjct: 812 KASEVLYHPLFWSSELRLSFLRDASDRVELEDRESNSHVLKALEGTAPTALGGKWNEKME 871
Query: 687 TKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPK 746
F+ +IGRYRRYK+D+VRDLLRVIRNK NH+RELP++IQE+LGS PEGF +YFS RFP+
Sbjct: 872 PAFLADIGRYRRYKFDSVRDLLRVIRNKWNHYRELPREIQEILGSVPEGFDSYFSSRFPR 931
Query: 747 LLIEVYNVIFTYCKGEEVFHKY 768
LLIEVY V+ +CKGEE F KY
Sbjct: 932 LLIEVYKVVSRHCKGEECFQKY 953
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074275|ref|XP_002304333.1| predicted protein [Populus trichocarpa] gi|222841765|gb|EEE79312.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/781 (50%), Positives = 517/781 (66%), Gaps = 56/781 (7%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY-VLDFSASTPGFQSDENKHVVPVDGYEE 60
P++S+DG V LG+ KT+VF+V+ K+GR++ + D +S F+ H ++ ++
Sbjct: 87 PHMSEDGAVMLGSKKTTVFVVEAKTGRLIRTFKSPDSPSSLQSFEEGSGLHD-DLNNNKD 145
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGY 120
L++SG N Q++YI+RTDY LQ+ +S +V W+ A A F C++V
Sbjct: 146 LLKSGSSN---TAQVIYILRTDYALQTFGPNSDKVSWSTKVATIGATFLCKDV------- 195
Query: 121 HFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQN 180
+ SE+ +L +++S P Q V + +D S ++ S G + G LP S+ N
Sbjct: 196 --ENPSEV-FNLSFELDSDTPLSCQSRRIVVQRQDKS--QYSS--GDIHGEDKLPLSAPN 248
Query: 181 SLLGP---VDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVS-EINKKHAFVEGF 236
+L V+++ L D R LA PS + L +P S + E++ + + +
Sbjct: 249 LMLTTQPGVEKS----LDDHHARMLLAAPSEHGK--EMLALPSASAAGEVHYRFGMLLMW 302
Query: 237 RSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRR----PGYNR 292
S QSFI LF+ + ++ F+ Y SK+ + E +T TG+ ++ PG +
Sbjct: 303 -STTQSFI-LFVGIL-LLCFVLYLSKESFTL---EGQLTGTGLKASSSKKKKAKKPG--K 354
Query: 293 NTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKE 352
N + E I P E K L L+D +GRRIGKL V N E
Sbjct: 355 NNVSVENGNEIAPGEGV--------------NKTLSDLNKLVDGGANGRRIGKLFVSNTE 400
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412
IAKGSNGTVVLEG YEGR VAVKRLV+THHDVA KEIQNLIASD+HPNIVRWYGVE D+D
Sbjct: 401 IAKGSNGTVVLEGVYEGRLVAVKRLVQTHHDVAWKEIQNLIASDRHPNIVRWYGVEYDED 460
Query: 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472
FVYLSLERCTCSL+DLI + S S + K++ S E ++RL V +D+ LWKA
Sbjct: 461 FVYLSLERCTCSLDDLIQIYSDSSLNPVYGKDRTSRAAIEHKLRLDSVKGVMQDLNLWKA 520
Query: 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 532
GHPS LL + RD+VSGL HLHE+G+IHRDLKPQNVLI K++S CAKLSDMGISKRL G
Sbjct: 521 TGHPSPLLLTLMRDMVSGLVHLHELGIIHRDLKPQNVLIIKERSLCAKLSDMGISKRLLG 580
Query: 533 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA 592
DMS L +ATG GSSGWQAPEQL R+TRA+DLFSLGC+LF+CITGG+HP+G+ ERD
Sbjct: 581 DMSSLAYHATGSGSSGWQAPEQLHHRRETRAVDLFSLGCVLFYCITGGRHPFGDHLERDV 640
Query: 593 NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
NIVK++KDLFLVE+IPEA DL +RLL+P+P+LRPKA VL+HP FW ++ RLSFLRD SD
Sbjct: 641 NIVKNQKDLFLVEYIPEAEDLISRLLNPDPELRPKALEVLHHPMFWNSELRLSFLRDTSD 700
Query: 653 RVELEDRESDSKLLRALEGIALVAL-NGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVI 711
RVELEDR SDS +L+ALEGIA AL GKW+EKME FI +IGR+RRYK+D +RDLLRVI
Sbjct: 701 RVELEDRVSDSDILKALEGIAPTALGGGKWNEKMEPAFITDIGRHRRYKFDGIRDLLRVI 760
Query: 712 RNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 771
RNK NH+RELP +IQEL+G PEG+ NYF+ RFPKLLIEVY V+ YC+ EE F KY+ +
Sbjct: 761 RNKLNHYRELPNEIQELVGPVPEGYDNYFASRFPKLLIEVYKVVRKYCREEEWFQKYIKS 820
Query: 772 D 772
+
Sbjct: 821 N 821
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177897|dbj|BAB11229.1| unnamed protein product [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/773 (48%), Positives = 490/773 (63%), Gaps = 41/773 (5%)
Query: 1 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEE 60
+PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 197 LPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIVLSKEAPL 255
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGY 120
L SG + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E + SG
Sbjct: 256 LFGSGFKKSEDFPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHESVQFISGL 314
Query: 121 HFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQN 180
+ G ++ P + + +LR+ +G + + LP +
Sbjct: 315 SSSVG-----------KNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALYLPFQDRK 363
Query: 181 SLLGPVDRNSPLFLP-DKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSY 239
+ + L LP +K L+LP ET I + GS + GF S
Sbjct: 364 PNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQ--------AGFASK 415
Query: 240 IQSFIVLFIALC----PIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTT 295
IVL C + G FY +Q S + E ++++ I KK +
Sbjct: 416 FSGLIVLIFGFCVTMLSVCGLFFYRLRQ--SIRIKEPYVSEVPIATPKKKKSKKNGTTKA 473
Query: 296 NSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAK 355
+K I G SH N ++ L F L + +G R+GKL V NKEIAK
Sbjct: 474 VHKKENGFIS-----GGNKDPSH-EENEKRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAK 527
Query: 356 GSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415
GSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+H NIVRWYGV+ D+ F+Y
Sbjct: 528 GSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVDQDEHFIY 587
Query: 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 475
+SLE C CSLNDLIY S E + + S I++ P+ EN K +ELWK NGH
Sbjct: 588 ISLELCACSLNDLIYASSALLESPMASSSIHS-------IQINPIFENGKGVELWKENGH 640
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
PS LLK+ RDIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISKRL D S
Sbjct: 641 PSPVLLKLMRDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISKRLPADTS 700
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
LT+N+TG GSSGWQAPEQL RQTRA+DLFSLGC+LFFC+TGGKHPYG+++ERD N++
Sbjct: 701 ALTRNSTGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGDNYERDVNVL 760
Query: 596 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVE 655
D+KDLFL+E +PEAV L T LL+P+P+LRP+AQ+V++HP FW +D RLSFLRD SDRVE
Sbjct: 761 NDQKDLFLIESLPEAVHLLTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSFLRDASDRVE 820
Query: 656 LEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKS 715
LE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++RDLLRVIRNK
Sbjct: 821 LENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRNKL 880
Query: 716 NHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE F KY
Sbjct: 881 NHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKY 933
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297808453|ref|XP_002872110.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] gi|297317947|gb|EFH48369.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/784 (48%), Positives = 485/784 (61%), Gaps = 71/784 (9%)
Query: 1 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEE 60
+PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 137 LPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIVLSKEAPI 195
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGY 120
L SG + + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E G
Sbjct: 196 LFGSGFKESEDLPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHESVHLMGGL 254
Query: 121 HFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQN 180
+ G + ++HLP + V +LR+ + +G + + LP
Sbjct: 255 SSSDGIPIRTSW---GKNHLPLSYTTSVPVVQLRNVNYETLFPRLGFLDEALYLPFQ--- 308
Query: 181 SLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYI 240
DR P D LALPS + +++I GF S
Sbjct: 309 ------DRKPNRLAPG--DGKHLALPSNKE---------AEEITDIIDGSTTQAGFASKF 351
Query: 241 QSFIVLFIALC----PIIGFLFYHSKQ---VKSKKQNEEHIT--------KTGIPKKKKS 285
IVL C + G F +Q +K +E I K G KK+
Sbjct: 352 SGLIVLLFGFCVTMLSVCGIFFCRLRQGMWIKDPYVSEVPIAIPKKKKSKKNGTHKKENG 411
Query: 286 RRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDR-VDGRRIG 344
G N++ +N E N ++ L F L ++ +G R+G
Sbjct: 412 LISGGNKDPSNEE-----------------------NDKRLLTAFPGLNNNSSAEGYRVG 448
Query: 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRW 404
KL V NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+HPNIVRW
Sbjct: 449 KLFVSNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHPNIVRW 508
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
YGV+ D+ F+Y+SLERC CSLNDLIY S E + + I+ P+ EN
Sbjct: 509 YGVDQDEHFIYISLERCACSLNDLIYASSALLESPVASSSIQP-------IQRNPIFENG 561
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
K +ELWK NGHPS LLK+ DIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDM
Sbjct: 562 KGVELWKENGHPSPVLLKLMSDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSVCAKLSDM 621
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
GISKRL D S LT+N+TG GSSGWQAPEQL RQTRA+DLFSLGC+LFFC+T GKHPY
Sbjct: 622 GISKRLPADTSALTRNSTGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTAGKHPY 681
Query: 585 GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644
G+++ERD N++ DRKDLFL+E +PEAV L + LL+P+P+LRP+AQ VL+HP FW +D RL
Sbjct: 682 GDNYERDVNVLNDRKDLFLIESLPEAVHLLSGLLNPDPNLRPRAQEVLHHPLFWNSDMRL 741
Query: 645 SFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNV 704
SFLRD SDRVELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++
Sbjct: 742 SFLRDASDRVELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSI 801
Query: 705 RDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEV 764
RDLLRVIRNK NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE
Sbjct: 802 RDLLRVIRNKLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEF 861
Query: 765 FHKY 768
F KY
Sbjct: 862 FFKY 865
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561453|ref|XP_002521737.1| kinase, putative [Ricinus communis] gi|223539128|gb|EEF40724.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/777 (49%), Positives = 505/777 (64%), Gaps = 33/777 (4%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY-VLDFSASTPGFQSDENKHVVPVDGYEE 60
P++S+DG V LG+ T+VF+V+ K+GR+V Y LD +S + +E + + +
Sbjct: 152 PHVSEDGAVILGSKITTVFVVEAKTGRLVQTYKSLDPPSSLQ--RDEEGNAFLNENRNND 209
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEV-GKSFSG 119
L+ + + QL+YI RTDY LQ+ +S ++ WN+ A +A F C++V G+S
Sbjct: 210 LI---ISDSATSAQLIYITRTDYTLQNFGPNSDKISWNMKVAMIEAAFLCKDVEGRSNFD 266
Query: 120 YHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQ 179
+ S ++ + + ++ T L +L L +V SL +
Sbjct: 267 MPLSCQSR---RMVVRRQGNPQSSSEATHGDEMLPVPALDLVLPSQPRVGK--SLQDHHE 321
Query: 180 NSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGS--VSEINKKHAFVEGF- 236
+L + L L KVD P P+ ++E L +P S N + AF +
Sbjct: 322 GRMLSGSASDFVLPLQSKVDELPTFHPTDDSE--GMLALPNDSEGFDAHNARVAFDDWLN 379
Query: 237 ----RSYIQSFIVLFIALCPIIGFLFYHSKQV-KSKKQNEEHITKTGIPKKKKSRRPGYN 291
RS SF +F + ++GF FY S V KSK +E + + R+
Sbjct: 380 ILIKRSTTLSF--MFFIVIILLGFNFYPSNLVGKSKVASEGLSSDSSSKASSSKRKKSRK 437
Query: 292 RNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNK 351
N + +P E+ G T ++ + +K LL +D V+GRRIGKL V N
Sbjct: 438 SGKKNGKD----VPFENDDGPT-----LSDSSDKKLLDLNKHVDRGVNGRRIGKLFVSNA 488
Query: 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ 411
EIAKGSNGT+VLEG YEGR VAVKRLV+ HH+VA KEIQNLIASD+HPNIVRWYGVE+D
Sbjct: 489 EIAKGSNGTIVLEGIYEGRPVAVKRLVQAHHEVAFKEIQNLIASDRHPNIVRWYGVENDN 548
Query: 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 471
DFVYLSLERCTCSL+DLI + S Q+ +++Q + + ++RL V +D+ LWK
Sbjct: 549 DFVYLSLERCTCSLDDLIQIYCDSSFNQVFSEDQATRVATNYKLRLNKVKGILQDLNLWK 608
Query: 472 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531
+NGHPS +L + RD+V GL HLHE+G+IHRDLKPQNVLI K++S AKLSDMGISKRL
Sbjct: 609 SNGHPSPLMLLLMRDVVCGLVHLHELGIIHRDLKPQNVLILKERSLSAKLSDMGISKRLL 668
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 591
GDMS L +ATG GSSGWQAPE LLQGRQTRA+DLFSLGC+LFFCITGG+HP+G+ ERD
Sbjct: 669 GDMSSLGYHATGCGSSGWQAPELLLQGRQTRAVDLFSLGCVLFFCITGGRHPFGDRLERD 728
Query: 592 ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVS 651
NIVK++ DLFLVE+ PEA DL +RLL+ +P+LRPKA VL+HP FW+++ RLSFLR+ S
Sbjct: 729 VNIVKNKMDLFLVEYFPEAGDLISRLLNHDPELRPKALEVLHHPMFWSSEMRLSFLRETS 788
Query: 652 DRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVI 711
DRVELEDRES S LL+ALE IA AL GKWDEKME FI NIG YRRYKYD+VRDLLRV+
Sbjct: 789 DRVELEDRESGSVLLKALESIASTALGGKWDEKMEPAFITNIGHYRRYKYDSVRDLLRVL 848
Query: 712 RNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
RNK NH+RELP++IQEL+G PEG+ YF+ RFPKLLIEVY V++ +C+ E+ FHKY
Sbjct: 849 RNKLNHYRELPKEIQELVGPIPEGYDGYFASRFPKLLIEVYKVVYRFCREEDCFHKY 905
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15277137|dbj|BAB63366.1| Ire1 homolog-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/775 (48%), Positives = 487/775 (62%), Gaps = 43/775 (5%)
Query: 1 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEE 60
+PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 137 LPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIVLSKEAPL 195
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGY 120
L SG + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E + SG
Sbjct: 196 LFGSGFKKSEDFPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHESVQFISGL 254
Query: 121 HFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQN 180
+ G ++ P + + +LR+ +G + + LP +
Sbjct: 255 SSSVG-----------KNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALYLPFQDRK 303
Query: 181 SLLGPVDRNSPLFLP-DKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSY 239
+ + L LP +K L+LP ET I + GS + GF S
Sbjct: 304 PNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQ--------AGFASK 355
Query: 240 IQSFIVLFIALC----PIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTT 295
IVL C + G FY +Q S + E ++++ I KK +
Sbjct: 356 FSGLIVLIFGFCVTMLSVCGLFFYRLRQ--SIRIKEPYVSEVPIATPKKKKSKKNGTTKA 413
Query: 296 NSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAK 355
+K I G SH N ++ L F L + +G R+GKL V NKEIAK
Sbjct: 414 VHKKENGFIS-----GGNKDPSH-EENEKRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAK 467
Query: 356 GSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415
GSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+H NIVRWYGV+ D+ F+Y
Sbjct: 468 GSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVDQDEHFIY 527
Query: 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 475
+SLE C CSLNDLIY S E + + S I++ P+ EN K +ELWK NGH
Sbjct: 528 ISLELCACSLNDLIYASSALLESPMASSSIHS-------IQINPIFENGKGVELWKENGH 580
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
PS LLK+ RDIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISKRL D S
Sbjct: 581 PSPVLLKLMRDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISKRLPADTS 640
Query: 536 CLTQNATGYGSSG--WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN 593
LT+N+ G GS WQAPEQL RQTRA+DLFSLGC+LFFC+TGGKHPYG+++ERD N
Sbjct: 641 ALTRNSIGLGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGDNYERDVN 700
Query: 594 IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 653
++ D+KDLFL+E +PEAV L T LL+P+P+LRP+AQ+V++HP FW +D RLSFLRD SDR
Sbjct: 701 VLNDQKDLFLIESLPEAVHLLTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSFLRDASDR 760
Query: 654 VELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRN 713
VELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++RDLLRVIRN
Sbjct: 761 VELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRN 820
Query: 714 KSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
K NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE F KY
Sbjct: 821 KLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKY 875
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18420784|ref|NP_568444.1| protein inositol requiring 1-1 [Arabidopsis thaliana] gi|15982747|gb|AAL09714.1| AT5g24360/K16H17_7 [Arabidopsis thaliana] gi|16506693|gb|AAL17714.1| endoribonuclease/protein kinase Ire1p-like protein [Arabidopsis thaliana] gi|332005918|gb|AED93301.1| protein inositol requiring 1-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/775 (48%), Positives = 488/775 (62%), Gaps = 43/775 (5%)
Query: 1 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEE 60
+PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 137 LPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIVLSKEAPL 195
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGY 120
L SG + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E + SG
Sbjct: 196 LFGSGFKKSEDFPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHESVQFISGL 254
Query: 121 HFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQN 180
+ G ++ P + + +LR+ +G + + LP +
Sbjct: 255 SSSVG-----------KNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALYLPFQDRK 303
Query: 181 SLLGPVDRNSPLFLP-DKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSY 239
+ + L LP +K L+LP ET I + GS + GF S
Sbjct: 304 PNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQ--------AGFASK 355
Query: 240 IQSFIVLFIALC----PIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTT 295
IVL C + G FY +Q S + E ++++ I KK +
Sbjct: 356 FSGLIVLIFGFCVTMLSVCGLFFYRLRQ--SIRIKEPYVSEVPIATPKKKKSKKNGTTKA 413
Query: 296 NSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAK 355
+K I G SH N ++ L F L + +G R+GKL V NKEIAK
Sbjct: 414 VHKKENGFIS-----GGNKDPSH-EENEKRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAK 467
Query: 356 GSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415
GSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+H NIVRWYGV+ D+ F+Y
Sbjct: 468 GSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVDQDEHFIY 527
Query: 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 475
+SLE C CSLNDLIY S E + + S I++ P+ EN K +ELWK NGH
Sbjct: 528 ISLELCACSLNDLIYASSALLESPMASSSIHS-------IQINPIFENGKGVELWKENGH 580
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
PS LLK+ RDIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISKRL D S
Sbjct: 581 PSPVLLKLMRDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISKRLPADTS 640
Query: 536 CLTQNATGYGSSG--WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN 593
LT+N+TG GS WQAPEQL RQTRA+DLFSLGC+LFFC+TGGKHPYG+++ERD N
Sbjct: 641 ALTRNSTGLGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGDNYERDVN 700
Query: 594 IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 653
++ D+KDLFL+E +PEAV L T LL+P+P+LRP+AQ+V++HP FW +D RLSFLRD SDR
Sbjct: 701 VLNDQKDLFLIESLPEAVHLLTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSFLRDASDR 760
Query: 654 VELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRN 713
VELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++RDLLRVIRN
Sbjct: 761 VELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRN 820
Query: 714 KSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
K NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE F KY
Sbjct: 821 KLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKY 875
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | ||||||
| TAIR|locus:2053928 | 841 | IRE1A [Arabidopsis thaliana (t | 0.622 | 0.573 | 0.616 | 9.4e-170 | |
| WB|WBGene00002147 | 967 | ire-1 [Caenorhabditis elegans | 0.374 | 0.299 | 0.421 | 1.7e-83 | |
| DICTYBASE|DDB_G0267650 | 984 | ireA "IRE family protein kinas | 0.633 | 0.497 | 0.346 | 3.9e-79 | |
| TAIR|locus:2081551 | 554 | AT3G11870 [Arabidopsis thalian | 0.591 | 0.826 | 0.395 | 5.1e-74 | |
| UNIPROTKB|F1NPU5 | 946 | Gga.10887 "Uncharacterized pro | 0.386 | 0.316 | 0.368 | 1.8e-70 | |
| MGI|MGI:1930134 | 977 | Ern1 "endoplasmic reticulum (E | 0.373 | 0.295 | 0.369 | 4.4e-68 | |
| RGD|1559716 | 963 | Ern1 "endoplasmic reticulum to | 0.373 | 0.300 | 0.369 | 5.2e-68 | |
| UNIPROTKB|F1RSL5 | 914 | ERN1 "Uncharacterized protein" | 0.370 | 0.314 | 0.373 | 8.5e-68 | |
| UNIPROTKB|E7ETG2 | 874 | ERN2 "Endoribonuclease" [Homo | 0.370 | 0.328 | 0.39 | 1.2e-67 | |
| POMBASE|SPAC167.01 | 1072 | ire1 "serine/threonine protein | 0.272 | 0.196 | 0.370 | 1.2e-67 |
| TAIR|locus:2053928 IRE1A [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 9.4e-170, Sum P(3) = 9.4e-170
Identities = 307/498 (61%), Positives = 368/498 (73%)
Query: 276 KTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLID 335
K G KKKK+R+ + TN + +P G+ D I G + LL F +
Sbjct: 357 KAGPSKKKKNRK---SAKDTNRQS----VPR----GQ-DQFELIEGG--QMLLGFNNFQS 402
Query: 336 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS 395
DGR+IGKL + +KEIAKGSNGTVV EG YEGR VAVKRLV++HH+VA KEIQNLIAS
Sbjct: 403 GATDGRKIGKLFLSSKEIAKGSNGTVVFEGIYEGRPVAVKRLVRSHHEVAFKEIQNLIAS 462
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVR 454
DQH NI+RWYGVE DQDFVYLSLERCTCSL+DLI L S + L + + +
Sbjct: 463 DQHTNIIRWYGVEYDQDFVYLSLERCTCSLDDLIKSYLEFSMTKVLENNDSTEGVA-AYK 521
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
I+L + K WK GHPS +LK+ RDIV G+ HLHE+G++HRDLKPQNVLISKD
Sbjct: 522 IQLDSLEGVIKGNNFWKVGGHPSPLMLKLMRDIVCGIVHLHELGIVHRDLKPQNVLISKD 581
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
+ AKLSDMGISKR+ DMS L ATG GSSGWQAPEQLLQGRQTRA+D+FSLGC++F
Sbjct: 582 MTLSAKLSDMGISKRMSRDMSSLGHLATGSGSSGWQAPEQLLQGRQTRAVDMFSLGCVIF 641
Query: 575 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ ITG KHP+G+ ERD NIVK++ DLFLVEH+PEA DL +RLL+P+PDLRP A VL H
Sbjct: 642 YTITGCKHPFGDDLERDVNIVKNKVDLFLVEHVPEASDLISRLLNPDPDLRPSATEVLLH 701
Query: 635 PFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIG 694
P FW ++ RLSFLRD SDRVELE+RE+DS++L+A+E A VA+ GKWDEK+E FI NIG
Sbjct: 702 PMFWNSEMRLSFLRDASDRVELENREADSEILKAMESTAPVAIGGKWDEKLEPVFITNIG 761
Query: 695 RYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNV 754
RYRRYKYD++RDLLRVIRNK NH RELP +IQEL+G+ PEGF YF+ RFPKLLIEVY V
Sbjct: 762 RYRRYKYDSIRDLLRVIRNKLNHHRELPPEIQELVGTVPEGFDEYFAVRFPKLLIEVYRV 821
Query: 755 IFTYCKGEEVFHKYVTND 772
I +C+ EEVF KY D
Sbjct: 822 ISLHCREEEVFRKYFKCD 839
|
|
| WB|WBGene00002147 ire-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.7e-83, Sum P(4) = 1.7e-83
Identities = 127/301 (42%), Positives = 189/301 (62%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSC 536
L + + GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR+Q +
Sbjct: 613 LRDIMKQATDGLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKRVQPGKNS 672
Query: 537 LTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 594
+++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S R ANI
Sbjct: 673 ISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKSLHRQANI 732
Query: 595 VKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVS 651
V L + + + A DL + +L+ P R A VLNHPFFWT++ RL++ DVS
Sbjct: 733 VNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRLAYFSDVS 792
Query: 652 DRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVI 711
DRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +VRDLLR +
Sbjct: 793 DRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSVRDLLRAM 850
Query: 712 RNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 771
RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE VF +Y ++
Sbjct: 851 RNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAVFKRYYSD 909
Query: 772 D 772
D
Sbjct: 910 D 910
|
|
| DICTYBASE|DDB_G0267650 ireA "IRE family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 3.9e-79, Sum P(3) = 3.9e-79
Identities = 184/531 (34%), Positives = 286/531 (53%)
Query: 260 HSKQVKSKKQNEEH-ITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 318
++ Q ++ N+ + I PKKKK ++ N N E +N I N + + D +
Sbjct: 471 NNNQNNNQNSNQNNNINNKKTPKKKKKKQKNKNNKNNNDEDDENEIENYND-NQNDLIDE 529
Query: 319 -ITGNG--------EKFLLTFTDLIDD---RV---DGR-RIGKL-VVFNKEIAKGSNGTV 361
I+ N ++ L+ ++ I++ ++ +G +IGKL ++ NK + GS GT+
Sbjct: 530 FISTNSVIQQQQQQQQQLINSSNKINNGSGKIILDNGNVKIGKLEIITNKILGTGSCGTI 589
Query: 362 VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421
V EG EGR VAVKR++ A +E+ LI SD+H N+VR+Y E D +F+YL++ C
Sbjct: 590 VYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTNVVRYYAKEEDDEFIYLAISFC 649
Query: 422 TCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480
SL+ + LS + Q SN N + ++ N + Q+
Sbjct: 650 QKSLDMYVQQTLSLQISPTDSPSIQSSNNNGNGNNG-----NNNNNNQIIIDN--KTKQM 702
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 540
+ ++ GL HLH + ++HRD+KP NVLI D + K+SDMG+ K L D LT
Sbjct: 703 IL---ELFKGLEHLHSLNIVHRDIKPHNVLI--DPNNRVKISDMGLGKLLDNDDQSLTFT 757
Query: 541 ATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
+ S GWQ P + L G R T+ +D+FSLGC++++ +TG HP+G + R+ N++K +
Sbjct: 758 SD---SHGWQ-PAEYLNGTNRNTKKVDIFSLGCVVYYLLTGA-HPFGHRYNREKNVLKGK 812
Query: 599 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELED 658
D+ ++H+P+ L ++ P+ RP +NHPFFW +LSFL SD +E E
Sbjct: 813 FDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECINHPFFWEVHKKLSFLVAASDYLEFEK 872
Query: 659 RESDSKLLRALEGIALVAL-NGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNH 717
S L + LV +G W K++ I+NIGRYR+Y ++RDLLRVIRNK NH
Sbjct: 873 PTSPLNL-EIDSHVDLVTDGSGDWWLKIDQVLIDNIGRYRKYNGKSIRDLLRVIRNKFNH 931
Query: 718 FRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
+R+L + Q LG P+GF+NYF +FP+L I Y I K ++ F +Y
Sbjct: 932 YRDLSPEEQTCLGILPDGFFNYFDLKFPQLFIVTYLFILKNLKNDQYFVQY 982
|
|
| TAIR|locus:2081551 AT3G11870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
Identities = 200/506 (39%), Positives = 280/506 (55%)
Query: 289 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGK-LV 347
G TNSE +P++ + +T L + + E L D ++ G+ + + L+
Sbjct: 69 GEENEKTNSESKVLSVPSDQNINKT--LPVMLPSLE---LRKYD--ENETPGKVVNRRLL 121
Query: 348 VFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRW 404
V E+ G NG V +G Y RS VAVK L H A EI N D H NI+R+
Sbjct: 122 VSTNEMKYGRNGYEVFQGVYGRRSSVAVKCLDLAHTTEAFIQNEIDNHCLCDDHSNIIRF 181
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+G+E DQ F Y+ LE CSL+DLI + + ++D+ + V L VM
Sbjct: 182 HGLEQDQSFAYICLEPWKCSLDDLIKL-------SVRRTKRDTQAVAPVD-DLEKVM--- 230
Query: 465 KDIELWKANGHPS--AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKL 521
K I+ WK G P +LK+ RD+V GL+HLH++ IHR+L PQNVLI KD + AK+
Sbjct: 231 KRIKFWKEKGKPLPLTPMLKLMRDVVCGLAHLHKLKTIHRNLNPQNVLIIVKDMTLTAKI 290
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA---IDLFSLGCILFFCIT 578
SDM +SK L G S AT GSSGWQAPEQL + ++ + D+F+ GC+L + +
Sbjct: 291 SDMSLSKHLGGKKSSYKHLATCSGSSGWQAPEQLNKDKKKKEDFPADMFNFGCLLHYAVM 350
Query: 579 GGKHPYGESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
G HP+G ERD NI + K +L LV ++ EA++L +LL+ PDLRP A VL HP F
Sbjct: 351 G-THPFGSPSERDTNIKTNNKTNLSLVTNL-EAINLIEQLLNYKPDLRPSATQVLLHPLF 408
Query: 638 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFI---ENIG 694
W ++ RL FLR+ SDR+EL D L + + L + W K+ FI EN+
Sbjct: 409 WDSEKRLFFLREASDRIEL-DITMWGDLNKTIAPRVL-GESKDWASKLGKTFITHIENLA 466
Query: 695 R---------YRR-YKYDNVRDLLRVIRNKSNHFRELPQD--IQELLGSHPEGFYNYFSC 742
+ Y R YKY ++R LLR+IRN +H RE+ D I+E++G PEG +F+
Sbjct: 467 QAQPGQESRQYNRSYKYWSLRHLLRLIRNILSHHREILDDPKIKEMVGKVPEGLDIFFTA 526
Query: 743 RFPKLLIEVYNVIFTYCKGEEVFHKY 768
RFP L++E+Y I +CKGEE F KY
Sbjct: 527 RFPNLMMEIYAFISMHCKGEEAFEKY 552
|
|
| UNIPROTKB|F1NPU5 Gga.10887 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 1.8e-70, Sum P(3) = 1.8e-70
Identities = 115/312 (36%), Positives = 177/312 (56%)
Query: 471 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMGIS 527
KA H Q + + + SGL++LH + ++HRDLKP N+LIS + A +SD G+
Sbjct: 627 KAFSHHGLQPIALLQQTTSGLAYLHSLSIVHRDLKPHNILISMPNAHGKVKAMISDFGLC 686
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPY 584
K+L ++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+
Sbjct: 687 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPF 746
Query: 585 GESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640
G+S +R ANI+ L FL E + DL ++++ +P RP A VL HPFFW+
Sbjct: 747 GKSLQRQANILLGAYSLEFLDAGRHEDIVARDLIEQMINMDPQKRPSASCVLKHPFFWSL 806
Query: 641 DTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYK 700
+ +L F +DVSDR+E E D +++ LE + W E + ++ ++R YK
Sbjct: 807 EKQLQFFQDVSDRIEKE--ALDGPIVKQLERGGREVVKMDWREHITVPLQTDLRKFRSYK 864
Query: 701 YDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCK 760
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL+ Y+ + C+
Sbjct: 865 GGSVRDLLRAMRNKKHHYRELPPEVQETLGSIPDDFVCYFTARFPHLLLHTYHAMRICCQ 924
Query: 761 GEEVFHKYVTND 772
E +F Y D
Sbjct: 925 -ERLFQHYYQQD 935
|
|
| MGI|MGI:1930134 Ern1 "endoplasmic reticulum (ER) to nucleus signalling 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 4.4e-68, Sum P(3) = 4.4e-68
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 475 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 531
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 660 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 719
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 588
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 720 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYYVISEGNHPFGKSL 779
Query: 589 ERDANIVKD--RKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 780 QRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 839
Query: 645 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 702
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 840 QFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 895
Query: 703 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 762
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 896 SVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHTYQAM-ELCRHE 954
Query: 763 EVFHKY 768
+F Y
Sbjct: 955 RLFQTY 960
|
|
| RGD|1559716 Ern1 "endoplasmic reticulum to nucleus signaling 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 5.2e-68, Sum P(3) = 5.2e-68
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 475 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 531
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 646 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 705
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 588
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 706 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGNHPFGKSL 765
Query: 589 ERDANIVKDR--KDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 766 QRQANILLGACSLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 825
Query: 645 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 702
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 826 QFFQDVSDRIEKESL--DGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 881
Query: 703 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 762
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 882 SVRDLLRAMRNKRHHYRELPLEVQETLGSIPDDFVRYFTSRFPHLLSHTYRAM-ELCRHE 940
Query: 763 EVFHKY 768
+F Y
Sbjct: 941 RLFQTY 946
|
|
| UNIPROTKB|F1RSL5 ERN1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 8.5e-68, Sum P(3) = 8.5e-68
Identities = 115/308 (37%), Positives = 179/308 (58%)
Query: 475 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 531
H + + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 598 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 657
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 588
++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+G+S
Sbjct: 658 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPFGKSL 717
Query: 589 ERDANIVKDRKDLFLVEHIPE------AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642
+R ANI+ L + H PE A +L +++ +P RP A++VL HPFFW+ +
Sbjct: 718 QRQANILLGAYSLDCL-H-PEKHEDVIARELIEKMISMDPQKRPSAKHVLKHPFFWSLEK 775
Query: 643 RLSFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYK 700
+L F +DVSDR+E E D +++ LE G A+V ++ W E + ++ ++R YK
Sbjct: 776 QLQFFQDVSDRIEKESL--DGPIVQQLERGGRAVVRMD--WRENITVPLQTDLRKFRTYK 831
Query: 701 YDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCK 760
+VRDLLR +RNK +H+RELP D+QE LG+ P+GF YF+ RFP LL Y + C+
Sbjct: 832 GGSVRDLLRAMRNKKHHYRELPVDVQETLGTLPDGFVRYFTSRFPHLLAHTYRAM-ELCR 890
Query: 761 GEEVFHKY 768
E F Y
Sbjct: 891 HERPFQPY 898
|
|
| UNIPROTKB|E7ETG2 ERN2 "Endoribonuclease" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.2e-67, Sum P(3) = 1.2e-67
Identities = 117/300 (39%), Positives = 174/300 (58%)
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAK--LSDMGISKRLQGDMSCLTQ 539
V + ++SGL+HLH + ++HRDLKP N+LI+ D + LSD G+ K+L +
Sbjct: 565 VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGRVVLSDFGLCKKLPAGRCSFSL 624
Query: 540 NATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 596
++ G+ GW APE QLL T A+D+FS GC+ ++ ++GG HP+G+S R ANI+
Sbjct: 625 HSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYYVLSGGSHPFGDSLYRQANILT 684
Query: 597 DRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
L L E + + V DL +L P P RP A VL HPFFW+ +L F +DVSD
Sbjct: 685 GAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQVLAHPFFWSRAKQLQFFQDVSD 744
Query: 653 RVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 712
+E E + L+RALE + W E + ++ ++R YK +VRDLLR +R
Sbjct: 745 WLEKESEQEP--LVRALEAGGCAVVRDNWHEHISMPLQTDLRKFRSYKGTSVRDLLRAVR 802
Query: 713 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTND 772
NK +H+RELP ++++ LG P+GF YF+ RFP+LL+ + + + C E +F Y D
Sbjct: 803 NKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHTHRAMRS-CASESLFLPYYPPD 861
|
|
| POMBASE|SPAC167.01 ire1 "serine/threonine protein kinase, sensor for unfolded proteins in the ER Ire1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 1.2e-67, Sum P(4) = 1.2e-67
Identities = 80/216 (37%), Positives = 131/216 (60%)
Query: 559 RQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDL 613
RQ + A D+F+LGCI ++ +TGG HP+G ++ + NI+K L ++ + E A DL
Sbjct: 855 RQASHATDIFALGCIFYYTLTGGMHPFGSHYDCEGNILKGNYCLVHLQSLGECGVLAADL 914
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIA 673
++ P RP + VLNHP FW +L FL DVSDR E+E+R+ S LL+ LE +
Sbjct: 915 IEDMIAFEPSKRPTIEVVLNHPLFWDYAKKLDFLIDVSDRFEVEERDPPSPLLQMLENNS 974
Query: 674 LVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP 733
+ W + + ++N+G+YR+Y + D+LRV+RNK +H+++LP+ ++ +LG P
Sbjct: 975 KSVIGENWTTCLHSSLVDNLGKYRKYDGSKILDILRVLRNKRHHYQDLPESVRRVLGDLP 1034
Query: 734 EGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 769
+GF +YF +FP LL+ Y+++ E F +Y+
Sbjct: 1035 DGFTSYFVEKFPMLLLHCYHLVKDVLYEESQFKRYL 1070
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.1.26 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 774 | |||
| cd10422 | 129 | cd10422, RNase_Ire1, RNase domain (also known as t | 6e-60 | |
| pfam06479 | 127 | pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | 9e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-19 | |
| cd10321 | 127 | cd10321, RNase_Ire1_like, RNase domain (also known | 1e-18 | |
| cd09213 | 312 | cd09213, Luminal_IRE1_like, The Luminal domain, a | 3e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| smart00580 | 57 | smart00580, PUG, domain in protein kinases, N-glyc | 4e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd10423 | 119 | cd10423, RNase_RNase-L, RNase domain (also known a | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd09769 | 295 | cd09769, Luminal_IRE1, The Luminal domain, a dimer | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|199217 cd10422, RNase_Ire1, RNase domain (also known as the kinase extension nuclease domain) of Ire1 | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 6e-60
Identities = 70/126 (55%), Positives = 87/126 (69%)
Query: 643 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 702
RLSFL+DVSDR E E R+ S LL ALE A + G W EK++ FI+N+G+YR+YK
Sbjct: 3 RLSFLQDVSDRFEKEPRDPPSPLLLALESGADEVVGGDWREKLDKTFIDNLGKYRKYKGS 62
Query: 703 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 762
+VRDLLR +RNK +H+RELP D+QELLG P+GF YF+ RFP LLI VY + K E
Sbjct: 63 SVRDLLRALRNKKHHYRELPPDVQELLGPLPDGFLRYFTSRFPNLLIHVYRAVSDSLKNE 122
Query: 763 EVFHKY 768
F KY
Sbjct: 123 STFKKY 128
|
The model represents the C-terminal endoribonuclease domain of the multi-functional protein Ire1; Ire1 in addition contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR), which acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain. This leads to a conformational change that stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is homologous to the RNase domain of RNase L, and possesses a novel fold for a nuclease and appears to be rigid irrespective of the activation state of IRE1. Structural analysis and mutational studies have revealed that an early stage 'phosphoryl-transfer' competent conformation of IRE1 favors face-to-face dimerization of the kinase domains which precedes and is distinct from the RNase 'active' back-to-back conformation. Furthermore, in yeast IRE1, the flavonol quercetin activates the RNase and potentiates activation of the protein kinase by ADP, hinting at the possible existence of endogenous cytoplasmic ligands that may function along with stress signals from ER lumen in order to modulate IRE1 activity, thus identifying IRE1 as a target for development of ATP-competitive inhibitors to modulate the UPR with specific relevance for multiple myeloma. Length = 129 |
| >gnl|CDD|219051 pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 9e-56
Identities = 65/126 (51%), Positives = 94/126 (74%), Gaps = 1/126 (0%)
Query: 643 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 702
RLSFL DVSDR E+EDR+ S LL+ LE + + G W +K++ F++++G++R+YK D
Sbjct: 2 RLSFLCDVSDRFEIEDRDPPSPLLKLLERTSRAVVGGDWTKKLDKAFMDDLGKFRKYKGD 61
Query: 703 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 762
+VRDLLR IRNK +H+RELP++++E+LG P+GF YF+ RFP LLI VY V+ C+ E
Sbjct: 62 SVRDLLRAIRNKKHHYRELPEELKEILGDLPDGFLQYFTERFPDLLIHVYTVLK-NCEYE 120
Query: 763 EVFHKY 768
++F KY
Sbjct: 121 KLFPKY 126
|
This domain is a endoribonuclease. Specifically it cleaves an intron from Hac1 mRNA in humans, which causes it to be much more efficiently translated. Length = 127 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 8e-45
Identities = 90/299 (30%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 405
+++ +GS G V L G+ VA+K + K L+EI+ L HPNIVR Y
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLY 63
Query: 406 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V D+D +YL +E C L DL+ + L+E R
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---------------KKRGRLSEDEAR-------- 100
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
R I+S L +LH G++HRDLKP+N+L+ D+ KL+D
Sbjct: 101 -----------------FYLRQILSALEYLHSKGIVHRDLKPENILL--DEDGHVKLADF 141
Query: 525 GISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G++++L + T + G+ + APE LL +A+D++SLG IL+ +T GK P
Sbjct: 142 GLARQLDP-----GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPP 195
Query: 584 YGESFERDA--NIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ + + K F PEA DL +LL +P+ R A+ L HPFF
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-43
Identities = 85/290 (29%), Positives = 126/290 (43%), Gaps = 82/290 (28%)
Query: 353 IAKGSNGTVVL-EGNYEGRSVAVKRLVK----THHDVALKEIQNLIASDQHPNIVRWYGV 407
+ +G GTV L G+ VA+K + K + + L+EI+ L HPNIV+ YGV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEIL-KKLNHPNIVKLYGV 59
Query: 408 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
D++ +YL +E C SL DL+ G E
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSED--------------------------- 92
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
++L++ I+ GL +LH G+IHRDLKP+N+L+ D + KL+D G+
Sbjct: 93 ------------EILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGL 139
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG 585
SK L D S L T G+ + APE LL G + D++SLG IL+
Sbjct: 140 SKLLTSDKSLLK---TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE---------- 186
Query: 586 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
+PE DL ++L +P+ RP A+ +L H
Sbjct: 187 ---------------------LPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 65/307 (21%)
Query: 348 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNI 401
+++ GS GTV + G+ VAVK L K A +EI+ L HPNI
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRIL-RRLSHPNI 60
Query: 402 VRWYGVESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
VR D+D +YL +E C L D + G E
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSED--------------------- 98
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ K+ I+ GL +LH G+IHRDLKP+N+L+ ++ K
Sbjct: 99 ------------------EAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV--K 138
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 579
++D G++K+L S LT G+ + APE LL G +D++SLG IL + +
Sbjct: 139 IADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGYGPKVDVWSLGVIL-YELLT 194
Query: 580 GKHPYGESFERDANIVKDRKDL---------FLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630
GK P+ D + R+ L EA DL + L+ +P RP A+
Sbjct: 195 GKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 631 VLNHPFF 637
+L HP+F
Sbjct: 254 ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 90/300 (30%), Positives = 131/300 (43%), Gaps = 58/300 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIA---SDQHPNIVRW 404
+ + +GS G+V L G +AVK V+ D L+ ++ I S QHPNIVR+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS-VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 405 YGVESD--QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
YG E D ++ + + LE + SL+ L+ G E + IR
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--------------IR----- 104
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
K TR I+ GL++LH G++HRD+K N+L+ D KL
Sbjct: 105 --------------------KYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKL 142
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
+D G +KRL + G+ W APE + RA D++SLGC + T GK
Sbjct: 143 ADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GK 200
Query: 582 HPYGESFERDAN---IVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
P+ E A I + + EH+ EA D + L +P RP A +L HPF
Sbjct: 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 82/308 (26%)
Query: 351 KEIAKGSNGTVVLEGNYEGRS------VAVKRL---VKTHHDVALKEIQNLIASDQHPNI 401
++I KG G V Y+ R VA+K + K + + EIQ ++ +HPNI
Sbjct: 6 EKIGKGGFGEV-----YKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNI 59
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
V++YG +D +++ +E C+ SL DL+ + + E
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES--------------------- 98
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
Q+ V ++++ GL +LH G+IHRD+K N+L++ D K
Sbjct: 99 ------------------QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VK 138
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
L D G+S +L + T G+ W APE + D++SLG G
Sbjct: 139 LIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-G 193
Query: 581 KHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKA 628
K PY E + K LF + E D + L NP+ RP A
Sbjct: 194 KPPYSEL-----PPM---KALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245
Query: 629 QNVLNHPF 636
+ +L HPF
Sbjct: 246 EQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 83/326 (25%), Positives = 139/326 (42%), Gaps = 86/326 (26%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWY 405
K++ G+ G+V L N E G VA+K++ K + + L+E+++L ++HPNIV+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
V + D +Y E +L L+ K++ +E IR
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLM-------------KDRKGKPFSESVIR--------- 102
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+ I+ GL+H+H+ G HRDLKP+N+L+S K++D G
Sbjct: 103 ----------------SIIYQILQGLAHIHKHGFFHRDLKPENLLVS--GPEVVKIADFG 144
Query: 526 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQT---RAIDLFSLGCIL-------- 573
+++ ++ S T Y S+ W +APE LL R T +D+++LGCI+
Sbjct: 145 LAREIR---SRPPY--TDYVSTRWYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRP 197
Query: 574 ----------FFCI-----TGGKHPYGESFE--RDANIVKDRKDLFLVEHI-----PEAV 611
+ I T K + E ++ + + + PEA+
Sbjct: 198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI 257
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFF 637
DL +L +P RP A L HP+F
Sbjct: 258 DLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 62/298 (20%)
Query: 352 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-ALKEIQ---NLIASDQHPNIVRWYG 406
I +G+ G V N E G VA+K++ ALK I +L+ + +HPNIV++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
D +Y+ LE Y +GS L
Sbjct: 67 SIETSDSLYIILE----------YAENGS-------------LRQ--------------- 88
Query: 467 IELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+ K G L+ V ++ GL++LHE G+IHRD+K N+L +KD KL+D G
Sbjct: 89 --IIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFG 144
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585
++ +L G+ W APE + + A D++SLGC + +T G PY
Sbjct: 145 VATKLNDVSKDDASVV---GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPY- 199
Query: 586 ESFERDA-----NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
++ + IV+D L E I PE D + +P+LRP A+ +L HP+
Sbjct: 200 --YDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 87/299 (29%), Positives = 132/299 (44%), Gaps = 64/299 (21%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQ---NLIASDQHPNIVRW 404
+ GS G+V N + G AVK + A+K+++ L++ QHPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G E ++D +Y+ LE V GS + L + E IRL
Sbjct: 68 LGTEREEDNLYIFLE----------LVPGGSLAKLL----KKYGSFPEPVIRLY------ 107
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
TR I+ GL +LH+ +HRD+K N+L+ D + KL+D
Sbjct: 108 -------------------TRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADF 146
Query: 525 GISKRL--QGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGK 581
G++K++ GS W APE + QG A D++SLGC + T GK
Sbjct: 147 GMAKQVVEFSFAKSFK------GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GK 199
Query: 582 HPYGESFERDA--NIVKDRKDLFLV-EHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
P+ + A I + K+L + +H+ EA D + L +P LRP A +L HPF
Sbjct: 200 PPWSQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 81/323 (25%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNI 401
F K I +GS TVVL + + A+K L K E + L + HP I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
++ Y D++ +Y LE G + + L+E R
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPN----------GELLQYIR----KYGSLDEKCTRFY--- 107
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+A+ I+ L +LH G+IHRDLKP+N+L+ KD K+
Sbjct: 108 ---------------AAE-------ILLALEYLHSKGIIHRDLKPENILLDKDMH--IKI 143
Query: 522 SDMGISKRLQGD----------MSCLTQNATGY-------GSSGWQAPEQLLQGRQTRAI 564
+D G +K L + + +Q G++ + +PE L + ++
Sbjct: 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203
Query: 565 DLFSLGCILFFCITGGKHP-YGES----FERDANIVKDRKDLFLVEHIPE-AVDLFTRLL 618
DL++LGCI++ +T GK P G + F++ + + F + P A DL +LL
Sbjct: 204 DLWALGCIIYQMLT-GKPPFRGSNEYLTFQK----ILKLEYSFP-PNFPPDAKDLIEKLL 257
Query: 619 DPNPDLRP----KAQNVLNHPFF 637
+P R + HPFF
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 54/297 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKR-----LVKTHHDVALKEIQNLIASDQHPNIVRW 404
K+I KGS G V L +G+ +K + + + AL E++ ++ HPNI+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKY 64
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
Y ++ + + +E Y G +++ ++++ E +I
Sbjct: 65 YESFEEKGKLCIVME----------YADGGDLSQKIKKQKKEGKPFPEEQI--------- 105
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
L + L +LH ++HRD+KPQN+ ++ + KL D
Sbjct: 106 ----------------LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDF 147
Query: 525 GISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 582
GISK L + T T Y S PE L Q + D++SLGC+L+ T KH
Sbjct: 148 GISKVLSSTVDLAKTVVGTPYYLS----PE-LCQNKPYNYKSDIWSLGCVLYELCT-LKH 201
Query: 583 P-YGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
P GE+ A I+K + ++ E +L + LL +P+ RP +L PF
Sbjct: 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (274), Expect = 7e-26
Identities = 84/338 (24%), Positives = 131/338 (38%), Gaps = 64/338 (18%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRW 404
+++ +GS G V L + + VA+K L K L+EIQ L + + PNIV+
Sbjct: 6 RKLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
Y D+ +YL +E YV GS E+ L + L
Sbjct: 64 YDFFQDEGSLYLVME----------YVDGGSLEDLLKKIGRKGPL--------------- 98
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
++ L + I+S L +LH G+IHRD+KP+N+L+ +D KL D
Sbjct: 99 -----------SESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-GRVVKLIDF 146
Query: 525 GISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 578
G++K L S + A T G+ G+ APE LL + + D++SLG L+ +T
Sbjct: 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206
Query: 579 GGKHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 625
G GE + A DL +LL +P R
Sbjct: 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266
Query: 626 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDS 663
+ + L+H + S L D+ +
Sbjct: 267 LSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSL 304
|
Length = 384 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 66/303 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQN---LIASDQ 397
+ K++ +G+ G V +G +G+ VAVK L + + ++E ++
Sbjct: 1 LTLGKKLGEGAFG-EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HPN+V+ GV ++++ +Y+ +E Y+ G L ++ L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVME----------YMEGGDLLSYL--RKNRPKL-------- 99
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ LL I G+ +L IHRDL +N L+ ++
Sbjct: 100 ------------------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-- 139
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
K+SD G+S+ L D Y G W APE L +G+ T D++S G
Sbjct: 140 VVKISDFGLSRDLYDDDY--------YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 191
Query: 572 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQ 629
+L+ T G+ PY S E +K+ L + P + DL + +P+ RP
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 630 NVL 632
++
Sbjct: 252 ELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 63/303 (20%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 398
+ K++ +G+ G V +G+ + VAVK L + + ++E ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
PNIV+ GV ++++ + + +E Y+ G + L
Sbjct: 61 PNIVKLLGVCTEEEPLMIVME----------YMPGGDLLDYL------------------ 92
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
+ EL + LL I G+ +L IHRDL +N L+ ++
Sbjct: 93 ---RKNRPKEL------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--V 141
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCI 572
K+SD G+S+ L D Y G W APE L +G+ T D++S G +
Sbjct: 142 VKISDFGLSRDLYDDDY--------YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 573 LFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQN 630
L+ T G+ PY S +K L + P + L + +P+ RP
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSE 253
Query: 631 VLN 633
++
Sbjct: 254 LVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 87/308 (28%), Positives = 132/308 (42%), Gaps = 61/308 (19%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL-KEIQ------NLI 393
R GKL + +G+ G V L + + GR +AVK++ KE+ L+
Sbjct: 5 RRGKL------LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+ QH IV++YG D + + + +E Y+ GS ++QL A L E
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFME----------YMPGGSVKDQLKA----YGALTET 104
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
R K TR I+ G+ +LH ++HRD+K N+L +
Sbjct: 105 VTR-------------------------KYTRQILEGVEYLHSNMIVHRDIKGANIL--R 137
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
D + KL D G SKRLQ S T + G+ W +PE + R D++S+GC +
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 574 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 629
+T K P+ E FE A I + L H+ P+A + R N RP A+
Sbjct: 198 VEMLT-EKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAE 255
Query: 630 NVLNHPFF 637
+L H F
Sbjct: 256 ELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 96/309 (31%)
Query: 378 VKTHHDVALKEIQNLIASD----------------QHPNIVRWYGVESDQDFVYLSLERC 421
KT VALK+I+ + +HPNIV+ V + +YL E C
Sbjct: 21 KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80
Query: 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
L + G N ++ + QLL
Sbjct: 81 DMDLKKYLDKRPGPLSP------------NLIKSIMY--------------------QLL 108
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN- 540
GL++ H ++HRDLKPQN+LI++D KL+D G+++ + T
Sbjct: 109 -------RGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEV 159
Query: 541 ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP--YGES--------FE 589
T + ++APE LL + + A+D++S+GCI ITG P G+S F+
Sbjct: 160 VTLW----YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG--KPLFPGDSEIDQLFKIFQ 213
Query: 590 ----------RDANIVKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKA 628
+ D K F L + +P E +DL +++L NP R A
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273
Query: 629 QNVLNHPFF 637
+ L HP+F
Sbjct: 274 KEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 353 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR-W 404
+ KGS G V+L G+ A+K L K + KE++ N+++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
Y + ++ +YL LE +L L +E R R
Sbjct: 60 YAFQ-TEEKLYLVLEYAPG--GELFSHL------------SKEGRFSEERARF------- 97
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ A +IV L +LH +G+I+RDLKP+N+L+ D KL+D
Sbjct: 98 -----YAA-------------EIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDF 137
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 583
G++K L + S G+ + APE LL +A+D +SLG +L+ +T GK P
Sbjct: 138 GLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPF 193
Query: 584 YGESFER-DANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 637
Y E + I+KD L E + PEA DL + LL +P R A+ + HPFF
Sbjct: 194 YAEDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 74/309 (23%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQ---NLIASDQHPNIVRW 404
+I G+ G V N + G +AVK R+ +KEI ++ +HPN+V++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHPNLVKY 64
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
YGVE ++ VY+ +E C+ G+ EE L +L+E IR+
Sbjct: 65 YGVEVHREKVYIFMEYCS----------GGTLEELLEHGR----ILDEHVIRVY------ 104
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ QLL+ GL++LH G++HRD+KP N+ + D + KL D
Sbjct: 105 ------------TLQLLE-------GLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDF 143
Query: 525 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQT---RAIDLFSLGCILFFCITGG 580
G + +L+ + + + G+ + APE + G+ RA D++SLGC++ T G
Sbjct: 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-G 202
Query: 581 KHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627
K P+ E + + I+ + PE D R L+ +P RP
Sbjct: 203 KRPWSE-LDNEFQIMFHVGAGHKPPIPDSLQLS-------PEGKDFLDRCLESDPKKRPT 254
Query: 628 AQNVLNHPF 636
A +L HPF
Sbjct: 255 ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 79/323 (24%), Positives = 134/323 (41%), Gaps = 83/323 (25%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHD----VALKEIQNLIASDQHPNIVRWYG 406
I +G++G V + E G +VA+K++ ++ AL+EI+ L A QHP +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V L +E L++++ ++++ L
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVL-------------RDEERPL----------------- 96
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
P AQ+ R ++ G++++H G++HRDLKP N+LIS D K++D G+
Sbjct: 97 ---------PEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGL 145
Query: 527 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 584
++ + L + + W +APE L R+ +DL+++GCI + G
Sbjct: 146 ARLFSEEEPRLYSHQVA---TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
Query: 585 GES----------------------FER--DANIV--KDRKDLFLVEHIP----EAVDLF 614
GE+ D N + + K + L E P EA+DL
Sbjct: 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLL 262
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF 637
LL +P R A L HP+F
Sbjct: 263 KGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 76/318 (23%), Positives = 121/318 (38%), Gaps = 98/318 (30%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 394
K + +GS+G V + T ALK+I L +
Sbjct: 7 KVLGQGSSGVV---------YKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+ P +V+ YG + + + LE Y+ GS L ++
Sbjct: 56 C-ESPYVVKCYGAFYKEGEISIVLE----------YMDGGS--------------LADLL 90
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISK 513
++ + E L + R I+ GL +LH +IHRD+KP N+LI+
Sbjct: 91 KKVGKIPEP---------------VLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
K++D GISK L+ + L Q T G+ + +PE++ + A D++SLG L
Sbjct: 136 KG--EVKIADFGISKVLE---NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 574 FFCITGGKHPYGESFERDANIVKDRKDLF-LVEHI--------------PEAVDLFTRLL 618
C GK P+ + + F L++ I PE D + L
Sbjct: 191 LECAL-GKFPF---------LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 619 DPNPDLRPKAQNVLNHPF 636
+P RP A +L HPF
Sbjct: 241 QKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 88/306 (28%), Positives = 129/306 (42%), Gaps = 69/306 (22%)
Query: 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV-----------ALKEIQNLIASDQHPN 400
I GS G+V L N G +AVK++ AL L+ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
IV++ G D D + + LE YV GS LN + E +R
Sbjct: 68 IVQYLGSSLDADHLNIFLE----------YVPGGSVAALLN----NYGAFEETLVR---- 109
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
R I+ GL++LH G+IHRD+K N+L+ D K
Sbjct: 110 ---------------------NFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIK 146
Query: 521 LSDMGISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
+SD GISK+L+ + N + GS W APE + Q TR D++SLGC++ +
Sbjct: 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
Query: 578 TGGKHPYGES------FERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 630
T GKHP+ + F+ N + + +I EA+D + + + + RP A
Sbjct: 207 T-GKHPFPDCTQLQAIFKIGENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAE 260
Query: 631 VLNHPF 636
+L HPF
Sbjct: 261 LLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 52/298 (17%)
Query: 351 KEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVR 403
K++ +G+ G V + + + VAVK L + + K+ HPN+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
GV ++++ +YL LE Y+ G +LL+ +R
Sbjct: 61 LLGVCTEEEPLYLVLE----------YMEGG-------------DLLDYLRKSRPVFPSP 97
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
K LL I G+ +L +HRDL +N L+ +D K+SD
Sbjct: 98 EKST-------LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISD 148
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
G+S+ + D + + G W APE L G T D++S G +L+ T
Sbjct: 149 FGLSRDVYDDDYYRKK------TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 579 GGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 634
G PY S E ++ L E+ P+ + +L +P+ RP ++
Sbjct: 203 LGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/162 (34%), Positives = 85/162 (52%), Gaps = 14/162 (8%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK-----RLQGDMSCLTQNA 541
IV L +LH G+IHRDLKP N+LI + KL+D G+SK R ++
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 542 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK 599
G+ + APE +L ++ +D +SLGCIL+ + G P+ + NI+ +
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGKI 218
Query: 600 D-LFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 637
+ VE EA+DL ++LL P+P+ R A + + NHPFF
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 78/323 (24%)
Query: 352 EIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIVR 403
EI +G+ GTV + GR VA+K++ V + L+EI L + S +HPNIVR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
V +R L V FE +QD L +
Sbjct: 66 LLDV-----CHGPRTDREL----KLTLV----FEHV----DQD----------LATYLSK 98
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
G P + + R ++ G+ LH ++HRDLKPQN+L++ D K++D
Sbjct: 99 CP------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV--KIAD 150
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI---------LF 574
G+++ +M+ + T + ++APE LLQ +D++S+GCI LF
Sbjct: 151 FGLARIYSFEMALTSVVVTLW----YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206
Query: 575 ------------FCITG----GKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLF 614
F + G + P S R + + K V I E +DL
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS--FVPEICEEGLDLL 264
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF 637
++L NP R A L HP+F
Sbjct: 265 KKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 84/306 (27%), Positives = 129/306 (42%), Gaps = 65/306 (21%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASD-------QHP 399
I KG+ G V L N G +AVK + HD K++ + S+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NIV++ G E+ ++++ + LE G FEEQL +R
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL--------------VRFF- 113
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
T ++ GL++LH G++HRDLK N+L+ D C
Sbjct: 114 ------------------------TEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GIC- 147
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRA-IDLFSLGCILFFCI 577
K+SD GISK+ D+ QN + GS W APE + + A +D++SLGC++ +
Sbjct: 148 KISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE-M 205
Query: 578 TGGKHPYG--ESFERDANIVKDRKDLFLVEHI-----PEAVDLFTRLLDPNPDLRPKAQN 630
G+ P+ E+ + R + + P A+D NPD RP A+
Sbjct: 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265
Query: 631 VLNHPF 636
+L HPF
Sbjct: 266 LLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 64/306 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-------SDQHPNIV 402
K I+KG+ G+V L + G A+K L K+ A ++ N+ A + P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVA 60
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ Y +D++YL +E Y+ G L+ +
Sbjct: 61 KLYYSFQSKDYLYLVME----------YLNGGDCAS------------------LIKTL- 91
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
G P + ++V G+ LH+ G+IHRD+KP+N+LI D++ KL+
Sbjct: 92 ----------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLT 139
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G+S+ G N G+ + APE +L + D +SLGC++F + G
Sbjct: 140 DFGLSR--NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
Query: 583 PYGESFERD-ANIVKDRKDL--FLVEHI-PEAVDLFTRLLDPNPDLRPKA---QNVLNHP 635
+ E+ + NI+ R + + E PEAVDL RLL +P R A Q + +HP
Sbjct: 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 636 FFWTAD 641
FF + +
Sbjct: 253 FFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 90/309 (29%)
Query: 369 GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424
G+ A+K + K + L+EIQ L HPNI+R + ++ +R T
Sbjct: 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL------IEVLF---DRKTGR 74
Query: 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 484
L L++ L D NL ++ R P+ E ++ QLLK
Sbjct: 75 LA-LVFEL------------MDMNLYELIKGRKRPLPEKRVKSYMY--------QLLK-- 111
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT----QN 540
L H+H G+ HRD+KP+N+LI D KL+D G SC
Sbjct: 112 -----SLDHMHRNGIFHRDIKPENILIKDD---ILKLADFG---------SCRGIYSKPP 154
Query: 541 ATGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCILFFCIT-----GGKH----------- 582
T Y S+ W +APE LL G +D++++GC+ F ++ G +
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
Query: 583 ---PYGE-------SFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 628
P E S + N +K L + +P E +DL +LL +PD R A
Sbjct: 215 LGTPDAEVLKKFRKSRHMNYNFPS-KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273
Query: 629 QNVLNHPFF 637
+ L HP+F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 4e-21
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 67/298 (22%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 397
+ K++ +G+ G V +G VAVK L + + L+E +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS- 59
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HPNIVR GV + + +Y+ E Y+ G + L ++ L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTE----------YMPGGDLLDFL--RKHGEKL-------- 99
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
LL++ I G+ +L +HRDL +N L++++
Sbjct: 100 ------------------TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENL-- 139
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 570
K+SD G+S+ + D Y G W APE L G+ T D++S G
Sbjct: 140 VVKISDFGLSRDIYEDDY--------YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 571 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+L+ T G+ PY G S E +++D L E+ P+ + +L + +P+ RP
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 77/325 (23%), Positives = 133/325 (40%), Gaps = 84/325 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
+I +G+ G V + G VA+K++ AL+EI+ L+ HPNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKL 63
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + +YL E D++L ++ R + E+
Sbjct: 64 LDVFRHKGDLYLVFEFM------------------------DTDLYKLIKDRQRGLPESL 99
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
L+ QLL+ GL+ H G++HRDLKP+N+LI+ + KL+D
Sbjct: 100 IKSYLY--------QLLQ-------GLAFCHSHGILHRDLKPENLLINTEGVL--KLADF 142
Query: 525 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG--- 579
G+++ + T Y + W +APE LL + + +D++S+GCI ++
Sbjct: 143 GLARSFGSPVRPYTH----YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 580 --GKH--------------------PYGESFERDANI-VKDRKDLFLVEHIP----EAVD 612
GK P S R+ + + L + P +A+D
Sbjct: 199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALD 258
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFF 637
L +++L +P R A+ L HP+F
Sbjct: 259 LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 82/329 (24%), Positives = 126/329 (38%), Gaps = 80/329 (24%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 402
K I G+ G V GR VA+K++ D+ L+EI+ L+ +H NI+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENII 62
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ S E ND +Y+++ E L+ + L + I+
Sbjct: 63 GLLDI-----LRPPSPE----DFND-VYIVTELMETDLHKVIKSPQPLTDDHIQYF---- 108
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKL 521
Q+L+ GL +LH +IHRDLKP N+L++ + C K+
Sbjct: 109 --------------LYQILR-------GLKYLHSANVIHRDLKPSNILVNSN---CDLKI 144
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 579
D G++ R T Y + W +APE LL + T+AID++S+GCI +T
Sbjct: 145 CDFGLA-RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
Query: 580 -----GKH--------------PYGE--SFERDANIVKDRKDLFLVEHIP---------- 608
G+ P E F K L P
Sbjct: 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP 263
Query: 609 EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
EA+DL ++L +P R A L HP+
Sbjct: 264 EAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 68/304 (22%)
Query: 353 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ-------HPNIVRW 404
+ G G V L + + R+ A+K VK H V Q I S++ HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC-VKKRHIVETG-QQEHIFSEKEILEECNHPFIVKL 58
Query: 405 YGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
Y D+ ++Y+ +E C L ++ +D L +E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------------RDRGLFDE----------- 92
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+A+ +V +LH G+I+RDLKP+N+L+ D + KL D
Sbjct: 93 ------------YTARFY--IACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVD 136
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G +K+L+ + T G+ + APE +L ++D +SLG +L+ +TG P
Sbjct: 137 FGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP-P 191
Query: 584 YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-----VLN 633
+GE E +I+K L +I A DL +LL NP+ R +
Sbjct: 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251
Query: 634 HPFF 637
H +F
Sbjct: 252 HKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 79/305 (25%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 410
+ +GS G+V + E G+ VA+K + V+ +KEI L D P IV++YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFK 69
Query: 411 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469
+++ +E C S++D++ + + + E+
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEE------------------------------ 99
Query: 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
++ + + GL +LH IHRD+K N+L++++ AKL+D G+S +
Sbjct: 100 ---------EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQ 148
Query: 530 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPY 584
L M+ + T G+ W APE + + D++SLG IT GK PY
Sbjct: 149 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG------ITAIEMAEGKPPY 199
Query: 585 GESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQNVL 632
+ + + +F++ + P E D + L +P+ RP A +L
Sbjct: 200 SD--------IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251
Query: 633 NHPFF 637
HPF
Sbjct: 252 QHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 85/340 (25%), Positives = 146/340 (42%), Gaps = 76/340 (22%)
Query: 324 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-VLEGNYEGRSVAVK--RLVKT 380
E+ D++ + G K I +G++G V G+ VA+K RL K
Sbjct: 2 EELKAALKDIVSE---GDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQ 57
Query: 381 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 440
+ ++ + EI ++ +HPNIV +Y D +++ +E Y+ GS + +
Sbjct: 58 NKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME----------YMDGGSLTDII 106
Query: 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500
+NE Q+ V R+++ GL +LH +I
Sbjct: 107 TQNFVR---MNE-------------------------PQIAYVCREVLQGLEYLHSQNVI 138
Query: 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 560
HRD+K N+L+SKD S KL+D G + +L + S + + G+ W APE + +
Sbjct: 139 HRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDY 193
Query: 561 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR--KDLFLV--EHIP-------- 608
+D++SLG I+ + G+ PY +++ + LFL+ + IP
Sbjct: 194 GPKVDIWSLG-IMCIEMAEGEPPY----------LREPPLRALFLITTKGIPPLKNPEKW 242
Query: 609 --EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 646
E D + L +P+ RP A+ +L HPF A + F
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 83/312 (26%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK--------EIQNLIASD------ 396
E+ G++G V T +A+K IQ I +
Sbjct: 7 GELGAGNSGVVSK-----------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK 55
Query: 397 -QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
P IV +YG + + + +E GS ++ +L EV+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDG----------GSLDK----------ILKEVQG 95
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKD 514
R+ P L K+ ++ GL++LHE +IHRD+KP N+L++
Sbjct: 96 RI------------------PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
KL D G+S +L ++ T G+S + APE++ + D++SLG L
Sbjct: 138 GQI--KLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 575 FCITGGKHPYGES-------FERDANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLR 625
TG + PY FE IV + L P+ D L +P R
Sbjct: 191 ELATG-RFPYPPENDPPDGIFELLQYIVNEPPPR-LPSGKFSPDFQDFVNLCLIKDPRER 248
Query: 626 PKAQNVLNHPFF 637
P + +L HPF
Sbjct: 249 PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 62/303 (20%)
Query: 349 FNKEIAKGSNGTV-VLEGNYEGRSVAVKRLVKTHHDVALKEIQN------LIASDQHPNI 401
+ I KG+ G V +++ + A+K + K V ++N ++ HP +
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFL 62
Query: 402 VR-WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
V WY + D++ +YL + DL+ L G L+ K + +E +++
Sbjct: 63 VNLWYSFQ-DEENMYLVV--------DLL--LGGDLRYHLSQKVK----FSEEQVKFWIC 107
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+IV L +LH G+IHRD+KP N+L+ D+
Sbjct: 108 -------------------------EIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVH 140
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
++D I+ ++ D T + G+ G+ APE L + + A+D +SLG + C+ G
Sbjct: 141 ITDFNIATKVTPD----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-G 195
Query: 581 KHPY-GESFERDANIV---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR--PKAQNVLNH 634
K PY G S I + L+ EA+D +LL+ +P R +++ NH
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
Query: 635 PFF 637
P+F
Sbjct: 256 PYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 57/244 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPN 400
+ I KG G V + G+Y G+ VAVK L K Q +A +HPN
Sbjct: 8 LKLGATIGKGEFGDV-MLGDYRGQKVAVKCL-KDD----STAAQAFLAEASVMTTLRHPN 61
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+V+ GV + +Y+ E Y+ G +L++ +R R V
Sbjct: 62 LVQLLGVVLQGNPLYIVTE----------YMAKG-------------SLVDYLRSRGRAV 98
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ AQ L D+ G+ +L E +HRDL +NVL+S+D AK
Sbjct: 99 IT--------------LAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED--LVAK 142
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
+SD G++K + Q +G W APE L + + + D++S G +L+ + G
Sbjct: 143 VSDFGLAKE-----ASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 581 KHPY 584
+ PY
Sbjct: 197 RVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
G P A+ + I+ GL HLH+ +++RDLKP+NVL+ + ++SD+G++ L+G
Sbjct: 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGG 148
Query: 534 MSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA 592
+ G G+ G+ APE L ++D F+LGC L+ I G+ P+ + E+
Sbjct: 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVE 202
Query: 593 NIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTA 640
++ K L + PEA DL LL +P+ R A V HP F
Sbjct: 203 K--EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
Query: 641 DTRLSFL 647
+ R
Sbjct: 261 NWRRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|199216 cd10321, RNase_Ire1_like, RNase domain (also known as the kinase extension nuclease domain) of Ire1 and RNase L | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 643 RLSFLRDVSDRVELEDRESDSKLLRALEGI----ALVALNGKWDEKMETKFIENIGRYRR 698
++ F+ V + ++ + S L + L + L+ W+ ++ ++++ + R
Sbjct: 3 KIQFIDAVLNLLKDSN-LPPSTLNKLLNPGSDTVSSSFLSKPWNTLIDKNLMDDLSNFVR 61
Query: 699 --YKYDNVRDLLRVIRNKSNHFRE----LPQDIQELLG--SHPEGFYNYFSCRFPKLLIE 750
Y YD V+DL+R IRN H +E LP+ +E+L + F+NYF RFP LLI
Sbjct: 62 RTYNYDQVKDLIRCIRNTIQHHKEIKNQLPEKNKEILESLKSQDSFFNYFESRFPNLLIF 121
Query: 751 VYN 753
+Y
Sbjct: 122 LYY 124
|
This RNase domain is found in the multi-functional protein Ire1; Ire1 also contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). The UPR is activated when protein misfolding is detected in the ER in order to reduce the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor; IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain which stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is also found in Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase. RNase L is a highly regulated, latent endoribonuclease widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system; the interferon (IFN)-inducible 2'-5'-oligoadenylate synthetase (OAS)/RNase L pathway blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. Length = 127 |
| >gnl|CDD|188873 cd09213, Luminal_IRE1_like, The Luminal domain, a dimerization domain, of Inositol-requiring protein 1-like proteins | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 42/120 (35%), Positives = 61/120 (50%), Gaps = 15/120 (12%)
Query: 2 PYISK---DGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGY 58
P +S D V +G+ +TSVF +D K+G+++ Y D ST G SD N P +
Sbjct: 85 PLVSDTNEDDVVVVGSKRTSVFALDAKTGKIIKTYRADGLPSTGGSDSDGNSTPGPDELQ 144
Query: 59 EELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFS 118
EE +L+YI RTDYVLQ+ SG+ LWNV Y +++A + + S
Sbjct: 145 EE------------EELLYIGRTDYVLQAIDPRSGKELWNVTYGEYEALTLDADELGTSS 192
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), eukaryotic translation Initiation Factor 2-Alpha Kinase 3 (EIF2AK3), and similar proteins. IRE1 and EIF2AK3 are serine/threonine protein kinases (STKs) and are type I transmembrane proteins that are localized in the endoplasmic reticulum (ER). They are kinase receptors that are activated through the release of BiP, a chaperone bound to their luminal domains under unstressed conditions. This results in dimerization through their luminal domains, allowing trans-autophosphorylation of their kinase domains and activation. They play roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), contains an endoribonuclease domain in its cytoplasmic side and acts as an ER stress sensor. It is the oldest and most conserved component of the UPR in eukaryotes. Its activation results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. EIF2AK3, also called PKR-like Endoplasmic Reticulum Kinase (PERK), phosphorylates the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. It functions as the central regulator of translational control during the UPR pathway. In addition to the eIF-2 alpha subunit, EIF2AK3 also phosphorylates Nrf2, a leucine zipper transcription factor which regulates cellular redox status and promotes cell survival during the UPR. Length = 312 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 108/323 (33%)
Query: 373 AVKRLVKTHHDVALKEI----QNLIASD---------------QHPNIVRWYGV---ESD 410
A+ R +T VALK+I +N A+D HPNIV+ V E+D
Sbjct: 26 AIDR--RTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81
Query: 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 470
+D +YL E L+ +I +N+L +V R + ++
Sbjct: 82 KD-IYLVFEYMETDLHAVI----------------RANILEDVHKRYI----------MY 114
Query: 471 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKR 529
QLLK + I SG +IHRDLKP N+L++ D C KL+D G+++
Sbjct: 115 --------QLLKALKYIHSG-------NVIHRDLKPSNILLNSD---CRVKLADFGLARS 156
Query: 530 LQGDMSCLTQNA-TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG------ 580
L T Y ++ W +APE LL + T+ +D++S+GCIL + G
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216
Query: 581 ------------------------KHPYGESFERDANIVKDRKDL--FLVEHIPEAVDLF 614
K P+ + + RK L L + +A+DL
Sbjct: 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP-SRPRKPLDELLPKASDDALDLL 275
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF 637
+LL NP+ R A+ L HP+
Sbjct: 276 KKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 86/313 (27%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYG 406
+ I G+ G V + G VA+K ++K + IQ I+ + HPNIV ++G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+D +++ +E C SL D+ V G E
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------------------------- 101
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+ V R+ + GL++LHE G IHRD+K N+L+++D KL+D G
Sbjct: 102 -------------QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFG 146
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPE---QLLQGRQTRAIDLFSLGCILFFCITG--- 579
+S +L ++ + + G+ W APE +G D+++LG IT
Sbjct: 147 VSAQLTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG------ITAIEL 197
Query: 580 --GKHPYGESFERDANIVKDRKDLFLV------------EHI--PEAVDLFTRLLDPNPD 623
+ P + + + LFL+ + P D + L +P
Sbjct: 198 AELQPPMFD--------LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 624 LRPKAQNVLNHPF 636
RP A +L HPF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 476 PSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM 534
P L K+ IV L +LH + +IHRD+KP NVLI+++ KL D GIS L +
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV--KLCDFGISGYLVDSV 158
Query: 535 SCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSLGCILFFCITGGKHPY---GE 586
+ T +A G + APE++ +G ++ D++SLG I + G+ PY
Sbjct: 159 A-KTIDA---GCKPYMAPERINPELNQKGYDVKS-DVWSLG-ITMIELATGRFPYDSWKT 212
Query: 587 SFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
F++ +V++ + F PE D + L N RP +L HPFF
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKF----SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
Query: 642 TRLSFLRDVSDRVELE 657
++ + DV+ V L
Sbjct: 269 SKNT---DVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 63/302 (20%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHDVALKEIQ------NLIASDQHPNIVRW 404
+ KG+ GTV +G+ +AVK++ ++ A KE + +L+ S +H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G L+ T S+ + +V GS LN R P+
Sbjct: 68 LGT---------CLDDNTISIF-MEFVPGGSISSILN--------------RFGPL---- 99
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
P K T+ I+ G+++LH ++HRD+K NV++ + KL D
Sbjct: 100 -----------PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDF 146
Query: 525 GISKRL-----QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
G ++RL G S + ++ +G+ W APE + + R D++S+GC +F TG
Sbjct: 147 GCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
Query: 580 GKHPYGESFERDANIVKDRKDLFLVEHIPE-----AVDLFTRLLDPNPDLRPKAQNVLNH 634
P S +R A + L+ +P+ A+D T L + RP A +L H
Sbjct: 205 --KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262
Query: 635 PF 636
F
Sbjct: 263 DF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 90/338 (26%), Positives = 138/338 (40%), Gaps = 86/338 (25%)
Query: 356 GSNGTVVLEGNYE-GRSVAVKRLVKTH-HDV--ALKEIQNLIASDQHPNIVRWYGVESDQ 411
GSNG V + + + VAVK++V T V AL+EI+ +I H NIV+ Y V
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGP- 73
Query: 412 DFVYLSLERCTCSLNDL-----IYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTK 465
S T + L +Y++ E L N EQ L+E RL
Sbjct: 74 -----SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLF------- 119
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
QLL+ GL ++H ++HRDLKP NV I+ + K+ D G
Sbjct: 120 -----------MYQLLR-------GLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDFG 160
Query: 526 ISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 579
+++ + S L++ + +++P LL T+AID+++ GCI +TG
Sbjct: 161 LARIVDPHYSHKGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 580 ---GKH------------PYGESFERD-------ANIVKD----RKDL--FLVEHIPEAV 611
G H P +R+ + + D R+ L L PEA+
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 649
D ++L NP R A+ L HP+ + S D
Sbjct: 278 DFLEQILTFNPMDRLTAEEALMHPYM----SCYSCPFD 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 77/308 (25%), Positives = 116/308 (37%), Gaps = 64/308 (20%)
Query: 349 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHP 399
F K++ +G G V L G+ G VAVK L + H +EI+ L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL-RTLDHE 66
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NIV++ GV L L + Y+ SGS + L + +D L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLI--------MEYLPSGSLRDYLQ-RHRDQINL--------- 108
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+LL + I G+ +L IHRDL +N+L+ +
Sbjct: 109 ------------------KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LV 148
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K+SD G++K L D G W APE L + + A D++S G L+ T
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
Query: 580 G---KHPYGESF-----ERDANIV-------KDRKDLFLVEHIPEAV-DLFTRLLDPNPD 623
G + P E + IV K+ + L P+ V DL + P
Sbjct: 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ 268
Query: 624 LRPKAQNV 631
RP ++
Sbjct: 269 DRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 91/312 (29%)
Query: 369 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV--RWYGVESDQDFVYLSLERC 421
G VA+K+L +L+EI L+ QHPNIV + V S+ D +Y+ +E
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88
Query: 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
L L+ + F L +EV+ +L QLL
Sbjct: 89 EHDLKSLMETMKQPF------------LQSEVKCLML--------------------QLL 116
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 541
SG++HLH+ ++HRDLK N+L++ K+ D G+++ + TQ
Sbjct: 117 -------SGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 542 TGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCI---------LF------------FCIT 578
+ W +APE LL + AID++S+GCI LF F +
Sbjct: 168 V----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223
Query: 579 GGKHPYGESFERDANIVKDRKDLF-------LVEHIPE------AVDLFTRLLDPNPDLR 625
G P + + + + +K F L + P DL RLL +P R
Sbjct: 224 GT--PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281
Query: 626 PKAQNVLNHPFF 637
A++ L HP+F
Sbjct: 282 ISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 86/301 (28%), Positives = 134/301 (44%), Gaps = 66/301 (21%)
Query: 353 IAKGSNGTVVLEGNYEGR------SVAVKRL-VKTHHDVA-LKEIQNLIASDQHPNIVRW 404
+ KG+ G V Y R +A+K + + V L E L + +H NIV++
Sbjct: 16 LGKGTYGIV-----YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G +S+ F + +E+ V GS S LL R + P+ +N
Sbjct: 71 LGSDSENGFFKIFMEQ----------VPGGSL----------SALL---RSKWGPLKDNE 107
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ I + T+ I+ GL +LH+ ++HRD+K NVL++ K+SD
Sbjct: 108 QTIIFY-------------TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV-KISDF 153
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH 582
G SKRL G C T+ T G+ + APE + +G + D++SLGC + T GK
Sbjct: 154 GTSKRLAGINPC-TETFT--GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKP 209
Query: 583 PYGESFERDANIVKDRKDLFLVEH--IPEAV-----DLFTRLLDPNPDLRPKAQNVLNHP 635
P+ E E A + K H IPE++ + R +P+PD R A ++L P
Sbjct: 210 PFIELGEPQAAMFKVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
Query: 636 F 636
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 472 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531
P+ + ++ G++H H+ G++HRDLKPQN+L+ K K K++D+G+ +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL-KIADLGLGRAFS 162
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES-FE 589
+ T + ++APE LL + +D++S+GCI G+S +
Sbjct: 163 IPVKSYTHEIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
Query: 590 RDANI--------------VKDRKDL------------FLVEHI-PEAVDLFTRLLDPNP 622
+ +I V +D V + PE +DL ++L +P
Sbjct: 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279
Query: 623 DLRPKAQNVLNHPFF 637
R A+ L HP+F
Sbjct: 280 AKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 77/308 (25%)
Query: 352 EIAKGSNGTVVLEGNYE-GRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNIV 402
++ +G G V L + G VA+KR+ K H + ++I + + + +V
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI---LTTTKSEWLV 64
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ D +++YL++E YV G F LN +L+E R
Sbjct: 65 KLLYAFQDDEYLYLAME----------YVPGGDFRTLLNNL----GVLSEDHARFYMA-- 108
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
++ + LHE+G IHRDLKP+N LI D S KL+
Sbjct: 109 -----------------------EMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLT 143
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 579
D G+SK +T + GS + APE +L+G+ +D +SLGC+L+ + G
Sbjct: 144 DFGLSK------GIVTYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
Query: 580 ---GKHPYGESFERDANIVKDRKDL-------FLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629
G P E++E N+ ++ L EA DL T+L++ +
Sbjct: 197 PFSGSTP-NETWE---NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLE 252
Query: 630 NVLNHPFF 637
++ NHPFF
Sbjct: 253 DIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 70/326 (21%), Positives = 122/326 (37%), Gaps = 85/326 (26%)
Query: 352 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 405
+ +G+ G V+ N G VA+K+ ++ D AL+E++ L +H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLK 66
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+ +YL E +L +L+ E L +R
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELL--------------EASPGGLPPDAVRSY------- 105
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+W QLL+ +++ H +IHRD+KP+N+L+S+ KL D G
Sbjct: 106 ---IW--------QLLQ-------AIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFG 145
Query: 526 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 579
++ L+ T Y ++ W +APE L+ + +D++++GCI+ + G
Sbjct: 146 FARALRARP---ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
Query: 580 ----------------GKHP--YGESFERDAN----IVKDRKDLFLVEHIPE------AV 611
G P + E F + + +E A+
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFF 637
D L +P R +L HP+F
Sbjct: 263 DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDVALKEIQ-NLIASDQHPNIV 402
K + +G+ G V L + + GR +A K++ +T +V+ E + L+ + QH IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
++YG D+ L++ + Y+ GS ++QL A L E R
Sbjct: 68 QYYGCLRDRAEKTLTIF--------MEYMPGGSVKDQLKA----YGALTESVTR------ 109
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
K TR I+ G+S+LH ++HRD+K N+L +D + KL
Sbjct: 110 -------------------KYTRQILEGMSYLHSNMIVHRDIKGANIL--RDSAGNVKLG 148
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G SKRLQ T + G+ W +PE + R D++SLGC + +T K
Sbjct: 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKP 207
Query: 583 PYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
P+ E +E A I K + L HI E F + RP A+ +L HPF
Sbjct: 208 PWAE-YEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 103/318 (32%)
Query: 369 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLER 420
G VA+K+ ++ ++ A++EI+ L+ +HPNIVR + + +Y+ E
Sbjct: 24 GELVALKK-IRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480
L L+ F E K QL
Sbjct: 82 MDHDLTGLLDSPEVKFTES-QIK-------------------------------CYMKQL 109
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMS- 535
L+ GL +LH G++HRD+K N+LI+ D KL+D G +KR D +
Sbjct: 110 LE-------GLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTN 160
Query: 536 ---CLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGG---------- 580
L W P +LL G R +D++S+GCIL G
Sbjct: 161 RVITL-----------WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
Query: 581 ---------------------KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 619
K P+ E+ + + ++ F P A+DL +LL
Sbjct: 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT 269
Query: 620 PNPDLRPKAQNVLNHPFF 637
+P R A L H +F
Sbjct: 270 LDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 351 KEIAKGSNGTVVLEGNYEGR-SVAVK--RLVKTHHDVA--LKEIQNLIASDQHPNIVRWY 405
++I KG+ G V +G +G VAVK R L+E + L D HPNIV+
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
GV + +Y+ +E V GS L +R
Sbjct: 59 GVCVQKQPIYIVME----------LVPGGSL-------------LTFLRK---------- 85
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
K N +LL+++ D +G+ +L IHRDL +N L+ ++ K+SD G
Sbjct: 86 -----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL--KISDFG 138
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
+S+ +G + + + W APE L GR T D++S G +L+ + G PY
Sbjct: 139 MSREEEGGIYTV-SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
Query: 585 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 633
G S ++ ++ + + PE + L + +P+ RP + N
Sbjct: 198 GMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 85/317 (26%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 407
+ I +G+ G V + + G+ VA+K +++ + +E L HPNI +YG
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 408 ------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ D ++L +E C GS ++L+ +R + +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCG----------GGSV----------TDLVKGLRKKGKRLK 111
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
E + + R+ + GL++LHE +IHRD+K QN+L++K+ KL
Sbjct: 112 EE---------------WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN--AEVKL 154
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFC 576
D G+S +L S L + T G+ W APE + Q A D++SLG
Sbjct: 155 VDFGVSAQLD---STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------ 205
Query: 577 ITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLD 619
IT GK P + + + LF + P + D + L
Sbjct: 206 ITAIELADGKPPLCD--------MHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLI 257
Query: 620 PNPDLRPKAQNVLNHPF 636
N + RP + +L HPF
Sbjct: 258 KNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 46/186 (24%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYG 545
I+ GL ++H G+IHRDLKP N+ +++D C K+ D G+++ +M TGY
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDDEM-------TGYV 176
Query: 546 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPY-------------G 585
++ W +APE +L + +D++S+GCI+ +TG G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 586 ESF------ERDANIV--------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 631
E E N + KD K++F P A+DL ++L +PD R A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 632 LNHPFF 637
L HP+
Sbjct: 296 LAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 76/315 (24%), Positives = 119/315 (37%), Gaps = 100/315 (31%)
Query: 369 GRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420
GR VA+K++ + AL+EI+ L+ +HPNI+ V + + L E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLVFE- 82
Query: 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480
+ E+ ++ + I L P DI+ +
Sbjct: 83 ----------FMETDLEK----------VIKDKSIVLTP-----ADIKSY------MLMT 111
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 540
L+ GL +LH ++HRDLKP N+LI+ D KL+D G+++ +T
Sbjct: 112 LR-------GLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQ 162
Query: 541 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------FFCITGGKHPYGES--- 587
+ W +APE L R +D++S+GCI F G+S
Sbjct: 163 VV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL--------PGDSDID 210
Query: 588 -----F-------ERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 622
F E + V D + P +A+DL RLL NP
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 623 DLRPKAQNVLNHPFF 637
+ R A+ L HP+F
Sbjct: 271 NKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 64/299 (21%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVR 403
K++ KGS G+V + + + A+K + K D A+ EI+ ++AS HPNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIR-ILASVNHPNIIS 63
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ D + + + +E DL +S ++ L+ E I
Sbjct: 64 YKEAFLDGNKLCIVME--YAPFGDLSKAISKR--------KKKRKLIPEQEI-------- 105
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
W+ QLL+ GL LHE ++HRDLK N+L+ + K+ D
Sbjct: 106 ------WRI----FIQLLR-------GLQALHEQKILHRDLKSANILLVANDLV--KIGD 146
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 582
+GISK L+ +M+ T G+ + APE + +GR + D++SLGC+L+ T
Sbjct: 147 LGISKVLKKNMA-----KTQIGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMAT-FAP 199
Query: 583 PY-GESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 635
P+ S + V+ K IP + + +L P LRP +L P
Sbjct: 200 PFEARSMQDLRYKVQRGK----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 62/297 (20%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAV------KRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 406
+ KG+ G L E S+ V RL + AL EI +++ QHPNI+ +Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI-VILSLLQHPNIIAYYN 66
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
D + + + +E G+ +++ Q L E
Sbjct: 67 HFMDDNTLLIEMEYAN----------GGTLYDKIV--RQKGQLFEE-------------- 100
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+L IVS +S++H+ G++HRD+K N+ ++K KL D GI
Sbjct: 101 -----------EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGI 147
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILFFCITGGKHPYG 585
SK L + S T G+ + +PE L QG + D+++LGC+L+ +T +
Sbjct: 148 SKILGSEYS---MAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKR---- 199
Query: 586 ESFERD------ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+F+ IV+ + + E + L LL +P+ RP A VL+ P
Sbjct: 200 -TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 542
+ R+++ GL +LHE G IHRD+K N+L+S++ KL+D G+S +L MS + T
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMS---KRNT 157
Query: 543 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPYGESFERDANIVKD 597
G+ W APE + Q D++SLG G HP F I K+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----IPKN 213
Query: 598 RKDLFLVEHIPEAVDLFTRL-LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 653
+ F L L+ +P RP A+ +L H F A + S+L + +R
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA-KKTSYLTLLIER 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-----QGDMSCLTQNA 541
+V L +H++G IHRD+KP N+LI D KL+D G+ K++ + + N
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHI--KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 542 TGY---------------------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
G+ + APE L D +SLG IL+ + G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 581 KHPYGESFERDAN-IVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
Y ++ + N I+ ++ L PEA+DL RLL D + + +HPF
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
Query: 637 F----WTADTRLS--FLRDVSD 652
F W F+ ++S
Sbjct: 288 FKGIDWENLRETKPPFVPELSS 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 55/161 (34%), Positives = 86/161 (53%), Gaps = 18/161 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 544
+I L HLH+ G+I+RDLKP+N+L+ D KL+D G+ K + T T
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL-- 601
G+ + APE L++ +A+D +SLG +++ +TG E+ ++ + I+K + +L
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
Query: 602 FLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
+L PEA DL +LL NP R A V +HPFF
Sbjct: 222 YLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 84/317 (26%)
Query: 349 FNKEIAKGSNGTVVL---EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA------SDQHP 399
F K + GS G V+L +G+ G+ A+K L K V LK++++++ S +HP
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS--GKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+V YG D +YL +E YV G L + P
Sbjct: 62 FLVNLYGSFQDDSNLYLVME----------YVPGGELFSHLR------------KSGRFP 99
Query: 460 VMENTKDIELWKANGHPSAQLLKVTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
V R +V L +LH + +++RDLKP+N+L+ D
Sbjct: 100 ---------------------EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
K++D G +KR++G L G+ + APE +L +A+D ++LG +++
Sbjct: 139 YI--KITDFGFAKRVKGRTYTLC------GTPEYLAPEIILSKGYGKAVDWWALGILIYE 190
Query: 576 CITGGKHP--YGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD-----L 624
+ G +P + ++ +E+ I++ + F P+A DL LL + L
Sbjct: 191 MLAG--YPPFFDDNPIQIYEK---ILEGKVR-FPSFFSPDAKDLIRNLLQVDLTKRLGNL 244
Query: 625 RPKAQNVLNHPFFWTAD 641
+ ++ NHP+F D
Sbjct: 245 KNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 89/317 (28%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 394
+ I KGS GTV V+R + KEI N++
Sbjct: 6 ETIGKGSFGTVRK----------VRR-KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR 54
Query: 395 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
+HPNIVR+Y ++ +Y+ +E C DL ++ K++ +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVME--YCEGGDLAQLIQ-------KCKKERKYI--- 102
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQ 507
+ ++ ++ L H ++HRDLKP
Sbjct: 103 -----------------------EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139
Query: 508 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDL 566
N+ + + KL D G++K L D + A Y G+ + +PEQL D+
Sbjct: 140 NIFLDANN--NVKLGDFGLAKILGHD----SSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193
Query: 567 FSLGCILF-FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPE--AVDLF---TRLLD 619
+SLGC+++ C P+ + + A+ +K+ K IP + +L +L+
Sbjct: 194 WSLGCLIYELC--ALSPPFTARNQLQLASKIKEGK----FRRIPYRYSSELNEVIKSMLN 247
Query: 620 PNPDLRPKAQNVLNHPF 636
+PD RP + +L P
Sbjct: 248 VDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 17/166 (10%)
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
+ I G+ HLH + +++RD+KP+NVL+ D+ C +LSD+G++ L+ + +TQ A
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNC-RLSDLGLAVELKDGKT-ITQRA-- 155
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDR--KD 600
G++G+ APE L + + +D F++GC ++ + G+ P+ + E+ +K R +D
Sbjct: 156 -GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKEKVAKEELKRRTLED 213
Query: 601 LFLVEH---IPEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWT 639
EH E+ D+ L P+ R K + H FF T
Sbjct: 214 EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQG----DMSCLTQNA 541
++ L+ H G++HRDLKPQN+++S AK+ D GI L G D++ LT+
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 542 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 587
G+ + APEQL T DL++ G I C+TG + G S
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|197798 smart00580, PUG, domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-14
Identities = 28/55 (50%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 704 VRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLI-EVYNVI 755
VRDLLR +RN +H RE I+E LG P GF YF+ FP+LLI EVY +
Sbjct: 2 VRDLLRALRNILHHPREEKGNPAIKERLGPVPGGFELYFTVGFPRLLISEVYTLP 56
|
Length = 57 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 57/296 (19%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHH-DVALKEIQNLIASD-QHPNIVRWY 405
+I +GS G V + + GR VAVK+ L K ++ E+ +I D QHPNIV Y
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPNIVEMY 82
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
D +++ +E ++ G+ ++++ R+
Sbjct: 83 SSYLVGDELWVVME----------FLEGGAL----------TDIVTHTRMN--------- 113
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G
Sbjct: 114 -----------EEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG 160
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
++ ++ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 161 FCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG-IMVIEMVDGEPPYF 216
Query: 585 GESFERDANIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
E + ++D L P R+L +P R A +LNHPF
Sbjct: 217 NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412
I +G G V L+G Y G+ VAVK + A E ++ H N+VR GV
Sbjct: 14 IGEGEFGAV-LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472
+Y+ +E + NL+N +R R ++
Sbjct: 73 -LYIVMELMS-----------------------KGNLVNFLRTRGRALV----------- 97
Query: 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK--RL 530
QLL+ + D+ G+ +L L+HRDL +N+L+S+D AK+SD G+++ +
Sbjct: 98 ---SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM 152
Query: 531 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
D S L W APE L + + D++S G +L+ + G+ PY
Sbjct: 153 GVDNSKLPVK--------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QLLK G++ HE ++HRDLKPQN+LI+K KL+D G+++ ++ +
Sbjct: 108 QLLK-------GIAFCHENRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFS 158
Query: 539 QNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES---------- 587
+ ++AP+ LL R + +ID++S+GCI+ ITG G +
Sbjct: 159 NEVV---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
Query: 588 ------------------FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKA 628
++ + L H P +DL RLL NP+LR A
Sbjct: 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275
Query: 629 QNVLNHPFF 637
+ L HP+F
Sbjct: 276 HDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 87/307 (28%), Positives = 139/307 (45%), Gaps = 60/307 (19%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRL------VKTHHDV-ALK-EIQNL 392
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-L 57
Query: 393 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
+ + +H IV++YG D + LS+ + Y+ GS ++QL A L E
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIF--------VEYMPGGSIKDQLKA----YGALTE 105
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 512
R + TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------RYTRQILQGVSYLHSNMIVHRDIKGANIL-- 138
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572
+D + KL D G SKR+Q T + G+ W +PE + R D++S+ C
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 573 LFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629
+ +T K P+ E +E A I K L + + +A F + + RP A+
Sbjct: 199 VVEMLT-EKPPWAE-YEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAE 256
Query: 630 NVLNHPF 636
+L HPF
Sbjct: 257 FLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 73/292 (25%)
Query: 369 GRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424
VA+KR+ +T D KE+Q ++ HPN+V++Y D ++L + +
Sbjct: 26 NEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG- 83
Query: 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 484
GS LL +M+++ + G A + V
Sbjct: 84 ---------GS---------------------LLDIMKSS-----YPRGGLDEAIIATVL 108
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GDMSCLTQNAT 542
++++ GL +LH G IHRD+K N+L+ +D S K++D G+S L GD + + T
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRK-T 165
Query: 543 GYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGE--------------- 586
G+ W APE + Q D++S G I + G PY +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG-ITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 587 -SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
S E A+ K K + + L +P RP A+ +L H FF
Sbjct: 225 PSLETGADYKKYSKSF---------RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 26/179 (14%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
G P + T I+SGL HLH+ +I+RDLKP+NVL+ D + ++SD+G++ L+
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDG 150
Query: 534 MSCLTQNAT-GY-GSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 590
Q+ T GY G+ G+ APE LLQG + ++D F+LG L+ I + P+ E+
Sbjct: 151 -----QSKTKGYAGTPGFMAPE-LLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEK 203
Query: 591 DANIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLRPKAQN-----VLNHPFF 637
N K+ K L + + P + LL +P+ R ++ + HP F
Sbjct: 204 VEN--KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 546 SSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 604
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + V
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAV 216
Query: 605 E----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 648
E PE L LL + + R AQ V HPFF + D ++ FL+
Sbjct: 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 92/311 (29%), Positives = 139/311 (44%), Gaps = 68/311 (21%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDV-ALK-EIQNL 392
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-L 57
Query: 393 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
+ + H IV++YG D LS+ + ++ GS ++QL + L E
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIF--------MEHMPGGSIKDQLKS----YGALTE 105
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 512
R K TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------KYTRQILEGVSYLHSNMIVHRDIKGANIL-- 138
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY----GSSGWQAPEQLLQGRQTRAIDLFS 568
+D KL D G SKRLQ CL+ TG G+ W +PE + R D++S
Sbjct: 139 RDSVGNVKLGDFGASKRLQ--TICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 569 LGCILFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 625
+GC + +T K P+ E FE A I K + L H+ + F + + LR
Sbjct: 195 VGCTVVEMLT-EKPPWAE-FEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLR 252
Query: 626 PKAQNVLNHPF 636
P A +L H F
Sbjct: 253 PSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 83/327 (25%), Positives = 140/327 (42%), Gaps = 91/327 (27%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 406
+ +GS G V+ + E G+ VA+K+ +++ D +A++EI+ ++ +H N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIE 67
Query: 407 VESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
V + +YL E + L+DL E+ N L+E R+R
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---------------EKYPNGLDESRVR--------- 103
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
K I+ G+ H +IHRD+KP+N+L+S +S KL D G
Sbjct: 104 ----------------KYLFQILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFG 145
Query: 526 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 582
++ L + T Y ++ W +APE LL G + RA+D++++GC++ +TG
Sbjct: 146 FARTLAAP----GEVYTDYVATRWYRAPE-LLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200
Query: 583 PYGES---------------FERDANIVKDRKDLFLVEHIPEA----------------- 610
G+S R I + LF +PE
Sbjct: 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259
Query: 611 VDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+DL + L +PD RP + +L+H FF
Sbjct: 260 LDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 46/188 (24%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 545
I+ GL ++H ++HRDLKP N+L++ + C K+ D G++ R+ T T Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLA-RIADPEHDHTGFLTEYV 170
Query: 546 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKH--------------PY 584
++ W +APE +L + T+AID++S+GCIL ++ GK P
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230
Query: 585 GESFERDANIVKDR----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628
E I+ R LF P+A+DL ++L NP R
Sbjct: 231 QEDLN---CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITV 286
Query: 629 QNVLNHPF 636
+ L HP+
Sbjct: 287 EEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 43/133 (32%), Positives = 73/133 (54%), Gaps = 4/133 (3%)
Query: 461 MEN-TKDIELWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
MEN + D L K +G + QL+ + R I SG+ +L ++G +HRDL +N+L+ + +
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLV 144
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
K+SD G+S+ L+ D G W APE + + T A D++S G +++ ++
Sbjct: 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 579 GGKHPYGESFERD 591
G+ PY E +D
Sbjct: 205 YGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 94/347 (27%)
Query: 351 KEIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 402
KE+ +G+ G V N E +VA+K++ AL+E++ L H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
Y D D V+ + N+L Y+ +EE + A L+++ IR
Sbjct: 66 CLY----DMDIVFPG------NFNEL-YL----YEELMEAD------LHQI-IR------ 97
Query: 463 NTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+G P A I+ GL ++H ++HRDLKP N+L++ D K
Sbjct: 98 ----------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD--CELK 145
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL----- 573
+ D G+++ + T Y ++ W +APE +L + T+AID++S+GCIL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 574 ----------------FFCITGGKHPYGESFERDA------------NIVKDRKDLFLVE 605
+ G P E+ R NI K +
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGT--PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN 263
Query: 606 HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
P A+DL +LL +P R + L HP+ L+ D D
Sbjct: 264 ANPLALDLLEKLLAFDPTKRISVEEALEHPY-------LAIWHDPDD 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 544
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK + + A +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEE---EERAYSFC 167
Query: 545 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 602
G+ + APE + G +A+D +SLG + F +TG P+ E+ N +
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS-PFTVDGEQ--NSQSEISRRI 224
Query: 603 LVEHIP-------EAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 637
L P EA D +LL+ +P R A + NHPFF
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 61/206 (29%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA--KLSDMGISKRLQGDMSCLTQNATGY 544
I++G+ +LH ++HRDLKP N+L+ + K+ D+G+++ + L A
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---APLKPLADLD 173
Query: 545 G---SSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LFFCITGGKHP----YGES 587
+ ++APE LL R T+AID++++GCI +F +
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 588 FERDANIVK-----DRKDLFLVEHIPE-------------------------------AV 611
ER I + KD ++ +PE
Sbjct: 234 LER---IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFF 637
DL +LL+ +P R A+ L HP+F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 69/306 (22%)
Query: 348 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNI 401
F + + KGS G V L +G+ +K+L + A +E Q L++ +HPNI
Sbjct: 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ-LLSQLKHPNI 61
Query: 402 V----RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
V W G E ++ + C DL + L KEQ LL
Sbjct: 62 VAYRESWEG-EDGLLYIVMGF----CEGGDLYHKL----------KEQKGKLL------- 99
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
P Q+++ I L +LHE ++HRDLK QNV ++ ++
Sbjct: 100 ------------------PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT--RTN 139
Query: 518 CAKLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
K+ D+GI++ L Q DM+ +T G+ + +PE D+++LGC ++
Sbjct: 140 IIKVGDLGIARVLENQCDMA-----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 576 CITGGKHPYGESFERDAN-----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630
T KH + +D N I++ + ++ PE +L +L P+ RP ++
Sbjct: 195 MAT-LKHAFN---AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKS 250
Query: 631 VLNHPF 636
+L P+
Sbjct: 251 ILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 31/178 (17%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
A ++ T ++ GLS+LHE +IHRD+K N+LI +++D G + RL +
Sbjct: 103 AVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGT-- 159
Query: 538 TQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 590
G G+ + APE +L+G Q R+ D++S+GC++ T K P+
Sbjct: 160 ---GAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAE--- 211
Query: 591 DANIVKDRKDLFLV----------EHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFF 637
+F + EH+ + D+ R L+ P+ RP ++ +L HP F
Sbjct: 212 --KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 405
K+I +GS G + L + + +K + T V KE L+A +HPNIV ++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+ +++ +E C G +++N Q L +E
Sbjct: 66 ASFQENGRLFIVMEYCD----------GGDLMKRIN--RQRGVLFSE------------- 100
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+L I GL H+H+ ++HRD+K QN+ +SK+ AKL D G
Sbjct: 101 ------------DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN-GMVAKLGDFG 147
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF-FCITGGKHPY 584
I+++L M L T G+ + +PE D++SLGC+L+ C KHP+
Sbjct: 148 IARQLNDSME-LAY--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL--KHPF 202
Query: 585 -GESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
G + + I + + L ++L +P RP ++L PF
Sbjct: 203 EGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 397
+V K + +G G VV L+G +VAVK L + L+++ NL+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HP++++ YG S + L +E Y GS + L E R ++
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVE----------YAKYGSLR----------SFLRESR-KV 100
Query: 458 LPVMENTKDIELWKANGHPSAQ------LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
P + +P + L+ I G+ +L E+ L+HRDL +NVL+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
++ + K+SD G+S+ + + S + + + G W A E L T D++S G
Sbjct: 161 AEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 572 ILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+L+ +T G +PY G + ER N++K + E+ E + +L PD RP
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 82/324 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVRW 404
++I +G+ G V N G VA+K RL V A++EI +L+ HPNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI-SLLKELNHPNIVKL 64
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V ++ +YL E F Q K D++ L+ +
Sbjct: 65 LDVIHTENKLYLVFE----------------FLHQDLKKFMDASPLSGI----------- 97
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
P + ++ GL+ H ++HRDLKPQN+LI+ + + KL+D
Sbjct: 98 -----------PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--KLADF 144
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHP 583
G+++ + T + ++APE LL + + A+D++SLGCI +T
Sbjct: 145 GLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
Query: 584 YGESFERD-------------------ANIVKDRKDLF-------LVEHIP----EAVDL 613
G+S E D + D K F + +P + DL
Sbjct: 202 PGDS-EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDL 260
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
+++L +P+ R A+ L HPFF
Sbjct: 261 LSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 67/250 (26%)
Query: 349 FNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHHDVALKE---IQ--NLIASDQHPNIV 402
F KE+ G G V L G + G VA+K + + A+ E I+ ++ HPN+V
Sbjct: 8 FLKELGSGQFGVVHL-GKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ YGV + Q +++ E Y+ +G LLN +R R
Sbjct: 63 QLYGVCTKQRPIFIVTE----------YMANGC-------------LLNYLRER--KGKL 97
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
T LL + D+ + +L G IHRDL +N L+ +D K+S
Sbjct: 98 GT-------------EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED--NVVKVS 142
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 575
D G+++ + D Y SS W PE R + D++S G +++
Sbjct: 143 DFGLARYVLDDQ---------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 576 CITGGKHPYG 585
+ GK PY
Sbjct: 194 VFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 488 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY--- 544
V L +LH G++HRDLKP N+LI+ KL+D G+SK G MS T G+
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHI--KLTDFGLSK--IGLMSLTTNLYEGHIEK 166
Query: 545 -----------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DA 592
G+ + APE +L+ + +D +++G IL+ + G +G++ E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 593 NIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF----WTAD 641
++ D D+ E +A DL +RLL NP R A V H FF W
Sbjct: 227 QVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN-- 282
Query: 642 TRLSFLRDVSDRVELEDRESDS 663
LR ++ + + E D+
Sbjct: 283 ---GLLRQKAEFIPQLESEDDT 301
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 24/197 (12%)
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
++L +A Q+ + ++I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
+ +L + T G+ W APE + Q D++SLG IT + GE
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG------ITAIELAKGE 198
Query: 587 SFERDANIVKDRKDLFLVEHI--PEAVDLFTR--------LLDPNPDLRPKAQNVLNHPF 636
D + + + LFL+ P F++ L+ +P RP A+ +L H F
Sbjct: 199 PPNSDMHPM---RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
Query: 637 FWTADTRLSFLRDVSDR 653
+ S+L ++ DR
Sbjct: 256 IVKNAKKTSYLTELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 24/197 (12%)
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
++L K + + R+I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
+ +L + T G+ W APE + Q D++SLG I + G+ P +
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG-ITAIELAKGEPPNSD 203
Query: 587 SFERDANIVKDRKDLFLV----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+ + LFL+ ++ + L+ +P RP A+ +L H F
Sbjct: 204 --------LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
Query: 637 FWTADTRLSFLRDVSDR 653
+ SFL ++ DR
Sbjct: 256 ITRYTKKTSFLTELIDR 272
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 352 EIAKGSNGTV-VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYG 406
EI +G+ GTV + G +AVKR+ + L ++ ++ S P IV++YG
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ ++ +E SL D Y V E K
Sbjct: 71 ALFREGDCWICMELMDISL-DKFYKY---------------------------VYEVLKS 102
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+ P L K+ V L++L E+ +IHRD+KP N+L+ D++ KL D G
Sbjct: 103 V-------IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFG 153
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGK 581
IS +L D T++A G + APE++ G R+ D++SLG I + + GK
Sbjct: 154 ISGQLV-DSIAKTRDA---GCRPYMAPERIDPSARDGYDVRS-DVWSLG-ITLYEVATGK 207
Query: 582 HPY---GESFERDANIVK-DRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634
PY F++ +VK D L E P V+ L + RPK + +L H
Sbjct: 208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
Query: 635 PFF 637
PF
Sbjct: 268 PFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 86/349 (24%), Positives = 137/349 (39%), Gaps = 81/349 (23%)
Query: 304 IPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-V 362
+P S + S +G+ + ++L +RV RIG G+ GTV
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSEL--ERV--NRIGS----------GAGGTVYK 92
Query: 363 LEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYGVESDQDFVYLSLE 419
+ GR A+K + H D ++I I HPN+V+ + + + + LE
Sbjct: 93 VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 479
++ GS E A EQ
Sbjct: 153 ----------FMDGGSLEGTHIADEQ---------------------------------F 169
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLT 538
L V R I+SG+++LH ++HRD+KP N+LI+ K+ K++D G+S+ L M C
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPC-- 225
Query: 539 QNATGYGSSGWQAPEQ----LLQGR-QTRAIDLFSLG-CILFFCITGGKHPYGESFERD- 591
N++ G+ + +PE+ L G A D++SLG IL F + G+ P+G + D
Sbjct: 226 -NSS-VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL--GRFPFGVGRQGDW 281
Query: 592 ----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
I + E + L P R A +L HPF
Sbjct: 282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/114 (32%), Positives = 64/114 (56%), Gaps = 15/114 (13%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QL+ + R I SG+ +L E+ +HRDL +N+L++ + K+SD G+S+RL+
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRRLE------D 158
Query: 539 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
AT Y + G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 159 SEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I+ L HLH++G+++RD+K +N+L+ + L+D G+SK + T + G
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV--LTDFGLSKEFLSEEKERTYSFC--G 168
Query: 546 SSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 604
+ + APE + +G +A+D +SLG ++F +TG P+ ER+ R+ L
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS-PFTLEGERNTQSEVSRRILKCD 227
Query: 605 EHIP-----EAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF----WTA 640
P EA DL +LL +P R A + HPFF W A
Sbjct: 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 48/216 (22%)
Query: 457 LLPVMENTKDIELWKANGHPSAQ--LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
++P M+ +L K GHP ++ + + ++ GL ++H G+IHRDLKP N+ +++D
Sbjct: 98 VMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI 572
K+ D G+++ +M TGY + W +APE +L + +D++S+GCI
Sbjct: 154 CEL--KILDFGLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 573 LFFCITG-----GK--------------HPYGESFER-----DANIVKD-----RKDLFL 603
+ +TG GK P E ++ + +K RKD
Sbjct: 205 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST 264
Query: 604 V--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ + P+AVDL ++L+ + D R A L HP+F
Sbjct: 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 362 VLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418
V G + G + VAVK L L+E Q ++ +H +V+ Y V S+++ +Y+
Sbjct: 22 VWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 478
E Y+ GS + L K + L LP
Sbjct: 81 E----------YMSKGSLLDFL--KSGEGKKLR------LP------------------- 103
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QL+ + I G+++L IHRDL +N+L+ ++ K++D G+++ ++ D
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG--ENLVCKIADFGLARLIEDDEYTAR 161
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ A W APE GR T D++S G +L +T G+ PY
Sbjct: 162 EGAK--FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GL ++H +IHRDLKP N+L+++D ++ D G+++ L + T Y +
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCEL--RIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 547 SGW-QAPEQLLQ-GRQTRAIDLFSLGCI---------LFFCITGGKHP------------ 583
+ W +APE LL T AID++S+GCI LF GK+
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF----PGKNYVHQLKLILSVLG 229
Query: 584 -----------------YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 626
Y ++ R +F PEA+DL +++L +P+ R
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQ--PVPWSKIFPKAS-PEALDLLSQMLQFDPEERI 286
Query: 627 KAQNVLNHPFF 637
+ L HPF
Sbjct: 287 TVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 53/255 (20%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 397
+V +E+ +G+ G V L Y VAVK L +T + A K+ + L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H NIV++YGV ++ D + E Y+ G + L + D+ L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFE----------YMEHGDLNKFLRSHGPDAAFL------- 109
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
++ EL + QLL++ I SG+ +L +HRDL +N L+ D
Sbjct: 110 --KSPDSPMGELTLS------QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--L 159
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G+S+ + T Y G W PE ++ + T D++S
Sbjct: 160 VVKIGDFGMSRDVY---------TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210
Query: 570 GCILFFCITGGKHPY 584
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
T +++ L +LH+ +I+RDLKP+N+L+ D L D G+ K +M + T
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKL---NMKDDDKTNTF 153
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 603
G+ + APE LL T+A+D ++LG +L+ +TG Y E+ + F
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213
Query: 604 VEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 637
+A DL LL +P R AQ + NHPFF
Sbjct: 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
G + + +I GL LH+ +++RDLKP+N+L+ ++SD+G++ +
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI--RISDLGLAVHVPEG 155
Query: 534 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG------- 585
Q G G+ G+ APE + R T + D ++LGC+L+ I G+ P+
Sbjct: 156 -----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIK 209
Query: 586 -ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
E ER +VK+ ++ + + P+A L LL +P R A+ V HP F
Sbjct: 210 REEVER---LVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 58/239 (24%)
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HPNIV+ GV + + +Y+ +E V G F L K+ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVME----------LVPGGDFLSFLRKKKDELKT-------- 92
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
QL+K D +G+++L IHRDL +N L+ ++
Sbjct: 93 --------------------KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 570
K+SD G+S++ + Y SSG W APE L GR + D++S G
Sbjct: 133 --KISDFGMSRQEDDGI---------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 571 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 627
+L+ + G PY G + ++ V+ + + P+ V + R D P+ RPK
Sbjct: 182 ILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 532
G P L ++T +V GL L E +IHRD+KP NVL++ + KL D G+S L
Sbjct: 98 GIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA 155
Query: 533 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI------DLFSLGCILFFCITGGKHPY-- 584
++ T G + APE++ G + D++SLG + G++PY
Sbjct: 156 SLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPP 209
Query: 585 ---GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
F + + IV + +A D + L+ P+ RP +L HP+
Sbjct: 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 91/313 (29%)
Query: 366 NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420
G VA+K++ D A++EI +L+ HPNIVR V ++ +YL E
Sbjct: 21 KLTGEIVALKKIRLETEDEGVPSTAIREI-SLLKELNHPNIVRLLDVVHSENKLYLVFE- 78
Query: 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480
F + K DS P+ + +
Sbjct: 79 ---------------FLDLDLKKYMDS----------SPLTGLDPPL------------I 101
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 540
++ G+++ H ++HRDLKPQN+LI ++ + KL+D G+++ + T
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL--KLADFGLARAFGVPVRTYTHE 159
Query: 541 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANI---- 594
+ W +APE LL RQ + +D++S+GCI + + P F D+ I
Sbjct: 160 VV----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN--RRPL---FPGDSEIDQLF 210
Query: 595 -------------------VKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDL 624
+ D K F L + +P + +DL +++L +P
Sbjct: 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
Query: 625 RPKAQNVLNHPFF 637
R A+ L HP+F
Sbjct: 271 RISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 544
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK D + A +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFHEDE---VERAYSFC 167
Query: 545 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL- 601
G+ + AP+ + G +A+D +S+G +++ +TG P+ E+++ R+ L
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS-PFTVDGEKNSQAEISRRILK 226
Query: 602 ----FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 637
+ E A D+ RLL +P R P A + HPFF
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 352 EIAKGSNGTVVLEGNYE--GRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIV 402
EI +G+ G V + + GR VA+KR+ V+T + ++E+ L + + +HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R + V CT S D L+ FE +QD L ++
Sbjct: 68 RLFDV-------------CTVSRTDRETKLTLVFEHV----DQD----------LTTYLD 100
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ G P+ + + ++ GL LH ++HRDLKPQN+L++ KL+
Sbjct: 101 KVPE------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLA 152
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
D G+++ M+ + T + ++APE LLQ +DL+S+GCI
Sbjct: 153 DFGLARIYSFQMALTSVVVTLW----YRAPEVLLQSSYATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 45/192 (23%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 543
+IV GL LHE G+I+RDLK NVL+ + K++D G+ K L G + +T
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHI-KIADFGMCKEGILGGVTT-----STF 156
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF- 602
G+ + APE L A+D ++LG +L + + G+ P FE D D +LF
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSP----FEGD-----DEDELFQ 206
Query: 603 -LVE---HIP-----EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFFWTADTRLSFLR 648
++E P EA + L NP+ R P Q++ HPFF R
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF----------R 256
Query: 649 DVSDRVELEDRE 660
++ D +LE +E
Sbjct: 257 EI-DWDKLERKE 267
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 49/204 (24%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GL ++H G+IHRDLKP N+ +++D K+ D G++++ +M TGY
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL--KILDFGLARQTDSEM-------TGYVV 177
Query: 547 SGW-QAPEQLLQG-RQTRAIDLFSLGCILFFCIT------GGKH-------------PYG 585
+ W +APE +L T+ +D++S+GCI+ +T G H P
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
Query: 586 ESFER----DA-NIVK-----DRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633
E ++ DA N VK +KD L P AV++ ++L + + R A L
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 634 HPFFWTADTRLSFLRDVSDRVELE 657
HP+F D D E
Sbjct: 298 HPYF-------EEFHDPEDETEAP 314
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 55/255 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 397
+V +E+ +G+ G V L Y + VAVK L K D A K+ L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQ 65
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H +IV++YGV + D + + E Y+ G + L A D+ L+ E
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFE----------YMKHGDLNKFLRAHGPDAVLMAEGN--- 112
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
E T+ +Q+L + + I +G+ +L +HRDL +N L+ ++
Sbjct: 113 -RPAELTQ------------SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--L 157
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G+S+ + +T Y G W PE ++ + T D++SL
Sbjct: 158 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 570 GCILFFCITGGKHPY 584
G +L+ T GK P+
Sbjct: 209 GVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVES 409
K++ G G V + VAVK L V A E NL+ + QH +VR Y V +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469
++ +Y+ E Y+ GS + L + E LL
Sbjct: 72 KEEPIYIITE----------YMAKGSLLDFLKSDEGGKVLL------------------- 102
Query: 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
+L+ + I G++++ IHRDL+ NVL+S +S K++D G+++
Sbjct: 103 --------PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS--ESLMCKIADFGLARV 152
Query: 530 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
++ + + A W APE + G T D++S G +L+ +T GK PY
Sbjct: 153 IEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 395 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
S + P IV++YG ++ + +++E C GS + ++ +
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCE----------GGSLD----------SIYKK 94
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 512
V+ R + E L K+ ++ GLS+LH +IHRD+KP N+L++
Sbjct: 95 VKKRGGRIGEKV---------------LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572
+ KL D G+S L + T G+S + APE++ + D++SLG
Sbjct: 140 RKGQ--VKLCDFGVSGEL-----VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 573 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-----PEAVD--------------L 613
L + + P+ E ++ L+ +I PE D
Sbjct: 193 LLE-VAQNRFPFPPEGEPPLGPIE------LLSYIVNMPNPELKDEPGNGIKWSEEFKDF 245
Query: 614 FTRLLDPNPDLRPKAQNVLNHPF 636
+ L+ +P RP ++L HP+
Sbjct: 246 IKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 86/330 (26%), Positives = 133/330 (40%), Gaps = 93/330 (28%)
Query: 351 KEIAKGSNGTVVLEGNYE--GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVR 403
++I +G+ G VV +G + G+ VA+K RL V A++EI +L+ QHPNIV
Sbjct: 6 EKIGEGTYG-VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-SLLKELQHPNIVC 63
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
V + +YL E + L K DS LP
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLK----------------KYLDS----------LP---- 93
Query: 464 TKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ A+L+K I+ G+ H ++HRDLKPQN+LI D KL+
Sbjct: 94 --------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLA 143
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 581
D G+++ + T + ++APE LL R + +D++S+G I F K
Sbjct: 144 DFGLARAFGIPVRVYTHEVV---TLWYRAPEVLLGSPRYSTPVDIWSIGTI--FAEMATK 198
Query: 582 HPYGESFERDANI-----------------------VKDRKDLF-------LVEHIP--- 608
P F D+ I + D K+ F L +
Sbjct: 199 KPL---FHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD 255
Query: 609 -EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ +DL ++L +P R A+ LNHP+F
Sbjct: 256 EDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 78/312 (25%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVRW 404
K + G+ G V L + +++ + LK+ Q ++ HP I+R
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ E DQ F+Y+ +E YV G L + SN
Sbjct: 67 FWTEHDQRFLYMLME----------YVPGGELFSYLRNSGRFSNSTG------------- 103
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
L +IV L +LH +++RDLKP+N+L+ K+ KL+D
Sbjct: 104 ----------------LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI--KLTDF 145
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG----- 579
G +K+L+ + T G+ + APE + +A+D ++LG +++ + G
Sbjct: 146 GFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 580 GKHPYG---------ESFERDAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629
+P+G F R + KD LV VD RL +++ A
Sbjct: 200 DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV------VDRTRRL----GNMKNGAD 249
Query: 630 NVLNHPFFWTAD 641
+V NH +F + D
Sbjct: 250 DVKNHRWFKSVD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 80/325 (24%), Positives = 127/325 (39%), Gaps = 87/325 (26%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 406
I +GS G V N E G+ VA+K+ V++ D +AL+EI+ L +HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML-KQLKHPNLVNLIE 67
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V + ++L E C D +LNE+
Sbjct: 68 VFRRKRKLHLVFEYC------------------------DHTVLNELEKN---------- 93
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
G P + K+ + ++ H+ IHRD+KP+N+LI+K KL D G
Sbjct: 94 -----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQI--KLCDFGF 146
Query: 527 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG----- 579
++ L G + T Y ++ W +APE L+ Q +D++++GC+ +TG
Sbjct: 147 ARILTGP----GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 580 GK----------HPYGESFERDANIVKDRKDLFLVEHIPE-----------------AVD 612
GK G+ R I + F IPE A+
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ-FFKGLSIPEPETREPLESKFPNISSPALS 261
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFF 637
L +P R + +L HP+F
Sbjct: 262 FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 82/307 (26%), Positives = 117/307 (38%), Gaps = 75/307 (24%)
Query: 352 EIAKGSNGTVV-LEGNYEGRSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG 406
EI G+ G V + G +AVK++ +T + K I ++ S P IV+ YG
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 407 V---ESDQDFVYLSLE---RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+SD V++ +E C L I
Sbjct: 82 YFITDSD---VFICMELMSTCLDKLLKRIQ------------------------------ 108
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCA 519
P L K+T IV L +L E G+IHRD+KP N+L+ D S
Sbjct: 109 ------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNV 154
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-----RAIDLFSLGCILF 574
KL D GIS RL + G + + APE++ RA D++SLG L
Sbjct: 155 KLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRA-DVWSLGISLV 209
Query: 575 FCITGGKHPYGE---SFERDANIVKDR-KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 629
T G+ PY FE I+++ L E P+ L + RPK +
Sbjct: 210 ELAT-GQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR 268
Query: 630 NVLNHPF 636
+L HPF
Sbjct: 269 ELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 102/325 (31%)
Query: 369 GRSVAVKR-LVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423
GR VA+K+ L+ D AL+EI+ ++ +HPN+V
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVP-------------------- 71
Query: 424 SLNDLIYVLSGSFEEQLNA-------KEQD-SNLLNEVRIRLLPVMENTKDIELWKANGH 475
L D+ + + + + D S LL ++L K L
Sbjct: 72 -LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL--TESQIKCYML------ 122
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI-------SK 528
QLL+ G+++LHE ++HRD+K N+LI D K++D G+
Sbjct: 123 ---QLLE-------GINYLHENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPP 170
Query: 529 RLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--FFC---ITGGK 581
+G T+ T + W + PE LL R+ T A+D++ +GC+ F I GK
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 582 H--------------------------PYGE---SFERDANIVKDRKDLFLVEHIPEAVD 612
P E SF +++R + PE +D
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER----FGKLGPEGLD 286
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFF 637
L ++LL +P R A + L HP+F
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P Q+ + I+ GL+HLH ++HRD+K N+ + + K+ D+G++K L D +
Sbjct: 99 PEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLL-SDNT 155
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
T G+ + +PE D+++LG +L+ C T GKHP+ ++ + A I+
Sbjct: 156 NFAN--TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPF-DANNQGALIL 211
Query: 596 KDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
K + +F + + L + L + RP +L +P
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/297 (23%), Positives = 128/297 (43%), Gaps = 61/297 (20%)
Query: 352 EIAKGSNGTVVL-EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASD-QHPNIVRWYG 406
+I +GS G V + + GR VAVK + + ++ E+ +I D QH N+V Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEV--VIMRDYQHQNVVEMYK 85
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ +++ +E ++ G+ ++++++ R+
Sbjct: 86 SYLVGEELWVLME----------FLQGGAL----------TDIVSQTRLN---------- 115
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
Q+ V ++ L +LH G+IHRD+K ++L++ D KLSD G
Sbjct: 116 ----------EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF 163
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 585
++ D+ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 164 CAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG-IMVIEMVDGEPPYFS 219
Query: 586 ESFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+S + ++D K+ + P D R+L P R AQ +L+HPF
Sbjct: 220 DSPVQAMKRLRDSPPPKLKNAHKIS--PVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 79/324 (24%), Positives = 122/324 (37%), Gaps = 84/324 (25%)
Query: 352 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 405
+I +G+ GTV N E VA+KR+ D AL+EI L+ +H NIVR Y
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLY 65
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
V + L E C L +G + ++ V+ +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI------------VKSFMF------- 106
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
QLLK GL+ H ++HRDLKPQN+LI+K+ KL+D G
Sbjct: 107 -------------QLLK-------GLAFCHSHNVLHRDLKPQNLLINKNGEL--KLADFG 144
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP 583
+++ + C + + W P +L G + + +ID++S GCI G+
Sbjct: 145 LARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
Query: 584 Y-GESFERDANIV------------------KDRKDLFLV------EHI-----PEAVDL 613
+ G + + D K + ++ DL
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDL 260
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
LL NP R A+ L HP+F
Sbjct: 261 LQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
+V GL +LHE +++RDLK N+L+ + K++D G+ K M + +T G+
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFV--KIADFGLCKE---GMGFGDRTSTFCGT 164
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFER--DANIVKD--RKDL 601
+ APE L + TRA+D + LG +L + + G+ P+ G+ E D+ IV D R
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLG-VLIYEMLVGESPFPGDDEEEVFDS-IVNDEVRYPR 222
Query: 602 FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 637
FL EA+ + RLL NP+ R K A++V PFF
Sbjct: 223 FLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 73/256 (28%)
Query: 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-------- 396
K + F KE+ G G VV G + G+ +DVA+K I+ S+
Sbjct: 4 KDLTFLKELGTGQFG-VVKYGKWRGQ-----------YDVAIKMIKEGSMSEDEFIEEAK 51
Query: 397 -----QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
H +V+ YGV + Q +Y+ E Y+ +G N L
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTE----------YMSNGCL----------LNYLR 91
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
E R P +QLL++ +D+ G+++L IHRDL +N L+
Sbjct: 92 EHGKRFQP------------------SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFS 568
D C K+SD G+S+ + D + + GS W PE LL + + D+++
Sbjct: 134 --DDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 569 LGCILFFCITGGKHPY 584
G +++ + GK PY
Sbjct: 187 FGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GS 546
L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y G+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSFCGT 161
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL--FL 603
+ APE + + T++ D +S G ++F +TG G+ + I+K + + FL
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL 221
Query: 604 VEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTRLSFLRDVS 651
PEA L L NP R A + + HPFF T D + R++
Sbjct: 222 S---PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
Q+ + R+I+ GL +LH IHRD+K NVL+S+ KL+D G++ +L
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---I 156
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
+ T G+ W APE + Q D++SLG I + G+ P+ E +
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPHSE--------LHPM 207
Query: 599 KDLFLV-EHIPEAV---------DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 648
K LFL+ ++ P + + L+ P RP A+ +L H F + S+L
Sbjct: 208 KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267
Query: 649 DVSDR 653
++ DR
Sbjct: 268 ELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 52/255 (20%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHD---VALKEIQ---NLIASDQH 398
+V +E+ +G+ G V L Y K LV K D A K+ Q L+ + QH
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
+IV++YGV D D + + E Y+ G + L A D+ +L + + R
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFE----------YMKHGDLNKFLRAHGPDAMILVDGQPR-- 114
Query: 459 PVMENTKDIELWKANGHPS-AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+A G +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 115 ------------QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 160
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G+S+ + +T Y G W PE ++ + T D++S
Sbjct: 161 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 570 GCILFFCITGGKHPY 584
G IL+ T GK P+
Sbjct: 212 GVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 33/191 (17%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
G P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G+++
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQ 161
Query: 534 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL--------FFCITGGKHPYG 585
M+ T + ++APE LLQ +D++S+GCI FC G
Sbjct: 162 MALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217
Query: 586 ESFERDANIVKDR--KDLFLVEH-------------IPE----AVDLFTRLLDPNPDLRP 626
+ F+ +D +D+ L +PE L +L NP R
Sbjct: 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277
Query: 627 KAQNVLNHPFF 637
A L HPFF
Sbjct: 278 SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 45/293 (15%)
Query: 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI---QNLIASDQHPNIVRWYGVE 408
E+ +G+ ++ G+ R VAVK L K D KE +L+++ HPNIV+ GV
Sbjct: 10 EVYEGTATDILGPGSGPIR-VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68
Query: 409 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 468
+ Y+ +E DL+ L + E+ LL + E
Sbjct: 69 LLNEPQYIIMELMEGG--DLLSYLRDARVERFGPP-------------LLTLKE------ 107
Query: 469 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMG 525
LL + D+ G +L ++ IHRDL +N L+S+ K+ D G
Sbjct: 108 -----------LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
+++ + + G W APE LL G+ T D++S G +++ +T G+ PY
Sbjct: 157 LARDIYKS-DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 585 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP---KAQNVLN 633
+ + V L E+ P+ + L T +P RP + Q +L
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 78/322 (24%), Positives = 129/322 (40%), Gaps = 93/322 (28%)
Query: 349 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASD 396
F + + GS G V+L ++ VA+KR K+ H + ++I N I
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYI--- 88
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
HP V YG D+ ++YL LE +V+ G F L ++ N
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLE----------FVIGGEFFTFLRRNKRFPN-------- 130
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
D+ + A AQ++ + +L + +++RDLKP+N+L+ KD
Sbjct: 131 ---------DVGCFYA-----AQIVLI-------FEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
K++D G +K + T+ T G+ + APE LL +A D ++LG ++
Sbjct: 170 I--KMTDFGFAKVVD------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 577 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN--------------- 621
+ G Y + L + + I E + F + LD N
Sbjct: 222 LVGCPPFYAN------------EPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269
Query: 622 --PDLRPKAQNVLNHPFFWTAD 641
+L+ AQNV HP+F D
Sbjct: 270 RYGNLKKGAQNVKEHPWFGNID 291
|
Length = 340 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-ESDQ 411
I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV ++
Sbjct: 14 IGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 471
+Y+ E Y+ GS L++ +R R V+
Sbjct: 73 GGLYIVTE----------YMAKGS-------------LVDYLRSRGRSVLGGDC------ 103
Query: 472 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++K
Sbjct: 104 --------LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS 153
Query: 532 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
TQ+ TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 154 S-----TQD-TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 347 VVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 397
+V E+ +G+ G V L + VAVK L K + A ++ Q L+ Q
Sbjct: 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQ 65
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H +IVR+YGV ++ + + E Y+ G L + D+ +L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFE----------YMRHGDLNRFLRSHGPDAKILAGGE--- 112
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ L Q+L + I SG+ +L + +HRDL +N L+ +
Sbjct: 113 ---DVAPGQLTL--------GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG--L 159
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G+S+ + +T Y G W PE +L + T D++S
Sbjct: 160 VVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210
Query: 570 GCILFFCITGGKHPY 584
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P L ++ +V GL++L + ++HRD+KP N+L++ KL D G+S +L ++
Sbjct: 93 PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIA 150
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
T G++ + APE++ + D++SLG I F + G+ PY + + +++
Sbjct: 151 -----KTYVGTNAYMAPERISGEQYGIHSDVWSLG-ISFMELALGRFPYPQIQKNQGSLM 204
Query: 596 ----------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+D L + + + V T+ + P RP +N+++HPF
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
G + + +I GL LH +++RDLKP+N+L+ D ++SD+G++ +
Sbjct: 98 GFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEG 155
Query: 534 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP---YGESFE 589
+ G G+ G+ APE + R T + D + LGC+++ I GK P E +
Sbjct: 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVK 209
Query: 590 RDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADT 642
R+ VK+ ++ + + A + +LL +P R A+ V HPFF TA+
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
Query: 643 R 643
+
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 477 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 536
S QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+SD G+S+ L+ D
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDPEG 163
Query: 537 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
+ G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+IVS L +LH +++RDLK +N+++ KD K++D G+ K +S T G
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHI--KITDFGLCKE---GISDGATMKTFCG 157
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 605
+ + APE L RA+D + LG +++ + G+ P+ + +D + +L L+E
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF---YNQDHEKL---FELILME 210
Query: 606 HI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 641
I PEA L LL +P R A+ ++ H FF + +
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 33/269 (12%)
Query: 372 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 428
VAVK L + + Q L+A HPNIV+ GV + + L E
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE--------- 88
Query: 429 IYVLSGSFEEQL---NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485
Y+ G E L + + Q S + R N + + L + +
Sbjct: 89 -YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG--LNPLPLS--------CTEQLCIAK 137
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 544
+ +G+++L E +HRDL +N L+ ++ K++D G+S+ + D ++N
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSADYYKASEN--DA 193
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFL 603
W PE + R T D+++ G +L+ + G PY G + E V+D L
Sbjct: 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC 253
Query: 604 VEHIP-EAVDLFTRLLDPNPDLRPKAQNV 631
++ P E +L P RP ++
Sbjct: 254 PDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 26/167 (15%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I+ GL LH+ G+I+RDLK NVL+ KD K++D G+ K +M+ + +T G
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI--KIADFGMCKE---NMNGEGKASTFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--- 602
+ + APE L + ++D +S G +L+ + G +GE D +LF
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----------DEDELFDSI 208
Query: 603 LVE--HIP-----EAVDLFTRLLDPNPDLR-PKAQNVLNHPFFWTAD 641
L + H P EA D ++L + +P R ++ HPFF D
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 50/270 (18%)
Query: 370 RSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 429
+ + V+++ K A E Q ++ HPNI+ +Y + + + +E
Sbjct: 31 KQIPVEQMTKDERLAAQNECQ-VLKLLSHPNIIEYYENFLEDKALMIVME---------- 79
Query: 430 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489
Y G+ E + ++ ++LL+E I L I+
Sbjct: 80 YAPGGTLAEYIQ--KRCNSLLDEDTI-------------------------LHFFVQILL 112
Query: 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 549
L H+H ++HRDLK QN+L+ K K K+ D GISK L S ++ T G+ +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKIL----SSKSKAYTVVGTPCY 167
Query: 550 QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--LVEH 606
+PE L +G+ + D+++LGC+L+ + + + A ++K F + +
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAPISDR 224
Query: 607 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
P+ L +L+ +P RP+ ++ P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 68/250 (27%), Positives = 100/250 (40%), Gaps = 66/250 (26%)
Query: 351 KEIAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 402
K + G+ GTV + EG VA+K L + A KEI + ++AS HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
R G+ C S LI + G LL+ VR
Sbjct: 73 RLLGI-------------CLSSQVQLITQLMPLGC-------------LLDYVR------ 100
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ +I S LL I G+S+L E L+HRDL +NVL+ + K
Sbjct: 101 -NHKDNIG--------SQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VK 149
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILF 574
++D G++K L D Y + G W A E +L T D++S G ++
Sbjct: 150 ITDFGLAKLLDVD-------EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 575 FCITGGKHPY 584
+T G PY
Sbjct: 203 ELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 544
+I+ GL LH ++RDLKP+N+L+ ++SD+G++ ++ +G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHI--RISDLGLAVKIPEGESI-----RGRV 162
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER------DANIVKDR 598
G+ G+ APE L R T + D + LGC+++ I G+ P+ E+ D +++
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLET- 220
Query: 599 KDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
++++ + EA + LL +P R A V HPFF
Sbjct: 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 44/185 (23%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GL ++H G+IHRDLKP NV +++D ++ D G++++ +M TGY +
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL--RILDFGLARQADDEM-------TGYVA 177
Query: 547 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK----HPYGESFERDANIV----- 595
+ W +APE +L + +D++S+GCI+ + G + Y + +R +V
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 596 -----------------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
+D K +F + P A+DL ++L + D R A L
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGAN-PLAIDLLEKMLVLDSDKRISASEAL 296
Query: 633 NHPFF 637
HP+F
Sbjct: 297 AHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 12/119 (10%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QL+ + R I +G+ +L E+ +HRDL +N+L+ + + K+SD G+S+ L+ D S
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS--- 161
Query: 539 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 591
+ T S G W APE + + T A D++S G +++ ++ G+ PY + +D
Sbjct: 162 -DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 68/237 (28%)
Query: 353 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHD------VALKEIQNLIASDQHPN 400
I +G+ G V Y R VA+K+ V+ ++ +L+EI L+ +HPN
Sbjct: 15 IGEGTYGIV-----YRARDTTSGEIVALKK-VRMDNERDGIPISSLREITLLLNL-RHPN 67
Query: 401 IVRWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
IV V + D ++L +E C L L+ + F E
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-------------------- 107
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
+Q+ + ++ GL +LHE +IHRDLK N+L++ DK C
Sbjct: 108 -------------------SQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKG-C 146
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGR-QTRAIDLFSLGCIL 573
K++D G+++ +T + W +APE LL T AID++++GCIL
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 347 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQH 398
+ F I +G+ G V+ ++ + + A+K L + H D A E++ L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHH 62
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
PNI+ G ++ ++Y+++E Y G NLL+ +R +
Sbjct: 63 PNIINLLGACENRGYLYIAIE----------YAPYG-------------NLLDFLRKSRV 99
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
+ E A+ S QLL+ D+ +G+ +L E IHRDL +NVL+ ++
Sbjct: 100 LETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN--LA 157
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
+K++D G+S+ G+ + G W A E L T D++S G +L+ ++
Sbjct: 158 SKIADFGLSR---GE-EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
Query: 579 GGKHPY 584
G PY
Sbjct: 214 LGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 596
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 597 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 637
L PE + D R L+ + D R A+ +L HPF
Sbjct: 229 TNGTPELQN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 44/185 (23%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+ GL ++H +IHRDLKP N+ +++D K+ D G+++ +M TGY +
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEM-------TGYVA 179
Query: 547 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVK------- 596
+ W +APE +L + +D++S+GCI+ +TG P + ++ I++
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 597 ------------------------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
+ ++F+ + P AVDL ++L + D R A L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 633 NHPFF 637
H +F
Sbjct: 299 AHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 46/198 (23%)
Query: 477 SAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDM 534
S+ +KV I+ GL +LH G++HRD+KP N+L++ + C K+ D G+++ + D
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDE 157
Query: 535 SC-LTQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK---------- 581
S +TQ T Y ++APE L+ R T A+D++S+GCI F + G +
Sbjct: 158 SKHMTQEVVTQY----YRAPEILMGSRHYTSAVDIWSVGCI-FAELLGRRILFQAQSPIQ 212
Query: 582 ----------HPYGESFE-----------RDANIVKDRKDLFLV--EHIPEAVDLFTRLL 618
P E+ R + L+ + + EAV L R+L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
Query: 619 DPNPDLRPKAQNVLNHPF 636
+PD R A + L HP+
Sbjct: 273 VFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+IVS L +LH +++RD+K +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHI--KITDFGLCKEGISDGATMK---TFCG 157
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 605
+ + APE L RA+D + LG +++ + G Y + ER ++ + F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 217
Query: 606 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
PEA L LL +P R A+ V+ H FF
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 546 SSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL- 603
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + DR L +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEI-DRMTLTVN 215
Query: 604 VE----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 648
VE PE L LL + R AQ V H FF D + +L+
Sbjct: 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 65/209 (31%), Positives = 88/209 (42%), Gaps = 56/209 (26%)
Query: 483 VTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS----------- 527
VTR + V + +H++G IHRD+KP N+LI + KLSD G+S
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI--KLSDFGLSTGFHKQHDSAY 159
Query: 528 --KRLQGD--------------------MSCLTQNAT--------GYGSSG---WQAPEQ 554
K LQG MS Q AT Y + G + APE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 555 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHI---PEA 610
LQ + D +SLG I+F C+ G E S E I+ R+ L+ + I EA
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279
Query: 611 VDLFTRLL-DPNPDL-RPKAQNVLNHPFF 637
DL RL+ + L R A + +HPFF
Sbjct: 280 EDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 77/297 (25%)
Query: 351 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKT-HHDVALKEIQN--LIASDQHPNI 401
+ I +G+ G V + GR VAVK +T D+ K +Q ++ HPNI
Sbjct: 1 ERIGRGNFGEV-----FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 55
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-VRIRLLPV 460
VR GV + + +Y+ +E V G F + L E R+++
Sbjct: 56 VRLIGVCTQKQPIYIVME----------LVQGGDFL---------TFLRTEGPRLKV--- 93
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+L+++ + +G+ +L IHRDL +N L+++ K
Sbjct: 94 -----------------KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL--K 134
Query: 521 LSDMGISKRLQGDMSCLTQNATG-YGSSG--------WQAPEQLLQGRQTRAIDLFSLGC 571
+SD G+S+ + G Y S+G W APE L GR + D++S G
Sbjct: 135 ISDFGMSR----------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 572 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+L+ + G PY S ++ ++ L E P+AV L R + +P RP
Sbjct: 185 LLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 482 KVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 540
K+ +V GL++L+ + ++HRD+KP N+L++ KL D G+S L ++
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI--KLCDFGVSGELINSIA----- 159
Query: 541 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 600
T G+S + +PE++ G+ T D++SLG + GK P+ S D
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGI 218
Query: 601 LFLVEHI--------------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 646
L L++ I + D L +P RP Q + P F A +
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 79/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 351 KEIAKGSNGTVV-LEGNYEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 402
K+I KG V +GR VA+K++ K D LKEI +L+ HPN++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEI-DLLKQLDHPNVI 65
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVL----SGSFEEQL-NAKEQDSNLLNEVRIRL 457
++ F+ N+L VL +G + + K+Q RL
Sbjct: 66 KYLA-----SFIEN---------NELNIVLELADAGDLSRMIKHFKKQK---------RL 102
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+P E T +WK + S L H+H ++HRD+KP NV I+
Sbjct: 103 IP--ERT----IWK-----------YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
KL D+G+ + S T + G+ + +PE++ + D++SLGC+L+ +
Sbjct: 146 --KLGDLGLGRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE-M 199
Query: 578 TGGKHP-YGES---FERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
+ P YG+ + I K D L + E DL +R ++P+P+ RP VL
Sbjct: 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
Query: 633 N 633
Sbjct: 260 Q 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 48/242 (19%)
Query: 345 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK-THHDVALKEIQNLIASDQHPNIV 402
KLV K++ G G V + G Y G VA+K L + + A NL+ QHP +V
Sbjct: 9 KLV---KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R Y V + Q+ +Y+ E Y+ +GS + L E
Sbjct: 65 RLYAVVT-QEPIYIITE----------YMENGSLVDFLKTPE------------------ 95
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ + K L+ + I G++ + IHRDL+ N+L+S ++ C K++
Sbjct: 96 -GIKLTINK--------LIDMAAQIAEGMAFIERKNYIHRDLRAANILVS--ETLCCKIA 144
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G++ RL D + + W APE + G T D++S G +L +T G+
Sbjct: 145 DFGLA-RLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 583 PY 584
PY
Sbjct: 203 PY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 67/303 (22%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGV 407
+ I G+ G V N +A +++K D A+ + + ++ D +H NIV ++G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 408 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+D +++ +E C SL D IY ++G E
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+Q+ V+R+ + GL +LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGV 152
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-------------TRAIDLFSLGCIL 573
S ++ + + + + G+ W APE R+ AI+L L +
Sbjct: 153 SAQIT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
Query: 574 FFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633
F HP F + + K ++ L NP RP A+ +L
Sbjct: 210 F-----DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
Query: 634 HPF 636
HPF
Sbjct: 265 HPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 467 IELWKANGH--PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+E K G Q+ + ++ G+ ++H+ ++HRDLK +N+ + + K+ D
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDF 149
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILF-FCITGGKH 582
G+S+ L G T T G+ + +PE L QG +++ D++SLGCIL+ C H
Sbjct: 150 GVSRLLMGSCDLAT---TFTGTPYYMSPEALKHQGYDSKS-DIWSLGCILYEMCCL--AH 203
Query: 583 PY-GESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDLRPKAQNVLNHPF 636
+ G++F + + L E ++ + +L+ +P LRP A +L +PF
Sbjct: 204 AFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 373 AVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427
A+KR+ + H D A E++ L HPNI+ G + ++YL++E
Sbjct: 38 AIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE-------- 88
Query: 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 487
Y G NLL+ +R + + I A+ S QLL D+
Sbjct: 89 --YAPHG-------------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 488 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 547
G+ +L + IHRDL +N+L+ ++ + AK++D G+S+ + G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSR----GQEVYVKKTMGRLPV 187
Query: 548 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
W A E L T D++S G +L+ ++ G PY
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
AQ+ V R+ + L LH +IHRD+K NVL+ D S KL+D G ++ + S
Sbjct: 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 596
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 597 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 637
L PE + D R L+ + + R A+ +L HPF
Sbjct: 229 TNGTPELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
+++++ +I G+++L+ +HRDL +N +++ D F K+ D G+++ + +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD--FTVKIGDFGMTRDIY-ETDYYR 176
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKD 597
+ G W APE L G T + D++S G +L+ + + PY G S E+ V D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 598 RKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN------HPFF 637
L ++ PE V DL NP +RP ++N HP F
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 372 VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427
VAVK L KT + LKEI+ +++ ++PNI+R GV D + + E
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLLGVCVSDDPLCMITE-------- 97
Query: 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS---AQLLKVT 484
Y+ +G + L+ +E +S AN PS A LL +
Sbjct: 98 --YMENGDLNQFLSQREIESTFT--------------------HANNIPSVSIANLLYMA 135
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 543
I SG+ +L + +HRDL +N L+ + K++D G+S+ L GD + A
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAV- 192
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVKDRKDLF 602
W A E +L G+ T A D+++ G L+ T K PY S D ++++ + F
Sbjct: 193 -LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY--SLLSDEQVIENTGEFF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 32/99 (32%), Positives = 60/99 (60%), Gaps = 8/99 (8%)
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 542
+ R+++ L ++H++G+IHRD+K N+L++ + KL D G++ L + S + +T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSS---KRST 160
Query: 543 GYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 579
G+ W APE + +G+ T+A D++SLG ++ TG
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKA-DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 44/194 (22%)
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMSCL 537
KV + +++GL ++H ++HRD+K N+LI+KD KL+D G S +
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRY 180
Query: 538 TQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL---------------------- 573
T T + ++ PE LL R ID++ GCI+
Sbjct: 181 TNRVVTLW----YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
Query: 574 -FFC--ITGGKHPYGESFERDANIV-----KDRKDLFLVEHI--PEAVDLFTRLLDPNPD 623
C IT P + E + K + L ++ P A+DL +LL +P
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 624 LRPKAQNVLNHPFF 637
R A LNH FF
Sbjct: 297 KRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP--- 171
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
+ + G+ W APE + + +D++SLG ++ + G + E + +++D
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 599 -----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640
K+L V P RLL +P R A +L HPF A
Sbjct: 232 LPPKLKNLHKVS--PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 58/298 (19%)
Query: 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 407
E+ G+ G V N E ++A ++++T + L+ EI+ ++A+ HP IV+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGA 77
Query: 408 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
+++ +E C D I + E D L E +I++
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML------------ELDRGL-TEPQIQV---------- 114
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
+ R ++ L +LH + +IHRDLK NVL++ D KL+D G+S
Sbjct: 115 ---------------ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDI--KLADFGVS 157
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITGGKH 582
+ ++ L + + G+ W APE ++ D++SLG I + +
Sbjct: 158 AK---NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 213
Query: 583 PYGE--SFERDANIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
P+ E I K + E D LD +P+ RP A +L HPF
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 59/233 (25%)
Query: 362 VLEGNYEGRS-VAVKRL---VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417
V EG ++ R VA+K L KE+Q L +H +++ + V
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQAL-KRLRHKHLISLFAV---------- 70
Query: 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS 477
CS+ + +Y+++ +L K L ++LPV
Sbjct: 71 -----CSVGEPVYIIT-----ELMEKGSLLAFLRSPEGQVLPV----------------- 103
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
A L+ + + G+++L E IHRDL +N+L+ +D K++D G+++ ++ D+
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED--LVCKVADFGLARLIKEDV--- 158
Query: 538 TQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
Y SS W APE G + D++S G +L+ T G+ PY
Sbjct: 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 44/194 (22%)
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------- 534
I++GL+ LH+ +HRDL P N+ I+ K C K++D G+++R
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGIC-KIADFGLARRYGYPPYSDTLSKDET 183
Query: 535 SCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGES----- 587
+ T + W +LL G + A+D++S+GCI +TG GE+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 588 ------------------------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 623
E KD K +F +A+DL LL NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNAS-DDAIDLLQSLLKLNPL 302
Query: 624 LRPKAQNVLNHPFF 637
R A+ L H +F
Sbjct: 303 ERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 596
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 597 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640
L PE + D R L+ + + R A+ +L HPF A
Sbjct: 229 TNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 381 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 440
H D A E++ L HPNI+ G + ++YL++E Y G
Sbjct: 39 HRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----------YAPHG------ 81
Query: 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500
NLL+ +R + + I A+ S QLL D+ G+ +L + I
Sbjct: 82 -------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 134
Query: 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 560
HRDL +N+L+ ++ + AK++D G+S+ G + G W A E L
Sbjct: 135 HRDLAARNILVGEN--YVAKIADFGLSR---GQ-EVYVKKTMGRLPVRWMAIESLNYSVY 188
Query: 561 TRAIDLFSLGCILFFCITGGKHPY 584
T D++S G +L+ ++ G PY
Sbjct: 189 TTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QL+ + I G++++ + IHRDL+ N+L+ + K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--LVCKIADFGLARLIEDNEYTAR 160
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
Q A W APE L GR T D++S G +L +T G+ PY R+ +R
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
Query: 599 K-DLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+ + PE++ +L +PD RP
Sbjct: 219 GYRMPCPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 54/198 (27%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCL 537
QLL+ L ++H + HRDLKP+N+L + D C K+ D G+++ D
Sbjct: 111 QLLR-------ALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFND---- 156
Query: 538 TQNA---TGYGSSGW-QAPEQL--LQGRQTRAIDLFSLGCILFFCITG-----GKH---- 582
T A T Y ++ W +APE + T AID++S+GCI +TG GK+
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216
Query: 583 ----------PYGESFERDANIVKDRKDLFLVEHI-------------PEAVDLFTRLLD 619
P E+ R N K R+ L + P A+ L RLL
Sbjct: 217 LDLITDLLGTPSPETISRVRN-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA 275
Query: 620 PNPDLRPKAQNVLNHPFF 637
+P RP A+ L P+F
Sbjct: 276 FDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 81/346 (23%), Positives = 134/346 (38%), Gaps = 88/346 (25%)
Query: 352 EIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTH---HDVALKEIQNLIASDQHPNIVR 403
EI GS G V N + VAVK++ +T+ D+ +KE++ + +HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVK-FLQQLKHPNTIE 85
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ G + +L +E C S +DL+ V +E
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------- 120
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
++ +T + GL++LH +IHRD+K N+L+++ KL+D
Sbjct: 121 --------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLAD 164
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 580
G S + + G+ W APE +L +G+ +D++SLG CI
Sbjct: 165 F-------GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT---CI--- 211
Query: 581 KHPYGESFERDANIVKDRKDLFLVEHIP----------EAVDLFTRLLD----PNPDLRP 626
E ER + + + + HI E D F +D P RP
Sbjct: 212 -----ELAERKPPLF-NMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP 265
Query: 627 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 672
+ +L H F D L D+ R + RE D+ R ++ I
Sbjct: 266 ASAELLRHDFVRR-DRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 66/308 (21%)
Query: 351 KEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPNIV 402
+++ +G G V L EG+ G VAVK L +H LK+ ++ + H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 403 RWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 70 KYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPRNKNKINL----------- 108
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
Q LK I G+ +L +HRDL +NVL+ + K
Sbjct: 109 -----------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VK 149
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT-- 578
+ D G++K ++ D T W APE L+Q + A D++S G L+ +T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
Query: 579 -GGKHPYGE------------SFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDL 624
P + R ++++ K L + PE V L + + P
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 625 RPKAQNVL 632
R QN++
Sbjct: 270 RTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 38/250 (15%)
Query: 347 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVK--THHDVA--LKEIQNLIA 394
+V K + +G G VV Y + +VAVK L T D+A + E++ +
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL 73
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+H NI+ GV + + +Y+ +E Y G+ E L R
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVE----------YAAKGNLREFL-------------R 110
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
R P + T DI L+ + G+ +L IHRDL +NVL+++D
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
K++D G+++ + D+ + + G W APE L T D++S G +++
Sbjct: 171 NVM--KIADFGLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227
Query: 575 FCITGGKHPY 584
T G PY
Sbjct: 228 EIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 70/329 (21%), Positives = 127/329 (38%), Gaps = 85/329 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-THHDVALKEIQNLIASDQHPNIVRWY 405
+ +EI G G V L E R VA+K + + + E ++ HP +V+ Y
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
GV +++ + L E ++ G + L A+
Sbjct: 66 GVCTERSPICLVFE----------FMEHGCLSDYLRAQR--------------------- 94
Query: 466 DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
G S + LL + D+ G+++L +IHRDL +N L+ +++ K+SD
Sbjct: 95 --------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDF 144
Query: 525 GISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
G+++ + D Q + G+ W +PE + + D++S G +++ + GK
Sbjct: 145 GMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
Query: 582 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTA 640
PY ++R + +VE I L+ P L ++ ++ H +
Sbjct: 200 TPY-----------ENRSNSEVVETINAGFRLY------KPRLASQSVYELMQHCW---- 238
Query: 641 DTRLSFLRDVSDRVELEDRESDSKLLRAL 669
+ EDR S S LL L
Sbjct: 239 ------------KERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 544
++V L HLH+ +++RDLKP+N+L+ L D G+SK + LT N T
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIA--LCDFGLSK------ANLTDNKTTNT 155
Query: 545 --GSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL 601
G++ + APE LL + T+ +D +SLG ++F G Y E ++ + K
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
Query: 602 FLVEHIPEAVDLFTR-LLDPNPDLR----PKAQNVLNHPFF 637
F + + F + LL+ NP R A + HPFF
Sbjct: 216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 544
+IV GL LH G+I+RDLK NV++ +D K++D G+ K + GD + +T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI--KIADFGMCKENVFGD----NRASTFC 157
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 604
G+ + APE L + T ++D +S G +L+ + G +G+ + D R D
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVD---T 212
Query: 605 EHIP-----EAVDLFTRLLDPNPDLRPKAQ-NVLNHPFF----WTA 640
H P E+ D+ +L + +P R N+ HPFF WTA
Sbjct: 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
Q+ V ++ LS+LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI--KLSDFGFCAQVSKEVP--- 173
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598
+ + G+ W APE + + +D++SLG ++ I G + E + ++D
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
Query: 599 -----KDLFLVEHIPEA-VDLFTRLLDPNPDLRPKAQNVLNHPFF 637
KD V + +DL +L P R AQ +L HPF
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 42/183 (22%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+ GL ++H G++HRDLKP N+LI+++ K+ D G+++ M TGY S
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDL--KICDFGLARIQDPQM-------TGYVS 167
Query: 547 SG-WQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPYGE------------- 586
+ ++APE +L ++ +D++S GCI + G GK +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 587 ------SFERDANIVKD---RKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN 633
E V+ R+ + E P A+DL ++L +P R A L
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 634 HPF 636
HP+
Sbjct: 288 HPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 77/333 (23%), Positives = 123/333 (36%), Gaps = 88/333 (26%)
Query: 342 RIGKLVVFN------------KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 389
GK ++F+ + I KG+ G V N + S A +++ HD+ +EI
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEI 61
Query: 390 QN----LIASDQHPNIVRWYGVESDQDFV-----YLSLERCTCSLNDLIYVLSGSFEEQL 440
+ L A HPN+V++YG+ +D +L LE C GS + +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN----------GGSVTDLV 111
Query: 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500
+ + E I + + + GL HLH I
Sbjct: 112 KGFLKRGERMEEPIIAY-------------------------ILHEALMGLQHLHVNKTI 146
Query: 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP-----EQL 555
HRD+K N+L++ + KL D G+S +L S + T G+ W AP EQ
Sbjct: 147 HRDVKGNNILLTTEGG--VKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 556 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP------- 608
L D++SLG I + G P + + + LF + P
Sbjct: 202 LDSTYDARCDVWSLG-ITAIELGDGDPPLAD--------LHPMRALFKIPRNPPPTLHQP 252
Query: 609 -----EAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
E D + L + + RP ++L H F
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 97/332 (29%)
Query: 351 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHD-----VALKEIQNLIASDQHP 399
++I +G+ G V Y+ R ++A+K++ D A++EI +L+ QH
Sbjct: 8 EKIGEGTYGVV-----YKARDRVTNETIALKKIRLEQEDEGVPSTAIREI-SLLKEMQHG 61
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NIVR V + +YL E Y+ L+ K+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFE----------YL-------DLDLKKH-------------- 90
Query: 460 VMENTKDIELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
M+++ D A +L+K I+ G+++ H ++HRDLKPQN+LI + +
Sbjct: 91 -MDSSPDF----AKNP---RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-A 141
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI----- 572
KL+D G+++ + T + ++APE LL R + +D++S+GCI
Sbjct: 142 LKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
Query: 573 ----LF------------FCITGGKHPYGESFERDANIVKDRKDLF----------LVEH 606
LF F I G P E++ + D K F +V
Sbjct: 199 NQKPLFPGDSEIDELFKIFRILGT--PNEETW-PGVTSLPDYKSAFPKWPPKDLATVVPT 255
Query: 607 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ P VDL +++L +P R A+ L H +F
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 40/261 (15%)
Query: 372 VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 428
V VK L KT + E + ++ H N+VR G+ + + Y+ LE
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE--------- 88
Query: 429 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488
Y G ++ L A E K + Q + + I
Sbjct: 89 -YTDLGDLKQFLRA--------------------TKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 548
G+ HL +HRDL +N L+S K+S + +SK + +NA
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ--REVKVSLLSLSKDVYNSEYYKLRNA--LIPLR 183
Query: 549 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRK-DLFLVEH 606
W APE + + + D++S G +++ T G+ P+ S E N ++ K +L + E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 607 IPEAV-DLFTRLLDPNPDLRP 626
P + L TR NP RP
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 38/250 (15%)
Query: 347 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVK--THHDVA--LKEIQNLIA 394
+ K + +G G VV+ + E +VAVK L T D++ + E++ +
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 76
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+H NI+ G + +Y+ +E Y G+ E L R
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL-------------R 113
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
R P ME + DI L+ T + G+ +L IHRDL +NVL++++
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
K++D G+++ + ++ + G W APE L T D++S G +++
Sbjct: 174 NVM--KIADFGLARDVN-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 575 FCITGGKHPY 584
T G PY
Sbjct: 231 EIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTAR 160
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
Q A W APE L GR T D++S G +L T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 404
K I G+ G V G +VAVK+L + TH A +E+ L+ H NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISL 85
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + Q SLE D+ V+ + D+NL + + L
Sbjct: 86 LNVFTPQK----SLEE----FQDVYLVM----------ELMDANLCQVIHMEL------- 120
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D + K+ D
Sbjct: 121 -DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDF 167
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
G+++ + T Y ++APE +L +D++S+GCI+
Sbjct: 168 GLARTACTNFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 53/244 (21%)
Query: 351 KEIAKGSNGTVVLEG---NYEGR--SVAVK-----RLVKTHHDVALKEIQNLIASDQHPN 400
K++ GS G VV G G+ VAVK +L D LKE ++ S H N
Sbjct: 1 KKLGDGSFG-VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF-LKEA-AIMHSLDHEN 57
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++R YGV + ++ E GS ++L + + L+
Sbjct: 58 LIRLYGVVLTHPLMMVT-ELAPL----------GSLLDRLR--------KDALGHFLIST 98
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
L + Q I +G+ +L IHRDL +N+L++ D K
Sbjct: 99 --------LC----DYAVQ-------IANGMRYLESKRFIHRDLAARNILLASDDK--VK 137
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
+ D G+ + L + W APE L + A D++ G L+ T G
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 581 KHPY 584
+ P+
Sbjct: 198 EEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 54/186 (29%), Positives = 77/186 (41%), Gaps = 44/186 (23%)
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM--DANGMVRCDTA 203
Query: 544 YGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGES------------ 587
G+ + +PE L R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 588 ----FERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--- 637
F D I K KDL FL D RL R + +HPFF
Sbjct: 264 NSLTFPDDIEISKQAKDLICAFL-------TDREVRL------GRNGVDEIKSHPFFKND 310
Query: 638 -WTADT 642
WT D
Sbjct: 311 QWTFDN 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 404
K+I +GS G +L + E G+ +K ++ + + KE+ ++++ +HPNIV++
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQY 64
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ +Y+ ++ C G +++NA+
Sbjct: 65 QESFEENGNLYIVMDYCE----------GGDLYKKINAQ--------------------- 93
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ P Q+L I L H+H+ ++HRD+K QN+ ++KD + KL D
Sbjct: 94 ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI--KLGDF 145
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
GI++ L + T G+ + +PE D+++LGC+L+ T KH +
Sbjct: 146 GIARVLNSTVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAF 201
Query: 585 --GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
G I++ + + +L ++L NP RP ++L F
Sbjct: 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 41/186 (22%)
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 544
+ ++ GL++ H+ +HRD+K N+L++ KL+D G+++ + S N
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQI--KLADFGLARLYNSEESRPYTNKV-- 178
Query: 545 GSSGWQAPEQLLQG--RQTRAIDLFSLGCIL--FFC-------------------ITGG- 580
+ W P +LL G R AID++S GCIL F + G
Sbjct: 179 -ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 581 ---------KHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 630
K PY + + + ++ F IP A+DL +L +P R A+
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF--SFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 631 VLNHPF 636
LN P+
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 471 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530
K N + + R+I+ GLSHLH+ +IHRD+K QNVL++++ KL D G+S +L
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161
Query: 531 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITGGKHPYG 585
D + +N T G+ W APE + A DL+SLG I + G P
Sbjct: 162 --DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLC 217
Query: 586 ESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ + + LFL+ P + L N RP + ++ H
Sbjct: 218 D--------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269
Query: 635 PF 636
PF
Sbjct: 270 PF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 59/284 (20%)
Query: 369 GRSVAVKRLVKTHHDVALKEIQNLIASDQ------HPNIVRWYGVESDQDFVYLSLERCT 422
G A+K L K + +K++Q++ HP IV D++ VY LE
Sbjct: 43 GEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE--- 98
Query: 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482
+V+ G L +R KA P+
Sbjct: 99 -------FVVGGE-------------LFTHLR----------------KAGRFPNDVAKF 122
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 542
++V +LH +I+RDLKP+N+L+ K++D G +K++ + T
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV--KVTDFGFAKKVP------DRTFT 174
Query: 543 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 602
G+ + APE + +A+D +++G +L+ I G + ++ R + + F
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
Query: 603 LVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFWTAD 641
A DL LL + L+ +V NHP+F A+
Sbjct: 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 544
+I+ GL LH G+++RDLK N+L+ D K++D G+ K + GD + T
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHI--KIADFGMCKENMLGD----AKTCTFC 157
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 604
G+ + APE LL + ++D +S G +L+ + G +G E ++ +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 641
EA D+ +L P+ R + ++ HPFF D
Sbjct: 218 WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 486 DIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 544
+IVS L +LH E +++RDLK +N+++ KD K++D G+ K D + + T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI--KITDFGLCKEGIKDGATMK---TFC 157
Query: 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 604
G+ + APE L RA+D + LG +++ + G Y + E+ ++ + F
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
Query: 605 EHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
PEA L + LL +P R A+ ++ H FF
Sbjct: 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 532
NG P ++ ++ + H+ ++HRD+KP+N+LIS + KL D G ++ L
Sbjct: 95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL--KLCDFGFARNLSE 152
Query: 533 DMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 573
+ N T Y ++ W ++PE LL +A+D++S+GCIL
Sbjct: 153 GSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 59/241 (24%)
Query: 351 KEIAKGSNGTV------VLEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHP 399
K I G+ G V +LE R+VA+K+L + TH A +E+ L+ H
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHK 83
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NI+ V + Q SLE D+ V+ + D+NL +++ L
Sbjct: 84 NIIGLLNVFTPQK----SLEE----FQDVYIVM----------ELMDANLCQVIQMEL-- 123
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D +
Sbjct: 124 ------DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-- 165
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K+ D G+++ T Y ++APE +L +D++S+GCI+ I G
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 580 G 580
G
Sbjct: 222 G 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 38/183 (20%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GLS+ H+ ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGEL--KLADFGLARA----KSVPTKTYSNEVV 165
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 595
+ W P +L G + ID++ +GCIL+ TG G + + + +++
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225
Query: 596 ----------KDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ R LF L+ H P + +DL + LL R A+ L H
Sbjct: 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285
Query: 635 PFF 637
+F
Sbjct: 286 SYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCL 537
QL+ + I G+S+LH+ G+IH+D+ +N +I D+ K++D +S+ L D CL
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNALSRDLFPMDYHCL 175
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIV 595
N W A E L+ + A D++S G +L+ +T G+ PY E FE A +
Sbjct: 176 GDNE--NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYL 232
Query: 596 KD 597
KD
Sbjct: 233 KD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
L+ + + +G++++ + IHRDL+ N+L+ D C K++D G+++ ++ +
Sbjct: 103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVC-KIADFGLARLIEDNEYTAR 160
Query: 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
Q A W APE L GR T D++S G +L +T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
T ++V L +H +GLIHRD+KP N+L+ DK KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKM--DETGMVRCDTA 203
Query: 544 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK 599
G+ + +PE L G R D +S+G LF + G Y +S + + D K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 600 DLFLVEHIPEAVDLFTR--------LLDPNPDL-RPKAQNVLNHPFF----WTADT---- 642
+ + PE V++ L D L R + + HPFF W D
Sbjct: 264 NSL---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRET 320
Query: 643 ------RLSFLRDVSDRVELEDRESDSK 664
LS D S+ ++ED + D +
Sbjct: 321 AAPVVPELSSDIDSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 68/297 (22%)
Query: 362 VLEGNYEGR---SVAVKRLVKTHHDVALKEIQN-------LIASDQHPNIVRWYGVESDQ 411
V EG Y GR +V ++ VKT + ++ ++ +++ H NIVR GV ++
Sbjct: 22 VYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81
Query: 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 471
++ LE +++G + K + L E R R
Sbjct: 82 LPRFILLE-----------LMAGG-----DLK----SFLRENRPRP-------------- 107
Query: 472 ANGHPSA----QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGI 526
PS+ LL RD+ G +L E IHRD+ +N L++ K AK++D G+
Sbjct: 108 --ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 527 SKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
++ + A+ Y G W PE L G T D++S G +L+ +
Sbjct: 166 ARDIYR--------ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 580 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 634
G PY G + + V L + P V + T P+ RP +L
Sbjct: 218 GYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I S L +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GIEHSKTTSTFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 602
+ + APE L + R +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPF---YSRDTAEMYDNILNKPLR 214
Query: 603 LVEHI-PEAVDLFTRLLDPNPDLRPKAQN----VLNHPFF 637
L +I A L LL + R A++ + NH FF
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 351 KEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEI---QNLIASDQHPNIV 402
KE+ G+ G+VV +G Y +S VAVK L + H KE +++A HP IV
Sbjct: 1 KELGHGNFGSVV-KGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R GV C L+ V+ + L + R +PV
Sbjct: 60 RLIGV---------------CKGEPLMLVMELAPLGPLLKYLKKR--------REIPV-- 94
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
D++ +V G+++L +HRDL +NVL+ AK+S
Sbjct: 95 --SDLKEL---------AHQVAM----GMAYLESKHFVHRDLAARNVLLVNRHQ--AKIS 137
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G+S+ L G W APE + G+ + D++S G L+ + G
Sbjct: 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 583 PYGE 586
PYGE
Sbjct: 198 PYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 72/312 (23%)
Query: 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 407
E+ G+ G V + E A ++++ + L+ EI ++++ +HPNIV Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEA 70
Query: 408 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
++ +++ +E C +L+ ++ L E
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTE---------------------------- 102
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
Q+ V R ++ L+ LH +IHRDLK N+L++ D KL+D G+
Sbjct: 103 -----------PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGV 149
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCILFFCITGG 580
S + + S L + T G+ W APE + +A D++SLG IT
Sbjct: 150 SAKNK---STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA-DIWSLG------ITLI 199
Query: 581 KHPYGESFERDAN-------IVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNV 631
+ E + N I+K D L +PD RP A +
Sbjct: 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
Query: 632 LNHPFFWTADTR 643
L HPF
Sbjct: 260 LKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 171
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 596
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 597 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640
L PE + D R LD + + R A+ +L H F A
Sbjct: 230 TNGTPELQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 79/263 (30%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ----------- 397
F KE+ G G V L G + + VA+K I S++
Sbjct: 8 FMKELGSGQFGVVHL-GKW-----------RAQIKVAIKAINEGAMSEEDFIEEAKVMMK 55
Query: 398 --HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
HP +V+ YGV + Q +Y+ E F E + LLN +R
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTE----------------FME-------NGCLLNYLRQ 92
Query: 456 RLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
R G S LL + +D+ G+ +L IHRDL +N L+S
Sbjct: 93 R----------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-- 134
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGC 571
+ K+SD G+++ + D + + G+ W PE + + D++S G
Sbjct: 135 STGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 572 ILFFCITGGKHPYGESFERDANI 594
+++ T GK P FE+ +N
Sbjct: 190 LMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 402
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQQLRHPNTI 78
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ G + +L +E C S +D++ V L EV I
Sbjct: 79 EYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--------------LQEVEIA------ 118
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ + GL++LH IHRD+K N+L+++ + KL+
Sbjct: 119 -------------------AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLA 157
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG--CI 572
D G S ++ + G+ W APE +L +G+ +D++SLG CI
Sbjct: 158 DF-------GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 362 VLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418
V EG + VAVK L D L E Q ++ +HP +++ Y V
Sbjct: 22 VWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAV----------- 69
Query: 419 ERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 473
C+L + IY+++ GS E L R LP
Sbjct: 70 ----CTLEEPIYIVTELMKYGSLLEYLQGGAG--------RALKLP-------------- 103
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
QL+ + + SG+++L IHRDL +NVL+ + + C K++D G+++ ++ D
Sbjct: 104 -----QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNIC-KVADFGLARVIKED 156
Query: 534 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ + A W APE L R + D++S G +L +T G+ PY
Sbjct: 157 IYEAREGAK--FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+IVS L +LH +++RDLK +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHI--KITDFGLCKEGITDAATMK---TFCG 157
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 605
+ + APE L RA+D + LG +++ + G Y + E+ ++ F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT 217
Query: 606 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
+A L + LL +P+ R A+ ++ H FF
Sbjct: 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 38/160 (23%), Positives = 78/160 (48%), Gaps = 5/160 (3%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
+++++ +I G+++L+ +HRDL +N ++++D F K+ D G+++ + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIY-ETD 173
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANI 594
+ G W +PE L G T D++S G +L+ T + PY G S E+
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233
Query: 595 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 633
V + L ++ P+ + +L NP +RP +++
Sbjct: 234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 41/186 (22%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GL+++H ++HRDLKPQN+LIS KL+D G+++ S +Q +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGEL--KLADFGLAR----AKSIPSQTYSSEVV 165
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH--------------------PY 584
+ W P +L G + A+D++ GCI + G P
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225
Query: 585 GESFERDANIVKDRKDLFL-------------VEHIPEAVDLFTRLLDPNPDLRPKAQNV 631
+++ + + + + FL + P+A DL +++L P R AQ+
Sbjct: 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285
Query: 632 LNHPFF 637
L HP+F
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 469 LWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
L K G A QL+ + + SG+ +L E+G +H+ L VL++ D K+S
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD--LVCKISGFR-- 152
Query: 528 KRLQGD-MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
RLQ D + +G W APE + + A D++S G +++ ++ G+ PY +
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 587 SFERDANIVKDRKDLF 602
+D ++K +D F
Sbjct: 212 MSGQD--VIKAVEDGF 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSIPTKTYSNEVV 166
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 595
+ W P +L G + ID++ +GCI + TG G + E + +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 596 ------------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLN 633
K R D L H P + +L ++LL R A+ +
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285
Query: 634 HPFFWTADTRLSFLRD 649
HP+F R+ L D
Sbjct: 286 HPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|199218 cd10423, RNase_RNase-L, RNase domain (also known as the kinase extension nuclease domain) of RNase L | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 642 TRLSFLRDVSDRVELEDRESDSKLLRAL--EGIALVALNGKWDEKMETKFIENIGRY--- 696
R LR+V + +++ R+ S +LR L W K++ + ++ + ++
Sbjct: 2 NRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECSRSFPNWTSKIDKEVMDIMNKFYEK 61
Query: 697 RRYKY-DNVRDLLRVIRNKSNHFRELP-QDIQELLGSHPEGFYNYFSCRFPKLLIEVYN 753
+++ Y D V DLL+ IRN H E + ++E++G E YF FP L+I VY
Sbjct: 62 KKFFYQDTVGDLLKFIRNLGEHIDEEKNKRMKEIIGDPSE----YFQKTFPDLVIYVYK 116
|
Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target. Length = 119 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 77/308 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQH------ 398
+ +E+ +GS G V YEG K +VK + VA+K + + +
Sbjct: 8 ITLIRELGQGSFGMV-----YEG---LAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 399 ---------PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 449
++VR GV S + +E + G + L ++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVME----------LMAKGDLKSYLRSRRPE--- 106
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQN 508
L P+ Q +++ +I G+++L +HRDL +N
Sbjct: 107 --AENNPGLGP---------------PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 509 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQ 560
++++D K+ D G+++ + T Y G G W APE L G
Sbjct: 150 CMVAED--LTVKIGDFGMTRDI---------YETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 561 TRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLL 618
T D++S G +L+ T + PY G S E V D L L E+ P+ + +L
Sbjct: 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCW 258
Query: 619 DPNPDLRP 626
NP +RP
Sbjct: 259 QYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 63/236 (26%)
Query: 351 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 404
K I G+ G V + G++VA+K+L + TH A +E+ L+ H NI+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGL 80
Query: 405 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
V +S ++F VYL +E +L +I + L+ R+ L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----------------LDHERMSYL 123
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
L+ Q+L G+ HLH G+IHRDLKP N+++ KS C
Sbjct: 124 ----------LY--------QML-------CGIKHLHSAGIIHRDLKPSNIVV---KSDC 155
Query: 519 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
K+ D G+++ T Y ++APE +L +D++S+GCI+
Sbjct: 156 TLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 83/315 (26%), Positives = 122/315 (38%), Gaps = 88/315 (27%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRL-------VKTHHDVALK-EIQNLIASDQHPNIVRW 404
+ G+ G V Y+GR V +L V + +K EI L H NI +
Sbjct: 24 VGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 405 YGV------ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
YG D ++L +E C S+ DL+ G NA ++D
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG------NALKED----------- 121
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
W A + R+I+ GL+HLH +IHRD+K QNVL++++
Sbjct: 122 ------------WIA---------YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE- 159
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCI 572
KL D G+S +L D + +N T G+ W APE + A D++SLG I
Sbjct: 160 -VKLVDFGVSAQL--DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG-I 214
Query: 573 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPN 621
+ G P + A LFL+ P + +D L N
Sbjct: 215 TAIEMAEGAPPLCDMHPMRA--------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKN 266
Query: 622 PDLRPKAQNVLNHPF 636
RP + +L HPF
Sbjct: 267 YLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGV 407
K++ G G V + + VAVK + V A N++ + QH +V+ + V
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 408 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
+ + +Y+ E ++ GS + L + E
Sbjct: 70 VTKEP-IYIITE----------FMAKGSLLDFLKSDE----------------------- 95
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
+ P +L+ + I G++ + + IHRDL+ N+L+S S K++D G++
Sbjct: 96 ----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFGLA 149
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ ++ + + A W APE + G T D++S G +L +T G+ PY
Sbjct: 150 RVIEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 44/253 (17%)
Query: 347 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 395
+V K + +G G VV+ E VAVK L D K++ +LI+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEM 76
Query: 396 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL----------- 115
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
R R P ME + L+ + G+ +L IHRDL +NVL+
Sbjct: 116 --RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
++D K++D G+++ + + + G W APE L T D++S G
Sbjct: 174 TEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230
Query: 572 ILFFCITGGKHPY 584
+L+ T G PY
Sbjct: 231 LLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ + H+H +IHRD+K N+L+ + KL D G SK +S T G+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAATVSD-DVGRTFCGT 208
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDAN-IVKDRKDLFLV 604
+ APE + ++ D+FSLG +L+ +T K P+ GE+ E + + R D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
PE ++ T LL +P RP + +LN P
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
+ LL + I S + +L + IHRDL +N L+ ++ K++D G+S+ + GD
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT- 158
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
T +A W APE L + + D+++ G +L+ T G PY
Sbjct: 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
++V + +H++G +HRD+KP+NVLI D++ KL+D G + RL + ++ G
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPV--G 165
Query: 546 SSGWQAPEQLLQGRQTRA-------IDLFSLGCILFFCITGGKHPYGE--SFERDANIVK 596
+ + APE +L D +SLG I + I G+ P+ E S + NI+
Sbjct: 166 TPDYIAPE-VLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMN 223
Query: 597 DRKDLFLVEHIP---EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
++ L E + +DL LL R + + HPFF
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 38/193 (19%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSVPTKTYSNEVV 166
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 595
+ W P +L G + ID++ +GCI F +G G + E + +++
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 596 -----------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 634
K L+ H P E ++L T+ L R A+ + H
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286
Query: 635 PFFWTADTRLSFL 647
+F + TR+ L
Sbjct: 287 AYFRSLGTRIHSL 299
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 74/309 (23%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 347 VVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALK-EIQN---LIASD 396
V F +E+ +G+ G V SVA+K L K + + ++ E + L++
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDL 65
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDL-IYVLSGSFEEQLNAKEQDSNLLNEVRI 455
QHPNIV GV + + + E + DL +++ S + A+ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFE--YLAHGDLHEFLVRNSPHSDVGAESGD--------- 114
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
E K L + L + I +G+ +L +HRDL +N L+ +
Sbjct: 115 ------ETVKSS-LD------CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161
Query: 516 SFCAKLSDMGISK--------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567
+ K+SD G+S+ R+Q S L W PE +L G+ T D++
Sbjct: 162 T--VKISDFGLSRDIYSADYYRVQSK-SLLPVR--------WMPPEAILYGKFTTESDIW 210
Query: 568 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 625
S G +L+ + G PY G S + +++ R+ L E P V L + P R
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270
Query: 626 PKAQNVLNH 634
P+ +++
Sbjct: 271 PRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 30/278 (10%)
Query: 359 GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVY 415
G + L G + VA+K L ++ E Q +L+A HPNIV GV + + V
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 475
+ E Y+ G E L + S++ + +D + + H
Sbjct: 84 MLFE----------YLNQGDLHEFLIMRSPHSDV----------GCSSDEDGTVKSSLDH 123
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
L + I +G+ +L +H+DL +N+LI + K+SD+G+S+ +
Sbjct: 124 --GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISDLGLSREIYSADY 179
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANI 594
Q + W PE ++ G+ + D++S G +L+ + G P YG S + +
Sbjct: 180 YRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 595 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNV 631
V+ R+ L E P + L T P RP+ +++
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 534
P L++ DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC--VADFGLSKKIYSGDY 168
Query: 535 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG--ESFERDA 592
Q W A E L T D+++ G ++ +T G+ PY E+ E
Sbjct: 169 --YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
Query: 593 NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 626
++K + + + + +L + P P RP
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 50/201 (24%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 545
++ GL ++H ++HRDLKP N+L++ + C K+ D G+++ +T+ Y
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE----YV 169
Query: 546 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK--------------------HP 583
+ W +APE LL + T AID++S+GCI F + G K P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 584 YGES--FERDANIVKDRKDLFLVEHI----------PEAVDLFTRLLDPNPDLRPKAQNV 631
E F R+ + + L P A+DL ++L +P R +
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 632 LNHPFFWTADTRLSFLRDVSD 652
L HP+ L+ L D SD
Sbjct: 289 LAHPY-------LASLHDPSD 302
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQGD 533
P + + + I+ G+ +LH ++HRDLKP N+L+ + + K++DMG ++
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 534 MSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 573
+ L + ++APE LL R T+AID++++GCI
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 9/114 (7%)
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAK 520
N K ++L P + + I+ G+ +LH ++HRDLKP N+L+ + + K
Sbjct: 99 NKKPVQL------PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 573
++DMG ++ + L + ++APE LL R T+AID++++GCI
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 51/189 (26%)
Query: 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------------GDM 534
+H++G IHRD+KP N+L+ D KLSD G+ L+ D
Sbjct: 117 IHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 535 SCLTQNATGYGSSGWQ-----------------APEQLLQGRQTRAIDLFSLGCILFFCI 577
++ + W+ APE LQ + D +SLG I++ +
Sbjct: 175 ISKPMSSKRKAET-WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 578 TGGKHP---YGESFERDANIVKDRKDLFLVEHIP---EAVDLFTRLLDPNPDLR---PKA 628
G +P E I+ ++ L + +P EA DL RL + R
Sbjct: 234 VG--YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGV 290
Query: 629 QNVLNHPFF 637
+ +HPFF
Sbjct: 291 NEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
+ ++++ + G+ +L +HRDL +NVL+ AK+SD G+SK L D S
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDS 150
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ G W APE + + + D++S G ++ + G+ PY
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
AQ+ V R ++S + ++H G+IHRD+K +NVL++ + C L D G + +G S
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWS-- 315
Query: 538 TQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 574
YG +G APE L T ++D++S G ++F
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 534
P+ L+K DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC--VADFGLSKKIYNGDY 167
Query: 535 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
Q W A E L T D++S G ++ T G+ PY
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 477 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 536
S LL I G+S+L E+ L+HRDL +NVL+ K++D G+++ L D
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID--- 162
Query: 537 LTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 590
T Y + G W A E +L R T D++S G ++ +T G PY
Sbjct: 163 ----ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY------ 212
Query: 591 DANIVKDRKDLFLVEHIPEAVDLFTRLLDP 620
D IP+ ++ RL P
Sbjct: 213 ---------DGIPAREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ G+ HLH G+IHRDLKP N+++ D + K+ D G+++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRY-- 183
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCIL 573
++APE +L +D++S+GCI+
Sbjct: 184 --YRAPEVILGMGYKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
++V + +H++G +HRD+KP NVL+ DK+ +L+D G RL D + Q+ G
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT--VQSNVAVG 165
Query: 546 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 600
+ + +PE L +GR D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 601 LF----LVEHIPE-AVDLFTRLLDPNPDLR---PKAQNVLNHPFF 637
F V + E A DL RL+ P+ R Q+ +HPFF
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 65/304 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHH----DVALKEIQNLIAS 395
+ F K + G+ G VV E G S VAVK L T H + + E++ +
Sbjct: 37 LSFGKTLGAGAFGKVV-EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
H NIV G + + + E C Y +LLN +R
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCC-------Y----------------GDLLNFLR- 131
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
R +D LL + + G++ L IHRDL +NVL++ K
Sbjct: 132 RKRESFLTLED-------------LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGC 571
K+ D G+++ + D N G++ W APE + T D++S G
Sbjct: 179 --IVKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 572 ILFFCITGGKHPYGESFERDANIVKDRKDLFLV---EHIPEAV-DLFTRLLDPNPDLRPK 627
+L+ + G +PY D+ K K+ + + EH P + D+ D +P RP
Sbjct: 232 LLWEIFSLGSNPY-PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
Query: 628 AQNV 631
+ +
Sbjct: 291 FKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 77/334 (23%), Positives = 120/334 (35%), Gaps = 95/334 (28%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNI 401
K + KG G V L G+ A+K L K L E + L D HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLD-HPFL 63
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
Y + ++ L ++ C +L +L + Q L+E R
Sbjct: 64 PTLYASFQTETYLCLVMD--YCPGGELFRLL----------QRQPGKCLSEEVARF---- 107
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+ A +++ L +LH +G+++RDLKP+N+L+ + L
Sbjct: 108 --------YAA-------------EVLLALEYLHLLGIVYRDLKPENILLHESGHI--ML 144
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQ---------------------------APEQ 554
SD +SK+ A GS APE
Sbjct: 145 SDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 555 LLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDA---NIVKDRKDLFLVEHIP-- 608
+ A+D ++LG IL + + G P+ G + RD NI+K K++ P
Sbjct: 204 ISGDGHGSAVDWWTLG-ILLYEMLYGTTPFKGSN--RDETFSNILK--KEVTFPGSPPVS 258
Query: 609 -EAVDLFTRLLDPNPDLR----PKAQNVLNHPFF 637
A DL +LL +P R A + HPFF
Sbjct: 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 2/95 (2%)
Query: 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 549
G+ +L E +HRDL +NVL+ AK+SD G+SK L D + G W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 550 QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
APE + + + D++S G +++ + G+ PY
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 47/201 (23%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
++ GLS++H+ ++HRDLKPQN+LIS KL+D G+++ S + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGEL--KLADFGLARA----KSVPSHTYSNEVV 165
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG-----GKHPYGESFER--------- 590
+ W P +L G + +D++ +GCI I G G + ER
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 591 ----------------------DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628
N+ + L V H A DL ++LL P R A
Sbjct: 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH---AEDLASKLLQCFPKNRLSA 282
Query: 629 QNVLNHPFFWTADTRLSFLRD 649
Q L+H +F RL L D
Sbjct: 283 QAALSHEYFSDLPPRLWELTD 303
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDM 524
D L KA P L K++ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 87 DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 144
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570
G+S +L M+ + G+ + +PE+L T D++SLG
Sbjct: 145 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 56/297 (18%)
Query: 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 408
E+ G+ G V N E +A +++ T + L++ +++AS HPNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 409 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 468
++ +++ +E C D + +E
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM------------------------------------LE 95
Query: 469 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528
L + P ++ V + + L++LHE +IHRDLK N+L + D KL+D G+S
Sbjct: 96 LERPLTEPQIRV--VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI--KLADFGVSA 151
Query: 529 RLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTR----AIDLFSLGCILFFCITGGKHP 583
+ + + + + G+ W APE ++ + + R D++SLG I + + P
Sbjct: 152 K---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG-ITLIEMAQIEPP 207
Query: 584 YGE--SFERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+ E I K E D + L+ N D R +L HPF
Sbjct: 208 HHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + T +T G
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKEGIFN-GKTT--STFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR--KDL 601
+ + APE L + ++D +++G +L + + G P+ E D I+ D
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMG-VLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 602 FLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFF 637
+L + +AVD+ + NP +R + + +L HPFF
Sbjct: 218 WLSQ---DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 44/225 (19%)
Query: 451 NEVRIRLLPVMENT-----KDIELWKANGHPSAQLLK--VTRDIVSGLSHLHEIGLIHRD 503
NE I L VME K ++ + N H L + + L+++H + HRD
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195
Query: 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-T 561
LKPQN+LI + KL D G +K L Q + Y S ++APE +L T
Sbjct: 196 LKPQNLLIDP-NTHTLKLCDFGSAKNLLAG-----QRSVSYICSRFYRAPELMLGATNYT 249
Query: 562 RAIDLFSLGCILFFCITGGKHPYGESF--------------------ERDANIV------ 595
IDL+SLGCI+ I G G+S E + N
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD 309
Query: 596 ---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
KD K +F +A++ ++ L P R L PFF
Sbjct: 310 VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 80/347 (23%), Positives = 134/347 (38%), Gaps = 76/347 (21%)
Query: 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSV-AVKRLV-------KTHHDVALKEIQNLIASD 396
KL +EI GS G V + V A+K++ + D+ +KE++ +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQKL 72
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
+HPN +++ G + +L +E C S +DL+ V +E
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------ 114
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
++ VT + GL++LH +IHRD+K N+L+S+
Sbjct: 115 ---------------------VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 573
KL D G S + G+ W APE +L +G+ +D++SLG
Sbjct: 154 --VKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT- 203
Query: 574 FFCITGG--KHPYGESFERDA-----NIVKDRKDLFLVEHIPEAVDLFT-RLLDPNPDLR 625
CI K P F +A +I ++ H E F L P R
Sbjct: 204 --CIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 626 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 672
P ++ +L H F + + + D+ R + RE D+ R ++ I
Sbjct: 259 PTSEVLLKHRFV-LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-07
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 61/252 (24%)
Query: 353 IAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDVA------LKEIQNLIASD-QHPNIV 402
I KG G V L Y+ R VA+K++ + + L+E + IA+D HP IV
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAK--IAADLIHPGIV 65
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVM 461
Y + SD D VY ++ Y+ + + L + +++S L
Sbjct: 66 PVYSICSDGDPVYYTMP----------YIEGYTLKSLLKSVWQKES----------LS-- 103
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
K++ A L + I + + ++H G++HRDLKP N+L+ +
Sbjct: 104 ---KEL----AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVI 154
Query: 522 SDMG--ISKRLQGD-------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566
D G I K+L+ + S +T G+ + APE+LL + + D+
Sbjct: 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 567 FSLGCILFFCIT 578
++LG IL+ +T
Sbjct: 215 YALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 45/210 (21%)
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE--GMVRCDTA 203
Query: 544 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGES------------ 587
G+ + +PE L G R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
Query: 588 ----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF----WT 639
F D +I K+ K+L V L R + + H FF W
Sbjct: 264 NSLTFPDDNDISKEAKNLICAFLTDREVRLG----------RNGVEEIKRHLFFKNDQWA 313
Query: 640 ----ADTRLSFLRDVS---DRVELEDRESD 662
DT + D+S D +D E D
Sbjct: 314 WETLRDTVAPVVPDLSSDIDTSNFDDIEED 343
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIAS-DQHPNIVRWYGV- 407
I KG+ G V N + S+A +++ DV +EI+ N++ S HPN+V++YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 408 -ESDQ---DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
++D+ ++L LE C GS E + L+E I +
Sbjct: 89 YKADKLVGGQLWLVLELCN----------GGSVTELVKGLLICGQRLDEAMISYI----- 133
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
L+ A + GL HLH +IHRD+K N+L++ + KL D
Sbjct: 134 -----LYGA---------------LLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVD 171
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPE 553
G+S +L S + T G+ W APE
Sbjct: 172 FGVSAQL---TSTRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
IV L +H ++HRDLK N+ + + KL D G SK+ +S L ++ G+
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLM--PTGIIKLGDFGFSKQYSDSVS-LDVASSFCGT 234
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLV 604
+ APE + R ++ D++SLG IL+ +T + P+ +R+ ++ + D F
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHR-PFKGPSQREIMQQVLYGKYDPFPC 293
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF-WTADTRLSFLRDVSDRVELEDRESDS 663
L LL NP LRP Q +L+ F + A+ +R S+ + DRE
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRH-SETISPHDRE--- 349
Query: 664 KLLRALEG 671
++LR L+
Sbjct: 350 EILRQLQE 357
|
Length = 478 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 370 RSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG-VESDQDFVYLSLERCTCS 424
++VA+K L K + L+E + + QHPNIV G V +Q LS+ CS
Sbjct: 36 QAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---LSMIFSYCS 91
Query: 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 484
+DL E L + S++ +T D + K+ P A + +
Sbjct: 92 HSDL--------HEFLVMRSPHSDV------------GSTDDDKTVKSTLEP-ADFVHIV 130
Query: 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 543
I +G+ L ++H+DL +NVL+ DK K+SD+G+ + + D L N+
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVF-DK-LNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 602
W +PE ++ G+ + D++S G +L+ + G PY G S + ++++R+ L
Sbjct: 189 --PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 603 LVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFFW 638
+ P V L + P RP+ +++ + W
Sbjct: 247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 368 EGRS--VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421
+GR VAVK L K + LKE++ +++ + PNI+R GV D+D + + E
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101
Query: 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
DL LS L+ KE++ N L + + S LL
Sbjct: 102 ENG--DLNQFLS---SHHLDDKEENGNDAVPPAHCLPAI-------------SYSS--LL 141
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQN 540
V I SG+ +L + +HRDL +N L+ ++ K++D G+S+ L GD +
Sbjct: 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN--LTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 541 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 586
A W A E +L G+ T A D+++ G IL C + PYGE
Sbjct: 200 AV--LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC---KEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 44/253 (17%)
Query: 347 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 395
+ K + +G G VV+ + + +VAVK L D K++ +L++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML---KDDATDKDLSDLVSEMEM 70
Query: 396 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVE----------YASKGNLREYL----------- 109
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
R R P M+ + D L+ + G+ +L IHRDL +NVL+
Sbjct: 110 --RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
++D K++D G+++ + ++ + G W APE L T D++S G
Sbjct: 168 TEDNVM--KIADFGLARDVH-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224
Query: 572 ILFFCITGGKHPY 584
+L+ T G PY
Sbjct: 225 LLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
LL T + G+ L +HRDL +NVL+++ K K+ D G+++ + D + +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSK 296
Query: 540 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-----GESFERDANI 594
+T + W APE + T D++S G +L+ + G PY +F N
Sbjct: 297 GST-FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---YNK 352
Query: 595 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+K + +H + V D+ + + P+ RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 36/170 (21%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 543
+I GL LH G+I+RDLK NV++ + K++D G+ K G + T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI--KIADFGMCKENIFGGKTTR-----TF 161
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 602
G+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQPPFDGE----------DEDELF 210
Query: 603 --LVEHIP--------EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFF 637
++EH EAV + LL +P R P +++ H FF
Sbjct: 211 QSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P + K + S + H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES---FERDA 592
T + G+ + +PE++ + D++SLGC+L+ YG+ F
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218
Query: 593 NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
I + EH E + +L + + P+PD RP
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 56/230 (24%)
Query: 372 VAVKRLVKTHHDVALKEIQNLIAS-------DQHPNIVRWYGVESDQDFVYLSLERCTCS 424
VAVK L + K++ +L++ +H NI+ GV + + +Y+ +E
Sbjct: 45 VAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA--- 98
Query: 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 484
NL + +R R P + D P + L
Sbjct: 99 --------------------AHGNLRDFLRARRPPGEYASPDDP------RPPEETLT-Q 131
Query: 485 RDIVS-------GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
+D+VS G+ L IHRDL +NVL+++D K++D G+++ D+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED--HVMKIADFGLAR----DIHHI 185
Query: 538 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ G W APE L T D++S G +L+ T G PY
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 538
QLL+ GL++ H+ ++HRDLKPQN+LIS+ KL+D G+++ S +
Sbjct: 111 QLLR-------GLAYCHQRRVLHRDLKPQNLLISERGEL--KLADFGLARA----KSVPS 157
Query: 539 QNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG----------------- 579
+ + + W P +L G + ++D++ +GCI + TG
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
Query: 580 ---------GKHPYGESFE--RDANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPD 623
P S + + + ++ IP +L + L P
Sbjct: 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK 277
Query: 624 LRPKAQNVLNHPFF 637
R A + HP+F
Sbjct: 278 KRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 62/247 (25%), Positives = 92/247 (37%), Gaps = 79/247 (31%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ-GD-- 533
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q GD
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 534 ------------------------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563
CL + G + + APE LL+ T+
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--YIAPEVLLRTGYTQL 224
Query: 564 IDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIP-------EAVDLF 614
D +S+G IL+ + G+ P+ E ++ L HIP EA DL
Sbjct: 225 CDWWSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTL----HIPSQAKLSREASDLI 279
Query: 615 TRLLDPNPDLR---PKAQNVLNHPFFWTAD-------------TRLSFLRDVS--DRVEL 656
RL + R A + HPFF D +++ D S D V+
Sbjct: 280 LRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDP 338
Query: 657 EDRESDS 663
E SD
Sbjct: 339 EKLRSDD 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 48/261 (18%)
Query: 376 RLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLS 433
RL K+ V + KE L+A +HPNIV + +Y+ +E C
Sbjct: 34 RLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVMEYC------------ 80
Query: 434 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493
+L+ + I+L + P +L+ + G+ H
Sbjct: 81 -----------DGGDLMQK--------------IKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 553
+HE ++HRD+K +N+ ++++ KL D G ++ L + T G+ + PE
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPE 170
Query: 554 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAV 611
D++SLGCIL+ T KHP+ + ++ + + + E
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 612 DLFTRLLDPNPDLRPKAQNVL 632
L ++ NP RP A +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P Q L + + I+ GL +LH +IHRD+K +N+ I+ C + D+G ++
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC--IGDLGAAQ------- 205
Query: 536 CLTQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 574
G +G APE L + + D++S G +LF
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 69/253 (27%), Positives = 101/253 (39%), Gaps = 52/253 (20%)
Query: 342 RIGKLVVFNKE--IAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN--- 391
RI K F K + G+ GTV + EG VA+K L + A KEI +
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 392 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
++AS +P++ R G+ C S LI L LL+
Sbjct: 62 VMASVDNPHVCRLLGI-------------CLTSTVQLITQLMPF-----------GCLLD 97
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
VR E+ +I S LL I G+++L E L+HRDL +NVL+
Sbjct: 98 YVR-------EHKDNI--------GSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
+ K++D G++K L D G W A E +L T D++S G
Sbjct: 143 KTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 572 ILFFCITGGKHPY 584
++ +T G PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 456 RLLPVME--NTKDI--ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
RL VME N D+ ++ ++ + ++ L LH G+I+RDLK N+L+
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
+ C KL+D G+ K +G ++ +T T G+ + APE L + ++D ++LG
Sbjct: 130 DAE-GHC-KLADFGMCK--EGILNGVT-TTTFCGTPDYIAPEILQELEYGPSVDWWALG- 183
Query: 572 ILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR---- 625
+L + + G+ P+ E D +I+ D L+ V EAV + + NP+ R
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESILHD-DVLYPVWLSKEAVSILKAFMTKNPNKRLGCV 242
Query: 626 ---PKAQNVLNHPFF----WTA 640
+ HPFF W
Sbjct: 243 ASQGGEDAIKQHPFFKEIDWVL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
+L + R ++ + +LHE +IHRD+K +N+ I+ C L D G +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFG--------AA 229
Query: 536 CLTQNATGYGSSGW------QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 589
C + GW APE L + A+D++S G +LF T + FE
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----HDSLFE 285
Query: 590 RD 591
+D
Sbjct: 286 KD 287
|
Length = 391 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P + K + S L H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
T + G+ + +PE++ + D++SLGC+L+ YG+ N+
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLY 214
Query: 596 KDRKDLFLVEHIPEAVDLFTRLL--------DPNPDLRP 626
K + ++ P D ++ L +P+P+ RP
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG- 543
++ GL L +++RDLKP+N+L+ D ++SD+G++ ++ +G + G
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEG------ETVRGR 161
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK--HPYGESFERDA--NIVKDRK 599
G+ G+ APE + + T + D + LGC+++ I G E +R+ VK+ +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 600 DLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
+ + + +A + LL NP R A V HP F
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 402
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVK-FLQRIKHPNSI 88
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ G + +L +E C S +DL+ V +E
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------ 124
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
++ +T + GL++LH +IHRD+K N+L+++ KL+
Sbjct: 125 ---------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLA 167
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 570
D G S + + G+ W APE +L +G+ +D++SLG
Sbjct: 168 DF-------GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 59/301 (19%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPNIVRW 404
+EI G G V+L Y VA + + + + KE + QHPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G + L E C L DL LS
Sbjct: 61 LGQCVEAIPYLLVFE--YCELGDLKSYLSQ------------------------------ 88
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
E W L ++ +I +G++H+H+ +H DL +N ++ D K+ D
Sbjct: 89 ---EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--LTVKVGDY 143
Query: 525 GIS-KRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 576
GI R + D + W APE L+ QT+ ++++LG L+
Sbjct: 144 GIGPSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
Query: 577 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAV-DLFTRLLD---PNPDLRPKAQN 630
PY +R+ +++KD++ + + + +L +P+ R A+
Sbjct: 202 FENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEE 261
Query: 631 V 631
V
Sbjct: 262 V 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|188875 cd09769, Luminal_IRE1, The Luminal domain, a dimerization domain, of the Serine/Threonine protein kinase, Inositol-requiring protein 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 25/106 (23%), Positives = 42/106 (39%), Gaps = 13/106 (12%)
Query: 1 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEE 60
P S DG + G+ +T+ + VD ++G + + S V P D +
Sbjct: 82 SPCRSSDGILYTGSKQTTWYTVDPRTGEKIQVLGSGGADSN-----CPESCVDPDDDEQS 136
Query: 61 LVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 106
S +YI RT+Y + + E +WNV Y+D+
Sbjct: 137 ECSS--------SSTIYIGRTEYTVTIYDSKTREPIWNVTYSDYTP 174
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), a serine/threonine protein kinase (STK) and a type I transmembrane protein that is localized in the endoplasmic reticulum (ER). IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), is a kinase receptor that also contains an endoribonuclease domain in the cytoplasmic side. It plays roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its luminal domain and forms oligomers, allowing the kinase domain to undergo trans-autophosphorylation. This leads to a conformational change that stimulates its endoribonuclease activity and results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. Mammals contain two IRE1 proteins, IRE1alpha (or ERN1) and IRE1beta (or ERN2). IRE1alpha is expressed in all cells and tissues while IRE1beta is found only in intestinal epithelial cells. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 349 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPN 400
F +++ KG+ G+V L + G VAVK+L H +EI+ L S QH N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDN 66
Query: 401 IVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
IV++ GV + + + L +E Y+ GS + L + R+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVME----------YLPYGSLRDYLQK--------HRERLD-- 106
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
H LL I G+ +L +HRDL +N+L+ +
Sbjct: 107 ----------------HRK--LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE--NR 146
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
K+ D G++K L D G W APE L + + + A D++S G +L+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 72/349 (20%), Positives = 123/349 (35%), Gaps = 118/349 (33%)
Query: 352 EIAKG-SNGTVVLEGNYE--GRSVAVKRL---VKTHHDVALKEIQNLI---ASDQHPNIV 402
I K + +V ++ VAVK++ + D LK +Q I QHPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED--LKLLQQEIITSRQLQHPNIL 62
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRL 457
+ F+ + +YV+S GS E+ L K L E+ I
Sbjct: 63 PYV-----TSFIV----------DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF 105
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ +D+++ L ++H G IHR +K ++L+S D
Sbjct: 106 -------------------------ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK- 139
Query: 518 CAKLSDMGIS-------KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFS 568
LS + S KR Q + +++ + W +PE L Q Q D++S
Sbjct: 140 -VVLSGLRYSVSMIKHGKR-QRVVHDFPKSSV--KNLPWLSPEVLQQNLQGYNEKSDIYS 195
Query: 569 LGCILFFCIT-----GGKHPYGE----------------------SFERDANIVKDRKDL 601
+G IT G P+ + ++ + + +
Sbjct: 196 VG------ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249
Query: 602 FLVEHIPEAVD-LFTRLLDP------------NPDLRPKAQNVLNHPFF 637
+ ++VD +TR +P+ RP A +LNH FF
Sbjct: 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 54/207 (26%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 531
++ + +H++G IHRD+KP N+LI D KL+D G+ SK Q
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 532 -------------------GD-MSCLTQNATG----------YGSSGWQAPEQLLQGRQT 561
GD + L Q AT G+ + APE LL+ T
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 562 RAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHI---PEAVDLFTR 616
+ D +S+G ILF + G+ P+ E ++ L + + PEAVDL T+
Sbjct: 227 QLCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285
Query: 617 LLDPNPDL--RPKAQNVLNHPFFWTAD 641
L + R A ++ HPFF D
Sbjct: 286 LCCSAEERLGRNGADDIKAHPFFSEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 3/107 (2%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
L+ + + +G+ L +HRDL +NVLI + K K+ D G+++ + D + +++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISK 298
Query: 540 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586
+T + W APE + T D++S G +L+ T G PY E
Sbjct: 299 GST-FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 49/207 (23%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGV 407
+ + G+ G V N +A +++K IQ ++ +H NIV ++G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 408 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
++ +++ +E C SL D IY ++G E
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
Q+ V R+ + GL++LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGV 152
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPE 553
+ ++ ++ + + G+ W APE
Sbjct: 153 AAKITATIA---KRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537
AQLL + I G+++LH IHRDL +NVL+ D+ K+ D G++K +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYY 164
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
G W A E L + + + A D++S G L+ +T
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 58/209 (27%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 531
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 532 -----------GDMS---------------------CLTQNATGYGSSGWQAPEQLLQGR 559
GD + CL + G+ + APE LL+
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV--GTPNYIAPEVLLRTG 224
Query: 560 QTRAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFL---VEHIPEAVDLF 614
T+ D +S+G IL+ + G+ P+ E ++ + L + + PEA DL
Sbjct: 225 YTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
Query: 615 TRLL-DPNPDL-RPKAQNVLNHPFFWTAD 641
+L P L + A + HPFF T D
Sbjct: 284 IKLCRGPEDRLGKNGADEIKAHPFFKTID 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I S L +LH I +++RDLKP+N+L+ D L+D G+ K ++ T G
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCKE---GIAQSDTTTTFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKD---RKDLF 602
+ + APE + + +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPF---YCRDVAEMYDNILHKPLV 214
Query: 603 LVEHIPEAV-DLFTRLLDPNPDLRPKAQN----VLNHPFF 637
L + LL+ + R A+ + HPFF
Sbjct: 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 468 ELWKANGH-PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL--ISKDKSFCAKLSDM 524
+L K G A++ K+ R +V L+ LH+ +IH D+K +NVL +KD+ + L D
Sbjct: 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY---LCDY 154
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
G+ K + G SC G+ + +PE++ + D +++G +L + + GKHP+
Sbjct: 155 GLCKII-GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVG-VLTYELLTGKHPF 206
Query: 585 GESFERDANI--VKDR--KDLFLVEHIPE-AVDLFTRLLDPNPDLR-PKAQNVLNHPFF 637
E + + ++ + R K L ++++ + A D +L N + R ++ HPF
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 73/305 (23%), Positives = 115/305 (37%), Gaps = 66/305 (21%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVA---VKRLVKT----HHDVALKEIQNLIASDQHPNIVR 403
EI G G V+L + G S A VK L + + L+E+Q HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQ 59
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
G + L LE C L DL L + ++D
Sbjct: 60 CLGQCIESIPYLLVLE--FCPLGDLKNYLRSNRGMVAQMAQKDV---------------- 101
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
L ++ ++ SGL LH+ IH DL +N ++ D S K+ D
Sbjct: 102 ----------------LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGD 143
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 576
G++ + +T++ W APE LL QT+ +++SLG ++
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 577 ITGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 626
T PY + E+D + K + DL + E V F L +P+ RP
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE-VMQFCWL---DPETRP 258
Query: 627 KAQNV 631
A+ V
Sbjct: 259 TAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I S L +LH + +++RDLKP+N+L+ D L+D G+ K ++ +T G
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE---NIEHNGTTSTFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 18/128 (14%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 543
+I L+ LHE G+I+RDLK NVL+ D KL+D G+ K GD + +T
Sbjct: 104 EICIALNFLHERGIIYRDLKLDNVLLDADGHI--KLTDYGMCKEGLGPGDTT-----STF 156
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 603
G+ + APE L ++D ++LG +L F + G+ P+ +I+ D D+
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALG-VLMFEMMAGRSPF--------DIITDNPDMNT 207
Query: 604 VEHIPEAV 611
+++ + +
Sbjct: 208 EDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
++ S + +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GVEPEETTSTFCG 158
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
LL I G+ +L E ++HR+L +N+L+ D +++D G++ L D
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD--SIVQIADFGVADLLYPDDKKYFY 168
Query: 540 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ W A E +L GR T D++S G ++ ++ G PY
Sbjct: 169 SEHK-TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 477 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 536
S LL I G+ +L E L+HRDL +NVL+ K++D G+++ L+GD
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKE 165
Query: 537 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ G W A E + + T D++S G ++ +T G PY
Sbjct: 166 YNADG-GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 524
D L KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 583
G+S +L M+ + G+ + +PE+L + D++S+G L + G++P
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE-MAIGRYPI 202
Query: 584 -----------YGESFERDA 592
+G E D
Sbjct: 203 PPPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
++V + +H++ +HRD+KP N+L+ D + +L+D G +L D + Q++ G
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT--VQSSVAVG 165
Query: 546 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 600
+ + +PE L +G+ D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 601 LF----LVEHIPE-AVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 641
F V + E A DL RL+ + ++ HPFF D
Sbjct: 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 74/259 (28%)
Query: 345 KLVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHDVALKE--------IQN 391
+ + + I +G G V +G Y E +VAVK K +++E ++
Sbjct: 6 EDITLGRCIGEGQFGDV-YQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQ 63
Query: 392 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
HP+IV+ GV ++ V++ +E G L + + L
Sbjct: 64 F----DHPHIVKLIGVITENP-VWIVMELAP----------LGELRSYL---QVNKYSL- 104
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
A L+ + + + L++L +HRD+ +NVL+
Sbjct: 105 ------------------------DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS------GWQAPEQLLQGRQTRAID 565
S C KL D G+S+ L+ + + Y +S W APE + R T A D
Sbjct: 141 SSPD--CVKLGDFGLSRYLEDE--------SYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 566 LFSLGCILFFCITGGKHPY 584
++ G ++ + G P+
Sbjct: 191 VWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 543
+I L+ LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHI--KLTDYGMCKEGIRPGDTT-----STF 156
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 600
G+ + APE L ++D ++LG +L F + G+ P+ G S D N +D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGMSDNPDQN-TEDYLF 214
Query: 601 LFLVE---HIP-----EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 641
++E IP +A + L+ +P R P+ +++ +HPFF D
Sbjct: 215 QVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
++V + +H++ +HRD+KP NVL+ D + +L+D G ++ D + Q++ G
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT--VQSSVAVG 165
Query: 546 SSGWQAPEQLLQ------GRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDR 598
+ + +PE +LQ G+ D +SLG ++ + G Y ES E I+
Sbjct: 166 TPDYISPE-ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
Query: 599 KDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN----HPFF----WTADTRLS- 645
+ HI EA DL RL+ R QN + H FF W L
Sbjct: 225 ERFQFPSHITDVSEEAKDLIQRLICSRE--RRLGQNGIEDFKKHAFFEGIDWENIRNLEA 282
Query: 646 -FLRDVSDRVELEDRESDSKLLRALE 670
++ DVS + + + D +LR E
Sbjct: 283 PYIPDVSSPSDTSNFDVDDDVLRNPE 308
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 33/186 (17%)
Query: 460 VMENTK----DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
V E K D+ L + + S L V + + S L +L + L+H ++ +N+L+++
Sbjct: 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137
Query: 515 K-----SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL--LQGRQTRAIDLF 567
KLSD GI + + + W APE + Q T A D +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVER-------IPWIAPECIRNGQASLTIAADKW 190
Query: 568 SLGCILFFCITGGKHPYG-------ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 620
S G L + G+ P E F +D + + + E +L +
Sbjct: 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-------MPDCAELANLINQCWTY 243
Query: 621 NPDLRP 626
+P RP
Sbjct: 244 DPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 543
+I L++LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHI--KLTDYGMCKEGLRPGDTT-----STF 156
Query: 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 600
G+ + APE L ++D ++LG +L F + G+ P+ G S D N
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 601 LFLVEHIP-------EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 641
+ L + I +A + L+ +P R P+ ++ HPFF D
Sbjct: 216 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)
Query: 372 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 428
VAVK L D A ++ +++ PNI R GV + + + +E
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIME--------- 99
Query: 429 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488
Y+ +G + L +++ L N+K + + LL + I
Sbjct: 100 -YMENGDLNQFLQKHVAETSGLAC----------NSKSL--------SFSTLLYMATQIA 140
Query: 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGSS 547
SG+ +L + +HRDL +N L+ K++ K++D G+S+ L D Y
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLV--GKNYTIKIADFGMSRNLYSSDY---------YRVQ 189
Query: 548 G-------WQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 586
G W A E +L G+ T D+++ G IL C + PY
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC---REQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 534
P LLK DI G+ +L IHRDL +N ++ +D + C ++D G+SK++ GD
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC--VADFGLSKKIYSGDY 168
Query: 535 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
Q W A E L T D+++ G ++ T G+ PY
Sbjct: 169 --YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 22/48 (45%), Positives = 31/48 (64%), Gaps = 2/48 (4%)
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528
+K ++ L +LH G+IHRDLKP N+LIS + KL+D G+SK
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHI--KLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 54/237 (22%)
Query: 398 HPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
HPNIVR+Y + D +Y+ ++ L + L KE+ E
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----------KEKKQRFTEE---- 113
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK 515
+W + +V L +LH E ++HRDL P N+++ +D
Sbjct: 114 -----------RIWN-----------IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
++D G++K+ + S LT G+ + PE + D+++ GCIL+
Sbjct: 152 K--VTITDFGLAKQ-KQPESKLTSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205
Query: 576 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV------DLFTRLLDPNPDLRP 626
T Y + A + + E +PE + D+ T L P+ + RP
Sbjct: 206 MCTLQPPFYSTNMLSLATKIVEAV----YEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 39/178 (21%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG------ISKR 529
P + + ++V L LH G++ RDL P N+L L D G S+
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL----------LDDRGHIQLTYFSRW 132
Query: 530 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK----HPYG 585
+ + SC + + + APE +T A D +SLG ILF +TG HP G
Sbjct: 133 SEVEDSCDGEAV----ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
Query: 586 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 637
+ L + E + EA L +LL NP R A +++ +HPFF
Sbjct: 189 ---------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSG 548
G+ +L +HRDL +N ++ D+SF K++D G+++ + N TG
Sbjct: 110 GMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 549 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIVKDRKDLFLVEH 606
W A E L + T D++S G +L+ +T G PY + SF+ +++ R+ L E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEY 226
Query: 607 IPEAV-DLFTRLLDPNPDLRP 626
P+ + ++ P P++RP
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMG 525
+ R I+ L LH G++HRD+KPQN++ S SF K+ D+G
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
LL+ + + G+ L IHRD+ +NVL++ + AK+ D G+++ + D
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMND-----S 266
Query: 540 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
N G++ W APE + T D++S G +L+ + GK PY
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
V R +++GL LH IG++HRD+KP+N+L++ D K+ D G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 524
D L +A P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
G+S +L M+ + G+ + +PE+L + D++S+G L
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
LL + + G+S L IHRDL +N+L++ + K+ D G+++ ++ D
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRND-----S 268
Query: 540 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
N G++ W APE + T D++S G +L+ + G PY D+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVDSKFY 327
Query: 596 KDRKD---LFLVEHIP-EAVDLFTRLLDPNPDLRP 626
K K+ + E P E D+ D +P RP
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRP 362
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 372 VAVKRLV----KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427
VAVK L K + LKEI+ +++ + PNI+R V D + + E
Sbjct: 49 VAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIRLLAVCITSDPLCMITE-------- 99
Query: 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 487
Y+ +G + L+ E + I + L+ + I
Sbjct: 100 --YMENGDLNQFLSRHEPQEA----------AEKADVVTISY--------STLIFMATQI 139
Query: 488 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGS 546
SG+ +L + +HRDL +N L+ K+ + K++D G+S+ L GD + A
Sbjct: 140 ASGMKYLSSLNFVHRDLATRNCLVGKN--YTIKIADFGMSRNLYSGDYYRIQGRAV--LP 195
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGE 586
W + E +L G+ T A D+++ G L+ +T K PY +
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
L ++ +I GL HLH+ IH DL +N L++ D + K+ D G+S + +T
Sbjct: 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTP 159
Query: 540 NATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ + W APE LL QT+ +++SLG ++ G PY
Sbjct: 160 DQL-WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P Q + + R ++ L++LH G+IHRD+K +N+ + D+ A L D G + +L D
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKL--DAH 238
Query: 536 CLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
T G+ G+ +PE L D++S G +LF
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
+I GL LH G+I+RDLK NV++ + K++D G+ K D T G
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI--KIADFGMCKEHMVDGVT---TRTFCG 163
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF-- 602
+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYG-VLLYEMLAGQPPFDGE----------DEDELFQS 212
Query: 603 LVEH--------IPEAVDLFTRLLDPNPDLR----PKAQ-NVLNHPFFWTAD 641
++EH EAV + L+ +P R P+ + ++ H FF D
Sbjct: 213 IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-04
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 37/184 (20%)
Query: 480 LLKVTRDIVSGLSHLHEIG-------LIHRDLKPQNVLISK---------------DKSF 517
++ +TR ++ L++ H + ++HRDLKPQN+ +S +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 518 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--RAIDLFSLGCI 572
AK+ D G+SK + + SC+ G+ + +PE LL ++ D+++LGCI
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCV-------GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 573 LFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630
++ + GK P+ +F + + +K DL + E L LL+ + RP A
Sbjct: 233 IYE-LCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291
Query: 631 VLNH 634
L +
Sbjct: 292 CLGY 295
|
Length = 1021 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 29/119 (24%)
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
LL+V R++ S + LHE G + D+ + L+S D + D +
Sbjct: 119 LLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD----------SKVVLVDSDSFQINA 168
Query: 540 NATGY----GSSGWQAPEQLLQGRQTRAI----------DLFSLGCILFFCITGGKHPY 584
N T + G S + PE QT D F L ++F + GG+HPY
Sbjct: 169 NGTLHLCPVGVSEFTPPE-----LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222
|
Length = 637 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 40/194 (20%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------- 531
+ V + +H++G IHRD+KP N+L+ D KLSD G+ L+
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 532 --GDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
D S N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 574 FFCITGGKHPYGESFERDANIVKD-RKDLFLVEHIP---EAVDLFTRLL--DPNPDLRPK 627
+ + G E+ + V + ++ L +P +A DL R N
Sbjct: 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNG 286
Query: 628 AQNVLNHPFFWTAD 641
+ + +HPFF D
Sbjct: 287 VEEIKSHPFFEGVD 300
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
+ G+ L IHRDL +N+L+S++ K+ D G+++ + D + + GS
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRK-----GS 235
Query: 547 S----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ W APE + T D++S G +L+ + G PY
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----------------ISKR 529
+ V + +H++G IHRD+KP N+L+ D KLSD G ++
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 530 LQGDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
L D + N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 574 FFCITG 579
+ + G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PF06479 | 129 | Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR0105 | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.52 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.35 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.93 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.9 | |
| smart00580 | 58 | PUG domain in protein kinases, N-glycanases and ot | 98.89 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.51 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.38 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.91 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.62 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.1 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.06 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 97.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.4 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.19 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.07 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.94 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 94.02 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 93.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.23 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.72 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 91.29 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 90.82 | |
| PF14593 | 104 | PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A. | 90.7 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 89.78 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 89.54 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 88.41 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 88.19 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 87.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 87.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.12 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-81 Score=704.06 Aligned_cols=386 Identities=53% Similarity=0.935 Sum_probs=357.0
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhH
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 428 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~ 428 (774)
-.+++|.|+.|+|+..+.++|+.||||++.....+.+.+|+..++....||||||+||..++..++||+.|+|.++|.|+
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dl 592 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDL 592 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHH
Confidence 34579999999998889999999999999988888999999999999999999999999999999999999999999999
Q ss_pred HHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCC
Q 004097 429 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 508 (774)
Q Consensus 429 iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 508 (774)
+..... +..... .-..+.++.|++.||+|||+.+||||||||+|
T Consensus 593 ie~~~~---d~~~~~---------------------------------~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQN 636 (903)
T KOG1027|consen 593 IESSGL---DVEMQS---------------------------------DIDPISVLSQIASGLAHLHSLKIVHRDLKPQN 636 (903)
T ss_pred Hhcccc---chhhcc---------------------------------cccHHHHHHHHHHHHHHHHhcccccccCCCce
Confidence 965411 111000 01236789999999999999999999999999
Q ss_pred eeecC---CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 509 VLISK---DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 509 ILl~~---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|||+. ++.++++|+|||+++++..+.+......+..||.+|+|||++.....+.++||||+|||+|++++||.+||+
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99976 677899999999999999888777777788899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHHhhccccccccCCH--HHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhhhhccccchhccccchH
Q 004097 586 ESFERDANIVKDRKDLFLVEHIP--EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDS 663 (774)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~--~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l~~~~~~~e~~~~~~~~ 663 (774)
+..+++.+++.........+..+ ++.|||.+|+++||..||+|.+||.|||||+.++|+.|+++++|++|++.+...+
T Consensus 717 d~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s 796 (903)
T KOG1027|consen 717 DSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPS 796 (903)
T ss_pred chHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCch
Confidence 99999999999988776666556 9999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhCCCchHHHhHHHHhhhhhhcccCCCCHHHHHHHHHhccccccCCChhHHHhhCCCCcccccccccc
Q 004097 664 KLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCR 743 (774)
Q Consensus 664 ~~~~~le~~~~~~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~ir~~~~h~~e~~~~~~~~~g~~p~~f~~yf~~~ 743 (774)
++++++|..+..+..++|+++++..+++++++||+|+++++|||||+||||+|||+|+|++++|++|.+|+||..||++|
T Consensus 797 ~lL~~le~~~~~vv~~~W~~kl~~~~~~~l~kyR~Yk~~svrDLLR~iRNk~hHyrELp~~v~ellG~vPdgF~~YFt~R 876 (903)
T KOG1027|consen 797 ELLRALEAGARVVVSGDWTEKLDKTFMDNLRKYRSYKGSSVRDLLRAIRNKKHHYRELPPEVRELLGDVPDGFDLYFTKR 876 (903)
T ss_pred HHHHhhccCCceEecCchhhhhCHHHHHHHHHhcCcccccHHHHHHHHHhhhhhhhhcCHHHHHhcCCCCcHHHHHHHHh
Confidence 99999998888888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccHHHHHHHHHhhhccchhhhccccc
Q 004097 744 FPKLLIEVYNVIFTYCKGEEVFHKYVTN 771 (774)
Q Consensus 744 fp~ll~~~y~~~~~~~~~~~~~~~y~~~ 771 (774)
||+||+|||.+++. |+.|+.|++||..
T Consensus 877 FP~Lli~vY~~~~~-c~~E~~F~~Y~~~ 903 (903)
T KOG1027|consen 877 FPNLLIHVYTVLSD-CSGEEIFKKYYSP 903 (903)
T ss_pred hhHHHHHHHHHHHH-ccchhhhhhccCC
Confidence 99999999999987 9999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=406.41 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=209.6
Q ss_pred ccccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc----------hHHHHHHHHHHHhCCCCCeeEEeeecc
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVES 409 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~ 409 (774)
+.+.+.|.+.+.||+|+||.|-+| ...+|+.||||++.+... ....+|+ +++.+++|||||++++++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~Ei-eILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEI-EILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHH-HHHHhcCCCCEEEEeeeee
Confidence 345677899999999999999888 567899999999965421 1123455 5889999999999999999
Q ss_pred CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 410 ~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+.+..||||| |+.+|.|.+.+..+. .+.+.....+++|++.
T Consensus 247 ~~ds~YmVlE----------~v~GGeLfd~vv~nk-----------------------------~l~ed~~K~~f~Qll~ 287 (475)
T KOG0615|consen 247 VPDSSYMVLE----------YVEGGELFDKVVANK-----------------------------YLREDLGKLLFKQLLT 287 (475)
T ss_pred cCCceEEEEE----------EecCccHHHHHHhcc-----------------------------ccccchhHHHHHHHHH
Confidence 9999999999 888888888765432 2344556789999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCC-CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC---CCcch
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAID 565 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sD 565 (774)
|+.|||+.||+||||||+|||++.+ ..+.+||+|||+|+.... .+...+.||||.|.|||++....+ ..++|
T Consensus 288 avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD 363 (475)
T KOG0615|consen 288 AVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD 363 (475)
T ss_pred HHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchhe
Confidence 9999999999999999999999765 457899999999998763 355678999999999999987653 45889
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHH---HHHHhhccccc---cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 566 LFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~~---~~~~~~~~~~~---~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+||+||++|-|++| .+||.+..... .++.++..... ..+.++++++||.+||..||++|||+.|+|+||||..
T Consensus 364 iWSlGcvLfvcLsG-~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 364 IWSLGCVLFVCLSG-YPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred eeeccceEEEEecc-CCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99999999999997 88998765433 34555554433 2345689999999999999999999999999999976
Q ss_pred cc
Q 004097 640 AD 641 (774)
Q Consensus 640 ~~ 641 (774)
..
T Consensus 443 ~~ 444 (475)
T KOG0615|consen 443 AP 444 (475)
T ss_pred cc
Confidence 54
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=416.30 Aligned_cols=248 Identities=33% Similarity=0.530 Sum_probs=214.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|...+.||+|+|++||.+.. .+|..||+|++.+. ..+...+||+ +.+.+.|||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIe-IHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIE-IHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHH-HHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6688899999999999999876 88999999998652 2345667875 88999999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+|+|. +|+|..++ .+.+.+++++++.+++||+.||.|||+.
T Consensus 97 LELC~----------~~sL~el~-----------------------------Krrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 97 LELCH----------RGSLMELL-----------------------------KRRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred EEecC----------CccHHHHH-----------------------------HhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 99876 34444332 1235688899999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+|||||-.|++|+++ +.+||+|||||..+..+. .+..+.||||.|+|||++....++..+||||+||+||-||
T Consensus 138 ~IiHRDLKLGNlfL~~~--~~VKIgDFGLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL 212 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFLNEN--MNVKIGDFGLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL 212 (592)
T ss_pred CceecccchhheeecCc--CcEEecccceeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh
Confidence 99999999999999766 459999999999987542 3457889999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 578 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 578 tg~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
.| +|||... .......++......|...+.+++|||.+||++||.+|||+++||.|+||.
T Consensus 213 ~G-~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 213 VG-RPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred hC-CCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 97 8999876 455556677777777888899999999999999999999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=414.47 Aligned_cols=386 Identities=25% Similarity=0.356 Sum_probs=282.8
Q ss_pred ccccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
++-..+|.|++.||+|+|.+||+| ...+++.+|||++.+... ....+|-..|...-.||.||+||..|+|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344567999999999999999998 456799999999965432 1222333323333389999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|+| |.++|.|.++++. .+.+++..++.++.+|+.||+|
T Consensus 149 LYFvLe----------~A~nGdll~~i~K-----------------------------~Gsfde~caR~YAAeIldAley 189 (604)
T KOG0592|consen 149 LYFVLE----------YAPNGDLLDLIKK-----------------------------YGSFDETCARFYAAEILDALEY 189 (604)
T ss_pred eEEEEE----------ecCCCcHHHHHHH-----------------------------hCcchHHHHHHHHHHHHHHHHH
Confidence 999999 6666776666533 2446777889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc--------cc--ccccCcCCCCCCchhhhhcCCCCCc
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------LT--QNATGYGSSGWQAPEQLLQGRQTRA 563 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~--------~~--~~~~~~gt~~y~aPE~l~~~~~~~~ 563 (774)
||++|||||||||+||||+.|++ +||+|||.|+.+.+.... .. +..+.+||..|++||+|.....+..
T Consensus 190 lH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~ 267 (604)
T KOG0592|consen 190 LHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS 267 (604)
T ss_pred HHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc
Confidence 99999999999999999988876 899999999988643221 11 1245789999999999999999999
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 564 IDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
+|+|+||||+|.|+.| .|||....+.. .+.+......++....+.+.|||+++|..||..|+|++++.+||||.+.++
T Consensus 268 sDiWAlGCilyQmlaG-~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 268 SDLWALGCILYQMLAG-QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cchHHHHHHHHHHhcC-CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 9999999999999997 88998766554 344555555678888899999999999999999999999999999955433
Q ss_pred hh----------hhhhhccccchhcccc--------------------------c-----hHHHH---------------
Q 004097 643 RL----------SFLRDVSDRVELEDRE--------------------------S-----DSKLL--------------- 666 (774)
Q Consensus 643 ~~----------~~l~~~~~~~e~~~~~--------------------------~-----~~~~~--------------- 666 (774)
.- +|....+-..+..... . ..+..
T Consensus 347 ~nlw~~~PP~l~py~p~~~~s~e~~s~~~~~~~~~~~~~~~~~~~~~S~s~~~psn~~~~~~~~~~~~~~~~~~s~~~~~ 426 (604)
T KOG0592|consen 347 ENLWQQTPPKLQPYKPATSISPEYYSAYTPLEPGLDERALFQVPSSASQSSALPSNVTHNGDKVAQPVAPSASSSESKND 426 (604)
T ss_pred hhhhhcCCCcccCCCCcccCCcccCcccccccCCccccccccccccccccccCCCcccccccchhhccccccccccCcch
Confidence 21 1111110000000000 0 00000
Q ss_pred -HHHHHHHHHhhCCCchHHHhHHHHhhhhhh--cccCCCCHHHHHHHHHhccccccCCChhHHHhhCCCC---------c
Q 004097 667 -RALEGIALVALNGKWDEKMETKFIENIGRY--RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------E 734 (774)
Q Consensus 667 -~~le~~~~~~~~~~w~~~~~~~~~~~~~~~--r~~~~~~~~dllr~ir~~~~h~~e~~~~~~~~~g~~p---------~ 734 (774)
..+..+........|....+..++.+.+.. |+.-++..|+++.+- ..|+-+.++...++.|++| +
T Consensus 427 ~~R~q~le~~~~~~~w~~f~~~~~i~k~~~l~k~~~lf~rkr~lllTn---~~rll~~~~~~~~lk~eip~~~~~~~e~~ 503 (604)
T KOG0592|consen 427 TARLQSLESQSKDNPWHQFLEGSLILKEGALEKRQGLFARKRMLLLTN---GPRLLYVDPQNLVLKGEIPWSPDLRVELK 503 (604)
T ss_pred hhhhhhccccccCccHHHhhhhhhHHhHHHHHhhhhhhhceeEEEecC---CCeEEEEecccceeccccccCcccceeec
Confidence 001122223345669999887777766644 444555566665432 2344567777788889998 8
Q ss_pred cccccccccCC--ccHHHHHHHHHhhhcc-chhhhccccc
Q 004097 735 GFYNYFSCRFP--KLLIEVYNVIFTYCKG-EEVFHKYVTN 771 (774)
Q Consensus 735 ~f~~yf~~~fp--~ll~~~y~~~~~~~~~-~~~~~~y~~~ 771 (774)
++..+|.+++. ++|++.-+.+..||++ +.+-++|...
T Consensus 504 n~~~~~i~TP~k~~~l~d~~~~as~w~~ai~~~~~~~~~~ 543 (604)
T KOG0592|consen 504 NSSTFFIHTPNKVYYLEDPEQRASVWCKAIETVRKRYSGT 543 (604)
T ss_pred cCcceEEECCccceeccCcccchhHHHHhhhhhhhcccCC
Confidence 89999999999 8899999999999998 7775555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=384.09 Aligned_cols=244 Identities=30% Similarity=0.462 Sum_probs=205.8
Q ss_pred eEeecccCceEEEEE-eeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc-eeEEeccccCC
Q 004097 350 NKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERCTC 423 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~~~LV~E~~~~ 423 (774)
.+.||+|..|+||++ ...+++.+|+|.+.... ..+..+|++ ++...+||+||.+||.|.+++ .++|+||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~-il~~~~spyIV~~ygaF~~~~~~isI~mE---- 158 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELE-ILRSCQSPYIVGFYGAFYSNGEEISICME---- 158 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHH-HHhhCCCCCeeeEeEEEEeCCceEEeehh----
Confidence 467999999999998 45679999999994332 245677886 556669999999999999998 5999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCcccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHR 502 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHr 502 (774)
||.+|+|+..+.. .+.+++..+-+|+.++++||.|||+ ++||||
T Consensus 159 ------YMDgGSLd~~~k~-----------------------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR 203 (364)
T KOG0581|consen 159 ------YMDGGSLDDILKR-----------------------------VGRIPEPVLGKIARAVLRGLSYLHEERKIIHR 203 (364)
T ss_pred ------hcCCCCHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhccCeeec
Confidence 8888888876532 2457889999999999999999996 899999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++..|+ +||||||.++.+... ...+.+||..|||||.+.+..|+.++||||||+.++||.+| +.
T Consensus 204 DIKPsNlLvNskGe--VKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G-rf 275 (364)
T KOG0581|consen 204 DIKPSNLLVNSKGE--VKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG-RF 275 (364)
T ss_pred cCCHHHeeeccCCC--EEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC-CC
Confidence 99999999998887 999999999988753 44678899999999999999999999999999999999997 77
Q ss_pred CCCCc-------hHHHHHHHhhcccccccc-CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 583 PYGES-------FERDANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 583 Pf~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
||... .+....++....+..+.. ++++++++|.+||++||.+||++.|+++|||+...+
T Consensus 276 P~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 276 PYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 77653 222335555555555554 899999999999999999999999999999996543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=382.06 Aligned_cols=261 Identities=30% Similarity=0.381 Sum_probs=214.5
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.++|.+.+.||+|+||+|+... ..+++.+|+|++++... .....|. .++..++||.||+++..|++.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er-~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAER-NILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHH-HHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568888999999999999874 45699999999976532 2223343 57778999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+| |+.+|.|..+|.. .+.+++..++-++.+|+.||.|||+
T Consensus 103 Vld----------~~~GGeLf~hL~~-----------------------------eg~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 103 VLD----------YLNGGELFYHLQR-----------------------------EGRFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred EEe----------ccCCccHHHHHHh-----------------------------cCCcchhHHHHHHHHHHHHHHHHHh
Confidence 999 8899999888743 3457888899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.|||||||||+||||+.+|+ ++|+||||++..... ...+.+.|||+.|||||++.+..|+.++|+||||+++|||
T Consensus 144 ~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 144 KGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEM 218 (357)
T ss_pred CCeeeccCCHHHeeecCCCc--EEEeccccchhcccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHH
Confidence 99999999999999999987 899999999965432 2345678999999999999999999999999999999999
Q ss_pred HhCCCCCCC-CchHHHHHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCc----CHHHHHcCCCCCCccchhhhhhhc
Q 004097 577 ITGGKHPYG-ESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTADTRLSFLRDV 650 (774)
Q Consensus 577 ltg~~~Pf~-~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rp----s~~elL~HPff~~~~~~~~~l~~~ 650 (774)
++| .+||. ++.......+...+ ...+.-.+++++++++++|..||++|. ++.++.+||||...++...+.+.+
T Consensus 219 L~G-~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 219 LTG-KPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred hhC-CCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 998 55654 44444444444444 444444788999999999999999996 688999999998877765544444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=378.74 Aligned_cols=251 Identities=32% Similarity=0.518 Sum_probs=205.4
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..|.+.++||+|+||+||+|. ..++..||||.+.+.. .+...+|+. +++.++|||||+|++++++++++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~-iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIK-ILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHH-HHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 346677789999999999985 4568999999996653 233456775 788999999999999999999999999
Q ss_pred cccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 419 ERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 419 E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||. |+|.+||. +.+++++..++.++.|||.||++||++
T Consensus 89 EyC~gGDLs~yi~----------------------------------------~~~~l~e~t~r~Fm~QLA~alq~L~~~ 128 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR----------------------------------------RRGRLPEATARHFMQQLASALQFLHEN 128 (429)
T ss_pred EeCCCCCHHHHHH----------------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9888 57766662 234578888999999999999999999
Q ss_pred CccccccCCCCeeecCC-CC---ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 498 GLIHRDLKPQNVLISKD-KS---FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~-~~---~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
+||||||||+||||+.. +. ..+||+|||+|+.+... ....+.||++-|||||++...+|+.|+|+||+|+|+
T Consensus 129 ~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 129 NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 99999999999999764 33 68999999999998743 344677999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHH-HHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 574 FFCITGGKHPYGESFERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~~-~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|+|++| ++||......+.. .++... ...+...++...+++...++.+|..|.+..+.+.|+|.|...
T Consensus 205 yq~l~g-~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 205 YQCLTG-KPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHHhC-CCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999997 8899865544432 222211 122333456677999999999999999999999999998654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.63 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=212.6
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
++|.+.+.||.|+||+|.+.. ..+|..+|+|+|.+..... -...+..++..+.||.++++++.|.|.+++||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 346667889999999999874 4568999999997653211 1122335788889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |.++|.|..+|+. .+.++++.++.++.||+.||+|||+.+
T Consensus 124 e----------yv~GGElFS~Lrk-----------------------------~~rF~e~~arFYAAeivlAleylH~~~ 164 (355)
T KOG0616|consen 124 E----------YVPGGELFSYLRK-----------------------------SGRFSEPHARFYAAEIVLALEYLHSLD 164 (355)
T ss_pred e----------ccCCccHHHHHHh-----------------------------cCCCCchhHHHHHHHHHHHHHHHHhcC
Confidence 9 8899999988743 456888999999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|++|||||+||||+.+|. +||+|||+|+.+.+ .+.+.||||.|+|||++....|..++|+|||||++|||+.
T Consensus 165 iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred eeeccCChHHeeeccCCc--EEEEeccceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 999999999999998887 89999999998874 3567899999999999999999999999999999999999
Q ss_pred CCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCC-----cCHHHHHcCCCCCCccchhh
Q 004097 579 GGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLS 645 (774)
Q Consensus 579 g~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R-----ps~~elL~HPff~~~~~~~~ 645 (774)
| .+||..... .....+-.....++...+++++|||+++|+.|-.+| ....++..||||.+.++..-
T Consensus 237 G-~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 237 G-YPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred C-CCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 7 666655443 333444455556788889999999999999999999 45779999999987766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.68 Aligned_cols=250 Identities=30% Similarity=0.503 Sum_probs=197.2
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc-eeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~~~LV~ 418 (774)
++|...++||.|+||.||+| ...+|..||||++++... -..+||+..+.+.-.|||||+|..++.|.+ .+|+||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 44566788999999999998 456799999999976532 345788885544444999999999999998 999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||++++|.+++.- +.+.+++..++.|+.||++||+|+|.+|
T Consensus 90 E~Md~NLYqLmK~---------------------------------------R~r~fse~~irnim~QilqGL~hiHk~G 130 (538)
T KOG0661|consen 90 EFMDCNLYQLMKD---------------------------------------RNRLFSESDIRNIMYQILQGLAHIHKHG 130 (538)
T ss_pred HhhhhhHHHHHhh---------------------------------------cCCcCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 9999999888732 1345788999999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ell 577 (774)
+.|||+||+|||+.. ...+||+|||+||.+.+.. .....+.|.+|.|||++.. +.|+.++||||+|||++|+.
T Consensus 131 fFHRDlKPENiLi~~--~~~iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 131 FFHRDLKPENILISG--NDVIKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred cccccCChhheEecc--cceeEecccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH
Confidence 999999999999964 3459999999999887542 2234567999999999865 56899999999999999999
Q ss_pred hCCCCCCCCchHHH-H-HHHh---------------------hccc--------cccccCCHHHHHHHHHhcCCCCCCCc
Q 004097 578 TGGKHPYGESFERD-A-NIVK---------------------DRKD--------LFLVEHIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~-~~~~---------------------~~~~--------~~~~~~~~~~~dli~~~L~~dP~~Rp 626 (774)
+- ++-|....+-+ . .++. -... ......++++.++|.+||..||.+||
T Consensus 205 sL-rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 205 SL-RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred Hh-cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 96 55554333222 1 1111 0000 00112457899999999999999999
Q ss_pred CHHHHHcCCCCCCc
Q 004097 627 KAQNVLNHPFFWTA 640 (774)
Q Consensus 627 s~~elL~HPff~~~ 640 (774)
||+|+|+||||...
T Consensus 284 TA~~al~~pffq~~ 297 (538)
T KOG0661|consen 284 TASQALQHPFFQVG 297 (538)
T ss_pred cHHHHhcCcccccc
Confidence 99999999999764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=354.70 Aligned_cols=243 Identities=27% Similarity=0.420 Sum_probs=192.5
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.++|+|+||+||++.. .+|+.||||++..+.++ .+++||. |++.++|||+|.|+.+|.....++||+|||+.+
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIr-mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIR-MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHH-HHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 5699999999999854 56999999999876653 3566775 889999999999999999999999999999976
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
+.+.+. ...++.+...+.+++.|++.|+.|+|++++|||||
T Consensus 87 vL~eLe---------------------------------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDI 127 (396)
T KOG0593|consen 87 VLHELE---------------------------------------RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDI 127 (396)
T ss_pred HHHHHH---------------------------------------hccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccC
Confidence 443331 22456788888999999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
||+|||++..+. +||||||+|+.+....+.+ ...+.|.+|.|||.+.+ .+|+..+||||+||++.||++| .+-
T Consensus 128 KPENILit~~gv--vKLCDFGFAR~L~~pgd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G-~pL 201 (396)
T KOG0593|consen 128 KPENILITQNGV--VKLCDFGFARTLSAPGDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTG-EPL 201 (396)
T ss_pred ChhheEEecCCc--EEeccchhhHhhcCCcchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcC-CcC
Confidence 999999998875 8999999999887433322 23457999999999988 6799999999999999999998 545
Q ss_pred CCC-chHHHH-HHHh--------------hccc-----cc-----------cccCCHHHHHHHHHhcCCCCCCCcCHHHH
Q 004097 584 YGE-SFERDA-NIVK--------------DRKD-----LF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQNV 631 (774)
Q Consensus 584 f~~-~~~~~~-~~~~--------------~~~~-----~~-----------~~~~~~~~~dli~~~L~~dP~~Rps~~el 631 (774)
|.. +.-.+. .+.+ .... .+ .+..+..+.|++++||+.||.+|++.+|+
T Consensus 202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 533 332221 1111 0000 00 01122467899999999999999999999
Q ss_pred HcCCCCCC
Q 004097 632 LNHPFFWT 639 (774)
Q Consensus 632 L~HPff~~ 639 (774)
|.||||.+
T Consensus 282 l~H~yFd~ 289 (396)
T KOG0593|consen 282 LHHPYFDG 289 (396)
T ss_pred hcChHHHH
Confidence 99999944
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=372.57 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=205.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
-+.|.+.++||+|+||.||++.. .+|..+|+|+|++... ..-.+.+..+|...++|+||+||..|+|.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 35678889999999999999954 5699999999987532 12223334567778999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|| |.++|++..+|. +.+.+++..++.++.+++.|++-||+.
T Consensus 220 ME----------ylPGGD~mTLL~-----------------------------~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 220 ME----------YLPGGDMMTLLM-----------------------------RKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred EE----------ecCCccHHHHHH-----------------------------hcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 99 888888888763 345688889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCC---------------------Cccc-----c-------------
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD---------------------MSCL-----T------------- 538 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~---------------------~~~~-----~------------- 538 (774)
|+|||||||+|+||+..|+ +||+||||+..+... .+.. .
T Consensus 261 gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 338 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK 338 (550)
T ss_pred CcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence 9999999999999998887 899999998644210 0000 0
Q ss_pred -----ccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccc---cccCCH
Q 004097 539 -----QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLF---LVEHIP 608 (774)
Q Consensus 539 -----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~---~~~~~~ 608 (774)
.....+|||.|||||++.+..|+..+|+||||||+||||.| -|||....... .+++.+..... ....++
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvG-yPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVG-YPPFCSETPQETYRKIVNWRETLKFPEEVDLSD 417 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhhhccCCCcCcccH
Confidence 00134799999999999999999999999999999999997 66776544333 35555553322 233468
Q ss_pred HHHHHHHHhcCCCCCCCcC---HHHHHcCCCCCCccc
Q 004097 609 EAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT 642 (774)
Q Consensus 609 ~~~dli~~~L~~dP~~Rps---~~elL~HPff~~~~~ 642 (774)
+++|||.+||. ||++|.. ++||.+||||...++
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 99999999999 9999974 899999999977654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=379.95 Aligned_cols=249 Identities=31% Similarity=0.443 Sum_probs=213.2
Q ss_pred eEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
-+.+++.||+|+.|.|-+| ...+|+.+|||++.+.. .....+||. +|+.+.||||++||++++++.++|||+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIv-iMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIV-IMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhH-HHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3677899999999999888 45689999999996541 234567876 778999999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |+++|.|+++|. ..+++++.++.++++||+.|+.|||..+
T Consensus 92 E----------yv~gGELFdylv-----------------------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~ 132 (786)
T KOG0588|consen 92 E----------YVPGGELFDYLV-----------------------------RKGPLPEREAAHFFRQILDGVSYCHAFN 132 (786)
T ss_pred E----------ecCCchhHHHHH-----------------------------hhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 9 888888888763 3466888999999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~ell 577 (774)
|+||||||+|+||+..++ +||+|||+|..-.++ ....+.||+|.|.|||++.+.+| +.++||||+|||||.||
T Consensus 133 icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL 206 (786)
T KOG0588|consen 133 ICHRDLKPENLLLDVKNN--IKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL 206 (786)
T ss_pred ceeccCCchhhhhhcccC--EeeeccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH
Confidence 999999999999988776 999999999865543 44567899999999999999998 58999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 578 TGGKHPYGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|| +.||++...+.. ..++......+...++++++||.+||..||++|.|++|+++|||+....
T Consensus 207 tG-~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 207 TG-KLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred hC-CCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 97 889987665543 4445555555677789999999999999999999999999999996543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=373.55 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=206.1
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||+||+| ..++.+.||+|.+.+..... ..+|+ ++++.++|||||.++.+|+...++|+|+||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev-~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEV-RILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHH-HHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 455678999999999998 56789999999997654322 34455 478899999999999999999999999998
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.|+|..++ -....+|++.+..|+.+++.||.|||+.+|+
T Consensus 83 a~g~L~~il----------------------------------------~~d~~lpEe~v~~~a~~LVsaL~yLhs~ril 122 (808)
T KOG0597|consen 83 AVGDLFTIL----------------------------------------EQDGKLPEEQVRAIAYDLVSALYYLHSNRIL 122 (808)
T ss_pred hhhhHHHHH----------------------------------------HhccCCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 888776665 2234588999999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|||+||+|||+...+. +|+||||+|+-...... ......|||.|||||++.++.|+..+|+||+|||+|||.+|
T Consensus 123 hrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~---vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G- 196 (808)
T KOG0597|consen 123 HRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTS---VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG- 196 (808)
T ss_pred cccCCcceeeecCCCc--eeechhhhhhhcccCce---eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC-
Confidence 9999999999977765 99999999998764322 22334599999999999999999999999999999999997
Q ss_pred CCCCC-CchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 581 KHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 581 ~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+|||- .+.......+......++...+..+..+++.+|++||.+|.|..+++.|||++.
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 66664 444444555555566677788899999999999999999999999999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.56 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=210.2
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
-+.|.+.++||+|+||+|+++.. .+++.+|||.+++... +....|...+...-+||.+++|+++|+..+++|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46789999999999999999854 4688999999987632 2223333322222379999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||| |..+|++..+ ...+.+++..++.++..|+.||+|||+
T Consensus 447 vme----------y~~Ggdm~~~------------------------------~~~~~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 447 VME----------YVAGGDLMHH------------------------------IHTDVFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred EEE----------ecCCCcEEEE------------------------------EecccccHHHHHHHHHHHHHHHHHHHh
Confidence 999 6666663322 122558888999999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
+||||||||-+|||||.+|+ +||+||||++..... ...+.+.||||.|||||++.+..|+.++|+|||||+||||
T Consensus 487 ~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~---g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeM 561 (694)
T KOG0694|consen 487 NGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQ---GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEM 561 (694)
T ss_pred cCceeeecchhheEEcccCc--EEecccccccccCCC---CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHH
Confidence 99999999999999999987 899999999975532 3466889999999999999999999999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccch
Q 004097 577 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 643 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~~ 643 (774)
|.| ..||....+ ....-+......++...+.|+.++++++|.++|++|..+ .+|..||||++.++.
T Consensus 562 L~G-q~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 562 LVG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HcC-CCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 997 778875444 445666666777888899999999999999999999865 689999999887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=372.88 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=205.8
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
..|.-.++||+|+.|.||.| ...+++.||||++.... .+-.+.|+. ++...+|+|||+++..|..++.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~-Vm~~~~H~NiVnfl~Sylv~deLWVVME- 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEIL-VMRDLHHPNIVNFLDSYLVGDELWVVME- 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHH-HHHhccchHHHHHHHHhcccceeEEEEe-
Confidence 44666688999999999998 56678999999996543 244567776 6678899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
||.+|+|.+.+.. ..+++.++..|+++++.||+|||..||+
T Consensus 351 ---------ym~ggsLTDvVt~------------------------------~~~~E~qIA~Icre~l~aL~fLH~~gIi 391 (550)
T KOG0578|consen 351 ---------YMEGGSLTDVVTK------------------------------TRMTEGQIAAICREILQGLKFLHARGII 391 (550)
T ss_pred ---------ecCCCchhhhhhc------------------------------ccccHHHHHHHHHHHHHHHHHHHhccee
Confidence 8888887775422 2367788999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||.+|||++.+|. +||+|||+|..+.... ....+.+|||.|||||++....|+.++||||||++++||+-|
T Consensus 392 HrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~---~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG- 465 (550)
T KOG0578|consen 392 HRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQ---SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG- 465 (550)
T ss_pred eeccccceeEeccCCc--EEEeeeeeeecccccc---CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC-
Confidence 9999999999998887 9999999999887543 255678999999999999999999999999999999999997
Q ss_pred CCCCC-CchHHHHHHHhh-ccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 581 KHPYG-ESFERDANIVKD-RKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 581 ~~Pf~-~~~~~~~~~~~~-~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
.|||- +..-+....+.. ... ..+...+++++||+.+||+.|+++|+++.|||+||||..
T Consensus 466 EPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 466 EPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 66665 444333333322 221 234456799999999999999999999999999999943
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=354.04 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=209.7
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..+.|.+.++||.|..++||+|. ...+..||||++.-... +...+|++ .++.++|||||+++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~-~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQ-TMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHH-HhhhcCCCCcceEEEEEEecceeEEe
Confidence 35678899999999999999984 56689999999964332 33455665 67889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|. ||..|++.+.+... ...++.+..+..|++++++||.|||.+
T Consensus 103 mp----------fMa~GS~ldIik~~---------------------------~~~Gl~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 103 MP----------FMAGGSLLDIIKTY---------------------------YPDGLEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred eh----------hhcCCcHHHHHHHH---------------------------ccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 99 88888888876432 235688899999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhc--CCCCCcchhHhHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGvll~ 574 (774)
|.||||||+.||||+.+|. +||+|||.+..+....... ....+.+||+.|||||++.. ..|+.|+||||||+...
T Consensus 146 G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 146 GHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred CceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999999987 8999999887665433222 22266789999999999765 45899999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHhhccccc-----------cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 575 FCITGGKHPYGESFERDANIVKDRKDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
||.+| ..||.+-.+...-.++-....+ .......++.+|..||+.||.+|||++++|+|+||+....+
T Consensus 224 ELA~G-~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 224 ELAHG-HAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHhcC-CCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 99997 8899876655443333222211 11123478899999999999999999999999999876544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.31 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=196.9
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCc--eeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~--~~~LV~E~ 420 (774)
+...+.||+|+||+||++... +|...|||.+.... .+...+|+. ++..++|||||+++|...... .+++.||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~-iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE- 96 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIR-ILSRLNHPNIVQYYGSSSSRENDEYNIFME- 96 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHH-HHHhCCCCCEEeeCCccccccCeeeEeeee-
Confidence 344578999999999998654 48999999986543 223456665 788888999999999865554 6999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+++|+|.+++.... ..++++.++++.+||++||+|||++|||
T Consensus 97 ---------y~~~GsL~~~~~~~g----------------------------~~l~E~~v~~ytr~iL~GL~ylHs~g~v 139 (313)
T KOG0198|consen 97 ---------YAPGGSLSDLIKRYG----------------------------GKLPEPLVRRYTRQILEGLAYLHSKGIV 139 (313)
T ss_pred ---------ccCCCcHHHHHHHcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 666777766553211 1478899999999999999999999999
Q ss_pred ccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHh
Q 004097 501 HRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 501 HrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~ellt 578 (774)
||||||+|||++. ++. +||+|||+++................||+.|||||++..+. ...++|||||||++.||+|
T Consensus 140 H~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 140 HCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred ccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 9999999999987 454 99999999988774222223344567999999999999633 3459999999999999999
Q ss_pred CCCCCCCCc-hHHH--HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 579 GGKHPYGES-FERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 579 g~~~Pf~~~-~~~~--~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
| .+||.+. .... ..+.... .+..+...++++++++.+|+..||++||||+++|+|||.....
T Consensus 218 g-~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 218 G-KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred C-CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 7 8899873 2111 2222222 2244556678999999999999999999999999999986544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=419.44 Aligned_cols=231 Identities=25% Similarity=0.349 Sum_probs=170.8
Q ss_pred EeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhh
Q 004097 349 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~ 427 (774)
..+.||+|+||.||+|.. .+|+.||||++..... ...+|+ ..+..++|||||+++|+|.+.+..|+|||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~-~~l~~l~HpnIv~~~~~~~~~~~~~lv~E-------- 763 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEI-ADMGKLQHPNIVKLIGLCRSEKGAYLIHE-------- 763 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHH-HHHhhCCCCCcceEEEEEEcCCCCEEEEe--------
Confidence 346799999999999865 6789999999865432 223344 46778899999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---HcCcccccc
Q 004097 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH---EIGLIHRDL 504 (774)
Q Consensus 428 ~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~ivHrDL 504 (774)
|+++|+|.++++ .++|..+.+|+.||++||+||| +.+|+||||
T Consensus 764 --y~~~g~L~~~l~--------------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 764 --YIEGKNLSEVLR--------------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred --CCCCCcHHHHHh--------------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 566666666542 1456677899999999999999 569999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
||+||+++.++. +++. ||....... .....||+.|+|||++.+..++.++|||||||++|||+|| +.||
T Consensus 810 kp~Nil~~~~~~--~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg-~~p~ 878 (968)
T PLN00113 810 SPEKIIIDGKDE--PHLR-LSLPGLLCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPA 878 (968)
T ss_pred CHHhEEECCCCc--eEEE-ecccccccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC-CCCC
Confidence 999999987665 4443 554433221 1223588999999999999999999999999999999997 6676
Q ss_pred CCchHHHHHHHhh-------------cccc------ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 585 GESFERDANIVKD-------------RKDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 585 ~~~~~~~~~~~~~-------------~~~~------~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
.........+..+ .... .......++.+++.+||+.||++|||+.|+++.
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 4322110000000 0000 001112357789999999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=364.78 Aligned_cols=240 Identities=29% Similarity=0.456 Sum_probs=194.0
Q ss_pred EeEeecccCceEEEEEeeeCCcE-EEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc-eeEEecccc
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERC 421 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~-VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~~~LV~E~~ 421 (774)
+.+.||+|+||+||+ +.+.|.. ||||++..... ....+|+ .++.+++|||||+++|+|.+.. .++||||
T Consensus 45 ~~~~iG~G~~g~V~~-~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~-~il~~l~HpNIV~f~G~~~~~~~~~~iVtE-- 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYK-GKWRGTDVVAVKIISDPDFDDESRKAFRREA-SLLSRLRHPNIVQFYGACTSPPGSLCIVTE-- 120 (362)
T ss_pred hhhhcccCCceeEEE-EEeCCceeEEEEEecchhcChHHHHHHHHHH-HHHHhCCCCCeeeEEEEEcCCCCceEEEEE--
Confidence 445699999999998 5566666 99999975431 2344555 4788899999999999999988 7999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC-cc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LI 500 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-iv 500 (774)
|+++|+|..+|+... .+.+++..+++|+.|||+||.|||+.+ ||
T Consensus 121 --------y~~~GsL~~~l~~~~---------------------------~~~l~~~~~l~~aldiArGm~YLH~~~~iI 165 (362)
T KOG0192|consen 121 --------YMPGGSLSVLLHKKR---------------------------KRKLPLKVRLRIALDIARGMEYLHSEGPII 165 (362)
T ss_pred --------eCCCCcHHHHHhhcc---------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Confidence 888999998887531 245788889999999999999999999 99
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh--cCCCCCcchhHhHHHHHHHHHh
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSlGvll~ellt 578 (774)
||||||+|||++.+. .++||+|||+++...... .......||+.|||||++. ...|+.++||||||+++|||+|
T Consensus 166 HrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t 241 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKG-KTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT 241 (362)
T ss_pred ecccChhhEEEcCCC-CEEEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH
Confidence 999999999997765 369999999998766421 1122256999999999999 6689999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 579 GGKHPYGESFERD--ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
| +.||....... ..+. .......+....+.+..+|.+||+.||.+||++.+++
T Consensus 242 ~-~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 242 G-EIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred C-CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 7 78887765422 2222 3334444555778999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=334.65 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=197.5
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|...+.||+|.||.||+| ...+|+.||||+++..+ ...+.+||. +++.++||||+.|+++|-+.+.+-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK-~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIK-LLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHH-HHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 444578999999999998 55679999999996543 246889997 67888999999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
++.+|+..|.- +...+...++..++.++++||+|||++.|+
T Consensus 83 m~tdLe~vIkd---------------------------------------~~i~l~pa~iK~y~~m~LkGl~y~H~~~Il 123 (318)
T KOG0659|consen 83 MPTDLEVVIKD---------------------------------------KNIILSPADIKSYMLMTLKGLAYCHSKWIL 123 (318)
T ss_pred ccccHHHHhcc---------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 99888877731 123456678899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg 579 (774)
||||||.|+|++.+|. +||+|||+|+.+....... ...+-|.+|.|||.+.+. .|+..+||||.|||+.||+.|
T Consensus 124 HRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 124 HRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred cccCCccceEEcCCCc--EEeecccchhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 9999999999999986 8999999999887543222 223679999999999875 599999999999999999996
Q ss_pred CCCCCCC-chHHHHHHHhh------------------------cccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 580 GKHPYGE-SFERDANIVKD------------------------RKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 580 ~~~Pf~~-~~~~~~~~~~~------------------------~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
.|.|.. +.-.+..++-. .+.. .....++++.||+.+||..||.+|+|++|
T Consensus 199 -~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 199 -VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred -CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 555533 32222111110 0000 11223467899999999999999999999
Q ss_pred HHcCCCCCCc
Q 004097 631 VLNHPFFWTA 640 (774)
Q Consensus 631 lL~HPff~~~ 640 (774)
+|+||||.+.
T Consensus 278 aL~~~yf~~~ 287 (318)
T KOG0659|consen 278 ALKHPYFKSL 287 (318)
T ss_pred HhcchhhhcC
Confidence 9999999764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.79 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=202.9
Q ss_pred cceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecC-----C---chHHHHHHHHHHHhCC-CCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----H---HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~-----~---~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~ 413 (774)
...|.+.+.||+|+||+|++| ...+|..||||++.+. . .....+|+. +++.++ ||||++++.++.....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~-~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREIS-ILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHH-HHHHhccCCCEeEEEEEEecCCe
Confidence 456888999999999999998 5567899999976543 1 223446775 556666 9999999999999999
Q ss_pred eEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 414 ~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
+|+|||||.+ +|.++| .. .+.+.+..+..+++|++.|++
T Consensus 95 ~~ivmEy~~gGdL~~~i-----------~~-----------------------------~g~l~E~~ar~~F~Qlisav~ 134 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYI-----------VN-----------------------------KGRLKEDEARKYFRQLISAVA 134 (370)
T ss_pred EEEEEEecCCccHHHHH-----------HH-----------------------------cCCCChHHHHHHHHHHHHHHH
Confidence 9999997663 454444 22 244666788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CC-CcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QT-RAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDvwSlG 570 (774)
|||+.||+||||||+|||++.+. ..+||+|||++..... ......+.+||+.|+|||++.+.. |+ .++||||+|
T Consensus 135 y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~G 210 (370)
T KOG0583|consen 135 YCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLG 210 (370)
T ss_pred HHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhH
Confidence 99999999999999999998772 3499999999997741 123457789999999999999977 75 899999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HHHHHhhccccccccC-CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 571 CILFFCITGGKHPYGESFER-DANIVKDRKDLFLVEH-IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~-~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|+||.|++| ..||.+.... ....+.......+... ++++++|+.+||..||.+|+|+.++++||||..
T Consensus 211 ViLy~ml~G-~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 211 VILYVLLCG-RLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHhC-CCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999997 8888874433 2333444444556666 899999999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.95 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=202.5
Q ss_pred cceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.++||+|.|..||+. ...+|+.+|+|++.-. +.-+.++++..+...++|||||+|...+.+..+.|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 344666788999999999986 5567889999877321 12233344445788999999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| .|.+|.|..-+-... -+++..+-.+++||+.+|.|+|..+
T Consensus 90 e----------~m~G~dl~~eIV~R~-----------------------------~ySEa~aSH~~rQiLeal~yCH~n~ 130 (355)
T KOG0033|consen 90 D----------LVTGGELFEDIVARE-----------------------------FYSEADASHCIQQILEALAYCHSNG 130 (355)
T ss_pred e----------cccchHHHHHHHHHH-----------------------------HHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 9 666666665443221 1345667889999999999999999
Q ss_pred ccccccCCCCeeec-CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~-~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|||||+||+|+||. ++...-+||+|||+|..+.++ ..-...+|||+|||||+++..+|+..+|||+.|||||-|+
T Consensus 131 IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 131 IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 99999999999994 344456999999999988732 2334567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHhhccccc---cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchh
Q 004097 578 TGGKHPYGESFERDA-NIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~~~~~~~~~~---~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~ 644 (774)
.|..|+|+++..+.. .+++...+.. ....++++++||.+||..||.+|+|+.|+|+|||+.+.+.-.
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~A 277 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVA 277 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHH
Confidence 985555555666654 4444443332 334568999999999999999999999999999997765443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.73 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=197.3
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV~ 418 (774)
|...++||+|.||.||+| ...+|+.||+|++.-.. ...+.+||. ++++++||||++|.+...+. ..+|||+
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~-ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK-ILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH-HHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 344478999999999998 56789999999986443 235678987 78899999999999988776 7899999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||++.+|.-++.. ..-.+++.++..+++||+.||+|||.+|
T Consensus 198 eYMdhDL~GLl~~---------------------------------------p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 198 EYMDHDLSGLLSS---------------------------------------PGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred ecccchhhhhhcC---------------------------------------CCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 9888776655521 1124678899999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ell 577 (774)
|+|||||.+||||+.+|. +||+|||||+.+..... ......+-|.+|.|||.|.+. .|+.++|+||.||||.||+
T Consensus 239 vlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred eeeccccccceEEcCCCC--EEeccccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 999999999999988876 89999999998775432 223456789999999999975 6999999999999999999
Q ss_pred hCCCCCCCCchHHHH-H-HHh---------hc-ccc------------------ccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 578 TGGKHPYGESFERDA-N-IVK---------DR-KDL------------------FLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~-~~~---------~~-~~~------------------~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+| ++.|....+.++ . |.+ +. ..+ .....++.+.+|+..||..||.+|.|
T Consensus 315 ~g-kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 315 LG-KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred cC-CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 97 777766544321 1 111 00 000 01122467889999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 004097 628 AQNVLNHPFFWTA 640 (774)
Q Consensus 628 ~~elL~HPff~~~ 640 (774)
|.++|+|+||+..
T Consensus 394 A~~aL~seyF~t~ 406 (560)
T KOG0600|consen 394 ASSALQSEYFTTE 406 (560)
T ss_pred HHHHhcCcccccC
Confidence 9999999999654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=338.67 Aligned_cols=239 Identities=23% Similarity=0.390 Sum_probs=188.3
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEee-eccCCce-eEEec
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYG-VESDQDF-VYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g-~~~~~~~-~~LV~ 418 (774)
|.+.++||+|+||+||++ .+.+|..||.|.+.-.. .+...+|+. +++.++|||||++|+ .+.+++. ++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~-lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEIS-LLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHH-HHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 445688999999999997 67899999999886322 233456764 889999999999999 4555555 89999
Q ss_pred cccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-
Q 004097 419 ERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE- 496 (774)
Q Consensus 419 E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~- 496 (774)
|+|. |+|.++|.. .. ...+.+|++.+++++.|+++||.++|.
T Consensus 100 E~c~~GDLsqmIk~-----------~K-------------------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~ 143 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKH-----------FK-------------------------KQKRLIPEKTVWKYFVQLCRALYHCHSK 143 (375)
T ss_pred HhhcccCHHHHHHH-----------HH-------------------------hccccCchHHHHHHHHHHHHHHHHHhcc
Confidence 9776 456555522 11 123458999999999999999999999
Q ss_pred -cC--ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 497 -IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 497 -~~--ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
.. |+||||||.||+|+.+|. +||+||||++.+.... +...+.+|||.||+||.+....|+.+|||||+||++
T Consensus 144 ~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCll 218 (375)
T KOG0591|consen 144 IPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLL 218 (375)
T ss_pred ccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHH
Confidence 44 999999999999988775 9999999999987542 334567899999999999999999999999999999
Q ss_pred HHHHhCCCCCC-CCchHHHHHHHhhc-ccccc-ccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 574 FFCITGGKHPY-GESFERDANIVKDR-KDLFL-VEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 574 ~elltg~~~Pf-~~~~~~~~~~~~~~-~~~~~-~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
|||+.- .+|| ++........+... ....+ ...+.++..||..|+..||+.||+.
T Consensus 219 yEMcaL-~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 219 YEMCAL-QSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHhc-CCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999997 5555 44444333333333 22222 4457789999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=347.82 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=214.5
Q ss_pred ccccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+|...|.+.+.||+|.|..|-+| ..++|..||||++.++.. ...++|+. -++..+||||||||.+......+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVR-CMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVR-CMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHH-HHHHhcCcCeeeeeehhcccceE
Confidence 456778899999999999999887 678999999999987653 34678887 56889999999999999999999
Q ss_pred EEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|||+|+-++ +|.|||. . ...++.+..+.+++.||+.|+.|
T Consensus 93 yLiLELGD~GDl~DyIm-----------K----------------------------He~Gl~E~La~kYF~QI~~AI~Y 133 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIM-----------K----------------------------HEEGLNEDLAKKYFAQIVHAISY 133 (864)
T ss_pred EEEEEecCCchHHHHHH-----------h----------------------------hhccccHHHHHHHHHHHHHHHHH
Confidence 999997763 6666662 1 12456777889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCC-CcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSlGvl 572 (774)
+|+.++|||||||+||.+-+.-. .+||+|||++..+.++ .+..+.||+..|.|||++.+..|+ +++||||||||
T Consensus 134 CHqLHVVHRDLKPENVVFFEKlG-lVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVI 208 (864)
T KOG4717|consen 134 CHQLHVVHRDLKPENVVFFEKLG-LVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVI 208 (864)
T ss_pred HhhhhhhcccCCcceeEEeeecC-ceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHH
Confidence 99999999999999999976654 4899999999888754 456788999999999999999986 78999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 573 LFFCITGGKHPYGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
||.|++| ++||.+....+. -++..-+...+...+.+++|||..||+.||.+|.+.+|+..|+|.+..+.-
T Consensus 209 LyMLVCG-q~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 209 LYMLVCG-QPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHhC-CCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999996 889987554432 333333444566677899999999999999999999999999999766543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.08 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=195.6
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++... +|+.||||++.... . ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK-RVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHH-HHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4677899999999999998554 68999999986432 1 1223444 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| .+|+|.+++.. .+.+++..+..++.||+.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 121 (291)
T cd05612 81 EYV----------PGGELFSYLRN-----------------------------SGRFSNSTGLFYASEIVCALEYLHSKE 121 (291)
T ss_pred eCC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 45555544322 123566778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~ 193 (291)
T cd05612 122 IVYRDLKPENILLDKEGH--IKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193 (291)
T ss_pred eeecCCCHHHeEECCCCC--EEEEecCcchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987765 899999999876432 123468999999999998889999999999999999999
Q ss_pred CCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 579 GGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 579 g~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
| ..||...... ....+.......+...+++++++|++||+.||.+||+ ++++++||||...++
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 194 G-YPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred C-CCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 7 6677654332 2222222333344556789999999999999999995 999999999976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.10 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=194.4
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~-- 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-VLQNTRHPFLTALKYSFQTHDRLCFVMEYA-- 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHH-HHHhCCCCCCCCEEEEEEcCCEEEEEEeCC--
Confidence 3699999999999854 5789999999875321 12334443 678889999999999999999999999954
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 78 --------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 78 --------NGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred --------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 45555554422 23467778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 121 lkp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P 194 (323)
T cd05571 121 LKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEECCCCC--EEEeeCCCCcccccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC-CCC
Confidence 9999999987765 8999999987543211 122345699999999999999999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 584 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 584 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
|.... ......+......++...++++.++|.+||+.||++|| ++.++++||||....+.
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 195 FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 75433 33333333333344556778999999999999999999 89999999999775543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.93 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=197.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+ .++..++||||+++++++.+++..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK-SILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHH-HHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4578889999999999999865 468999999986432 12233455 467888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 97 ~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 97 LEFVV----------GGELFTHLRK-----------------------------AGRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred EcCCC----------CChHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99554 4444444321 12356677889999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 138 ~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred CeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 9999999999999988775 899999999876432 12356999999999999999999999999999999999
Q ss_pred hCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~ 643 (774)
+| .+||..... .....+.......+...++++.+||.+||+.||.+||+ ++++++||||....+.
T Consensus 210 tg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 210 AG-YPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred cC-CCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 97 667754432 22222322333334456788999999999999999987 7999999999765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=348.05 Aligned_cols=259 Identities=30% Similarity=0.438 Sum_probs=200.5
Q ss_pred ccccccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----------------chHHHHHHHHHHHhCCC
Q 004097 337 RVDGRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----------------HDVALKEIQNLIASDQH 398 (774)
Q Consensus 337 ~~~~~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----------------~~~~~~Ei~~ll~~l~H 398 (774)
..+.+..-+.|.+.+.||+|.||.|-+|. ..+++.||||++.+.. .+...+||. ++++++|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa-ilKkl~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA-ILKKLHH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH-HHHhcCC
Confidence 33445666789999999999999999984 4579999999996432 134567776 7799999
Q ss_pred CCeeEEeeeccCC--ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCC-C
Q 004097 399 PNIVRWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-H 475 (774)
Q Consensus 399 pNIV~l~g~~~~~--~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-l 475 (774)
||||+|+.+..|. +.+|||+|||. .|.+... -.... +
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s----------~G~v~w~------------------------------p~d~~el 207 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCS----------KGEVKWC------------------------------PPDKPEL 207 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEecc----------CCccccC------------------------------CCCcccc
Confidence 9999999998764 77999999654 3433210 00122 6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCC--ccccccccCcCCCCCCchh
Q 004097 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM--SCLTQNATGYGSSGWQAPE 553 (774)
Q Consensus 476 ~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~~gt~~y~aPE 553 (774)
.+.++++|+++++.||+|||.+|||||||||+|+||+.+|. +||+|||.+.....+. ....+....+|||.|+|||
T Consensus 208 s~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE 285 (576)
T KOG0585|consen 208 SEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE 285 (576)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence 67889999999999999999999999999999999998876 9999999998774321 1112233467999999999
Q ss_pred hhhcCC----CCCcchhHhHHHHHHHHHhCCCCCCCCchHH-HHHHHhhcccccccc--CCHHHHHHHHHhcCCCCCCCc
Q 004097 554 QLLQGR----QTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 554 ~l~~~~----~~~~sDvwSlGvll~elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~--~~~~~~dli~~~L~~dP~~Rp 626 (774)
.+..+. .+.+.||||+||+||.|+.| +.||.+.... ....+....-.++.. ..++++|||.+||.+||++|.
T Consensus 286 ~c~~~~~~~~~g~a~DiWalGVTLYCllfG-~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 286 LCSGGNSFSYSGFALDIWALGVTLYCLLFG-QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred hhcCCCCccccchhhhhhhhhhhHHHhhhc-cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee
Confidence 998733 35799999999999999997 6666554443 344454444444433 468999999999999999999
Q ss_pred CHHHHHcCCCCCC
Q 004097 627 KAQNVLNHPFFWT 639 (774)
Q Consensus 627 s~~elL~HPff~~ 639 (774)
+..++..|||...
T Consensus 365 ~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 365 TLPDIKLHPWVTR 377 (576)
T ss_pred ehhhheecceecc
Confidence 9999999999843
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=342.61 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=189.9
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||+||++.. .+++.||||+++... .....+|+. ++..++||||+++++++.+.+..|+|||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHH-HHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 477789999999999999854 468999999986432 224456765 67888999999999999999999999998
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... ...+++..+..++.||+.||+|||+.+|+
T Consensus 85 ~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 85 LDSDLKQYLDNC---------------------------------------GNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred CCcCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 877766655211 12245677889999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg 579 (774)
||||||+|||++.++. +||+|||+++....... ......|++.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 126 H~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 126 HRDLKPQNLLINEKGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred cCCCCHHHEEECCCCC--EEECcCcceeeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 9999999999988775 89999999876542211 1233468999999999875 4689999999999999999997
Q ss_pred CCCCCCCchHHH-HH-HHhhc------------------cccc-----------cccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 580 GKHPYGESFERD-AN-IVKDR------------------KDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~-~~~~~------------------~~~~-----------~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
.+||....... .. +.... ...+ ....+++++|||.+||+.||.+|||+
T Consensus 201 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~ 279 (288)
T cd07871 201 -RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH
Confidence 67775433221 11 10000 0000 11235689999999999999999999
Q ss_pred HHHHcCCCC
Q 004097 629 QNVLNHPFF 637 (774)
Q Consensus 629 ~elL~HPff 637 (774)
+|+++||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07871 280 EAALRHSYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=345.29 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=192.6
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHH-HHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 45778899999999999998654 689999999864321 23455654 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 84 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i 124 (303)
T cd07869 84 YVHTDLCQYMDKH---------------------------------------PGGLHPENVKLFLFQLLRGLSYIHQRYI 124 (303)
T ss_pred CCCcCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8877766554211 1235667788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 125 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 125 LHRDLKPQNLLISDTGE--LKLADFGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ecCCCCHHHEEECCCCC--EEECCCCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999987765 8999999987543221 11233568999999999875 457899999999999999999
Q ss_pred CCCCCCCCchHHHH---HHHhh--cc------------cc-----------------ccccCCHHHHHHHHHhcCCCCCC
Q 004097 579 GGKHPYGESFERDA---NIVKD--RK------------DL-----------------FLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 579 g~~~Pf~~~~~~~~---~~~~~--~~------------~~-----------------~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
| .+||........ .+... .. .. .....++++.+|+.+||+.||.+
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 200 G-VAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred C-CCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 7 778865322111 11000 00 00 00012357889999999999999
Q ss_pred CcCHHHHHcCCCCCCccch
Q 004097 625 RPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 625 Rps~~elL~HPff~~~~~~ 643 (774)
|||++|+++||||.+...+
T Consensus 279 R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 279 RLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred ccCHHHHhcCcccccCChh
Confidence 9999999999999765443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.47 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=192.4
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~ 418 (774)
|...+.|++|+||.||+| ...+++.||+|+++-... -..++||. ++...+|||||.+..+... -+.+||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIn-iLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREIN-ILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHH-HHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 445578999999999998 456789999999975432 35689997 5567789999999987654 46799999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||+.+|..++.. ....+...++..++.|+++||+|||...
T Consensus 157 e~~EhDLksl~d~---------------------------------------m~q~F~~~evK~L~~QlL~glk~lH~~w 197 (419)
T KOG0663|consen 157 EYVEHDLKSLMET---------------------------------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW 197 (419)
T ss_pred HHHHhhHHHHHHh---------------------------------------ccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence 9999887766621 1134667788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ell 577 (774)
|+|||||++|+|++..|. +||+|||||+.+.... ......+-|.+|.|||.+.+. .|+.++|+||+|||+.|++
T Consensus 198 ilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~---k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l 272 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL---KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL 272 (419)
T ss_pred eEecccchhheeeccCCc--EEecccchhhhhcCCc---ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH
Confidence 999999999999988875 8999999999887542 233445679999999999875 4899999999999999999
Q ss_pred hCCCCCCC-CchHHHHHHHhh---cc----------------------------cccccc-CCHHHHHHHHHhcCCCCCC
Q 004097 578 TGGKHPYG-ESFERDANIVKD---RK----------------------------DLFLVE-HIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 578 tg~~~Pf~-~~~~~~~~~~~~---~~----------------------------~~~~~~-~~~~~~dli~~~L~~dP~~ 624 (774)
++ +|-|. .+...+...+-. .+ ..+... .+....+|+..+|..||.+
T Consensus 273 ~~-kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~k 351 (419)
T KOG0663|consen 273 TQ-KPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGK 351 (419)
T ss_pred hc-CCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccc
Confidence 97 55553 332222111100 00 001111 2357789999999999999
Q ss_pred CcCHHHHHcCCCCCCc
Q 004097 625 RPKAQNVLNHPFFWTA 640 (774)
Q Consensus 625 Rps~~elL~HPff~~~ 640 (774)
|.||+|.|+|.||...
T Consensus 352 R~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 352 RITAEDGLKHEYFRET 367 (419)
T ss_pred cccHHHhhcccccccC
Confidence 9999999999999763
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.53 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=192.1
Q ss_pred cceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccC-----Cc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESD-----QD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-----~~ 412 (774)
...|...+.||+|+||.|..| ...+|+.||||++... .....++|+. ++..++|+||+.++.++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElk-lLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELK-LLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHH-HHHHhcCCCcceEEeecccccccccc
Confidence 344555688999999999987 4567899999998632 2345678886 7788899999999998765 35
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.+|+|+|+++.+|.+.|.. ...+....+..++.||++||.
T Consensus 100 DvYiV~elMetDL~~iik~----------------------------------------~~~L~d~H~q~f~YQiLrgLK 139 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS----------------------------------------QQDLTDDHAQYFLYQILRGLK 139 (359)
T ss_pred eeEEehhHHhhHHHHHHHc----------------------------------------CccccHHHHHHHHHHHHHhcc
Confidence 6899999887777666621 112455677899999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
|+|+.+|+||||||+|+|++.+.. +||+|||+|+..... +........+.|.+|.|||++.. ..|+.++||||.||
T Consensus 140 yiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGC 216 (359)
T KOG0660|consen 140 YIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGC 216 (359)
T ss_pred hhhcccccccccchhheeeccCCC--EEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhH
Confidence 999999999999999999977755 799999999988643 22223345568999999999865 56999999999999
Q ss_pred HHHHHHhCCCCCCC-CchHHHH------------------------HHHhhcccc-------ccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYG-ESFERDA------------------------NIVKDRKDL-------FLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~-~~~~~~~------------------------~~~~~~~~~-------~~~~~~~~~~dli~~~L~ 619 (774)
|+.||++| ++-|. ...-.+. ..++..... ..+...+++.||+++||.
T Consensus 217 I~AEmL~g-kplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~ 295 (359)
T KOG0660|consen 217 ILAEMLTG-KPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLV 295 (359)
T ss_pred HHHHHHcC-CCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhc
Confidence 99999997 54443 2221110 011111100 112446899999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 004097 620 PNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~ 639 (774)
.||.+|+|++|+|.|||+..
T Consensus 296 fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 296 FDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred cCccccCCHHHHhcChhhhh
Confidence 99999999999999999854
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=325.10 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=206.9
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+++.||+|.||.||+|. ..++-.||+|++.+++. .+..+|++ +.+.++||||+++|++|.|....||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiE-Iqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIE-IQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeE-eecccCCccHHhhhhheeccceeEEE
Confidence 346677899999999999984 45678999999976542 23345553 78899999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+| |..+|++...|... +...+++.....+++|+|.||.|+|..
T Consensus 101 lE----------ya~~gel~k~L~~~---------------------------~~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 101 LE----------YAPRGELYKDLQEG---------------------------RMKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred EE----------ecCCchHHHHHHhc---------------------------ccccccccchhHHHHHHHHHHHHhccC
Confidence 99 88888888776432 234466677789999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+||||||||+|+|++.++. +||+|||-+.... .....+.|||..|.+||...+..++..+|+|++|++.||++
T Consensus 144 ~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 144 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred CcccCCCCHHHhccCCCCC--eeccCCCceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999988876 8999999887554 23557789999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
.| .+||.+....+ ...+......++...+.++.|+|.+||..+|.+|.+..|++.|||+.
T Consensus 217 vg-~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 217 VG-LPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred hc-CCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 97 88887655333 23334444445667778999999999999999999999999999974
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=342.39 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=195.3
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .+|+.||||.+.+... ....+|+ .++..++|+||+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHH-HHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 45678899999999999854 5799999999864321 1223454 47788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|...+... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ~~----------~~g~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 81 IM----------NGGDLKFHIYNM---------------------------GNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred ec----------CCCcHHHHHHhh---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 55 445554433211 11246778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 124 VYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99999999999987765 8999999998754321 12334689999999999999999999999999999999996
Q ss_pred CCCCCCCchHH-----HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 580 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 580 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
++||...... ....+.......+...++++.+||.+||+.||.+||+ ++++++||||....+
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 198 -QSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -CCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 7788654321 1111222223344556789999999999999999997 899999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.77 Aligned_cols=242 Identities=27% Similarity=0.433 Sum_probs=195.4
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCC-c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
+.+.||+|-||.||++.......||||.++... . +...+|++ ++..++|+|||+|+|+|..++.+|||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~-iMk~L~H~~lV~l~gV~~~~~piyIVtE------- 281 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQ-IMKKLRHEKLVKLYGVCTKQEPIYIVTE------- 281 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHH-HHHhCcccCeEEEEEEEecCCceEEEEE-------
Confidence 457799999999999666555699999997643 2 34445654 7889999999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
||++|+|.++|..... ..+...+.+.++.|||+|++||+++++|||||.+
T Consensus 282 ---~m~~GsLl~yLr~~~~---------------------------~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 282 ---YMPKGSLLDYLRTREG---------------------------GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred ---ecccCcHHHHhhhcCC---------------------------CccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence 8889999888865221 2355678899999999999999999999999999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
.|||++++ .++||+|||||+...++ .+.......-...|.|||.+..+.++.+||||||||+|||++|-|+.||..
T Consensus 332 RNiLV~~~--~~vKIsDFGLAr~~~d~--~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 332 RNILVDED--LVVKISDFGLARLIGDD--EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hheeeccC--ceEEEcccccccccCCC--ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 99999766 46999999999954433 222222233466799999999999999999999999999999999999877
Q ss_pred chHHH-HHHHhhcccc-ccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 587 SFERD-ANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 587 ~~~~~-~~~~~~~~~~-~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
....+ ...+.....+ .|..+++++.+++..||..+|++|||.+.+.
T Consensus 408 msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 408 MSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 54433 3445544444 4555677899999999999999999998654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.87 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=189.1
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC-----cee
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~~ 414 (774)
+|.+.+.||+|+||.||++. ..+|+.||||++.... .....+|+. ++..++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHH-HHHhCCCCCEeeecceEeccCCCCCceE
Confidence 36778999999999999985 4578999999986421 123455664 67889999999999987543 358
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||.++|.+++. ....+++..+..++.||+.||+||
T Consensus 80 ~lv~e~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 80 YVVFELMESDLHQVIK----------------------------------------ANDDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred EEEEecCCCCHHHHHH----------------------------------------hcccCCHHHHHHHHHHHHHHHHHH
Confidence 9999988776665541 112366778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc--CCCCCcchhHhHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCI 572 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGvl 572 (774)
|+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+ ..++.++|||||||+
T Consensus 120 H~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 120 HTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999987765 899999999865432211112234569999999999876 578999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHH------------------------Hhh---ccc----cccccCCHHHHHHHHHhcCC
Q 004097 573 LFFCITGGKHPYGESFERD-ANI------------------------VKD---RKD----LFLVEHIPEAVDLFTRLLDP 620 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~-~~~------------------------~~~---~~~----~~~~~~~~~~~dli~~~L~~ 620 (774)
+|||++| ++||....... ... ... ... .......+++.++|.+||+.
T Consensus 198 l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 198 FAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 9999997 77885432111 000 000 000 00113456789999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCc
Q 004097 621 NPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 621 dP~~Rps~~elL~HPff~~~ 640 (774)
||++|||++|+++||||...
T Consensus 277 ~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 277 DPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CcccCCCHHHHhcCchhhhc
Confidence 99999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=366.22 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=201.4
Q ss_pred ceEEEeEeecccCceEEEEEeeeC------CcEEEEEEeecCCchH---HHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~------g~~VAVK~l~~~~~~~---~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.+.++||+|+||+||+|..+. ...||||.+++....+ .|+.+.+|++.++|||||+|+|+|.+++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 346677899999999999985542 4689999998765442 2333336999999999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||+| ||..|+|.++|........... .+.+ ....+...+.+.|+.|||.|++||-
T Consensus 566 MvFE----------Ym~~GDL~eFLra~sP~a~~~~-----------~g~~----~~~~L~~~q~L~iA~QIAaGM~YLs 620 (774)
T KOG1026|consen 566 MVFE----------YMDHGDLHEFLRARSPKADKLA-----------SGQD----TPPPLSTSQFLHIATQIAAGMEYLS 620 (774)
T ss_pred EEEE----------ecccccHHHHHHhhCCcccccc-----------CCCC----CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7777777777765543322110 0000 1344777899999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
++.+|||||..+|+|+.+. +.+||+||||++.+-+... +.......-..+||+||.+..+++|.+||||||||+|||
T Consensus 621 ~~~FVHRDLATRNCLVge~--l~VKIsDfGLsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWE 697 (774)
T KOG1026|consen 621 SHHFVHRDLATRNCLVGEN--LVVKISDFGLSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWE 697 (774)
T ss_pred hCcccccchhhhhceeccc--eEEEecccccchhhhhhhh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhh
Confidence 9999999999999999655 6799999999998765432 222222335778999999999999999999999999999
Q ss_pred HHhCCCCCCCCc-hHHHHHHHhhcccc-ccccCCHHHHHHHHHhcCCCCCCCcCHHHH
Q 004097 576 CITGGKHPYGES-FERDANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 631 (774)
Q Consensus 576 lltg~~~Pf~~~-~~~~~~~~~~~~~~-~~~~~~~~~~dli~~~L~~dP~~Rps~~el 631 (774)
+++-|+.||..- .++-...+..+..+ .+...+.++.+|+..||+.+|.+||+.+||
T Consensus 698 IFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 698 IFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 999888888654 33333444444333 445566799999999999999999999987
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=350.51 Aligned_cols=249 Identities=28% Similarity=0.367 Sum_probs=196.4
Q ss_pred ceEEEeEeecccCceEEEEEeeeC--CcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~--g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||.||++.... +..||||++.+.. .....+|+ .++..++|||||++++++.+.+..|+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457788999999999999986443 3689999986431 12233454 47788999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||| .+|+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 109 v~Ey~----------~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 109 VLEFV----------IGGEFFTFLRR-----------------------------NKRFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred EEeCC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99955 44555444321 2346777889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++..... ..+..||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred CCeEccCCCHHHEEECCCCC--EEEecCCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHH
Confidence 99999999999999987765 899999999865422 2345699999999999988899999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 577 ITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
++| .+||...... ....+.......+...++++.++|++||+.||++|+ +++++++||||.+.++
T Consensus 222 l~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 222 LVG-CPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred hcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 997 6677654332 222333333334555678999999999999999995 8999999999976554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.65 Aligned_cols=255 Identities=31% Similarity=0.443 Sum_probs=194.6
Q ss_pred ccchhhccccccccccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeE
Q 004097 327 LLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVR 403 (774)
Q Consensus 327 ~~~~~~l~~~~~~~~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~ 403 (774)
.+++.++. ..++.|.-...||+|+||+||+|.+.+|+.||||++..... .++..|+. ++++++|||+|+
T Consensus 64 ~fs~~el~-------~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~-~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 64 SFSYDELR-------KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVE-ILSRLRHPNLVK 135 (361)
T ss_pred eeeHHHHH-------HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHH-HHhcCCCcCccc
Confidence 35555553 33455666688999999999999999999999999976443 34555664 788999999999
Q ss_pred EeeeccCCc-eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHH
Q 004097 404 WYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482 (774)
Q Consensus 404 l~g~~~~~~-~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 482 (774)
|+|||.+.+ ..+|||| ||++|+|.++|+..... .++|..+++
T Consensus 136 LlGyC~e~~~~~~LVYE----------ym~nGsL~d~L~~~~~~---------------------------~L~W~~R~k 178 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYE----------YMPNGSLEDHLHGKKGE---------------------------PLDWETRLK 178 (361)
T ss_pred EEEEEecCCceEEEEEE----------ccCCCCHHHHhCCCCCC---------------------------CCCHHHHHH
Confidence 999999999 5999999 99999999998864321 478899999
Q ss_pred HHHHHHHHHHHHHHc---CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccC-cCCCCCCchhhhhcC
Q 004097 483 VTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG 558 (774)
Q Consensus 483 i~~qia~gL~yLH~~---~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~ 558 (774)
|+.++|+||+|||+. .||||||||+|||||++ +.+||+|||+|+..... .....+. .||.+|+|||+...+
T Consensus 179 Ia~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~--~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 179 IALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED--FNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred HHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC--CCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccC
Confidence 999999999999986 49999999999999766 55999999999665431 1111122 799999999999999
Q ss_pred CCCCcchhHhHHHHHHHHHhCCCCCCCCchHH------H--HHHHhhc-----cccc-c-ccC-----CHHHHHHHHHhc
Q 004097 559 RQTRAIDLFSLGCILFFCITGGKHPYGESFER------D--ANIVKDR-----KDLF-L-VEH-----IPEAVDLFTRLL 618 (774)
Q Consensus 559 ~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~------~--~~~~~~~-----~~~~-~-~~~-----~~~~~dli~~~L 618 (774)
..+.++|||||||++.|++||+ .+.+..... + ...+... .+.. . ... ...+..+..+|+
T Consensus 254 ~lt~KsDVySFGVvllElitgr-~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~ 332 (361)
T KOG1187|consen 254 KLTEKSDVYSFGVVLLELITGR-KAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCL 332 (361)
T ss_pred CcCcccccccchHHHHHHHhCC-cccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHc
Confidence 9999999999999999999984 454432100 0 0111110 0000 0 111 123567888999
Q ss_pred CCCCCCCcCHHHHH
Q 004097 619 DPNPDLRPKAQNVL 632 (774)
Q Consensus 619 ~~dP~~Rps~~elL 632 (774)
+.+|..||+|.||+
T Consensus 333 ~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 333 RPDPKERPTMSQVV 346 (361)
T ss_pred CcCCCcCcCHHHHH
Confidence 99999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.17 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=190.4
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++... +++.||||++..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHH-HHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4778899999999999998654 688999999865321 23445665 7788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.+++.+.+. .....+++..++.++.|++.||+|||+.+|
T Consensus 81 ~~~~~~l~~~~---------------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 81 YVEKNMLELLE---------------------------------------EMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cCCCCHHHHHH---------------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77654433221 011346777889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 ~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 122 VHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred ecCCCCHHHEEEcCCCc--EEEeeccCccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999987765 89999999987643211 112234689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhc-------------c------c------------cccccCCHHHHHHHHHhcCCCCCCCc
Q 004097 580 GKHPYGESFERDA--NIVKDR-------------K------D------------LFLVEHIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~~-------------~------~------------~~~~~~~~~~~dli~~~L~~dP~~Rp 626 (774)
++||........ .+.... . . ......++++.+||++||+.||++||
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 198 -QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 778865332111 000000 0 0 00112356799999999999999999
Q ss_pred CHHHHHcCCCC
Q 004097 627 KAQNVLNHPFF 637 (774)
Q Consensus 627 s~~elL~HPff 637 (774)
|++|+++||||
T Consensus 277 s~~~~l~hp~f 287 (287)
T cd07848 277 LTEQCLNHPAF 287 (287)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.96 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=195.5
Q ss_pred EeecccCceEEEEE-eeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCC-eeEEeeeccCCc------eeEEe
Q 004097 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPN-IVRWYGVESDQD------FVYLS 417 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~------~~~LV 417 (774)
++||+|+||+||+| ...+|+.||+|++.-... ..+.+|+. ++..++|+| ||+|++++...+ .+|||
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREis-llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREIS-LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHH-HHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 56999999999998 456799999999964432 35688986 889999999 999999998877 89999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+||++.+|.+++-..... ..+++...++.+++||++||+|||++
T Consensus 96 fe~~d~DL~~ymd~~~~~------------------------------------~~g~~~~~ik~~m~Qll~gl~~~H~~ 139 (323)
T KOG0594|consen 96 FEFLDRDLKKYMDSLPKK------------------------------------PQGLPPRLIKSFMRQLLRGLAFLHSH 139 (323)
T ss_pred EEeecccHHHHHHhcccc------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999999888877322110 03456677899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~el 576 (774)
+|+||||||+|||++++|. +||+|||+|+...-... .....++|..|.|||++.+. .|+..+||||+|||+.||
T Consensus 140 ~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm 214 (323)
T KOG0594|consen 140 GILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEM 214 (323)
T ss_pred CeecccCCcceEEECCCCc--EeeeccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHH
Confidence 9999999999999999876 79999999996552221 13455789999999999987 689999999999999999
Q ss_pred HhCCCCCCC-CchHHHH-HHHh--hc---------------ccccc------------ccCCHHHHHHHHHhcCCCCCCC
Q 004097 577 ITGGKHPYG-ESFERDA-NIVK--DR---------------KDLFL------------VEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 577 ltg~~~Pf~-~~~~~~~-~~~~--~~---------------~~~~~------------~~~~~~~~dli~~~L~~dP~~R 625 (774)
+++ ++-|. .+...+. .+.. +. ...++ ....++..+++.+||+.+|.+|
T Consensus 215 ~~~-~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 215 FTR-RPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HhC-CCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 997 44443 3332221 1111 00 00011 1112578999999999999999
Q ss_pred cCHHHHHcCCCCCCccchh
Q 004097 626 PKAQNVLNHPFFWTADTRL 644 (774)
Q Consensus 626 ps~~elL~HPff~~~~~~~ 644 (774)
.|++.+|.||||.....+.
T Consensus 294 ~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 294 ISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cCHHHHhcChhhcccccch
Confidence 9999999999997765443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.95 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=197.3
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
|.-.++||+|...+|.++ ...+|+..|||++..... +...+|+..+.....||||+.+.++++.+.++
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 444577999999988775 556789999999853211 23456777777888999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|+| .++.|.|.++|... ..++++..++|++|+..|++||
T Consensus 99 FlVFd----------l~prGELFDyLts~-----------------------------VtlSEK~tR~iMrqlfegVeyl 139 (411)
T KOG0599|consen 99 FLVFD----------LMPRGELFDYLTSK-----------------------------VTLSEKETRRIMRQLFEGVEYL 139 (411)
T ss_pred hhhhh----------hcccchHHHHhhhh-----------------------------eeecHHHHHHHHHHHHHHHHHH
Confidence 99999 67778888777543 3467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc------CCCCCcchhHh
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAIDLFS 568 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDvwS 568 (774)
|..+||||||||+|||++++. ++||+|||+++.+..+ ......||||+|+|||.+.. ..|+..+|+||
T Consensus 140 Ha~~IVHRDLKpENILlddn~--~i~isDFGFa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa 213 (411)
T KOG0599|consen 140 HARNIVHRDLKPENILLDDNM--NIKISDFGFACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA 213 (411)
T ss_pred HHhhhhhcccChhheeecccc--ceEEeccceeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHH
Confidence 999999999999999997665 4999999999988754 34456789999999999864 35788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHH-HHHHHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 569 LGCILFFCITGGKHPYGESFER-DANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~-~~~~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
+|||||-|+.| .+||-...+. ....+...+..+ ..+.+.+.+|||.+||+.||.+|.|++|+|.||||.
T Consensus 214 ~GVImyTLLaG-cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 214 CGVIMYTLLAG-CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHHHcC-CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99999999997 6666543332 233333333222 223456899999999999999999999999999993
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.52 Aligned_cols=243 Identities=29% Similarity=0.365 Sum_probs=189.9
Q ss_pred ecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||+||++.. .+++.||||++.+.. .....+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~---- 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER-TVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI---- 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCcEeceeeEEecCCeEEEEEcCC----
Confidence 79999999999854 468899999986431 11233454 4677889999999999999999999999955
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|||||
T Consensus 76 ------~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk 120 (312)
T cd05585 76 ------NGGELFHHLQR-----------------------------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120 (312)
T ss_pred ------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence 45555554422 1235677788999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.
T Consensus 121 p~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~ 194 (312)
T cd05585 121 PENILLDYQGH--IALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFY 194 (312)
T ss_pred HHHeEECCCCc--EEEEECcccccCccCC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC-CCCcC
Confidence 99999987775 8999999987643221 122345699999999999999999999999999999999997 77775
Q ss_pred Cch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc---CHHHHHcCCCCCCcc
Q 004097 586 ESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP---KAQNVLNHPFFWTAD 641 (774)
Q Consensus 586 ~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp---s~~elL~HPff~~~~ 641 (774)
... ......+.......+...++++.++|.+||+.||.+|| ++.|+++||||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 195 DENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 533 22222222333334556678999999999999999997 589999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.68 Aligned_cols=246 Identities=25% Similarity=0.337 Sum_probs=193.2
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++||||+++++++.+.+..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey--- 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTES-RVLKNTRHPFLTSLKYSFQTKDRLCFVMEY--- 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCEEEEEEeC---
Confidence 359999999999985 45789999999975321 1233454 477889999999999999999999999994
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 77 -------~~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 77 -------VNGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred -------CCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 455555544321 23467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 121 ikp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG-~~P 194 (328)
T cd05593 121 LKLENLMLDKDGH--IKITDFGLCKEGITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (328)
T ss_pred cCHHHeEECCCCc--EEEecCcCCccCCCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC-CCC
Confidence 9999999987765 8999999987543221 112345699999999999988999999999999999999997 677
Q ss_pred CCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 584 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
|..... .....+.......+...++++.++|.+||+.||.+|+ ++.++++||||....+
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 195 FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 754332 2223332233334556678999999999999999997 8999999999976544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.58 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=191.5
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++.+.. .....+|+..+....+||||+++++++.+.+.+|+|||||.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~- 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN- 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC-
Confidence 3599999999999855 468899999986431 12334555544445689999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|..++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 80 ---------~g~L~~~i~~-----------------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~d 121 (320)
T cd05590 80 ---------GGDLMFHIQK-----------------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRD 121 (320)
T ss_pred ---------CchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 4455443321 23466778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIli~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (320)
T cd05590 122 LKLDNVLLDHEGH--CKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195 (320)
T ss_pred CCHHHeEECCCCc--EEEeeCCCCeecCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC-CCC
Confidence 9999999988775 8999999987543211 112345699999999999988999999999999999999997 778
Q ss_pred CCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH------HHHHcCCCCCCcc
Q 004097 584 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~------~elL~HPff~~~~ 641 (774)
|....... ...+.......+...++++.++|.+||+.||.+||++ +++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 86544332 2223333333444567899999999999999999998 8999999996643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.69 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=193.3
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++. ..+|+.||+|++.+... ....+|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~i~~~~~~~~~~~~~~lv~E---- 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhCCCCCCcceeeEEecCCEEEEEEe----
Confidence 369999999999985 45789999999865311 1223444 47788899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 76 ------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 5555555544321 23467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 121 lkp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g-~~P 194 (323)
T cd05595 121 IKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEEcCCCC--EEecccHHhccccCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC-CCC
Confidence 9999999987765 8999999987543221 112335699999999999988999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 584 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 584 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
|.... ......+.......+...++++.++|.+||+.||.+|+ ++.++++||||....+.
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 195 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 75443 22222222223334556678999999999999999998 89999999999775543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.80 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=186.8
Q ss_pred EeecccCceEEEEEeee---CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEeccccCCC
Q 004097 351 KEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERCTCS 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~E~~~~s 424 (774)
++||+|+||+||++... +++.||||.+..... ....+|+. ++..++||||+++++++.+ +...|++||++.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHH-HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 57999999999998643 568999999875433 34566765 7788999999999998754 46789999988888
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
|.+++......... .+...+++..++.++.||+.||+|||+.+|+||||
T Consensus 86 l~~~~~~~~~~~~~-------------------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDl 134 (317)
T cd07868 86 LWHIIKFHRASKAN-------------------------------KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134 (317)
T ss_pred HHHHHHhccccccc-------------------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence 77766432211000 11234778889999999999999999999999999
Q ss_pred CCCCeeecCC--CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCCC
Q 004097 505 KPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 505 kp~NILl~~~--~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~~ 581 (774)
||+|||++.+ ....+||+|||+++................||+.|+|||++.+. .++.++||||+||++|||++| .
T Consensus 135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~ 213 (317)
T cd07868 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-E 213 (317)
T ss_pred CHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC-C
Confidence 9999999422 22359999999998765432222233445789999999999874 589999999999999999997 6
Q ss_pred CCCCCchHH-----------HHHHHhh--------------cc-----------c------------cccccCCHHHHHH
Q 004097 582 HPYGESFER-----------DANIVKD--------------RK-----------D------------LFLVEHIPEAVDL 613 (774)
Q Consensus 582 ~Pf~~~~~~-----------~~~~~~~--------------~~-----------~------------~~~~~~~~~~~dl 613 (774)
+||...... ...+... .. . .......+++.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 293 (317)
T cd07868 214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293 (317)
T ss_pred CCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHH
Confidence 777532110 0000000 00 0 0001123568899
Q ss_pred HHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 614 FTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 614 i~~~L~~dP~~Rps~~elL~HPff 637 (774)
|.+||+.||.+|||++|+|+||||
T Consensus 294 i~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 294 LQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.69 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=187.3
Q ss_pred eEEEeEeecccCceEEEEEee--eCCcEEEEEEeecCC-----chHHHHHHHHH--HHhCCCCCeeEEeeecc-----CC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVES-----DQ 411 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~--~~g~~VAVK~l~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~-----~~ 411 (774)
+|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+..+ +..+.||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 467789999999999999864 347889999986432 12344555432 33457999999999875 34
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...++|||++.++|.+++... ....+++..++.++.||+.||
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--------------------------------------~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--------------------------------------PEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--------------------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 568999998877766655210 112367778899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999999999999999999988765 899999999765432 1223456899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH--HHHHhhccc--------------------------cccccCCHHHHHHHHHhcCCCCC
Q 004097 572 ILFFCITGGKHPYGESFERD--ANIVKDRKD--------------------------LFLVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~--~~~~~~~~~--------------------------~~~~~~~~~~~dli~~~L~~dP~ 623 (774)
++|||++| .+||......+ ..+...... ......++.+.++|.+||+.||+
T Consensus 198 il~el~~g-~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 198 IFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHcC-CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 99999996 77886543221 111111000 00123446788999999999999
Q ss_pred CCcCHHHHHcCCCC
Q 004097 624 LRPKAQNVLNHPFF 637 (774)
Q Consensus 624 ~Rps~~elL~HPff 637 (774)
+|||+.|+++||||
T Consensus 277 ~R~s~~~~l~hp~f 290 (290)
T cd07862 277 KRISAYSALSHPYF 290 (290)
T ss_pred hcCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=352.87 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=190.4
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..|.+.+.||+|+||.||++. ..+++.||||.... ....+|+. +++.++|||||++++++...+..++|+|++.+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAH-ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHH-HHHhCCCCCCCCEeEEEEECCeeEEEEecCCC
Confidence 458899999999999999984 45689999997643 23456765 77889999999999999999999999997766
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|.+++. ....+++..++.|+.||+.||+|||+.+|+|||
T Consensus 168 ~L~~~l~----------------------------------------~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrD 207 (391)
T PHA03212 168 DLYCYLA----------------------------------------AKRNIAICDILAIERSVLRAIQYLHENRIIHRD 207 (391)
T ss_pred CHHHHHH----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 6554431 113466778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 208 iKP~NIll~~~~~--vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 208 IKAENIFINHPGD--VCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred CChHhEEEcCCCC--EEEEeCCccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999988776 8999999997543211 11223456999999999999989999999999999999999986555
Q ss_pred CCCch-------HHH-HHHHhh--------------------------cccc--------ccccCCHHHHHHHHHhcCCC
Q 004097 584 YGESF-------ERD-ANIVKD--------------------------RKDL--------FLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 584 f~~~~-------~~~-~~~~~~--------------------------~~~~--------~~~~~~~~~~dli~~~L~~d 621 (774)
|.... ... ..++.. .... .......++.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 54210 000 000000 0000 00012347889999999999
Q ss_pred CCCCcCHHHHHcCCCCCCc
Q 004097 622 PDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 622 P~~Rps~~elL~HPff~~~ 640 (774)
|.+|||++|+|+||||...
T Consensus 364 P~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhhCCCHHHHhcChhhccC
Confidence 9999999999999999653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=342.50 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=190.1
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+|+.||||++++.. ......|+..+....+||||+++++++.+.+..|+|||||.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~- 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN- 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC-
Confidence 3699999999999854 468899999997531 12334455544455799999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 80 ---------~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrD 121 (316)
T cd05620 80 ---------GGDLMFHIQD-----------------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121 (316)
T ss_pred ---------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 4444443321 12356677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g-~~P 195 (316)
T cd05620 122 LKLDNVMLDRDGH--IKIADFGMCKENVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEeCccCCCeecccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC-CCC
Confidence 9999999987765 8999999987532211 122345699999999999999999999999999999999997 677
Q ss_pred CCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-HHHHcCCCCCCcc
Q 004097 584 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-~elL~HPff~~~~ 641 (774)
|...... ....+.......+...++++.++|.+||+.||++||++ +++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 196 FHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 7554332 22333333333444567899999999999999999998 5899999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=357.32 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=192.4
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC--------Cce
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------QDF 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--------~~~ 413 (774)
..+.|.+.+.||+|+||+||++.. .+++.||||++.... ....+|+. ++..++|||||++++++.. ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELL-IMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHH-HHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 346799999999999999999855 468999999986532 22345664 7788999999999887532 235
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+++|||||+++|.+++.... .....+++..++.++.||+.||+|
T Consensus 142 l~lvmE~~~~~l~~~~~~~~------------------------------------~~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYA------------------------------------RNNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred EEEEEecCCccHHHHHHHHh------------------------------------hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 78999988877766552100 112346778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvl 572 (774)
||+.+|+||||||+|||++.++. .+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 186 LH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 186 IHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 99999999999999999976543 48999999998765321 22345689999999998764 68999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhc----------------------------cccccccCCHHHHHHHHHhcCCCC
Q 004097 573 LFFCITGGKHPYGESFERD--ANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~~dli~~~L~~dP 622 (774)
+|||++| .+||....... ..++... ...++...++++.+||.+||+.||
T Consensus 261 l~elltG-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 261 IAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 9999997 67775432211 1111100 001122345789999999999999
Q ss_pred CCCcCHHHHHcCCCCCCc
Q 004097 623 DLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~~ 640 (774)
.+|||+.|+++||||...
T Consensus 340 ~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 340 LKRLNPIEALADPFFDDL 357 (440)
T ss_pred hHCcCHHHHhCChhHHhh
Confidence 999999999999999653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.15 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=190.7
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++++.. ......|...+....+||||+++++++.+++..|+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~-- 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL-- 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC--
Confidence 3699999999999854 457899999986531 1223345444444568999999999999999999999955
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 79 --------~gg~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 79 --------NGGDLMFHIQS-----------------------------SGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred --------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 45555444321 12366778889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nill~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~P 195 (316)
T cd05592 122 LKLDNVLLDKDGH--IKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEEccCcCCeECCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC-CCC
Confidence 9999999987765 8999999997653221 122345699999999999998999999999999999999997 778
Q ss_pred CCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH-HHHcCCCCCCccc
Q 004097 584 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~-elL~HPff~~~~~ 642 (774)
|...... ....+.......+...++++.++|.+||+.||.+||++. ++++||||...++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 196 FHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 7654332 222233333334455678999999999999999999864 8889999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=345.96 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=192.1
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+..|.+.+.||+|+||.||++... .++.||||.... ....+|+. ++..++|||||++++++..++..++|||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~-iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEAR-LLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 3556889999999999999998554 578999996432 23456665 778899999999999999999999999977
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.++|.+++.. ....+++..++.|+.||+.||+|||+.+|+|
T Consensus 243 ~~~L~~~l~~---------------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 243 RSDLYTYLGA---------------------------------------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred CCCHHHHHHh---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 6655544411 1124677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 284 rDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 284 RDIKTENVLVNGPED--ICLGDFGAACFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred CcCCHHHEEECCCCC--EEEcccCCceeccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999987765 899999999876432211 11223469999999999999999999999999999999999865
Q ss_pred CCCCCch--------HHHHHHHhhcc---cccc-------------------------------ccCCHHHHHHHHHhcC
Q 004097 582 HPYGESF--------ERDANIVKDRK---DLFL-------------------------------VEHIPEAVDLFTRLLD 619 (774)
Q Consensus 582 ~Pf~~~~--------~~~~~~~~~~~---~~~~-------------------------------~~~~~~~~dli~~~L~ 619 (774)
+.|.... .....++.... ..++ ....+++.+||.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 5554321 11111211100 0000 0123578999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 004097 620 PNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~ 639 (774)
.||.+|||+.|+|+||||++
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999964
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.49 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=191.6
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+|+.||||++.+.. ....+.|+..++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~-- 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV-- 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC--
Confidence 3699999999999855 468999999986432 1223455555678899999999999999999999999954
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 79 --------~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d 121 (323)
T cd05575 79 --------NGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121 (323)
T ss_pred --------CCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 45555544322 12356777889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~p 195 (323)
T cd05575 122 LKPENILLDSQGH--VVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (323)
T ss_pred CCHHHeEECCCCc--EEEeccCCCcccccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC-CCC
Confidence 9999999988765 8999999987543221 122345699999999999998999999999999999999997 667
Q ss_pred CCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCCCCCCcc
Q 004097 584 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HPff~~~~ 641 (774)
|..... .....+...........++++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 765432 222222222223344567899999999999999999987 6999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.77 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=199.9
Q ss_pred EEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|...+.||+|+||.||+| ...+++.||+|++.-...+ ...+|+ .+++.++++||.++||.+..+..++++||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei-~~Ls~~~~~~it~yygsyl~g~~LwiiMe-- 91 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEI-SVLSQCDSPNITEYYGSYLKGTKLWIIME-- 91 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHH-HHHHhcCcchHHhhhhheeecccHHHHHH--
Confidence 444578999999999998 4567899999999654332 334454 47888999999999999999999999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+|++.+.|... ..+++..+.-|+++++.||.|||.++.+|
T Consensus 92 --------y~~gGsv~~lL~~~-----------------------------~~~~E~~i~~ilre~l~~l~ylH~~~kiH 134 (467)
T KOG0201|consen 92 --------YCGGGSVLDLLKSG-----------------------------NILDEFEIAVILREVLKGLDYLHSEKKIH 134 (467)
T ss_pred --------HhcCcchhhhhccC-----------------------------CCCccceeeeehHHHHHHhhhhhhcceec
Confidence 55556655544221 11245566789999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
||||+.|||+..+|. +|++|||.+..+.... ....+.+||+.|||||++.+..|+.++||||||++.+||++| .
T Consensus 135 rDIKaanil~s~~g~--vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G-e 208 (467)
T KOG0201|consen 135 RDIKAANILLSESGD--VKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG-E 208 (467)
T ss_pred ccccccceeEeccCc--EEEEecceeeeeechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC-C
Confidence 999999999998876 9999999998877532 334788999999999999988999999999999999999997 8
Q ss_pred CCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 582 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 582 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
||+.+..+.-. .+-+..++.....+++.+++||..||+.||+.||+|.++|+|+|++...
T Consensus 209 PP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 89877554221 2223333333345678899999999999999999999999999997743
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=339.61 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=185.9
Q ss_pred eEeecccCceEEEEEeee---CCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCCeeEEeeecc--CCceeEEeccccCC
Q 004097 350 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSLERCTC 423 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpNIV~l~g~~~--~~~~~~LV~E~~~~ 423 (774)
..+||+|+||+||++... +++.||||.+...... ...+|+. ++..++||||+++++++. ++...|+|+||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA-LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHH-HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999998654 4578999998765433 3445654 778899999999999884 45678999999888
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|.+++......... .....+++..+..++.||+.||+|||+.+|+|||
T Consensus 85 ~l~~~~~~~~~~~~~-------------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 85 DLWHIIKFHRASKAN-------------------------------KKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred cHHHHHHhhhccccC-------------------------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 877766322111000 1123467788899999999999999999999999
Q ss_pred cCCCCeeecCC--CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 504 LKPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 504 Lkp~NILl~~~--~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||+|||+..+ ....+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg- 212 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS- 212 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC-
Confidence 99999999422 12358999999998765432222223345689999999998764 579999999999999999997
Q ss_pred CCCCCCchHHH-----------HHHHhh--------------c-----------c------------ccccccCCHHHHH
Q 004097 581 KHPYGESFERD-----------ANIVKD--------------R-----------K------------DLFLVEHIPEAVD 612 (774)
Q Consensus 581 ~~Pf~~~~~~~-----------~~~~~~--------------~-----------~------------~~~~~~~~~~~~d 612 (774)
.+||....+.. ..+... . . ..........+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 77775322110 000000 0 0 0000112346889
Q ss_pred HHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 613 LFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 613 li~~~L~~dP~~Rps~~elL~HPff 637 (774)
||.+||+.||.+|||++|+|+||||
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=344.17 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=190.1
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||+|++.+... ....+|+..+....+||||+++++++.+.+..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~--- 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY--- 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC---
Confidence 3699999999999854 4688999999975321 12334555444556899999999999999999999995
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 78 -------~~~~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~D 121 (329)
T cd05618 78 -------VNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRD 121 (329)
T ss_pred -------CCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 445555443321 23467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nili~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (329)
T cd05618 122 LKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHEEECCCCC--EEEeeCCccccccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC-CCC
Confidence 9999999988775 8999999987543211 122345699999999999999999999999999999999997 778
Q ss_pred CCCc----------hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC------HHHHHcCCCCCCccc
Q 004097 584 YGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~----------~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps------~~elL~HPff~~~~~ 642 (774)
|... .......+.......+...++++.++|.+||+.||.+||+ +.++++||||+..++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 7421 0111122222233345556789999999999999999998 579999999977544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.08 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=190.9
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++.+.. ......|...+....+||||+++++++.+.+..|+|||||.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~- 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN- 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC-
Confidence 3599999999999855 457899999986531 11233455444445589999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|...+.. .+.+++..+..++.||+.||+|||+.+|+|||
T Consensus 80 ---------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 121 (321)
T cd05591 80 ---------GGDLMFQIQR-----------------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121 (321)
T ss_pred ---------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 4444443321 23466778889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~P 195 (321)
T cd05591 122 LKLDNILLDAEGH--CKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-QPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEeecccceecccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC-CCC
Confidence 9999999988775 8999999987543221 112345689999999999998999999999999999999996 778
Q ss_pred CCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-------CHHHHHcCCCCCCccc
Q 004097 584 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-------KAQNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-------s~~elL~HPff~~~~~ 642 (774)
|....... ...+.......+...++++.++|.+||+.||++|| +++++++||||...++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 196 FEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 86554332 22222223334445678999999999999999999 8999999999966443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.80 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=194.4
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHH--HHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~--~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+. .++..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 35678999999999999854 468999999997432 112223333 234567899999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|...++ ...+++..++.++.||+.||+|||+.
T Consensus 81 ~E~~~----------~~~L~~~~~------------------------------~~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 81 MEYAA----------GGDLMMHIH------------------------------TDVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred EcCCC----------CCcHHHHhh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99554 455544322 12367778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 121 ~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 121 KIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred CeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 9999999999999988875 8999999987543221 1223457999999999999989999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
+| .+||....... ...+.......+...++++.++|.+||+.||.+|| ++.++++||||.+...
T Consensus 196 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 196 VG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 97 77886544322 22233333334556678999999999999999999 6999999999977544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=341.85 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=190.5
Q ss_pred EEEeEeecccCceEEEEEee----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhC-CCCCeeEEeeeccCCcee
Q 004097 347 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~ 414 (774)
|.+.+.||+|+||+||++.. .+++.||||++.+... ....+|+. ++..+ +||||+++++++.+.+.+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERN-VLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHHhccCCCCcccEEEEEecCCEE
Confidence 56789999999999998754 3688999999864211 12334554 45555 699999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||||| .+|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 81 ~lv~e~~----------~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~l 121 (332)
T cd05614 81 HLILDYV----------SGGEMFTHLYQ-----------------------------RDNFSEDEVRFYSGEIILALEHL 121 (332)
T ss_pred EEEEeCC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 44555544321 23467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++
T Consensus 122 H~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 197 (332)
T cd05614 122 HKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197 (332)
T ss_pred HHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence 9999999999999999988875 89999999986543211 112345699999999999865 478999999999999
Q ss_pred HHHHhCCCCCCCCchH-----HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCcc
Q 004097 574 FFCITGGKHPYGESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 641 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~ 641 (774)
|||++| ..||..... .....+.......+...++++.++|.+||+.||++|| +++++++||||....
T Consensus 198 ~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 198 FELLTG-ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred hhhhcC-CCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999997 778853211 1111122222233445678999999999999999999 888999999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.28 Aligned_cols=254 Identities=23% Similarity=0.330 Sum_probs=191.1
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++. ..+++.||||++.+... ...++.+..++..++||||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 46778999999999999985 45689999999975321 1122333346788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| ++|+|.+++.. ...+++..++.++.|++.||+|||+.+|
T Consensus 82 ~~----------~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 82 FL----------PGGDMMTLLMK-----------------------------KDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred CC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55 44555554422 2346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCcc--------------------------------ccccccCcCCC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 547 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~--------------------------------~~~~~~~~gt~ 547 (774)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 123 IHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred EecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 99999999999988775 899999998765321100 00012357999
Q ss_pred CCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccc-ccc--ccCCHHHHHHHHHhcCCCC
Q 004097 548 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 548 ~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~-~~~--~~~~~~~~dli~~~L~~dP 622 (774)
.|+|||++.+..++.++|||||||++|||++| .+||....... ..+...... .++ ...+++++++|.+|+. +|
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 99999999999999999999999999999997 77886543322 223322111 122 2346799999999775 44
Q ss_pred C---CCcCHHHHHcCCCCCCccc
Q 004097 623 D---LRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 623 ~---~Rps~~elL~HPff~~~~~ 642 (774)
. .||+++|+++||||...++
T Consensus 279 ~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 279 EHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred hhcCCCCCHHHHhCCCCCCCCCH
Confidence 4 4689999999999977554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.76 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=190.7
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCC-----cee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~~ 414 (774)
+...-.|.-.+.+|.|+||.||.|.+. +++.||||+..... ...-+|++ ++..++|||||+|..+|... -++
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~-im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQ-IMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHH-HHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 334445677789999999999998654 46899999985432 22345666 45699999999999887542 245
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
.+||||++.+|.+.+.... .....+|.-.++-++.||++||+||
T Consensus 98 nlVleymP~tL~~~~r~~~------------------------------------~~~~~mp~~~iKLYt~Qlfrgl~yL 141 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYT------------------------------------RANQRMPLLEIKLYTYQLFRGLAYL 141 (364)
T ss_pred HHHHHhchHHHHHHHHHHh------------------------------------hcCCCCceeeeHHHHHHHHHHHHHH
Confidence 6899988887776662100 1123355566788999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|+|++.+.. .+||||||.|+.+..+.. ..+..-|..|.|||.+.+. .|+.+.||||.||++
T Consensus 142 h~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~ 216 (364)
T KOG0658|consen 142 HSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVM 216 (364)
T ss_pred HhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccCCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHH
Confidence 9999999999999999998754 599999999998875432 2334468889999999875 599999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HHHh--------------hc------------c--ccccccCCHHHHHHHHHhcCCCCCC
Q 004097 574 FFCITGGKHPYGESFERDA-NIVK--------------DR------------K--DLFLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-~~~~--------------~~------------~--~~~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
.||+-|+..+-+++...+. .+++ .. . ..+.....+++.+|+.++|+.+|.+
T Consensus 217 aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~ 296 (364)
T KOG0658|consen 217 AELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSK 296 (364)
T ss_pred HHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhh
Confidence 9999984444343322211 1111 00 0 0122334689999999999999999
Q ss_pred CcCHHHHHcCCCCC
Q 004097 625 RPKAQNVLNHPFFW 638 (774)
Q Consensus 625 Rps~~elL~HPff~ 638 (774)
|.++.|++.||||.
T Consensus 297 R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 297 RLSALEALAHPFFD 310 (364)
T ss_pred cCCHHHHhcchhhH
Confidence 99999999999994
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=342.61 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=188.2
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++++... ....+|+..+....+||||+++++++.+.+.+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~-- 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV-- 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC--
Confidence 3699999999999854 4689999999975321 122344443333448999999999999999999999955
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
++|+|..++. +.+.+++..++.++.||+.||+|||+.+|+|||
T Consensus 79 --------~~g~L~~~~~-----------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 121 (329)
T cd05588 79 --------SGGDLMFHMQ-----------------------------RQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121 (329)
T ss_pred --------CCCCHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 4455544332 123477888899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~P 195 (329)
T cd05588 122 LKLDNVLLDAEGH--IKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHeEECCCCC--EEECcCccccccccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC-CCC
Confidence 9999999987765 8999999987532211 122345799999999999999999999999999999999997 778
Q ss_pred CCCch----------HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC------HHHHHcCCCCCCcc
Q 004097 584 YGESF----------ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~----------~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps------~~elL~HPff~~~~ 641 (774)
|.... ......+.......+...++++.++|.+||+.||.+|++ ++++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred cccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 85211 011122222222334456789999999999999999987 78999999996643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.59 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=192.7
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~-- 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLCFVMEYA-- 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCCceEEEEEcCCEEEEEEeCC--
Confidence 369999999999975 45789999999975321 1223344 4677889999999999999999999999954
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCcccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHR 502 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHr 502 (774)
.+|+|..++.. ...+++..+..++.||+.||+|||+ .+|+||
T Consensus 78 --------~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 78 --------NGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred --------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 45555444321 2346778889999999999999997 799999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..
T Consensus 121 Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG-~~ 194 (325)
T cd05594 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RL 194 (325)
T ss_pred CCCCCeEEECCCCC--EEEecCCCCeecCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC-CC
Confidence 99999999988775 8999999987543221 112335699999999999998999999999999999999997 66
Q ss_pred CCCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 583 PYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 583 Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
||.... ......+.......+...++++.++|.+||+.||++|+ ++.++++||||......
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 775443 23333333333334556678999999999999999997 89999999999765433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=345.71 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=195.4
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++... +|+.||||++.+.. ....+.++..++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4678899999999999998544 68999999996432 12233444457888899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|.+++.. ...+++..++.++.||+.||+|||+.||
T Consensus 82 ~~----------~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 82 YM----------PGGDLMNLLIR-----------------------------KDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred CC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55 44555554422 1346777889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCc--------------------------cccccccCcCCCCCCchh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--------------------------CLTQNATGYGSSGWQAPE 553 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~--------------------------~~~~~~~~~gt~~y~aPE 553 (774)
+||||||+|||++.++. +||+|||+++....... .........||+.|+|||
T Consensus 123 iH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 123 IHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred eccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999988876 89999999987653320 001123456999999999
Q ss_pred hhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-H-HHHhhccc-ccc--ccCCHHHHHHHHHhcCCCCCCCcC-
Q 004097 554 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-A-NIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDLRPK- 627 (774)
Q Consensus 554 ~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~-~~~~~~~~-~~~--~~~~~~~~dli~~~L~~dP~~Rps- 627 (774)
++.+..++.++|||||||++|||++| .+||....... . .+...... ..+ ...++++.++|.+||. ||.+||+
T Consensus 201 ~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s 278 (350)
T cd05573 201 VLRGTPYGLECDWWSLGVILYEMLYG-FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS 278 (350)
T ss_pred HHcCCCCCCceeeEecchhhhhhccC-CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence 99999999999999999999999997 67776544322 2 22221111 112 2247899999999997 9999999
Q ss_pred HHHHHcCCCCCCcc
Q 004097 628 AQNVLNHPFFWTAD 641 (774)
Q Consensus 628 ~~elL~HPff~~~~ 641 (774)
++++++||||...+
T Consensus 279 ~~~ll~hp~~~~~~ 292 (350)
T cd05573 279 FEEIKSHPFFKGID 292 (350)
T ss_pred HHHHhcCCCcCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.60 Aligned_cols=253 Identities=29% Similarity=0.335 Sum_probs=198.3
Q ss_pred ccccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCC-C-----CCeeEEeeeccCC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-H-----PNIVRWYGVESDQ 411 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-H-----pNIV~l~g~~~~~ 411 (774)
..++.+|.+.+.||+|+||.|.+| +..+++.||||++++.. ..++..|+. +|..++ | -|||+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~-iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIR-ILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHH-HHHHHhccCCCCCeeEEEeeeccccc
Confidence 344558899999999999999998 55679999999997643 345566665 445544 3 4899999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+++|||+|++..+|.+++.. .+-.+++...++.|++||+.||
T Consensus 261 ~HlciVfELL~~NLYellK~--------------------------------------n~f~Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKN--------------------------------------NKFRGLSLPLVRKFAQQILTAL 302 (586)
T ss_pred cceeeeehhhhhhHHHHHHh--------------------------------------cCCCCCCHHHHHHHHHHHHHHH
Confidence 99999999998888887732 2235688899999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
.+||+.+|||+||||+||||..-+...+||+|||.+....... .+.+-+..|.|||++.+.+|+.+.|||||||
T Consensus 303 ~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 303 LFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred HHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc------eeeeeccccccchhhccCCCCCccceeehhh
Confidence 9999999999999999999987776789999999998766432 2445678899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-H-HHHh---------------------h------------------------------c
Q 004097 572 ILFFCITGGKHPYGESFERD-A-NIVK---------------------D------------------------------R 598 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~-~~~~---------------------~------------------------------~ 598 (774)
|+.||++| .|-|....+.+ . .+++ . .
T Consensus 377 IlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~ 455 (586)
T KOG0667|consen 377 ILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARL 455 (586)
T ss_pred hHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcc
Confidence 99999998 54453322211 0 0000 0 0
Q ss_pred ccccc-c----------cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 599 KDLFL-V----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 599 ~~~~~-~----------~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
....+ . .....+.|+|++||+.||.+|+|+.++|+||||..
T Consensus 456 ~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 456 ERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 00001 0 01135789999999999999999999999999964
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=339.83 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=191.0
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++.... ......|...+....+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey--- 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY--- 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC---
Confidence 3699999999999865 457899999986531 123344555444457999999999999999999999995
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+.+|+|..++.. ...+++.++..++.|++.||+|||+.+|+|||
T Consensus 78 -------~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 78 -------LNGGDLMFHIQS-----------------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred -------CCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 445555554322 12356777889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 ikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (316)
T cd05619 122 LKLDNILLDTDGH--IKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHEEECCCCC--EEEccCCcceECCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC-CCC
Confidence 9999999988765 8999999987543211 112345689999999999998999999999999999999997 678
Q ss_pred CCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH-HHHcCCCCCCccc
Q 004097 584 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~-elL~HPff~~~~~ 642 (774)
|....... ...+.......+...+.++.++|.+||+.||++||++. ++++||||....+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 196 FHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 76543322 22233333334445678899999999999999999996 8999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.23 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=191.8
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCC-CCeeEEeeeccCCceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~H-pNIV~l~g~~~~~~~~~LV~ 418 (774)
|.+.+.||+|+||+||++... +++.||||++.+.. ......|.. ++..+.| ++|+++++++.+.+.+|+||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 567899999999999998544 57899999986431 122334544 4455544 56889999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|..++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~~----------~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 81 EYVN----------GGDLMYHIQQ-----------------------------VGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred cCCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9554 4555444321 123567788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 122 IIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred eEecCCCHHHeEEcCCCC--EEEeecCcceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999988765 8999999987533211 12234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccc
Q 004097 579 GGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 642 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~ 642 (774)
| .+||....... ...+.......+...++++.+++.+||+.||.+|+++ +++++||||...++
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 197 G-QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred C-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 6 77886544322 2222233333455667899999999999999999986 89999999976544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=343.94 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=191.3
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|+..++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~-- 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV-- 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC--
Confidence 359999999999985 4578999999986431 1223455555678899999999999999999999999955
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|..++. +...+++..+..++.||+.||+|||+.||+|||
T Consensus 79 --------~~~~L~~~l~-----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 79 --------NGGELFFHLQ-----------------------------RERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred --------CCCCHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 4555544332 123467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (325)
T cd05604 122 LKPENILLDSQGH--VVLTDFGLCKEGIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEeecCCcccCCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC-CCC
Confidence 9999999988875 8999999987543211 122345699999999999999999999999999999999997 667
Q ss_pred CCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCCCCCCcc
Q 004097 584 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HPff~~~~ 641 (774)
|..... .....+...........+.++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 754432 222222222222334567889999999999999999976 5899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=346.55 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=193.4
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chH-HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDV-ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ... ..+|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAER-DILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 467789999999999999854 468999999997532 111 22344 4778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| .+|+|.+++.. ...+++..++.|+.||+.||+|||+.+
T Consensus 81 E~~----------~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~ 121 (364)
T cd05599 81 EYL----------PGGDMMTLLMK-----------------------------KDTFTEEETRFYIAETILAIDSIHKLG 121 (364)
T ss_pred CCC----------CCcHHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 44555544322 123677788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-----------------------------------cccccC
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------------------------------TQNATG 543 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-----------------------------------~~~~~~ 543 (774)
|+||||||+|||++.++. +||+|||+++.+....... ......
T Consensus 122 ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 122 YIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred eEeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999988775 8999999987653211000 001124
Q ss_pred cCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccc-c--ccCCHHHHHHHHHhc
Q 004097 544 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLF-L--VEHIPEAVDLFTRLL 618 (774)
Q Consensus 544 ~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~-~--~~~~~~~~dli~~~L 618 (774)
+||+.|+|||++....++.++|||||||++|||++| .+||....... ..+........ + ...++++.++|.+||
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll 278 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHc
Confidence 699999999999999999999999999999999997 77886544322 22332222111 1 134689999999999
Q ss_pred CCCCCCCcC---HHHHHcCCCCCCccc
Q 004097 619 DPNPDLRPK---AQNVLNHPFFWTADT 642 (774)
Q Consensus 619 ~~dP~~Rps---~~elL~HPff~~~~~ 642 (774)
. +|.+|++ +.|+++||||...++
T Consensus 279 ~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 279 C-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred c-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 7 9999997 999999999976543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=341.43 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=194.3
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||.||++... +++.||||++.+... ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTER-DILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHH-HHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4778899999999999998654 589999999975321 1233454 4677888999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| ++|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 e~~----------~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ 121 (333)
T cd05600 81 EYV----------PGGDFRTLLNN-----------------------------LGVLSEDHARFYMAEMFEAVDALHELG 121 (333)
T ss_pred eCC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 45555554422 123567788899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 193 (333)
T cd05600 122 YIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193 (333)
T ss_pred ccccCCCHHHEEECCCCC--EEEEeCcCCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh
Confidence 999999999999988765 89999999986543 2234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcccc-cc------ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 579 GGKHPYGESFERDA--NIVKDRKDL-FL------VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~~~-~~------~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
| .+||........ .+....... .+ ...++++.++|.+||..+|.+||+++++++||||....
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 194 G-FPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred C-CCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 7 778865433221 122111110 01 13367999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.76 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=194.1
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|.+.+.||+|+||+||++.. .+++.||||++.+... .....|...+....+||+|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 56778999999999999854 4578999999875321 1223344444444578999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|...+.. ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ~~----------~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 82 YV----------NGGDLMYQIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred CC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 55 45555444321 1336677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred EecCCCHHHeEECCCCc--EEEccCCCceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 99999999999988865 8999999987543211 122345699999999999999999999999999999999996
Q ss_pred CCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccc
Q 004097 580 GKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 642 (774)
Q Consensus 580 ~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~ 642 (774)
.+||...... ....+......++...++++.+++.+||+.||.+|+++ .++++||||...++
T Consensus 198 -~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 198 -QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 7788654332 22223333333455677899999999999999999984 89999999976443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.94 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=189.7
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++. ..+++.||||++.+... ....+|+ .++..++||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36678899999999999984 45688999999965321 1123344 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| ++|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~----------~gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~aL~~LH~~g 121 (381)
T cd05626 81 DYI----------PGGDMMSLLIR-----------------------------MEVFPEVLARFYIAELTLAIESVHKMG 121 (381)
T ss_pred ecC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 955 45555554422 123567778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCcc------------------------------------------
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------------------------------------ 536 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~------------------------------------------ 536 (774)
|+||||||+|||++.++. +||+|||+++.+......
T Consensus 122 ivHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 122 FIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred eeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 999999999999987765 899999998643210000
Q ss_pred --ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc---ccccCCHH
Q 004097 537 --LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDL---FLVEHIPE 609 (774)
Q Consensus 537 --~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~---~~~~~~~~ 609 (774)
.....+.+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..++...... .....+++
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 278 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG-QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPE 278 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhC-CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHH
Confidence 0001234699999999999988899999999999999999997 77886544322 2232222111 11235789
Q ss_pred HHHHHHHhc--CCCCCCCcCHHHHHcCCCCCCcc
Q 004097 610 AVDLFTRLL--DPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 610 ~~dli~~~L--~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+.++|.+|+ ..+|..|+++.++++||||....
T Consensus 279 ~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 279 AVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999965 45555699999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.97 Aligned_cols=245 Identities=30% Similarity=0.407 Sum_probs=190.7
Q ss_pred EeecccCceEEEEEee----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 351 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.||+|+||+||++.. .+++.||||++.+... .....|+ .++..++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER-NILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHH-HHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999754 3678999999875321 1123344 47788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|.+++.. ...+++..+..++.||+.||+|||+.+|
T Consensus 81 ~~----------~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (323)
T cd05584 81 YL----------SGGELFMHLER-----------------------------EGIFMEDTACFYLSEISLALEHLHQQGI 121 (323)
T ss_pred CC----------CCchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 54 45555544322 1235566778899999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 122 IYRDLKPENILLDAQGH--VKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ecCCCCHHHeEECCCCC--EEEeeCcCCeecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 99999999999987765 8999999987543221 122345699999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCcc
Q 004097 580 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 641 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~ 641 (774)
.+||....... ...+.......+...++++.++|.+||+.||++|| +++++++||||....
T Consensus 197 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 197 -APPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred -CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 77886543322 22222222233445678999999999999999999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.89 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=190.9
Q ss_pred EeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++... +++.||||++.+.. .....+|+..+....+||||+++++++.+.+.+|+|||||.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~- 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN- 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC-
Confidence 36999999999998554 57899999997531 12233455433334479999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 80 ---------~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 121 (318)
T cd05570 80 ---------GGDLMFHIQR-----------------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121 (318)
T ss_pred ---------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccC
Confidence 4455443321 23467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| ..|
T Consensus 122 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G-~~p 195 (318)
T cd05570 122 LKLDNVLLDSEGH--IKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QSP 195 (318)
T ss_pred CCHHHeEECCCCc--EEecccCCCeecCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC-CCC
Confidence 9999999988765 8999999987532211 122334689999999999999999999999999999999997 778
Q ss_pred CCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccc
Q 004097 584 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~ 642 (774)
|....... ...+.......+...++++.++|.+||+.||.+||++ .++++||||....+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 196 FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 86543322 2223333333445567899999999999999999999 99999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.24 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=194.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
...|.+.+.||+|+||+||++.. .+++.||||++.+.. ....+.++..++..++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45688889999999999999854 468999999986421 112233334578889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||| .+|+|.+++.. ..+++..+..++.||+.||+|||+.
T Consensus 122 ~Ey~----------~gg~L~~~l~~------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~ 161 (370)
T cd05596 122 MEYM----------PGGDLVNLMSN------------------------------YDIPEKWARFYTAEVVLALDAIHSM 161 (370)
T ss_pred EcCC----------CCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9955 45555554321 1245667788999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC----CCCCcchhHhHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG----RQTRAIDLFSLGCIL 573 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDvwSlGvll 573 (774)
+|+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++... .++.++|||||||++
T Consensus 162 ~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil 237 (370)
T cd05596 162 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence 9999999999999988775 89999999987643211 122345799999999998753 378999999999999
Q ss_pred HHHHhCCCCCCCCchHH-H-HHHHhhccc-cccc--cCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCccch
Q 004097 574 FFCITGGKHPYGESFER-D-ANIVKDRKD-LFLV--EHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~-~-~~~~~~~~~-~~~~--~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~~~ 643 (774)
|||++| .+||...... . ..+...... .++. ..+.++.++|.+||+.+|.+ |++++++++||||+...+.
T Consensus 238 yelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 238 YEMLVG-DTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHhC-CCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999997 6777654322 2 222222211 1222 35689999999999999988 9999999999999875443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.10 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=189.9
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||+|++.+.. .....+|+..++..++||||+++++++.+.+..|+|||||.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~- 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN- 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC-
Confidence 3699999999999854 467899999986432 12234455556788999999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|...+.. ...+++..++.++.||+.||+|||+.||+|||
T Consensus 80 ---------~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrD 121 (325)
T cd05602 80 ---------GGELFYHLQR-----------------------------ERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121 (325)
T ss_pred ---------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 4455444321 12355667788999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (325)
T cd05602 122 LKPENILLDSQGH--IVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEccCCCCcccccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC-CCC
Confidence 9999999987765 8999999987543221 122345699999999999999999999999999999999997 667
Q ss_pred CCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH----HHHcCCCCCCcc
Q 004097 584 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ----NVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~----elL~HPff~~~~ 641 (774)
|...... ....+...........++++.++|.+||+.||.+|+++. ++++|+||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 7554322 222222222233445678999999999999999999876 899999996543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.74 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=189.4
Q ss_pred ecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||+||++.. .+|+.||||.+.+... .....|+ .++..++||||+++++++.+++..|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~---- 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEK-RILAKVHSRFIVSLAYAFQTKTDLCLVMTIM---- 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHH-HHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC----
Confidence 79999999999754 5789999999865321 1223444 3778889999999999999999999999954
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.+|+|...+..... ....+++..++.++.||+.||+|||+.+|+|||||
T Consensus 76 ------~~g~L~~~~~~~~~-------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 124 (280)
T cd05608 76 ------NGGDLRYHIYNVDE-------------------------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK 124 (280)
T ss_pred ------CCCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 45555444322110 12346788889999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. ++|+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.
T Consensus 125 p~Nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~ 198 (280)
T cd05608 125 PENVLLDNDGN--VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA-RGPFR 198 (280)
T ss_pred HHHEEECCCCC--EEEeeCccceecCCCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 89999999976653321 12334689999999999999999999999999999999997 77886
Q ss_pred CchHH--HH---HHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCcc
Q 004097 586 ESFER--DA---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 641 (774)
Q Consensus 586 ~~~~~--~~---~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~ 641 (774)
..... .. ..+.......+...++++.+++.+||+.||++|| +++++++||||....
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 199 ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 53221 11 1111112223345678999999999999999999 889999999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=335.98 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=191.9
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||.||++... +|..||+|.+..... ....+|+. ++..++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 45778899999999999998554 688999999865422 22345554 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-C
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 498 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ 498 (774)
| +.+|+|.+++.. ...+++..+..++.|++.||.|||+. +
T Consensus 84 ~----------~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 84 H----------MDGGSLDQVLKE-----------------------------AKRIPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred c----------CCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 4 455555554422 12366778899999999999999986 6
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred EEcCCCChhhEEEcCCCc--EEEccCccccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999988775 899999998766432 1233468999999999998899999999999999999999
Q ss_pred CCCCCCCCchHHHHH-HHh-----------------------------------------------hc-cccccccCCHH
Q 004097 579 GGKHPYGESFERDAN-IVK-----------------------------------------------DR-KDLFLVEHIPE 609 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~-~~~-----------------------------------------------~~-~~~~~~~~~~~ 609 (774)
| +.||......... +.. .. ........+++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T cd06649 198 G-RYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276 (331)
T ss_pred C-CCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH
Confidence 7 7787543222111 000 00 00001124578
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+++||.+||+.||++|||+.|+++||||...
T Consensus 277 l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 277 FQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=341.23 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=193.4
Q ss_pred ccceEEEeEeecccCceEEEEEee---eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
....|.+.+.||+|+||+||++.. ..++.||||.+.... ...+|+. ++..++|||||++++++.+.+..|+|||
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--~~~~E~~-il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--TPGREID-ILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--cHHHHHH-HHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 345689999999999999999743 346789999986542 3456665 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
++.++|.+++. ....+++..++.|+.||+.||+|||+.+|
T Consensus 167 ~~~~~l~~~l~----------------------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~gi 206 (392)
T PHA03207 167 KYKCDLFTYVD----------------------------------------RSGPLPLEQAITIQRRLLEALAYLHGRGI 206 (392)
T ss_pred hcCCCHHHHHH----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77766655441 11346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. ++|+|||+++....... ........||+.|+|||++....++.++|||||||++|||++|
T Consensus 207 vHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 283 (392)
T PHA03207 207 IHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283 (392)
T ss_pred cccCCCHHHEEEcCCCC--EEEccCccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999987765 89999999987654321 1122345699999999999998999999999999999999998
Q ss_pred CCCCCCCchH----HHHHHHhhc--------------------------cccc-------cccCCHHHHHHHHHhcCCCC
Q 004097 580 GKHPYGESFE----RDANIVKDR--------------------------KDLF-------LVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 580 ~~~Pf~~~~~----~~~~~~~~~--------------------------~~~~-------~~~~~~~~~dli~~~L~~dP 622 (774)
..++++.... ....++... ...+ ......++.++|.+||+.||
T Consensus 284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 5544443211 011111000 0000 01123578899999999999
Q ss_pred CCCcCHHHHHcCCCCCCcc
Q 004097 623 DLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~~~ 641 (774)
++|||+.|+|.||||....
T Consensus 364 ~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 364 EFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhCCCHHHHhhCchhhccc
Confidence 9999999999999996543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.88 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=189.4
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++|||||++++++.+.+..|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46778999999999999984 45789999999865321 1223344 4678899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..++.++.|++.||+|||+.+
T Consensus 81 E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 81 EFLP----------GGDLMTMLIK-----------------------------YDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred eCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9554 4455444321 133567778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCc------------cc-----------------------------
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------CL----------------------------- 537 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~------------~~----------------------------- 537 (774)
|+||||||+|||++.++. +||+|||+++....... ..
T Consensus 122 ivHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 122 FIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred eeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999987765 89999999964321100 00
Q ss_pred ---cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccc-c--ccCCHH
Q 004097 538 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLF-L--VEHIPE 609 (774)
Q Consensus 538 ---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~-~--~~~~~~ 609 (774)
......+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+........ + ...+++
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG-WPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC-CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHH
Confidence 000124699999999999998999999999999999999997 77886544322 22322222111 1 134679
Q ss_pred HHHHHHHhcCCCCCCC---cCHHHHHcCCCCCCcc
Q 004097 610 AVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 641 (774)
Q Consensus 610 ~~dli~~~L~~dP~~R---ps~~elL~HPff~~~~ 641 (774)
+.++|.+||. +|.+| +++.|+++||||...+
T Consensus 279 ~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 279 AEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999998 67665 6999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.72 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=190.8
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|...+.||+|+||+||++.. .+++.||||++.+... ....+|+ .++..++|||||++++++.+++.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER-DILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHH-HHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 367789999999999999854 5688999999865321 1223344 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~~----------gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 81 DYIP----------GGDMMSLLIR-----------------------------MGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred eCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9554 4555444321 123566778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCc-------------------------------------------
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------------------------------------- 535 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~------------------------------------------- 535 (774)
|+||||||+|||++.++. +||+|||+++.+.....
T Consensus 122 ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (382)
T cd05625 122 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199 (382)
T ss_pred eecCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence 999999999999988876 89999999754321000
Q ss_pred -cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc---ccccCCHH
Q 004097 536 -CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDL---FLVEHIPE 609 (774)
Q Consensus 536 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~---~~~~~~~~ 609 (774)
........+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+....... .....+++
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (382)
T cd05625 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPE 278 (382)
T ss_pred cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhC-CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHH
Confidence 00001234699999999999999999999999999999999997 77886543322 2233222111 12345789
Q ss_pred HHHHHHHhcCCCCCCCcC---HHHHHcCCCCCCcc
Q 004097 610 AVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTAD 641 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps---~~elL~HPff~~~~ 641 (774)
+.++|.+|+ .+|.+|++ +.++++||||....
T Consensus 279 ~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 279 ASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 999999986 59999987 99999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.40 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=191.0
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+|+.||||++.+.. .....+|+..++..++||||+++++++.+.+..|+|||||.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN- 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC-
Confidence 3699999999999855 468999999986432 12334555557788999999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|...+.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 80 ---------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 80 ---------GGELFFHLQR-----------------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred ---------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 4555443321 12356677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (321)
T cd05603 122 LKPENILLDSQGH--VVLTDFGLCKEGVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEccCCCCccCCCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC-CCC
Confidence 9999999988775 8999999987542211 122345689999999999988899999999999999999997 667
Q ss_pred CCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCCCCCCccc
Q 004097 584 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HPff~~~~~ 642 (774)
|..... .....+.......+.....++.++|.+||+.||.+||++ .++++||||....+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 196 FYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 755432 222222223333444567789999999999999999875 59999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.59 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=188.2
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHH-HHHhCCCCCEeeeeeeeccCCCccc
Confidence 346688899999999999999854 568999999986432 123445654 678889999999999886543
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..|+||||+.++|.+.+. ..+++..+..++.||+.|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~~~~qi~~~ 135 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH------------------------------------------MELDHERMSYLLYQMLCG 135 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh------------------------------------------ccCCHHHHHHHHHHHHHH
Confidence 579999988766544431 124556678899999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++||||||
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 209 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHH
Confidence 99999999999999999999988775 899999999765422 112334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--H----------------------HHhhcccc-------------------ccccCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--N----------------------IVKDRKDL-------------------FLVEHI 607 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~----------------------~~~~~~~~-------------------~~~~~~ 607 (774)
|++|+|++| .+||........ . ........ ......
T Consensus 210 ~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (359)
T cd07876 210 CIMGELVKG-SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288 (359)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccc
Confidence 999999997 778864322110 0 00000000 000123
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 608 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 608 ~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+++++||.+||+.||++|||+.|+++||||..
T Consensus 289 ~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 289 SQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 57899999999999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.14 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=201.7
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCC-CCCeeEEeeeccCCc
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQ-HPNIVRWYGVESDQD 412 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~ 412 (774)
..+...|.+.++||+|.||.||++... +|+.+|+|.+.+... ....+|+. ++..+. |||||.+++++++.+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~-il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVA-ILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHH-HHHhccCCCCEEEEEEEEEcCC
Confidence 344567889999999999999998554 599999999976533 35567776 555565 999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.+|+|||+|. +|.|.+.+... .+++..+..+++|++.+++
T Consensus 110 ~~~lvmEL~~----------GGeLfd~i~~~------------------------------~~sE~da~~~~~~il~av~ 149 (382)
T KOG0032|consen 110 SVYLVMELCE----------GGELFDRIVKK------------------------------HYSERDAAGIIRQILEAVK 149 (382)
T ss_pred eEEEEEEecC----------CchHHHHHHHc------------------------------cCCHHHHHHHHHHHHHHHH
Confidence 9999999776 34444433210 1567788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCC--CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|||+.||+||||||+|+|+.... ...+|++|||++...... ......+||+.|+|||++....|+..+||||+|
T Consensus 150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G 225 (382)
T KOG0032|consen 150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG 225 (382)
T ss_pred HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence 99999999999999999996542 246999999999988752 344667899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC-CchHHHHH-HHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 571 CILFFCITGGKHPYG-ESFERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 571 vll~elltg~~~Pf~-~~~~~~~~-~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|++|.|++| .+||. +....... +..... ..+....+..++++|.+||..||.+|+|+.++|+|||+.+.
T Consensus 226 vi~yiLL~G-~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 226 VILYILLSG-VPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHhhC-CCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999997 55554 44333333 333322 12233346789999999999999999999999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=342.06 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=194.1
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
....+.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....+.++..++..++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 33456788999999999999999854 468899999986421 122344445678889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||||| .+|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~Ey~----------~gg~L~~~l~~------------------------------~~~~~~~~~~~~~qil~aL~~L 158 (370)
T cd05621 119 YMVMEYM----------PGGDLVNLMSN------------------------------YDVPEKWAKFYTAEVVLALDAI 158 (370)
T ss_pred EEEEcCC----------CCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 45555554321 2356677889999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC----CCCcchhHhHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 570 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDvwSlG 570 (774)
|+.+|+||||||+|||++.++. +||+|||++....... .....+.+||+.|+|||++.... ++.++||||||
T Consensus 159 H~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05621 159 HSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred HHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh
Confidence 9999999999999999988765 8999999998764321 11223557999999999997643 78899999999
Q ss_pred HHHHHHHhCCCCCCCCchH-HH-HHHHhhccc-ccc--ccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCcc
Q 004097 571 CILFFCITGGKHPYGESFE-RD-ANIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~-~~-~~~~~~~~~-~~~--~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~ 641 (774)
|++|||++| .+||..... .. ..+...... ..+ ...++.++++|.+||..++.+ |+++.|+++||||....
T Consensus 235 ~ilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 235 VFLFEMLVG-DTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 999999997 667754432 22 222222211 112 234678999999999866544 89999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.02 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=189.3
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..|.+.+.||+|+||+||++... +++.||+|...+. ....|+. ++..++||||+++++++.+.+..|+|+|++.+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 141 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAM-LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHH-HHHhCCCCCCcChhheEEeCCeeEEEEEccCC
Confidence 34888899999999999998554 5789999976443 2345654 77889999999999999999999999998776
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|.+++.. ....+++..++.|+.||+.||+|||+.+|+|||
T Consensus 142 ~l~~~l~~---------------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 182 (357)
T PHA03209 142 DLYTYLTK---------------------------------------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182 (357)
T ss_pred cHHHHHHh---------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 66555421 113467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++++.++
T Consensus 183 lkp~Nill~~~~~--~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQ--VCIGDLGAAQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCC--EEEecCccccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999987765 899999998754321 1112345899999999999999999999999999999999987777
Q ss_pred CCCchHH-----------HHHHHhhc---ccccc------------------------------ccCCHHHHHHHHHhcC
Q 004097 584 YGESFER-----------DANIVKDR---KDLFL------------------------------VEHIPEAVDLFTRLLD 619 (774)
Q Consensus 584 f~~~~~~-----------~~~~~~~~---~~~~~------------------------------~~~~~~~~dli~~~L~ 619 (774)
|...... ...++... ...++ .....++.++|.+||+
T Consensus 257 f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 336 (357)
T PHA03209 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336 (357)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHc
Confidence 6542111 00111100 00000 1223467789999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 004097 620 PNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~ 639 (774)
.||.+|||+.|+|+||||.+
T Consensus 337 ~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 337 FDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCcccCcCHHHHhcCchhcc
Confidence 99999999999999999964
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=333.63 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=192.1
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---c---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---H---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. . .....|+..+....+|++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56778999999999999854 468999999986431 1 1233454433334456888899999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|..++.. ...+++.+++.|+.||+.||+|||+.+|
T Consensus 82 y~----------~~g~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~i 122 (323)
T cd05615 82 YV----------NGGDLMYHIQQ-----------------------------VGKFKEPQAVFYAAEISVGLFFLHRRGI 122 (323)
T ss_pred CC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55 44555444321 2346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred eccCCCHHHeEECCCCC--EEEeccccccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 99999999999988765 8999999987543221 122345689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 580 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
.+||....... ...+.......+...++++.+++.+||+.||.+|++ .+++++||||...++
T Consensus 198 -~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 198 -QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 77886544322 222222333344556789999999999999999997 478999999976543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.09 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=191.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
..|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHH-HHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 3477889999999999999854 4688999999864321 23445665 6788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.++|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 85 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (309)
T cd07872 85 YLDKDLKQYMDDC---------------------------------------GNIMSMHNVKIFLYQILRGLAYCHRRKV 125 (309)
T ss_pred CCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8877666554211 1224566778999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+|||++.++. +||+|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 126 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ecCCCCHHHEEECCCCC--EEECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999987765 89999999876543211 1123457899999999875 457899999999999999999
Q ss_pred CCCCCCCCchHHHH-HHHhh----------------------cccc--------ccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 579 GGKHPYGESFERDA-NIVKD----------------------RKDL--------FLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 579 g~~~Pf~~~~~~~~-~~~~~----------------------~~~~--------~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
| .+||......+. ..+.. .... .....++++.++|.+||+.||.+|||
T Consensus 201 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 279 (309)
T cd07872 201 G-RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279 (309)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC
Confidence 7 778765432111 10000 0000 01124568899999999999999999
Q ss_pred HHHHHcCCCCCCccc
Q 004097 628 AQNVLNHPFFWTADT 642 (774)
Q Consensus 628 ~~elL~HPff~~~~~ 642 (774)
+.|+++||||.....
T Consensus 280 ~~e~l~h~~~~~~~~ 294 (309)
T cd07872 280 AEEAMKHAYFRSLGT 294 (309)
T ss_pred HHHHhcChhhhhccc
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.52 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=189.2
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||+||++.. .+++.||||++.+... ....+|+..+....+||||+++++++.+.+.+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-- 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV-- 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC--
Confidence 3599999999999854 4678999999975321 123345544444457999999999999999999999955
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|..++. +.+.+++..++.++.||+.||+|||+.+|+|||
T Consensus 79 --------~~~~L~~~~~-----------------------------~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrD 121 (327)
T cd05617 79 --------NGGDLMFHMQ-----------------------------RQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121 (327)
T ss_pred --------CCCcHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 4455544332 123467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g-~~p 195 (327)
T cd05617 122 LKLDNVLLDADGH--IKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG-RSP 195 (327)
T ss_pred CCHHHEEEeCCCC--EEEeccccceeccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC-CCC
Confidence 9999999988775 8999999987533211 122345699999999999999999999999999999999997 778
Q ss_pred CCCch--------HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC------HHHHHcCCCCCCccc
Q 004097 584 YGESF--------ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~--------~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps------~~elL~HPff~~~~~ 642 (774)
|.... ......+.......+...++.+.++|.+||+.||.+|++ ++++++||||....+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 84211 111222222233344456788999999999999999998 469999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.89 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=199.5
Q ss_pred EEEeEeecccCceEEEEEeeeC-CcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|.-|+||++.+.+ +..+|+|++.+..... ..+-++++++.++||.+..||+.++.+++.||||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3445789999999999997654 5899999997653221 111223578999999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+ +|+|...++. ...+.+++..++.++.+++.||+|||-.|||
T Consensus 159 Cp----------GGdL~~Lrqk---------------------------Qp~~~fse~~aRFYaAEvl~ALEYLHmlGiv 201 (459)
T KOG0610|consen 159 CP----------GGDLHSLRQK---------------------------QPGKRFSESAARFYAAEVLLALEYLHMLGIV 201 (459)
T ss_pred CC----------CccHHHHHhh---------------------------CCCCccchhhHHHHHHHHHHHHHHHHhhcee
Confidence 65 4555544332 2235688899999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCC---------------------------------c------------
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------------------------------S------------ 535 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~---------------------------------~------------ 535 (774)
+|||||+||||.+||+ +.|+||.|+....... .
T Consensus 202 YRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 202 YRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 9999999999999998 7799999876542100 0
Q ss_pred --------cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccccc-
Q 004097 536 --------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLV- 604 (774)
Q Consensus 536 --------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~- 604 (774)
........+||-.|+|||++.+...+.++|+|+||+++|||+.| ..||.....++ .+++.... .++.
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG-~TPFKG~~~~~Tl~NIv~~~l-~Fp~~ 357 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG-TTPFKGSNNKETLRNIVGQPL-KFPEE 357 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC-CCCcCCCCchhhHHHHhcCCC-cCCCC
Confidence 00122345799999999999999999999999999999999997 66776544333 34443332 2222
Q ss_pred -cCCHHHHHHHHHhcCCCCCCCcC----HHHHHcCCCCCCccch
Q 004097 605 -EHIPEAVDLFTRLLDPNPDLRPK----AQNVLNHPFFWTADTR 643 (774)
Q Consensus 605 -~~~~~~~dli~~~L~~dP~~Rps----~~elL~HPff~~~~~~ 643 (774)
..+..++|||+++|.+||.+|.. |+||.+||||...+|.
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 33478999999999999999998 9999999999887765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=326.69 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=194.9
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHH-HHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 55678899999999999854 4689999999864321 12344654 7788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|..++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ~~----------~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 81 LM----------NGGDLKFHIYNM---------------------------GNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred cc----------CCCcHHHHHHhc---------------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 54 455554443211 11346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||++++++. ++|+|||++....... ......|++.|+|||++.+..++.++||||+||++|||++|
T Consensus 124 vH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 124 VYRDLKPENILLDDYGH--IRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred EecCCCHHHEEECCCCC--EEEeeCCCceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 99999999999987765 8999999988654321 11234689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-----HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 580 GKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 580 ~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
.+||....... ...+.......+...++.+.++|.+||+.||.+|| +++++++||||...++
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 198 -KSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred -CCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 77886543211 11122222233445678899999999999999999 8999999999976443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.04 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=185.5
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHH--HHHhCCCCCeeEEeeeccC-----Cce
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVESD-----QDF 413 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~~-----~~~ 413 (774)
|.+.+.||+|+||+||++.. .+|+.||+|.+.... .....+|+.. .+..++||||+++++++.+ ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 56778999999999999854 468999999986432 1233455542 2344589999999998764 345
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.++|||++.++|.+++.. .....+++..++.++.|++.||+|
T Consensus 82 ~~lv~e~~~~~l~~~~~~--------------------------------------~~~~~~~~~~~~~~~~qi~~al~~ 123 (288)
T cd07863 82 VTLVFEHVDQDLRTYLDK--------------------------------------VPPPGLPAETIKDLMRQFLRGLDF 123 (288)
T ss_pred EEEEEcccccCHHHHHHh--------------------------------------cCCCCCCHHHHHHHHHHHHHHHHH
Confidence 899999877666555421 011236778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++|||||||++
T Consensus 124 lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 124 LHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99999999999999999988775 8999999998664321 12234689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhc---------c------c-----------cccccCCHHHHHHHHHhcCCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDR---------K------D-----------LFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~---------~------~-----------~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
|||++| .+||....... ..+.... . . ........++.++|.+||+.||++|
T Consensus 198 ~~l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 198 AEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHhC-CcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999986 77775443221 1111100 0 0 0011234678999999999999999
Q ss_pred cCHHHHHcCCCC
Q 004097 626 PKAQNVLNHPFF 637 (774)
Q Consensus 626 ps~~elL~HPff 637 (774)
||+.|++.||||
T Consensus 277 ~t~~~~l~hp~f 288 (288)
T cd07863 277 ISAFRALQHPFF 288 (288)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=340.35 Aligned_cols=245 Identities=28% Similarity=0.404 Sum_probs=185.6
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|...+.||+|+||+||++.. .+|+.||||++...... ...+|+. ++..++|+||+++++++.+.+.+|+|||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE-ILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHH-HHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 34457899999999999854 46899999999654332 2334554 778899999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.... ...+..+..++.||+.||+|||+.+|+|
T Consensus 155 ~----------~~~L~~~~---------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH 191 (353)
T PLN00034 155 D----------GGSLEGTH---------------------------------IADEQFLADVARQILSGIAYLHRRHIVH 191 (353)
T ss_pred C----------CCcccccc---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 4 44443210 1233456789999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHhHHHHHHHH
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSlGvll~el 576 (774)
|||||+|||++.++. +||+|||+++.+.... .......||..|+|||++.. ...+.++|||||||++|||
T Consensus 192 rDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 192 RDIKPSNLLINSAKN--VKIADFGVSRILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred cCCCHHHEEEcCCCC--EEEcccccceeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 999999999987765 8999999998765321 11234569999999998743 2345689999999999999
Q ss_pred HhCCCCCCCCchHHH----H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 577 ITGGKHPYGESFERD----A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~----~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++| +.||....... . .+............++++.+||.+||+.||++||++.|+++||||....
T Consensus 267 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 267 YLG-RFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HhC-CCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 997 77886322111 1 1111122223344567999999999999999999999999999997643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.34 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=193.9
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ....++++..++..++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 467889999999999999854 578999999997532 12334455567888999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ~~----------~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 82 YQ----------PGGDLLSLLNRY----------------------------EDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred CC----------CCCCHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55 455555544321 1246777888999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh------cCCCCCcchhHhHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDvwSlGvll 573 (774)
+||||||+|||++.++. +||+|||++..+...... ......||+.|+|||++. ...++.++|||||||++
T Consensus 124 ~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 124 VHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred EcccCchHheEECCCCC--EEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 99999999999988775 899999999876533211 123346899999999987 45678999999999999
Q ss_pred HHHHhCCCCCCCCchHH-H-HHHHhhccc-cc--cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 574 FFCITGGKHPYGESFER-D-ANIVKDRKD-LF--LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~-~-~~~~~~~~~-~~--~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|||++| ..||...... . ..+...... .+ ....++++.+||.+||+ +|.+||+++++++||||...+
T Consensus 200 ~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 200 YEMIYG-RSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred eeeccC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999997 7788654322 2 222222111 11 12356789999999998 999999999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=343.16 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=190.7
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++. ..+++.||||++.+.. . ....+|+ .++..++||||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46788999999999999985 4568999999986421 1 1223444 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 E~~~----------~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (376)
T cd05598 81 DYIP----------GGDMMSLLIR-----------------------------LGIFEEDLARFYIAELTCAIESVHKMG 121 (376)
T ss_pred eCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9654 4444444321 123566778889999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCc----------------------------------------ccc
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS----------------------------------------CLT 538 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~----------------------------------------~~~ 538 (774)
|+||||||+|||++.++. +||+|||++..+..... ...
T Consensus 122 ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 122 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred eEeCCCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 999999999999988775 89999999753310000 000
Q ss_pred ccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcccc---ccccCCHHHHHH
Q 004097 539 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRKDL---FLVEHIPEAVDL 613 (774)
Q Consensus 539 ~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~~~---~~~~~~~~~~dl 613 (774)
.....+||+.|+|||++.+..++.++|||||||++|||++| .+||........ .+....... .....++++.++
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC-CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH
Confidence 01234699999999999999999999999999999999997 778865543322 222222111 122456899999
Q ss_pred HHHhcCCCCCCCc---CHHHHHcCCCCCCcc
Q 004097 614 FTRLLDPNPDLRP---KAQNVLNHPFFWTAD 641 (774)
Q Consensus 614 i~~~L~~dP~~Rp---s~~elL~HPff~~~~ 641 (774)
|.+|+ .+|.+|+ ++.++++||||...+
T Consensus 279 i~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 279 ILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99976 5999999 999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=345.41 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=184.4
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHh------CCCCCeeEEeeeccCC-c
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIAS------DQHPNIVRWYGVESDQ-D 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~------l~HpNIV~l~g~~~~~-~ 412 (774)
..+.|.+.+.||+|+||+||++.. ..++.||||+++... ......|++ ++.. ..|++|+++++++... +
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQ-FMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHH-HHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 356799999999999999999854 468899999986432 122233443 2333 3456799999988754 5
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
+.|+|||++.++|.+++. +...+++..+..|+.||+.||+
T Consensus 206 ~~~iv~~~~g~~l~~~l~----------------------------------------~~~~l~~~~~~~i~~qi~~aL~ 245 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIM----------------------------------------KHGPFSHRHLAQIIFQTGVALD 245 (467)
T ss_pred eEEEEEeccCCCHHHHHH----------------------------------------HcCCCCHHHHHHHHHHHHHHHH
Confidence 789999977666655542 1123667788999999999999
Q ss_pred HHHH-cCccccccCCCCeeecCCCC--------------ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc
Q 004097 493 HLHE-IGLIHRDLKPQNVLISKDKS--------------FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ 557 (774)
Q Consensus 493 yLH~-~~ivHrDLkp~NILl~~~~~--------------~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 557 (774)
|||+ .+||||||||+|||++.++. ..+||+|||++..... .....+||+.|+|||++.+
T Consensus 246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc
Confidence 9998 59999999999999976542 2489999998754321 1234579999999999999
Q ss_pred CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcc------------------------c------------
Q 004097 558 GRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRK------------------------D------------ 600 (774)
Q Consensus 558 ~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~------------------------~------------ 600 (774)
..++.++|||||||++|||++| ++||......+ ...+.... .
T Consensus 320 ~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTG-KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHh
Confidence 9999999999999999999997 78886533211 11000000 0
Q ss_pred ------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 601 ------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 601 ------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.......+.+.|||.+||+.||.+|||++|+|+||||...
T Consensus 399 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 399 IARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0000012467899999999999999999999999999653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.18 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=192.2
Q ss_pred EeecccCceEEEEEee----eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 351 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
+.||+|+||+||++.. .+|+.||||++.+... ....+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER-DILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHH-HHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5699999999998743 4689999999975321 2233455 4778899999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+|+|.+++.. ...+++..++.++.||+.||+|||+.+|+|
T Consensus 81 ----------~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 81 ----------RGGDLFTRLSK-----------------------------EVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred ----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 45555544321 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .
T Consensus 122 ~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~ 195 (318)
T cd05582 122 RDLKPENILLDEEGH--IKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-S 195 (318)
T ss_pred CCCCHHHeEECCCCc--EEEeeccCCcccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC-C
Confidence 999999999987765 8999999987654321 122345699999999999988899999999999999999997 7
Q ss_pred CCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 582 HPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 582 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
.||....... ...+.......+...++++.++|.+||+.||++||+ +.++++||||....+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 7886543322 222222222334456789999999999999999999 677999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=340.06 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=189.6
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc-----eeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-----~~~ 415 (774)
|...+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK-MLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHH-HHHhCCCCCcCCHhheecCCCccccceEE
Confidence 44568899999999999854 5789999999864321 23455654 677889999999999998876 789
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|+||+.++|.+++. ....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~~----------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 81 VVTELMQSDLHKIIV----------------------------------------SPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred EEeeccccCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999977666554441 1133667788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|
T Consensus 121 ~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred hCCeeCCCCChHHEEECCCCC--EEeccccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 999999999999999987765 89999999986543211 112234588999999999874 4789999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-HHHh------------------------hccc--------cccccCCHHHHHHHHHhcCCC
Q 004097 575 FCITGGKHPYGESFERDA-NIVK------------------------DRKD--------LFLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~-~~~~------------------------~~~~--------~~~~~~~~~~~dli~~~L~~d 621 (774)
||++| ++||........ ..+. .... ......++++.+||.+||+.|
T Consensus 197 el~~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 275 (372)
T cd07853 197 ELLGR-RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275 (372)
T ss_pred HHHcC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC
Confidence 99997 778865432111 0000 0000 011234578999999999999
Q ss_pred CCCCcCHHHHHcCCCCCCcc
Q 004097 622 PDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 622 P~~Rps~~elL~HPff~~~~ 641 (774)
|.+|||+.|+++||||....
T Consensus 276 P~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 276 PDKRISAADALAHPYLDEGR 295 (372)
T ss_pred hhhCcCHHHHhcCHhhCCCc
Confidence 99999999999999997643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.36 Aligned_cols=286 Identities=21% Similarity=0.330 Sum_probs=189.2
Q ss_pred cceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC-c
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-D 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-~ 412 (774)
.++|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+..+....+|||||+++++|.+. +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35678889999999999999853 3457899999965322 23456665444444899999999988764 4
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhh----HHHH--------------Hhhcc-----cccchhhHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLL----NEVR--------------IRLLP-----VMENTKDIE 468 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l----~~~~--------------~~~~~-----~~~~~~~~~ 468 (774)
.+|+|||||+ ++|.+++......+..+........... .... ....+ .........
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999665 3555554321110000000000000000 0000 00000 000000011
Q ss_pred HHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCC
Q 004097 469 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 548 (774)
Q Consensus 469 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 548 (774)
.| ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++........ .......+++.
T Consensus 166 ~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~ 241 (338)
T cd05102 166 LW-KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRKGSARLPLK 241 (338)
T ss_pred cc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcch-hcccCCCCCcc
Confidence 12 235788899999999999999999999999999999999987765 899999999876432211 11223346788
Q ss_pred CCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCC
Q 004097 549 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 549 y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
|+|||++.+..++.++|||||||++|||++.+.+||...... ....+... ....+...++++.+++.+||+.||.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999899999999999999999998558888654321 12222222 222234456789999999999999999
Q ss_pred cCHHHHHc
Q 004097 626 PKAQNVLN 633 (774)
Q Consensus 626 ps~~elL~ 633 (774)
||+.|+++
T Consensus 322 Ps~~el~~ 329 (338)
T cd05102 322 PTFSALVE 329 (338)
T ss_pred cCHHHHHH
Confidence 99999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.91 Aligned_cols=244 Identities=34% Similarity=0.550 Sum_probs=189.2
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHH-----HHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~-----~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|++.+.||+|+||+||++... +++.||+|++......... +|+. .+..++||||+++++++.+.+..++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIK-ILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHH-HHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhh-ccccccccccccccccccccccccccccc
Confidence 567899999999999998554 5679999999876543332 2444 56667999999999999999999999997
Q ss_pred cCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 421 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 421 ~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|.+ +|.+++. +...+++..++.++.||+.||+|||+.+|
T Consensus 80 ~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i 119 (260)
T PF00069_consen 80 CPGGSLQDYLQ----------------------------------------KNKPLSEEEILKIAYQILEALAYLHSKGI 119 (260)
T ss_dssp ETTEBHHHHHH----------------------------------------HHSSBBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ccccccccccc----------------------------------------ccccccccccccccccccccccccccccc
Confidence 775 5555552 12335667889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-cCCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSlGvll~ellt 578 (774)
+|+||||+||+++.++. ++|+|||++...... ........++..|+|||++. ...++.++||||+|+++|+|++
T Consensus 120 ~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 194 (260)
T PF00069_consen 120 VHRDIKPENILLDENGE--VKLIDFGSSVKLSEN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT 194 (260)
T ss_dssp EESSBSGGGEEESTTSE--EEESSGTTTEESTST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccc--ccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999987765 899999998764211 12233456899999999998 7889999999999999999999
Q ss_pred CCCCCCCCch-HHHHHHH----hhccccc---cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 579 GGKHPYGESF-ERDANIV----KDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 579 g~~~Pf~~~~-~~~~~~~----~~~~~~~---~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
| ..||.... ....... ....... .....+++.++|.+||+.||++||++.++++||||
T Consensus 195 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 195 G-KLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp S-SSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred c-ccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 7 67777652 1111111 1111000 11112789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.76 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=194.1
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+...+.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....+.++..++..++||||+++++++.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 44457789999999999999999854 468899999986421 122234444578889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||+ +|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~Ey~~----------gg~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~L 158 (371)
T cd05622 119 YMVMEYMP----------GGDLVNLMSN------------------------------YDVPEKWARFYTAEVVLALDAI 158 (371)
T ss_pred EEEEcCCC----------CCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999554 4555444321 2356667788999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC----CCCcchhHhHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 570 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDvwSlG 570 (774)
|+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.... ++.++||||||
T Consensus 159 H~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG 234 (371)
T cd05622 159 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (371)
T ss_pred HHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence 9999999999999999988776 89999999987653211 1223457999999999997543 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HH-HHHhhccc-cc--cccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCccc
Q 004097 571 CILFFCITGGKHPYGESFER-DA-NIVKDRKD-LF--LVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~-~~~~~~~~-~~--~~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~~ 642 (774)
|++|||++| .+||...... .. .+...... .+ ....++++.++|.+||..++.+ |++++++++||||++...
T Consensus 235 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 235 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 999999997 7777654322 22 22222111 11 1245689999999999844443 789999999999977543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.10 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=187.5
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 411 (774)
.+.|.+.+.||+|+||.||++.. ..++.||||++.... .....+|+. ++..++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHH-HHHhcCCCCccccceeeccccccccc
Confidence 46688899999999999999853 468899999986432 123445554 67888999999999987643
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...|+||||+.++|.+++. ..+++..+..++.|++.||
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~~~~qi~~aL 139 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCGI 139 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------------------------------------------hcCCHHHHHHHHHHHHHHH
Confidence 3579999988776655441 1244566788999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++|||||||
T Consensus 140 ~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 213 (364)
T cd07875 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213 (364)
T ss_pred HHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHH
Confidence 9999999999999999999987765 8999999998654321 123346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-H-HHHh----------------------hccc-------------------cccccCCH
Q 004097 572 ILFFCITGGKHPYGESFERD-A-NIVK----------------------DRKD-------------------LFLVEHIP 608 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~-~~~~----------------------~~~~-------------------~~~~~~~~ 608 (774)
++|||++| ..||....... . .++. .... ........
T Consensus 214 il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (364)
T cd07875 214 IMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292 (364)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccH
Confidence 99999997 67775432211 0 1100 0000 00001235
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 609 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 609 ~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++++||.+||+.||.+|||+.|+|+||||..
T Consensus 293 ~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 293 QARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 7899999999999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=337.54 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=192.0
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++.+..++..++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 466779999999999999854 468999999996432 11222223346778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| ++|+|.+++.. ...+++..++.++.|++.||+|||+.+|
T Consensus 82 ~~----------~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~gi 122 (360)
T cd05627 82 FL----------PGGDMMTLLMK-----------------------------KDTLSEEATQFYIAETVLAIDAIHQLGF 122 (360)
T ss_pred CC----------CCccHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55 44555544321 2346777889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCcc--------------------------------ccccccCcCCC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 547 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~--------------------------------~~~~~~~~gt~ 547 (774)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 123 IHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred EccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 99999999999987775 899999998755321100 00012346999
Q ss_pred CCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccc-cccc--cCCHHHHHHHHHhcCCCC
Q 004097 548 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD-LFLV--EHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 548 ~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~-~~~~--~~~~~~~dli~~~L~~dP 622 (774)
.|+|||++.+..++.++|||||||++|||++| .+||....... ..+...... .++. ..+++++++|.+|+. ||
T Consensus 201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p 278 (360)
T cd05627 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DS 278 (360)
T ss_pred cccCHHHHcCCCCCCcceeccccceeeecccC-CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-Ch
Confidence 99999999999999999999999999999997 77886544332 222222211 1222 246799999999875 99
Q ss_pred CCCc---CHHHHHcCCCCCCccch
Q 004097 623 DLRP---KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 623 ~~Rp---s~~elL~HPff~~~~~~ 643 (774)
.+|+ +++++++||||...++.
T Consensus 279 ~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 279 ENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred hhcCCCCCHHHHhcCCCCCCCCHH
Confidence 9998 48999999999775543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.48 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=193.5
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .+++.||||.+..... ....+|+. ++..++|+||+.+++.+.+++..|+|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHH-HHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 45568899999999999744 4689999999864321 12345554 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+|
T Consensus 81 ----------~~~g~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 81 ----------LMNGGDLKFHIYHM---------------------------GEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHHh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 45555555444221 12346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 124 iH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 124 VYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeccceeecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999987765 8999999987654321 11234689999999999998999999999999999999996
Q ss_pred CCCCCCCchHH-----HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCc
Q 004097 580 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~ 640 (774)
.+||...... ............+....+++.+|+.+||+.||++||| ++|+++||||...
T Consensus 198 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 198 -QSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -CCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 7788653211 1112222222234456788999999999999999999 8999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.63 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=186.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ------ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 411 (774)
.+.|...+.||+|+||+||++.. ..++.||||++..... ....+|+. ++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHH-HHHHhCCCchhceeeeeecccccccc
Confidence 45688889999999999999853 4689999999864321 23345554 67888999999999987643
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...|+|||||.++|.+.+. ..+++..+..++.|++.||
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------------------------------------------~~l~~~~~~~~~~qi~~aL 132 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCGI 132 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------------------------------------------hcCCHHHHHHHHHHHHHHH
Confidence 3579999977765544331 1245566788999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||
T Consensus 133 ~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 206 (355)
T cd07874 133 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_pred HHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHH
Confidence 9999999999999999999988765 899999999865432 1123356899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH--HHH----------------------hhccc-------------------cccccCCH
Q 004097 572 ILFFCITGGKHPYGESFERDA--NIV----------------------KDRKD-------------------LFLVEHIP 608 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~~--~~~----------------------~~~~~-------------------~~~~~~~~ 608 (774)
++|+|++| +.||........ ..+ ..... ........
T Consensus 207 il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T cd07874 207 IMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285 (355)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccch
Confidence 99999997 777754321110 000 00000 00011235
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 609 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 609 ~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+++++|.+||+.||++|||+.|+++||||..
T Consensus 286 ~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 286 QARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 7899999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.41 Aligned_cols=245 Identities=26% Similarity=0.304 Sum_probs=184.8
Q ss_pred ecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhC--CCCCeeEEeeeccCCceeEEeccccCC
Q 004097 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASD--QHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 353 LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l--~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
||+|+||+||++.. .+|+.||||++.+... .....|...+.... .||||+++++++.+.+..|+|||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~-- 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM-- 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC--
Confidence 79999999999854 4689999999864321 11223443333333 7999999999999999999999954
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 79 --------~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrD 121 (330)
T cd05586 79 --------SGGELFWHLQK-----------------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121 (330)
T ss_pred --------CCChHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 45555444321 23467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~~~ 582 (774)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG-~~ 195 (330)
T cd05586 122 LKPENILLDATGH--IALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG-WS 195 (330)
T ss_pred CCHHHeEECCCCC--EEEecCCcCcCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC-CC
Confidence 9999999988765 8999999987543221 122345699999999999765 479999999999999999997 66
Q ss_pred CCCCchH-HHHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCc----CHHHHHcCCCCCCccc
Q 004097 583 PYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 583 Pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rp----s~~elL~HPff~~~~~ 642 (774)
||..... .....+... ........++++.++|.+||+.||.+|| ++.++++||||....+
T Consensus 196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 7654332 222222222 2222223568899999999999999998 7899999999976543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.52 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=202.7
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
..+|.+.+.||+|.||+|-+|. ...|+.||||.+++.... ...+||+ +++.++||||+.+|.+|+..+.+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIe-IMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIE-IMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHH-HHhhcCCCceeehhhhhcCCceEEE
Confidence 3456667889999999998884 478999999998765321 2345665 7899999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||| |..+|.|++++.. .+.+++.+++.+++||+.|+.|+|.
T Consensus 131 vME----------YaS~GeLYDYiSe-----------------------------r~~LsErEaRhfFRQIvSAVhYCHk 171 (668)
T KOG0611|consen 131 VME----------YASGGELYDYISE-----------------------------RGSLSEREARHFFRQIVSAVHYCHK 171 (668)
T ss_pred EEE----------ecCCccHHHHHHH-----------------------------hccccHHHHHHHHHHHHHHHHHHhh
Confidence 999 6666777666533 2457888899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~e 575 (774)
++++|||||-+||||+.+++ +||+||||+..+... ....+.||+|-|.+||++.+.+| .+.+|-|||||+||-
T Consensus 172 nrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYt 245 (668)
T KOG0611|consen 172 NRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYT 245 (668)
T ss_pred ccceecccchhheeecCCCC--eeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHH
Confidence 99999999999999988776 999999999887753 34467899999999999999998 589999999999999
Q ss_pred HHhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 576 CITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 576 lltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|+.| ..||+.... +....+..... ..++...++.-||++||-.||++|.|+.++..|-|.
T Consensus 246 LVyG-tMPFDG~Dhk~lvrQIs~GaY-rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 246 LVYG-TMPFDGRDHKRLVRQISRGAY-REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred Hhhc-ccccCCchHHHHHHHhhcccc-cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 9997 788876543 33333433332 223445689999999999999999999999999886
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=346.95 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=198.9
Q ss_pred ccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc--
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 412 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-- 412 (774)
+..++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. .+..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC-CLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHH-HHhcCCCCcEEEeecceeccccc
Confidence 3445789999999999999999985 45799999999865422 12334544 567789999999988765432
Q ss_pred ------eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 413 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 413 ------~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
.+++||| |+.+|+|.+++.... .....+++..+..++.|
T Consensus 107 ~~~~~~~i~lV~E----------y~~~gsL~~~l~~~~-------------------------~~~~~l~e~~~~~i~~q 151 (496)
T PTZ00283 107 NPENVLMIALVLD----------YANAGDLRQEIKSRA-------------------------KTNRTFREHEAGLLFIQ 151 (496)
T ss_pred CcccceEEEEEEe----------CCCCCcHHHHHHHhh-------------------------ccCCCCCHHHHHHHHHH
Confidence 3789999 555666666554321 11234677888999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchh
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv 566 (774)
++.||+|||+.+|+||||||+|||++.++. +||+|||+++........ ......+||+.|+|||++.+..++.++||
T Consensus 152 ll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV 228 (496)
T PTZ00283 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADM 228 (496)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHH
Confidence 999999999999999999999999987765 899999999876532211 12234579999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 567 FSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|||||++|||++| ..||....... ..+........+...++++.+++.+||+.||.+||++.++++|||+..
T Consensus 229 wSlGvilyeLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 229 FSLGVLLYELLTL-KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999997 77886543322 122222333344556789999999999999999999999999999854
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.48 Aligned_cols=249 Identities=31% Similarity=0.458 Sum_probs=201.9
Q ss_pred eecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhH
Q 004097 352 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 428 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~ 428 (774)
+||+|.||+||-|.. .+...+|||.+.... ..+-+.|+..+.+.++|.|||+++|.|.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME--------- 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME--------- 652 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee---------
Confidence 599999999998854 456789999985443 23445666568899999999999999999999999999
Q ss_pred HHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCC
Q 004097 429 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 508 (774)
Q Consensus 429 iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 508 (774)
.+++|+|..+|..+ |..-.-.+..+-.+.+||++||.|||+..|||||||-+|
T Consensus 653 -qVPGGSLSsLLrsk--------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 653 -QVPGGSLSSLLRSK--------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred -cCCCCcHHHHHHhc--------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 88999999887653 332222456678899999999999999999999999999
Q ss_pred eeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC--CCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 509 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 509 ILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
||++.-.. .+||+|||-++.+.+-.. .+.+.-||..|||||++..+ .|+.++|||||||.+.||.|| +|||.+
T Consensus 706 VLvNTySG-vlKISDFGTsKRLAginP---~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG-rPPF~E 780 (1226)
T KOG4279|consen 706 VLVNTYSG-VLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG-RPPFVE 780 (1226)
T ss_pred EEEeeccc-eEEecccccchhhccCCc---cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC-CCCeee
Confidence 99976554 489999999998875422 33456699999999999875 488999999999999999997 889976
Q ss_pred chHHHHHHHhhc----cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 587 SFERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 587 ~~~~~~~~~~~~----~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
-....+.+.+-. .+..+.+.+.+++.+|.+|+.+||..||+++++|..||.....
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 554444333322 2234455667899999999999999999999999999997653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.73 Aligned_cols=244 Identities=24% Similarity=0.429 Sum_probs=186.4
Q ss_pred ecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||+||++.. .+|+.||+|++.... ......|++ ++..++||||+++++++.++...|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~i~~~~~~~~~~~~~~lv~e~~---- 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE-ILEKVNSPFIVNLAYAFESKTHLCLVMSLM---- 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHH-HHHhcCCCcEEEEEEEEecCCeEEEEEecC----
Confidence 79999999999854 468999999985421 112234554 678889999999999999999999999954
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.+|+|..++... ....+++..+..++.||+.||+|||+.+|+|||||
T Consensus 76 ------~g~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 122 (277)
T cd05607 76 ------NGGDLKYHIYNV---------------------------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122 (277)
T ss_pred ------CCCCHHHHHHhc---------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC
Confidence 455555443221 12235677788999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++| .+||.
T Consensus 123 p~Nili~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~p~~ 195 (277)
T cd05607 123 PENVLLDDQGN--CRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG-RTPFK 195 (277)
T ss_pred hHhEEEcCCCC--EEEeeceeeeecCCCc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 8999999988765321 11234589999999999988899999999999999999997 77886
Q ss_pred CchHH--HHHH----HhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCCCCCCcc
Q 004097 586 ESFER--DANI----VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 641 (774)
Q Consensus 586 ~~~~~--~~~~----~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HPff~~~~ 641 (774)
..... ...+ ............++++.++|.+||+.||++||++ ++++.||||....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 196 DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred CCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 43221 1111 1111111122456899999999999999999999 6788999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.64 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=196.8
Q ss_pred ceEEEeEeecccCceEEEEEeee-C-CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-E-GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~-g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
..|.+.+.||+|++|.||++... + ++.||+|.+...... ...+|+ .+++.++|||||++++++.+.+.+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~-~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSEL-HCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 34888999999999999998443 3 678899876443322 223454 47788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
| +.+|+|.++|.... .....+++..+..++.||+.||+|||+.+|
T Consensus 146 ~----------~~gg~L~~~l~~~~-------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 190 (478)
T PTZ00267 146 Y----------GSGGDLNKQIKQRL-------------------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKM 190 (478)
T ss_pred C----------CCCCCHHHHHHHHH-------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5 45555555443211 112346677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 191 vHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred EECCcCHHhEEECCCCc--EEEEeCcCceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 99999999999987765 89999999987653321 1123345699999999999998999999999999999999997
Q ss_pred CCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 580 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
..||....... . .+........+...++++.++|.+||+.||++||++.+++.|||+..
T Consensus 268 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 268 -HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 67776543322 1 22222222334456689999999999999999999999999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=325.44 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=182.2
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.+.+.||+|+||+||+|..+. .||||.+.-... -++|+.+...++.-+|.||+=+.|||..... .||+.+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 34567889999999999976654 499999965432 2445554557888999999999999998877 9999988
Q ss_pred CC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 422 TC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 422 ~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
.| +|+. +||..+ ..+.....+.|++|||+|+.|||.++||
T Consensus 470 eGsSLY~-----------hlHv~e----------------------------tkfdm~~~idIAqQiaqGM~YLHAK~II 510 (678)
T KOG0193|consen 470 EGSSLYT-----------HLHVQE----------------------------TKFDMNTTIDIAQQIAQGMDYLHAKNII 510 (678)
T ss_pred cCchhhh-----------hccchh----------------------------hhhhHHHHHHHHHHHHHhhhhhhhhhhh
Confidence 86 4544 444322 1245567899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll~ell 577 (774)
|||||+.||+|.+++. |||+||||+..-..- ....+.....|...|||||+++. .+|++.+|||||||++|||+
T Consensus 511 HrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl 587 (678)
T KOG0193|consen 511 HRDLKSNNIFLHEDLK--VKIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL 587 (678)
T ss_pred hhhccccceEEccCCc--EEEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence 9999999999987755 999999998643321 22233344558899999999974 46899999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHhhcccc-----ccc-cCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDANIVKDRKDL-----FLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+| ..||......+.-.+.++... ... ....++++|+..||..++++||...+||.
T Consensus 588 tg-~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 588 TG-ELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hC-cCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 97 889983332222111111111 111 22248999999999999999999999874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.52 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=189.7
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++..++||||+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 467889999999999999854 468999999986421 12234444457778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (331)
T cd05597 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVLAIDSVHQLGY 123 (331)
T ss_pred ----------cCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44555555544221 1236777889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHhHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSlGvll~ 574 (774)
+||||||+|||++.++. +||+|||++..+..... .......||+.|+|||++.. ..++.++|||||||++|
T Consensus 124 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCCCC--EEEEECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 99999999999987775 89999999876643211 11123469999999999973 45788999999999999
Q ss_pred HHHhCCCCCCCCchH-HHH-HHHhhcc--c--cccccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESFE-RDA-NIVKDRK--D--LFLVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~~-~~~-~~~~~~~--~--~~~~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~ 641 (774)
||++| ..||..... ... .+..... . ......+++++++|.+||..++++ |+++.++++||||....
T Consensus 200 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 200 EMLYG-ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHhhC-CCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99997 677755332 221 2222111 1 111234678999999998765444 78999999999996643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.39 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=191.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||.||++.. .+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHH-HHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3478889999999999999854 4688999999864321 23445554 6788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 85 ~~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (301)
T cd07873 85 YLDKDLKQYLDDC---------------------------------------GNSINMHNVKLFLFQLLRGLNYCHRRKV 125 (301)
T ss_pred ccccCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 8777665554211 1235567788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+|+||||+||+++.++. +||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 126 ~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred eCCCCCHHHEEECCCCc--EEECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 99999999999988765 89999999876542211 11233578999999998754 47889999999999999999
Q ss_pred CCCCCCCCchHHH-HH-HHh---------------hc------ccc--------ccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 579 GGKHPYGESFERD-AN-IVK---------------DR------KDL--------FLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~~-~~~---------------~~------~~~--------~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
| .+||....... .. +.. .. ... .....++++.+||.+||+.||.+|||
T Consensus 201 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 201 G-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred C-CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 7 77876533211 10 000 00 000 01124568899999999999999999
Q ss_pred HHHHHcCCCCCCccc
Q 004097 628 AQNVLNHPFFWTADT 642 (774)
Q Consensus 628 ~~elL~HPff~~~~~ 642 (774)
++|+++||||.....
T Consensus 280 ~~eil~h~~f~~~~~ 294 (301)
T cd07873 280 AEEAMKHPYFHCLGE 294 (301)
T ss_pred HHHHhcCcccccccc
Confidence 999999999966443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=328.40 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=189.4
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||++... ++..||+|++..... ....+|+. ++..++||||++++++|.+++..|+|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 45778899999999999998554 688999998865422 22345554 6778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-C
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 498 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ 498 (774)
|| .+|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 84 ~~----------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 84 HM----------DGGSLDQVLKK-----------------------------AGRIPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred cC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 55 44555444321 12356677789999999999999985 7
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||++..+... ......||..|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred EEecCCChhhEEEcCCCC--EEEeeCCcchhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999987765 899999998765432 1123468999999999998889999999999999999999
Q ss_pred CCCCCCCCchHHHHHHH----------------------------------------------hhcccc-ccccCCHHHH
Q 004097 579 GGKHPYGESFERDANIV----------------------------------------------KDRKDL-FLVEHIPEAV 611 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~~~----------------------------------------------~~~~~~-~~~~~~~~~~ 611 (774)
| ..||........... ...... .....++++.
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 198 G-RYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred C-CCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 7 667754322211100 000000 0012346889
Q ss_pred HHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 612 dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+||.+||+.||++|||+.|++.||||...
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 99999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.20 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=188.3
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|+. ++..++||||+++++++.+.+..|+|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHH-HHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 56778999999999999855 4689999999864321 23445664 67788999999999999999999999998
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... ...+++..++.++.||+.||+|||+.+|+
T Consensus 81 ~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 81 CDQDLKKYFDSC---------------------------------------NGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred CCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 877665554211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~elltg 579 (774)
||||||+||+++.++. +||+|||+++....... ......++..|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 122 H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg 196 (284)
T cd07839 122 HRDLKPQNLLINKNGE--LKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196 (284)
T ss_pred cCCCCHHHEEEcCCCc--EEECccchhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence 9999999999987765 89999999986543211 112345789999999987654 68999999999999999998
Q ss_pred CCCCCCCchHHH-H-HHHhh-----------------c--c---------ccccccCCHHHHHHHHHhcCCCCCCCcCHH
Q 004097 580 GKHPYGESFERD-A-NIVKD-----------------R--K---------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~-~~~~~-----------------~--~---------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~ 629 (774)
+.++|....... . .+... . . .......++++.++|.+||+.||.+|||++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 276 (284)
T cd07839 197 GRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276 (284)
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence 666554332111 1 00000 0 0 001123457889999999999999999999
Q ss_pred HHHcCCCC
Q 004097 630 NVLNHPFF 637 (774)
Q Consensus 630 elL~HPff 637 (774)
++++||||
T Consensus 277 ~il~h~~f 284 (284)
T cd07839 277 EALQHPYF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=322.63 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=195.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+...+.++||+|-||.|.++....+..||||.++.... ....+|++ .+.+++|||||+|+|+|..++.+++|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIk-iLsqLkhPNIveLvGVC~~DePicmI~E- 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIK-ILSRLKHPNIVELLGVCVQDDPLCMITE- 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHH-HHhccCCCCeeEEEeeeecCCchHHHHH-
Confidence 44678899999999999998888889999999976543 34567776 5677899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
||++|+|.++|..+.... .......+|+.||+.|++||.+.++|
T Consensus 616 ---------YmEnGDLnqFl~aheapt---------------------------~~t~~~vsi~tqiasgmaYLes~nfV 659 (807)
T KOG1094|consen 616 ---------YMENGDLNQFLSAHELPT---------------------------AETAPGVSICTQIASGMAYLESLNFV 659 (807)
T ss_pred ---------HHhcCcHHHHHHhccCcc---------------------------cccchhHHHHHHHHHHHHHHHhhchh
Confidence 999999999987654321 12234467999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC-
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG- 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg- 579 (774)
||||.+.|+|+ ++++++||+|||+++.+-.+..... ....+-...|||+|.+.-++++.++|||+||+.+||+++-
T Consensus 660 Hrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~yy~v-qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C 736 (807)
T KOG1094|consen 660 HRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDYYRV-QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC 736 (807)
T ss_pred hccccccceee--cCcccEEecCcccccccccCCceee-ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence 99999999999 5556699999999997765433222 2233457889999999999999999999999999997652
Q ss_pred CCCCCCCchHHHHH-----HHhhcc----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 580 GKHPYGESFERDAN-----IVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 580 ~~~Pf~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
...||.+...++.. ...... ...+.-+...+.++|.+||..|.++||+.+++..
T Consensus 737 ~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 737 REQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 46788765443321 111111 1123334568889999999999999999999853
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=332.24 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=203.6
Q ss_pred eEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCce-eEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-VYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~-~~LV~ 418 (774)
.|...+.+|+|+||.+++. +..+++.+|+|.+.-.. ...+.+|+. +++++.|||||.+++.|.+++. ++|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~-lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMD-LLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHH-HHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4556688999999999875 55678899999885332 235677775 7888999999999999999988 99999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
+||+ +|++.+.+.. ++..-++++.+..++.||+.|+.|||+.+
T Consensus 84 ~Y~e----------Gg~l~~~i~~---------------------------~k~~~f~E~~i~~~~~Q~~~av~ylH~~~ 126 (426)
T KOG0589|consen 84 EYCE----------GGDLAQLIKE---------------------------QKGVLFPEERILKWFVQILLAVNYLHENR 126 (426)
T ss_pred eecC----------CCCHHHHHHH---------------------------HhhccccHHHHHHHHHHHHHHHHHHHhhh
Confidence 9776 3444443322 22234678889999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+|||||+.||+++.++. +||+|||+|+.+.... ....+.+||+.||.||++.+.+|..++|||||||++|||++
T Consensus 127 iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~ 201 (426)
T KOG0589|consen 127 VLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT 201 (426)
T ss_pred hhcccchhhhhhccccCc--eeecchhhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh
Confidence 999999999999999987 6999999999988643 23456789999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 579 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
- +++|....-.. ..+........+...+.+++.+|+.||..+|..||++.++|.+|...
T Consensus 202 l-k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 202 L-KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred c-ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 5 88887654332 24444444555666788999999999999999999999999998764
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.99 Aligned_cols=249 Identities=30% Similarity=0.399 Sum_probs=190.6
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.|...+.||+|++|.||++.. .+++.||||.+..... ....+|+ .++..++||||+++++++.+++..|+
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEI-QLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 366778999999999999854 4689999999864321 1223344 46788999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+|++ ++++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 82 v~e~~----------~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 82 FMEYM----------PGGSVKDQLKA-----------------------------YGALTETVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred EEEEC----------CCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99955 44454444321 1235667778999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||+|+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++||+
T Consensus 123 ~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 200 (263)
T cd06625 123 NMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200 (263)
T ss_pred CCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 8999999987654321111111234578899999999998899999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 577 ITGGKHPYGESFERDA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++| ++||........ ..... .....+....+++.++|.+||..+|.+|||+.++++||||
T Consensus 201 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 201 LTE-KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HhC-CCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 997 678765332221 11111 1222334556799999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=326.62 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=190.4
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....++++..++..++|+||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 467789999999999999854 457899999986421 12234444457778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+|+|.+++... ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ----------y~~~g~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i 123 (332)
T cd05623 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVIAIDSVHQLHY 123 (332)
T ss_pred ----------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55566666555321 1235677788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~ 574 (774)
+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|
T Consensus 124 iHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 124 VHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred EecCCCHHHEEECCCCC--EEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence 99999999999987765 89999999876543211 1123356999999999986 345789999999999999
Q ss_pred HHHhCCCCCCCCch-HHHHH-HHhhccc----cccccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESF-ERDAN-IVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~-~~~~~-~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~ 641 (774)
||++| .+||.... ..... +...... ......++++.++|.+||..++.+ |++++|+++||||....
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 200 EMLYG-ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHhcC-CCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99997 66775433 22222 2221111 111235689999999999765554 68999999999997644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.21 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=188.0
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC-----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 411 (774)
+.+.|...+.||+|+||+||++. ..+++.||||++..... ....+|+. ++..++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR-LLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHH-HHHhcCCCchhhhhhhhcccccccc
Confidence 34567788999999999999985 45688999999865321 23345654 67888999999999987643
Q ss_pred -ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 -~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
...|+++|++.++|.+++. ...+++..+..++.||+.|
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK-----------------------------------------CQKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 4579999977666554431 1236677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhH
Confidence 99999999999999999999988765 899999999865432 223468999999999877 468999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhh-----------------------cccc-------ccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKD-----------------------RKDL-------FLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~-----------------------~~~~-------~~~~~~~~~~dli~~~ 617 (774)
||++|+|++| .+||....... . .+... .... ......+.+.+||.+|
T Consensus 203 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 203 GCIMAELLKG-KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 9999999997 77775432111 0 00000 0000 0112345688999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||+.|+++||||...
T Consensus 282 L~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 282 LVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cCCChhhCCCHHHHhcCcchhcc
Confidence 99999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.40 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=195.8
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||.|+||.||+|. ..+...||||++.-.. ..+.++|+. .+..++|||+|.+.|+|-.+...|||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVr-FL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVR-FLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHH-HHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 579999999999984 4578899999995322 234677876 67889999999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+-.|++-+.. .++-+-++..|+.+.+.||+|||+.+.||||
T Consensus 111 SAsDlleVhk---------------------------------------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRD 151 (948)
T KOG0577|consen 111 SASDLLEVHK---------------------------------------KPLQEVEIAAITHGALQGLAYLHSHNRIHRD 151 (948)
T ss_pred cHHHHHHHHh---------------------------------------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhh
Confidence 8877775433 2344456789999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHHHhCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||..||||++.|- +||+|||.|....+ ..+++|||.|||||++. .+.|+-++||||||+...||...
T Consensus 152 iKAGNILLse~g~--VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER- 221 (948)
T KOG0577|consen 152 IKAGNILLSEPGL--VKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 221 (948)
T ss_pred ccccceEecCCCe--eeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc-
Confidence 9999999988875 99999999876553 35678999999999986 47899999999999999999995
Q ss_pred CCCCCCchHHH--HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 581 KHPYGESFERD--ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 581 ~~Pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+||+....... ..|..+.. .+...+++..++.|+..||++-|..|||.+++++|+|...
T Consensus 222 kPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred CCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 77765543322 23444332 3344556778999999999999999999999999999854
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.18 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=201.6
Q ss_pred EeEeecccCceEEEEE-eeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC-CCh
Q 004097 349 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSL 425 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~-~sL 425 (774)
+.++||+|+||.||+| ....|..||||.+.-. .-....+|+. ++.....|++|++||.+..+..+|+|||||. |+.
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEIS-IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEIS-IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHH-HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 3467999999999998 5667999999998543 3345667776 5677889999999999999999999999887 455
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.|.+... ..++.+.++..|++..+.||+|||...-||||||
T Consensus 116 SDI~R~R---------------------------------------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK 156 (502)
T KOG0574|consen 116 SDIMRAR---------------------------------------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK 156 (502)
T ss_pred HHHHHHh---------------------------------------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc
Confidence 5555332 3456677888999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
..||||+.+|. +||+|||.|-.+.+. ....++..|||.|||||++..-.|+.++||||||+...||..| +|||.
T Consensus 157 AGNILLNT~G~--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG-~PPYs 230 (502)
T KOG0574|consen 157 AGNILLNTDGI--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG-RPPYS 230 (502)
T ss_pred cccEEEcccch--hhhhhccccchhhhh---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC-CCCcc
Confidence 99999998886 899999999877643 2345678899999999999999999999999999999999996 88998
Q ss_pred CchHHHH-HHHhhccc-c--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 586 ESFERDA-NIVKDRKD-L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 586 ~~~~~~~-~~~~~~~~-~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
+-.+.-+ .++...+. . .+...+.++-|+|++||.+.|++|-|+.++++|||.+++..
T Consensus 231 DIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 231 DIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred cccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 7544322 12211111 1 13345678999999999999999999999999999987643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.98 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=194.7
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||.||++.. .+|+.||+|++..... ...+.|+..+++..+||||+++++++.+++..|++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 467789999999999999855 4699999999865422 23455666667788999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Cc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 499 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~i 499 (774)
++++|.+++. ... -....+++..++.++.||+.||+|||+. ++
T Consensus 82 ~~~~l~~~l~-----------~~~-------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i 125 (283)
T cd06617 82 MDTSLDKFYK-----------KVY-------------------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125 (283)
T ss_pred hcccHHHHHH-----------Hhc-------------------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 6655554441 110 0113467888999999999999999997 99
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc----CCCCCcchhHhHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDvwSlGvll~e 575 (774)
+||||||+||+++.++. +||+|||+++...... ......|+..|+|||.+.+ ..++.++|+|||||++|+
T Consensus 126 ~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 126 IHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred ecCCCCHHHEEECCCCC--EEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 99999999999987765 8999999988664321 1122458889999998865 446889999999999999
Q ss_pred HHhCCCCCCCCch---HHHHHHHhhccccc-cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 576 CITGGKHPYGESF---ERDANIVKDRKDLF-LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 576 lltg~~~Pf~~~~---~~~~~~~~~~~~~~-~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
|++| ..||.... +............. ....++++.++|.+||..+|.+||++.++++||||.....
T Consensus 200 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 200 LATG-RFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred HHhC-CCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 9996 77886422 22222222222222 2234678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.65 Aligned_cols=247 Identities=28% Similarity=0.382 Sum_probs=187.7
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|++|+||++.. .++..||||++..... ....+|+. ++..++||||+++++++.+++..|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS-LLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHH-HHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 56778999999999999865 4689999999854321 23445554 67788999999999999999999999997
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... .....+++..++.++.||+.||+|||+.+|+
T Consensus 81 ~~~~l~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 123 (285)
T cd07861 81 LSMDLKKYLDSL-------------------------------------PKGQYMDAELVKSYLYQILQGILFCHSRRVL 123 (285)
T ss_pred CCCCHHHHHhcC-------------------------------------CCCCcCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 776665544110 0113367778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg 579 (774)
||||||+||+++.++. ++|+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 124 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 124 HRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred ecCCCHHHEEEcCCCc--EEECcccceeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988775 8999999987654221 111233578899999998754 478999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhh------------------c----------cccccccCCHHHHHHHHHhcCCCCCCCcCHH
Q 004097 580 GKHPYGESFERDA--NIVKD------------------R----------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~------------------~----------~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~ 629 (774)
.+||........ ..... . ........++++.++|.+||+.||.+|||+.
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 199 -KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 777764432111 00000 0 0001123467889999999999999999999
Q ss_pred HHHcCCCC
Q 004097 630 NVLNHPFF 637 (774)
Q Consensus 630 elL~HPff 637 (774)
++++||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.01 Aligned_cols=232 Identities=27% Similarity=0.421 Sum_probs=183.2
Q ss_pred eecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHHHH
Q 004097 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 431 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~ 431 (774)
=||.|+.|.|+++.+ .++.||||+++.. ...+|. -+..++||||+.+.|+|.....++||||||.
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~el----kETdIK-HLRkLkH~NII~FkGVCtqsPcyCIiMEfCa--------- 195 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVREL----KETDIK-HLRKLKHPNIITFKGVCTQSPCYCIIMEFCA--------- 195 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhhh----hhhhHH-HHHhccCcceeeEeeeecCCceeEEeeeccc---------
Confidence 399999999999554 5689999987532 223443 5688999999999999999999999999665
Q ss_pred hcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeee
Q 004097 432 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511 (774)
Q Consensus 432 ~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 511 (774)
.|.|++.|... +.+....+..|.++||.|+.|||.+.|||||||+-||||
T Consensus 196 -~GqL~~VLka~-----------------------------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 196 -QGQLYEVLKAG-----------------------------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred -cccHHHHHhcc-----------------------------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 45555554332 334556678999999999999999999999999999999
Q ss_pred cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH
Q 004097 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 591 (774)
Q Consensus 512 ~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~ 591 (774)
+.+.. +||+|||-++.+... .....++||..|||||+++..+.++|+||||||||||||||| ..||.+-....
T Consensus 246 s~~d~--VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~-EiPYkdVdssA 318 (904)
T KOG4721|consen 246 SYDDV--VKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG-EIPYKDVDSSA 318 (904)
T ss_pred eccce--EEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc-CCCccccchhe
Confidence 87764 999999998876642 223457899999999999999999999999999999999997 88997643221
Q ss_pred H--HHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 592 A--NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 592 ~--~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
. .+-.+.- ...+..+..-++-||++||+..|..||++.+++.|-
T Consensus 319 IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 319 IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 1 0001111 123444556788899999999999999999999984
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.75 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=187.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCC------cee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~~ 414 (774)
+..|.+.+.||+|+||+||++.. .+++.||||++.... ......|+..+....+||||+++++++.+. ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34466678899999999999854 468899999986543 234556666444444799999999998653 468
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|++|||| .+|+|.+++... +...+++..+..++.|++.||+||
T Consensus 85 ~iv~e~~----------~~~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~L 127 (272)
T cd06637 85 WLVMEFC----------GAGSVTDLIKNT---------------------------KGNTLKEEWIAYICREILRGLSHL 127 (272)
T ss_pred EEEEEcC----------CCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 445555544321 112366778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSL 569 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSl 569 (774)
|+.+|+||||||+||+++.++. ++|+|||++....... .......|+..|+|||++. ...++.++|||||
T Consensus 128 H~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 202 (272)
T cd06637 128 HQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202 (272)
T ss_pred HHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHH
Confidence 9999999999999999987765 8999999988654321 1223456899999999986 3357889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH-HHHhhc--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 570 GCILFFCITGGKHPYGESFERDA-NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~-~~~~~~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
||++|||++| ..||........ ...... ........+.++.+++.+||+.||.+|||+.++++||||
T Consensus 203 Gv~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 203 GITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHhC-CCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999997 667754332222 111111 111222345789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.52 Aligned_cols=261 Identities=26% Similarity=0.368 Sum_probs=215.5
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCchHHHHHH------HHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEI------QNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~~~~~Ei------~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|.||+|.++ ...+|+.+|+|++++.-. .+..|+ ...+...+||.+..|...|+..+.+|+|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45667789999999999987 566899999999987532 111222 2467888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|| |..+|.|.-+|.. .+.+++...+.+...|+.||.|||+.
T Consensus 247 Me----------yanGGeLf~HLsr-----------------------------er~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 247 ME----------YANGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred EE----------EccCceEeeehhh-----------------------------hhcccchhhhhhhHHHHHHhhhhhhC
Confidence 99 8888888877643 24467778889999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+||.||||-+|+||+.||+ +||+||||++.-.. ......+.||||.|+|||++....|..++|+|.+||++|||+
T Consensus 288 ~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~---~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 288 NIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIK---YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred CeeeeechhhhheeccCCc--eEeeecccchhccc---ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 9999999999999999987 89999999986432 234567899999999999999999999999999999999999
Q ss_pred hCCCCCCC-CchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccchhhhhhhcc
Q 004097 578 TGGKHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRLSFLRDVS 651 (774)
Q Consensus 578 tg~~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~~~~l~~~~ 651 (774)
+| +.||. ...+....++....-.++...+++++.|+..+|.+||.+|.. +.|+++|+||.+.++...+.+.+.
T Consensus 363 CG-RLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 363 CG-RLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE 441 (516)
T ss_pred hc-cCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence 98 55554 444444455555555678888999999999999999999964 889999999998887766555443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.50 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=194.5
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .+++.||||.+..... ....+|+. ++..++|+||+.+++++.+++..|+|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ-ILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 45568899999999999754 4689999999864321 12345554 6778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
| +.+++|..++... ...++++..+..++.|++.||.|||+.+|
T Consensus 81 ~----------~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 81 I----------MNGGDLKFHIYNM---------------------------GNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred e----------ccCccHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4 4455555443211 12347888899999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|+|||||++|||++|
T Consensus 124 iH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 124 VYRDLKPENILLDDYGH--IRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred eecCCCHHHEEECCCCC--EEEecCCcceecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999987764 8999999987654321 12334689999999999988899999999999999999996
Q ss_pred CCCCCCCchHHH--HHH---HhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 580 GKHPYGESFERD--ANI---VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 580 ~~~Pf~~~~~~~--~~~---~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
.+||....... ..+ +............+++.+|+.+||+.||++||+ +.+++.||||.....
T Consensus 198 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 198 -QSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 77886543221 111 111122334456678999999999999999999 889999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.90 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=191.1
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 477889999999999999854 468899999986421 12234455567788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+|+|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------y~~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred ----------CCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45555555554321 1235677788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHhHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSlGvll~ 574 (774)
+||||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 124 iHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCCCC--EEEEeccceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence 99999999999987765 89999999987653321 11223569999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCchHH-HH-HHHhhccc-cc---cccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESFER-DA-NIVKDRKD-LF---LVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~~~-~~-~~~~~~~~-~~---~~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~ 641 (774)
||++| ..||...... .. .+...... .. ....++++.++|.+||..++.+ |++++++++||||...+
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 200 EMLYG-ETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred hhhhC-CCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99997 7777543322 22 22221111 11 1234679999999999876654 57899999999997644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.62 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=208.0
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|..-++||+|+||.||-+. ..+|+.+|.|++.+... ..++.|- .++.+++.+.||.+-..|+..+.+++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk-~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEK-QILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHH-HHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456777899999999999764 45799999998854432 2334444 47788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+. .|.+|+|.-+|.. ....++++..++.++.+|+.||++||.
T Consensus 263 VLt----------lMNGGDLkfHiyn---------------------------~g~~gF~e~ra~FYAAEi~cGLehlH~ 305 (591)
T KOG0986|consen 263 VLT----------LMNGGDLKFHIYN---------------------------HGNPGFDEQRARFYAAEIICGLEHLHR 305 (591)
T ss_pred EEE----------eecCCceeEEeec---------------------------cCCCCCchHHHHHHHHHHHhhHHHHHh
Confidence 999 6666666554422 122478999999999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+||+|||||+|||||+.|+ ++|+|+|||..+..+ ......+||.+|||||++.+..|+...|+|||||++|||
T Consensus 306 ~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g----~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYem 379 (591)
T KOG0986|consen 306 RRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEG----KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEM 379 (591)
T ss_pred cceeeccCChhheeeccCCC--eEeeccceEEecCCC----CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHH
Confidence 99999999999999998887 889999999988754 233445899999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH-----HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccchh
Q 004097 577 ITGGKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRL 644 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~~ 644 (774)
+.| ..||....+.. .+.+......++...+++++++.+.+|++||++|.. ++++.+||||++.+++.
T Consensus 380 i~G-~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 380 IAG-HSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred Hcc-cCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 997 77886544332 223334444566778899999999999999999974 67999999999877765
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.42 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=183.2
Q ss_pred eEeeccc--CceEEEEEe-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 350 NKEIAKG--SNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 350 ~~~LG~G--sfG~Vy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.++||+| +||+||++. ..+|+.||||++..... ...++++..+++.++||||+++++++.+++..|+|||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e--- 79 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS--- 79 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe---
Confidence 4679999 788999974 46789999999965421 1233434457788899999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+|+|.+++... ...++++..++.++.|++.||+|||+.+|+||
T Consensus 80 -------~~~~~~l~~~~~~~---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~ 125 (327)
T cd08227 80 -------FMAYGSAKDLICTH---------------------------FMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125 (327)
T ss_pred -------ccCCCcHHHHHHhh---------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 55555555544221 11346778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhc--CCCCCcchhHhHHHHHHHH
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGvll~el 576 (774)
||||+|||++.++. ++++|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|||
T Consensus 126 dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 203 (327)
T cd08227 126 SVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203 (327)
T ss_pred CCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence 99999999988775 8899998655433211100 01122346788999999976 4588999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhhcc---------------------------------------------ccccccCCHH
Q 004097 577 ITGGKHPYGESFERDA--NIVKDRK---------------------------------------------DLFLVEHIPE 609 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~--~~~~~~~---------------------------------------------~~~~~~~~~~ 609 (774)
++| ..||........ ....... .......+++
T Consensus 204 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 204 ANG-HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HHC-CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 996 778864322111 0000000 0001123468
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.++|.+||+.||++|||++|+++||||..
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 899999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.00 Aligned_cols=244 Identities=23% Similarity=0.370 Sum_probs=188.8
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||+||++. ..+++.||||++...... ...+|+. ++..++||||+++++++.+.+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE-ILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35667899999999999985 457899999998654222 2334544 67788999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ .+|++..+ ..+++..+..++.|++.||+|||+.+|+
T Consensus 81 ~----------~~~~l~~~---------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 117 (279)
T cd06619 81 M----------DGGSLDVY---------------------------------RKIPEHVLGRIAVAVVKGLTYLWSLKIL 117 (279)
T ss_pred C----------CCCChHHh---------------------------------hcCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 4 44544321 1245566789999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||||+|||++.++. ++|+|||++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 118 H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g- 189 (279)
T cd06619 118 HRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG- 189 (279)
T ss_pred eCCCCHHHEEECCCCC--EEEeeCCcceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC-
Confidence 9999999999988775 899999999765432 12334689999999999988899999999999999999996
Q ss_pred CCCCCCchHH--------HHHHHh-hc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFER--------DANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~~--------~~~~~~-~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||...... ....+. .. ........++++.++|.+||+.||++||+++|+++||||...+
T Consensus 190 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 7777542211 111111 11 1111223567899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.27 Aligned_cols=248 Identities=28% Similarity=0.376 Sum_probs=190.4
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|...+.||+|+||+||++...+|+.||||.+..... ....+|+ ..++.++|+||+++++++.+.+..|++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEV-DLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHH-HHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 455678999999999998777899999998864321 1223344 477888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+||+ ++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 81 ~e~~----------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 81 MEFV----------PGGSISSILNR-----------------------------FGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred EecC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9954 45555554421 12356778889999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCc---cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+|+|+||+|+||+++.++. ++|+|||++........ .........|+..|+|||++.+..++.++|||||||++|
T Consensus 122 ~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~ 199 (265)
T cd06631 122 CVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199 (265)
T ss_pred CcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHH
Confidence 9999999999999987765 89999999886532111 011122345899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhh--ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 575 FCITGGKHPYGESFERDA--NIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~--~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
+|++| ..||........ .+... .....+.....++.++|.+||+.+|.+||++.++++||||
T Consensus 200 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 200 EMATG-KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhC-CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99997 778865332221 11111 1112333456789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.08 Aligned_cols=239 Identities=25% Similarity=0.344 Sum_probs=178.8
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCCeeEEeeeccCCc----eeEEeccccCC
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSLERCTC 423 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~l~g~~~~~~----~~~LV~E~~~~ 423 (774)
+.+.||+|.||.||+|.+ +++.||||++...+...+..|-.. -+-.+.|+||++++++....+ .++||+|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~---- 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE---- 288 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee----
Confidence 446799999999999665 459999999976554444333321 123678999999999987766 7899999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc------
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI------ 497 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------ 497 (774)
|.++|+|.++|.. +.++|....+|+..+++||+|||+.
T Consensus 289 ------fh~kGsL~dyL~~------------------------------ntisw~~~cria~SmarGLa~LHee~p~~d~ 332 (534)
T KOG3653|consen 289 ------FHPKGSLCDYLKA------------------------------NTISWNSLCRIAESMARGLAHLHEELPRGDH 332 (534)
T ss_pred ------eccCCcHHHHHHh------------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCCC
Confidence 9999999998643 4578899999999999999999975
Q ss_pred ---CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC------CCcchhHh
Q 004097 498 ---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 568 (774)
Q Consensus 498 ---~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~sDvwS 568 (774)
+|+|||||++|||+..|+. +.|+|||||..+..+.... .....+||.+|||||++.+..- -.+.||||
T Consensus 333 ~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 333 HKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred CCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 6999999999999988866 7799999999987554332 3344789999999999986432 24799999
Q ss_pred HHHHHHHHHhC-------CCCCCCCchH----------HHH-HHHhhc-ccccccc-----CCHHHHHHHHHhcCCCCCC
Q 004097 569 LGCILFFCITG-------GKHPYGESFE----------RDA-NIVKDR-KDLFLVE-----HIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 569 lGvll~elltg-------~~~Pf~~~~~----------~~~-~~~~~~-~~~~~~~-----~~~~~~dli~~~L~~dP~~ 624 (774)
+|.||||+++. ..++|.-.++ +.. ..+..+ ...++.. ....+++.+..||+.||+.
T Consensus 410 mgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 410 MGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 99999999984 1223322222 111 122222 2222211 1246789999999999999
Q ss_pred CcCHHHH
Q 004097 625 RPKAQNV 631 (774)
Q Consensus 625 Rps~~el 631 (774)
|.|+.-+
T Consensus 490 RLTA~Cv 496 (534)
T KOG3653|consen 490 RLTAGCV 496 (534)
T ss_pred hhhhHHH
Confidence 9998754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=305.70 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=189.6
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC-CceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~LV~E 419 (774)
|.+.+.||+|++|.||++.. .+++.||||++..... ....+|+ .+++.++||||+++++.+.. +..+|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEA-QLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHH-HHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 67889999999999999854 4578999999864321 1223343 47788899999999998764 456899999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
+| ++++|.+++... ....+++.++..++.|++.||+|||+.+|
T Consensus 81 ~~----------~~~~l~~~l~~~---------------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 123 (257)
T cd08223 81 FC----------EGGDLYHKLKEQ---------------------------KGKLLPENQVVEWFVQIAMALQYLHEKHI 123 (257)
T ss_pred cc----------CCCcHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55 444554443221 11236778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. ++|+|||++....... .......+++.|+|||++.+..++.++|||||||++|++++|
T Consensus 124 ~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred eccCCCchhEEEecCCc--EEEecccceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 99999999999987765 8999999998764321 122344689999999999998899999999999999999997
Q ss_pred CCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 580 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||....... . .+........+...++++.+++.+||+.||+.||++.++++||||
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 199 -KHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 66776543222 1 222222222334566899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=305.92 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=192.9
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|++|.||++.. .+++.||+|.+.... .....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSSYIIRYYESFLDKGKLNIVME- 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHH-HHHhcCCCCeehheeeeccCCEEEEEEE-
Confidence 56778999999999999854 468999999986432 123344554 6788899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+++++|.++++... ...+++..+..++.|++.||.|||+.+|+
T Consensus 80 ---------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~ 123 (256)
T cd08529 80 ---------YAENGDLHKLLKMQR---------------------------GRPLPEDQVWRFFIQILLGLAHLHSKKIL 123 (256)
T ss_pred ---------eCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 445555555543211 12356778889999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||||+||+++.++. ++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 124 h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g- 197 (256)
T cd08529 124 HRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG- 197 (256)
T ss_pred cCCCCcceEEEeCCCC--EEEcccccceeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC-
Confidence 9999999999988765 89999999887654321 12334588999999999998899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........ .+.............+++.++|.+||+.+|++||++.++++|||.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 198 KHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 778865543221 122222222233456789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.75 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=189.4
Q ss_pred EEEeEeecccCceEEEEEeee---CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~ 415 (774)
|.+.+.||+|+||.||++... +++.||||.+.... .....+|+. ++..++||||+++++++.+. +.+|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA-LLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHH-HHHhcCCCCccceEEEEeCCCCceEE
Confidence 567788999999999998553 57999999997622 234456664 77889999999999999988 8899
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||+|.++|.+++..... .....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~-----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQ-----------------------------------AKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred EEEeCCCcCHHHHHHhhcc-----------------------------------CCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999888776655421000 00124677888999999999999999
Q ss_pred HcCccccccCCCCeeecC----CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHH
Q 004097 496 EIGLIHRDLKPQNVLISK----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLG 570 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlG 570 (774)
+.+|+||||||+||+++. ++ .+||+|||+++................++..|+|||++.+. .++.++||||||
T Consensus 126 ~~~i~h~dlkp~Nil~~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 126 SNWVLHRDLKPANILVMGEGPERG--VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred hCCEeeCCCCHHHEEEcCCCCccc--eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 999999999999999987 54 48999999998765432211222344688999999988764 578999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-----------HHHHh------------------------hc-ccccc-----------
Q 004097 571 CILFFCITGGKHPYGESFERD-----------ANIVK------------------------DR-KDLFL----------- 603 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-----------~~~~~------------------------~~-~~~~~----------- 603 (774)
|++|+|++| .+||....... ..+.. .. ...+.
T Consensus 204 ~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (316)
T cd07842 204 CIFAELLTL-EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282 (316)
T ss_pred HHHHHHHhc-CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence 999999997 77875432211 00000 00 00000
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 604 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 604 ~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
....+++.+++.+||+.||++|||+.|+++||||
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0344678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.20 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=191.8
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHH-hCCCCCeeEEeeeccCC----ceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-SDQHPNIVRWYGVESDQ----DFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~-~l~HpNIV~l~g~~~~~----~~~~ 415 (774)
+.+.+++.+.+.||+|.||.||+ +.+-|..||||++...+...+++|-+.... .++|+||+.+++.-..+ .++|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwr-G~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWR-GRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceee-ccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 67789999999999999999998 667889999999998888889998875544 47999999999875433 4689
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||.+ |+++|||+++|.. ..++....++++..+|.||+|||
T Consensus 286 LvTd----------YHe~GSL~DyL~r------------------------------~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 286 LVTD----------YHEHGSLYDYLNR------------------------------NTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred Eeee----------cccCCcHHHHHhh------------------------------ccCCHHHHHHHHHHHhhhHHHHH
Confidence 9999 9999999998754 34566778999999999999999
Q ss_pred Hc--------CccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhcCCC------
Q 004097 496 EI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQ------ 560 (774)
Q Consensus 496 ~~--------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~------ 560 (774)
.. .|.|||||+.|||+.+++. +.|+|+|||........ -....+..+||..|||||++...-.
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes 403 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES 403 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhh
Confidence 75 5999999999999988876 67999999988765532 2334567789999999999975421
Q ss_pred CCcchhHhHHHHHHHHHh----CC-----CCCCCCchHHH------HHHH--hhccccccc-cCC-H---HHHHHHHHhc
Q 004097 561 TRAIDLFSLGCILFFCIT----GG-----KHPYGESFERD------ANIV--KDRKDLFLV-EHI-P---EAVDLFTRLL 618 (774)
Q Consensus 561 ~~~sDvwSlGvll~ellt----g~-----~~Pf~~~~~~~------~~~~--~~~~~~~~~-~~~-~---~~~dli~~~L 618 (774)
-..+||||||.|+||++. || .+||.+..+.+ ...+ +...+..+. +.+ + .+..+|+.||
T Consensus 404 yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 404 YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 257999999999999764 32 46775533322 2111 111111121 222 2 4567899999
Q ss_pred CCCCCCCcCHHHHH
Q 004097 619 DPNPDLRPKAQNVL 632 (774)
Q Consensus 619 ~~dP~~Rps~~elL 632 (774)
..+|..|.|+-.+.
T Consensus 484 ~~Np~aRltALriK 497 (513)
T KOG2052|consen 484 YANPAARLTALRIK 497 (513)
T ss_pred cCCchhhhHHHHHH
Confidence 99999999876553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.48 Aligned_cols=286 Identities=23% Similarity=0.309 Sum_probs=191.8
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 413 (774)
+.|.+.+.||+|+||+||++.. .++..||||+++.... ....+|+. ++..+ +|||||+++++|.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHH-HHHHhcCCcceeeeeeeeccCCc
Confidence 3577889999999999999753 2456899999864322 23456766 45555 89999999999999999
Q ss_pred eEEeccccC-CChhhHHHHhcCChHH--------------HhhhhhhcchhhHHHHHh---------------------h
Q 004097 414 VYLSLERCT-CSLNDLIYVLSGSFEE--------------QLNAKEQDSNLLNEVRIR---------------------L 457 (774)
Q Consensus 414 ~~LV~E~~~-~sL~~~iy~~~gsL~~--------------~L~~~~~~~~~l~~~~~~---------------------~ 457 (774)
.|+|||||+ ++|.+++...++.... .+.........+...... .
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999665 3555554322211000 000000000000000000 0
Q ss_pred cccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc
Q 004097 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 537 (774)
Q Consensus 458 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~ 537 (774)
+................+++..++.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNY- 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccc-
Confidence 00000000111122345788999999999999999999999999999999999987654 899999999876533211
Q ss_pred cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHhhc-cccccccCCHHHHHHH
Q 004097 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLF 614 (774)
Q Consensus 538 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~dli 614 (774)
.......++..|+|||++.+..++.++|||||||++|||++++.+||...... ....+... ....+...+.++.++|
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 11122335678999999999999999999999999999999668888654322 12222222 1122233457899999
Q ss_pred HHhcCCCCCCCcCHHHHHcC
Q 004097 615 TRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 615 ~~~L~~dP~~Rps~~elL~H 634 (774)
.+||+.||++||++.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.65 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=196.6
Q ss_pred EEEeEeecccCceEEEEEeeeC-----CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC-CceeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~-----g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~ 415 (774)
|...+.||+|.||.||+|...+ .+.+|+|+++.+. ...+.+|+. +++.++||||+.|..++.. +..++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREia-L~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIA-LLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHH-HHHHhcCCcchhHHHHHhccCceEE
Confidence 5566789999999999983322 2379999997542 356889986 7888999999999999887 78899
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|++||.+.+|.+.|.....+ +.+.+|...+..|+.||+.|+.|||
T Consensus 105 l~fdYAEhDL~~II~fHr~~-----------------------------------~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 105 LLFDYAEHDLWHIIKFHRAS-----------------------------------KAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred EEehhhhhhHHHHHHHhccc-----------------------------------hhccCCHHHHHHHHHHHHhhhHHHh
Confidence 99999998888887543322 1234677788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCC--ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 572 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvl 572 (774)
+..|+||||||.|||+..|+. .++||+|||+++.+...-.........+.|.+|.|||.+.+. .||.++||||.|||
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI 229 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence 999999999999999977631 369999999999987654444344556789999999999985 58999999999999
Q ss_pred HHHHHhCCCCCCCCch-------------HHHHH---------------------HHhhccccc------------cccC
Q 004097 573 LFFCITGGKHPYGESF-------------ERDAN---------------------IVKDRKDLF------------LVEH 606 (774)
Q Consensus 573 l~elltg~~~Pf~~~~-------------~~~~~---------------------~~~~~~~~~------------~~~~ 606 (774)
+.||+|-...+++... .+... .+......+ ....
T Consensus 230 faElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k 309 (438)
T KOG0666|consen 230 FAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK 309 (438)
T ss_pred HHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC
Confidence 9999996332222110 00000 000000000 0012
Q ss_pred CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 607 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 607 ~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++.+.+|+.+||+.||.+|.|++++|+|+||...+
T Consensus 310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 34588999999999999999999999999997654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.75 Aligned_cols=248 Identities=33% Similarity=0.498 Sum_probs=189.9
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------------hHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
|.+...||+|++|.||+|.. .+++.||||.+..... ....+|+ .++..++||||+++++++.+.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREI-ALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEeCCc
Confidence 44567899999999999854 4688999998854321 1122333 47788999999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.++||||+ ++++|.+++... ..+++..+..++.|++.||+|
T Consensus 81 ~~lv~e~~----------~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~ 121 (267)
T cd06628 81 LNIFLEYV----------PGGSVAALLNNY-----------------------------GAFEETLVRNFVRQILKGLNY 121 (267)
T ss_pred cEEEEEec----------CCCCHHHHHHhc-----------------------------cCccHHHHHHHHHHHHHHHHH
Confidence 99999954 445555444221 235667788999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc---cccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
||+.+++||||+|+||+++.++. ++|+|||+++......... .......|+..|+|||.+.+..++.++|+||||
T Consensus 122 lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 199 (267)
T cd06628 122 LHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199 (267)
T ss_pred HHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHH
Confidence 99999999999999999987765 8999999998775321111 111233588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 571 CILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|++|+|++| ..||....... ..+........+.....++.++|++||+.||.+||++.++++||||
T Consensus 200 ~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 200 CLVVEMLTG-KHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHhhC-CCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999996 77886543222 1222222222334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.47 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=186.3
Q ss_pred ceEEEeEeecccCceEEEEEeee-----------------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 403 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-----------------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 403 (774)
..|.+.+.||+|+||.||++... .+..||||.+...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHH-HHhhcCCCCeeE
Confidence 45778899999999999997542 2347999998754322 2345654 678889999999
Q ss_pred EeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHH
Q 004097 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483 (774)
Q Consensus 404 l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 483 (774)
+++++.+.+..++|||||. +|+|.+++............ +...........+++..+.++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~----------~~~L~~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 84 LLGVCVDEDPLCMITEYME----------NGDLNQFLSSHHLDDKEENG----------NDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred EEEEEecCCceEEEEecCC----------CCcHHHHHHhcccccccccc----------ccccccccccccccHHHHHHH
Confidence 9999999999999999554 44444444322110000000 000000011234677888999
Q ss_pred HHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCc
Q 004097 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563 (774)
Q Consensus 484 ~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 563 (774)
+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||++....++.+
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 220 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTA 220 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCch
Confidence 999999999999999999999999999987765 89999999986643221 112223346788999999998899999
Q ss_pred chhHhHHHHHHHHHhC-CCCCCCCchHHHH-HHH----hhc----cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 564 IDLFSLGCILFFCITG-GKHPYGESFERDA-NIV----KDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 564 sDvwSlGvll~elltg-~~~Pf~~~~~~~~-~~~----~~~----~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
+|||||||++|||+++ +..||........ ... ... ....+...++.+.++|.+||+.||++|||+.++.
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999999999999874 4567765332211 111 000 1112234457899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=312.91 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=195.2
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
...+.|...+.||+|+||+||++. ..+++.||+|.+..... ....+|+. ++..+.||||+++++++.+.+..|+|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHH-HHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 344678888999999999999985 45789999999865432 23344554 66788999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|| |+.+++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 96 ~e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 96 ME----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred ec----------ccCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 5556666654421 1245667789999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 136 gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~ 210 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210 (296)
T ss_pred CcccCCCCHHHEEEcCCCC--EEECccccchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 9999999999999987765 89999999886543211 122346889999999999888999999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-c-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFERDA--NIVKDRK-D-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~-~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+| .+||........ ....... . ..+....+.+.++|.+||..||++||++.++++||||...
T Consensus 211 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 211 EG-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred hC-CCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 97 677765433221 1111111 1 1123345789999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.14 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=200.8
Q ss_pred ceEEEe-EeecccCceEEEEE-eeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEec
Q 004097 345 KLVVFN-KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~-~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~ 418 (774)
+.|.+. ++||-|-.|.|..+ ...+|+.+|+|+|... ..+.+|++.-...-.|||||.++++|.. ..++++||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 334433 57999999999876 5567999999999754 5677888755556689999999998764 47789999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| .|.+|.|+..+.... ...+++.++..|++||+.|+.|||+.+
T Consensus 139 E----------~meGGeLfsriq~~g---------------------------~~afTErea~eI~~qI~~Av~~lH~~n 181 (400)
T KOG0604|consen 139 E----------CMEGGELFSRIQDRG---------------------------DQAFTEREASEIMKQIGLAVRYLHSMN 181 (400)
T ss_pred e----------cccchHHHHHHHHcc---------------------------cccchHHHHHHHHHHHHHHHHHHHhcc
Confidence 9 888999988775533 244778899999999999999999999
Q ss_pred ccccccCCCCeeecCC-CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|.||||||+|+|.+.. .+..+||+|||+|+..... ....+.+-||.|.|||++...+|+..+|+||+||++|-|+
T Consensus 182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_pred hhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh
Confidence 9999999999999643 3456899999999976532 2345678899999999999999999999999999999999
Q ss_pred hCCCCCCCCchHH-----HHHHHhhccccccccC----CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFER-----DANIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.| .|||...... ....+......++... +.+++|+|+++|..+|.+|.|+++++.|||....
T Consensus 258 CG-yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 258 CG-YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred cC-CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 97 6666543321 2333444444444332 4688999999999999999999999999998553
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.07 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=189.1
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||.||++.. .++..||+|.+..... ....+|++ ++..++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK-VLHECNSPYIVGFYGAFYSDGEISICME- 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCEEEEEee-
Confidence 467789999999999999854 4688999998864322 22445554 6777899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 499 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~i 499 (774)
|..+++|.+++.. ...+++..+..++.|++.||+|||+ .++
T Consensus 80 ---------y~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 80 ---------HMDGGSLDQVLKK-----------------------------AGRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred ---------ccCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 5555566555432 1335677789999999999999998 589
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. +||+|||++...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 122 MHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred EECCCChHHEEEecCCc--EEEccCCCccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998765432 12335689999999999888899999999999999999997
Q ss_pred CCCCCCCchHHHH-HHHhhc-------------------------------------c-ccccccCCHHHHHHHHHhcCC
Q 004097 580 GKHPYGESFERDA-NIVKDR-------------------------------------K-DLFLVEHIPEAVDLFTRLLDP 620 (774)
Q Consensus 580 ~~~Pf~~~~~~~~-~~~~~~-------------------------------------~-~~~~~~~~~~~~dli~~~L~~ 620 (774)
..||........ ...... . .......++++.++|.+||..
T Consensus 195 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 195 -RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred -CCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 667643221111 111000 0 000012356799999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCc
Q 004097 621 NPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 621 dP~~Rps~~elL~HPff~~~ 640 (774)
||++||++.++++||||..+
T Consensus 274 ~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 274 NPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.10 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=195.3
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+.|.+.+.||.|++|+||++. ..+|+.||||.+..... ....+|+ .++..++||||+++++++.+.+..|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI-LVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHH-HHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4668899999999999999974 46789999999864332 2233454 46788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|..+++|..++. ...+++.++..++.|++.||+|||+.++
T Consensus 97 ----------~~~~~~L~~~~~------------------------------~~~l~~~~~~~i~~~l~~al~~LH~~~i 136 (296)
T cd06655 97 ----------YLAGGSLTDVVT------------------------------ETCMDEAQIAAVCRECLQALEFLHANQV 136 (296)
T ss_pred ----------ecCCCcHHHHHH------------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 555555555432 1235678889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. +||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 137 IHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 89999999886653321 11234588999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HH-HHhhcc--ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESFERD-AN-IVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~-~~~~~~--~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||....... .. +..... ...+...++.+.++|.+||..||.+||++.+++.||||...
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 212 -EPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 66776543322 11 111111 11233456789999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=305.48 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=191.2
Q ss_pred eEEEeEeecccCceEEEEEeeeC-CcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.|.+.+.||+|+||.||++...+ ++.||+|.+..... ....+|+. ++..++||||+++++++.+....|+++|++.
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~- 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS-ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG- 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHH-HHHhCCCCcEeeeeeeeecCCcEEEEEecCC-
Confidence 46677889999999999986654 78999999865432 33444554 6777899999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+++|.+++... ...+++..+..++.|++.||.|||+.+++|+|
T Consensus 82 ---------~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~d 124 (256)
T cd06612 82 ---------AGSVSDIMKIT----------------------------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124 (256)
T ss_pred ---------CCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 44444443211 12367778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++| .+|
T Consensus 125 l~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g-~~p 198 (256)
T cd06612 125 IKAGNILLNEEGQ--AKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPP 198 (256)
T ss_pred CCcceEEECCCCc--EEEcccccchhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC-CCC
Confidence 9999999988765 89999999887654321 12234478899999999988999999999999999999997 778
Q ss_pred CCCchHHHHHHHhhc--cc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 584 YGESFERDANIVKDR--KD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 584 f~~~~~~~~~~~~~~--~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|.............. .. ..+.....++.++|.+||+.||++|||+.|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 765433322111111 10 1112234689999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=311.68 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=195.5
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||.||++... +++.||||.+.+.. .+...+|++ ++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKR-ILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4778899999999999998544 68999999986432 122344554 678889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| .+++|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qil~~l~~lH~~~ 121 (290)
T cd05580 81 EYV----------PGGELFSHLRK-----------------------------SGRFPEPVARFYAAQVVLALEYLHSLD 121 (290)
T ss_pred ecC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 34444443321 134667788899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+|+||+|+||+++.++. +||+|||+++..... .....|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 122 i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 193 (290)
T cd05580 122 IVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193 (290)
T ss_pred EecCCCCHHHEEECCCCC--EEEeeCCCccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999987765 899999999876533 233468999999999988888999999999999999999
Q ss_pred CCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 579 GGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
| ..||....... ...+.......+....+.+.++|.+||+.||.+|+ +++|+++||||....+
T Consensus 194 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 194 G-YPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred C-CCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 7 77876544322 22222222233445578999999999999999999 8999999999976553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.91 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=186.2
Q ss_pred ceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||.||++... .+..||+|.++..... ...+|+. .+..++||||+++++++.+++..|+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL-TLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45788899999999999997542 4678999998754322 2334554 6677899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||| |+.+|+|.+++... ...+++..++.++.||+.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 84 VTE----------YMSNGALDSFLRKH----------------------------EGQLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred EEE----------eCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 55555555554321 1236777889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+++||||||+|||++.++. ++++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+
T Consensus 126 ~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 201 (266)
T cd05064 126 MGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201 (266)
T ss_pred CCEeeccccHhhEEEcCCCc--EEECCCcccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence 99999999999999987764 89999998765432211 111223456789999999999999999999999999998
Q ss_pred HhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 577 ITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++.|..||....... ...+... ....+......+.+++.+||+.+|.+||+++++++
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 202 MSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 864577886543322 2222222 22233345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.45 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=186.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||.||++.. .+|+.||||++..... ....+|+. ++..++|+||+++++++.+++..|+|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHH-HHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5688889999999999999854 5689999999864321 23445664 6778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.++|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 84 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i 124 (291)
T cd07870 84 YMHTDLAQYMIQH---------------------------------------PGGLHPYNVRLFMFQLLRGLAYIHGQHI 124 (291)
T ss_pred cccCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 7776655544211 1224556678899999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+|+||||+||+++.++. +||+|||+++....... ......+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 125 ~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 125 LHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ccCCCChHHEEEcCCCc--EEEeccccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999987765 89999999876432211 11233578999999998754 47889999999999999999
Q ss_pred CCCCCCCCchHHHHHHHhh-----------------c----cccc-------------cccCCHHHHHHHHHhcCCCCCC
Q 004097 579 GGKHPYGESFERDANIVKD-----------------R----KDLF-------------LVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~~~~~-----------------~----~~~~-------------~~~~~~~~~dli~~~L~~dP~~ 624 (774)
| .+||.........+... . .... .....+++.+++.+||+.||.+
T Consensus 200 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~ 278 (291)
T cd07870 200 G-QPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKD 278 (291)
T ss_pred C-CCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCccc
Confidence 7 77886433211110000 0 0000 0012457889999999999999
Q ss_pred CcCHHHHHcCCCC
Q 004097 625 RPKAQNVLNHPFF 637 (774)
Q Consensus 625 Rps~~elL~HPff 637 (774)
|||+.|++.||||
T Consensus 279 R~t~~~~l~h~~~ 291 (291)
T cd07870 279 RISAQDALLHPYF 291 (291)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.16 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=195.2
Q ss_pred EeEeecccCceEEEEEeeeC-CcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 349 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
+...||.|+||+||+|...+ +-..|-|++..... +..+-||. +++.++||+||+|++.|...+.+||..|+|.|.
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIe-ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIE-ILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhh-hhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 34569999999999986554 44556677643322 23445664 778889999999999999999999999999875
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
--|-|... -.+++.+.++..+++|++.||.|||+.+||||||
T Consensus 115 AVDaimlE--------------------------------------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDL 156 (1187)
T KOG0579|consen 115 AVDAIMLE--------------------------------------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDL 156 (1187)
T ss_pred hHhHHHHH--------------------------------------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhc
Confidence 44444221 1245788899999999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHHHHHhC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~elltg 579 (774)
|..|||++.||. ++|+|||.+..... ......+.+|||.|||||++. ..+|+.++||||||+.|.||..+
T Consensus 157 KAGNiL~TldGd--irLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 157 KAGNILLTLDGD--IRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI 231 (1187)
T ss_pred cccceEEEecCc--Eeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence 999999999998 88999998866543 233456788999999999875 46899999999999999999996
Q ss_pred CCCCCCCchHHH--HHHHhhcc--ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 580 GKHPYGESFERD--ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 580 ~~~Pf~~~~~~~--~~~~~~~~--~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
.||..+-...- ..+.+..+ ...+..++..+.|++.+||.+||..||+++++++||||.+....
T Consensus 232 -EPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 232 -EPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred -CCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 77776543321 12222222 12345566799999999999999999999999999999866543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.38 Aligned_cols=233 Identities=20% Similarity=0.263 Sum_probs=181.0
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEeccc
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLER 420 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~E~ 420 (774)
..||+|++|.||+|. .+|+.||||++..... +...+|+ .++..++|||||+++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E- 102 (283)
T PHA02988 26 VLIKENDQNSIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEI-KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE- 102 (283)
T ss_pred eEEeeCCceEEEEEE-ECCEEEEEEeccccccccHHHHHHHHHHH-HHHHhcCCCCEEEEeeeEEecccCCCceEEEEE-
Confidence 459999999999965 5899999999965422 1223555 47788999999999999877 457899999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Cc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 499 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~i 499 (774)
|+.+|+|.+++... ..+++.....++.|++.||+|||+. ++
T Consensus 103 ---------y~~~g~L~~~l~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 144 (283)
T PHA02988 103 ---------YCTRGYLREVLDKE-----------------------------KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144 (283)
T ss_pred ---------eCCCCcHHHHHhhC-----------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCC
Confidence 55556666554321 2356677789999999999999985 99
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc--CCCCCcchhHhHHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGvll~ell 577 (774)
+||||||+|||++.++. +||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 145 ~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 145 PYKNLTSVSFLVTENYK--LKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCcCChhhEEECCCCc--EEEcccchHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 99999999999988765 899999999865432 123468899999999976 67899999999999999999
Q ss_pred hCCCCCCCCchHHHH-H-HHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA-N-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~-~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+| ..||........ . +.... ....+...++++.+++.+||+.||++|||++|+++
T Consensus 217 ~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TG-KIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HC-CCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 96 778876543322 2 22222 22223356789999999999999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=332.86 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=201.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCchHHHHHH---HHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDVALKEI---QNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~~~~~Ei---~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..+.+.++||.|.||.|+++.+.. ...||||.|+....+...+++ ..++...+||||++|-|+......++||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999987653 358999999866544433333 2478889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
.| ||+||+|..+|+.++.. +.+-++.-++++||.|++||-+.
T Consensus 709 TE----------yMENGsLDsFLR~~DGq----------------------------ftviQLVgMLrGIAsGMkYLsdm 750 (996)
T KOG0196|consen 709 TE----------YMENGSLDSFLRQNDGQ----------------------------FTVIQLVGMLRGIASGMKYLSDM 750 (996)
T ss_pred hh----------hhhCCcHHHHHhhcCCc----------------------------eEeehHHHHHHHHHHHhHHHhhc
Confidence 99 99999999999876542 45557788999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
++|||||..+|||+ +.++.+|++||||++.+.++......+....-...|.|||.+..+++|.++||||||++|||.+
T Consensus 751 ~YVHRDLAARNILV--NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 751 NYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 828 (996)
T ss_pred Cchhhhhhhhheee--ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence 99999999999999 5558899999999998876653322222223457899999999999999999999999999988
Q ss_pred hCCCCCCCCch-HHHHHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 578 TGGKHPYGESF-ERDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 578 tg~~~Pf~~~~-~~~~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+-|.-||-+.. +.-.+.+..... ..+.+++..+..|+..||++|-.+||...+++.+
T Consensus 829 SyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 829 SYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 86666665543 333444444444 4455666678899999999999999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=304.86 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=201.9
Q ss_pred EeecccCceEEEEE-eeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
+.||+|+||.|--+ .+.+|.++|||++.+.. ....++|++.+...-.|+||+.|+.+|+|++.+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE------- 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE------- 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe-------
Confidence 56999999999654 67889999999997653 24678999988888899999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
.|.+|.|..+++. ...+.+.++.++.++|+.||.|||.+||.||||||
T Consensus 157 ---Km~GGplLshI~~-----------------------------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP 204 (463)
T KOG0607|consen 157 ---KMRGGPLLSHIQK-----------------------------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKP 204 (463)
T ss_pred ---cccCchHHHHHHH-----------------------------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc
Confidence 9999999887754 34477788999999999999999999999999999
Q ss_pred CCeeecCCCCc-eEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHHHH
Q 004097 507 QNVLISKDKSF-CAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 507 ~NILl~~~~~~-~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~el 576 (774)
+|||-.....+ -+||+||.|...+.-..+. .....+.+|+..|||||+.. ...|+.++|.||||||+|-|
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 99999654443 4899999887654322111 12335678999999999874 23588999999999999999
Q ss_pred HhCCCCCCCCchH----------------HHHHHHhhccccccccC----CHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 577 ITGGKHPYGESFE----------------RDANIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 577 ltg~~~Pf~~~~~----------------~~~~~~~~~~~~~~~~~----~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
|.| .+||...-. ....-++..+..++.+. +.+++|+|+.+|..|+..|.++.++++|||
T Consensus 285 LsG-YpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 285 LSG-YPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HhC-CCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 997 778843211 11233444555555433 578999999999999999999999999999
Q ss_pred CCCccc
Q 004097 637 FWTADT 642 (774)
Q Consensus 637 f~~~~~ 642 (774)
+.....
T Consensus 364 ~~~~~~ 369 (463)
T KOG0607|consen 364 VQRCAP 369 (463)
T ss_pred ccccch
Confidence 976543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.71 Aligned_cols=248 Identities=30% Similarity=0.381 Sum_probs=184.2
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~ 415 (774)
|...+.||+|+||.||++.. .+++.||+|++..... ....+|+ .++..++||||+++++++.+ .+..+
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEI-QLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHH-HHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 55668899999999999854 4689999998864311 1233454 47788899999999998765 46789
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+++|++ .+++|.+++... ..+++..++.++.|++.||+|||
T Consensus 83 l~~e~~----------~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~LH 123 (266)
T cd06651 83 IFMEYM----------PGGSVKDQLKAY-----------------------------GALTESVTRKYTRQILEGMSYLH 123 (266)
T ss_pred EEEeCC----------CCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 999955 444554443221 22456677899999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+||+++.++. ++|+|||+++.+..............++..|+|||.+.+..++.++|||||||++||
T Consensus 124 ~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~e 201 (266)
T cd06651 124 SNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE 201 (266)
T ss_pred hCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 999999999999999987765 899999998865432111111223458899999999998889999999999999999
Q ss_pred HHhCCCCCCCCchHHHH--HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 576 CITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|++| .+||........ ...... ....+....+.+.+++ +||..+|++||+++|+++||||.
T Consensus 202 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 202 MLTE-KPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHC-CCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9997 778865432221 111111 1122333456788888 67778999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.03 Aligned_cols=247 Identities=26% Similarity=0.460 Sum_probs=192.1
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. .++.++||||+++++++.+.+..|+|+||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHH-HHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 66789999999999999744 468999999986431 123445554 67889999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ .+++|.+.+... ....+++.+++.++.|++.||+|||+.+++
T Consensus 81 ~----------~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08218 81 C----------EGGDLYKKINAQ---------------------------RGVLFPEDQILDWFVQICLALKHVHDRKIL 123 (256)
T ss_pred C----------CCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 4 445554443321 112356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. ++|+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 124 h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08218 124 HRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC--EEEeeccceeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC-
Confidence 9999999999987765 89999999976643211 11234588899999999988899999999999999999997
Q ss_pred CCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||....... . .+........+.....++.++|.+||+.+|.+||++.++++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 198 KHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 66775443222 1 222233333344556789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=347.48 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=192.5
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC--Ccee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD--QDFV 414 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~ 414 (774)
.-..|.+.+.||+|+||+||++.. .++..||+|.+.... ......|+. ++..++|||||++++++.+ ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~-IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN-VMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHH-HHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345688999999999999999854 457899999886432 123445654 7788999999999998754 4678
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|||||||. +|+|.++|.... -....+++..++.|+.||+.||+||
T Consensus 90 yIVMEY~~----------gGSL~~lL~k~~-------------------------~~~g~L~E~~Il~Ia~QIL~ALaYL 134 (1021)
T PTZ00266 90 YILMEFCD----------AGDLSRNIQKCY-------------------------KMFGKIEEHAIVDITRQLLHALAYC 134 (1021)
T ss_pred EEEEeCCC----------CCcHHHHHHHHh-------------------------hccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999655 444444433211 0113478889999999999999999
Q ss_pred HHc-------CccccccCCCCeeecCC---------------CCceEEEcccCccccccCCCccccccccCcCCCCCCch
Q 004097 495 HEI-------GLIHRDLKPQNVLISKD---------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552 (774)
Q Consensus 495 H~~-------~ivHrDLkp~NILl~~~---------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP 552 (774)
|+. +||||||||+||||+.+ +...+||+|||++..+... .......||+.|+||
T Consensus 135 Hs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAP 210 (1021)
T PTZ00266 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSP 210 (1021)
T ss_pred HhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCH
Confidence 984 49999999999999642 2335899999999866432 112345699999999
Q ss_pred hhhhc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCchH--HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 553 EQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 553 E~l~~--~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
|++.+ ..++.++||||||||+|||++| .+||..... .....+...........++++.+||.+||+.+|.+||++
T Consensus 211 EvL~ge~~~~s~KSDVWSLG~ILYELLTG-k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 211 ELLLHETKSYDDKSDMWALGCIIYELCSG-KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred HHHhccCCCCCchhHHHHHHHHHHHHHHC-CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence 99864 4578999999999999999997 778864322 222233333333333456899999999999999999999
Q ss_pred HHHHcCCCCCC
Q 004097 629 QNVLNHPFFWT 639 (774)
Q Consensus 629 ~elL~HPff~~ 639 (774)
.|+|.|||+..
T Consensus 290 ~QlL~h~~ik~ 300 (1021)
T PTZ00266 290 LQCLGYQIIKN 300 (1021)
T ss_pred HHHhccHHHhh
Confidence 99999999963
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.60 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=186.5
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|++|+||++... +++.||||.+..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS-LLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHH-HHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 45778899999999999998654 689999999864321 23445664 7788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.++|.+++... ...+++..++.++.|++.||.|||+.+|
T Consensus 84 ~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i 124 (291)
T cd07844 84 YLDTDLKQYMDDC---------------------------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRV 124 (291)
T ss_pred cCCCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7776665544211 1235667789999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+||+++.++. +||+|||+++....... ......++..|+|||++.+ ..++.++||||+||++|+|++
T Consensus 125 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 125 LHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ecccCCHHHEEEcCCCC--EEECccccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999987765 89999999875432111 1122346889999999875 457899999999999999999
Q ss_pred CCCCCCCCchHH-H-HH-HHhhc---------------------c-----c-----cccccCCHHHHHHHHHhcCCCCCC
Q 004097 579 GGKHPYGESFER-D-AN-IVKDR---------------------K-----D-----LFLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 579 g~~~Pf~~~~~~-~-~~-~~~~~---------------------~-----~-----~~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
| .+||...... . .. +.... . . .......+++.+++.+||+.+|++
T Consensus 200 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 200 G-RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred C-CCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 7 7788544311 1 00 00000 0 0 000111267889999999999999
Q ss_pred CcCHHHHHcCCCC
Q 004097 625 RPKAQNVLNHPFF 637 (774)
Q Consensus 625 Rps~~elL~HPff 637 (774)
|||+.|+++||||
T Consensus 279 Rps~~e~l~~~~f 291 (291)
T cd07844 279 RISAAEAMKHPYF 291 (291)
T ss_pred ccCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.82 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=188.3
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.|.+.+.||+|+||.||++...++..+|+|.+..... ....+|+. ++..++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~-- 81 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK-VMMKLSHPKLVQLYGVCTQQKPLYIVTEFM-- 81 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHH-HHHHCCCCCceeEEEEEccCCCEEEEEEcC--
Confidence 4667789999999999999887788999998864432 34455554 778899999999999999999999999955
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
++|+|.++++... ..+++..++.++.|++.||+|||+.+|+|||
T Consensus 82 --------~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 125 (256)
T cd05114 82 --------ENGCLLNYLRQRQ----------------------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125 (256)
T ss_pred --------CCCcHHHHHHhCc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 4555554443211 1256677899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|||++++++|
T Consensus 126 l~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 126 LAARNCLVSSTGV--VKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred cCcceEEEcCCCe--EEECCCCCccccCCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence 9999999977654 89999999886543211 1111223566899999998888999999999999999999955888
Q ss_pred CCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 584 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 584 f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|....... ...+. ......+....+++.+++.+||+.+|.+||+++++++
T Consensus 202 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 202 FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 86644322 22222 2222223345678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.77 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=184.8
Q ss_pred eecccCceEEEEEee-eCCcEEEEEEeecCCc-----hH-HHHHH--HHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 352 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DV-ALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~-~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.||+|+||.||++.. .+++.||||.+.+... .. ..+|. ..++...+||||+.+++++.+++..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e--- 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD--- 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe---
Confidence 389999999999855 4689999998864321 11 12222 234445689999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+|+|.+++.. ...+++..+..|+.|++.||+|||+.+|+||
T Consensus 78 -------~~~~~~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 121 (279)
T cd05633 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121 (279)
T ss_pred -------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCC
Confidence 5555555554321 1346778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg~~ 581 (774)
||||+|||++.++. ++|+|||++....... .....||..|+|||.+.. ..++.++|||||||++|||++| .
T Consensus 122 dikp~Nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~ 193 (279)
T cd05633 122 DLKPANILLDEHGH--VRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG-H 193 (279)
T ss_pred CCCHHHEEECCCCC--EEEccCCcceeccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC-C
Confidence 99999999987765 8999999987554221 123458999999999864 5588999999999999999997 6
Q ss_pred CCCCCchHHH---H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 582 HPYGESFERD---A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 582 ~Pf~~~~~~~---~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
.||....... . ..........+...++++.++|.+||+.||.+|| +++|+++||||......
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 194 SPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred CCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 6775432111 1 1111112223345668999999999999999999 69999999999775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=312.81 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=194.5
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+.|.+.+.||+|+||.||++.. .+++.||||.+..... +...+|+ .++..++||||+++++++.+++..|+|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI-LVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 46688889999999999999864 5789999999865332 2233454 46788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+|
T Consensus 97 ----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~l~~~L~~LH~~~i 136 (297)
T cd06656 97 ----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALDFLHSNQV 136 (297)
T ss_pred ----------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 5566666654321 234666788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++. ++|+|||++........ ......+++.|+|||.+.+..++.++|+|||||++|++++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg 211 (297)
T cd06656 137 IHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (297)
T ss_pred ccCCCCHHHEEECCCCC--EEECcCccceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999987765 89999999876543321 12234588999999999988899999999999999999997
Q ss_pred CCCCCCCchHHHH-H-HHhhcc-c-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESFERDA-N-IVKDRK-D-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~~~-~-~~~~~~-~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||........ . ...... . ..+....+.+.+++.+||+.||++||++.++++||||...
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 212 -EPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -CCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 777754332211 1 111111 1 1223345688999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=324.80 Aligned_cols=275 Identities=22% Similarity=0.307 Sum_probs=188.6
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 413 (774)
+.|.+.+.||+|+||.||++.. .++..||||++...... ...+|+. ++..+ +|||||+++++|.+.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK-ILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHH-HHHhhccCCceeeEeeEecCCCC
Confidence 4577889999999999998742 23458999999754322 2345665 55555 89999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhH-----------HHHH---------------------------
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN-----------EVRI--------------------------- 455 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~-----------~~~~--------------------------- 455 (774)
.|+|||||. +|+|.+++........... .+..
T Consensus 117 ~~lv~ey~~----------~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 117 VLVITEYCC----------YGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred eEEeHhhcc----------CCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 999999655 4444444432211000000 0000
Q ss_pred ---hhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccC
Q 004097 456 ---RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 532 (774)
Q Consensus 456 ---~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~ 532 (774)
...................+++..+++|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~ 264 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMN 264 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccC
Confidence 0000000000011112245788899999999999999999999999999999999987654 89999999986643
Q ss_pred CCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhc-cccccccCCHH
Q 004097 533 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPE 609 (774)
Q Consensus 533 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~~ 609 (774)
.... .......++..|+|||++.+..++.++|||||||++|||++.|++||....... ....... ....+...+++
T Consensus 265 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 265 DSNY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred Ccce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 3211 111223356789999999988999999999999999999984488886543221 1222222 11222334689
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+.++|.+||+.||.+||++.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.77 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=195.9
Q ss_pred cccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.-++.|.+.+.||+||...||++...+.+.+|+|++..... +....|+..|-+.-.|.+||+||+|...++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34566888889999999999998777788899988753322 2345677755555679999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||+-+++|...+....+.... -.++.+.+||+.++.+.|+
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~---------------------------------------~~lk~ywkqML~aV~~IH~ 478 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPD---------------------------------------WFLKFYWKQMLLAVKTIHQ 478 (677)
T ss_pred EeecccccHHHHHHhccCCCch---------------------------------------HHHHHHHHHHHHHHHHHHH
Confidence 9998778887777433332221 1457899999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-----------CCCcch
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----------QTRAID 565 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sD 565 (774)
+||||.||||.|.|+-.. .+||+|||+|..+..+.... ...+.+||+.||+||.+.... .++++|
T Consensus 479 ~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTsI-~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SD 554 (677)
T KOG0596|consen 479 HGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTSI-VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSD 554 (677)
T ss_pred hceeecCCCcccEEEEee---eEEeeeechhcccCccccce-eeccccCcccccCHHHHhhccccccCCCcceeecCccc
Confidence 999999999999999643 48999999999887654432 334568999999999997533 457999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHHHH---HHhhccc-cccccCC-HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 566 LFSLGCILFFCITGGKHPYGESFERDAN---IVKDRKD-LFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~~~~---~~~~~~~-~~~~~~~-~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|||||||||+|+.| ++||+.-...... +...... .++.-.. .++.++++.||..||.+|||+.|||+|||..-
T Consensus 555 vWSLGCILYqMvYg-ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 555 VWSLGCILYQMVYG-KTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hhhhhhHHHHHHhc-CCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99999999999996 8899875433322 2222121 2222111 25999999999999999999999999999854
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.38 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=189.5
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.|.+.++||+|+||+||++...++..||+|.+..... ...+.+...++..++||||+++++++.+.+..|++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE---- 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe----
Confidence 45788899999999999999877888999999865332 2233333457788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+++|||
T Consensus 82 ------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~d 128 (261)
T cd05072 82 ------YMAKGSLLDFLKSDE---------------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128 (261)
T ss_pred ------cCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 555555555543221 12356677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++. ++|+|||+++....... .......++..|+|||++....++.++|||||||++|+|++++.+|
T Consensus 129 l~p~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 129 LRAANVLVSESLM--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred cchhhEEecCCCc--EEECCCccceecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCC
Confidence 9999999987764 89999999987653211 1112233567899999998888999999999999999999956889
Q ss_pred CCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 584 YGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|....... ...+... ........+.++.+++.+||..+|++||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 205 YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 86543322 2222211 11222344578999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.91 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=187.3
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|++|.||++... +|+.||+|++..... ....+|+. ++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR-MLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHH-HHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4677889999999999998654 689999999864321 22345554 7788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+++ +.+...+. ....+++..++.++.|++.||+|||+.++
T Consensus 81 ~~~~----------~~l~~~~~-----------------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i 121 (286)
T cd07847 81 YCDH----------TVLNELEK-----------------------------NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121 (286)
T ss_pred ccCc----------cHHHHHHh-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6554 33333211 11236778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+||+++.++. ++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 122 IHRDVKPENILITKQGQ--IKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred eecCCChhhEEEcCCCc--EEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999987765 89999999987654321 1123357889999999876 457899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhc----------------------cc--------cccccCCHHHHHHHHHhcCCCCCCCc
Q 004097 579 GGKHPYGESFERDA--NIVKDR----------------------KD--------LFLVEHIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~----------------------~~--------~~~~~~~~~~~dli~~~L~~dP~~Rp 626 (774)
| .+||......+. .+.... .. ......++.+.++|.+||+.||++||
T Consensus 197 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 197 G-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 7 778865432211 111000 00 00112356789999999999999999
Q ss_pred CHHHHHcCCCC
Q 004097 627 KAQNVLNHPFF 637 (774)
Q Consensus 627 s~~elL~HPff 637 (774)
++.|++.||||
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.64 Aligned_cols=264 Identities=21% Similarity=0.317 Sum_probs=193.6
Q ss_pred cceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.++|.+.+.||+|+||.||++... .+..||||.+...... ...+|+ ..+..++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA-SVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEcCCCC
Confidence 456788899999999999997432 3568999988644321 223343 46788899999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||| +.+|+|.+++......... . -.....++..+..++.|++.||+|
T Consensus 84 ~~lv~e~----------~~~g~L~~~l~~~~~~~~~---~----------------~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 84 TLVVMEL----------MAHGDLKSYLRSLRPEAEN---N----------------PGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred cEEEEeC----------CCCCCHHHHHHHhcccccc---C----------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 9999994 4555555555432110000 0 001223456778999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+||+++.++. ++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 135 lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 135 LNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHhCCCcCCCCChheEEEcCCCc--EEECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 99999999999999999987765 89999999986543221 1112223457789999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-H-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc------CCCCCCc
Q 004097 574 FFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN------HPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~------HPff~~~ 640 (774)
|||++++.+||........ . +........+....+++.+++.+||+.||.+|||+.++++ ||||...
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 9999977888865443322 2 2222222223344678999999999999999999999985 9999654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.38 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=186.4
Q ss_pred ccceEEEeEeecccCceEEEEEeeeC--CcEEEEE------------------EeecCC--chHHHHHHHHHHHhCCCCC
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVK------------------RLVKTH--HDVALKEIQNLIASDQHPN 400 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~--g~~VAVK------------------~l~~~~--~~~~~~Ei~~ll~~l~HpN 400 (774)
+...|.+.+.||+|+||+||++.... +..+++| .+.... .....+|+. ++..++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~-il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL-ALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHH-HHHhCCCCC
Confidence 44678999999999999999874322 2222222 111111 112345554 778899999
Q ss_pred eeEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHH
Q 004097 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480 (774)
Q Consensus 401 IV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 480 (774)
||++++++.+.+..|+|+|++.++|.++++.. .+. |. .......+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~--------------------------------~~-~~~~~~~~ 269 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDE--AFD--------------------------------WK-DRPLLKQT 269 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhc--ccc--------------------------------cc-ccccHHHH
Confidence 99999999999999999998887777665321 110 11 11223456
Q ss_pred HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC
Q 004097 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 560 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 560 (774)
+.|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+..... .......||..|+|||++.+..+
T Consensus 270 ~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCC
Confidence 789999999999999999999999999999988765 89999999987653321 11233569999999999999999
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchH----HHHHHHhhcc---c-----------------------c-----cccc
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFE----RDANIVKDRK---D-----------------------L-----FLVE 605 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~----~~~~~~~~~~---~-----------------------~-----~~~~ 605 (774)
+.++|||||||++|||++|+.+|+..... ....++.... . . ....
T Consensus 346 ~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 425 (501)
T PHA03210 346 CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG 425 (501)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC
Confidence 99999999999999999987777754321 1111111000 0 0 0011
Q ss_pred CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 606 HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 606 ~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
...++.++|.+||+.||.+|||+.|+|.||||....
T Consensus 426 ~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 426 LPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred CChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 234678889999999999999999999999996643
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=307.39 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=186.3
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||.||++.. .+++.||+|++..... ....+|+ .++..++||||+++++++.+++..|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~-~~l~~~~h~~ii~~~~~~~~~~~~~iv~e- 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI-FMVKECKHCNIVAYFGSYLSREKLWICME- 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHH-HHHHhcCCCCeeeeeEEEEeCCEEEEEEe-
Confidence 4577789999999999999864 5789999999864322 2233455 46788999999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+.+++|.++++. ...+++..+..++.|++.||+|||+.+|+
T Consensus 87 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 87 ---------YCGGGSLQDIYHV-----------------------------TGPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred ---------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4555555554432 12356778889999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~ell 577 (774)
||||||+||+++.++. ++|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||+
T Consensus 129 H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 129 HRDIKGANILLTDNGD--VKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ccCCCHHHEEECCCCC--EEECcCccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999987765 8999999998764321 1122345889999999985 345788999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 578 TGGKHPYGESFERDA--NIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
+| .+||........ .+...... ......+.++.++|.+||+.||++||+++++++|+|
T Consensus 204 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 204 EL-QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hC-CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 97 556643322111 11111100 011233578999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=344.47 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=202.5
Q ss_pred ceEEEeEeecccCceEEEEEeeeC--Cc----EEEEEEeecCCchH----HHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE--GR----SVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~--g~----~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
....+...||+|.||.||.|...+ |. .||||.+.+....+ +.+|. .+++..+|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea-~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEA-LLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCcceeeEEEeecCCCCc
Confidence 346778899999999999985543 43 49999997654332 33443 588999999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|++| ||.+|+|..+|...+... .....+...+++.++.|||+|+.||
T Consensus 771 ~i~le----------yM~gGDL~sflr~~r~~~----------------------~~~~~L~~~dLl~~a~dvA~G~~YL 818 (1025)
T KOG1095|consen 771 LILLE----------YMEGGDLLSFLRESRPAP----------------------FQPSNLSMRDLLAFALDVAKGMNYL 818 (1025)
T ss_pred EEEeh----------hcccCcHHHHHHhccccc----------------------CCCCCCCHHHHHHHHHHHhhhhHHH
Confidence 99999 999999999987654321 2245578889999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+++++|||||..+|+||+.. ..+||+|||||+.+.... .+.......-...|||||.+..+.++.++|||||||++|
T Consensus 819 e~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllW 895 (1025)
T KOG1095|consen 819 ESKHFVHRDLAARNCLLDER--RVVKIADFGLARDIYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLW 895 (1025)
T ss_pred HhCCCcCcchhhhheeeccc--CcEEEcccchhHhhhhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHH
Confidence 99999999999999999776 459999999999655332 222222223456899999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++|.|..||.+....+. .......-..+..+...+.++|.+||+.+|+.||+...+++
T Consensus 896 EifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 896 EIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999988655443 23444444444555567889999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.79 Aligned_cols=259 Identities=19% Similarity=0.276 Sum_probs=191.3
Q ss_pred ccceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.|.+.+.||+|+||+||++.. .++..||||++..... ....+|+. ++..++||||+++++++.+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEcCCC
Confidence 356688889999999999998743 2357899999864322 12344554 677889999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..++||||+ ++|+|.+++......... ......+++..++.++.|++.||+
T Consensus 83 ~~~lv~e~~----------~~~~L~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 83 PTLVIMELM----------TRGDLKSYLRSLRPEMEN-------------------NPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred CeEEEEecC----------CCCCHHHHHHHcCccccc-------------------cccccCCCHHHHHHHHHHHHHHHH
Confidence 999999954 455555554332110000 011123466778999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+++||||||+||+++.++. ++|+|||+++........ .......+++.|+|||++.+..++.++|||||||+
T Consensus 134 ~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 999999999999999999987765 899999998765432211 11122346788999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 573 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|||++++.+||........ . +........+....+.+.+++.+||+.||++|||+.|++++
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999976888866443322 1 22222222334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.04 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=194.0
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|...+.||+|++|+||++... +++.||||.+...... ....|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHH-HHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4677889999999999998654 5899999999754322 223344 4778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|. +++|.+++... ....+++..+..++.|++.||+|||+.+
T Consensus 81 e~~~----------~~~L~~~~~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 81 DYCP----------GGELFRLLQRQ---------------------------PGKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred EecC----------CCCHHHHHHhC---------------------------CCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9554 44444443211 1123667778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccc--------------------------cccccCcCCCCCCch
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--------------------------TQNATGYGSSGWQAP 552 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~--------------------------~~~~~~~gt~~y~aP 552 (774)
++|+||||+||+++.++. ++|+|||++.......... .......||..|+||
T Consensus 124 i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 124 IVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred eeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 999999999999988765 8999999987653221100 011234688999999
Q ss_pred hhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH-HHHhhcccccccc--CCHHHHHHHHHhcCCCCCCCcC--
Q 004097 553 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA-NIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPK-- 627 (774)
Q Consensus 553 E~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~~dli~~~L~~dP~~Rps-- 627 (774)
|++.+..++.++|||||||++|+|++| ..||........ ..+.......+.. .++++.++|.+||+.||++||+
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYG-TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhC-CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch
Confidence 999988899999999999999999997 778765433221 1111111112222 4678999999999999999999
Q ss_pred --HHHHHcCCCCCCccc
Q 004097 628 --AQNVLNHPFFWTADT 642 (774)
Q Consensus 628 --~~elL~HPff~~~~~ 642 (774)
++|++.||||.+..+
T Consensus 281 ~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 281 RGAAEIKQHPFFRGVNW 297 (316)
T ss_pred hhHHHHHcCchhhcCCh
Confidence 999999999977543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.58 Aligned_cols=244 Identities=32% Similarity=0.456 Sum_probs=189.7
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|...+.||+|++|+||++... +++.||+|.+..... ....+|+ .++..++||||+++++++.+++..|++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEI-ALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHH-HHHHhcCCCCchheeeeEecCCeEEEE
Confidence 345678999999999998665 789999999864321 2233455 477888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+||+ ++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 81 ~e~~----------~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 81 LELV----------PGGSLAKLLKK-----------------------------YGSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred EEec----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9954 44555544321 12356677789999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~el 576 (774)
+|+|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|
T Consensus 122 ~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 122 NTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred CcccCCCCHHHEEECCCCC--EEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999987765 8999999987764322 123445889999999998766 89999999999999999
Q ss_pred HhCCCCCCCCchHHHHH--HHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 577 ITGGKHPYGESFERDAN--IVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~--~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++| .+||......... +.. ......+....+++.+++.+||+.+|.+||++.+++.|||+
T Consensus 196 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 196 ATG-KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhC-CCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 997 7788765432221 111 11122233456789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.94 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=183.8
Q ss_pred EEeEeecccCceEEEEEeee-----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 348 VFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~-----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.+.||.|+||.||+|... .+..||||.+..... +...+|+. .+..++||||++++|+|.+.+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQ-ILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHH-HHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccc-ccccccccccccccccccccccccccc
Confidence 45688999999999998766 367899999965432 23445554 666779999999999999888899999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |+++|+|.++|.... ...+++..+..|+.||+.||+|||+.+
T Consensus 81 e----------~~~~g~L~~~L~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~ 123 (259)
T PF07714_consen 81 E----------YCPGGSLDDYLKSKN---------------------------KEPLSEQQRLSIAIQIAEALSYLHSNN 123 (259)
T ss_dssp E------------TTEBHHHHHHHTC---------------------------TTTSBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c----------ccccccccccccccc---------------------------ccccccccccccccccccccccccccc
Confidence 9 555566666554431 123567788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
++|+||+++||+++.++ .+||+|||++........ ........+...|+|||.+....++.++||||||+++||+++
T Consensus 124 iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 124 IIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccc--cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998775 599999999987732211 122233446778999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 579 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++..||.+..... ..+........+...+..+.++|.+||..||++||+++++++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 7678887654333 233333333334456778999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.05 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=189.6
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCC-----cee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 414 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~~ 414 (774)
....|.+.+.||+|+||.||++.. .+++.+|+|++..... ....+|+..+....+||||+++++++... +..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 356688899999999999999855 4688999999865432 23345655444444899999999998653 468
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||| |+.+|+|.++++... .....+++..++.++.|++.||+||
T Consensus 100 ~lv~e----------y~~~~sL~~~~~~~~-------------------------~~~~~~~~~~~~~~~~qi~~al~~l 144 (291)
T cd06639 100 WLVLE----------LCNGGSVTELVKGLL-------------------------ICGQRLDEAMISYILYGALLGLQHL 144 (291)
T ss_pred EEEEE----------ECCCCcHHHHHHHhh-------------------------hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 555555555443211 1123467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-----CCCcchhHhH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----QTRAIDLFSL 569 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~sDvwSl 569 (774)
|+.+|+||||||+||+++.++. +||+|||++........ ......|+..|+|||++.... ++.++|||||
T Consensus 145 H~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 145 HNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 9999999999999999988765 89999999887653211 112345889999999986432 6889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
||++|||++| ++||........ .+...... ..+.....++.++|.+||+.+|++||++.|+++||||.
T Consensus 220 Gvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 220 GITAIELGDG-DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhC-CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999997 778765432211 11111111 11223456899999999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=308.06 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=194.1
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+|.+.+.||.|++|.||++... +++.||+|++..... ....+|+. +++.++||||+++++++.++...|+|+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ-FLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHH-HHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3556678999999999998644 689999999865432 22344554 67888999999999999999999999994
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
..+++|.+++.. ..+++..+..++.|++.||.|||+.+++
T Consensus 81 ----------~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~ 120 (274)
T cd06609 81 ----------CGGGSCLDLLKP------------------------------GKLDETYIAFILREVLLGLEYLHEEGKI 120 (274)
T ss_pred ----------eCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 445555554321 1356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. ++|+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|++|
T Consensus 121 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg- 194 (274)
T cd06609 121 HRDIKAANILLSEEGD--VKLADFGVSGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG- 194 (274)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 8999999998776432 122334588899999999988899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhcccccccc-CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~-~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||........ .+........... .++++.+++.+||..||++|||++++++||||....
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 195 EPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 778865433221 1112222222222 467899999999999999999999999999997644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.73 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=189.2
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC-----c
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~ 412 (774)
+++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-ILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHH-HHHhCCCCCcCchhheeecccccccc
Confidence 45678899999999999999984 45789999999864321 22344554 77888999999999986554 3
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+++|++.++|.+++ ....+++..+..++.|++.||+
T Consensus 82 ~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~i~~ql~~aL~ 120 (336)
T cd07849 82 DVYIVQELMETDLYKLI-----------------------------------------KTQHLSNDHIQYFLYQILRGLK 120 (336)
T ss_pred eEEEEehhcccCHHHHH-----------------------------------------hcCCCCHHHHHHHHHHHHHHHH
Confidence 58999997765544332 1234677788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
|||+.+|+||||||+||+++.++. +||+|||+++................||+.|+|||.+.+ ..++.++|||||||
T Consensus 121 ~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 121 YIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred HHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 999999999999999999987765 899999999876533221122233468999999998765 46889999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HH----------------HHhh--------c---cc----cccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYGESFERD-AN----------------IVKD--------R---KD----LFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~~----------------~~~~--------~---~~----~~~~~~~~~~~dli~~~L~ 619 (774)
++|+|++| ++||....... .. +... . .. ......++++.++|.+||+
T Consensus 199 il~el~~G-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (336)
T cd07849 199 ILAEMLSN-RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT 277 (336)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC
Confidence 99999997 77875432110 00 0000 0 00 0012345688999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~ 640 (774)
.||++|||+.|+++||||+..
T Consensus 278 ~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 278 FNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CChhhCcCHHHHhcCcccccc
Confidence 999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.11 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=185.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc------
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD------ 412 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------ 412 (774)
+.|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+. +++.++||||+++++++.+.+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHH-HHHhCCCCCccceEEEEecccccccCC
Confidence 4578889999999999999854 4689999998854321 22345664 778889999999999886653
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..|+|||||.++|.+++... ...+++.+++.++.||+.|
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~a 131 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNK---------------------------------------NVKFTLSEIKKVMKMLLNG 131 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhc---------------------------------------ccCCCHHHHHHHHHHHHHH
Confidence 45999998877665554210 1235777889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCC-CCCcchhHh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR-QTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwS 568 (774)
|+|||+.+++|+||||+||+++.++. +||+|||++.......... .......++..|+|||.+.+.. ++.++||||
T Consensus 132 l~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 209 (310)
T cd07865 132 LYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209 (310)
T ss_pred HHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHH
Confidence 99999999999999999999987765 8999999998764322111 1112345788999999987643 688999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHH-HHHhhccc--------------------------------cccccCCHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERDA-NIVKDRKD--------------------------------LFLVEHIPEAVDLFT 615 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~-~~~~~~~~--------------------------------~~~~~~~~~~~dli~ 615 (774)
|||++|||++| .+||........ ..+..... .......+.+.++|.
T Consensus 210 lG~~l~el~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~ 288 (310)
T cd07865 210 AGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID 288 (310)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence 99999999996 677754432211 10000000 000012356789999
Q ss_pred HhcCCCCCCCcCHHHHHcCCCC
Q 004097 616 RLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 616 ~~L~~dP~~Rps~~elL~HPff 637 (774)
+||..||.+|||++|+++||||
T Consensus 289 ~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 289 KLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhcCChhhccCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.65 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=189.0
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||+||++...++..||||.+..... +...+|+. ++..++||||+++++++.+.+..|++||||.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHH-HHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 34778899999999999998766667799998875432 33455554 6788899999999999999999999999554
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+|+|.+++... ...+++..++.++.||+.||+|||+.+++|+
T Consensus 83 ----------~~~l~~~i~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05113 83 ----------NGCLLNYLREH----------------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124 (256)
T ss_pred ----------CCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 44444443221 1135677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++.+..
T Consensus 125 dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 125 DLAARNCLVDDQGC--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ccCcceEEEcCCCC--EEECCCccceecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999987764 89999999886643211 111122356789999999988899999999999999999995588
Q ss_pred CCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 583 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 583 Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||....... ..+........+...++.+.+++.+||+.||.+||++.+++.+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 886543322 2222222222233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.15 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=192.3
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||.|+||+||++.. .++..||+|++..... ....+|+. .+..++|+||+++++.+.+.+..|+|+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHH-HHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 477889999999999999864 4688999999864332 23344554 67788999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +++|.+.+.... ....+++..+..++.|++.||+|||+.+|+
T Consensus 81 ~~----------~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~ 124 (267)
T cd06610 81 LS----------GGSLLDIMKSSY--------------------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124 (267)
T ss_pred cC----------CCcHHHHHHHhc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 54 444444433211 112367778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
||||+|+||++++++. ++|+|||++..+....... .......|+..|+|||++... .++.++|+|||||++|+|++
T Consensus 125 h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred cCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999987765 8999999998776432221 112334689999999999877 78999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhcccccc-----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 579 GGKHPYGESFERD--ANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
| ..||....... ............ ...++++.+++.+||+.||++||++.++++||||
T Consensus 203 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 203 G-AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred C-CCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7 77886543221 112221111111 1345788999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=310.64 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=188.0
Q ss_pred EeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 349 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..+.||+|+||.||++.. .+|+.||||.+..... ....+|+..+.....||||+++++++.+.+..+++||++..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 346799999999999754 4689999999864322 23455665444444599999999999999999999998887
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Ccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHR 502 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHr 502 (774)
++.++... +.. .....+++..+..++.|++.||+|||+. +|+||
T Consensus 88 ~l~~l~~~--------~~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 132 (288)
T cd06616 88 SLDKFYKY--------VYE---------------------------VLKSVIPEEILGKIAVATVKALNYLKEELKIIHR 132 (288)
T ss_pred CHHHHHHH--------HHH---------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeecc
Confidence 66554311 000 1123467788899999999999999985 99999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC---CCCCcchhHhHHHHHHHHHhC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDvwSlGvll~elltg 579 (774)
||||+||+++.++. +||+|||+++.+..... .....|+..|+|||++... .++.++|||||||++|||++|
T Consensus 133 dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 206 (288)
T cd06616 133 DVKPSNILLDRNGN--IKLCDFGISGQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206 (288)
T ss_pred CCCHHHEEEccCCc--EEEeecchhHHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhC
Confidence 99999999987765 89999999986653211 1233588999999999876 688999999999999999996
Q ss_pred CCCCCCCchHHHH---HHHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESFERDA---NIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~~~---~~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||........ .......... ....++++.+||.+||+.||++|||+.++++||||+..
T Consensus 207 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 207 -KFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -CCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 778865432111 1111111111 12356789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.33 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=184.4
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.|.+.+.||+|+||.||++.. .+++.||+|.++..... ...+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~-~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 355567899999999999854 46899999998654322 233444 4778889999999999999999999999965
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +++|.+++.. ...+++.+++.++.|++.||+|||+.+++|
T Consensus 89 ~----------~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 129 (267)
T cd06645 89 G----------GGSLQDIYHV-----------------------------TGPLSESQIAYVSRETLQGLYYLHSKGKMH 129 (267)
T ss_pred C----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5 4444443321 123667788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHHHh
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~ellt 578 (774)
+||||+||+++.++. ++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++
T Consensus 130 ~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 130 RDIKGANILLTDNGH--VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred CCCCHHHEEECCCCC--EEECcceeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 999999999987765 8999999987654321 1123346899999999985 4457899999999999999999
Q ss_pred CCCCCCCCchHHH-HH-HHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 579 GGKHPYGESFERD-AN-IVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~~-~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
| .+||....... .. ........ .....+..+.++|.+||+.+|++||+++++++|||
T Consensus 205 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 205 L-QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred C-CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7 55664332211 11 11111100 11134567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.00 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=195.4
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|...+.||.|+||.||++.. .++..||||.+...... ...+|+ .++..++||||+++++++.+++..|+|||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKGTKLWIIME-- 82 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEECCEEEEEEe--
Confidence 44557799999999999864 46889999998754322 223344 46778899999999999999999999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|..+|+|.+++.. ..+++.++..++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~i~~------------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH 124 (277)
T cd06640 83 --------YLGGGSALDLLRA------------------------------GPFDEFQIATMLKEILKGLDYLHSEKKIH 124 (277)
T ss_pred --------cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 5555555554321 22455677889999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++| .
T Consensus 125 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg-~ 198 (277)
T cd06640 125 RDIKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred cCCChhhEEEcCCCC--EEEcccccceeccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC-C
Confidence 999999999987765 89999999977653221 12233578899999999888899999999999999999997 7
Q ss_pred CCCCCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhhhhc
Q 004097 582 HPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 650 (774)
Q Consensus 582 ~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l~~~ 650 (774)
+||........ ..+ ..............+.++|.+||+.+|++||++.++++||||.....+...+..+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06640 199 PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTEL 269 (277)
T ss_pred CCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHH
Confidence 78765433221 111 1112222223456889999999999999999999999999997666555544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.99 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=186.9
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCCeeEEeeecc-----CCce
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVES-----DQDF 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~-----~~~~ 413 (774)
..+.|.+.+.||+|+||+||++.. .+++.||+|++..... .....|+. ++..+ +||||+++++++. +++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN-ILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHH-HHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 456688889999999999999744 5688999998865332 23345554 44555 7999999999873 4567
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||| +.+++|.++++.... ....+++..+..++.|++.||.|
T Consensus 95 ~~lv~e~----------~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~ 139 (286)
T cd06638 95 LWLVLEL----------CNGGSVTDLVKGFLK-------------------------RGERMEEPIIAYILHEALMGLQH 139 (286)
T ss_pred EEEEEee----------cCCCCHHHHHHHhhc-------------------------cCccccHHHHHHHHHHHHHHHHH
Confidence 9999994 455555554432110 11336677889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHh
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 568 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwS 568 (774)
||+.+|+||||||+||+++.++. ++|+|||+++...... .......|++.|+|||++.. ..++.++||||
T Consensus 140 lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 140 LHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 99999999999999999988776 8999999988764321 11233468999999999853 44788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-H-HHHhhccc-c-ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 569 LGCILFFCITGGKHPYGESFERD-A-NIVKDRKD-L-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~-~-~~~~~~~~-~-~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|||++|||++| ..||....... . ........ . .+.....++.++|.+||+.||++|||+.|+++||||
T Consensus 215 lGvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDG-DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcC-CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99999999997 66765443221 1 11111111 1 112234689999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.54 Aligned_cols=244 Identities=28% Similarity=0.431 Sum_probs=183.7
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV~E 419 (774)
|.+.+.||+|+||.||++.. .+++.||||++++... ...++|+..+.....||||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 34668899999999999854 4689999999865321 23356766555555699999999999987 89999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.++|.+.+. . ....+++..++.++.|++.||+|||+.++
T Consensus 81 ~~~~~l~~~l~-----------~----------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 81 LMDMNLYELIK-----------G----------------------------RKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred cCCccHHHHHH-----------h----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77655544431 1 01236778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+||||+|+||+++. + .+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|||++
T Consensus 122 ~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 122 FHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred eecccCHHHEEEcC-C--CeEEEecccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 99999999999987 4 489999999987653221 122457889999998754 457899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHh-----------h---c---ccc-----------ccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 579 GGKHPYGESFERDA--NIVK-----------D---R---KDL-----------FLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~-----------~---~---~~~-----------~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
| .+||......+. .+.. . . ... .....+.++.++|.+||+.||++||++
T Consensus 195 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 195 L-FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred C-CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 6 778864332110 0000 0 0 000 011335789999999999999999999
Q ss_pred HHHHcCCCC
Q 004097 629 QNVLNHPFF 637 (774)
Q Consensus 629 ~elL~HPff 637 (774)
+++++||||
T Consensus 274 ~~~l~~~~~ 282 (282)
T cd07831 274 KQALRHPYF 282 (282)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.72 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=190.0
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
|...+.||+|++|.||++. ..+++.||+|.+.... .....+|+. +++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR-LMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHH-HHHHcCCCceehhhceeccCCeEEE
Confidence 4456789999999999974 4678999999986432 122344554 6778999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+| |+.+++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 81 FVE----------WMAGGSVSHLLSK-----------------------------YGAFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred EEe----------ccCCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 4455555554422 1235677789999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+++|+||+|+||+++.++. .+||+|||++.......... .......|+..|+|||.+.+..++.++||||+||++|+
T Consensus 122 ~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 200 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200 (268)
T ss_pred CCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHH
Confidence 99999999999999976653 48999999988765431111 11123458899999999988889999999999999999
Q ss_pred HHhCCCCCCCCchHH--HHHHHh----hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 576 CITGGKHPYGESFER--DANIVK----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 576 lltg~~~Pf~~~~~~--~~~~~~----~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
+++| ..||...... ...+.. ......+....+++.+++.+||+.+|.+||++.++++||||.
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 201 MATA-KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhC-CCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9997 6777543211 111111 111222334567899999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.48 Aligned_cols=286 Identities=22% Similarity=0.343 Sum_probs=191.2
Q ss_pred cceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++... .+..||||++..... +...+|+. ++..+ .|||||+++++|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK-IMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCCeeeEEEEEccCC
Confidence 456788899999999999997542 235799999965432 23456665 55666 4999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcc----------hhhHHHH---------------------------
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDS----------NLLNEVR--------------------------- 454 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~----------~~l~~~~--------------------------- 454 (774)
..|||||||. ++|.+++......+........... .....+.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999776 4566655332211100000000000 0000000
Q ss_pred ------------Hhhcc---cccchhhHH-HH---hhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCC
Q 004097 455 ------------IRLLP---VMENTKDIE-LW---KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515 (774)
Q Consensus 455 ------------~~~~~---~~~~~~~~~-~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 515 (774)
....+ ...+..... .. ....+++..++.++.||+.||+|||+.+|+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 00000 000000000 01 124588899999999999999999999999999999999997765
Q ss_pred CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HH
Q 004097 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--AN 593 (774)
Q Consensus 516 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~ 593 (774)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++.+..||....... ..
T Consensus 275 --~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 275 --IVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred --EEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 4899999999876432211 122234577889999999988899999999999999999985577776533221 12
Q ss_pred HHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 594 IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 594 ~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.+... ....+...++++.+++.+||+.||++||++.++.+
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22222 22223345678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.22 Aligned_cols=245 Identities=30% Similarity=0.434 Sum_probs=184.1
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
..||+|+||.||++.. .++..||||.+...... ...+|+ .++..++||||+++++++.+++..|+|+|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e------- 85 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI-ALHSYLKHRNIVQYLGSDSENGFFKIFME------- 85 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHH-HHHHhcCCCCeeeeeeeeccCCEEEEEEe-------
Confidence 5799999999999864 46789999988654322 233454 47788999999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
|..+++|.+++.... .....++..+..++.||+.||+|||+.+|+||||||
T Consensus 86 ---~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p 136 (268)
T cd06624 86 ---QVPGGSLSALLRSKW--------------------------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG 136 (268)
T ss_pred ---cCCCCCHHHHHHHhc--------------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 445555555543211 000115567788999999999999999999999999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC--CCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
+||+++.+.. .++|+|||++........ ......|++.|+|||++.... ++.++|||||||++|+|++| .+||
T Consensus 137 ~nil~~~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g-~~p~ 211 (268)
T cd06624 137 DNVLVNTYSG-VVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG-KPPF 211 (268)
T ss_pred HHEEEcCCCC-eEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC-CCCC
Confidence 9999976432 489999999876543211 112234789999999986643 78999999999999999996 7787
Q ss_pred CCchHHHHHHH----hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 585 GESFERDANIV----KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 585 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
........... .......+....+++.+++.+||+.+|.+|||+.|++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 65332211111 111122334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.18 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=191.7
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+ .+++.++||||+++++.+.+++..++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNEC-QVLKLLSHPNIIEYYENFLEDKALMIVME- 79 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHH-HHHhhCCCCchhheeeeEecCCEEEEEEe-
Confidence 66778999999999999744 5788999999865421 1233444 47788899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++++|.+++.... ...+++..+++++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 123 (256)
T cd08220 80 ---------YAPGGTLAEYIQKRC---------------------------NSLLDEDTILHFFVQILLALHHVHTKLIL 123 (256)
T ss_pred ---------cCCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 555555555543211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. .+||+|||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 124 h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~- 197 (256)
T cd08220 124 HRDLKTQNILLDKHKM-VVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC-EEEEccCCCceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC-
Confidence 9999999999976554 58999999998765321 12234588999999999988889999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........ .+........+...++++.+++.+||+.||.+|||+.|+++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 667765432221 122222222333456789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.44 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=190.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~L 416 (774)
+.|.+.+.||+|+||.||++.. .+|+.||+|++..... ....+|+. ++..++|+||+++++++.+. +..|+
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT-LLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHH-HHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4578889999999999999865 4689999999864321 12345664 67788999999999998755 56899
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||.++|.+++.... ..+++.++..++.||+.||+|||+
T Consensus 86 v~e~~~~~l~~~l~~~~---------------------------------------~~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 86 VMEYCEQDLASLLDNMP---------------------------------------TPFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred EEecCCCCHHHHHHhcc---------------------------------------cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99988877766653211 235677889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~e 575 (774)
.+++||||||+||+++.++. +||+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++||
T Consensus 127 ~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 127 NFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 99999999999999987765 89999999987653211 1122345788999999875 457899999999999999
Q ss_pred HHhCCCCCCCCchHHHH--HHHhhcc-------------------cc--c--------cccCCHHHHHHHHHhcCCCCCC
Q 004097 576 CITGGKHPYGESFERDA--NIVKDRK-------------------DL--F--------LVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~--~~~~~~~-------------------~~--~--------~~~~~~~~~dli~~~L~~dP~~ 624 (774)
|++| .+||........ .+..... .. . ....++++.++|.+||+.||++
T Consensus 202 l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 202 LLAH-KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHhC-CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9997 778765433221 1111000 00 0 0113578899999999999999
Q ss_pred CcCHHHHHcCCCCCCc
Q 004097 625 RPKAQNVLNHPFFWTA 640 (774)
Q Consensus 625 Rps~~elL~HPff~~~ 640 (774)
|||+++++.||||...
T Consensus 281 R~t~~~il~h~~f~~~ 296 (309)
T cd07845 281 RATAEEALESSYFKEK 296 (309)
T ss_pred CcCHHHHhcChhhccC
Confidence 9999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.89 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=184.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccC------CceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD------QDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~~~~ 415 (774)
..|.+.+.||+|+||+||++.. .+++.||+|++..... .....|+..+....+||||+++++++.. .+..|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4566778999999999999855 4688999999865432 2334455544444489999999999853 46789
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
++||||. +|+|.+++... +...+++..++.++.||+.||+|||
T Consensus 96 iv~e~~~----------~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 96 LVMEFCG----------AGSVTDLVKNT---------------------------KGNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred EEEEeCC----------CCcHHHHHHHc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999655 44444333211 1123556677899999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLG 570 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlG 570 (774)
+.+|+||||+|+||+++.++. ++|+|||++....... .......|++.|+|||.+. ...++.++||||||
T Consensus 139 ~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG 213 (282)
T cd06636 139 AHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213 (282)
T ss_pred HCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence 999999999999999988775 8999999987654221 1223456899999999986 34578899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHHHhhc-c-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 571 CILFFCITGGKHPYGESFERD-ANIVKDR-K-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-~~~~~~~-~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|++|||++| .+||....... ....... . .......++++.++|.+||+.||.+||++.|+++||||
T Consensus 214 ~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 214 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhC-CCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999997 66775433222 1111111 1 11122356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.64 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=194.4
Q ss_pred EeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 349 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..+.||+|+||.||++.. .+++.||||.+...... ...+|+. +++.++||||+++++++.+++..|+|||
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 82 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYITRYYGSYLKGTKLWIIME---- 82 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHH-HHHcCCCCccHhhhcccccCCceEEEEE----
Confidence 346699999999999854 46889999998644322 2334544 6788899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+.+++|+|
T Consensus 83 ------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~d 126 (277)
T cd06642 83 ------YLGGGSALDLLKP------------------------------GPLEETYIATILREILKGLDYLHSERKIHRD 126 (277)
T ss_pred ------ccCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccC
Confidence 4455555544321 2355677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|+|+||+++.++. ++|+|||++..+..... ......|+..|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 127 l~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p 200 (277)
T cd06642 127 IKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EPP 200 (277)
T ss_pred CChheEEEeCCCC--EEEccccccccccCcch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC-CCC
Confidence 9999999987765 89999999876653211 11234578899999999988899999999999999999997 778
Q ss_pred CCCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhhhhc
Q 004097 584 YGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 650 (774)
Q Consensus 584 f~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l~~~ 650 (774)
|........ ..+ .............++.++|.+||+.+|++||++.++++||||.....+..++.+.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06642 201 NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTEL 269 (277)
T ss_pred CcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHHHHHHH
Confidence 764432221 111 1111112223456899999999999999999999999999997766666665443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.86 Aligned_cols=236 Identities=22% Similarity=0.377 Sum_probs=181.5
Q ss_pred ecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHHHH
Q 004097 353 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 431 (774)
Q Consensus 353 LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~ 431 (774)
||+|+||+||++.. .+++.+|+|.+..........++..+ ..+||||+++++++.+.+..|+||| |+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~--~~~h~~iv~~~~~~~~~~~~~iv~e----------~~ 91 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL--MKDNPNFIKLYYSVTTLKGHVLIMD----------YI 91 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHH--hhcCCCEEEEEEEEecCCeeEEEEE----------cC
Confidence 69999999999754 56889999998754322211122212 2379999999999999999999999 55
Q ss_pred hcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeee
Q 004097 432 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511 (774)
Q Consensus 432 ~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 511 (774)
++|+|.+++... ..+++.+++.++.|+++||+|||+.+++||||||+||++
T Consensus 92 ~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 92 KDGDLFDLLKKE-----------------------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred CCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 555655544321 246778889999999999999999999999999999999
Q ss_pred cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH
Q 004097 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 591 (774)
Q Consensus 512 ~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~ 591 (774)
+.++. .++|+|||+++..... ....|+..|+|||++.+..++.++|||||||++|||++| ..||.......
T Consensus 143 ~~~~~-~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~ 213 (267)
T PHA03390 143 DRAKD-RIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG-KHPFKEDEDEE 213 (267)
T ss_pred eCCCC-eEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCcch
Confidence 87762 4899999998765422 223588999999999988899999999999999999997 77886443221
Q ss_pred H---HH--HhhccccccccCCHHHHHHHHHhcCCCCCCCcC-HHHHHcCCCCC
Q 004097 592 A---NI--VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-AQNVLNHPFFW 638 (774)
Q Consensus 592 ~---~~--~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-~~elL~HPff~ 638 (774)
. .. ............++.+.++|.+||+.||.+||+ ++++++||||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 1 11 111111223346789999999999999999996 69999999995
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.56 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=190.0
Q ss_pred eEEEeEeecccCceEEEEEeeeC------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.|.+.+.||+|+||.||++.... ...||+|.+...... ...+|+. ++..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHH-HHHhcCCcccceEEEEEcCCCceE
Confidence 46677899999999999985433 257999998654332 2334554 678889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
++|||+. +|+|.+++........... . .........+++..++.++.|++.||+|||
T Consensus 85 ~~~e~~~----------~~~L~~~l~~~~~~~~~~~----------~---~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 85 MLFEYLA----------HGDLHEFLVRNSPHSDVGA----------E---SGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEEecCC----------CCcHHHHHHhcCCCccccc----------c---cccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999554 4445444433211000000 0 000011245778889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+++||||||+||+++.++. ++|+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCCeeccccccceEEEcCCCc--EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999999999999999987765 89999999986543211 112233457889999999998899999999999999999
Q ss_pred HHhCCCCCCCCch-HHHHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESF-ERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~-~~~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++.+..||.... ......+.. .....+...++++.+|+.+||+.||.+||+++|++++
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9983366765433 333333322 2223344567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.40 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=191.3
Q ss_pred cceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
++.|.+.+.||+|++|.||++... .+..||+|.+..... ....+|+. ++..++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-IMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCC
Confidence 345778899999999999998654 357899998864332 22344544 6788899999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+||||+ .+|+|.+++....... -....+++..+++++.||+.||+|
T Consensus 84 ~~lv~e~~----------~g~~L~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 84 RFILLELM----------AGGDLKSFLRENRPRP----------------------ERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred cEEEEecC----------CCCCHHHHHHHhCCCC----------------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 99999954 4555555443321100 011246778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
||+.+++||||||+||+++.++ ...+||+|||+++.+..... .........+..|+|||++.+..++.++|||||||+
T Consensus 132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 9999999999999999997654 23589999999987643211 111122234568999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 573 LFFCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|||++++..||....... ...+. ......+...++++.+++.+||+.+|++||++.++++|
T Consensus 211 l~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999986688987543222 22222 22223344566789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.88 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=187.8
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC-----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 411 (774)
+.+.|...+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHH-HHHhcCCCCCcceeeeeccCCCccc
Confidence 456788889999999999999854 578999999986432 123445664 67889999999999987644
Q ss_pred -ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 -~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
...|+|||+|.++|.+++.. .++...+..++.|++.|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~------------------------------------------~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM------------------------------------------DLDHERMSYLLYQMLCG 130 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh------------------------------------------cCCHHHHHHHHHHHHHH
Confidence 35799999887766655421 14556678899999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+||+++.++. +||+|||+++...... ......++..|+|||++.+..++.++||||||
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 99999999999999999999988765 8999999998764321 12334588999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH--HHHH----------------------hhccc-------------cc-------cccC
Q 004097 571 CILFFCITGGKHPYGESFERD--ANIV----------------------KDRKD-------------LF-------LVEH 606 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~--~~~~----------------------~~~~~-------------~~-------~~~~ 606 (774)
|++|+|++| +.||....... ..++ ..... .+ ....
T Consensus 205 ~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T cd07850 205 CIMGEMIRG-TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK 283 (353)
T ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccc
Confidence 999999997 66775432110 0000 00000 00 0012
Q ss_pred CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 607 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 607 ~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
.+++.++|.+||+.||.+|||+.|+|+||||..
T Consensus 284 ~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 284 ASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 346889999999999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.77 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=188.1
Q ss_pred EEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 348 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.+.+.||+|+||+||++... ++..+|+|.+...... ...+|+. ++..++||||+++++++.+.+..|+|+||+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~-- 84 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIEFC-- 84 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHH-HHHHCCCCCeeeEEEEEeeCCEEEEEEEec--
Confidence 34577999999999998554 5788999998654322 2344554 677889999999999999999999999954
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
.+|++...++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 85 --------~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~d 128 (282)
T cd06643 85 --------AGGAVDAVMLEL----------------------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128 (282)
T ss_pred --------CCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 455554443221 13467778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHHHHHh
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~ellt 578 (774)
|||+||+++.++. +||+|||++....... .......++..|+|||++. ...++.++|||||||++|||++
T Consensus 129 lkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 129 LKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred CCcccEEEccCCC--EEEccccccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 9999999987765 8999999987654321 1123346899999999984 3457789999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 579 GGKHPYGESFERD--ANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
| .+||....... ..+...... ..+...+.++.++|.+||+.||.+||++.++++||||...
T Consensus 204 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 204 I-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred C-CCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 7 67776533222 122221111 1223345789999999999999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.92 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=186.1
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|...+.||+|++|+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHH-HHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 55678899999999999854 4689999998864321 23445654 77888999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+.++|.+++. .. ....+++..+..++.|++.||+|||+.+++
T Consensus 81 ~~~~l~~~~~-----------~~---------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 81 LHQDLKKFMD-----------AS---------------------------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred cccCHHHHHH-----------hC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 6555544432 11 112356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~elltg 579 (774)
||||+|+||+++.++. +||+|||++....... .......++..|+|||++.+.. ++.++|||||||++|||+||
T Consensus 123 H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 123 HRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred cCCCCHHHEEECCCCC--EEEeeccchhhcccCc---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988765 8999999987654321 1122335788999999887644 58899999999999999997
Q ss_pred CCCCCCCchHHH--HHHHhhcc----------------------------ccccccCCHHHHHHHHHhcCCCCCCCcCHH
Q 004097 580 GKHPYGESFERD--ANIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629 (774)
Q Consensus 580 ~~~Pf~~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~ 629 (774)
..||....+.. ..+..... ........+++.++|.+||+.||.+|||++
T Consensus 198 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 198 -RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence 66775432211 11111000 000112456889999999999999999999
Q ss_pred HHHcCCCC
Q 004097 630 NVLNHPFF 637 (774)
Q Consensus 630 elL~HPff 637 (774)
++++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07860 277 AALAHPFF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.40 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=189.4
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+.|.+.+.||+|+||.||++.. .+++.||+|.+...... ...+|+. +++.++||||+++++++..++..|+|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 35577788999999999999855 45899999998654432 2234443 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+ .++++...+... ...+++..+..++.|++.||+|||+.++
T Consensus 90 ~~----------~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 90 FC----------PGGAVDAIMLEL----------------------------DRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred cC----------CCCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 55 444444433211 1236677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~ 574 (774)
+||||||+||+++.++. ++|+|||++....... .......+++.|+|||++. ...++.++|||||||++|
T Consensus 132 ~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 132 IHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred eecCCCcceEEEcCCCC--EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 99999999999987765 8999999987643221 1122345788999999985 345688999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H-HHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 575 FCITGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||++| .+||....... . .+...... ..+...+.++.++|.+||+.||++||++.++++||||..
T Consensus 207 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 207 EMAQI-EPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHhcC-CCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99997 66775433221 1 11111111 112334578999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.12 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=189.3
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
..|.+.+.||+|+||.||++... .++.||+|++..... ....+|+. ++..++||||+++++++.+.+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE-- 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHH-HHHhCCCCChhheEEEEcCCCCcEEEEE--
Confidence 34778899999999999998544 588999999875432 23445655 6677899999999999999999999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 127 (263)
T cd05052 83 --------FMTYGNLLDYLRECN---------------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127 (263)
T ss_pred --------eCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 555556655543211 123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+||+++.++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++++.
T Consensus 128 ~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~ 203 (263)
T cd05052 128 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203 (263)
T ss_pred cccCcceEEEcCCCc--EEeCCCcccccccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence 999999999987765 89999999987653211 11112234678999999998899999999999999999999557
Q ss_pred CCCCCchHH-HHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.||...... ....+.. .....+...++++.++|.+||+.||++||++.++++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 787653322 2222222 122334445689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.85 Aligned_cols=246 Identities=27% Similarity=0.461 Sum_probs=187.4
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||.||++.. .+|+.||||++..... ....+|+. +++.++||||+++++++.+.+..|+|+|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK-ALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHH-HHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 66788999999999999865 4689999999875431 23445554 67788999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+.++|.+++ ... ...+++.+++.++.||+.||+|||+.+++
T Consensus 81 ~~~~L~~~~-----------~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (286)
T cd07832 81 MPSDLSEVL-----------RDE----------------------------ERPLPEAQVKSYMRMLLKGVAYMHANGIM 121 (286)
T ss_pred cCCCHHHHH-----------Hhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 544444433 211 13367778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg 579 (774)
|+||||+||+++.++. ++|+|||++........ .......|+..|+|||++... .++.++||||+||++|||++|
T Consensus 122 H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 122 HRDLKPANLLISADGV--LKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred cCCcCHHHEEEcCCCc--EEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 9999999999987765 89999999987654321 112334689999999998654 468999999999999999998
Q ss_pred CCCCCCCchHHHH--HHHhhc------------------c-----------ccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 580 GKHPYGESFERDA--NIVKDR------------------K-----------DLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~~------------------~-----------~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
.+||........ .+.... . .........++.++|.+||+.||++||++
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 198 -SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred -CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 777754332110 111000 0 00011234788999999999999999999
Q ss_pred HHHHcCCCC
Q 004097 629 QNVLNHPFF 637 (774)
Q Consensus 629 ~elL~HPff 637 (774)
+++++||||
T Consensus 277 ~~~l~h~~~ 285 (286)
T cd07832 277 AEALRHPYF 285 (286)
T ss_pred HHHhhCcCc
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.31 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=186.9
Q ss_pred eecccCceEEEEEee-eCCcEEEEEEeecCCch------HHHHHH--HHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 352 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD------VALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.||+|+||+||++.. .+++.||+|.+.+.... ....|. ..++....||||+++++++.+.+..|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD--- 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe---
Confidence 389999999999854 46899999998653211 112222 234455689999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+|+|..++.. ...+++..++.|+.|++.||+|||+.+|+||
T Consensus 78 -------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 121 (278)
T cd05606 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121 (278)
T ss_pred -------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 4555555544321 2346788899999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~~ 581 (774)
||||+||+++.++. ++|+|||++...... ......|+..|+|||++..+ .++.++||||+||++|||++| .
T Consensus 122 di~p~nili~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g-~ 193 (278)
T cd05606 122 DLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-H 193 (278)
T ss_pred CCCHHHEEECCCCC--EEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC-C
Confidence 99999999987765 899999998765432 12234689999999999754 589999999999999999997 7
Q ss_pred CCCCCchHH---H-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccchh
Q 004097 582 HPYGESFER---D-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTRL 644 (774)
Q Consensus 582 ~Pf~~~~~~---~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~~ 644 (774)
.||...... . ...........+...++++.+++.+||..+|.+|| ++.++++||||....+..
T Consensus 194 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 194 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred CCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 788654211 1 11111112223334568999999999999999999 999999999997765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.72 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=184.9
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--cee
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~ 414 (774)
.|.+.+.||+|+||.||.+.. .+|+.||||.+.... . ....+|+. ++..++||||+++++++.+. ..+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-LLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHH-HHHhcCCCCeeeEEeEeccCCCceE
Confidence 466789999999999999854 468999999885321 1 12234554 67888999999999988763 568
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|++|||+ ++++|.+++... ..+++..+++++.|++.||+||
T Consensus 82 ~~v~e~~----------~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~l 122 (265)
T cd06652 82 SIFMEHM----------PGGSIKDQLKSY-----------------------------GALTENVTRKYTRQILEGVSYL 122 (265)
T ss_pred EEEEEec----------CCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 8999954 455555443211 2245667789999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++|
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 200 (265)
T cd06652 123 HSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200 (265)
T ss_pred HhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHH
Confidence 9999999999999999987765 89999999886543211111223345889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 575 FCITGGKHPYGESFERDA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
||++| .+||........ ..... .....+......+.++|.+|+. +|++||+++++++|||+
T Consensus 201 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 201 EMLTE-KPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHhhC-CCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 99997 678765322211 11111 1122233445678999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.89 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=190.1
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..|.+.+.||+|+||+||++.. .++..||||.+..... ....+|+. ++..++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccE
Confidence 4577889999999999999854 2346799999865432 22345554 778889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+||||+ .+++|.+++...........+ .-....+++..++.++.|++.||+|||
T Consensus 84 lv~e~~----------~~~~L~~~i~~~~~~~~~~~~----------------~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 84 MVFEYM----------KHGDLNKFLRAHGPDAVLMAE----------------GNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred EEEEcC----------CCCCHHHHHHHcCCccccccc----------------cCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999954 445555444322111000000 011234788899999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+++||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||++|+
T Consensus 138 ~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred hCCeeecccCcceEEEccCCc--EEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999986643211 111223346788999999998889999999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 576 CITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
|++++.+||....... ..+........+...++++.+++.+||+.||.+|||+.+++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9996688886644332 12222222222334567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.07 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=189.8
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|...+.||+|+||+||++... +|+.||+|.+..... ....+|+. ++..++||||++++++|.+.+..|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 345777789999999999998654 689999999864321 12345554 6788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+|||.++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 93 v~e~~~g~l~~~~~~~---------------------------------------~~~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 93 VMEYCLGSASDILEVH---------------------------------------KKPLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred EHHhhCCCHHHHHHHc---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9997776655444211 1235667789999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll 573 (774)
.+|+||||+|+||+++.++. ++|+|||++...... ....++..|+|||++. ...++.++||||||+++
T Consensus 134 ~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 134 HERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred CCceecCCCcccEEECCCCC--EEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 99999999999999988765 899999998765422 2345788999999874 35688999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HH-HHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD-AN-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~-~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|||++| .+||....... .. +.... ........+.++.++|.+||+.||++||++.+++.||||..
T Consensus 205 ~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 205 IELAER-KPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999997 66765433222 11 11111 11122234568999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.49 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=185.9
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCce-----e
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-----V 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~-----~ 414 (774)
.|...+.||+|+||+||++.. .+|+.||||++.... .....+|+..+....+||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 366778999999999999864 468999999875432 13455677644433467999999999887665 8
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||.++|.+++....+ .....+++..++.++.||+.||+||
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~qi~~~L~~L 126 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGR-----------------------------------GPGRPLPAKTIKSFMYQLLKGVAHC 126 (295)
T ss_pred EEEeeccCcCHHHHHHHhcc-----------------------------------cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999877776665521110 0113467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+||+++.+. ..+||+|||+++....... ......+++.|+|||++.+ ..++.++|||||||++
T Consensus 127 H~~~i~H~dl~~~nil~~~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 202 (295)
T cd07837 127 HKHGVMHRDLKPQNLLVDKQK-GLLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIF 202 (295)
T ss_pred HHCCeeecCCChHHEEEecCC-CeEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHH
Confidence 999999999999999998722 2489999999886543211 1122346889999999865 4578999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhc-----------------------c----ccccccCCHHHHHHHHHhcCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDR-----------------------K----DLFLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~-----------------------~----~~~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
|+|++| .+||....... ..+.... . .......++++.++|.+||+.||.+
T Consensus 203 ~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 281 (295)
T cd07837 203 AEMSRK-QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK 281 (295)
T ss_pred HHHHcC-CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhh
Confidence 999997 66775432111 1111100 0 0001234678999999999999999
Q ss_pred CcCHHHHHcCCCCC
Q 004097 625 RPKAQNVLNHPFFW 638 (774)
Q Consensus 625 Rps~~elL~HPff~ 638 (774)
||++.|++.||||.
T Consensus 282 R~~~~eil~~~~~~ 295 (295)
T cd07837 282 RISAKAALTHPYFD 295 (295)
T ss_pred cCCHHHHhcCCCcC
Confidence 99999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.57 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=178.1
Q ss_pred eecccCceEEEEEeeeC-------------CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 352 EIAKGSNGTVVLEGNYE-------------GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~-------------g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.||+|+||+||++...+ ...||||.+...... ..+.|+..++..++||||+++++++.++...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999985321 236899987654322 234455567888999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||+ +|+|..+++.. ...+++..+++++.||+.||+|||+
T Consensus 82 v~e~~~----------~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 82 VEEFVE----------FGPLDLFMHRK----------------------------SDVLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred EEeccc----------CCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 999554 44444433211 1235667789999999999999999
Q ss_pred cCccccccCCCCeeecCCCC-----ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-cCCCCCcchhHhHH
Q 004097 497 IGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLG 570 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~-----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSlG 570 (774)
.+|+||||||+|||++.++. ..++++|||++...... ....++..|+|||.+. ...++.++||||||
T Consensus 124 ~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 124 KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 99999999999999975542 23799999998755321 2345788999999987 46689999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 571 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++|||++++..||.......................+++.++|.+||+.||.+||++.+++++
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999998766888876443332222122112222345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.21 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=190.5
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|.+.+.||+|+||+||++... +|+.||+|.+..... ....+|+. ++..++||||+++++++...+..|+|||||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD-ILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 556688999999999998654 689999998864322 23345554 667789999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCcc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLI 500 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~iv 500 (774)
+ +++|..++.... ....+++..+..++.|++.||.|||+ .+|+
T Consensus 82 ~----------~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~ 125 (286)
T cd06622 82 D----------AGSLDKLYAGGV--------------------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125 (286)
T ss_pred C----------CCCHHHHHHhcc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 4 455544432210 01246778889999999999999997 5999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC------CCCCcchhHhHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG------RQTRAIDLFSLGCILF 574 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDvwSlGvll~ 574 (774)
||||||+||+++.++. ++|+|||++...... ......+++.|+|||.+.+. .++.++|+|||||++|
T Consensus 126 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 126 HRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred eCCCCHHHEEECCCCC--EEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 9999999999987665 899999998765422 12334588899999998553 3578999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H----HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESFERD-A----NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~----~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+|++| ..||....... . .+........+...++++.++|.+||+.+|++||++.+++.||||+...
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 199 EMALG-RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHhC-CCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99997 77885432211 1 1222222233445678999999999999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.58 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=189.4
Q ss_pred ecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||+||++. ..+|+.||+|.+..... .....|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEK-KILEKVSSRFIVSLAYAFETKDDLCLVMT------ 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHH-HHHHhCCCCCEeeeeeEEecCCeEEEEEe------
Confidence 6999999999985 45689999999864321 1223454 46788899999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
|+.+++|.+++.... ...+++..++.++.|++.||.|||+.+++||||+
T Consensus 74 ----~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~ 122 (277)
T cd05577 74 ----LMNGGDLKYHIYNVG---------------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122 (277)
T ss_pred ----cCCCCcHHHHHHHcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 555555555443211 1246778889999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. ++|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++| ..||.
T Consensus 123 p~Nil~~~~~~--~~l~dfg~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 195 (277)
T cd05577 123 PENVLLDDHGN--VRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG-RSPFR 195 (277)
T ss_pred HHHEEECCCCC--EEEccCcchhhhccC----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC-CCCCC
Confidence 99999988765 899999998765432 112234578899999999888899999999999999999996 77886
Q ss_pred CchHH-H-HHH---HhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 586 ESFER-D-ANI---VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 586 ~~~~~-~-~~~---~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
..... . ..+ ........+...++++.++|.+||+.||.+|| ++.++++||||+..+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred CCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 54321 1 111 11112223344578999999999999999999 88999999999765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.07 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=186.9
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch--------HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~--------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|.+.+.||+|++|.||++.. .+|+.||||++...... ....|+. ++..++|+||+++++++.+.+..|+|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHH-HHhhcCCCCChhhhheeecCCEEEEE
Confidence 56678899999999999864 46899999999654321 2234554 67788999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||+. |+|.+++.... ..+++..++.++.||++||+|||+.
T Consensus 81 ~e~~~-----------~~L~~~i~~~~----------------------------~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 81 FEFME-----------TDLEKVIKDKS----------------------------IVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred EcccC-----------CCHHHHHhccC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99554 44444332110 1366778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~el 576 (774)
+|+|+||+|+||+++.++. ++|+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||
T Consensus 122 ~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 122 WILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred CeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999988765 89999999987654321 1122346788999999865 4578999999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhcc---------------------------ccccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 577 ITGGKHPYGESFERD--ANIVKDRK---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~--~~~~~~~~---------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
++| .+||....... ..+..... .......+.++.++|.+||+.||.+|||
T Consensus 197 ~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 197 LLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred HcC-CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 997 76765432211 11110000 0001123467889999999999999999
Q ss_pred HHHHHcCCCCCCcc
Q 004097 628 AQNVLNHPFFWTAD 641 (774)
Q Consensus 628 ~~elL~HPff~~~~ 641 (774)
+.|+++||||.+..
T Consensus 276 ~~e~l~~~~~~~~~ 289 (298)
T cd07841 276 ARQALEHPYFSNDP 289 (298)
T ss_pred HHHHhhCccccCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=324.49 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=195.3
Q ss_pred cccccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEe------ecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l------~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
....++..++..+||+|+|-|||+| ...+|..||=-.+ +....-+.+.++..|++.++|||||++|.+|.+.+
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 3445677788899999999999998 4556777764222 22222245556667999999999999999998876
Q ss_pred e--eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 F--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 ~--~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
. +-+|+| .+..|+|..++.. .+......+..|++||++|
T Consensus 115 n~~in~iTE----------L~TSGtLr~Y~kk-----------------------------~~~vn~kaik~W~RQILkG 155 (632)
T KOG0584|consen 115 NKTINFITE----------LFTSGTLREYRKK-----------------------------HRRVNIKAIKSWCRQILKG 155 (632)
T ss_pred Cceeeeeee----------cccCCcHHHHHHH-----------------------------hccCCHHHHHHHHHHHHHH
Confidence 5 778899 5556666665432 2335567889999999999
Q ss_pred HHHHHHc--CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHh
Q 004097 491 LSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~--~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 568 (774)
|.|||++ .|||||||-+||+|+.+.. .+||+|+|||+..... .....+|||.|||||+.. ..|++.+||||
T Consensus 156 L~yLHs~~PPIIHRDLKCDNIFinG~~G-~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVYa 228 (632)
T KOG0584|consen 156 LVYLHSQDPPIIHRDLKCDNIFVNGNLG-EVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVYA 228 (632)
T ss_pred hhhhhcCCCCccccccccceEEEcCCcC-ceeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchhhhhhh
Confidence 9999998 6999999999999975432 5999999999987643 223468999999999987 78999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH---HHHHhhcccc-ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 569 LGCILFFCITGGKHPYGESFERD---ANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~---~~~~~~~~~~-~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||+.++||+|+ ..||.+..... ..++.+.++. +..-..|+++++|.+||.. ...|||+.|+|+||||...
T Consensus 229 FGMCmLEMvT~-eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 229 FGMCMLEMVTS-EYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hhHHHHHHHhc-cCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999996 88998754322 2233333221 1222358999999999999 9999999999999999765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.01 Aligned_cols=242 Identities=30% Similarity=0.439 Sum_probs=190.4
Q ss_pred ecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||.|++|+||++... +++.||||++.+... ....+|+ .++..++||||+++++++.+++..|+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLYRTFKDKKYIYMLME------ 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHH-HHHHhCCCCCEeeeeeeEEcCCccEEEEe------
Confidence 699999999998654 489999999865321 2233444 47788899999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
|+.+++|.+++... ..+++..+..++.||+.||+|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 74 ----YCLGGELWTILRDR-----------------------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred ----cCCCCcHHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 66666766655322 225667788999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. ++|+|||++....... ......|++.|++||.+....++.++|+||||+++|+|++| .+||.
T Consensus 121 ~~nilv~~~~~--~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 193 (262)
T cd05572 121 PENLLLDSNGY--VKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG-RPPFG 193 (262)
T ss_pred HHHEEEcCCCC--EEEeeCCcccccCccc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC-CCCcC
Confidence 99999988765 8999999998765431 12234588999999999888899999999999999999997 77886
Q ss_pred CchHH---HH-HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCcc
Q 004097 586 ESFER---DA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 641 (774)
Q Consensus 586 ~~~~~---~~-~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~ 641 (774)
..... .. .+.. ......+....+++.++|.+||+.||.+||+ ++|+++||||.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 194 EDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 55411 11 1221 1222333444679999999999999999999 99999999997643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.20 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=190.8
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||.||++.. .+|..||+|.+... ..+...+|++ +++.++||||+++++.+.+.+..|+|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHH-HHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 56778999999999999854 46889999998643 1223445554 67888999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ .+++|.+++.... ...+++..++.++.|++.||+|||+.+++
T Consensus 81 ~----------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (257)
T cd08225 81 C----------DGGDLMKRINRQR---------------------------GVLFSEDQILSWFVQISLGLKHIHDRKIL 123 (257)
T ss_pred C----------CCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 5 4455544432211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||||+||+++.++. .+||+|||.+........ ......|++.|+|||++....++.++|+|||||++||+++|
T Consensus 124 H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g- 198 (257)
T cd08225 124 HRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL- 198 (257)
T ss_pred cccCCHHHEEEcCCCC-eEEecccccchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999987754 479999999887653221 11234588999999999888899999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........ .+..............++.++|.+||+.+|++|||+.++++||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 667764432221 122222222223445789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.62 Aligned_cols=261 Identities=20% Similarity=0.335 Sum_probs=190.1
Q ss_pred EEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|.+.+.||+|+||+||++... +++.||||++...... ..+.++..++..++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 344577999999999998653 3578999999754322 2233333577889999999999999999999999
Q ss_pred ccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
+||+. ++|.+++.+....... ..... ..-....+++..++.++.|++.||+|||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~-----------------------~~~~~-~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDV-----------------------GSTDD-DKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccc-----------------------ccccc-ccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 99765 3555555332111000 00000 00112346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||+++.++. +||+|||+++....... ........+++.|+|||++....++.++|||||||++|||
T Consensus 143 ~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 219 (283)
T cd05091 143 HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219 (283)
T ss_pred cCccccccchhheEecCCCc--eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 99999999999999987765 89999999886643211 1122233467899999999988899999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++++.+||....... ...+.. .....+....+++.+++.+||+.+|.+||++++++..
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 996688886543332 222222 2223344566789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=297.10 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=192.4
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||.|+||.||.+. ..+++.||+|.+.... .....+|+. +++.++|+||+++++++.+.+..+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV-ILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHH-HHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6678999999999998864 4568999999875432 123455654 67888999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
| .+|+|.+++.... ...+++..+..++.|++.||+|||+.+++
T Consensus 81 ~----------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08221 81 A----------NGGTLYDKIVRQK---------------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123 (256)
T ss_pred c----------CCCcHHHHHHhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5 4555555443211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. +||+|||++........ ......|++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 124 h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08221 124 HRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL- 197 (256)
T ss_pred ccCCChHhEEEeCCCC--EEECcCcceEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC-
Confidence 9999999999987765 89999999987654321 22344689999999999888889999999999999999997
Q ss_pred CCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||....... . .+............+.++.++|.+||..+|.+||++.++++|||+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 198 KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 56775543222 2 222222222233456789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.58 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=189.5
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|++|.||++...+++.||||.++.... ....+|+. ++..++||||+++++++.+.+..|++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHH-HHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 345788899999999999998777778999999875432 33445554 778889999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+++|.+++.... ...+++..+..++.|++.||.|||+.+|+|
T Consensus 84 ----------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 126 (261)
T cd05068 84 ----------KYGSLLEYLQGGA---------------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIH 126 (261)
T ss_pred ----------cCCcHHHHHhccC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 3444444432211 123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+||+++.++. ++|+|||+++....... ........+..|+|||++....++.++|||||||++|||++++.
T Consensus 127 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 202 (261)
T cd05068 127 RDLAARNVLVGENNI--CKVADFGLARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred ccCCcceEEEcCCCC--EEECCcceEEEccCCcc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999999988775 89999999987653211 11111123457999999998889999999999999999999668
Q ss_pred CCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+||....... ...+... ....+...+..+.+++.+||+.+|.+||++.++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 203 MPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8886644322 2222222 22223345678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.78 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=189.4
Q ss_pred eEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.|.+.+.||+|+||.||++... +++.||||.+...... ...+|+ .++..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA-ELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHH-HHHHhcCCCCchheeeEEecCCCeE
Confidence 3566788999999999998653 3478999998754332 334455 4778899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+||||+ .+|+|.+++.........+. ...-....+++..+..++.|++.||+|||
T Consensus 85 lv~e~~----------~~~~L~~~i~~~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 85 MVFEYM----------EHGDLNKFLRSHGPDAAFLK---------------SPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred EEEecC----------CCCCHHHHHHhcCCchhhhc---------------ccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 999954 45555555433221100000 00011234677889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+++||||||+||+++.++. +||+|||+++........ .......+++.|+|||++.+..++.++|||||||++||
T Consensus 140 ~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 140 SQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred hCCeeccccccceEEEcCCCe--EEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 999999999999999987765 899999999765432111 11123346788999999999999999999999999999
Q ss_pred HHhCCCCCCCCch-HHHHHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESF-ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~-~~~~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++.+..||.... ......+. ......+...+.++.+++.+||+.||++||++.|+++
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9984477765433 22222222 2222233445679999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.06 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=190.6
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
|.+.+.||.|+||+||++.. .++..||+|.+...... ...+|+ .++..++||||+++++++.+++..|+|||
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 82 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEAYFYENKLWILIE--- 82 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEecCCeEEEEee---
Confidence 55667899999999999865 46899999998654322 233455 47788899999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+++|.+++... ...+++..++.++.|++.||+|||+.+|+|+
T Consensus 83 -------~~~~~~L~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~ 127 (280)
T cd06611 83 -------FCDGGALDSIMLEL----------------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127 (280)
T ss_pred -------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 55555555544221 1246778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHhHHHHHHHHH
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSlGvll~ell 577 (774)
||||+||+++.++. ++|+|||++....... .......+++.|+|||++.. ..++.++|+|||||++|||+
T Consensus 128 dl~p~nili~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 128 DLKAGNILLTLDGD--VKLADFGVSAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred CCChhhEEECCCCC--EEEccCccchhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 99999999987765 8999999887654321 11223458999999999853 34678999999999999999
Q ss_pred hCCCCCCCCchHHH-H-HHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+| .+||....... . .+...... ..+...+.++.++|.+||+.+|.+||++.++++||||.+.
T Consensus 203 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 203 QM-EPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred hC-CCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 97 77876543222 1 12111111 1123456789999999999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.26 Aligned_cols=288 Identities=20% Similarity=0.305 Sum_probs=191.3
Q ss_pred cceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC-Cc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~ 412 (774)
.++|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+..+....+||||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34577889999999999999743 2357899999864332 2345676644444489999999998764 46
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchh----h--------HH--------H-HHhhcccccchhhHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNL----L--------NE--------V-RIRLLPVMENTKDIELW 470 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~----l--------~~--------~-~~~~~~~~~~~~~~~~~ 470 (774)
.+|++|||++ ++|.+++.................... . .. . ........++.......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7899999655 245554432111000000000000000 0 00 0 00000000111111223
Q ss_pred hhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCC
Q 004097 471 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 550 (774)
Q Consensus 471 ~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~ 550 (774)
....+++..+..++.||+.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+...... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcch-hhccCCCCCcccc
Confidence 3457899999999999999999999999999999999999987765 899999999876533221 1222344677899
Q ss_pred chhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 551 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 551 aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
|||++.+..++.++|||||||++|||++.+..||...... ....+.. .....+....+++.+++.+||+.+|++||+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999999999999998447888653221 1122222 122223345678999999999999999999
Q ss_pred HHHHHcC
Q 004097 628 AQNVLNH 634 (774)
Q Consensus 628 ~~elL~H 634 (774)
+.|+++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.54 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=198.5
Q ss_pred EeEeecccCceEEEEE-eeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 349 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
-.+.||+|.||+||-+ ...+|+.||||++.+.. .+..++.+..++..++||.||.|-..|+..+.+++|||-+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4578999999999986 45689999999996532 334444444588999999999999999999999999995555
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+..++| |..+ .+.+++.....++.||+.||.|||.++|+|+|
T Consensus 648 DMLEMI----------LSsE----------------------------kgRL~er~TkFlvtQIL~ALr~LH~knIvHCD 689 (888)
T KOG4236|consen 648 DMLEMI----------LSSE----------------------------KGRLPERITKFLVTQILVALRYLHFKNIVHCD 689 (888)
T ss_pred hHHHHH----------HHhh----------------------------cccchHHHHHHHHHHHHHHHHHhhhcceeecc
Confidence 444333 2221 23466677788999999999999999999999
Q ss_pred cCCCCeeecCCCC-ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 504 LKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 504 Lkp~NILl~~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
|||+||||..... .++||||||+|+.+... ....+.+|||.|+|||+++.+.|...-|+||.|||+|--++| ..
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG-TF 764 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG-TF 764 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchh----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc-cc
Confidence 9999999975433 37999999999998753 334567899999999999999999999999999999999996 88
Q ss_pred CCCCchHHHHHHHhhcc----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 583 PYGESFERDANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 583 Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||.+..+-..+ +++.. .....+.++++.|||..+|+..-.+|.|..+.|.|||.++.
T Consensus 765 PFNEdEdIndQ-IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 765 PFNEDEDINDQ-IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCCCccchhHH-hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99775443222 23222 22334567899999999999999999999999999998653
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.00 Aligned_cols=239 Identities=26% Similarity=0.361 Sum_probs=180.3
Q ss_pred eecccCceEEEEEee---eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 352 EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+||+|+||+||++.. .+++.||||++...... ...+|+ .++..++||||+++++++.+ +..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~--- 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIVRMIGICEA-ESWMLVMEL--- 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHH-HHHHhCCCCCcceEEEEEcC-CCcEEEEec---
Confidence 589999999999743 45789999998644321 233444 47788999999999998864 567899994
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
..+|+|.+++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 77 -------~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 77 -------AELGPLNKFLQK-----------------------------NKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred -------CCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 445555554422 12356778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++ .+||+|||+++................++..|+|||.+....++.++|||||||++|||++.+.+|
T Consensus 121 lkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 198 (257)
T cd05116 121 LAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198 (257)
T ss_pred cchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999998765 489999999987654332222222334567899999998888999999999999999999844888
Q ss_pred CCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 584 YGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 584 f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|....... ...+.. .....+...++++.++|.+||+.||++||++++|.+
T Consensus 199 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 199 YKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 87543322 222322 222334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.05 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=188.1
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.+.+.+.||+|+||.||++...++..+|||.+.+.. .....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e---- 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK-VMMKLSHPNLVQLYGVCTKQRPIFIVTE---- 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEEEEEEEEcCCCceEEEEe----
Confidence 356778899999999999877677789999986543 234455655 6778899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 125 (256)
T cd05059 80 ------YMANGCLLNYLRERK----------------------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125 (256)
T ss_pred ------cCCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 445555555443211 1356778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++. +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++++.+|
T Consensus 126 l~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 126 LAARNCLVGEDNV--VKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccHhhEEECCCCc--EEECCcccceecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence 9999999987765 89999999886643211 1111112445799999999889999999999999999999966888
Q ss_pred CCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 584 YGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|....... ...+... ....+...++++.+++.+||..+|++|||+.|+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 86543222 1222211 122233456799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.44 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=186.3
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..|...+.||+|+||+||++... +|. .||||++...... ...+|+ .++..++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 34777889999999999998643 343 4899998644322 223344 577889999999999999875 567
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+++| |+.+|+|.+++.... ..+++..++.++.||+.||+|||
T Consensus 85 ~v~e----------~~~~g~l~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH 126 (316)
T cd05108 85 LITQ----------LMPFGCLLDYVREHK----------------------------DNIGSQYLLNWCVQIAKGMNYLE 126 (316)
T ss_pred eeee----------cCCCCCHHHHHHhcc----------------------------ccCCHHHHHHHHHHHHHHHHHHH
Confidence 8999 566677766654321 23566778899999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. +||+|||+++.......... .....++..|+|||++.+..++.++|||||||++||
T Consensus 127 ~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~e 203 (316)
T cd05108 127 ERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203 (316)
T ss_pred hcCeeccccchhheEecCCCc--EEEccccccccccCCCccee-ccCCccceeecChHHhccCCCCchhhhHHHHHHHHH
Confidence 999999999999999987765 89999999987654322111 122234678999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFERD-ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++.+..||....... ..+..... ...+.....++.+++.+||..||.+||++.+++.+
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 204 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9984578887643322 22332221 12233456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.60 Aligned_cols=242 Identities=30% Similarity=0.496 Sum_probs=185.8
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.||+|+||.||+|.. .+|+.||||.+.+... .....|...+....+||||+++++++.+++..|+|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e---- 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME---- 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe----
Confidence 4699999999999854 4689999999865421 1123344445556789999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|||
T Consensus 78 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 78 ------YLNGGDCASLIKT-----------------------------LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred ------ccCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 5555566554422 12356778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|+|+||+++.++. ++|+|||+++.... .....|+..|+|||.+.+..++.++||||||+++|+|++| .+|
T Consensus 123 l~p~nil~~~~~~--~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g-~~p 192 (260)
T cd05611 123 IKPENLLIDQTGH--LKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPP 192 (260)
T ss_pred CCHHHeEECCCCc--EEEeecccceeccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC-CCC
Confidence 9999999987765 89999999875432 1234588899999999888889999999999999999996 778
Q ss_pred CCCchHHHH-HHHhhcc----ccccccCCHHHHHHHHHhcCCCCCCCcC---HHHHHcCCCCCCcc
Q 004097 584 YGESFERDA-NIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~~~~-~~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~Rps---~~elL~HPff~~~~ 641 (774)
|........ ....... .......++++.++|.+||+.||++||+ ++|++.||||.+.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 865433321 1111111 1112234679999999999999999995 47999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.01 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=190.5
Q ss_pred eEEEeEeecccCceEEEEEee-----eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-----~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.|.+.+.||+|+||+||+|.. ..++.||+|.+...... ...+|+ .+++.++||||+++++++.+++..|+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA-SLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCCeeeEEEEEecCCceEE
Confidence 366779999999999999853 35679999999754322 233455 47788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||+. +|+|.+++......... .............+++.+++.++.|++.||+|||+
T Consensus 85 v~e~~~----------~~~L~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 142 (283)
T cd05090 85 LFEYLN----------QGDLHEFLIMRSPHSDV------------GCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred EEEcCC----------CCcHHHHHHhcCCCCcc------------ccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 999655 44444443321110000 00000000112346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||
T Consensus 143 ~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 219 (283)
T cd05090 143 HFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219 (283)
T ss_pred cCeehhccccceEEEcCCCc--EEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 899999999876432211 112333467789999999888899999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 577 ITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
++++.+||..... .....+.... ...+....+++.+++.+||+.||++||++.+++++-
T Consensus 220 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 220 FSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 9955778755332 2223222222 222334567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=343.43 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=212.3
Q ss_pred ccccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 339 DGRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 339 ~~~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.-..+|.+.++||+|+||.|.+.. ..+++.+|+|++.+ ......|+|...++...+.+-||+|+..|+|++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 335556778888999999999998864 45789999999975 334567899998999889999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
++|+||| ||++|+|-.+|...+ .+|+.-++.++..|+.||.
T Consensus 149 ~LYlVMd----------Y~pGGDlltLlSk~~-----------------------------~~pE~~ArFY~aEiVlAld 189 (1317)
T KOG0612|consen 149 YLYLVMD----------YMPGGDLLTLLSKFD-----------------------------RLPEDWARFYTAEIVLALD 189 (1317)
T ss_pred ceEEEEe----------cccCchHHHHHhhcC-----------------------------CChHHHHHHHHHHHHHHHH
Confidence 9999999 889999888775432 4777888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLF 567 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvw 567 (774)
-||+.|+|||||||+||||+..|+ +||+|||.|-.+..+. .-.....+|||.|++||++.. +.|+..+|+|
T Consensus 190 slH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW 265 (1317)
T KOG0612|consen 190 SLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW 265 (1317)
T ss_pred HHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence 999999999999999999988887 8999999998876432 234456789999999999973 5689999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccc-ccc--ccCCHHHHHHHHHhcCCCCCCCcC---HHHHHcCCCCCCc
Q 004097 568 SLGCILFFCITGGKHPYGESFERD-ANIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTA 640 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~-~~~--~~~~~~~~dli~~~L~~dP~~Rps---~~elL~HPff~~~ 640 (774)
|+||++|||+.|..|+|.++.-.. ..|+..... .+| ...++++++||.+++. +|+.|.. ++++..||||.+.
T Consensus 266 SlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 266 SLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 999999999998666666554333 344433222 223 3457899999999876 7888888 9999999999766
Q ss_pred cc
Q 004097 641 DT 642 (774)
Q Consensus 641 ~~ 642 (774)
+|
T Consensus 345 ~W 346 (1317)
T KOG0612|consen 345 DW 346 (1317)
T ss_pred Ch
Confidence 54
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.69 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=193.4
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|...+.||+|+||.||++.. .+++.||||.+...... ...+|+ ..+..++||||+++++++.+++..|+|||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHH-HHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 55668899999999999854 56889999988643322 223344 4678899999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
+ +++|.+++.. ..+++..+..++.|++.||.|||+.+++|
T Consensus 85 ~----------~~~l~~~i~~------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (277)
T cd06641 85 G----------GGSALDLLEP------------------------------GPLDETQIATILREILKGLDYLHSEKKIH 124 (277)
T ss_pred C----------CCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence 4 4444443321 22566778999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
+||+|+||+++.++. ++|+|||++..+..... ......++..|+|||.+.....+.++|+|||||++|+|++| .
T Consensus 125 ~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~ 198 (277)
T cd06641 125 RDIKAANVLLSEHGE--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred CCCCHHhEEECCCCC--EEEeecccceecccchh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC-C
Confidence 999999999987765 89999999876643211 11234578899999999888889999999999999999997 7
Q ss_pred CCCCCchHHHH-HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhh
Q 004097 582 HPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFL 647 (774)
Q Consensus 582 ~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l 647 (774)
.||........ ..+. ..........+.++.++|.+||+.+|.+||++.++++||||.....+..++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~ 266 (277)
T cd06641 199 PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYL 266 (277)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhccchH
Confidence 78865433221 1111 112222334567899999999999999999999999999997654443333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=306.09 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=189.7
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||.||++.. .+++.||||.+..... ....+|+ .++..++||||+++++.+.+++..|+||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-DILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 366778999999999999854 4578999999865421 1223444 4778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |+.+++|.+++.. ...+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (305)
T cd05609 81 E----------YVEGGDCATLLKN-----------------------------IGALPVDMARMYFAETVLALEYLHNYG 121 (305)
T ss_pred e----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5555666555422 123567778899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCcc------------ccccccCcCCCCCCchhhhhcCCCCCcchh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------LTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv 566 (774)
++||||||+||+++.++. ++|+|||+++........ ........++..|+|||.+.+..++.++|+
T Consensus 122 i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 122 IVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred ccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999987765 899999998742111000 001112357889999999988889999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCch-HHHHHHHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcC---HHHHHcCCCCCC
Q 004097 567 FSLGCILFFCITGGKHPYGESF-ERDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWT 639 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~-~~~~~~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps---~~elL~HPff~~ 639 (774)
|||||++||+++| ..||.... ........... .......++++.++|.+||+.||++||+ +.++++||||..
T Consensus 200 ~slG~vl~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 200 WAMGIILYEFLVG-CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 9999999999997 55665432 22222211111 1111134678999999999999999998 789999999966
Q ss_pred ccc
Q 004097 640 ADT 642 (774)
Q Consensus 640 ~~~ 642 (774)
.+.
T Consensus 279 ~~~ 281 (305)
T cd05609 279 LDW 281 (305)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.16 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=189.2
Q ss_pred EEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch-----------------HHHHHHHHHHHhCCCCCeeEEeeecc
Q 004097 348 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----------------VALKEIQNLIASDQHPNIVRWYGVES 409 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----------------~~~~Ei~~ll~~l~HpNIV~l~g~~~ 409 (774)
.+.+.||+|+||+||++.. .+++.||||.+...... ...+|+. ++..++||||+++++++.
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-IMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHH-HHHhCCCcceeeeeEEEe
Confidence 3567799999999999854 46899999998643221 2345654 678889999999999999
Q ss_pred CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 410 ~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+.+..|+|||++.++|.+++. . ...+++..+..++.|++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~l~-----------~-----------------------------~~~~~~~~~~~~~~ql~~ 130 (335)
T PTZ00024 91 EGDFINLVMDIMASDLKKVVD-----------R-----------------------------KIRLTESQVKCILLQILN 130 (335)
T ss_pred cCCcEEEEEeccccCHHHHHH-----------h-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 999999999977666555441 1 123566778999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-----------cccccccCcCCCCCCchhhhhcC
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQLLQG 558 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~l~~~ 558 (774)
||+|||+.+|+|+||+|+||+++.++. ++|+|||+++....... .........++..|+|||.+.+.
T Consensus 131 aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 131 GLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred HHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999999999999999999999987765 89999999976651110 01111223468899999998764
Q ss_pred -CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc---c------------------------cccccCCH
Q 004097 559 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRK---D------------------------LFLVEHIP 608 (774)
Q Consensus 559 -~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~---~------------------------~~~~~~~~ 608 (774)
.++.++|||||||++|||++| .+||........ .+..... . ......++
T Consensus 209 ~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (335)
T PTZ00024 209 EKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD 287 (335)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCCh
Confidence 468999999999999999996 778765432211 1111000 0 00112356
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 609 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 609 ~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
++.++|.+||+.+|++||+++|++.||||+.....
T Consensus 288 ~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 288 DAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 78999999999999999999999999999876554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=321.66 Aligned_cols=245 Identities=28% Similarity=0.364 Sum_probs=195.5
Q ss_pred ccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
....|.+...+|.|+|+.|-++ ...+++..|||++.+. ..+..+|+..++...+||||+.+++++.+..+.|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e-- 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME-- 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeeh--
Confidence 4567888889999999999665 5567899999999765 33445666667777899999999999999999999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+.+|-+.+.+.. ..... .++..|+++|+.|+.|||++||||
T Consensus 397 --------~l~g~ell~ri~~-----------------------------~~~~~-~e~~~w~~~lv~Av~~LH~~gvvh 438 (612)
T KOG0603|consen 397 --------LLDGGELLRRIRS-----------------------------KPEFC-SEASQWAAELVSAVDYLHEQGVVH 438 (612)
T ss_pred --------hccccHHHHHHHh-----------------------------cchhH-HHHHHHHHHHHHHHHHHHhcCeee
Confidence 5555544443321 11122 466789999999999999999999
Q ss_pred cccCCCCeee-cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl-~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+|||+ +.+++ ++|+|||.++..... ..+.+-|..|.|||++....|++++||||||++||+||+|
T Consensus 439 RDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G- 509 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGH--LRLTYFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTG- 509 (612)
T ss_pred cCCChhheeecCCCCc--EEEEEechhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhC-
Confidence 9999999999 46665 889999999887643 2345678999999999999999999999999999999997
Q ss_pred CCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........-...-....+....+++++|||.+||+.||.+||++.+++.||||
T Consensus 510 ~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 510 RTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 767765443322111122223336678899999999999999999999999999999
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.08 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=186.9
Q ss_pred EEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCce-----
Q 004097 348 VFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF----- 413 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~----- 413 (774)
.+.+.||+|+||.||++.... +..||||++..... ....+|+. .+..++||||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAA-CMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHH-HHHhCCCCCeeeEEeeeccCCccccCc
Confidence 356789999999999986542 36899999864321 23345554 6778899999999998876554
Q ss_pred -eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 414 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 414 -~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.++++| |+.+|+|...+...... .....+++..++.++.|++.||+
T Consensus 81 ~~~~v~e----------~~~~~~l~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 81 KPMVILP----------FMKHGDLHSFLLYSRLG-----------------------GLPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred ccEEEEe----------ccCCCCHHHHHHHhhcc-----------------------CCcccCCHHHHHHHHHHHHHHHH
Confidence 799999 55666666655332110 01124677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+||++++++. +||+|||+++......... ......++..|+|||.+....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~i 204 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204 (273)
T ss_pred HHHhCCeeccccchheEEECCCCe--EEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHH
Confidence 999999999999999999987765 8999999998765432211 1122235678999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 573 LFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|||++++.+||........ .+........+....+++.+++.+||+.||.+||++.|++++
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 205 MWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999966888865433221 222222223344566899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.28 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=190.0
Q ss_pred ceEEEeEeecccCceEEEEEeeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||++.... ++.||||++.+... ....+|+..+.....||||+++++++.+....|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 446778999999999999986654 89999999975432 2234555545555569999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cC
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IG 498 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ 498 (774)
|+.++|.+++.. ....+++..+..++.|++.||+|||+ .+
T Consensus 95 ~~~~~l~~l~~~---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 95 LMSTCLDKLLKR---------------------------------------IQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred ccCcCHHHHHHH---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 776555444321 11245677788999999999999997 59
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC----CCCcchhHhHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLGCILF 574 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDvwSlGvll~ 574 (774)
|+||||+|+||+++.++. +||+|||++..+..... .....++..|+|||.+.... ++.++|||||||++|
T Consensus 136 i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 136 VIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred EecCCCcHHHEEEcCCCC--EEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 999999999999987765 89999999876643211 12234788999999987553 788999999999999
Q ss_pred HHHhCCCCCCCCchHH---HHHHHhhcccccc--ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESFER---DANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~~~---~~~~~~~~~~~~~--~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+|++| +.||...... ...+......... .....++.++|.+||+.||.+||++.++++||||....
T Consensus 210 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 210 ELATG-QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHhC-CCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99996 7788653221 1122222111111 12457899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.13 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=192.9
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|.+.+.||.|+||.||++... +++.||+|.+.+.. .....+|++ .++.++||||+++++++.+++..|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERR-ILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHH-HHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 677899999999999998654 58999999996532 123344554 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+++|..++... ..+++..+..++.||+.||+|||+.++
T Consensus 81 ~~----------~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 81 LL----------LGGDLRYHLSQK-----------------------------VKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred CC----------CCCCHHHHHHhc-----------------------------CCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55 445555443221 235677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+....++.++|+||||+++|+|++|
T Consensus 122 ~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 122 IHRDIKPDNILLDEQGH--VHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred eccCCCHHHeEEcCCCC--EEEeecccccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 99999999999988776 8999999988765321 12334588899999999988899999999999999999997
Q ss_pred CCCCCCCchH---HH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH--HHHHcCCCC
Q 004097 580 GKHPYGESFE---RD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA--QNVLNHPFF 637 (774)
Q Consensus 580 ~~~Pf~~~~~---~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~--~elL~HPff 637 (774)
..||..... .. ...........+...++++.++|.+||+.||.+||++ +|+++||||
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 196 -KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -CCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 667765432 11 1222212233444556799999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.91 Aligned_cols=238 Identities=23% Similarity=0.278 Sum_probs=177.9
Q ss_pred eecccCceEEEEEeeeC-------------------------CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeEE
Q 004097 352 EIAKGSNGTVVLEGNYE-------------------------GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRW 404 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~-------------------------g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l 404 (774)
.||+|+||.||++.... ...||||++...... ..+.+...+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 48999999999975321 245899998654322 234444567888999999999
Q ss_pred eeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHH
Q 004097 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 484 (774)
Q Consensus 405 ~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 484 (774)
+++|.+.+..|+||| |+.+|+|..++... ...+++..++.++
T Consensus 82 ~~~~~~~~~~~lv~e----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~ 123 (274)
T cd05076 82 HGVCVRGSENIMVEE----------FVEHGPLDVCLRKE----------------------------KGRVPVAWKITVA 123 (274)
T ss_pred EEEEEeCCceEEEEe----------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHH
Confidence 999999999999999 55555555544221 1235677789999
Q ss_pred HHHHHHHHHHHHcCccccccCCCCeeecCCC-----CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-C
Q 004097 485 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-----SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-G 558 (774)
Q Consensus 485 ~qia~gL~yLH~~~ivHrDLkp~NILl~~~~-----~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~ 558 (774)
.||+.||+|||+.+|+||||||+|||++.++ ...+|++|||++...... ....++..|+|||.+.+ .
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCC
Confidence 9999999999999999999999999997543 224799999987654321 12347888999998875 4
Q ss_pred CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 559 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 559 ~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
.++.++|||||||++||+++++.+||..................+....+++.++|.+||+.+|++||++.+++++
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5899999999999999997656888865433322111111222233345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.48 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=188.2
Q ss_pred ceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||+||+|... +...||||.+...... ...+|+. ++..++||||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEAS-IMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCcceEeEEEecCCceEE
Confidence 34778899999999999998653 2458999998654332 2334554 6788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
+||+ ..+++|.+++... ...+++..++.++.|++.||+|||+
T Consensus 83 v~e~----------~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 83 ITEY----------MENGSLDKFLREN----------------------------DGKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred EEEc----------CCCCCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9994 4455555544321 1235677889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||+++.++. ++|+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|+|
T Consensus 125 ~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CCcccCCCCcceEEEcCCCC--EEECccchhhccccccccee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 99999999999999987765 89999999988752211111 1123356789999999988899999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++.+..||.+.... ....+. ......+...++.+.+++.+||+.+|++||++.+++++
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 98447787554322 222222 21222334556789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=299.00 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=187.3
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
..|.+.++||+|+||+||++...+...||||++..... ....+|+. ++..++||||+++++++.+ +..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE--- 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHH-HHHhCCCCCcceEEEEECC-CCcEEEEE---
Confidence 45888999999999999998766667899999975432 23445555 6778899999999998754 56899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+++||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 126 (262)
T cd05071 81 -------YMSKGSLLDFLKGEM---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126 (262)
T ss_pred -------cCCCCcHHHHHhhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 445555555443211 1235677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. ++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++++.+
T Consensus 127 dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 127 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred ccCcccEEEcCCCc--EEeccCCceeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999987765 89999999976653221 111223467789999999888899999999999999999997788
Q ss_pred CCCCchHHHH-HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||........ ..+.. .........+..+.++|.+||+.||++||++.++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 203 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9876543321 22211 112223345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.66 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=189.3
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|.+.+.||+|++|.||++... +++.||+|++...... ...+|+. +++.++||||+++++++.+.+..|+++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD-ILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHH-HHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 455678999999999998654 6899999998755322 2345554 567788999999999999999999999966
Q ss_pred C-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCc
Q 004097 422 T-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 499 (774)
Q Consensus 422 ~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~i 499 (774)
. ++|.+++ ... ...+++..+.+++.|++.||+|||+ .++
T Consensus 82 ~~~~L~~~~-----------~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i 122 (265)
T cd06605 82 DGGSLDKIL-----------KEV----------------------------QGRIPERILGKIAVAVLKGLTYLHEKHKI 122 (265)
T ss_pred CCCcHHHHH-----------HHc----------------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCCe
Confidence 5 3454443 211 0235667788999999999999999 999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+|+||||+||+++.++. ++|+|||.+........ ....++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 123 ~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 123 IHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999988765 89999999876643211 125688999999999988999999999999999999997
Q ss_pred CCCCCCCch---H---HH-HHHHhhcccccccc-CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESF---E---RD-ANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~---~---~~-~~~~~~~~~~~~~~-~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
..||.... . .. ..+........+.. .++++.++|.+||..||++|||+.+++.||||...
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 196 -RFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -CCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 66775431 1 11 11122211122222 56789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.40 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=187.5
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|++|+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHH-HHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 477889999999999999854 4789999999854321 23345554 6778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.++|.+++. .. ....+++..+..++.||+.||+|||+.++
T Consensus 82 ~~~~~l~~~~~-----------~~---------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 123 (294)
T PLN00009 82 YLDLDLKKHMD-----------SS---------------------------PDFAKNPRLIKTYLYQILRGIAYCHSHRV 123 (294)
T ss_pred cccccHHHHHH-----------hC---------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 76655444331 10 01123556778999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+||||+|+||+++.++. .+||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 124 ~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred eCCCCCcceEEEECCCC-EEEEcccccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999975443 589999999976543211 11233578899999998764 57899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcc--------------------c--------cccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 579 GGKHPYGESFERDA--NIVKDRK--------------------D--------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~--------------------~--------~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
| .+||........ .+..... . ......++++.+++.+||+.+|++||++
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 200 Q-KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 7 778864332211 1110000 0 0112345788999999999999999999
Q ss_pred HHHHcCCCCCCc
Q 004097 629 QNVLNHPFFWTA 640 (774)
Q Consensus 629 ~elL~HPff~~~ 640 (774)
.++++||||.+.
T Consensus 279 ~~~l~~~~~~~~ 290 (294)
T PLN00009 279 RAALEHEYFKDL 290 (294)
T ss_pred HHHhcCchHhHH
Confidence 999999999653
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=297.45 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=188.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||.||++.. .+++.+|+|.+..... ....+|+. +++.++||||+++++++.+.+.+|++||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS-MLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHH-HHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4577889999999999999865 4578999999865432 23344544 77889999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+. +++|.+++... ...+++..+..++.|++.||+|||+.+|+
T Consensus 82 ~~----------~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 123 (262)
T cd06613 82 CG----------GGSLQDIYQVT----------------------------RGPLSELQIAYVCRETLKGLAYLHETGKI 123 (262)
T ss_pred CC----------CCcHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 55 44444433211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC---CCCCcchhHhHHHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDvwSlGvll~ell 577 (774)
|+||+|+||+++.++. +||+|||++....... .......++..|+|||.+... .++.++|+|||||++|||+
T Consensus 124 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 124 HRDIKGANILLTEDGD--VKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ecCCChhhEEECCCCC--EEECccccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999987765 8999999987665321 112234588899999999776 7889999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhc--cc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 578 TGGKHPYGESFERD-ANIVKDR--KD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~--~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
+| .+||....... ....... .. ......+.++.+++.+||..+|..|||+++++.|||
T Consensus 199 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 199 EL-QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hC-CCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 97 66775543222 1111111 00 011223467899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.32 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=186.0
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||.||++... +++.||+|++.+... ....+|+. ++..++||||+++++++.+++..|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHH-HHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4677899999999999998654 589999999854322 22345554 7788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+ +.+..+.. ....+++..++.++.||+.||+|||+.+|
T Consensus 81 ~~~~----------~~l~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (286)
T cd07846 81 FVDH----------TVLDDLEK-----------------------------YPNGLDESRVRKYLFQILRGIEFCHSHNI 121 (286)
T ss_pred cCCc----------cHHHHHHh-----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6654 33333211 11236677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+|+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 122 ~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 122 IHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred cccCCCHHHEEECCCCc--EEEEeeeeeeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 99999999999988765 89999999887643321 1223457889999999875 347889999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhh--------------------ccc----------cccccCCHHHHHHHHHhcCCCCCCCc
Q 004097 579 GGKHPYGESFERD--ANIVKD--------------------RKD----------LFLVEHIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~--------------------~~~----------~~~~~~~~~~~dli~~~L~~dP~~Rp 626 (774)
| .+||....... ..+... ... ......+..+.+++.+||+.+|++||
T Consensus 197 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 197 G-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred C-CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 7 67775432211 011100 000 00123356799999999999999999
Q ss_pred CHHHHHcCCCC
Q 004097 627 KAQNVLNHPFF 637 (774)
Q Consensus 627 s~~elL~HPff 637 (774)
++.++++||||
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.94 Aligned_cols=248 Identities=30% Similarity=0.526 Sum_probs=189.0
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|...+.||+|+||.||++.. .+++.||||.+...... ....|+ .++..++|+||+++++++.+.+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEM-KVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHH-HHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 56678999999999999854 46899999998754332 233444 477888999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ .+++|.+++... ..+++..+..++.|++.||+|||+.+|+
T Consensus 81 ~----------~~~~L~~~~~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 121 (264)
T cd06626 81 C----------SGGTLEELLEHG-----------------------------RILDEHVIRVYTLQLLEGLAYLHSHGIV 121 (264)
T ss_pred C----------CCCcHHHHHhhc-----------------------------CCCChHHHHHHHHHHHHHHHHHHHCCcc
Confidence 5 445554443221 1245667789999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccc-cccCcCCCCCCchhhhhcCC---CCCcchhHhHHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ-NATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFC 576 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~---~~~~sDvwSlGvll~el 576 (774)
|+||+|+||+++.++. +||+|||++............ .....++..|+|||++.... ++.++|||||||++|++
T Consensus 122 H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l 199 (264)
T cd06626 122 HRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM 199 (264)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHH
Confidence 9999999999988765 899999998876543221111 22345788999999998766 88999999999999999
Q ss_pred HhCCCCCCCCchHHH--H-HHHhhccccccccC--CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 577 ITGGKHPYGESFERD--A-NIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~--~-~~~~~~~~~~~~~~--~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++| ..||....... . .+........+... .+.+.++|.+||+.+|.+||++.+++.|||+
T Consensus 200 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 200 ATG-KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HhC-CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 997 77886432211 1 11111111222222 6788999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.04 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=188.1
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~ 418 (774)
.|...+.||.|++|.||++.. .+++.||+|.+..... ....+|++ +++.++||||+++++++.+ .+.+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE-INKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 366778999999999999865 4688999999875432 23456665 6788899999999998865 45789999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||| .+++|.+++.... .....+++..+..++.||+.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~l~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 81 EYC----------EGGSLDSIYKKVK-------------------------KRGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred Eec----------CCCCHHHHHHHHH-------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 4445544432211 01233567788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
++|+||+|+||+++.++. ++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 126 i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 126 IIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred cccCCCCHHHEEEecCCe--EEEeeccccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987765 8999999987654221 122347889999999998899999999999999999999
Q ss_pred CCCCCCCCchH------HHHHHHhhcccccc-------ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 579 GGKHPYGESFE------RDANIVKDRKDLFL-------VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 579 g~~~Pf~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
| ..||..... .....+........ ...++++.++|.+||+.+|.+|||+.|+++||||.+.
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 199 N-RFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred C-CCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 7 778765411 11111111111111 1123578999999999999999999999999999553
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.35 Aligned_cols=247 Identities=32% Similarity=0.500 Sum_probs=186.6
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-------------hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-------------DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
|...+.||+|+||+||++.. .+|+.||||.+..... +...+|+ .++..++||||+++++++.+.+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEI-ETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHH-HHHHhcCCCCcceEEEEeccCC
Confidence 56678899999999999854 4689999998753210 1123344 4678889999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..++||| |..+|+|.+.+... ..+++..+..++.||+.||.
T Consensus 82 ~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~ 122 (272)
T cd06629 82 YLSIFLE----------YVPGGSIGSCLRTY-----------------------------GRFEEQLVRFFTEQVLEGLA 122 (272)
T ss_pred ceEEEEe----------cCCCCcHHHHHhhc-----------------------------cCCCHHHHHHHHHHHHHHHH
Confidence 9999999 55555555544321 23566778899999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC--CCCcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSlG 570 (774)
|||+.+++||||+|+||+++.++. ++|+|||+++........ .......|+..|+|||.+.... ++.++|+||||
T Consensus 123 ~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG 199 (272)
T cd06629 123 YLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG 199 (272)
T ss_pred HHhhCCeeecCCChhhEEEcCCCe--EEEeeccccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHH
Confidence 999999999999999999987765 899999998765432111 1122345889999999987654 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhc-ccccc----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDR-KDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~-~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
+++|++++| ..||........ ...... ....+ ...+.++.++|.+||..||..||++.++++||||
T Consensus 200 ~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 200 CVVLEMFAG-RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHhC-CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999997 778764332221 111111 11111 2335789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=297.17 Aligned_cols=241 Identities=25% Similarity=0.381 Sum_probs=182.2
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
+.||+|+||+||++.. .+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIGVCTQKQPIYIVME------ 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEcCCCCeEEEEe------
Confidence 3599999999999855 4789999998764332 23445554 6788899999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
|..+++|.+++... ...+++..++.++.|++.||+|||+.+|+|||||
T Consensus 74 ----~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 121 (252)
T cd05084 74 ----LVQGGDFLTFLRTE----------------------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121 (252)
T ss_pred ----eccCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 55555555554321 1235677889999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. +||+|||++........ ........++..|+|||.+....++.++|||||||++|||++++.+||.
T Consensus 122 p~nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 122 ARNCLVTEKNV--LKISDFGMSREEEDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred hheEEEcCCCc--EEECccccCcccccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 99999987765 89999999876543211 0001111234569999999988899999999999999999986688886
Q ss_pred CchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 586 ESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 586 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
...... ...+ .......+...+..+.+++.+||+.||++|||+.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 199 NLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 543322 2222 22222333445678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.21 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=186.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCC--------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQ-------- 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-------- 411 (774)
+..|.+.+.||.|+||+||++.. .+|+.||+|.+..... ....+|+. ++..++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHH-HHHhcCCCcchhhHhhhccccccccccc
Confidence 56788999999999999999854 5689999999865432 23445654 67888999999999876554
Q ss_pred ------ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 412 ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 412 ------~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
...|+||||+.++|.+++. ...+++..++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~~~~ 121 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE-----------------------------------------QGPLSEEHARLFMY 121 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH-----------------------------------------cCCCCHHHHHHHHH
Confidence 3579999977665544331 12356778899999
Q ss_pred HHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcc
Q 004097 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAI 564 (774)
Q Consensus 486 qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~s 564 (774)
||+.||+|||+.+|+||||||+||+++.++. .+||+|||+++.+..............++..|+|||.+.. ..++.++
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence 9999999999999999999999999975543 5899999999866432111111122357889999998765 4578899
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhh-----------------------c-cc-----cccccCCHHHHHH
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDA--NIVKD-----------------------R-KD-----LFLVEHIPEAVDL 613 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~-----------------------~-~~-----~~~~~~~~~~~dl 613 (774)
|||||||++|+|++| ..||........ ..... . .. ........++.++
T Consensus 201 DiwSlGvil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 201 DMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999997 667754322111 11000 0 00 0112345788999
Q ss_pred HHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 614 FTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 614 i~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|.+||+.||.+|||+.++++||||..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcccc
Confidence 99999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.84 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=186.2
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEe
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLS 417 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV 417 (774)
.|.+.+.||+|+||.||++... +++.||||.++.... ....+|+. ++..++||||+++++++.+. +..|+|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN-ILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHH-HHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4566788999999999998654 588999999864321 12345665 66788899999999998877 899999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.++|.+++... ...+++..++.++.||+.||+|||+.
T Consensus 85 ~e~~~~~L~~~~~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~ 125 (293)
T cd07843 85 MEYVEHDLKSLMETM---------------------------------------KQPFLQSEVKCLMLQLLSGVAHLHDN 125 (293)
T ss_pred ehhcCcCHHHHHHhc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 997766655544210 12356778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~el 576 (774)
+++|+||||+||+++.++. ++|+|||++....... .......+++.|+|||.+.+.. ++.++|+|||||++|+|
T Consensus 126 ~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 126 WILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred CeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 9999999999999987765 8999999998765431 1112345788999999987644 68999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhhc------------------------------ccccccc-CCHHHHHHHHHhcCCCCC
Q 004097 577 ITGGKHPYGESFERDA--NIVKDR------------------------------KDLFLVE-HIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~--~~~~~~------------------------------~~~~~~~-~~~~~~dli~~~L~~dP~ 623 (774)
++| .+||........ .+.... ...++.. .++.+.++|.+||+.||+
T Consensus 201 ~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTK-KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhC-CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 997 777754322110 000000 0001111 356789999999999999
Q ss_pred CCcCHHHHHcCCCC
Q 004097 624 LRPKAQNVLNHPFF 637 (774)
Q Consensus 624 ~Rps~~elL~HPff 637 (774)
+|||+.|+++||||
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.78 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=189.7
Q ss_pred EeecccCceEEEEEeeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 351 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.||+|+||.||++.... +..||||.+...... ...+|+. ++..++|+||+++++++.+....+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEAR-VMKKLGHPNVVRLLGVCTEEEPLYLVLEYM- 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHH-HHhhcCCCChheeeeeecCCCceEEEEEec-
Confidence 359999999999986654 789999999765432 3334444 667788999999999999999999999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+++|.+++........ ......+++..+..++.|++.||+|||+.+++||
T Consensus 79 ---------~~~~L~~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 129 (262)
T cd00192 79 ---------EGGDLLDYLRKSRPVFP--------------------SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR 129 (262)
T ss_pred ---------cCCcHHHHHhhcccccc--------------------ccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 44455444432210000 0012447888899999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||.+........ ........++..|+|||.+....++.++|||||||++|||+++|..
T Consensus 130 di~p~nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 130 DLAARNCLVGEDLV--VKISDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCcceEEECCCCc--EEEcccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 99999999988765 89999999987764322 1222334578899999999888899999999999999999997788
Q ss_pred CCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 583 PYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 583 Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||....... ...+. ......+...++++.+++.+||+.||.+|||+.++++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 987654322 22222 22222344456899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.67 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=187.0
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCCeeEEeeeccCCc------e
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESDQD------F 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~------~ 413 (774)
.+.|.+.+.||+|++|+||++.. .+++.||+|++..... +...+|+. ++..+ .||||+++++++.+.. .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-ILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 45688889999999999999865 4678999999875432 33445655 44555 7999999999986644 5
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +++|.+++.... .....+++..+..++.|++.||+|
T Consensus 84 ~~lv~e~~~----------~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 84 LWLVMELCG----------GGSVTDLVKGLR-------------------------KKGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred EEEEEEcCC----------CCcHHHHHHHHh-------------------------hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 899999554 444444432211 012346777889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CCCCCcchhHh
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 568 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwS 568 (774)
||+.+++|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||++.. ..++.++||||
T Consensus 129 lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 129 LHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 99999999999999999987765 8999999987654321 12233458999999999854 34678999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 569 LGCILFFCITGGKHPYGESFERD--ANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|||++|+|++| .+||....... ..+....... .....++++.++|.+||..||++|||+.++++|||+
T Consensus 204 lG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 204 LGITAIELADG-KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hHHHHHHHHhC-CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999997 77886432211 1222111111 111245689999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.21 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=185.8
Q ss_pred ceEEEeEeecccCceEEEEEeeeCC----cE-EEEEEeecCC--c----hHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEG----RS-VAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g----~~-VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.++.+.++||+|+||.||+|.+..+ .. ||||..+... . ....+|. +++..++|||||++||++.+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EA-rvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEA-RVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEcCCCc
Confidence 3456668999999999999865542 23 8999987422 1 2234444 46777999999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|||||+|. +|+|.++|.... ..++..+...++.+.|.||+|
T Consensus 236 l~ivmEl~~----------gGsL~~~L~k~~----------------------------~~v~~~ek~~~~~~AA~Gl~Y 277 (474)
T KOG0194|consen 236 LMLVMELCN----------GGSLDDYLKKNK----------------------------KSLPTLEKLRFCYDAARGLEY 277 (474)
T ss_pred cEEEEEecC----------CCcHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHhHHHH
Confidence 999999555 555555553321 136677889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||++++|||||..+|+|++.++. +||+||||++..... ........-...|+|||.+....|+.++|||||||++
T Consensus 278 Lh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 278 LHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLL 352 (474)
T ss_pred HHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeE
Confidence 99999999999999999987654 899999998765411 1111111246789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH--HHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 574 FFCITGGKHPYGESFERDA--NIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~--~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||+++.+..||......+. .+...... ..+.....++..++.+|+..||+.||+|.++.
T Consensus 353 ~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 353 WEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred EeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 9999966778877554433 33243333 33444556788999999999999999999886
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=271.71 Aligned_cols=244 Identities=28% Similarity=0.450 Sum_probs=194.1
Q ss_pred EeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 351 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
++||+|.||+|+++... +++.||+|+++-.. ...+++||- +++.+.|.||||++++...+..+-+|+|+|+.+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreic-llkelkhknivrl~dvlhsdkkltlvfe~cdqd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHH-HHHHhhhcceeehhhhhccCceeEEeHHHhhHH
Confidence 67999999999998654 57899999986443 246889985 888999999999999999999999999999998
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
|..|.-.-||.+ +.+.++.++.|+++||.|+|+++++||||
T Consensus 87 lkkyfdslng~~---------------------------------------d~~~~rsfmlqllrgl~fchshnvlhrdl 127 (292)
T KOG0662|consen 87 LKKYFDSLNGDL---------------------------------------DPEIVRSFMLQLLRGLGFCHSHNVLHRDL 127 (292)
T ss_pred HHHHHHhcCCcC---------------------------------------CHHHHHHHHHHHHhhhhhhhhhhhhhccC
Confidence 888876555543 44566889999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHhCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~elltg~~~P 583 (774)
||+|.||+.+|+ +|++|||+++-+.-...++ ...+.|.+|.+|.++.+.+ |+...|+||.|||+.|+...|+|-
T Consensus 128 kpqnllin~nge--lkladfglarafgipvrcy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 128 KPQNLLINRNGE--LKLADFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred CcceEEeccCCc--EEecccchhhhcCCceEee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 999999998887 8999999999776432222 2345799999999998765 899999999999999999888887
Q ss_pred CCCchHHHH--HHHhh--c--c---------------ccccc---------cCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 584 YGESFERDA--NIVKD--R--K---------------DLFLV---------EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 584 f~~~~~~~~--~~~~~--~--~---------------~~~~~---------~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|....-.+. .+... . . ..++. .....-+|+++++|.-+|.+|.+++++++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 765433221 11110 0 0 00110 01124579999999999999999999999
Q ss_pred CCCCCC
Q 004097 634 HPFFWT 639 (774)
Q Consensus 634 HPff~~ 639 (774)
||||.+
T Consensus 283 hpyf~d 288 (292)
T KOG0662|consen 283 HPYFSD 288 (292)
T ss_pred Cccccc
Confidence 999965
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.05 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=188.8
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.|.+.+.||+|+||.||++... ++..||+|.+..... ....+|+. .++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCceE
Confidence 34777899999999999997532 356799999865432 23345554 778899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+||||+ .+++|.+++.........+. + .........+++..++.++.||+.||+|||
T Consensus 84 lv~e~~----------~~~~L~~~i~~~~~~~~~~~----------~---~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 84 MVFEYM----------KHGDLNKFLRAHGPDAMILV----------D---GQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEEecC----------CCCcHHHHHHhcCccccccc----------c---cccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999955 44444444433211000000 0 000011133678889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. ++|+|||+++....... ........++..|+|||++.+..++.++|||||||++||
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCCeeecccCcceEEEccCCc--EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987764 89999999976543211 111223456788999999999899999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 576 CITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
|++++..||....... ...+.. .........+.++.+++.+||+.||++||++.+++
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 9995588876543322 222222 12222333457899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.01 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=188.8
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|++ ++..++||||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLNENNICMCME- 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHH-HHHHcCCCCcceEeeeEecCCEEEEEEe-
Confidence 355668899999999999854 4689999998864432 23345554 6677899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 499 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~i 499 (774)
|+++|+|..++.. ...+++..+..++.+++.||.|||+ .++
T Consensus 84 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 125 (284)
T cd06620 84 ---------FMDCGSLDRIYKK-----------------------------GGPIPVEILGKIAVAVVEGLTYLYNVHRI 125 (284)
T ss_pred ---------cCCCCCHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcCe
Confidence 5555555554321 1236677889999999999999997 589
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. ++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|++++|
T Consensus 126 ~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 198 (284)
T cd06620 126 MHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198 (284)
T ss_pred eccCCCHHHEEECCCCc--EEEccCCcccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998755322 11234689999999999888899999999999999999997
Q ss_pred CCCCCCCchHH------------H-HHHHhhcccccc-ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 580 GKHPYGESFER------------D-ANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 580 ~~~Pf~~~~~~------------~-~~~~~~~~~~~~-~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
..||...... . ..++.......+ .....++.+++.+||+.||++|||+.|+++||||..
T Consensus 199 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 199 -KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 7788643321 0 111111111111 124568999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.26 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=188.3
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|.+.+.||+|++|+||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+.+..|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-LMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHH-HHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 567789999999999998654 68999999986432 234455655 677889999999999999999999999977
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.++|.+++.. . .....+++..+..++.|++.||+|||+.+++|
T Consensus 81 ~~~l~~~~~~-----------~--------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h 123 (284)
T cd07836 81 DKDLKKYMDT-----------H--------------------------GVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123 (284)
T ss_pred CccHHHHHHh-----------c--------------------------CCCCCcCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 7666555421 0 01123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+||+++.++. ++|+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|
T Consensus 124 ~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g- 197 (284)
T cd07836 124 RDLKPQNLLINKRGE--LKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG- 197 (284)
T ss_pred CCCCHHHEEECCCCc--EEEeecchhhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC-
Confidence 999999999987765 89999999976543211 11234578899999998664 468899999999999999997
Q ss_pred CCCCCCchHHHH--HHHhh--------------cc--------------ccccccCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 581 KHPYGESFERDA--NIVKD--------------RK--------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~--------------~~--------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
.+||........ .+... .. .......++++.++|.+||+.||.+||++.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 777764332110 11000 00 0001123568899999999999999999999
Q ss_pred HHcCCCC
Q 004097 631 VLNHPFF 637 (774)
Q Consensus 631 lL~HPff 637 (774)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.83 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=191.1
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~ 418 (774)
|.+.+.||.|+||+||++. ..+|+.||+|++..... .....|+ .+++.++||||+++++++.+ +...|++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHH-HHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5667889999999999984 45788999999864332 1222344 47788999999999997754 45689999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--- 495 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--- 495 (774)
| |..+++|.+++.... .....+++..++.++.||+.||+|||
T Consensus 81 e----------~~~~~~L~~~l~~~~-------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 125 (265)
T cd08217 81 E----------YCEGGDLAQLIQKCK-------------------------KERKYIEEEFIWRILTQLLLALYECHNRS 125 (265)
T ss_pred h----------hccCCCHHHHHHHHh-------------------------hcccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence 9 555566655543221 11234677888999999999999999
Q ss_pred --HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 496 --EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 496 --~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
+.+++|+||+|+||+++.++. +||+|||++........ ......+++.|+|||++....++.++|+||||+++
T Consensus 126 ~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 126 DPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 889999999999999987765 89999999987754321 12234689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 574 FFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
|+|++| ..||....... ...+ .......+....+++.+++.+||+.+|.+||++.++++|||+
T Consensus 201 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 201 YELCAL-SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHC-CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999997 77886543222 1222 222222344556899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.06 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=186.1
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
++|.+.+.||+|+||+||++...++..||+|.+..... +...+|+. ++..++||||+++++++.+ +..|++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQ-IMKKLRHDKLVQLYAVVSE-EPIYIVTE--- 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHH-HHHhcCCCceEEEEeEECC-CCcEEEEE---
Confidence 34667789999999999999877888999999875332 33445554 7788999999999998754 56899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
|+.+++|.++++... ...+++..++.++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05070 81 -------YMSKGSLLDFLKDGE---------------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126 (260)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 555555555543211 1235677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. ++|+|||++........ .......++..|+|||.+....++.++|||||||++|+|++++.+
T Consensus 127 di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 127 DLRSANILVGDGLV--CKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred CCccceEEEeCCce--EEeCCceeeeeccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCC
Confidence 99999999987654 89999999986643211 111122356789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 583 PYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 583 Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||....... ...+... ....+...+..+.+++.+||+.||.+|||+.++.
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 203 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 886543322 2222211 2222334567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.95 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=189.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeecc----CCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVES----DQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~----~~~~ 413 (774)
+..|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-ILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHH-HHHhcCCCCccCHHHhccccCCCCce
Confidence 46688889999999999999854 468999999986532 123445664 778889999999999875 3457
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+||||+.++|.+++ .. ...+++..+..++.||+.||+|
T Consensus 83 ~~lv~e~~~~~l~~~~-----------~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~ 122 (334)
T cd07855 83 VYVVMDLMESDLHHII-----------HS-----------------------------DQPLTEEHIRYFLYQLLRGLKY 122 (334)
T ss_pred EEEEEehhhhhHHHHh-----------cc-----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 8999996655444433 11 1236777889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
||+.+|+||||||+||+++.++. +||+|||++.......... .......|+..|+|||.+.. ..++.++|||||||
T Consensus 123 LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 200 (334)
T cd07855 123 IHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200 (334)
T ss_pred HHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHH
Confidence 99999999999999999988765 8999999997764322111 11123468899999999865 45889999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HH------------------------HHhhcc--cc-----ccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYGESFERD-AN------------------------IVKDRK--DL-----FLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~~------------------------~~~~~~--~~-----~~~~~~~~~~dli~~~L~ 619 (774)
++|||++| ++||....... .. ...... .. .....++++.++|.+||+
T Consensus 201 ~l~el~~g-~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 279 (334)
T cd07855 201 IFAEMLGR-RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQ 279 (334)
T ss_pred HHHHHHcC-CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHcc
Confidence 99999996 77885432110 00 000000 00 012346789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~ 640 (774)
.||.+||++++++.||||...
T Consensus 280 ~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 280 FDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred CChhhCcCHHHHHhChhhhhc
Confidence 999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=305.85 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=187.4
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
..||+|+||.||++.. .+++.||||.+.... .....+|+. ++..++||||+++++++..++..|+|+||+
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~----- 100 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHQNVVEMYKSYLVGEELWVLMEFL----- 100 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHH-HHHhCCCCchhhhhhheeeCCeEEEEEecC-----
Confidence 4699999999999854 468999999985432 223445554 667789999999999999999999999954
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
.+++|..++. ...+++..++.++.|++.||+|||+.+++||||||
T Consensus 101 -----~~~~L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p 145 (297)
T cd06659 101 -----QGGALTDIVS------------------------------QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145 (297)
T ss_pred -----CCCCHHHHHh------------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 4555544321 12356678899999999999999999999999999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
+||+++.++. +||+|||++....... .......|+..|+|||++.+..++.++|||||||++|||++| ..||..
T Consensus 146 ~Nill~~~~~--~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~~p~~~ 219 (297)
T cd06659 146 DSILLTLDGR--VKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG-EPPYFS 219 (297)
T ss_pred HHeEEccCCc--EEEeechhHhhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999988765 8999999987654321 112335689999999999988899999999999999999997 666654
Q ss_pred chH-HHHHHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 587 SFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 587 ~~~-~~~~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
... .....+..... .......+++.++|.+||+.+|++||+++++++||||..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 220 DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 322 22222221111 1122345789999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.54 Aligned_cols=242 Identities=28% Similarity=0.384 Sum_probs=184.1
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCCeeEEeeec-cCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVE-SDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~-~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||.||++. ..|..||+|.+....... ..+|+ .+++.++|+||+++++++ .+++..|++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~k~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~- 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM- 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEE-EcCCcEEEEEeCCCchHHHHHHHH-HHHHhCCCCCeeeEEEEEEcCCCceEEEEECC-
Confidence 346778999999999999964 458889999987554333 34454 477889999999999975 4556789999954
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.+++.... ...+++..++.++.|++.||+|||+.+|+||
T Consensus 83 ---------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 126 (256)
T cd05082 83 ---------AKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126 (256)
T ss_pred ---------CCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 4555555443211 1225677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||+++...... ....++..|+|||++....++.++|||||||++|||++.+.+
T Consensus 127 dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~ 198 (256)
T cd05082 127 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred ccchheEEEcCCCc--EEecCCccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999987765 8999999987654321 122346689999999988899999999999999999985588
Q ss_pred CCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||....... ...+ ...........++.+.+++.+||+.+|++|||+.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 199 PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 886543322 1222 22122223445678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.02 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=188.4
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.++||+|+||+||++...+++.||||.+..... ....+|+ .++..++||||+++++++. .+..|++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~-~~~~~~v~e-- 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEA-NLMKQLQHPRLVRLYAVVT-QEPIYIITE-- 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHH-HHHHhcCCcCeeeEEEEEc-cCCcEEEEE--
Confidence 456788899999999999999888899999999875432 3344555 4778889999999999874 457899999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+|+|.+++.... ...+++.+++.++.|++.||+|||+.+++|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H 125 (260)
T cd05067 81 --------YMENGSLVDFLKTPE---------------------------GIKLTINKLIDMAAQIAEGMAFIERKNYIH 125 (260)
T ss_pred --------cCCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 445555555443211 123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+||+++.++. ++|+|||++........ .......++..|+|||++....++.++|||||||++||+++++.
T Consensus 126 ~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 126 RDLRAANILVSETLC--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred ccccHHhEEEcCCCC--EEEccCcceeecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 999999999987765 89999999977652211 11122335678999999988889999999999999999999558
Q ss_pred CCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+||....... ...+... ....+...+.++.++|.+||+.+|++||+++++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 202 IPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8986543322 2222222 12223334578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.78 Aligned_cols=256 Identities=20% Similarity=0.310 Sum_probs=190.3
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||.||++... .+..||+|.+...... ...+|+ .++..++||||+++++++.+....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA-SVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEcCCCCc
Confidence 45778899999999999997543 3478999998654321 233444 467788999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||||+. +|+|.+++......... .-....+++..++.++.|++.||.||
T Consensus 85 ~~v~e~~~----------~~~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~~~l~~l 135 (277)
T cd05032 85 LVVMELMA----------KGDLKSYLRSRRPEAEN-------------------NPGLGPPTLQKFIQMAAEIADGMAYL 135 (277)
T ss_pred EEEEecCC----------CCCHHHHHHhcccchhh-------------------ccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999554 44444443322110000 01123357788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+||+++.++. +||+|||+++....... ........++..|+|||.+....++.++|||||||++|
T Consensus 136 H~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 136 AAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HhCCccccccChheEEEcCCCC--EEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 9999999999999999988775 89999999986653221 12223445788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|+++++.+||....... ..... ......+...+.++.++|.+||+.+|++|||+.++++
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99995588886543322 22222 2222334455689999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.83 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=187.7
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
|.+.+.||+|+||.||++.. .+++.||+|.+..... +...+|+ .++..++||||+++++++.+++..|++|||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEA-VLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHH-HHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 56779999999999999854 4689999998854321 2233454 4678899999999999999999999999954
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
++|++.+++... ....+++..++.++.|++.||.|||+.+|+|
T Consensus 81 ----------~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 123 (255)
T cd08219 81 ----------DGGDLMQKIKLQ---------------------------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123 (255)
T ss_pred ----------CCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 455555443221 1123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
+||||+||+++.++. ++++|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++| .
T Consensus 124 ~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~ 197 (255)
T cd08219 124 RDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL-K 197 (255)
T ss_pred CCCCcceEEECCCCc--EEEcccCcceeeccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc-c
Confidence 999999999987765 89999999876643211 11234588999999999988899999999999999999997 6
Q ss_pred CCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 582 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 582 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+||........ .+........+...+.++.++|.+||+.||++||++.+++.-
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 198 HPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 67765433221 222222222334456789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.11 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=190.0
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+++.+.++||+|+||+||++.. .++..||+|.+..... ....+|+. ++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHH-HHhcCCCCCCceEEEEEecCCceE
Confidence 3466778999999999999743 2466899998865432 23344554 778889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
++|||+. +|+|.++++.......... ....-....+++..++.++.||+.||+|||
T Consensus 84 lv~e~~~----------~~~L~~~i~~~~~~~~~~~--------------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 84 MVFEYMR----------HGDLNRFLRSHGPDAKILA--------------GGEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred EEEecCC----------CCCHHHHHHhcCcchhhhc--------------ccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999554 4444444433221100000 000011234678889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+++||||||+|||+++++. +||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 140 ~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 999999999999999987655 89999999876543211 111122345788999999998899999999999999999
Q ss_pred HHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++++.+||.+..... . .+........+...++.+.++|.+||+.||.+||++.++++
T Consensus 217 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 217 IFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9996688886543322 2 22222222333455688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.88 Aligned_cols=243 Identities=25% Similarity=0.412 Sum_probs=186.2
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
..||+|+||.||++.. .++..||||.+..... ....+|+. .+..++||||+++++.+.+.+..|+|||||.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~---- 102 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-IMRDYHHENVVDMYNSYLVGDELWVVMEFLE---- 102 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHH-HHHhCCCCcHHHHHHheecCCeEEEEEeCCC----
Confidence 5699999999999854 4688999999864332 23345554 6677899999999999999999999999554
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
+++|.+++.. ..+++..+..++.||+.||+|||+.+|+||||||
T Consensus 103 ------~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 146 (292)
T cd06658 103 ------GGALTDIVTH------------------------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146 (292)
T ss_pred ------CCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 4444443311 1245667889999999999999999999999999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
+||+++.++. ++|+|||++....... .......|+..|+|||.+.+..++.++|||||||++|||++| ..||..
T Consensus 147 ~Nill~~~~~--~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g-~~p~~~ 220 (292)
T cd06658 147 DSILLTSDGR--IKLSDFGFCAQVSKEV---PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG-EPPYFN 220 (292)
T ss_pred HHEEEcCCCC--EEEccCcchhhccccc---ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999987765 8999999987654321 112334589999999999888899999999999999999997 667654
Q ss_pred chHH-HHHHHhhc-ccc--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 587 SFER-DANIVKDR-KDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 587 ~~~~-~~~~~~~~-~~~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.... ....+... ... .....++.+.+++.+||..||.+|||++++++||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 221 EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 3322 22222111 111 112345789999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.28 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=193.1
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|++|.||++... +++.||||++..... ....+|+. .+..++||||+++++++.+.+..|+|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK-TLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3567789999999999998655 599999999876532 23344544 56778899999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-cCc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 499 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~i 499 (774)
++ +++|.+++.. ...+++..++.++.|++.||+|||+ .++
T Consensus 81 ~~----------~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 81 MD----------GGSLADLLKK-----------------------------VGKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred cC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 54 4455444321 1335677889999999999999999 999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||+|+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++|+||||+++|+|++|
T Consensus 122 ~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 122 IHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998876543221 1234578899999999988899999999999999999996
Q ss_pred CCCCCCCch--HH---HHHHHhhcccccccc-CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESF--ER---DANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~--~~---~~~~~~~~~~~~~~~-~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||.... .. ...+........... .+..+.++|.+||..+|++||++.++++||||...
T Consensus 197 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 197 -KFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -CCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 77886553 11 112222222222223 56789999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.23 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=190.3
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...+++.||||.+..... ....+|+. ++..++||||+++++++.+....++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e-- 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVTE-- 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHH-HHhhCCCCCEeeeeeeeecCCceEEEEe--
Confidence 456888899999999999998877788999999875432 33445554 7788999999999999999899999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 82 --------~~~~~~L~~~i~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h 126 (261)
T cd05034 82 --------YMSKGSLLDFLKSGE---------------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126 (261)
T ss_pred --------ccCCCCHHHHHhccc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 555555555443211 123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
+||||+||+++.++. ++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+++++++
T Consensus 127 ~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 127 RDLAARNILVGENLV--CKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred CCcchheEEEcCCCC--EEECccccceeccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999988765 89999999887653211 11112234678999999998889999999999999999999668
Q ss_pred CCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 582 HPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 582 ~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
+||....... . .+........+...++++.+++.+||+.+|.+||++++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 203 VPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 8986543322 1 2222112222334567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.41 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=189.9
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.|.+.+.||.|+||+||++...+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..|+|||||
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQ-ALKRLRHKHLISLFAVCSVGEPVYIITELM- 84 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHH-HHhcCCCcchhheeeeEecCCCeEEEEeec-
Confidence 3666788999999999999877799999999875543 23344554 678889999999999999999999999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
++|+|.+++.... ...+++..++.++.||+.||+|||+.+|+||
T Consensus 85 ---------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~ 128 (261)
T cd05148 85 ---------EKGSLLAFLRSPE---------------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128 (261)
T ss_pred ---------ccCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4455554443211 1235667889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||++......... .....++..|+|||.+....++.++|||||||++|+|++++.+
T Consensus 129 dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred ccCcceEEEcCCce--EEEccccchhhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999987765 899999999876532211 1233467789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||....... .. +........+...++++.++|.+||+.||.+|||+.++++
T Consensus 204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 204 PYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 986543322 22 2222222233455688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.24 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=189.2
Q ss_pred ceEEEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 411 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~ 411 (774)
+.|.+.+.||+|+||+||++... ++..||+|.+...... ....|+. ++..+ +||||+++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEecC
Confidence 45888999999999999987532 2357999999754322 2344555 45555 899999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|+|||||. +|+|.+++......... ............+++.++++++.|++.||
T Consensus 97 ~~~~lv~e~~~----------~~~L~~~i~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 97 GPLYVIVEYAS----------KGNLREYLRARRPPGME-------------YCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred CceEEEEecCC----------CCcHHHHHHhcCCcccc-------------cccccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999999554 44555544332110000 00000001123467888999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+++||||||+||+++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 230 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230 (307)
T ss_pred HHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence 9999999999999999999987765 89999999876543211 11112223457899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++.+||....... ...+... ....+.....++.++|.+||..+|.+||++.+++++
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999996688886644332 2222222 222334456799999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.38 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=180.2
Q ss_pred eecccCceEEEEEeee--------CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 352 EIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.||+|+||+||++... ....||+|.+..... ...+.++..++..+.||||+++++++.+++..++|||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5899999999997542 234589998865432 233444456788899999999999999999999999954
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+|+|..++.... ..+++..++.++.||+.||+|||+.+|+|
T Consensus 82 ----------~~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH 123 (258)
T cd05078 82 ----------KFGSLDTYLKKNK----------------------------NLINISWKLEVAKQLAWALHFLEDKGLTH 123 (258)
T ss_pred ----------CCCcHHHHHhcCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4555555443211 12456677899999999999999999999
Q ss_pred cccCCCCeeecCCCCc------eEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHH
Q 004097 502 RDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 574 (774)
Q Consensus 502 rDLkp~NILl~~~~~~------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ 574 (774)
|||||+||+++.++.. .++++|||++...... ....++..|+|||++.+. .++.++|||||||++|
T Consensus 124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred CCCccceEEEecccccccCCCceEEecccccccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 9999999999876542 3789999988654321 224578899999999864 5789999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|+.+||..................+....+++.++|.+||+.||++|||++++++.
T Consensus 197 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 197 EIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999987778765443332222222223334455789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.95 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=181.7
Q ss_pred EeEeecccCceEEEEEeeeC-Cc--EEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC------cee
Q 004097 349 FNKEIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 414 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~-g~--~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~~ 414 (774)
+.+.||+|+||.||++.... +. .||||.++... .....+|+. .+..++||||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAV-CMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45789999999999986544 32 69999886432 122334544 67788999999999987432 346
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+++|| |+.+|+|.+++...... .....+++..+..++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~l~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 82 VVILP----------FMKHGDLHSFLLYSRLG-----------------------DCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred EEEEE----------eCCCCcHHHHHHHhccc-----------------------CCcccCCHHHHHHHHHHHHHHHHHH
Confidence 89999 55555555544221100 1123467888899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ .......+++.|+|||.+....++.++|||||||++|
T Consensus 129 H~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 899999999876532211 1112234677899999999889999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++++..||....... ...+.. ............+.++|.+||+.||++|||+.+++++
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99996688886543322 122222 2222334456789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.66 Aligned_cols=245 Identities=30% Similarity=0.467 Sum_probs=187.5
Q ss_pred ecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||+||++... +|+.||+|++..... ....+|+ .++..++||||+++++.+.+++..|+++|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~---- 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTER-DILSQAQSPYVVKLYYSFQGKKNLYLVMEYL---- 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHH-HHHHhCCCcchhHHHHheecCcEEEEEEecC----
Confidence 689999999998665 489999999865432 1233344 4677889999999999999999999999954
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.+++|.+++.. ...+++..+..++.||+.||+|||+.+++|+||+
T Consensus 76 ------~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 76 ------PGGDLASLLEN-----------------------------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred ------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 45555544322 1236777889999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCcc-----ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+++.++. ++|+|||++......... ........++..|+|||.+....++.++||||||+++|++++|
T Consensus 121 ~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 197 (265)
T cd05579 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG- 197 (265)
T ss_pred HHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC-
Confidence 99999988875 899999998765432110 0112234578899999999888899999999999999999997
Q ss_pred CCCCCCchHHHH-HHHhhccccccccC--CHHHHHHHHHhcCCCCCCCcCH---HHHHcCCCCCCc
Q 004097 581 KHPYGESFERDA-NIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFFWTA 640 (774)
Q Consensus 581 ~~Pf~~~~~~~~-~~~~~~~~~~~~~~--~~~~~dli~~~L~~dP~~Rps~---~elL~HPff~~~ 640 (774)
..||........ ..........+... ++++.+++.+||+.+|.+|||+ .++++||||.+.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 198 IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 778765443322 22222222222222 6789999999999999999999 999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.21 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=189.8
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 413 (774)
..|.+.+.||+|+||.||++... ....||+|++...... ...+|+. ++..+ +||||+++++++.+++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEcCCCC
Confidence 45777899999999999997543 2368999998754322 2345665 45555 89999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|++|||| ++|+|..++........... ..........+++..++.++.|++.||+|
T Consensus 91 ~~li~e~~----------~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 91 LYVVVEYA----------AHGNLRDFLRARRPPGEYAS-------------PDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred eEEEEEeC----------CCCcHHHHHHhcCCCccccc-------------cccccccccccCHHHHHHHHHHHHHHHHH
Confidence 99999955 44455444433211000000 00000112457788999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+||+++.++. +||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred HHHCCccccccceeeEEEcCCCe--EEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 99999999999999999987764 89999999987653221 1111223356789999999888999999999999999
Q ss_pred HHHHhCCCCCCCCchHH-HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||+++.+..||...... ....+... ....+....+++.+++.+||..||++|||+.|++++
T Consensus 225 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99998557787654322 22222222 222334556799999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.26 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=186.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+.|.+.+.||+|+||+||++.. .+|+ .||||.+...... ...+|+ ..+..+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA-YVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHH-HHHHhcCCCCCceEEEEEcCC-Cc
Confidence 34577889999999999999853 3454 4899998654332 223344 466788999999999998764 57
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++++| |+++|+|.+++... ...+++..++.++.|++.||+||
T Consensus 84 ~l~~~----------~~~~g~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~l 125 (279)
T cd05109 84 QLVTQ----------LMPYGCLLDYVREN----------------------------KDRIGSQDLLNWCVQIAKGMSYL 125 (279)
T ss_pred EEEEE----------cCCCCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 88999 66667776655321 12367788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|
T Consensus 126 H~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 202 (279)
T cd05109 126 EEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVW 202 (279)
T ss_pred HHCCeeccccccceEEEcCCCc--EEECCCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHH
Confidence 9999999999999999987765 8999999998765322111 111223567899999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++.+.+||....... ...+... ....+...++++.+++.+||+.||+.||++.+++.
T Consensus 203 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 203 ELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99995588887544322 2222222 22223445678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.34 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=179.5
Q ss_pred eecccCceEEEEEeee---CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 352 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.||+|+||.||++... .+..||||++...... ...+|+. ++..++||||+++++++.. +..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~-~~~~lv~e----- 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAE-IMHQLDNPYIVRMIGVCEA-EALMLVME----- 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHH-HHHhcCCCCeEEEEEEEcC-CCeEEEEE-----
Confidence 3899999999997543 4567999998654322 2334544 7788999999999998864 57899999
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
|+++|+|.+++... ...+++..+++++.|++.||+|||+.+++||||
T Consensus 75 -----~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 121 (257)
T cd05115 75 -----MASGGPLNKFLSGK----------------------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121 (257)
T ss_pred -----eCCCCCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 44555555544321 123677888999999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
||+|||++.++. +||+|||++.................++..|+|||++....++.++|||||||++||+++.+.+||
T Consensus 122 kp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 122 AARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred chheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999999987754 899999999865433222111122234678999999988889999999999999999997447888
Q ss_pred CCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 585 GESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 585 ~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
........ ..+ .......+....+++.++|.+||+.||++||++.++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 200 KKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66443322 222 22222334455789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.05 Aligned_cols=249 Identities=30% Similarity=0.431 Sum_probs=193.3
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCC-CCCeeEEeeeccCCceeEEe
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~~~LV 417 (774)
.|.+.+.||+|+||.||++... +|+.||+|++.+.. .....+|. .++..++ ||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHH-HHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4678899999999999998654 78999999986521 12233444 4566777 99999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||++ .+++|.+++.. ...+++..++.|+.|++.||+|||+.
T Consensus 81 ~e~~----------~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~ 121 (280)
T cd05581 81 LEYA----------PNGELLQYIRK-----------------------------YGSLDEKCTRFYAAEILLALEYLHSK 121 (280)
T ss_pred EcCC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9965 34444443321 12467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-----------------ccccccCcCCCCCCchhhhhcCCC
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----------------LTQNATGYGSSGWQAPEQLLQGRQ 560 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~l~~~~~ 560 (774)
+++|+||+|+||+++.++. ++|+|||++......... ........++..|+|||++....+
T Consensus 122 ~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 122 GIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred CeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 9999999999999988775 899999998876543211 012233457899999999988889
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCC
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHP 635 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HP 635 (774)
+.++|+|||||+++++++| ..||....... ...........+...++.+.++|.+||+.||.+||++ +++++||
T Consensus 200 ~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTG-KPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred ChhhhHHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 9999999999999999996 77887654322 1222222333444557899999999999999999999 9999999
Q ss_pred CC
Q 004097 636 FF 637 (774)
Q Consensus 636 ff 637 (774)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.51 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=180.8
Q ss_pred eEEEeEeecccCceEEEEEe-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--cee
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~ 414 (774)
.+.+.+.||+|+||+||++. ..+++.||+|.+..... ....+|+. ++..++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN-ILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCCceE
Confidence 34778899999999998743 24678999999865432 23345554 77889999999999987653 468
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||| ..+|+|.+++.. ..+++.+++.++.|++.||+||
T Consensus 84 ~lv~e~----------~~~~~l~~~~~~------------------------------~~l~~~~~~~i~~~l~~~l~~l 123 (283)
T cd05080 84 QLIMEY----------VPLGSLRDYLPK------------------------------HKLNLAQLLLFAQQICEGMAYL 123 (283)
T ss_pred EEEecC----------CCCCCHHHHHHH------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 999994 455555554321 2367778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. ++|+|||+++................++..|+|||.+....++.++|||||||++|
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~ 201 (283)
T cd05080 124 HSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201 (283)
T ss_pred HHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHH
Confidence 9999999999999999987765 89999999987654322111112234567799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHHH----------------HHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERDAN----------------IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++| ..||......... ..... ....+...+.++.+++.+||+.||+.|||++++++
T Consensus 202 el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 202 ELLTH-CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhC-CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99997 6676543211100 00000 11112334578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.39 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=181.8
Q ss_pred eEEEeEeecccCceEEEEEeee-CCc----EEEEEEeecCCchHHHHHHH---HHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~----~VAVK~l~~~~~~~~~~Ei~---~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.|.+.+.||+|+||+||++... +|+ .||+|.+........++++. ..++.++||||+++++++.+ ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 3566788999999999998543 444 47788775433333333332 25578899999999998764 557889
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+| |+++|+|.+++... ...+++..++.|+.||+.||+|||+.
T Consensus 87 ~e----------~~~~gsL~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 87 TQ----------LSPLGSLLDHVRQH----------------------------RDSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred EE----------eCCCCcHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 56666666655422 12367778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+++||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++||++
T Consensus 129 ~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 129 RMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKKY-FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred CEeccccCcceEEEcCCCc--EEEcCCccceeccCCCccc-ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999977654 8999999998764332111 112334677899999999889999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccc-cccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKDLF-LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~~~-~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+.+..||....... ..++....... +.....++.+++.+||..||++|||+.|+++
T Consensus 206 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 206 SYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 84477886543332 23333222222 2234468899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.90 Aligned_cols=245 Identities=26% Similarity=0.434 Sum_probs=184.9
Q ss_pred EEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 348 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.+.||.|++|+||++.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+.+..|++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-LLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHH-HHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 3457899999999999854 479999999986432 123455665 678889999999999999999999999966
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.++|.+++ .... ...+++..++.++.|++.||+|||+.+++|
T Consensus 81 ~~~l~~~~-----------~~~~---------------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H 122 (283)
T cd07835 81 DLDLKKYM-----------DSSP---------------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122 (283)
T ss_pred CcCHHHHH-----------hhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 55554443 1110 023677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 123 ~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g- 196 (283)
T cd07835 123 RDLKPQNLLIDREGA--LKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR- 196 (283)
T ss_pred CCCCHHHEEEcCCCc--EEEeecccccccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC-
Confidence 999999999988765 89999999876542211 11223468899999988664 468899999999999999997
Q ss_pred CCCCCCchHHH--HHHHhh---------------------c-------cccccccCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 581 KHPYGESFERD--ANIVKD---------------------R-------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 581 ~~Pf~~~~~~~--~~~~~~---------------------~-------~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
.+||....... ..+... . ........++++.++|.+||+.||.+|||++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 67775432211 111110 0 00011233468899999999999999999999
Q ss_pred HHcCCCC
Q 004097 631 VLNHPFF 637 (774)
Q Consensus 631 lL~HPff 637 (774)
+++||||
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.82 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=188.7
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.++|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-VLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHH-HHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4778899999999999998554 58899999886432 123445554 6788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+.+++.+.+ . .+...+++..+..++.||+.||+|||+.++
T Consensus 81 ~~~~~~l~~~----------~-----------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 81 YVERTLLELL----------E-----------------------------ASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cCCCCHHHHH----------H-----------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 7765443322 1 111235677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+|+||+|+||+++.++. +||+|||++........ .......++..|+|||++... .++.++||||||+++|+|++
T Consensus 122 ~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 122 IHRDIKPENILVSESGV--LKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred ecCCCCHHHeEECCCCC--EEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999987765 89999999887654321 112234578899999999888 78999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhh-------------------c------------cccccccCCHHHHHHHHHhcCCCCCCC
Q 004097 579 GGKHPYGESFERDA--NIVKD-------------------R------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~-------------------~------------~~~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
| .+||......+. .+... . ...++...++++.++|++||+.+|++|
T Consensus 198 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 198 G-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 7 677764322111 00000 0 000111235789999999999999999
Q ss_pred cCHHHHHcCCCC
Q 004097 626 PKAQNVLNHPFF 637 (774)
Q Consensus 626 ps~~elL~HPff 637 (774)
|+++++++||||
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.31 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=188.4
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC-----c
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~ 412 (774)
.+.|...+.||+|+||+||++.. .+|+.||||.+.... .....+|+. ++..++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK-LLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHH-HHHhcCCCCccchHHheecccccccC
Confidence 45688889999999999999854 568999999986431 123445654 67778999999999987654 3
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|+||+.++|.+++. ....+++..+..++.|++.||+
T Consensus 83 ~~~lv~e~~~~~L~~~~~----------------------------------------~~~~l~~~~~~~i~~qi~~aL~ 122 (337)
T cd07858 83 DVYIVYELMDTDLHQIIR----------------------------------------SSQTLSDDHCQYFLYQLLRGLK 122 (337)
T ss_pred cEEEEEeCCCCCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHHH
Confidence 589999987766655441 1123567788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
|||+.+++||||||+||+++.++. +||+|||+++...... .......++..|+|||.+.. ..++.++|||||||
T Consensus 123 ~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (337)
T cd07858 123 YIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC 197 (337)
T ss_pred HHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHH
Confidence 999999999999999999987765 8999999998764321 11233457889999999875 46889999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HH-H-----------------------Hhhc---c----ccccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYGESFERD-AN-I-----------------------VKDR---K----DLFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~~-~-----------------------~~~~---~----~~~~~~~~~~~~dli~~~L~ 619 (774)
++|+|++| .+||....... .. + .... . .......++++.++|.+||+
T Consensus 198 il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 276 (337)
T cd07858 198 IFAELLGR-KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLV 276 (337)
T ss_pred HHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhc
Confidence 99999996 77775432110 00 0 0000 0 00112456789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 004097 620 PNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~ 639 (774)
.||++|||++++++||||..
T Consensus 277 ~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 277 FDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CChhhccCHHHHHcCcchhh
Confidence 99999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=345.72 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=197.5
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-h---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-D---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.-++.-...||.|.||.||-+. ..+|...|||.++-... . ....|+..++..++|||+|++||+..+++.+||
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 334444555679999999999985 45699999998753221 1 223455568899999999999999999999999
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
.||||. |+|.+++.. ++ ..++.....+..|++.|++|||
T Consensus 1312 FMEyC~~GsLa~ll~~-gr---------------------------------------i~dE~vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GR---------------------------------------IEDEMVTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred HHHHhccCcHHHHHHh-cc---------------------------------------hhhhhHHHHHHHHHHHHHHHHH
Confidence 999776 456555521 11 1233344678899999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhcCC---CCCcchhHhHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGC 571 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDvwSlGv 571 (774)
++|||||||||.||+|+.+| .+|++|||.|..+..... ........+||+.|||||++.+.. ...+.||||+||
T Consensus 1352 ~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1352 EHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred hcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 99999999999999998877 489999999998876531 112234567999999999998644 568999999999
Q ss_pred HHHHHHhCCCCCCCCchHH---HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 572 ILFFCITGGKHPYGESFER---DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|+.||+|| +-||.+-... ...+..+..+..|...+++.+|+|.+||+.||++|.++.|+++|-|-..
T Consensus 1430 VVlEM~tG-krPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1430 VVLEMATG-KRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred eEEEeecC-CCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999998 6688653322 2234444555566677899999999999999999999999999998644
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.05 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=185.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..|.+.+.||+|+||.||++.. .+++.||||.+..... ....+|+. +++.++||||+++++++.+.+..|++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEID-LLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCcceeeeeeeEEECCeEEEE
Confidence 3577889999999999999854 4789999998754221 12344554 77888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+||++ +|+|.+++.... .+...+++..+..++.|++.||+|||+.
T Consensus 81 ~e~~~----------~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 81 LELAD----------AGDLSQMIKYFK-------------------------KQKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred EEecC----------CCcHHHHHHHhh-------------------------hccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 99554 455544432111 0112357778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+++|+||||+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|||+
T Consensus 126 ~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 126 RVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CeeCCCCCHHHEEEcCCCC--EEECccccceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 9999999999999988765 89999999887653211 112345889999999998888999999999999999999
Q ss_pred hCCCCCCCCchHH---HHHHHhhcc--ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 578 TGGKHPYGESFER---DANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 578 tg~~~Pf~~~~~~---~~~~~~~~~--~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+| ..||...... ....+.... .......+.++.++|.+||+.+|++||++.++++.
T Consensus 201 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 201 AL-QSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cC-CCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 97 4455432211 112221111 11122345689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.59 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=185.6
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|++|+||++....+..||+|++..... ....+|+. ++..++||||+++++++. .+..|++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~-~~~~~~v~e~-- 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQ-IMKKLRHDKLVPLYAVVS-EEPIYIVTEF-- 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHH-HHHhCCCCCeeeEEEEEc-CCCcEEEEEc--
Confidence 45778889999999999998777777899998865432 23345554 778899999999999875 4568999994
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+.+|+|.+++.... ...+++..+..++.|++.||+|||+.+++|+
T Consensus 82 --------~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05069 82 --------MGKGSLLDFLKEGD---------------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126 (260)
T ss_pred --------CCCCCHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 44555555443211 1225667788999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||++++++. ++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++++.+
T Consensus 127 dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 127 DLRAANILVGDNLV--CKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCcceEEEcCCCe--EEECCCccceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999987764 89999999976643211 111222356789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||....... ...+... ....+...+..+.+++.+||..||++||+++++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 203 PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 886644322 2222221 12223345678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.79 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=187.8
Q ss_pred cceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||.||++... ++..||||+++..... ...+|+. ++..+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK-IMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHH-HHHhccCCCCcceEEEEEecCC
Confidence 456888899999999999997532 3568999998754322 2344555 56666 8999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|++|| |+.+|+|.++++... ...+++.++..++.|++.||+
T Consensus 113 ~~~lv~e----------~~~~~~L~~~i~~~~---------------------------~~~l~~~~~~~i~~~i~~~l~ 155 (302)
T cd05055 113 PILVITE----------YCCYGDLLNFLRRKR---------------------------ESFLTLEDLLSFSYQVAKGMA 155 (302)
T ss_pred ceEEEEE----------cCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 9999999 555566665543211 122677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+|+||||+|||++.++ .++++|||+++........ .......++..|+|||.+....++.++|||||||+
T Consensus 156 ~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvi 232 (302)
T cd05055 156 FLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232 (302)
T ss_pred HHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHH
Confidence 99999999999999999997665 4899999999866533211 11122346788999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 573 LFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|||++++.+||....... ....... ....+...++++.+++.+||+.+|++|||+.|+++
T Consensus 233 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999985577876543222 1222211 11222344678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=302.61 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=189.4
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .++..||||++..... ....+|+. .++.++|||++++++++.+++..|+|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK-FLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHH-HHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 55667899999999999864 4689999999864321 12344554 6788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++... ...+++..+..++.|++.||.|||+.+|
T Consensus 106 ~~~g~l~~~~~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~i 146 (317)
T cd06635 106 YCLGSASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHNM 146 (317)
T ss_pred CCCCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 8877665554211 1235667888999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~el 576 (774)
+||||+|+||+++.++. ++|+|||++..... .....|+..|+|||++. .+.++.++|||||||++|||
T Consensus 147 ~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 147 IHRDIKAGNILLTEPGQ--VKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred ccCCCCcccEEECCCCC--EEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHH
Confidence 99999999999987765 89999998875432 12345889999999984 45688999999999999999
Q ss_pred HhCCCCCCCCch-HHHH-HHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 577 ITGGKHPYGESF-ERDA-NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 577 ltg~~~Pf~~~~-~~~~-~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
++| .+||.... .... .+..... .......++.+.++|.+||+.+|.+||++.++++|||+.....
T Consensus 218 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 218 AER-KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HhC-CCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 997 55654432 2222 2222221 1122234578999999999999999999999999999966543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.48 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=175.0
Q ss_pred eecccCceEEEEEeeeC---CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 352 EIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~---g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
+||+|+||+||++.... ...||||.+...... ...+|+. .+..++||||+++++++.+.+..|+||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~h~nii~~~~~~~~~~~~~lv~e~~--- 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ-PYRELNHPNVLQCLGQCIESIPYLLVLEFC--- 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHH-HHHhCCCCCcceEEEEECCCCceEEEEEeC---
Confidence 59999999999986544 357889987644322 2334544 567789999999999999999999999954
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
.+|+|.+++...... .....++..++.++.||+.||+|||+.+|+||||
T Consensus 78 -------~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 126 (269)
T cd05042 78 -------PLGDLKNYLRSNRGM------------------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL 126 (269)
T ss_pred -------CCCcHHHHHHhcccc------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence 455555554332110 0112345677899999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-------CCCCCcchhHhHHHHHHHHH
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSlGvll~ell 577 (774)
||+|||++.++. +||+|||++......... .......++..|+|||++.. ..++.++|||||||++|||+
T Consensus 127 kp~Nill~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 127 ALRNCQLTADLS--VKIGDYGLALEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred cHhheEecCCCc--EEEeccccccccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 999999987765 899999998754322111 11122346778999999753 34678999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA--NIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+++.+||........ ..+.... ........+.+.+++..|+ .||++|||+++|++
T Consensus 204 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 977888876543321 1122111 1112234567888999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.04 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=189.3
Q ss_pred EEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 348 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..-+.||+|++|.||++.. .+++.||+|++..... ....+|+. ++..++||||+++++++...+..|+++|
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~-~l~~~~h~~vv~~~~~~~~~~~~~~v~e---- 96 (285)
T cd06648 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV-IMRDYQHPNIVEMYSSYLVGDELWVVME---- 96 (285)
T ss_pred hcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHHcCCCChheEEEEEEcCCeEEEEEe----
Confidence 3346899999999999854 5788999998854322 23445554 6778899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+.+++|.+++.. ..+++..+..++.|++.||+|||+.+|+|||
T Consensus 97 ------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 140 (285)
T cd06648 97 ------FLEGGALTDIVTH------------------------------TRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140 (285)
T ss_pred ------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 5555555554321 2356677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|+|+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|||++| .+|
T Consensus 141 l~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g-~~p 214 (285)
T cd06648 141 IKSDSILLTSDGR--VKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG-EPP 214 (285)
T ss_pred CChhhEEEcCCCc--EEEcccccchhhccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC-CCC
Confidence 9999999987765 89999998876543211 12234589999999999888899999999999999999997 666
Q ss_pred CCCchH-HHHHHHhhccc-c--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 584 YGESFE-RDANIVKDRKD-L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~-~~~~~~~~~~~-~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|..... ........... . .....++.+.++|.+||+.+|++||++.++++||||..+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 215 YFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 654322 22222222111 1 1122457899999999999999999999999999996643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.40 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=186.2
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ------ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 411 (774)
.+.|.+.+.||+|+||.||++.. .+++.||||++..... ....+|++ ++..++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHH-HHHhcCCCCccchhhheecccccccc
Confidence 45688899999999999999854 4689999999854321 23456665 67888999999999987543
Q ss_pred --ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 412 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 412 --~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
..+|+|+||+..+|.+.+.. ....+++..+..++.|+++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~ 126 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLEN---------------------------------------PSVKLTESQIKCYMLQLLE 126 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhc---------------------------------------cccCCCHHHHHHHHHHHHH
Confidence 35799999776655443311 1123677888999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcccc--------ccccCcCCCCCCchhhhhcC-CC
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--------QNATGYGSSGWQAPEQLLQG-RQ 560 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~-~~ 560 (774)
||+|||+.+|+|+||||+||+++.++. ++|+|||+++.......... ......+++.|+|||.+.+. .+
T Consensus 127 al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 127 GINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 999999999999999999999988765 89999999986653221111 11223578889999988754 57
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc--------------c---------------cccccCCHH
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRK--------------D---------------LFLVEHIPE 609 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~--------------~---------------~~~~~~~~~ 609 (774)
+.++|||||||++|||++| .+||........ .+..... . .......++
T Consensus 205 ~~~~Dv~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283 (311)
T ss_pred CchhHhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChh
Confidence 8999999999999999997 778764332211 1110000 0 000123367
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
+.++|.+||+.||.+|||+.|++.||||
T Consensus 284 ~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.61 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=187.5
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .+|+.||+|++..... ....+|+ .++..++||||+++++++.+.+..|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV-KFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHH-HHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 44557799999999999854 4689999999864321 1233455 47788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++... ...+++.+++.++.||+.||+|||+.++
T Consensus 102 ~~~~~l~~~l~~~---------------------------------------~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 102 YCLGSASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred cCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8877665554211 1235667788999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~el 576 (774)
+|+||+|+||+++.++. +||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|
T Consensus 143 ~H~dl~p~nili~~~~~--~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 143 IHRDIKAGNILLTEPGQ--VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred ecCCCChhhEEECCCCC--EEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999987765 89999998864321 12346889999999984 35678899999999999999
Q ss_pred HhCCCCCCCCchH-HHH-HHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 577 ITGGKHPYGESFE-RDA-NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~-~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++| .+||..... ... .+..... ..........+.+++.+||+.+|.+||++.+++.||||....
T Consensus 214 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 214 AER-KPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HhC-CCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 997 556644322 222 2221111 111223446799999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.06 Aligned_cols=236 Identities=24% Similarity=0.323 Sum_probs=178.2
Q ss_pred EeecccCceEEEEEeeeCC-----------cEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 351 KEIAKGSNGTVVLEGNYEG-----------RSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g-----------~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.||+|+||.||++...+. ..||+|.+..... ...+.+...+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 3589999999999866543 2588888765433 3334444457888999999999999988 7789999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |+.+|+|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 80 e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 80 E----------YVKFGPLDVFLHREK----------------------------NNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred E----------cCCCCcHHHHHHhhc----------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9 555566655543211 13567778999999999999999999
Q ss_pred ccccccCCCCeeecCCCC-----ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC--CCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~-----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlGv 571 (774)
|+||||||+|||++.++. ..+||+|||++..... .....++..|+|||++... .++.++|||||||
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 999999999999987652 1489999999886543 1223467789999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++|+..||........ ..... ....+.....++.++|.+||..+|.+|||+.++++
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999977888866532221 11111 11122223378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.95 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=177.9
Q ss_pred EeecccCceEEEEEeee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeecc-CCceeEEecccc
Q 004097 351 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES-DQDFVYLSLERC 421 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~-~~~~~~LV~E~~ 421 (774)
+.||+|+||+||++... .+..||+|++..... ....+|+. +++.++||||+++++++. .++..|++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~lv~e-- 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVLSLLGICLPSEGSPLVVLP-- 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHH-HHccCCCCCcceEEEEeecCCCCcEEEEe--
Confidence 35899999999998643 245799999854322 22334544 678899999999999775 4566899999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+|+|.+++.... ...++..++.++.|++.||+|||+.+++|
T Consensus 78 --------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 78 --------YMKHGDLRNFIRSET----------------------------HNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred --------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 555555555543211 11344566889999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCcc-ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+|||++.++. +||+|||+++........ ........++..|+|||.+....++.++|||||||++|||++|+
T Consensus 122 ~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 999999999987765 899999999865432111 11112234677899999998888999999999999999999987
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
.+||........ .+........+...++.+.+++.+||+.+|++||++.++++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 888865433221 122222222233345789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=292.56 Aligned_cols=240 Identities=27% Similarity=0.391 Sum_probs=179.9
Q ss_pred EeecccCceEEEEEeee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 351 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
++||+|+||.||+|... .+..||+|.+..... ....+|+. +++.+.|||||++++++. .+..++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~- 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS-VMAQLDHPCIVRLIGVCK-GEPLMLVMELA- 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEc-CCceEEEEEeC-
Confidence 36999999999997432 236899999875443 22344554 677889999999999876 45689999954
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.+++... ..+++..++.++.|++.||+|||..+++||
T Consensus 78 ---------~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 119 (257)
T cd05060 78 ---------PLGPLLKYLKKR-----------------------------REIPVSDLKELAHQVAMGMAYLESKHFVHR 119 (257)
T ss_pred ---------CCCcHHHHHHhC-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 445555444221 135677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++................++..|+|||.+....++.++|||||||++||+++++.+
T Consensus 120 di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~ 197 (257)
T cd05060 120 DLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197 (257)
T ss_pred CcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence 99999999987765 8999999998775433222222222345689999999988999999999999999999985588
Q ss_pred CCCCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||........ ..+ .......+...++.+.++|.+||..+|++||++.++++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 198 PYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9876543322 222 22222334445678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.27 Aligned_cols=287 Identities=22% Similarity=0.306 Sum_probs=191.8
Q ss_pred ceEEEeEeecccCceEEEEEe------eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC-Cce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~------~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 413 (774)
++|.+.+.||+|+||+||++. ..+++.||||+++.... ....+|+..+....+||||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 457788999999999999984 34578999999965332 2345677655444489999999998765 456
Q ss_pred eEEeccccC-CChhhHHHHhcCCh--------------------HHHhhhhhhcchhhHH--H-----HHhhcccccchh
Q 004097 414 VYLSLERCT-CSLNDLIYVLSGSF--------------------EEQLNAKEQDSNLLNE--V-----RIRLLPVMENTK 465 (774)
Q Consensus 414 ~~LV~E~~~-~sL~~~iy~~~gsL--------------------~~~L~~~~~~~~~l~~--~-----~~~~~~~~~~~~ 465 (774)
.+++||||+ ++|.+++....+.. ...+............ . ............
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 899999776 46666664322111 1110000000000000 0 000000000000
Q ss_pred hHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcC
Q 004097 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545 (774)
Q Consensus 466 ~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 545 (774)
....+....+++..+..++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcch-hhcCCCCC
Confidence 111122345788999999999999999999999999999999999987765 899999999876432211 11122335
Q ss_pred CCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHh-hccccccccCCHHHHHHHHHhcCCCC
Q 004097 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 546 t~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP 622 (774)
+..|+|||++.+..++.++|||||||++|+|++++..||...... ....+. ......+...++++.+++.+||+.||
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999988889999999999999999998567888653211 111121 11222233345789999999999999
Q ss_pred CCCcCHHHHHcC
Q 004097 623 DLRPKAQNVLNH 634 (774)
Q Consensus 623 ~~Rps~~elL~H 634 (774)
++||++.|+++|
T Consensus 324 ~~Rps~~eil~~ 335 (343)
T cd05103 324 SQRPTFSELVEH 335 (343)
T ss_pred hhCcCHHHHHHH
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=293.23 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=184.7
Q ss_pred ceEEEeEeecccCceEEEEEeee-CC---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
..|...+.||+|+||.||++... ++ ..||||.+...... ....|+ .++..++||||+++++++.+.+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEA-SIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 34667789999999999998654 33 37999998654322 233454 46788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||| |+.+++|.+++... ...+++..+..++.|++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~al~~lH~ 125 (268)
T cd05063 84 ITE----------YMENGALDKYLRDH----------------------------DGEFSSYQLVGMLRGIAAGMKYLSD 125 (268)
T ss_pred EEE----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 45555555544321 1235677789999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+++||||||+||+++.++. +||+|||++..................+..|+|||++....++.++|||||||++||+
T Consensus 126 ~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 126 MNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CCeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 99999999999999987654 8999999988665322111111112234579999999988899999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 577 ITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++.+..||..... .....+.. ...........++.+++.+||+.+|+.||++.++++
T Consensus 204 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 204 MSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9844777754332 22222222 122223345678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.61 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=184.9
Q ss_pred ceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+|.+.+.||+|+||.||++... .+..||+|.++.... ....+|+ .++..++||||+++++++.+++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEecCCccEE
Confidence 35677899999999999998653 234799999865432 2234454 46778899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||| +++|+|.+++... ...+++.+++.++.|++.||+|||+
T Consensus 83 v~e~----------~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~ 124 (267)
T cd05066 83 VTEY----------MENGSLDAFLRKH----------------------------DGQFTVIQLVGMLRGIASGMKYLSD 124 (267)
T ss_pred EEEc----------CCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9994 4455555544321 1235667789999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+++||||||+|||++.++. ++|+|||++.................++..|+|||.+.+..++.++|+|||||++||+
T Consensus 125 ~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 125 MGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 99999999999999977754 8999999998765432211111222345689999999988899999999999999998
Q ss_pred HhCCCCCCCCchHH-HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 577 ITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++.+..||...... ....+... ........++.+.+++.+||+.+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 87347787654322 22222221 11222344678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.08 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=189.7
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc-----eeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-----~~~ 415 (774)
|.+.+.||+|++|.||++... +|+.||||++.... .....+|+. .+..++||||+++++++.+.+ ..|
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHH-HHHhcCCcchhhhhhhhcccCcccccceE
Confidence 667889999999999998654 48999999986532 123445554 667889999999999998875 789
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
++||++.++|.+++ . ....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~l-----------~-----------------------------~~~~l~~~~~~~i~~~l~~~l~~LH 120 (330)
T cd07834 81 IVTELMETDLHKVI-----------K-----------------------------SPQPLTDDHIQYFLYQILRGLKYLH 120 (330)
T ss_pred EEecchhhhHHHHH-----------h-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99996655444333 1 1124677788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. ++|+|||++.................++..|+|||++.+. .++.++|+|||||++|
T Consensus 121 ~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~ 198 (330)
T cd07834 121 SANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFA 198 (330)
T ss_pred hCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHH
Confidence 999999999999999987765 8999999998775432111122334578999999999887 7899999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H-HHHhhc-----------------------c-------ccccccCCHHHHHHHHHhcCCCC
Q 004097 575 FCITGGKHPYGESFERD-A-NIVKDR-----------------------K-------DLFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~-~~~~~~-----------------------~-------~~~~~~~~~~~~dli~~~L~~dP 622 (774)
+|++| .+||....... . .+.... . .......++++.++|.+||+.+|
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 199 ELLTR-KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred HHHcC-CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 99997 77875433211 0 000000 0 00012245688999999999999
Q ss_pred CCCcCHHHHHcCCCCCCc
Q 004097 623 DLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~~ 640 (774)
.+||++++++.||||...
T Consensus 278 ~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 278 KKRITADEALAHPYLAQL 295 (330)
T ss_pred hhCCCHHHHHhCccHHhh
Confidence 999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.13 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=184.6
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ------ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 411 (774)
...|...+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT-LLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHH-HHHhcCCCCccchhheecccccCCCC
Confidence 45677889999999999999864 5689999999864321 23445665 67788999999999998754
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...|+|+|++..+|.+++ ...+++..+..++.|++.||
T Consensus 93 ~~~~lv~e~~~~~l~~~~------------------------------------------~~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIM------------------------------------------GHPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred ceEEEEecccccCHHHHH------------------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 346999996554332211 12356778889999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 570 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlG 570 (774)
+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||++.+ ..++.++||||||
T Consensus 131 ~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 202 (342)
T cd07879 131 KYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVG 202 (342)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHH
Confidence 9999999999999999999987765 899999998765321 123357889999999876 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HH-HHHhhc----------------------cccc--------cccCCHHHHHHHHHhc
Q 004097 571 CILFFCITGGKHPYGESFER-DA-NIVKDR----------------------KDLF--------LVEHIPEAVDLFTRLL 618 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~-~~~~~~----------------------~~~~--------~~~~~~~~~dli~~~L 618 (774)
|++|||++| +.||...... .. .+.... .... .....+++.++|.+||
T Consensus 203 vil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 281 (342)
T cd07879 203 CIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281 (342)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc
Confidence 999999997 6677643211 11 111000 0000 1124567899999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCCc
Q 004097 619 DPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 619 ~~dP~~Rps~~elL~HPff~~~ 640 (774)
+.||++||++++++.||||...
T Consensus 282 ~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 282 ELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCChhhCcCHHHHhcCcchhhc
Confidence 9999999999999999999664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.21 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=181.5
Q ss_pred ceEEEeEeecccCceEEEEEee-----eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccC--Ccee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-----~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~ 414 (774)
+.+.+.+.||+|+||+||++.. .+++.||||++...... ...+|++ ++..++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIE-ILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEEEEccCCCCce
Confidence 3567789999999999999753 35889999998654322 2345554 6778999999999998653 4578
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|+| |+++|+|.+++... ...+++..++.++.|++.||+||
T Consensus 83 ~lv~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~aL~~L 124 (284)
T cd05081 83 RLVME----------YLPYGSLRDYLQKH----------------------------RERLDHRKLLLYASQICKGMEYL 124 (284)
T ss_pred EEEEE----------ecCCCCHHHHHHhc----------------------------CcCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 66666666654321 12356778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+||+++.++. +||+|||+++................++..|+|||++.+..++.++|||||||++|
T Consensus 125 H~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 125 GSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 89999999987654322211112223445699999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-----------------HHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD-----------------ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-----------------~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++|.. ++....... ...+..... .......+++.++|.+||..+|++|||+.|+++
T Consensus 203 el~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCC-cCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999743 432221110 011111111 112334578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=290.16 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=188.3
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.+.+.+.||+|+||.||++...+++.+|||++..... ....+|+. ++..++||||+++++++.+....++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~--- 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQ-VMMKLSHPKLVQLYGVCTERSPICLVFEF--- 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHH-HHHhCCCCCeeeEEEEEccCCceEEEEEc---
Confidence 4677899999999999998777788999999865432 34455654 77788999999999999999999999994
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
..+++|.+++... ...+++..+..++.|++.||+|||+.+++|||
T Consensus 81 -------~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~d 125 (256)
T cd05112 81 -------MEHGCLSDYLRAQ----------------------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125 (256)
T ss_pred -------CCCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 4455555444321 12256677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++. ++|+|||+++....... .......++.+|+|||.+.+..++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 126 LAARNCLVGENQV--VKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred cccceEEEcCCCe--EEECCCcceeecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999976654 89999999876543211 1112223567899999999888999999999999999999955888
Q ss_pred CCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 584 YGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 584 f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|....... ...+.. .....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 87544322 222221 1212233346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=290.25 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=182.5
Q ss_pred eecccCceEEEEEeeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhh
Q 004097 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~ 427 (774)
.||+|+||.||++...+++.||+|++...... ...+|+. ++..++||||+++++++.+.+..++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~----- 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVMELVP----- 75 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEECCC-----
Confidence 58999999999998778899999998654322 2334554 6778899999999999999999999999554
Q ss_pred HHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCC
Q 004097 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 507 (774)
Q Consensus 428 ~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 507 (774)
+++|.+++... ...+++..++.++.|++.||.|||+.+++||||||+
T Consensus 76 -----~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ 122 (250)
T cd05085 76 -----GGDFLSFLRKK----------------------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122 (250)
T ss_pred -----CCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChh
Confidence 45554443221 122466778999999999999999999999999999
Q ss_pred CeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCc
Q 004097 508 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 587 (774)
Q Consensus 508 NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~ 587 (774)
||+++.++. +||+|||++........ .......++..|+|||++....++.++|||||||++|++++.+..||...
T Consensus 123 nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 123 NCLVGENNV--LKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred eEEEcCCCe--EEECCCccceecccccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999987765 89999999876443211 11112234678999999988889999999999999999999557888654
Q ss_pred hHHHH-HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 588 FERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 588 ~~~~~-~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
..... ..+... ....+...++++.+++.+||+.+|++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 199 TNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 33222 222211 22233445689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=298.93 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=187.4
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
..+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-ILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHH-HHHhCCCCCeeeeeheecCcchhhh
Confidence 3455778899999999999998654 589999999864321 22344554 677889999999999987655
Q ss_pred ------eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 413 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 413 ------~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
..|+|+||+++++.+++.. ....+++..++.++.|
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~---------------------------------------~~~~~~~~~~~~i~~q 124 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLES---------------------------------------GLVHFSEDHIKSFMKQ 124 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhc---------------------------------------CCCCCCHHHHHHHHHH
Confidence 7999999777655444311 1123677888999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcch
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAID 565 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sD 565 (774)
|+.||+|||+.+|+||||||+||+++.++. +||+|||++........ .......++..|+|||.+.+. .++.++|
T Consensus 125 i~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 200 (302)
T cd07864 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAID 200 (302)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhH
Confidence 999999999999999999999999987765 89999999987653321 111223467889999988653 4789999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhh--cc-c--------------------------cccccCCHHHHHHH
Q 004097 566 LFSLGCILFFCITGGKHPYGESFERDA--NIVKD--RK-D--------------------------LFLVEHIPEAVDLF 614 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~--~~-~--------------------------~~~~~~~~~~~dli 614 (774)
||||||++|||++| ++||........ .+... .. . ......++.+.++|
T Consensus 201 i~slG~~~~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 201 VWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 99999999999997 788865432211 11110 00 0 00112357899999
Q ss_pred HHhcCCCCCCCcCHHHHHcCCCC
Q 004097 615 TRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 615 ~~~L~~dP~~Rps~~elL~HPff 637 (774)
.+||+.||.+||++.+++.||||
T Consensus 280 ~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 280 DHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=301.43 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=187.8
Q ss_pred ceEEEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 411 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~ 411 (774)
.+|.+.+.||+|+||.||++... ....||+|.+...... ...+|+. ++..+ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME-LMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHH-HHHhccCCCCeeeEEEEEccC
Confidence 45778899999999999997432 3457999998754322 2345655 44555 799999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|++|| |+.+|+|.+++.......... ...........+++.+++.++.||+.||
T Consensus 91 ~~~~lv~e----------~~~~g~L~~~i~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 91 GPLYVIVE----------YAAKGNLREFLRARRPPGPDY-------------TFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCCcccc-------------cccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999999 445555555543321100000 0000001123477888999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 9999999999999999999987765 899999999876532111 1112223456899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++++..||....... ...+... ....+.....++.+++.+||+.||++||++.++++
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999996678886543322 2222222 11223345578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.87 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=192.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||+||++.. .+++.||+|.+..... +...+|+. ++..++||||+++++++.+.+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e- 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPNIVNYLDSYLVGDELWVVME- 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHH-HHhhcCCCCeeehhheeeeCCcEEEEEe-
Confidence 4577789999999999999853 4688999999854322 23345554 6778899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+.+++
T Consensus 97 ---------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~gi~ 137 (293)
T cd06647 97 ---------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQVI 137 (293)
T ss_pred ---------cCCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5555555554321 2245667789999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||+++.++. ++|+|||++........ ......|++.|+|||.+....++.++|+|||||++|++++|
T Consensus 138 H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g- 211 (293)
T cd06647 138 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG- 211 (293)
T ss_pred eccCCHHHEEEcCCCC--EEEccCcceeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999987765 89999999876553221 11234588999999999888899999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhcccc--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFERDA--NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||........ .+....... ......+.+.++|.+||+.+|++||++.+++.||||....
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 778865433221 111111111 1122346799999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.26 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=190.2
Q ss_pred cceEEEeEeecccCceEEEEEee--------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 410 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~--------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 410 (774)
...|.+.+.||+|+||.||++.. .++..||+|.+..... ....+|+. ++..+ +||||+++++++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHH-HHHhhccCCCchheeEEEec
Confidence 45577889999999999998753 2345899999865322 23445555 55566 89999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|++|||| .+|+|.+++........... ..........+++..++.++.||+.|
T Consensus 93 ~~~~~lv~e~~----------~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 93 DGPLYVIVEYA----------SKGNLREYLRARRPPGMEYS-------------YDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred CCceEEEEecC----------CCCcHHHHHHhcCCcccccc-------------cccccCCcccccHHHHHHHHHHHHHH
Confidence 99999999955 44555554443221100000 00000112346788899999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+||+++.++. +||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 150 l~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 150 MEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred HHHHHHCCeeecccccceEEEcCCCc--EEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 99999999999999999999987764 899999999876532211 112233467789999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 571 CILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++|++++++..||...... ....+... ....+...+.++.+++.+||+.+|.+||++.|+++.
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999667777654322 22222222 222233456789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.54 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=187.0
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCC---CCCeeEEeeeccCCceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ---HPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~---HpNIV~l~g~~~~~~~~~LV~ 418 (774)
|...+.||+|+||.||++.. .+++.||||.+..... ....+|+. +++.+. ||||+++++++.++...|+||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA-LLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHH-HHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 44557899999999999864 5789999999864322 23344554 455554 999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||+ .+++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 82 e~~----------~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 82 EYA----------EGGSVRTLMKA------------------------------GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred ecC----------CCCcHHHHHHc------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 954 44555443321 23567788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ell 577 (774)
|+|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||.+... .++.++|+|||||++|+|+
T Consensus 122 i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll 196 (277)
T cd06917 122 VIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196 (277)
T ss_pred cccCCcCHHHEEEcCCCC--EEEccCCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence 999999999999987765 8999999998765432 112234588999999998754 4689999999999999999
Q ss_pred hCCCCCCCCchHHHHH-HHhhc-cccccc-cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 578 TGGKHPYGESFERDAN-IVKDR-KDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~~-~~~~~-~~~~~~-~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+| .+||......... ..... ...... ....++.+++.+||+.||++||++.++++||||..
T Consensus 197 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 197 TG-NPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hC-CCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 96 7788654332211 11111 111111 24578999999999999999999999999999954
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=289.83 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=193.2
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||.||++... +++.||+|++..... ....+|++ .+..++|||++++++.+.+.+..++|+|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHH-HHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 566788999999999998554 589999999865432 22344544 67788999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
++ +++|.+.+.... .+...+++..+..++.+++.||+|||+.+++
T Consensus 81 ~~----------~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 125 (258)
T cd08215 81 AD----------GGDLSQKIKKQK-------------------------KEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125 (258)
T ss_pred cC----------CCcHHHHHHHhh-------------------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 54 444444433211 1124577888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. ++|+|||++....... .......|++.|+|||.+....++.++|+||+|+++|+|++|
T Consensus 126 H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 199 (258)
T cd08215 126 HRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL- 199 (258)
T ss_pred cccCChHHeEEcCCCc--EEECCccceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC-
Confidence 9999999999987765 8999999998765432 122334688999999999888899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........ ..........+.....++.+++.+||..+|++||++.++++||||
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 200 KHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 778765432221 122222222333456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=286.97 Aligned_cols=244 Identities=30% Similarity=0.506 Sum_probs=189.1
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
|...+.||+|++|.||++... +++.||+|++..... ....+|+ .++..++||||+++++++.+.+..++++|+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-QILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 556788999999999998654 689999999966542 2344555 47788899999999999999999999999555
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+++|.+++... ...+++..+..++.|++.||+|||+.+++||
T Consensus 81 ----------~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 81 ----------GGSLKDLLKST----------------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred ----------CCcHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 44444433211 0246777889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||+|+||+++.++. ++|+|||.+........ .....++..|+|||.+....++.++||||||+++|+|++| .+
T Consensus 123 dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g-~~ 195 (253)
T cd05122 123 DIKAANILLTSDGE--VKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG-KP 195 (253)
T ss_pred CCCHHHEEEccCCe--EEEeecccccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC-CC
Confidence 99999999987765 89999999887654321 2344688999999999888899999999999999999997 67
Q ss_pred CCCCchHHH-H-HHHhhccccccc--cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 583 PYGESFERD-A-NIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 583 Pf~~~~~~~-~-~~~~~~~~~~~~--~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
||....... . ............ ....++.++|.+||+.||++|||+.++++|||
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 776542211 1 111111111111 12578999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.58 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=180.0
Q ss_pred Eeeccc--CceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKG--SNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~G--sfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..||+| +||+||++.. .+|+.||||++..... ...++++..+++.++||||+++++++.+++..|+|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e---- 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP---- 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe----
Confidence 346666 9999999854 5799999999864331 1233344457778999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
|+..|++.+++... ...++++..+..++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~l~~~l~~~---------------------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrD 126 (328)
T cd08226 80 ------FMAYGSANSLLKTY---------------------------FPEGMSEALIGNILFGALRGLNYLHQNGYIHRN 126 (328)
T ss_pred ------cccCCCHHHHHHhh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 55555555544321 123467788899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhcC--CCCCcchhHhHHHHHHHHH
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlGvll~ell 577 (774)
|||+|||++.++. ++++|||.+.......... .......++..|+|||++.+. .++.++|||||||++|||+
T Consensus 127 lkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 127 IKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred CCHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999987765 8999998654332211100 001112356679999999764 4789999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc----------------------------------------------ccccccCCHH
Q 004097 578 TGGKHPYGESFERDA--NIVKDRK----------------------------------------------DLFLVEHIPE 609 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~----------------------------------------------~~~~~~~~~~ 609 (774)
+| .+||........ ....... ........++
T Consensus 205 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (328)
T cd08226 205 TG-RVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPA 283 (328)
T ss_pred hC-CCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHH
Confidence 96 778865432211 1111000 0001123457
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.+||.+||+.||++|||+.|+++||||..
T Consensus 284 ~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 284 FQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 899999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.23 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=189.4
Q ss_pred EEEeEeecccCceEEEEEee----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhC-CCCCeeEEeeeccCCcee
Q 004097 347 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~ 414 (774)
|.+.+.||+|+||.||++.. .+|+.||+|++..... +...+|+. ++..+ +|+||+++++++..++..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHH-HHHhcccCCChhceeeEeecCCeE
Confidence 56678999999999999754 4789999999864321 22344555 45555 699999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|+| |+++++|.+++.. ...+++..+..++.|++.||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~al~~l 121 (290)
T cd05613 81 HLILD----------YINGGELFTHLSQ-----------------------------RERFKEQEVQIYSGEIVLALEHL 121 (290)
T ss_pred EEEEe----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 5555555554432 12356677888999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC--CCCCcchhHhHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 572 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlGvl 572 (774)
|+.+++||||+|+|||++.++. +||+|||++........ .......|+..|+|||.+... .++.++|||||||+
T Consensus 122 H~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 122 HKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197 (290)
T ss_pred HhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence 9999999999999999988765 89999999986543211 112234588999999998753 46789999999999
Q ss_pred HHHHHhCCCCCCCCch-----HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCcc
Q 004097 573 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 641 (774)
Q Consensus 573 l~elltg~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~ 641 (774)
+|+|++| ..||.... ......+.......+....+.+.+++.+||+.||++|| ++.+++.||||....
T Consensus 198 l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 198 MYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHhcC-CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999997 77875321 11112222222233445668899999999999999997 889999999996544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.55 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=203.3
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hH--HHHHHHHHHHh-CCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DV--ALKEIQNLIAS-DQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~--~~~Ei~~ll~~-l~HpNIV~l~g~~~~~~~~~L 416 (774)
..|.|..+||+|+||+|.+|.. -+.+.+|||++++.-. +. ...|- .+++. .+-|.++.++.+++.-+.+|.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EK-rvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK-RVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhh-hheecCCCCchHHHHHHHhhhhhheee
Confidence 4578889999999999999844 4567899999976521 11 11232 23343 456889999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||| |..+|+|.-++. +.+.+.++.+..++..||-||-+||+
T Consensus 428 VME----------yvnGGDLMyhiQ-----------------------------Q~GkFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 428 VME----------YVNGGDLMYHIQ-----------------------------QVGKFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred EEE----------EecCchhhhHHH-----------------------------HhcccCCchhhhhhHHHHHHhhhhhc
Confidence 999 555565554442 23456677889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
+|||+||||.+||||+.+|+ +||+|||+++.-.- ....+.+.+|||.|+|||++..++|+.++|+||+||+||||
T Consensus 469 kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~---~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm 543 (683)
T KOG0696|consen 469 KGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 543 (683)
T ss_pred CCeeeeeccccceEeccCCc--eEeeeccccccccc---CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence 99999999999999988887 89999999986432 23445788999999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccch
Q 004097 577 ITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 643 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~~ 643 (774)
+.| ++||+...+.+ ...+......++...+.|+.++.+.+|.+.|.+|..+ .++-.||||+..++.
T Consensus 544 laG-QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 544 LAG-QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred HcC-CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 997 78887655544 4555566667888889999999999999999999754 579999999766553
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=290.90 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=187.4
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
..+.|.+.+.||+|+||.||++...++..||+|.+..... ....+|+. +++.++|+||+++++++.+ ...|++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEAN-VMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHH-HHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 3566888999999999999999877778899998865432 23445554 7788999999999999888 778999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ .+|+|.+++.... ...+++..++.++.|++.||+|||+.+++
T Consensus 82 ~----------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 124 (260)
T cd05073 82 M----------AKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124 (260)
T ss_pred C----------CCCcHHHHHHhCC---------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4 4455555443211 12245667889999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||+++.++. +||+|||++........ .......++..|+|||++....++.++|+|||||++|++++++
T Consensus 125 H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g 200 (260)
T cd05073 125 HRDLRAANILVSASLV--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200 (260)
T ss_pred ccccCcceEEEcCCCc--EEECCCcceeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcC
Confidence 9999999999977754 89999999976643211 1112223567899999998888999999999999999999966
Q ss_pred CCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 581 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 581 ~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
.+||....... ...+... ........+.++.+++.+||+.+|++||++.+++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred CCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 88886543322 2222222 1122334567899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.83 Aligned_cols=245 Identities=29% Similarity=0.442 Sum_probs=185.1
Q ss_pred EEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEecc
Q 004097 348 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 419 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV~E 419 (774)
.+.+.||+|++|.||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+. +..|+|+|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHH-HHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 45688999999999998654 58999999997652 123345554 67788899999999999988 89999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|++++|.+++. .. ...+++..++.++.||+.||+|||+.++
T Consensus 81 ~~~~~l~~~~~-----------~~----------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~ 121 (287)
T cd07840 81 YMDHDLTGLLD-----------SP----------------------------EVKFTESQIKCYMKQLLEGLQYLHSNGI 121 (287)
T ss_pred cccccHHHHHh-----------cc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 66655444431 10 1235677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ellt 578 (774)
+|+||+|+||+++.++. ++|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 122 ~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 197 (287)
T cd07840 122 LHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197 (287)
T ss_pred eeccCcHHHeEEcCCCC--EEEccccceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh
Confidence 99999999999988765 89999999987654321 11123356888999998765 457899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcc-----------------------------cccccc-CCHHHHHHHHHhcCCCCCCCc
Q 004097 579 GGKHPYGESFERDA--NIVKDRK-----------------------------DLFLVE-HIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~-----------------------------~~~~~~-~~~~~~dli~~~L~~dP~~Rp 626 (774)
| .+||........ .+..... ...... .++++.++|.+||+.+|.+||
T Consensus 198 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (287)
T cd07840 198 G-KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276 (287)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence 7 777765432211 1100000 000011 257889999999999999999
Q ss_pred CHHHHHcCCCC
Q 004097 627 KAQNVLNHPFF 637 (774)
Q Consensus 627 s~~elL~HPff 637 (774)
+++++++||||
T Consensus 277 ~~~~~l~~~~~ 287 (287)
T cd07840 277 SADQALQHEYF 287 (287)
T ss_pred CHHHHhhCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.36 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=184.3
Q ss_pred eEEEeEeecccCceEEEEEeee-CC--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EG--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||.||++... ++ ..+|+|.++.... ....+|+..+.+..+||||+++++++.+.+..|+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 4678899999999999998654 33 3579998864322 233456554434448999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW-KANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
| |.++|+|.++++......... .....+ ....+++..++.|+.|++.||+|||+.
T Consensus 83 e----------~~~~~~L~~~l~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 138 (297)
T cd05089 83 E----------YAPYGNLLDFLRKSRVLETDP--------------AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138 (297)
T ss_pred E----------ecCCCcHHHHHHhcccccccc--------------ccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 555555555554322100000 000001 123478889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||+
T Consensus 139 ~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 139 QFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CcccCcCCcceEEECCCCe--EEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987754 899999998643211 1111122356799999998888999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 578 TGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+.+.+||....... ....... ....+...++++.++|.+||+.+|.+||+++++++.
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 84477886543332 2222211 112233456789999999999999999999999744
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.67 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=199.3
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
...|.+.+.||+|.|++|.++. ..++..||||.+.++..+ ...+|++ ++..++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~-imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVD-IMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHH-HHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457888999999999999984 557999999999876532 3467776 66789999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|| |..+|.++++|..... ..+..+..++.|+++|++|||++
T Consensus 134 ~e----------ya~~ge~~~yl~~~gr-----------------------------~~e~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 134 ME----------YASGGELFDYLVKHGR-----------------------------MKEKEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred EE----------eccCchhHHHHHhccc-----------------------------chhhhhhhhhHHHHHHHHHHhhc
Confidence 99 5556666666544332 22345678999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~el 576 (774)
+|+|||||++||||+.+.+ +||+|||++..+... ....+.+|++.|.|||+..+..| ++.+|+||+|+++|-|
T Consensus 175 ~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 175 NIVHRDLKAENILLDENMN--IKIADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ceeccccchhhcccccccc--eeeeccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 9999999999999977755 899999999988743 44567899999999999998877 5899999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 577 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.| ..||+...-... ..+... ...+.-.+.++.++|.++|..+|.+|++++++++|+|...
T Consensus 249 V~G-sLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 249 VEG-SLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred eec-ccccCCcccccccchheeee-ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 996 889876432221 122221 1123334569999999999999999999999999999744
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.15 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=188.0
Q ss_pred cceEEEeEeecccCceEEEEEeeeC-----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC-Cce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~-----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 413 (774)
++.|.+.+.||+|+||.||++.... +..||+|++..... ....+|+. .+..++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC-LLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCCC
Confidence 4567888999999999999987655 78999999865432 22344544 6778899999999998766 577
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.++++|++ .+|+|.+++........ -....+++..++.++.|++.||+|
T Consensus 84 ~~~~~~~~----------~~~~L~~~l~~~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~ 132 (280)
T cd05043 84 PFVLYPYM----------NWGNLKLFLQQCRLGEA---------------------NNPQALSTQQLVHMAIQIACGMSY 132 (280)
T ss_pred CEEEEEcC----------CCCcHHHHHHhcccccc---------------------ccccCCCHHHHHHHHHHHHHHHHH
Confidence 89999954 44555544432211000 011346788889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+++||||||+||+++.++. +||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++
T Consensus 133 LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 133 LHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 99999999999999999987754 899999999866432211 111223457789999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||+++.+++||........ ..+... ........++++.+++.+||..||++|||+.++++
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999955888876433222 222222 11122344678999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=283.25 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=189.7
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCchHH----HHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~----~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
..||.|+.|+|+++.. .+|..+|||.+.+...... +..+..++..-+.|.||+.+|||..+..++++||.+..-+
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ 177 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCA 177 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHH
Confidence 5699999999999854 5689999999976654333 3344445555668999999999999999999999543222
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Ccccccc
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDL 504 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDL 504 (774)
+.++. ...+++|+..+-++...++.||.||.++ +|+|||+
T Consensus 178 ekLlk---------------------------------------rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDv 218 (391)
T KOG0983|consen 178 EKLLK---------------------------------------RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 218 (391)
T ss_pred HHHHH---------------------------------------HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeeccc
Confidence 22221 1234577777888999999999999976 8999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHHHHHHhCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll~elltg~~ 581 (774)
||+|||+++.|+ +|+||||++-.+.+.. ......|.+.|||||.+.- ..|+.++||||||+.++||.|| .
T Consensus 219 KPSNILlDe~Gn--iKlCDFGIsGrlvdSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg-~ 291 (391)
T KOG0983|consen 219 KPSNILLDERGN--IKLCDFGISGRLVDSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATG-Q 291 (391)
T ss_pred CccceEEccCCC--EEeecccccceeeccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcc-c
Confidence 999999988877 8999999998876532 2234569999999999864 4689999999999999999997 7
Q ss_pred CCCCCc---hHHHHHHHhhcccccc--ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 582 HPYGES---FERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 582 ~Pf~~~---~~~~~~~~~~~~~~~~--~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.||... ++....++...+...+ ..+++++++++..||++|+.+||...++|+|||+...+
T Consensus 292 yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 292 YPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 788653 3333344443332222 23689999999999999999999999999999986544
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=296.43 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=196.2
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
..+.|.+.+.||+|++|.||++... +++.||+|++.... .....+|+. ++..++|+||+++++++.+.+..|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHH-HHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3455777788999999999998655 68899999997654 234455654 7788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|+. +++|.+++.... ..+++..+..++.|++.||+|||+.||
T Consensus 96 ~~~----------~~~L~~~l~~~~----------------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 96 YMD----------GGSLTDIITQNF----------------------------VRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred ccC----------CCcHHHHHHHhc----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 555 445544433211 146677889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+|+||+|+||+++.++. ++|+|||++........ ......++..|++||++.+..++.++|+|||||++|+|++|
T Consensus 138 ~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 138 IHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred eeCCCChhhEEEcCCCC--EEECccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999987775 89999999876543211 11234578899999999888899999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhcccc--ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 580 GKHPYGESFERDA--NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
..||........ .+....... .......++.++|.+||+.+|.+||++.++++||||....
T Consensus 213 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 213 -EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 778765433221 111111111 1112457899999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=290.66 Aligned_cols=242 Identities=28% Similarity=0.408 Sum_probs=187.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||.||++.. .|+.||||.+..... ....+|+. ++..++|+||+++++++.+.+..|+|||++.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS-VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHH-HHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4567789999999999999754 589999999976543 23445554 7788899999999999999999999999554
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+++|.+++.... ...+++..+..++.|++.||.|||+.+++||
T Consensus 84 ----------~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 126 (256)
T cd05039 84 ----------KGSLVDYLRSRG---------------------------RAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126 (256)
T ss_pred ----------CCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence 445544432211 1236778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. ++|+|||+++....... ...++..|+|||++....++.++|||||||++||+++.+..
T Consensus 127 di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 127 DLAARNVLVSEDLV--AKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred hcccceEEEeCCCC--EEEcccccccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999999987765 89999999987642211 22346679999999888899999999999999999984478
Q ss_pred CCCCchHHHH-HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||........ ..+... ....+...++++.++|.+||..+|++||++.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 199 PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8866543332 222211 22223345688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.42 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=190.2
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCce---
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF--- 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~--- 413 (774)
+++.|.+.+.||+|++|+||++... +++.||||++.... .....+|+. ++..++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-LLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHH-HHHhccCCCHHHHHHHhhccccccc
Confidence 4567888999999999999998554 58899999986432 123445665 6677899999999998876654
Q ss_pred ---eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 414 ---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 414 ---~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.|+|+|++.++|.+++. ...+++..+..++.|++.|
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~~~~ql~~a 130 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVK-----------------------------------------CQKLSDDHIQFLVYQILRG 130 (343)
T ss_pred cccEEEEEecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 89999977666655442 1236677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSl 569 (774)
|+|||+.+|+||||||+||+++.++. ++|+|||++...... .....++..|+|||.+.+. .++.++|||||
T Consensus 131 L~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 202 (343)
T cd07851 131 LKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence 99999999999999999999987765 899999998865432 2234578899999998753 67899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhcc---------------------------c---cccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKDRK---------------------------D---LFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~~~---------------------------~---~~~~~~~~~~~dli~~~ 617 (774)
||++|||++| .+||....... . .+..... . ......++++.++|.+|
T Consensus 203 Gv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~ 281 (343)
T cd07851 203 GCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHh
Confidence 9999999997 67775432211 1 1110000 0 00112467899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|+.||++|||+.++++||||....
T Consensus 282 l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 282 LVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred CCCChhhCCCHHHHhcCCCccccC
Confidence 999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=294.26 Aligned_cols=246 Identities=30% Similarity=0.444 Sum_probs=184.4
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHH--HHHhCCCCCeeEEeeeccCCce-----
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQN--LIASDQHPNIVRWYGVESDQDF----- 413 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~--ll~~l~HpNIV~l~g~~~~~~~----- 413 (774)
|.+.+.||+|+||.||++... +++.||||++..... ....+|+.. .+..+.||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 346688999999999998665 489999999964321 123345442 2344579999999999988776
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.+++||++.++|.+++. .. ....+++..++.++.|++.||+|
T Consensus 81 ~~l~~e~~~~~l~~~l~-----------~~---------------------------~~~~l~~~~~~~~~~~i~~al~~ 122 (287)
T cd07838 81 LTLVFEHVDQDLATYLS-----------KC---------------------------PKPGLPPETIKDLMRQLLRGVDF 122 (287)
T ss_pred eEEEehhcccCHHHHHH-----------Hc---------------------------cCCCCCHHHHHHHHHHHHHHHHH
Confidence 99999976655554431 11 01236778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+++|+||+|+||+++.++. +||+|||++....... ......++..|+|||++.+..++.++|+|||||++
T Consensus 123 LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 123 LHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 99999999999999999987754 8999999987764321 11223478899999999998999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhcc--------------------------ccccccCCHHHHHHHHHhcCCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDRK--------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
|||++| .+||......+ ..+..... ........+++.++|.+||+.||.+|
T Consensus 197 ~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (287)
T cd07838 197 AELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKR 275 (287)
T ss_pred HHHHhC-CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccC
Confidence 999997 77776543221 11111000 00001223677899999999999999
Q ss_pred cCHHHHHcCCCC
Q 004097 626 PKAQNVLNHPFF 637 (774)
Q Consensus 626 ps~~elL~HPff 637 (774)
|++.+++.||||
T Consensus 276 p~~~~il~~~~~ 287 (287)
T cd07838 276 ISAFEALQHPYF 287 (287)
T ss_pred CCHHHHhcCcCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.83 Aligned_cols=247 Identities=33% Similarity=0.507 Sum_probs=191.6
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV~ 418 (774)
|...+.||+|++|.||++... +++.|++|++..... +...+|+ ..++.++||||+++++.+.+. +..++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREI-RILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 456688999999999998655 689999999865542 2333444 477888999999999999988 8999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|++ .+++|.+++... ..+++..+..++.|++.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 81 EYV----------SGGSLSSLLKKF-----------------------------GKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred Eec----------CCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 444554443221 14677788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
++|+||+|+||+++.++. ++|+|||.+......... .......++..|+|||.+.....+.++||||||+++|+|++
T Consensus 122 ~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 122 IVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred ccccCCCHHHEEEcCCCC--EEEcccccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999988765 899999998877643211 01233458899999999988889999999999999999999
Q ss_pred CCCCCCCCchHHHHHH--Hh--hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 579 GGKHPYGESFERDANI--VK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~~--~~--~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
| ..||.......... .. ......+....+++.++|.+||+.||.+||++.++++||||
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 199 G-KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred C-CCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 6 77876644211111 11 11122233446789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=291.65 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=186.8
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--cee
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~ 414 (774)
.|.+.+.||+|+||.||++.. .+++.||+|.+.... . ....+|+ .++..++||||+++++++.+. +..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei-~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEI-QLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHH-HHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 467889999999999999854 568999999875321 1 1223454 477888999999999998764 568
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++++|++. +++|.+.+.. ...+++..++.++.|++.||.||
T Consensus 82 ~~v~e~~~----------~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~al~~L 122 (264)
T cd06653 82 SIFVEYMP----------GGSIKDQLKA-----------------------------YGALTENVTRRYTRQILQGVSYL 122 (264)
T ss_pred EEEEEeCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999554 4444443321 12356677789999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+++|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|+|||||++|
T Consensus 123 H~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 200 (264)
T cd06653 123 HSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVV 200 (264)
T ss_pred HhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHH
Confidence 9999999999999999987765 89999999987643211111112345889999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 575 FCITGGKHPYGESFERDA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++++| .+||.+...... .+... .....+....+++.++|.+||+ +|.+||++.+++.|||.
T Consensus 201 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 201 EMLTE-KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHhC-CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99996 778876433221 11111 1223345566899999999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=282.67 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=191.0
Q ss_pred cccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCc-----
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD----- 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~----- 412 (774)
..+++|.+.+.||+|+|.-||+. +..+++.+|+|++.-.. .+.+.+|+. +.++.+||||+++++++..+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid-~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREID-NHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHH-HHHhhCCcchHHHHHHHHHhhccCce
Confidence 44688999999999999999997 57789999999985332 345667775 678899999999999876543
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..||+++ |...|+|.+.+.... .+...+++.+++.|+.+|++||+
T Consensus 97 ~~yll~P----------yy~~Gsl~d~i~~~k-------------------------~kg~~~sE~~iL~if~gic~gL~ 141 (302)
T KOG2345|consen 97 EAYLLLP----------YYKRGSLLDEIERLK-------------------------IKGNFVSEAQILWIFLGICRGLE 141 (302)
T ss_pred eEEEEee----------hhccccHHHHHHHHh-------------------------hcCCccCHHHHHHHHHHHHHHHH
Confidence 4899999 777777777654322 22234788899999999999999
Q ss_pred HHHHcC--ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccc------cccCcCCCCCCchhhhhc---CCCC
Q 004097 493 HLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ------NATGYGSSGWQAPEQLLQ---GRQT 561 (774)
Q Consensus 493 yLH~~~--ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~---~~~~ 561 (774)
+||+.. ++||||||.|||++.++. ++|.|||.++...-......+ -....-|..|.|||.+.- ...+
T Consensus 142 ~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ 219 (302)
T KOG2345|consen 142 ALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTIT 219 (302)
T ss_pred HHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccc
Confidence 999997 999999999999987665 899999998765321111000 011235888999999864 3468
Q ss_pred CcchhHhHHHHHHHHHhCCCCCCCCchHHHH---HHHhhcccccc--ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 562 RAIDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 562 ~~sDvwSlGvll~elltg~~~Pf~~~~~~~~---~~~~~~~~~~~--~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+++|||||||++|+|+.| ..||....+.-. -.+......++ ...++.+.++|++||+.||.+||++.+++.+
T Consensus 220 ertDIWSLGCtLYa~mf~-~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 220 ERTDIWSLGCTLYAMMFG-ESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccchhhhhHHHHHHHHc-CCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999999999997 778865443211 01111111111 1256788999999999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=330.06 Aligned_cols=256 Identities=25% Similarity=0.311 Sum_probs=185.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+ .+++.++||||+++++++.+++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi-~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA-KIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHH-HHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3577889999999999999854 4689999999864321 2234455 477889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||| .+|+|.+++........ +. .-.....++..++.++.||+.||+|||+.
T Consensus 81 MEY~----------eGGSL~~lL~s~~~~~~-l~-----------------e~~~~~lsv~~iL~I~~QIa~AL~yLHs~ 132 (932)
T PRK13184 81 MPYI----------EGYTLKSLLKSVWQKES-LS-----------------KELAEKTSVGAFLSIFHKICATIEYVHSK 132 (932)
T ss_pred EEcC----------CCCCHHHHHHHhhhccc-cc-----------------hhhhcccCHHHHHHHHHHHHHHHHHHHHC
Confidence 9955 45555554432111000 00 00123356677899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCc---------------cccccccCcCCCCCCchhhhhcCCCCC
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---------------CLTQNATGYGSSGWQAPEQLLQGRQTR 562 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ 562 (774)
+|+||||||+|||++.++. +||+|||+++....... ........+||+.|+|||++.+..++.
T Consensus 133 GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 133 GVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred CccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 9999999999999988876 89999999987621110 001112346999999999999999999
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHHHHH---Hhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERDANI---VKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~---~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
++|||||||++|||+|| .+||.......... ...... ......++.+.+++.+||+.||++|++..+.+
T Consensus 211 kSDIWSLGVILyELLTG-~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 211 STDIYALGVILYQMLTL-SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred HhHHHHHHHHHHHHHHC-CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999997 77886533222111 101000 11224567899999999999999998765544
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.98 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=183.1
Q ss_pred eEEEeEeecccCceEEEEEe-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--cee
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~ 414 (774)
.|...+.||+|+||.||++. ..+++.||||.+..... ....+|+. +++.++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEecCCCCce
Confidence 35667889999999999975 34688999999864432 23344554 77889999999999998775 678
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++||| |.++++|.+++... ...+++..+..++.|++.||+||
T Consensus 84 ~lv~e----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~i~~aL~~l 125 (284)
T cd05079 84 KLIME----------FLPSGSLKEYLPRN----------------------------KNKINLKQQLKYAVQICKGMDYL 125 (284)
T ss_pred EEEEE----------ccCCCCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 55556665554221 12356778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+++||||||+||+++.++. ++|+|||+++.+..............++..|+|||++.+..++.++|||||||++|
T Consensus 126 H~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 126 GSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 9999999999999999987765 89999999987654322212222345677899999998888999999999999999
Q ss_pred HHHhCCCCCCCCchH----------------HHHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFE----------------RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~----------------~~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||+++. .|+..... ........ .....+...++++.+|+.+||+.||.+||++.+++++
T Consensus 204 ellt~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYC-DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCC-CCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999963 33321110 00111111 1111233456799999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.00 Aligned_cols=157 Identities=32% Similarity=0.530 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcccccc----C----C-------Cccccccc
Q 004097 477 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ----G----D-------MSCLTQNA 541 (774)
Q Consensus 477 ~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~----~----~-------~~~~~~~~ 541 (774)
....++++++|+.||+|+|+.|||||||||.||+|+++++ +||+|||+|+... . . ........
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 5678999999999999999999999999999999988776 9999999998722 0 0 00111224
Q ss_pred cCcCCCCCCchhhhhcCC---CCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc------ccCCHHHHH
Q 004097 542 TGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL------VEHIPEAVD 612 (774)
Q Consensus 542 ~~~gt~~y~aPE~l~~~~---~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~d 612 (774)
..+||.-|+|||++.+.. |+.|+|+||||+|++||+. ||+...++...+..-+....+ ....+.-..
T Consensus 774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHHH
Confidence 467999999999998654 9999999999999999986 799988887644443332222 223467789
Q ss_pred HHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 613 LFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 613 li~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+|.+|++.||.+||||.|+|++-||-.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999999999999999999964
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.43 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=186.0
Q ss_pred ceEEEeEeecccCceEEEEEeee-----------------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 403 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-----------------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 403 (774)
+.|.+.+.||+|+||.||++... .+..||+|++...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK-ILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHH-HHHhcCCCCEeE
Confidence 34667789999999999987543 2356899998754322 2334554 677889999999
Q ss_pred EeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHH
Q 004097 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483 (774)
Q Consensus 404 l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 483 (774)
+++++.+++..++++|++. +++|.+++.......... ......+++..++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~----------~~~L~~~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 135 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYME----------NGDLNQFLQKHVAETSGL------------------ACNSKSLSFSTLLYM 135 (296)
T ss_pred EEEEEecCCCcEEEEecCC----------CCCHHHHHHhcccccccc------------------cccCCCCCHHHHHHH
Confidence 9999999999999999554 444544443221100000 011234788889999
Q ss_pred HHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCc
Q 004097 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563 (774)
Q Consensus 484 ~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 563 (774)
+.|++.||+|||+.+|+||||||+||+++.++. ++|+|||+++....... ........++..|+|||++....++.+
T Consensus 136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred HHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCcc
Confidence 999999999999999999999999999987755 89999999986543221 111223446788999999998889999
Q ss_pred chhHhHHHHHHHHHhC-CCCCCCCchHHHH--HHHhh-----c--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 564 IDLFSLGCILFFCITG-GKHPYGESFERDA--NIVKD-----R--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 564 sDvwSlGvll~elltg-~~~Pf~~~~~~~~--~~~~~-----~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|||||||++|||+++ +..||........ ..... . ....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 9999999999999984 4677765332221 11111 0 01112234578999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.44 Aligned_cols=245 Identities=31% Similarity=0.514 Sum_probs=191.5
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|++|.||++.. .+++.||||.+..... ....+|+ .++..++||||+++++++.+.+..|++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEI-DLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHH-HHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 56678999999999999854 4678999999865532 1233444 467788999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+. +++|.+++.. ...+++..+..++.|++.||.|||+.+|+
T Consensus 81 ~~----------~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (254)
T cd06627 81 AE----------NGSLRQIIKK-----------------------------FGPFPESLVAVYVYQVLQGLAYLHEQGVI 121 (254)
T ss_pred CC----------CCcHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 54 4455444321 13467778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||+|+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++||||+|+++|+|++|
T Consensus 122 H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g- 195 (254)
T cd06627 122 HRDIKAANILTTKDGV--VKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG- 195 (254)
T ss_pred cCCCCHHHEEECCCCC--EEEeccccceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC-
Confidence 9999999999987665 899999999877643221 2334588999999999888889999999999999999997
Q ss_pred CCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
.+||....... ...........+....+++.+++.+||+.+|++||++.+++.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 196 NPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 67776533222 1222222333334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=311.08 Aligned_cols=285 Identities=22% Similarity=0.340 Sum_probs=191.5
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCC-CCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQ-HPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~ 413 (774)
+.+.+.+.||+|+||.||++.. ..++.||||++...... ...+|+. ++..+. |||||+++++|.+.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK-IMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHH-HHHhcCCCCCeEEEEEEEccCCC
Confidence 4466778999999999999853 23568999999754322 3345665 556665 9999999999999999
Q ss_pred eEEeccccC-CChhhHHHHhcCChHHHhhhhhhcc-hhhHH---------------------------------------
Q 004097 414 VYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDS-NLLNE--------------------------------------- 452 (774)
Q Consensus 414 ~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~-~~l~~--------------------------------------- 452 (774)
.|+|||||. ++|.+++.................. .....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999766 3666665432221111100000000 00000
Q ss_pred ----HHHh---------------hcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecC
Q 004097 453 ----VRIR---------------LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513 (774)
Q Consensus 453 ----~~~~---------------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 513 (774)
.... ..+... ...........+++..++.|+.||+.||+|||+.+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERT-RRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCc-chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 0000 000000 00000112235678889999999999999999999999999999999977
Q ss_pred CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--
Q 004097 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-- 591 (774)
Q Consensus 514 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-- 591 (774)
++ .+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++++..||.......
T Consensus 275 ~~--~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 275 GK--LVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred CC--EEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 65 4899999999865432211 111233578899999999988899999999999999999995577886533222
Q ss_pred HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 592 ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 592 ~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
...+... ....+...+.++.+++.+||+.+|.+||+++++++.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1222222 122233456799999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.64 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=182.6
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.|.+.+.||+|+||.||++ ..+++.||+|.+....... ..+|+ .++..++||||+++++++.++ ..|++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~-~~~~~~~~iK~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~- 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQG-EYTGQKVAVKNIKCDVTAQAFLEET-AVMTKLHHKNLVRLLGVILHN-GLYIVMELMS- 81 (254)
T ss_pred HHceeeeeeccCCCCceEec-ccCCCceEEEeecCcchHHHHHHHH-HHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC-
Confidence 44778899999999999985 4678899999986543333 34454 477889999999999998765 4799999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|.+++.... ...+++..++.++.|++.||+|||+.+++|||
T Consensus 82 ---------~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~d 125 (254)
T cd05083 82 ---------KGNLVNFLRTRG---------------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125 (254)
T ss_pred ---------CCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 444444432211 12356677889999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+||+++.++. +||+|||++....... .....+..|+|||.+.+..++.++|+|||||++|||++++.+|
T Consensus 126 l~p~nili~~~~~--~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 126 LAARNILVSEDGV--AKVSDFGLARVGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred cCcceEEEcCCCc--EEECCCccceeccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999987765 8999999987643211 1123456799999998888999999999999999999856888
Q ss_pred CCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 584 YGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 584 f~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|....... ...+... ........++++.+++.+||+.+|++||++++++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 198 YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 86543322 1222211 12223345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.05 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=186.9
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||.||++... +|+.||+|.++... .....+|+. ++..++|+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~-~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID-LLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35788899999999999998655 78999999885321 123345554 67788999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||| +.+|+|..++..... ....+++.+++.++.|++.||+|||+.
T Consensus 81 ~e~----------~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 81 LEL----------ADAGDLSRMIKHFKK-------------------------QKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred Eec----------CCCCCHHHHHHHhcc-------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 994 455555554432110 112367788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 126 ~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 126 RIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CEecCCcChhhEEECCCCc--EEEeccceeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 9999999999999988765 89999999876543211 112345888999999999888999999999999999999
Q ss_pred hCCCCCCCCchHHHH----HHHhhccccccc-cCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA----NIVKDRKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~----~~~~~~~~~~~~-~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+| ..||........ .+........+. ....++.++|.+||..+|++||++.++++
T Consensus 201 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 201 AL-QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HC-CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97 667644322111 111111111222 44568999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=321.18 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=187.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCC-cEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeee-cc---CC---ce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGV-ES---DQ---DF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g-~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~-~~---~~---~~ 413 (774)
-.+++.+.|.+|||+.||+|....+ ..||+|++...+. ....+||..|-..-.|||||.|++. .. .+ -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4477889999999999999987776 9999999965432 2345677655444559999999993 21 11 35
Q ss_pred eEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 414 ~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
++|.||||. ++|.|++- . ....+|.+.++++|+.|+++|++
T Consensus 117 vllLmEyC~gg~Lvd~mn-----------~---------------------------Rlq~~lte~eVLkIf~dv~~AVa 158 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMN-----------T---------------------------RLQTRLTEDEVLKIFYDVCEAVA 158 (738)
T ss_pred EEeehhhccCCcHHHHHH-----------H---------------------------HHhccCChHHHHHHHHHHHHHHH
Confidence 799999888 47777662 1 11234888999999999999999
Q ss_pred HHHHcC--ccccccCCCCeeecCCCCceEEEcccCccccccCCCcc------ccccccCcCCCCCCchhhhh---cCCCC
Q 004097 493 HLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------LTQNATGYGSSGWQAPEQLL---QGRQT 561 (774)
Q Consensus 493 yLH~~~--ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~------~~~~~~~~gt~~y~aPE~l~---~~~~~ 561 (774)
+||... |||||||-+||||+.+++ .||||||.+......... ........-|+.|+|||++. +...+
T Consensus 159 ~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~ 236 (738)
T KOG1989|consen 159 AMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG 236 (738)
T ss_pred HHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence 999986 999999999999998887 899999998654322110 01112234699999999974 56789
Q ss_pred CcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc-ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 562 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 562 ~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|+|||||||+||-|+.. .+||++.-. ..|+......++ ...+..+.+||..||+.||.+||++.+++.+
T Consensus 237 eKsDIWALGclLYkLCy~-t~PFe~sg~--laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 237 EKSDIWALGCLLYKLCYF-TTPFEESGK--LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred chhHHHHHHHHHHHHHHh-CCCcCcCcc--eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 999999999999999995 899987532 122333322222 3567799999999999999999999998754
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=296.15 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=187.9
Q ss_pred EEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
|.+.+.||+|+||+||++... ....||+|.+...... ...+|+. ++..++||||+++++.+.+++..|+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN-LLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCCEeeEEEEEecCCCcEE
Confidence 456688999999999997542 2357999988654322 3445655 6788899999999999999999999
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhh-HHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD-IELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|||. ++|.+++ ........... ..-...... ........+++..++.++.|++.||+||
T Consensus 81 v~e~~~~~~L~~~l-----------~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 81 IVEYAKYGSLRSFL-----------RESRKVGPSYL------GSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred EEEecCCCCHHHHH-----------HhcCCcccccc------ccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 999665 3555544 22110000000 000000000 0001124578889999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|
T Consensus 144 H~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~ 220 (290)
T cd05045 144 AEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 220 (290)
T ss_pred HHCCeehhhhhhheEEEcCCCc--EEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHH
Confidence 9999999999999999987764 899999999866433221 1122234577899999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++++..||....... ....... ....+...+.++.+++.+||+.+|++||++.++++
T Consensus 221 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 221 EIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99995588886544332 2222221 22223445679999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=299.44 Aligned_cols=260 Identities=24% Similarity=0.319 Sum_probs=183.4
Q ss_pred eEEEeEeecccCceEEEEEeee-CCc--EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~--~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.+.+.||+|+||+||++... ++. .+|+|++...... ...+|+..+....+||||+++++++.+++..|+||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4677899999999999998653 454 4688877543221 23456654444448999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||+ ++|+|.++++.......... ..........+++..++.++.||+.||+|||+.+
T Consensus 88 e~~----------~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 88 EYA----------PHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred EeC----------CCCcHHHHHHhccccccccc-------------ccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 955 44555554433211000000 0000001134678889999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++..... .......++..|+|||++....++.++|||||||++|||+|
T Consensus 145 i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 145 FIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred ccccccchheEEecCCCc--EEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 999999999999987765 899999998643211 11112234667999999988889999999999999999998
Q ss_pred CCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 579 GGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++.+||....... ....... ....+...++++.++|.+||+.+|++||++++++.+
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 219 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4477875433222 2222221 111233456789999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=295.55 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=187.7
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||.||++... ++..||+|++...... ...+|+. +++.++||||+++++++.+++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCcc
Confidence 34667788999999999998542 4689999998754332 2334544 77888999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|++||+|. ++|.+++.............. ... ..........+++..++.++.|++.||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-~~~-----------------~~~~~~~~~~l~~~~~~~~~~~i~~aL~~ 145 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHS-TSS-----------------ARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCcccccccccc-ccc-----------------cccccccccccCHHHHHHHHHHHHHHHHH
Confidence 99999665 355555432111100000000 000 00000112346788899999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+++||||||+||+++.++. ++|+|||++..+...... ........+..|+|||.+.+..++.++|||||||++
T Consensus 146 lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 146 LSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred HHhCCeecccccHhheEecCCCc--eEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 99999999999999999987765 899999998765432211 111222356779999999988999999999999999
Q ss_pred HHHHhCCCCCCCCc-hHHHHHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGES-FERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~-~~~~~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|||++.+..||... .......+.... ...+...++++.++|.+||+.||++|||+.|+++
T Consensus 223 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99998556676443 332222222221 1123345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.88 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=178.8
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEeecCC-c----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.+.+|.|+++.||++ ..+++.||||++.... . ....+|+. .+..++||||+++++++.+.+..|++||||.
T Consensus 7 ~~~~~~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~-- 82 (314)
T cd08216 7 GKCFEDLMIVHLAKH-KPTNTLVAVKKINLDSCSKEDLKLLQQEII-TSRQLQHPNILPYVTSFIVDSELYVVSPLMA-- 82 (314)
T ss_pred hHhhcCCceEEEEEe-cCCCCEEEEEEEeccccchhHHHHHHHHHH-HHHhcCCcchhhhhheeecCCeEEEEEeccC--
Confidence 344566666666653 4479999999986541 1 23345554 6778899999999999999999999999554
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
+|++.+++.... ...+++..+..++.|++.||+|||+.+|+||||
T Consensus 83 --------~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dl 127 (314)
T cd08216 83 --------YGSCEDLLKTHF---------------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127 (314)
T ss_pred --------CCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 455555443211 123567778899999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhcC--CCCCcchhHhHHHHHHHHHh
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlGvll~ellt 578 (774)
||+||+++.++. +||+|||.+......... ........++..|+|||++... .++.++|||||||++|||++
T Consensus 128 k~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~ 205 (314)
T cd08216 128 KASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205 (314)
T ss_pred CcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh
Confidence 999999987765 899999988765432110 1111233577889999998763 57899999999999999999
Q ss_pred CCCCCCCCchHHHHH--HHhhcc---------------------------------ccccccCCHHHHHHHHHhcCCCCC
Q 004097 579 GGKHPYGESFERDAN--IVKDRK---------------------------------DLFLVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~--~~~~~~---------------------------------~~~~~~~~~~~~dli~~~L~~dP~ 623 (774)
| ..||......... ...... .......++++.+++.+||+.||+
T Consensus 206 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 284 (314)
T cd08216 206 G-HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284 (314)
T ss_pred C-CCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence 6 7788654322111 010000 000001124688999999999999
Q ss_pred CCcCHHHHHcCCCCCC
Q 004097 624 LRPKAQNVLNHPFFWT 639 (774)
Q Consensus 624 ~Rps~~elL~HPff~~ 639 (774)
+|||++++++||||..
T Consensus 285 ~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 285 SRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCcCHHHHhcCchHhh
Confidence 9999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=303.32 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=188.3
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
+++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCccceeeeecCCccccc
Confidence 46678889999999999999985 45789999999854321 22345554 778889999999999987653
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..++|||++.++|.+++. ...+++..++.++.||+.|
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMK-----------------------------------------HEKLSEDRIQFLVYQMLKG 130 (343)
T ss_pred cceEEEEEecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 458999977655544431 1235677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|+|||+.+|+||||||+||+++.++. ++|+|||++...... .....+++.|+|||.+.+ ..++.++|+|||
T Consensus 131 l~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 131 LKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 99999999999999999999987765 899999998865432 123357889999999876 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH--HHHHhhc-----------------------c-------ccccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD--ANIVKDR-----------------------K-------DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~--~~~~~~~-----------------------~-------~~~~~~~~~~~~dli~~~ 617 (774)
||++|++++| .+||....... ..+.... . ........+++.++|.+|
T Consensus 203 G~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 281 (343)
T cd07880 203 GCIMAEMLTG-KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM 281 (343)
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence 9999999997 77886532211 1111000 0 001123456789999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||+.+++.||||...
T Consensus 282 l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 282 LVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cCCChhhCCCHHHHhcCccHhhh
Confidence 99999999999999999999654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=303.83 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=186.1
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC----
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ---- 411 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~---- 411 (774)
.+.+.|...+.||+|+||.||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHH-HHHHcCCCcccceeeeeeeccccc
Confidence 345678889999999999999985 45789999999865321 23345554 77888999999999987543
Q ss_pred --ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 412 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 412 --~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+..|++++++.++|.+++. ...+++..+..++.|++.
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~ 131 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVK-----------------------------------------CQKLTDDHVQFLIYQILR 131 (345)
T ss_pred ccccEEEEehhcccCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 3478888865555443331 123566778899999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHh
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 568 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwS 568 (774)
||+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||.+.+ ..++.++||||
T Consensus 132 aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 132 GLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 999999999999999999999988775 899999998765321 123457899999999876 46789999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH--HHHHhh-----------------------ccc-------cccccCCHHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERD--ANIVKD-----------------------RKD-------LFLVEHIPEAVDLFTR 616 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~--~~~~~~-----------------------~~~-------~~~~~~~~~~~dli~~ 616 (774)
|||++|||++| .+||....... ..+... ... ......++++.++|.+
T Consensus 204 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 204 VGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 99999999997 66775332111 000000 000 0011235688999999
Q ss_pred hcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 617 LLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 617 ~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||+.||.+||++.+++.||||...
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhhc
Confidence 999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=293.86 Aligned_cols=245 Identities=29% Similarity=0.497 Sum_probs=184.1
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|++|+||+|... +++.||||++..... ....+|+. .+..++ ||||+++++++.+++..|+|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK-SLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHH-HHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 346688999999999998664 578999999865422 22345665 445666 99999999999999999999997
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++ .... ...+++..++.++.|++.||.|||+.+++
T Consensus 80 ~~~~l~~~~-----------~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 80 MEGNLYQLM-----------KDRK---------------------------GKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred CCCCHHHHH-----------Hhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 665555443 1110 12357788899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg 579 (774)
|+||+|+||+++.++. ++|+|||++....... ......++..|+|||++.. ..++.++|+||||+++|||++|
T Consensus 122 H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 122 HRDLKPENLLVSGPEV--VKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred cCCCChhhEEEcCCCC--EEEeecccceeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 9999999999987665 8999999998665321 1123457889999998854 4578999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhh------------------c-----------cccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 580 GKHPYGESFERDA--NIVKD------------------R-----------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~------------------~-----------~~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
.+||........ .+... . .........+++.++|.+||+.||++|||+
T Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 196 -RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred -CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 677754322110 00000 0 000011224689999999999999999999
Q ss_pred HHHHcCCCC
Q 004097 629 QNVLNHPFF 637 (774)
Q Consensus 629 ~elL~HPff 637 (774)
+|++.||||
T Consensus 275 ~ei~~~~~~ 283 (283)
T cd07830 275 SQALQHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=294.10 Aligned_cols=243 Identities=28% Similarity=0.474 Sum_probs=185.9
Q ss_pred EeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 349 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
..+.||+|++|.||++.. .+|+.+|+|++..... ....+|+. +++.++||||+++++++.+++..|+|+||+.
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHH-HHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 457899999999999854 4689999999865432 23445554 6778889999999999999999999999777
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
++|.+++... ...+++..++.++.|++.||+|||+.+|+|+
T Consensus 82 ~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 122 (283)
T cd05118 82 TDLYKLIKDR---------------------------------------QRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122 (283)
T ss_pred CCHHHHHHhh---------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 6665544211 1235677889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~~ 581 (774)
||||+||+++.++. ++|+|||.+....... .......++..|+|||.+.+. .++.++|+|||||++|+|++| .
T Consensus 123 dl~p~nili~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg-~ 196 (283)
T cd05118 123 DLKPENLLINTEGV--LKLADFGLARSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-R 196 (283)
T ss_pred CcCHHHEEECCCCc--EEEeeeeeeEecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC-C
Confidence 99999999987765 8999999988765432 111223578899999999876 789999999999999999997 6
Q ss_pred CCCCCchHHHH--HHHhhcc-----------------------------ccccccCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 582 HPYGESFERDA--NIVKDRK-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 582 ~Pf~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
+||......+. .+..... .......+.++.++|.+||+.||.+||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 77754332111 0000000 0001123568899999999999999999999
Q ss_pred HHcCCCC
Q 004097 631 VLNHPFF 637 (774)
Q Consensus 631 lL~HPff 637 (774)
++.||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.70 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=182.0
Q ss_pred EeecccCceEEEEEeeeC--C--cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 351 KEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~--g--~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.||+|++|+||++...+ + ..||||.+...... ...+|+. .+..++||||+++++++.+ ...++|+|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~- 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAA-IMHSLDHENLIRLYGVVLT-HPLMMVTELA- 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHH-HHhhcCCCCccceeEEEcC-CeEEEEEEec-
Confidence 358999999999986543 3 36999999765431 2334554 6788899999999999988 8899999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.+.+.... ...+++..+..++.|++.||+|||+.+++||
T Consensus 78 ---------~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 121 (257)
T cd05040 78 ---------PLGSLLDRLRKDA---------------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHR 121 (257)
T ss_pred ---------CCCcHHHHHHhcc---------------------------cccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 4455554443211 0235777889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||+++.+..............++..|+|||++....++.++|||||||++|||++.|..
T Consensus 122 di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 122 DLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred ccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999987764 8999999998775432222222234578899999999988999999999999999999994477
Q ss_pred CCCCchHHH-HHHHh-hc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 583 PYGESFERD-ANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 583 Pf~~~~~~~-~~~~~-~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||......+ ...+. .. ....+...+.++.+++.+||+.+|++||++.++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 885433222 11111 11 11122334578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.27 Aligned_cols=240 Identities=28% Similarity=0.381 Sum_probs=183.2
Q ss_pred eecccCceEEEEEeeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhh
Q 004097 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 427 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~ 427 (774)
.||+|+||.||++...+++.||+|++...... ...+|+ .++..++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e-------- 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEA-EILKQYDHPNIVKLIGVCVQKQPIYIVME-------- 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCCeEEEEE--------
Confidence 58999999999997766999999998654332 233444 47788999999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCC
Q 004097 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 507 (774)
Q Consensus 428 ~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 507 (774)
|+.+++|.+++... ...+++..++.++.+++.||+|||+.+++||||||+
T Consensus 73 --~~~~~~l~~~l~~~----------------------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ 122 (251)
T cd05041 73 --LVPGGSLLTFLRKK----------------------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122 (251)
T ss_pred --cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcc
Confidence 44455555544321 122456677899999999999999999999999999
Q ss_pred CeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCc
Q 004097 508 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 587 (774)
Q Consensus 508 NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~ 587 (774)
||+++.++. ++|+|||++......... .......++..|+|||.+.+..++.++|+|||||++|||++++..||...
T Consensus 123 nili~~~~~--~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 123 NCLVGENNV--LKISDFGMSREEEGGIYT-VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eEEEcCCCc--EEEeeccccccccCCcce-eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 999987765 899999998765422111 11112234667999999988889999999999999999999668888654
Q ss_pred hHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 588 FERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 588 ~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.... ...+... ....+...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 200 SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4322 2222221 11223345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.54 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=188.9
Q ss_pred cceEEEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 410 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 410 (774)
..+|.+.+.||+|+||.||++... .+..||+|.+..... ....+|+. ++..+ +||||++++++|.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHH-HHHhhcCCCCeeeeeEEEcc
Confidence 345788899999999999998532 124799998865332 23445665 45555 89999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+++||+. +|+|.+++........... ..........+++..++.++.|++.|
T Consensus 90 ~~~~~lv~e~~~----------~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 90 DGPLYVLVEYAS----------KGNLREYLRARRPPGMDYS-------------FDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred CCceEEEEecCC----------CCcHHHHHHhcCCcccccc-------------cccccCccccCCHHHHHHHHHHHHHH
Confidence 999999999554 4445444432211000000 00000112346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++||||||
T Consensus 147 l~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 223 (334)
T cd05100 147 MEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223 (334)
T ss_pred HHHHHHCCeeccccccceEEEcCCCc--EEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHH
Confidence 99999999999999999999987765 89999999986643211 1111223345789999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 571 CILFFCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++|||++++.+||....... ...+.. .....+.....++.+++.+||+.+|++||++.|++++
T Consensus 224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999996677886543322 222222 2222333456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=291.97 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=184.1
Q ss_pred eecccCceEEEEEeeeC-------CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 352 EIAKGSNGTVVLEGNYE-------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~-------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.||+|+||.||++...+ ++.||||.+.+.. .....+|+ .+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEA-HLMSNFNHPNIVKLLGVCLLNEPQYIIME- 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHH-HHHHhcCCCCeeeEeeeecCCCCeEEEEe-
Confidence 58999999999975432 3689999886532 12334444 47788999999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+++|+|.+++....... .....+++.+++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 128 (269)
T cd05044 80 ---------LMEGGDLLSYLRDARVER----------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFI 128 (269)
T ss_pred ---------ccCCCcHHHHHHHhhhcc----------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 666666666654322110 0123367788899999999999999999999
Q ss_pred ccccCCCCeeecCCC---CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 501 HRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 501 HrDLkp~NILl~~~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|+||||+||+++.++ ...++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+
T Consensus 129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred cCCCChheEEEecCCCCCCcceEECCcccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 999999999997654 22589999999986643211 11122334678899999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+.+..||........ ..+. ......+...++.+.++|.+||+.+|.+||++.++++
T Consensus 208 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 208 TLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 844778865433221 1111 1112223345678999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.93 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=187.9
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhC-CCCCeeEEeeeccCC--c
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASD-QHPNIVRWYGVESDQ--D 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~--~ 412 (774)
.+.+.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|+. ++..+ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM-FLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHH-HHHHhcCCCCccceeeeeccCCCc
Confidence 34566777889999999999998654 68899999885421 123455665 66777 999999999998653 4
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||+|.++|.+++.. ..+++..++.++.||+.||+
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-----------------------------------------~~~~~~~~~~i~~qi~~~L~ 121 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRA-----------------------------------------NILEDVHKRYIMYQLLKALK 121 (337)
T ss_pred eEEEEecccccCHHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 6899999877666554410 12445567889999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc--ccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|||+.+|+||||||+||+++.++. +||+|||++......... ........||..|+|||++.+ ..++.++|||||
T Consensus 122 ~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 122 YIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 999999999999999999988765 899999999876543211 011223458999999998765 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhh--------------------------cc----ccccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKD--------------------------RK----DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~--------------------------~~----~~~~~~~~~~~~dli~~~ 617 (774)
||++|+|++| ++||........ .+... .. .......+.++.++|.+|
T Consensus 200 G~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 200 GCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 9999999997 777754321110 00000 00 001112457899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||+.++++||||...
T Consensus 279 l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 279 LVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred ccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=290.81 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=186.0
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
|.+.+.||+|+||+||++... .+..+++|.++... ......|+. ++..++||||+++++++.+.+..++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ-LLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHH-HHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 667789999999999997543 34556666654211 112334554 67888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+||+ .+++|...+.... .....+++..++.++.|++.||+|||+.
T Consensus 81 ~e~~----------~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 81 TEYC----------EGRDLDCKLEELK-------------------------HTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred EEeC----------CCCCHHHHHHHHh-------------------------hcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 9954 4555555443211 1123467888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+++|+||+|+||+++.+ .++|+|||+++....... ......|++.|+|||.+....++.++|+||||+++|+|+
T Consensus 126 ~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 126 RILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred CccccCCChhheEeecC---CEeecccCceeecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999643 389999999877643221 122345788999999998888899999999999999999
Q ss_pred hCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 578 TGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 578 tg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
+| ..||....... ..+........+...+.++.++|.+||+.||++||++.++++||||
T Consensus 200 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 200 CL-AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hC-CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 97 66775433221 1222222222333456799999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.14 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=189.1
Q ss_pred EeecccCceEEEEEe-eeCCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCCeeEEeeeccCC--------ceeEE
Q 004097 351 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQ--------DFVYL 416 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--------~~~~L 416 (774)
.+||+|.||.|++|. ..+|+.||+|+..- .....+++|+. ++..+.|+|++.++..|... ..+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreik-iL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHH-HHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 469999999999984 45688899987632 23456788886 77889999999999988642 45899
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|+++|..+|..++-. ....++..++.++++++..||.|+|.
T Consensus 102 Vf~~cehDLaGlLsn---------------------------------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 102 VFDFCEHDLAGLLSN---------------------------------------RKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred eHHHhhhhHHHHhcC---------------------------------------ccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999887666511 11235667889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-ccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 574 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ 574 (774)
..|+|||+|+.|+||+.|+. +||+|||+++.+...... .......+.|..|.+||.+.+. .|+.+.|||..|||+.
T Consensus 143 ~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 143 NKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMA 220 (376)
T ss_pred hhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHH
Confidence 99999999999999988875 899999999876533221 1222334579999999999875 5899999999999999
Q ss_pred HHHhCCCCCCCCchH-HHHHHHhhc-----cc----------------c--------------ccccCCHHHHHHHHHhc
Q 004097 575 FCITGGKHPYGESFE-RDANIVKDR-----KD----------------L--------------FLVEHIPEAVDLFTRLL 618 (774)
Q Consensus 575 elltg~~~Pf~~~~~-~~~~~~~~~-----~~----------------~--------------~~~~~~~~~~dli~~~L 618 (774)
||+|+ .|-+....+ .....+... +. . .+-...+++.||+.+||
T Consensus 221 eMwtr-spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 221 EMWTR-SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHcc-CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 99997 544443332 221111100 00 0 00011358999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCCccch
Q 004097 619 DPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 619 ~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
..||.+|++++++++|.|||.....
T Consensus 300 ~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccCcccCcchHhhhchhhhhcCCcc
Confidence 9999999999999999999986544
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.85 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=184.8
Q ss_pred EEEeEeecccCceEEEEEeee-C--CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC----Ccee
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-E--GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD----QDFV 414 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~--g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~ 414 (774)
|.+.+.||+|+||.||++... . +..||||++.... .....+|+..+.....||||+++++++.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 567789999999999998543 3 7799999986432 12345676644444479999999987532 2457
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+++|++.++|.+++. ....+++..++.++.||+.||+||
T Consensus 82 ~~~~e~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 82 YLYEELMEADLHQIIR----------------------------------------SGQPLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred EEEEecccCCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 8999977666555441 123466778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-ccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 572 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvl 572 (774)
|+.+|+||||||+||+++.++. +||+|||+++.+...... ........||..|+|||++.+ ..++.++|||||||+
T Consensus 122 H~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 122 HSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred HhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 9999999999999999988765 899999999876533211 111233468999999998866 468999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHH-----------------------hhc---c-c---cccccCCHHHHHHHHHhcCC
Q 004097 573 LFFCITGGKHPYGESFERDA--NIV-----------------------KDR---K-D---LFLVEHIPEAVDLFTRLLDP 620 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~--~~~-----------------------~~~---~-~---~~~~~~~~~~~dli~~~L~~ 620 (774)
+|+|++| .+||........ .++ ... . . ........++.+++.+||+.
T Consensus 200 l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 278 (332)
T cd07857 200 LAELLGR-KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF 278 (332)
T ss_pred HHHHHhC-CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC
Confidence 9999986 778864321110 000 000 0 0 00112356899999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCcc
Q 004097 621 NPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 621 dP~~Rps~~elL~HPff~~~~ 641 (774)
||.+|||+.+++.||||..+.
T Consensus 279 ~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 279 DPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CcccCCCHHHHhcChhhhhhc
Confidence 999999999999999996553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.93 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=183.3
Q ss_pred eEEEeEeecccCceEEEEEeee-CC---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.+.+.||+|+||.||++... ++ ..||||.+...... ....|+ .++..++||||+++++++.+++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4678899999999999998654 23 36999998754322 233444 467788999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||| +.+|+|.+++... ...+++.+++.++.|++.||+|||+.
T Consensus 84 ~e~----------~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~l~~al~~lH~~ 125 (269)
T cd05065 84 TEF----------MENGALDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYLSEM 125 (269)
T ss_pred Eec----------CCCCcHHHHHhhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 994 4455555544321 12356778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccC--cCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+++||||||+||+++.++ .+||+|||++................ ..+..|+|||.+....++.++|||||||++||
T Consensus 126 g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 126 NYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred CEeecccChheEEEcCCC--cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 999999999999997665 48999999987665332211111111 12457999999998899999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+++.+.+||....... ...+.. .....+...++++.+++.+||+.+|.+||++.+++.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9874477776543322 222221 122223445678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=286.66 Aligned_cols=244 Identities=26% Similarity=0.388 Sum_probs=186.6
Q ss_pred EEeEeecccCceEEEEEeeeC-----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 348 VFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~~-----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.+.||+|+||.||++.... +..||+|++...... ...+|+. ++..++||||+++++++.+.+..|++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREAR-IMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345789999999999986543 488999999755432 3344554 666779999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|++ ++++|.+++.... ...+++..+..++.|++.||+|||+.+
T Consensus 81 e~~----------~~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 81 EYM----------EGGDLLDYLRKNR---------------------------PKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred ecc----------CCCCHHHHHHhhh---------------------------hccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 954 4555555443211 011677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
++|+||||+||+++.++. ++|+|||+++.......... ....+++.|+|||.+....++.++|||||||++|+|++
T Consensus 124 ~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~ 199 (258)
T smart00219 124 FIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199 (258)
T ss_pred eeecccccceEEEccCCe--EEEcccCCceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence 999999999999987764 89999999987764322111 12237789999999988889999999999999999999
Q ss_pred CCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 579 GGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++.+||....... . .+........+...+.++.+++.+||..||++|||+.++++
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 200 LGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7688887543222 2 22222222233445678999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.49 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=175.3
Q ss_pred eecccCceEEEEEeee---CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 352 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.||+|+||.||++... ++..+|+|.+...... ...+|+ .++..++||||+++++++.+....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEA-QPYRSLQHSNLLQCLGQCTEVTPYLLVME----- 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCCcEEEEE-----
Confidence 5899999999998543 3467999998654321 233454 47788999999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
|+++|+|.++++..... .....++..++.++.|++.||+|||+.+++||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 126 (269)
T cd05087 76 -----FCPLGDLKGYLRSCRKA------------------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL 126 (269)
T ss_pred -----CCCCCcHHHHHHHhhhc------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 55556666555432210 0112345667889999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-------CCCCcchhHhHHHHHHHHH
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-------RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDvwSlGvll~ell 577 (774)
||+||+++.++. +||+|||+++....... ........++..|+|||++... .++.++|||||||++|||+
T Consensus 127 kp~nil~~~~~~--~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 127 ALRNCLLTADLT--VKIGDYGLSHNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred CcceEEEcCCCc--EEECCccccccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 999999987654 89999999875432211 1112234578889999998642 3578999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc-----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA--NIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+.|.+||........ ..+..... .......+.+.+++.+|+ .+|++|||++||+.
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 204 ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 734788865433322 11111111 111123567899999998 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.76 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=193.1
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
|.+.+.||+|+||.||++. ..+++.+|||.+..... ....+|+ .+++.++||||+++++++.+....|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e- 79 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEI-RILASVNHPNIISYKEAFLDGNKLCIVME- 79 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHH-HHHHhCCCCCchhhhhhhccCCEEEEEeh-
Confidence 5677899999999999974 45788999999865321 1223444 36788899999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|+++++|.+++..... ....+++..+..++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~al~~lh~~~i~ 125 (256)
T cd08530 80 ---------YAPFGDLSKAISKRKK-------------------------KRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125 (256)
T ss_pred ---------hcCCCCHHHHHHHHHh-------------------------hcCCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 5566666665533211 123467788899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|+||+|+||+++.++. +||+|||++...... ......+++.|++||.+.+..++.++|+||||+++|+|++|
T Consensus 126 h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g- 197 (256)
T cd08530 126 HRDLKSANILLVANDL--VKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF- 197 (256)
T ss_pred cCCCCcceEEEecCCc--EEEeeccchhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999987665 899999999877543 12234588999999999988899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
..||........ .+..............++.+++.+||+.+|++||++.++++||+.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 198 APPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 778866543221 122222222223456789999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.41 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=185.2
Q ss_pred ceEEEeEeecccCceEEEEEeee-----------------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 403 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-----------------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~ 403 (774)
++|.+.+.||+|+||+||++... ++..||||++..... ....+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCcce
Confidence 45788899999999999986322 245799999865432 23345654 677889999999
Q ss_pred EeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHH
Q 004097 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483 (774)
Q Consensus 404 l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 483 (774)
+++++.+.+..|+||||+ .+|+|.+++........ ...+....+++.++..+
T Consensus 84 ~~~~~~~~~~~~lv~e~~----------~~~~L~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 84 LLAVCITSDPLCMITEYM----------ENGDLNQFLSRHEPQEA------------------AEKADVVTISYSTLIFM 135 (296)
T ss_pred EEEEEecCCccEEEEEeC----------CCCcHHHHHHhcCcccc------------------cccccccccCHHHHHHH
Confidence 999999999999999955 44455444433211100 00022234677889999
Q ss_pred HHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCc
Q 004097 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563 (774)
Q Consensus 484 ~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 563 (774)
+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+...... .......++..|+|||......++.+
T Consensus 136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccch
Confidence 999999999999999999999999999987765 899999999866432211 11122335678999999988889999
Q ss_pred chhHhHHHHHHHHHhC-CCCCCCCchHHH-HHHH-h---h----ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 564 IDLFSLGCILFFCITG-GKHPYGESFERD-ANIV-K---D----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 564 sDvwSlGvll~elltg-~~~Pf~~~~~~~-~~~~-~---~----~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|||||||++|||+++ +..||....... .... . . .....+....+.+.+++.+||+.||.+||++.++++
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999984 467775432211 1100 0 0 011112334578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.61 Aligned_cols=242 Identities=23% Similarity=0.369 Sum_probs=173.6
Q ss_pred eecccCceEEEEEeeeCCc---EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 352 EIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~---~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
+||+|+||+||++...++. .+++|.+..... ....+|+ .++..++||||++++++|.+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~---- 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQG-DPYRILQHPNILQCLGQCVEAIPYLLVFEY---- 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHH-HHHhccCCcchhheEEEecCCCccEEEEec----
Confidence 5999999999998655543 466776654322 2334444 466788999999999999999999999994
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
+.+|+|.++++... +.....++..++.++.||+.||+|||+.+++||||
T Consensus 77 ------~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 77 ------CELGDLKSYLSQEQ-------------------------WHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred ------CCCCcHHHHHHhhh-------------------------cccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 45555655554321 11122445567899999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-------CCCCCcchhHhHHHHHHHHH
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSlGvll~ell 577 (774)
||+|||++.++. ++|+|||++....... .........++..|+|||++.. ..++.++|||||||++|||+
T Consensus 126 kp~nil~~~~~~--~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 126 ALRNCFLTSDLT--VKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ccceEEEcCCcc--EEecccccccccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 999999977765 8999999986432211 1112233468899999999853 23578999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERDA--NIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+++.+||........ .+..... ........+.+.+++..|| .+|.+||+++++++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 987888865433221 2222211 1112234578899999999 67999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.22 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=184.1
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|.+.+.||+|+||.||++. ..+|+.||||.+..... ....+|+. ++..++||||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEID-LLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHH-HHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4566889999999999986 45789999998864321 12334554 6778899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
++ .+++|.+++.... .....+++..+..++.||+.||+|||+.++
T Consensus 83 ~~----------~~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 127 (267)
T cd08229 83 LA----------DAGDLSRMIKHFK-------------------------KQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127 (267)
T ss_pred ec----------CCCCHHHHHHHhh-------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 54 4555555443211 012346788889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+|+||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 128 ~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ecCCCCHHHEEEcCCCC--EEECcchhhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 89999999876643221 11234588999999999888899999999999999999997
Q ss_pred CCCCCCCchHHHHH----HHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 580 GKHPYGESFERDAN----IVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 580 ~~~Pf~~~~~~~~~----~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
..||......... +...... ......++++.+++.+||+.||++|||+.++++
T Consensus 203 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 203 -QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 5566433221111 1111111 112234578999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.27 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=187.4
Q ss_pred EEEeEeecccCceEEEEEee----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhC-CCCCeeEEeeeccCCcee
Q 004097 347 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~ 414 (774)
|.+.+.||+|++|+||++.. .+++.||||.+++... .....|+. ++..+ +||||+++++.+.+++..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQ-VLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHH-HHHhccCCcchhhhheeeecCCEE
Confidence 56778999999999999753 3578999999864321 22345555 44555 799999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||| |+.+|+|.+++.. ...+++..++.++.|++.||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~~l~~l 121 (288)
T cd05583 81 HLILD----------YVNGGELFTHLYQ-----------------------------REHFTESEVRVYIAEIVLALDHL 121 (288)
T ss_pred EEEEe----------cCCCCcHHHHHhh-----------------------------cCCcCHHHHHHHHHHHHHHHHHH
Confidence 99999 5555555554322 12356677889999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC--CCCcchhHhHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCI 572 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSlGvl 572 (774)
|+.+++||||+|+||+++.++. ++|+|||+++........ ......|+..|+|||.+.+.. .+.++||||||++
T Consensus 122 H~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 122 HQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197 (288)
T ss_pred HHCCeeccCCCHHHeEECCCCC--EEEEECcccccccccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence 9999999999999999987765 899999998776533211 112345889999999987655 6889999999999
Q ss_pred HHHHHhCCCCCCCCch-----HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC---HHHHHcCCCCCCccc
Q 004097 573 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT 642 (774)
Q Consensus 573 l~elltg~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps---~~elL~HPff~~~~~ 642 (774)
+|||++| ..||.... ..............+....+++.++|.+||+.||++||| +.++++||||...++
T Consensus 198 l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 198 TFELLTG-ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHhC-CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999996 77775321 111111111222233345678999999999999999998 567799999977654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.26 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=175.3
Q ss_pred cccceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCchHH-----------HHHHH--HHHHhCCCCCeeEE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDVA-----------LKEIQ--NLIASDQHPNIVRW 404 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~~~-----------~~Ei~--~ll~~l~HpNIV~l 404 (774)
..++.|.+.+.||+|+||+||++...+ +..+|+|+......... ..++. ..+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345779999999999999999986544 45667775432211100 01111 12345789999999
Q ss_pred eeeccCCc----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHH
Q 004097 405 YGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480 (774)
Q Consensus 405 ~g~~~~~~----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 480 (774)
++++.... ..++++|++..++.+++. .....++..+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~ 128 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFK----------------------------------------RIKCKNKKLI 128 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHH----------------------------------------hhccCCHHHH
Confidence 99765543 347788865544433321 0012355667
Q ss_pred HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhh
Q 004097 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLL 556 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~ 556 (774)
+.|+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+....... .......||+.|+|||+..
T Consensus 129 ~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 899999999999999999999999999999977655 8999999998764321111 1112346999999999999
Q ss_pred cCCCCCcchhHhHHHHHHHHHhCCCCCCCCchH--HHH-----HHHhh--ccccccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 557 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDA-----NIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 557 ~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~--~~~-----~~~~~--~~~~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+..++.++|||||||++|||++| .+||..... ... ..... ..........+++.++++.|+..+|++||+
T Consensus 207 ~~~~~~~~DiwSlG~~l~el~~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 207 GACVTRRGDLESLGYCMLKWAGI-KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhC-CCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997 889865421 111 11111 011123344678999999999999999999
Q ss_pred HHHHHc
Q 004097 628 AQNVLN 633 (774)
Q Consensus 628 ~~elL~ 633 (774)
+.++++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 999874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.66 Aligned_cols=244 Identities=30% Similarity=0.482 Sum_probs=186.6
Q ss_pred EEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 348 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.+.||+|++|.||++... +++.||+|++.... ......|+. .+..++||||+++++++.+.+..++|+|++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS-LLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHH-HHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 34577999999999998655 58999999987542 123345554 667889999999999999999999999987
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.++|.+++.... ..+++..+..++.|++.||+|||+.+|+|
T Consensus 81 ~~~l~~~i~~~~---------------------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 121 (282)
T cd07829 81 DMDLKKYLDKRP---------------------------------------GPLSPNLIKSIMYQLLRGLAYCHSHRILH 121 (282)
T ss_pred CcCHHHHHHhhc---------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 766666552110 23567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||+|+||+++.++. ++|+|||+++....... ......++..|+|||.+... .++.++|||||||++||+++|
T Consensus 122 ~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~- 195 (282)
T cd07829 122 RDLKPQNILINRDGV--LKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG- 195 (282)
T ss_pred CCCChheEEEcCCCC--EEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC-
Confidence 999999999987765 89999999887653221 12233467889999998776 789999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhh--------------c---c---c--------cccccCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 581 KHPYGESFERDA--NIVKD--------------R---K---D--------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~--------------~---~---~--------~~~~~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
.+||........ .+... . . . ........++.++|.+||+.||++||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 778865432111 00000 0 0 0 001122467999999999999999999999
Q ss_pred HHcCCCC
Q 004097 631 VLNHPFF 637 (774)
Q Consensus 631 lL~HPff 637 (774)
+++||||
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=297.22 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=187.0
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC-CceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~ 415 (774)
+++.|.+.+.||+|+||.||++. ..+|+.||||++.+.. .....+|+. ++..++||||+++++++.. .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK-LLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHH-HHHhcCCCCeeeEeeeEecCCCcEE
Confidence 56778999999999999999985 4579999999885422 123445655 6788899999999998865 56789
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+++|++.++|.+++ . ...+++..+..++.|++.||+|||
T Consensus 87 lv~e~~~~~L~~~~-----------~------------------------------~~~~~~~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 87 FVTELLGTDLHRLL-----------T------------------------------SRPLEKQFIQYFLYQILRGLKYVH 125 (328)
T ss_pred EEeehhccCHHHHH-----------h------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99996655544333 1 123456667889999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||+|+||+++.++. ++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|
T Consensus 126 ~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 197 (328)
T cd07856 126 SAGVVHRDLKPSNILINENCD--LKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197 (328)
T ss_pred hCCcccCCCCHHHEeECCCCC--EEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHH
Confidence 999999999999999987765 899999998754321 123357889999998765 56899999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-----H--------------------HHhhc---cc----cccccCCHHHHHHHHHhcCCCC
Q 004097 575 FCITGGKHPYGESFERDA-----N--------------------IVKDR---KD----LFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~-----~--------------------~~~~~---~~----~~~~~~~~~~~dli~~~L~~dP 622 (774)
+|++| .+||........ . ..... .. .......+++.++|.+||+.+|
T Consensus 198 el~tg-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 276 (328)
T cd07856 198 EMLEG-KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276 (328)
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh
Confidence 99997 778754322110 0 00000 00 0012245789999999999999
Q ss_pred CCCcCHHHHHcCCCCCCc
Q 004097 623 DLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~~ 640 (774)
++||++++++.||||...
T Consensus 277 ~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 277 QKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhCCCHHHHhcCCccccc
Confidence 999999999999999543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.72 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=185.7
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||+|+||+||++.. .++..||||.+.... . ....+|+. ++..++|||++++++++.+.+..|+|||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 34456799999999999864 467899999986321 1 12345554 7788899999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++...+ ..+++..+..++.|++.||.|||+.++
T Consensus 96 ~~~~~l~~~~~~~~---------------------------------------~~l~~~~~~~~~~~l~~~l~~LH~~~i 136 (308)
T cd06634 96 YCLGSASDLLEVHK---------------------------------------KPLQEVEIAAVTHGALQGLAYLHSHNM 136 (308)
T ss_pred ccCCCHHHHHHHcC---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 88777665543211 224566778999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~el 576 (774)
+||||+|+||+++.++. ++|+|||++...... ....++..|+|||.+. ...++.++|||||||++|+|
T Consensus 137 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 137 IHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred ccCCCCHHhEEECCCCc--EEECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 99999999999987765 899999998765421 2345788999999985 34678899999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 577 ITGGKHPYGESFERD--ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++| ..||....... ..+..... .......+..+.++|.+||+.+|++||+++++++|||+..
T Consensus 208 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 208 AER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HcC-CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 997 55664432221 12222111 1112234568999999999999999999999999999855
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.26 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=184.4
Q ss_pred ceEEEeEeecccCceEEEEEeeeC---------------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE---------------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWY 405 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~---------------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~ 405 (774)
++|.+.+.||+|+||.||++.... ...||||.+...... ...+|++ ++..++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCcCeEE
Confidence 357778899999999999864321 235999998654222 2345554 77889999999999
Q ss_pred eeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 406 g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
+++...+..|+|||| +.+++|.+++........ .. .......+++..++.++.
T Consensus 84 ~~~~~~~~~~lv~e~----------~~~~~L~~~l~~~~~~~~-~~----------------~~~~~~~~~~~~~~~i~~ 136 (295)
T cd05097 84 GVCVSDDPLCMITEY----------MENGDLNQFLSQREIEST-FT----------------HANNIPSVSIANLLYMAV 136 (295)
T ss_pred EEEcCCCccEEEEec----------CCCCcHHHHHHhcccccc-cc----------------ccccCCcccHHHHHHHHH
Confidence 999999999999994 445555555433211000 00 001112356788899999
Q ss_pred HHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcch
Q 004097 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 565 (774)
Q Consensus 486 qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 565 (774)
|++.||+|||+.+++||||||+||+++.++. +||+|||++........ ........++..|+|||++....++.++|
T Consensus 137 ~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhh
Confidence 9999999999999999999999999987765 89999999976543211 11122234577899999999888999999
Q ss_pred hHhHHHHHHHHHhC-CCCCCCCchHHH-H-HHHh---h--c--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 566 LFSLGCILFFCITG-GKHPYGESFERD-A-NIVK---D--R--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 566 vwSlGvll~elltg-~~~Pf~~~~~~~-~-~~~~---~--~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||||||++|+|+++ +..||....... . .... . . ........++.+.+++.+||+.||++||++.++++
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999984 356776533221 1 1111 0 0 01112234578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=287.58 Aligned_cols=228 Identities=25% Similarity=0.271 Sum_probs=175.5
Q ss_pred cCceEEEEEe-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHHHHhcC
Q 004097 356 GSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSG 434 (774)
Q Consensus 356 GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~g 434 (774)
|.+|+||++. ..+++.||+|++.... ...+|.. .+....||||+++++++.+.+..|+||| |+.+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e----------~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERL-TIIPHCVPNMVCLHKYIVSEDSVFLVLQ----------HAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHH-HHHhcCCCceeehhhheecCCeEEEEEe----------cCCCC
Confidence 8999999984 4578999999997643 2223333 3344569999999999999999999999 55556
Q ss_pred ChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCC
Q 004097 435 SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514 (774)
Q Consensus 435 sL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 514 (774)
+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 71 ~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~ 121 (237)
T cd05576 71 KLWSHISK-----------------------------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121 (237)
T ss_pred CHHHHHHH-----------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence 66554422 1236778889999999999999999999999999999999887
Q ss_pred CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 004097 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 594 (774)
Q Consensus 515 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~ 594 (774)
+. ++++|||++...... .....++..|+|||.+....++.++|+||+||++|||++| ..|+........
T Consensus 122 ~~--~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~~~~~~~~~~~-- 190 (237)
T cd05576 122 GH--IQLTYFSRWSEVEDS------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGIN-- 190 (237)
T ss_pred CC--EEEecccchhccccc------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHC-cchhhcCchhcc--
Confidence 76 899999988665432 1223467789999999888899999999999999999997 555543221100
Q ss_pred HhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCC
Q 004097 595 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 637 (774)
Q Consensus 595 ~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff 637 (774)
.......+...++++.++|.+||+.||++||++ +++++||||
T Consensus 191 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 -THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 001111233456789999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.64 Aligned_cols=244 Identities=26% Similarity=0.450 Sum_probs=186.7
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
..||+|+||.||++.. .+|..||||++..... ....+|+. ++..++||||+++++++.+.+..|+||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~---- 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVMEFLE---- 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHH-HHHhcCCcchhheeeEEEeCCEEEEEEecCC----
Confidence 5699999999999855 5789999998753221 23445654 6788999999999999999999999999554
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
+++|.+++. ...+++..+..++.|++.||+|||+.+++|+||+|
T Consensus 101 ------~~~L~~~~~------------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p 144 (292)
T cd06657 101 ------GGALTDIVT------------------------------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144 (292)
T ss_pred ------CCcHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 444444321 12245677889999999999999999999999999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
+||+++.++. ++|+|||++....... .......|++.|+|||.+....++.++|+||+||++|+|++| .+||..
T Consensus 145 ~Nilv~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg-~~p~~~ 218 (292)
T cd06657 145 DSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFN 218 (292)
T ss_pred HHEEECCCCC--EEEcccccceeccccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999988765 8999999987654321 112234588999999999888889999999999999999997 667754
Q ss_pred chH-HHHHHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 587 SFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 587 ~~~-~~~~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
... ........... ......++++.+++.+||+.||.+||++.++++||||....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 219 EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 332 22222221111 11223467899999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.79 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=177.7
Q ss_pred eecccCceEEEEEeeeC-Cc--EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 352 EIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~-g~--~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.||+|+||.||++...+ +. .+|+|.+..... ....+|+..+....+||||+++++++...+..|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~--- 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA--- 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC---
Confidence 58999999999986543 43 578898864322 233456654433338999999999999999999999954
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
++|+|.+++........... . ....-....+++..++.++.|++.||+|||+.+++||||
T Consensus 79 -------~~~~L~~~i~~~~~~~~~~~---------~----~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 79 -------PHGNLLDFLRKSRVLETDPA---------F----AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred -------CCCcHHHHHHhccccccccc---------c----ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 45555554433211000000 0 000011234678889999999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
||+||+++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||++++.+||
T Consensus 139 kp~nili~~~~~--~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 139 AARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred ccceEEEcCCCe--EEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999977754 899999998633211 11112234667999999988889999999999999999998457788
Q ss_pred CCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 585 GESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 585 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
....... ...+... ....+.....++.+++.+||+.||.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 213 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 5433222 2222221 11223344578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=287.00 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=183.4
Q ss_pred ceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||.||+|...+ ...||||........ ...+|+ .++..++||||+++++++.+ +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA-YIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHH-HHHHhCCCCchhceeEEEcC-CCcEE
Confidence 447788999999999999986543 247999988654321 233444 47788899999999999876 45789
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||+|. +|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 84 v~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 84 VMELAP----------LGELRSYLQVN----------------------------KYSLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred EEEcCC----------CCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999554 44554443221 1235677889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+++||||||+||+++.++. ++|+|||+++........ ......++..|+|||.+....++.++|||||||++||+
T Consensus 126 ~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 201 (270)
T cd05056 126 KRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYY--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201 (270)
T ss_pred CCeeccccChheEEEecCCC--eEEccCceeeecccccce--ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 899999999876543211 11122345689999999888899999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++.+.+||........ .+........+...++++.++|.+|+..+|.+|||+.+++.+
T Consensus 202 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 202 LMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9744788865543222 222222222344556899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=288.03 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=187.2
Q ss_pred eEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.|...+.||+|+||+||++... +.+.||+|.+...... ...+|+. ++..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD-MFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHH-HHHhcCCcceeeeEEEECCCCcce
Confidence 3566788999999999998643 3568999988654322 3445554 678889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++........ .-+...+++..+..++.|++.||+|||
T Consensus 85 lv~e~~~----------~~~L~~~i~~~~~~~~--------------------~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 85 MILEYTD----------LGDLKQFLRATKSKDE--------------------KLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred EEEEecC----------CCcHHHHHHhcccccc--------------------cccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 9999655 4444444332210000 001124678889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+||+++.++. ++++|||+++...... ........++..|+|||.+.+..++.++|||||||++|+
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hcCcccCcCccceEEEeCCCc--EEEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999988765 8899999987543221 112223346778999999988888999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhcc--ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFERD-ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~~~--~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+++++.+||....... ........ .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 211 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 211 VFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9997688886533222 22222111 11223455789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=287.72 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=184.6
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..|.+.+.||+|+||+||++... +|. .||+|.+...... ...+|+. .+..++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY-VMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEec-CceE
Confidence 45677899999999999998643 333 6999988655432 2334544 6778899999999999987 7899
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+||| |..+|+|.+++... ...+++..++.++.||+.||+|||
T Consensus 85 ~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 85 LITQ----------LMPLGCLLDYVRNH----------------------------KDNIGSQYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEe----------cCCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 44555555554321 123567788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+||+++.++. +||+|||+++.......... .....++..|+|||.+....++.++|+|||||++||
T Consensus 127 ~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05057 127 EKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203 (279)
T ss_pred hCCEEecccCcceEEEcCCCe--EEECCCcccccccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999987654322111 112224668999999988889999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 576 CITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
+++.+.+||....... ...+.. .....+.....++.+++.+||..||..||++.+++
T Consensus 204 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 204 LMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred HhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9984477886644332 222222 22223334567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=283.78 Aligned_cols=239 Identities=32% Similarity=0.471 Sum_probs=186.1
Q ss_pred ecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 353 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
||+|+||.||++... +++.||+|++.+... .....|+ .++..++||||+++++.+.+++..|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~---- 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLHYAFQTEEKLYLVLEYA---- 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHH-HHHHHcCCCcHHHHHHHeecCCeeEEEEecC----
Confidence 699999999998544 589999999865432 1334455 4778889999999999999999999999966
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccC
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 505 (774)
.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+
T Consensus 76 ------~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~ 120 (250)
T cd05123 76 ------PGGELFSHLSK-----------------------------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120 (250)
T ss_pred ------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 33444433321 1235677889999999999999999999999999
Q ss_pred CCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 004097 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585 (774)
Q Consensus 506 p~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~ 585 (774)
|+||+++.++. ++|+|||++....... .......++..|++||...+...+.++|+||||+++|++++| ..||.
T Consensus 121 p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g-~~p~~ 194 (250)
T cd05123 121 PENILLDADGH--IKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFY 194 (250)
T ss_pred cceEEEcCCCc--EEEeecCcceecccCC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC-CCCCC
Confidence 99999987765 8999999988765321 112334578899999999888889999999999999999996 77886
Q ss_pred CchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH---HHHHcCCCC
Q 004097 586 ESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 637 (774)
Q Consensus 586 ~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~---~elL~HPff 637 (774)
...... ...+.......+...+.++.++|++||..||+.||++ +++++||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 195 AEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 544322 2222222222334446789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.12 Aligned_cols=246 Identities=27% Similarity=0.357 Sum_probs=182.3
Q ss_pred eEEEeEeecccCceEEEEEeee-----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC--Ccee
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 414 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~ 414 (774)
.+.+.+.||+|+||+||++... +++.||||++...... ...+|+. ++..+.||||+++++++.+ ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~-~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE-ILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHH-HHHhCCCCChheEEeeeecCCCCce
Confidence 4566688999999999998643 4789999999755432 3445554 6778899999999999887 5689
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+++|||| ++++|.+++.... ..+++..++.++.|++.||+||
T Consensus 84 ~lv~e~~----------~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~l~~aL~~l 125 (284)
T cd05038 84 RLIMEYL----------PSGSLRDYLQRHR----------------------------DQINLKRLLLFSSQICKGMDYL 125 (284)
T ss_pred EEEEecC----------CCCCHHHHHHhCc----------------------------cccCHHHHHHHHHHHHHHHHHH
Confidence 9999955 4445554443211 1256778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+++|+||||+||+++.++. ++|+|||++.................++..|+|||.+....++.++|||||||++|
T Consensus 126 H~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 203 (284)
T cd05038 126 GSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY 203 (284)
T ss_pred HhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhh
Confidence 9999999999999999987755 89999999987764322222222234566799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH----------------HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD----------------ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~----------------~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++|. .|+....... ...+.... ...+.....++.+++.+||+.+|.+|||+.|+++
T Consensus 204 el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 204 ELFTYG-DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eeeccC-CCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999974 4554321111 11111111 1112234568999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=291.13 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=182.8
Q ss_pred eEEEeEeecccCceEEEEEee-eCCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.|...+.||+|+||.||++.. .+|. .||+|.+...... ...+|+ .++..++||||++++++|... ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-LIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 355668899999999999854 3444 5799988654332 223444 477888999999999998764 4678
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
++| |+++|+|.+++... ...+++..+..++.|++.||+|||+
T Consensus 86 v~e----------~~~~g~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~ 127 (303)
T cd05110 86 VTQ----------LMPHGCLLDYVHEH----------------------------KDNIGSQLLLNWCVQIAKGMMYLEE 127 (303)
T ss_pred eeh----------hcCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999 55666666554321 1235667789999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||+++.++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++||+
T Consensus 128 ~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 128 RRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred cCeeccccccceeeecCCCc--eEEccccccccccCccccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99999999999999987765 8999999998765332211 11223457789999999988899999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFER-DANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++.+..||...... ....+..... ..+......+.+++.+||..+|++||++.++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98446787654322 2333332221 1223345789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=285.44 Aligned_cols=246 Identities=21% Similarity=0.345 Sum_probs=184.5
Q ss_pred EEEeEeecccCceEEEEEeeeC--CcEEEEEEeecCC---------c----hHHHHHHHHHHHhCCCCCeeEEeeeccCC
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH---------H----DVALKEIQNLIASDQHPNIVRWYGVESDQ 411 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~--g~~VAVK~l~~~~---------~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 411 (774)
|.+.+.||+|+||.||++.... ++.||||.+.... . ....+|+..+.+.++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4556789999999999986544 7899999875321 1 12345555455568999999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..+++|||+ .+++|.+.+.... .....+++..++.++.|++.||
T Consensus 82 ~~~~lv~e~~----------~~~~l~~~l~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l 126 (269)
T cd08528 82 DRLYIVMDLI----------EGAPLGEHFNSLK-------------------------EKKQRFTEERIWNIFVQMVLAL 126 (269)
T ss_pred CeEEEEEecC----------CCCcHHHHHHHHH-------------------------hccCCCCHHHHHHHHHHHHHHH
Confidence 9999999955 4445544432110 0113467778899999999999
Q ss_pred HHHHH-cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 492 SHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 492 ~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
.|||+ .+++|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+.+..++.++||||||
T Consensus 127 ~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 200 (269)
T cd08528 127 RYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFG 200 (269)
T ss_pred HHhccCCceeecCCCHHHEEECCCCc--EEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHH
Confidence 99996 68999999999999987765 8999999998755322 22334588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHH-Hhhcccccc-ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 571 CILFFCITGGKHPYGESFERD-ANI-VKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-~~~-~~~~~~~~~-~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+++|+|++| .+||....... ... ......... ....+++.++|.+||+.||++||++.|+..+
T Consensus 201 ~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 201 CILYQMCTL-QPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHhC-CCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999997 77876543322 111 111111111 1346799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=312.33 Aligned_cols=274 Identities=17% Similarity=0.182 Sum_probs=169.8
Q ss_pred cceEEEeEeecccCceEEEEEeee-C----CcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeee------ccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-E----GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~----g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~------~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++... + +..||||++..........+. .+....+.+++.+... +.+++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456889999999999999998654 4 689999998654322211111 1222223333332222 24567
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..+||+||+. +++|.+++....... .+.++ .... ..............+..|+.||+.||+
T Consensus 209 ~~~LV~ey~~----------~gsL~~~l~~~~~~~-~v~~~-------l~~~-~~~l~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 209 EYWLVWRYEG----------ESTLADLMQSKEFPY-NVEPY-------LLGK-VQDLPKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred ceEEEEEecC----------CCcHHHHHHhcCCch-hHHHH-------hccc-hhhccccchhhHHHHHHHHHHHHHHHH
Confidence 8999999655 444444333211000 00000 0000 000000011123456789999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-------------
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR------------- 559 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------------- 559 (774)
|||+.+|+||||||+|||++.+. ..+||+|||+++.+..... .......+|+.|+|||.+....
T Consensus 270 yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 270 GLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred HHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 99999999999999999997543 2489999999986643321 1223457899999999764322
Q ss_pred ---------CCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhc--------c---cccc----------ccCCHH
Q 004097 560 ---------QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR--------K---DLFL----------VEHIPE 609 (774)
Q Consensus 560 ---------~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~--------~---~~~~----------~~~~~~ 609 (774)
++.++|||||||++|||+++ ..++..........+... . .... .....+
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFP-NLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhC-cCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 34567999999999999996 445443322211111100 0 0000 001224
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
..+||.+||+.||.+|||+.|+|+||||.....
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 568999999999999999999999999977554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=286.28 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=182.7
Q ss_pred EEeEeecccCceEEEEEeee----CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc------
Q 004097 348 VFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD------ 412 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------ 412 (774)
.+.+.||+|+||+||++... +++.||||++..... +...+|+. +++.++||||+++++++...+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAA-CMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCCCCccc
Confidence 45578999999999998543 468999999865321 23445654 778899999999999876532
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..++++| |..+|+|..++...... -+...+++..+++++.|++.||+
T Consensus 81 ~~~~~~~----------~~~~~~l~~~~~~~~~~-----------------------~~~~~l~~~~~~~~~~~i~~~l~ 127 (273)
T cd05074 81 IPMVILP----------FMKHGDLHTFLLMSRIG-----------------------EEPFTLPLQTLVRFMIDIASGME 127 (273)
T ss_pred ceEEEEe----------cCCCCcHHHHHHHhccc-----------------------CCCCCCCHHHHHHHHHHHHHHHH
Confidence 2477888 44555555444321100 00123567788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+||+++.++. +||+|||+++....... ........+++.|++||.+....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~i 204 (273)
T cd05074 128 YLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVT 204 (273)
T ss_pred HHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHH
Confidence 999999999999999999977765 89999999987643221 111222345678999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 573 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|||++++.+||........ . +........+....+++.+++.+||+.+|+.||++.+++.+
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 205 MWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999966888876543321 1 22222222234456799999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.18 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=194.2
Q ss_pred EeecccCceEEEEE-eeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCCh
Q 004097 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 425 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL 425 (774)
..||.|+||+|++- ....|+..|||+++.... .+.+.|....++.-+.||||++||.+..++..|++||+++-+|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 45999999999985 566799999999975543 3456677777888899999999999999999999999998876
Q ss_pred hhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Ccccccc
Q 004097 426 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDL 504 (774)
Q Consensus 426 ~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDL 504 (774)
..+ |+. .+ .-+...+|+..+-.|..-++.||.||-+. +|||||+
T Consensus 150 Dkl-Yk~-------vy---------------------------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv 194 (361)
T KOG1006|consen 150 DKL-YKR-------VY---------------------------SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV 194 (361)
T ss_pred HHH-HHH-------HH---------------------------HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence 544 321 10 02234577888888999999999999975 8999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc--CCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||+||||+..|. +||||||++-.+.+.. ......|...|||||.+.. ..|+.+|||||||+.|||+.|| ..
T Consensus 195 KPSNILldr~G~--vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG-~f 267 (361)
T KOG1006|consen 195 KPSNILLDRHGD--VKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG-NF 267 (361)
T ss_pred ChhheEEecCCC--EeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC-CC
Confidence 999999977765 9999999998776431 1123468899999999864 3489999999999999999997 88
Q ss_pred CCCCchHHH---HHHHhhcccc--cc---ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 583 PYGESFERD---ANIVKDRKDL--FL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 583 Pf~~~~~~~---~~~~~~~~~~--~~---~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||......- ..++.+.... +. .+.+..+..+|..||.+|-..||...+++++||+...
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 987764332 2333332221 11 2356789999999999999999999999999998653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=302.79 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=194.7
Q ss_pred EEEeEeecccCceEEEEEeee--CCc--EEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY--EGR--SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~--~g~--~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.+.++||+|+||.|++|... .|+ .||||.++... .+++++|.. .+.+++|||+|||||+..+ ..+.||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas-~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREAS-HMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHH-HHHhccCcceeEEeeeecc-chhhHHh
Confidence 345678999999999997543 344 68999996542 345677775 6678899999999999888 7789999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+| +.|+|.+.|+... ...+....+..++.|||.|+.||.+++
T Consensus 190 ELa----------plGSLldrLrka~---------------------------~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 190 ELA----------PLGSLLDRLRKAK---------------------------KAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hhc----------ccchHHHHHhhcc---------------------------ccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 955 4566666666521 123455677899999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
+|||||...|+||-... .+||+||||.+-+......+.......-...|+|||.+....++.++|||+|||.||||+|
T Consensus 233 lvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPR--TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred hhhhhhhhhhheecccc--eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 99999999999997654 4999999999998876655544444445678999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH-HHHhhcccc-ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 579 GGKHPYGESFERDA-NIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 579 g~~~Pf~~~~~~~~-~~~~~~~~~-~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|..||......+. ..+.....+ .+..++.++.++++.||..+|+.|||+..+.+.
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 99999977554332 333333333 344556789999999999999999999988644
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=297.55 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=198.3
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..|+..+.||-|+||.|-++.. .+...+|.|.|.+.+ +..-.+.+..+|+..+.+-||+||..|+|++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4467778899999999999754 456789999987643 1222344456788889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |+++|++..+|.. .+.+++..++.++.++..|+++.|..|
T Consensus 709 d----------YIPGGDmMSLLIr-----------------------------mgIFeE~LARFYIAEltcAiesVHkmG 749 (1034)
T KOG0608|consen 709 D----------YIPGGDMMSLLIR-----------------------------MGIFEEDLARFYIAELTCAIESVHKMG 749 (1034)
T ss_pred e----------ccCCccHHHHHHH-----------------------------hccCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 9 8888888877633 345777888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccC--C------Cc------------------cc-------------cc
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG--D------MS------------------CL-------------TQ 539 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~--~------~~------------------~~-------------~~ 539 (774)
+|||||||+|||||.||+ +||+|||||.-+.- + .+ +. ..
T Consensus 750 FIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ 827 (1034)
T KOG0608|consen 750 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL 827 (1034)
T ss_pred ceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence 999999999999999987 89999999865421 0 00 00 00
Q ss_pred cccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHhhccc---cccccCCHHHHHHH
Q 004097 540 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDRKD---LFLVEHIPEAVDLF 614 (774)
Q Consensus 540 ~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~~~~~---~~~~~~~~~~~dli 614 (774)
.+..+||+.|+|||++....|+..+|+||.|||||||+.| ++||...... +..++.+... .+....++++.++|
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g-~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC-CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHH
Confidence 1234699999999999999999999999999999999997 8888654432 2334444432 23445678999999
Q ss_pred HHhcCCCCCCCcC---HHHHHcCCCCCCccc
Q 004097 615 TRLLDPNPDLRPK---AQNVLNHPFFWTADT 642 (774)
Q Consensus 615 ~~~L~~dP~~Rps---~~elL~HPff~~~~~ 642 (774)
.+++. +++.|.. +++|..||||+..+.
T Consensus 907 ~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 907 QKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 88654 6778864 678999999987653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=307.62 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=198.0
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeEEeeeccC-----CceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESD-----QDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~-----~~~~~L 416 (774)
+.+.+.+.||.|.+|.||++ +..+|+.+|||++...... +...|...++...+|||++.+||++.- ++.+||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 44778899999999999997 6678999999998655433 333333455666789999999999753 578999
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||. |+..|++.- . +...+.|+.+..|++.+++||.|||
T Consensus 99 VMEfC~gGSVTDLVKn---~-----------------------------------~g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKN---T-----------------------------------KGNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred EeeccCCccHHHHHhh---h-----------------------------------cccchhhHHHHHHHHHHHHHHHHHh
Confidence 999887 466666621 1 1234567788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-----CCCCcchhHhHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSLG 570 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDvwSlG 570 (774)
...++|||||-.|||++.++. +||.|||++..+... .....+.+|||.|||||++... .|+..+|+||||
T Consensus 141 ~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred hcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 999999999999999998887 999999999887643 3456778999999999998643 467899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 571 CILFFCITGGKHPYGESFERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
++..||.-| .||+.+..+.-+-+...+.+. .+...+.++.++|..||.+|-++||++.++|+|||..
T Consensus 216 ITaIEladG-~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 216 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ceeehhcCC-CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 999999996 778876554433222222111 1334467899999999999999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=316.44 Aligned_cols=142 Identities=32% Similarity=0.434 Sum_probs=113.9
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-DALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHH-HHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 45778899999999999998654 689999999975321 2223343 467888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||| .+++|..++.. ...+++..++.|+.||+.||+|||..
T Consensus 83 mEy~----------~g~~L~~li~~-----------------------------~~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 83 MEYL----------IGGDVKSLLHI-----------------------------YGYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred EeCC----------CCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9955 44455444321 12356677899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
+|+||||||+|||++.++. +||+|||+++
T Consensus 124 gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999999999999987765 8999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=301.11 Aligned_cols=277 Identities=19% Similarity=0.273 Sum_probs=179.6
Q ss_pred cccceEEEeEeecccCceEEEEEee-----------------eCCcEEEEEEeecCCch---H--------------HHH
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-----------------YEGRSVAVKRLVKTHHD---V--------------ALK 387 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-----------------~~g~~VAVK~l~~~~~~---~--------------~~~ 387 (774)
...+.|.+.++||+|+||+||+|.. ..++.||||++...... . ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3456788999999999999999743 24578999998643211 1 112
Q ss_pred HHHHHHHhCCCCC-----eeEEeeeccC--------CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcc-hhhHHH
Q 004097 388 EIQNLIASDQHPN-----IVRWYGVESD--------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDS-NLLNEV 453 (774)
Q Consensus 388 Ei~~ll~~l~HpN-----IV~l~g~~~~--------~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~-~~l~~~ 453 (774)
|+. ++..++|.+ +++++++|.. .+..||||| |+.+|+|.++|+...... ..+.++
T Consensus 222 E~~-~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E----------y~~~gsL~~~L~~~~~~~~~~L~e~ 290 (507)
T PLN03224 222 EAY-MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK----------FESDATLGDALDGKLGPFPGCLEEF 290 (507)
T ss_pred HHH-HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE----------cCCCCcHHHHHhhccCCCcchHHHH
Confidence 332 445555554 4678887753 356899999 555555555554321110 001100
Q ss_pred HHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCC
Q 004097 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533 (774)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~ 533 (774)
.. .............+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +||+|||+++.....
T Consensus 291 l~------~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~ 362 (507)
T PLN03224 291 MM------AGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTG 362 (507)
T ss_pred Hh------cCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccC
Confidence 00 0000001112234677889999999999999999999999999999999987765 899999999765432
Q ss_pred CccccccccCcCCCCCCchhhhhcCC--------------------C--CCcchhHhHHHHHHHHHhCCCCCCCCchHHH
Q 004097 534 MSCLTQNATGYGSSGWQAPEQLLQGR--------------------Q--TRAIDLFSLGCILFFCITGGKHPYGESFERD 591 (774)
Q Consensus 534 ~~~~~~~~~~~gt~~y~aPE~l~~~~--------------------~--~~~sDvwSlGvll~elltg~~~Pf~~~~~~~ 591 (774)
.. .......+|+.|+|||.+.... + ..+.||||+||++|+|++|...|+.......
T Consensus 363 ~~--~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~ 440 (507)
T PLN03224 363 IN--FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN 440 (507)
T ss_pred Cc--cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh
Confidence 11 1112234589999999986432 1 1347999999999999998655765321110
Q ss_pred ---------H---HHHhhcccc--ccccCCHHHHHHHHHhcCCCC---CCCcCHHHHHcCCCCCC
Q 004097 592 ---------A---NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNP---DLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 592 ---------~---~~~~~~~~~--~~~~~~~~~~dli~~~L~~dP---~~Rps~~elL~HPff~~ 639 (774)
. ......... .....++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 441 ~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 441 TELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 001111111 122345789999999999876 68999999999999953
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=297.56 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=188.8
Q ss_pred eEeecccCceEEEEEeeeC-C----cEEEEEEeecCCchH---HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 350 NKEIAKGSNGTVVLEGNYE-G----RSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~-g----~~VAVK~l~~~~~~~---~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.++||+|+||+||++.... | -+||+|++......+ .+-|....+++++|||++||+|+|.... +.||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq-- 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ-- 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH--
Confidence 4679999999999986543 3 479999986554332 2333334788999999999999998876 888999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
+|+.|+|.++++.++ ..+.....+.|+.|||+|+.|||++.++|
T Consensus 778 --------~mP~G~LlDyvr~hr----------------------------~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 778 --------LMPLGCLLDYVREHR----------------------------DNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred --------hcccchHHHHHHHhh----------------------------ccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 777777777765432 22445677999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||..+|||+.+-.. +||+|||+++.+..+...+... ...-.+.|||-|.+....|+.++|||||||.+||++|-|.
T Consensus 822 rdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~-~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAP-GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhheeecCCCe--EEEEecchhhccCccccccccc-ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 999999999987655 8999999999988665443322 2223567999999999999999999999999999999877
Q ss_pred CCCCCchH-HHHHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 582 HPYGESFE-RDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 582 ~Pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
.||..... ...+.++.... ..++-...++.-++.+||..|+..||+++++.
T Consensus 899 ~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 78766443 34445544433 34445567899999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.32 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=195.1
Q ss_pred eEEEeEeecccCceEEEEEeeeC-CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.+....+||-|.||.||-+.... .-.||||.|+.... +++++|.. +++.+.|||+|+|+|+|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAA-vMKeikHpNLVqLLGVCT~EpPFYIiTE--- 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTHEPPFYIITE--- 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHH-HHHhhcCccHHHHhhhhccCCCeEEEEe---
Confidence 35677889999999999875432 46899999976533 34556654 7788999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
||..|+|.++|+..... -++.-.+++++.||..|++||..+++|||
T Consensus 344 -------fM~yGNLLdYLRecnr~---------------------------ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 344 -------FMCYGNLLDYLRECNRS---------------------------EVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred -------cccCccHHHHHHHhchh---------------------------hcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 88888888887654332 13344568999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||...|+|+.++. .+|++||||++.+.++.. +......-...|.|||.+....++.++|||+|||+|||+.|-|-.
T Consensus 390 DLAARNCLVgEnh--iVKvADFGLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMs 465 (1157)
T KOG4278|consen 390 DLAARNCLVGENH--IVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS 465 (1157)
T ss_pred hhhhhhccccccc--eEEeeccchhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCC
Confidence 9999999997664 599999999999986532 222222235679999999999999999999999999999998888
Q ss_pred CCCCchHHH-HHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 583 PYGESFERD-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 583 Pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||..-...+ ..++..... ..+..+.+...+|+..||+..|..||+..|+-
T Consensus 466 PYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 466 PYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 987654332 234444433 34556778899999999999999999999873
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.76 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=186.4
Q ss_pred eEEEeEeecccCceEEEEEeeeC---C--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYE---G--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~---g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
++...+.||.|-||.||.|...+ | --||||..+.... +.++.|. .+++..+|||||+|+|+|.+. ..||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa-~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEA-SIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHH-HHHHhCCCcchhheeeeeecc-ceeE
Confidence 34566789999999999974322 2 3689998876432 3344454 478899999999999999874 6899
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||+|+ |.|+.|+..... .++...+..++.||+.||+|||
T Consensus 468 vmEL~~~GELr~yLq~nk~---------------------------------------sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD---------------------------------------SLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred EEecccchhHHHHHHhccc---------------------------------------cchHHHHHHHHHHHHHHHHHHH
Confidence 999776 455555532222 2444567889999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+..+|||||..+|||+... -|+||+||||++.+..+.. +.. ....-...|||||.+.-++++.++|||-|||.+||
T Consensus 509 SkrfVHRDIAaRNiLVsSp--~CVKLaDFGLSR~~ed~~y-Yka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWE 584 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILVSSP--QCVKLADFGLSRYLEDDAY-YKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWE 584 (974)
T ss_pred hhchhhhhhhhhheeecCc--ceeeecccchhhhccccch-hhc-cccccceeecCccccchhcccchhhHHHHHHHHHH
Confidence 9999999999999999765 4799999999998876533 222 23335667999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 576 CITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
++.-|..||..-...+ ..+..+.....++.++|.+..|+.+||..||.+||...|+.
T Consensus 585 Il~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 585 ILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 9988788886543322 23344445556677788999999999999999999987753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=292.19 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=195.1
Q ss_pred EeecccCceEEEEEeeeCCc-EEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~-~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..||-|+||.|=+......+ .+|+|++++.+.. ..+.|- +++...+.|.||+||-.|.|..++|+.||-|-
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr-~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl- 503 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSER-NIMMECRSDFIVRLYRTFRDSKYVYMLMEACL- 503 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHH-HHHHhcCchHHHHHHHHhccchhhhhhHHhhc-
Confidence 45999999999775443332 4899999776532 223343 35566679999999999999999999999665
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|.+-..|. +.+.++...++.++..++.|++|||++|||+||
T Consensus 504 ---------GGElWTiLr-----------------------------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRD 545 (732)
T KOG0614|consen 504 ---------GGELWTILR-----------------------------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRD 545 (732)
T ss_pred ---------Cchhhhhhh-----------------------------hcCCcccchhhhhHHHHHHHHHHHHhcCceecc
Confidence 444444332 234466677789999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|++|+.+|- +||.|||+|+.+..+ ..+.+.||||.|+|||++.++..+.++|.||||+++|||++| .||
T Consensus 546 LKPENllLd~~Gy--~KLVDFGFAKki~~g----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G-~pP 618 (732)
T KOG0614|consen 546 LKPENLLLDNRGY--LKLVDFGFAKKIGSG----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG-SPP 618 (732)
T ss_pred CChhheeeccCCc--eEEeehhhHHHhccC----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC-CCC
Confidence 9999999988886 899999999998854 456789999999999999999999999999999999999997 889
Q ss_pred CCCchHHHH--HHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 584 YGESFERDA--NIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 584 f~~~~~~~~--~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
|....+... .++++... .++......+.+||+++...+|.+|.. +.++.+|.||-+.++
T Consensus 619 Fs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 619 FSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred CCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 987655432 33333322 244455678999999999999999976 789999999966554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.10 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=200.4
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHH-HHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVA-LKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~-~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+..+||+|+|.+|.++.+ .+.+.+|+|++++.- .-.+ ..|-...-...+||.+|-|+.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 4467778999999999988754 467899999987541 1112 22222233556899999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
.| |+++|+|.-++ .+.+.+|++.++.+...|+.||.|||+.
T Consensus 330 ie----------yv~ggdlmfhm-----------------------------qrqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 330 IE----------YVNGGDLMFHM-----------------------------QRQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred EE----------EecCcceeeeh-----------------------------hhhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 99 77777765543 2345689999999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|||.||||.+|+||+..|+ +||+|+|+++.-... ...+.+.+|||.|+|||++++..|...+|+|+|||+++||+
T Consensus 371 giiyrdlkldnvlldaegh--ikltdygmcke~l~~---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred CeeeeeccccceEEccCCc--eeecccchhhcCCCC---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 9999999999999988887 899999999865432 23456789999999999999999999999999999999999
Q ss_pred hCCCCCCCC-----c---hH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC------HHHHHcCCCCCCccc
Q 004097 578 TGGKHPYGE-----S---FE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 642 (774)
Q Consensus 578 tg~~~Pf~~-----~---~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps------~~elL~HPff~~~~~ 642 (774)
.| +.||+- + .+ ...+++-...-..+...+-.+..+++..|++||.+|.. ..++..||||+..++
T Consensus 446 ag-rspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 446 AG-RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cC-CCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 97 778842 1 11 11233333333345555667889999999999999964 678999999987666
Q ss_pred hh
Q 004097 643 RL 644 (774)
Q Consensus 643 ~~ 644 (774)
.+
T Consensus 525 d~ 526 (593)
T KOG0695|consen 525 DL 526 (593)
T ss_pred HH
Confidence 44
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=305.47 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=192.2
Q ss_pred EEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 348 VFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.||+|.||+|++|... ....||||.++.... .....|+..|.....|||||.++|+|..++.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45568999999999997433 145899999975543 344567777777888999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhh--CCCCHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA--NGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|||. .|+|..+|......... .... .... ..++..+++.++.|||.|++|
T Consensus 379 ~v~Ey~~----------~G~L~~~Lr~~r~~~~~---------~~~~------~~~~~~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 379 VIVEYAE----------HGDLLEFLRKKRVTESI---------DGSG------VFPNERDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred EEEEecc----------CCcHHHHHHhccccccc---------cccC------CCccccCCcCHHHHHHHHHHHHHHHHH
Confidence 9999554 45555554443300000 0000 0000 237888999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|++.++|||||..+|||++.+. .+||+|||+|+................-...|||||.+....|+.++||||||++|
T Consensus 434 L~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 434 LASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred HhhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 9999999999999999998774 48999999999765433222111110123459999999999999999999999999
Q ss_pred HHHHhCCCCCCCCch--HHHHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 574 FFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 574 ~elltg~~~Pf~~~~--~~~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||++|.|..||.... ......++.. ....+....+++.++++.||+.+|++||+..++.
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 999999999998732 2223334433 3345556678999999999999999999999886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=282.04 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=186.7
Q ss_pred cccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCC-C----CeeEEeeeccCCce
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQH-P----NIVRWYGVESDQDF 413 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~H-p----NIV~l~g~~~~~~~ 413 (774)
.+..+|.+.+.+|+|.||.|... ....+..||||+++.-. .+.+.-|++.+.....+ | -+|.+.+++.-.++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 34677888899999999999875 33347899999986432 34455666644333232 2 37888889999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.+||+|.++.++.|++. ++ +..++|...++.+++|++++++|
T Consensus 166 iCivfellG~S~~dFlk--~N------------------------------------~y~~fpi~~ir~m~~QL~~sv~f 207 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLK--EN------------------------------------NYIPFPIDHIRHMGYQLLESVAF 207 (415)
T ss_pred eEEEEeccChhHHHHhc--cC------------------------------------CccccchHHHHHHHHHHHHHHHH
Confidence 99999977766666551 11 12347788999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCC------------------CceEEEcccCccccccCCCccccccccCcCCCCCCchhhh
Q 004097 494 LHEIGLIHRDLKPQNVLISKDK------------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 555 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l 555 (774)
||+.+++|-||||+|||+.+.. +..++++|||.|+.-.... .+.+.|..|.|||++
T Consensus 208 Lh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 208 LHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVI 281 (415)
T ss_pred HHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchhe
Confidence 9999999999999999984211 2358999999998765432 445679999999999
Q ss_pred hcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH----HH--------HHhhc--------ccc--------------
Q 004097 556 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD----AN--------IVKDR--------KDL-------------- 601 (774)
Q Consensus 556 ~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~----~~--------~~~~~--------~~~-------------- 601 (774)
.+-.++.++||||+||||.|+.||...+......+. .. ++... ...
T Consensus 282 LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 282 LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred eccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 999999999999999999999998654443321110 00 11000 000
Q ss_pred ---------ccccC---CHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 602 ---------FLVEH---IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 602 ---------~~~~~---~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.... ..++.|||++||..||.+|+|+.|+|.||||..
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 00000 135789999999999999999999999999954
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=294.31 Aligned_cols=197 Identities=33% Similarity=0.553 Sum_probs=163.2
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCc------eeE
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQD------FVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------~~~ 415 (774)
+...+.||+|+||.||++. ..+|+.||||.+++. ..+..-+|++ ++++++|||||+++++..+.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eie-ilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIE-ILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHH-HHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445779999999999986 678999999998763 2355678886 778889999999999877654 568
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|...|..- -+..|+|+.+++.++.+++.||.|||
T Consensus 94 lvmEyC~----------gGsL~~~L~~P--------------------------EN~~GLpE~e~l~lL~d~~~al~~Lr 137 (732)
T KOG4250|consen 94 LVMEYCS----------GGSLRKVLNSP--------------------------ENAYGLPESEFLDLLSDLVSALRHLR 137 (732)
T ss_pred EEEeecC----------CCcHHHHhcCc--------------------------ccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 45555544321 23578999999999999999999999
Q ss_pred HcCccccccCCCCeeec--CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-cCCCCCcchhHhHHHH
Q 004097 496 EIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCI 572 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~--~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSlGvl 572 (774)
++||+||||||.||++- .||...-||+|||.|+.+.++. ...+.+||..|.+||+.. .+.|+..+|.|||||+
T Consensus 138 En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvt 213 (732)
T KOG4250|consen 138 ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVT 213 (732)
T ss_pred HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhH
Confidence 99999999999999983 5577778999999999887653 456678999999999998 4889999999999999
Q ss_pred HHHHHhCCCCCCC
Q 004097 573 LFFCITGGKHPYG 585 (774)
Q Consensus 573 l~elltg~~~Pf~ 585 (774)
+|+++|| ..||-
T Consensus 214 lY~caTG-~lPF~ 225 (732)
T KOG4250|consen 214 LYECATG-ELPFI 225 (732)
T ss_pred HHHHhcc-CCCCC
Confidence 9999997 66664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=258.60 Aligned_cols=234 Identities=36% Similarity=0.565 Sum_probs=181.2
Q ss_pred CceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHHHH
Q 004097 357 SNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 431 (774)
Q Consensus 357 sfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~ 431 (774)
+||.||++... +|+.||+|++..... ....+|++ .+..++|+||+++++++.+....++++|++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~--------- 70 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREIS-ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCD--------- 70 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHH-HHHhCCCCcHHHHHhheeeCCEEEEEEeCCC---------
Confidence 58999998665 489999999865432 33445554 6677899999999999999999999999554
Q ss_pred hcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeee
Q 004097 432 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511 (774)
Q Consensus 432 ~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 511 (774)
+++|.+++... ..+++..+..++.+++.++.|||+.+++|+||+|+||++
T Consensus 71 -~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 71 -GGDLFDLLKKR-----------------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL 120 (244)
T ss_pred -CCCHHHHHHhc-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE
Confidence 44444443211 114567788999999999999999999999999999999
Q ss_pred cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC-c-hH
Q 004097 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-S-FE 589 (774)
Q Consensus 512 ~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~-~-~~ 589 (774)
+.++. ++|+|||++....... ......++..|++||.+....++.++||||||++++++++| ..||.. . ..
T Consensus 121 ~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~ 193 (244)
T smart00220 121 DEDGH--VKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTG-KPPFPGDDQLL 193 (244)
T ss_pred CCCCc--EEEccccceeeecccc----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Confidence 87765 8999999998775431 22344588899999999888899999999999999999997 678765 2 22
Q ss_pred HHHHHHhhcccccccc---CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 590 RDANIVKDRKDLFLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 590 ~~~~~~~~~~~~~~~~---~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
................ ...++.+++.+||..+|++||++.++++||||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 194 ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 2222222222222211 55789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=281.58 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=191.2
Q ss_pred cccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC--chHHHHHHHHHHHhCC------CCCeeEEeeeccC
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ------HPNIVRWYGVESD 410 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~------HpNIV~l~g~~~~ 410 (774)
++.+..+|.+....|+|-|++|+.|. ...|..||||++.... ....++|++ +|..++ --|+++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~Ele-iLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELE-ILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHH-HHHHhhccCchhhhHHHHHHHHhhh
Confidence 34556778888889999999999984 4457899999997653 244567776 444443 3579999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+++|||+|.+.-+|.+.+.-.+. ..++....+..++.|+..|
T Consensus 506 knHLClVFE~LslNLRevLKKyG~-------------------------------------nvGL~ikaVRsYaqQLflA 548 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGR-------------------------------------NVGLHIKAVRSYAQQLFLA 548 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCc-------------------------------------ccceeehHHHHHHHHHHHH
Confidence 999999999877777777643332 2345567789999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|..|-.+||+|.||||+|||+++... .+||||||.|....... ......+..|.|||++.+-+|+...|+||.|
T Consensus 549 LklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~ene-----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvg 622 (752)
T KOG0670|consen 549 LKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASENE-----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVG 622 (752)
T ss_pred HHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccccccc-----ccHHHHHHhccCcceeecCcccCCccceeec
Confidence 99999999999999999999987765 69999999987765321 1222345679999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC-chHHHHH------------HHh------------------------------------hccc-
Q 004097 571 CILFFCITGGKHPYGE-SFERDAN------------IVK------------------------------------DRKD- 600 (774)
Q Consensus 571 vll~elltg~~~Pf~~-~~~~~~~------------~~~------------------------------------~~~~- 600 (774)
|.||||.|| +.-|.. ....+.. ++. ....
T Consensus 623 ctLYElYtG-kIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl 701 (752)
T KOG0670|consen 623 CTLYELYTG-KILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDL 701 (752)
T ss_pred eeeEEeecc-ceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhH
Confidence 999999998 444422 2111100 000 0000
Q ss_pred --------ccccc---CCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 601 --------LFLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 601 --------~~~~~---~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
..+.+ ....+.+|+.+||..||++|.|+.++|.||||..
T Consensus 702 ~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 702 GSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00000 1136889999999999999999999999999953
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.11 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=193.5
Q ss_pred cccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEee--cCCc--------hHHHHHHHHHHHhCCCCCeeEEeeecc-
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLV--KTHH--------DVALKEIQNLIASDQHPNIVRWYGVES- 409 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~--~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~- 409 (774)
.+.++|-+...||+|+|..||+| .+...+.||||+-. +... ..+.+|- .+...++||.||++|+|+.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREy-rIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREY-RIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHH-hhhhccCcceeeeeeeeeee
Confidence 34455555667999999999998 67788999999752 2211 1223443 3678899999999999986
Q ss_pred CCceeEEeccccCCC-hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488 (774)
Q Consensus 410 ~~~~~~LV~E~~~~s-L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 488 (774)
|.+.+|-|+|||+|+ |.-|+. ..+-+++.+++.|+.||+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK----------------------------------------QhklmSEKEARSIiMQiV 578 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK----------------------------------------QHKLMSEKEARSIIMQIV 578 (775)
T ss_pred ccccceeeeeecCCCchhHHHH----------------------------------------hhhhhhHHHHHHHHHHHH
Confidence 667789999999874 443331 112256678899999999
Q ss_pred HHHHHHHHc--CccccccCCCCeeecCCCC-ceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhcC---
Q 004097 489 SGLSHLHEI--GLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--- 558 (774)
Q Consensus 489 ~gL~yLH~~--~ivHrDLkp~NILl~~~~~-~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~--- 558 (774)
.||.||.+. .|||-||||.||||-.... ..+||+||||++.+.++... ..-+....||.+|++||.+.-+
T Consensus 579 nAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP 658 (775)
T KOG1151|consen 579 NALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP 658 (775)
T ss_pred HHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCC
Confidence 999999987 6999999999999953221 24899999999998765322 1233456799999999987643
Q ss_pred -CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH-----HHHhhccccccc--cCCHHHHHHHHHhcCCCCCCCcCHHH
Q 004097 559 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA-----NIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQN 630 (774)
Q Consensus 559 -~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~dli~~~L~~dP~~Rps~~e 630 (774)
+.+.++||||+|||+|.|+.| +.||+....... -+++.....++. ..+++++++|++||+.--+.|..+.+
T Consensus 659 PKIsnKVDVWSvGVIFyQClYG-rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 659 PKISNKVDVWSVGVIFYQCLYG-RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred CccccceeeEeeehhhhhhhcc-CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 468899999999999999997 779987654332 223333333332 34689999999999999999999999
Q ss_pred HHcCCCCCC
Q 004097 631 VLNHPFFWT 639 (774)
Q Consensus 631 lL~HPff~~ 639 (774)
+..||||..
T Consensus 738 LA~dpyllP 746 (775)
T KOG1151|consen 738 LACDPYLLP 746 (775)
T ss_pred HccCccccc
Confidence 999999965
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.53 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=188.5
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCC-ce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ-DF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-~~ 413 (774)
.+++....+-+|.||.||+|-+ .+.+.|-||.++....+ ..+.|- .++-...|||++...|++.+. +.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es-~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQES-MLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHH-HHHhcCcCCCccceeEEEeeccCc
Confidence 4467777899999999999833 33456777877543322 223333 356677899999999998754 56
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.++++. ++.-|+|..+|...+.... ...+.+...++..++.|++.|++|
T Consensus 363 P~V~y~----------~~~~gNLK~FL~~Cr~~~~---------------------~~aqtvtt~qlV~masQla~am~h 411 (563)
T KOG1024|consen 363 PFVLYP----------ATGVGNLKSFLQICRGDDP---------------------SYAQTVTTIQLVLMASQLAMAMEH 411 (563)
T ss_pred ceEEEe----------ccCcchHHHHHHHhccCCC---------------------ccccchhHHHHHHHHHHHHHHHHH
Confidence 678888 5666666666653221100 112345556788999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||..+|||.||..+|++|+ ..+++||+|=.+++.+-+....- -....-....||+||.+.+..|+.++|||||||+|
T Consensus 412 lh~~~ViHkDiAaRNCvId--d~LqVkltDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 412 LHNHGVIHKDIAARNCVID--DQLQVKLTDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHhcCcccchhhhhcceeh--hheeEEeccchhccccCcccccc-cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 9999999999999999994 45889999999999765432111 11112246689999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 574 FFCITGGKHPYGESFERD-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
|||+|-|+.||.+-.+.+ ...++..+. ..+..+++++..++..||..+|++||+.+|+.
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 999999999998865544 344554444 44556778999999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=263.17 Aligned_cols=242 Identities=24% Similarity=0.394 Sum_probs=179.4
Q ss_pred EeecccCceEEEEE-eeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC-----ceeEEecc
Q 004097 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFVYLSLE 419 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~~~LV~E 419 (774)
+-||-|+||.||.. .-.+|+.||.|++.... ....++|+. |+...+|.|++..++..+.. .++|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~k-mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIK-MLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHH-HHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 45999999999975 44579999999986543 245688886 78899999999998876544 34688888
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
++..+|...|- ....++...+.-++.||++||+|||+.+|
T Consensus 138 LmQSDLHKIIV----------------------------------------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~I 177 (449)
T KOG0664|consen 138 LMQSDLHKIIV----------------------------------------SPQALTPDHVKVFVYQILRGLKYLHTANI 177 (449)
T ss_pred HHHhhhhheec----------------------------------------cCCCCCcchhhhhHHHHHhhhHHHhhcch
Confidence 66665555441 22345666778899999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+||||||.|.|++.+ +.+||||||+++....+.. ......+.|..|.|||++++. .|+.++||||.|||+.|++.
T Consensus 178 LHRDIKPGNLLVNSN--CvLKICDFGLARvee~d~~--~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 178 LHRDIKPGNLLVNSN--CILKICDFGLARTWDQRDR--LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred hhccCCCccEEeccC--ceEEecccccccccchhhh--hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 999999999999555 7799999999997654321 122334568899999999985 58999999999999999987
Q ss_pred CCCCCCCCchHH-H------------------------HHHHhhcccc------c----cccCCHHHHHHHHHhcCCCCC
Q 004097 579 GGKHPYGESFER-D------------------------ANIVKDRKDL------F----LVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 579 g~~~Pf~~~~~~-~------------------------~~~~~~~~~~------~----~~~~~~~~~dli~~~L~~dP~ 623 (774)
. +.-|....+- + ..++...... + +.....++.+++.++|..||.
T Consensus 254 R-rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 254 R-KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred h-hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 4 6555432111 1 0111111110 0 011124788999999999999
Q ss_pred CCcCHHHHHcCCCCC
Q 004097 624 LRPKAQNVLNHPFFW 638 (774)
Q Consensus 624 ~Rps~~elL~HPff~ 638 (774)
+|.+.++.+.|++.-
T Consensus 333 kris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 333 KRISVEEALQHRYLE 347 (449)
T ss_pred ccccHhhhccccccc
Confidence 999999999999873
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=249.43 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=188.3
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEecccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLERC 421 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV~E~~ 421 (774)
+.|.+.+++|+|.++.|+-|. ..+...++||+++........+|+..+.....||||+.|+++..|. ....||+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE-- 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE-- 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh--
Confidence 345666789999999999873 4567899999998777777889998666666699999999998875 45678999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
|+.+-++.... ..++...++.++.+++.||.|||+.||.|
T Consensus 116 --------~v~n~Dfk~ly--------------------------------~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 116 --------YVNNTDFKQLY--------------------------------PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred --------hhccccHHHHh--------------------------------hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 66555544321 12445567899999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg~ 580 (774)
||+||.|++|+.... .++|+|+|||.....+.+. +..+.+..|.-||.+.. +.|+.+-|+|||||++..|+...
T Consensus 156 RDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccCCcceeeechhhc-eeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 999999999986543 5889999999988765433 33456778899999876 45899999999999999999976
Q ss_pred CCCCCCchHHH--HHH---------------------------Hhhccc----cccc-----cCCHHHHHHHHHhcCCCC
Q 004097 581 KHPYGESFERD--ANI---------------------------VKDRKD----LFLV-----EHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 581 ~~Pf~~~~~~~--~~~---------------------------~~~~~~----~~~~-----~~~~~~~dli~~~L~~dP 622 (774)
.|+|......+ ..+ +..... .+.. -.+|++.||+.++|..|-
T Consensus 231 epFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 231 EPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred CcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 65554322111 110 000000 0000 114899999999999999
Q ss_pred CCCcCHHHHHcCCCCCC
Q 004097 623 DLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~ 639 (774)
..|+|+.|++.||||..
T Consensus 311 qeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 311 QERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccccchHHHhcCchHHH
Confidence 99999999999999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=258.23 Aligned_cols=242 Identities=29% Similarity=0.460 Sum_probs=180.1
Q ss_pred eEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccCC------ce
Q 004097 346 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ------DF 413 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~ 413 (774)
+|.-.+-+|.|.- .|.-| ....++.||+|++... +...+.+|.. ++..+.|+||++++.++.-. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~-l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELK-LMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhh-hhhhhcccceeeeeeccCccccHHHHHh
Confidence 3444466888887 45444 4456899999988533 3456778886 67889999999999998754 35
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||++..+|.+.+.+. ++-..+..|..|++.|++|
T Consensus 96 ~y~v~e~m~~nl~~vi~~e------------------------------------------lDH~tis~i~yq~~~~ik~ 133 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILME------------------------------------------LDHETISYILYQMLCGIKH 133 (369)
T ss_pred HHHHHHhhhhHHHHHHHHh------------------------------------------cchHHHHHHHHHHHHHHHH
Confidence 7999998888877776432 1223567899999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+||++..+. .+||.|||+|+..... -.....+.|..|.|||++.+..|...+||||+||++
T Consensus 134 lhs~~IihRdLkPsnivv~~~~--~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 134 LHSAGIIHRDLKPSNIVVNSDC--TLKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (369)
T ss_pred HHhcceeecccCcccceecchh--heeeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHH
Confidence 9999999999999999997775 4899999999865532 123445688999999999998899999999999999
Q ss_pred HHHHhCCCCCC-CCchHHHH-----------------------HHHhhc--------ccccc-----------ccCCHHH
Q 004097 574 FFCITGGKHPY-GESFERDA-----------------------NIVKDR--------KDLFL-----------VEHIPEA 610 (774)
Q Consensus 574 ~elltg~~~Pf-~~~~~~~~-----------------------~~~~~~--------~~~~~-----------~~~~~~~ 610 (774)
.||++| ..-| +.....+. ...... ...++ ...+..+
T Consensus 208 gEli~~-~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~a 286 (369)
T KOG0665|consen 208 GELILG-TVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLA 286 (369)
T ss_pred HHHhhc-eEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHH
Confidence 999997 4333 22211100 000000 00000 0112468
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 611 ~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
+|++.+||..||++|.+++++|+||||.
T Consensus 287 rdll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 287 RDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhccChhhcccHHHHhcCCeee
Confidence 9999999999999999999999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=259.93 Aligned_cols=130 Identities=28% Similarity=0.360 Sum_probs=105.7
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCC----C---CCeeEEeeeccC----
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ----H---PNIVRWYGVESD---- 410 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~----H---pNIV~l~g~~~~---- 410 (774)
.+|.+.++||=|.|.|||++ .....+.||+|+.+... .+.++.||..+..... | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 67889999999999999998 55567899999987643 3567888875443322 3 479999999875
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
+.+++||+|++..+|..+|.. ...+++|...+.+|++||+.|
T Consensus 158 G~HVCMVfEvLGdnLLklI~~--------------------------------------s~YrGlpl~~VK~I~~qvL~G 199 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKY--------------------------------------SNYRGLPLSCVKEICRQVLTG 199 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHH--------------------------------------hCCCCCcHHHHHHHHHHHHHH
Confidence 467999999888887777632 234678999999999999999
Q ss_pred HHHHHHc-CccccccCCCCeeec
Q 004097 491 LSHLHEI-GLIHRDLKPQNVLIS 512 (774)
Q Consensus 491 L~yLH~~-~ivHrDLkp~NILl~ 512 (774)
|.|||.. ||||-||||+|||+.
T Consensus 200 LdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 200 LDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HHHHHHhcCccccCCCcceeeee
Confidence 9999976 999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=234.80 Aligned_cols=195 Identities=28% Similarity=0.398 Sum_probs=156.6
Q ss_pred eEeecccCceEEEEE-eeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 350 NKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
...||+|++|.|-+- ...+|+..|||++..+- +...++|+...+.....|.+|++||...+...++++||.++.+
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tS 130 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTS 130 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhh
Confidence 357999999988443 66789999999996432 2345567766777788999999999999999999999987776
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRD 503 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrD 503 (774)
|..+... -+.+...+|+..+-+|+..+++||.|||++ .+||||
T Consensus 131 ldkfy~~------------------------------------v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD 174 (282)
T KOG0984|consen 131 LDKFYRK------------------------------------VLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD 174 (282)
T ss_pred HHHHHHH------------------------------------HHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence 6544310 012345678888999999999999999987 899999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc----CCCCCcchhHhHHHHHHHHHhC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDvwSlGvll~elltg 579 (774)
+||+|||++.+|. +|+||||.+-.+.+... .....|...|||||.+.. ..|+.++||||||+.+.||.++
T Consensus 175 vKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 175 VKPSNILINYDGQ--VKICDFGISGYLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred CCcceEEEccCCc--EEEcccccceeehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 9999999998886 99999999987764311 111358889999998753 4689999999999999999997
Q ss_pred CCCCCCCc
Q 004097 580 GKHPYGES 587 (774)
Q Consensus 580 ~~~Pf~~~ 587 (774)
+.||...
T Consensus 249 -r~PY~~w 255 (282)
T KOG0984|consen 249 -RFPYESW 255 (282)
T ss_pred -ccccccc
Confidence 8888654
|
|
| >PF06479 Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR010513 The proteins listed below share a common architecture with a protein kinase homology domain (see PDOC00100 from PROSITEDOC) followed by an ~135-residue globular kinase-extension nuclease (KEN) domain made of eight helices []: - Mammalian 2-5A-dependent RNase or RNase L (EC 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=232.14 Aligned_cols=129 Identities=53% Similarity=0.986 Sum_probs=114.2
Q ss_pred chhhhhhhccccchhccccchHHHHHHHHHHHHHhhCCCchHHHhHHHHhhhhhhcccCCCCHHHHHHHHHhccccccCC
Q 004097 642 TRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFREL 721 (774)
Q Consensus 642 ~~~~~l~~~~~~~e~~~~~~~~~~~~~le~~~~~~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~ir~~~~h~~e~ 721 (774)
+++.|++++||++|.+.+...+.++.+||..+..+.+++|++++|..++++++++|+|++++++||||+|||+.|||+|+
T Consensus 1 krl~Fl~dvSDr~E~~~~~~~s~~l~~Le~~~~~v~~~~W~~~ld~~l~~~l~~~R~Y~~~sv~DLLR~IRNk~~Hy~el 80 (129)
T PF06479_consen 1 KRLSFLQDVSDRIEKESRDPPSPLLQELESNAEDVLGGDWDKKLDPELLDDLGKYRKYDGDSVRDLLRAIRNKKHHYQEL 80 (129)
T ss_dssp HHHHHHHHHHHHCSSS-TTTTSHHHHHHHHCCCCCTTS-CGGCSBHHHHHCCTTTSS--TT-HHHHHHHHHHHHHTCCCS
T ss_pred ChhHHHHHhhhHhhhcccccchHHHHHHHhcCCCCCCccHhHHhCHHHHHHHHhccCCCccCHHHHHHHHHcchHhHHHC
Confidence 46889999999999999998899999999877777789999999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCccccccccccCCccHHHHHHHHHhhhccchhhhccccc
Q 004097 722 PQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 771 (774)
Q Consensus 722 ~~~~~~~~g~~p~~f~~yf~~~fp~ll~~~y~~~~~~~~~~~~~~~y~~~ 771 (774)
|+++++.+|++|+||..||+++||.||+|||.++. .|++|++|++||..
T Consensus 81 ~~~~k~~lg~~p~gf~~YF~~rFP~Ll~~~Y~~~~-~~~~e~~F~~y~~~ 129 (129)
T PF06479_consen 81 PEEVKEILGSLPDGFLNYFTSRFPNLLIHVYNFVR-NCKNEPHFKKYFNP 129 (129)
T ss_dssp -HHHHHHC-STTHHHHHHHHTT-TTHHHHHHHHHH-HCTTSCCCHHHH--
T ss_pred CHHHHHHhCCCchHHHHHHHHHCcHHHHHHHHHHH-hcCccHHHHhhccC
Confidence 99999999999999999999999999999999998 99999999999963
|
1.26.-), an interferon- induced enzyme implicated in both the molecular mechanisms of interferon action and the fundamental control of RNA stability. 2-5A-dependent RNase is a unique enzyme in that it requires 2-5A, unusual oligoadenylates with 2',5'-phosphodiester linkages. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5'-phosphorylated 2', 5'-linked oligoadenylate (2-5A), in the N-terminal half. RNase L consists of three domains, namely the N-terminal ankyrin repeat domain (see PDOC50088 from PROSITEDOC), the protein kinase homology domain, and the C-terminal KEN domain [, , ]. - Eukaryotic Ire1/Ern1, an ancient transmembrane sensor of endoplasmic reticulum (ER) stress with dual protein kinase and ribonuclease activities. In response to ER stress Ire1/Ern1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. Ire1/Ern1 is a type 1 transmembrane receptor consisting of an N-terminal ER luminal domain, a transmembrane segment and a cytoplasmic region. The cytoplasmic region encompasses a protein kinase domain followed by a C-terminal KEN domain [, ]. The dimerisation of the kinase domain activates the ribonuclease function of the KEN domain [].; GO: 0016891 endoribonuclease activity, producing 5'-phosphomonoesters, 0006397 mRNA processing; PDB: 3SDJ_D 3FBV_L 3LJ2_A 3SDM_A 3LJ0_A 2RIO_A 3LJ1_A 3P23_A. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=253.29 Aligned_cols=257 Identities=29% Similarity=0.425 Sum_probs=186.1
Q ss_pred ccccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.+.|...++||+|+|++||++... ..+.||+|.+..... .....|++.+-....+.||+.+.+++..++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 445566778899999999999998543 468999999965543 456678876666778999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|+||. +.-...+++ ..++..+++.+++.++.||+++|
T Consensus 112 ivlp~~----------~H~~f~~l~--------------------------------~~l~~~~i~~Yl~~ll~Al~~~h 149 (418)
T KOG1167|consen 112 IVLPYF----------EHDRFRDLY--------------------------------RSLSLAEIRWYLRNLLKALAHLH 149 (418)
T ss_pred EEeccc----------CccCHHHHH--------------------------------hcCCHHHHHHHHHHHHHHhhhhh
Confidence 999944 444443332 12445677899999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCC------c--------------------------cc------
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM------S--------------------------CL------ 537 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~------~--------------------------~~------ 537 (774)
..|||||||||+|+|.+...+ .-.|.|||||....... . ..
T Consensus 150 ~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~ 228 (418)
T KOG1167|consen 150 KNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCND 228 (418)
T ss_pred ccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCC
Confidence 999999999999999975543 35699999997321100 0 00
Q ss_pred ---cccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCc-hHHH----------------HHHHh
Q 004097 538 ---TQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGES-FERD----------------ANIVK 596 (774)
Q Consensus 538 ---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg~~~Pf~~~-~~~~----------------~~~~~ 596 (774)
.......||+||.|||++.. ...+.++||||.|||++.++++ +.||... ...+ .....
T Consensus 229 ~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~-~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 229 GRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSR-RYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred CccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcc-ccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 00112469999999999875 5578999999999999999997 5565321 1100 00000
Q ss_pred hc---------------------------cc-cc--------cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 597 DR---------------------------KD-LF--------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 597 ~~---------------------------~~-~~--------~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+. .. .. ....+..+.||+.+||..||.+|.|++++|+||||...
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 00 00 00012368899999999999999999999999999754
Q ss_pred c
Q 004097 641 D 641 (774)
Q Consensus 641 ~ 641 (774)
+
T Consensus 388 ~ 388 (418)
T KOG1167|consen 388 D 388 (418)
T ss_pred h
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=268.54 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=192.8
Q ss_pred ceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+...+|.|+||.||++ ....++..|||+++-.-. ....+||. ++...+|||||.|+|.+-..+.+|++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~-~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIG-MLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccccccccee-eeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 45677789999999999998 456799999999875432 22345554 67788999999999999999999999999
Q ss_pred cCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 421 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 421 ~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|.+ +|++. |.--| .+.+.++...++..++||+|||+.|=
T Consensus 94 cgggslQdi-y~~Tg---------------------------------------plselqiayvcRetl~gl~ylhs~gk 133 (829)
T KOG0576|consen 94 CGGGSLQDI-YHVTG---------------------------------------PLSELQIAYVCRETLQGLKYLHSQGK 133 (829)
T ss_pred cCCCcccce-eeecc---------------------------------------cchhHHHHHHHhhhhccchhhhcCCc
Confidence 885 45443 33333 34555678899999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhh---hcCCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDvwSlGvll~el 576 (774)
+|||||-.|||+++.|. +|++|||.+..+... ........||+.|||||+- +.+.|...+|||++|+...|+
T Consensus 134 ~hRdiKGanilltd~gD--vklaDfgvsaqitat---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 134 IHRDIKGANILLTDEGD--VKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred ccccccccceeecccCc--eeecccCchhhhhhh---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 99999999999998887 899999998776532 3345667899999999986 356789999999999999998
Q ss_pred HhCCCCCCCCchHHHHHHHhhc-ccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 577 ITGGKHPYGESFERDANIVKDR-KDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~~~~~~-~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
-....+-|+-...+...++... ... ......+.+.+|++.+|.++|.+||+++.+|.|||....
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 7753333443333332222221 111 112345778899999999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=290.90 Aligned_cols=204 Identities=19% Similarity=0.238 Sum_probs=145.3
Q ss_pred CC-CCeeEEeeec-------cCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHH
Q 004097 397 QH-PNIVRWYGVE-------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 468 (774)
Q Consensus 397 ~H-pNIV~l~g~~-------~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 468 (774)
.| +||++++++| .+.+.+++++|++..+|.+++...
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~------------------------------------ 73 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP------------------------------------ 73 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc------------------------------------
Confidence 34 5788888877 334567888897766666655211
Q ss_pred HHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCC-----------------CceEEEcccCcccccc
Q 004097 469 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQ 531 (774)
Q Consensus 469 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~-----------------~~~~kl~DFGla~~~~ 531 (774)
...+++.+++.|++||++||+|||++||+||||||+||||+..+ ...+|++|||+++...
T Consensus 74 ---~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 ---DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred ---cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 12366778899999999999999999999999999999995422 2346788888876532
Q ss_pred CCCc-------------cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhc
Q 004097 532 GDMS-------------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 598 (774)
Q Consensus 532 ~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~ 598 (774)
.... ........+||+.|||||++.+..++.++|||||||+||||++| .+|+.........+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~-~~~~~~~~~~~~~~~~~~ 229 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP-VSSREEKSRTMSSLRHRV 229 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC-CCchhhHHHHHHHHHHhh
Confidence 1100 00011124689999999999999999999999999999999996 666654322211111111
Q ss_pred cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 599 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 599 ~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.........++..+++.+||++||.+||++.|+++||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 230 LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 111112235677899999999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=223.83 Aligned_cols=207 Identities=39% Similarity=0.662 Sum_probs=169.6
Q ss_pred ecccCceEEEEEeeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC-CChh
Q 004097 353 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLN 426 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~-~sL~ 426 (774)
||+|++|.||++.... ++.++||++..... ....+|+. .+..+.|++|+++++++......++++|++. .+|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE-ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999986654 89999999976654 34556665 6778899999999999999999999999665 3444
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
+++ .... ..+++..+..++.+++++|++||+.+++|+||+|
T Consensus 80 ~~~-----------~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~ 120 (215)
T cd00180 80 DLL-----------KENE----------------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120 (215)
T ss_pred HHH-----------Hhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 443 2110 1356677899999999999999999999999999
Q ss_pred CCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 507 QNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 507 ~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
.||+++. ++. ++|+|||.+........ ......+...|++||.+... .++.+.|+|++|++++++
T Consensus 121 ~ni~~~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 121 ENILLDSDNGK--VKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred hhEEEeCCCCc--EEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------
Confidence 9999987 554 89999999986653311 12234478889999999877 788999999999999998
Q ss_pred CCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 585 GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
..+.+++.+|++.||.+||++.++++|+
T Consensus 188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6789999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=249.77 Aligned_cols=190 Identities=26% Similarity=0.422 Sum_probs=151.9
Q ss_pred EEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc--h---------HHHHHHHHHHHhCC---CCCeeEEeeeccCC
Q 004097 347 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--D---------VALKEIQNLIASDQ---HPNIVRWYGVESDQ 411 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~--~---------~~~~Ei~~ll~~l~---HpNIV~l~g~~~~~ 411 (774)
|...+.+|+|+||.|++|. ..+...|+||.+.+... + ..-.||+ +++.++ |+||++++.+|+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIq-Ila~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQ-ILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHH-HHHHhhhcCccchhhhhheeecC
Confidence 7778899999999999984 44567899999876532 1 1224776 455555 99999999999999
Q ss_pred ceeEEeccccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 412 ~~~~LV~E~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
++.||+||--.. +|.++| .. ...++++++..|++|++.
T Consensus 642 d~yyl~te~hg~gIDLFd~I-----------E~-----------------------------kp~m~E~eAk~IFkQV~a 681 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFI-----------EF-----------------------------KPRMDEPEAKLIFKQVVA 681 (772)
T ss_pred CeeEEEecCCCCCcchhhhh-----------hc-----------------------------cCccchHHHHHHHHHHHh
Confidence 999999994332 333333 11 123677888999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHh
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 568 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwS 568 (774)
|+++||+.+|||||||-+||.++.+| .+||+|||.+.....+ .....+||.+|.|||++.+.+| ...-|||+
T Consensus 682 gi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwa 754 (772)
T KOG1152|consen 682 GIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWA 754 (772)
T ss_pred ccccccccCceecccccccEEEecCC--eEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhh
Confidence 99999999999999999999996554 6999999998877643 3356789999999999999887 57899999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 004097 569 LGCILFFCITGGKHPYG 585 (774)
Q Consensus 569 lGvll~elltg~~~Pf~ 585 (774)
+|++||-++.. ..||.
T Consensus 755 lgillytivyk-enpyy 770 (772)
T KOG1152|consen 755 LGILLYTIVYK-ENPYY 770 (772)
T ss_pred hhheeeEEEec-cCCCc
Confidence 99999998884 55653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=209.86 Aligned_cols=146 Identities=21% Similarity=0.193 Sum_probs=114.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCch
Q 004097 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552 (774)
Q Consensus 473 ~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP 552 (774)
.++++.+++.|+.||+.||+|||+.+ ||+|||++.++. +|+ ||+++..... ...||+.||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~--------~~~g~~~y~aP 73 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE--------QSRVDPYFMAP 73 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc--------cCCCcccccCh
Confidence 34788999999999999999999998 999999987765 677 9998765432 12589999999
Q ss_pred hhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--H-HHHHhhccccc------cccCCH--HHHHHHHHhcCCC
Q 004097 553 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--D-ANIVKDRKDLF------LVEHIP--EAVDLFTRLLDPN 621 (774)
Q Consensus 553 E~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~-~~~~~~~~~~~------~~~~~~--~~~dli~~~L~~d 621 (774)
|++.+..++.++|||||||++|||++| .+||...... . ..+........ ...... ++.++|.+||+.|
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 152 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDY-ELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRL 152 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhC-CCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcc
Confidence 999999999999999999999999997 6677543221 1 11111111110 111112 6899999999999
Q ss_pred CCCCcCHHHHHcCCCC
Q 004097 622 PDLRPKAQNVLNHPFF 637 (774)
Q Consensus 622 P~~Rps~~elL~HPff 637 (774)
|.+||++.|+++|+|+
T Consensus 153 p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 153 PQRREAANHYLAHCRA 168 (176)
T ss_pred cccccCHHHHHHHHHH
Confidence 9999999999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=209.53 Aligned_cols=194 Identities=35% Similarity=0.564 Sum_probs=152.6
Q ss_pred EEeEeecccCceEEEEEeeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 348 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.+.+.||+|++|+||++.... ++.+|||.+..... ....+|+. .+..++|+|++++++++...+..++++|+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIR-ILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHH-HHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456789999999999986664 88999999976532 23445554 6677799999999999999999999999555
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-HPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
+ ++|.+++... .. +++..+..++.+++.+|.+||+.+++|
T Consensus 81 ~----------~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 121 (225)
T smart00221 81 G----------GDLFDYLRKK-----------------------------GGKLSEEEARFYLRQILEALEYLHSLGIVH 121 (225)
T ss_pred C----------CCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4 4444433211 11 456677899999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhh-hcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
+||+|.||+++.++. ++|+|||++........ .......++..|++||.+ ....++.++|+|+||+++++|++|
T Consensus 122 ~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g- 196 (225)
T smart00221 122 RDLKPENILLGMDGL--VKLADFGLARFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG- 196 (225)
T ss_pred CCCCHHHEEEcCCCC--EEEeeCceeeEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC-
Confidence 999999999987654 89999999987754320 022334578899999998 666778899999999999999996
Q ss_pred CCCCCC
Q 004097 581 KHPYGE 586 (774)
Q Consensus 581 ~~Pf~~ 586 (774)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 888855
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=217.15 Aligned_cols=234 Identities=23% Similarity=0.356 Sum_probs=172.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeee-ccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~-~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|.||.+-++.. .+...+|+|.+.+.. ..+..+|..--+....|.||+.-|.+ |+..+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE- 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE- 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec-
Confidence 4577788999999999998754 457789999886543 24556777655556679999988875 677788889999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.+.|+|.+-+. ..|+.+....+++.|+++|+.|||++++|
T Consensus 103 ---------~aP~gdL~snv~------------------------------~~GigE~~~K~v~~ql~SAi~fMHsknlV 143 (378)
T KOG1345|consen 103 ---------FAPRGDLRSNVE------------------------------AAGIGEANTKKVFAQLLSAIEFMHSKNLV 143 (378)
T ss_pred ---------cCccchhhhhcC------------------------------cccccHHHHHHHHHHHHHHHHHhhccchh
Confidence 555566554321 13455667789999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-----CCCCcchhHhHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSLGCILFF 575 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDvwSlGvll~e 575 (774)
|||||.+||||-...-.++||||||+++....... ..-.+..|.+||.+... ...+.+|+|.||+|+|.
T Consensus 144 HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~ 217 (378)
T KOG1345|consen 144 HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFY 217 (378)
T ss_pred hcccccceEEEecCCccEEEeeecccccccCceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeee
Confidence 99999999999654445899999999886653211 11245678999987542 24678999999999999
Q ss_pred HHhCCCCCCCCchHH---HHHHHhhcccc------ccccCCHHHHHHHHHhcCCCCCCC
Q 004097 576 CITGGKHPYGESFER---DANIVKDRKDL------FLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 576 lltg~~~Pf~~~~~~---~~~~~~~~~~~------~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
++|| .+||...... ..+..++.... .....++.+..+.++-|.++|+.|
T Consensus 218 cltG-~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 218 CLTG-KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eecC-CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 9997 8899743221 12222222111 122346789999999999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=224.12 Aligned_cols=237 Identities=27% Similarity=0.385 Sum_probs=186.5
Q ss_pred ecccCceEEEEE----eeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCC-CCCeeEEeeeccCCceeEEeccccCC
Q 004097 353 IAKGSNGTVVLE----GNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 353 LG~GsfG~Vy~a----~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+|+|+||.|++. +...|..+|.|.+++.... ...+-+..++...+ ||.+|+++..++.+..+|++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld---- 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD---- 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh----
Confidence 799999999874 4445778999988654321 11122223445444 9999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+..+|.+...+... ..+.+.....+...++-+++++|+.+|+|||
T Consensus 78 ------~~rgg~lft~l~~~-----------------------------~~f~~~~~~~~~aelaLald~lh~l~iiyrd 122 (612)
T KOG0603|consen 78 ------FLRGGDLFTRLSKE-----------------------------VMFDELDVAFYLAELALALDHLHKLGIAYRD 122 (612)
T ss_pred ------hcccchhhhccccC-----------------------------CchHHHHHHHHHHHHHHHHhhcchhHHHHhc
Confidence 77888877765332 2234455677888999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
+|++||+++.+|+ +++.|||+++...... ..|||..|||||++. ....++|.||||++++||+|| ..|
T Consensus 123 ~k~enilld~~Gh--i~~tdfglske~v~~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg-~~p 190 (612)
T KOG0603|consen 123 YKLENVLLLLEGH--IKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG-TLP 190 (612)
T ss_pred ccccceeecccCc--cccCCchhhhHhHhhh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC-CCC
Confidence 9999999998887 8999999998775431 228999999999997 678899999999999999997 778
Q ss_pred CCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccch
Q 004097 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 643 (774)
Q Consensus 584 f~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~ 643 (774)
|.. .....+.......+.+.+.++++++..++..+|..|.. +.|+++|+|||..++.
T Consensus 191 f~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 191 FGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred Cch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 876 23333444455567777899999999999999999975 4689999999887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-22 Score=231.11 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=176.6
Q ss_pred EEeEeecccCceEEEEEee-eCCcEEEEEEee----cCCchHH----HHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 348 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~----~~~~~~~----~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.....+|.|++|.|+.... ...+..+.|..+ ....... ..++..+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457799999997765432 233444554332 2221111 111122445689999999988888887777779
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||+.+|..++- .+ ..+...++..+++|++.||+|||+.|
T Consensus 401 E~~~~Dlf~~~~-~~---------------------------------------~~~~~~e~~c~fKqL~~Gv~y~h~~G 440 (601)
T KOG0590|consen 401 EYCPYDLFSLVM-SN---------------------------------------GKLTPLEADCFFKQLLRGVKYLHSMG 440 (601)
T ss_pred hcccHHHHHHHh-cc---------------------------------------cccchhhhhHHHHHHHHHHHHHHhcC
Confidence 988865544441 11 12334566789999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-ccccccCcCCCCCCchhhhhcCCCC-CcchhHhHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCILFFC 576 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSlGvll~el 576 (774)
|.|||+|++|++++.++. +||+|||.+....-..+. .......+|+..|+|||++.+..|. ..+||||.|+++..|
T Consensus 441 iahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred ceeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence 999999999999988875 899999998766433221 2334556799999999999999886 579999999999999
Q ss_pred HhCCCCCCCCchHHHHH--HHh--------hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 577 ITGGKHPYGESFERDAN--IVK--------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++| +.||......+.. ... ............+.+.+|.+||+.||.+|.|++++++.+||+..+
T Consensus 519 ~~~-~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 519 ILG-RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ecC-CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 997 8898654332211 000 001111112234678999999999999999999999999997643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-19 Score=192.15 Aligned_cols=251 Identities=31% Similarity=0.471 Sum_probs=182.9
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCC-CeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHP-NIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~Hp-NIV~l~g~~~~~~~~~LV~E 419 (774)
|...+.||.|+||.||++... ..+|+|.+..... ....+|+. ++..+.|+ +|++++.++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQ-ILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHH-HHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 456788999999999997665 7899999865432 23445554 66777877 79999999988888899999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
++. ++++.+.+..... + ..++......++.|++.+++|+|+.++
T Consensus 79 ~~~----------~~~l~~~~~~~~~------------------------~--~~~~~~~~~~~~~~~~~~l~~~H~~~~ 122 (384)
T COG0515 79 YVD----------GGSLEDLLKKIGR------------------------K--GPLSESEALFILAQILSALEYLHSKGI 122 (384)
T ss_pred cCC----------CCcHHHHHHhccc------------------------c--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 555 4444422211100 0 235667789999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCcccc---ccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT---QNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 573 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll 573 (774)
+|||+||+||+++..+. .++++|||+++.......... ......||..|+|||.+.. ..+....|+||+|+++
T Consensus 123 ~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 123 IHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999977652 489999999986654322211 2355679999999999987 5788999999999999
Q ss_pred HHHHhCCCCCCCCchH-----HHHHHHhhcccc---ccccCC------HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 574 FFCITGGKHPYGESFE-----RDANIVKDRKDL---FLVEHI------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~-----~~~~~~~~~~~~---~~~~~~------~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
+++++| ..||..... .....+...... ...... ..+.+++.+++..+|..|.++.+...++|..
T Consensus 202 ~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 202 YELLTG-LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred HHHHhC-CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 999997 666665442 222222222111 111111 3688999999999999999999998886653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=205.48 Aligned_cols=166 Identities=20% Similarity=0.157 Sum_probs=119.1
Q ss_pred ccccceEEEeEeecccCceEEEEEeee--CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCCeeE-Eeeecc
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVR-WYGVES 409 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~--~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~-l~g~~~ 409 (774)
+.+...|.+.+.||+|+||+||+|... +++.||||++.... .....+|+. ++..++|+||+. ++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~-iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIR-ALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHH-HHHhccCCCCCcEEEEc--
Confidence 344567889999999999999998553 57889999875321 112345554 778899999985 5442
Q ss_pred CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 410 ~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+..|||||||. +++|... .. . ....++.|++.
T Consensus 91 --~~~~LVmE~~~----------G~~L~~~-~~--------------------------------~---~~~~~~~~i~~ 122 (365)
T PRK09188 91 --GKDGLVRGWTE----------GVPLHLA-RP--------------------------------H---GDPAWFRSAHR 122 (365)
T ss_pred --CCcEEEEEccC----------CCCHHHh-Cc--------------------------------c---chHHHHHHHHH
Confidence 45799999655 3444311 00 0 01357889999
Q ss_pred HHHHHHHcCcccccc-CCCCeeecCCCCceEEEcccCccccccCCCcccc-----ccccCcCCCCCCchhhhhcCC
Q 004097 490 GLSHLHEIGLIHRDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-----QNATGYGSSGWQAPEQLLQGR 559 (774)
Q Consensus 490 gL~yLH~~~ivHrDL-kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~ 559 (774)
||+|||+.||+|||| ||+|||++.++. +||+|||+|+.+........ ...+..+++.|+|||.+....
T Consensus 123 aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 123 ALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred HHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999999999999 999999977665 89999999997764322111 113456889999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=194.53 Aligned_cols=201 Identities=22% Similarity=0.305 Sum_probs=138.6
Q ss_pred CCCCCeeEEeeeccCC---------------------------ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcch
Q 004097 396 DQHPNIVRWYGVESDQ---------------------------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 448 (774)
Q Consensus 396 l~HpNIV~l~g~~~~~---------------------------~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~ 448 (774)
-.|||||++.++|.|. ..+|+||..++++|++|+....
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--------------- 337 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--------------- 337 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---------------
Confidence 3699999999886553 3579999998888888773221
Q ss_pred hhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeee--cCCCCceEEEcccCc
Q 004097 449 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCAKLSDMGI 526 (774)
Q Consensus 449 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl--~~~~~~~~kl~DFGl 526 (774)
.+.....-|+.|+++|+.|||.+||.|||+|++|||+ ++|+-..+.|+|||.
T Consensus 338 --------------------------~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 338 --------------------------RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred --------------------------CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 2223346789999999999999999999999999999 455555788999997
Q ss_pred cccccCC--C-ccccccccCcCCCCCCchhhhhcCC------CCCcchhHhHHHHHHHHHhCCCCCCCCchHHH---HHH
Q 004097 527 SKRLQGD--M-SCLTQNATGYGSSGWQAPEQLLQGR------QTRAIDLFSLGCILFFCITGGKHPYGESFERD---ANI 594 (774)
Q Consensus 527 a~~~~~~--~-~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~---~~~ 594 (774)
+---... . ...+.....-|...-||||+....+ .-.++|.|+.|.+.||+++. ..||...-+.. ...
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~-~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGR-SNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhcc-CCcccccchheechhhh
Confidence 6432211 0 0111111223677899999986532 13689999999999999986 55664422111 111
Q ss_pred HhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH---HHHcCCCCCC
Q 004097 595 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ---NVLNHPFFWT 639 (774)
Q Consensus 595 ~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~---elL~HPff~~ 639 (774)
.+..-...+....+.+++++..+|+.||++|++.. .++ |-+.|.
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl-~LsLw~ 517 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL-NLSLWR 517 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH-HHHHhc
Confidence 12222233445678999999999999999998854 444 444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=188.83 Aligned_cols=205 Identities=21% Similarity=0.322 Sum_probs=167.0
Q ss_pred cccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEee-cCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLV-KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~-~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+|-.|.++++||+|+||..+.+ .+.+++.||||.-. ++...+...|.....-....++|...|.+-.++-+-.||+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 45677899999999999999987 57889999999753 33344555565533333467999999988899989999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
++.-+|+|++- |..+.++.+.+..|+.|++.-++|+|++.+
T Consensus 105 LLGPSLEDLFD---------------------------------------~CgR~FSvKTV~miA~Qmi~rie~vH~k~L 145 (449)
T KOG1165|consen 105 LLGPSLEDLFD---------------------------------------LCGRRFSVKTVAMIAKQMITRIEYVHEKDL 145 (449)
T ss_pred hhCcCHHHHHH---------------------------------------HhcCcccHHhHHHHHHHHHHHHHHHHhcce
Confidence 98888888762 667788899999999999999999999999
Q ss_pred cccccCCCCeeecCCC---CceEEEcccCccccccCCCc----cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 500 IHRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 500 vHrDLkp~NILl~~~~---~~~~kl~DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|.|||||+|.||...+ .-.+.++|||+|+.+.+... .+.......||..||+-..-.++..+.+.|+-|||-+
T Consensus 146 IYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHv 225 (449)
T KOG1165|consen 146 IYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHV 225 (449)
T ss_pred eecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhh
Confidence 9999999999995322 12478999999998865432 2233345569999999998889999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 004097 573 LFFCITGGKHPYGE 586 (774)
Q Consensus 573 l~elltg~~~Pf~~ 586 (774)
+.+.|-| ..||..
T Consensus 226 FmYFLRG-sLPWQG 238 (449)
T KOG1165|consen 226 FMYFLRG-SLPWQG 238 (449)
T ss_pred hhhhccC-CCcccc
Confidence 9999986 889964
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-19 Score=191.67 Aligned_cols=248 Identities=23% Similarity=0.258 Sum_probs=172.2
Q ss_pred eEEEeEeecccCceEEEEEeeeCC--cEEEEEEeecCCc---hHHHHHHHHHHHhC---CCCCeeEEeeec-cCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEG--RSVAVKRLVKTHH---DVALKEIQNLIASD---QHPNIVRWYGVE-SDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g--~~VAVK~l~~~~~---~~~~~Ei~~ll~~l---~HpNIV~l~g~~-~~~~~~~L 416 (774)
.|.+.+.||+|+||.||++..... ..+|+|....... .....|...+.... .-+++.+++... ....+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688999999999999999865543 5799998764321 13344544332222 235888888888 58889999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||+++..+|.++..... .+.++..++++|+.|++.+|++||+
T Consensus 99 VM~l~G~sL~dl~~~~~--------------------------------------~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNP--------------------------------------PGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred EEeccCccHHHHHHhCC--------------------------------------CCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 99999988888652211 1346667889999999999999999
Q ss_pred cCccccccCCCCeeecCCC-C--ceEEEcccCccc--cccCCCcc----ccc-cccCcCCCCCCchhhhhcCCCCCcchh
Q 004097 497 IGLIHRDLKPQNVLISKDK-S--FCAKLSDMGISK--RLQGDMSC----LTQ-NATGYGSSGWQAPEQLLQGRQTRAIDL 566 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~-~--~~~kl~DFGla~--~~~~~~~~----~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv 566 (774)
.|++||||||+|+++.... . ..+.|.|||+++ ........ ... .....||..|+++.+..+...+++.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999997553 1 358999999999 43322211 111 123459999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHH--HHHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 567 FSLGCILFFCITGGKHPYGESFER--DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~~~--~~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||++.++.|++.| ..||...... ........... .......++.++...+-..+...+|....+.
T Consensus 221 es~~Y~l~el~~g-~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 221 ESLFYMLLELLKG-SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hhHHHHHHHHhcC-CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 9999999999997 6898543311 11111111110 1111234556666666556777777666554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=181.57 Aligned_cols=205 Identities=22% Similarity=0.296 Sum_probs=158.5
Q ss_pred ccceEEEeEeecccCceEEEEE-eeeCCcEEEEEEeecCC-chHHHHHHHHHHHhCC-CCCeeEEeeeccCCceeEEecc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+..|.+.++||.|+||.+|+| ...+|..||||.-.... ..+..-|-. +-..++ -..|..++.|..+.++-.||||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEsk-vY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESK-VYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHH-HHHHhccCCCCchhhhhccccccceeeee
Confidence 4566889999999999999998 66789999999865432 233344443 223333 3567777888889999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
+..-+|++++-+. .+.++..+++-++-|++.-++|+|.+++
T Consensus 92 LLGPsLEdLfnfC---------------------------------------~R~ftmkTvLMLaDQml~RiEyvH~r~f 132 (341)
T KOG1163|consen 92 LLGPSLEDLFNFC---------------------------------------SRRFTMKTVLMLADQMLSRIEYVHLRNF 132 (341)
T ss_pred ccCccHHHHHHHH---------------------------------------hhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence 9998988887432 2346667889999999999999999999
Q ss_pred cccccCCCCeeecCCCCc-eEEEcccCccccccCCCc----cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSF-CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~-~~kl~DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|||||||+|.|..-+.+. .+.++|||+|+.+.+..+ .........||..|.+-....+...+...|+-|+|.++.
T Consensus 133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM 212 (341)
T ss_pred ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence 999999999999644322 478999999998764322 122334456999999988888788899999999999988
Q ss_pred HHHhCCCCCCCCch
Q 004097 575 FCITGGKHPYGESF 588 (774)
Q Consensus 575 elltg~~~Pf~~~~ 588 (774)
+..-| ..||..-.
T Consensus 213 YfnrG-~LPWQglk 225 (341)
T KOG1163|consen 213 YFNRG-SLPWQGLK 225 (341)
T ss_pred eeecC-CCcccccc
Confidence 87775 88997643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=215.99 Aligned_cols=244 Identities=23% Similarity=0.249 Sum_probs=170.9
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+...+.||++.|=+|.++...+|. |+||++.+... .+.++|++ ....+|||++.+.-+...+.-.|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 3556788999999999998888886 99999976542 23445554 56678999999988877777788888
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
+|...+|.|-+ +...+| ..-+.+.|+.|++.||.-+|..|
T Consensus 101 qyvkhnLyDRl-----STRPFL-----------------------------------~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 101 QYVKHNLYDRL-----STRPFL-----------------------------------VLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred HHHhhhhhhhh-----ccchHH-----------------------------------HHHHHHHHHHHHHHHHHHHHHcC
Confidence 86655554444 111111 12244789999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCcccccc--CC--CccccccccCcCCCCCCchhhhhcC----------C-CCCc
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GD--MSCLTQNATGYGSSGWQAPEQLLQG----------R-QTRA 563 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~--~~--~~~~~~~~~~~gt~~y~aPE~l~~~----------~-~~~~ 563 (774)
|+|+|||.+||||+.-.- +.|+||..-+..- .+ .+......+...-..|+|||.+... . .+++
T Consensus 141 VcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~pa 218 (1431)
T KOG1240|consen 141 VCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPA 218 (1431)
T ss_pred ccccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChh
Confidence 999999999999987665 6799998655432 11 1111111233344579999987642 1 5678
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccccc--CCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 564 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
-||||+||++.||++-|+|+|.-+.--..............+ ....++.+|..|++.||++|.+|++.|+.
T Consensus 219 MDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 219 MDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 999999999999999889999643211110000000000000 12368999999999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-19 Score=180.35 Aligned_cols=235 Identities=20% Similarity=0.285 Sum_probs=173.5
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
+..+|.+...|..|+ +.+.|..+++|++.-.+ ....+.|+--.+....||||+.++|.|....++.++..
T Consensus 194 l~tkl~e~hsgelwr-grwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq----- 267 (448)
T KOG0195|consen 194 LITKLAESHSGELWR-GRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ----- 267 (448)
T ss_pred hhhhhccCCCccccc-ccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee-----
Confidence 335678888899998 55667788888885332 12334444335667789999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-Ccc-cc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLI-HR 502 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~iv-Hr 502 (774)
||+.|+|+..||..... -.+..++.+++.+|++|++|||+. .++ --
T Consensus 268 -----~mp~gslynvlhe~t~v---------------------------vvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 268 -----YMPFGSLYNVLHEQTSV---------------------------VVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred -----eccchHHHHHHhcCccE---------------------------EEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 89999999998875421 123457789999999999999997 343 44
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC---CCcchhHhHHHHHHHHHhC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDvwSlGvll~elltg 579 (774)
-|.+..+++++|-..++-.+|--++- +.......|.||+||.+...+- -+++|+|||++++||+.|.
T Consensus 316 ~lns~hvmidedltarismad~kfsf----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSF----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred hcccceEEecchhhhheecccceeee----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 68899999987755333334432221 1223346789999999987654 3689999999999999994
Q ss_pred CCCCCCCchHHHH---HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 580 GKHPYGESFERDA---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 580 ~~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
..||.+....+. -.+++.....++..++....|+.-|++.||.+||....++
T Consensus 386 -evpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 386 -EVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -ccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 889987654432 2233444456677788999999999999999999877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4e-18 Score=197.84 Aligned_cols=154 Identities=32% Similarity=0.436 Sum_probs=119.9
Q ss_pred HHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCC------------ccccccccCcCCCCCCchhhh
Q 004097 488 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM------------SCLTQNATGYGSSGWQAPEQL 555 (774)
Q Consensus 488 a~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~~gt~~y~aPE~l 555 (774)
+.+++|||+-+|+|||+||+|.+|+.-|+ +|++|||+++...... ...-.....+||+.|.|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 78999999999999999999999988876 8999999987643211 011122445899999999999
Q ss_pred hcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccc---cccCCHHHHHHHHHhcCCCCCCC---cCHH
Q 004097 556 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLR---PKAQ 629 (774)
Q Consensus 556 ~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~dli~~~L~~dP~~R---ps~~ 629 (774)
..+.|...+|+|++|+|+||.+.|..++|++..+.....+......+ .....+|++++|.++|+.+|..| +.+-
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 99999999999999999999999866666665555443322222222 33456899999999999999999 4567
Q ss_pred HHHcCCCCCCccch
Q 004097 630 NVLNHPFFWTADTR 643 (774)
Q Consensus 630 elL~HPff~~~~~~ 643 (774)
++.+|+||..-++.
T Consensus 311 evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 311 EVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhccceeecccc
Confidence 89999999665544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.9e-18 Score=170.08 Aligned_cols=135 Identities=17% Similarity=0.102 Sum_probs=93.5
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc---h--------------------------HHHHHHHHHHHhCCCCCe
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---D--------------------------VALKEIQNLIASDQHPNI 401 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---~--------------------------~~~~Ei~~ll~~l~HpNI 401 (774)
..||+|+||+||+|...+|+.||||+++.... . ...+|+. .+..+.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR-NLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH-HHHHHHHCCC
Confidence 56999999999999777899999999965321 0 0112544 4455555554
Q ss_pred eEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 402 V~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
.....+.. ...+||||||+++ ++.... ....+++...+.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~----------~l~~~~-----------------------------~~~~~~~~~~~~ 120 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDD----------GWAAPR-----------------------------LKDAPLSESKAR 120 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCC----------CCcchh-----------------------------hhcCCCCHHHHH
Confidence 32222211 2238999977653 211110 011345667889
Q ss_pred HHHHHHHHHHHHH-HHcCccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 482 KVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 482 ~i~~qia~gL~yL-H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
.++.|++.+|+|| |+.||+||||||+|||+++ + .++|+|||+|...
T Consensus 121 ~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~~ 167 (190)
T cd05147 121 ELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEccccccC
Confidence 9999999999999 6899999999999999973 3 3899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.6e-18 Score=172.17 Aligned_cols=167 Identities=14% Similarity=0.098 Sum_probs=121.3
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hH----------HHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DV----------ALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~----------~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
+...|...+.||.|+||.||++.. ++..+|||.+..... +. ..+|+. .+.++.||+|.....++.+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~-~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIV-QTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHH-HHHHHHHCCCCcceEeeee
Confidence 456789999999999999999655 677899999964322 11 123433 5677799999999888554
Q ss_pred C--------ceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 411 Q--------DFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 411 ~--------~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
. +..+|+|||++| +|.++. . ++ .
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----------~---------------------------------~~----~ 138 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----------E---------------------------------IS----E 138 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-----------h---------------------------------cc----H
Confidence 3 358999997765 443321 0 01 1
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCC
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 561 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 561 (774)
....+++.+|..||+.|++|||+||+||+++.++ ++|+|||..+....... ...++....|.
T Consensus 139 ~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a---------------~d~~vler~y~ 200 (232)
T PRK10359 139 DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKA---------------KDRIDLERHYG 200 (232)
T ss_pred HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhh---------------HHHHHHHhHhc
Confidence 2456899999999999999999999999998776 78999998765532111 01144556677
Q ss_pred CcchhHhHHHHHHHHH
Q 004097 562 RAIDLFSLGCILFFCI 577 (774)
Q Consensus 562 ~~sDvwSlGvll~ell 577 (774)
.++|+||||+.+....
T Consensus 201 ~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 201 IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccccceeEeehHHH
Confidence 8999999999877544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=165.48 Aligned_cols=136 Identities=18% Similarity=0.138 Sum_probs=96.9
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCch-----------------------------HHHHHHHHHHHhCCCCCe
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----------------------------VALKEIQNLIASDQHPNI 401 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~-----------------------------~~~~Ei~~ll~~l~HpNI 401 (774)
..||+|++|+||+|...+|+.||||++...... ...+|. ..+..+.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF-RNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH-HHHHHHHhCCC
Confidence 569999999999997768999999998754210 012333 35566778877
Q ss_pred eEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 402 V~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
.....+... ..|||||||++. ++.... .....++...+.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~----------~~~~~~-----------------------------l~~~~~~~~~~~ 120 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDD----------GSPAPR-----------------------------LKDVPLEEEEAE 120 (190)
T ss_pred CCceEEEec--CCEEEEEEecCC----------Cchhhh-----------------------------hhhccCCHHHHH
Confidence 543333322 248999977653 111100 011234556778
Q ss_pred HHHHHHHHHHHHHHH-cCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 482 KVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 482 ~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
+++.|++.+|.+||+ .||+||||||+|||++ ++. ++|+|||++....
T Consensus 121 ~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~--~~liDFG~a~~~~ 168 (190)
T cd05145 121 ELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK--PYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--EEEEEcccceecC
Confidence 999999999999999 9999999999999997 544 8999999998665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=161.67 Aligned_cols=183 Identities=18% Similarity=0.138 Sum_probs=127.9
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEeecCCc--h-----HHHHHHHHHHHhC-CCCCeeEEeeeccCCceeEEecccc
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--D-----VALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~-----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
...|++|+||+||++.. .+..++.+.+..... . .+.+|++ ++..+ .|++|.+++++ +..|++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~-iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREAL-ALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHH-HHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 46799999999998665 778888887754322 1 2456776 44555 56889999886 4469999954
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +.+|...+.. ....++.|++.+|+++|+.||+|
T Consensus 81 ~----------G~~L~~~~~~------------------------------------~~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 81 A----------GAAMYQRPPR------------------------------------GDLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred c----------CccHHhhhhh------------------------------------hhHHHHHHHHHHHHHHHHCcCcc
Confidence 4 4444321100 01357789999999999999999
Q ss_pred ccc-CCCCeeecCCCCceEEEcccCccccccCCCcc---cc-------ccccCcCCCCCCchhhhhcC-CC-CCcchhHh
Q 004097 502 RDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC---LT-------QNATGYGSSGWQAPEQLLQG-RQ-TRAIDLFS 568 (774)
Q Consensus 502 rDL-kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~---~~-------~~~~~~gt~~y~aPE~l~~~-~~-~~~sDvwS 568 (774)
||| ||+|||++.++. ++|+|||++........- .. .......++.|+.|+...-- .. -...++++
T Consensus 115 rDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~ 192 (218)
T PRK12274 115 NDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA 192 (218)
T ss_pred CCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence 999 799999987775 899999999855432210 00 00112368889999865422 22 35778999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 004097 569 LGCILFFCITGGKHPYGE 586 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~ 586 (774)
.|+-+|.++|++-+.|++
T Consensus 193 ~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 193 TGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hcchHHHHHhccCCcccc
Confidence 999999999986655554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=168.02 Aligned_cols=235 Identities=25% Similarity=0.260 Sum_probs=139.2
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC----------CCC------eeE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ----------HPN------IVR 403 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~----------HpN------IV~ 403 (774)
.++....||.|+++.||.+.. .+|+.+|||++.-... -..++|......... |-. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678899999999999754 4589999999853321 112222221111111 111 222
Q ss_pred Eee---eccCC---c-----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhh
Q 004097 404 WYG---VESDQ---D-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472 (774)
Q Consensus 404 l~g---~~~~~---~-----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 472 (774)
+-+ +.... + +.+++|+...++|.+++-. |........
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~--------l~~~~~~~~------------------------ 140 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEA--------LFSRAQTHS------------------------ 140 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHH--------HHHHTTTSH------------------------
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHH--------Hhhcccccc------------------------
Confidence 221 01111 1 3477888777888776521 111111000
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCch
Q 004097 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552 (774)
Q Consensus 473 ~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP 552 (774)
.+.....+.+..|+++.+++||..|++|+||+|+|++++.+|. ++|+||+.......... ....+..|.+|
T Consensus 141 -~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~------~~~~~~~~~PP 211 (288)
T PF14531_consen 141 -PLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYR------CSEFPVAFTPP 211 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEE------GGGS-TTTS-H
T ss_pred -hhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceee------ccCCCcccCCh
Confidence 0111234678899999999999999999999999999999987 88999987765543211 12346789999
Q ss_pred hhhhcC--------CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCC
Q 004097 553 EQLLQG--------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 553 E~l~~~--------~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
|..... .++.+.|.|+||+++|.|+++ ..||+.......... ...... +.++.+++||..+|+.||.+
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~-~lPf~~~~~~~~~~~--~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG-RLPFGLSSPEADPEW--DFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS-S-STCCCGGGSTSGG--GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc-cCCCCCCCccccccc--cchhcC-CcCHHHHHHHHHHccCCccc
Confidence 987553 468899999999999999997 888876433211000 111112 44567899999999999998
Q ss_pred C
Q 004097 625 R 625 (774)
Q Consensus 625 R 625 (774)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 7
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-17 Score=180.38 Aligned_cols=154 Identities=29% Similarity=0.528 Sum_probs=120.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCC---ccccccccCcCCCCCCc
Q 004097 475 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQA 551 (774)
Q Consensus 475 l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~~gt~~y~a 551 (774)
.++...+.++.|++.|++| ++.+|||+||.||....+.. +||.|||+........ ..........||..||+
T Consensus 356 ~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Yms 430 (516)
T KOG1033|consen 356 RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMS 430 (516)
T ss_pred cchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCC
Confidence 3456678999999999999 99999999999999987764 8999999988765443 11233445679999999
Q ss_pred hhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc---ccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 552 PEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 552 PE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
||.+.+..|+.++||||||+|++|++. +|....++.......+...++ ....|+-.+|+.+|+.+.|.+||++
T Consensus 431 PEQi~g~~y~~kvdIyaLGlil~EL~~----~f~T~~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 431 PEQIRGQQYSEKVDIYALGLILAELLI----QFSTQFERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHHHhhhhhhhhcchhhHHHHHHHHHH----HhccHHHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 999999999999999999999999998 455544444433332322222 2234677899999999999999988
Q ss_pred HHHHcCCCC
Q 004097 629 QNVLNHPFF 637 (774)
Q Consensus 629 ~elL~HPff 637 (774)
.+.-.|+|.
T Consensus 507 ~~~~~~~~~ 515 (516)
T KOG1033|consen 507 IEVALHEFL 515 (516)
T ss_pred HHHhhhhhc
Confidence 888777763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=188.40 Aligned_cols=199 Identities=22% Similarity=0.245 Sum_probs=148.5
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHH--HHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~--~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..-+..|.+.++||+|+||+||+|...+|+.||+|+-+.....+.. .++...|...--+-|..+...+.-.+.-+||+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 4456778899999999999999998888999999987665432211 12211111111244666666666677889999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
| |.+-|+|.+++.. .+..++..++.+..|+++-+++||..+
T Consensus 774 e----------y~~~Gtlld~~N~-----------------------------~~~m~e~lv~~~~~qml~ive~lH~~~ 814 (974)
T KOG1166|consen 774 E----------YSPYGTLLDLINT-----------------------------NKVMDEYLVMFFSCQMLRIVEHLHAMG 814 (974)
T ss_pred e----------ccccccHHHhhcc-----------------------------CCCCCchhhhHHHHHHHHHHHHHHhcc
Confidence 9 5555665555431 133566677899999999999999999
Q ss_pred ccccccCCCCeeec-----CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 499 LIHRDLKPQNVLIS-----KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 499 ivHrDLkp~NILl~-----~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|||+||||+|.||. +.+..-++|+|||.+..+.--.. .......++|-++-.+|++.++.+++.+|.|.|+.++
T Consensus 815 IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~-~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~ 893 (974)
T KOG1166|consen 815 IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD-GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATV 893 (974)
T ss_pred eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC-CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHH
Confidence 99999999999994 22334589999999876542111 1333456789999999999999999999999999999
Q ss_pred HHHHhC
Q 004097 574 FFCITG 579 (774)
Q Consensus 574 ~elltg 579 (774)
+-||.|
T Consensus 894 h~mLFG 899 (974)
T KOG1166|consen 894 HVMLFG 899 (974)
T ss_pred HHHHHH
Confidence 999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=159.01 Aligned_cols=134 Identities=16% Similarity=0.192 Sum_probs=92.6
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecC---CchHHHHHHHHHHHhC-----CCCCeeEEeeeccCCc---eeE-Eec
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT---HHDVALKEIQNLIASD-----QHPNIVRWYGVESDQD---FVY-LSL 418 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~---~~~~~~~Ei~~ll~~l-----~HpNIV~l~g~~~~~~---~~~-LV~ 418 (774)
+.||+|+||.||. ...++.. +||++... ......+|+. ++..+ .||||++++|++.++. .++ +|+
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~-~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELK-YYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHH-HHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 5799999999996 4445444 79988653 2345667776 44445 6899999999998863 444 789
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH-HHHHHc
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL-SHLHEI 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~ 497 (774)
||+. ..+|+|.+++.. ..+++. ..++.|++.++ +|||+.
T Consensus 85 e~~G--------~~~~tL~~~l~~------------------------------~~~~e~--~~~~~~~L~~l~~yLh~~ 124 (210)
T PRK10345 85 DFDG--------KPSITLTEFAEQ------------------------------CRYEED--VAQLRQLLKKLKRYLLDN 124 (210)
T ss_pred cCCC--------CcchhHHHHHHc------------------------------ccccHh--HHHHHHHHHHHHHHHHHC
Confidence 9733 123344443311 012222 35678888888 999999
Q ss_pred CccccccCCCCeeecCC--CCceEEEcccCcc
Q 004097 498 GLIHRDLKPQNVLISKD--KSFCAKLSDMGIS 527 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~--~~~~~kl~DFGla 527 (774)
+|+||||||+|||++.. +...++|+||+.+
T Consensus 125 ~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 125 RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999999742 3346999995533
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=173.35 Aligned_cols=196 Identities=26% Similarity=0.331 Sum_probs=141.8
Q ss_pred HhCCCCCeeEEeeeccCCceeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhh
Q 004097 394 ASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472 (774)
Q Consensus 394 ~~l~HpNIV~l~g~~~~~~~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 472 (774)
..+.|.|+.+++|.+.++...++|.+||. |+|.|.++...-
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-------------------------------------- 43 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-------------------------------------- 43 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------------------------------------
Confidence 45789999999999999999999999887 577777653211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCc-cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCc
Q 004097 473 NGHPSAQLLKVTRDIVSGLSHLHEIGL-IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 551 (774)
Q Consensus 473 ~~l~~~~~~~i~~qia~gL~yLH~~~i-vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a 551 (774)
.+++.-...++++|+.||+|||...| .|+.+++.|+++ |..+.+||+|||+........ .........-..-|.|
T Consensus 44 -~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--d~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~a 119 (484)
T KOG1023|consen 44 -KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--DSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTA 119 (484)
T ss_pred -CccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee--eeeEEEEechhhhcccccccc-cccccchhHHHHhccC
Confidence 23344457899999999999999876 999999999999 555789999999987764310 0011111123456999
Q ss_pred hhhhhcCC-------CCCcchhHhHHHHHHHHHhCCCCCCCCchH-----HHHHHHhh-cccccc-----c-cCCHHHHH
Q 004097 552 PEQLLQGR-------QTRAIDLFSLGCILFFCITGGKHPYGESFE-----RDANIVKD-RKDLFL-----V-EHIPEAVD 612 (774)
Q Consensus 552 PE~l~~~~-------~~~~sDvwSlGvll~elltg~~~Pf~~~~~-----~~~~~~~~-~~~~~~-----~-~~~~~~~d 612 (774)
||.+.... .+.+.||||||++++|+++. ..||..... +....++. ....+. . +..++...
T Consensus 120 Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r-~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~ 198 (484)
T KOG1023|consen 120 PELLRGALSQSLESALTQKGDIYSFGIIMYEILFR-SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLL 198 (484)
T ss_pred HHHhcccccccccccccccCCeehHHHHHHHHHhc-cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHH
Confidence 99998641 46789999999999999995 778865221 11222222 111111 1 33457889
Q ss_pred HHHHhcCCCCCCCcCHHHHH
Q 004097 613 LFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 613 li~~~L~~dP~~Rps~~elL 632 (774)
++.+||..+|..||+++++-
T Consensus 199 l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 199 LVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHHhcccChhhCccHHHHH
Confidence 99999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.9e-15 Score=153.49 Aligned_cols=140 Identities=21% Similarity=0.181 Sum_probs=96.2
Q ss_pred cceEEEeEeecccCceEEEEEe--eeCCcEEEEEEeecCCc---------------------------hHHHHHHHHHHH
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG--NYEGRSVAVKRLVKTHH---------------------------DVALKEIQNLIA 394 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~--~~~g~~VAVK~l~~~~~---------------------------~~~~~Ei~~ll~ 394 (774)
|..|.+.+.||+|++|.||+|. ..+|+.||||++..... ....+|+.. +.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-L~ 105 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN-LQ 105 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH-HH
Confidence 4456677899999999999997 67899999999864321 012345543 33
Q ss_pred hCCC--CCeeEEeeeccCCceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHh
Q 004097 395 SDQH--PNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 471 (774)
Q Consensus 395 ~l~H--pNIV~l~g~~~~~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 471 (774)
.+.+ ..+.+.+++ ...++||||+.+ +|.... ..
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~-~~--------------------------------------- 141 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR-LK--------------------------------------- 141 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc-cc---------------------------------------
Confidence 4443 334444543 235899997765 222211 00
Q ss_pred hCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 472 ANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 472 ~~~l~~~~~~~i~~qia~gL~yLH~~~-ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
........+..++.||+.+|++||+.| |+||||||+||+++ ++. ++|+|||++....
T Consensus 142 ~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~--i~LiDFg~a~~~~ 199 (237)
T smart00090 142 DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGK--VVIIDVSQSVELD 199 (237)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCC--EEEEEChhhhccC
Confidence 011223345789999999999999999 99999999999997 444 8899999887543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.2e-14 Score=144.15 Aligned_cols=131 Identities=19% Similarity=0.296 Sum_probs=97.4
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.||+|++|.||++.. .|..|+||+...... ....+|+. ++..+.|++|.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREAR-IMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHH-HHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999755 778899998653221 12234443 5667788888877777777788899999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|++ +++|.+.+... .. ....++.+++.+|.+||+.++
T Consensus 80 ~~~----------G~~L~~~~~~~--------------------------------~~-~~~~i~~~i~~~l~~lH~~~i 116 (211)
T PRK14879 80 YIE----------GEPLKDLINSN--------------------------------GM-EELELSREIGRLVGKLHSAGI 116 (211)
T ss_pred EeC----------CcCHHHHHHhc--------------------------------cH-HHHHHHHHHHHHHHHHHhCCc
Confidence 554 44444433211 01 457899999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCcccc
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
+|+|++|.|||++ ++. ++|+|||++..
T Consensus 117 ~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999999997 443 78999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-14 Score=142.94 Aligned_cols=133 Identities=17% Similarity=0.131 Sum_probs=94.2
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-------------------------hHHHHHHHHHHHhCCCC--
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------------------------DVALKEIQNLIASDQHP-- 399 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-------------------------~~~~~Ei~~ll~~l~Hp-- 399 (774)
+.+.+.||+|+||.||++...+|+.||||++..... ....+|+. ++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA-ALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH-HHHHHHHcCC
Confidence 556688999999999998777899999998754320 01233443 44555566
Q ss_pred CeeEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHH
Q 004097 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 479 (774)
Q Consensus 400 NIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 479 (774)
.+...++ ....++||||+++ +++...... ..
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g----------~~L~~~~~~-----------------------------------~~ 126 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDG----------VELYRVRVL-----------------------------------ED 126 (198)
T ss_pred CCCceee----cCCceEEEEEeCC----------cchhhcccc-----------------------------------cc
Confidence 3444443 2345899996554 343322100 12
Q ss_pred HHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 480 ~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
...++.+++.++.++|+.+|+||||||+||+++.++. ++|+|||++....
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~~~ 176 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCccccCC
Confidence 3578899999999999999999999999999987665 8999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.4e-14 Score=142.07 Aligned_cols=126 Identities=22% Similarity=0.373 Sum_probs=90.9
Q ss_pred ecccCceEEEEEeeeCCcEEEEEEeecCC--c---------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTH--H---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
||+|+||+||++. .+|..|+||+..... . ....+|+. ++..+.|+++.....++.+.+..++|||++
T Consensus 2 ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEAR-LLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHH-HHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 8999999999976 678899999864321 0 11223444 556667776554444455666779999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
+ +++|.+.+.... ..++.+++.+|.+||+.+++|
T Consensus 80 ~----------g~~l~~~~~~~~------------------------------------~~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 80 E----------GKPLKDVIEEGN------------------------------------DELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred C----------CccHHHHHhhcH------------------------------------HHHHHHHHHHHHHHHHCCeec
Confidence 4 445544321100 168899999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCcccc
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
+|++|.||+++ ++. ++++|||++..
T Consensus 114 ~Dl~~~Nil~~-~~~--~~liDfg~a~~ 138 (199)
T TIGR03724 114 GDLTTSNIIVR-DDK--LYLIDFGLGKY 138 (199)
T ss_pred CCCCcceEEEE-CCc--EEEEECCCCcC
Confidence 99999999997 444 88999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-15 Score=177.06 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=180.6
Q ss_pred EEeEeecccCceEEEEEee--eCCcEEEEEEeecCC-chH----HHHHHHHHHHhCC-CCCeeEEeeeccCCceeEEecc
Q 004097 348 VFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-HDV----ALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~--~~g~~VAVK~l~~~~-~~~----~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.+.+.||+|+|+.|-.+.. .....+|+|.+.... ... .-+|.. +..... |+|++++++...+.+..+++++
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~-~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETD-IQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccc-ccccccccccccccCCccCCCcccccccC
Confidence 3445699999999976543 345677888775432 111 112332 334444 9999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHh-hhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH-Hc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EI 497 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~ 497 (774)
+ ..+|++...+ +.. ..+.+...+..++.|+..++.|+| ..
T Consensus 102 ~----------s~g~~~f~~i~~~~----------------------------~~~~~~~~~~~~~~ql~s~l~~~H~~~ 143 (601)
T KOG0590|consen 102 Y----------SDGGSLFSKISHPD----------------------------STGTSSSSASRYLPQLNSGLSYLHPEN 143 (601)
T ss_pred c----------ccccccccccccCC----------------------------ccCCCCcchhhhhhhhccCccccCccc
Confidence 4 4444444432 110 013444566789999999999999 99
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcC-CCCCCchhhhhcC-CCCCcchhHhHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSGWQAPEQLLQG-RQTRAIDLFSLGCILFF 575 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDvwSlGvll~e 575 (774)
++.|||+||+|.+++..+. ..+++|||+|..+.............+| ++.|+|||...+. ......|+||.|+++.-
T Consensus 144 ~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 144 GVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred ccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 9999999999999987773 4889999999887652222233344568 9999999999885 45789999999999999
Q ss_pred HHhCCCCCCCCchHHHHHH---Hhhc---cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 576 CITGGKHPYGESFERDANI---VKDR---KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~~~---~~~~---~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+++| ..|+.......... .... .............+++.+++..+|..|.+.+++..+||+..
T Consensus 223 ~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 223 MLTG-ELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccC-CCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 9997 66776544332211 1111 12223344578899999999999999999999999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.50 E-value=8e-14 Score=162.34 Aligned_cols=132 Identities=20% Similarity=0.324 Sum_probs=97.5
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecC--Cc---------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT--HH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~--~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+...+.||+|+||+||++.. .+..+++|+.... .. ....+|. .++..++|++|+..+.++.+.+..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~-~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEY-LGRDAVIKERVPKGYRHPELDERLRTERTRAEA-RLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEee-cCccceeEEEecccccchhHHHHHHHHHHHHHH-HHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34568899999999999654 4445555543211 10 1123444 4678889999998888888878889
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+||| |+.+++|.+.+. ....++.+++.+|.|||
T Consensus 413 lv~E----------~~~g~~L~~~l~-------------------------------------~~~~~~~~i~~~L~~lH 445 (535)
T PRK09605 413 IVME----------YIGGKDLKDVLE-------------------------------------GNPELVRKVGEIVAKLH 445 (535)
T ss_pred EEEE----------ecCCCcHHHHHH-------------------------------------HHHHHHHHHHHHHHHHH
Confidence 9999 555566655432 12578999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
+.+++||||||+|||++ ++. ++|+|||+++..
T Consensus 446 ~~giiHrDlkp~NILl~-~~~--~~liDFGla~~~ 477 (535)
T PRK09605 446 KAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKYS 477 (535)
T ss_pred hCCCccCCCChHHEEEE-CCc--EEEEeCcccccC
Confidence 99999999999999993 443 889999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=137.33 Aligned_cols=132 Identities=20% Similarity=0.207 Sum_probs=86.9
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCch--HH-------------------------HHHHHHHHHhCCC--CCe
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VA-------------------------LKEIQNLIASDQH--PNI 401 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~--~~-------------------------~~Ei~~ll~~l~H--pNI 401 (774)
+.||+|+||+||++...+|+.||||++...... .. ..|...+ ..+.+ -.+
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL-KRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH-HHHHHcCCCC
Confidence 569999999999997778999999998653211 00 1122211 11111 123
Q ss_pred eEEeeeccCCceeEEeccccCCC-hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHH
Q 004097 402 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480 (774)
Q Consensus 402 V~l~g~~~~~~~~~LV~E~~~~s-L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 480 (774)
.+.+++ ...++||||+.+. +.. ..+.+.. .. ..+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~------~~l~~~~----------------------------------~~-~~~ 116 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPA------PRLKDVR----------------------------------LL-EDP 116 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccC------hhhhhhh----------------------------------hc-ccH
Confidence 344433 2458999966641 100 1111100 00 345
Q ss_pred HHHHHHHHHHHHHHHH-cCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 481 LKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
..++.+++.++.++|. .+|+||||||+||+++ ++. ++++|||.+....
T Consensus 117 ~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~--~~liDfg~a~~~~ 165 (187)
T cd05119 117 EELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK--VYIIDVPQAVEID 165 (187)
T ss_pred HHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--EEEEECccccccc
Confidence 7899999999999999 9999999999999998 544 8899999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3e-13 Score=151.27 Aligned_cols=251 Identities=25% Similarity=0.288 Sum_probs=179.2
Q ss_pred EEEeEeecc--cCceEEEEEee---eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 347 VVFNKEIAK--GSNGTVVLEGN---YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 347 ~~~~~~LG~--GsfG~Vy~a~~---~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. ......+|+......-.|+|.|+.+..+.+.+.+|+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445577999 99999999755 56889999984321 112334565544555679999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH----HHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS----GLS 492 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~----gL~ 492 (774)
-+|+|..+|..+..... .-+|...++.+..+... ||.
T Consensus 196 qtE~~~~sl~~~~~~~~---------------------------------------~~~p~~~l~~~~~~~~~~~~~al~ 236 (524)
T KOG0601|consen 196 QTELCGESLQSYCHTPC---------------------------------------NFLPDNLLWNSLRDWLSRDVTALS 236 (524)
T ss_pred eeccccchhHHhhhccc---------------------------------------ccCCchhhhhHHhhhhhccccccc
Confidence 99999977766652211 11445566677777777 999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-c-cccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-L-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
++|+.+++|-|+||.||++..+. ...+++|||+...+...... . .......|...|++||.+. ..++...|+|++|
T Consensus 237 ~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 237 HLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLG 314 (524)
T ss_pred ccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchh
Confidence 99999999999999999998884 24899999999888754311 1 1112225778899999875 4678999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 571 CILFFCITGGKHPYGESFERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
.++.+..++-.+|-......-..+... ....+....+.++...+..|++.+|-.|++++.++.|++..
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 999999887554433211110000000 11122223344666699999999999999999999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.9e-12 Score=132.59 Aligned_cols=130 Identities=18% Similarity=0.236 Sum_probs=88.5
Q ss_pred Eeec-ccCceEEEEEeeeCCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCCe--eEEeeeccCC
Q 004097 351 KEIA-KGSNGTVVLEGNYEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNI--VRWYGVESDQ 411 (774)
Q Consensus 351 ~~LG-~GsfG~Vy~a~~~~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNI--V~l~g~~~~~ 411 (774)
..|| .|+.|+||+... ++..+|||++.... .....+|+. ++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~-ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFR-LLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHH-HHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888887544 47789999884321 123445664 6677777774 6777764432
Q ss_pred -ce---eEEeccccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 412 -DF---VYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 412 -~~---~~LV~E~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
.. .++|||++++ +|.+++ .. ..++. ..+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l-----------~~------------------------------~~l~~----~~~~ 149 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALL-----------QE------------------------------APLSE----EQWQ 149 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHH-----------hc------------------------------CCCCH----HHHH
Confidence 22 2599996663 343332 11 01121 2357
Q ss_pred HHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcccc
Q 004097 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 486 qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
+|+.+|.+||+.||+||||||.|||++.++. ++|+|||.+..
T Consensus 150 ~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~ 191 (239)
T PRK01723 150 AIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCccc
Confidence 8999999999999999999999999987764 89999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-11 Score=116.60 Aligned_cols=129 Identities=18% Similarity=0.247 Sum_probs=96.5
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC--CCeeEEeeeccCCceeEEeccccCCChhh
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSLERCTCSLND 427 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~~~LV~E~~~~sL~~ 427 (774)
+.||+|.++.||++... +..++||....... ....+|+. ++..+.| .++.+++++....+..|++||++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~~~~~~~e~~-~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g---- 77 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREKGADREREVA-ILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG---- 77 (155)
T ss_pred eecccccccceEEEEec-CCeEEEEecCCCCchhHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC----
Confidence 67999999999997654 47899999866432 23445554 4455544 6899999998888899999995543
Q ss_pred HHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Q 004097 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDL 504 (774)
Q Consensus 428 ~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~ivHrDL 504 (774)
+.+... +......++.+++.+|++||.. +++|+|+
T Consensus 78 ------~~~~~~------------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl 115 (155)
T cd05120 78 ------ETLDEV------------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115 (155)
T ss_pred ------eecccC------------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCC
Confidence 332211 1123367889999999999985 6999999
Q ss_pred CCCCeeecCCCCceEEEcccCcccc
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
+|.||++++++ .++++|||.++.
T Consensus 116 ~~~Nil~~~~~--~~~l~Df~~~~~ 138 (155)
T cd05120 116 HPGNILVDDGK--ILGIIDWEYAGY 138 (155)
T ss_pred CcceEEEECCc--EEEEEecccccC
Confidence 99999998754 489999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-11 Score=127.27 Aligned_cols=203 Identities=21% Similarity=0.273 Sum_probs=135.5
Q ss_pred hCCCCCeeEEeeeccCCc-----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHH
Q 004097 395 SDQHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469 (774)
Q Consensus 395 ~l~HpNIV~l~g~~~~~~-----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 469 (774)
.+.|.|||+++.|+.+.. ...++.| ||..|++..+|......
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFite----------ymssgs~~~fLkrt~~~----------------------- 169 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITE----------YMSSGSLKQFLKRTKKN----------------------- 169 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEe----------cccchhHHHHHHHHHHh-----------------------
Confidence 346999999999987653 4678889 89999999988654321
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHHHHc--CccccccCCCCeeecCCCCceEEEcccCccccccCCCc-c-ccccccCcC
Q 004097 470 WKANGHPSAQLLKVTRDIVSGLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-C-LTQNATGYG 545 (774)
Q Consensus 470 ~~~~~l~~~~~~~i~~qia~gL~yLH~~--~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~-~~~~~~~~g 545 (774)
...+......+|+-||+.||.|||+. .|+|+++.-+-|++..++- +|+.- +.-........ . ........+
T Consensus 170 --~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~-~ap~s~h~s~~~~~~~Ek~~~~~ 244 (458)
T KOG1266|consen 170 --QKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGS-VAPDSTHPSVNSTREAEKSVNTS 244 (458)
T ss_pred --hhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecc-cCccccchhhhhhhHhhhhcccc
Confidence 12234455579999999999999998 6999999999999986653 44421 11000000000 0 001112236
Q ss_pred CCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCc--hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCC
Q 004097 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES--FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 546 t~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 623 (774)
-++|.|||.=.....+.++|||+||....||..+.-.|-... ...+..+..- .+. -..+.-+++|.+|++..|.
T Consensus 245 ~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~---i~~-len~lqr~~i~kcl~~eP~ 320 (458)
T KOG1266|consen 245 LPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV---IIG-LENGLQRGSITKCLEGEPN 320 (458)
T ss_pred CCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh---eee-ccCccccCcCcccccCCCC
Confidence 789999998776777889999999999999988744332211 1111111100 000 1112345789999999999
Q ss_pred CCcCHHHHHcCCCCCC
Q 004097 624 LRPKAQNVLNHPFFWT 639 (774)
Q Consensus 624 ~Rps~~elL~HPff~~ 639 (774)
.||+|.+++.||....
T Consensus 321 ~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 321 GRPDARLLLFHPLLFE 336 (458)
T ss_pred CCcchhhhhcCceeee
Confidence 9999999999997643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.4e-11 Score=133.48 Aligned_cols=138 Identities=24% Similarity=0.213 Sum_probs=87.0
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCchHHH-------------------------------------------H
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-------------------------------------------K 387 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~-------------------------------------------~ 387 (774)
+.||.|++|.||+|.+.+|+.||||+.+....+... +
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998643211111 1
Q ss_pred HHHH---HHHhCCCCCeeEEeeecc-CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccc
Q 004097 388 EIQN---LIASDQHPNIVRWYGVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463 (774)
Q Consensus 388 Ei~~---ll~~l~HpNIV~l~g~~~-~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~ 463 (774)
|..+ +.....|.+-|..-.++. ..+..+|||||++| +++.+......
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G----------~~L~~~~~~~~------------------- 253 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDG----------IPLSDIAALDE------------------- 253 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECC----------cccccHHHHHh-------------------
Confidence 1111 111223333333333332 23457999996654 33333221100
Q ss_pred hhhHHHHhhCCCCHHHHHHHHHHHHH-HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 464 TKDIELWKANGHPSAQLLKVTRDIVS-GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 464 ~~~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
.+. ....++.+++. .+..+|..|++|+|+||.||+++.++. ++++|||++..+.
T Consensus 254 ---------~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l~ 308 (437)
T TIGR01982 254 ---------AGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRLS 308 (437)
T ss_pred ---------cCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence 001 11346666665 478899999999999999999988776 8899999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.7e-11 Score=139.23 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=172.7
Q ss_pred EEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC--chHHHHHHH---HHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~---~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.+.+-+-+|+++.+..+... .|...+.|...... .....+.+. .+.-.-+||-+++....+.-....+|+++
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~- 884 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH- 884 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH-
Confidence 444456778888888765322 23334444332110 000111111 12222356777777766667788999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|..+++|...||... +....-.+.....+..+++|||...++
T Consensus 885 ---------~~~~~~~~Skl~~~~-----------------------------~~saepaRs~i~~~vqs~e~L~s~~r~ 926 (1205)
T KOG0606|consen 885 ---------YLNGGDLPSKLHNSG-----------------------------CLSAEPARSPILERVQSLESLHSSLRK 926 (1205)
T ss_pred ---------HhccCCchhhhhcCC-----------------------------CcccccccchhHHHHhhhhccccchhh
Confidence 777788888776543 122333456777888999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCcccccc------CC--C--------------------ccccccccCcCCCCCCch
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQ------GD--M--------------------SCLTQNATGYGSSGWQAP 552 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~------~~--~--------------------~~~~~~~~~~gt~~y~aP 552 (774)
|||++|.|+|...+++ .+++|||...... +. . ..........||+.|.+|
T Consensus 927 h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen 927 HRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred cccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence 9999999999988876 6799998433221 00 0 000112334699999999
Q ss_pred hhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhc--cccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 553 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 553 E~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
|.+.+......+|+|++|++++|.++| .+||........ ++.... ...-+....+++++++..++..+|.+|..+
T Consensus 1005 e~~lg~~hgs~ad~~~~g~~l~e~l~g-~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1005 EILLGRRHGSAADWWSSGVCLFEVLTG-IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cccccccCCCcchhhhhhhhhhhhhcC-CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 999999999999999999999999997 888876554432 222111 122334556899999999999999999888
Q ss_pred H---HHHcCCCCCCccch
Q 004097 629 Q---NVLNHPFFWTADTR 643 (774)
Q Consensus 629 ~---elL~HPff~~~~~~ 643 (774)
. ++-.||||....+.
T Consensus 1084 ~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred ccccccccCCccCCCCcc
Confidence 7 89999999776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.4e-11 Score=131.77 Aligned_cols=243 Identities=23% Similarity=0.203 Sum_probs=168.3
Q ss_pred eEEEeEeecccCceEEEEEee--eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~--~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.|.....||.|.|+.|+.... .++..+|+|.+.+.-. ...+.|+........|.++++++..|...+..|+=.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 355667899999999988643 3578999998865422 233456654455667999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.+ +++...... ...+.+...+++..|++.++.++|+..
T Consensus 346 e~~~~----------~s~~l~~~~-----------------------------~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 346 EFCEG----------GSSSLRSVT-----------------------------SQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred hhhcC----------cchhhhhHH-----------------------------HHhcCcchhhhhHHHHHhccccccchh
Confidence 97753 222221100 011344556889999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCC--chhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ--APEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
++|+|+||+||++..++ +..++.|||.+..+.-. .....+.-+++ +++......+..+.|++|||.-+.+.
T Consensus 387 ~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~ 459 (524)
T KOG0601|consen 387 FVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFS------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA 459 (524)
T ss_pred hhcccccccceeeccch-hhhhcccccccccccee------cccccccccccccchhhcccccccccccccccccccccc
Confidence 99999999999998765 44789999988753311 01112333344 55555666788999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 577 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
+++...+... .....+...... .......++..+.+.++.+++..||.+.++..|+-|
T Consensus 460 ~~~~~ls~~~--~~~~~i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 460 ITGSPLSESG--VQSLTIRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccCcccCccc--ccceeeeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 9974443322 111112222111 122223678889999999999999999999988754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-08 Score=116.10 Aligned_cols=164 Identities=20% Similarity=0.327 Sum_probs=113.4
Q ss_pred eeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhh
Q 004097 365 GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNA 442 (774)
Q Consensus 365 ~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~ 442 (774)
...++.+|.|...+.... ....++...-++.++||||++++..+...+.+|||+|.+.- |...+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P------------l~~~lk- 99 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP------------LETVLK- 99 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc------------HHHHHH-
Confidence 445778899988865544 12223333466889999999999999999999999996541 111111
Q ss_pred hhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccCCCCeeecCCCCceEEE
Q 004097 443 KEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKL 521 (774)
Q Consensus 443 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~~~~~kl 521 (774)
. +....+...+.||+.||.||| ..+++|++|.-+.|+++..|+ .||
T Consensus 100 -----------------------------~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkL 146 (690)
T KOG1243|consen 100 -----------------------------E--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKL 146 (690)
T ss_pred -----------------------------H--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEE
Confidence 1 112345678899999999998 568999999999999999987 789
Q ss_pred cccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 522 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
++|-++....+... ......---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 147 ggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 147 GGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99988765543211 001111122355665443222 457999999999999987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.6e-10 Score=127.52 Aligned_cols=37 Identities=30% Similarity=0.442 Sum_probs=30.5
Q ss_pred HHcCccccccCCCCeeecCCC--CceEEEcccCcccccc
Q 004097 495 HEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQ 531 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~~~~ 531 (774)
+..|++|+|+||.||+++.++ ...+++.|||++..+.
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 358999999999999998776 1248899999987665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.9e-09 Score=102.11 Aligned_cols=124 Identities=17% Similarity=0.089 Sum_probs=82.4
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCC-eeEEeeeccCCceeEEeccccCCChhh
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSLND 427 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~~~LV~E~~~~sL~~ 427 (774)
+.|+.|.++.||+... .+..|+||...... .....+|... +..+.+.+ +.+++++.. +..++|||+++
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~-l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~----- 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAEN-SKLAAEAGIGPKLYYFDP--ETGVLITEFIE----- 74 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHH-HHHHHHhCCCCceEEEeC--CCCeEEEEecC-----
Confidence 5689999999998654 47889999875543 1223455543 33333333 335555433 34589999554
Q ss_pred HHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc-----ccc
Q 004097 428 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHR 502 (774)
Q Consensus 428 ~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i-----vHr 502 (774)
+.++... . .....++.+++++|+.||..++ +|+
T Consensus 75 -----G~~l~~~----~---------------------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg 112 (170)
T cd05151 75 -----GSELLTE----D---------------------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHN 112 (170)
T ss_pred -----CCccccc----c---------------------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence 4333221 0 0013467799999999999885 999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccc
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
|++|.||+++ ++. ++++|||.+.
T Consensus 113 D~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 113 DLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred CCCcCcEEEE-CCe--EEEEeccccc
Confidence 9999999997 443 7899999775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >smart00580 PUG domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.8e-10 Score=89.02 Aligned_cols=53 Identities=51% Similarity=0.835 Sum_probs=49.5
Q ss_pred CCHHHHHHHHHhccccccCC--ChhHHHhhCCCCccccccccccCCccHHH-HHHH
Q 004097 702 DNVRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLIE-VYNV 754 (774)
Q Consensus 702 ~~~~dllr~ir~~~~h~~e~--~~~~~~~~g~~p~~f~~yf~~~fp~ll~~-~y~~ 754 (774)
.+++||||+|||+.+||+|+ ++.+|+.+|++|+++..||..+||.|+++ +|..
T Consensus 1 ~sv~dLLr~irNi~~hp~e~k~n~~~~~~l~~~pg~~~~l~~~gFp~l~~~~~y~l 56 (58)
T smart00580 1 ESVRDLLRALRNILHHPREEKGNPAIKERLGDVPGGFELYFTVGFPRLLISEVYTL 56 (58)
T ss_pred CcHHHHHHHHHHHhhCcchhhcCHHHHHHhcCCCcHHHHHHHcCCCcccccceeee
Confidence 36899999999999999999 99999999999999999999999999998 7653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-09 Score=122.88 Aligned_cols=164 Identities=23% Similarity=0.378 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHc-CccccccCCCCeeecCCCCceEEEcccCccccccCCCcc----cccc--ccCcCCCCCCchhhhhc
Q 004097 485 RDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQN--ATGYGSSGWQAPEQLLQ 557 (774)
Q Consensus 485 ~qia~gL~yLH~~-~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~----~~~~--~~~~gt~~y~aPE~l~~ 557 (774)
.+++.||.|+|.. ++||++|.|++|.++..+. .||+.|+++....+.... +... ....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3555999999976 8999999999999988776 899999988776653221 1100 11124567999999999
Q ss_pred CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH-----HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 558 GRQTRAIDLFSLGCILFFCITGGKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 558 ~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
...+.++|+||+||++|.+..||+.-+...... ...........+.....+|+++-+.+++..++..||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999999999999886666544322111 111111111112344568999999999999999999999999
Q ss_pred cCCCCCCccc-hhhhhhhc
Q 004097 633 NHPFFWTADT-RLSFLRDV 650 (774)
Q Consensus 633 ~HPff~~~~~-~~~~l~~~ 650 (774)
..|||.+..- .++|+.++
T Consensus 264 ~~~ff~D~~~~aLrfLD~l 282 (700)
T KOG2137|consen 264 SIPFFSDPGLKALRFLDDL 282 (700)
T ss_pred cccccCCchhhhhhhcccc
Confidence 9999976543 34555444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=103.77 Aligned_cols=223 Identities=18% Similarity=0.188 Sum_probs=148.8
Q ss_pred eEEEEE-eeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEeccccCC--ChhhHH
Q 004097 359 GTVVLE-GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLERCTC--SLNDLI 429 (774)
Q Consensus 359 G~Vy~a-~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~E~~~~--sL~~~i 429 (774)
.+.|++ ...+|..|+.||+..... ......+.++.+++.|+|||.+..++.. +.-+++||+|.++ +|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467887 677899999999932221 1112234456788899999999998873 3458999999885 577665
Q ss_pred HHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCe
Q 004097 430 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509 (774)
Q Consensus 430 y~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 509 (774)
+...-. ... . .....-...+.++..++.++.|+..||.++|+.|..-+-|.+.+|
T Consensus 370 F~~~~~-t~~------~------------------n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 370 FANPPF-TKR------T------------------NSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred ccCCcc-ccc------c------------------ccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 432111 100 0 000012234568889999999999999999999999999999999
Q ss_pred eecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchH
Q 004097 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 589 (774)
Q Consensus 510 Ll~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~ 589 (774)
|++.+ .+++|+..|..-.+..+. + |-+. .-.+-|.=.||.++..|.||...-+.....
T Consensus 425 lv~G~--~RIriS~C~i~Dvl~~d~----------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~ 482 (655)
T KOG3741|consen 425 LVTGK--MRIRISGCGIMDVLQEDP----------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST 482 (655)
T ss_pred EeeCc--ceEEEecccceeeecCCC----------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch
Confidence 99544 568898888776555331 0 0111 123568889999999999984433332222
Q ss_pred HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 590 RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
....+ .......+.+++++|.-+...++.. -++.+++.|
T Consensus 483 ~~s~~-----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 483 QSSHL-----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHH-----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11111 1112234568899999999998887 678888865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.4e-08 Score=98.36 Aligned_cols=51 Identities=22% Similarity=0.276 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHHH-HHcCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 478 AQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 478 ~~~~~i~~qia~gL~yL-H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
.+...+..+++.+|..| |..+|+|+||++.|||+.. +. +.|+|||.+....
T Consensus 124 ~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~~--v~iIDF~qav~~~ 175 (197)
T cd05146 124 EEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-GK--VWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-Cc--EEEEECCCceeCC
Confidence 44567889999999999 8999999999999999964 33 7899999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=99.93 Aligned_cols=150 Identities=25% Similarity=0.358 Sum_probs=104.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhh
Q 004097 475 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 554 (774)
Q Consensus 475 l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 554 (774)
..|+.+++.++.++.+.+-||+.|.+-+|+.++|+|+++++. +.|.|-..-.... ........+|.+.|.+||.
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~----ng~~~~cpVg~~eftPPEl 187 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINA----NGTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeecc----CCceEecccCccccCCHHH
Confidence 457889999999999999999999999999999999988876 5566533211111 1123345679999999997
Q ss_pred hh-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH-------HHHHHhh--------cc--cc----ccc-cCC
Q 004097 555 LL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-------DANIVKD--------RK--DL----FLV-EHI 607 (774)
Q Consensus 555 l~-----~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~-------~~~~~~~--------~~--~~----~~~-~~~ 607 (774)
-. +..-+...|.|.|||++++++.||++||..-... +..|... +. .. .+. -..
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence 65 2334678999999999999999999999653211 1111111 00 00 111 123
Q ss_pred HHHHHHHHHhcCCC--CCCCcCHHH
Q 004097 608 PEAVDLFTRLLDPN--PDLRPKAQN 630 (774)
Q Consensus 608 ~~~~dli~~~L~~d--P~~Rps~~e 630 (774)
+.+..|..+|+..- +.-|||++-
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHH
Confidence 68888999998753 668999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.51 E-value=4e-07 Score=92.93 Aligned_cols=76 Identities=14% Similarity=0.202 Sum_probs=51.1
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCC--CCeeEEeeeccCC---ceeEEecccc
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH--PNIVRWYGVESDQ---DFVYLSLERC 421 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~---~~~~LV~E~~ 421 (774)
+.|+.|..+.||+....+|+.++||...... .....+|.. .+..+.+ .++.+++.+..+. +..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~-~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYR-VLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHH-HHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999877667899999876432 233445554 3444443 3456677776654 3678999988
Q ss_pred CC-Chhh
Q 004097 422 TC-SLND 427 (774)
Q Consensus 422 ~~-sL~~ 427 (774)
.+ ++.+
T Consensus 83 ~G~~l~~ 89 (223)
T cd05154 83 DGRVLRD 89 (223)
T ss_pred CCEecCC
Confidence 86 3443
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.2e-07 Score=86.34 Aligned_cols=138 Identities=22% Similarity=0.284 Sum_probs=88.1
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEE-eecCCc----------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~-l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
..|-+|+-+.|++ +.+.|+...||. +.+... ....+|.. ++.++.--.|.--.-++.|...-.|+||
T Consensus 13 ~likQGAEArv~~-~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear-~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPR-GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEAR-LLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEee-eccCCceeEEeecccccccchHHHHHHHHHHHHHHHH-HHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678999999987 567788877773 333211 12234444 3333222222222223456666678899
Q ss_pred ccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 420 RCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 420 ~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
+.++ ++.+++.....+ ....+....+++.|-+.+.-||..
T Consensus 91 ~~~g~~~vk~~i~~~~~~--------------------------------------~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED--------------------------------------ESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred eccchhHHHHHHHHHccC--------------------------------------cccchhHHHHHHHHHHHHHHhhhC
Confidence 8887 666666322110 011122357888888999999999
Q ss_pred CccccccCCCCeeecCCCC-ceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKS-FCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~-~~~kl~DFGla~ 528 (774)
+|+|+||..+||+|..++. ..+.++|||++.
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999999999999976654 345899999875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=84.71 Aligned_cols=127 Identities=20% Similarity=0.303 Sum_probs=79.1
Q ss_pred eecccCceEEEEEeeeCCcEEEEEE-eecCCc----h------HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 352 EIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----D------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~~VAVK~-l~~~~~----~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.+++|+-..+|.+.. -|..+.+|. +.+... + ...+|.. ++....--.|-.-+=+..|.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Ear-il~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREAR-ILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 478999999998644 444566663 333211 1 2233443 33333222222222234567778899996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
.+| ..|.+.+... ...+++.+=.-+.-||..||+
T Consensus 81 I~G----------~~lkd~l~~~------------------------------------~~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 81 IEG----------ELLKDALEEA------------------------------------RPDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred eCC----------hhHHHHHHhc------------------------------------chHHHHHHHHHHHHHHhcCee
Confidence 665 3333332211 135666777788899999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCcccc
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
|+||.++||.+..++ +.++||||+..
T Consensus 115 HGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 115 HGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred cCCCccceEEEeCCc---EEEEECCcccc
Confidence 999999999997554 67999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.9e-06 Score=85.78 Aligned_cols=53 Identities=13% Similarity=0.219 Sum_probs=45.0
Q ss_pred CHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecC-----CCCceEEEcccCccc
Q 004097 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-----DKSFCAKLSDMGISK 528 (774)
Q Consensus 476 ~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~-----~~~~~~kl~DFGla~ 528 (774)
+......++.+++..+.-||..||+|+|+++.|||++. ++...+.++||+.+.
T Consensus 136 ~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 136 DPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 33455789999999999999999999999999999975 234568999999775
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.8e-07 Score=107.26 Aligned_cols=59 Identities=12% Similarity=-0.018 Sum_probs=29.8
Q ss_pred cccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCCCC------CCCCCCCCCCCC
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSS------QNSLLGPVDRNS 190 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~~------~~sf~GN~~lcg 190 (774)
...+|+.+.+.+|+|+|.+| .+..+ .|+.|||++|+|+|.||..... ..+|.||..+||
T Consensus 464 ~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccC
Confidence 34455555555555555555 24444 3555555555555555532211 123346666665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.19 E-value=5e-06 Score=83.19 Aligned_cols=49 Identities=22% Similarity=0.437 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHHHH-HHHcCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 480 LLKVTRDIVSGLSH-LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 480 ~~~i~~qia~gL~y-LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
...++.+++..+.. +|..||+|+||.+.|||++++ . +.|+|||.+....
T Consensus 108 ~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~~~ 157 (188)
T PF01163_consen 108 PKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCcceecC
Confidence 35677788886655 578999999999999999766 3 8899999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4e-07 Score=102.71 Aligned_cols=244 Identities=18% Similarity=0.188 Sum_probs=160.5
Q ss_pred EEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCC-eeEEeeeccCCceeEEeccccCCChh
Q 004097 348 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
.+-..+++|+++++|++.-...+...++.+... ...+=+.+|+.+.+||| .++.++-+..++..++++++|.+.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~-- 319 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG-- 319 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC--
Confidence 334568899999999865444444446655433 22222235889999999 888888888889999999976632
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
. +..... ...+. .+..-+...+++.-+++|++||+..=+|||
T Consensus 320 -----r--s~~~~~--------~~se~--------------------~~~~~~~~~~~r~et~~l~~l~~~~~~~~d--- 361 (829)
T KOG0576|consen 320 -----R--SSALEM--------TVSEI--------------------ALEQYQFAYPLRKETRPLAELHSSYKVHRD--- 361 (829)
T ss_pred -----c--cccccC--------ChhhH--------------------hhhhhhhhhhhhhhcccccccccccccCcc---
Confidence 0 100000 00000 011223456778888999999998779999
Q ss_pred CCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 004097 507 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 586 (774)
Q Consensus 507 ~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~ 586 (774)
||+.++.. .+..||+....+.... ...+..+|+.|+|||+.....+....|+|++|+--.++.-| .+|-..
T Consensus 362 -~~l~s~~~---~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~-~pPr~~ 432 (829)
T KOG0576|consen 362 -NILGSEEE---VKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG-LPPRSS 432 (829)
T ss_pred -cccccccc---cccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC-CCCCCC
Confidence 88887643 6899999887776432 34566799999999999999999999999999866666664 444433
Q ss_pred chHHHHHHHhhccc---ccc-c-cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchh
Q 004097 587 SFERDANIVKDRKD---LFL-V-EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644 (774)
Q Consensus 587 ~~~~~~~~~~~~~~---~~~-~-~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~ 644 (774)
...... .+..... +.. . +...+-.++...|+...|..|+...+++.|.+|..+..+.
T Consensus 433 P~~~~~-~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 433 PPAVLP-MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred CccccC-CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 111110 0000000 000 0 0111223577889999999999999999999998776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.1e-05 Score=78.93 Aligned_cols=53 Identities=26% Similarity=0.456 Sum_probs=45.4
Q ss_pred HHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCC-CceEEEcccCccccc
Q 004097 478 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRL 530 (774)
Q Consensus 478 ~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~ 530 (774)
.....++.+++..++-||..||+|+|+++.|||++.++ ...+.++||+.++..
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 34578999999999999999999999999999998764 456889999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00018 Score=72.80 Aligned_cols=138 Identities=12% Similarity=0.085 Sum_probs=89.3
Q ss_pred ecccCceEEEEEeeeCCcEEEEEEee---------cCCchHHHHHHHHHHHh--CCCCCeeEEeeecc--CC--ceeEEe
Q 004097 353 IAKGSNGTVVLEGNYEGRSVAVKRLV---------KTHHDVALKEIQNLIAS--DQHPNIVRWYGVES--DQ--DFVYLS 417 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~~g~~VAVK~l~---------~~~~~~~~~Ei~~ll~~--l~HpNIV~l~g~~~--~~--~~~~LV 417 (774)
-|+||-+.|+. -..+|+.+=||+-. ........+|+..+... ..=| +.+...... .. -..+||
T Consensus 26 ~~rgG~SgV~r-~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQC-VERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEE-EEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEE
Confidence 46788888887 44556678888764 11234566777643322 2222 334332221 11 236899
Q ss_pred ccccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 418 ~E~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|-+.+ +|.+++ .+ |.....+......+..+++..++-||
T Consensus 104 Te~L~g~~~L~~~l--~~------------------------------------~~~~~~~~~~k~~il~~va~~ia~LH 145 (216)
T PRK09902 104 TEDMAGFISIADWY--AQ------------------------------------HAVSPYSDEVRQAMLKAVALAFKKMH 145 (216)
T ss_pred EEeCCCCccHHHHH--hc------------------------------------CCcCCcchHHHHHHHHHHHHHHHHHH
Confidence 996663 555443 11 11112344555789999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
..|+.|+|+.+.||+++.++.+.++++||.-++..
T Consensus 146 ~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 146 SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 99999999999999998666667999999866543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=5.6e-05 Score=86.73 Aligned_cols=137 Identities=24% Similarity=0.188 Sum_probs=81.9
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc-----------------------------hHHHH--------------
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------------------------DVALK-------------- 387 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----------------------------~~~~~-------------- 387 (774)
+-|+.+|-|.||+|.+.+|+.||||+.+..-. .....
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45999999999999999999999998754210 00111
Q ss_pred HHHH---HHHhCCCCCeeEEeeecc-CCceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhccccc
Q 004097 388 EIQN---LIASDQHPNIVRWYGVES-DQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462 (774)
Q Consensus 388 Ei~~---ll~~l~HpNIV~l~g~~~-~~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~ 462 (774)
|..+ +-.......=+++=.++. -.+...|+|||++| .+.+.....
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~------------------------------ 260 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK------------------------------ 260 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH------------------------------
Confidence 1111 112222332333334443 35667899997776 233332111
Q ss_pred chhhHHHHhhCCCCHHHHHHHHHHHHH-HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 463 NTKDIELWKANGHPSAQLLKVTRDIVS-GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 463 ~~~~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
..+++. ..|+..+++ -+..+-..|+.|.|.+|.||++..++. +.+.|||+...+.
T Consensus 261 ---------~~g~d~---k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~ 316 (517)
T COG0661 261 ---------SAGIDR---KELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLD 316 (517)
T ss_pred ---------hcCCCH---HHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCc--EEEEcCcceecCC
Confidence 112221 122222222 223334479999999999999998876 6799999987665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0001 Score=76.38 Aligned_cols=132 Identities=17% Similarity=0.150 Sum_probs=84.5
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecC------------------C-------chHHHHHHHHHHHhCCC-CC
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT------------------H-------HDVALKEIQNLIASDQH-PN 400 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~------------------~-------~~~~~~Ei~~ll~~l~H-pN 400 (774)
..++..||.|--+.||.+....|.++|||.=+-. + ...+.+|.+.|...-.+ -.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4466889999999999998889999999942110 0 11345666644332222 13
Q ss_pred eeEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHH
Q 004097 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480 (774)
Q Consensus 401 IV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 480 (774)
+.+-++ .+...+|||+.++. .|... .+.....
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~----------eL~~~----------------------------------r~~~en~ 204 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGV----------ELYRL----------------------------------RLDVENP 204 (304)
T ss_pred CCCccc----cccceeeeehcccc----------eeecc----------------------------------cCcccCH
Confidence 333333 35678999965542 11110 0011122
Q ss_pred HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
-.|+..|+.-+..+-..||||+|+.+=||++++||. +.++||=.+.
T Consensus 205 ~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 205 DEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 345556666666666899999999999999999877 7899996554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00018 Score=86.90 Aligned_cols=153 Identities=22% Similarity=0.314 Sum_probs=103.3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCC---CeeecCCCCceEEEc--ccCccccccCCCccccccccCcCCC
Q 004097 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ---NVLISKDKSFCAKLS--DMGISKRLQGDMSCLTQNATGYGSS 547 (774)
Q Consensus 473 ~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~---NILl~~~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~ 547 (774)
..++....+.+..++..||+|+|+....|.-+..+ +-..+.++. ..++ ||+.++.+..... .....-+.
T Consensus 281 ~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~----~~~~~~~~ 354 (1351)
T KOG1035|consen 281 GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEK----SFSDLLAE 354 (1351)
T ss_pred cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccce--eecchhhhcccccCCCccc----chhhcCcc
Confidence 44667788899999999999999997776666555 333433433 4455 8888776653211 12223456
Q ss_pred CCCchhhhhcCCCCC--cchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCC
Q 004097 548 GWQAPEQLLQGRQTR--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 548 ~y~aPE~l~~~~~~~--~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
.|.++|......+.. ..|+|.+|.+...+..|...+-..... ... .......+..+...+|+..++++|
T Consensus 355 ~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~--~~~-------l~~~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 355 IRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP--VSL-------LDVLSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred ccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch--hhh-------hccccchhhhhhhhhhcchhhhhc
Confidence 688888887766554 479999999999999874433211000 000 111111267889999999999999
Q ss_pred cCHHHHHcCCCCCCc
Q 004097 626 PKAQNVLNHPFFWTA 640 (774)
Q Consensus 626 ps~~elL~HPff~~~ 640 (774)
+++.+++.|||....
T Consensus 426 l~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 426 LSALELLTHPFLRFP 440 (1351)
T ss_pred cchhhhhhchhcccc
Confidence 999999999997543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00048 Score=78.95 Aligned_cols=139 Identities=22% Similarity=0.192 Sum_probs=84.1
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCch----------------------------------------HHHHHHH
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----------------------------------------VALKEIQ 390 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~----------------------------------------~~~~Ei~ 390 (774)
+.||.-+.|.||+|.+.+|+.||||+-+..-.+ +..+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 569999999999999999999999986532100 0111222
Q ss_pred ---HHHHhCCCCCe---eEEeeeccC-CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhccccc
Q 004097 391 ---NLIASDQHPNI---VRWYGVESD-QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462 (774)
Q Consensus 391 ---~ll~~l~HpNI---V~l~g~~~~-~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~ 462 (774)
.......|-+. |..=.++++ .....|+||||+| .+.|+-++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----------------------------- 297 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----------------------------- 297 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----------------------------
Confidence 12233445551 222233333 3567899998876 4544433322
Q ss_pred chhhHHHHhhCCCCHHHHHHHHHHHHHHHH-HHHHcCccccccCCCCeeecCC--CCceEEEcccCcccccc
Q 004097 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLS-HLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 463 ~~~~~~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~ivHrDLkp~NILl~~~--~~~~~kl~DFGla~~~~ 531 (774)
.+++.. .|+..+.++.. -+-..|++|+|-+|.||++.++ +...+.+-|||+...+.
T Consensus 298 ----------~gi~~~---~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 298 ----------RGISPH---DILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ----------cCCCHH---HHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 222222 23333333221 1224689999999999999853 35678999999987665
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=9.8e-05 Score=87.74 Aligned_cols=60 Identities=12% Similarity=0.009 Sum_probs=47.6
Q ss_pred cccCcccCCCCCcccccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCCC
Q 004097 116 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGS 177 (774)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~ 177 (774)
+.+++++.+|.. +.-+.+|+.+.+.+|+|+|.|| .+..+ .|+.|||++|+|+|.||....
T Consensus 426 ~~n~L~g~ip~~--i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~ 487 (623)
T PLN03150 426 DNQGLRGFIPND--ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487 (623)
T ss_pred CCCCccccCCHH--HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh
Confidence 344555666665 4467889999999999999998 58888 699999999999999985443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0013 Score=68.11 Aligned_cols=70 Identities=11% Similarity=0.028 Sum_probs=45.7
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCC--CeeEEeeeccCCceeEEeccccCCC
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHP--NIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~Hp--NIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
..||+|..+.||+. .|..+++|....... ....+|.+ .+..+..- .+.+.++++.+.+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~-~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFD-ASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHH-HHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999973 355678888765332 33445554 33333221 2456677777777889999999873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0048 Score=62.89 Aligned_cols=43 Identities=28% Similarity=0.516 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 483 i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
+...++.++.-||..|+.|+|..|.|++++.++ ++++||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 445677889999999999999999999998654 7899998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0044 Score=63.91 Aligned_cols=50 Identities=24% Similarity=0.398 Sum_probs=41.6
Q ss_pred HHHHHHHHHHHHHHHHHH-cCccccccCCCCeeecCCCCceEEEcccCcccccc
Q 004097 479 QLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 531 (774)
Q Consensus 479 ~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~ 531 (774)
+...+..++++.+.-|-. .++||+||..=|||+. ++. +.|+|||.|....
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~~~ 217 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVTID 217 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccccC
Confidence 567788888999988887 7999999999999997 444 7899999876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00057 Score=85.87 Aligned_cols=72 Identities=10% Similarity=0.047 Sum_probs=46.1
Q ss_pred CcccCCCCCcccccccCcccccccCccccchhhh-hccC-CchhhhhhccceeccccCC----CCCCCCCCCCCCCCCCC
Q 004097 119 GYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLP----GSSQNSLLGPVDRNSPL 192 (774)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip~~----~~~~~sf~GN~~lcg~~ 192 (774)
.+++.+|.. +.....|+.+.+.+|+++|.+|. +..+ .|+.|||++|+|+|.||.. .+...++.||..+||+.
T Consensus 534 ~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 534 QLSGQIPAS--FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred cccccCChh--HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence 333344444 34456677777777777777763 5666 4777777777777777733 23455667888888743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0039 Score=64.99 Aligned_cols=70 Identities=13% Similarity=0.031 Sum_probs=42.8
Q ss_pred ecccCc-eEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 353 IAKGSN-GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 353 LG~Gsf-G~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
|-.|.+ ..||+... ++..+.||+..........+|...+...-.+--+.+++++..+.+.-++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 334444 67888654 34678888875542233445555332222233355777777766778999998887
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0059 Score=61.74 Aligned_cols=133 Identities=19% Similarity=0.234 Sum_probs=85.8
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCC-------------------chHHHHHHHHHH-----HhCCCCCeeEEee
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-------------------HDVALKEIQNLI-----ASDQHPNIVRWYG 406 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-------------------~~~~~~Ei~~ll-----~~l~HpNIV~l~g 406 (774)
..||+|+.=.||. ..+.....||++.... ..+..+|+.... ....+.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999995 3445568899887655 355566665322 2345889999999
Q ss_pred eccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 407 ~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
+.+.+--.-+|+|.....= =...-+|.+++ +...++. .+...
T Consensus 85 ~veT~~G~Glv~e~I~d~d----G~~s~TL~~~l------------------------------~~~~~~~----~~~~~ 126 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDAD----GNISPTLEDYL------------------------------KEGGLTE----ELRQA 126 (199)
T ss_pred EEecCCceEEEEEEEECCC----CCcCccHHHHH------------------------------HcCCccH----HHHHH
Confidence 9999988899999764200 00112233322 1122222 33444
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCC--CceEEEcc
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSD 523 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~--~~~~kl~D 523 (774)
+-.-.+||-+.+|+.+|++|.||++.... ...+.|+|
T Consensus 127 L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 127 LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 44556788899999999999999996432 32466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.007 Score=61.78 Aligned_cols=72 Identities=14% Similarity=0.131 Sum_probs=43.0
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCC-chHHHHHHH--HHHHhCCCCCeeEEeeecc---CCceeEEeccccCCC
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-HDVALKEIQ--NLIASDQHPNIVRWYGVES---DQDFVYLSLERCTCS 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-~~~~~~Ei~--~ll~~l~HpNIV~l~g~~~---~~~~~~LV~E~~~~s 424 (774)
+.|+.|..+.||+....+ ..+++|...... .....+|.. ..+..... .+.+++.++. .....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCC-CCceEEeecccccccccceEEEEEeccc
Confidence 568999999999976665 689999875541 122333433 22222211 3455555432 334578999999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.014 Score=58.79 Aligned_cols=40 Identities=33% Similarity=0.596 Sum_probs=33.0
Q ss_pred HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCcc
Q 004097 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla 527 (774)
.+-+.+|.+-|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---C----CEEEecccC
Confidence 345667888899999999999999999986 3 369999854
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0076 Score=74.26 Aligned_cols=74 Identities=12% Similarity=0.191 Sum_probs=49.0
Q ss_pred eEeecccCceEEEEEeeeCC---cEEEEEEeecCC----chHHHHHHHHHHHhC-CCCCe--eEEeeeccCC---ceeEE
Q 004097 350 NKEIAKGSNGTVVLEGNYEG---RSVAVKRLVKTH----HDVALKEIQNLIASD-QHPNI--VRWYGVESDQ---DFVYL 416 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g---~~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNI--V~l~g~~~~~---~~~~L 416 (774)
.+.|+.|.++.+|+....++ ..+++|+..... .....+|... +..+ .|++| .+.+++|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~-l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQV-LRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHH-HHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46789999999998654443 467777753321 1244566654 3444 35554 7888888775 46789
Q ss_pred eccccCCC
Q 004097 417 SLERCTCS 424 (774)
Q Consensus 417 V~E~~~~s 424 (774)
|||++++.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999874
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.02 Score=56.18 Aligned_cols=125 Identities=22% Similarity=0.319 Sum_probs=74.6
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHH-HHHHHHHHHhCCCCCee-EEeeeccCCceeEEeccccCCChh
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIV-RWYGVESDQDFVYLSLERCTCSLN 426 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~-~~Ei~~ll~~l~HpNIV-~l~g~~~~~~~~~LV~E~~~~sL~ 426 (774)
..+.||+|.+|.||++. +.|..+|+|+-+....... .+|.+ ++..+.-.++- ++|.|-.+ ++.||
T Consensus 26 v~~~L~KG~~s~Vyl~~-~~~~~~a~Kvrr~ds~r~~l~kEak-iLeil~g~~~~p~vy~yg~~----~i~me------- 92 (201)
T COG2112 26 VEKELAKGTTSVVYLGE-WRGGEVALKVRRRDSPRRNLEKEAK-ILEILAGEGVTPEVYFYGED----FIRME------- 92 (201)
T ss_pred hhhhhhcccccEEEEee-ccCceEEEEEecCCcchhhHHHHHH-HHHHhhhcCCCceEEEechh----hhhhh-------
Confidence 34679999999999954 4566899998765544433 34443 45554444443 45555332 34599
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
|..+..|.+.-... + .+-...++..---|-..||-|+.|.-
T Consensus 93 ---~i~G~~L~~~~~~~--------------------------------~----rk~l~~vlE~a~~LD~~GI~H~El~~ 133 (201)
T COG2112 93 ---YIDGRPLGKLEIGG--------------------------------D----RKHLLRVLEKAYKLDRLGIEHGELSR 133 (201)
T ss_pred ---hhcCcchhhhhhcc--------------------------------c----HHHHHHHHHHHHHHHHhccchhhhcC
Confidence 55554544431110 0 22333444554445567999999874
Q ss_pred --CCeeecCCCCceEEEcccCccc
Q 004097 507 --QNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 507 --~NILl~~~~~~~~kl~DFGla~ 528 (774)
.||++. ++. +.|+||..|+
T Consensus 134 ~~k~vlv~-~~~--~~iIDFd~At 154 (201)
T COG2112 134 PWKNVLVN-DRD--VYIIDFDSAT 154 (201)
T ss_pred CceeEEec-CCc--EEEEEccchh
Confidence 466664 333 7899999876
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.027 Score=60.86 Aligned_cols=74 Identities=18% Similarity=0.035 Sum_probs=47.5
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCC--CCeeEEeeeccC---CceeEEeccccC
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQH--PNIVRWYGVESD---QDFVYLSLERCT 422 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~---~~~~~LV~E~~~ 422 (774)
-.+.||.|..+.||.....+++ +.||..+.. .......|...+...-.+ -.+.+.+++|.+ .+..+||||+++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 3467999999999987655554 666764432 223455666543332222 356677776654 366899999988
Q ss_pred C
Q 004097 423 C 423 (774)
Q Consensus 423 ~ 423 (774)
+
T Consensus 97 G 97 (297)
T PRK10593 97 G 97 (297)
T ss_pred C
Confidence 6
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.071 Score=59.70 Aligned_cols=71 Identities=24% Similarity=0.251 Sum_probs=46.6
Q ss_pred EeecccCceEEEEEeeeCC-cEEEEEEeec------C----CchHHHHHHHHHHH--hCCCCCeeEEeeeccCCceeEEe
Q 004097 351 KEIAKGSNGTVVLEGNYEG-RSVAVKRLVK------T----HHDVALKEIQNLIA--SDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g-~~VAVK~l~~------~----~~~~~~~Ei~~ll~--~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.||.|.+..||+....+| +.|.||.-.. . ..+....|...+.. ...-.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999877776 5899997431 1 11223344433322 2233567788877 44567899
Q ss_pred ccccCC
Q 004097 418 LERCTC 423 (774)
Q Consensus 418 ~E~~~~ 423 (774)
||+++.
T Consensus 110 ME~L~~ 115 (401)
T PRK09550 110 MEDLSD 115 (401)
T ss_pred EecCCC
Confidence 999885
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.044 Score=56.64 Aligned_cols=69 Identities=17% Similarity=0.081 Sum_probs=39.7
Q ss_pred EeecccCceEEEEEeeeC--CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~--g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.|..|-...+|+....+ ++.|++|+...... ....+|...+...-.+.-..++++.+.. .++|||+++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 567888888999865553 57888997654321 1223455422222123234455554332 379999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.059 Score=58.33 Aligned_cols=30 Identities=37% Similarity=0.510 Sum_probs=24.8
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.+++|+|+.+.||+++.++ ...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 4799999999999998765 25799999653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.029 Score=56.31 Aligned_cols=54 Identities=22% Similarity=0.173 Sum_probs=46.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHc---CccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 475 HPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 475 l~~~~~~~i~~qia~gL~yLH~~---~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
.+|..+.+|+.+++..+++|+.. .+.-.|++++|+-++.++. +|++|...+...
T Consensus 56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~~~ 112 (188)
T PF12260_consen 56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVFVE 112 (188)
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcchh
Confidence 47788899999999999999983 5777999999999988766 899999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.11 Score=55.59 Aligned_cols=163 Identities=14% Similarity=0.010 Sum_probs=77.5
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCC--CeeEEeeec------cCCceeEEeccccC
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHP--NIVRWYGVE------SDQDFVYLSLERCT 422 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~Hp--NIV~l~g~~------~~~~~~~LV~E~~~ 422 (774)
+.|..|....+|+... ++..+++|+...........|+. ++..+.+. .+.+.+... ...+..++++++++
T Consensus 20 ~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~~~~~~~~e~~-~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 20 EGISAGIENTNYFVTT-DSGRYVLTLFEKVSAEELPFFLA-LLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred ecccCccccceEEEEe-CCCcEEEEEcCCCChHhccHHHH-HHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 5577888888998654 34578889876432233334443 22322211 244544421 22355689999998
Q ss_pred CC-hh---hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHh---hCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 423 CS-LN---DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK---ANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 423 ~s-L~---~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|. +. .-....-|..--.+|......... .+......-...+. ...+.. ... ..+..++.++.
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~-~~~---~~~~~~~~~l~ 166 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGE-------RNNLRGLAWIRELGKDLLPLLSA-EDR---ALLADELARQD 166 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc-------CCCcCCcHHHHHHHHHhccccCH-HHH---HHHHHHHHHHH
Confidence 73 21 112222333333344322110000 00000000000000 000111 111 12233344444
Q ss_pred H-------cCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 496 E-------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 496 ~-------~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
. .+++|+|+.|.||+++.++. +.|.||+.+.
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 3 36999999999999976542 5799998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.063 Score=55.68 Aligned_cols=29 Identities=28% Similarity=0.471 Sum_probs=23.3
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.++|+|+.+.||+++.++ ...|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 589999999999997543 25699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.009 Score=74.33 Aligned_cols=150 Identities=13% Similarity=0.032 Sum_probs=101.6
Q ss_pred HhCCCCCeeEEeeeccC--CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHh
Q 004097 394 ASDQHPNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 471 (774)
Q Consensus 394 ~~l~HpNIV~l~g~~~~--~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 471 (774)
+...|+++.+.+.-..+ ....|.+++ |...|.+.+.+...-.+...+.
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~----------~~~~g~~f~iIikg~ee~~~ld-------------------- 1333 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSL----------YVEFGKLFSIIIKGLEESPDLD-------------------- 1333 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHH----------HHHHhHHHHHHHhccccCCcch--------------------
Confidence 34579998887765443 345577777 6667777777655443332221
Q ss_pred hCCCCHHHHHHHHHHHHHHHHHHHHc-----CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCC
Q 004097 472 ANGHPSAQLLKVTRDIVSGLSHLHEI-----GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546 (774)
Q Consensus 472 ~~~l~~~~~~~i~~qia~gL~yLH~~-----~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 546 (774)
..-+....++.+.+..-+|+. -.+|++||+.|.+|..+ ..+|+.++|+.+...... .......++
T Consensus 1334 -----~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn--y~v~~gk~gLdKIknp~~---sf~Gl~l~s 1403 (2724)
T KOG1826|consen 1334 -----RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN--YNVKLGKGGLDKIKNPVL---SFFGLELCS 1403 (2724)
T ss_pred -----hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC--CcccccccccccccCchH---hhhhhhhCC
Confidence 112233344446667777755 27899999999999544 458999999998433221 122345678
Q ss_pred CCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 547 ~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
+.|++|++...-.++.++|+|..|+.+|+...| ..+|
T Consensus 1404 p~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~-n~~f 1440 (2724)
T KOG1826|consen 1404 PIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG-NAYF 1440 (2724)
T ss_pred HHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc-cHHH
Confidence 889999998888888889999999999988775 4444
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.23 Score=53.97 Aligned_cols=29 Identities=34% Similarity=0.486 Sum_probs=23.6
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
+++|+|+.|.||+++.+. ...|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 799999999999997443 24699999663
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.23 Score=53.43 Aligned_cols=29 Identities=28% Similarity=0.379 Sum_probs=24.3
Q ss_pred CccccccCCCCeeecCC----CCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKD----KSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~----~~~~~kl~DFGla~ 528 (774)
.++|+|+.+.||+++.+ +. +.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKK--LVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCC
Confidence 58999999999999864 54 7899998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.021 Score=42.80 Aligned_cols=35 Identities=14% Similarity=0.111 Sum_probs=29.3
Q ss_pred CcccccccCccccchhhh-hccCC-chhhhhhccceec
Q 004097 135 DVESHLPCHTQMTASVYR-LRDNS-LPEFLSVIGKVAG 170 (774)
Q Consensus 135 ~~~~~~~~nN~fsG~i~~-l~~l~-L~~Lnls~N~fsG 170 (774)
+|+.+.+.+|+++ .||. +..++ |+.||+++|+++-
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 6788999999999 6876 99995 9999999999884
|
... |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.077 Score=48.88 Aligned_cols=37 Identities=14% Similarity=-0.124 Sum_probs=22.5
Q ss_pred CCcccccccchhhHHHHHHHHHHHHHHHHhhhccccc
Q 004097 229 KHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVK 265 (774)
Q Consensus 229 ~~~~~~~~~i~Iv~~v~~~lvll~~i~~~~~~~~~~k 265 (774)
.+.+..+.+++|++++++++++++++++++++|+++|
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 5567777888888888777766655544444444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.11 Score=58.67 Aligned_cols=77 Identities=22% Similarity=0.208 Sum_probs=49.8
Q ss_pred CcchhHhHHHHHHHHHhCCCCCCCCchHH-HHHHH-h-----------hccccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 562 RAIDLFSLGCILFFCITGGKHPYGESFER-DANIV-K-----------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 562 ~~sDvwSlGvll~elltg~~~Pf~~~~~~-~~~~~-~-----------~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
+|+||||+|.++.|+..| ..-+.+.... ....+ + ........+.....+++..+|+-..|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~-~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLG-ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHh-hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 499999999999999887 2222211110 00000 0 00112223334567789999999999999999
Q ss_pred HHHHcCCCCCC
Q 004097 629 QNVLNHPFFWT 639 (774)
Q Consensus 629 ~elL~HPff~~ 639 (774)
.++++|+-|..
T Consensus 189 ~~~~k~~i~~e 199 (725)
T KOG1093|consen 189 MELSKRCSFTE 199 (725)
T ss_pred hHHhcCccHHH
Confidence 99999998843
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.1 Score=55.95 Aligned_cols=132 Identities=17% Similarity=0.163 Sum_probs=81.9
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeec-----------------CC--------chHHHHHHHHHHHhCCCCCe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-----------------TH--------HDVALKEIQNLIASDQHPNI 401 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~-----------------~~--------~~~~~~Ei~~ll~~l~HpNI 401 (774)
+.+++.||-|--..||.+...+|+..++|.=+- .. .-.+.+|++-|-+.-.|-.=
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 346678999999999999988999999983210 00 01234566533332222211
Q ss_pred eEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 402 V~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
|+ --.|.+..++|||+..+ -.|...-+ .....
T Consensus 174 VP---kpiD~~RH~Vvmelv~g----------~Pl~~v~~-----------------------------------v~d~~ 205 (465)
T KOG2268|consen 174 VP---KPIDHNRHCVVMELVDG----------YPLRQVRH-----------------------------------VEDPP 205 (465)
T ss_pred CC---CcccccceeeHHHhhcc----------cceeeeee-----------------------------------cCChH
Confidence 11 11345667899995553 11111000 01123
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.+...+..-+.-|..+|+||+|..-=||++.+++. ++++||=.+.
T Consensus 206 ~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 206 TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred HHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeechHhh
Confidence 45555666677788999999999999999987766 7899996543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.21 Score=52.42 Aligned_cols=28 Identities=21% Similarity=0.356 Sum_probs=23.8
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.++|+|+.|.||++++++ +.++||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 589999999999998765 5799998664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.73 E-value=1.4 Score=47.73 Aligned_cols=29 Identities=14% Similarity=0.248 Sum_probs=24.7
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
+++|+|+.+.|+|++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 7999999999999987765 6789998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.72 E-value=2 Score=48.21 Aligned_cols=71 Identities=14% Similarity=0.122 Sum_probs=45.6
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEee-----cC-----CchHHHHHHHHHHH--hCCCCCeeEEeeeccCCceeEEe
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLV-----KT-----HHDVALKEIQNLIA--SDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~-----~~-----~~~~~~~Ei~~ll~--~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.||.|....||+... ++..|.||+-. .. .......|...|.. .....++.++++++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 46789999999998654 45679999754 11 12333444433322 2223478888988874 45788
Q ss_pred ccccCC
Q 004097 418 LERCTC 423 (774)
Q Consensus 418 ~E~~~~ 423 (774)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999865
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=91.29 E-value=1.4 Score=48.67 Aligned_cols=70 Identities=24% Similarity=0.295 Sum_probs=42.2
Q ss_pred eecccCceEEEEEeeeCC-cEEEEEEeec------C----CchHHHHHHHHHHHhCC-CC-CeeEEeeeccCCceeEEec
Q 004097 352 EIAKGSNGTVVLEGNYEG-RSVAVKRLVK------T----HHDVALKEIQNLIASDQ-HP-NIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g-~~VAVK~l~~------~----~~~~~~~Ei~~ll~~l~-Hp-NIV~l~g~~~~~~~~~LV~ 418 (774)
+||.|....||+....+| +.|+||.-.. . ..+...-|...|...-. -| .+.++|.+ |.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999866544 6899996421 1 11233344443333222 23 45566654 556677999
Q ss_pred cccCC
Q 004097 419 ERCTC 423 (774)
Q Consensus 419 E~~~~ 423 (774)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98863
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.22 E-value=1.6 Score=47.82 Aligned_cols=29 Identities=34% Similarity=0.586 Sum_probs=24.3
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
+||+|+.|.||+++.+.. .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999987754 36799999653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.82 E-value=1.9 Score=47.40 Aligned_cols=135 Identities=21% Similarity=0.177 Sum_probs=82.2
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeecC------------------------Cc-----hHHHHHHHHHHHh--
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT------------------------HH-----DVALKEIQNLIAS-- 395 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~------------------------~~-----~~~~~Ei~~ll~~-- 395 (774)
..+...|..|--..||.+...+|..+|||+.+.. +. .-+.+|+.++...
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3456678999999999999999999999987421 00 1234566654332
Q ss_pred --CCCCCeeEEeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhC
Q 004097 396 --DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 473 (774)
Q Consensus 396 --l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 473 (774)
+..|--+-|. ...|||++|..+ |--... .+.-
T Consensus 226 aGIP~PePIlLk-------~hVLVM~FlGrd---------gw~aPk------------------------------LKd~ 259 (520)
T KOG2270|consen 226 AGIPCPEPILLK-------NHVLVMEFLGRD---------GWAAPK------------------------------LKDA 259 (520)
T ss_pred cCCCCCCceeee-------cceEeeeeccCC---------CCcCcc------------------------------cccc
Confidence 2222222221 246899976532 000000 1122
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HcCccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 474 GHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 474 ~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
.++...+..+-.|++.-+.-|- .+++||.||.-=|+|+.. |. +.|+|.+.+...
T Consensus 260 ~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~--lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 260 SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK--LYIIDVSQSVEH 314 (520)
T ss_pred cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE--EEEEEccccccC
Confidence 2333445555666666666554 458999999999999964 33 789998866543
|
|
| >PF14593 PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A | Back alignment and domain information |
|---|
Probab=90.70 E-value=0.00085 Score=60.10 Aligned_cols=88 Identities=20% Similarity=0.286 Sum_probs=61.7
Q ss_pred CchHHHh-HHHHhhhhhh--cccCCCCHHHHHHHHHhccccccCCChhHHHhhCCCC---------ccccccccccCC--
Q 004097 680 KWDEKME-TKFIENIGRY--RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------EGFYNYFSCRFP-- 745 (774)
Q Consensus 680 ~w~~~~~-~~~~~~~~~~--r~~~~~~~~dllr~ir~~~~h~~e~~~~~~~~~g~~p---------~~f~~yf~~~fp-- 745 (774)
.|+..++ .+.+-..+.. |+.-+...|+|+.+-.++. | +++++.+++.|++| .++..|+.+++.
T Consensus 2 ~w~~fl~~ge~Il~~g~v~K~kgl~~kkR~liLTd~PrL--~-Yvdp~~~~~KGeI~~~~~l~v~~k~~~~F~I~tp~Rt 78 (104)
T PF14593_consen 2 KWHRFLNPGELILKQGYVKKRKGLFAKKRQLILTDGPRL--F-YVDPKKMVLKGEIPWSKELSVEVKSFKTFFIHTPKRT 78 (104)
T ss_dssp TTGGGTT-T--EEEEEEEEEEETTEEEEEEEEEETTTEE--E-EEETTTTEEEEEE--STT-EEEECSSSEEEEEETTEE
T ss_pred chHHhhcCCCeEEEEEEEEEeeceEEEEEEEEEccCCEE--E-EEECCCCeECcEEecCCceEEEEccCCEEEEECCCcE
Confidence 4666666 4444444422 4445566677766655554 3 67788889999998 788999999998
Q ss_pred ccHHHHHHHHHhhhcc-chhhhcccc
Q 004097 746 KLLIEVYNVIFTYCKG-EEVFHKYVT 770 (774)
Q Consensus 746 ~ll~~~y~~~~~~~~~-~~~~~~y~~ 770 (774)
++|.++.+.+..||+. +++.+.||+
T Consensus 79 Y~l~d~~~~A~~W~~~I~~~~~~~~~ 104 (104)
T PF14593_consen 79 YYLEDPEGNAQQWVEAIEEVKKQYYK 104 (104)
T ss_dssp EEEE-TTS-HHHHHHHHHHHHHHHH-
T ss_pred EEEECCCCCHHHHHHHHHHHHHHhcC
Confidence 8999999999999998 999999985
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.78 E-value=2.1 Score=47.82 Aligned_cols=72 Identities=19% Similarity=0.043 Sum_probs=44.1
Q ss_pred eEeecccCceEEEEEeeeC-CcEEEEEEeec---C------CchHHHHHHHHH--HHhCCCCCeeEEeeeccCCceeEEe
Q 004097 350 NKEIAKGSNGTVVLEGNYE-GRSVAVKRLVK---T------HHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~---~------~~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.||.|.-..||+....+ ++.|+||.-.. . ..+...-|...| +..+.-..+.++|.+ |.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4679999999999976532 57899996421 1 112333344333 233322356667664 66677899
Q ss_pred ccccCC
Q 004097 418 LERCTC 423 (774)
Q Consensus 418 ~E~~~~ 423 (774)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998863
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=89.54 E-value=0.2 Score=47.58 Aligned_cols=14 Identities=14% Similarity=-0.330 Sum_probs=6.3
Q ss_pred cchhhHHHHHHHHH
Q 004097 237 RSYIQSFIVLFIAL 250 (774)
Q Consensus 237 ~i~Iv~~v~~~lvl 250 (774)
+|++|+++++.+++
T Consensus 51 VIGvVVGVGg~ill 64 (154)
T PF04478_consen 51 VIGVVVGVGGPILL 64 (154)
T ss_pred EEEEEecccHHHHH
Confidence 44555554443333
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=88.41 E-value=2 Score=45.78 Aligned_cols=31 Identities=35% Similarity=0.503 Sum_probs=24.6
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCcccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
.++|+|++|.||+++.++. ..-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence 4899999999999986444 256999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.19 E-value=1.3 Score=49.12 Aligned_cols=39 Identities=36% Similarity=0.476 Sum_probs=28.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HcCccccccCCCCeeec
Q 004097 474 GHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLIS 512 (774)
Q Consensus 474 ~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~ 512 (774)
..|++...+++.-.+.||--+- -.+++|.|+.|.||++.
T Consensus 340 ~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 340 SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3445555667766677765444 45899999999999994
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=87.69 E-value=0.23 Score=45.85 Aligned_cols=39 Identities=21% Similarity=0.134 Sum_probs=30.6
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHH
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 389 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei 389 (774)
+-||.||.|.||+|.+.+|+.||||+.+..-......++
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl 55 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADL 55 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHHHHHHHHH
Confidence 459999999999999999999999998765433333333
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=87.56 E-value=3.2 Score=44.55 Aligned_cols=74 Identities=18% Similarity=0.098 Sum_probs=43.3
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHH--HHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
-.+.++.|....+|+.. .+++.+-||.-..........|...+ +....--.+.+.+++....+.-||+||+.+.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678999999999854 67789999987744444455555533 2223344566778877666677999998763
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.12 E-value=5.7 Score=43.23 Aligned_cols=160 Identities=16% Similarity=0.170 Sum_probs=0.0
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEE----EeecCCchHHHHHHHHHHHhCC-CCCeeEEeeeccCCc--eeEEecccc
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQ-HPNIVRWYGVESDQD--FVYLSLERC 421 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK----~l~~~~~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~--~~~LV~E~~ 421 (774)
..+.+-.|-.-.+|+.... ++.++|. .-.........+|...+-.... ---+-+-+++|.++. ..|.||+++
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Q ss_pred CC----------Chh-hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHH---
Q 004097 422 TC----------SLN-DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI--- 487 (774)
Q Consensus 422 ~~----------sL~-~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi--- 487 (774)
.| +.. ++++..-+..-.-||.-+....... ++.+.....++..+..+.
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~------------------g~~~~~~~rql~~~~~~~~~~ 169 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDP------------------GKPNAYRGRQLARWDDEYRRA 169 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCC------------------CccCccccchhhHHHHHHHHH
Q ss_pred -----------HHHHHHHHHc--------CccccccCCCCeeecCCCCceEEEcccCcccc
Q 004097 488 -----------VSGLSHLHEI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529 (774)
Q Consensus 488 -----------a~gL~yLH~~--------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~ 529 (774)
..-..||+.. .++|+|+.+.|++++.++. +-+.||+++..
T Consensus 170 ~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l 228 (321)
T COG3173 170 KKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL 228 (321)
T ss_pred HHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEecccccc
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 774 | ||||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-84 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-84 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-83 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-83 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-68 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 |
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-155
Identities = 166/454 (36%), Positives = 253/454 (55%), Gaps = 59/454 (12%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 400
+ + LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPN 70
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++R+Y E+ F+Y++LE C +L DL+ E N +++ L E
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYNPI---- 118
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-- 518
+ R I SG++HLH + +IHRDLKPQN+L+S F
Sbjct: 119 ---------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157
Query: 519 ---------AKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQG-------RQT 561
+SD G+ K+L S N G+SGW+APE L + R T
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 562 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK------DRKDLFLVEHIPEAVDLFT 615
R+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++ + K L I EA DL +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 616 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIA-L 674
+++D +P RP A VL HP FW +L FL VSDR+E+E+R+ S LL + +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDF 337
Query: 675 VALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPE 734
V +G W K + F++N+ RYR+Y + DLLR +RNK +HF +LP+DI EL+G P+
Sbjct: 338 VIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPD 397
Query: 735 GFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
GFY+YF+ RFP LLI VY ++ +++ ++
Sbjct: 398 GFYDYFTKRFPNLLIGVYMIVKENLSDDQILREF 431
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-155
Identities = 141/449 (31%), Positives = 225/449 (50%), Gaps = 53/449 (11%)
Query: 331 TDLIDDRVDGRRIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 389
D D+ +GK+ + G+ GT+V G ++ R VAVKR++ A +E+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV 68
Query: 390 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 449
Q L SD+HPN++R++ E D+ F Y+++E C +L + +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV-------------------- 108
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
K H + + + + SGL+HLH + ++HRDLKP N+
Sbjct: 109 -------------------EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 510 LIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRA 563
LIS A +SD G+ K+L ++ + G+ GW APE L + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 564 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIPEAVDLFTRLLD 619
+D+FS GC+ ++ I+ G HP+G+S +R ANI+ L + A +L +++
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 620 PNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNG 679
+P RP A++VL HPFFW+ + +L F +DVSDR+E E D +++ LE +
Sbjct: 270 MDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKM 327
Query: 680 KWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNY 739
W E + ++ ++R YK +VRDLLR +RNK +H+RELP +++E LG+ P+ F Y
Sbjct: 328 DWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDFVCY 387
Query: 740 FSCRFPKLLIEVYNVIFTYCKGEEVFHKY 768
F+ RFP LL Y C E +F Y
Sbjct: 388 FTSRFPHLLAHTYRA-MELCSHERLFQPY 415
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 72/295 (24%), Positives = 104/295 (35%), Gaps = 57/295 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ GS G V +GR AVKR + L E+ + QHP VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ +YL E C SL S E
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE-------------------------- 156
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
AQ+ RD + L+HLH GL+H D+KP N+ + KL D
Sbjct: 157 -------------AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDF 201
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 583
G+ L + Q G + APE LLQG A D+FSLG + + P
Sbjct: 202 GLLVELGTAGAGEVQE----GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH 256
Query: 584 YGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
GE +++ + + + E + +L+P+P LR A+ +L P
Sbjct: 257 GGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 46/295 (15%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-E 408
+ I G G V + +G++ +KR VK +++ A +E+ +A H NIV + G +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREV-KALAKLDHVNIVHYNGCWD 74
Query: 409 SDQDFVYLSLERCTCSLNDLIYVL-----SGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
S + + S +++ G+ E+ + +++ L++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDK----------- 121
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
L++ I G+ ++H LI+RDLKP N+ + K K+ D
Sbjct: 122 --------------VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD 165
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G+ L+ D T + +PEQ+ + +DL++LG IL +
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLR----YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638
FE R + + L +LL P+ RP +L W
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 74/317 (23%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
++I G G+V +G A+KR K AL+E+ QH ++VR+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ ++ D + + E Y GS + ++ + + E ++
Sbjct: 77 FSAWAEDDHMLIQNE----------YCNGGSLADAISENYRIMSYFKEAELK-------- 118
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---------- 514
+ + GL ++H + L+H D+KP N+ IS+
Sbjct: 119 -----------------DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161
Query: 515 -------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAID 565
K+ D+G R+ G S + A E +LQ D
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRISSPQVEE-------GDSRFLANE-VLQENYTHLPKAD 213
Query: 566 LFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 623
+F+L + C G + G+ + I + R E +L ++ P+P+
Sbjct: 214 IFALALTV-VCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE 269
Query: 624 LRPKAQNVLNHPFFWTA 640
RP A ++ H +A
Sbjct: 270 RRPSAMALVKHSVLLSA 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 63/324 (19%), Positives = 119/324 (36%), Gaps = 43/324 (13%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 406
+ + +G G V + + + A+KR+ + ++A +++ +A +HP IVR++
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP------- 459
+ E L D S ++A ++ +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 460 -------VME--NTKDIELWKANG-----HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 505
M+ ++++ W L + I + LH GL+HRDLK
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191
Query: 506 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLL 556
P N+ + D K+ D G+ + D T + +PEQ+
Sbjct: 192 PSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 557 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDL 613
+ +D+FSLG ILF + + + ER I R F + P+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
+L P+P RP+A +++ + F
Sbjct: 306 VQDMLSPSPTERPEATDIIENAIF 329
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 54/295 (18%)
Query: 353 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 408
+ KG+ G V + +A+K + + + L +H NIV++ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 409 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
S+ F+ + +E+ SL+ L+ G ++ NE I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKD------------NEQTIGFY--------- 127
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
T+ I+ GL +LH+ ++HRD+K NVLI+ S K+SD G S
Sbjct: 128 ----------------TKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTS 170
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYG 585
KRL G C T G+ + APE + +G + +A D++SLGC + T GK P+
Sbjct: 171 KRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFY 226
Query: 586 ESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
E E A + + + E + EA + +P+PD R A ++L F
Sbjct: 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 77/305 (25%), Positives = 118/305 (38%), Gaps = 20/305 (6%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 401
I +GS G V + N A+K + K + E++ + HPNI
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
R Y V D+ ++ L +E C L D + V + + + +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ + + R I S L +LH G+ HRD+KP+N L S +KSF K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 521 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 577
L D G+SK + T G+ + APE L + D +S G +L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 578 TGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVL 632
G P G + + V ++K F + P A DL + LL+ N D R A L
Sbjct: 271 M-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 633 NHPFF 637
HP+
Sbjct: 330 QHPWI 334
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 60/308 (19%), Positives = 112/308 (36%), Gaps = 66/308 (21%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 404
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
Y E ++Y+ +E LN + S + E +
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 111
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 112 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDF 151
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 573
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 152 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 574 FFCITGGKHPYG---ESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 629
++ GK P+ + I+ ++ + + D+ L +P R
Sbjct: 211 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 630 NVLNHPFF 637
+L HP+
Sbjct: 270 ELLAHPYV 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 60/308 (19%), Positives = 114/308 (37%), Gaps = 66/308 (21%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 404
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
Y E ++Y+ +E LN + S + E +
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 130
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 131 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM---LKLIDF 170
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 573
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 171 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 574 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 629
++ GK P+ + + + I+ ++ + + D+ L +P R
Sbjct: 230 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 630 NVLNHPFF 637
+L HP+
Sbjct: 289 ELLAHPYV 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 60/293 (20%), Positives = 100/293 (34%), Gaps = 51/293 (17%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 409
+ +GS G V + + G AVK+ V+ ++E+ A P IV YG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLE-VFRVEEL-VACAGLSSPRIVPLYGAVR 120
Query: 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469
+ +V + +E + GS + + + L E R
Sbjct: 121 EGPWVNIFME----------LLEGGSLGQLI----KQMGCLPEDRAL------------- 153
Query: 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
+ GL +LH ++H D+K NVL+S D S L D G +
Sbjct: 154 ------------YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA-ALCDFGHALC 200
Query: 530 LQGDMSCLTQNATGY--GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 587
LQ D + Y G+ APE ++ +D++S C++ + G HP+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259
Query: 588 FERDA--NIVKDRKDLF-LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
F I + + + P L P R A +
Sbjct: 260 FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 67/400 (16%), Positives = 134/400 (33%), Gaps = 98/400 (24%)
Query: 259 YHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 318
+H + +T K ++ + T + +K + V
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-------- 53
Query: 319 ITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV 378
G + + ++IG G + V N + + A+K +
Sbjct: 54 ---KGRIYSI-----------LKQIGS----------GGSSKVFQVLNEKKQIYAIKYVN 89
Query: 379 KTHHD-VALKEIQNLIA-----SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 432
D L +N IA I+R Y E ++Y+ +E LN +
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KK 148
Query: 433 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492
S + E + ++++ +
Sbjct: 149 KKSIDP------------WERK---------------------------SYWKNMLEAVH 169
Query: 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552
+H+ G++H DLKP N LI KL D GI+ ++Q D + + ++ + G+ + P
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPP 225
Query: 553 EQLL-----------QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR 598
E + + + + D++SLGCIL++ GK P+ + + + I+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPN 284
Query: 599 KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
++ + + D+ L +P R +L HP+
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 62/302 (20%), Positives = 119/302 (39%), Gaps = 66/302 (21%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
++I +GS G +L + +GR +K + + + +E+ ++A+ +HPNIV++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV-AVLANMKHPNIVQY 88
Query: 405 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ +Y+ ++ C L I Q L E
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-------------NAQKGVLFQE----------- 124
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
Q+L I L H+H+ ++HRD+K QN+ ++KD + +L D
Sbjct: 125 --------------DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGD 168
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 582
GI++ L + G+ + +PE + + + D+++LGC+L+ T KH
Sbjct: 169 FGIARVLNSTVELAR---ACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCT-LKH 223
Query: 583 PY-GESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 635
+ S + I+ + + L ++L NP RP ++L
Sbjct: 224 AFEAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278
Query: 636 FF 637
F
Sbjct: 279 FI 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 58/298 (19%), Positives = 113/298 (37%), Gaps = 54/298 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVR 403
K+I +G V +G VA+K++ +KEI +L+ HPN+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIK 96
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+Y + + + + LE +G + ++ L+ E +
Sbjct: 97 YYASFIEDNELNIVLE----------LADAGDLSRMIKHFKKQKRLIPERTV-------- 138
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
K + S L H+H ++HRD+KP NV I+ KL D
Sbjct: 139 -----------------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGD 179
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
+G+ + + + G+ + +PE++ + D++SLGC+L+ + P
Sbjct: 180 LGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSP 235
Query: 584 Y-GESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+ G+ + I + +H E L ++P+P+ RP V +
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 50/322 (15%), Positives = 104/322 (32%), Gaps = 28/322 (8%)
Query: 336 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 394
+ G R + +V + + + + E G S V T + +
Sbjct: 70 ESELGER-PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 122
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
++R + ++ + DL+ ++ E+D +L+
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 455 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
+ E+ ++ L++T ++ L+ LH GL+H L+P ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAI 564
++ + L+ R S ++ G+ A L G+ T A
Sbjct: 243 VLDQRGG--VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPD 623
D ++LG +++ P DA + ++IP+ V L L +
Sbjct: 299 DTWTLGLAIYWIWC-ADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
Query: 624 LRPKAQNVLNHPFFWTADTRLS 645
R + P + T LS
Sbjct: 354 DRLLPLQAMETPEYEQLRTELS 375
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 69/326 (21%), Positives = 122/326 (37%), Gaps = 89/326 (27%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGV 407
+ +G+ G VV + R A+K++ T + L E+ L+AS H +VR+Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAA 70
Query: 408 ESDQD-------------FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
++ +++ +E C +L DLI+ + + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-------------- 116
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
+ ++ R I+ LS++H G+IHRDLKP N+ I +
Sbjct: 117 -------------------------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-----------GSSGWQAPEQLLQ-GRQT 561
++ K+ D G++K + + L ++ G++ + A E L G
Sbjct: 152 SRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 562 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----------PEAV 611
ID++SLG I F I F V K L V
Sbjct: 210 EKIDMYSLGIIFFEMIYP--------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ L+D +P+ RP A+ +LN +
Sbjct: 262 KIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/318 (19%), Positives = 118/318 (37%), Gaps = 76/318 (23%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 405
+ + +G G V + + + A+KR+ + ++ ++E++ +A +HP IVR++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYF 69
Query: 406 GVESDQD------------FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
+++ ++Y+ ++ C +L D + + + E
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------------NGRCTIEERE 116
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 512
L + I + LH GL+HRDLKP N+ +
Sbjct: 117 RS------------------------VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLLQGRQTRA 563
D K+ D G+ + D T + +PEQ+ +
Sbjct: 153 MDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 564 IDLFSLGCILF-FCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLD 619
+D+FSLG ILF +P+ ER + R F + P + +L
Sbjct: 211 VDIFSLGLILFELL-----YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265
Query: 620 PNPDLRPKAQNVLNHPFF 637
P+P RP+A N++ + F
Sbjct: 266 PSPMERPEAINIIENAVF 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-34
Identities = 48/329 (14%), Positives = 88/329 (26%), Gaps = 46/329 (13%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIA 394
+ + + + + G V L + E A+K + L E A
Sbjct: 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+ D + V S QL+ + D + N +
Sbjct: 118 RLLGESPEEARDRRRLLLPS------------DAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 455 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
+ ++ L +T ++ ++L GL+H P N+
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL 225
Query: 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDL 566
I D L D+ ++ AP + L T A++
Sbjct: 226 FIMPDGR--LMLGDVSALWKVGTRGPAS-------SVPVTYAPREFLNASTATFTHALNA 276
Query: 567 FSLGCILFFCITGGKHPYGESFERDANIVK---------DRKDLFLVEHIPEAV-DLFTR 616
+ LG ++ P+G K D +P+ V L R
Sbjct: 277 WQLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 617 LLDPNPDLRPKAQNVLNHPFFWTADTRLS 645
L+ + R + P F +S
Sbjct: 336 FLNFDRRRRLLPLEAMETPEFLQLQNEIS 364
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 66/322 (20%), Positives = 115/322 (35%), Gaps = 66/322 (20%)
Query: 338 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLI 393
+D + +F +++ +G V L EG ++G A+KR++ A +E
Sbjct: 26 IDNKH----YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH- 80
Query: 394 ASDQHPNIVRWYGVESDQDF----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 449
HPNI+R + +L L + G+ ++ + N
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLP----------FFKRGTLWNEIERLKDKGNF 130
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
L E +I L + I GL +H G HRDLKP N+
Sbjct: 131 LTEDQI-------------------------LWLLLGICRGLEAIHAKGYAHRDLKPTNI 165
Query: 510 LISKDKSFCAKLSDMGISK------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563
L+ + L D+G L A + ++APE L +
Sbjct: 166 LLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCV 222
Query: 564 I----DLFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLFLVEHI-PEAVDLFT 615
I D++SLGC+L+ + G+ PY F++ A V+++ + L
Sbjct: 223 IDERTDVWSLGCVLYAMMF-GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281
Query: 616 RLLDPNPDLRPKAQNVLNHPFF 637
++ +P RP +L+
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEA 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-33
Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 79/304 (25%)
Query: 336 DRVDGR-RIGKLVVFNKEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHDVALK----E 388
D V G+ + IA G G + L + N GR V +K LV + A E
Sbjct: 76 DIVAGQYEVKGC------IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAE 129
Query: 389 IQNLIASDQHPNIVRWY--GVESDQD---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 443
Q L A HP+IV+ + +D+ Y+ +E YV S
Sbjct: 130 RQFL-AEVVHPSIVQIFNFVEHTDRHGDPVGYIVME----------YVGGQS-------- 170
Query: 444 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503
L + + LPV A+ + +I+ LS+LH IGL++ D
Sbjct: 171 ------LKRSKGQKLPV-----------------AEAIAYLLEILPALSYLHSIGLVYND 207
Query: 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 563
LKP+N+++++++ KL D+G R + YG+ G+QAPE ++ T A
Sbjct: 208 LKPENIMLTEEQ---LKLIDLGAVSR-------INSFGYLYGTPGFQAPEI-VRTGPTVA 256
Query: 564 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNP 622
D++++G L + V + V ++ L R +DP+P
Sbjct: 257 TDIYTVGRTLAALTL-DLPTR------NGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 623 DLRP 626
R
Sbjct: 310 RQRF 313
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-32
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 60/309 (19%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 395
+ ++ K++ G+ G V+L A+K + + + L+E+ L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
D HPNI++ Y D+ YL +E L D I + F E A
Sbjct: 94 D-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAV----------- 140
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 513
+ + ++SG+++LH+ ++HRDLKP+N+L+ SK
Sbjct: 141 ----------------------------IIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
+K K+ D G+S + + G++ + APE +L+ + D++S+G IL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKER----LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 574 FFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 628
F + G P G++ + V+ K F A DL ++L + R A
Sbjct: 228 FILLA-GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286
Query: 629 QNVLNHPFF 637
Q L HP+
Sbjct: 287 QQALEHPWI 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 50/328 (15%), Positives = 105/328 (32%), Gaps = 39/328 (11%)
Query: 336 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 394
+ G R LV + + + + E G S V T + +
Sbjct: 65 ESELGERPRTLV-RGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 117
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
++R + ++ + DL+ ++ E+D +L+
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 455 IRLLPVMENTKDIELWKANGHPSAQL-----LKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
+ E+ ++ L L++T ++ L+ LH GL+H L+P ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----------QG 558
++ + L+ R + S G++ PE +
Sbjct: 238 VLDQRGG--VFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRT 288
Query: 559 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRL 617
T + D ++LG ++++ P +DA + ++IP+ V L
Sbjct: 289 LMTFSFDAWALGLVIYWIWC-ADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGF 343
Query: 618 LDPNPDLRPKAQNVLNHPFFWTADTRLS 645
L + R + P + T LS
Sbjct: 344 LRYPKEDRLLPLQAMETPEYEQLRTELS 371
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 79/343 (23%), Positives = 135/343 (39%), Gaps = 71/343 (20%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLI 393
+ + KGS G V+L + G+ AVK + K + L+E+Q L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
D HPNI++ Y D+ + YL E T L D I + F E A+
Sbjct: 82 QLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAAR--------- 130
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI- 511
+ R ++SG++++H+ ++HRDLKP+N+L+
Sbjct: 131 ------------------------------IIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
SK K ++ D G+S + + G++ + APE +L G D++S G
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDK----IGTAYYIAPE-VLHGTYDEKCDVWSTGV 215
Query: 572 ILFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 626
IL+ ++ G P G + V+ K F + A DL ++L P +R
Sbjct: 216 ILYILLS-GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 627 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 669
A++ L+H W ++ + D S + +
Sbjct: 275 SARDALDHE--W--------IQTYTKEQISVDVPSLDNAILNI 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 65/308 (21%), Positives = 110/308 (35%), Gaps = 69/308 (22%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
I GS G +G+ + K L + E+ NL+ +HPNIVR+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRY 70
Query: 405 YG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
Y ++ +Y+ +E C G + ++ L+E +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCE----------GGDLASVITKGTKERQYLDEEFV------- 113
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHRDLKPQNVLISKDKSF 517
L+V + L H +HRDLKP NV + ++
Sbjct: 114 ------------------LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN- 154
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 576
KL D G+++ L D S T G+ + +PE + D++SLGC+L+
Sbjct: 155 -VKLGDFGLARILNHDTSFAK---TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209
Query: 577 ITGGKHP-YGESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQ 629
P S + I + + IP E ++ TR+L+ RP +
Sbjct: 210 CAL-MPPFTAFSQKELAGKIREGK-----FRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 630 NVLNHPFF 637
+L +P
Sbjct: 264 EILENPLI 271
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 71/302 (23%), Positives = 114/302 (37%), Gaps = 59/302 (19%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 407
++I GS AVK + K+ D +EI+ L+ QHPNI+ V
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-TEEIEILLRYGQHPNIITLKDV 84
Query: 408 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
D +VY+ E L D I + F E+
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKI-LRQKFFSER--------------------------- 116
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDM 524
+A+ V I + +LH G++HRDLKP N+L ++ D
Sbjct: 117 ----EAS--------AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 583
G +K+L+ + L T ++ + APE L + A D++SLG +L+ +TG +
Sbjct: 165 GFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTP 219
Query: 584 -YGESFERDANI---VKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
+ I + K + A DL +++L +P R A VL HP
Sbjct: 220 FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 636 FF 637
+
Sbjct: 280 WI 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 78/342 (22%), Positives = 135/342 (39%), Gaps = 69/342 (20%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA 394
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 78 LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR---------- 125
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-S 512
+ + + SG++++H+ ++HRDLKP+N+L+ S
Sbjct: 126 -----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572
K+K K+ D G+S Q + + + G++ + APE +L+G D++S G I
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 573 LFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 627
L+ ++ G P YG++ V+ K F + +A DL ++L +P LR
Sbjct: 212 LYILLS-GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 628 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 669
A L HP W + S+ + D S + +
Sbjct: 271 ATQCLEHP--W-------IQKYSSETPTISDLPSLESAMTNI 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 75/315 (23%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 338 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK-EIQ 390
VD R + V + + KG + + A K L+K H + EI
Sbjct: 9 VDPRSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67
Query: 391 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 449
S H ++V ++G D DFV++ LE C SL +L + E
Sbjct: 68 IH-RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEP---------- 115
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
E R R IV G +LH +IHRDLK N+
Sbjct: 116 --EAR---------------------------YYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 568
+ ++ K+ D G++ +++ D G+ + APE +L + + +D++S
Sbjct: 147 FL--NEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VLSKKGHSFEVDVWS 200
Query: 569 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 622
+GCI++ + GK P FE + + + + + +HI P A L ++L +P
Sbjct: 201 IGCIMYTLLV-GKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 623 DLRPKAQNVLNHPFF 637
RP +LN FF
Sbjct: 255 TARPTINELLNDEFF 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 74/352 (21%), Positives = 141/352 (40%), Gaps = 81/352 (23%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT----------------HHDV 384
+IG+ +++ G+ G V+L + A+K + K+ H+
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 385 ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAK 443
EI L + D HPNI++ + V D+ + YL E L + I + F+E A
Sbjct: 93 IYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAAN 150
Query: 444 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503
+ + I+SG+ +LH+ ++HRD
Sbjct: 151 ---------------------------------------IMKQILSGICYLHKHNIVHRD 171
Query: 504 LKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 562
+KP+N+L+ +K+ K+ D G+S D L G++ + APE +L+ +
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL---GTAYYIAPE-VLKKKYNE 226
Query: 563 AIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRL 617
D++S G I++ + G P G++ + V+ K F +I EA +L +
Sbjct: 227 KCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 618 LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 669
L + + R A+ LN W ++ ++ + D+++ L +
Sbjct: 286 LTYDYNKRCTAEEALNSR--W--------IKKYANNINKSDQKTLCGALSNM 327
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 67/283 (23%)
Query: 369 GRSVAVK-----RLVKTHHDVALK-EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422
A K L+K H + EI S H ++V ++G D DFV++ LE C
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIH-RSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 423 C-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
SL +L + E E R
Sbjct: 125 RRSLLELH-KRRKALTEP------------EAR--------------------------- 144
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 541
R IV G +LH +IHRDLK N+ + ++ K+ D G++ +++ D
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGERKK--- 199
Query: 542 TGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK- 599
G+ + APE +L + + +D++S+GCI++ + GK P FE + + +
Sbjct: 200 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV-GKPP----FE-TSCLKETYLR 252
Query: 600 ----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ + +HI P A L ++L +P RP +LN FF
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 71/314 (22%)
Query: 345 KLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR 403
L + +K + +GS ++ AVK + K KEI L + HPNIV+
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 404 WYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ V DQ +L +E L + I F E +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASY------------------- 110
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 521
+ R +VS +SH+H++G++HRDLKP+N+L ++ + K+
Sbjct: 111 --------------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
D G ++ D L T + + APE L Q + DL+SLG IL+ ++G
Sbjct: 151 IDFGFARLKPPDNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-- 205
Query: 582 HP--YGESFERDANIVKDRKDLFLVEHI----------------PEAVDLFTRLLDPNPD 623
+ ++ + I EA DL LL +P+
Sbjct: 206 QVPFQSHD---RSLTCTSAVEIM--KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260
Query: 624 LRPKAQNVLNHPFF 637
R K + + +
Sbjct: 261 KRLKMSGLRYNEWL 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 73/305 (23%), Positives = 136/305 (44%), Gaps = 52/305 (17%)
Query: 343 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQH 398
I L +F +++ G+ G V L E G +K + K V +++I+ I S H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
PNI++ + V D +Y+ +E C G E++ + + L+E +
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCE----------GGELLERIVSAQARGKALSEGYVA-- 127
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 517
++ + +++ L++ H ++H+DLKP+N+L
Sbjct: 128 -----------------------ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
K+ D G+++ + D T A G++ + APE + + T D++S G +++F +
Sbjct: 165 PIKIIDFGLAELFKSD-EHSTNAA---GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLL 219
Query: 578 TGGKHP--YGESFERDANIVKDRKDLFLVE--HI-PEAVDLFTRLLDPNPDLRPKAQNVL 632
TG G S E ++ + VE + P+AVDL ++L +P+ RP A VL
Sbjct: 220 TG--CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277
Query: 633 NHPFF 637
+H +F
Sbjct: 278 HHEWF 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 64/310 (20%)
Query: 344 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQ 397
G+ + F+ EI +GS TV + E VA +L K+ +E + L Q
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-Q 83
Query: 398 HPNIVR----WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
HPNIVR W + + L E + SG+ + L + ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYL----KRFKVMKIK 129
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 511
+R R I+ GL LH +IHRDLK N+ I
Sbjct: 130 VLR-------------------------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
+ + K+ D+G++ + + G+ + APE + + + ++D+++ G
Sbjct: 165 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPE-MYEEKYDESVDVYAFGM 217
Query: 572 ILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPK 627
+ T ++PY E V + + PE ++ + N D R
Sbjct: 218 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
Query: 628 AQNVLNHPFF 637
+++LNH FF
Sbjct: 277 IKDLLNHAFF 286
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 62/310 (20%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 395
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 79 D-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR----------- 125
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 513
+ + + SG++++H+ ++HRDLKP+N+L+ SK
Sbjct: 126 ----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
+K K+ D G+S Q + + + G++ + APE +L+G D++S G IL
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
Query: 574 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 627
+ ++G P YG++ V+ K F + I +A DL ++L +P LR
Sbjct: 213 YILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 628 AQNVLNHPFF 637
A L HP+
Sbjct: 271 ATQCLEHPWI 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 343 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQ 397
I + I +GS G V + A K V+ +EI+ + + D
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLD- 64
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
HPNI+R Y D +YL +E CT L + + V F E A+
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAAR------------- 110
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDK 515
+ +D++S +++ H++ + HRDLKP+N L ++
Sbjct: 111 --------------------------IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
KL D G++ R + + G+ + +P+ +L+G D +S G +++
Sbjct: 145 DSPLKLIDFGLAARFKPG-KMMRTKV---GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 199
Query: 576 CITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 629
+ G +P + +++ F + ++ P+A L RLL +P R +
Sbjct: 200 LLCG--YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257
Query: 630 NVLNHPFF 637
L H +F
Sbjct: 258 QALEHEWF 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 71/315 (22%), Positives = 120/315 (38%), Gaps = 72/315 (22%)
Query: 340 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK---EIQ 390
G +I V + KGS V + G VA+K + K ++ +I
Sbjct: 7 GEKIEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 391 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 449
+ +HP+I+ Y D ++VYL LE C +N + F E
Sbjct: 66 CQL---KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---------- 112
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
E R I++G+ +LH G++HRDL N+
Sbjct: 113 --EAR---------------------------HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 510 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 568
L+ ++ K++D G++ +L+ T G+ + +PE + D++S
Sbjct: 144 LL--TRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPE-IATRSAHGLESDVWS 197
Query: 569 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 622
LGC+ + + G+ P F+ + D + + EA DL +LL NP
Sbjct: 198 LGCMFYTLLI-GRPP----FD-TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNP 251
Query: 623 DLRPKAQNVLNHPFF 637
R +VL+HPF
Sbjct: 252 ADRLSLSSVLDHPFM 266
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWY 405
+ + + +G+ G V + + + VA+K++ ++ + E++ L + HPNIV+ Y
Sbjct: 10 IEVEEVVGRGAFGVV-CKAKWRAKDVAIKQIESESERKAFIVELRQL-SRVNHPNIVKLY 67
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
G + V L +E Y GS L+ E
Sbjct: 68 GACLNP--VCLVME----------YAEGGSLYNVLHGAEPLPYY---------------- 99
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLS 522
+A + G+++LH + LIHRDLKP N+L+ + K+
Sbjct: 100 ----------TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKIC 148
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G + +Q M+ GS+ W APE + D+FS G IL+ IT +
Sbjct: 149 DFGTACDIQTHMTNNK------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRK 201
Query: 583 PYGE---SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
P+ E R V + L++++P+ + L TR +P RP
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRP 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 81/365 (22%), Positives = 137/365 (37%), Gaps = 60/365 (16%)
Query: 338 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQN 391
+ R + +E+ KG+ V G+ A +L H +E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 392 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLL 450
HPNIVR + S++ YL + T L + I V + E +
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASH------- 114
Query: 451 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 510
+ I+ + H H++G++HR+LKP+N+L
Sbjct: 115 --------------------------------CIQQILEAVLHCHQMGVVHRNLKPENLL 142
Query: 511 -ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569
SK K KL+D G++ ++G+ G+ G+ +PE L + + +DL++
Sbjct: 143 LASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 570 GCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPD 623
G IL+ + G +P + E R +K F + PEA DL ++L NP
Sbjct: 200 GVILYILLVG--YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 624 LRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 683
R A L HP+ T S + L+ + KL A+ + L N +
Sbjct: 258 KRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRK 317
Query: 684 KMETK 688
+ K
Sbjct: 318 QEIIK 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 54/290 (18%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 401
+ ++I GS GTV + G VAVK L++ +E+ + +HPNI
Sbjct: 39 LNIKEKIGAGSFGTV-HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIM-KRLRHPNI 96
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V + G + + + E Y+ GS L+ L
Sbjct: 97 VLFMGAVTQPPNLSIVTE----------YLSRGSLYRLLHKSGAREQL------------ 134
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLISKDKSFCA 519
+ L + D+ G+++LH ++HR+LK N+L+ DK +
Sbjct: 135 --------------DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTV 178
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K+ D G+S+ A G+ W APE L D++S G IL+ T
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT- 234
Query: 580 GKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+ P+G + A + K L + ++ V + P RP
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 63/316 (19%)
Query: 335 DDRVDGRR---IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EI 389
D +DG + E+ +G+ V + + A+K L KT ++ EI
Sbjct: 40 DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 390 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSN 448
L+ HPNI++ + + L LE T L D I V G + E+ A
Sbjct: 100 GVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAAD----- 152
Query: 449 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 508
+ I+ +++LHE G++HRDLKP+N
Sbjct: 153 ----------------------------------AVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 509 VL-ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567
+L + K++D G+SK ++ + G+ G+ APE L +D++
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVC---GTPGYCAPEILRGCAYGPEVDMW 234
Query: 568 SLGCILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLD 619
S+G I + + G Y E ++ I+ F+ + A DL +L+
Sbjct: 235 SVGIITYILLCG--FEPFYDERGDQFMFRRILNCEYY-FISPWWDEVSLNAKDLVRKLIV 291
Query: 620 PNPDLRPKAQNVLNHP 635
+P R L HP
Sbjct: 292 LDPKKRLTTFQALQHP 307
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 56/304 (18%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIA---SDQHPN 400
+ I KG V G+ AVK + ++ ++++ + +HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
IV S +Y+ E + DL E + + + +E
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGA--DL-------CFE-IVKRADAGFVYSEAVAS---- 133
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 519
R I+ L + H+ +IHRD+KP VL SK+ S
Sbjct: 134 ---------------------HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
KL G++ +L G+ + APE + + + +D++ G ILF ++G
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV---GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 580 GKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 633
YG I+K + HI A DL R+L +P R LN
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
Query: 634 HPFF 637
HP+
Sbjct: 287 HPWL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 54/337 (16%), Positives = 108/337 (32%), Gaps = 89/337 (26%)
Query: 348 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIV 402
+ + + +G+ V + + G A+K DV ++E + L + H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIV 70
Query: 403 RWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ + +E + L +E + GS L + L E
Sbjct: 71 KLFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL---- 115
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 518
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 ---------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSL 569
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+
Sbjct: 155 YKLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSI 209
Query: 570 GCILFFCITG------------------------GKHPYGESFERDANIVKDRKDLFLVE 605
G + TG + + + D+ +
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269
Query: 606 HIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ + +L+ + +
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 81/323 (25%)
Query: 347 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIV 402
+ + +A+G V + GR A+KRL+ + ++E+ + HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 403 RWYGV--------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
++ ++ Q L E C L + + K + L+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK------------KMESRGPLSC-- 135
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLIS 512
+LK+ + H+H +IHRDLK +N+L+S
Sbjct: 136 -----------------------DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172
Query: 513 KDKSFCAKLSDMGISKRLQG---------DMSCLTQNATGYGSSGWQAPEQL-LQGRQ-- 560
+ KL D G + + + + + T + ++ PE + L
Sbjct: 173 NQGTI--KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 561 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-------EAVDL 613
D+++LGCIL+ +HP FE D ++ + IP L
Sbjct: 231 GEKQDIWALGCILYLLCF-RQHP----FE-DGAKLRIVNGKY---SIPPHDTQYTVFHSL 281
Query: 614 FTRLLDPNPDLRPKAQNVLNHPF 636
+L NP+ R V++
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-28
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 79/336 (23%)
Query: 348 VFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIV 402
+ + G G V+ + + G VA+K L + + EIQ + HPN+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVV 75
Query: 403 RWYGVESDQ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
V D L++E Y G + LN E L E IR
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAME----------YCEGGDLRKYLNQFEN-CCGLKEGPIR 124
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 515
+ DI S L +LHE +IHRDLKP+N+++ +
Sbjct: 125 -------------------------TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 574
K+ D+G +K L C G+ + APE LL+ ++ T +D +S G + F
Sbjct: 160 RLIHKIIDLGYAKELDQGELC----TEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAF 214
Query: 575 FCITG-------------------GKHPYGESFERDANIVKDRKDLFLVEHIP-----EA 610
CITG + + ++ VK L H+ +
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274
Query: 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 646
+L + R N F D+ LS
Sbjct: 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-28
Identities = 85/378 (22%), Positives = 145/378 (38%), Gaps = 80/378 (21%)
Query: 306 NESKVG--------ETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 357
N VG ++ + F+ + D V + + + +K + G+
Sbjct: 88 NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 358 NGTVVL-EGNYEGRSVAVKRLVK-----------THHDVALKEIQNLIASDQHPNIVRWY 405
G V L + VA++ + K EI+ L + HP I++
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206
Query: 406 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+D Y+ LE L D + V + +E K
Sbjct: 207 NFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK--------------------- 242
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLSD 523
++ + +LHE G+IHRDLKP+NVL+ S+++ K++D
Sbjct: 243 -----------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGG 580
G SK + G+ S + T G+ + APE L+ RA+D +SLG ILF C++G
Sbjct: 286 FGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG- 340
Query: 581 KHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 633
+P + + + K F+ E + +A+DL +LL +P R + L
Sbjct: 341 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 634 HPFFWTADTRLSFLRDVS 651
HP+ D + F +S
Sbjct: 400 HPWLQDEDMKRKFQDLLS 417
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 43/338 (12%), Positives = 99/338 (29%), Gaps = 68/338 (20%)
Query: 349 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPN 400
+ + +G+ V + +K + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 401 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+++Y Q+ L E + +L + I K ++ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI----------NLYKNTPEKVMPQGLVI--- 175
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS------- 512
++ + +H+ +IH D+KP N ++
Sbjct: 176 ----------------------SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 513 --KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSGWQAPEQLLQGRQTRAIDLF 567
D S L D+G S DM + +SG+Q E L ID F
Sbjct: 214 DEDDLSAGLALIDLGQSI----DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 568 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627
+ ++ + G + ++ + + L ++ + F +L+
Sbjct: 270 GVAATVYCMLF-GTYMKVKNEGGECKPEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLP 325
Query: 628 AQNVLNHPFF-W---TADTRLSFLRDVSDRVELEDRES 661
+ ++L ++ LR+ + LE + S
Sbjct: 326 SLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRS 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 68/310 (21%), Positives = 115/310 (37%), Gaps = 61/310 (19%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 395
+ +E+ KG+ V G A K +L +E +
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RK 84
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
QHPNIVR + ++ F YL + T L + I V + E +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH----------- 132
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISK 513
+ I+ +++ H G++HR+LKP+N+L SK
Sbjct: 133 ----------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
K KL+D G++ + D A G+ G+ +PE L + ++ +D+++ G IL
Sbjct: 165 AKGAAVKLADFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
Query: 574 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 627
+ + G +P + E R +K + + PEA L +L NP R
Sbjct: 221 YILLVG--YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278
Query: 628 AQNVLNHPFF 637
A L P+
Sbjct: 279 ADQALKVPWI 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/301 (22%), Positives = 114/301 (37%), Gaps = 61/301 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 404
+E+ KG+ V G A K +L +E + QHPNIVR
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRL 70
Query: 405 YGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ ++ F YL + T L + I V + E +
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH-------------------- 109
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 522
+ I+ +++ H G++HR+LKP+N+L SK K KL+
Sbjct: 110 -------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G++ + D A G+ G+ +PE L + ++ +D+++ G IL+ + G +
Sbjct: 151 DFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--Y 204
Query: 583 P--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
P + E R +K + + PEA L +L NP R A L P+
Sbjct: 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264
Query: 637 F 637
Sbjct: 265 I 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 59/315 (18%), Positives = 116/315 (36%), Gaps = 79/315 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR--SVAVKRLVKTHHDVA----------LKEIQNLIA 394
+ + K+I KG G V +G VA+K L+ + +E+ + +
Sbjct: 21 IEYEKQIGKGGFGLV-HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM-S 78
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNE 452
+ HPNIV+ YG+ ++ +V G + L +
Sbjct: 79 NLNHPNIVKLYGL-------------MHNPPR-MVMEFVPCGDL----------YHRLLD 114
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVL 510
+ + L++ DI G+ ++ ++HRDL+ N+
Sbjct: 115 KAHPI------------------KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 511 IS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAI 564
+ ++ CAK++D G+S++ +S L G+ W APE + + T
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLL------GNFQWMAPE-TIGAEEESYTEKA 209
Query: 565 DLFSLGCILFFCITGGKHPYGE----SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLD 619
D +S IL+ +T G+ P+ E + I ++ + E P + ++
Sbjct: 210 DTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 620 PNPDLRPKAQNVLNH 634
+P RP ++
Sbjct: 269 GDPKKRPHFSYIVKE 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 59/299 (19%), Positives = 115/299 (38%), Gaps = 61/299 (20%)
Query: 347 VVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNI 401
++ + + KG G ++ + G + +K L++ + LKE++ ++ +HPN+
Sbjct: 12 LIHGEVLGKGCFGQA-IKVTHRETGEVMVMKELIRFDEETQRTFLKEVK-VMRCLEHPNV 69
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+++ GV + E Y+ G+ + K DS
Sbjct: 70 LKFIGVLYKDKRLNFITE----------YIKGGTLRGII--KSMDSQY------------ 105
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
P +Q + +DI SG+++LH + +IHRDL N L+ ++ +
Sbjct: 106 --------------PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVV 149
Query: 522 SDMGISKRLQGDMSCLTQNA-----------TGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570
+D G+++ + + + T G+ W APE + +D+FS G
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 571 CILFFCITGGK-HPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+L I P D V+ D + + P + + R D +P+ RP
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 77/408 (18%), Positives = 134/408 (32%), Gaps = 77/408 (18%)
Query: 258 FYHSKQVKSKKQNEEHITK---TGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETD 314
+HS V +K E + +P + +R + R+ + + E+K
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 315 GLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVA 373
+ + D + D + + I +G + V G A
Sbjct: 65 QPKGTENLYFQSM-GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 374 VKRLVKT-----------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422
VK + T + +E L HP+I+ F++L +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 423 CS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
L D + + E+ +
Sbjct: 184 KGELFDYL-TEKVALSEK-ETR-------------------------------------- 203
Query: 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 541
+ R ++ +S LH ++HRDLKP+N+L+ + +LSD G S L+ L
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI--RLSDFGFSCHLEPG-EKLR--- 257
Query: 542 TGYGSSGWQAPEQLLQGRQTR------AIDLFSLGCILFFCITGGKHP--YGESFERDAN 593
G+ G+ APE L +DL++ G ILF + G P +
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWHRRQILMLR 315
Query: 594 IVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
++ + + F DL +RLL +P+ R A+ L HPFF
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/315 (19%), Positives = 107/315 (33%), Gaps = 74/315 (23%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------------HDVALKEIQNLIAS 395
+ + +G + V + AVK + T + LKE+ L
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
HPNI++ F +L + L D + + E+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEK-ETR----------- 127
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
K+ R ++ + LH++ ++HRDLKP+N+L+ D
Sbjct: 128 ---------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 568
+ KL+D G S +L L G+ + APE + + +D++S
Sbjct: 161 MNI--KLTDFGFSCQLDPG-EKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 569 LGCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 622
G I++ + G P + ++ F DL +R L P
Sbjct: 215 TGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 623 DLRPKAQNVLNHPFF 637
R A+ L HPFF
Sbjct: 273 QKRYTAEEALAHPFF 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/296 (17%), Positives = 104/296 (35%), Gaps = 67/296 (22%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 401
+ F ++ + +G + +G ++G + VK L +E L HPN+
Sbjct: 12 LNFLTKLNENHSGEL-WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL-RIFSHPNV 69
Query: 402 VRWYGVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+ G + +L ++ GS L
Sbjct: 70 LPVLGACQSPPAPHPTLITH----------WMPYGS---------------------LYN 98
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSF 517
V+ + + +Q +K D+ G++ LH E + L ++V+I D+
Sbjct: 99 VLHEGTNFVV------DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDM 150
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----TRAIDLFSLGCIL 573
A++S D+ Q+ + W APE LQ + R+ D++S +L
Sbjct: 151 TARISM--------ADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLL 201
Query: 574 FFCITGGKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+ +T + P+ + + E + + + I V L ++ +P RP
Sbjct: 202 WELVT-REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 79/331 (23%), Positives = 125/331 (37%), Gaps = 83/331 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 401
+ + KG G V L + +A+K L K H EIQ+ + +HPNI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNI 71
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R YG D VYL LE Y G + + Q + +E R
Sbjct: 72 LRLYGYFHDATRVYLILE----------YAPLG----TVYRELQKLSKFDEQRTA----- 112
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
++ + LS+ H +IHRD+KP+N+L+ + K+
Sbjct: 113 --------------------TYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKI 150
Query: 522 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
+D G S C G+ + PE + +DL+SLG + + +
Sbjct: 151 ADFGWSVHAPSSRRTDLC--------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 579 GGKHPYGESFERDANIVKDRK----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLN 633
GK P FE + ++ + + + A DL +RLL NP RP + VL
Sbjct: 203 -GKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 634 HPFFWTADTRLSFLRDVSDRVELEDRESDSK 664
HP+ + S +++ES SK
Sbjct: 258 HPW---------ITANSSKPSNCQNKESASK 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/325 (20%), Positives = 121/325 (37%), Gaps = 93/325 (28%)
Query: 331 TDLIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHD 383
+ +I ++ R +I + G TV Y VA+K +
Sbjct: 2 SHMIGKIINERYKIVDK------LGGGGMSTV-----YLAEDTILNIKVAIKAI---FIP 47
Query: 384 VAL---------KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLS 433
+E+ N + H NIV V+ + D YL +E +L++ I
Sbjct: 48 PREKEETLKRFEREVHN-SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---- 102
Query: 434 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSGLS 492
+++G + T I+ G+
Sbjct: 103 -------------------------------------ESHGPLSVDTAINFTNQILDGIK 125
Query: 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552
H H++ ++HRD+KPQN+LI +K+ K+ D GI+K L + LTQ G+ + +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSP 181
Query: 553 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDLFL 603
EQ D++S+G +L+ + G+ P+ GE+ + V +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVPNVTTD----V 236
Query: 604 VEHIPEAVD-LFTRLLDPNPDLRPK 627
+ IP+++ + R + + R K
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYK 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 75/329 (22%), Positives = 121/329 (36%), Gaps = 74/329 (22%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 405
E+ G+ G V + G +AVK++ ++ + K I ++ S P IV+ +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
G V++++E L + G E+
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER-------------------------- 124
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 524
L K+T IV L +L E G+IHRD+KP N+L+ + KL D
Sbjct: 125 -------------ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDF 169
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITG 579
GIS RL D + G + + APE++ T+ D++SLG L T
Sbjct: 170 GISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT- 224
Query: 580 GKHPYGES---FERDANIVKD------RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 630
G+ PY FE ++++ F + L + RPK
Sbjct: 225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----SGDFQSFVKDCLTKDHRKRPKYNK 280
Query: 631 VLNHPFFWTADTR----LSFLRDVSDRVE 655
+L H F +T S+ +DV + E
Sbjct: 281 LLEHSFIKRYETLEVDVASWFKDVMAKTE 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 67/299 (22%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-------LKEIQNLIASDQHP 399
+ + I G G V + G VAVK + +E + L A +HP
Sbjct: 9 LTLEEIIGIGGFGKV-YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK-LFAMLKHP 66
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NI+ GV + + L +E + G L+ K
Sbjct: 67 NIIALRGVCLKEPNLCLVME----------FARGGPLNRVLSGKRI-------------- 102
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG---LIHRDLKPQNVLISKDKS 516
P L+ I G+++LH+ +IHRDLK N+LI +
Sbjct: 103 ----------------PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 517 F------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570
K++D G+++ T + G+ W APE + ++ D++S G
Sbjct: 147 NGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 571 CILFFCITGGKHPYGE-SFERDANIVKDRKD-LFLVEHIPEAV-DLFTRLLDPNPDLRP 626
+L+ +T G+ P+ A V K L + PE L +P+P RP
Sbjct: 202 VLLWELLT-GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 81/329 (24%), Positives = 133/329 (40%), Gaps = 76/329 (23%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK------------THHDVALKEIQNLIAS 395
+K + G+ G V L + VA+K + K +V EI+ L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-ETEIEILKKL 72
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+ HP I++ +D Y+ LE L D + V + +E K
Sbjct: 73 N-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK----------- 117
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 513
++ + +LHE G+IHRDLKP+NVL+ S+
Sbjct: 118 ---------------------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLG 570
++ K++D G SK + G+ S + T G+ + APE L+ RA+D +SLG
Sbjct: 151 EEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 571 CILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 622
ILF C++G +P + I + + F+ E + +A+DL +LL +P
Sbjct: 207 VILFICLSG--YPPFSEHRTQVSLKDQITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 623 DLRPKAQNVLNHPFFWTADTRLSFLRDVS 651
R + L HP+ D + F +S
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKFQDLLS 292
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 67/324 (20%), Positives = 112/324 (34%), Gaps = 78/324 (24%)
Query: 350 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---THHDVALKEIQNLIASDQHPNIVRWY 405
+ +G++ V + AVK + K +E++ L H N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 406 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
++D YL E+ S+ I F E +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEASV--------------------- 115
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLSD 523
V +D+ S L LH G+ HRDLKP+N+L ++ K+ D
Sbjct: 116 ------------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 524 MGISKRLQGDMSCLTQNA----TGYGSSGWQAPEQLLQGRQTR-----AIDLFSLGCILF 574
+ ++ + C + T GS+ + APE + + DL+SLG IL+
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 575 FCITG-----GKHPYGESFERDANIVKDRKDLFLVEHI----------------PEAVDL 613
++G G+ ++R + LF E I A DL
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF--ESIQEGKYEFPDKDWAHISCAAKDL 275
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
++LL + R A VL HP+
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 58/333 (17%), Positives = 110/333 (33%), Gaps = 89/333 (26%)
Query: 349 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 403
+ + +G+ V + + G A+K DV ++E + L + H NIV+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVK 71
Query: 404 WYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ +E + L +E + GS L + L E
Sbjct: 72 LFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL----- 115
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCA 519
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 --------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSLG 570
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+G
Sbjct: 156 KLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSIG 210
Query: 571 CILFFCITG----------------------GKHPYGESFERDA--NIVKDRKDLFLVEH 606
+ TG GK S + A + D+ +
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270
Query: 607 IP-----EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ + +L+ + +
Sbjct: 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 78/306 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 401
+ + KG G V L + +A+K L K+ H EIQ+ + +HPNI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL---RHPNI 76
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R Y D+ +YL LE + G +L + Q +E R
Sbjct: 77 LRMYNYFHDRKRIYLMLE----------FAPRG----ELYKELQKHGRFDEQRSA----- 117
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
++ L + HE +IHRD+KP+N+L+ K+
Sbjct: 118 --------------------TFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKI 155
Query: 522 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 577
+D G S C G+ + PE +++G+ +DL+ G + + +
Sbjct: 156 ADFGWSVHAPSLRRRTMC--------GTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 578 TGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 631
G P F+ + + + DL + + DL ++LL +P R + V
Sbjct: 207 V-GMPP----FD-SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
Query: 632 LNHPFF 637
+ HP+
Sbjct: 261 MEHPWV 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/333 (19%), Positives = 111/333 (33%), Gaps = 83/333 (24%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 398
R + + + + + KG G V G+++G +VAVK E+ N + +H
Sbjct: 4 RTVARDITLLECVGKGRYGEV-WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML-RH 61
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIR 456
NI+ + SD + S + LI Y GS + L D
Sbjct: 62 ENILGFIA--SDMTSRHSSTQLW------LITHYHEMGSLYDYLQLTTLD---------- 103
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQN 508
L++ I SGL+HLH + HRDLK +N
Sbjct: 104 -------------TV-------SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 509 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQT 561
+L+ K+ ++D+G++ + L G+ + APE Q+
Sbjct: 144 ILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 562 RAIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK------- 599
+ +D+++ G + + K P+ + SFE +V +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261
Query: 600 DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
F + L NP R A +
Sbjct: 262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 66/304 (21%)
Query: 350 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV- 407
+ + G NG V+ G+ A+K L + A +E+ + + P+IV V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVY 91
Query: 408 ---ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ + + +E L I +E+ E
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRI-------------QERGDQAFTE----------- 127
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 522
++ +A++++ DI + + LH + HRD+KP+N+L SK+K KL+
Sbjct: 128 -RE----------AAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 523 DMGISKRL-QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
D G +K Q + T + + APE L + ++ D++SLG I++ + G
Sbjct: 174 DFGFAKETTQNALQ------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-- 225
Query: 582 HP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 631
P Y + + + +K R + F + +A L LL +P R
Sbjct: 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
Query: 632 LNHP 635
+NHP
Sbjct: 286 MNHP 289
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 69/353 (19%), Positives = 131/353 (37%), Gaps = 65/353 (18%)
Query: 348 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 406
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 122
Query: 407 V----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V + + + + +E L I +++ E
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 160
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 520
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 161 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
L+D G +K S T + + APE L + ++ D++SLG I++ + G
Sbjct: 205 LTDFGFAKETTSHNSLTTP----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG- 259
Query: 581 KHP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 630
+P Y + +K R + F + E L LL P R
Sbjct: 260 -YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 318
Query: 631 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 683
+NHP W + + L++ + + ++ AL + +++
Sbjct: 319 FMNHP--WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQ 369
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 58/315 (18%), Positives = 114/315 (36%), Gaps = 56/315 (17%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQ 397
+ + + + +++ +G G V ++ K + D KEI ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIAR 59
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H NI+ + + + + E ++ E++N + LNE I
Sbjct: 60 HRNILHLHESFESMEELVMIFE----------FISGLDIFERINTSAFE---LNEREIV- 105
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ L LH + H D++P+N++ +S
Sbjct: 106 ------------------------SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
K+ + G +++L+ + + + APE + A D++SLG +++ +
Sbjct: 142 TIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 578 TGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 630
+ G +P E+ + NI+ F E I EA+D RLL R A
Sbjct: 198 S-GINPFLAET-NQQIIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 631 VLNHPFFWTADTRLS 645
L HP+ R+S
Sbjct: 255 ALQHPWLKQKIERVS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 83/315 (26%)
Query: 336 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVA---- 385
+ +G + G + + + +G G V YE R VA+K + ++
Sbjct: 26 ESREGTQFGPYRL-RRLVGRGGMGDV-----YEAEDTVRERIVALKLM---SETLSSDPV 76
Query: 386 -----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 440
+E + Q P++V + +Y+ + + +
Sbjct: 77 FRTRMQREART-AGRLQEPHVVPIHDFGEIDGQLYVDMR----------LI------NGV 119
Query: 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500
+ +L + L + + + R I S L H G
Sbjct: 120 DLAA----MLRR-QGPL------------------APPRAVAIVRQIGSALDAAHAAGAT 156
Query: 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 560
HRD+KP+N+L+S D A L D GI+ LTQ G+ + APE+ +
Sbjct: 157 HRDVKPENILVSADDF--AYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 561 TRAIDLFSLGCILFFCITGGKHPY-GES-------FERDANIVKDRKDLFLVEHIPEAVD 612
T D+++L C+L+ C+T G PY G+ + + IP A D
Sbjct: 213 TYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST-----VRPGIPVAFD 266
Query: 613 -LFTRLLDPNPDLRP 626
+ R + NP+ R
Sbjct: 267 AVIARGMAKNPEDRY 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 69/327 (21%), Positives = 118/327 (36%), Gaps = 96/327 (29%)
Query: 333 LIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHDVA 385
+ R +G++ + G V + R VAVK L D+A
Sbjct: 5 TTPSHLSDRYELGEI------LGFGGMSEV-----HLARDLRDHRDVAVKVL---RADLA 50
Query: 386 L---------KEIQNLIASDQHPNIVRWYGVESDQD----FVYLSLERCT-CSLNDLIYV 431
+E QN A+ HP IV Y + Y+ +E +L D++
Sbjct: 51 RDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-- 107
Query: 432 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSG 490
G + ++V D
Sbjct: 108 ---------------------------------------HTEGPMTPKRAIEVIADACQA 128
Query: 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 550
L+ H+ G+IHRD+KP N++IS + K+ D GI++ + + +TQ A G++ +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 551 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDL 601
+PEQ D++SLGC+L+ +T G+ P+ G+S D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 602 FLVEHIPEAVD-LFTRLLDPNPDLRPK 627
E + +D + + L NP+ R +
Sbjct: 242 -RHEGLSADLDAVVLKALAKNPENRYQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 76/327 (23%), Positives = 135/327 (41%), Gaps = 65/327 (19%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 405
EI +G+ G+V + G+ +AVKR+ T + K++ ++ S P IV++Y
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
G + ++ +E + S + K
Sbjct: 88 GALFREGDCWICMELMSTSFDKFY-----------------------------------K 112
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 524
+ + P L K+T V L+HL E +IHRD+KP N+L+ + + KL D
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDF 170
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 579
GIS +L ++ T++A G + APE++ R+ D++SLG L+ T
Sbjct: 171 GISGQLVDSIAK-TRDA---GCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELAT- 224
Query: 580 GKHPYGES---FERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
G+ PY + F++ +VK + E P ++ L + RPK + +L
Sbjct: 225 GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 633 NHPFFWTADTR----LSFLRDVSDRVE 655
HPF + R ++ + D++
Sbjct: 285 KHPFILMYEERAVEVACYVCKILDQMP 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 67/312 (21%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWY 405
E+ +G+ G V + G+ +AVKR+ T + L ++ + + P V +Y
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
G + V++ +E SL+ +V + + E+
Sbjct: 73 GALFREGDVWICMELMDTSLDKF---------------------YKQVIDKGQTIPED-- 109
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
L K+ IV L HLH ++ +IHRD+KP NVLI+ K+ D
Sbjct: 110 -------------ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDF 154
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 579
GIS L D++ +A G + APE++ ++ D++SLG +
Sbjct: 155 GISGYLVDDVAKDI-DA---GCKPYMAPERINPELNQKGYSVKS-DIWSLGITMIELAI- 208
Query: 580 GKHPYGES---FERDANIVKD-----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 631
+ PY F++ +V++ D F E VD ++ L N RP +
Sbjct: 209 LRFPYDSWGTPFQQLKQVVEEPSPQLPADKF----SAEFVDFTSQCLKKNSKERPTYPEL 264
Query: 632 LNHPFFWTADTR 643
+ HPFF +++
Sbjct: 265 MQHPFFTLHESK 276
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/326 (17%), Positives = 115/326 (35%), Gaps = 85/326 (26%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYG 406
+ A+G G V VAVK E+ +L +H NI+++ G
Sbjct: 28 LLEVKARGRFGCVWK-AQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIG 85
Query: 407 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+++ + ++ LI + GS + L +N+++
Sbjct: 86 --AEKRGTSVDVDLW------LITAFHEKGSLSDFLK-----ANVVS------------- 119
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE----------IGLIHRDLKPQNVLISKD 514
W +L + + GL++LHE + HRD+K +NVL+
Sbjct: 120 -----WN-------ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--K 165
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSL 569
+ A ++D G++ + + S + G+ + APE L Q ID++++
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 570 GCILFFCITG----------GKHPYGESFERDANI-------VKDRKDLFLVEHIP--EA 610
G +L+ + P+ E + ++ V +K L ++
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 611 VDLFTRLL----DPNPDLRPKAQNVL 632
+ + + D + + R A V
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVG 310
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/332 (18%), Positives = 106/332 (31%), Gaps = 79/332 (23%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 398
R I + +V + I KG G V G + G VAVK EI +H
Sbjct: 38 RTIARTIVLQESIGKGRFGEV-WRGKWRGEEVAVKIFSSREERSWFREAEIYQT-VMLRH 95
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
NI+ + ++ + + L + Y GS + LN
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRYTVT------------ 137
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 510
+ ++K+ SGL+HLH + HRDLK +N+L
Sbjct: 138 -----------VE-------GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 511 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQTRA 563
+ K+ ++D+G++ R + G+ + APE + +
Sbjct: 180 VKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 564 IDLFSLGCIL----FFCITGGKH-----PYGESFERDAN-------IVKDR------KDL 601
D++++G + C GG H PY + D + + + +
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297
Query: 602 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633
E + + N R A +
Sbjct: 298 QSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/336 (15%), Positives = 112/336 (33%), Gaps = 95/336 (28%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----------------------E 388
+ + +G ++L + + A+K+ K+ + +
Sbjct: 37 RTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 389 IQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 448
I I ++ + G+ ++ D VY+ E Y+ + + ++
Sbjct: 96 IITDI---KNEYCLTCEGIITNYDEVYIIYE----------YMEND----SILKFDEYFF 138
Query: 449 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQ 507
+L++ +P+ + + + +++ S++H E + HRD+KP
Sbjct: 139 VLDKNYTCFIPIQV-----------------IKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 508 NVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--- 561
N+L+ DK+ KLSD G S+ + S G+ + PE +
Sbjct: 182 NILM--DKNGRVKLSDFGESEYMVDKKIKGSR--------GTYEFMPPE-FFSNESSYNG 230
Query: 562 RAIDLFSLGCILFFCITG-------------------GKHPYGESFERDANIVKDRKDLF 602
+D++SLG L+ Y + ++K
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 603 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ E +D L NP R +++ L H +
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/360 (20%), Positives = 127/360 (35%), Gaps = 87/360 (24%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALK---EIQNL 392
+ IGK ++ + +GS G V + E AVK + ++ + EIQ L
Sbjct: 2 KLIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 393 IASDQHPNIVRWYGV---ESDQDFVYLSLERCTCSLNDLI-YVLSGSFEEQLNAKEQDSN 448
H N+++ V E Q +Y+ +E C C + +++ V F
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKRFPV---------- 108
Query: 449 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 508
+ ++ GL +LH G++H+D+KP N
Sbjct: 109 --CQAH---------------------------GYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 509 VLISKDKSFCAKLSDMGIS----KRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT 561
+L+ K+S +G++ D S GS +Q PE + G T
Sbjct: 140 LLL--TTGGTLKISALGVAEALHPFAADDTCRTSQ--------GSPAFQPPE-IANGLDT 188
Query: 562 ---RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK-----DRKDLFLVEHI-PEAVD 612
+D++S G L+ T G +P FE NI K + + P D
Sbjct: 189 FSGFKVDIWSAGVTLYNITT-GLYP----FE-GDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 672
L +L+ P R + + H +F + + +DR ++ LE +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 72/428 (16%), Positives = 129/428 (30%), Gaps = 70/428 (16%)
Query: 261 SKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 320
+K +SK ++K+ R + + N +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY- 144
Query: 321 GNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK 379
+ + D + D D ++E+ G+ G V G + A K ++
Sbjct: 145 ---PQPVEIKHDHVLDHYD---------IHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 380 TH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGS 435
H + KEIQ ++ +HP +V + D + + + E + L + +
Sbjct: 193 PHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 436 FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495
E + R + GL H+H
Sbjct: 252 MSEDEAVE---------------------------------------YMRQVCKGLCHMH 272
Query: 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 555
E +H DLKP+N++ + +S KL D G++ L G++ + APE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVA 328
Query: 556 LQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEA 610
D++S+G + + ++ G P GE+ + VK I +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALE 670
D +LL +P+ R L HP W K
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHP--WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 445
Query: 671 GIALVALN 678
L L
Sbjct: 446 PEPLPPLG 453
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 72/332 (21%), Positives = 113/332 (34%), Gaps = 81/332 (24%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKE--IQNLIASDQH 398
R I K + K+I KG G V G + G VAVK T +E I + +H
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEV-WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM-RH 90
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
NI+ + + + L T Y +GS + L + D
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITD------YHENGSLYDYLKSTTLD------------ 132
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 510
K +LK+ VSGL HLH + HRDLK +N+L
Sbjct: 133 -----------AK-------SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 511 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-------TR 562
+ K+ ++D+G++ + D + + G+ + PE +L
Sbjct: 175 VKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYI 231
Query: 563 AIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK-------D 600
D++S G C+ + + PY + S+E IV +K
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 601 LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
E + + L T NP R A V
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 70/308 (22%), Positives = 103/308 (33%), Gaps = 78/308 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNLI---ASDQ 397
+ KG GTV VA+K + + E+ L A
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 398 HPNIVRWYGVESDQDFVYLSLER-CTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
HP ++R Q+ L LER L D I G E R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGE------------GPSR- 142
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+V+ + H H G++HRD+K +N+LI +
Sbjct: 143 --------------------------CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 516 SFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLG 570
CAKL D G L + G+ + PE + Q ++SLG
Sbjct: 177 -GCAKLIDFGSGALLHDEPYTDFD--------GTRVYSPPE-WISRHQYHALPATVWSLG 226
Query: 571 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 629
+L+ + G P FERD I+ +L H+ P+ L R L P P RP +
Sbjct: 227 ILLYDMVC-GDIP----FERDQEIL--EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 630 NVLNHPFF 637
+L P+
Sbjct: 280 EILLDPWM 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 61/300 (20%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIVR 403
+E+ G+ G V GR K + V EI ++ HP ++
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEIS-IMNQLHHPKLIN 112
Query: 404 WYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ D+ + L LE + L D I + ++E +
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIA--------------AEDYKMSEAEVINY---- 154
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
R GL H+HE ++H D+KP+N++ K+ K+
Sbjct: 155 ---------------------MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G++ +L D ++ + APE + + D++++G + + ++ G
Sbjct: 194 DFGLATKLNPD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLS 248
Query: 583 P-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
P GE + + N+ + + F + + PEA D LL P R + L HP
Sbjct: 249 PFAGED-DLETLQNVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 73/347 (21%), Positives = 126/347 (36%), Gaps = 96/347 (27%)
Query: 334 IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK 387
D ++ + + EI KGS G V L N A+K +L++
Sbjct: 3 SGSSGDCVQLNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 388 EIQNLIASDQ-----------------------HPNIVRWYGV--ESDQDFVYLSLERCT 422
+ + HPN+V+ V + ++D +Y+ E
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE--- 118
Query: 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482
V G PVM ++ Q
Sbjct: 119 -------LVNQG------------------------PVM----EVP--TLKPLSEDQARF 141
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 542
+D++ G+ +LH +IHRD+KP N+L+ +D K++D G+S +G + L +
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALL---SN 196
Query: 543 GYGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGESFERDANIV--- 595
G+ + APE L + +A+D++++G L +C G+ P F D I+
Sbjct: 197 TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL-YCFVFGQCP----FM-DERIMCLH 249
Query: 596 -KDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
K + + DL TR+LD NP+ R + HP+
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 61/306 (19%), Positives = 102/306 (33%), Gaps = 76/306 (24%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNL-IASDQHP 399
+ G G+V VA+K + K + E+ L S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 400 NIVRWYGVESDQDFVYLSLERCTCS--LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
++R D L LER L D I G+ +E R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQE------------ELAR--- 152
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
++ + H H G++HRD+K +N+LI ++
Sbjct: 153 ------------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-G 187
Query: 518 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCI 572
KL D G L+ + G+ + PE ++ + R+ ++SLG +
Sbjct: 188 ELKLIDFGSGALLKDTVYTDFD--------GTRVYSPPE-WIRYHRYHGRSAAVWSLGIL 238
Query: 573 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 631
L+ + G P FE D I++ +F + + E L L P RP + +
Sbjct: 239 LYDMVC-GDIP----FEHDEEIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291
Query: 632 LNHPFF 637
NHP+
Sbjct: 292 QNHPWM 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 70/309 (22%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 401
F K + +GS TVVL R A+K L K H + ++ ++++ HP
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V+ Y D + +Y L Y +G + + + +E R
Sbjct: 93 VKLYFTFQDDEKLYFGLS----------YAKNGELLKYI----RKIGSFDETCTRFY--- 135
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+A+ IVS L +LH G+IHRDLKP+N+L+ ++ ++
Sbjct: 136 ---------------TAE-------IVSALEYLHGKGIIHRDLKPENILL--NEDMHIQI 171
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
+D G +K L + N + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 172 TDFGTAKVLSPESKQARAN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-- 228
Query: 582 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRP------KA 628
P + F+ I+K + E P+A DL +LL + R
Sbjct: 229 LPPFRAGNEYLIFQ---KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283
Query: 629 QNVLNHPFF 637
+ HPFF
Sbjct: 284 GPLKAHPFF 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 66/322 (20%)
Query: 348 VFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNI 401
+ +KE+ +G V G+ A K R + L EI L + P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 402 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ + V + + L LE + L + + +++E +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCL-------------PELAEMVSENDVI---- 134
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 519
++ + I+ G+ +LH+ ++H DLKPQN+L S
Sbjct: 135 ---------------------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K+ D G+S+++ L + G+ + APE L T A D++++G I + +T
Sbjct: 174 KIVDFGMSRKIGHA-CELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 580 GKHP--YGES----FERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 629
GE + NI + D + E + A D LL NP+ RP A+
Sbjct: 230 --TSPFVGEDNQETYL---NISQVNVD-YSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 630 NVLNHPFFWTADTRLSFLRDVS 651
L+H + D F + +
Sbjct: 284 ICLSHSWLQQWDFENLFHPEET 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 70/365 (19%), Positives = 131/365 (35%), Gaps = 73/365 (20%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 407
K + GS G V + E G+ A+K+ V +E+ ++ H NI++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK-VLQDPRYKNRELD-IMKVLDHVNIIKLVDYFY 70
Query: 408 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT--K 465
+ + + + + + + LN + + + +T K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI----MEYVPDTLHK 126
Query: 466 DIELWKANGHP---------SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
++ + +G QL + + +H +G+ HRD+KPQN+L+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLV--NSK 177
Query: 517 FCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 573
KL D G +K+L + + Y S + +APE +L + T +IDL+S+GC+
Sbjct: 178 DNTLKLCDFGSAKKLIPS-----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 574 FFCITG-----GKH--------------PYGESFERDANIVKDRK----------DLFLV 604
I G G+ P E R + + +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 664
A+DL ++L PDLR + HPFF LR+ + +
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF-------DHLRNSYESEVKNNSNFPHG 345
Query: 665 LLRAL 669
+ + +
Sbjct: 346 VNQNI 350
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 64/348 (18%), Positives = 118/348 (33%), Gaps = 68/348 (19%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 399
+E+ G V G A K + + V+ +EI+ ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 400 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
N++ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSF 517
+ I+ G+++LH + H DLKP+N+++ K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 518 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
KL D G++ ++ +G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 577 ITGGKHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 629
++G G++ + ANI D F E H A D +LL R Q
Sbjct: 212 LSG--ASPFLGDTKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 630 NVLNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 675
L HP+ + V + + + + ++L
Sbjct: 269 EALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSFSIVSLC 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/311 (19%), Positives = 110/311 (35%), Gaps = 64/311 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHPNI 401
+E+ G V G+ A K RL + V+ +EI+ + +HPNI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 402 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ + + ++ V L LE + L D + S E E
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTED------------EAT------ 111
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 518
+ + I+ G+ +LH + H DLKP+N+++ +
Sbjct: 112 ---------------------QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
KL D GI+ +++ + +G+ + APE + D++S+G I + ++
Sbjct: 151 IKLIDFGIAHKIEAG-NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
Query: 579 GGKHP--YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVL 632
G GE+ + + F E+ A D RLL +P R L
Sbjct: 207 G--ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 633 NHPFFWTADTR 643
H + R
Sbjct: 265 EHSWIKAIRRR 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 63/296 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 401
+ + I GS GTV +G + G VAVK L T E+ L +H NI
Sbjct: 26 ITVGQRIGSGSFGTV-YKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNI 82
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ + G S + + + C SL ++ FE +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMK--------------------- 120
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+L+ + R G+ +LH +IHRDLK N+ + + K
Sbjct: 121 ------------------KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVK 160
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCI 577
+ D G++ + S Q GS W APE + + D+++ G +L+ +
Sbjct: 161 IGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 578 TGGKHPYGESFERDANIV----KDRKDLFLV--EHIPEAV-DLFTRLLDPNPDLRP 626
T G+ PY RD I + P+ + L L D RP
Sbjct: 220 T-GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 77/306 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNIVRW 404
K I KG+ V L + GR VA+K + KT + +E++ + HPNIV+
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKL 79
Query: 405 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ V + +YL +E + + D + V G +E E R
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKE------------KEAR--------- 117
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
R IVS + + H+ ++HRDLK +N+L+ D K++D
Sbjct: 118 ------------------SKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIAD 157
Query: 524 MGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 577
G S C G+ + APE L QG++ +D++SLG IL+ +
Sbjct: 158 FGFSNEFTVGGKLDAFC--------GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 578 TGGKHPYGESFERDANIVKDRKDLFLVE-HIP-----EAVDLFTRLLDPNPDLRPKAQNV 631
+ G P F+ N+ + R+ + + IP + +L R L NP R + +
Sbjct: 209 S-GSLP----FD-GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
Query: 632 LNHPFF 637
+ +
Sbjct: 263 MKDRWI 268
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 78/356 (21%), Positives = 125/356 (35%), Gaps = 117/356 (32%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----WY 405
K I GS G V + G VA+K+ V +E+Q ++ H NIVR +Y
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQ-IMRKLDHCNIVRLRYFFY 117
Query: 406 GVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+D VYL+L + ++ + S + L + ++L
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKLY----- 161
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
QL + L+++H G+ HRD+KPQN+L+ D + KL D
Sbjct: 162 -------------MYQLFR-------SLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCD 200
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI--------- 572
G +K+L + Y S + +APE + T +ID++S GC+
Sbjct: 201 FGSAKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
Query: 573 LF------------FCITG----------------------GKHPYGESFERDANIVKDR 598
+F + G HP+ + F
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP----- 310
Query: 599 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRV 654
PEA+ L +RLL+ P R H FF LRD + ++
Sbjct: 311 ---------PEAIALCSRLLEYTPTARLTPLEACAHSFF-------DELRDPNVKL 350
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 62/346 (17%), Positives = 115/346 (33%), Gaps = 64/346 (18%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 399
+E+ G V G A K + + V +EI+ ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 400 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
NI+ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 517
+ I+ G+++LH + H DLKP+N++ + K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 518 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
KL D G++ ++ G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 577 ITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 631
++ G P G++ + + F E A D +LL R Q
Sbjct: 212 LS-GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 632 LNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 675
L HP+ + V + + + + + ++L
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLC 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 75/319 (23%)
Query: 337 RVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-------HDVALK- 387
+G K + G+ G V + E + V VK + K D L
Sbjct: 17 ACEGEYSQKYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 388 ---EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS---LNDLIYVLSGSFEEQLN 441
EI L + +H NI++ + +Q F L +E+ S L I +E
Sbjct: 76 VTLEIAIL-SRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFI-DRHPRLDE--- 129
Query: 442 AKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501
+ R +VS + +L +IH
Sbjct: 130 ---------PLAS---------------------------YIFRQLVSAVGYLRLKDIIH 153
Query: 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 561
RD+K +N++I + F KL D G + L+ T G+ + APE +L G
Sbjct: 154 RDIKDENIVI--AEDFTIKLIDFGSAAYLERG-KLFY---TFCGTIEYCAPE-VLMGNPY 206
Query: 562 R--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLL 618
R ++++SLG L+ + ++P F V + + E + L + LL
Sbjct: 207 RGPELEMWSLGVTLYTLVF-EENP----FCELEETV--EAAIHPPYLVSKELMSLVSGLL 259
Query: 619 DPNPDLRPKAQNVLNHPFF 637
P P+ R + ++ P+
Sbjct: 260 QPVPERRTTLEKLVTDPWV 278
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 77/339 (22%), Positives = 129/339 (38%), Gaps = 75/339 (22%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNIVRWYG 406
K + G NG V + + + VA+K++V T L+EI+ +I H NIV+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFE 75
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ LN +Y++ E L + L E RL
Sbjct: 76 ILGPSGSQLTDDVGSLTELNS-VYIVQEYMETDLANVLE-QGPLLEEHARLF-------- 125
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 525
++ QLL+ GL ++H ++HRDLKP N+ I + K+ D G
Sbjct: 126 --MY--------QLLR-------GLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFG 166
Query: 526 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 579
++ R+ + + + W ++P LL T+AID+++ GCI +TG
Sbjct: 167 LA-RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 580 -GKH--------------PYGESFERDANIVKD---------RKDL--FLVEHIPEAVDL 613
G H + E + +++ K L L EAVD
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
++L +P R A+ L+HP+ +S D
Sbjct: 286 LEQILTFSPMDRLTAEEALSHPY-------MSIYSFPMD 317
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 68/307 (22%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 399
+E+ G V G A K R + V+ ++I+ ++ QHP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 400 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
N++ + V ++ V L LE L D + S E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTE-------------------- 113
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKS 516
++ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------EEA-------------TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
K+ D G++ ++ + G+ + APE + D++S+G I +
Sbjct: 155 PRIKIIDFGLAHKIDFG-NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 577 ITGGKHP--YGESFERD--ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 628
++G G++ +++ AN+ + F E+ A D RLL +P R
Sbjct: 211 LSG--ASPFLGDT-KQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 629 QNVLNHP 635
Q+ L HP
Sbjct: 267 QDSLQHP 273
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 47/301 (15%), Positives = 98/301 (32%), Gaps = 68/301 (22%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 401
+ + I KG G V G + G VA++ + + +E+ +H N+
Sbjct: 35 LEIGELIGKGRFGQV-YHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAY-RQTRHENV 91
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
V + G + + C +L ++ +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--------------------- 130
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ ++ ++IV G+ +LH G++H+DLK +NV K
Sbjct: 131 ------------------KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK---VV 169
Query: 521 LSDMGIS--KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----------TRAIDLFS 568
++D G+ + + G APE +++ ++ D+F+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 569 LGCILFFCITGGKHPY-GESFERDANIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 625
LG I + + P+ + E + + +L + E D+ + R
Sbjct: 229 LGTIWYELHA-REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
Query: 626 P 626
P
Sbjct: 288 P 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 74/334 (22%), Positives = 140/334 (41%), Gaps = 80/334 (23%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVE 408
+++ +GS G+V + E G+ VA+K++ V++ +KEI + D P++V++YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSY 93
Query: 409 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
+++ +E C S++D+I + + + E
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED---------------------------- 125
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
++ + + + GL +LH + IHRD+K N+L++ + AKL+D G++
Sbjct: 126 -----------EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVA 172
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKH 582
+L M+ + T G+ W APE + + D++SLG IT GK
Sbjct: 173 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG------ITAIEMAEGKP 223
Query: 583 PYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQN 630
PY + + + +F++ P D + L +P+ R A
Sbjct: 224 PYAD--------IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 631 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 664
+L HPF +A +S LRD+ + +
Sbjct: 276 LLQHPFVRSAKG-VSILRDLINEAMDVKLKRQES 308
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 81/324 (25%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV--- 407
K I GS G V E VA+K+ V +E+Q ++ +HPN+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK-VLQDKRFKNRELQ-IMRIVKHPNVVDLKAFFYS 103
Query: 408 ---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ D+ F+ L LE ++ + + + + I+L
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYA-----------KLKQTMPMLLIKLY------ 146
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
QLL+ L+++H IG+ HRD+KPQN+L+ KL D
Sbjct: 147 ------------MYQLLR-------SLAYIHSIGICHRDIKPQNLLLDPPSGVL-KLIDF 186
Query: 525 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------F 574
G +K L + Y S + +APE + T ID++S GC++
Sbjct: 187 GSAKILIAG-----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 575 FCITGGKH-----------PYGESFERDANIVKDRK----------DLFLVEHIPEAVDL 613
F G P E + + K +F P+A+DL
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDL 301
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
+RLL+ P R A L HPFF
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFF 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 4e-22
Identities = 74/312 (23%), Positives = 108/312 (34%), Gaps = 91/312 (29%)
Query: 369 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422
VA+KR V+ D AL+EI L+ +H NIVR + V + L E C
Sbjct: 27 HEIVALKR-VRLDDDDEGVPSSALREI-CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482
L +G + V+ L QLLK
Sbjct: 85 QDLKKYFDSCNGDLDP------------EIVKSFLF--------------------QLLK 112
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 541
GL H ++HRDLKPQN+LI+++ KL++ G+++ + C +
Sbjct: 113 -------GLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVV 163
Query: 542 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GESFERD------ 591
T W + P+ L + + +ID++S GCI G+ P G D
Sbjct: 164 T-----LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR-PLFPGND-VDDQLKRIF 216
Query: 592 --------------------ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 627
LV +P DL LL NP R
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 628 AQNVLNHPFFWT 639
A+ L HP+F
Sbjct: 277 AEEALQHPYFSD 288
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 66/327 (20%), Positives = 124/327 (37%), Gaps = 84/327 (25%)
Query: 369 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423
GR VA+K+ +++ D +A++EI L+ +H N+V V + YL E
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483
++ D + E N L+ ++ L+ Q++
Sbjct: 109 TILDDL--------------ELFPNGLDYQVVQKY----------LF--------QIIN- 135
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 543
G+ H +IHRD+KP+N+L+S+ KL D G ++ L
Sbjct: 136 ------GIGFCHSHNIIHRDIKPENILVSQSGVV--KLCDFGFARTLAAPGEVYDD---- 183
Query: 544 YGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------LF---------FCI------ 577
++ W +APE L+ + +A+D++++GC+ LF + I
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
Query: 578 -TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQN 630
+ + ++ L P +DL + L +PD RP
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 631 VLNHPFFWTADTRLSFLRDVSDRVELE 657
+L+H FF F +++ +V+ +
Sbjct: 304 LLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 70/350 (20%), Positives = 122/350 (34%), Gaps = 88/350 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHHDVALKEIQNLI---ASDQHPNIVRW 404
+EI GS G V + VA+K+ + ++I + +HPN +++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G + +L +E C S +DL+ V +E
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------- 154
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 155 --------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDF 198
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLGCILFFCITG-- 579
G + S + + G+ W APE +L + + +D++SLG IT
Sbjct: 199 GSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG------ITCIE 245
Query: 580 ---GKHPYGESFERDANIVKDRKDLFLV-----------EHIPEAVDLFTRLLDPNPDLR 625
K P + L+ + + L P R
Sbjct: 246 LAERKPPLFN--------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 626 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 675
P ++ +L H F + + D+ R + RE D+ R ++ I
Sbjct: 298 PTSEVLLKHRFVLRE-RPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 74/389 (19%), Positives = 133/389 (34%), Gaps = 76/389 (19%)
Query: 272 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 331
H + + + + N +S N + + L
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 332 D----LIDDRVDGRRIGKL-----VVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RL 377
D R+ + G + V + + G G V E G +A K R
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 378 VKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLS 433
+K +V EI L H N+++ Y ++ + L +E L D I S
Sbjct: 127 MKDKEEV-KNEISVMNQL----DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 434 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493
+ E D + + I G+ H
Sbjct: 182 YNLTE--------------------------LDT-------------ILFMKQICEGIRH 202
Query: 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 553
+H++ ++H DLKP+N+L + K+ D G+++R + + +G+ + APE
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGTPEFLAPE 258
Query: 554 QLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI 607
+ + D++S+G I + ++ G P G++ + + NI+ R D E I
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDN-DAETLNNILACRWD-LEDEEFQDI 315
Query: 608 -PEAVDLFTRLLDPNPDLRPKAQNVLNHP 635
EA + ++LL R A L HP
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHP 344
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 61/306 (19%), Positives = 106/306 (34%), Gaps = 86/306 (28%)
Query: 348 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 406
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 78
Query: 407 V----ESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V + + + + +E L I +++ E
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 116
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 520
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 117 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF--CIT 578
L+D G A E + ++ D++SLG I++ C
Sbjct: 161 LTDFGF------------------------AKE-TTGEKYDKSCDMWSLGVIMYILLC-- 193
Query: 579 GGKHP-YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 629
G P Y + +K R + F + E L LL P R
Sbjct: 194 -GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
Query: 630 NVLNHP 635
+NHP
Sbjct: 253 EFMNHP 258
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 72/330 (21%), Positives = 128/330 (38%), Gaps = 92/330 (27%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 406
I +G+ G V N G + A+K+ ++ + ++EI +++ +H NIV+ Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREI-SILKELKHSNIVKLYD 67
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V + + L E L L+ V G E + LL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES------------VTAKSFLL-------- 107
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
QLL G+++ H+ ++HRDLKPQN+LI+++ K++D G+
Sbjct: 108 ------------QLLN-------GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGL 146
Query: 527 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 583
++ + T T W +AP+ L+ ++ + ID++S+GCI + G P
Sbjct: 147 ARAFGIPVRKYTHEIVT-----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG--TP 199
Query: 584 Y--GESFERD--ANIVK-----------------DRKDLF-------LVEHIP----EAV 611
G S E D I + F + +
Sbjct: 200 LFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
DL +++L +P+ R A+ L H +F +
Sbjct: 259 DLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 78/342 (22%), Positives = 128/342 (37%), Gaps = 96/342 (28%)
Query: 351 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVALKEIQNLI---ASDQHPNI 401
++I KGS G V ++G VA+K + + +++IQ I + P +
Sbjct: 28 EKIGKGSFGEV-----FKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++YG +++ +E S DL+ + L+E +I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----------------EPGPLDETQIAT--- 123
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ R+I+ GL +LH IHRD+K NVL+S+ K
Sbjct: 124 ----------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VK 159
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG- 579
L+D G++ +L + T G+ W APE + Q D++SLG IT
Sbjct: 160 LADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG------ITAI 210
Query: 580 ----GKHPYGESFERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 622
G+ P+ E + K LFL IP + L+ P
Sbjct: 211 ELARGEPPHSE--------LHPMKVLFL---IPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 623 DLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 664
RP A+ +L H F + S+L ++ DR + E
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 75/356 (21%), Positives = 127/356 (35%), Gaps = 109/356 (30%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--------------ALKEIQNLIASD 396
+ I+ GS G V + EG VA+KR+ T D L+EI+ L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHF 86
Query: 397 QHPNIVRWYGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
HPNI+ + + +YL E L +I+ +++
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--------------DQRIVIS 132
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
I+ ++ +L GL LHE G++HRDL P N+L+
Sbjct: 133 PQHIQYF----------MY--------HILL-------GLHVLHEAGVVHRDLHPGNILL 167
Query: 512 SKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFS 568
+ + + D +++ D N T Y + W +APE ++Q + T+ +D++S
Sbjct: 168 ADN---NDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 569 LGCILFFCITG-----GKH-------------------------PYGESFERDANIVKDR 598
GC++ G P + R++
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 599 KDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
+ V P A+DL ++L+ NP R + L HP+F L D D
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF-------ESLFDPLD 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 66/328 (20%), Positives = 124/328 (37%), Gaps = 85/328 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
+I +GS G V N + G+ VA+K+ +++ D +AL+EI ++ +HPN+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNL 67
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + ++L E C ++ + ++ + E ++ +
Sbjct: 68 LEVFRRKRRLHLVFEYCDHTVLHEL--------------DRYQRGVPEHLVKSI------ 107
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
W Q L+ ++ H+ IHRD+KP+N+LI+K KL D
Sbjct: 108 ----TW--------QTLQ-------AVNFCHKHNCIHRDVKPENILITKHSVI--KLCDF 146
Query: 525 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------L 573
G ++ L G ++ W ++PE L+ Q +D++++GC+ L
Sbjct: 147 GFARLLTGPSDYYDD----EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202
Query: 574 F---------FCI-------TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAV 611
+ + I + + I L P A+
Sbjct: 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWT 639
L L +P R + +L+HP+F
Sbjct: 263 GLLKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 92/313 (29%)
Query: 369 GRSVAVKRLVKTHHDV---------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419
+ VA+K+ +K H AL+EI L+ HPNI+ + + L +
Sbjct: 35 NQIVAIKK-IKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 479
L +I S + ++ +L
Sbjct: 93 FMETDLEVIIKDNSLVLTP------------SHIKAYML--------------------M 120
Query: 480 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 539
L+ GL +LH+ ++HRDLKP N+L+ ++ KL+D G++K T
Sbjct: 121 TLQ-------GLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTH 171
Query: 540 N-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES------- 587
T W +APE L R +D++++GCIL + P+ G+S
Sbjct: 172 QVVT-----RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR--VPFLPGDSDLDQLTR 224
Query: 588 -FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 626
FE D K + L + +DL L NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 627 KAQNVLNHPFFWT 639
A L +F
Sbjct: 285 TATQALKMKYFSN 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 85/348 (24%), Positives = 139/348 (39%), Gaps = 105/348 (30%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ + G+ G V + G VA+K+L + A +E++ L+ +H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 89
Query: 405 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
V E+ DF YL + L L+ L E RI+ L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----------------HEKLGEDRIQFL 133
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
++ Q+LK GL ++H G+IHRDLKP N+ +++D C
Sbjct: 134 ----------VY--------QMLK-------GLRYIHAAGIIHRDLKPGNLAVNED---C 165
Query: 519 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 575
K+ D G++++ +M TGY + W +APE +L + T+ +D++S+GCI+
Sbjct: 166 ELKILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 576 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 604
ITG G P E +R + ++KD L
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
P AV+L ++L + + R A L HP+F L D D
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-------ESLHDTED 319
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 87/355 (24%), Positives = 127/355 (35%), Gaps = 107/355 (30%)
Query: 351 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 402
+ + G+ G V Y+GR A+K + T + +EI L H NI
Sbjct: 30 ELVGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 403 RWYG------VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
+YG D ++L +E C S+ DLI K N L E I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------------KNTKGNTLKEEWI 131
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+ R+I+ GLSHLH+ +IHRD+K QNVL++++
Sbjct: 132 AY-------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLG 570
KL D G+S +L + + T G+ W APE + A DL+SLG
Sbjct: 167 E--VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 571 CILFFCITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP--------------EAV 611
IT G P + + + LFL IP +
Sbjct: 222 ------ITAIEMAEGAPPLCD--------MHPMRALFL---IPRNPAPRLKSKKWSKKFQ 264
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR---LSFLRDVSDRVELEDRESDS 663
L N RP + ++ HPF L+D DR + + E D
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDE 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 78/316 (24%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 393
R IG ++ + + +GS G V L +Y+ + VA+K + + D+ ++ EI L
Sbjct: 6 RHIGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL- 63
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+HP+I++ Y V + + + +E L D I V E +E
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTE------------DEG 110
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
R + + I+ + + H ++HRDLKP+N+L+
Sbjct: 111 R---------------------------RFFQQIICAIEYCHRHKIVHRDLKPENLLL-- 141
Query: 514 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 567
D + K++D G+S + SC GS + APE ++ G+ +D++
Sbjct: 142 DDNLNVKIADFGLSNIMTDGNFLKTSC--------GSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 568 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 621
S G +L+ + G+ P F+ D I K + + + P A L R++ +
Sbjct: 193 SCGIVLYVMLV-GRLP----FD-DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 622 PDLRPKAQNVLNHPFF 637
P R Q + P+F
Sbjct: 247 PMQRITIQEIRRDPWF 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 405
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 406 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 525 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 580
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 581 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 632
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 633 NHPFF 637
++
Sbjct: 261 KDRWY 265
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 76/333 (22%), Positives = 137/333 (41%), Gaps = 91/333 (27%)
Query: 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 406
+ +G+ G V + +GR VA+KR ++ + A++EI +L+ HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREI-SLLKELHHPNIVSLID 86
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V + + L E L ++ ++ ++++I L
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD------------SQIKIYLY-------- 126
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
QLL+ G++H H+ ++HRDLKPQN+LI+ D KL+D G+
Sbjct: 127 ------------QLLR-------GVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGL 165
Query: 527 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 583
++ + T T W +AP+ L+ ++ + ++D++S+GCI ITG P
Sbjct: 166 ARAFGIPVRSYTHEVVT-----LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG--KP 218
Query: 584 Y--GES--------FE----------------RDANIV--KDRKDLFLVEHIP----EAV 611
G + F + + IP E +
Sbjct: 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 644
DL + +L +P+ R A++ +NHP+F D ++
Sbjct: 279 DLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 77/316 (24%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 393
+IG V+ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 8 VKIGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL- 65
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+HP+I++ Y V S ++ +E YV G + + + + E+
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVME----------YVSGGELFDYICKHGR----VEEM 111
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
R ++ + I+S + + H ++HRDLKP+NVL+
Sbjct: 112 EAR-------------------------RLFQQILSAVDYCHRHMVVHRDLKPENVLL-- 144
Query: 514 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 567
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 195
Query: 568 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 621
S G IL+ + G P F+ D ++ K ++ E++ L +L +
Sbjct: 196 SCGVILYALLC-GTLP----FD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249
Query: 622 PDLRPKAQNVLNHPFF 637
P R +++ H +F
Sbjct: 250 PLKRATIKDIREHEWF 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 75/346 (21%), Positives = 131/346 (37%), Gaps = 97/346 (28%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 405
I +G+ G V + VA+K++ H L+EI+ ++ +H NI+
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGIN 91
Query: 406 GV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ + + VY+ + L L+ + L+ I
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLK----------------TQHLSNDHICYF-- 133
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA- 519
L+ Q+L+ GL ++H ++HRDLKP N+L++ C
Sbjct: 134 --------LY--------QILR-------GLKYIHSANVLHRDLKPSNLLLNTT---CDL 167
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCI 577
K+ D G++ R+ T T Y ++ W +APE +L + T++ID++S+GCIL +
Sbjct: 168 KICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 578 TG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLVEH 606
+ GKH P E N+ K++
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286
Query: 607 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
+A+DL ++L NP R + + L HP+ D SD
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYL-------EQYYDPSD 325
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 69/333 (20%), Positives = 121/333 (36%), Gaps = 90/333 (27%)
Query: 369 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423
VA+K ++ H+ A++E+ +L+ +H NIV + + + + L E
Sbjct: 27 DNLVALKE-IRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483
L + + V++ L QLL+
Sbjct: 85 DLKQYLDDCGNIINM------------HNVKLFLF--------------------QLLR- 111
Query: 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-AT 542
GL++ H ++HRDLKPQN+LI++ KL+D G+++ T
Sbjct: 112 ------GLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 543 GYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE- 589
W + P+ LL + ID++ +GCI + TG P G + F
Sbjct: 164 -----LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG--RPLFPGSTVEEQLHFIFRI 216
Query: 590 ---------------RDANIVK--DRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 628
+ + L+ H P + DL T+LL R A
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276
Query: 629 QNVLNHPFFWTADTRLSFLRDVSDRVELEDRES 661
++ + HPFF + R+ L D + L++ +
Sbjct: 277 EDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 309
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 84/325 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYG 406
+I +GS G V L GR VAVK + + + N + QH N+V Y
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+ +++ +E +L D++ LNE +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----------------SQVRLNEEQIAT-------- 145
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
V ++ L++LH G+IHRD+K ++L++ D KLSD G
Sbjct: 146 -----------------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFG 186
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 580
++ D+ + + G+ W APE + + +D++SLG I G
Sbjct: 187 FCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLG------IMVIEMVDG 237
Query: 581 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 628
+ PY + + + + P D R+L +P R A
Sbjct: 238 EPPYFS--------DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATA 289
Query: 629 QNVLNHPFFWTADTRLSFLRDVSDR 653
Q +L+HPF L +
Sbjct: 290 QELLDHPFLLQTGL-PECLVPLIQL 313
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 67/321 (20%), Positives = 107/321 (33%), Gaps = 98/321 (30%)
Query: 369 GRSVAVKRLVKTHHD---------VALKEIQNL--IASDQHPNIVRWYGVESDQDF---- 413
G VA+K V+ + ++E+ L + + +HPN+VR V +
Sbjct: 34 GHFVALKS-VRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92
Query: 414 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472
V L E +QD L ++ L
Sbjct: 93 KVTLVFEHV----------------------DQD----------LRTYLDKAPPPGL--- 117
Query: 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 532
P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G++ R+
Sbjct: 118 ---PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLA-RIYS 171
Query: 533 DMSCLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES- 587
LT T W +APE LLQ +D++S+GCI + P G S
Sbjct: 172 YQMALTPVVVT-----LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR--RKPLFCGNSE 224
Query: 588 -------FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDP 620
F+ + +P L +L
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTF 283
Query: 621 NPDLRPKAQNVLNHPFFWTAD 641
NP R A L H + +
Sbjct: 284 NPHKRISAFRALQHSYLHKDE 304
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 62/344 (18%), Positives = 111/344 (32%), Gaps = 99/344 (28%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 406
E+ G+ G V + G +A K + +I ++ P IV +YG
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 407 VESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+ + +E SL D + +G EQ
Sbjct: 99 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQ-------------------------- 131
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 524
L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 132 -------------ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDF 176
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
G+S +L M+ + G+ + +PE+L + D++S+G L G++P
Sbjct: 177 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 230
Query: 585 -------------------------------GESFERDANIVKDRKDLFLVEHI------ 607
+ + L+++I
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 608 --------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643
E D + L NP R + ++ H F +D
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 69/325 (21%), Positives = 123/325 (37%), Gaps = 84/325 (25%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLI---ASDQHPNIVRWYG 406
++I +G++GTV + G+ VA+++ + + I N I +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
D +++ +E SL D++ ++E +I
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----------------TETCMDEGQIAA-------- 120
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 121 -----------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 580
++ + S + +T G+ W APE + + +D++SLG I G
Sbjct: 162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG------IMAIEMIEG 212
Query: 581 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 628
+ PY + L+L+ + D R L+ + + R A
Sbjct: 213 EPPYLN--------ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 264
Query: 629 QNVLNHPFFWTADTRLSFLRDVSDR 653
+ +L H F A LS L +
Sbjct: 265 KELLQHQFLKIAKP-LSSLTPLIAA 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 79/315 (25%), Positives = 121/315 (38%), Gaps = 91/315 (28%)
Query: 369 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423
G VA+K VK + A++EI +L+ +H NIVR Y V ++ + L E
Sbjct: 30 GVYVALKE-VKLDSEEGTPSTAIREI-SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 424 SLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482
L + + L LN V+ QLL+
Sbjct: 88 DLKKYM--------DSRTVGNTPRGLELNLVKYFQW--------------------QLLQ 119
Query: 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 541
GL+ HE ++HRDLKPQN+LI+K KL D G+++ ++ +
Sbjct: 120 -------GLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 542 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE 589
T W +AP+ L+ R + +ID++S GCIL ITG P G + F+
Sbjct: 171 T-----LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG--KPLFPGTNDEEQLKLIFD 223
Query: 590 ----------------RDANIV------KDRKDLFLVEHIP----EAVDLFTRLLDPNPD 623
N +D + + +D LL NPD
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 624 LRPKAQNVLNHPFFW 638
+R A+ L+HP+F
Sbjct: 284 MRLSAKQALHHPWFA 298
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 74/348 (21%), Positives = 136/348 (39%), Gaps = 105/348 (30%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ G+ G+V + + G VAVK+L + + +E++ L+ +H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 93
Query: 405 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
V S ++F VYL LN+++ L + ++ L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFL 137
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
++ Q+L+ GL ++H +IHRDLKP N+ +++D C
Sbjct: 138 ----------IY--------QILR-------GLKYIHSADIIHRDLKPSNLAVNED---C 169
Query: 519 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 575
K+ D G+++ +M TGY ++ W +APE +L + +D++S+GCI+
Sbjct: 170 ELKILDFGLARHTADEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 576 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 604
+TG G P E ++ ++ + + +
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
P AVDL ++L + D R A L H +F + D D
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-------AQYHDPDD 323
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 405
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 406 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 525 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 580
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 581 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 632
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 633 NHPFF 637
++
Sbjct: 261 KDRWY 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 60/337 (17%), Positives = 106/337 (31%), Gaps = 94/337 (27%)
Query: 348 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNIVRWYG 406
+ I +G G V +G+ + R VAVK + + E + +H NI R+
Sbjct: 16 KLLELIGRGRYGAV-YKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 407 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ + +E L+ Y +GS + L+ D
Sbjct: 75 GDE-RVTADGRMEYL------LVMEYYPNGSLXKYLSLHTSDWV---------------- 111
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---------IGLIHRDLKPQNVLISKDK 515
++ + GL++LH + HRDL +NVL+
Sbjct: 112 --------------SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KN 155
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY-----GSSGWQAPEQLLQGR--------QTR 562
+SD G+S RL G+ G+ + APE +L+G +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALK 214
Query: 563 AIDLFSLGCIL------------FFCITGGKHPYGESFERDANIVKDRKDLFLVEH---- 606
+D+++LG I + + + +D + L E
Sbjct: 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF-EDMQVLVSREKQRPK 273
Query: 607 IPEAVDLFTRLL-----------DPNPDLRPKAQNVL 632
PEA + + D + + R AQ
Sbjct: 274 FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
+V L +L +IHRD+KP N+L+ D+ ++D I+ L + TQ T G+
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRE----TQITTMAGT 177
Query: 547 SGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 603
+ APE + + A+D +SLG + + G+ PY R + K+ F
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY---HIRSSTSSKEIVHTFE 233
Query: 604 VEHI-------PEAVDLFTRLLDPNPDLR-PKAQNVLNHPFF 637
+ E V L +LL+PNPD R + +V N P+
Sbjct: 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 82/335 (24%), Positives = 131/335 (39%), Gaps = 89/335 (26%)
Query: 351 KEIAKGSNGTVVLEGNYEGR------SVAVKR--LVKTHHDVAL--KEIQNLIASDQHPN 400
+ I G+ V VA+KR L K + KEIQ + HPN
Sbjct: 21 EVIGSGATAVV-----QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPN 74
Query: 401 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
IV +Y +D ++L ++ + S+ D+I + + E S +L+E I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII-------KHIVAKGEHKSGVLDESTIAT-- 125
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+ R+++ GL +LH+ G IHRD+K N+L+ +D S
Sbjct: 126 -----------------------ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--V 160
Query: 520 KLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFF 575
+++D G+S L GD++ T G+ W APE + Q R +A D++S G
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA-DIWSFG----- 214
Query: 576 CITG-----GKHPYGE----------------SFERDANIVKDRKDLFLVEHIPEAVDLF 614
IT G PY + S E + K +
Sbjct: 215 -ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-----GKSFRKMI 268
Query: 615 TRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 649
+ L +P+ RP A +L H FF A + FL++
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNK-EFLQE 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 71/317 (22%), Positives = 113/317 (35%), Gaps = 93/317 (29%)
Query: 369 GRSVAVKRLVKTHHDV------ALKEIQNL--IASDQHPNIVRWYGV-----ESDQDFVY 415
GR VA+KR V+ ++E+ L + + +HPN+VR + V + +
Sbjct: 37 GRFVALKR-VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 475
L E +QD L ++ + +
Sbjct: 96 LVFEHV----------------------DQD----------LTTYLDKVPEPGV------ 117
Query: 476 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 535
P+ + + ++ GL LH ++HRDLKPQN+L++ KL+D G++ R+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA-RIYSFQM 174
Query: 536 CLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES---- 587
LT T W +APE LLQ +DL+S+GCI + P G S
Sbjct: 175 ALTSVVVT-----LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR--RKPLFRGSSDVDQ 227
Query: 588 ----FE----------------RDANIVKDRKDLF--LVEHI-PEAVDLFTRLLDPNPDL 624
+ V I DL + L NP
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287
Query: 625 RPKAQNVLNHPFFWTAD 641
R A + L+HP+F +
Sbjct: 288 RISAYSALSHPYFQDLE 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 69/324 (21%), Positives = 115/324 (35%), Gaps = 77/324 (23%)
Query: 335 DDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA--LKEIQN 391
D + K+I G+ G L + VAVK + + +EI N
Sbjct: 11 LDMPIMHDSDRYDF-VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN 69
Query: 392 LIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLL 450
S +HPNIVR+ V + + +E + L + I +G F E
Sbjct: 70 H-RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSE------------ 115
Query: 451 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 510
+E R + ++SG+S+ H + + HRDLK +N L
Sbjct: 116 DEAR---------------------------FFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 511 ISKDKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAI 564
+ + K+ D G SK + G+ + APE +L ++ +
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTV--------GTPAYIAPE-VLLRQEYDGKIA 199
Query: 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIP-------EAVDL 613
D++S G L+ + G +P FE RK + + IP E L
Sbjct: 200 DVWSCGVTLYVMLV-GAYP----FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
+R+ +P R + H +F
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWF 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 76/350 (21%), Positives = 126/350 (36%), Gaps = 98/350 (28%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGV 407
+ +G+ GTV L G SVA+K+ V +E+Q + +A HPNIV+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 408 -----ESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
E D+ +YL++ E +L+ ++ + I++
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCC--------RNYYRRQVA---PPPILIKVF-- 134
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--IGLIHRDLKPQNVLISKDKSFC 518
QL++ + LH + + HRD+KP NVL+ +++
Sbjct: 135 ----------------LFQLIR-------SIGCLHLPSVNVCHRDIKPHNVLV--NEADG 169
Query: 519 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 575
KL D G +K+L + Y S + +APE + + T A+D++S+GCI
Sbjct: 170 TLKLCDFGSAKKLSPS-----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 576 CITG-----GKH--------------PYGESFERDANIVKDRKDLFLVEH---------- 606
+ G G + P E + D
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284
Query: 607 ---IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 653
EA DL + LL P+ R K L HP+F L D + +
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF-------DELHDPATK 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 75/340 (22%), Positives = 125/340 (36%), Gaps = 106/340 (31%)
Query: 353 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDV------ALKEIQNLIASDQHPN 400
+ +G+ G V Y+ VA+KR ++ H+ A++E+ +L+ QH N
Sbjct: 42 LGEGTYGEV-----YKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIREV-SLLKELQHRN 94
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLP 459
I+ V ++L E L + D N ++ I+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYM----------------DKNPDVSMRVIKSF- 137
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF-- 517
QL+ G++ H +HRDLKPQN+L+S +
Sbjct: 138 -----------------LYQLIN-------GVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 518 -CAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI- 572
K+ D G+++ + T T W + PE LL R + ++D++S+ CI
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEIIT-----LWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 573 --------LF------------FCITG----------GKHP-YGESFERDANIVKDRKDL 601
LF F + G P + +SF + K K +
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRG--KTLKRV 286
Query: 602 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
E +DL T +L+ +P R A+N L HP+F D
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 75/340 (22%), Positives = 122/340 (35%), Gaps = 93/340 (27%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVAL--KEIQNLIASDQHPNIVRWYG 406
E+ G+ G V N E G A K + K+ ++ EI+ L D HP IV+ G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLG 83
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+++ +E C +++ ++ L E
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------------------------- 117
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+ V R ++ L+ LH +IHRDLK NVL++ + +L+D G
Sbjct: 118 -------------QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFG 162
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITG- 579
+S + + + + G+ W APE ++ D++SLG IT
Sbjct: 163 VSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG------ITLI 213
Query: 580 ----GKHPYGESFERDANIVKDRKDLFLVEHIP---------------EAVDLFTRLLDP 620
+ P+ E + + L I E D LD
Sbjct: 214 EMAQIEPPHHE--------LNPMRVLLK---IAKSDPPTLLTPSKWSVEFRDFLKIALDK 262
Query: 621 NPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRE 660
NP+ RP A +L HPF + T LR++ + E E
Sbjct: 263 NPETRPSAAQLLEHPFVSSI-TSNKALRELVAEAKAEVME 301
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 82/348 (23%), Positives = 143/348 (41%), Gaps = 77/348 (22%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 393
+IG ++ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 13 VKIGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL- 70
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+HP+I++ Y V S +++ +E YV G + + + L+E
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVME----------YVSGGELFDYICKNGR----LDEK 116
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
R ++ + I+SG+ + H ++HRDLKP+NVL+
Sbjct: 117 ESR-------------------------RLFQQILSGVDYCHRHMVVHRDLKPENVLL-- 149
Query: 514 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 567
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 200
Query: 568 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 621
S G IL+ + G P F+ D ++ K + +++ P + L +L +
Sbjct: 201 SSGVILYALLC-GTLP----FD-DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 622 PDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 669
P R +++ H +F + F D S + D E+ ++
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 78/363 (21%), Positives = 127/363 (34%), Gaps = 121/363 (33%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
K++ KG+ G V + G VAVK++ + +EI L H NIV
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 405 YGV---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V ++D+D VYL + L+ +I +N+L V + +
Sbjct: 75 LNVLRADNDRD-VYLVFDYMETDLHAVIR----------------ANILEPVHKQYV--- 114
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-K 520
++ QL+K + +LH GL+HRD+KP N+L++ + C K
Sbjct: 115 -------VY--------QLIK-------VIKYLHSGGLLHRDMKPSNILLNAE---CHVK 149
Query: 521 LSDMGISKRLQGDMSCLTQNA-----------------TGYGSSGW-QAPEQLLQGRQ-T 561
++D G+S+ T Y ++ W +APE LL + T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 562 RAIDLFSLGCI---------LF------------FCITG--------------------- 579
+ ID++SLGCI +F +
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 580 ----GKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ + + EA+DL +LL NP+ R A + L H
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329
Query: 635 PFF 637
PF
Sbjct: 330 PFV 332
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 77/334 (23%), Positives = 129/334 (38%), Gaps = 101/334 (30%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ G+ G+V + G VA+K+L + A +E+ L+ QH N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGL 88
Query: 405 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
V + D YL + L ++ E +I+
Sbjct: 89 LDVFTPASSLRNFYD-FYLVMPFMQTDLQKIMG----------------LKFSEE-KIQY 130
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L ++ Q+LK GL ++H G++HRDLKP N+ +++D
Sbjct: 131 L----------VY--------QMLK-------GLKYIHSAGVVHRDLKPGNLAVNED--- 162
Query: 518 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILF 574
C K+ D G+++ +M TGY + W +APE +L + +D++S+GCI+
Sbjct: 163 CELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 575 FCITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FL 603
+TG GK P E ++ + RKD
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 604 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
P+A DL ++L+ + D R A L HPFF
Sbjct: 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 72/325 (22%), Positives = 113/325 (34%), Gaps = 103/325 (31%)
Query: 369 GRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGV--------ESDQDFV 414
G+ VA+K+ V ++ AL+EI+ L H N+V + + +
Sbjct: 42 GQKVALKK-VLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSI 99
Query: 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQD-SNLLNEVRIRLLPVMENTKDIELWKAN 473
YL + C E D + LL+ V ++ K +
Sbjct: 100 YLVFDFC----------------------EHDLAGLLSNVLVKFTL--SEIKRVMQ---- 131
Query: 474 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 533
LL GL ++H ++HRD+K NVLI++D KL+D G+++
Sbjct: 132 -----MLLN-------GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLA 177
Query: 534 MSCLTQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LF--- 574
+ T Y + PE LL R IDL+ GCI +
Sbjct: 178 KNSQPNRYTNRVVTLWY-----RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232
Query: 575 ---------FCITG----------GKHPYGESFERDANIVKDRKDLF-LVEHIPEAVDLF 614
+ G + E E + KD P A+DL
Sbjct: 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292
Query: 615 TRLLDPNPDLRPKAQNVLNHPFFWT 639
+LL +P R + + LNH FFW+
Sbjct: 293 DKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+ GL H+H +++RDLKP N+L+ D+ ++SD+G++ + G+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK-----KPHASVGT 353
Query: 547 SGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 602
G+ APE L +G + D FSLGC+LF + G P+ + +D + + +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 603 LVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 637
L + PE L LL + + R AQ V PFF
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
IVSGL HLH+ +I+RDLKP+NVL+ D ++SD+G++ + T+ G+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVE---LKAGQTKTKGYAGT 352
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KDL 601
G+ APE LL ++D F+LG L+ I + + +K R + +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA--RGPFRARGEKVENKELKQRVLEQAV 410
Query: 602 FLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 641
+ P + D LL +P+ R + HP F
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 402
+ ++ G G V EG ++ S VAVK L + +V LKE + +HPN+V
Sbjct: 222 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM-KEIKHPNLV 279
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 280 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 315
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ LL + I S + +L + IHR+L +N L+ ++ K++
Sbjct: 316 -------------SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN--HLVKVA 360
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 575
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 361 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 576 CITGGKHPY 584
T G PY
Sbjct: 412 IATYGMSPY 420
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 71/373 (19%), Positives = 128/373 (34%), Gaps = 103/373 (27%)
Query: 334 IDDRVDGRRIGKLVVFNKEIAKGSNGT--VVLEG----NYEGRSVAVKRLVKTHHDV-AL 386
++ R +F E K GT V + + + A+K++ T + A
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC 66
Query: 387 KEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 444
+EI L+ +HPN++ V V+L + E
Sbjct: 67 REIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYA----------------------E 103
Query: 445 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRD 503
D L +++ + + K ++K + I+ G+ +LH ++HRD
Sbjct: 104 HD----------LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 504 LKPQNVLISKDKSF--CAKLSDMGISKRLQGDMSCLTQNATG-----YGSSGWQAPEQLL 556
LKP N+L+ + K++DMG ++ + L Y +APE LL
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY-----RAPELLL 208
Query: 557 QGRQ-TRAIDLFSLGCI---------LF---------------------FCITG------ 579
R T+AID++++GCI +F F + G
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 580 ----GKHPYGESFE---RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 628
K P + R ++ +H +A L +LL +P R +
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328
Query: 629 QNVLNHPFFWTAD 641
+ + P+F
Sbjct: 329 EQAMQDPYFLEDP 341
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 69/354 (19%), Positives = 133/354 (37%), Gaps = 105/354 (29%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 405
+ +G+ G V + G VA+K++ + L+EI+ ++ +H NI+ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIF 75
Query: 406 GV------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+ E+ + VY+ E L+ +I + +L++ I+
Sbjct: 76 NIQRPDSFENFNE-VYIIQELMQTDLHRVI----------------STQMLSDDHIQYF- 117
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
++ Q L+ + LH +IHRDLKP N+LI+ + C
Sbjct: 118 ---------IY--------QTLR-------AVKVLHGSNVIHRDLKPSNLLINSN---CD 150
Query: 520 -KLSDMGISKRLQGDMSCLTQNA------TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLG 570
K+ D G+++ + + ++ + ++ W +APE +L + +RA+D++S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 571 CILFFCITG-----GKH--------------PYGESF------ERDANIV-----KDRKD 600
CIL G+ P+ ++ R +
Sbjct: 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270
Query: 601 L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
L P+ +DL R+L +P R A+ L HP+ D +D
Sbjct: 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL-------QTYHDPND 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-G 545
I GL LH +++RDLKP+N+L+ D ++SD+G++ + Q G G
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEG-----QTIKGRVG 347
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KD 600
+ G+ APE + R T + D ++LGC+L+ I G + V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG--QSPFQQRKKKIKREEVERLVKEVP 405
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 641
E P+A L ++LL +P R A+ V HP F +
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+ F K + G+ G VV L + +VAVK L + H + E++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
H NIV G + + E Y G +LLN +R +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITE----------YCCYG-------------DLLNFLRRK 121
Query: 457 LLPVMENTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
+ + + + + LL + + G++ L IHRDL +N+L++
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 567
+ K+ D G+++ ++ D + Y G W APE + T D++
Sbjct: 182 R--ITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 568 SLGCILFFCITGGKHPY 584
S G L+ + G PY
Sbjct: 232 SYGIFLWELFSLGSSPY 248
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 78/312 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR 403
K + GS G V+L + G A+K L K V LK+I+ ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
D +Y+ +E YV G L + +E R
Sbjct: 106 LEFSFKDNSNLYMVME----------YVAGGEMFSHL----RRIGRFSEPHARFY----- 146
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+AQ IV +LH + LI+RDLKP+N+LI D+ +++D
Sbjct: 147 -------------AAQ-------IVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTD 184
Query: 524 MGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
G +KR++G C G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-- 234
Query: 582 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQ 629
+P + + +E IV + + H + DL LL + R
Sbjct: 235 YPPFFADQPIQIYE---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 630 NVLNHPFFWTAD 641
++ NH +F T D
Sbjct: 290 DIKNHKWFATTD 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 63/251 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRL--VKTHHDVA--LKEIQNLIASDQHPN 400
+V ++I +G+ G V G + VAVK A L+E + ++ HPN
Sbjct: 116 LVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPN 173
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
IVR GV + + +Y+ +E V G F L + + + L
Sbjct: 174 IVRLIGVCTQKQPIYIVME----------LVQGGDFLTFL--RTEGARL----------- 210
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
LL++ D +G+ +L IHRDL +N L+++ K
Sbjct: 211 ---------------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLK 253
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCIL 573
+SD G+S+ + S G W APE L GR + D++S G +L
Sbjct: 254 ISDFGMSREEADGVY--------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 574 FFCITGGKHPY 584
+ + G PY
Sbjct: 306 WETFSLGASPY 316
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 403
+ F +EI G G +V G + + VA+K + + ++E + ++ HP +V+
Sbjct: 10 LTFVQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQ 67
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
YGV +Q + L E ++ G + L + Q
Sbjct: 68 LYGVCLEQAPICLVTE----------FMEHGCLSDYL--RTQRGLF-------------- 101
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+ LL + D+ G+++L E +IHRDL +N L+ ++ K+SD
Sbjct: 102 ------------AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN--QVIKVSD 147
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
G+++ + D S+G W +PE R + D++S G +++
Sbjct: 148 FGMTRFVLDD--------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 578 TGGKHPY 584
+ GK PY
Sbjct: 200 SEGKIPY 206
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 403
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 269 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 326
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 327 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 360
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 361 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 406
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 576
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 407 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 577 ITGGKHPY 584
T G+ PY
Sbjct: 458 TTKGRVPY 465
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 67/346 (19%)
Query: 263 QVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGN 322
+++ + K+ RR + T ++E ++ N V T LS
Sbjct: 4 SHHHHHHSQDPPAVHKLTKRIPLRR----QVTVSAESSSSMNSNTPLVRITTRLSSTADT 59
Query: 323 GEKFLLTFTDLIDDR---VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-------- 371
++ +L +D ++ K + +G G VV G
Sbjct: 60 PMLAGVSEYELPEDPKWEFPRDKL----TLGKPLGEGCFGQVV-MAEAVGIDKDKPKEAV 114
Query: 372 -VAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 426
VAVK L + + E++ + +H NI+ G + +Y+ +E
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE------- 167
Query: 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486
Y G NL +R R P ME + DI L+ T
Sbjct: 168 ---YASKG-------------NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 544
+ G+ +L IHRDL +NVL++++ K++D G+++ D+ N Y
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLAR----DI-----NNIDYYK 260
Query: 545 -GSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
++G W APE L T D++S G +++ T G PY
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 403
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 186 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 243
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 244 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 277
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 278 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 323
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 576
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 324 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 577 ITGGKHPY 584
T G+ PY
Sbjct: 375 TTKGRVPY 382
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 43/255 (16%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+ F K + G+ G V+ + VAVK L + + E++ +
Sbjct: 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
H NIV G + +YL E Y G L +K + +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFE----------YCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
+ E L LL + G+ L +HRDL +NVL++ K
Sbjct: 157 QKRLEEEEDLNVL------TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK- 209
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G+++ + D + Y G W APE L +G T D++S
Sbjct: 210 -VVKICDFGLARDIMSDSN--------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 570 GCILFFCITGGKHPY 584
G +L+ + G +PY
Sbjct: 261 GILLWEIFSLGVNPY 275
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
IV L HLH++G+I+RD+K +N+L+ D + L+D G+SK D + G+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAY--DFCGT 223
Query: 547 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP--YGESFERDA-----NIVKD 597
+ AP+ + G +A+D +SLG +++ +TG + + I+K
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKS 281
Query: 598 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
+ + + A DL RLL +P R P+ A + H FF +
Sbjct: 282 --EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 61/335 (18%), Positives = 105/335 (31%), Gaps = 101/335 (30%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 407
+++ +G V N V VK L +EI+ L PNI+ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 408 -ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ + L L+ ++R +
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT----------------DYDIRFYMY-------- 137
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 525
++LK L + H +G++HRD+KP NV+I D +L D G
Sbjct: 138 ------------EILK-------ALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWG 176
Query: 526 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL---------F 574
++ +S + + PE L+ + ++D++SLGC+L F
Sbjct: 177 LA-EFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
Query: 575 FCITGGKH--------------PYGESFERDANIVKDR--------------KDLFLVEH 606
F G + NI D + E+
Sbjct: 232 FH---GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 288
Query: 607 I----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
PEA+D +LL + R A+ + HP+F
Sbjct: 289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 67/400 (16%), Positives = 111/400 (27%), Gaps = 110/400 (27%)
Query: 351 KEIAKGSNGT-VVLEGNYE--GRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNIV 402
I KG V Y+ G V V+R+ E+ + HPNIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIV 89
Query: 403 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ + +++ S DLI + +NE+ I
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLI-------------CTHFMDGMNELAIAY---- 132
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+ + ++ L ++H +G +HR +K ++LIS D L
Sbjct: 133 ---------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169
Query: 522 SDMGISKRLQGDMSCL-TQNATGYGSSG---WQAPEQLLQGRQ--TRAIDLFSLGC---- 571
S + + + + S W +PE L Q Q D++S+G
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
Query: 572 ---------------ILFFCITGG--------KHPYGESFERDANIVKDRKDLFLVEHIP 608
+L + G P E + V + +
Sbjct: 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289
Query: 609 EAVDLFTRLLDP-------------------NPDLRPKAQNVLNHPFFWTA-DTRLSFLR 648
P NPD RP A +LNH FF L
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 349
Query: 649 DVSDRVELEDRESDSKLLRALEGIALVALN------GKWD 682
++ V + + GI + N W+
Sbjct: 350 ELLRPVT-PITNFEGSQSQDHSGIFGLVTNLEELEVDDWE 388
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 50/252 (19%)
Query: 347 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQHP 399
+ F I +G+ G V+ ++ + A+KR+ + E++ L HP
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NI+ G + ++YL++E Y G NLL+ +R +
Sbjct: 87 NIINLLGACEHRGYLYLAIE----------YAPHG-------------NLLDFLRKSRVL 123
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ ++ A
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA 181
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCI 572
K++D G L++ Y W A E L T D++S G +
Sbjct: 182 KIADFG-----------LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 573 LFFCITGGKHPY 584
L+ ++ G PY
Sbjct: 231 LWEIVSLGGTPY 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 393
+ K + +G+ G VV G VAVK L + + E++ +
Sbjct: 37 LTLGKPLGEGAFGQVV-MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 132
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
R R P ME + DI L+ T + G+ +L IHRDL +NVL+++
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 565
+ K++D G+++ D+ N Y ++G W APE L T D
Sbjct: 193 NNV--MKIADFGLAR----DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 566 LFSLGCILFFCITGGKHPY 584
++S G +++ T G PY
Sbjct: 242 VWSFGVLMWEIFTLGGSPY 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 34/314 (10%), Positives = 72/314 (22%), Gaps = 109/314 (34%)
Query: 338 VDGR-RIGKLVVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALKEIQ 390
+GR R+ L R VA+ V + +Q
Sbjct: 29 ANGRYRLLIF------HGGVPPLQFWQALDTAL-----DRQVALT-FVDPQGVLPDDVLQ 76
Query: 391 NLI------ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 444
+ + P + R V + + E ++ GS +E +
Sbjct: 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE----------WIRGGSLQEVADT-- 124
Query: 445 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504
P ++ + + + H G+
Sbjct: 125 -----------SPSP------------------VGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 564
P V +S D L+
Sbjct: 156 HPSRVRVSIDGD--VVLAYPATM-----------------------PDA-------NPQD 183
Query: 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--------LVEHIPEAVD-LFT 615
D+ +G L+ + + P E+ + + +D + IP + +
Sbjct: 184 DIRGIGASLYALLV-NRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 616 RLLDPNPDLRPKAQ 629
R + + +R +
Sbjct: 242 RSVQGDGGIRSAST 255
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 71/257 (27%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR---------SVAVKRLVKTHHDVA----LKEIQNLI 393
+ +K + G G V GR SVA+K L + + L E ++
Sbjct: 47 ISIDKVVGAGEFGEV-----CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS-IM 100
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
HPNI+R GV + V + E Y+ +GS + L ++ D+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTE----------YMENGSLDSFL--RKHDAQF---- 144
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
QL+ + R I SG+ +L ++G +HRDL +N+LI+
Sbjct: 145 ----------------------TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLF 567
+ K+SD G+ + L+ D Y + G W +PE + + T A D++
Sbjct: 183 N--LVCKVSDFGLGRVLEDDPE------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ ++ G+ PY
Sbjct: 235 SYGIVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 402
+ ++ G G V EG ++ S VAVK L + +V LKE ++ +HPN+V
Sbjct: 15 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLV 72
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 73 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 108
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ LL + I S + +L + IHRDL +N L+ ++ K++
Sbjct: 109 -------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVA 153
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 575
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 154 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 576 CITGGKHPY 584
T G PY
Sbjct: 205 IATYGMSPY 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 76/358 (21%), Positives = 131/358 (36%), Gaps = 114/358 (31%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGL 89
Query: 405 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
V +S ++F VY+ +E +L +I + + L+ R+ L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------------QME---LDHERMSYL 132
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
L+ Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 133 ----------LY--------QMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 164
Query: 519 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 576
K+ D G+++ T Y + + +APE +L +D++S+GCI+
Sbjct: 165 TLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 577 ITG-----GKHPY------------------------------------GESFERD-ANI 594
I G G G SFE+ ++
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279
Query: 595 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 652
+ +A DL +++L + R L HP+ ++ D S+
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY-------INVWYDPSE 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 53/257 (20%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 397 QHPNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
H N+V G + + + +E + G NL +R
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVE----------FCKFG-------------NLSTYLRS 125
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+ + E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 567
K+ D G+++ D+ W APE + T D++
Sbjct: 186 --VVKICDFGLAR----DI-----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ + G PY
Sbjct: 235 SFGVLLWEIFSLGASPY 251
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 403
+ F KE+ G G VV G + G VA+K + + D ++E + ++ + H +V+
Sbjct: 26 LTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQ 83
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
YGV + Q +++ E Y+ +G L +E
Sbjct: 84 LYGVCTKQRPIFIITE----------YMANGCLLNYL--REMRHRF-------------- 117
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+ QLL++ +D+ + +L +HRDL +N L++ K+SD
Sbjct: 118 ------------QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ--GVVKVSD 163
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
G+S+ + D S G W PE L+ + + D+++ G +++
Sbjct: 164 FGLSRYVLDD--------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 578 TGGKHPY 584
+ GK PY
Sbjct: 216 SLGKMPY 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 8e-17
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 59/247 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 403
+ KE+ G G VV G ++G+ VAVK + + D +E Q + HP +V+
Sbjct: 10 ITLLKELGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVK 67
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+YGV S + +Y+ E Y+ +G L + +
Sbjct: 68 FYGVCSKEYPIYIVTE----------YISNGCLLNYLRSHGKGLEP-------------- 103
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+QLL++ D+ G++ L IHRDL +N L+ +D C K+SD
Sbjct: 104 --------------SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD--LCVKVSD 147
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
G+++ + D S G W APE + + D+++ G +++
Sbjct: 148 FGMTRYVLDD--------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 578 TGGKHPY 584
+ GK PY
Sbjct: 200 SLGKMPY 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 24/179 (13%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 543
+V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + A G
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 544 YGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGKHP--YGES-FERDANIVK 596
Y +PE L G R D +S+G L+ + G Y +S + I+
Sbjct: 235 Y-----ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSLVGTYSKIMN 287
Query: 597 DRKDLFLVEHI---PEAVDLFTRLL-DPNPDLRPK-AQNVLNHPFFWTADTRLSFLRDV 650
+ L + EA +L L D L + + H FF LRD
Sbjct: 288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 72/258 (27%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR----------SVAVKRLVKTHHDVA----LKEIQNL 392
V K I G G V Y+G VA+K L + + L E +
Sbjct: 46 VTRQKVIGAGEFGEV-----YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-I 99
Query: 393 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 452
+ H NI+R GV S + + E Y+ +G+ ++ L +E+D
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITE----------YMENGALDKFL--REKDGEF--- 144
Query: 453 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 512
QL+ + R I +G+ +L + +HRDL +N+L++
Sbjct: 145 -----------------------SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 513 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDL 566
+ K+SD G+S+ L+ D Y +SG W APE + + T A D+
Sbjct: 182 SN--LVCKVSDFGLSRVLEDDPE------ATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 567 FSLGCILFFCITGGKHPY 584
+S G +++ +T G+ PY
Sbjct: 234 WSFGIVMWEVMTYGERPY 251
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 63/253 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 397
+ K I G +G V G VA+K L + + L E ++
Sbjct: 51 IHIEKIIGSGDSG-EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS-IMGQFD 108
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HPNI+R GV + + E Y+ +GS + L + D
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTE----------YMENGSLDTFL--RTHDGQF-------- 148
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
QL+ + R + +G+ +L ++G +HRDL +NVL+ +
Sbjct: 149 ------------------TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--L 188
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
K+SD G+S+ L+ D Y ++G W APE + + A D++S G
Sbjct: 189 VCKVSDFGLSRVLEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 572 ILFFCITGGKHPY 584
+++ + G+ PY
Sbjct: 243 VMWEVLAYGERPY 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
IVS L +LH +++RD+K +N+++ KD K++D G+ K +S T G+
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKD-GHI-KITDFGLCKE---GISDGATMKTFCGT 168
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE L RA+D + LG +++ + G Y + FE I+ + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHERLFE---LILME--E 221
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
+ + PEA L LL +P R P A+ V+ H FF + +
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I L HLH+ G+I+RDLKP+N+++ + KL+D G+ K + T T G+
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCKE---SIHDGTVTHTFCGT 184
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE L++ RA+D +SLG +++ +TG P GE+ + I+K
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID---KILKC--K 237
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
L L ++ EA DL +LL N R P A V HPFF +
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 52/247 (21%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 403
+ K++ G G V Y VAVK + V L E + + QH +V+
Sbjct: 190 LKLEKKLGAGQFG-EVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVK 247
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ V + ++ +Y+ E ++ GS + L K + +
Sbjct: 248 LHAVVT-KEPIYIITE----------FMAKGSLLDFL--KSDEGSKQ------------- 281
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
P +L+ + I G++ + + IHRDL+ N+L+S K++D
Sbjct: 282 ------------PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS--LVCKIAD 327
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 328 FGLARVIEDN--------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 578 TGGKHPY 584
T G+ PY
Sbjct: 380 TYGRIPY 386
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 66/314 (21%), Positives = 121/314 (38%), Gaps = 78/314 (24%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 401
+ + GS G V L + GR A+K L K V LK+++ +++ HP I
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+R +G D +++ ++ Y+ G L + S +
Sbjct: 69 IRMWGTFQDAQQIFMIMD----------YIEGGELFSLL----RKSQRFPNPVAKFY--- 111
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+A+ + L +LH +I+RDLKP+N+L+ DK+ K+
Sbjct: 112 ---------------AAE-------VCLALEYLHSKDIIYRDLKPENILL--DKNGHIKI 147
Query: 522 SDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
+D G +K + C G+ + APE + ++ID +S G +++ + G
Sbjct: 148 TDFGFAKYVPDVTYTLC--------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 580 GKHP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PK 627
+ Y + +E I+ L + DL +RL+ + R
Sbjct: 200 --YTPFYDSNTMKTYE---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 252
Query: 628 AQNVLNHPFFWTAD 641
++V NHP+F
Sbjct: 253 TEDVKNHPWFKEVV 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 173
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 603
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 604 VEHI-------PEAVDLFTRLLDPNPDLR----PK--AQNVLNHPFFWTAD 641
+ I +A + L+ +P R P+ ++ HPFF D
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 30/175 (17%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 543
IV + +H +G +HRD+KP N+L+ D+ +L+D G +L+ D + + A G
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 544 YGSSGWQAPEQLL-------QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-AN 593
Y +PE L G D ++LG + G Y +S
Sbjct: 229 Y-----LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG--QTPFYADSTAETYGK 281
Query: 594 IVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 641
IV ++ L L EA D RLL P+ R A + HPFF+ D
Sbjct: 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 397
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 572 ILFFCITGGKHPY 584
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 67/258 (25%)
Query: 345 KLVVFNKEIAKGSNGTVVLEGNYEGRS----VAVKRL-----VKTHHDVALKEIQNLIAS 395
L + +KE+ G+ G V +G Y+ + VAVK L D L E ++
Sbjct: 17 LLTLEDKELGSGNFG-TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQ 74
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
+P IVR G+ + + L +E G L ++
Sbjct: 75 LDNPYIVRMIGI-CEAESWMLVME----------MAELGP-------------LNKYLQ- 109
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 568
AK+SD G+SK L+ D + Y + W APE + + + D++S
Sbjct: 155 --YAKISDFGLSKALRADENY-------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 569 LGCILFFCITGGKHPYGE 586
G +++ + G+ PY
Sbjct: 206 FGVLMWEAFSYGQKPYRG 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 65/276 (23%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 398
+ + ++ KG+ G+V L G+ G VAVK+L + D +EIQ ++ +
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ-ILKALHS 83
Query: 399 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
IV++ GV + + L +E Y+ SG + L + + L
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVME----------YLPSGCLRDFL--QRHRARL------- 124
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
+++LL + I G+ +L +HRDL +N+L+ +
Sbjct: 125 -------------------DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-- 163
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 569
K++D G++K L D Y W APE L +R D++S
Sbjct: 164 AHVKIADFGLAKLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 570 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 605
G +L+ T S E + +R L
Sbjct: 217 GVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 30/166 (18%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 544
+ L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSF 186
Query: 545 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 597
G+ + APE + + T++ D +S G ++F +TG G+ I+K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMT---MILKA 241
Query: 598 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 637
L + + + PEA L L NP R P + + H FF
Sbjct: 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 61/246 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 405
+ + I KG G V+ G+Y G VAVK + A L E ++ +H N+V+
Sbjct: 23 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLL 80
Query: 406 GVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 81 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 114
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 115 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 161
Query: 525 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
G++K W APE L + + + D++S G +L+ +
Sbjct: 162 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
Query: 579 GGKHPY 584
G+ PY
Sbjct: 210 FGRVPY 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 59/259 (22%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 393
+V K + +G+ G VV G VAVK L + + E++ +
Sbjct: 71 LVLGKPLGEGAFGQVV-LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 394 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 166
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 513
+ R P +E + + S L+ + G+ +L IHRDL +NVL+++
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 565
D K++D G+++ D+ + Y ++G W APE L T D
Sbjct: 227 DN--VMKIADFGLAR----DI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 566 LFSLGCILFFCITGGKHPY 584
++S G +L+ T G PY
Sbjct: 276 VWSFGVLLWEIFTLGGSPY 294
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 61/246 (24%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 405
+ + I KG G V+ G+Y G VAVK + A L E + +H N+V+
Sbjct: 195 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM-TQLRHSNLVQLL 252
Query: 406 GVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 253 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 286
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 287 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 333
Query: 525 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
G++K W APE L + + + D++S G +L+ +
Sbjct: 334 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 579 GGKHPY 584
G+ PY
Sbjct: 382 FGRVPY 387
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 74/344 (21%), Positives = 122/344 (35%), Gaps = 109/344 (31%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 126
Query: 405 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
V E QD VYL +E +L +I L+ R+
Sbjct: 127 LNVFTPQKTLEEFQD-VYLVMELMDANLCQVI-----------------QMELDHERMSY 168
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L Q+L G+ HLH G+IHRDLKP N+++ D
Sbjct: 169 L------------------LYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD--- 200
Query: 518 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFF 575
C K+ D G++ R G + T Y + + +APE +L +D++S+GCI+
Sbjct: 201 CTLKILDFGLA-RTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 576 CITG-----GKH--------------PYGESFER---DA--------------------N 593
+ G+ P E ++ +
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 315
Query: 594 IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ +A DL +++L +P R + L HP+
Sbjct: 316 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 67/363 (18%), Positives = 125/363 (34%), Gaps = 61/363 (16%)
Query: 230 HAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPG 289
VE + I CP + + H + P+++
Sbjct: 233 WQLVEYLKLKADGLIYCLKEACPNSS---ASNASGAAAPTLPAHPSTLTHPQRRIDTLNS 289
Query: 290 YNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVF 349
+ T ++ + +T + E+ L D L++
Sbjct: 290 -DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD--------NLLIA 340
Query: 350 NKEIAKGSNGTVVLEGNYEGRS----VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIV 402
+ E+ G+ G+V +G Y R VA+K L + +E+ ++ +P IV
Sbjct: 341 DIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R GV + + L +E G + L + +
Sbjct: 400 RLIGVCQAEA-LMLVME----------MAGGGPLHKFL--VGKREEI------------- 433
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
P + + ++ + G+ +L E +HR+L +NVL+ AK+S
Sbjct: 434 -------------PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKIS 478
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G+SK L D S T + G W APE + + + D++S G ++ ++ G+
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 583 PYG 585
PY
Sbjct: 539 PYK 541
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 59/257 (22%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEG-------RSVAVKRLVKTHHDVA----LKEIQNLIAS 395
+ F K + G+ G VV E G VAVK L T H + E++ +
Sbjct: 48 LQFGKTLGAGAFGKVV-EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
QH NIV G + V + E C L + + S E +S
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA----- 161
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
+ LL + + G++ L IHRD+ +NVL++
Sbjct: 162 ---------------------STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 567
AK+ D G+++ + D + Y G W APE + T D++
Sbjct: 201 H--VAKIGDFGLARDIMNDSN--------YIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ + G +PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 216
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 603
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 604 VEHI-------PEAVDLFTRLLDPNPDLR------PKAQNVLNHPFFWTAD 641
+ I +A + L+ +P R ++ HPFF D
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 543
+V + +H++ +HRD+KP N+L+ D + +L+D G +L D + + A G
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 544 YGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIV 595
Y +PE L +GR D +SLG ++ + G Y ES I+
Sbjct: 242 Y-----ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIM 294
Query: 596 KDRKDLFLVEHI----PEAVDLFTRLLDPNPD-L-RPKAQNVLNHPFF 637
++ + A DL RL+ L + ++ HPFF
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 544
I S L +LH + +++RDLKP+N+L+ D L+D G+ K + N+T
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE------NIEHNSTTSTF 199
Query: 545 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 597
G+ + APE L + R +D + LG +L+ + G P Y + ++ NI+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYD---NILNK 254
Query: 598 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWTAD 641
L L +I A L LL + R + +H FF +
Sbjct: 255 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+V K + +G G VV L+G +VAVK L + L E N++
Sbjct: 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQV 83
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRI 455
HP++++ YG S + L +E Y GS L +++ L
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVE----------YAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
R +++ + L L+ I G+ +L E+ L+HRDL +N+L+++ +
Sbjct: 134 RNSSSLDHPDERAL------TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 567
K+SD G+S+ D+ S G W A E L T D++
Sbjct: 188 --KMKISDFGLSR----DV-----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ +T G +PY
Sbjct: 237 SFGVLLWEIVTLGGNPY 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 53/257 (20%), Positives = 101/257 (39%), Gaps = 61/257 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 395
+ ++E+ +GS G V EG +G VA+K + + L E ++
Sbjct: 27 ITMSRELGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKE 84
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
++VR GV S + +E + G +L + +R
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIME----------LMTRG-------------DLKSYLRS 121
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+ N ++++++ +I G+++L+ +HRDL +N ++++D
Sbjct: 122 LRPAMANNPVLAPP------SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 174
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 567
F K+ D G+++ + T Y G G W +PE L G T D++
Sbjct: 175 -FTVKIGDFGMTRDIY---------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ T + PY
Sbjct: 225 SFGVVLWEIATLAEQPY 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 184
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 237
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 60/257 (23%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASD 396
+ +++ +G G V L + G VAVK L K +EI ++ +
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID-ILRTL 90
Query: 397 QHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
H +I+++ G ++ + L +E YV GS + L
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVME----------YVPLGSLRDYL-------------- 126
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
+ AQLL + I G+++LH IHRDL +NVL+ D
Sbjct: 127 ----------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQTRAIDLFSLGCI 572
K+ D G++K + G S W APE L + + A D++S G
Sbjct: 171 --RLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 573 LFFCITGGKHPYGESFE 589
L+ +T +
Sbjct: 227 LYELLTHCDSSQSPPTK 243
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+ GL LH G+++RDLK N+L+ KD K++D G+ K +M + T G+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKD-GHI-KIADFGMCKE---NMLGDAKTNTFCGT 181
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE LL + ++D +S G +L+ + G +G+ F +I D +
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG--QSPFHGQDEEELFH---SIRMD--N 234
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-VLNHPFFWTAD 641
F + EA DL +L P+ R + + HP F +
Sbjct: 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 487 IVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 545
IVS L +LH E +++RDLK +N+++ DK K++D G+ K + T G
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKE---GIKDGATMKTFCG 311
Query: 546 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIVKDRKDLF 602
+ + APE L RA+D + LG +++ + G Y + E+ I+ + ++
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHEKLFELILME--EIR 367
Query: 603 LVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
+ PEA L + LL +P R + A+ ++ H FF
Sbjct: 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 398
+ F +++ KG+ G+V + + G VAVK+L + + +EI+ ++ S QH
Sbjct: 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 70
Query: 399 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 111
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 112 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 150
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G++K L D + W APE L + + + A D++S
Sbjct: 151 NRVKIGDFGLTKVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203
Query: 570 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 623
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 204 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I+S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + AT G+
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKE---GICNGVTTATFCGT 187
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE L + A+D +++G +L+ + G H E+ FE I+ D +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG--HAPFEAENEDDLFE---AILND--E 240
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR------PKAQNVLNHPFFWTAD 641
+ + +A + + NP +R +L HPFF D
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 70/327 (21%)
Query: 272 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 331
I +K+ R + + + Q + + V ETD + I + T+T
Sbjct: 323 GATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED----TYT 378
Query: 332 DLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVAL 386
+ +R + + + I +G G V +G Y VA+K D
Sbjct: 379 MPSTRDYEIQR--ERIELGRCIGEGQFGDVH-QGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 387 KEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 443
++ + HP+IV+ GV ++ V++ +E G L +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--Q 482
Query: 444 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503
+ +L A L+ + + L++L +HRD
Sbjct: 483 VRKFSL--------------------------DLASLILYAYQLSTALAYLESKRFVHRD 516
Query: 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQ 557
+ +NVL+S + C KL D G+S+ ++ T Y +S W APE +
Sbjct: 517 IAARNVLVSSN--DCVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINF 566
Query: 558 GRQTRAIDLFSLGCILFFCITGGKHPY 584
R T A D++ G ++ + G P+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 45/256 (17%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+ + ++I +G+ G V L VAVK L + +E L+A
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEF 107
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
+PNIV+ GV + + L E Y+ G E L + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
++ A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 158 STRARVSSPGPPPL-----SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-- 210
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLFS 568
K++D G+S+ + + Y + W PE + R T D+++
Sbjct: 211 MVVKIADFGLSRNIY---------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261
Query: 569 LGCILFFCITGGKHPY 584
G +L+ + G PY
Sbjct: 262 YGVVLWEIFSYGLQPY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 63/256 (24%)
Query: 345 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 397
L++ + E+ G+ G+V V + VA+K L + ++E Q ++
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLD 68
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
+P IVR GV + + L +E G + L + +
Sbjct: 69 NPYIVRLIGV-CQAEALMLVME----------MAGGGPLHKFL--VGKREEI-------- 107
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
P + + ++ + G+ +L E +HRDL +NVL+
Sbjct: 108 ------------------PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-- 147
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 570
AK+SD G+SK L D S Y + W APE + + + D++S G
Sbjct: 148 YAKISDFGLSKALGADDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 571 CILFFCITGGKHPYGE 586
++ ++ G+ PY +
Sbjct: 201 VTMWEALSYGQKPYKK 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQH 398
+ F +++ KG+ G+V + + G VAVK+L + H +EI+ ++ S QH
Sbjct: 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 101
Query: 399 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 142
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 143 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 181
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 569
K+ D G++K L D Y W APE L + + + A D++S
Sbjct: 182 NRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 570 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 623
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 53/256 (20%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 395
V F +E+ + G V +G+ G + VA+K L E L A
Sbjct: 11 VRFMEELGEDRFGKVY-KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM-LRAR 68
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
QHPN+V GV + + + ++ F + +L + +
Sbjct: 69 LQHPNVVCLLGV---------------VTKDQPLSMI---FSYCSH-----GDLHEFLVM 105
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
R + D + + + + I +G+ +L ++H+DL +NVL+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK- 164
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 568
K+SD+G+ + + A Y G W APE ++ G+ + D++S
Sbjct: 165 -LNVKISDLGLFREV--------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 569 LGCILFFCITGGKHPY 584
G +L+ + G PY
Sbjct: 216 YGVVLWEVFSYGLQPY 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 546
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 505
Query: 547 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 600
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 558
Query: 601 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 641
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 55/283 (19%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASD 396
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 397 QHPNIVRWYGVESDQDF-VYLSLERCTC-SLNDLI---------YVLSGSFEEQLNAKEQ 445
H N+V G + + + +E C +L+ + Y G+ Q
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 446 DSNLLNEVRIRLLPVMENTKDIELWKANGH-----------------PSAQLLKVTRDIV 488
+ + R+ + +++ + L+ + +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 548
G+ L IHRDL +N+L+S+ K+ D G+++ + D Y G
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD--------YVRKG 253
Query: 549 -------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
W APE + T D++S G +L+ + G PY
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 403
+ + + G G V G Y G VAVK L + L E L+ QH +VR
Sbjct: 15 LKLVERLGAGQFG-EVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVR 72
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
Y V + Q+ +Y+ E Y+ +GS + L K L
Sbjct: 73 LYAVVT-QEPIYIITE----------YMENGSLVDFL--KTPSGIKLT------------ 107
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+LL + I G++ + E IHRDL+ N+L+S K++D
Sbjct: 108 -------------INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT--LSCKIAD 152
Query: 524 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 153 FGLARLIEDN--------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 578 TGGKHPY 584
T G+ PY
Sbjct: 205 THGRIPY 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 48/253 (18%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRL-VKTHHDVA--LKEIQNLIASD 396
+V +E+ +G+ G V S VAVK L T +E + L+ +
Sbjct: 17 IVLKRELGEGAFGKVF-LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNL 74
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
QH +IV++YGV D D + + E Y+ G +L +R
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFE----------YMKHG-------------DLNKFLRAH 111
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 516
M +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-- 169
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGC 571
K+ D G+S+ + + + G W PE ++ + T D++S G
Sbjct: 170 LLVKIGDFGMSRDVY------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 572 ILFFCITGGKHPY 584
IL+ T GK P+
Sbjct: 224 ILWEIFTYGKQPW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 395
+V E+ +G+ G V VAVK L K + A +E + L+
Sbjct: 43 IVLKWELGEGAFGKVF-LAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAE-LLTM 99
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
QH +IVR++GV ++ + + E Y+ G LN
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFE----------YMRHGD--------------LNRFLR 135
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
P + E QLL V + +G+ +L + +HRDL +N L+ +
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 567
K+ D G+S+ + +T Y G W PE +L + T D++
Sbjct: 195 -LVVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 568 SLGCILFFCITGGKHPY 584
S G +L+ T GK P+
Sbjct: 245 SFGVVLWEIFTYGKQPW 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 70/314 (22%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 349 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 400
F+ + I G G V VL +G VA+KR ++E + ++ +HP+
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPH 96
Query: 401 IVRWYG--VESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
+V G E ++ +Y + Y+ +G+ + L + + ++
Sbjct: 97 LVSLIGFCDERNEMILIY---K----------YMENGNLKRHLYGSDLPTMSMS------ 137
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
W+ Q L++ GL +LH +IHRD+K N+L+ D++F
Sbjct: 138 ------------WE-------QRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENF 176
Query: 518 CAKLSDMGISK-RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576
K++D GISK + D + L+ G+ G+ PE ++GR T D++S G +LF
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 577 ITGGKHPYGESFERD-ANIV-------KDRK-----DLFLVEHIPE-----AVDLFTRLL 618
+ + +S R+ N+ + + D L + I D + L
Sbjct: 235 LC-ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 619 DPNPDLRPKAQNVL 632
+ + RP +VL
Sbjct: 294 ALSSEDRPSMGDVL 307
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 70/259 (27%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA---LKEIQNLIA 394
++FN+ + +G+ + +G V +K L K H + + + +++
Sbjct: 10 LIFNESLGQGTFTKIF-KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS-MMS 67
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
H ++V YGV D L E +V GS + L K+ + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQE----------FVKFGSLDTYL--KKNKNCI----- 110
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
L+V + + + + L E LIH ++ +N+L+ ++
Sbjct: 111 ---------------------NILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 515 KSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQ-TRAID 565
+ KLSD GIS + W PE + + A D
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATD 200
Query: 566 LFSLGCILFFCITGGKHPY 584
+S G L+ +GG P
Sbjct: 201 KWSFGTTLWEICSGGDKPL 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 1e-14
Identities = 81/518 (15%), Positives = 157/518 (30%), Gaps = 153/518 (29%)
Query: 297 SEKMQNIIPNESKVGETDGLSHITGNG---EKFLLTFTDLIDDRVDG--RRIGKLVVFN- 350
+ ++I+ E E D HI + L F L+ + + + + +++ N
Sbjct: 39 QDMPKSILSKE----EID---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91
Query: 351 ----KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHDVALKEIQNLIASDQ- 397
I ++ Y V K V +++ + +
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY--LKLRQALLELRP 149
Query: 398 HPNIV-----------------RWYGVESDQDF-VY-LSLERCTCS------LNDLIYVL 432
N++ Y V+ DF ++ L+L+ C L L+Y +
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 433 SGSFEEQLNAKEQDSNLLNEVRIRL------------LPVMENTKDIELWKA-NGHPSAQ 479
++ + + ++ ++ L L V+ N ++ + W A N +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--CK 267
Query: 480 LLKVTRD--IVSGLSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMS 535
+L TR + LS H L ++ ++ D+ K D
Sbjct: 268 ILLTTRFKQVTDFLSAATT---THISLDHHSMTLTPDEVKSLLLKYLDC--------RPQ 316
Query: 536 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 595
L P ++L + L I ES RD
Sbjct: 317 DL--------------PREVLT------TNPRRLSII------------AESI-RDGLAT 343
Query: 596 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS-FLRDV---- 650
D + + ++ +L+P + R F RLS F
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPA-EYR---------KMFD----RLSVFPPSAHIPT 389
Query: 651 -------SDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDN 703
D ++ + +KL + +LV K K T I +I + K +N
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKY----SLVE---KQP-KESTISIPSIYLELKVKLEN 441
Query: 704 VRDLLRVIRNKSNHFRELPQDIQELLGSHPEG-FYNYF 740
L R I + N + D +L+ + + FY++
Sbjct: 442 EYALHRSIVDHYNIPKTFDSD--DLIPPYLDQYFYSHI 477
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 7e-09
Identities = 81/613 (13%), Positives = 179/613 (29%), Gaps = 155/613 (25%)
Query: 103 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVE-SHLPCHTQMTASVYRL-------R 154
F F C++V ++ ++ E H+ + RL +
Sbjct: 28 AFVDNFDCKDV------------QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 155 DNSLPEFL-SVIGKVAGWI-----------SLPGSSQNSLLGPVDRNSPLFLPDKVDRPP 202
+ + +F+ V+ ++ S+ + ++ +F V R
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135
Query: 203 L------ALPSTETEIPWTL--GMPG-G-SV--SEINKKHAFVEGFRSYIQSFIVLFIAL 250
AL L G+ G G + ++ + F + ++ L
Sbjct: 136 PYLKLRQALLELRPA-KNVLIDGVLGSGKTWVALDVCLSYKVQCKM-----DFKIFWLNL 189
Query: 251 ----CP--IIGFL--FYHSKQVKSKKQNEEHITKTGIP----KKKKSR---RPGYNR--- 292
P ++ L + + + +H + + + + R Y
Sbjct: 190 KNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 293 ---NTTNSEKMQ--NIIPNESKVGETDGLSHITGNGEKFLLTFTDL-IDDRVDGRRIGKL 346
N N++ N+ K+ LLT + D + +
Sbjct: 249 VLLNVQNAKAWNAFNL---SCKI----------------LLTTRFKQVTDFLSAATTTHI 289
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRSVA-VKRLVKTHHDVALKEIQNLIASDQHPNIVRWY 405
+ + + + L Y + R V T + L ++IA + W
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL----SIIAESIRDGLATW- 344
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
++ +++ ++ L +I S L E + + + + P +
Sbjct: 345 -----DNWKHVNCDK----LTTII----ESSLNVLEPAEY-RKMFDRLSV--FP--PSAH 386
Query: 466 DIE------LWKANGHPS------AQLLK---VTRDIVSGLSHLHEIGLIHRDLKPQNVL 510
I +W + S +L K V + + I+ +LK +
Sbjct: 387 -IPTILLSLIW-FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVK--- 438
Query: 511 ISKDKSFCAKLSDM-GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569
+ + + + D I K D + Y L + LF +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQY--FYSHIGHHLKNIEHPERMTLFRM 495
Query: 570 GCILF--FCITGGK--HPYGESFERDANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDL 624
+F F K H ++ +I+ + L F +I + + RL++ D
Sbjct: 496 ---VFLDFRFLEQKIRHD-STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 625 RPK-AQNVLNHPF 636
PK +N++ +
Sbjct: 552 LPKIEENLICSKY 564
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/253 (21%), Positives = 93/253 (36%), Gaps = 66/253 (26%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 397
+ + I +G G V +G Y VA+K D L+E +
Sbjct: 17 IELGRCIGEGQFGDVH-QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-TMRQFD 74
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HP+IV+ GV ++ V++ +E G L + + +L
Sbjct: 75 HPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--QVRKYSL-------- 113
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
A L+ + + L++L +HRD+ +NVL+S +
Sbjct: 114 ------------------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--D 153
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
C KL D G+S+ ++ T Y +S W APE + R T A D++ G
Sbjct: 154 CVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 572 ILFFCITGGKHPY 584
++ + G P+
Sbjct: 206 CMWEILMHGVKPF 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 397
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 572 ILFFCITGGKHPY 584
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 41/228 (17%), Positives = 71/228 (31%), Gaps = 58/228 (25%)
Query: 468 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
E K N +P + + + L LHE L H DLKP+N+L +
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 525 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 573
++ + + ++ T ++ ++ PE +L+ + D++S+GCIL
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 574 ------------------------------------------FFCITGGKHPYGESFERD 591
F+
Sbjct: 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 592 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
K K L + + + DL R+L+ +P R L HPFF
Sbjct: 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 70/257 (27%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL-------VKTHHDVALKEIQNLIA 394
+ +++ GS G V G ++ S VAVK L + D ++E+ +
Sbjct: 20 LRLLEKLGDGSFGVV-RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF-IREVN-AMH 76
Query: 395 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
S H N++R YGV + + E GS ++L ++ +
Sbjct: 77 SLDHRNLIRLYGVVLTPP-MKMVTE----------LAPLGSLLDRL--RKHQGHF----- 118
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
L + + G+ +L IHRDL +N+L++
Sbjct: 119 ---------------------LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 567
K+ D G+ + L + Y W APE L + A D +
Sbjct: 158 D--LVKIGDFGLMRALPQNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 568 SLGCILFFCITGGKHPY 584
G L+ T G+ P+
Sbjct: 209 MFGVTLWEMFTYGQEPW 225
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 42/228 (18%), Positives = 77/228 (33%), Gaps = 58/228 (25%)
Query: 468 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ K NG + K+ I ++ LH L H DLKP+N+L + A +
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 525 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 573
+R + + ++ + S+ ++APE +L ++ D++S+GCIL
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 574 ------------------------------------------FFCITGGKHPYGESFERD 591
F + +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 592 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+ K K+ L + + DL ++L+ +P R + L HPFF
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 69/336 (20%), Positives = 119/336 (35%), Gaps = 64/336 (19%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 396
+ + + G+ G V + + VAVK L + + L E +I+
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKF 90
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
H NIVR GV ++ +E + G +L + +R
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILME----------LMAGG-------------DLKSFLR-E 126
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDK 515
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 127 TRPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 567
AK+ D G+++ + Y G W PE ++G T D +
Sbjct: 179 GRVAKIGDFGMARDIYR---------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 568 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 625
S G +L+ + G PY +S + V + ++ P V + T+ P+ R
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 626 PKAQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 660
P +L + T D ++ + +E+ E
Sbjct: 290 PNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 69/334 (20%), Positives = 119/334 (35%), Gaps = 60/334 (17%)
Query: 347 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQ 397
+ + + G+ G V + + VAVK L + + + +I+
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H NIVR GV ++ LE + G +L + +R
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLE----------LMAGG-------------DLKSFLR-ET 168
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKS 516
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 169 RPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 517 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 569
AK+ D G+++ + A Y G W PE ++G T D +S
Sbjct: 221 RVAKIGDFGMARDI--------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 570 GCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 627
G +L+ + G PY +S + V + ++ P V + T+ P+ RP
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 628 AQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 660
+L + T D ++ + +E+ E
Sbjct: 333 FAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 366
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 55/222 (24%)
Query: 369 GRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG--VESDQDFVYLSLERCTC 423
G VAVKRL + + Q +I+ H N++R G + + R
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--------RL-- 103
Query: 424 SLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481
L+Y + +GS L + + L+ W
Sbjct: 104 ----LVYPYMANGSVASCLRERPESQPPLD------------------WPKR-------Q 134
Query: 482 KVTRDIVSGLSHLHE---IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL- 537
++ GL++LH+ +IHRD+K N+L+ D+ F A + D G++K + + +
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 538 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
T G+ G APE L G+ + D+F G +L ITG
Sbjct: 193 TAVR---GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 51/253 (20%), Positives = 94/253 (37%), Gaps = 66/253 (26%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 397
VV N+ + +G G V EG Y VAVK K + E ++ +
Sbjct: 14 VVLNRILGEGFFGEV-YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLD 71
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HP+IV+ G+ ++ ++ +E G L + +L
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIME----------LYPYGELGHYLERNKNSLKVL------- 113
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L+ + I +++L I +HRD+ +N+L++
Sbjct: 114 ---------------------TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP--E 150
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
C KL D G+S+ ++ + Y +S W +PE + R T A D++
Sbjct: 151 CVKLGDFGLSRYIEDE--------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 572 ILFFCITGGKHPY 584
++ ++ GK P+
Sbjct: 203 CMWEILSFGKQPF 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 76/255 (29%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
I +GS G V L + ++VA+K++ + D+ L+EI ++ + I+R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRL 90
Query: 405 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
Y + + F +Y+ LE L L L E I+ +
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKT---------------PIFLTEEHIKTI- 134
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
L+ LL G + +HE G+IHRDLKP N L+++D C+
Sbjct: 135 ---------LY--------NLLL-------GENFIHESGIIHRDLKPANCLLNQD---CS 167
Query: 520 -KLSDMGISKRLQGDMSCLTQNA------------------TGYGSSGW-QAPEQLLQGR 559
K+ D G+++ + + N T + + W +APE +L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 560 Q-TRAIDLFSLGCIL 573
T++ID++S GCI
Sbjct: 228 NYTKSIDIWSTGCIF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 66/266 (24%)
Query: 347 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 397
+ +++ +G G V L EG+ G VAVK L KEI+ ++ +
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLY 81
Query: 398 HPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
H NIV++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPKNKNKINL------ 125
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
Q LK I G+ +L +HRDL +NVL+ +
Sbjct: 126 ----------------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE- 162
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 568
K+ D G++K ++ D Y W APE L+Q + A D++S
Sbjct: 163 -HQVKIGDFGLTKAIETDKE-------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 569 LGCILFFCITGGKHPYGESFERDANI 594
G L +T I
Sbjct: 215 FGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 51/234 (21%), Positives = 75/234 (32%), Gaps = 72/234 (30%)
Query: 468 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
EL K N G + K I+ L LH+ +IH DLKP+N+L+ + K+ D
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 525 GISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL--------- 573
G S SC Q Y S + +APE +L R ID++SLGCIL
Sbjct: 247 G-S-------SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 574 ---------------------------------FFCITGGKH--------------PYGE 586
F G G
Sbjct: 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 587 SFERDANIVKDRKDLFLVEHIPEA---VDLFTRLLDPNPDLRPKAQNVLNHPFF 637
S + ++ + +D + L+ +P +R L HP+
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 53/253 (20%), Positives = 90/253 (35%), Gaps = 64/253 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 397
+ K + G GTV +G + V +K + + + + I S
Sbjct: 15 LRKLKVLGSGVFGTVH-KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
H +IVR G+ + L + Y+ GS LL+ VR
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQ----------YLPLGS-------------LLDHVR--- 106
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
++ + LL I G+ +L E G++HR+L +NVL+
Sbjct: 107 ----QHRGAL--------GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP--S 152
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 571
+++D G++ L D S W A E + G+ T D++S G
Sbjct: 153 QVQVADFGVADLLPPD-------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 572 ILFFCITGGKHPY 584
++ +T G PY
Sbjct: 206 TVWELMTFGAEPY 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 81/260 (31%)
Query: 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
I GS G V + R VA+K++++ D+ L+EI ++ H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKV 117
Query: 405 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+ + + F +Y+ LE L L E+ I+ L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---------------PVYLTELHIKTL- 161
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
L+ LL G+ ++H G++HRDLKP N L+++D C+
Sbjct: 162 ---------LY--------NLLV-------GVKYVHSAGILHRDLKPANCLVNQD---CS 194
Query: 520 -KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ------------------------APEQ 554
K+ D G+++ + + +Q APE
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 555 LLQGRQ-TRAIDLFSLGCIL 573
+L T AID++S+GCI
Sbjct: 255 ILLQENYTEAIDVWSIGCIF 274
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 84/281 (29%)
Query: 362 VLEGNYEGRSVAVKRLVKTHHDVA--------LKEIQNLIASDQHPNIVRWYG--VESDQ 411
V +G +VAVK+L D+ +EI ++A QH N+V G + D
Sbjct: 47 VYKGYVNNTTVAVKKL-AAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDGDD 104
Query: 412 DFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469
C L+Y + +GS ++L+ + L +R
Sbjct: 105 --------LC------LVYVYMPNGSLLDRLSCLDGTPPLSWHMR--------------- 135
Query: 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
K+ + +G++ LHE IHRD+K N+L+ D++F AK+SD G+++
Sbjct: 136 -----------CKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLAR- 181
Query: 530 LQGDMSCLTQNAT------GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
+ T + Y APE L+G T D++S G +L ITG
Sbjct: 182 -ASEKFAQTVMTSRIVGTTAY-----MAPE-ALRGEITPKSDIYSFGVVLLEIITGLP-- 232
Query: 584 YGESFERDANIVKDRKDLFLVEH---IPEAVDLFTRLLDPN 621
+ + R+ L++ I + +D
Sbjct: 233 ---------AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 39/236 (16%), Positives = 72/236 (30%), Gaps = 66/236 (27%)
Query: 468 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
E+ N + + +I+ L++L ++ L H DLKP+N+L+ + ++
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 525 GISKRLQGDMSCLTQNATG---YGSSGWQ--------------APEQLLQGRQTRAIDLF 567
++ + + +G + ++ APE +L + D++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 568 SLGCILFFCITG--------------------GK-------------------------- 581
S GC+L TG
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 582 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
P S VK L+ + D +L +P LRP +L H F
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 59/252 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQN---LIASDQH 398
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 91 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 399 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
PN++ G+ + + L Y+ G + + + N
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 189
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L+ + G+ L +HRDL +N ++ + F
Sbjct: 190 ------------------TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--F 229
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 572
K++D G+++ + N TG W A E L + T D++S G +
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 573 LFFCITGGKHPY 584
L+ +T G PY
Sbjct: 286 LWELMTRGAPPY 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 59/252 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQ---NLIASDQH 398
++ I KG G V G Y ++ A+K L + ++ L+ H
Sbjct: 23 THSDRVIGKGHFGVVY-HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 399 PNIVRWYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
PN++ G+ + ++ L Y+ G + + + N
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLP----------YMCHGDLLQFI--RSPQRNP-------- 121
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L+ + G+ +L E +HRDL +N ++ + F
Sbjct: 122 ------------------TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES--F 161
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 572
K++D G+++ + Q W A E L R T D++S G +
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRH----ARLPVKWTALESLQTYRFTTKSDVWSFGVL 217
Query: 573 LFFCITGGKHPY 584
L+ +T G PY
Sbjct: 218 LWELLTRGAPPY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 70/262 (26%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL---VKTHHDVA--LKEIQNLIASD 396
+ + KG G+V E + VAVK L + D+ L+E +
Sbjct: 25 FTLGRMLGKGEFGSVR-EAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEF 82
Query: 397 QHPNIVRWYGVESDQD------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL 450
HP++ + GV + L ++ G +L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILP----------FMKHG-------------DLH 119
Query: 451 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 510
+ + EN ++ P L++ DI G+ +L IHRDL +N +
Sbjct: 120 AFLLASRIG--ENPFNL--------PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 511 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTR 562
+++D ++D G+S+++ + Y G + W A E L T
Sbjct: 170 LAED--MTVCVADFGLSRKIY---------SGDYYRQGCASKLPVKWLALESLADNLYTV 218
Query: 563 AIDLFSLGCILFFCITGGKHPY 584
D+++ G ++ +T G+ PY
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPY 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 64/227 (28%)
Query: 468 ELWKANGH---PSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISK----DKSFCA 519
L K H P + ++++ ++ GL ++H G+IH D+KP+NVL+ +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-APEQLLQGRQTRAIDLFSLGCILFFCIT 578
K++D+G + ++ T + +PE LL D++S C++F IT
Sbjct: 178 KIADLGNA-------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 579 G-----GKHPYGESFERD--ANIV-----------------------------------K 596
G + + + D A I+
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 597 DRKDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+D+ F + E D + +L +P R A ++NHP+
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 59/252 (23%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR-----SVAVKRLVKTHHDVALKEIQN---LIASDQH 398
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 27 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 399 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
PN++ G+ + + L Y+ G + + + N
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 125
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L+ + G+ +L +HRDL +N ++ + F
Sbjct: 126 ------------------TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK--F 165
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 572
K++D G+++ DM + + W A E L + T D++S G +
Sbjct: 166 TVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 573 LFFCITGGKHPY 584
L+ +T G PY
Sbjct: 222 LWELMTRGAPPY 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 67/260 (25%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA-----LKEIQNLIASD 396
++ K + +G G+V+ EGN + VAVK + + L E +
Sbjct: 36 LILGKILGEGEFGSVM-EGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA-CMKDF 93
Query: 397 QHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 451
HPN++R GV + + L ++ G +L
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILP----------FMKYG-------------DLHT 130
Query: 452 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 511
+ L T + P LLK DI G+ +L +HRDL +N ++
Sbjct: 131 YLLYSRLE----TGPKHI------PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAI 564
D ++D G+SK++ + Y W A E L T
Sbjct: 181 RDD--MTVCVADFGLSKKI--------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 565 DLFSLGCILFFCITGGKHPY 584
D+++ G ++ T G PY
Sbjct: 231 DVWAFGVTMWEIATRGMTPY 250
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 350 NKEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNL------IASDQHPN 400
+ I KGS G VV + VA+K + K + A E++ L ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY-Y 117
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
IV ++ + L E + +L DL+ + + ++ R
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL-------------RNTNFRGVSLNLTR---- 160
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSFC 518
K + + + L L E+ +IH DLKP+N+L+ K
Sbjct: 161 ---------------------KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199
Query: 519 AKLSDMGISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 576
K+ D G SC L Q Y S + ++PE LL AID++SLGCIL
Sbjct: 200 IKIVDFG--------SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 577 ITG 579
TG
Sbjct: 252 HTG 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 48/195 (24%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 399
+G K+I G+ G + L N Y VA+K +K+ E +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 400 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
I V ++G + + LE SL DL + +F
Sbjct: 66 GIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTF--------------------- 102
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ K + L + ++S + ++H LI+RD+KP+N LI + +
Sbjct: 103 -----SLKTV-------------LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK 144
Query: 518 CAK---LSDMGISKR 529
+ + D ++K
Sbjct: 145 TQQVIHIIDFALAKE 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 45/261 (17%), Positives = 77/261 (29%), Gaps = 90/261 (34%)
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLIS------------- 512
I G P + K+ + ++ GL +LH + +IH D+KP+N+L+S
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 513 --------------KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-------- 550
+ A + ++ + L G++ W
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254
Query: 551 ------APEQLLQGRQTRAIDLFSLGCILFFCITG------------------------- 579
+ E L+ D++S C+ F TG
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 580 -GKHPY---------GESFERDANIVKDR--KDLFLVEHIPE-----------AVDLFTR 616
GK P E F + ++ K L E + E D
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374
Query: 617 LLDPNPDLRPKAQNVLNHPFF 637
+L+ P+ R A L HP+
Sbjct: 375 MLELIPEKRATAAECLRHPWL 395
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 55/203 (27%)
Query: 335 DDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKR-LVKTHHDVALKEIQN 391
++ V ++G+ I +GS G + N + VA+K ++ E +
Sbjct: 5 NNVVGVHYKVGR------RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 58
Query: 392 LIASDQHPNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 449
I V ++G E L ++ SL DL+ + F
Sbjct: 59 YKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKF------------- 103
Query: 450 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509
+ K + + +++ + +HE L++RD+KP N
Sbjct: 104 -------------SVKTV-------------AMAAKQMLARVQSIHEKSLVYRDIKPDNF 137
Query: 510 LISKDKSFCAK---LSDMGISKR 529
LI + S A + D G+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 24/240 (10%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVK-------RLVKTHHDVALKEIQNLIASDQHPNIVR 403
++I +G G V + VA+K LV H +EI I + +++
Sbjct: 26 EKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 404 WYGVESDQDFVYL-SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ F+ L S+ S L+ + + + + ++ ++ E
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 463 N-TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAK 520
D+E + A + + + L+ + HRDL NVL+ K+ K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL--KKTSLKK 202
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSG-----------WQAPEQLLQGRQTRAIDLFSL 569
L K L + Y S E L G D++ L
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 45/194 (23%), Positives = 69/194 (35%), Gaps = 46/194 (23%)
Query: 341 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKR-LVKTHHDVALKEIQNLIASDQH 398
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 399 PNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
I +RW G E D+ + +E SL DL S F
Sbjct: 65 VGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKF-------------------- 102
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-DK 515
+ K + L + ++S + ++H IHRD+KP N L+ K
Sbjct: 103 ------SLKTV-------------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143
Query: 516 SFCAKLSDMGISKR 529
+ D G++K+
Sbjct: 144 GNLVYIIDFGLAKK 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 468 ELWKANGHPSAQL-LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
++ NG L++ ++ L ++HE +H D+K N+L+ L+D G+
Sbjct: 140 KISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 527 SKR 529
S R
Sbjct: 200 SYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 11/49 (22%), Positives = 23/49 (46%)
Query: 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
L+V ++ L LHE +H ++ +N+ + + L+ G + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 46/193 (23%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKR-LVKTHHDVALKEIQNLIASDQHP 399
R+G ++I GS G + L N VA+K VKT H L E +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 400 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
I VRW+GVE D+ L ++ SL DL S
Sbjct: 64 GIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKL--------------------- 100
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ K + L + +++ + +H +HRD+KP N L+ +
Sbjct: 101 -----SLKTV-------------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 518 -CAKLSDMGISKR 529
+ D G++K+
Sbjct: 143 NQVYIIDFGLAKK 155
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} Length = 339 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 19/105 (18%), Positives = 41/105 (39%), Gaps = 14/105 (13%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEEL 61
I +D V G+M+T ++ +++ +G ++ + G QS + + E
Sbjct: 106 GKIVEDEKVYTGSMRTIMYTINMLNGEIISAFGPGSKNGYFGSQSVDCSPEEKIKLQEC- 164
Query: 62 VESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 106
++ I +T + L S D +NV Y+ ++
Sbjct: 165 -----------ENMIVIGKTIFELGIHSYDGAS--YNVTYSTWQQ 196
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/43 (30%), Positives = 23/43 (53%)
Query: 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
I+ L ++HE +H D+K N+L++ L D G++ R
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 28/105 (26%)
Query: 2 PYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEEL 61
P S DG + +G + +++D+ +G S + P
Sbjct: 87 PCRSSDGILYMGKKQDIWYVIDLLTGEKQQT-----------LSSAFADSLSPSTS---- 131
Query: 62 VESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 106
L+Y+ RT+Y + + E+ WN Y D+ A
Sbjct: 132 -------------LLYLGRTEYTITMYDTKTRELRWNATYFDYAA 163
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.87 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.73 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 96.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.9 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 96.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.43 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 96.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.03 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 94.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.73 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 94.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.24 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 94.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.17 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 93.68 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 93.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 93.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.22 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 91.94 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 91.87 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 91.86 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.74 | |
| 2be1_A | 339 | Serine/threonine-protein kinase/endoribonuclease; | 91.3 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 91.25 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 90.99 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 90.38 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 89.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 89.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 89.61 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 89.57 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 89.37 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 88.02 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 87.32 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 87.14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 86.87 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 86.84 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 86.81 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 86.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 86.69 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 86.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 86.63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 86.56 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 86.38 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 86.04 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 86.03 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 85.96 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 85.73 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.66 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.65 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 85.38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 85.04 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 85.03 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 84.97 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 84.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 84.67 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 84.38 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 83.93 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 83.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.65 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 82.52 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 82.46 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 82.08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 81.64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 81.51 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 81.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 81.13 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 80.79 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 80.28 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 80.25 |
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-67 Score=597.38 Aligned_cols=397 Identities=41% Similarity=0.774 Sum_probs=318.4
Q ss_pred cccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.+.+...+.||+|+||+||+++..+|+.||||++.....+...+|+..+....+|||||++++++.+.+..|+|||+|
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 44567788899999999999988888999999999987655667788876656679999999999999999999999999
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.++|.+++...... ... ....++..++.|+.||+.||+|||+.+|+|
T Consensus 92 ~gsL~~~l~~~~~~-~~~--------------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 138 (434)
T 2rio_A 92 NLNLQDLVESKNVS-DEN--------------------------------LKLQKEYNPISLLRQIASGVAHLHSLKIIH 138 (434)
T ss_dssp SEEHHHHHHTC---------------------------------------------CCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCHHHHHhccCCC-chh--------------------------------hhhccchhHHHHHHHHHHHHHHHHHCCccc
Confidence 88888877321110 000 000112235789999999999999999999
Q ss_pred cccCCCCeeecCC-----------CCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhc-------CCCCC
Q 004097 502 RDLKPQNVLISKD-----------KSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQ-------GRQTR 562 (774)
Q Consensus 502 rDLkp~NILl~~~-----------~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-------~~~~~ 562 (774)
|||||+|||++.+ ....+||+|||+++......... .......||+.|+|||++.+ ..++.
T Consensus 139 rDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 218 (434)
T 2rio_A 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218 (434)
T ss_dssp CCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCT
T ss_pred cCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcch
Confidence 9999999999754 24579999999998876432211 12234579999999999976 56899
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccc------cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
++|||||||++|||+++|.+||.........+.......... ..++++.++|.+||+.||.+|||+.++++|||
T Consensus 219 ~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 219 SIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 999999999999999966999987665555554443222111 12368999999999999999999999999999
Q ss_pred CCCccchhhhhhhccccchhccccchHHHHHHHHHHHHH-hhCCCchHHHhHHHHhhhhhhcccCCCCHHHHHHHHHhcc
Q 004097 637 FWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV-ALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKS 715 (774)
Q Consensus 637 f~~~~~~~~~l~~~~~~~e~~~~~~~~~~~~~le~~~~~-~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~ir~~~ 715 (774)
||...+++.++.+++++.+.+.+...+.++..++..... ...++|..+++..++++++++|+|++++++||||+|||+.
T Consensus 299 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~y~~~~~~dllr~~rn~~ 378 (434)
T 2rio_A 299 FWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALRNKY 378 (434)
T ss_dssp GSCHHHHHHHHHHHHHHHHTSCBTTBCHHHHHHHTTHHHHSCSSCGGGGSCSTTCC-----CCCCSSCHHHHHHHHHHHH
T ss_pred cCCcHHHHHHHHHHHHHHhhcccCCchHHHHHHHhCCCeeeeCCChhHhcCHHHHhhccCccccCcchHHHHHHHHHchh
Confidence 999999999999999998888887778888777755433 3578999999999999999999999999999999999999
Q ss_pred ccccCCChhHHHhhCCCCccccccccccCCccHHHHHHHHHhhhccchhhhccccc
Q 004097 716 NHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 771 (774)
Q Consensus 716 ~h~~e~~~~~~~~~g~~p~~f~~yf~~~fp~ll~~~y~~~~~~~~~~~~~~~y~~~ 771 (774)
|||+|+|+++++++|++|+||..||++|||.||+|+|.+++++|++|+.|++||..
T Consensus 379 ~h~~~~~~~~~~~~~~~~~~~~~y~~~~fp~l~~~~y~~~~~~~~~~~~~~~~~~~ 434 (434)
T 2rio_A 379 HHFMDLPEDIAELMGPVPDGFYDYFTKRFPNLLIGVYMIVKENLSDDQILREFLYS 434 (434)
T ss_dssp HTGGGSCHHHHHHTCSTTHHHHHHHHHHCTTHHHHHHHHHHHHCTTCTTTHHHHHC
T ss_pred hhhhhhCHHHHHHhCCCchHHHHHHHHhccHHHHHHHHHHHhhccCChHHHHhhcC
Confidence 99999999999999999999999999999999999999999999999999999963
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-67 Score=592.26 Aligned_cols=386 Identities=35% Similarity=0.688 Sum_probs=315.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
..|...+.||+|+||+||..+..+|+.||||++.........+|+..+....+|||||++++++.+.+..|||||+|.++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~ 103 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT 103 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCC
Confidence 45888899999999998877888999999999977665556778875544448999999999999999999999999888
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
|.+++..... .+++..++.++.||+.||+|||+.+|+||||
T Consensus 104 L~~~l~~~~~---------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 144 (432)
T 3p23_A 104 LQEYVEQKDF---------------------------------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144 (432)
T ss_dssp HHHHHHSSSC---------------------------------------CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHhcCC---------------------------------------CccchhHHHHHHHHHHHHHHHHHCcCEeCCC
Confidence 8777632211 1222345789999999999999999999999
Q ss_pred CCCCeeec---CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHHHHHHh
Q 004097 505 KPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 505 kp~NILl~---~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll~ellt 578 (774)
||+|||++ .++.+.+||+|||+++................||+.|+|||++. ...++.++|||||||++|||++
T Consensus 145 Kp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp STTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred CHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence 99999995 35556789999999988764433333344567999999999997 4567889999999999999999
Q ss_pred CCCCCCCCchHHHHHHHhhcccccc----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhhhhccccc
Q 004097 579 GGKHPYGESFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRV 654 (774)
Q Consensus 579 g~~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l~~~~~~~ 654 (774)
++.+||+.................. ....+.+.+||.+||+.||.+|||++|+++|||||+.+++..++++++++.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~~~~~~~~~~~~ 304 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRI 304 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHHHHHHHHHHHHh
Confidence 7799998766655544433322111 111246889999999999999999999999999999999999999998876
Q ss_pred hhccccchHHHHHHHHHHHHHhhCCCchHHHhHHHHhhhhhhcccCCCCHHHHHHHHHhccccccCCChhHHHhhCCCCc
Q 004097 655 ELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPE 734 (774)
Q Consensus 655 e~~~~~~~~~~~~~le~~~~~~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~ir~~~~h~~e~~~~~~~~~g~~p~ 734 (774)
+.+. ....+.+.++.....+...+|++.++..++.++++||+|++++++||||+|||++|||+|+|+++++.+|++|+
T Consensus 305 ~~~~--~~~~~~~~l~~~~~~~~~~~w~~~i~~~~~~~l~~~~~~~~~~~~dllr~~rn~~~h~~~~~~~~~~~~g~~p~ 382 (432)
T 3p23_A 305 EKES--LDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPD 382 (432)
T ss_dssp SCSC--SSCHHHHHHHHTCSTTTTSCGGGSSCHHHHHHTSSCCSCCSSCHHHHHHHHHHHHHTTTTSCHHHHHHHCSTTH
T ss_pred hccc--ccchHHHHHHHcccccccCcHHHhcCHHHHHhccCccCcChhHHHHHHHHHhCchhchhhcCHHHHHhhCCCch
Confidence 5433 44567777776665566789999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccHHHHHHHHHhhhccchhhhcccccC
Q 004097 735 GFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTND 772 (774)
Q Consensus 735 ~f~~yf~~~fp~ll~~~y~~~~~~~~~~~~~~~y~~~~ 772 (774)
+|..||+++||+||||+|+++. .|+.|+.|++||..+
T Consensus 383 ~~~~y~~~~fp~l~~~~y~~~~-~~~~~~~~~~~~~~~ 419 (432)
T 3p23_A 383 DFVCYFTSRFPHLLAHTYRAME-LCSHERLFQPYYFHE 419 (432)
T ss_dssp HHHHHHHSSCTTHHHHHHHHGG-GGSSSGGGTTTCCC-
T ss_pred HHHHHHHhhCcHHHHHHHHHHH-HcCCchhhhhhcCCC
Confidence 9999999999999999999995 899999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=438.94 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=191.9
Q ss_pred cccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
+..++ .|.+.+.||+|+||+||++. ..+|+.||||++.+.. .....+|+. +++.++|||||++++++.+++
T Consensus 9 G~~ig-~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 9 GAHIG-NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREIS-YLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHH-HHHHCCCTTBCCEEEEEECSS
T ss_pred CCEee-CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECC
Confidence 34444 48889999999999999985 4579999999996532 123456665 778899999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.+|||||||.++|.+++. +...+++.+++.+++||+.||+
T Consensus 87 ~~~ivmEy~~g~L~~~l~----------------------------------------~~~~l~e~~~~~~~~qi~~al~ 126 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIV----------------------------------------QRDKMSEQEARRFFQQIISAVE 126 (275)
T ss_dssp EEEEEEECCCEEHHHHHH----------------------------------------HSCSCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEeCCCCCHHHHHH----------------------------------------HcCCCCHHHHHHHHHHHHHHHH
Confidence 999999988777766652 2245788889999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGv 571 (774)
|||+++|+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..| +.++||||+||
T Consensus 127 ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 127 YCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp HHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred HHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 999999999999999999988776 899999999876532 22345689999999999998876 58999999999
Q ss_pred HHHHHHhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 572 ILFFCITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++|||++| .+||..... .....+.......+...++++++||.+||+.||++|||++|+++||||+.
T Consensus 201 ily~lltg-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 201 ILYVMLCR-RLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999997 778865433 23333444444455667899999999999999999999999999999954
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=441.91 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=207.0
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
++|.+.+.||+|+||+||++. ..+|+.||||++.+. ......+|+. +++.++|||||++++++++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 458899999999999999985 457999999999643 1233456664 78899999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++. +.+.+++.+++.|+.||+.||+|||++
T Consensus 111 mEy~~----------gG~L~~~i~-----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~~ 151 (311)
T 4aw0_A 111 LSYAK----------NGELLKYIR-----------------------------KIGSFDETCTRFYTAEIVSALEYLHGK 151 (311)
T ss_dssp ECCCT----------TEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCC----------CCCHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99665 444444432 124578889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+|+.+..... .....+.+||+.|||||++.+..|+.++||||+||++|||+
T Consensus 152 ~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 152 GIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp TEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred CCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999988876 89999999998754321 23345678999999999999999999999999999999999
Q ss_pred hCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHH------HHcCCCCCCccc
Q 004097 578 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN------VLNHPFFWTADT 642 (774)
Q Consensus 578 tg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~e------lL~HPff~~~~~ 642 (774)
+| .+||..... .....+......++...++++++||.+||+.||++|||++| +++||||.+.++
T Consensus 229 ~G-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 229 AG-LPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 97 778865433 33333333344456677899999999999999999999988 689999977654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=445.45 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.++||+|+||+||+|.. .+|+.||||++.... .+...+|+. +++.++|||||++++++.+++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4578889999999999999854 579999999996432 234567775 77889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++. ...+++.+++.|+.||+.||+|||+++||
T Consensus 153 ~~----------gg~L~~~l~------------------------------~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii 192 (346)
T 4fih_A 153 LE----------GGALTDIVT------------------------------HTRMNEEQIAAVCLAVLQALSVLHAQGVI 192 (346)
T ss_dssp CT----------TEEHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCcHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 65 444444331 13477888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||||+.++. +||+|||+|+.+.... ....+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 193 HRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G- 266 (346)
T 4fih_A 193 HRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG- 266 (346)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-
T ss_pred cccCCHHHEEECCCCC--EEEecCcCceecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-
Confidence 9999999999988876 8999999999876432 233567899999999999999999999999999999999997
Q ss_pred CCCCCCchH-HHHHHHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFE-RDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~-~~~~~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||..... .....+.... .......++++++||.+||+.||++|||++|+|+||||....
T Consensus 267 ~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 267 EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 777765433 2223332221 112345678999999999999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=448.49 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=197.4
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
++|.+.+.||+|+||+||++. ..+|+.||||++.+... +...+|+. +++.++|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA-VLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 458899999999999999985 45799999999975432 23445664 778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.++|... +...+++.+++.|+.||+.||+|||+++
T Consensus 103 Ey~~----------gg~L~~~i~~~---------------------------~~~~~~e~~~~~~~~qi~~aL~ylH~~~ 145 (350)
T 4b9d_A 103 DYCE----------GGDLFKRINAQ---------------------------KGVLFQEDQILDWFVQICLALKHVHDRK 145 (350)
T ss_dssp ECCT----------TCBHHHHHHHT---------------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCC----------CCcHHHHHHHc---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9665 44444443221 1123577788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
||||||||+||||+.++. +||+|||+|+.+... .....+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 146 IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 146 ILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNST---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220 (350)
T ss_dssp CEETTCCGGGEEECTTCC--EEECSTTEESCCCHH---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeccCCHHHEEECCCCC--EEEcccccceeecCC---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999988876 899999999876532 112345679999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 579 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 579 g~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
| .+||....... ..+........+...++++.+||.+||+.||++|||++|+|+||||..
T Consensus 221 G-~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 221 L-KHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp S-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred C-CCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 7 77886544332 234444433445567889999999999999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=430.47 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=194.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC----Cce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~ 413 (774)
++.+.+.++||+|+||+||+|.. .+++.||||++.+... ....+|+ .+++.++|||||+++++|.+ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 55668889999999999999854 5689999999965432 2234555 47899999999999999865 467
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|||||||+ +|+|.+++.. ...+++..++.|+.||+.||+|
T Consensus 104 ~~lvmEy~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 104 IVLVTELMT----------SGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp EEEEEECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCC----------CCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 899999555 4555554422 2347788899999999999999
Q ss_pred HHHcC--ccccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 494 LHEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 494 LH~~~--ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
||+++ ||||||||+||||+. ++. +||+|||+|+.... ....+.+||+.|||||++.+ .|+.++||||||
T Consensus 145 lH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~~~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlG 216 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeCCC-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHH
Confidence 99998 999999999999974 554 99999999986442 22345789999999998865 699999999999
Q ss_pred HHHHHHHhCCCCCCCCchH--HHHHHHhhc--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 571 CILFFCITGGKHPYGESFE--RDANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~--~~~~~~~~~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|++|||+|| .+||.+... .....+... +...+...++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 217 vilyelltg-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 217 MCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHC-CCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999997 778864322 222222222 12234456789999999999999999999999999999964
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=436.31 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=199.9
Q ss_pred ceEEEeEeecccCceEEEEEee----eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+|.+.+.||+|+||+||++.. .+++.||||++.+.. .....+|+. +++.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD-ILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------C-CCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEE
Confidence 5689999999999999999854 257899999986432 123455654 678899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||||||. +|+|.+++. +.+.+++.+++.|+.||+.||+|||
T Consensus 103 ivmEy~~----------gg~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~aL~ylH 143 (304)
T 3ubd_A 103 LILDFLR----------GGDLFTRLS-----------------------------KEVMFTEEDVKFYLAELALALDHLH 143 (304)
T ss_dssp EEECCCT----------TCEEHHHHH-----------------------------HHCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcCC----------CCCHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 444444432 2245788899999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+++|+||||||+|||++.++. +||+|||+|+...... ....+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 144 ~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 218 (304)
T 3ubd_A 144 SLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218 (304)
T ss_dssp HTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHH
T ss_pred HCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHH
Confidence 999999999999999988876 8999999998764321 23356789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 576 CITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 576 lltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
|+|| .+||...... ....+......++...++++++||.+||+.||++||| ++|+++||||.+.++
T Consensus 219 mltG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 219 MLTG-TLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHhC-CCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 9997 7788654333 3333333444456667899999999999999999998 579999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=447.46 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.++||+|+||+||+|.. .+|+.||||++.... .+...+|+. +++.++|||||++++++.+++.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 5688899999999999999854 579999999996432 244567776 77889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++. ...+++.++..|+.||+.||+|||++|||
T Consensus 230 ~~----------gG~L~~~i~------------------------------~~~l~e~~~~~~~~qil~aL~ylH~~~Ii 269 (423)
T 4fie_A 230 LE----------GGALTDIVT------------------------------HTRMNEEQIAAVCLAVLQALSVLHAQGVI 269 (423)
T ss_dssp CT----------TEEHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCcHHHHHh------------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 65 444444321 23477888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||||+.++. +||+|||+|+.+.... ....+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 270 HRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G- 343 (423)
T 4fie_A 270 HRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG- 343 (423)
T ss_dssp CCCCSTTTEEECTTCC--EEECCCTTCEECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-
T ss_pred cccCCHHHEEEcCCCC--EEEecCccceECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-
Confidence 9999999999988876 8999999999876432 233567899999999999999999999999999999999997
Q ss_pred CCCCCCchH-HHHHHHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFE-RDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~-~~~~~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||..... .....+.... .......++++++||.+||+.||++|||++|+|+||||....
T Consensus 344 ~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 344 EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 777755433 2233332221 112335678999999999999999999999999999997644
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=431.16 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=197.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
..|.+.++||+|+||+||++.. .+|+.||||+++.... ..+|+. +++.++|||||++++++.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~-il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~- 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELV-ACAGLSSPRIVPLYGAVREGPWVNIFMELLE- 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHH-TTTTCCCTTBCCEEEEEEETTEEEEEECCCT-
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEeccC-
Confidence 5688889999999999999854 5699999999976432 235664 6788999999999999999999999999555
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|+|.++|.. .+.+++..++.|+.||+.||+|||+++|||||
T Consensus 134 ---------gg~L~~~l~~-----------------------------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 175 (336)
T 4g3f_A 134 ---------GGSLGQLIKQ-----------------------------MGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175 (336)
T ss_dssp ---------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred ---------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 4555554421 24578889999999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccc--cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||+||||+.++. .+||+|||+|+.+....... ......+||+.|||||++.+..|+.++|||||||++|||++| .
T Consensus 176 lKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG-~ 253 (336)
T 4g3f_A 176 VKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG-C 253 (336)
T ss_dssp CCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-S
T ss_pred cCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-c
Confidence 9999999988763 48999999999876432211 122345799999999999999999999999999999999997 7
Q ss_pred CCCCCchHH--HHHHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHH-------------HcCCCCCC
Q 004097 582 HPYGESFER--DANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV-------------LNHPFFWT 639 (774)
Q Consensus 582 ~Pf~~~~~~--~~~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~el-------------L~HPff~~ 639 (774)
+||...... ...+...... ..+...++++.++|.+||+.||.+|||+.|+ ++|||+..
T Consensus 254 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 788653322 2233332221 2345667899999999999999999999997 57999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=427.19 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=192.7
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.+.+.++||+|+||+||+|... +++.||||+++.... +...+|+. +++.++|||||+++|+|.+.+.+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~-il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEE
Confidence 45788899999999999998643 578999999975442 23345654 788999999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||| .+|+|.++|+.......... .........+++.+++.|+.|||.||+|||
T Consensus 120 lV~Ey~----------~~G~L~~~l~~~~~~~~~~~--------------~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 120 MVFEYM----------RHGDLNRFLRSHGPDAKLLA--------------GGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp EEEECC----------TTCBHHHHHHTSSCC-------------------------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcC----------CCCcHHHHHHhcCccccccc--------------ccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 999955 45555555543322111000 000122356899999999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+||||||||+||||+.++ .+||+|||+++.+..... .......+||+.|||||++.+..|+.++|||||||++||
T Consensus 176 ~~~iiHRDLKp~NILl~~~~--~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTTCCCSCCCGGGEEEETTT--EEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCeecccccHhhEEECCCC--cEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 99999999999999998775 599999999987653321 222344579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|+|.|++||......+ . .+........+...++++.+||.+||+.||++|||++||+++
T Consensus 253 llt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9995588887643322 2 333333444556678899999999999999999999999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=423.51 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=197.3
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.|.+.+.||+|+||+||+|... +++.||||+++.... ....+|+. +++.++|||||+++|+|.+++.+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~-il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHH-HHHhCCCCCCccEEEEEeeCCEEE
Confidence 45788999999999999998653 478999999976532 23345654 788999999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||| ++|+|.++|+.......... .......+++.+++.|+.||+.||+|||
T Consensus 92 lV~Ey~----------~~G~L~~~l~~~~~~~~~~~----------------~~~~~~~l~~~~~~~i~~qia~gl~yLH 145 (299)
T 4asz_A 92 MVFEYM----------KHGDLNKFLRAHGPDAVLMA----------------EGNPPTELTQSQMLHIAQQIAAGMVYLA 145 (299)
T ss_dssp EEEECC----------TTCBHHHHHHHTSHHHHHC--------------------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcC----------CCCcHHHHHHhcCccccccc----------------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999955 55555555544321100000 0012346889999999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+++||||||||+||||+.++. +||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++||
T Consensus 146 ~~~iiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~E 222 (299)
T 4asz_A 146 SQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 222 (299)
T ss_dssp HTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCcccCccCHhhEEECCCCc--EEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 999999999999999977754 99999999987654321 122234469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 576 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
|+|.|++||......+ . .+........+...++++.+||.+||+.||++|||++|++
T Consensus 223 llt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 223 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9995588887644332 2 3333333445566778999999999999999999999994
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=422.61 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=198.7
Q ss_pred eEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.++||+|+||+||+|.. .+++.||||+++.... +...+|+ .+++.++|||||+++|+|.+++.+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~-~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA-MLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHH-HHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHH-HHHHhCCCCCCCCcceEEEECCEEE
Confidence 467889999999999999864 3578999999965432 2344555 4788999999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||| ++|+|.++|+.......... ..........+++.++++|+.|||.||+|||
T Consensus 106 lV~Ey~----------~~G~L~~~L~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 106 MIFSYC----------SHGDLHEFLVMRSPHSDVGS-------------TDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp EEEECC----------SSCBHHHHHHTTCSSCCCC------------------CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcC----------CCCcHHHHHHhhCccccccc-------------cccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 999955 45555555543321110000 0000012346889999999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+||||||||+||||+.++. +||+|||+++.+..... .......+||+.|||||++.+..|+.++|||||||++||
T Consensus 163 ~~~iiHRDLK~~NILl~~~~~--~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~E 239 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239 (308)
T ss_dssp HTTCCCSCCSGGGEEECGGGC--EEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCccccceEECCCCC--EEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHH
Confidence 999999999999999977754 99999999987754321 222345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|+|.|.+||......+ ...+. ......+...++++.+||.+||+.||++|||++||+++
T Consensus 240 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 240 VFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9996688887654332 22333 33333455677899999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=432.29 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=198.7
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC------
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD------ 410 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------ 410 (774)
+++.|.+.+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. +++.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK-ILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHH-HHHhcCCCCcceEeeeeeccccccc
Confidence 45679999999999999999985 45799999999965432 23456775 7788999999999998653
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+.+|||||||.++|.+++. +.+.+++..++.|++||+.|
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~----------------------------------------~~~~l~~~~~~~~~~qil~a 170 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIH----------------------------------------SSQPLTLEHVRYFLYQLLRG 170 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHT----------------------------------------SSSCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeCCCCCHHHHHH----------------------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 46799999988877766551 22457888999999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhcC-CCCCcchhHh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwS 568 (774)
|+|||++|||||||||+|||++.++. +||+|||+|+.+..... ......+.+||+.|||||++.+. .++.++||||
T Consensus 171 l~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS 248 (398)
T 4b99_A 171 LKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248 (398)
T ss_dssp HHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheeh
Confidence 99999999999999999999988876 89999999987654321 22334567899999999998875 4699999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-HH-HHhhccc------------------------------cccccCCHHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERD-AN-IVKDRKD------------------------------LFLVEHIPEAVDLFTR 616 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~-~~-~~~~~~~------------------------------~~~~~~~~~~~dli~~ 616 (774)
+||++|||++| .+||....... .. +...... ......++++.|||.+
T Consensus 249 lG~il~ell~G-~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 327 (398)
T 4b99_A 249 VGCIFGEMLAR-RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 327 (398)
T ss_dssp HHHHHHHHHHT-SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred hHHHHHHHHHC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999997 77886543222 21 1111000 0012346789999999
Q ss_pred hcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 617 LLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 617 ~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||+.||.+|||++|+|+||||...
T Consensus 328 mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 328 MLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HCcCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=417.49 Aligned_cols=253 Identities=23% Similarity=0.450 Sum_probs=182.7
Q ss_pred eEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc--------
Q 004097 346 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD-------- 412 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-------- 412 (774)
.|.+.+.||+|+||+||+|. ..+|+.||||++.....+ ...+|+. +++.++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~-il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 47888999999999999985 457999999999754432 3445665 778899999999999987544
Q ss_pred ----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 004097 413 ----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488 (774)
Q Consensus 413 ----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 488 (774)
.+|||||||. +|+|.+++...... ...++..++.|+.||+
T Consensus 85 ~~~~~l~ivmE~~~----------gg~L~~~l~~~~~~--------------------------~~~~~~~~~~i~~qi~ 128 (299)
T 4g31_A 85 SPKVYLYIQMQLCR----------KENLKDWMNGRCTI--------------------------EERERSVCLHIFLQIA 128 (299)
T ss_dssp --CEEEEEEEECCC----------SCCHHHHHHTCCSG--------------------------GGSCHHHHHHHHHHHH
T ss_pred CCCcEEEEEEecCC----------CCcHHHHHHhcCCC--------------------------ChhHHHHHHHHHHHHH
Confidence 4799999665 34444443321110 1123456789999999
Q ss_pred HHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc---------ccccccCcCCCCCCchhhhhcCC
Q 004097 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC---------LTQNATGYGSSGWQAPEQLLQGR 559 (774)
Q Consensus 489 ~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~l~~~~ 559 (774)
.||+|||+++|+||||||+|||++.++. +||+|||+|+.+...... .....+.+||+.|||||++.+..
T Consensus 129 ~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 9999999999999999999999988875 899999999987643211 11223457999999999999999
Q ss_pred CCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHH---hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 560 QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 560 ~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
|+.++|||||||++|||++ ||....+....+. ...........++++.+||.+||+.||++|||+.|+++|||
T Consensus 207 y~~~~DiwSlGvilyell~----Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY----PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS----CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHHHHHcc----CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 9999999999999999996 6765443322221 11111222334578899999999999999999999999999
Q ss_pred CCCcc
Q 004097 637 FWTAD 641 (774)
Q Consensus 637 f~~~~ 641 (774)
|.+.+
T Consensus 283 ~~~~~ 287 (299)
T 4g31_A 283 FEDLD 287 (299)
T ss_dssp GCCC-
T ss_pred hCCCC
Confidence 97643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=418.99 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=192.7
Q ss_pred ccccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.+.|.+.+.||+|+||+||+|... +++.||||++.+... ....+|+..+....+|||||++++++.+.+++|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 345677999999999999999998542 478999999876543 345677775555558999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||||||+ +|+|.+.+ +.+++.+++.+++||+.||+|||
T Consensus 97 lvmE~~~----------g~~L~~~~--------------------------------~~l~~~~~~~~~~qll~al~ylH 134 (361)
T 4f9c_A 97 IAMPYLE----------HESFLDIL--------------------------------NSLSFQEVREYMLNLFKALKRIH 134 (361)
T ss_dssp EEEECCC----------CCCHHHHH--------------------------------TTCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCC----------cccHHHHH--------------------------------cCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 34443332 12567788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-------------------------ccccccCcCCCCCC
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-------------------------LTQNATGYGSSGWQ 550 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-------------------------~~~~~~~~gt~~y~ 550 (774)
++||+||||||+|||++.+.. .+||+|||+|+........ .....+.+||+.||
T Consensus 135 ~~gIiHRDiKPeNiLl~~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 213 (361)
T 4f9c_A 135 QFGIVHRDVKPSNFLYNRRLK-KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFR 213 (361)
T ss_dssp HTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGC
T ss_pred HCCeEeCcCCHHHeEEeCCCC-eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCcccc
Confidence 999999999999999976632 4899999999865432110 11223457999999
Q ss_pred chhhhhcC-CCCCcchhHhHHHHHHHHHhCCCCCCC-CchHHH--HHHHhh-----------------------------
Q 004097 551 APEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYG-ESFERD--ANIVKD----------------------------- 597 (774)
Q Consensus 551 aPE~l~~~-~~~~~sDvwSlGvll~elltg~~~Pf~-~~~~~~--~~~~~~----------------------------- 597 (774)
|||++.+. .|+.++||||+||++|||++| ++||. ...+.+ ..+...
T Consensus 214 APE~l~~~~~y~~~~DiWSlG~il~ell~G-~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~ 292 (361)
T 4f9c_A 214 APEVLTKCPNQTTAIDMWSAGVIFLSLLSG-RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLR 292 (361)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHT-CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHH
T ss_pred CHHHHcCCCCCCCccchhhhHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhh
Confidence 99999875 489999999999999999997 66663 322111 011000
Q ss_pred --------c----------------cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 598 --------R----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 598 --------~----------------~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
. ........+++++|||.+||+.||++|||++|+|+||||.+
T Consensus 293 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 293 KLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0 00011234678999999999999999999999999999965
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=407.71 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=181.5
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.+.+.++||+|+||+||+|... ..||||+++.... ....+|+ .+++.++|||||+++|+|.+ +.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~-~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEV-AVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 34567899999999999998643 3699999864332 2233455 47889999999999999865 56899999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|| .+|+|.++|+.. ...+++.+++.|+.|||.||+|||+.+|
T Consensus 112 y~----------~gGsL~~~l~~~----------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~I 153 (307)
T 3omv_A 112 WC----------EGSSLYKHLHVQ----------------------------ETKFQMFQLIDIARQTAQGMDYLHAKNI 153 (307)
T ss_dssp CC----------SSCBHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cC----------CCCCHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 55 556666555322 1347888899999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll~el 576 (774)
|||||||+||||+.++ .+||+|||+|+....... .....+.+||+.|||||++.. ..|+.++|||||||++|||
T Consensus 154 iHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 154 IHRDMKSNNIFLHEGL--TVKIGDFGLATVKSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp BCSCCCSSSEEEETTE--EEEECCCSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHH
T ss_pred cCCccCHHHEEECCCC--cEEEeeccCceecccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHH
Confidence 9999999999997775 599999999987653221 223345679999999999974 3589999999999999999
Q ss_pred HhCCCCCCCCchH--HHHHHHhhccc-----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 577 ITGGKHPYGESFE--RDANIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 577 ltg~~~Pf~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|| ++||..... .....+..... ..+...++++.+||.+||+.||++|||+.|+++
T Consensus 231 ltg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 231 MTG-ELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHS-SCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHC-CCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 996 788865332 22223322211 123345678999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=437.58 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=204.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chH-HHHH--HHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDV-ALKE--IQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~-~~~E--i~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
-+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ... ..+| +..++..++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 35699999999999999999854 579999999996432 122 2222 23455678999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
||||||| .+|+|..+|.. .+.+++..++.|+.||+.||+||
T Consensus 268 ylVmEy~----------~GGdL~~~l~~-----------------------------~~~l~E~~a~~y~~qIl~aL~yL 308 (689)
T 3v5w_A 268 SFILDLM----------NGGDLHYHLSQ-----------------------------HGVFSEADMRFYAAEIILGLEHM 308 (689)
T ss_dssp EEEECCC----------CSCBHHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 45555555422 24578889999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll 573 (774)
|++|||||||||+||||+.+|. +||+|||+|+.+... ...+.+||+.|||||++.. ..|+.++|||||||++
T Consensus 309 H~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 309 HNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381 (689)
T ss_dssp HTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHH
T ss_pred HHCCccccCCchHHeEEeCCCC--EEecccceeeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999988876 899999999877542 3356789999999999974 5799999999999999
Q ss_pred HHHHhCCCCCCCCchH----HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccchh
Q 004097 574 FFCITGGKHPYGESFE----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRL 644 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~~ 644 (774)
|||++| .+||..... .....+......++...++++++||.+||+.||.+|++ ++|+++||||.+.++..
T Consensus 382 YEmLtG-~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 382 FKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHHS-SCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHhC-CCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 999997 788864322 11222333344456677899999999999999999998 79999999998876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=411.12 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=198.3
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC-Cce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD-QDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 413 (774)
+.|.+.+.||+|+||+||+|... .++.||||++...... ...+|+..+....+|||||+++|+|.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 46889999999999999998644 2468999999765432 345676655444566999999999876 467
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+||||||| .+|+|.++|+......... ...........+++..++.|+.|||+||+|
T Consensus 144 ~~iV~Ey~----------~~G~L~~~L~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 144 LMVIVEFC----------KFGNLSTYLRSKRNEFVPY-------------KVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp CEEEEECC----------TTEEHHHHHHHTGGGBCCC--------------------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEcC----------CCCCHHHHHHhcccccccc-------------cccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 99999955 4555555554432211000 000001223457889999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+++||||||||+|||++.++. +||+|||+|+.+..... .....+.+||+.|||||++.+..|+.++|||||||++
T Consensus 201 LH~~~iiHRDLK~~NILl~~~~~--vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCCeecCccCccceeeCCCCC--EEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999999999999999987764 99999999997754322 2233445799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCch--HHHHHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESF--ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~--~~~~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||+|.|.+||.... ......+. ......+...++++.++|.+||+.||++|||++|+++|
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999995588886532 22223333 33334455678899999999999999999999999977
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=401.37 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=181.7
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCCeeEEeeeccCCc----eeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~l~g~~~~~~----~~~LV~ 418 (774)
.+++.+.+.||+|+||+||+|. .+|+.||||++.........+|.+. .+..++|||||+++|+|.+.+ .+||||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~-~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEE-ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEE-ECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678899999999999999975 4799999999976654444544432 345689999999999998654 689999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 497 (774)
| |+++|+|.++|+. .+++++.+.+|+.|++.||+|||+.
T Consensus 81 E----------y~~~gsL~~~l~~------------------------------~~l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 81 D----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp E----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred c----------CCCCCcHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 9 5556666665532 2467788899999999999999987
Q ss_pred -------CccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcC------CCCCc
Q 004097 498 -------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG------RQTRA 563 (774)
Q Consensus 498 -------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~------~~~~~ 563 (774)
+||||||||+||||+.++. +||+|||+|+......... ......+||+.|||||++.+. .++.+
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh
Confidence 8999999999999987765 9999999998876443221 223345799999999999764 35779
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCc----------------hHHHHHHHh-hccc-cccc-----cCCHHHHHHHHHhcCC
Q 004097 564 IDLFSLGCILFFCITGGKHPYGES----------------FERDANIVK-DRKD-LFLV-----EHIPEAVDLFTRLLDP 620 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~----------------~~~~~~~~~-~~~~-~~~~-----~~~~~~~dli~~~L~~ 620 (774)
+|||||||++|||+|| .+||+.. .......+. .... ..+. +..+.+.+|+.+||+.
T Consensus 199 ~DVwS~Gvvl~El~tg-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHT-BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred HhhhhHHHHHHHHHHC-CCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 9999999999999997 4444321 111111111 1111 1111 1123678999999999
Q ss_pred CCCCCcCHHHHHc
Q 004097 621 NPDLRPKAQNVLN 633 (774)
Q Consensus 621 dP~~Rps~~elL~ 633 (774)
||++|||+.|+++
T Consensus 278 dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 278 NGAARLTALRIKK 290 (303)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=425.25 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=203.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... +...+|+. +++.++|||||++++++.+.+.+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHH-HHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 5689999999999999999854 5799999999976543 23455665 77889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.++|.. +...+++.++..|++||+.||+|||+++|+
T Consensus 236 ~~----------gg~L~~~i~~----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~~~ii 277 (573)
T 3uto_A 236 MS----------GGELFEKVAD----------------------------EHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277 (573)
T ss_dssp CC----------CCBHHHHHTC----------------------------TTSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cC----------CCcHHHHHHH----------------------------hCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 55 4455444321 113467788899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+|||++.+....+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G- 352 (573)
T 3uto_A 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG- 352 (573)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCSSCEECCTT----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS-
T ss_pred eccCChhhccccCCCCCCEEEeeccceeEccCC----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC-
Confidence 999999999998654345999999999987643 223456799999999999999999999999999999999997
Q ss_pred CCCCCCchHHH-HH-HHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 581 KHPYGESFERD-AN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 581 ~~Pf~~~~~~~-~~-~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||....... .. +..... .......++++++||.+||+.||.+|||++|+|+||||....
T Consensus 353 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 353 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred CCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 77886544332 22 222221 122235678999999999999999999999999999997543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=373.77 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=201.8
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
-..|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 34588999999999999999865 6899999999975432 23345665 67888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ...+++..++.++.||+.||+|||+.
T Consensus 93 ~e~~~----------~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 93 MEYAS----------GGEVFDYLVA-----------------------------HGRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp ECCCT----------TCBHHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EECCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99654 4444444321 23467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCC-CcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSlGvll~el 576 (774)
+|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..+. .++|||||||++|+|
T Consensus 134 ~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 134 RIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVG----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp TCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSS----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred CEeccCCCHHHEEEcCCCC--EEEeeccCceecCCC----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 9999999999999987765 899999999876533 223456799999999999988875 799999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 577 ITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
++| .+||...... ....+.......+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 208 l~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 208 VSG-SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HhC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 997 7788654433 23333333334455667899999999999999999999999999999654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=374.83 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=203.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+. ......+|+ .++..++||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHH-HHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4588899999999999999854 46899999999653 122334455 467889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|..++.. ...+++..++.++.||+.||+|||+.
T Consensus 84 ~E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 124 (337)
T 1o6l_A 84 MEYAN----------GGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EECCT----------TCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99554 4555444321 23467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++...... ....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 125 ~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 199 (337)
T 1o6l_A 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CeecCcCCHHHEEECCCCC--EEEeeccchhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh
Confidence 9999999999999988876 8999999998643221 2234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
+| .+||.... ......+......++...++++.++|.+||+.||.+|| +++|+++||||...++.
T Consensus 200 ~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 200 CG-RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred cC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 97 66775443 33333333333445556788999999999999999999 89999999999876554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=370.18 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=199.3
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.+.|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS-LLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHH-HHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHH-HHHHcCCCCEeeeeeEEccCCEEE
Confidence 445678999999999999999999887899999999864322 23445654 678889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||.++|.+++.. ....+++..++.++.||+.||+|||
T Consensus 96 lv~e~~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~~~~qi~~~l~~LH 136 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDE---------------------------------------NKTGLQDSQIKIYLYQLLRGVAHCH 136 (311)
T ss_dssp EEEECCSEEHHHHHHT---------------------------------------CTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCCHHHHHHh---------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999888776665521 1133677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp HTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred HCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 999999999999999988875 8999999998765321 12234568999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCchHHH--HHHHhhccc-----------------------------cccccCCHHHHHHHHHhcCCCCC
Q 004097 575 FCITGGKHPYGESFERD--ANIVKDRKD-----------------------------LFLVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~--~~~~~~~~~-----------------------------~~~~~~~~~~~dli~~~L~~dP~ 623 (774)
+|++| .+||....... ..+...... ......++++.+||.+||+.||.
T Consensus 212 ~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 290 (311)
T 3niz_A 212 EMITG-KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290 (311)
T ss_dssp HHHHS-SCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTT
T ss_pred HHHhC-CCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChh
Confidence 99997 77886433221 111110000 01123457899999999999999
Q ss_pred CCcCHHHHHcCCCCCCcc
Q 004097 624 LRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 624 ~Rps~~elL~HPff~~~~ 641 (774)
+|||++|+++||||.+.+
T Consensus 291 ~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 291 KRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TSCCHHHHHTSGGGTTSC
T ss_pred HCCCHHHHhcCcccccCC
Confidence 999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=381.13 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=199.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|...+....+||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 5688899999999999999864 468999999997531 223445555443344899999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|..++.. ...+++..++.++.||+.||+|||+.
T Consensus 103 ~E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 143 (353)
T 3txo_A 103 MEFVN----------GGDLMFHIQK-----------------------------SRRFDEARARFYAAEIISALMFLHDK 143 (353)
T ss_dssp EECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99655 4444444321 23477888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++..... .....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 144 givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 218 (353)
T 3txo_A 144 GIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN---GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218 (353)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHH
T ss_pred CCcccCCCHHHEEECCCCC--EEEccccceeecccC---CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHH
Confidence 9999999999999988876 899999999864322 12334567999999999999989999999999999999999
Q ss_pred hCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH------HHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~------~elL~HPff~~~~~~ 643 (774)
+| .+||...... ....+......++...++++.++|.+||+.||.+||++ +|+++||||...++.
T Consensus 219 ~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 219 CG-HAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 97 7777654433 33333344444566678899999999999999999998 899999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=381.91 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=202.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+++.||||++++.. .....+|...+....+|||||++++++.+.+.+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 5688999999999999999865 468899999997542 123456666555556999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|..++.. .+.+++..++.++.||+.||+|||+.
T Consensus 132 ~E~~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~ 172 (396)
T 4dc2_A 132 IEYVN----------GGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHER 172 (396)
T ss_dssp EECCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99554 4555544321 24578888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++..... .....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 173 givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell 247 (396)
T 4dc2_A 173 GIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247 (396)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT---TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEEeccCCHHHEEECCCCC--EEEeecceeeecccC---CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999988876 899999999864322 12335568999999999999999999999999999999999
Q ss_pred hCCCCCCCCc----------hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH------HHHHcCCCCCCcc
Q 004097 578 TGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~----------~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~------~elL~HPff~~~~ 641 (774)
+| .+||... .......+.......+...++++.+||.+||+.||.+||++ +|+++||||.+.+
T Consensus 248 ~G-~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 248 AG-RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HS-SCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred hC-CCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 97 7788421 11122233333444556678899999999999999999985 7999999998765
Q ss_pred ch
Q 004097 642 TR 643 (774)
Q Consensus 642 ~~ 643 (774)
+.
T Consensus 327 w~ 328 (396)
T 4dc2_A 327 WD 328 (396)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=370.58 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=197.5
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.+.|.+.+.||+|+||+||++... +|+.||||++..... ...+.|+..+....+||||++++++|.+++..|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3466889999999999999998665 799999999865322 2334555556666799999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||+|.++|.+++... ...+++..++.|+.||+.||+|||+
T Consensus 135 v~e~~~~~L~~~~~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~ 175 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAW---------------------------------------GASLPEAQVWGYLRDTLLALAHLHS 175 (311)
T ss_dssp EEECCCCBHHHHHHHH---------------------------------------CSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeccCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9998887776665321 2347788899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|||
T Consensus 176 ~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 176 QGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTA----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp TTEECCCCSGGGEEECGGGC--EEECCCTTCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHH
T ss_pred CCEecCCCCHHHEEECCCCC--EEEccceeeeecccC----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHH
Confidence 99999999999999987765 999999998876532 12234569999999999875 789999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 577 ITGGKHPYGESFERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++|..+|+...... .+.... ........++++.++|.+||+.||++|||++|+++||||+.
T Consensus 249 ~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 249 ACNMELPHGGEGWQ--QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHTCCCCSSHHHHH--HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HhCCCCCCCccHHH--HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99877676543221 111111 12233456789999999999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=370.36 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ......++..++..++||||+++++++.+.+.+|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 4588899999999999999855 469999999996531 2223333345778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 86 e~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ 126 (318)
T 1fot_A 86 DYIE----------GGELFSLLRK-----------------------------SQRFPNPVAKFYAAEVCLALEYLHSKD 126 (318)
T ss_dssp CCCC----------SCBHHHHHHH-----------------------------TSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eCCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9665 4444444321 234677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++..... ..+.+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 127 ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 127 IIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp EECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred ccccCCChheEEEcCCCC--EEEeecCcceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999988876 899999999876432 234679999999999999999999999999999999999
Q ss_pred CCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 579 GGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 579 g~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
| .+||..... .....+......++...++++.++|.+||+.||.+|| +++++++||||....+.
T Consensus 199 g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 199 G-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp S-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 7 667755432 2222233333344556778999999999999999999 89999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=364.59 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=198.0
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+++..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHH-HHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 3588899999999999999855 4689999999964432 23345554 778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.++|.+++... ...+++..++.++.||+.||+|||+.+
T Consensus 81 e~~~~~l~~~~~~~---------------------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~ 121 (292)
T 3o0g_A 81 EFCDQDLKKYFDSC---------------------------------------NGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECCSEEHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99887766554211 234677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 122 ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 196 (292)
T 3o0g_A 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred eecCCCCHHHEEEcCCCC--EEEeecccceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHH
Confidence 999999999999988775 8999999998765321 2223456899999999998766 799999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc----------------------------cccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 578 TGGKHPYGESFERDA--NIVKDRKD----------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+|+.++|........ .+...... ......++++.+||.+||+.||++|||
T Consensus 197 ~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 276 (292)
T 3o0g_A 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence 987777765433221 11110000 011134578999999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 004097 628 AQNVLNHPFFWTA 640 (774)
Q Consensus 628 ~~elL~HPff~~~ 640 (774)
++|+++||||.+.
T Consensus 277 ~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcCcccccC
Confidence 9999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.04 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=202.7
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---------hHHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS-ILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHTTCCCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHH-HHHhCCCcCCCcEEEEEEe
Confidence 44567799999999999999999854 4689999999975432 23445654 7788899999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+|||||. +|+|.+++.. ...+++..+..++.||+.|
T Consensus 87 ~~~~~lv~e~~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~a 127 (361)
T 2yab_A 87 RTDVVLILELVS----------GGELFDFLAQ-----------------------------KESLSEEEATSFIKQILDG 127 (361)
T ss_dssp SSEEEEEEECCC----------SCBHHHHHTT-----------------------------CSCCBHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEcCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHH
Confidence 999999999664 3444443321 1346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCC--ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 568 (774)
|+|||+.||+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|||++.+..++.++||||
T Consensus 128 L~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 203 (361)
T 2yab_A 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203 (361)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred HHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHH
Confidence 99999999999999999999976652 258999999998765431 224457999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHH-HH-HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 569 LGCILFFCITGGKHPYGESFER-DA-NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~-~~-~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
|||++|+|++| .+||...... .. .+...... ......++++++||.+||+.||.+|||+.|+++||||...+.
T Consensus 204 lGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 204 IGVITYILLSG-ASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HHHHHHHHHHS-CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 99999999997 6677554332 22 22222211 122355789999999999999999999999999999986544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=375.42 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=203.2
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++.+. .......|...+....+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 35688899999999999999865 46899999999753 123345566545455699999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 96 v~E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 136 (345)
T 1xjd_A 96 VMEYLN----------GGDLMYHIQS-----------------------------CHKFDLSRATFYAAEIILGLQFLHS 136 (345)
T ss_dssp EEECCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999654 4455444321 2346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 137 ~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (345)
T 1xjd_A 137 KGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211 (345)
T ss_dssp TTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHH
Confidence 99999999999999988875 8999999998653221 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH-HHHcCCCCCCccc
Q 004097 577 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTADT 642 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~-elL~HPff~~~~~ 642 (774)
++| .+||..... .....+......++...++++.++|.+||+.||.+||++. ++++||||...++
T Consensus 212 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 212 LIG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred hcC-CCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 997 677765433 2333333334445556778999999999999999999998 9999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.83 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=199.1
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..+.|.+.+.||+|+||+||++. ..+|+.||||++.... .....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHH-HHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 34567788999999999999985 4678999999986432 22334555 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++. ...+++..+..++.|++.||+|||+.+
T Consensus 97 e~~~----------~~~L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (297)
T 3fxz_A 97 EYLA----------GGSLTDVVT------------------------------ETCMDEGQIAAVCRECLQALEFLHSNQ 136 (297)
T ss_dssp ECCT----------TCBHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCC----------CCCHHHHHh------------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9664 444444332 123677788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 137 i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 211 (297)
T 3fxz_A 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (297)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH
T ss_pred ceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999988876 89999999987654322 2344579999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhc--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 579 GGKHPYGESFERDA--NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
| .+||........ .+.... ....+...++++.++|.+||+.||++|||++|+++||||...
T Consensus 212 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 212 G-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp S-SCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 7 778765443222 122111 112344567889999999999999999999999999999643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=370.86 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|...+....+|||||++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4588899999999999999865 4689999999975421 12344554343445899999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ...+++..++.++.||+.||+|||+.
T Consensus 89 ~e~~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 89 IEYVN----------GGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp ECCCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99654 4444444321 23467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 130 ~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 204 (345)
T 3a8x_A 130 GIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204 (345)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CceecCCCHHHEEECCCCC--EEEEeccccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH
Confidence 9999999999999988875 8999999998643221 2234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCc----------hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH------HHHHcCCCCCCcc
Q 004097 578 TGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~----------~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~------~elL~HPff~~~~ 641 (774)
+| .+||... .......+.......+...++++.++|.+||+.||.+||++ +|+++||||.+.+
T Consensus 205 ~g-~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 205 AG-RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HS-SCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred hC-CCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 97 7788531 11122223333334455677899999999999999999995 8999999997765
Q ss_pred c
Q 004097 642 T 642 (774)
Q Consensus 642 ~ 642 (774)
+
T Consensus 284 w 284 (345)
T 3a8x_A 284 W 284 (345)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=359.00 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=193.8
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+|||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHH-HHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788899999999999999877799999999864332 33456664 67888999999999999999999999998
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... ...+++..++.++.||+.||+|||+.+|+
T Consensus 82 ~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 122 (288)
T 1ob3_A 82 LDQDLKKLLDVC---------------------------------------EGGLESVTAKSFLLQLLNGIAYCHDRRVL 122 (288)
T ss_dssp CSEEHHHHHHTS---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred cCCCHHHHHHhc---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 887776665321 13466778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg 579 (774)
||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 123 H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 123 HRDLKPQNLLINREGE--LKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp CSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEEcCCCC--EEEeECccccccCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999988775 8999999998765321 122334689999999999764 589999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhcc----------------------------ccccccCCHHHHHHHHHhcCCCCCCCcCHH
Q 004097 580 GKHPYGESFERDA--NIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 629 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~ 629 (774)
.+||........ .+..... .......++++.+||.+||+.||++|||++
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 276 (288)
T 1ob3_A 198 -TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (288)
T ss_dssp -SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred -CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 677765433221 1111000 001123467899999999999999999999
Q ss_pred HHHcCCCCCC
Q 004097 630 NVLNHPFFWT 639 (774)
Q Consensus 630 elL~HPff~~ 639 (774)
|+++||||.+
T Consensus 277 e~l~hp~f~~ 286 (288)
T 1ob3_A 277 QALEHAYFKE 286 (288)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCcchhh
Confidence 9999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=361.27 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=193.8
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--------chHHHHHHHHH--HHhCCCCCeeEEeeeccC
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--------HDVALKEIQNL--IASDQHPNIVRWYGVESD 410 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--------~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~ 410 (774)
.+..+|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+..+ +..+.||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4466789999999999999999854 678999999986322 13445565532 344569999999999876
Q ss_pred Cc-----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 411 QD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 411 ~~-----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
.. ..++|||+|.++|.+++... ....+++..++.|+.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--------------------------------------~~~~~~~~~~~~i~~ 127 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKA--------------------------------------PPPGLPAETIKDLMR 127 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTC--------------------------------------CTTCSCHHHHHHHHH
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhc--------------------------------------cCCCCCHHHHHHHHH
Confidence 54 58999998888777665211 112367888999999
Q ss_pred HHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcch
Q 004097 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 565 (774)
Q Consensus 486 qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 565 (774)
||+.||+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|
T Consensus 128 qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~D 201 (308)
T 3g33_A 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQ----MALTPVVVTLWYRAPEVLLQSTYATPVD 201 (308)
T ss_dssp HHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSCCCSTHH
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCC----cccCCccccccccCchHHcCCCCCchHH
Confidence 9999999999999999999999999987765 899999999866532 2223457899999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhccc--------------------------cccccCCHHHHHHHHHh
Q 004097 566 LFSLGCILFFCITGGKHPYGESFERDA--NIVKDRKD--------------------------LFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~~~dli~~~ 617 (774)
||||||++|||++| .+||........ .+...... ......++++.+||.+|
T Consensus 202 iwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 280 (308)
T 3g33_A 202 MWSVGCIFAEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEM 280 (308)
T ss_dssp HHHHHHHHHHTTTS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHH
Confidence 99999999999997 777765443321 12111000 01124567899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||+.|+|+||||...
T Consensus 281 L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 281 LTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TCSSTTTSCCHHHHHTSTTC---
T ss_pred hcCCCccCCCHHHHhcCccccCC
Confidence 99999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=374.67 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=201.2
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC--------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++... ..+...+|+. ++..++||||+++++++.+.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS-ICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999854 56899999998532 1233445554 778889999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||. ++|.+++ .... .....+++..+..++.||+.||
T Consensus 100 ~~~lv~e~~~g~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~qi~~al 143 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEI-----------VKRA-------------------------DAGFVYSEAVASHYMRQILEAL 143 (351)
T ss_dssp EEEEEEECCSSCBHHHHH-----------HHHH-------------------------HTTCCCCHHHHHHHHHHHHHHH
T ss_pred EEEEEEeCCCCCCHHHHH-----------HHhc-------------------------ccCCCCCHHHHHHHHHHHHHHH
Confidence 9999999766 3454443 2211 0112367788899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
+|||+.+|+||||||+|||++.++ ...+||+|||+++...... ......+||+.|+|||++.+..++.++||||||
T Consensus 144 ~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 220 (351)
T 3c0i_A 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220 (351)
T ss_dssp HHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHH
Confidence 999999999999999999997654 2358999999998775432 122345799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHH-HHhhccccc---cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 571 CILFFCITGGKHPYGESFERDAN-IVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~~-~~~~~~~~~---~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|++|+|++| .+||......... +........ ....++++.+||.+||+.||++|||+.|+++||||...
T Consensus 221 ~il~~ll~g-~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 221 VILFILLSG-CLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHS-SCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHC-CCCCCCcHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999999997 7788765443332 222222111 13457899999999999999999999999999999653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=363.85 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=201.0
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEe
Confidence 34567799999999999999999854 468999999996542 123445654 7788899999999999999
Q ss_pred CceeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 411 ~~~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.+..|+|||||. ++|.+++ .. ...+++..++.++.||+.
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~i~~qi~~ 125 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFL-----------AE-----------------------------KESLTEEEATEFLKQILN 125 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHH-----------TT-----------------------------SSCCBHHHHHHHHHHHHH
T ss_pred CCEEEEEEEcCCCCCHHHHH-----------Hh-----------------------------cCCcCHHHHHHHHHHHHH
Confidence 999999999665 3554443 11 134677888999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCC--CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvw 567 (774)
||+|||+.+|+||||||+|||++.++ ...+||+|||+++...... ......||+.|+|||++.+..++.++|||
T Consensus 126 al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 201 (326)
T 2y0a_A 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMW 201 (326)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHH
T ss_pred HHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHH
Confidence 99999999999999999999998765 2258999999998775322 22345699999999999989999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHH-HHHHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 568 SLGCILFFCITGGKHPYGESFER-DANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~-~~~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
||||++|+|++| .+||...... ....+..... ......++++.+||.+||+.||.+|||++|+++||||.....
T Consensus 202 slG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 202 SIGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHHHHHHS-CCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHHHHHHC-cCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 999999999997 6677544322 2222221111 122345788999999999999999999999999999976543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=373.01 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=199.5
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+.+..|+|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS-YLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4588999999999999999864 678999999986421 223455664 77889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.++|.+++. ....+++..++.++.||+.||+|||+.
T Consensus 88 ~E~~~g~l~~~l~----------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~ 127 (336)
T 3h4j_B 88 IEYAGGELFDYIV----------------------------------------EKKRMTEDEGRRFFQQIICAIEYCHRH 127 (336)
T ss_dssp ECCCCEEHHHHHH----------------------------------------HHCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCcHHHHHH----------------------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9988767666552 123467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~el 576 (774)
||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..+ +.++|||||||++|+|
T Consensus 128 givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 201 (336)
T 3h4j_B 128 KIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201 (336)
T ss_dssp TCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTS----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHH
T ss_pred CeEecCCchhhEEEcCCCC--EEEEEeccceeccCC----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHH
Confidence 9999999999999987765 899999999876543 22345679999999999988776 6899999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 577 ITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
++| .+||....... ...+.......+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 202 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 202 LVG-RLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHS-SCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HhC-CCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 997 77886543221 1111112222344567899999999999999999999999999999653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=370.47 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=200.2
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHh-CCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIAS-DQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~-l~HpNIV~l~g~~~~~~~~~L 416 (774)
..|.+.+.||+|+||+||++... +|+.||||++.+.. ......|.. ++.. .+||||+++++++.+.+.+|+
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~-~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHH-HHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 45888999999999999998654 57899999997531 123344554 4444 489999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 99 v~E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 139 (353)
T 2i0e_A 99 VMEYVN----------GGDLMYHIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLQS 139 (353)
T ss_dssp EEECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999654 4444444321 2346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.||+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 140 ~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (353)
T 2i0e_A 140 KGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214 (353)
T ss_dssp TTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred CCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHH
Confidence 99999999999999988876 8999999998643221 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccch
Q 004097 577 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 643 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~ 643 (774)
++| .+||..... .....+......++...++++.+||.+||+.||.+||+ ++++++||||...++.
T Consensus 215 l~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 215 LAG-QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred HcC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 997 677765433 22333333344455667889999999999999999995 6999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=369.04 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=202.6
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
-+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+ .++..++||||+++++++.+.+.+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 35688899999999999999865 468999999986432 12334455 46788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 119 v~e~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (350)
T 1rdq_E 119 VMEYVA----------GGEMFSHLRR-----------------------------IGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp EEECCT----------TCBHHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCC----------CCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999664 4444444321 2346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++..... ..+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 160 ~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp TTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCcccccCccceEEECCCCC--EEEcccccceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 99999999999999988775 899999999876532 2345799999999999999999999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccch
Q 004097 577 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 643 (774)
Q Consensus 577 ltg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~ 643 (774)
++| .+||..... .....+......++...++++.++|.+||+.||.+||+ ++|+++||||...++.
T Consensus 232 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 232 AAG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 997 667765433 22233333334455667889999999999999999998 9999999999776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=377.67 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+...+.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....+.++..++..++|||||++++++.+.+.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34456799999999999999999865 468999999996521 122233344577889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+||||| .+|+|.+++. ...+++..++.++.||+.||+||
T Consensus 145 ~lV~E~~----------~gg~L~~~l~------------------------------~~~~~e~~~~~~~~qi~~aL~~L 184 (410)
T 3v8s_A 145 YMVMEYM----------PGGDLVNLMS------------------------------NYDVPEKWARFYTAEVVLALDAI 184 (410)
T ss_dssp EEEECCC----------TTEEHHHHHH------------------------------HCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCC----------CCCcHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 4455554432 12367778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC----CCCcchhHhHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 570 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDvwSlG 570 (774)
|+.+|+||||||+|||++.++. +||+|||+++...... .....+.+||+.|+|||++.... ++.++||||||
T Consensus 185 H~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlG 260 (410)
T 3v8s_A 185 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260 (410)
T ss_dssp HHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHH
T ss_pred HHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecch
Confidence 9999999999999999988876 8999999998765432 12234568999999999998765 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HH-HHHhhcc-cccc--ccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCccc
Q 004097 571 CILFFCITGGKHPYGESFER-DA-NIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~-~~~~~~~-~~~~--~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~~ 642 (774)
|++|||++| .+||...... .. .+..... ..++ ...++++++||.+||+.+|.+ ||+++|+++||||.+.++
T Consensus 261 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 261 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred HHHHHHHhC-CCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 999999997 6677554322 22 3333221 1122 346789999999999999988 999999999999976544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=374.21 Aligned_cols=254 Identities=25% Similarity=0.299 Sum_probs=198.5
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..|.+.+.||+|+||+||++.. .+++.||||++.+... ....+|...++..++|||||++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5588899999999999999865 4588999999975432 12334444345678999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ...+++..++.++.||+.||+|||+.
T Consensus 118 ~E~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 158 (373)
T 2r5t_A 118 LDYIN----------GGELFYHLQR-----------------------------ERCFLEPRARFYAAEIASALGYLHSL 158 (373)
T ss_dssp EECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99554 4455444322 23467778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++...... ....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (373)
T 2r5t_A 159 NIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233 (373)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CceecCCCHHHEEECCCCC--EEEeeCccccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999988876 8999999998644321 2334567999999999999999999999999999999999
Q ss_pred hCCCCCCCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH----HHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~----~elL~HPff~~~~~~ 643 (774)
+| .+||.... ......+.......+...++++.+||.+||+.||.+||++ .++++||||...++.
T Consensus 234 ~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 234 YG-LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp HS-SCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred cC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 97 66775543 3333333333334455677899999999999999999987 689999999876553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=370.69 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=199.0
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3456789999999999999999854 4689999999975432 22334554 778889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+.+.. ...+++..+..++.||+.||+|||
T Consensus 105 lv~e~~~----------gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH 145 (362)
T 2bdw_A 105 LVFDLVT----------GGELFEDIVA-----------------------------REFYSEADASHCIQQILESIAYCH 145 (362)
T ss_dssp EEECCCC----------SCBHHHHHTT-----------------------------CSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 3444443321 234677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++ ...+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 146 ~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 221 (362)
T 2bdw_A 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221 (362)
T ss_dssp HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999997643 2458999999998765321 223457999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCchH-HHHHHHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 575 FCITGGKHPYGESFE-RDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 575 elltg~~~Pf~~~~~-~~~~~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+|++| .+||..... .....+......+ ....++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 222 ~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 222 ILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99997 667754432 2222222221111 13457899999999999999999999999999999653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=381.17 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=182.4
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC-----C
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD-----Q 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-----~ 411 (774)
+.+.|.+.+.||+|+||+||++. ..+|+.||||++.+... ....+|+. ++..++|||||++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHH-HHHhCCCCCCCceEEEEecCCcccC
Confidence 45678999999999999999985 45789999999965322 23445665 6788899999999999844 3
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+.+|+|||+|.++|.+++. ....+++..++.|+.||+.||
T Consensus 130 ~~~~lv~e~~~~~L~~~~~----------------------------------------~~~~l~~~~~~~~~~qi~~aL 169 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFR----------------------------------------TPVYLTELHIKTLLYNLLVGV 169 (458)
T ss_dssp CCEEEEECCCSEEHHHHHH----------------------------------------SSCCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeccccchhhhcc----------------------------------------cCCCCCHHHHHHHHHHHHHHH
Confidence 6799999988877766551 123467788899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc------------------------cccccCcCCC
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL------------------------TQNATGYGSS 547 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~------------------------~~~~~~~gt~ 547 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++......... ......+||+
T Consensus 170 ~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 247 (458)
T 3rp9_A 170 KYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247 (458)
T ss_dssp HHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCCCCCC---------------------------CCC
T ss_pred HHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccc
Confidence 9999999999999999999988765 8999999998765321110 1223457899
Q ss_pred CCCchhhh-hcCCCCCcchhHhHHHHHHHHHhC----------CCCCCCCchH---------------------HHH-HH
Q 004097 548 GWQAPEQL-LQGRQTRAIDLFSLGCILFFCITG----------GKHPYGESFE---------------------RDA-NI 594 (774)
Q Consensus 548 ~y~aPE~l-~~~~~~~~sDvwSlGvll~elltg----------~~~Pf~~~~~---------------------~~~-~~ 594 (774)
.|+|||++ ....++.++|||||||++|||++| ++++|..... ... .+
T Consensus 248 ~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 327 (458)
T 3rp9_A 248 WYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVI 327 (458)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHH
T ss_pred cccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHH
Confidence 99999986 456799999999999999999984 4566643210 000 00
Q ss_pred Hhh-----------------------cc-------ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 595 VKD-----------------------RK-------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 595 ~~~-----------------------~~-------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
... .. .......++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 328 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 328 FNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 000 00 001123468999999999999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=363.21 Aligned_cols=253 Identities=28% Similarity=0.369 Sum_probs=194.7
Q ss_pred cceEEEeEeecccCceEEEEEee----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+ .++..++||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER-NILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HH-HHHHHCCCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHH-HHHHhCCCCCccceeEEEEcCC
Confidence 45688999999999999999865 4789999999975421 1223454 4778899999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||||. +|+|.+++.. ...+++..++.++.||+.||+
T Consensus 95 ~~~lv~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~ 135 (327)
T 3a62_A 95 KLYLILEYLS----------GGELFMQLER-----------------------------EGIFMEDTACFYLAEISMALG 135 (327)
T ss_dssp CEEEEEECCT----------TEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEeCCC----------CCcHHHHHHh-----------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 9999999665 3444443321 133667788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 136 ~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 136 HLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp HHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred HHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 999999999999999999988775 8999999997654221 12234579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccc
Q 004097 573 LFFCITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 642 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~ 642 (774)
+|||++| .+||...... ....+.......+...++++.++|.+||+.||.+|| ++.|+++||||...++
T Consensus 211 l~el~~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 211 MYDMLTG-APPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 9999997 7787654332 222222233334456678999999999999999999 8899999999976554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=374.20 Aligned_cols=255 Identities=29% Similarity=0.380 Sum_probs=184.6
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC--ce
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DF 413 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~ 413 (774)
.+.+.|.+.+.||+|+||+||++. ..+|+.||||++.+.. ....++|+..+.....||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345678999999999999999985 4578999999985432 123456776444444599999999998754 47
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|||||.++|.+++. ...+++..+..++.||+.||+|
T Consensus 86 ~~lv~e~~~~~L~~~~~-----------------------------------------~~~~~~~~~~~i~~qi~~~L~~ 124 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIR-----------------------------------------ANILEPVHKQYVVYQLIKVIKY 124 (388)
T ss_dssp EEEEEECCSEEHHHHHH-----------------------------------------HTCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEecccCcCHHHHHH-----------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 89999988877665552 1235667778999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc------------------cccccccCcCCCCCCchhhh
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------------CLTQNATGYGSSGWQAPEQL 555 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~------------------~~~~~~~~~gt~~y~aPE~l 555 (774)
||+.||+||||||+|||++.++. +||+|||+++.+..... ........+||+.|+|||++
T Consensus 125 LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 125 LHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp HHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred HHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 99999999999999999987765 89999999987643110 01112345799999999999
Q ss_pred hc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-H-HHHhhcc---------------------------------
Q 004097 556 LQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-A-NIVKDRK--------------------------------- 599 (774)
Q Consensus 556 ~~-~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~-~~~~~~~--------------------------------- 599 (774)
.+ ..++.++|||||||++|||++| .+||....... . .++....
T Consensus 203 ~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (388)
T 3oz6_A 203 LGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281 (388)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----C
T ss_pred cCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCH
Confidence 86 6789999999999999999997 77775543221 1 1111000
Q ss_pred -c------------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 600 -D------------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 600 -~------------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
. ......++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 0 0011456799999999999999999999999999999653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.62 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=199.3
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.+.|.+.+.||+|+||+||++.. .+++.||+|.+...... ...+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHH-HHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 456789999999999999999854 46899999998654322 2345554 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.+ |+|.+++... ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ~~~g----------~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~gi 123 (321)
T 1tki_A 82 FISG----------LDIFERINTS----------------------------AFELNEREIVSYVHQVCEALQFLHSHNI 123 (321)
T ss_dssp CCCC----------CBHHHHHTSS----------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eCCC----------CCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 7653 3444333211 1246778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.+....+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 124 vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 199 (321)
T 1tki_A 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987433459999999998775432 22345689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HH-HHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESFERD-AN-IVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~-~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||....... .. +....... .....++++.++|.+||+.||.+|||+.|+++||||...
T Consensus 200 -~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 200 -INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -CCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 66776543322 22 22222111 123567899999999999999999999999999999654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=377.31 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=198.2
Q ss_pred ccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
..+.+.|.+.+.||+|+||+||++. ..+|+.||+|++..... ....+|+ .++..++|||||++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA-RICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHH-HHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCcCCCeEEEEEEECCEE
Confidence 4456779999999999999999984 46799999999975442 2234455 477888999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+.+.. ...+++..+..++.||+.||+||
T Consensus 86 ~lv~E~~~----------gg~L~~~i~~-----------------------------~~~~~e~~~~~i~~qil~aL~~l 126 (444)
T 3soa_A 86 YLIFDLVT----------GGELFEDIVA-----------------------------REYYSEADASHCIQQILEAVLHC 126 (444)
T ss_dssp EEEECCCB----------CCBHHHHHHH-----------------------------CSCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 3444433321 23467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCC-CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|||++.+ ....+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 127 H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203 (444)
T ss_dssp HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHH
Confidence 99999999999999999743 223589999999987654321 22345799999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCchH-HHHHHHhhcccccc----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 574 FFCITGGKHPYGESFE-RDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~-~~~~~~~~~~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|+|++| .+||..... .....+......++ ...++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 204 yell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 204 YILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHhC-CCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999997 667754433 22233322221111 245789999999999999999999999999999954
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=370.24 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=202.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++.+.. .....+|+. ++..++|||||++++++.+.+.+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ-IMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 35688999999999999999854 468999999986432 233445654 6788999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|..++.. ...+++..++.++.||+.||+|||+
T Consensus 93 v~e~~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~ 133 (384)
T 4fr4_A 93 VVDLLL----------GGDLRYHLQQ-----------------------------NVHFKEETVKLFICELVMALDYLQN 133 (384)
T ss_dssp EECCCT----------TEEHHHHHHT-----------------------------TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999554 4455444321 2346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 573 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll 573 (774)
.||+||||||+|||++.++. +||+|||+++.+... ....+.+||+.|+|||++.. ..++.++|||||||++
T Consensus 134 ~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 134 QRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp TTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHH
T ss_pred CCceeccCcHHHeEECCCCC--EEEeccceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHH
Confidence 99999999999999988876 899999999876532 23345679999999999974 4589999999999999
Q ss_pred HHHHhCCCCCCCCc----hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-HHHHHcCCCCCCccch
Q 004097 574 FFCITGGKHPYGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-AQNVLNHPFFWTADTR 643 (774)
Q Consensus 574 ~elltg~~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-~~elL~HPff~~~~~~ 643 (774)
|||++| .+||... .......+......++...++++.+||.+||+.||.+||+ ++++++||||...++.
T Consensus 208 ~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 208 YELLRG-RRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp HHHHHS-SCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred HHHHhC-CCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 999997 7777532 2222233333444455667889999999999999999998 8999999999876554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.05 Aligned_cols=255 Identities=27% Similarity=0.356 Sum_probs=186.5
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
..|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS-LMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHH-HHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHH-HHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4577789999999999999854 468999999996432 234556665 7788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.++|.+++...... .....+++..+..++.||+.||+|||+.+|
T Consensus 84 ~~~~~L~~~l~~~~~~----------------------------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i 129 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVG----------------------------------NTPRGLELNLVKYFQWQLLQGLAFCHENKI 129 (317)
T ss_dssp CCCCBHHHHHHHHHSS----------------------------------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ecCCCHHHHHHhcccc----------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 9888877766321100 011346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 130 vH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 204 (317)
T 2pmi_A 130 LHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204 (317)
T ss_dssp ECCCCCGGGEEECTTCC--EEECCCSSCEETTSCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred eeCCCChHHeEEcCCCC--EEECcCccceecCCCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999988775 8999999998765321 122345689999999999864 68999999999999999999
Q ss_pred CCCCCCCCchHHH-H-HHHhhcc---------------------------------ccccccCCHHHHHHHHHhcCCCCC
Q 004097 579 GGKHPYGESFERD-A-NIVKDRK---------------------------------DLFLVEHIPEAVDLFTRLLDPNPD 623 (774)
Q Consensus 579 g~~~Pf~~~~~~~-~-~~~~~~~---------------------------------~~~~~~~~~~~~dli~~~L~~dP~ 623 (774)
| .+||....... . .+..... .......++++.+||.+||+.||.
T Consensus 205 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 205 G-KPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence 7 77876543322 1 1111000 001113457899999999999999
Q ss_pred CCcCHHHHHcCCCCCCc
Q 004097 624 LRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 624 ~Rps~~elL~HPff~~~ 640 (774)
+|||++|+++||||...
T Consensus 284 ~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 284 MRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GSCCHHHHTTSGGGGGG
T ss_pred cCCCHHHHhCChhhhcc
Confidence 99999999999999653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=367.90 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=186.9
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHH-HHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVAL-KEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~-~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..+.+.|.+.+.||+|+||+||++... +++.||||++........+ +|+ .++..++||||+++++++.+.+..|+||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI-GVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------C-HHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHH-HHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 345667899999999999999998654 5889999999765433333 455 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 128 e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ 168 (349)
T 2w4o_A 128 ELVT----------GGELFDRIVE-----------------------------KGYYSERDAADAVKQILEAVAYLHENG 168 (349)
T ss_dssp CCCC----------SCBHHHHHTT-----------------------------CSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCC----------CCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9665 4444443321 123677888999999999999999999
Q ss_pred ccccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++. +....+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 169 ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp CCCCCCCGGGEEESSSSTTCCEEECCCC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred eEecCCCcccEEEecCCCCCCEEEccCccccccCcc----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence 999999999999975 22235999999999876532 1223456999999999999989999999999999999999
Q ss_pred hCCCCCCCCchHHH--H-HHHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 578 TGGKHPYGESFERD--A-NIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~~~~~--~-~~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+| ..||....... . .+....... .....++++.+||.+||+.||++|||+.|+++||||....
T Consensus 245 ~g-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 245 CG-FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HS-SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred hC-CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 97 66765433222 1 222222111 1234567999999999999999999999999999997644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=369.55 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=199.2
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ...+|+..+....+||||+++++++.+.+..|+||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 3456789999999999999999854 4689999999976543 3456777666667899999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++. ....+++..+..++.||+.||+|||+.||+
T Consensus 98 ~~----------gg~L~~~i~-----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~giv 138 (342)
T 2qr7_A 98 MK----------GGELLDKIL-----------------------------RQKFFSEREASAVLFTITKTVEYLHAQGVV 138 (342)
T ss_dssp CC----------SCBHHHHHH-----------------------------TCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCcHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 65 344443332 123467788899999999999999999999
Q ss_pred ccccCCCCeeecCC-CC-ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 501 HRDLKPQNVLISKD-KS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 501 HrDLkp~NILl~~~-~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
||||||+|||+..+ +. ..+||+|||+++...... ....+.+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 139 HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 99999999998543 22 348999999998765432 12345679999999999998889999999999999999999
Q ss_pred CCCCCCCCc----hHHHHHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 579 GGKHPYGES----FERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 579 g~~~Pf~~~----~~~~~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
| .+||... .......+...... .....++++.+||.+||+.||.+|||+.++++||||..+
T Consensus 216 g-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 216 G-YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp S-SCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred C-CCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 7 7788642 22222222222111 123457899999999999999999999999999999554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=377.97 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=200.8
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
...+.|.+.+.||+|+||+||++... +++.||||++.+.. ....++++..++..++||||++++++|.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34567899999999999999998654 57899999996521 1122344445778889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||| .+|+|.+++... ...+++..++.++.||+.||+|||
T Consensus 151 lV~Ey~----------~gg~L~~~l~~~----------------------------~~~l~e~~~~~~~~qi~~aL~~LH 192 (437)
T 4aw2_A 151 LVMDYY----------VGGDLLTLLSKF----------------------------EDRLPEEMARFYLAEMVIAIDSVH 192 (437)
T ss_dssp EEECCC----------TTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecC----------CCCcHHHHHHHc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999954 455555554321 134778889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLG 570 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlG 570 (774)
+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++. ...++.++||||||
T Consensus 193 ~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlG 268 (437)
T 4aw2_A 193 QLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268 (437)
T ss_dssp HTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHH
T ss_pred hCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHH
Confidence 999999999999999988775 89999999987654322 2233467999999999997 45689999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HH-HHHhhcc-cccc---ccCCHHHHHHHHHhcCCCCCC--CcCHHHHHcCCCCCCccc
Q 004097 571 CILFFCITGGKHPYGESFER-DA-NIVKDRK-DLFL---VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-~~-~~~~~~~-~~~~---~~~~~~~~dli~~~L~~dP~~--Rps~~elL~HPff~~~~~ 642 (774)
|++|||++| .+||...... .. .++.... ..++ ...++++++||.+||..+|++ |++++|+++||||...++
T Consensus 269 vil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 269 VCMYEMLYG-ETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred HHHHHHHhC-CCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 999999997 6677554322 22 3332211 1122 336789999999999999988 999999999999976554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=379.12 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=198.6
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|.+.+.||+|+||+||++. ..+|+.||||++.+.. .....+|+ .++..++||||+++++++.+.+.+|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHH-HHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3568899999999999999985 4578999999996431 11223344 36677899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|..++.. ...+++..++.++.||+.||+|||+
T Consensus 226 v~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 266 (446)
T 4ejn_A 226 VMEYAN----------GGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLHS 266 (446)
T ss_dssp EECCCS----------SCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999554 4555444321 2346788889999999999999998
Q ss_pred -cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 -IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 -~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 267 ~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 341 (446)
T 4ejn_A 267 EKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341 (446)
T ss_dssp HTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHH
T ss_pred cCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHH
Confidence 89999999999999988775 8999999998644321 22345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCch-HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 576 CITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 576 lltg~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
|++| .+||.... ......+......++...++++.+||.+||+.||.+|| +++|+++||||....+.
T Consensus 342 ll~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 342 MMCG-RLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HhhC-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 9997 66775543 33333333344445566788999999999999999999 99999999999876544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=377.60 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=184.7
Q ss_pred ccccceEEE-eEeecccCceEEEEEeee---CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeec--cCCce
Q 004097 341 RRIGKLVVF-NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVE--SDQDF 413 (774)
Q Consensus 341 ~~i~~~~~~-~~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~--~~~~~ 413 (774)
..+.+.|.+ +++||+|+||+||++... +++.||||++..... ....+|+. ++..++|||||++++++ .+...
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHH-HHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHH-HHHhcCCCCeeeEeeEEecCCCCe
Confidence 444556665 457999999999998654 578999999976543 34556665 77888999999999999 45788
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||.++|.+++........ ......+++..++.|+.||+.||+|
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~al~~ 143 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKA-------------------------------NKKPVQLPRGMVKSLLYQILDGIHY 143 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC--------------------------------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCHHHHHHHhccccc-------------------------------cccccCCCHHHHHHHHHHHHHHHHH
Confidence 999999998888777632210000 0112347888999999999999999
Q ss_pred HHHcCccccccCCCCeeec----CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHh
Q 004097 494 LHEIGLIHRDLKPQNVLIS----KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 568 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~----~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwS 568 (774)
||+.+|+||||||+|||+. .++ .+||+|||+++...............+||+.|+|||++.+. .++.++||||
T Consensus 144 LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 221 (405)
T 3rgf_A 144 LHANWVLHRDLKPANILVMGEGPERG--RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221 (405)
T ss_dssp HHHTTCCCCCCCGGGEEECCSSTTTT--CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHH
T ss_pred HHhCCEeCCCcCHHHeEEecCCCCCC--cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHH
Confidence 9999999999999999993 344 49999999998775432222333456799999999999874 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHH-----------HHHHHhhcc-------------------------cc-----------
Q 004097 569 LGCILFFCITGGKHPYGESFER-----------DANIVKDRK-------------------------DL----------- 601 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~-----------~~~~~~~~~-------------------------~~----------- 601 (774)
|||++|||++| .+||...... ...+..... ..
T Consensus 222 lG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (405)
T 3rgf_A 222 IGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300 (405)
T ss_dssp HHHHHHHHHHS-SCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred HHHHHHHHHhC-CCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence 99999999997 7787533211 011111000 00
Q ss_pred -ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 602 -FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 602 -~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.....++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 0011256889999999999999999999999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=363.89 Aligned_cols=255 Identities=23% Similarity=0.418 Sum_probs=189.7
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD------ 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------ 412 (774)
-+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++|||||++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHH-HHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHH-HHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 356888999999999999998654 799999999974332 23345554 778889999999999885543
Q ss_pred ---------------------------------------------------eeEEeccccCC-ChhhHHHHhcCChHHHh
Q 004097 413 ---------------------------------------------------FVYLSLERCTC-SLNDLIYVLSGSFEEQL 440 (774)
Q Consensus 413 ---------------------------------------------------~~~LV~E~~~~-sL~~~iy~~~gsL~~~L 440 (774)
..|+|||||.+ +|.+++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----------- 152 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM----------- 152 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHH-----------
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHH-----------
Confidence 38999997663 454444
Q ss_pred hhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEE
Q 004097 441 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520 (774)
Q Consensus 441 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~k 520 (774)
..... ....++..++.++.||+.||+|||+.+|+||||||+|||++.++. +|
T Consensus 153 ~~~~~--------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~k 204 (332)
T 3qd2_B 153 NRRCS--------------------------LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VK 204 (332)
T ss_dssp HTCCS--------------------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EE
T ss_pred hcccC--------------------------ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EE
Confidence 22111 011344567899999999999999999999999999999987765 89
Q ss_pred EcccCccccccCCCcc---------ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH
Q 004097 521 LSDMGISKRLQGDMSC---------LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 591 (774)
Q Consensus 521 l~DFGla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~ 591 (774)
|+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++| ..|+.......
T Consensus 205 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~-~~~~~~~~~~~ 283 (332)
T 3qd2_B 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-FSTQMERVRII 283 (332)
T ss_dssp ECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSC-CCCHHHHHHHH
T ss_pred EeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHc-CCChhHHHHHH
Confidence 9999999877643211 1122345699999999999999999999999999999999996 44543322222
Q ss_pred HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 592 ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
................+++.++|.+||+.||.+|||++|+++||||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 222222222223344678899999999999999999999999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=362.99 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=194.9
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.|.+.+.||+|+||+||++... +++.||||++...... ...+|+. ++..++||||+++++++.+.+..|+||||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHH-HHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHH-HHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5788899999999999998654 7899999998644322 2234654 67888999999999999999999999998
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... ...+++..++.++.||+.||+|||+.+|+
T Consensus 82 ~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 122 (324)
T 3mtl_A 82 LDKDLKQYLDDC---------------------------------------GNIINMHNVKLFLFQLLRGLAYCHRQKVL 122 (324)
T ss_dssp CSEEHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cccCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 887776665211 12366778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg 579 (774)
||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 123 H~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 123 HRDLKPQNLLINERGE--LKLADFGLARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ESSCCGGGEEECTTCC--EEECSSSEEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCcCHHHEEECCCCC--EEEccCcccccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999988875 8999999998654321 12234468999999999986 5689999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhccc-----------------------------cccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 580 GKHPYGESFERDA--NIVKDRKD-----------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 580 ~~~Pf~~~~~~~~--~~~~~~~~-----------------------------~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
.+||........ .+...... ......++++.+||.+||+.||.+|||+
T Consensus 198 -~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 276 (324)
T 3mtl_A 198 -RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276 (324)
T ss_dssp -SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH
Confidence 678865443321 11110000 0112345788999999999999999999
Q ss_pred HHHHcCCCCCCccchhhhhhhc
Q 004097 629 QNVLNHPFFWTADTRLSFLRDV 650 (774)
Q Consensus 629 ~elL~HPff~~~~~~~~~l~~~ 650 (774)
+|+++||||.+...+...+.+.
T Consensus 277 ~e~l~hp~f~~~~~~~~~~~~~ 298 (324)
T 3mtl_A 277 EDAMKHPFFLSLGERIHKLPDT 298 (324)
T ss_dssp HHHTTSGGGGGGCSTTSSSCTT
T ss_pred HHHhcChhhhhcccccccCCCC
Confidence 9999999998766554443333
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.15 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=195.3
Q ss_pred cccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCC-----CCCeeEEeeeccCC
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQ-----HPNIVRWYGVESDQ 411 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~-----HpNIV~l~g~~~~~ 411 (774)
+..+.+.|.+.+.||+|+||+||++.. .+++.||||++..... .....|+. ++..+. |||||++++++.+.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD-ILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHH-HHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHH-HHHHhcccCCCCCCeecccceeeEC
Confidence 356678899999999999999999855 5789999999974321 23334554 555554 99999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|+|||+|.++|.+++... ...++++..++.++.||+.||
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~--------------------------------------~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRN--------------------------------------NYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHT--------------------------------------TTCCCCHHHHHHHHHHHHHHH
T ss_pred CeeEEEEcCCCCCHHHHHHhc--------------------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 999999998876776665211 112467788899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCC-----------------------CCceEEEcccCccccccCCCccccccccCcCCCC
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKD-----------------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 548 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~-----------------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 548 (774)
+|||+.+|+||||||+|||++.+ ....+||+|||+++..... .....||+.
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~ 224 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQ 224 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGG
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCccc
Confidence 99999999999999999999751 1235899999999865432 234568999
Q ss_pred CCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccc---------------------------
Q 004097 549 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKD--------------------------- 600 (774)
Q Consensus 549 y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~--------------------------- 600 (774)
|+|||++.+..++.++|||||||++|||++| .+||....... ...+.....
T Consensus 225 y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 303 (360)
T 3llt_A 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303 (360)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEEC
T ss_pred ccCcHHHcCCCCCCccchHHHHHHHHHHHHC-CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceec
Confidence 9999999999999999999999999999997 77886543221 111110000
Q ss_pred -------------------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 601 -------------------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 601 -------------------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
.......+++.+||.+||+.||.+|||++|+|+||||+
T Consensus 304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00111236778999999999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=362.99 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=191.2
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.|.+.+.||+|+||+||++. ..+|+.||||++...... ...+|+. ++..++||||+++++++.+.+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS-LLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHH-HGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHH-HHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3568899999999999999985 457899999999644322 2345554 67888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.++|.+++. ....+++..++.|+.||+.||+|||+.
T Consensus 112 ~e~~~~~L~~~~~----------------------------------------~~~~~~~~~~~~i~~ql~~~l~~LH~~ 151 (329)
T 3gbz_A 112 FEYAENDLKKYMD----------------------------------------KNPDVSMRVIKSFLYQLINGVNFCHSR 151 (329)
T ss_dssp EECCSEEHHHHHH----------------------------------------HCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCCHHHHHh----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9988877766652 112367778899999999999999999
Q ss_pred CccccccCCCCeeecCCC---CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 573 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll 573 (774)
+|+||||||+|||++.++ ...+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++
T Consensus 152 ~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228 (329)
T ss_dssp TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 999999999999995322 2358999999998765321 122345689999999999875 489999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH--HHHhhccc-----------------------------cccccCCHHHHHHHHHhcCCCC
Q 004097 574 FFCITGGKHPYGESFERDA--NIVKDRKD-----------------------------LFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~--~~~~~~~~-----------------------------~~~~~~~~~~~dli~~~L~~dP 622 (774)
|||++| .+||........ .+...... ......++++.+||.+||+.||
T Consensus 229 ~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 229 AEMLMK-TPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred HHHHHC-CCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 999997 777765433221 12111000 0011145789999999999999
Q ss_pred CCCcCHHHHHcCCCCCCcc
Q 004097 623 DLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 623 ~~Rps~~elL~HPff~~~~ 641 (774)
.+|||++|+++||||...+
T Consensus 308 ~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 308 VKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGSCCHHHHHTSGGGSSSC
T ss_pred hhCCCHHHHhCCcccCCCC
Confidence 9999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=380.93 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=187.7
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCC-----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 411 (774)
+.++|.+.+.||+|+||+||++. ..+|+.||||++.+.. .....+|+. ++..++|||||++++++.+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHH-HHHhCCCCCCCcEEEEEccCCcccc
Confidence 35678999999999999999984 4568999999997542 123445654 67888999999999998654
Q ss_pred -ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 -~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
...|||||||.++|.+.+. ..+++..++.++.||+.|
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~------------------------------------------~~l~~~~~~~~~~qil~a 176 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCG 176 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHT------------------------------------------SCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCHHHHHh------------------------------------------hcCCHHHHHHHHHHHHHH
Confidence 4579999988766544431 125667788999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..|+.++||||||
T Consensus 177 L~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 250 (464)
T 3ttj_A 177 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250 (464)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred HHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHH
Confidence 99999999999999999999988765 899999999876532 123446799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-H-HHHhhccc------------------------------ccccc-----------CC
Q 004097 571 CILFFCITGGKHPYGESFERD-A-NIVKDRKD------------------------------LFLVE-----------HI 607 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-~-~~~~~~~~------------------------------~~~~~-----------~~ 607 (774)
|++|||++| ++||......+ . .++..... .++.. .+
T Consensus 251 ~il~ell~g-~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 329 (464)
T 3ttj_A 251 CIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 329 (464)
T ss_dssp HHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccC
Confidence 999999997 77886543221 1 11110000 00000 03
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 608 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 608 ~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+++.+||.+||+.||++|||++|+|+||||..+
T Consensus 330 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 330 SQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 578999999999999999999999999999643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=362.55 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=196.4
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHH-HHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHH-HHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 456889999999999999998544 789999999864432 2234555 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.+ |+|.+++. ....+++..++.++.||+.||+|||+.+
T Consensus 85 e~~~~----------~~L~~~l~-----------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~g 125 (323)
T 3tki_A 85 EYCSG----------GELFDRIE-----------------------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125 (323)
T ss_dssp ECCTT----------EEGGGGSB-----------------------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCCC----------CcHHHHHh-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 96653 33333321 1134677889999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 126 ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 202 (323)
T 3tki_A 126 ITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202 (323)
T ss_dssp EECSCCSGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred ccccccchHHEEEeCCCC--EEEEEeeccceeccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH
Confidence 999999999999987765 89999999986643211 112234579999999999988775 78999999999999999
Q ss_pred hCCCCCCCCchHHHH---HHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFERDA---NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~---~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+| .+||........ ....... .......++++.+||.+||+.||.+|||++|+++||||...
T Consensus 203 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 203 AG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HS-SCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred hC-CCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 97 778865433211 1111111 11224467899999999999999999999999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.65 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=192.5
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCC--CCeeEEeeeccCCceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~~~ 415 (774)
.++.|.+.+.||+|+||+||++...+++.||||++..... ....+|+. ++..++| |||+++++++.+.+..|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHH-HHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 4678999999999999999999878899999999865432 22345665 5555655 99999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||++.++|.+++. ....+++..+..|+.||+.||+|||
T Consensus 86 lv~e~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~i~~qi~~al~~lH 125 (343)
T 3dbq_A 86 MVMECGNIDLNSWLK----------------------------------------KKKSIDPWERKSYWKNMLEAVHTIH 125 (343)
T ss_dssp EEECCCSEEHHHHHH----------------------------------------HSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCHHHHHH----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999966667766652 1234677788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----------CCCCCcc
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAI 564 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~s 564 (774)
+.+|+||||||+|||++ ++ .+||+|||+++........ ......+||+.|+|||++.+ ..++.++
T Consensus 126 ~~~iiHrDikp~NIll~-~~--~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 126 QHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HTTCCCCCCCGGGEEEE-TT--EEEECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred hCCeecCCCCcceEEEE-CC--cEEEeecccccccCccccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99999999999999996 33 4899999999876543211 12234579999999999975 6788999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHH---HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~---~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|||||||++|||++| .+||........ .++... ....+....+++.++|.+||+.||.+|||+.|+++||||...
T Consensus 202 DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 202 DVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHHHHHHHS-SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hHHHHHHHHHHHHhC-CCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 999999999999997 778865433221 222211 222334445789999999999999999999999999999643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=373.89 Aligned_cols=254 Identities=26% Similarity=0.307 Sum_probs=197.3
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHh------CCCCCeeEEeeeccCC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIAS------DQHPNIVRWYGVESDQ 411 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~------l~HpNIV~l~g~~~~~ 411 (774)
..+..+|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++.. ..|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR-ILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHH-HHHHHhhccccCCcCEEEEEeecccC
Confidence 44567799999999999999999854 4689999999975432 23344554 2232 2688999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|+|||+|.++|.+++... ...++++..++.|+.||+.||
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~--------------------------------------~~~~~~~~~~~~i~~qi~~aL 213 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKN--------------------------------------KFQGFSLPLVRKFAHSILQCL 213 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHT--------------------------------------TTCCCCHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeccCCCHHHHHHhc--------------------------------------cCCCCCHHHHHHHHHHHHHHH
Confidence 999999998888777766321 123477888999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++...+||+|||+++.... ...+.+||+.|+|||++.+..++.++|||||||
T Consensus 214 ~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGC 287 (429)
T ss_dssp HHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHH
T ss_pred HHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC------cccccCCCCCccChHHHhCCCCCchHHHHhHHH
Confidence 99999999999999999999888765589999999976542 223457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH--HHHhhccc-------------------------------------------------
Q 004097 572 ILFFCITGGKHPYGESFERDA--NIVKDRKD------------------------------------------------- 600 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~~--~~~~~~~~------------------------------------------------- 600 (774)
++|||++| .+||........ .++.....
T Consensus 288 il~elltG-~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (429)
T 3kvw_A 288 ILAELLTG-YPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366 (429)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEEC
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccC
Confidence 99999997 777765433221 11110000
Q ss_pred ---------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 601 ---------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 601 ---------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.......+++.+||.+||+.||++|||++|+|+||||...
T Consensus 367 ~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred CccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 0001125678999999999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.83 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=194.0
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+...|.+.+.||+|+||+||++... +++.||||++.... .....+|+..+....+||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567889999999999999998654 79999999997532 13445666655444499999999999999999999
Q ss_pred eccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||++ +|.+++ .... .....+++..++.|+.||+.||+|||
T Consensus 89 v~e~~~~~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~qi~~al~~lH 132 (289)
T 1x8b_A 89 QNEYCNGGSLADAI-----------SENY-------------------------RIMSYFKEAELKDLLLQVGRGLRYIH 132 (289)
T ss_dssp EEECCTTCBHHHHH-----------HHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCcHHHHH-----------Hhhc-------------------------ccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9996653 555544 2211 11245788889999999999999999
Q ss_pred HcCccccccCCCCeeecCCC-----------------CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC
Q 004097 496 EIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG 558 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 558 (774)
+.+|+||||||+|||++.++ ...+||+|||++...... ....||+.|+|||++.+.
T Consensus 133 ~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN 205 (289)
T ss_dssp HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC
T ss_pred hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC
Confidence 99999999999999997543 235899999999876532 223589999999999876
Q ss_pred -CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 559 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 559 -~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
.++.++|||||||++|+|++| .+|+..... ...+........+...++++.++|.+||+.||.+|||+.|+++||||
T Consensus 206 ~~~~~~~Di~slG~il~~l~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 206 YTHLPKADIFALALTVVCAAGA-EPLPRNGDQ-WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp CTTHHHHHHHHHHHHHHHHTTC-CCCCSSSHH-HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred CCCCchhhHHHHHHHHHHHhcC-CCCCcchhH-HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 566899999999999999997 444433322 22333333334455667899999999999999999999999999999
Q ss_pred CCcc
Q 004097 638 WTAD 641 (774)
Q Consensus 638 ~~~~ 641 (774)
.+..
T Consensus 284 ~~~~ 287 (289)
T 1x8b_A 284 LSAS 287 (289)
T ss_dssp ----
T ss_pred hhhc
Confidence 7643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=374.05 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=188.0
Q ss_pred EEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEecccc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLERC 421 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~E~~ 421 (774)
+...+.||+|+||+||++.. .+|+.||||++... ....+|+..+....+||||+++++++.. .+.+|||||||
T Consensus 64 ~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 34457899999999999854 46899999999743 4566788777778899999999998765 67899999966
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++... ....+++..++.|+.||+.||+|||+.+|+|
T Consensus 142 ~----------gg~L~~~l~~~---------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 184 (400)
T 1nxk_A 142 D----------GGELFSRIQDR---------------------------GDQAFTEREASEIMKSIGEAIQYLHSINIAH 184 (400)
T ss_dssp C----------SEEHHHHHHCC------------------------------CCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred C----------CCcHHHHHHHh---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5 34444433221 1124677889999999999999999999999
Q ss_pred cccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+|||++.++ ...+||+|||+++..... ....+.+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g- 259 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG- 259 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHS-
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCC----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhC-
Confidence 99999999998621 245999999999866532 122456799999999999999999999999999999999997
Q ss_pred CCCCCCchHH-----H-HHHHhhccccc---cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 581 KHPYGESFER-----D-ANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 581 ~~Pf~~~~~~-----~-~~~~~~~~~~~---~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||...... . ..+........ ....++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 260 ~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 260 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 6777543221 1 12222221111 13457899999999999999999999999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=364.89 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=188.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+. ++..++||||+++++++.+.+..|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHH-HHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 45688999999999999999855 478999999997543 244556664 67888999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++. ....+++..++.++.||+.||+|||+.||+
T Consensus 98 ~~----------~~~L~~~l~-----------------------------~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 98 AS----------GGELYERIC-----------------------------NAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp CC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CC----------CCCHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 64 444444332 123477888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCc-chhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSlGvll~elltg 579 (774)
||||||+|||++.++...+||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp SCCCCGGGEEECSSSSCCEEECCCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEEcCCCCceEEEeecCcccccccc----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 999999999998776556999999999754322 12234569999999999988887655 8999999999999997
Q ss_pred CCCCCCCchH-----HHH-HHHhhcccc-ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 580 GKHPYGESFE-----RDA-NIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 580 ~~~Pf~~~~~-----~~~-~~~~~~~~~-~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
.+||..... ... .+....... .....++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 215 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 215 -AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp -SCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred -CCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 778865322 111 122211111 12245789999999999999999999999999999954
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.08 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=198.3
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
...+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ...++++..++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3456799999999999999999865 4799999999965321 112333445678889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||| .+|+|.+++... ...+++..++.++.||+.||+|||
T Consensus 138 lVmE~~----------~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH 179 (412)
T 2vd5_A 138 LVMEYY----------VGGDLLTLLSKF----------------------------GERIPAEMARFYLAEIVMAIDSVH 179 (412)
T ss_dssp EEECCC----------CSCBHHHHHHHH----------------------------SSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCC----------CCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999955 445555544321 124677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-------cCCCCCcchhHh
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-------QGRQTRAIDLFS 568 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~sDvwS 568 (774)
+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++. ...++.++||||
T Consensus 180 ~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwS 255 (412)
T 2vd5_A 180 RLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255 (412)
T ss_dssp HTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHH
T ss_pred HCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhH
Confidence 999999999999999988776 89999999987654321 1223457999999999997 356899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH--HHHHhhcc----ccccccCCHHHHHHHHHhcCCCCCCC---cCHHHHHcCCCCCC
Q 004097 569 LGCILFFCITGGKHPYGESFERD--ANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFFWT 639 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~--~~~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~R---ps~~elL~HPff~~ 639 (774)
|||++|||++| .+||....... ..+..... .......++++++||.+||. +|.+| |+++|+++||||.+
T Consensus 256 lGvilyelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 256 LGVFAYEMFYG-QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HhHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 99999999997 66775543322 23332211 11124567899999999999 99998 59999999999976
Q ss_pred ccc
Q 004097 640 ADT 642 (774)
Q Consensus 640 ~~~ 642 (774)
.++
T Consensus 334 i~w 336 (412)
T 2vd5_A 334 LDW 336 (412)
T ss_dssp CCS
T ss_pred CCH
Confidence 554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=354.82 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=201.8
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---------hHHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS-ILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHH-HHHhCCCCCcceEEEEEec
Confidence 44567799999999999999999865 4689999999965421 23445554 7788899999999999999
Q ss_pred CceeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 411 ~~~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.+..|+|||||. ++|.+++ .. ...+++..++.++.||+.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~i~~qi~~ 126 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFL-----------AQ-----------------------------KESLSEEEATSFIKQILD 126 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHH-----------HT-----------------------------CSCEEHHHHHHHHHHHHH
T ss_pred CCEEEEEEEcCCCCcHHHHH-----------Hh-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 999999999765 3555444 21 123566778999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCC--ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvw 567 (774)
||+|||+.+|+||||||+|||++.++. ..+||+|||+++...... ......||+.|+|||++.+..++.++|||
T Consensus 127 aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 202 (321)
T 2a2a_A 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMW 202 (321)
T ss_dssp HHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred HHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc----cccccCCCCCccCcccccCCCCCCccccH
Confidence 999999999999999999999987662 148999999998765432 22345699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcc-c---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 568 SLGCILFFCITGGKHPYGESFERD-ANIVKDRK-D---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
||||++|+|++| ..||....... ...+.... . ......++++.++|.+||+.||.+|||++|+++||||.....
T Consensus 203 slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 203 SIGVITYILLSG-ASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp HHHHHHHHHHHS-CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred HHHHHHHHHHHC-CCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 999999999997 66775543322 22222211 1 112345678999999999999999999999999999987654
Q ss_pred hh
Q 004097 643 RL 644 (774)
Q Consensus 643 ~~ 644 (774)
..
T Consensus 282 ~~ 283 (321)
T 2a2a_A 282 QQ 283 (321)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=371.60 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=193.2
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC----
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ---- 411 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~---- 411 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHH-HHHHcCCCCcceEEEEEecCCCCc
Confidence 4567799999999999999999854 5688999999975422 23445664 77888999999999998876
Q ss_pred -ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 -~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
+.+|+|||+|.++|.+++. ....+++..++.++.||+.|
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~----------------------------------------~~~~l~~~~~~~i~~qil~a 141 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFK----------------------------------------TPIFLTEEHIKTILYNLLLG 141 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHH----------------------------------------SSCCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCcCHHHHHh----------------------------------------ccCCCCHHHHHHHHHHHHHH
Confidence 5799999988877766652 12346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-------------------cccccCcCCCCCCc
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-------------------TQNATGYGSSGWQA 551 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-------------------~~~~~~~gt~~y~a 551 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++......... ......+||+.|+|
T Consensus 142 L~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 219 (432)
T 3n9x_A 142 ENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA 219 (432)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC-------------------------------CCCCCTTCC
T ss_pred HHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccC
Confidence 99999999999999999999987765 8999999998775432110 12245679999999
Q ss_pred hhhh-hcCCCCCcchhHhHHHHHHHHHhC----------CCCCCCCch------------------HHHH-HH-------
Q 004097 552 PEQL-LQGRQTRAIDLFSLGCILFFCITG----------GKHPYGESF------------------ERDA-NI------- 594 (774)
Q Consensus 552 PE~l-~~~~~~~~sDvwSlGvll~elltg----------~~~Pf~~~~------------------~~~~-~~------- 594 (774)
||++ ....++.++|||||||++|||++| +.++|.... .... .+
T Consensus 220 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p 299 (432)
T 3n9x_A 220 PELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299 (432)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSC
T ss_pred HHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCC
Confidence 9986 456699999999999999999974 445543221 0000 00
Q ss_pred ----------------Hhhcccc-------ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 595 ----------------VKDRKDL-------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 595 ----------------~~~~~~~-------~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+...... .....++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 0000000 0123578999999999999999999999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.92 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=189.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----------------------------hHHHHHHHHHHH
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----------------------------DVALKEIQNLIA 394 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----------------------------~~~~~Ei~~ll~ 394 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... +...+|+. ++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~ 91 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA-ILK 91 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH-HHH
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH-HHH
Confidence 4588899999999999999854 5689999999865421 23445654 778
Q ss_pred hCCCCCeeEEeeeccC--CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhh
Q 004097 395 SDQHPNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 472 (774)
Q Consensus 395 ~l~HpNIV~l~g~~~~--~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 472 (774)
.++||||+++++++.+ .+..|+|||||.+ |+|.+++ ..
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~----------~~l~~~~------------------------------~~ 131 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ----------GPVMEVP------------------------------TL 131 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTT----------CBSCCSS------------------------------CS
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCC----------CcHHHHh------------------------------hc
Confidence 8999999999999886 6789999997653 3332211 12
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCch
Q 004097 473 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 552 (774)
Q Consensus 473 ~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP 552 (774)
..+++..++.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ......||+.|+||
T Consensus 132 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aP 206 (298)
T 2zv2_A 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDA---LLSNTVGTPAFMAP 206 (298)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSC---EECCCCSCGGGCCG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--EEEecCCCccccccccc---cccCCcCCccccCh
Confidence 34678888999999999999999999999999999999988775 89999999987654321 12345699999999
Q ss_pred hhhhcCC---CCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcccc--ccccCCHHHHHHHHHhcCCCCCCCc
Q 004097 553 EQLLQGR---QTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRP 626 (774)
Q Consensus 553 E~l~~~~---~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~~--~~~~~~~~~~dli~~~L~~dP~~Rp 626 (774)
|++.+.. ++.++|||||||++|+|++| .+||....... ...+...... .....++++.++|.+||+.||++||
T Consensus 207 E~~~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 285 (298)
T 2zv2_A 207 ESLSETRKIFSGKALDVWAMGVTLYCFVFG-QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI 285 (298)
T ss_dssp GGCCTTCCCEESHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC
T ss_pred hhhccCCCCCCCchhhhHhHHHHHHHHHHC-CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCC
Confidence 9997665 37789999999999999997 67776543322 2222222111 1234568999999999999999999
Q ss_pred CHHHHHcCCCCC
Q 004097 627 KAQNVLNHPFFW 638 (774)
Q Consensus 627 s~~elL~HPff~ 638 (774)
|+.|+++||||.
T Consensus 286 s~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 VVPEIKLHPWVT 297 (298)
T ss_dssp CHHHHTTCHHHH
T ss_pred CHHHHhcCcccc
Confidence 999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=362.48 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=175.7
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCChhhHH
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 429 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~sL~~~i 429 (774)
+.||+|+||+||++.. .+|+.||||++.+.......+|+..+.....||||+++++++.+.+..|+|||||.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~------- 89 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN------- 89 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC-------
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC-------
Confidence 6799999999999855 46899999999876556666777655444459999999999999999999999665
Q ss_pred HHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCe
Q 004097 430 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 509 (774)
Q Consensus 430 y~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 509 (774)
+|+|.+++. ....+++..++.|+.||+.||+|||+.+|+||||||+||
T Consensus 90 ---~~~L~~~l~-----------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 90 ---GGELFERIK-----------------------------KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp ---SCBHHHHHH-----------------------------HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ---CCcHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 344444332 123477888999999999999999999999999999999
Q ss_pred eecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCch
Q 004097 510 LISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 588 (774)
Q Consensus 510 Ll~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~ 588 (774)
|++.++ ...+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| .+||....
T Consensus 138 ll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~ 213 (325)
T 3kn6_A 138 LFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-QVPFQSHD 213 (325)
T ss_dssp EEEC----CEEEECCCTTCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHS-SCTTC---
T ss_pred EEecCCCcccEEEeccccceecCCCC---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC-CCCCCCCc
Confidence 997654 3469999999998665321 222345689999999999999999999999999999999996 77886532
Q ss_pred H--------HHHHHHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 589 E--------RDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 589 ~--------~~~~~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
. .....+....... ....++++.+||.+||+.||.+|||++|+++||||...
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2 1112222211111 12457899999999999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=354.66 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=196.4
Q ss_pred eEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.|...+.||+|+||+||++... +|+.||||++..... +...+|+. ++..++||||+++++++.+.+..|+|||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 4677789999999999998655 799999999865432 23445554 778899999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++. ...+++..+..++.||+.||+|||+.+|+|
T Consensus 125 ~----------~~~L~~~l~------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 164 (321)
T 2c30_A 125 Q----------GGALTDIVS------------------------------QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164 (321)
T ss_dssp C----------SCBHHHHHT------------------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred C----------CCCHHHHHH------------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4 445544332 124677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++| .
T Consensus 165 ~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~ 238 (321)
T 2c30_A 165 RDIKSDSILLTLDGR--VKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-E 238 (321)
T ss_dssp CCCSGGGEEECTTCC--EEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-S
T ss_pred CCCCHHHEEECCCCc--EEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC-C
Confidence 999999999987765 89999999987654321 22345799999999999999999999999999999999997 6
Q ss_pred CCCCCchHH-HHHHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 582 HPYGESFER-DANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 582 ~Pf~~~~~~-~~~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+||...... ....+..... ......++++.++|.+||+.||++|||++|+++||||...
T Consensus 239 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 239 PPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 677554332 2222222111 1123456789999999999999999999999999999643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.22 Aligned_cols=256 Identities=25% Similarity=0.466 Sum_probs=193.1
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+.+..|+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE-VLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHH-HHHhCCCchHHhHHHheecCCeEEE
Confidence 3457789999999999999999854 5689999999865432 33445554 7788999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+.+.... .....+++..++.|+.||+.||+|||+
T Consensus 98 v~e~~~----------~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 98 VMETCE----------GGELLERIVSAQ-------------------------ARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp EECCCS----------CCBHHHHHHHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCC----------CCcHHHHHHhhh-------------------------hcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999665 344444332211 122457888899999999999999999
Q ss_pred cCccccccCCCCeeecCC-CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.+ ....+||+|||+++..... .......||+.|+|||++. ..++.++|||||||++||
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ 217 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD----EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYF 217 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHH
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc----ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHH
Confidence 999999999999999542 2235899999999876532 1223456899999999985 568999999999999999
Q ss_pred HHhCCCCCCCCchHHHH-HHHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 576 CITGGKHPYGESFERDA-NIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~-~~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|++| ..||........ ......... .....++++.++|.+||+.||.+|||+.|+++||||..
T Consensus 218 ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 218 LLTG-CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHhC-CCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9997 778765443322 222222111 12235689999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.98 Aligned_cols=254 Identities=28% Similarity=0.358 Sum_probs=189.4
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..+.|.+.+.||+|+||+||++.. .+|+.||||++...... ....|+..++..++||||+++++++.+.+..|+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346688999999999999999864 57899999999654322 2344555567889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.++|.+++... . .....+++..++.|+.||+.||+|||+.
T Consensus 85 ~e~~~~~l~~~l~~~-----------~-------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 85 MELMDTSLDKFYKQV-----------I-------------------------DKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp EECCSEEHHHHHHHH-----------H-------------------------HTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EehhccchHHHHHHH-----------H-------------------------hcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 998887776655210 0 1224578889999999999999999998
Q ss_pred -CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhh----hcCCCCCcchhHhHHHH
Q 004097 498 -GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL----LQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 498 -~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDvwSlGvl 572 (774)
+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++ ....++.++|||||||+
T Consensus 129 ~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 129 LSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp SCCCCCCCSGGGCEECTTCC--EEBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCC--EEEeecCCcccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 9999999999999987765 8999999998765431 12334699999999996 45678999999999999
Q ss_pred HHHHHhCCCCCCCCchHH---HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 573 LFFCITGGKHPYGESFER---DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~---~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+|+|++| ..||...... ........ ........++++.++|.+||+.||++|||+.|+++||||..
T Consensus 203 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 203 MIELAIL-RFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHT-SCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHC-CCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 9999997 7788642221 12222222 22223345789999999999999999999999999999954
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.85 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=189.0
Q ss_pred cceEEE-eEeecccCceEEEEEe-eeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVF-NKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~-~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+ .+.||+|+||+||++. ..+++.||||++.... .....+|+..+....+||||+++++++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 345666 4679999999999985 4578999999996543 2455677776655578999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 91 e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 91 EKMR----------GGSILSHIHK-----------------------------RRHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp ECCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCC----------CCcHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9665 3444433321 134677788999999999999999999
Q ss_pred ccccccCCCCeeecCCCC-ceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhc-----CCCCCcchhHh
Q 004097 499 LIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 568 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~-~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwS 568 (774)
|+||||||+|||++.++. ..+||+|||+++........ .......+||+.|+|||++.. ..++.++||||
T Consensus 132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 211 (316)
T 2ac3_A 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211 (316)
T ss_dssp CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence 999999999999986653 24899999999866422111 111234469999999999975 45889999999
Q ss_pred HHHHHHHHHhCCCCCCCCchH----------------HHHHHHhhcccccc----ccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 569 LGCILFFCITGGKHPYGESFE----------------RDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~----------------~~~~~~~~~~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
|||++|||++| .+||..... .....+.......+ ...++++.+||.+||+.||.+|||+
T Consensus 212 lG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (316)
T 2ac3_A 212 LGVILYILLSG-YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290 (316)
T ss_dssp HHHHHHHHHHS-SCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHHHHC-CCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence 99999999997 778754321 11111222211111 2456789999999999999999999
Q ss_pred HHHHcCCCCCCc
Q 004097 629 QNVLNHPFFWTA 640 (774)
Q Consensus 629 ~elL~HPff~~~ 640 (774)
+|+++||||...
T Consensus 291 ~e~l~hp~~~~~ 302 (316)
T 2ac3_A 291 AQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHSTTCC--
T ss_pred HHHhcChhhcCC
Confidence 999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=367.74 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=194.3
Q ss_pred ccceEEEeEeeccc--CceEEEEEeee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 343 IGKLVVFNKEIAKG--SNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 343 i~~~~~~~~~LG~G--sfG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.++.|.+.+.||+| +||+||++... +|+.||||++..... ....+|+ .++..++|||||++++++.+.+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL-HVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHH-HHHHhCCCCCCCcEeEEEEECCEE
Confidence 35678999999999 99999998654 699999999975432 1223344 478889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++... ....+++..++.|+.||+.||+||
T Consensus 102 ~lv~e~~~----------~~~L~~~l~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~L 144 (389)
T 3gni_B 102 WVVTSFMA----------YGSAKDLICTH---------------------------FMDGMNELAIAYILQGVLKALDYI 144 (389)
T ss_dssp EEEEECCT----------TCBHHHHHHHT---------------------------CTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEccC----------CCCHHHHHhhh---------------------------cccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 44444443221 113467788999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhc--CCCCCcchhHh
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFS 568 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwS 568 (774)
|+.+|+||||||+|||++.++. +||+|||++......... ........||+.|+|||++.+ ..++.++||||
T Consensus 145 H~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 222 (389)
T 3gni_B 145 HHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222 (389)
T ss_dssp HHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHH
Confidence 9999999999999999987775 899999998765422111 111233468999999999987 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHH--HHHhhc---------------------------------------------ccc
Q 004097 569 LGCILFFCITGGKHPYGESFERDA--NIVKDR---------------------------------------------KDL 601 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~--~~~~~~---------------------------------------------~~~ 601 (774)
|||++|||++| .+||........ .+.... ...
T Consensus 223 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (389)
T 3gni_B 223 VGITACELANG-HVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP 301 (389)
T ss_dssp HHHHHHHHHHS-SCTTTTCCSTTHHHHC----------------------------------------------------
T ss_pred HHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCc
Confidence 99999999997 778854322111 000000 001
Q ss_pred ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 602 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 602 ~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.....++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 302 ~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 302 YHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 2233567899999999999999999999999999996543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=360.43 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=195.4
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC--------
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-------- 410 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-------- 410 (774)
..|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++.+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHH-HHHhccCCCcccHhheeeccccccccC
Confidence 5688899999999999999865 578999999985432 234556665 6788899999999999876
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+|||||.++|.+.+.. ....+++..++.|+.||+.|
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~---------------------------------------~~~~~~~~~~~~i~~qi~~~ 136 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSN---------------------------------------VLVKFTLSEIKRVMQMLLNG 136 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHC---------------------------------------TTSCCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEeccCCCHHHHHhh---------------------------------------ccCCCCHHHHHHHHHHHHHH
Confidence 456899999988776665521 11346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhc-CCCCCcchhHh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwS 568 (774)
|+|||+.||+||||||+|||++.++. +||+|||+++.+..... .........||+.|+|||++.+ ..++.++||||
T Consensus 137 l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 214 (351)
T 3mi9_A 137 LYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214 (351)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHH
Confidence 99999999999999999999987765 89999999987653221 1122344578999999999976 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHH-HHHhhccccccc--------------------------------cCCHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERDA-NIVKDRKDLFLV--------------------------------EHIPEAVDLFT 615 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~-~~~~~~~~~~~~--------------------------------~~~~~~~dli~ 615 (774)
|||++|||++| .+||........ ..+.......+. ..++++.+||.
T Consensus 215 lG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (351)
T 3mi9_A 215 AGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293 (351)
T ss_dssp HHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHH
Confidence 99999999997 777765443321 111110000000 01467899999
Q ss_pred HhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 616 RLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 616 ~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+||+.||.+|||++|+++||||++.
T Consensus 294 ~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 294 KLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHhcCChhhCCCHHHHhCCCCcCCC
Confidence 9999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=346.83 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=199.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+ .++..++||||+++++++.+.+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA-RICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHH-HHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3467799999999999999999854 4689999999965432 1223444 4778889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||+|. +|+|.+.+. ....+++..+..++.|++.||+|||
T Consensus 82 ~v~e~~~----------~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~lH 122 (284)
T 3kk8_A 82 LVFDLVT----------GGELFEDIV-----------------------------AREFYSEADASHCIQQILESIAYCH 122 (284)
T ss_dssp EEECCCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC----------CCCHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 344443332 1234677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCC-ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+||+++.++. ..+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 123 ~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 198 (284)
T 3kk8_A 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 198 (284)
T ss_dssp HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHH
Confidence 999999999999999976543 358999999998765432 223456999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHH-HHHHHhhcccccc----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 575 FCITGGKHPYGESFER-DANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 575 elltg~~~Pf~~~~~~-~~~~~~~~~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
+|++| .+||...... ....+.......+ ...++++.++|.+||+.||.+|||++|+++||||......
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 199 ILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred HHHHC-CCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 99997 6676544332 2222222221111 2456899999999999999999999999999999765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=366.01 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=192.0
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC--CCCeeEEeeeccCCceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ--HPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~--HpNIV~l~g~~~~~~~~~ 415 (774)
.++.|.+.+.||+|+||+||++...+++.||||++..... ....+|+. ++..+. |||||++++++.+.+.+|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHH-HHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3567999999999999999998777799999999965432 23455665 444544 699999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||||++.++|.+++.. ...+++..++.|+.||+.||+|||
T Consensus 133 lv~E~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKK----------------------------------------KKSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp EEEECCSEEHHHHHHH----------------------------------------CSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999655667666521 123566678899999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----------CCCCCcc
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAI 564 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~s 564 (774)
+.+|+||||||+|||++ ++ .+||+|||+++.+...... ......+||+.|+|||++.+ ..++.++
T Consensus 173 ~~~ivHrDlkp~NIll~-~~--~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TTTCCCCCCCGGGEEES-SS--CEEECCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HCCeeecCCCHHHEEEE-CC--eEEEEecCccccccCCCcc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 99999999999999995 34 4899999999876543211 12234579999999999975 3688999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHH---HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERD---ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~---~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|||||||++|||++| .+||....... ..++.... ...+...++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 249 DiwSlGvil~ell~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 249 DVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHHHHHHS-SCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hHHHHHHHHHHHHHC-CCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 999999999999997 77886543221 22222221 12233445789999999999999999999999999999643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=365.48 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=200.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|+ .++..++||||+++++++.+.+..|+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEI-SIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHH-HHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHH-HHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3456799999999999999999854 4689999999976532 2234455 477889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++... ...+++..++.++.||+.||+|||+.
T Consensus 127 ~E~~~----------gg~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 127 LEFLS----------GGELFDRIAAE----------------------------DYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp EECCC----------CCBHHHHTTCT----------------------------TCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCC----------CCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99654 44554443211 12367788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++...+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 169 givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CeeecccchHHeEEecCCCCceEEEecccceecCCCc----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 9999999999999976544569999999998775432 122346999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+| .+||....... ...+..... ......++++.++|.+||+.||.+|||+.|+++||||....
T Consensus 245 tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 245 SG-LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HS-CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 97 77776543322 222222111 11234568999999999999999999999999999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=382.33 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=205.4
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
...+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++|||||++++++.+.+.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHH-HHHHcCCCCEeeEEEEEeeCCEE
Confidence 3456799999999999999999865 479999999996431 123345554 77889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++... ....+++..++.++.||+.||+||
T Consensus 260 ~lVmEy~~----------gg~L~~~l~~~---------------------------~~~~l~e~~~~~i~~qIl~aL~yL 302 (576)
T 2acx_A 260 CLVLTLMN----------GGDLKFHIYHM---------------------------GQAGFPEARAVFYAAEICCGLEDL 302 (576)
T ss_dssp EEEECCCC----------SCBHHHHHHSS---------------------------SSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCC----------CCcHHHHHHhc---------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999554 44444443211 113477888999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|
T Consensus 303 H~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 303 HRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376 (576)
T ss_dssp HHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHH
T ss_pred HHCCEeccCCchheEEEeCCCC--eEEEecccceecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHH
Confidence 9999999999999999988775 8999999998765432 123457999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCch-----HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 575 FCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 575 elltg~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
||++| .+||.... ......+......++...++++.+||.+||+.||.+|| +++|+++||||...++.
T Consensus 377 eLltG-~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 377 EMIAG-QSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHS-SCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HHHhC-CCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 99997 77886532 22223333344445566789999999999999999999 78999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=389.49 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=204.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
-..|.+.+.||+|+||+||++.. .+++.||||++.+. .......|...+....+||||+++++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 35688999999999999999854 46889999999743 123344555544334589999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||| .+|+|..++.. ...+++..++.|+.||+.||+|||+
T Consensus 420 V~E~~----------~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 460 (674)
T 3pfq_A 420 VMEYV----------NGGDLMYHIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLQS 460 (674)
T ss_dssp EEECC----------CSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCc----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99954 45555555432 2347788899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||||+.++. +||+|||+++...... ....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 461 ~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyel 535 (674)
T 3pfq_A 461 KGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535 (674)
T ss_dssp TSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHH
T ss_pred CCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHH
Confidence 99999999999999988876 8999999998643221 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCH-----HHHHcCCCCCCccch
Q 004097 577 ITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 643 (774)
Q Consensus 577 ltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~-----~elL~HPff~~~~~~ 643 (774)
++| .+||...... ....+......++...++++.+||.+||+.||.+||++ +|+++||||...++.
T Consensus 536 ltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 536 LAG-QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred HcC-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 997 7777654333 33334444445566778999999999999999999997 999999999876654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.32 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=196.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|...+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCeEEE
Confidence 45688889999999999999864 6799999999965421 12345554 6788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||.++|.+++... ...+++..+..++.|++.||+|||+
T Consensus 132 v~e~~~g~l~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~ 172 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVH---------------------------------------KKPLQEVEIAAVTHGALQGLAYLHS 172 (348)
T ss_dssp EEECCSEEHHHHHHHH---------------------------------------TSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9998887776655211 2346777889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvll 573 (774)
.+|+||||||+|||++.++. +||+|||+++..... ....||+.|+|||++. ...++.++|||||||++
T Consensus 173 ~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 243 (348)
T 1u5q_A 173 HNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243 (348)
T ss_dssp TTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred CCeeeCCCCHHHEEECCCCC--EEEeeccCceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence 99999999999999987764 999999999765432 2356999999999985 46789999999999999
Q ss_pred HHHHhCCCCCCCCchHH-H-HHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 574 FFCITGGKHPYGESFER-D-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~-~-~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|||++| .+||...... . ..+...... ......++++.++|.+||+.||.+|||++++++||||...
T Consensus 244 ~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 244 IELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 999997 6676543322 2 122222221 2233456789999999999999999999999999999553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=354.46 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=193.0
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEeccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLER 420 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~E~ 420 (774)
.+.|.+.+.||+|+||+||++. ..+++.||||++.........+|+..+.....||||+++++++.+ ....++|||+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 4678999999999999999985 467899999999876666677787644444459999999999987 6778999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +++|.+++. .+++..++.++.||+.||+|||+.+|+
T Consensus 115 ~~----------~~~l~~~~~--------------------------------~~~~~~~~~~~~qi~~~l~~lH~~~iv 152 (330)
T 3nsz_A 115 VN----------NTDFKQLYQ--------------------------------TLTDYDIRFYMYEILKALDYCHSMGIM 152 (330)
T ss_dssp CC----------CCCHHHHGG--------------------------------GCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cC----------chhHHHHHH--------------------------------hCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 55 444444321 155667889999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHHhC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~elltg 579 (774)
||||||+|||++.++. .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 153 H~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 227 (330)
T 3nsz_A 153 HRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227 (330)
T ss_dssp CCCCSGGGEEEETTTT-EEEECCCTTCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred eCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhC
Confidence 9999999999986653 58999999998765432 2234568999999999987 6689999999999999999997
Q ss_pred CCCCCCCch-HHH--HHHH------------hhcc------------------------ccccccCCHHHHHHHHHhcCC
Q 004097 580 GKHPYGESF-ERD--ANIV------------KDRK------------------------DLFLVEHIPEAVDLFTRLLDP 620 (774)
Q Consensus 580 ~~~Pf~~~~-~~~--~~~~------------~~~~------------------------~~~~~~~~~~~~dli~~~L~~ 620 (774)
..||.... ... ..+. .... .......++++.+||.+||+.
T Consensus 228 -~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 306 (330)
T 3nsz_A 228 -KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306 (330)
T ss_dssp -CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS
T ss_pred -CCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC
Confidence 56663321 111 0000 0000 000112468999999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCc
Q 004097 621 NPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 621 dP~~Rps~~elL~HPff~~~ 640 (774)
||.+|||++|+|+||||++.
T Consensus 307 dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 307 DHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp SGGGSCCHHHHHTSGGGTTC
T ss_pred CcccCCCHHHHhcCccHhhh
Confidence 99999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=346.45 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=195.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+ .++..++||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHH-HHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHH-HHHHcCCCCCCcchhheEecCCEEEE
Confidence 35688899999999999999854 457899999986432 12233444 57788999999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+.+.. ...+++..++.++.||+.||+|||+
T Consensus 87 v~e~~~----------~~~l~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T 3fdn_A 87 ILEYAP----------LGTVYRELQK-----------------------------LSKFDEQRTATYITELANALSYCHS 127 (279)
T ss_dssp EECCCT----------TEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999655 4444443321 1346778889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 128 ~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 128 KRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp TTCEECCCCGGGEEECTTSC--EEECSCCEESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 99999999999999988775 899999998655432 12345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 577 ITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++| .+||....... ...+.......+...++++.+||.+||+.||.+|||++|+++||||..
T Consensus 201 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 201 LVG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHS-SCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHC-CCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 997 77886544332 233333333445556789999999999999999999999999999954
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.17 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=198.1
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
+.+.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA-ILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHH-HHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHH-HHHhCCCCCEeeEEEEEee
Confidence 45679999999999999999985 46789999999975421 12345664 6788899999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..++|||+|... .+|.+++. ....+++..++.|+.||+.|
T Consensus 101 ~~~~~lv~e~~~~g---------~~l~~~~~-----------------------------~~~~l~~~~~~~i~~qi~~~ 142 (335)
T 3dls_A 101 QGFFQLVMEKHGSG---------LDLFAFID-----------------------------RHPRLDEPLASYIFRQLVSA 142 (335)
T ss_dssp SSEEEEEEECCTTS---------CBHHHHHH-----------------------------TCCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEeCCCC---------ccHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 99999999966521 13333321 12346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSl 569 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..+ +.++|||||
T Consensus 143 L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 216 (335)
T 3dls_A 143 VGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL 216 (335)
T ss_dssp HHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred HHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence 99999999999999999999987765 8999999998765432 2234569999999999988776 789999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 570 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
||++|+|++| ..||....... ......+...++++.+||.+||+.||.+|||++++++||||+....
T Consensus 217 G~il~el~~g-~~pf~~~~~~~-----~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 217 GVTLYTLVFE-ENPFCELEETV-----EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHHHHHS-SCSCSSGGGGT-----TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHHHHhC-CCchhhHHHHH-----hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 9999999997 77886533211 1112233346789999999999999999999999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=363.72 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=188.6
Q ss_pred EeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 349 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
..+.||+|+||+||++.. .+|+.||||++..... ....+|+ .++..++||||+++++++.+.+..|||||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~-- 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI-SVMNQLDHANLIQLYDAFESKNDIVLVMEYVD-- 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEECSSEEEEEEECCT--
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHH-HHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC--
Confidence 356899999999999854 5689999999976532 2334455 47788999999999999999999999999665
Q ss_pred hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Q 004097 425 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 504 (774)
Q Consensus 425 L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 504 (774)
+|+|.+++... ...+++..++.++.||+.||+|||+.+|+||||
T Consensus 170 --------~~~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 213 (373)
T 2x4f_A 170 --------GGELFDRIIDE----------------------------SYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213 (373)
T ss_dssp --------TCEEHHHHHHT----------------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------CCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 34443333211 123567778999999999999999999999999
Q ss_pred CCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCC
Q 004097 505 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 505 kp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf 584 (774)
||+|||+..+....+||+|||+++...... .....+||+.|+|||++....++.++|||||||++|||++| .+||
T Consensus 214 kp~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf 288 (373)
T 2x4f_A 214 KPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-LSPF 288 (373)
T ss_dssp CGGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS-SCTT
T ss_pred CHHHEEEecCCCCcEEEEeCCCceecCCcc----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC-CCCC
Confidence 999999954444469999999998775432 22345699999999999988899999999999999999997 6677
Q ss_pred CCchHHH--HHHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 585 GESFERD--ANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 585 ~~~~~~~--~~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
....... ..+...... ......++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 289 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 289 LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 6543322 223322221 1123457899999999999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.08 Aligned_cols=260 Identities=26% Similarity=0.378 Sum_probs=193.4
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--------------hHHHHHHHHHHHhCCCCCeeEEee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--------------DVALKEIQNLIASDQHPNIVRWYG 406 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--------------~~~~~Ei~~ll~~l~HpNIV~l~g 406 (774)
..+.+.|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. ++..++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHH-HHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHH-HHHhCCCcCccceee
Confidence 455677999999999999999999777899999999854221 23445654 678889999999999
Q ss_pred ecc-----CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 407 VES-----DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 407 ~~~-----~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
++. .....|+|||||.++|.+++... ...+++..++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~ 137 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ---------------------------------------RIVISPQHIQ 137 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCT---------------------------------------TSCCCHHHHH
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhc---------------------------------------ccCCCHHHHH
Confidence 983 34578999998887776665211 1246778889
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCC
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQ 560 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~ 560 (774)
.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+ ..+
T Consensus 138 ~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~ 211 (362)
T 3pg1_A 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGF 211 (362)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC-------------------CGGGCCHHHHTTCTTC
T ss_pred HHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCcccccccc----cccceecccceecCcHHhcCCCCC
Confidence 99999999999999999999999999999987765 899999999755432 12234568999999999987 678
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchHHH-H-HHHhhcc-------------------------------ccccccCC
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFERD-A-NIVKDRK-------------------------------DLFLVEHI 607 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~-~~~~~~~-------------------------------~~~~~~~~ 607 (774)
+.++|||||||++|+|++| .+||....... . .+..... .......+
T Consensus 212 ~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T 3pg1_A 212 TKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSC
T ss_pred CcHhHHHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCC
Confidence 9999999999999999997 77776543221 1 1111000 00112346
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhh
Q 004097 608 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFL 647 (774)
Q Consensus 608 ~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l 647 (774)
+++.+||.+||+.||.+|||+.|+++||||..........
T Consensus 291 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 330 (362)
T 3pg1_A 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT 330 (362)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc
Confidence 7899999999999999999999999999998764444333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.32 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=196.6
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCC-----c
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ-----D 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~ 412 (774)
++..|.+.+.||+|+||+||++. ..+++.||||++...... ...+|+. ++..++||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHH-HHHhcCCCCCccceeEEecCCccccc
Confidence 45779999999999999999985 446889999999754322 2345554 67888999999999998655 4
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||+|.++|.+++. ...+++..++.|+.||+.||+
T Consensus 104 ~~~iv~e~~~~~L~~~l~-----------------------------------------~~~~~~~~~~~i~~qi~~aL~ 142 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLK-----------------------------------------TQHLSNDHICYFLYQILRGLK 142 (364)
T ss_dssp CEEEEEECCSEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEcccCcCHHHHHH-----------------------------------------hCCCCHHHHHHHHHHHHHHHH
Confidence 689999988877665541 134677788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
|||+.+|+||||||+|||++.++. +||+|||+++...............+||+.|+|||++.+ ..++.++|||||||
T Consensus 143 ~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 143 YIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp HHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred HHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 999999999999999999987765 899999999876543322222344579999999998765 45899999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH--HHHHhhcc------------------------------ccccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYGESFERD--ANIVKDRK------------------------------DLFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~--~~~~~~~~------------------------------~~~~~~~~~~~~dli~~~L~ 619 (774)
++|+|++| .+||....... ..+..... .......++++.+||.+||+
T Consensus 221 il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 221 ILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHHHHS-SCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence 99999997 77886543221 11111000 00112346789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~ 640 (774)
.||.+|||++|+++||||...
T Consensus 300 ~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 300 FNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp SSTTTSCCHHHHHTSGGGTTT
T ss_pred CChhhCCCHHHHhcCcchhhc
Confidence 999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.30 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=188.3
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHH-HHHhCCCcCCCCceeeEecCCcccc
Confidence 456789999999999999999854 5799999999954322 23345654 778889999999999987763
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..|+|||+|.++|.+++. ...+++..+..++.||+.|
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~~~~qi~~~ 140 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMK-----------------------------------------HEKLGEDRIQFLVYQMLKG 140 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 469999987666665542 1235677789999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|+|||+.||+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||
T Consensus 141 L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 212 (367)
T 1cm8_A 141 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212 (367)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence 99999999999999999999988765 899999999876432 234568999999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhc-----------------------c-------ccccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKDR-----------------------K-------DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~~-----------------------~-------~~~~~~~~~~~~dli~~~ 617 (774)
||++|||++| .+||....... . .+.... . .......++++.+||.+|
T Consensus 213 G~il~ell~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m 291 (367)
T 1cm8_A 213 GCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291 (367)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 9999999997 67776543221 1 111100 0 001123468999999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||++|+++||||...
T Consensus 292 L~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 292 LVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccCChhHCCCHHHHhcChHHHhh
Confidence 99999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=376.68 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=203.8
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+.+.+|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK-ILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHH-HHHhcCCCCEeeEEEEEeeCCEEE
Confidence 346789999999999999999865 469999999996432 123345554 678889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|..++.... .....+++..++.++.||+.||+|||
T Consensus 262 lVmE~~~----------gg~L~~~l~~~~-------------------------~~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 262 LVMTIMN----------GGDIRYHIYNVD-------------------------EDNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp EEECCCT----------TCBHHHHHHTSS-------------------------TTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecc----------CCCHHHHHHHhh-------------------------cccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999554 455544443211 01234788889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. +||+|||+++.+.... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 307 ~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilye 381 (543)
T 3c4z_A 307 QRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381 (543)
T ss_dssp HTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHH
Confidence 999999999999999988876 8999999998765432 12234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCch-----HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 576 CITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 576 lltg~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
|++| .+||.... ......+......++...++++.+||.+||+.||.+||+ ++++++||||...++
T Consensus 382 lltG-~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 382 MIAA-RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHS-SCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHhC-CCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 9997 77886532 122222223333445667889999999999999999996 589999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.97 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=195.3
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.+.|.+.+.||+|+||+||++.. .++..||+|++.... .+...+|+ .++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI-EIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3456799999999999999999854 457899999986532 23344555 477889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +++|.+++. ....+++..++.++.|++.||+|||+.
T Consensus 85 ~e~~~----------~~~L~~~~~-----------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (277)
T 3f3z_A 85 MELCT----------GGELFERVV-----------------------------HKRVFRESDAARIMKDVLSAVAYCHKL 125 (277)
T ss_dssp EECCC----------SCBHHHHHH-----------------------------HHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeccC----------CCcHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99665 334433321 123467788899999999999999999
Q ss_pred CccccccCCCCeee---cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 498 GLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 498 ~ivHrDLkp~NILl---~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+|+||||||+|||+ +.++ .+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|
T Consensus 126 ~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~ 198 (277)
T 3f3z_A 126 NVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMY 198 (277)
T ss_dssp TEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCcc----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHH
Confidence 99999999999999 4454 48999999998765432 2234569999999999865 4899999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-HHHhhcccccc----ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 575 FCITGGKHPYGESFERDA-NIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~-~~~~~~~~~~~----~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+|++| .+||........ ..+.......+ ...++++.++|.+||+.||.+|||+.++++||||..
T Consensus 199 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 199 VLLCG-YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99997 778866443322 22222221122 245789999999999999999999999999999943
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=363.01 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=193.9
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeecc------------
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES------------ 409 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~------------ 409 (774)
..+.|.+.+.||+|+||+||++. ..+|+.||||++.... ....+|+. ++..++|||||++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELD-IMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHH-HHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHH-HHHHcCCCCccchhheeeecCccccccccc
Confidence 34668999999999999999985 4679999999986542 22335665 678899999999999983
Q ss_pred --------------------------CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccc
Q 004097 410 --------------------------DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463 (774)
Q Consensus 410 --------------------------~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~ 463 (774)
+...+++|||||+++|.+.+... +
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-------~----------------------- 132 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF-------I----------------------- 132 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHH-------H-----------------------
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHH-------H-----------------------
Confidence 34458999998887776665210 0
Q ss_pred hhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecC-CCCceEEEcccCccccccCCCcccccccc
Q 004097 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNAT 542 (774)
Q Consensus 464 ~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 542 (774)
.....+++..++.++.||+.||+|||+.||+||||||+|||++. ++ .+||+|||+++...... ....
T Consensus 133 ------~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~~~----~~~~ 200 (383)
T 3eb0_A 133 ------RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSE----PSVA 200 (383)
T ss_dssp ------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCCTTCEECCTTS----CCCC
T ss_pred ------hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEECCCCcccCCCC----CCcC
Confidence 12345788889999999999999999999999999999999973 44 59999999998765432 2234
Q ss_pred CcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhc---------------------
Q 004097 543 GYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR--------------------- 598 (774)
Q Consensus 543 ~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~--------------------- 598 (774)
..||+.|+|||++.+.. ++.++|||||||++|||++| .+||......+ ..++...
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCC
Confidence 56899999999988754 89999999999999999997 77886543322 1221100
Q ss_pred -------cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 599 -------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 599 -------~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
....+...++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 00122335678999999999999999999999999999953
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=373.72 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=200.2
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
....|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+.+..|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ-NLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEE
Confidence 345688999999999999999865 479999999996432 123445654 678899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 93 lv~E~~~----------gg~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH 133 (476)
T 2y94_A 93 MVMEYVS----------GGELFDYICK-----------------------------NGRLDEKESRRLFQQILSGVDYCH 133 (476)
T ss_dssp EEEECCS----------SEEHHHHTTS-----------------------------SSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999664 3444443321 134677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. +||+|||+++..... ....+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 134 ~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 134 RHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp TTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTT----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred HCCCCcccccHHHEEEecCCC--eEEEeccchhhcccc----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHH
Confidence 999999999999999987765 899999999876542 12345679999999999988765 68999999999999
Q ss_pred HHHhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 575 FCITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 575 elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+|++| .+||...... ....+.......+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 208 elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 208 ALLCG-TLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHS-SCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHhhC-CCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99997 7788654332 22233333333445567899999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.51 Aligned_cols=256 Identities=28% Similarity=0.384 Sum_probs=196.5
Q ss_pred cccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCC------ce
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ------DF 413 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~ 413 (774)
+......|.+.+.||+|+||+||++....+..||||++.... ....+|+. ++..++|||||++++++... ..
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQ-IMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHH-HHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHH-HHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 445567799999999999999999987777779999986543 22235664 77889999999999998543 34
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|||||.+++.+.+.... .....+++..++.++.||+.||+|
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~qi~~aL~~ 156 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYA------------------------------------KLKQTMPMLLIKLYMYQLLRSLAY 156 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHH------------------------------------HTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEeeccCccHHHHHHHHH------------------------------------hhcCCCCHHHHHHHHHHHHHHHHH
Confidence 89999988876544431100 113457888899999999999999
Q ss_pred HHHcCccccccCCCCeeec-CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHH
Q 004097 494 LHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGC 571 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~-~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGv 571 (774)
||+.+|+||||||+|||++ .++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||
T Consensus 157 LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 230 (394)
T 4e7w_A 157 IHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGC 230 (394)
T ss_dssp HHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHH
Confidence 9999999999999999997 454 48999999998765332 22345689999999999765 5899999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH--HHHHhhc----------------------------cccccccCCHHHHHHHHHhcCCC
Q 004097 572 ILFFCITGGKHPYGESFERD--ANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~~dli~~~L~~d 621 (774)
++|||++| .+||....... ..++... ...+....++++.+||.+||+.|
T Consensus 231 il~ell~g-~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (394)
T 4e7w_A 231 VMAELMQG-QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309 (394)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCC
Confidence 99999997 77776543221 1111110 00112235679999999999999
Q ss_pred CCCCcCHHHHHcCCCCCCc
Q 004097 622 PDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 622 P~~Rps~~elL~HPff~~~ 640 (774)
|.+|||+.|+++||||...
T Consensus 310 P~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 310 PSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GGGSCCHHHHHTSGGGSTT
T ss_pred hhhCCCHHHHhcChhhhhh
Confidence 9999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.92 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=189.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+ .++..++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHhCCCCCccchhheeecCCeEEEEE
Confidence 4588899999999999999865 45899999998654432 223455 4778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.+ +++..++. ....+++..+..++.|++.||+|||+.+
T Consensus 82 e~~~~----------~~l~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~ 122 (311)
T 4agu_A 82 EYCDH----------TVLHELDR-----------------------------YQRGVPEHLVKSITWQTLQAVNFCHKHN 122 (311)
T ss_dssp ECCSE----------EHHHHHHH-----------------------------TSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCC----------chHHHHHh-----------------------------hhcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 97764 33333221 1234677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 123 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 123 CIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999987765 89999999987653321 1234568999999999986 56899999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHhhc-cc------------------------------cccccCCHHHHHHHHHhcCCCCCCC
Q 004097 578 TGGKHPYGESFERDA-NIVKDR-KD------------------------------LFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~~~~~~-~~------------------------------~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
+| .+||........ ..+... .. ......++++.+||.+||+.||.+|
T Consensus 198 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 198 SG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 97 778865433221 111100 00 0012345689999999999999999
Q ss_pred cCHHHHHcCCCCCCcc
Q 004097 626 PKAQNVLNHPFFWTAD 641 (774)
Q Consensus 626 ps~~elL~HPff~~~~ 641 (774)
||++|+++||||++..
T Consensus 277 pt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 277 LTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCHHHHHTSGGGTTCC
T ss_pred CCHHHHhcChHHHhcc
Confidence 9999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.73 Aligned_cols=288 Identities=28% Similarity=0.391 Sum_probs=196.8
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-------c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-------H-DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-------~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+.+.|.+.+.||+|+||+||++.. .+++.||||++.+.. . ....+|+ .++..++||||+++++++.+.+
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV-RLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHH-HHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHH-HHHHhCCCCCcceeehhhccCC
Confidence 4467799999999999999999854 568899999986431 1 2334455 4778889999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchh---hHHHHHhhcccccchhh-----HH-H--HhhCCCCHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL---LNEVRIRLLPVMENTKD-----IE-L--WKANGHPSAQLL 481 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~---l~~~~~~~~~~~~~~~~-----~~-~--~~~~~l~~~~~~ 481 (774)
..|+|||||. +|+|.+++......... .........+....... .. . -....+++..++
T Consensus 102 ~~~lv~e~~~----------gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 102 YICLVMELCH----------GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp EEEEEEECCC----------SCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eEEEEEeCCC----------CCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 9999999664 34444433210000000 00000000000000000 00 0 000112456778
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhc--C
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQ--G 558 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~--~ 558 (774)
.|+.||+.||+|||+.+|+||||||+|||++.++...+||+|||+++.+..... .........||+.|+|||++.+ .
T Consensus 172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 999999999999999999999999999999877755699999999987643211 1112344569999999999975 6
Q ss_pred CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 559 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 559 ~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.++.++|||||||++|||++| .+||........ .+....... .....++++.++|.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMG-AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHC-CCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 789999999999999999997 778865443322 222222111 12235789999999999999999999999999
Q ss_pred CCCCCCcc
Q 004097 634 HPFFWTAD 641 (774)
Q Consensus 634 HPff~~~~ 641 (774)
||||....
T Consensus 331 hp~~~~~~ 338 (345)
T 3hko_A 331 HPWISQFS 338 (345)
T ss_dssp SHHHHTTS
T ss_pred ChhhccCh
Confidence 99996543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.45 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=184.4
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
+.+.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHH-HHHhcCCCCccceEEeecccccccc
Confidence 34668999999999999999985 45689999999975322 22345554 678889999999999987665
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..|+|||||.++|.+++. ..+++..+..++.||+.|
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~i~~qi~~a 139 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCG 139 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH------------------------------------------SCCCHHHHHHHHHHHHHH
T ss_pred ccceEEEEEcCCCCHHHHHh------------------------------------------hccCHHHHHHHHHHHHHH
Confidence 789999988877665541 125667788999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++||||||
T Consensus 140 l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 213 (371)
T 2xrw_A 140 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 213 (371)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred HHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHH
Confidence 99999999999999999999987765 899999999866532 122345699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhccc---------------------c--------------ccc------cCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRKD---------------------L--------------FLV------EHI 607 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~~---------------------~--------------~~~------~~~ 607 (774)
|++|||++| .+||........ .++..... . ++. ..+
T Consensus 214 ~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (371)
T 2xrw_A 214 CIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 292 (371)
T ss_dssp HHHHHHHHS-SCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccccc
Confidence 999999997 677765432211 11110000 0 000 013
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 608 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 608 ~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+++++||.+||+.||.+|||++|+++||||..+
T Consensus 293 ~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 293 SQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 578999999999999999999999999999653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=370.43 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=191.4
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeec
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVE 408 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~ 408 (774)
..+.+.|.+.+.||+|+||+||++.. .+++.||||++.+... ....+|+. ++..++|||||++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE-ILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHH-HHHHCCCTTBCCCCEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHH-HHHhCCCCCEeeEEEEE
Confidence 34567799999999999999999854 5689999999865321 12345664 77888999999999997
Q ss_pred cCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 004097 409 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488 (774)
Q Consensus 409 ~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 488 (774)
.. +..|+|||||. +|+|.+++. ....+++..++.++.||+
T Consensus 210 ~~-~~~~lv~e~~~----------~g~L~~~l~-----------------------------~~~~~~~~~~~~i~~qi~ 249 (419)
T 3i6u_A 210 DA-EDYYIVLELME----------GGELFDKVV-----------------------------GNKRLKEATCKLYFYQML 249 (419)
T ss_dssp ES-SEEEEEEECCT----------TCBGGGGTS-----------------------------SSCCCCHHHHHHHHHHHH
T ss_pred ec-CceEEEEEcCC----------CCcHHHHHh-----------------------------ccCCCCHHHHHHHHHHHH
Confidence 55 45799999654 444443321 123467888999999999
Q ss_pred HHHHHHHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcc
Q 004097 489 SGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAI 564 (774)
Q Consensus 489 ~gL~yLH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~s 564 (774)
.||+|||+.+|+||||||+|||++.++ ...+||+|||+++..... ......+||+.|+|||++.. ..++.++
T Consensus 250 ~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 325 (419)
T 3i6u_A 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 325 (419)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHH
T ss_pred HHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchh
Confidence 999999999999999999999997543 345999999999876532 22244679999999999863 5678899
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHH--HHHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFER--DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~--~~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|||||||++|+|++| .+||...... ....+...... .....++++.++|.+||+.||.+|||++|+++||||.
T Consensus 326 DiwslG~il~~lltg-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 326 DCWSLGVILFICLSG-YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp HHHHHHHHHHHHHHS-SCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred hhHhHHHHHHHHHHC-CCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 999999999999997 7788653221 11222222111 1234578999999999999999999999999999998
Q ss_pred Cccchhh
Q 004097 639 TADTRLS 645 (774)
Q Consensus 639 ~~~~~~~ 645 (774)
+.+.+..
T Consensus 405 ~~~~~~~ 411 (419)
T 3i6u_A 405 DEDMKRK 411 (419)
T ss_dssp CHHHHHH
T ss_pred ChhHHHH
Confidence 7655443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.82 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=193.8
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC------CceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD------QDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~~~~L 416 (774)
...|.+.+.||+|+||+||++... +|+.||||++.... ....+|+. ++..++|||||++++++.. ...+++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~-il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHH-HHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHH-HHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 346888999999999999998654 68999999986542 22335665 7788999999999998743 234789
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||.++|.+++... ......+++..++.++.||+.||+|||+
T Consensus 131 v~e~~~~~l~~~~~~~------------------------------------~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 174 (420)
T 1j1b_A 131 VLDYVPETVYRVARHY------------------------------------SRAKQTLPVIYVKLYMYQLFRSLAYIHS 174 (420)
T ss_dssp EEECCCEEHHHHHHHH------------------------------------HHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ehhcccccHHHHHHHH------------------------------------hhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9998887665544210 0122457888899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.++. .+||+|||+++.+.... .....+||+.|+|||++.+. .++.++|||||||++||
T Consensus 175 ~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 249 (420)
T 1j1b_A 175 FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249 (420)
T ss_dssp TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred CCccccCCChhhEEEeCCCC-eEEeccchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHH
Confidence 99999999999999986643 58999999998765332 22345689999999999765 68999999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHHHhhc-----------c---c--------------cccccCCHHHHHHHHHhcCCCCCCC
Q 004097 576 CITGGKHPYGESFERD--ANIVKDR-----------K---D--------------LFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~--~~~~~~~-----------~---~--------------~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
|++| .+||......+ ..++... . . .+....++++.+||.+||+.||.+|
T Consensus 250 ll~G-~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 328 (420)
T 1j1b_A 250 LLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328 (420)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHC
Confidence 9997 77886543221 1222110 0 0 0122346799999999999999999
Q ss_pred cCHHHHHcCCCCCC
Q 004097 626 PKAQNVLNHPFFWT 639 (774)
Q Consensus 626 ps~~elL~HPff~~ 639 (774)
||+.|+++||||..
T Consensus 329 ~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 329 LTPLEACAHSFFDE 342 (420)
T ss_dssp CCHHHHHTSGGGGG
T ss_pred CCHHHHhCCHhhcc
Confidence 99999999999954
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.46 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=198.0
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++... +++.||||++.... . ....+|+ .++..++||||+++++++.+.+..|+|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHH-HHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 56888999999999999998554 57899999986431 1 2334454 478889999999999999999999999
Q ss_pred ccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||+|.+ +|.+++ .. ...+++..++.++.||+.||+|||+
T Consensus 93 ~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~ 132 (284)
T 2vgo_A 93 LEFAPRGELYKEL-----------QK-----------------------------HGRFDEQRSATFMEELADALHYCHE 132 (284)
T ss_dssp ECCCTTEEHHHHH-----------HH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeCCCCcHHHHH-----------Hh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 996653 454443 21 1236777889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||+++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 133 ~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 205 (284)
T 2vgo_A 133 RKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205 (284)
T ss_dssp TTEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHH
T ss_pred CCceecCCCHHHEEEcCCCC--EEEecccccccCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHH
Confidence 99999999999999987775 899999998765432 12345689999999999998999999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 577 ITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++| .+||....... ...+.......+...++++.++|.+||+.||.+|||++++++||||+...
T Consensus 206 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 206 LVG-MPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHC-CCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 997 77886544332 22222223334455678999999999999999999999999999996543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.55 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=195.0
Q ss_pred ceEEEeEeecccCceEEEEEee----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+..+....+||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5689999999999999999865 378999999985421 23344566544333379999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++.. ...+++..++.++.||+.||+|
T Consensus 134 ~~lv~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~ 174 (355)
T 1vzo_A 134 LHLILDYIN----------GGELFTHLSQ-----------------------------RERFTEHEVQIYVGEIVLALEH 174 (355)
T ss_dssp EEEEECCCC----------SCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEeecCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 999999665 4444444321 1346778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc--CCCCCcchhHhHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGC 571 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGv 571 (774)
||+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 175 LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~ 250 (355)
T 1vzo_A 175 LHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250 (355)
T ss_dssp HHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred HHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHH
Confidence 99999999999999999987765 89999999987643211 22234579999999999986 34789999999999
Q ss_pred HHHHHHhCCCCCCCCch-----HHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCcc
Q 004097 572 ILFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 641 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~ 641 (774)
++|||++| ..||.... ......+.......+...++.+.+||.+||+.||.+|| +++|+++||||...+
T Consensus 251 il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 251 LMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHC-CCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 99999997 77875321 11122222233334556678999999999999999999 999999999997654
Q ss_pred c
Q 004097 642 T 642 (774)
Q Consensus 642 ~ 642 (774)
+
T Consensus 330 ~ 330 (355)
T 1vzo_A 330 W 330 (355)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=370.56 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=198.0
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCCeeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNIVR 403 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNIV~ 403 (774)
..+++.|.+.+.||+|+||+||++.. .+++.||||++.+.. .....+|+. ++..++|||||+
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS-LLKSLDHPNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHH-HHHTCCCTTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHH-HHHhCCCCCCCe
Confidence 45678899999999999999999854 468899999986532 123445554 778899999999
Q ss_pred EeeeccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHH
Q 004097 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 483 (774)
Q Consensus 404 l~g~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 483 (774)
+++++.+.+..|+|||||. +|+|.+.+. ....+++..++.|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~----------gg~L~~~l~-----------------------------~~~~~~~~~~~~i 151 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYE----------GGELFEQII-----------------------------NRHKFDECDAANI 151 (504)
T ss_dssp EEEEEECSSEEEEEEECCT----------TCBHHHHHH-----------------------------HHSCCCHHHHHHH
T ss_pred EEEEEEcCCEEEEEEecCC----------CCcHHHHHH-----------------------------HcCCCCHHHHHHH
Confidence 9999999999999999665 344433332 1234778889999
Q ss_pred HHHHHHHHHHHHHcCccccccCCCCeeecCCCC-ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCC
Q 004097 484 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 562 (774)
Q Consensus 484 ~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 562 (774)
+.||+.||+|||+.+|+||||||+|||++.++. ..+||+|||+++..... ......+||+.|+|||++. ..++.
T Consensus 152 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~ 226 (504)
T 3q5i_A 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK-KKYNE 226 (504)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT-TCBCT
T ss_pred HHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc-cCCCc
Confidence 999999999999999999999999999987653 35899999999876543 1234457999999999987 46899
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++|||||||++|+|++| .+||....... ...+......+ ....++++.+||.+||+.||.+|||++|+|+||||
T Consensus 227 ~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 227 KCDVWSCGVIMYILLCG-YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 99999999999999997 77886654332 22222222111 23457899999999999999999999999999999
Q ss_pred CCc
Q 004097 638 WTA 640 (774)
Q Consensus 638 ~~~ 640 (774)
...
T Consensus 306 ~~~ 308 (504)
T 3q5i_A 306 KKY 308 (504)
T ss_dssp HHT
T ss_pred hhc
Confidence 643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.41 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=174.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.... . ....+|+ .++..++||||+++++++.+.+..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV-KIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHH-HHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4588899999999999999865 578999999996432 1 2334454 477888999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||+|. +++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 90 ~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (278)
T 3cok_A 90 LEMCH----------NGEMNRYLKNR----------------------------VKPFSENEARHFMHQIITGMLYLHSH 131 (278)
T ss_dssp EECCT----------TEEHHHHHHTC----------------------------SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCC----------CCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99665 33343333211 13467788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+||+++.++. +||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 132 ~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (278)
T 3cok_A 132 GILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPH---EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206 (278)
T ss_dssp TEECSSCCGGGEEECTTCC--EEECCCTTCEECC-------------------------------CTHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCC---CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 8999999998765321 1123456899999999999888999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+| .+||....... ...........+...++++.++|.+||+.||++|||++++++||||...
T Consensus 207 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 207 IG-RPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HS-SCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred hC-CCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 97 77886543221 1111111122334456899999999999999999999999999999653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=352.47 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=193.8
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
+.+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+..+....+||||+++++++.+
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 4467899999999999999998764 799999999865431 1233455534333489999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+|||||. +|+|.+++.. ...+++..+..++.||+.|
T Consensus 172 ~~~~~lv~e~~~----------g~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~~ 212 (365)
T 2y7j_A 172 SSFMFLVFDLMR----------KGELFDYLTE-----------------------------KVALSEKETRSIMRSLLEA 212 (365)
T ss_dssp SSEEEEEECCCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEeCC----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHH
Confidence 999999999665 4444443321 1346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC------CCCCcc
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG------RQTRAI 564 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~s 564 (774)
|+|||+.||+||||||+|||++.++. +||+|||++..+.... ......||+.|+|||++.+. .++.++
T Consensus 213 L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 286 (365)
T 2y7j_A 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286 (365)
T ss_dssp HHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTH
T ss_pred HHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchh
Confidence 99999999999999999999988765 8999999998775432 22345799999999998743 578999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHH-HHHHH-hhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFER-DANIV-KDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~-~~~~~-~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|||||||++|+|++| .+||...... ....+ ...... .....++++.++|.+||+.||.+|||+.|+++||||.
T Consensus 287 Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 287 DLWACGVILFTLLAG-SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred hHHhHHHHHHHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 999999999999997 6677654322 22222 222111 1134567899999999999999999999999999995
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.44 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=195.3
Q ss_pred cccceEEEe-EeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFN-KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~-~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+.+.|.+. +.||+|+||+||++.. .+|+.||||++.... .....+|+..+.....||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 345556665 8999999999999854 468999999986432 234566776555555789999999999999999
Q ss_pred EEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|+|||||.+ +|.+++ .. .....+++..++.++.||+.||+|
T Consensus 105 ~lv~e~~~~~~L~~~~-----------~~---------------------------~~~~~~~~~~~~~i~~ql~~~L~~ 146 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLC-----------LP---------------------------ELAEMVSENDVIRLIKQILEGVYY 146 (327)
T ss_dssp EEEEECCTTEEGGGGG-----------SS---------------------------CC-CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCCcHHHHH-----------HH---------------------------hcccCCCHHHHHHHHHHHHHHHHH
Confidence 999996653 444433 11 012347788899999999999999
Q ss_pred HHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
||+.+|+||||||+|||++... ...+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 147 LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 222 (327)
T 3lm5_A 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222 (327)
T ss_dssp HHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHH
Confidence 9999999999999999997611 2348999999998765321 2234569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccch
Q 004097 573 LFFCITGGKHPYGESFERDA-N-IVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 643 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-~-~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~ 643 (774)
+|+|++| .+||........ . +...... ......++++.++|.+||+.||.+|||++++++||||...+..
T Consensus 223 l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 223 AYMLLTH-TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred HHHHHhC-CCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 9999997 677765443322 2 2221111 1223456789999999999999999999999999999776543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.01 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=192.4
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHH-HHhhCCCCCCCeEEEEEeeCCce
Confidence 46688889999999999999865 4589999999864321 23456665 67888999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||.++|.+++... ...+++..+..++.|++.||+||
T Consensus 88 ~lv~e~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~l~~l 128 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDN---------------------------------------SLVLTPSHIKAYMLMTLQGLEYL 128 (346)
T ss_dssp EEEEECCSEEHHHHHTTC---------------------------------------CSSCCSSHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCCCCHHHHHHhc---------------------------------------CcCCCHHHHHHHHHHHHHHHHHH
Confidence 999998887766554211 12356677899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++
T Consensus 129 H~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 203 (346)
T 1ua2_A 129 HQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 203 (346)
T ss_dssp HHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred HHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHH
Confidence 9999999999999999988775 8999999998765322 122345789999999999764 489999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhcccc---------------------------ccccCCHHHHHHHHHhcCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDRKDL---------------------------FLVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~~~~---------------------------~~~~~~~~~~dli~~~L~~dP~~ 624 (774)
|||++| .+||....... ..+....... .....++++.+||.+||+.||.+
T Consensus 204 ~ell~g-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 282 (346)
T 1ua2_A 204 AELLLR-VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 282 (346)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHC-CCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhh
Confidence 999996 77776543322 1222111000 01233578999999999999999
Q ss_pred CcCHHHHHcCCCCCCcc
Q 004097 625 RPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 625 Rps~~elL~HPff~~~~ 641 (774)
|||++|+++||||.+..
T Consensus 283 Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 283 RITATQALKMKYFSNRP 299 (346)
T ss_dssp SCCHHHHHTSGGGTSSS
T ss_pred CCCHHHHhcChhhhcCC
Confidence 99999999999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.07 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=200.2
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
...+.|.+.+.||+|+||+||++... +++.||+|++..... +...+|+ .++..++||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHH-HHHHhCCCCCEeeeeeeeccCCEE
Confidence 34577999999999999999998654 588999999865421 2233444 477889999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|+|||+|. ++|.+++ . ....+++..++.++.||+.||+|
T Consensus 91 ~lv~e~~~~~~L~~~~-----------~-----------------------------~~~~~~~~~~~~i~~qi~~~l~~ 130 (294)
T 2rku_A 91 FVVLELCRRRSLLELH-----------K-----------------------------RRKALTEPEARYYLRQIVLGCQY 130 (294)
T ss_dssp EEEEECCTTCBHHHHH-----------H-----------------------------HHCSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCHHHHH-----------H-----------------------------hcCCCCHHHHHHHHHHHHHHHHH
Confidence 99999665 3444433 1 12346778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 131 lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 131 LHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205 (294)
T ss_dssp HHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHH
T ss_pred HHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHH
Confidence 99999999999999999987765 89999999987653221 22345689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 574 FFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+|++| ..||....... ...+.......+...++++.++|.+||+.||++|||++|+++||||.+.
T Consensus 206 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 206 YTLLVG-KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999997 77886654332 2222222333445567899999999999999999999999999999654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=351.02 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=200.1
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..+.|.+.+.||+|+||+||++... +++.||+|++.... .....+|+ .++..++||||+++++++.+.+..|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3567899999999999999998554 57899999986542 12233454 4778899999999999999999999
Q ss_pred EeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 416 LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|||||. ++|.+++ . ....+++..++.++.||+.||+||
T Consensus 118 lv~e~~~~~~L~~~~-----------~-----------------------------~~~~l~~~~~~~i~~qi~~aL~~L 157 (335)
T 2owb_A 118 VVLELCRRRSLLELH-----------K-----------------------------RRKALTEPEARYYLRQIVLGCQYL 157 (335)
T ss_dssp EEECCCTTCBHHHHH-----------H-----------------------------HHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCHHHHH-----------h-----------------------------ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999766 3444433 1 123467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 158 H~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (335)
T 2owb_A 158 HRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232 (335)
T ss_dssp HHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT---CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHH
T ss_pred HHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc---ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 9999999999999999987765 8999999998765322 1223456999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 575 FCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+|++| ..||....... ...+.......+....+++.++|.+||+.||++|||++|+++||||.+.
T Consensus 233 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 233 TLLVG-KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHS-SCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHC-cCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99997 77886644332 2222222333445567899999999999999999999999999999654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=340.86 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=191.2
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC----
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD---- 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~---- 410 (774)
...++.|.+.+.||+|+||+||++.. .++..||||++..... ....+|+ .++..++||||+++++++.+
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHH-HHHHhCCCCCeeeeeeeeccccCC
Confidence 44567789999999999999999854 4688999999865432 1223344 47788999999999998764
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
....|+|||||. +|+|.+++.. ...+++..++.|+.||+.|
T Consensus 101 ~~~~~lv~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~ 141 (290)
T 1t4h_A 101 KKCIVLVTELMT----------SGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKG 141 (290)
T ss_dssp CEEEEEEEECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEEecC----------CCCHHHHHHH-----------------------------ccCCCHHHHHHHHHHHHHH
Confidence 467899999664 3344443321 1346777889999999999
Q ss_pred HHHHHHcC--ccccccCCCCeeec-CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhH
Q 004097 491 LSHLHEIG--LIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567 (774)
Q Consensus 491 L~yLH~~~--ivHrDLkp~NILl~-~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvw 567 (774)
|+|||+.+ |+||||||+|||++ .++. +||+|||++...... ......||+.|+|||++. ..++.++|||
T Consensus 142 l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~ 213 (290)
T 1t4h_A 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYE-EKYDESVDVY 213 (290)
T ss_dssp HHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGG-TCCCTHHHHH
T ss_pred HHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCccccccc-----ccccccCCcCcCCHHHHh-ccCCCcchHH
Confidence 99999999 99999999999997 4544 899999999755432 223456999999999886 4589999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHH--HHHHhhc--cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 568 SLGCILFFCITGGKHPYGESFERD--ANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~~--~~~~~~~--~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||||++|+|++| ..||....... ...+... ........++++.++|.+||+.||.+|||++|+++||||.+
T Consensus 214 slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 214 AFGMCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHhC-CCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999997 77886533222 1222211 22233445689999999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.04 Aligned_cols=251 Identities=15% Similarity=0.146 Sum_probs=187.0
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHH--HHHHhCCCCCeeEEe-------e
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWY-------G 406 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~--~ll~~l~HpNIV~l~-------g 406 (774)
..+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. .+++.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357799999999999999999864 569999999986431 123345653 345667899999998 4
Q ss_pred eccCCc-----------------eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHH
Q 004097 407 VESDQD-----------------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469 (774)
Q Consensus 407 ~~~~~~-----------------~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 469 (774)
++.+.+ ..|||||||.++|.+++...+ ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-----------~~~---------------------- 197 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-----------SHS---------------------- 197 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-----------HTT----------------------
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-----------ccc----------------------
Confidence 444432 389999988777777663211 000
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCC
Q 004097 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 549 (774)
Q Consensus 470 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y 549 (774)
.....+++..++.|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.... .....+| +.|
T Consensus 198 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~------~~~~~~g-~~y 268 (377)
T 3byv_A 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGA------RVVSSVS-RGF 268 (377)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTC------EEECCCC-TTC
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheecCC------cccCCCC-cCc
Confidence 00011334667889999999999999999999999999999988765 89999999986432 2234567 999
Q ss_pred CchhhhhcC-----------CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhc
Q 004097 550 QAPEQLLQG-----------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLL 618 (774)
Q Consensus 550 ~aPE~l~~~-----------~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 618 (774)
+|||++.+. .++.++|||||||++|||++| .+||........ .... .......++++.+||.+||
T Consensus 269 ~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg-~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~~li~~~L 344 (377)
T 3byv_A 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-DLPITKDAALGG--SEWI-FRSCKNIPQPVRALLEGFL 344 (377)
T ss_dssp CCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS-SCCC------CC--SGGG-GSSCCCCCHHHHHHHHHHT
T ss_pred cChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC-CCCCcccccccc--hhhh-hhhccCCCHHHHHHHHHHc
Confidence 999999987 899999999999999999996 778865332111 0000 0112355789999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCC
Q 004097 619 DPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 619 ~~dP~~Rps~~elL~HPff~~ 639 (774)
+.||++|||+.|+++||||..
T Consensus 345 ~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 345 RYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CSSGGGCCCHHHHHTSHHHHH
T ss_pred CCCchhCCCHHHHhhChHHHH
Confidence 999999999999999999954
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.98 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=201.8
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|...+.||+|+||+||++.. .+++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35588889999999999999854 5689999999965432 3334455 4678889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.+ ++|.+++. ...+++..+..++.||+.||+|||+.+
T Consensus 100 e~~~~----------~~L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 139 (303)
T 3a7i_A 100 EYLGG----------GSALDLLE------------------------------PGPLDETQIATILREILKGLDYLHSEK 139 (303)
T ss_dssp ECCTT----------EEHHHHHT------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCC----------CcHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 96653 34433321 134677788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+||+++.++. +||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 140 i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 214 (303)
T 3a7i_A 140 KIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214 (303)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECBTTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CccCCCChheEEECCCCC--EEEeecccceecCccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc
Confidence 999999999999987765 8999999998765432 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccchhhhh
Q 004097 579 GGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFL 647 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~~~~~l 647 (774)
| .+||........ .+............++++.++|.+||+.||.+|||+.++++||||.....+..++
T Consensus 215 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 284 (303)
T 3a7i_A 215 G-EPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284 (303)
T ss_dssp S-SCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGG
T ss_pred C-CCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHHH
Confidence 7 778866443322 2222223333445678899999999999999999999999999996654444433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.86 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=193.7
Q ss_pred ccccceEEEeEeecccCceEEEEEee--eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCC------CCCeeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQ------HPNIVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~--~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~------HpNIV~l~g~~~~ 410 (774)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++ |++|+++++++.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ-VLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHH-HHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHH-HHHHhhhcCCCCceeeEeeeccccc
Confidence 45667899999999999999999854 4689999999975422 23344554 344444 4569999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+|||+|.++|.+++... ....+++..++.++.||+.|
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~--------------------------------------~~~~~~~~~~~~~~~qi~~~ 130 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKEN--------------------------------------GFLPFRLDHIRKMAYQICKS 130 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT--------------------------------------TTCCCCHHHHHHHHHHHHHH
T ss_pred CCcEEEEEcCCCCCHHHHHHhc--------------------------------------CCCCCcHHHHHHHHHHHHHH
Confidence 9999999998877777665211 11236677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCC-----------------CceEEEcccCccccccCCCccccccccCcCCCCCCchh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 553 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE 553 (774)
|+|||+.+|+||||||+|||++.++ ...+||+|||+++..... .....||+.|+|||
T Consensus 131 l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE 204 (339)
T 1z57_A 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPE 204 (339)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHH
T ss_pred HHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChH
Confidence 9999999999999999999997643 235899999999865432 23456899999999
Q ss_pred hhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcccc-------------------------------
Q 004097 554 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDL------------------------------- 601 (774)
Q Consensus 554 ~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~~~~~~~------------------------------- 601 (774)
++.+..++.++|||||||++|||++| .+||....... ...+......
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
T 1z57_A 205 VILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283 (339)
T ss_dssp HHTTSCCCTHHHHHHHHHHHHHHHHS-SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred HhhCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccch
Confidence 99999999999999999999999997 77776543322 1111100000
Q ss_pred -------------ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 602 -------------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 602 -------------~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.....++++.+||.+||+.||.+|||++|+++||||...
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 000112568899999999999999999999999999654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.71 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=194.5
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.+.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN-ILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHH-HHHhCCCCCeeehhheecCCCe
Confidence 456889999999999999998654 68999999986542 123445554 7788899999999999999999
Q ss_pred eEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 414 ~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.|+|||+|. ++|.+++ .. ...+++..++.++.||+.||+
T Consensus 83 ~~lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~~i~~~l~ 122 (283)
T 3bhy_A 83 VVLILELVSGGELFDFL-----------AE-----------------------------KESLTEDEATQFLKQILDGVH 122 (283)
T ss_dssp EEEEEECCCSCBHHHHH-----------HH-----------------------------HSSCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEeecCCCcHHHHH-----------Hh-----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 999999664 3554444 21 134677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCC--CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|||+.+|+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||++.+..++.++||||||
T Consensus 123 ~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 198 (283)
T 3bhy_A 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 198 (283)
T ss_dssp HHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred HHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHH
Confidence 99999999999999999998765 2258999999998765321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 571 CILFFCITGGKHPYGESFERD-ANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~-~~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|++|+|++| ..||....... ...+..... ......++++.++|.+||+.||.+|||+.|+++||||..
T Consensus 199 ~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 199 VITYILLSG-ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHS-SCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHC-CCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999997 66776543322 222221111 112345678999999999999999999999999999954
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=358.06 Aligned_cols=254 Identities=28% Similarity=0.316 Sum_probs=192.9
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCC-----CeeEEeeeccCC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHP-----NIVRWYGVESDQ 411 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~Hp-----NIV~l~g~~~~~ 411 (774)
..+.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..+ .|+ +|+++++++.+.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR-LLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHH-HHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHH-HHHHHHhcccccceeEEEeeeeeccC
Confidence 45567799999999999999999854 4688999999975432 22334444 33333 354 499999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|+|||+|.++|.+++... ...++++..++.++.||+.||
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~--------------------------------------~~~~~~~~~~~~i~~qi~~al 170 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNT--------------------------------------NFRGVSLNLTRKFAQQMCTAL 170 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHT--------------------------------------TTSCCCHHHHHHHHHHHHHHH
T ss_pred CceEEEEecCCCCHHHHHhhc--------------------------------------CcCCCCHHHHHHHHHHHHHHH
Confidence 999999998888777766321 113467788899999999999
Q ss_pred HHHH--HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 492 SHLH--EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 492 ~yLH--~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
+||| +.+|+||||||+|||++.++...+||+|||+++..... .....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp HHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred HHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 9999 46999999999999997654456999999999876432 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhhcccc-----------------ccc--------------------------
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKDRKDL-----------------FLV-------------------------- 604 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~~~~~-----------------~~~-------------------------- 604 (774)
||++|||++| .+||........ .+....... .+.
T Consensus 245 G~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (382)
T 2vx3_A 245 GCILVEMHTG-EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323 (382)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHH
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHH
Confidence 9999999997 778865433221 111100000 000
Q ss_pred --------------------cCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 605 --------------------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 605 --------------------~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
...+++.+||.+||+.||++|||++|+|+||||...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 001378999999999999999999999999999653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.55 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=198.6
Q ss_pred cccceEEEeEeecccCceEEEEEee--eCCcEEEEEEeecCC-----chHHHHHHHH--HHHhCCCCCeeEEeeecc---
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVES--- 409 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~--~~g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~--- 409 (774)
...+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+.. .+..+.||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3456799999999999999999865 468899999986422 1234556543 234458999999999987
Q ss_pred --CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHH
Q 004097 410 --DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 487 (774)
Q Consensus 410 --~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 487 (774)
+....++|||++.++|.+++... ....+++..++.++.||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~--------------------------------------~~~~~~~~~~~~~~~qi 129 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKV--------------------------------------PEPGVPTETIKDMMFQL 129 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS--------------------------------------CTTCSCHHHHHHHHHHH
T ss_pred cCCCceEEEEEecCCCCHHHHHHhc--------------------------------------ccCCCCHHHHHHHHHHH
Confidence 66789999998887777665311 11236778889999999
Q ss_pred HHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhH
Q 004097 488 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 567 (774)
Q Consensus 488 a~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvw 567 (774)
+.||+|||+.||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||
T Consensus 130 ~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 203 (326)
T 1blx_A 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLW 203 (326)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHH
T ss_pred HHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCC----CCccccccccceeCHHHHhcCCCCcchhHH
Confidence 99999999999999999999999988775 899999999866432 122345689999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc--------------------------ccccccCCHHHHHHHHHhcC
Q 004097 568 SLGCILFFCITGGKHPYGESFERDA--NIVKDRK--------------------------DLFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~--------------------------~~~~~~~~~~~~dli~~~L~ 619 (774)
||||++|+|++| .+||........ .+..... .......++++.+||.+||+
T Consensus 204 slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 282 (326)
T 1blx_A 204 SVGCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282 (326)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcC
Confidence 999999999997 778865443221 2221100 01123356789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCcc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~~ 641 (774)
.||.+|||+.|+++||||....
T Consensus 283 ~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 283 FNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCcccCCCHHHHhcCccccccc
Confidence 9999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.94 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=189.7
Q ss_pred cccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeec-------
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVE------- 408 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~------- 408 (774)
+..++..|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++||||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECTTSCBC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHH-HHHhcCCCCeeEEEEecccccccc
Confidence 3456778999999999999999998654 489999999875542 23345554 77889999999999886
Q ss_pred -------cCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 409 -------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 409 -------~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
.+.+..|+|||||.++|.+++. ...+++..++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~~~~~~~~ 123 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMETDLANVLE-----------------------------------------QGPLLEEHAR 123 (320)
T ss_dssp CC----CCSCSEEEEEEECCSEEHHHHHT-----------------------------------------TCCCCHHHHH
T ss_pred ccccccccccCceeEEeeccCCCHHHHhh-----------------------------------------cCCccHHHHH
Confidence 3457889999988776665541 1235667789
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCC
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQ 560 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~ 560 (774)
.++.||+.||+|||+.+|+||||||+|||++.++ ..+||+|||+++................+|+.|+|||++.. ..+
T Consensus 124 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (320)
T 2i6l_A 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202 (320)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCC
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccC
Confidence 9999999999999999999999999999997443 35899999999876543222223344568999999999876 678
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc-----------------------------ccccccCCHH
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRK-----------------------------DLFLVEHIPE 609 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~~ 609 (774)
+.++|||||||++|||++| .+||........ .+..... .......+++
T Consensus 203 ~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (320)
T 2i6l_A 203 TKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281 (320)
T ss_dssp CHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHH
T ss_pred CchhhhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHH
Confidence 9999999999999999997 677765432211 1111100 0011245689
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+.++|.+||+.||.+|||++|+++||||...
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 282 AVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 9999999999999999999999999999653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.57 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=192.4
Q ss_pred ccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCC--------CCCeeEEeeecc
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQ--------HPNIVRWYGVES 409 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~--------HpNIV~l~g~~~ 409 (774)
..+.+.|.+.+.||+|+||+||++. ..+++.||||++..... ....+|+. ++..++ ||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR-LLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHH-HHHHHhhcCCCCCCcceeeeeeccee
Confidence 3445779999999999999999985 45689999999975432 33455665 334332 889999999987
Q ss_pred ----CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 410 ----DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 410 ----~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
+....|+|||+|.++|.+++... ....+++..++.|+.
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~--------------------------------------~~~~~~~~~~~~i~~ 153 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKS--------------------------------------NYQGLPLPCVKKIIQ 153 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHT--------------------------------------TTSCCCHHHHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhc--------------------------------------ccCCCCHHHHHHHHH
Confidence 66789999998887776655211 113477888999999
Q ss_pred HHHHHHHHHHHc-CccccccCCCCeeecCCCC-----------------------------------------------c
Q 004097 486 DIVSGLSHLHEI-GLIHRDLKPQNVLISKDKS-----------------------------------------------F 517 (774)
Q Consensus 486 qia~gL~yLH~~-~ivHrDLkp~NILl~~~~~-----------------------------------------------~ 517 (774)
||+.||+|||+. ||+||||||+|||++.++. .
T Consensus 154 qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (397)
T 1wak_A 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233 (397)
T ss_dssp HHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGC
T ss_pred HHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccccc
Confidence 999999999998 9999999999999986641 2
Q ss_pred eEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchH--------
Q 004097 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-------- 589 (774)
Q Consensus 518 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~-------- 589 (774)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.....
T Consensus 234 ~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~ 306 (397)
T 1wak_A 234 KVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEPHSGEEYTRDED 306 (397)
T ss_dssp CEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS-SCSCCCCCCSSSCHHHH
T ss_pred ceEecccccccccccc------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhC-CCCCCCCcccccCchHH
Confidence 5999999999876532 2345689999999999999999999999999999999997 778853211
Q ss_pred HHHHHHhhccc-----------------------------------------cccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 590 RDANIVKDRKD-----------------------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 590 ~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
....+...... .......+++.+||.+||+.||++|||+
T Consensus 307 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 386 (397)
T 1wak_A 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386 (397)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH
T ss_pred HHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH
Confidence 01111110000 0011122468899999999999999999
Q ss_pred HHHHcCCCCC
Q 004097 629 QNVLNHPFFW 638 (774)
Q Consensus 629 ~elL~HPff~ 638 (774)
+|+|+||||.
T Consensus 387 ~e~l~hp~~~ 396 (397)
T 1wak_A 387 AECLRHPWLN 396 (397)
T ss_dssp HHHHTSGGGG
T ss_pred HHHhhCcccc
Confidence 9999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.03 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=191.0
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
...+.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+.+..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ-NLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHH-HHhcCCCCCEeEEEEEEecCCeE
Confidence 34466889999999999999998654 78999999986432 123345554 67889999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|+|||+|. ++|.+++ .. ...+++..+..++.||+.||+|
T Consensus 87 ~lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~ 126 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYI-----------CK-----------------------------HGRVEEMEARRLFQQILSAVDY 126 (276)
T ss_dssp EEEEECCCSCBHHHHH-----------HH-----------------------------HCSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEeccCCCcHHHHH-----------hc-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 99999765 3555544 11 1236677889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvl 572 (774)
||+.+|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..+ +.++|||||||+
T Consensus 127 lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 200 (276)
T 2h6d_A 127 CHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200 (276)
T ss_dssp HHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHH
T ss_pred HHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHH
Confidence 99999999999999999987765 8999999998765321 1234468999999999987765 689999999999
Q ss_pred HHHHHhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 573 LFFCITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+|+|++| ..||...... ....+.......+...++++.++|.+||+.||.+|||+.|+++||||+..
T Consensus 201 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 201 LYALLCG-TLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHhC-CCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999997 7787654332 22333333333444567899999999999999999999999999999653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.50 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=194.8
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCC-----
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ----- 411 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 411 (774)
.+.+.|.+.+.||+|+||+||++... +|+.||||++...... ...+|+. ++..++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHH-HHHhCcCCCcCCeeeeecccccCcc
Confidence 45677999999999999999998654 6899999999654322 2345554 67888999999999987764
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...|+|||+|.++|.+++. ...+++..++.++.||+.||
T Consensus 87 ~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~~~~~~~~~~~~qi~~~L 125 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVIS-----------------------------------------TQMLSDDHIQYFIYQTLRAV 125 (353)
T ss_dssp CCEEEEECCCSEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeccCccHHHHHh-----------------------------------------hcCCCHHHHHHHHHHHHHHH
Confidence 6789999988877665541 12367778899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcccc-------ccccCcCCCCCCchhhhhc-CCCCCc
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-------QNATGYGSSGWQAPEQLLQ-GRQTRA 563 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~~ 563 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++.......... ......||+.|+|||++.. ..++.+
T Consensus 126 ~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (353)
T 2b9h_A 126 KVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA 203 (353)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHH
T ss_pred HHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccch
Confidence 9999999999999999999987765 89999999987653221110 1223468999999998865 678999
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCchHHHH-HHHhh-------------------------cc-------ccccccCCHHH
Q 004097 564 IDLFSLGCILFFCITGGKHPYGESFERDA-NIVKD-------------------------RK-------DLFLVEHIPEA 610 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~~~~~~-~~~~~-------------------------~~-------~~~~~~~~~~~ 610 (774)
+|||||||++|+|++| .+||........ ..+.. .. .......++++
T Consensus 204 ~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
T 2b9h_A 204 MDVWSCGCILAELFLR-RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG 282 (353)
T ss_dssp HHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred hhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHH
Confidence 9999999999999997 778765433221 11000 00 00112456789
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 611 ~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||.+||+.||.+|||++|+++||||....
T Consensus 283 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 283 IDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 9999999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=354.44 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=191.0
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee-
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV- 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~- 414 (774)
.+.+.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+ .++..++||||+++++++.+.+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL-LLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHH-HHHHhcCCCCchhhhhheeccCCcc
Confidence 345778999999999999999985 45689999999975432 2233455 477888999999999999887665
Q ss_pred -----EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 415 -----YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 415 -----~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
|+|||+|.++|.+++ ...+++..+..++.||+.
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~------------------------------------------~~~~~~~~~~~i~~qi~~ 155 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIM------------------------------------------GMEFSEEKIQYLVYQMLK 155 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHT------------------------------------------TSCCCHHHHHHHHHHHHH
T ss_pred cceeEEEEEccccccHHHHh------------------------------------------hcCCCHHHHHHHHHHHHH
Confidence 999998876654433 123677788999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHh
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 568 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwS 568 (774)
||+|||+.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 156 aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 156 GLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred HHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 999999999999999999999988765 899999999865432 234568999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHH--HHHhhc-----------------------c-------ccccccCCHHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERDA--NIVKDR-----------------------K-------DLFLVEHIPEAVDLFTR 616 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~--~~~~~~-----------------------~-------~~~~~~~~~~~~dli~~ 616 (774)
|||++|+|++| .+||......+. .+.... . .......++++.+||.+
T Consensus 228 lG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 306 (371)
T 4exu_A 228 VGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 306 (371)
T ss_dssp HHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHH
Confidence 99999999997 778865432211 111100 0 00112346899999999
Q ss_pred hcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 617 LLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 617 ~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||+.||.+|||++|+++||||...
T Consensus 307 ~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 307 MLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HCCCChhhcCCHHHHhcCcccccC
Confidence 999999999999999999999653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.78 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=179.3
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC-----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 411 (774)
+.+.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEecCCcccc
Confidence 45678999999999999999985 45789999999965322 23345664 67888999999999998654
Q ss_pred -ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 -~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
...|+|+|++.++|.+++. ...+++..++.++.||+.|
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~a 144 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVK-----------------------------------------CQKLTDDHVQFLIYQILRG 144 (367)
T ss_dssp CCCCEEEEECCCEECC----------------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEEecccCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 5689999988777766552 1236677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|+|||+.||+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 145 L~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (367)
T 2fst_X 145 LKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216 (367)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCC--EEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred HHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence 99999999999999999999987765 899999999875432 234568999999999987 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhc-----------------------cc-------cccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKDR-----------------------KD-------LFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~~-----------------------~~-------~~~~~~~~~~~dli~~~ 617 (774)
||++|||++| .+||....... . .+.... .. ......++++.+||.+|
T Consensus 217 G~il~ell~g-~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~m 295 (367)
T 2fst_X 217 GCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 295 (367)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHH
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHh
Confidence 9999999997 77886543221 1 111100 00 00123467899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||+.|+|+||||...
T Consensus 296 L~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 296 LVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCCcccCcCHHHHhcChhhhhc
Confidence 99999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=355.20 Aligned_cols=263 Identities=21% Similarity=0.335 Sum_probs=196.0
Q ss_pred cceEEEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESD 410 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 410 (774)
.+.|.+.+.||+|+||+||++... ++..||||++...... ...+|+. ++..+ +||||++++++|.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHH-HHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEcc
Confidence 356889999999999999998643 3568999999765432 2345655 55666 89999999999999
Q ss_pred CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 411 ~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.+.+|+|||||.+ +|.+++ .......... ..+........+++..++.++.||+.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l-----------~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~i~~qi~~ 214 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYL-----------RARRPPGMEY-------------SYDINRVPEEQMTFKDLVSCTYQLAR 214 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHH-----------HHTCCC------------------------CCCCCCHHHHHHHHHHHHH
T ss_pred CCCEEEEEEcCCCCCHHHHH-----------HhhCCccccc-------------cccccccccccCCHHHHHHHHHHHHH
Confidence 9999999996653 555554 3221100000 00000022345788899999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++|||||
T Consensus 215 aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 215 GMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999999999999999999988775 89999999987654321 122233457889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 570 GCILFFCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|||++++.+||....... ...+. ......+...++++.++|.+||+.||.+||++.|++++
T Consensus 292 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 292 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999995588886643332 22222 22233444567899999999999999999999999854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.41 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=189.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++....... ..+|+ .++..++||||+++++++.+.+..|+||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHH-HHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4588899999999999999865 458999999986544322 23454 4778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.+++ +..++ ....++++..+..++.||+.||+|||+.+
T Consensus 104 e~~~~~~----------l~~~~-----------------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 144 (331)
T 4aaa_A 104 EFVDHTI----------LDDLE-----------------------------LFPNGLDYQVVQKYLFQIINGIGFCHSHN 144 (331)
T ss_dssp ECCSEEH----------HHHHH-----------------------------HSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCcch----------HHHHH-----------------------------hhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9776532 22211 11234677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 145 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 219 (331)
T 4aaa_A 145 IIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219 (331)
T ss_dssp CCCCCCCGGGEEECTTSC--EEECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred EEccCcChheEEEcCCCc--EEEEeCCCceeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH
Confidence 999999999999987765 8999999998765321 122345689999999999875 6899999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc------------------------------cccccCCHHHHHHHHHhcCCCCCCC
Q 004097 578 TGGKHPYGESFERDA--NIVKDRKD------------------------------LFLVEHIPEAVDLFTRLLDPNPDLR 625 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~~~~------------------------------~~~~~~~~~~~dli~~~L~~dP~~R 625 (774)
+| .+||........ .+...... ......++++.+||.+||+.||.+|
T Consensus 220 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 298 (331)
T 4aaa_A 220 MG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298 (331)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccC
Confidence 97 678865433221 11110000 0012346789999999999999999
Q ss_pred cCHHHHHcCCCCCCccc
Q 004097 626 PKAQNVLNHPFFWTADT 642 (774)
Q Consensus 626 ps~~elL~HPff~~~~~ 642 (774)
||++|+|+||||.....
T Consensus 299 pt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 299 PFCAELLHHDFFQMDGF 315 (331)
T ss_dssp CCGGGGGGSHHHHGGGH
T ss_pred CCHHHHhcCchhccCCh
Confidence 99999999999976443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=337.42 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=196.7
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...+++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEA-EVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 356888999999999999999877889999999976432 3344555 4778899999999999999999999999966
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++... ...+++..++.++.|++.||+|||+.+|+|
T Consensus 88 ~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (269)
T 4hcu_A 88 E----------HGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIH 129 (269)
T ss_dssp T----------TCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred C----------CCcHHHHHHhc----------------------------CcccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5 44444443211 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+||+++.++. +||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|+|++++.
T Consensus 130 ~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 130 RDLAARNCLVGENQV--IKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp SCCCGGGEEECGGGC--EEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcchheEEEcCCCC--EEeccccccccccccc--cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 999999999977765 8999999998765321 112233457888999999999999999999999999999999668
Q ss_pred CCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 582 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 582 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+||........ .+........+...++++.+++.+||+.||.+|||++++++|
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 206 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 89876544332 222222333344557899999999999999999999999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=352.48 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=187.9
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--h----HHHHHHHHHHHhCCCCCeeEEeeeccCCce-
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--D----VALKEIQNLIASDQHPNIVRWYGVESDQDF- 413 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~- 413 (774)
.+.+.|.+.+.||+|+||+||++.. .+++.||||++..... . ...+|+ .++..++||||+++++++.+.+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-QNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHH-TTCCCCCCTTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHH-HHHHcCCCCCcceEEEeeeccCCC
Confidence 4567799999999999999999864 6789999999975422 1 123344 36677899999999999876543
Q ss_pred ---eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 414 ---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 414 ---~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.|+|||||. +|+|.+++.. ...+++..++.++.||+.|
T Consensus 88 ~~~~~lv~e~~~----------g~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~ 128 (311)
T 3ork_A 88 GPLPYIVMEYVD----------GVTLRDIVHT-----------------------------EGPMTPKRAIEVIADACQA 128 (311)
T ss_dssp EEEEEEEEECCC----------EEEHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHH
T ss_pred CcccEEEEecCC----------CCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHH
Confidence 499999665 3444443321 1346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+..++.++||||||
T Consensus 129 l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 206 (311)
T 3ork_A 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206 (311)
T ss_dssp HHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred HHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHH
Confidence 99999999999999999999988776 8999999998776443333333455799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|++|||++| .+||........ ......... .....++++.++|.+||+.||.+||++.+++.|+|+.
T Consensus 207 ~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 207 CVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 999999996 778866544332 222221111 1234578899999999999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=367.56 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=196.0
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+. ......+|+. ++..++|||||++++++.+.+..|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-LLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHH-HHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 456789999999999999999854 47899999998532 2234456665 7788899999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+.+. ....+++..+..|+.||+.||+|||+
T Consensus 99 v~e~~~----------~~~L~~~~~-----------------------------~~~~~~~~~~~~i~~qi~~al~~lH~ 139 (486)
T 3mwu_A 99 VGELYT----------GGELFDEII-----------------------------KRKRFSEHDAARIIKQVFSGITYMHK 139 (486)
T ss_dssp EECCCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCC----------CCcHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999665 344433322 12347788899999999999999999
Q ss_pred cCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++..+ ...+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+
T Consensus 140 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ 214 (486)
T 3mwu_A 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYI 214 (486)
T ss_dssp TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHH
T ss_pred CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHH
Confidence 9999999999999996432 235999999999876543 22334579999999999875 58999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhcc-c---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 576 CITGGKHPYGESFERD-ANIVKDRK-D---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|++| .+||....... ...+.... . ......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 215 ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 215 LLSG-TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHhC-CCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 9997 66775543322 22222221 1 1223457899999999999999999999999999999643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=347.77 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=192.3
Q ss_pred cccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.....|.+.+.||+|+||+||++... .+..||||++...... ...+|+ .++..++||||+++++++.+.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA-SIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECGGGC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEEeCCc
Confidence 34567899999999999999998653 3556999999764322 234455 47788899999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++... ...+++..++.|+.||+.||+|
T Consensus 125 ~~lv~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~L~~ 166 (325)
T 3kul_A 125 AMIVTEYME----------NGSLDTFLRTH----------------------------DGQFTIMQLVGMLRGVGAGMRY 166 (325)
T ss_dssp CEEEEECCT----------TCBHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHHH
T ss_pred cEEEeeCCC----------CCcHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHH
Confidence 999999664 34444433211 1246778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++................+|+.|+|||++.+..++.++|||||||++
T Consensus 167 LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 244 (325)
T 3kul_A 167 LSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244 (325)
T ss_dssp HHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHH
Confidence 99999999999999999987765 8999999998776443222223334568889999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-H-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|||++++..||........ . +........+...++++.++|.+||+.||.+|||+.++++
T Consensus 245 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 245 WEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999945778865443322 2 2222233344556789999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=367.27 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=194.9
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.|.+.+.||+|+||+||++.. .++..||||++.+.. .....+|+. ++..++|||||++++++.+.+..|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVA-VLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3556799999999999999999854 468999999986532 233445554 778899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+.+. ....+++..+..|+.||+.||+|||
T Consensus 113 lv~e~~~----------~g~L~~~~~-----------------------------~~~~~~~~~~~~i~~qi~~~l~~lH 153 (494)
T 3lij_A 113 LVMECYK----------GGELFDEII-----------------------------HRMKFNEVDAAVIIKQVLSGVTYLH 153 (494)
T ss_dssp EEEECCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC----------CCcHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 334433321 1234677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++..+ ...+||+|||+++..... ......+||+.|+|||++. ..++.++|||||||++|
T Consensus 154 ~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~ 228 (494)
T 3lij_A 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ----KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILF 228 (494)
T ss_dssp HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT----BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHH
T ss_pred HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC----ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHH
Confidence 99999999999999997533 245899999999876543 2234457999999999986 56999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 575 FCITGGKHPYGESFERD-ANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+|++| .+||....... ...+...... .....++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 229 ~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 229 ILLAG-YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99997 77886654332 2222222111 123457899999999999999999999999999999653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=343.31 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=195.5
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
..+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+|||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS-IMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHH-HHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4566889999999999999998554 589999999976543 34455654 77889999999999999999999999997
Q ss_pred cCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 421 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 421 ~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|.+ +|.+++.. ....+++..++.++.||+.||+|||+.+|
T Consensus 106 ~~~~~L~~~~~~---------------------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 146 (314)
T 3com_A 106 CGAGSVSDIIRL---------------------------------------RNKTLTEDEIATILQSTLKGLEYLHFMRK 146 (314)
T ss_dssp CTTEEHHHHHHH---------------------------------------HTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCCHHHHHHh---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 764 55555421 12346778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. +||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 221 (314)
T 3com_A 147 IHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221 (314)
T ss_dssp ECCCCSGGGEEECTTCC--EEECCCTTCEECBTTB---SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred cCCCcCHHHEEECCCCC--EEEeecccchhhhhhc---cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999988775 8999999998765432 122345689999999999998999999999999999999997
Q ss_pred CCCCCCCchHHHH-HHHhhc-cc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 580 GKHPYGESFERDA-NIVKDR-KD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 580 ~~~Pf~~~~~~~~-~~~~~~-~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.+||........ ...... .. ..+...++++.++|.+||+.||.+|||+.++++||||....
T Consensus 222 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 222 -KPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -SCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -CCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 778865433222 111111 11 11334567899999999999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=343.71 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=195.8
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA-VLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHH-HHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4567789999999999999999854 4789999999975432 23345554 67888999999999999999999999
Q ss_pred ccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||+|. ++|.+++ .. ...+++..+..++.||+.||+|||+
T Consensus 85 ~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~ 124 (304)
T 2jam_A 85 MQLVSGGELFDRI-----------LE-----------------------------RGVYTEKDASLVIQQVLSAVKYLHE 124 (304)
T ss_dssp ECCCCSCBHHHHH-----------HH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCccHHHHH-----------HH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99765 3554443 11 2346777889999999999999999
Q ss_pred cCccccccCCCCeee---cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 497 IGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 497 ~~ivHrDLkp~NILl---~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
.+|+||||||+||++ +.++ .+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 125 ~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 197 (304)
T 2jam_A 125 NGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197 (304)
T ss_dssp TTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHH
T ss_pred CCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHH
Confidence 999999999999999 4444 4899999998754422 12334689999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 574 FFCITGGKHPYGESFERD-ANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+|++| .+||....... ...+..... ......++++.++|.+||+.||.+|||++|+++||||...
T Consensus 198 ~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 198 YILLCG-YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHS-SCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHC-CCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999997 67776543322 222222211 1223456899999999999999999999999999999653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=361.28 Aligned_cols=248 Identities=16% Similarity=0.102 Sum_probs=175.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHH-HHH--HHHHHhCCCCCeeEEeeec------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVAL-KEI--QNLIASDQHPNIVRWYGVE------ 408 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~-~Ei--~~ll~~l~HpNIV~l~g~~------ 408 (774)
...|.+.+.||+|+||+||++.. .+|+.||||++..... ...+ +|+ ..++.. +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34588899999999999999864 4789999999986542 1222 332 234455 799988865332
Q ss_pred -cCC-----------------ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHH
Q 004097 409 -SDQ-----------------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 470 (774)
Q Consensus 409 -~~~-----------------~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 470 (774)
... ...|||||||.++|.+++...+..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----------------------------------- 184 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV----------------------------------- 184 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-----------------------------------
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-----------------------------------
Confidence 211 448999998887777776432111
Q ss_pred hhCCCCHHHH------HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCc
Q 004097 471 KANGHPSAQL------LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 544 (774)
Q Consensus 471 ~~~~l~~~~~------~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 544 (774)
+++..+ ..++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++..... .....
T Consensus 185 ----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~~------~~~~~ 252 (371)
T 3q60_A 185 ----YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKVGTR------GPASS 252 (371)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEETTCE------EEGGG
T ss_pred ----cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeecCCC------ccCcc
Confidence 122223 577799999999999999999999999999988775 999999999866421 11345
Q ss_pred CCCCCCchhhhhc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHh--------hccc--cccccCCHHHHH
Q 004097 545 GSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--------DRKD--LFLVEHIPEAVD 612 (774)
Q Consensus 545 gt~~y~aPE~l~~--~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~d 612 (774)
+|+.|+|||++.+ ..++.++|||||||++|||++| .+||............ .... ......++++.+
T Consensus 253 ~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (371)
T 3q60_A 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331 (371)
T ss_dssp SCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS-SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHH
T ss_pred CCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC-CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHH
Confidence 7799999999987 6799999999999999999996 7788765322110000 0010 111345689999
Q ss_pred HHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 613 LFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 613 li~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||.+||+.||++|||+.++++||||...
T Consensus 332 li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 332 LIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp HHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9999999999999999999999999653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=368.90 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=197.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++|||||++++++.+.+..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ-LLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCCEE
Confidence 4456799999999999999999854 478999999986432 233456664 77888999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||+|. +|+|.+.+. ....+++..+..|+.||+.||+||
T Consensus 102 ~lv~e~~~----------~~~L~~~~~-----------------------------~~~~~~~~~~~~i~~qi~~~l~~l 142 (484)
T 3nyv_A 102 YLVGEVYT----------GGELFDEII-----------------------------SRKRFSEVDAARIIRQVLSGITYM 142 (484)
T ss_dssp EEEECCCC----------SCBHHHHHH-----------------------------TCSCCBHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCC----------CCCHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 344443332 123467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCC-CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|||++.. ....+||+|||+++...... .....+||+.|+|||++.+ .++.++|||||||++
T Consensus 143 H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 217 (484)
T 3nyv_A 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217 (484)
T ss_dssp HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHH
T ss_pred HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHH
Confidence 99999999999999999531 22358999999998765432 2234569999999999876 699999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHhhcc-c---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 574 FFCITGGKHPYGESFERD-ANIVKDRK-D---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+|++| .+||....... ...+.... . ......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 218 ~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 218 YILLSG-CPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHC-CCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 999997 77886654332 22222221 1 1123457899999999999999999999999999999643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=352.12 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=194.3
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
....+.|.+.+.||+|+||+||++... +|+.||||++...... ...+|+ .++..++||||+++++++.+++..|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL-QVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHH-HHHHHCCCCCEEEEeEEEEECCEEE
Confidence 445677999999999999999998554 6899999999765332 233444 3667889999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 108 lv~e~~~----------~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~~i~~~l~~lh 148 (360)
T 3eqc_A 108 ICMEHMD----------GGSLDQVLKK-----------------------------AGRIPEQILGKVSIAVIKGLTYLR 148 (360)
T ss_dssp EEECCCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 3444443321 124677788999999999999999
Q ss_pred Hc-CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~-~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+. +|+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 149 ~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 221 (360)
T 3eqc_A 149 EKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221 (360)
T ss_dssp HHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHH
T ss_pred HhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHH
Confidence 96 9999999999999988876 899999999765421 223456999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHH--------------------------------------------Hhhccc-cccccCCHH
Q 004097 575 FCITGGKHPYGESFERDANI--------------------------------------------VKDRKD-LFLVEHIPE 609 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~~~--------------------------------------------~~~~~~-~~~~~~~~~ 609 (774)
+|++| ..||.......... ...... ......+++
T Consensus 222 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (360)
T 3eqc_A 222 EMAVG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 300 (360)
T ss_dssp HHHHT-SCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred HHHhC-CCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHH
Confidence 99997 77776533222110 001111 111224678
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.+||.+||+.||++|||++|+++||||..
T Consensus 301 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 301 FQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 999999999999999999999999999954
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=337.88 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=195.9
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHH-HHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHH-HHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 356888999999999999998654 689999999864322 2233444 4778899999999999999999999999
Q ss_pred cccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 419 ERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 419 E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|+|.+ +|.+++ .. ...+++..++.++.||+.||+|||+.
T Consensus 85 e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (276)
T 2yex_A 85 EYCSGGELFDRI-----------EP-----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGI 124 (276)
T ss_dssp ECCTTEEGGGGS-----------BT-----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCcHHHHH-----------hh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 97653 454433 11 12367778899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~el 576 (774)
+|+||||||+||+++.++. +||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|||
T Consensus 125 ~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 125 GITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp TEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHH
T ss_pred CeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHH
Confidence 9999999999999987765 89999999986643211 112234568999999999987665 7899999999999999
Q ss_pred HhCCCCCCCCchHHH---HHHHhhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 577 ITGGKHPYGESFERD---ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~---~~~~~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
++| ..||....... ........ .......++++.++|.+||+.||.+|||++|+++||||....
T Consensus 202 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 202 LAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHS-SCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HhC-CCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 997 77886543221 11111111 112234578999999999999999999999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.74 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=199.1
Q ss_pred cceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..++|||||++++++.+.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCC
Confidence 46688999999999999999863 35678999999654322 2345554 7788899999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++....... .....+++..++.|+.||+.||+|
T Consensus 149 ~~lv~e~~~----------~g~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 149 RFILLELMA----------GGDLKSFLRETRPRP----------------------SQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp CEEEEECCT----------TEEHHHHHHHHSCCS----------------------SSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEeCC----------CCCHHHHHHhhcccc----------------------CccccccHHHHHHHHHHHHHHHHH
Confidence 999999665 344444433221100 112347788899999999999999
Q ss_pred HHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
||+.+|+||||||+|||++.++ ...+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~i 275 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHH
Confidence 9999999999999999997543 23589999999986542211 122234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 573 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
+|||++++.+||........ . +........+...++++.+||.+||+.||.+|||+.++++|.++.
T Consensus 276 l~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 276 LWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999955888876544332 2 222223334445678899999999999999999999999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.98 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=193.2
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------------chHHHHHHHHHHHhC-CCCCeeEEeeecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------------HDVALKEIQNLIASD-QHPNIVRWYGVES 409 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------------~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~ 409 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..+ .||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD-ILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHH-HHHHHTTCTTBCCEEEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHH-HHHHhcCCCCEeeeeeeec
Confidence 45688899999999999999865 468999999996542 122345655 44445 6999999999999
Q ss_pred CCceeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488 (774)
Q Consensus 410 ~~~~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 488 (774)
+.+..|+|||+|. ++|.+++ .. ...+++..+..++.||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~~~~qi~ 134 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYL-----------TE-----------------------------KVTLSEKETRKIMRALL 134 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHH-----------HH-----------------------------HSSCCHHHHHHHHHHHH
T ss_pred cCCeEEEEEeccCCCcHHHHH-----------hc-----------------------------cCCCCHHHHHHHHHHHH
Confidence 9999999999665 3554444 21 12467778899999999
Q ss_pred HHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh------cCCCCC
Q 004097 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTR 562 (774)
Q Consensus 489 ~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~ 562 (774)
.||+|||+.+|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++. ...++.
T Consensus 135 ~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 208 (298)
T 1phk_A 135 EVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGK 208 (298)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCT
T ss_pred HHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCc
Confidence 9999999999999999999999988765 8999999998765432 223456899999999986 456789
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHH-HHHH-hhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERD-ANIV-KDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~-~~~~-~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++|||||||++|+|++| ..||....... ...+ ...... .....++++.++|.+||+.||.+|||+.|+++||||
T Consensus 209 ~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 209 EVDMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp HHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred ccccHhHHHHHHHHHHC-CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 99999999999999997 66775543322 2222 221111 113456789999999999999999999999999999
Q ss_pred CCc
Q 004097 638 WTA 640 (774)
Q Consensus 638 ~~~ 640 (774)
...
T Consensus 288 ~~~ 290 (298)
T 1phk_A 288 QQY 290 (298)
T ss_dssp CTT
T ss_pred hhc
Confidence 654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.75 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=196.1
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...++..||||++.... .....+|+. ++..++||||+++++++.+.+..|+|||+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45688999999999999999987788899999997653 233455664 677889999999999999999999999966
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
+ +|+|.+++... ...+++..++.++.|++.||+|||+.+|+|
T Consensus 86 ~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 127 (268)
T 3sxs_A 86 S----------NGCLLNYLRSH----------------------------GKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127 (268)
T ss_dssp T----------TCBHHHHHHHH----------------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred C----------CCcHHHHHHHc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5 34444433221 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+||+++.++. +||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++++.
T Consensus 128 ~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (268)
T 3sxs_A 128 RDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203 (268)
T ss_dssp SSCSGGGEEECTTCC--EEECCTTCEEECCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred CCcCcceEEECCCCC--EEEccCccceecchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence 999999999987765 89999999987654321 12233446778999999999899999999999999999999558
Q ss_pred CCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 582 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 582 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+||........ .+........+...++++.++|.+||+.||.+|||+.++++|
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 204 MPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88876544332 222222333344457889999999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.60 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=190.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccC------Cc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESD------QD 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~ 412 (774)
...+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+..+....+||||+++++++.+ .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3456789999999999999999865 478999999986442 34556677655444589999999999876 56
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||.+ +|.+++. .. ....+++..++.++.||+.||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~-----------~~---------------------------~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIK-----------NT---------------------------KGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp EEEEEEECCTTEEHHHHHH-----------HS---------------------------GGGCCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEEcCCCCcHHHHHH-----------hc---------------------------ccCCCCHHHHHHHHHHHHHHH
Confidence 89999997664 5555542 11 113467778899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchh
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDL 566 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv 566 (774)
+|||+.+|+||||||+|||++.++. +||+|||++....... .......||+.|+|||++. ...++.++||
T Consensus 143 ~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 217 (326)
T 2x7f_A 143 SHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 217 (326)
T ss_dssp HHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHH
T ss_pred HHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchH
Confidence 9999999999999999999987765 8999999998765321 1223456899999999997 5668999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHHH-HHH-hhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 567 FSLGCILFFCITGGKHPYGESFERDA-NIV-KDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~~~~~-~~~-~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|||||++|+|++| .+||........ ..+ ... ........++++.++|.+||+.||.+||++.++++||||+...
T Consensus 218 ~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 218 WSLGITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHHHHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 9999999999997 677765433222 111 111 1122334568999999999999999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=348.09 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=194.5
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeecc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVES 409 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~ 409 (774)
.+.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE-ILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHH-HHHHCCCTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHH-HHHhCCCCCCceEeeEEc
Confidence 3456789999999999999999854 4689999999864321 12345554 678889999999999987
Q ss_pred CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 410 ~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+++ .|+|||||. +|+|.+++.. ...+++..+..++.||+.
T Consensus 86 ~~~-~~lv~e~~~----------~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~ 125 (322)
T 2ycf_A 86 AED-YYIVLELME----------GGELFDKVVG-----------------------------NKRLKEATCKLYFYQMLL 125 (322)
T ss_dssp SSS-EEEEEECCT----------TEETHHHHST-----------------------------TCCCCHHHHHHHHHHHHH
T ss_pred CCc-eEEEEecCC----------CCcHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 665 899999665 3344333211 234677788999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcch
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAID 565 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sD 565 (774)
||+|||+.+|+||||||+|||++.++ ...+||+|||+++..... .......||+.|+|||++. ...++.++|
T Consensus 126 ~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 201 (322)
T 2ycf_A 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201 (322)
T ss_dssp HHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHH
T ss_pred HHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhh
Confidence 99999999999999999999997654 345899999999876532 1122346899999999985 456889999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHH--HHH-HHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 566 LFSLGCILFFCITGGKHPYGESFER--DAN-IVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~--~~~-~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||||||++|+|++| .+||...... ... +...... ......++++.++|.+||+.||.+|||+.++++||||+.
T Consensus 202 i~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 202 CWSLGVILFICLSG-YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHHHHHHHHS-SCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHHHhC-CCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999997 7788653221 111 2221111 112345789999999999999999999999999999987
Q ss_pred ccchhh
Q 004097 640 ADTRLS 645 (774)
Q Consensus 640 ~~~~~~ 645 (774)
...+..
T Consensus 281 ~~~~~~ 286 (322)
T 2ycf_A 281 EDMKRK 286 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 655433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=342.36 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=195.5
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------c-hHHHHHHHHHHHhCCCCCeeEEeeec--cCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------H-DVALKEIQNLIASDQHPNIVRWYGVE--SDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~-~~~~~Ei~~ll~~l~HpNIV~l~g~~--~~~~~~ 414 (774)
+.|.+.+.||+|+||+||++.. .+++.||||++.... . ....+|+ .++..++||||+++++++ .+.+..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-QLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHH-HHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHH-HHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4577788999999999999854 468899999996431 1 2334455 477888999999999998 455689
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||.++|.+++.. .....+++..+..++.||+.||+||
T Consensus 84 ~lv~e~~~~~l~~~~~~--------------------------------------~~~~~~~~~~~~~~~~qi~~al~~L 125 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDS--------------------------------------VPEKRFPVCQAHGYFCQLIDGLEYL 125 (305)
T ss_dssp EEEEECCSEEHHHHHHH--------------------------------------STTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEehhccCCHHHHHHh--------------------------------------CcccccCHHHHHHHHHHHHHHHHHH
Confidence 99999888766555421 1123467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC--CCcchhHhHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCI 572 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~sDvwSlGvl 572 (774)
|+.+|+||||||+|||++.++. +||+|||++......... .......||+.|+|||++.+... +.++|||||||+
T Consensus 126 H~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 202 (305)
T 2wtk_C 126 HSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202 (305)
T ss_dssp HHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHH
T ss_pred HHCCeeecCCCcccEEEcCCCc--EEeeccccccccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHH
Confidence 9999999999999999987765 899999999876532211 12234568999999999986543 779999999999
Q ss_pred HHHHHhCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 573 LFFCITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
+|||++| ..||...... ....+.......+...++++.++|.+||+.||.+|||++|+++||||....
T Consensus 203 l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 203 LYNITTG-LYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHhC-CCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999997 6777654332 223333333334556678999999999999999999999999999996543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=350.63 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=182.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCc-------ee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQD-------FV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-------~~ 414 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+++ ..+..++||||+++++++.+.+ ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIM-QDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHH-HHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHH-HHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 5688899999999999999865 468999999986532 22333444 3567779999999999986533 38
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|||||.++|.+.+... + .....+++..+..++.|++.||+||
T Consensus 102 ~lv~e~~~~~l~~~~~~~-------~-----------------------------~~~~~~~~~~~~~~~~qi~~al~~l 145 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNY-------Y-----------------------------RRQVAPPPILIKVFLFQLIRSIGCL 145 (360)
T ss_dssp EEEEECCSCBHHHHHHHH-------H-----------------------------TTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecccccHHHHHHHH-------h-----------------------------hcccCCCHHHHHHHHHHHHHHHHHH
Confidence 999999988766544210 0 1224467788899999999999999
Q ss_pred H--HcCccccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHH
Q 004097 495 H--EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLG 570 (774)
Q Consensus 495 H--~~~ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlG 570 (774)
| +.+|+||||||+|||++. ++ .+||+|||+++...... ......||+.|+|||++.+.. ++.++||||||
T Consensus 146 H~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 219 (360)
T 3e3p_A 146 HLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219 (360)
T ss_dssp TSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred hCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence 9 999999999999999986 54 59999999998765432 223456899999999997654 89999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhcc-------------------------------ccccccCCHHHHHHHHHh
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRK-------------------------------DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~-------------------------------~~~~~~~~~~~~dli~~~ 617 (774)
|++|||++| .+||........ .+..... .......++++.+||.+|
T Consensus 220 ~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 220 CIFAEMMLG-EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHHhC-CCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 999999997 778865433221 1111000 000111346899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
|+.||.+|||+.|+++||||.....
T Consensus 299 L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp TCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred hccCccccCCHHHHhcCccccccCC
Confidence 9999999999999999999976543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.21 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=193.6
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...++..||||++.... .....+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHH-HHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46688999999999999999988888899999997653 23344555 4778899999999999999999999999966
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++... ...+++..++.++.|++.||+|||+.+|+|
T Consensus 102 ~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 143 (283)
T 3gen_A 102 A----------NGCLLNYLREM----------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143 (283)
T ss_dssp T----------TCBHHHHHHCG----------------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred C----------CCcHHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 4 34444433211 124677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|+|++++.
T Consensus 144 ~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~ 219 (283)
T 3gen_A 144 RDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219 (283)
T ss_dssp SSCSGGGEEECTTSC--EEECSTTGGGGBCCHH--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCccceEEEcCCCC--EEEccccccccccccc--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999987765 8999999998765321 112233447888999999999999999999999999999999558
Q ss_pred CCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 582 HPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 582 ~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+||....... . .+........+...++++.++|.+||+.||.+|||++++++|
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 220 MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8887644332 2 223232333344557899999999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.54 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=188.9
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc--ee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~--~~ 414 (774)
..++.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+.+ ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE-VLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHH-HHHhcCCCCcceEEEEeecCCCceE
Confidence 44678999999999999999998654 58999999996532 233445654 778889999999999987655 78
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++.... ....+++..++.|+.||+.||+||
T Consensus 85 ~lv~e~~~----------~~~L~~~l~~~~--------------------------~~~~~~~~~~~~i~~qi~~~L~~L 128 (319)
T 4euu_A 85 VLIMEFCP----------CGSLYTVLEEPS--------------------------NAYGLPESEFLIVLRDVVGGMNHL 128 (319)
T ss_dssp EEEEECCT----------TCBHHHHHHSGG--------------------------GTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCC----------CCCHHHHHHHhc--------------------------cccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 344444332211 122378888999999999999999
Q ss_pred HHcCccccccCCCCeeec--CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh--------cCCCCCcc
Q 004097 495 HEIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--------QGRQTRAI 564 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~--~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~s 564 (774)
|+.+|+||||||+|||+. .++...+||+|||+++...... ......||+.|+|||++. +..++.++
T Consensus 129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (319)
T 4euu_A 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (319)
T ss_dssp HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTH
T ss_pred HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHH
Confidence 999999999999999981 2233469999999998775432 223456999999999987 46789999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCch------HHHHHHHhhcccc------------------cc------ccCCHHHHHHH
Q 004097 565 DLFSLGCILFFCITGGKHPYGESF------ERDANIVKDRKDL------------------FL------VEHIPEAVDLF 614 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~------~~~~~~~~~~~~~------------------~~------~~~~~~~~dli 614 (774)
|||||||++|||++| .+||.... .....+....... .+ ....+.+.++|
T Consensus 205 DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 283 (319)
T 4euu_A 205 DLWSIGVTFYHAATG-SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283 (319)
T ss_dssp HHHHHHHHHHHHHHS-SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHH
Confidence 999999999999997 77875321 1112222221110 00 11124788999
Q ss_pred HHhcCCCCCCCcCHHHHHcCC
Q 004097 615 TRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 615 ~~~L~~dP~~Rps~~elL~HP 635 (774)
.+||+.||++|||++|+++||
T Consensus 284 ~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 284 ANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhccCChhhhccHHHhhhcc
Confidence 999999999999999999997
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.11 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=180.6
Q ss_pred cccceEEEeEeecccCceEEEEEeeeC-C---cEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNYE-G---RSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~~-g---~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
...+.|.+.+.||+|+||+||++.... + ..||||++.... .....+|+. ++..++||||+++++++.+.+
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHH-HHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHH-HHHHCCCCceehhhceeeccc
Confidence 345678899999999999999986543 3 279999986532 123345554 678889999999999998876
Q ss_pred ee------EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 413 FV------YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 413 ~~------~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
.. |+|||||. +|+|.+++...... .....+++..++.|+.|
T Consensus 99 ~~~~~~~~~~v~e~~~----------~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 99 AKGRLPIPMVILPFMK----------HGDLHAFLLASRIG-----------------------ENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp ------CEEEEEECCT----------TCBHHHHHHHHHC--------------------------CCCCCHHHHHHHHHH
T ss_pred cccCCCccEEEEEecc----------CCcHHHHHHhhhcc-----------------------ccccccCHHHHHHHHHH
Confidence 65 99999655 44444443322110 11124788899999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchh
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv 566 (774)
|+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++||
T Consensus 146 i~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeecccccccccccc-ccccccccCcccccCchhhcCCCCCCccch
Confidence 999999999999999999999999987765 89999999987654321 112223457889999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-------HHHHHcCCCC
Q 004097 567 FSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-------AQNVLNHPFF 637 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-------~~elL~HPff 637 (774)
|||||++|||++++.+||....... ..+........+...++++.++|.+||+.||.+||| +++++.|||+
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 9999999999996688887644332 223333334445566789999999999999999999 6778899998
Q ss_pred CCc
Q 004097 638 WTA 640 (774)
Q Consensus 638 ~~~ 640 (774)
...
T Consensus 303 ~~~ 305 (323)
T 3qup_A 303 LST 305 (323)
T ss_dssp ---
T ss_pred cCC
Confidence 654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=343.27 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=181.6
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ-AMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHH-HHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 45678889999999999999854 4789999999864322 22334443 566789999999999999999999999
Q ss_pred cccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 419 ERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 419 E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|||. ++|.+++. ...... ......+++..++.++.||+.||+|||+.
T Consensus 93 e~~~~~~L~~~l~-----------~~~~~~---------------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 93 KLLSGGSVLDIIK-----------HIVAKG---------------------EHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp ECCTTCBHHHHHH-----------HHHHTT---------------------TTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhccCCchHHHHH-----------HHhhcc---------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9765 35555542 110000 01224478889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCcc--ccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ 574 (774)
+|+||||||+||+++.++. +||+|||++......... ........||+.|+|||++.. ..++.++|||||||++|
T Consensus 141 ~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 218 (303)
T 2vwi_A 141 GQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218 (303)
T ss_dssp TCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHH
T ss_pred CCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHH
Confidence 9999999999999988765 899999999876532211 112234569999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhhccc---------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 575 FCITGGKHPYGESFERDA--NIVKDRKD---------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
||++| ..||........ ........ ......++++.++|.+||+.||.+|||+.++++||||....
T Consensus 219 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 219 ELATG-AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHHHS-SCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHHhC-CCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 99997 778865433222 11111111 11123457899999999999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.74 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=199.0
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--------------------hHHHHHHHHHHHhCCCCCee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--------------------DVALKEIQNLIASDQHPNIV 402 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--------------------~~~~~Ei~~ll~~l~HpNIV 402 (774)
..+.|.+.+.||+|+||+||++.. +|+.||||++..... ....+|+. ++..++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ-IITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHH-HHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHH-HHHhCCCCCcc
Confidence 346789999999999999999877 999999999864311 34445554 77888999999
Q ss_pred EEeeeccCCceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 403 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 403 ~l~g~~~~~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
++++++.+.+..|+|||||.+ +|.+++.... . +.. .....+++..++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~----l~~---------------------------~~~~~~~~~~~~ 154 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFF-V----LDK---------------------------NYTCFIPIQVIK 154 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEE-S----SCS---------------------------SSCCCCCHHHHH
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhh-h----hhh---------------------------ccccCCCHHHHH
Confidence 999999999999999997764 5555420000 0 100 012457888899
Q ss_pred HHHHHHHHHHHHHHH-cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-C
Q 004097 482 KVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-R 559 (774)
Q Consensus 482 ~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~ 559 (774)
.++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||++...... ......||+.|+|||++.+. .
T Consensus 155 ~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~ 227 (348)
T 2pml_X 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESS 227 (348)
T ss_dssp HHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCC
T ss_pred HHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEEeccccccccccc-----cccCCCCCcCccCchhhcCCCC
Confidence 999999999999999 99999999999999988765 899999999876532 22345689999999999877 5
Q ss_pred CCC-cchhHhHHHHHHHHHhCCCCCCCCchH--HHHHHHhhcccccc-------------------ccCCHHHHHHHHHh
Q 004097 560 QTR-AIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKDLFL-------------------VEHIPEAVDLFTRL 617 (774)
Q Consensus 560 ~~~-~sDvwSlGvll~elltg~~~Pf~~~~~--~~~~~~~~~~~~~~-------------------~~~~~~~~dli~~~ 617 (774)
++. ++|||||||++|||++| .+||..... .....+.......+ ...++++.++|.+|
T Consensus 228 ~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 228 YNGAKVDIWSLGICLYVMFYN-VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp EEHHHHHHHHHHHHHHHHHHS-SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHH
T ss_pred CCcchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHH
Confidence 665 99999999999999997 778865432 22222222222222 34568999999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|+.||.+|||++|+++||||....
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccCChhhCCCHHHHhcCccccCCC
Confidence 999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.47 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=190.0
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCce---
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF--- 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~--- 413 (774)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCcccHhheEeccccccc
Confidence 456788999999999999999854 5689999999965432 22344554 6788899999999999987654
Q ss_pred ---eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 414 ---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 414 ---~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.|+|||+|.++|.+++ ...+++..+..++.||+.|
T Consensus 101 ~~~~~lv~e~~~~~l~~~~------------------------------------------~~~~~~~~~~~i~~qi~~a 138 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIM------------------------------------------GLKFSEEKIQYLVYQMLKG 138 (353)
T ss_dssp CCCCEEEEECCSEEGGGTT------------------------------------------TSCCCHHHHHHHHHHHHHH
T ss_pred ceeEEEEeccccCCHHHHh------------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 4999998877665443 1236677889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSl 569 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 139 l~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 210 (353)
T 3coi_A 139 LKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210 (353)
T ss_dssp HHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred HHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence 99999999999999999999987765 899999999865422 233468999999999987 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhh-----------------------cc-------ccccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKD-----------------------RK-------DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~-----------------------~~-------~~~~~~~~~~~~dli~~~ 617 (774)
||++|+|++| .+||....... . .+... .. .......++++.+||.+|
T Consensus 211 G~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 3coi_A 211 GCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289 (353)
T ss_dssp HHHHHHHHHS-SCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHH
Confidence 9999999997 77876543221 1 11110 00 001124467999999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||++|+++||||...
T Consensus 290 L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 290 LELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cCCCcccCCCHHHHhcCcchhhc
Confidence 99999999999999999999653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=348.04 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=179.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+..++..++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35577788999999999999865 46899999999765322 34456666778889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 497 (774)
|||.++|.+++.... . .....+++..+..++.|++.||+|||+.
T Consensus 101 e~~~~~l~~~~~~~~--------~---------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (327)
T 3aln_A 101 ELMSTSFDKFYKYVY--------S---------------------------VLDDVIPEEILGKITLATVKALNHLKENL 145 (327)
T ss_dssp CCCSEEHHHHHHHHH--------H---------------------------TTCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCChHHHHHHHH--------h---------------------------hhcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence 998887766652100 0 1124567888899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhh----hcCCCCCcchhHhHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL----LQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDvwSlGvll 573 (774)
+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++ .+..++.++|||||||++
T Consensus 146 ~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 146 KIIHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp SCCCSCCCGGGEEEETTTE--EEECCCSSSCC----------------------------------CCSHHHHHHHHHHH
T ss_pred CEeECCCCHHHEEEcCCCC--EEEccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 9999999999999987765 8999999998765321 12233689999999998 456789999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHH---Hhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 574 FFCITGGKHPYGESFERDANI---VKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~~~---~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+|++| ..||.......... ........ ....++++.++|.+||+.||.+|||+.++++||||...
T Consensus 220 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 220 YELATG-RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHHS-CCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHC-CCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 999997 77886543221111 11111111 12356799999999999999999999999999999643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=339.26 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=184.2
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
...|.+.+.||+|+||+||++. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVA-IMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTEEEEEEEECCCCCSHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEE-ECCCcEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 4568899999999999999975 4789999999865432 12345554 678889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++..... ...+++..++.++.||+.||+|||+.+
T Consensus 114 e~~~----------~~~L~~~l~~~~~--------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (309)
T 3p86_A 114 EYLS----------RGSLYRLLHKSGA--------------------------REQLDERRRLSMAYDVAKGMNYLHNRN 157 (309)
T ss_dssp ECCT----------TCBHHHHHHSTTH--------------------------HHHSCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred ecCC----------CCcHHHHHhhcCC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 9665 3444444322110 012677788999999999999999999
Q ss_pred --ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 499 --LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 499 --ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 232 (309)
T 3p86_A 158 PPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232 (309)
T ss_dssp SCCCCTTCCGGGEEECTTCC--EEECCCC--------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CCEECCCCChhhEEEeCCCc--EEECCCCCCccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999987765 8999999998654321 122345699999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHHH-HHH--hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 577 ITGGKHPYGESFERDA-NIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~-~~~--~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++| ..||........ ..+ .......+...++++.++|.+||+.||.+|||++++++
T Consensus 233 ltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 233 ATL-QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHC-CCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhC-CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 997 778876543332 222 12223344556789999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.18 Aligned_cols=289 Identities=20% Similarity=0.299 Sum_probs=197.0
Q ss_pred ccceEEEeEeecccCceEEEEEe------eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~------~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.|.+.+.||+|+||+||++. ..+++.||||++...... ...+|+..+....+|||||++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 35678999999999999999985 335689999999764332 34567765544458999999999988754
Q ss_pred -eeEEeccccCC-ChhhHHHHhcCChHH------Hhhhhhhc-chhhHHHHHhh-------------------cccccch
Q 004097 413 -FVYLSLERCTC-SLNDLIYVLSGSFEE------QLNAKEQD-SNLLNEVRIRL-------------------LPVMENT 464 (774)
Q Consensus 413 -~~~LV~E~~~~-sL~~~iy~~~gsL~~------~L~~~~~~-~~~l~~~~~~~-------------------~~~~~~~ 464 (774)
..|+|||||.+ +|.+++......... ........ ......+..++ .......
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999997764 676666433221000 00000000 00000000000 0000000
Q ss_pred hhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCc
Q 004097 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 544 (774)
Q Consensus 465 ~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 544 (774)
..........+++..++.|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~-~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD-YVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTT-CEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeeccccc-chhccccC
Confidence 0000111233788999999999999999999999999999999999987765 89999999987654322 12233456
Q ss_pred CCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH--HH-HHHhhccccccccCCHHHHHHHHHhcCCC
Q 004097 545 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 545 gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~--~~-~~~~~~~~~~~~~~~~~~~dli~~~L~~d 621 (774)
||+.|+|||++.+..++.++|||||||++|||++++.+||...... .. .+........+...++++.++|.+||+.|
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 8999999999999999999999999999999999448888654321 12 22222233344556789999999999999
Q ss_pred CCCCcCHHHHHcC
Q 004097 622 PDLRPKAQNVLNH 634 (774)
Q Consensus 622 P~~Rps~~elL~H 634 (774)
|.+|||++|+++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.20 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=192.0
Q ss_pred ccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE-ILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHH-HHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHH-HHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4566889999999999999998654 589999999864322 33445654 677889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|++ ++|.+++.. ....+++..++.++.||+.||+|||+.+
T Consensus 96 e~~~~----------~~l~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (302)
T 2j7t_A 96 EFCPG----------GAVDAIMLE----------------------------LDRGLTEPQIQVVCRQMLEALNFLHSKR 137 (302)
T ss_dssp ECCTT----------EEHHHHHHH----------------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCC----------CcHHHHHHh----------------------------hccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 96653 333333221 1234677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll 573 (774)
|+||||||+||+++.++. +||+|||++...... ........||+.|+|||++. ...++.++|||||||++
T Consensus 138 i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 138 IIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp CCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred cccCCCCHHHEEECCCCC--EEEEECCCCcccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 999999999999987765 899999987654321 11123346899999999984 56789999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH--HHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 574 FFCITGGKHPYGESFERDA--NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~--~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|+|++| .+||........ .+...... ..+...++++.++|.+||+.||.+|||+.++++||||....
T Consensus 213 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 213 IEMAQI-EPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHhcC-CCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 999997 778765443222 22222111 12344567899999999999999999999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.46 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=190.8
Q ss_pred cccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC--CCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ--HPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~--HpNIV~l~g~~~~~~~~ 414 (774)
..++.|.+.+.||+|+||+||++...+++.||||++..... ....+|+. ++..++ ||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHH-HHHhccccCCceEEEEEEeecCCEE
Confidence 34677999999999999999999777899999999965432 23345555 445554 69999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||++.++|.+++.. ...+++..++.++.||+.||+||
T Consensus 104 ~lv~e~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~aL~~L 143 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK----------------------------------------KKSIDPWERKSYWKNMLEAVHTI 143 (313)
T ss_dssp EEEECCCSEEHHHHHHH----------------------------------------CSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCcHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999666677766521 12356677899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----------CCCCCc
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRA 563 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~ 563 (774)
|+.+|+||||||+|||++. + .+||+|||+++........ .......||+.|+|||++.+ ..++.+
T Consensus 144 H~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 219 (313)
T 3cek_A 144 HQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219 (313)
T ss_dssp HHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHH
T ss_pred HHCCceecCCCcccEEEEC-C--eEEEeeccccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCch
Confidence 9999999999999999963 3 4899999999876543211 12234568999999999875 468889
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCchHHHH---HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 564 IDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~~~~~~---~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+|||||||++|||++| ..||........ ...... ....+...++++.++|.+||+.||.+||++.|+++||||..
T Consensus 220 ~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 220 SDVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHHHHHHHHHHHHS-SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHHHHHHHHHHHhC-CCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 9999999999999997 778865432221 222221 11233344678999999999999999999999999999965
Q ss_pred c
Q 004097 640 A 640 (774)
Q Consensus 640 ~ 640 (774)
.
T Consensus 299 ~ 299 (313)
T 3cek_A 299 Q 299 (313)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.86 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=194.9
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeecc--CCceeE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVES--DQDFVY 415 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~--~~~~~~ 415 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+ .++..++||||+++++++. +.+..|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHH-HHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 35688899999999999999855 4689999999975432 1233444 4678889999999999874 467899
Q ss_pred EeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 416 LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|||||.+ +|.+++ .... .....+++..++.++.|++.||+||
T Consensus 84 lv~e~~~~~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~l 127 (279)
T 2w5a_A 84 IVMEYCEGGDLASVI-----------TKGT-------------------------KERQYLDEEFVLRVMTQLTLALKEC 127 (279)
T ss_dssp EEEECCTTEEHHHHH-----------HHHH-------------------------HTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCCHHHHH-----------Hhhc-------------------------ccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99997653 555554 2211 1123477888999999999999999
Q ss_pred HHcC-----ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 495 HEIG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 495 H~~~-----ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
|+.+ |+||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||
T Consensus 128 H~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 128 HRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHHC------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred hcccCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHH
Confidence 9999 999999999999987765 89999999987653211 1123468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
||++|+|++| .+||....... . .+........+...++++.++|.+||+.||.+|||++|+++|||+...
T Consensus 203 G~il~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 203 GCLLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHHC-CCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999997 77887654332 2 222333323444567899999999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.61 Aligned_cols=248 Identities=29% Similarity=0.399 Sum_probs=187.2
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC-CChh
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLN 426 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~-~sL~ 426 (774)
..||+|+||+||++.. .+++.||||++..... ...+.++..++..++||||+++++++.+.+..++|||+|. ++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 3799999999999864 5688999999875432 2233333457888999999999999999999999999664 3454
Q ss_pred hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCC
Q 004097 427 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 506 (774)
Q Consensus 427 ~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 506 (774)
+++ .... ....+++..+..++.||+.||+|||+.+|+||||||
T Consensus 108 ~~l-----------~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 150 (295)
T 2clq_A 108 ALL-----------RSKW--------------------------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKG 150 (295)
T ss_dssp HHH-----------HHTT--------------------------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHH-----------Hhhc--------------------------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCCh
Confidence 444 2211 112245677889999999999999999999999999
Q ss_pred CCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC--CCCcchhHhHHHHHHHHHhCCCCC
Q 004097 507 QNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 507 ~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSlGvll~elltg~~~P 583 (774)
+||+++. ++ .+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++| ..|
T Consensus 151 ~Nil~~~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g-~~p 224 (295)
T 2clq_A 151 DNVLINTYSG--VLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG-KPP 224 (295)
T ss_dssp GGEEEETTTC--CEEECCTTTCEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT-SCT
T ss_pred hhEEEECCCC--CEEEeecccccccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC-CCC
Confidence 9999976 54 48999999998765321 1123456899999999997654 78999999999999999997 778
Q ss_pred CCCchHHHHHH----HhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 584 YGESFERDANI----VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 584 f~~~~~~~~~~----~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|.......... ........+...++++.++|.+||+.||++|||++++++||||....
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 225 FYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 85432222111 11122233445678999999999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=348.77 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=174.7
Q ss_pred ccceEEE-eEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEE
Q 004097 343 IGKLVVF-NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYL 416 (774)
Q Consensus 343 i~~~~~~-~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~L 416 (774)
+.+.|.+ .+.||+|+||+||++... +|+.||||++... ....+|+..++..+.||||+++++++.. ....|+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 3455666 457999999999998554 6899999999753 4556677777888999999999999876 566899
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||.+ |+|.+++... ....+++..++.++.||+.||+|||+
T Consensus 104 v~e~~~g----------g~L~~~l~~~---------------------------~~~~l~~~~~~~i~~ql~~~l~~LH~ 146 (336)
T 3fhr_A 104 IMECMEG----------GELFSRIQER---------------------------GDQAFTEREAAEIMRDIGTAIQFLHS 146 (336)
T ss_dssp EEECCTT----------EEHHHHHHTC----------------------------CCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeccCC----------CCHHHHHHhc---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9996653 4444433211 11346788899999999999999999
Q ss_pred cCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.++ ...+||+|||+++..... ......||+.|+|||++....++.++|||||||++|+
T Consensus 147 ~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~ 221 (336)
T 3fhr_A 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 221 (336)
T ss_dssp TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHH
Confidence 9999999999999997533 345899999999866532 2234568999999999988889999999999999999
Q ss_pred HHhCCCCCCCCchHHHH-----HHHhhc-c---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 576 CITGGKHPYGESFERDA-----NIVKDR-K---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~-----~~~~~~-~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|++| .+||........ ..+... . .......++++.+||.+||+.||.+|||++|+++||||..
T Consensus 222 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 222 LLCG-FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp HHHS-SCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHC-CCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 9997 778755432221 111111 1 1111345789999999999999999999999999999965
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.57 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=185.2
Q ss_pred ccceEEEeEeecccCceEEEEEee-----eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCC--c
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQ--D 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-----~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~ 412 (774)
..+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+ .++..++||||+++++++.+. .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCCC
Confidence 356789999999999999999853 46899999999765432 233455 477889999999999998654 5
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||||. +|+|.+++... ...+++..++.++.|++.||+
T Consensus 87 ~~~lv~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~ 128 (295)
T 3ugc_A 87 NLKLIMEYLP----------YGSLRDYLQKH----------------------------KERIDHIKLLQYTSQICKGME 128 (295)
T ss_dssp SCEEEEECCT----------TCBHHHHHHHC----------------------------GGGCCHHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeCC----------CCCHHHHHHhc----------------------------ccccCHHHHHHHHHHHHHHHH
Confidence 6899999664 34444433221 112667788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+|||++.++. +||+|||+++................+|..|+|||++.+..++.++|||||||+
T Consensus 129 ~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 129 YLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 206 (295)
T ss_dssp HHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHH
Confidence 999999999999999999987765 899999999877644332223334457788999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH------------------HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 573 LFFCITGGKHPYGESFERDA------------------NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|||++| ..|+........ .+........+...++++.++|.+||+.||++|||++|+++
T Consensus 207 l~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 207 LYELFTY-IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHT-TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhc-ccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999997 667665432211 11111222234456789999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.32 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=191.9
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CC-cEEEEEEeecCCc--hHHHHHHHHHHHhCCCCC------eeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EG-RSVAVKRLVKTHH--DVALKEIQNLIASDQHPN------IVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g-~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpN------IV~l~g~~~~ 410 (774)
..+.+.|.+.+.||+|+||+||++... ++ +.||||++..... ....+|+. ++..+.|+| ++.+++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN-VLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHH-HHHHHhhcCCCCceeEEEeeeeeee
Confidence 445677999999999999999998543 34 7899999975322 23334544 445555544 9999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+..|+|||+|.++|.+++... ....+++..++.|+.||+.|
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~--------------------------------------~~~~~~~~~~~~i~~qi~~~ 135 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKEN--------------------------------------NFQPYPLPHVRHMAYQLCHA 135 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT--------------------------------------TTCCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeccCCChHHHHHhc--------------------------------------cCCCCCHHHHHHHHHHHHHH
Confidence 9999999998877766655211 11346778889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCC-----------------CCceEEEcccCccccccCCCccccccccCcCCCCCCchh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKD-----------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 553 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~-----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE 553 (774)
|+|||+.+|+||||||+|||++.+ ....+||+|||+++..... .....||+.|+|||
T Consensus 136 L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE 209 (355)
T 2eu9_A 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPE 209 (355)
T ss_dssp HHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHH
T ss_pred HHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCe
Confidence 999999999999999999999432 1235899999999865432 23456999999999
Q ss_pred hhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHH-HHHhhccccc------------------------------
Q 004097 554 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA-NIVKDRKDLF------------------------------ 602 (774)
Q Consensus 554 ~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~-~~~~~~~~~~------------------------------ 602 (774)
++.+..++.++|||||||++|||++| .+||........ ..+.......
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 2eu9_A 210 VILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY 288 (355)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc
Confidence 99999999999999999999999997 778865433221 1111000000
Q ss_pred --------------cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 603 --------------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 603 --------------~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
.....+++.+||.+||+.||.+|||+.|+++||||....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred ccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 000124788999999999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=336.80 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=180.6
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||++... +|+.||||++...... ..+.|+..++..++||||+++++++.+.+..|+|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 45788899999999999998654 6899999999765432 334555567888999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-C
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 498 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ 498 (774)
+|.+.+..+.. .....+++..+..++.||+.||+|||+. +
T Consensus 105 ~~~~~~~~l~~---------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 145 (318)
T 2dyl_A 105 LMGTCAEKLKK---------------------------------------RMQGPIPERILGKMTVAIVKALYYLKEKHG 145 (318)
T ss_dssp CCSEEHHHHHH---------------------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ccCCcHHHHHH---------------------------------------HhccCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 87443332221 1123467788899999999999999995 9
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll 573 (774)
|+||||||+|||++.++. +||+|||++....... ......||+.|+|||++. ...++.++|||||||++
T Consensus 146 i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 219 (318)
T 2dyl_A 146 VIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219 (318)
T ss_dssp CCCCCCCGGGEEECTTSC--EEECCCTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHH
T ss_pred EEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHH
Confidence 999999999999987765 8999999997665321 123346899999999994 45688999999999999
Q ss_pred HHHHhCCCCCCCCchH---HHHHHHhhcccccc--ccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 574 FFCITGGKHPYGESFE---RDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|||++| ..||..... ....+........+ ...++++.++|.+||+.||.+||+++++++||||..
T Consensus 220 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 220 VELATG-QFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHS-SCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHhC-CCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999996 778865321 12223332222222 235689999999999999999999999999999953
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.16 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=194.8
Q ss_pred ccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc---------hHHHHHHHHHHHhC--CCCCeeEEeeec
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---------DVALKEIQNLIASD--QHPNIVRWYGVE 408 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l--~HpNIV~l~g~~ 408 (774)
..+.+.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..+ .||||+++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-LLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHH-HHHHHCSSSCSBCCEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHH-HHHhhccCCCCceEEEEEE
Confidence 4556779999999999999999985 45789999999965321 22345665 44444 379999999999
Q ss_pred cCCceeEEeccccC--CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 409 SDQDFVYLSLERCT--CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 409 ~~~~~~~LV~E~~~--~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
.+.+..++|||++. ++|.+++ .. ...+++..++.++.|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l-----------~~-----------------------------~~~l~~~~~~~i~~q 157 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFI-----------TE-----------------------------RGALQEELARSFFWQ 157 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHH-----------HH-----------------------------HCSCCHHHHHHHHHH
T ss_pred ecCCcEEEEEEcCCCCccHHHHH-----------hc-----------------------------cCCCCHHHHHHHHHH
Confidence 99999999999775 3555444 11 134677788999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeec-CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcc
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAI 564 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~-~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~s 564 (774)
|+.||+|||+.+|+||||||+|||++ .++ .+||+|||+++..... ......||+.|+|||++.+..+ +.++
T Consensus 158 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~ 230 (320)
T 3a99_A 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSA 230 (320)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHH
T ss_pred HHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccc
Confidence 99999999999999999999999997 444 4999999999876532 1233469999999999987775 6889
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|||||||++|||++| ..||..... +. ..........++++.++|.+||+.||.+|||++|+++||||.+.
T Consensus 231 Di~slG~il~el~~g-~~pf~~~~~----~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 231 AVWSLGILLYDMVCG-DIPFEHDEE----II-RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHHHHHS-SCSCCSHHH----HH-HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred hHHhHHHHHHHHHHC-CCCCCChhh----hh-cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 999999999999997 778865432 11 12223445567899999999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.47 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=188.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+ .++..++||||+++++++.+++..|+||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEV-KVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHH-HHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 5688899999999999999854 4689999999865432 2234555 477888999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++... ...+++..++.|+.||+.||+|||+.+|+
T Consensus 89 ~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~iv 130 (310)
T 3s95_A 89 IK----------GGTLRGIIKSM----------------------------DSQYPWSQRVSFAKDIASGMAYLHSMNII 130 (310)
T ss_dssp CT----------TCBHHHHHHHC----------------------------CTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cC----------CCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 65 44444443221 13467788899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccc-----------cccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+..++.++|||||
T Consensus 131 H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 131 HRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp CSCCSTTSEEECTTSC--EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CCCCCcCeEEECCCCC--EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 9999999999987765 8999999998765332111 11124579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH----HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 570 GCILFFCITGGKHPYGESFERDA----NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++|||++| ..||........ ..........+...++++.++|.+||+.||++|||+.++++
T Consensus 209 G~~l~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 209 GIVLCEIIGR-VNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHT-CCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcC-CCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999997 556644221110 01111111224456678999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.52 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=191.4
Q ss_pred cceEEEeEeecccCceEEEEEeee-CC-------cEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EG-------RSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g-------~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++... ++ +.||||++..... ....+|+ .++..++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA-SMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHH-HHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEEeCC
Confidence 466889999999999999998543 33 5799999865432 2334444 5788899999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||. ++|.+++ ... ...+++..++.++.||+.||
T Consensus 86 ~~~lv~e~~~~~~L~~~l-----------~~~----------------------------~~~~~~~~~~~i~~qi~~~L 126 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYL-----------KKN----------------------------KNCINILWKLEVAKQLAAAM 126 (289)
T ss_dssp CCEEEEECCTTCBHHHHH-----------HHT----------------------------GGGCCHHHHHHHHHHHHHHH
T ss_pred CCEEEEECCCCCCHHHHH-----------HhC----------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 9999999665 3555544 221 11256777899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCc------eEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcc
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAI 564 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~s 564 (774)
+|||+.+|+||||||+|||++.++.. .+||+|||++...... ....||+.|+|||++.+ ..++.++
T Consensus 127 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (289)
T 4fvq_A 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLAT 199 (289)
T ss_dssp HHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHH
T ss_pred HHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchh
Confidence 99999999999999999999876542 2899999998755421 22347899999999987 6789999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||||||++|||++|+.+||..................+...++++.++|.+||+.||.+|||++++++|
T Consensus 200 DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 200 DKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999987888876554433322223333444556789999999999999999999999866
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.28 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=193.3
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhC-CCCCeeEEeeeccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+++.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..+ +||||+++++++.+.+..|+||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR-FYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHH-HHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHH-HHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3567799999999999999999864 6799999999875433 34556766 44555 9999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|.++|.+++... ...+++..++.|+.||+.||+|||+.+
T Consensus 85 e~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 85 ELLGPSLEDLFDLC---------------------------------------DRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp ECCCCBHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 98766776665211 134677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCC---ceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~---~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
|+||||||+|||++.++. ..+||+|||+++......... .......||+.|+|||++.+..++.++|||||||
T Consensus 126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999999999999976543 228999999998765432211 1224567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchH----HH-HHHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFE----RD-ANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~----~~-~~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++| .+||..... .. ..+...... .......+++.++|.+||+.||.+||+++++++
T Consensus 206 il~ell~g-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 206 MFMYFLRG-SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHS-SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhcC-CCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999997 778865321 11 111111111 111223469999999999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.86 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=188.9
Q ss_pred cccccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 340 GRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 340 ~~~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
+..+.++|.+.+.||+|+||+||++. ..+++.||||++..... ....+|+ .++..++||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREV-HNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHH-HHHTTCCBTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHH-HHHhcCCCCCCceEEEeeeeCC
Confidence 45567789999999999999999985 45689999999854321 1223444 4678889999999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||||. +|+|.+++.. ...+++..++.++.|++.||+
T Consensus 85 ~~~lv~e~~~----------g~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~ 125 (294)
T 4eqm_A 85 CYYLVMEYIE----------GPTLSEYIES-----------------------------HGPLSVDTAINFTNQILDGIK 125 (294)
T ss_dssp EEEEEEECCC----------SCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCC----------CCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9999999665 3444443321 234677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+|||++.++. +||+|||+++...... ........||+.|+|||++.+..++.++|||||||+
T Consensus 126 ~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 201 (294)
T 4eqm_A 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201 (294)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHH
Confidence 999999999999999999988775 8999999998765321 122334569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 573 LFFCITGGKHPYGESFERDA--NIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~--~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
+|||++| .+||........ ..+..... ......++.+.++|.+||+.||.+||+..+.+.+.|
T Consensus 202 l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 202 LYEMLVG-EPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHS-SCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhC-CCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 9999996 778876544332 22222111 122345678999999999999999995555555554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.85 Aligned_cols=253 Identities=18% Similarity=0.226 Sum_probs=195.8
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..+++.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+..+....+|+||+++++++.+....|+||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 44577899999999999999999864 6799999999865433 345567665444448999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|.++|.+++... ...+++..++.|+.||+.||+|||+.+
T Consensus 86 e~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ 126 (298)
T 1csn_A 86 DLLGPSLEDLLDLC---------------------------------------GRKFSVKTVAMAAKQMLARVQSIHEKS 126 (298)
T ss_dssp ECCCCBHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EecCCCHHHHHHHh---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 97766666665211 123677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCC---ceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~---~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
|+||||||+|||++.++. ..+||+|||+++......... .......||+.|+|||++.+..++.++|||||||
T Consensus 127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (298)
T 1csn_A 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206 (298)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 999999999999976542 348999999998776432211 1234457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCch----HHH-HHHHhhcc----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESF----ERD-ANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~----~~~-~~~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++| .+||.... ... ..+..... .......++++.++|.+||+.||++||+++++++
T Consensus 207 il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 207 VFMYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHcC-CCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 99999997 77886521 111 11111111 1112345689999999999999999999999873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=346.02 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=196.9
Q ss_pred ccceEEEeEeecccCceEEEEEeee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeecc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVES 409 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~ 409 (774)
..+.|.+.+.||+|+||+||++... .+..||||++...... ...+|+. ++..+ +|||||++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHH-HHHHhcCCchhhhheeeec
Confidence 3467899999999999999998642 2367999999765432 3445665 44555 9999999999999
Q ss_pred CCceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 488 (774)
Q Consensus 410 ~~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 488 (774)
+.+..|+|||||.+ +|.+++. .......... ..........+++..++.|+.||+
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~ 201 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQ-----------ARRPPGLEYS-------------YNPSHNPEEQLSSKDLVSCAYQVA 201 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHH-----------HTCCSSSSSC-------------CCCCSSCCCCCCHHHHHHHHHHHH
T ss_pred cCCceEEEEEecCCCcHHHHHH-----------Hhcccccccc-------------cccccccccccCHHHHHHHHHHHH
Confidence 99999999996653 5555543 2211000000 000001123578899999999999
Q ss_pred HHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHh
Q 004097 489 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 568 (774)
Q Consensus 489 ~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 568 (774)
.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++||||
T Consensus 202 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diws 278 (382)
T 3tt0_A 202 RGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278 (382)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHH
Confidence 9999999999999999999999987765 89999999987653321 12223445788999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 569 LGCILFFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||++|||++++..||....... ...+ .......+...++++.++|.+||+.||++|||++|++++
T Consensus 279 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999995578887654332 2222 222333445667899999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=327.31 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=194.8
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...+++.||||++..... +...+|+ .++..++||||+++++++.+.+..|+|||+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEA-EVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHH-HHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356888999999999999999877889999999976532 3344555 4778889999999999999999999999966
Q ss_pred C-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 422 T-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 422 ~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
+ ++|.+++ ... ...+++..+..++.|++.||+|||+.+|+
T Consensus 86 ~~~~L~~~~-----------~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 126 (267)
T 3t9t_A 86 EHGCLSDYL-----------RTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVI 126 (267)
T ss_dssp TTCBHHHHH-----------HHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCCcHHHHH-----------hhC----------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5 3454444 211 12356778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||+++.++. +||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|+|++++
T Consensus 127 H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 127 HRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp CSSCCGGGEEECGGGC--EEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCchheEEECCCCC--EEEccccccccccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 9999999999977765 8999999998764321 11223345788999999999999999999999999999999966
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
.+||........ .+........+...++++.++|.+||+.||.+|||+++++++
T Consensus 203 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 203 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888876543322 222222233344457889999999999999999999999854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.15 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=188.8
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-----------CCCCeeEEeeecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-----------QHPNIVRWYGVES 409 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-----------~HpNIV~l~g~~~ 409 (774)
...|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..+ .||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHH-HHHHhhcccccchhccccchHHHHHHHhh
Confidence 45688999999999999999854 5789999999975421 23345554 33333 3899999999988
Q ss_pred CCc----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 410 DQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 410 ~~~----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
+.+ ..++|||+|.++|.+++.. .....+++..++.|+.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~--------------------------------------~~~~~~~~~~~~~i~~ 138 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKK--------------------------------------YEHRGIPLIYVKQISK 138 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH--------------------------------------TTTSCCCHHHHHHHHH
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHH--------------------------------------hhccCCcHHHHHHHHH
Confidence 654 7899999876677666521 1123467788899999
Q ss_pred HHHHHHHHHHHc-CccccccCCCCeeecCC----CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC
Q 004097 486 DIVSGLSHLHEI-GLIHRDLKPQNVLISKD----KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 560 (774)
Q Consensus 486 qia~gL~yLH~~-~ivHrDLkp~NILl~~~----~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 560 (774)
||+.||+|||+. +|+||||||+|||++.+ ....+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 139 qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCC
Confidence 999999999998 99999999999999532 2346999999999876532 233468999999999999999
Q ss_pred CCcchhHhHHHHHHHHHhCCCCCCCCchH--------HHHHHHhhcc---------------------------------
Q 004097 561 TRAIDLFSLGCILFFCITGGKHPYGESFE--------RDANIVKDRK--------------------------------- 599 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~~~Pf~~~~~--------~~~~~~~~~~--------------------------------- 599 (774)
+.++|||||||++|||++| .+||..... ....+.....
T Consensus 213 ~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 213 GCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CTHHHHHHHHHHHHHHHHS-SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CchHhHHHHHHHHHHHHhC-CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 9999999999999999997 778864321 1111111000
Q ss_pred --------ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 600 --------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 600 --------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
...+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 00111223578899999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.14 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=179.0
Q ss_pred cceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
...|.+.+.||+|+||+||++... ++..||||++...... ...+|+ .++..++||||+++++++.+.+..|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA-SIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEeeCCceE
Confidence 345677899999999999998654 5778999999754322 233454 4778899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++... ...+++..++.|+.||+.||+|||
T Consensus 123 lv~e~~~----------~~sL~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH 164 (373)
T 2qol_A 123 IVTEYME----------NGSLDSFLRKH----------------------------DAQFTVIQLVGMLRGIASGMKYLS 164 (373)
T ss_dssp EEEECCT----------TCBHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCC----------CCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999554 44444444221 123677788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. +||+|||+++................+|+.|+|||++.+..++.++|||||||++||
T Consensus 165 ~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 165 DMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 999999999999999987765 899999999877543222222223346788999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++.+..||....... ...+... ....+...++++.++|.+||+.||.+||++.++++
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9984477886543332 2222222 22233455678999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=349.78 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=192.1
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++... +++.||||++...... ...+|+ .++..++|||||++++++.+.+..|+||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA-RILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHH-HHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 356888999999999999998664 7899999998754322 233455 4778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +|+|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 192 e~~~----------~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ 233 (377)
T 3cbl_A 192 ELVQ----------GGDFLTFLRTEG----------------------------ARLRVKTLLQMVGDAAAGMEYLESKC 233 (377)
T ss_dssp ECCT----------TCBHHHHHHHHG----------------------------GGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCC----------CCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9554 445544443211 12567788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHh
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ellt 578 (774)
|+||||||+|||++.++. +||+|||+++....... ........+++.|+|||++....++.++|||||||++|||++
T Consensus 234 ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 310 (377)
T 3cbl_A 234 CIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310 (377)
T ss_dssp EECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cCCcccCHHHEEEcCCCc--EEECcCCCceecCCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987765 89999999986543211 111112235778999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH-HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 579 GGKHPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 579 g~~~Pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++.+||........ ..+.. .....+...++++.++|.+||+.||++|||++++++
T Consensus 311 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 311 LGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66889876543332 22222 222334456678999999999999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.98 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=194.9
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.+.|.+.+.||+|+||+||++... +++.||||++.... .....+|+. ++..++||||+++++++.+.+..|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-LLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhccCCCccEEEEEEeCCCeEE
Confidence 34577999999999999999998654 78999999986432 233445654 778889999999999999999999
Q ss_pred EeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 416 LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|||+|. ++|.+++ . ....+++..++.++.||+.||+||
T Consensus 98 lv~e~~~~~~L~~~l-----------~-----------------------------~~~~~~~~~~~~i~~qi~~~l~~L 137 (287)
T 2wei_A 98 IVGELYTGGELFDEI-----------I-----------------------------KRKRFSEHDAARIIKQVFSGITYM 137 (287)
T ss_dssp EEECCCCSCBHHHHH-----------H-----------------------------HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEccCCCCHHHHH-----------H-----------------------------hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999665 3444433 1 123467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 138 H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l 212 (287)
T 2wei_A 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212 (287)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHH
T ss_pred HHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHH
Confidence 999999999999999997643 3459999999998765321 1223358899999999875 489999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHhhcc-c---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 574 FFCITGGKHPYGESFERD-ANIVKDRK-D---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
|+|++| .+||....... ...+.... . ......++++.++|.+||+.||.+|||+.|+++||||..
T Consensus 213 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 213 YILLSG-TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 999997 66776543332 22222221 1 111345689999999999999999999999999999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=336.43 Aligned_cols=272 Identities=24% Similarity=0.334 Sum_probs=197.7
Q ss_pred ccceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+ .++..++||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCceeeEEEEEecCC
Confidence 356789999999999999999864 34589999999764432 233454 4678889999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||. ++|.+++......-...+..... .+...........+++..++.++.||+.||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 163 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS----------------RNSSSLDHPDERALTMGDLISFAWQISQGM 163 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC--------------------------------CEECHHHHHHHHHHHHHHH
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCccccccc----------------ccccccccccccCcCHHHHHHHHHHHHHHH
Confidence 9999999776 46666653221100000000000 000000011234478889999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++|||||||
T Consensus 164 ~~lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 240 (314)
T 2ivs_A 164 QYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240 (314)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHHHCCCcccccchheEEEcCCCC--EEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHH
Confidence 9999999999999999999987765 89999999987654322 12223445788999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCchHH-HHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++.+||...... ....+.. .....+...++++.++|.+||+.||.+|||+.+++++
T Consensus 241 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999447788654332 2222222 2233444567899999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.63 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=184.8
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHh-CCCCCeeEEeeeccC----CceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS-DQHPNIVRWYGVESD----QDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~-l~HpNIV~l~g~~~~----~~~~~ 415 (774)
+.+.+.|.+.+.||+|+||+||++.. +|+.||||++.........+|.+.+... ++||||+++++++.+ .+..|
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 34567789999999999999999754 7999999999776555555565533332 799999999998654 46689
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++. ...+++..++.|+.||+.||+|||
T Consensus 83 lv~e~~~----------~g~L~~~l~------------------------------~~~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 83 LITHYHE----------MGSLYDYLQ------------------------------LTTLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp EEECCCT----------TCBHHHHHT------------------------------TCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred Eehhhcc----------CCCHHHHHh------------------------------hcccCHHHHHHHHHHHHHHHHHHH
Confidence 9999655 444444431 123667788999999999999999
Q ss_pred --------HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcC------CC
Q 004097 496 --------EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG------RQ 560 (774)
Q Consensus 496 --------~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~------~~ 560 (774)
+.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+. .+
T Consensus 123 ~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 200 (301)
T 3q4u_A 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200 (301)
T ss_dssp SCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHH
T ss_pred HhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccC
Confidence 899999999999999987765 8999999998765432221 112344799999999999876 34
Q ss_pred CCcchhHhHHHHHHHHHhCC---------CCCCCCch------HHHHHHHhhc--ccccc-----ccCCHHHHHHHHHhc
Q 004097 561 TRAIDLFSLGCILFFCITGG---------KHPYGESF------ERDANIVKDR--KDLFL-----VEHIPEAVDLFTRLL 618 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~---------~~Pf~~~~------~~~~~~~~~~--~~~~~-----~~~~~~~~dli~~~L 618 (774)
+.++|||||||++|||++|. .+||.... .......... ....+ ...++++.++|.+||
T Consensus 201 ~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 280 (301)
T 3q4u_A 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHC
T ss_pred CchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHh
Confidence 57999999999999999971 45664321 1111111111 11111 112357899999999
Q ss_pred CCCCCCCcCHHHHHc
Q 004097 619 DPNPDLRPKAQNVLN 633 (774)
Q Consensus 619 ~~dP~~Rps~~elL~ 633 (774)
+.||++|||+.|+++
T Consensus 281 ~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 281 YQNPSARLTALRIKK 295 (301)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred hcChhhCCCHHHHHH
Confidence 999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.42 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=192.6
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++...++..||||+++.... +...+|+ .++..++|||||++++++. .+..|+|||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEA-NVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHH-HHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 456888999999999999999887788999999975432 3345555 4778899999999999987 56789999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+|+|.+++.... ...+++..++.++.||+.||+|||+.+|+|
T Consensus 265 ----------~~g~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 307 (454)
T 1qcf_A 265 ----------AKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307 (454)
T ss_dssp ----------TTCBHHHHHHSHH---------------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----------CCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 4455555443211 123567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++...... ........+|+.|+|||++....++.++|||||||++|||++++.
T Consensus 308 rDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 308 RDLRAANILVSASLV--CKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp SSCSGGGEEECTTCC--EEECSTTGGGGBCCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCHHHEEECCCCc--EEEeeCCCceEcCCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 999999999987765 8999999998765321 111223346788999999999999999999999999999999558
Q ss_pred CCCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+||....... .. +........+...++++.++|.+||+.||++|||++++++
T Consensus 384 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 384 IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8887643322 22 2222222334456789999999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.71 Aligned_cols=250 Identities=15% Similarity=0.177 Sum_probs=185.5
Q ss_pred ccceEEEeEeecccCceEEEEEeeeC------CcEEEEEEeecCCchHHHHHHH--------------HHHHhCCCCCee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVALKEIQ--------------NLIASDQHPNIV 402 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~------g~~VAVK~l~~~~~~~~~~Ei~--------------~ll~~l~HpNIV 402 (774)
.++.|.+.+.||+|+||+||++.... ++.||||++..... ...+|+. ..+..++||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH-HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch-hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45689999999999999999986543 47899999876532 2223322 134567899999
Q ss_pred EEeeeccCC----ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHH
Q 004097 403 RWYGVESDQ----DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 478 (774)
Q Consensus 403 ~l~g~~~~~----~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 478 (774)
++++++.+. ...|||||||.++|.+++.. ....+++.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~---------------------------------------~~~~l~~~ 152 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA---------------------------------------NAKRFSRK 152 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHH---------------------------------------TTSCCCHH
T ss_pred eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHh---------------------------------------ccCCCCHH
Confidence 999998765 56899999765555555421 11347788
Q ss_pred HHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhh
Q 004097 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQ 554 (774)
Q Consensus 479 ~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~ 554 (774)
.++.|+.||+.||+|||+.+|+||||||+|||++.+....+||+|||+++.+....... .......||+.|+|||+
T Consensus 153 ~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 232 (364)
T 3op5_A 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH
Confidence 89999999999999999999999999999999983233459999999998765332111 11234459999999999
Q ss_pred hhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhh----c-c-----ccccccCCHHHHHHHHHhcCCCC
Q 004097 555 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKD----R-K-----DLFLVEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 555 l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~----~-~-----~~~~~~~~~~~~dli~~~L~~dP 622 (774)
+.+..++.++|||||||++|||++| .+||....... ...... . . .......++++.++|.+||+.||
T Consensus 233 ~~~~~~~~~~Di~slG~~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 311 (364)
T 3op5_A 233 HNGVAPSRRGDLEILGYCMIQWLTG-HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDY 311 (364)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHS-CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCT
T ss_pred hCCCCCCchhhHHHHHHHHHHHHhC-CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999996 78887532111 110000 0 0 00113457899999999999999
Q ss_pred CCCcCHHHHHc
Q 004097 623 DLRPKAQNVLN 633 (774)
Q Consensus 623 ~~Rps~~elL~ 633 (774)
.+||+++++++
T Consensus 312 ~~RP~~~~l~~ 322 (364)
T 3op5_A 312 TEKPLYENLRD 322 (364)
T ss_dssp TCCCCHHHHHH
T ss_pred CCCCCHHHHHH
Confidence 99999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.60 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=189.1
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCCeeEEeeeccCCc-eeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++. ..|+.||||+++...... ..+|+ .++..++|||||++++++.+.+ ..|+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~vavK~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE-ETTEEEEEEEESSCTTSHHHHHHH-HHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEE-ecCCeEEEEEeCCchHHHHHHHHH-HHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 4568889999999999999965 468899999997654433 44555 5788999999999999987654 799999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++.... ...+++..++.++.||+.||+|||+.+|+|
T Consensus 270 ~----------~g~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 312 (450)
T 1k9a_A 270 A----------KGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312 (450)
T ss_dssp T----------TCBHHHHHHHHC---------------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred C----------CCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 4 445544443211 112567788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||++.+.
T Consensus 313 rDlkp~Nill~~~~~--~kl~DfG~a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 313 RDLAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp SCCCGGGEEECTTSC--EEECCCTTCEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCHhhEEECCCCC--EEEeeCCCccccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999987765 899999999854421 122357889999999999999999999999999999999558
Q ss_pred CCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.||....... ..+........+...++++.++|.+||+.||.+|||+.++++
T Consensus 385 ~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 385 VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8886543222 222233233344566789999999999999999999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=330.51 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=180.3
Q ss_pred ccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
..+.|.+.+.||+|+||+||++... .+..||||++...... ...+|+ .++..++||||+++++++. ++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCccceEEEEEc-cCcc
Confidence 3567889999999999999998543 3567999998654332 233444 4678889999999999985 4678
Q ss_pred EEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|+|||||.+ +|.+++ ... ...+++..++.++.|++.||+|
T Consensus 91 ~lv~e~~~~~~L~~~l-----------~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~ 131 (281)
T 1mp8_A 91 WIIMELCTLGELRSFL-----------QVR----------------------------KYSLDLASLILYAYQLSTALAY 131 (281)
T ss_dssp EEEEECCTTEEHHHHH-----------HHT----------------------------TTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCHHHHH-----------Hhc----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 999996653 454444 211 1236677889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++....++.++|||||||++
T Consensus 132 lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (281)
T 1mp8_A 132 LESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207 (281)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTE--EEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred HHhCCeecccccHHHEEECCCCC--EEECccccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHH
Confidence 99999999999999999987764 89999999987654321 122334578899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||++++.+||....... ..+........+...++++.++|.+||+.||++|||+.|++++
T Consensus 208 ~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 208 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999985688887544332 2222333333445667899999999999999999999999854
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=339.64 Aligned_cols=272 Identities=21% Similarity=0.263 Sum_probs=196.1
Q ss_pred ccceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.|.+.+.||+|+||+||++... +++.||||++...... ...+|+ .++..++||||+++++++.+.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA-ALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEccCC
Confidence 3466888999999999999998654 3489999999765432 233454 4778889999999999999999
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||.+ +|.+++..........+..... . ............+++.+++.|+.||+.||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~-----~-----------~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 187 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL-----S-----------TRARVSSPGPPPLSCAEQLCIARQVAAGM 187 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC--------------------------------------CCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccc-----c-----------ccccccccCCCCCCHHHHHHHHHHHHHHH
Confidence 99999997763 6666654321110000000000 0 00000001125688899999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++.+..++.++|||||||
T Consensus 188 ~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 264 (343)
T 1luf_A 188 AYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264 (343)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCCeecCCCCcceEEECCCCe--EEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHH
Confidence 9999999999999999999987765 89999999987653211 12223456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++..||....... . .+........+...++++.++|.+||+.||.+||++.+++++
T Consensus 265 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 265 VLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999994477886544332 2 222232333445567899999999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=341.39 Aligned_cols=249 Identities=17% Similarity=0.190 Sum_probs=182.3
Q ss_pred ccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch--------------HHHHHHHHHHHhCCCCCeeEE
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD--------------VALKEIQNLIASDQHPNIVRW 404 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~--------------~~~~Ei~~ll~~l~HpNIV~l 404 (774)
.++.|.+.+.||+|+||+||++... ++..||||++...... ...+|+ ..+..++||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~-~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW-IERKQLDYLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHH-HHHHTCSCCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHH-HhhccccccCccee
Confidence 4578999999999999999998654 6789999998754321 112232 35677899999999
Q ss_pred eeeccC----CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHH
Q 004097 405 YGVESD----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 480 (774)
Q Consensus 405 ~g~~~~----~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 480 (774)
++++.+ ....|+|||+|.++|.+++ .. ...+++..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~ 153 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKIS-----------GQ-----------------------------NGTFKKSTV 153 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHC-----------BG-----------------------------GGBCCHHHH
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHH-----------Hh-----------------------------cCCCCHHHH
Confidence 999887 7889999996644554443 21 124677889
Q ss_pred HHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhh
Q 004097 481 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLL 556 (774)
Q Consensus 481 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~ 556 (774)
+.|+.||+.||+|||+.+|+||||||+|||++.++...+||+|||+++.+...... ........||+.|+|||++.
T Consensus 154 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (345)
T 2v62_A 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK 233 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc
Confidence 99999999999999999999999999999998776335999999999876532211 11123457999999999999
Q ss_pred cCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH---HHHHHhhccccc---------cccCCHHHHHHHHHhcCCCCCC
Q 004097 557 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFER---DANIVKDRKDLF---------LVEHIPEAVDLFTRLLDPNPDL 624 (774)
Q Consensus 557 ~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~dli~~~L~~dP~~ 624 (774)
+..++.++|||||||++|||++| ..||...... ............ ....++++.++|.+||+.||++
T Consensus 234 ~~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 312 (345)
T 2v62_A 234 GVALSRRSDVEILGYCMLRWLCG-KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDE 312 (345)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHS-SCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTC
T ss_pred CCCCCchhhHHHHHHHHHHHHhC-CCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCccc
Confidence 99999999999999999999996 7788542111 111111100001 1156679999999999999999
Q ss_pred CcCHHHHHc
Q 004097 625 RPKAQNVLN 633 (774)
Q Consensus 625 Rps~~elL~ 633 (774)
||+++++++
T Consensus 313 Rps~~~l~~ 321 (345)
T 2v62_A 313 KPNYQALKK 321 (345)
T ss_dssp CCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.88 Aligned_cols=260 Identities=19% Similarity=0.267 Sum_probs=198.2
Q ss_pred ccccceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 410 (774)
+...+.|.+.+.||+|+||+||++... +++.||||++...... ...+|+ .++..++||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA-SVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHH-HHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHH-HHHHhcCCCCEeeeEEEEcc
Confidence 344677899999999999999998543 4789999999754432 233454 46788899999999999999
Q ss_pred CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 411 ~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.+..|+|||+|.+ +|.+++. ....... ..-....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~-----------~~~~~~~-------------------~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLR-----------SLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHH-----------HHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHH
T ss_pred CCccEEEEEeCCCCcHHHHHH-----------Hhchhhc-------------------cCCCCCCcCHHHHHHHHHHHHH
Confidence 9999999997653 5555542 2111000 0001134577889999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++.+..++.++|||||
T Consensus 150 ~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 150 GMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp HHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHCCCccCCCccceEEEcCCCe--EEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 999999999999999999999987765 89999999987653221 122234457899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|+|++++.+||........ .+........+...++++.++|.+||+.||.+|||+.|+++|
T Consensus 227 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999966888876543322 222222233345567889999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.82 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=183.4
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccC---------
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD--------- 410 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--------- 410 (774)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+ .++..++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHH-HHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346688999999999999999864 5789999999965322 2234455 47788899999999998754
Q ss_pred ----CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 004097 411 ----QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 485 (774)
Q Consensus 411 ----~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 485 (774)
.+..|+|||||.+ +|.+++. ... ..+++..++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~-----------~~~----------------------------~~~~~~~~~~i~~ 123 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIH-----------SEN----------------------------LNQQRDEYWRLFR 123 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHH-----------HSC----------------------------GGGCHHHHHHHHH
T ss_pred ccccCCceEEEEecCCCCCHHHhhh-----------ccc----------------------------cccchHHHHHHHH
Confidence 4678999997653 5555542 111 1234567789999
Q ss_pred HHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-----------cccccccCcCCCCCCchhh
Q 004097 486 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQ 554 (774)
Q Consensus 486 qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~ 554 (774)
||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... .........||+.|+|||+
T Consensus 124 qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (303)
T 1zy4_A 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201 (303)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred HHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence 9999999999999999999999999987765 89999999987643211 0112234568999999999
Q ss_pred hhcC-CCCCcchhHhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccc----cccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 555 LLQG-RQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 555 l~~~-~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~----~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+.+. .++.++|||||||++|||++ ||....... ...+..... ......++.+.++|.+||+.||.+|||
T Consensus 202 ~~~~~~~~~~~Di~slG~il~~l~~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 277 (303)
T 1zy4_A 202 LDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277 (303)
T ss_dssp HTSCSCCCTHHHHHHHHHHHHHHHS----CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred ccCCCCCcchhhHHHHHHHHHHHHh----ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC
Confidence 9865 68999999999999999998 444322221 111221111 122334567899999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 004097 628 AQNVLNHPFFWTA 640 (774)
Q Consensus 628 ~~elL~HPff~~~ 640 (774)
+.++++||||...
T Consensus 278 ~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 278 ARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSSCSCCC
T ss_pred HHHHhCCCCcCCC
Confidence 9999999999654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=336.98 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=185.1
Q ss_pred ccccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---------hHHHHHHHHHHHhC----CCCCeeEEee
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---------DVALKEIQNLIASD----QHPNIVRWYG 406 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l----~HpNIV~l~g 406 (774)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..+ +||||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA-LLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHH-HHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHH-HHHhhcccCCCCCeeeEEE
Confidence 44566788999999999999999854 5789999999965421 11234554 33444 8999999999
Q ss_pred eccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 407 ~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
++.+.+..++|||++ +.+++|.+++.. ...+++..++.++.|
T Consensus 106 ~~~~~~~~~~v~e~~---------~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~q 147 (312)
T 2iwi_A 106 WFETQEGFMLVLERP---------LPAQDLFDYITE-----------------------------KGPLGEGPSRCFFGQ 147 (312)
T ss_dssp EC-----CEEEEECC---------SSEEEHHHHHHH-----------------------------HCSCCHHHHHHHHHH
T ss_pred EEecCCeEEEEEEec---------CCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHH
Confidence 999999999999962 234444443321 123677888999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeec-CCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCC-Ccc
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAI 564 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~-~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~s 564 (774)
|+.||+|||+.+|+||||||+||+++ .++ .+||+|||+++...... .....||+.|+|||++.+..+. .++
T Consensus 148 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~ 220 (312)
T 2iwi_A 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPA 220 (312)
T ss_dssp HHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHH
T ss_pred HHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccc
Confidence 99999999999999999999999997 554 48999999998765421 2345689999999999877764 589
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|||||||++|||++| ..||..... +.. .....+...++++.++|.+||+.||++|||++|+++||||....
T Consensus 221 Di~slG~il~~l~~g-~~pf~~~~~----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 221 TVWSLGILLYDMVCG-DIPFERDQE----ILE-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHHHHHS-SCSCCSHHH----HHH-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred hHHHHHHHHHHHHHC-CCCCCChHH----Hhh-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999997 778875432 122 22223455678999999999999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=330.51 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=194.8
Q ss_pred ccccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC---------
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------- 410 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--------- 410 (774)
..++..|.+.+.||+|+||+||++... +|+.||||++.... ....+|+. ++..++||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVK-ALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHH-HHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHH-HHHhCCCCCEEEEeeeEeccccCccccc
Confidence 445677999999999999999998654 78999999997643 34556665 6788899999999998754
Q ss_pred -------CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHH
Q 004097 411 -------QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 482 (774)
Q Consensus 411 -------~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 482 (774)
....|+|||||.+ +|.+++ ... ....+++..++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l-----------~~~---------------------------~~~~~~~~~~~~ 126 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWI-----------EKR---------------------------RGEKLDKVLALE 126 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHH-----------HHG---------------------------GGSCCCHHHHHH
T ss_pred ccccccCcceEEEEEeccCCCCHHHHH-----------hhc---------------------------cCCCCCHHHHHH
Confidence 4568999996663 555544 221 123467788899
Q ss_pred HHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCC
Q 004097 483 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 562 (774)
Q Consensus 483 i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 562 (774)
++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.
T Consensus 127 i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~ 200 (284)
T 2a19_B 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGK 200 (284)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCT
T ss_pred HHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccc----cccccCCcccccChhhhccCCCcc
Confidence 9999999999999999999999999999987764 8999999998765432 123346899999999999999999
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
++|||||||++|+|++|. .|+.........+. ........++++.++|.+||+.||.+|||+.|+++|++.+.
T Consensus 201 ~~Di~slG~il~~l~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 201 EVDLYALGLILAELLHVC-DTAFETSKFFTDLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHHHHHHSCC-SSHHHHHHHHHHHH---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hhhhHHHHHHHHHHHhcC-CcchhHHHHHHHhh---cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999974 45432221111111 12233445678999999999999999999999999987644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.31 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=196.3
Q ss_pred cceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..+ +||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHH-HHhhcccCCCeeeEEEEEecCC
Confidence 46788999999999999999864 3468999999975543 23345655 45555 9999999999999999
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||+|.+ +|.+++........... ............+++..++.++.||+.||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 158 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSK----------------------TSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC------------------------------------CCCCHHHHHHHHHHHHHHH
T ss_pred CcEEEEecCCCCCHHHHHHhccccccccc----------------------ccccccccccccCCHHHHHHHHHHHHHHH
Confidence 99999997764 66666543222110000 00000001123578899999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||
T Consensus 159 ~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 235 (313)
T 1t46_A 159 AFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (313)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHCCeecCCCccceEEEcCCCC--EEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHHHH
Confidence 9999999999999999999987764 899999999877643221 1223345788999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHH--HHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++.+||...... ....+.. .....+...++++.++|.+||+.||.+|||+.|++++
T Consensus 236 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9999999558888654321 1222222 2223344567899999999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.34 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=189.9
Q ss_pred EEEeEeecccCceEEEEEee---eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 347 VVFNKEIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+...+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..++||||+++++++ +.+..|+|||
T Consensus 12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHH-HHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34445999999999999853 36789999999764322 2334554 67788999999999999 4567999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
+|. +++|.+++... ...+++..++.++.||+.||+|||+.+|
T Consensus 90 ~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 131 (287)
T 1u59_A 90 MAG----------GGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEEKNF 131 (287)
T ss_dssp CCT----------TEEHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eCC----------CCCHHHHHHhC----------------------------CccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 665 34444433211 1236778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+||+++.++. +||+|||+++................||+.|+|||++.+..++.++|||||||++|||+++
T Consensus 132 ~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 209 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 209 (287)
T ss_dssp ECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCchheEEEcCCCC--EEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999987764 8999999998776443333333444578999999999988999999999999999999994
Q ss_pred CCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 580 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
+.+||....... . .+........+...++++.++|.+||+.||.+||++.++++|.
T Consensus 210 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 210 GQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp SCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 478887644322 2 2223333334556778999999999999999999999999774
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=339.43 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=185.5
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCc----EEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~----~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
...|.+.+.||+|+||+||++.. .+|+ .||+|.+.... .....+|+ .++..++||||++++++|.+.+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHH-HHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCC-e
Confidence 35588899999999999999864 3444 46888875432 12344455 4778899999999999998765 7
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|+| |+.+|+|.+++... ...+++..++.|+.||+.||+||
T Consensus 92 ~~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~L 133 (327)
T 3poz_A 92 QLITQ----------LMPFGCLLDYVREH----------------------------KDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp EEEEE----------CCTTCBHHHHHHHS----------------------------TTSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 78888 44555555554321 13467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 134 H~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3poz_A 134 EDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCccc-ccccCCCccccccChHHhccCCCCchhhhhhhHHHHH
Confidence 9999999999999999987765 999999999877543221 1222345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++++.+||....... ...+.. .....+...++++.+++.+||+.||.+||++.|+++|
T Consensus 211 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99995588887644332 223322 2233444567899999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=338.74 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=194.9
Q ss_pred ccceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
..+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..++||||+++++++.+.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHH-HHhhCCCCCCCeEEEEEcCCC
Confidence 346688899999999999999852 35789999999654322 2344554 677889999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||. ++|.+++ ....... .....+++..++.++.||+.||
T Consensus 107 ~~~lv~e~~~~~~L~~~l-----------~~~~~~~----------------------~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFL-----------RETRPRP----------------------SQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp SCEEEEECCTTEEHHHHH-----------HHTSCCS----------------------SSTTSCCHHHHHHHHHHHHHHH
T ss_pred CcEEEEecCCCCcHHHHH-----------Hhhcccc----------------------cccccccHHHHHHHHHHHHHHH
Confidence 9999999664 3555554 2221100 0113467788899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
+|||+.+|+||||||+|||++.++ ...+||+|||+++....... ........||+.|+|||++.+..++.++||||||
T Consensus 154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999999997433 34589999999986643221 1222344689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|++|+|++++.+||........ .+........+...++++.++|.+||+.||.+||++.++++|.++.
T Consensus 233 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999999966888876543322 2222223334445678999999999999999999999999998763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.84 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=192.6
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
..+.|.+.+.||+|+||+||++...+++.||||++..... +...+|+ .++..++||||+++++++.+ +..|+|||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEA-NLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHH-HHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 3567889999999999999999877788999999975432 3344555 47788899999999999874 468999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +++|.+++.... ...+++..++.++.|++.||+|||+.+|+
T Consensus 89 ~~----------~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 131 (279)
T 1qpc_A 89 ME----------NGSLVDFLKTPS---------------------------GIKLTINKLLDMAAQIAEGMAFIEERNYI 131 (279)
T ss_dssp CT----------TCBHHHHTTSHH---------------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 54 444444432211 12367788899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||+++.++. +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++++
T Consensus 132 H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 207 (279)
T 1qpc_A 132 HRDLRAANILVSDTLS--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207 (279)
T ss_dssp CSCCSGGGEEECTTSC--EEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCHhhEEEcCCCC--EEECCCcccccccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCC
Confidence 9999999999987765 89999999987654321 1223345788999999999888999999999999999999966
Q ss_pred CCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 581 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 581 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.+||....... . .+........+...++++.++|.+||+.||++|||++++++
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 88887644332 2 22222222334456789999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=346.10 Aligned_cols=250 Identities=16% Similarity=0.160 Sum_probs=186.9
Q ss_pred ccceEEEeEeecccCceEEEEE------eeeCCcEEEEEEeecCCchHHHHHHHHHHHhCC---CCCeeEEeeeccCCce
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLE------GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYGVESDQDF 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a------~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~---HpNIV~l~g~~~~~~~ 413 (774)
.++.|.+.+.||+|+||+||++ ...+++.||||++.........+|+. ++..++ |+||+++++++.+.+.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~-~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHH-HHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHH-HHHHhhhhhhhhhhhhheeeecCCC
Confidence 3577999999999999999998 45678999999998766555555654 445555 9999999999999999
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|||||||. +|+|.+++..... .....+++..++.|+.||+.||+|
T Consensus 142 ~~lv~e~~~----------~g~L~~~l~~~~~------------------------~~~~~l~~~~~~~i~~qi~~~L~~ 187 (365)
T 3e7e_A 142 SVLVGELYS----------YGTLLNAINLYKN------------------------TPEKVMPQGLVISFAMRMLYMIEQ 187 (365)
T ss_dssp EEEEECCCC----------SCBHHHHHHHHHT------------------------STTCSCCHHHHHHHHHHHHHHHHH
T ss_pred cEEEEeccC----------CCcHHHHHHHhhc------------------------ccccCCCHHHHHHHHHHHHHHHHH
Confidence 999999654 4444444432111 123457889999999999999999
Q ss_pred HHHcCccccccCCCCeeecC-----------CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCC
Q 004097 494 LHEIGLIHRDLKPQNVLISK-----------DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 562 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~-----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 562 (774)
||+.+|+||||||+|||++. ++ .+||+|||+++.+..... .......+||+.|+|||++.+..++.
T Consensus 188 lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~--~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (365)
T 3e7e_A 188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA--GLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNY 264 (365)
T ss_dssp HHTTTEECCCCSGGGEEECGGGTCC------CT--TEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred HhhCCeecCCCCHHHEEecccccCccccccccC--CEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCc
Confidence 99999999999999999976 44 499999999976542211 12334567999999999999999999
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||||||++|||++| .+||.......... ..........+.+.+++.+||+.+|.+|++..+.+.+
T Consensus 265 ~~DiwslG~il~elltg-~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 265 QIDYFGVAATVYCMLFG-TYMKVKNEGGECKP---EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHHHHHHHHHHHS-SCCCEEEETTEEEE---CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred cccHHHHHHHHHHHHhC-CCccccCCCCceee---chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 99999999999999997 66764322211000 0000111224578899999999999999665544444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.90 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=190.5
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
....+.|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..|+|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE-TLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHH-GGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 344566777889999999999999877899999999865432 23344554 67888999999999999999999999
Q ss_pred ccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||. ++|.+++ .... .....+++..++.++.||+.||+|||+
T Consensus 114 ~e~~~~~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~ 157 (321)
T 2qkw_B 114 YKYMENGNLKRHL-----------YGSD-------------------------LPTMSMSWEQRLEICIGAARGLHYLHT 157 (321)
T ss_dssp EECCTTCBTGGGS-----------SSSC-------------------------CCSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCcHHHHH-----------hccC-------------------------CCccccCHHHHHHHHHHHHHHHHHhcC
Confidence 99665 3554443 2111 011347788899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 158 RAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp TTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCC--EEEeecccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHH
Confidence 99999999999999987765 89999999986543211 1122334589999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH----H----HHHhhc--c--------ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 577 ITGGKHPYGESFERD----A----NIVKDR--K--------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~----~----~~~~~~--~--------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
++| +.||....... . ...... . ........+++.+++.+||+.||++|||+.|+++|.
T Consensus 235 l~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 235 LCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHC-CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhC-CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 997 66665432111 0 000000 0 001112235788999999999999999999999763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.32 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=179.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
+.|.+.+.||+|+||+||++.. .|+.||||++..... ...++++..++..++||||+++++++.+.+..|+||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4588899999999999999764 589999999864321 122333345788899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||. +++|.+++. ...+++..++.++.|++.||+|||+.+
T Consensus 86 e~~~----------~~~L~~~~~------------------------------~~~~~~~~~~~i~~~l~~~l~~lH~~~ 125 (271)
T 3dtc_A 86 EFAR----------GGPLNRVLS------------------------------GKRIPPDILVNWAVQIARGMNYLHDEA 125 (271)
T ss_dssp ECCT----------TEEHHHHHT------------------------------SSCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred EcCC----------CCCHHHHhh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9664 444444321 234677888999999999999999999
Q ss_pred ---ccccccCCCCeeecCC------CCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 499 ---LIHRDLKPQNVLISKD------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 499 ---ivHrDLkp~NILl~~~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
|+||||||+|||++.+ ....+||+|||+++...... .....||+.|+|||++.+..++.++|||||
T Consensus 126 ~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred CCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 8999999999999752 12358999999998665321 123468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|+|++| .+||........ ...... ....+...++++.++|.+||+.||.+|||+.|+++|
T Consensus 201 G~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 201 GVLLWELLTG-EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHC-CCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999997 778866443322 111111 222344556889999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.40 Aligned_cols=249 Identities=20% Similarity=0.258 Sum_probs=189.0
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeee-ccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~-~~~~~~~~LV~ 418 (774)
.+++.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..+.|++++..+.+ ..+.+..|+||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHH-HHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHH-HHHHhhcCCCCCccccccCCCCceEEEE
Confidence 4567899999999999999999864 6799999999865443 34455655 5666777765555554 46678889999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.++|.+++.. ....+++..++.++.||+.||+|||+.+
T Consensus 85 e~~~~~L~~~~~~---------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 85 ELLGPSLEDLFNF---------------------------------------CSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp ECCCCBHHHHHHH---------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EecCCCHHHHHHh---------------------------------------hccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9876677666521 1234677888999999999999999999
Q ss_pred ccccccCCCCeeec---CCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl~---~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
|+||||||+|||++ .++ .+||+|||+++......... .......||+.|+|||++.+..++.++|||||||
T Consensus 126 ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp EECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHH
Confidence 99999999999994 454 48999999998776432211 1224457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchH-----HHHHHHhhc----cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFE-----RDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++| .+||..... ....+.... ........++++.++|.+||+.||.+|||++++++
T Consensus 204 il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 204 VLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHS-SCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHhC-CCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999997 778864211 111111111 11112455789999999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.61 Aligned_cols=248 Identities=26% Similarity=0.334 Sum_probs=189.2
Q ss_pred cceEEEeEeecccCceEEEEEe-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--c
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--D 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~ 412 (774)
.+.|.+.+.||+|+||+||++. ..+++.||||++..... ....+|+ .++..++||||+++++++.+. +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI-EILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHH-HHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHH-HHHHhCCCCCeeeeeeEEecCCCc
Confidence 3457888999999999999986 45789999999864422 3344555 477889999999999999876 6
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|+|||||. +|+|.+++... ...+++..++.++.|++.||+
T Consensus 99 ~~~lv~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~ 140 (302)
T 4e5w_A 99 GIKLIMEFLP----------SGSLKEYLPKN----------------------------KNKINLKQQLKYAVQICKGMD 140 (302)
T ss_dssp CEEEEEECCT----------TCBHHHHHHHH----------------------------TTTCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEEeCC----------CCcHHHHHHhc----------------------------cccCCHHHHHHHHHHHHHHHH
Confidence 7899999665 34444433211 123677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+|||++.++. +||+|||+++................||..|+|||++.+..++.++|||||||+
T Consensus 141 ~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 141 YLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218 (302)
T ss_dssp HHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred HhhcCCcccCCCchheEEEcCCCC--EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHH
Confidence 999999999999999999987764 899999999887654433333445568899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH----------------HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 573 LFFCITGGKHPYGESFERD----------------AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|+|++| ..|+....... .. +........+...++++.++|.+||+.||.+|||+.++++
T Consensus 219 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 219 LHELLTY-CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTT-TCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHc-cCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999997 55554322111 11 1112222334456789999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.98 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=188.3
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++....+..||||++..... +...+|+. ++..++||||+++++++.+ +..|+|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 456888999999999999998877778899999975432 34455554 7788999999999999877 6789999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+|+|.+++.... ...+++..++.++.||+.||+|||+.+|+|
T Consensus 261 ----------~~gsL~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 303 (452)
T 1fmk_A 261 ----------SKGSLLDFLKGET---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVH 303 (452)
T ss_dssp ----------TTCBHHHHHSHHH---------------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----------cCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 4455555543211 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++...... ........++..|+|||++....++.++|||||||++|||++++.
T Consensus 304 rDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 304 RDLRAANILVGENLV--CKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp SCCSGGGEEECGGGC--EEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhEEECCCCC--EEECCCccceecCCCc--eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 999999999977654 8999999998765321 111223347889999999999999999999999999999999668
Q ss_pred CCCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+||....... .. +........+...++++.++|.+||+.||++|||++++++
T Consensus 380 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 380 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8987654332 22 2222222334556788999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.36 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=195.7
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
...+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA-AVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567889999999999999998654 488999999975443 2344555 4778889999999999999999999999
Q ss_pred cccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 419 ERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 419 E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
|+|. ++|.+++ ... ....+++..++.++.||+.||+|||+.
T Consensus 89 e~~~~~~L~~~~-----------~~~---------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 89 EFMTYGNLLDYL-----------REC---------------------------NRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp ECCTTEEHHHHH-----------HHC---------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCcHHHHH-----------Hhc---------------------------ccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 9665 3555444 211 113367788899999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+||+++.++. +||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 131 ~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 206 (288)
T 3kfa_A 131 NFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206 (288)
T ss_dssp TCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCcceEEEcCCCC--EEEccCccceeccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 89999999987654321 1223344788999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 578 TGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+++.+||....... ...+ .......+...++++.++|.+||+.||.+|||+.++++
T Consensus 207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 207 TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 95588887644332 2222 22233344556789999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.18 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred ccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
..+.|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. ++..++||||+++++++.+.+..++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHH-GGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHH-HHHhccCCCccceEEEEecCCceEEEE
Confidence 4455667789999999999999877899999999865432 23455554 678899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 497 (774)
|||. +|+|.+++..... ....+++..+..|+.|++.||+|||+.
T Consensus 107 e~~~----------~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 107 PYMA----------NGSVASCLRERPE-------------------------SQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp ECCT----------TCBHHHHHHCCST-------------------------TCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred Eecc----------CCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9654 4444444432211 123477888999999999999999999
Q ss_pred --CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 498 --GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 498 --~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+|+||||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 152 ~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 227 (326)
T 3uim_A 152 DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227 (326)
T ss_dssp SSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHH
T ss_pred CCCeEeCCCchhhEEECCCCC--EEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHH
Confidence 9999999999999987765 89999999987653322 12233459999999999999899999999999999999
Q ss_pred HHhCCCCCCCCchHH------HHHHHhhcc--------------ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 576 CITGGKHPYGESFER------DANIVKDRK--------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 576 lltg~~~Pf~~~~~~------~~~~~~~~~--------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
|++| .+||...... ......... ........+++.+++.+||+.||.+|||++|+++|-
T Consensus 228 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 228 LITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHC-CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHhC-CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 9997 7788521110 001111000 001111225789999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=338.76 Aligned_cols=244 Identities=22% Similarity=0.280 Sum_probs=180.6
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchH--HHHHHHHHHHhCCCCCeeEEeeeccCCc----eeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQD----FVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~--~~~Ei~~ll~~l~HpNIV~l~g~~~~~~----~~~LV 417 (774)
.+.|.+.+.||+|+||+||++.. .++.||||++....... ..+|+. ++..++|||||++++++.+.. .+|+|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVY-SLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHH-HHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 45688999999999999999754 58999999997544322 233443 567789999999999998754 47999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ..+++..++.|+.||+.||+|||+.
T Consensus 101 ~e~~~----------~g~L~~~l~~------------------------------~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 101 TAFHE----------KGSLSDFLKA------------------------------NVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp EECCT----------TCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred EecCC----------CCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 99665 4444443321 2367778899999999999999999
Q ss_pred ----------CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-----CCCC
Q 004097 498 ----------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTR 562 (774)
Q Consensus 498 ----------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ 562 (774)
+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+. .++.
T Consensus 141 ~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 217 (322)
T 3soc_A 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217 (322)
T ss_dssp EEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHH
T ss_pred ccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCc
Confidence 9999999999999987765 899999999877643221 223345799999999999863 4567
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCchH-----------------HHHHHHhhc-cccccc------cCCHHHHHHHHHhc
Q 004097 563 AIDLFSLGCILFFCITGGKHPYGESFE-----------------RDANIVKDR-KDLFLV------EHIPEAVDLFTRLL 618 (774)
Q Consensus 563 ~sDvwSlGvll~elltg~~~Pf~~~~~-----------------~~~~~~~~~-~~~~~~------~~~~~~~dli~~~L 618 (774)
++|||||||++|||++| .+||..... ......... ...... ...+++.+||.+||
T Consensus 218 ~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 218 RIDMYAMGLVLWELASR-CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHHHHHHTT-BTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHT
T ss_pred cchhHHHHHHHHHHHhC-CCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHc
Confidence 88999999999999997 667753211 011111111 111000 11235899999999
Q ss_pred CCCCCCCcCHHHHHc
Q 004097 619 DPNPDLRPKAQNVLN 633 (774)
Q Consensus 619 ~~dP~~Rps~~elL~ 633 (774)
+.||++|||+.|+++
T Consensus 297 ~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 297 DHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.02 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=185.6
Q ss_pred ccccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ 411 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 411 (774)
....+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA-ACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHH-HHHhcCCCCCeeeeeEEEeec
Confidence 445677999999999999999998554 345899999864422 1233454 477889999999999998876
Q ss_pred c-----eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 412 D-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 412 ~-----~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
+ ..|+|||+|. +|+|.+++...... .....+++..++.|+.|
T Consensus 109 ~~~~~~~~~~v~e~~~----------~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~i~~q 155 (313)
T 3brb_A 109 SSQGIPKPMVILPFMK----------YGDLHTYLLYSRLE-----------------------TGPKHIPLQTLLKFMVD 155 (313)
T ss_dssp ------CEEEEEECCT----------TCBHHHHHHHTTBT-----------------------TSCCCCCHHHHHHHHHH
T ss_pred cccCCcccEEEEeccc----------CCCHHHHHHHhhhh-----------------------cCCccCCHHHHHHHHHH
Confidence 5 3599999665 34444433221100 11245788899999999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchh
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 566 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv 566 (774)
|+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+++.|+|||++.+..++.++||
T Consensus 156 i~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 232 (313)
T 3brb_A 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDV 232 (313)
T ss_dssp HHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHH
T ss_pred HHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhh
Confidence 999999999999999999999999987765 89999999987653321 112233457889999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 567 FSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 567 wSlGvll~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||||++|+|++++.+||....... ..+........+...++++.++|.+||+.||.+|||+.++++|
T Consensus 233 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 233 WAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999996688887644332 2233333334455667899999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=355.50 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=194.1
Q ss_pred cceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
...|.+.+.||+|+||+||++... ++..||||++.... .....+|+. ++..++|||||+++++|.+.+..||||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHH-HHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 355888999999999999998655 48899999997543 234445554 77889999999999999999999999995
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++.... ...+++..++.|+.||+.||+|||+.+|+
T Consensus 298 ~~----------~g~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 340 (495)
T 1opk_A 298 MT----------YGNLLDYLRECN---------------------------RQEVSAVVLLYMATQISSAMEYLEKKNFI 340 (495)
T ss_dssp CT----------TCBHHHHHHHSC---------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cC----------CCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 54 445554443211 12366778899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+|||++.++. +||+|||+++...... ........+++.|+|||++....++.++|||||||++|||++++
T Consensus 341 HrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g 416 (495)
T 1opk_A 341 HRNLAARNCLVGENHL--VKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416 (495)
T ss_dssp CSCCSGGGEEECGGGC--EEECCTTCEECCTTCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCChhhEEECCCCc--EEEeecccceeccCCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCC
Confidence 9999999999977754 9999999998765432 12223344678999999999999999999999999999999966
Q ss_pred CCCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 581 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 581 ~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.+||....... ...+... ....+...++++.+||.+||+.||.+|||+.++++
T Consensus 417 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 417 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 88887643322 2222222 22334456789999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.57 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=183.9
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeee-ccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~-~~~~~~~~LV~ 418 (774)
.+++.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++|+|++..+++ +.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHH-HHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHH-HHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4567799999999999999999864 6789999998754432 34455655 5566667666655554 46778899999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|.++|.+++.. ....+++..++.++.||+.||+|||+.+
T Consensus 85 e~~~~~L~~~~~~---------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (296)
T 4hgt_A 85 ELLGPSLEDLFNF---------------------------------------CSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp ECCCCBHHHHHHH---------------------------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EccCCCHHHHHHH---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9876677666521 1234677888999999999999999999
Q ss_pred ccccccCCCCeee---cCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl---~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
|+||||||+|||+ +.++. +||+|||+++......... .......||+.|+|||++.+..++.++|||||||
T Consensus 126 ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 126 FIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp EECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 9999999999999 55554 8999999998776432211 1223457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchH-----HHHHHHhhc----cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFE-----RDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|+|++| .+||..... ....+.... ........++++.++|.+||+.||++|||++++++
T Consensus 204 il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 204 VLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHS-SCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcC-CCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999997 778864221 111111111 11112345689999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=336.27 Aligned_cols=272 Identities=23% Similarity=0.293 Sum_probs=196.3
Q ss_pred ccceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCC----chHHHHHHHHHHHhC-CCCCeeEEeeeccCC
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQ 411 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~ 411 (774)
..+.|.+.+.||+|+||+||++... +++.||||++.... .....+|+. ++..+ +||||+++++++.+.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK-MMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHH-HHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEeeC
Confidence 3567899999999999999998652 45689999996432 234556665 45555 999999999999999
Q ss_pred ceeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 412 ~~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
+..|+|||||+ ++|.+++....+.+......... . ...........+++..++.++.||+.|
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~--------~---------~~~~~~~~~~~l~~~~~~~i~~qi~~a 184 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN--------Q---------KRLEEEEDLNVLTFEDLLCFAYQVAKG 184 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC--------------------------------------CCHHHHHHHHHHHHHH
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhh--------h---------cccccccccccCCHHHHHHHHHHHHHH
Confidence 99999999776 36666664333221110000000 0 000000112447888999999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 185 L~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 261 (344)
T 1rjb_A 185 MEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261 (344)
T ss_dssp HHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCcccCCCChhhEEEcCCCc--EEeCCCccCcccccCccc-eeccCccCccCccCHHHhccCCCChhHhHHHHH
Confidence 99999999999999999999987764 899999999876543221 122334578899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH--HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 571 CILFFCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
|++|||++++.+||...... ....+... ....+...++++.++|.+||+.||.+|||+.++++|.
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999558888654321 12222222 2233445678999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.02 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=193.5
Q ss_pred cceEEEeEeecccCceEEEEEee--------eCCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeEEeeeccC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESD 410 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~--------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 410 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..+ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHH-HHHHhhcCCCEeeEEEEEcc
Confidence 46688999999999999999864 35788999999765432 2345655 44555 99999999999999
Q ss_pred CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 411 ~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.+..|+|||||.+ +|.+++. ........ ............+++..++.++.||+.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~-----------~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~i~~qi~~ 168 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLR-----------ARRPPGME-------------YSYDINRVPEEQMTFKDLVSCTYQLAR 168 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHH-----------TTSCTTCC-------------SCC--------CCCHHHHHHHHHHHHH
T ss_pred CCceEEEEECCCCCcHHHHHH-----------Hhcccccc-------------ccccccccccccCCHHHHHHHHHHHHH
Confidence 9999999997753 5655553 21110000 000000012345788899999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++|||||
T Consensus 169 aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 169 GMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHhCCeeCCCCccceEEEcCCCC--EEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 999999999999999999999987765 89999999987654321 122233457889999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 570 GCILFFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|||++++..||....... ...+ .......+...++++.++|.+||+.||.+|||+.|++++
T Consensus 246 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 246 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999995578886544332 2222 222233344567899999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.10 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=180.9
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHH-HHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~-~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.|.+.+.||+|+||+||++.. .++.||||++........ .+|+ .++..++||||+++++++.+ ..|+|||||.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~- 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVEL-RQLSRVNHPNIVKLYGACLN--PVCLVMEYAE- 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHH-HHHHHCCCTTBCCEEEBCTT--TTEEEEECCT-
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHH-HHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC-
Confidence 5588889999999999999754 588999999976544333 4455 47788899999999999874 4799999664
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH---cCcc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---IGLI 500 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~iv 500 (774)
+|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+
T Consensus 83 ---------~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~iv 127 (307)
T 2eva_A 83 ---------GGSLYNVLHGAEP--------------------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127 (307)
T ss_dssp ---------TCBHHHHHHCSSS--------------------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCC
T ss_pred ---------CCCHHHHHhccCC--------------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence 4444444332111 0124567788999999999999999 8999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+|||++.++. .+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 128 H~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g- 199 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGT-VLKICDFGTACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR- 199 (307)
T ss_dssp CCCCSGGGEEEETTTT-EEEECCCCC------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT-
T ss_pred cCCCChhHEEEeCCCC-EEEEcccccccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC-
Confidence 9999999999987764 4799999999765432 1234589999999999999999999999999999999997
Q ss_pred CCCCCCchHHH----HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 581 KHPYGESFERD----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 581 ~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
..||....... ...............++++.++|.+||+.||.+|||+++++++
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 200 RKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 77886432211 1222222333344567899999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.39 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=186.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcE----EEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRS----VAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~----VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.+.|.+.+.||+|+||+||++.. .+++. ||+|.+..... ....+|+. ++..++||||+++++++. ++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML-AIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHH-HHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEc-CCcc
Confidence 34588899999999999999854 34543 78887753321 22344554 678889999999999986 4668
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|||||. +|+|.+++... ...+++..++.|+.||+.||+||
T Consensus 90 ~~v~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~l 131 (325)
T 3kex_A 90 QLVTQYLP----------LGSLLDHVRQH----------------------------RGALGPQLLLNWGVQIAKGMYYL 131 (325)
T ss_dssp EEEEECCT----------TCBSHHHHHSS----------------------------GGGSCTTHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCC----------CCCHHHHHHHc----------------------------cccCCHHHHHHHHHHHHHHHHHH
Confidence 99999554 44554443221 12356677899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ .......||..|+|||++.+..++.++|||||||++|
T Consensus 132 H~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (325)
T 3kex_A 132 EEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208 (325)
T ss_dssp HHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCccchheEEECCCCe--EEECCCCcccccCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHH
Confidence 9999999999999999987765 899999999887543221 1223345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++++.+||....... ...+. ......+...++++.++|.+||+.||.+|||+.++++|
T Consensus 209 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99994478887643322 22222 22333344456789999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=332.63 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=184.9
Q ss_pred ccceEEEeEeecccCceEEEEEeeeC-----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~~-----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
....|.+.+.||+|+||+||++.... +..||||++...... ...+|+ .++..++||||+++++++.+.+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEecCCC
Confidence 34568888999999999999986543 346999999754332 233454 47788999999999999999999
Q ss_pred eEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 414 ~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.|+|||+|.+ +|.+++ ... ...+++..++.++.||+.||+
T Consensus 121 ~~lv~e~~~~~~L~~~l-----------~~~----------------------------~~~~~~~~~~~i~~qi~~aL~ 161 (333)
T 1mqb_A 121 MMIITEYMENGALDKFL-----------REK----------------------------DGEFSVLQLVGMLRGIAAGMK 161 (333)
T ss_dssp EEEEEECCTTEEHHHHH-----------HHT----------------------------TTCSCHHHHHHHHHHHHHHHH
T ss_pred cEEEEeCCCCCcHHHHH-----------HhC----------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 9999996654 555444 211 123667788999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.+|+||||||+|||++.++. +||+|||+++................+|+.|+|||++.+..++.++|||||||+
T Consensus 162 ~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 239 (333)
T 1mqb_A 162 YLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 239 (333)
T ss_dssp HHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred HHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHH
Confidence 999999999999999999987765 899999999877543222222223346889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 573 LFFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|||++++..||....... ...+ .......+...++++.++|.+||+.||.+||++.+++++
T Consensus 240 l~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 240 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999994477886543322 2222 222222344566789999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.07 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=193.4
Q ss_pred cceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc-
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD- 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~- 412 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+..+....+||||+++++++.+.+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 56789999999999999999853 35689999999765432 34456654444448999999999987754
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||.+ +|.+++. .......... ..........+++..++.++.||+.||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~-----------~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~al 161 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYK-------------VAPEDLYKDFLTLEHLICYSFQVAKGM 161 (316)
T ss_dssp CCEEEEECCTTEEHHHHHH-----------TCTTSEECC--------------------CTTCEEHHHHHHHHHHHHHHH
T ss_pred ceEEEEEcCCCCcHHHHHH-----------hccccccccc-------------ccchhhhccccCHHHHHHHHHHHHHHH
Confidence 59999997763 5555553 2211000000 000001123367788999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+||+++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||
T Consensus 162 ~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 162 EFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238 (316)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccc-eeccCCCcceeecCchhhccccccchhHHHHHHH
Confidence 9999999999999999999987765 899999999876543221 1223345789999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHH--H-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFER--D-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~--~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++.+||...... . ..+........+...++++.++|.+||+.||.+|||+.|+++|
T Consensus 239 il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999558888654321 1 1222222233344567899999999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.41 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=189.2
Q ss_pred cceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeec-cCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVE-SDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~-~~~~~~ 414 (774)
...|.+.+.||+|+||+||++...+ +..||||.+...... ...+|+ .++..++||||+++++++ .+++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHH-HHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4568899999999999999986432 336899998754332 233454 477889999999999985 456788
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++... ...+++..++.|+.|++.||+||
T Consensus 103 ~~v~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 103 LVVLPYMK----------HGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp EEEEECCT----------TCBHHHHHHCT----------------------------TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCC----------CCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 34444433211 12356778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcc-ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ ........||+.|+|||++.+..++.++|||||||++
T Consensus 145 H~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 145 ASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp HHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhCCccCCCCchheEEECCCCC--EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999999987765 899999999876543211 1122334578899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|+|++|+.+||....... ..+........+...++++.++|.+||+.||.+|||++|+++
T Consensus 223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999998888887654332 233333333344556788999999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.00 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=192.0
Q ss_pred cceEEEeEeecccCceEEEEEe-----eeCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeecc--CCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVES--DQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-----~~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~--~~~~ 413 (774)
.+.|.+.+.||+|+||+||++. ..+++.||||++...... ...+|+ .++..++||||+++++++. +.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI-QILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHH-HHHHhcCCCceeEEEEEEecCCCce
Confidence 4568999999999999999986 346899999999765432 234455 4778889999999999876 5677
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++... ...+++..++.|+.||+.||+|
T Consensus 101 ~~lv~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~ 142 (327)
T 3lxl_A 101 LRLVMEYLP----------SGCLRDFLQRH----------------------------RARLDASRLLLYSSQICKGMEY 142 (327)
T ss_dssp EEEEEECCT----------TCBHHHHHHHH----------------------------GGGCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeecC----------CCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHH
Confidence 999999664 34444433221 1236778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+..++.++|||||||++
T Consensus 143 lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 143 LGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 99999999999999999987765 8999999998776543333334445688999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH----------------H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFERD----------------A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~----------------~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|+|++| ..||....... . .+........+...++++.++|.+||+.||.+|||++|+++|
T Consensus 221 ~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 221 YELFTY-CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTT-TCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhC-CCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999997 55664433211 1 111122223344567899999999999999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.38 Aligned_cols=242 Identities=27% Similarity=0.386 Sum_probs=182.5
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHH-HHHHHHHHHhCCCCCeeEEeeeccCC-ceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWYGVESDQ-DFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~-~~Ei~~ll~~l~HpNIV~l~g~~~~~-~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++. ..|+.||||++........ .+|+ .++..++||||+++++++.+. +..|+|||+|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~vavK~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE-ETTEEEEEEECCCCC--HHHHHTH-HHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEE-EcCCEEEEEEecchhHHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4568899999999999999975 4689999999976544333 4454 477889999999999986554 5799999976
Q ss_pred CC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 422 TC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 422 ~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
.+ +|.+++ .... ...+++..++.++.|++.||+|||+.+|+
T Consensus 98 ~~~~L~~~l-----------~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 139 (278)
T 1byg_A 98 AKGSLVDYL-----------RSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139 (278)
T ss_dssp TTEEHHHHH-----------HHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCCCHHHHH-----------Hhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 64 555544 2111 11256677899999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+||+++.++. +||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++++
T Consensus 140 H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 140 HRDLAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp CSCCSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCcceEEEeCCCc--EEEeecccccccccc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCC
Confidence 9999999999987765 899999998865432 12335789999999999999999999999999999999955
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 581 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.+||........ .+........+...++++.++|.+||+.||.+|||+.++++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 212 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 888876443322 22222223334456789999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=325.15 Aligned_cols=247 Identities=20% Similarity=0.287 Sum_probs=189.1
Q ss_pred eEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee-EE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV-YL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~-~L 416 (774)
.|...+.||+|+||+||++...+ +..||||++...... ...+|+ .++..++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG-LLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 46677999999999999986432 237999998754432 233454 477889999999999999876665 99
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||++ .+|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 101 v~e~~----------~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 101 LLPYM----------CHGDLLQFIRSP----------------------------QRNPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp EECCC----------TTCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecc----------cCCCHHHHHhcc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99955 344444443221 1335677889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.++. +||+|||+++....... .........+|+.|+|||.+.+..++.++|||||||++|+
T Consensus 143 ~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 143 QKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp TTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence 99999999999999987765 89999999986653321 1122234468899999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++|+.+||........ .+........+...++++.++|.+||+.||.+|||++++++
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99987888876544332 22222333344456788999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.25 Aligned_cols=248 Identities=15% Similarity=0.199 Sum_probs=188.2
Q ss_pred cceEEEeEeecccCceEEEEEeee---------CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeE-----------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY---------EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----------- 403 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~---------~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~----------- 403 (774)
++.|.+.+.||+|+||+||++... +++.||||++... ....+|+. ++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQN-FFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHH-HHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHH-HHHHhcccchhhhhhhhccCCcc
Confidence 578999999999999999998654 3789999999764 34556665 667778999987
Q ss_pred ----EeeeccC-CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHH
Q 004097 404 ----WYGVESD-QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 478 (774)
Q Consensus 404 ----l~g~~~~-~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 478 (774)
+++++.+ ++..|+|||||.++|.+++.. . ....+++.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-----------~---------------------------~~~~l~~~ 159 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-----------S---------------------------PKHVLSER 159 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHH-----------S---------------------------GGGCCCHH
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHh-----------C---------------------------CcCCCCHH
Confidence 5666654 688999999775566665521 1 11347788
Q ss_pred HHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhh
Q 004097 479 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQ 554 (774)
Q Consensus 479 ~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~ 554 (774)
.++.|+.||+.||+|||+.+|+||||||+|||++.++...+||+|||+++.+....... .......||+.|+|||+
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 239 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence 89999999999999999999999999999999987764469999999998765432111 11233479999999999
Q ss_pred hhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH---HHHHH---hhcccccc------ccCCHHHHHHHHHhcCCCC
Q 004097 555 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER---DANIV---KDRKDLFL------VEHIPEAVDLFTRLLDPNP 622 (774)
Q Consensus 555 l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~---~~~~~---~~~~~~~~------~~~~~~~~dli~~~L~~dP 622 (774)
+.+..++.++|||||||++|||++| ..||...... ..... ........ ...++++.++|.+||+.||
T Consensus 240 ~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 240 HKGCGPSRRSDLQSLGYCMLKWLYG-FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHS-CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred HccCCCCchhhHHHHHHHHHHHHhC-CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 9998999999999999999999997 7788654211 11111 11111111 1346899999999999999
Q ss_pred CCCcCHHHHHc
Q 004097 623 DLRPKAQNVLN 633 (774)
Q Consensus 623 ~~Rps~~elL~ 633 (774)
.+|||++++++
T Consensus 319 ~~Rps~~~l~~ 329 (352)
T 2jii_A 319 EEKPPYAMLRN 329 (352)
T ss_dssp TCCCCHHHHHH
T ss_pred hhCCCHHHHHH
Confidence 99999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.05 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=185.9
Q ss_pred ceEEEeE-eecccCceEEEEEee---eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNK-EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~-~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.|.+.+ .||+|+||+||++.. .+++.||||++..... ....+|+ .++..++||||+++++++ +.+..|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA-NVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHH-HHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 4567777 999999999999843 3468999999965432 2233444 477888999999999999 567789
Q ss_pred EeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 416 LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|||+|. ++|.+++ .. ...+++..++.++.||+.||+||
T Consensus 94 lv~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~L 133 (291)
T 1xbb_A 94 LVMEMAELGPLNKYL-----------QQ-----------------------------NRHVKDKNIIELVHQVSMGMKYL 133 (291)
T ss_dssp EEEECCTTEEHHHHH-----------HH-----------------------------CTTCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCHHHHH-----------Hh-----------------------------CcCCCHHHHHHHHHHHHHHHHHH
Confidence 9999665 3454444 21 12366778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++................+|+.|+|||++.+..++.++|||||||++|
T Consensus 134 H~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 211 (291)
T 1xbb_A 134 EESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211 (291)
T ss_dssp HHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred HhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHH
Confidence 9999999999999999987764 89999999987764433323333345788999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|++++..||........ ..+ .......+...++++.++|.+||+.||.+||++.++++
T Consensus 212 ~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 212 EAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999944778876543332 222 22223334556789999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.60 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=174.6
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeec--------cCC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVE--------SDQ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~--------~~~ 411 (774)
+..|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+..+....+||||+++++++ .+.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45789999999999999999864 4789999999865543 23445665444444699999999998 455
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
...++|||+|.++|.+++... .....+++..++.|+.||+.||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~-------------------------------------~~~~~~~~~~~~~i~~qi~~~l 149 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKM-------------------------------------ESRGPLSCDTVLKIFYQTCRAV 149 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHH-------------------------------------HTTCSCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEEecCCCHHHHHHHh-------------------------------------hccCCCCHHHHHHHHHHHHHHH
Confidence 668999998888777766210 1123477888999999999999
Q ss_pred HHHHHcC--ccccccCCCCeeecCCCCceEEEcccCccccccCCCccc---------cccccCcCCCCCCchhhh---hc
Q 004097 492 SHLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---------TQNATGYGSSGWQAPEQL---LQ 557 (774)
Q Consensus 492 ~yLH~~~--ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l---~~ 557 (774)
+|||+.+ |+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++ .+
T Consensus 150 ~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (337)
T 3ll6_A 150 QHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227 (337)
T ss_dssp HHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC-------------------------------CCTT
T ss_pred HHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcccc
Confidence 9999999 999999999999987765 8999999998765432111 111244689999999998 56
Q ss_pred CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 558 GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 558 ~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
..++.++|||||||++|+|++| .+||....... +.... .........+++.++|.+||+.||.+|||+.|+++|-
T Consensus 228 ~~~~~~~Dv~slG~il~el~~g-~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 228 FPIGEKQDIWALGCILYLLCFR-QHPFEDGAKLR--IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHS-SCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCChHHhHHHHHHHHHHHHhC-CCCCcchhHHH--hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 6788999999999999999997 77886533221 12111 1122233456899999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=329.90 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=188.4
Q ss_pred ceEEEeEeecccCceEEEEEee-----eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC--Cce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD--QDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-----~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~ 413 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+ .++..++||||+++++++.+ ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI-DILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHH-HHHHhCCCcchhhEEEEEecCCCce
Confidence 3458889999999999987632 36889999999765432 234555 47788899999999999987 467
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++. ...+++..++.++.||+.||+|
T Consensus 110 ~~lv~e~~~----------~~~L~~~l~------------------------------~~~~~~~~~~~i~~~l~~~l~~ 149 (318)
T 3lxp_A 110 LQLVMEYVP----------LGSLRDYLP------------------------------RHSIGLAQLLLFAQQICEGMAY 149 (318)
T ss_dssp EEEEECCCT----------TCBHHHHGG------------------------------GSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccc----------CCcHHHHHh------------------------------hCCCCHHHHHHHHHHHHHHHHH
Confidence 899999654 444444432 1236778889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+..++.++|||||||++
T Consensus 150 LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 227 (318)
T 3lxp_A 150 LHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227 (318)
T ss_dssp HHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HHhCCccCCCCchheEEEcCCCC--EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHH
Confidence 99999999999999999987765 8999999998876543333333445688899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH----------------HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERD----------------ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~----------------~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|+|++| ..||....... ...+ .......+...++++.++|.+||+.||.+|||+.|+++
T Consensus 228 ~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 228 YELLTH-CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTT-TCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhC-CCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999997 66776543221 1111 11122334456789999999999999999999999973
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=332.51 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=193.1
Q ss_pred cceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++... .++.||||++..... ....+|+. ++..+ +||||+++++++.+.+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK-IMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEecCC
Confidence 466889999999999999998543 235899999976532 22345655 55566 8999999999999999
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||.+ +|.+++. ........ .....+....+++..++.++.||+.||
T Consensus 124 ~~~lv~e~~~~g~L~~~l~-----------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~qi~~~l 177 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLR-----------RKSRVLET---------------DPAFAIANSTASTRDLLHFSSQVAQGM 177 (333)
T ss_dssp SCEEEEECCTTEEHHHHHH-----------HHHHHHSC---------------C-------CCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEecCCCCcHHHHHH-----------Hhcccccc---------------cccccccccccCHHHHHHHHHHHHHHH
Confidence 99999997653 5555552 21110000 000002234578889999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||
T Consensus 178 ~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 254 (333)
T 2i1m_A 178 AFLASKNCIHRDVAARNVLLTNGH--VAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254 (333)
T ss_dssp HHHHHTTEECSCCSGGGCEEEGGG--EEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhcCCcccCCcccceEEECCCC--eEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHH
Confidence 999999999999999999997765 489999999987654322 11223345788999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHH--HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 572 ILFFCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|||++++.+||...... ........ ....+...++++.++|.+||+.||.+|||+.|++++
T Consensus 255 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 255 LLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 9999999668888754322 12222222 222334456789999999999999999999999853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.74 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=179.6
Q ss_pred ceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC-CceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~ 415 (774)
..|.+.+.||+|+||+||++...+ +..||||.+..... ....+|+ .++..++||||++++++|.+ ++..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHH-TTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 457788999999999999986542 24689999865432 2233444 36778899999999998654 56889
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++... ...+++..++.++.||+.||+|||
T Consensus 168 lv~e~~~----------~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH 209 (373)
T 3c1x_A 168 VVLPYMK----------HGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKFLA 209 (373)
T ss_dssp EEEECCT----------TCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCC----------CCCHHHHHhhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 44444443211 123556778999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. +||+|||+++......... .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 210 ~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 210 SKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HCCEecCccchheEEECCCCC--EEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999999987765 8999999998764322111 1122345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++|+.+||....... ..+........+...++++.++|.+||+.||.+|||++|++++
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998788987643222 2333333333445567899999999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.48 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=183.9
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHH-hCCCCCeeEEeeeccCC----ceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-SDQHPNIVRWYGVESDQ----DFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~-~l~HpNIV~l~g~~~~~----~~~~ 415 (774)
..+.+.|.+.+.||+|+||+||++.. .|+.||||++.........+|.+.+.. .++||||+++++++.+. +..|
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 34567789999999999999999754 589999999976655555555543322 35899999999998877 7899
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++. ...+++..++.++.|++.||+|||
T Consensus 112 lv~e~~~----------~g~L~~~l~------------------------------~~~~~~~~~~~i~~~i~~~l~~lH 151 (337)
T 3mdy_A 112 LITDYHE----------NGSLYDYLK------------------------------STTLDAKSMLKLAYSSVSGLCHLH 151 (337)
T ss_dssp EEECCCT----------TCBHHHHHH------------------------------HCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeccC----------CCcHHHHhh------------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 344444331 123567788999999999999999
Q ss_pred Hc--------CccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCCCCCc---
Q 004097 496 EI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRA--- 563 (774)
Q Consensus 496 ~~--------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~--- 563 (774)
+. +|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+..++..
T Consensus 152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 229 (337)
T 3mdy_A 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229 (337)
T ss_dssp SCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH
T ss_pred HhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC
Confidence 98 9999999999999987765 8999999998765432211 12234579999999999988777665
Q ss_pred ---chhHhHHHHHHHHHhCC---------CCCCCCch------HHHHHHHhhc--cccccc-----cCCHHHHHHHHHhc
Q 004097 564 ---IDLFSLGCILFFCITGG---------KHPYGESF------ERDANIVKDR--KDLFLV-----EHIPEAVDLFTRLL 618 (774)
Q Consensus 564 ---sDvwSlGvll~elltg~---------~~Pf~~~~------~~~~~~~~~~--~~~~~~-----~~~~~~~dli~~~L 618 (774)
+|||||||++|||++|. ..||.... .......... ....+. ..++++.++|.+||
T Consensus 230 ~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 309 (337)
T 3mdy_A 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHS
T ss_pred ccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhh
Confidence 99999999999999972 44554321 1111111111 111111 22356899999999
Q ss_pred CCCCCCCcCHHHHHcC
Q 004097 619 DPNPDLRPKAQNVLNH 634 (774)
Q Consensus 619 ~~dP~~Rps~~elL~H 634 (774)
+.||.+|||+.|+++|
T Consensus 310 ~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 310 AHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred hhChhhCCCHHHHHHH
Confidence 9999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=357.87 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=182.2
Q ss_pred eEeecccCceEEEEEeee---CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 350 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
...||+|+||+||++... ++..||||+++... .....+|+. ++..++|||||+++++|.+ +.+|+|||||
T Consensus 341 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv~E~~- 417 (613)
T 2ozo_A 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALMLVMEMA- 417 (613)
T ss_dssp EEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHH-HHTTCCCTTBCCEEEEEES-SSEEEEEECC-
T ss_pred CcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCEeeEEEEecc-CCeEEEEEeC-
Confidence 348999999999998553 46789999997542 234455654 7788999999999999976 5699999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.+++... ...+++..++.|+.||+.||+|||+.+|+||
T Consensus 418 ---------~~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr 460 (613)
T 2ozo_A 418 ---------GGGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460 (613)
T ss_dssp ---------TTCBHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---------CCCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 455555544321 1236778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++.+..............+|+.|+|||++....++.++|||||||++|||++.|..
T Consensus 461 Dlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 461 NLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CCSGGGEEEEETTE--EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCHHHEEEcCCCc--EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999987764 9999999998775433222222334467899999999999999999999999999999984588
Q ss_pred CCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 583 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 583 Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||....... . .+........+...++++.++|.+||+.||++||++.+++
T Consensus 539 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 539 PYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887643322 2 2333333334556678999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.45 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=184.6
Q ss_pred cceEEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.|.+.+.||+|+||+||++.... +..||||++..... ....+|+. ++..++||||+++++++.++ ..|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHH-HHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHH-HHHhCCCCCcceEEEEEcCC-CCE
Confidence 4568899999999999999986443 34699999976532 22344554 66778999999999998754 568
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||+|. +++|.+++... ...+++..+..++.||+.||+|||
T Consensus 89 ~v~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH 130 (281)
T 3cc6_A 89 IIMELYP----------YGELGHYLERN----------------------------KNSLKVLTLVLYSLQICKAMAYLE 130 (281)
T ss_dssp EEEECCT----------TCBHHHHHHHH----------------------------TTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC----------CCCHHHHHHhc----------------------------cccCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 34444433211 123667788999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++||
T Consensus 131 ~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 131 SINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp HTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HCCcccCCCccceEEECCCCc--EEeCccCCCcccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHH
Confidence 999999999999999987764 89999999987654321 11233457889999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHH-HH-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFER-DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~-~~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++.+.+||...... .. .+........+...++++.++|.+||+.||.+|||+.|++++
T Consensus 207 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 207 ILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 998347777543322 22 222222233344567889999999999999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.51 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=193.1
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.|.+.+.||+|+||+||++....+..||||+++.... +...+|+. ++..++|||||++++++.+ +..|||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHH-HHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456889999999999999998877778899999975432 34455654 7788999999999999877 6789999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.++|... ....+++..++.|+.||+.||+|||+.+|+|
T Consensus 344 ~----------~gsL~~~l~~~---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 386 (535)
T 2h8h_A 344 S----------KGSLLDFLKGE---------------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386 (535)
T ss_dssp T----------TEEHHHHHSHH---------------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred c----------CCcHHHHHhhc---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 4 45555544321 1123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++...... ........++..|+|||++....++.++|||||||++|||++++.
T Consensus 387 rDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 387 RDLRAANILVGENLV--CKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp SCCSGGGEEECGGGC--EEECCTTSTTTCCCHH--HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred CCCCHhhEEEcCCCc--EEEcccccceecCCCc--eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999977654 8999999998765321 111223347788999999999999999999999999999999668
Q ss_pred CCCCCchHHH-HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.||....... ...+. ......+...++++.+||.+||+.||++|||++++++
T Consensus 463 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 463 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8987654332 22222 2222234456778999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.18 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=179.6
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+ .++..++||||+++++++.+.+..|+|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREA-RTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHH-HHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 5688999999999999999864 4689999999865421 2233444 467888999999999999999999999
Q ss_pred ccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||+|.+ +|.+++ .. ...+++..++.++.||+.||+|||+
T Consensus 113 ~e~~~~~~L~~~l-----------~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 113 MRLINGVDLAAML-----------RR-----------------------------QGPLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp EECCCCEEHHHHH-----------HH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCHHHHH-----------Hh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 997764 555544 11 1236777889999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (309)
T 2h34_A 153 AGATHRDVKPENILVSADDF--AYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228 (309)
T ss_dssp TTCCCSCCCGGGEEECTTSC--EEECSCCC------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHH
T ss_pred CcCCcCCCChHHEEEcCCCC--EEEecCccCccccccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHH
Confidence 99999999999999987765 8999999998765321 1122345689999999999988999999999999999999
Q ss_pred HhCCCCCCCCchHHHHH-HHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCc-CHHHHH
Q 004097 577 ITGGKHPYGESFERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRP-KAQNVL 632 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~~-~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rp-s~~elL 632 (774)
++| .+||......... .+.... .......++++.++|.+||+.||++|| ++++++
T Consensus 229 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 229 LTG-SPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp HHS-SCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHC-CCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 996 7788765543322 222111 112334567899999999999999999 888876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.39 Aligned_cols=239 Identities=19% Similarity=0.276 Sum_probs=182.6
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC--ceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. +|+.||||++..... ....+|+ .++..++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC-PRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHG-GGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHH-HHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4577889999999999999765 589999999975432 1233444 366778999999999999887 788999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.... ...+++..++.|+.||+.||+|||+.
T Consensus 88 ~e~~~----------~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 88 THWMP----------YGSLYNVLHEGT---------------------------NFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp EECCT----------TCBHHHHHHSCS---------------------------SCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred ecccC----------CCcHHHHHhhcc---------------------------cCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 99665 344444332211 12367888999999999999999999
Q ss_pred C--ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCC---cchhHhHHHH
Q 004097 498 G--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLGCI 572 (774)
Q Consensus 498 ~--ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDvwSlGvl 572 (774)
+ |+||||||+|||++.++. ++|+|||++..... ....||+.|+|||++.+..++. ++|||||||+
T Consensus 131 ~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i 200 (271)
T 3kmu_A 131 EPLIPRHALNSRSVMIDEDMT--ARISMADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200 (271)
T ss_dssp SSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred CCceecCCCccceEEEcCCcc--eeEEeccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence 9 999999999999988776 67777776543221 2346899999999998765554 7999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 573 LFFCITGGKHPYGESFERDA--NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|||++| ..||........ .... ......+...++++.++|.+||+.||++|||++++++
T Consensus 201 l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 201 LWELVTR-EVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHC-SCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhC-CCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999996 778865443322 2222 2223344556789999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.75 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=181.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcE----EEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRS----VAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~----VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
...|.+.+.||+|+||+||++.. .+++. ||+|.+.... .....+|+ .++..++||||+++++++.+.+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHH-HHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHH-HHHHhCCCCCeeEEEEEEecCC-c
Confidence 35688999999999999999864 34544 5777764322 23344555 4778899999999999998765 7
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|+|++ .+|+|.+++... ...+++..++.|+.||+.||+||
T Consensus 92 ~~v~~~~----------~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~L 133 (327)
T 3lzb_A 92 QLITQLM----------PFGCLLDYVREH----------------------------KDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp EEEECCC----------SSCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEec----------CCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 7888844 445555444321 13467788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 134 H~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3lzb_A 134 EDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTTCCCSCCCGGGEEEEETTE--EEECCTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHH
Confidence 9999999999999999987765 899999999876533221 1122345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 575 FCITGGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||++++.+||........ ..+. ......+...++++.++|.+||+.||.+||++.|+++.
T Consensus 211 ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999955888876543332 2222 22233444567899999999999999999999999853
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=332.27 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=176.5
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCCeeEEeee-----ccCCceeEEe
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGV-----ESDQDFVYLS 417 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~l~g~-----~~~~~~~~LV 417 (774)
.+.|.+.+.||+|+||+||++. .+++.||||++..........|... .+..++||||+++++. +.+....|+|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEE-ETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEE-ECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 3568889999999999999974 5889999999976554444444331 2345899999999974 3344578999
Q ss_pred ccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||+ ++|.+++ .. ...++..++.|+.||+.||+|||+
T Consensus 91 ~e~~~~g~L~~~l-----------~~------------------------------~~~~~~~~~~i~~qi~~~L~~LH~ 129 (336)
T 3g2f_A 91 MEYYPNGSLXKYL-----------SL------------------------------HTSDWVSSCRLAHSVTRGLAYLHT 129 (336)
T ss_dssp ECCCTTCBHHHHH-----------HH------------------------------CCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred EecCCCCcHHHHH-----------hh------------------------------cccchhHHHHHHHHHHHHHHHHHh
Confidence 99664 3554444 21 223556778999999999999999
Q ss_pred c---------CccccccCCCCeeecCCCCceEEEcccCccccccCCCc-----cccccccCcCCCCCCchhhhhc-----
Q 004097 497 I---------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----CLTQNATGYGSSGWQAPEQLLQ----- 557 (774)
Q Consensus 497 ~---------~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~----- 557 (774)
. +|+||||||+|||++.++. +||+|||+++.+..... .........||+.|+|||++.+
T Consensus 130 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp CBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred hhccccccccceeecccccceEEEcCCCc--EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 9 9999999999999987765 89999999987654321 1112234569999999999986
Q ss_pred --CCCCCcchhHhHHHHHHHHHhCCCCCCCCchHH-----------------H-HHHHhhc--ccccccc------CCHH
Q 004097 558 --GRQTRAIDLFSLGCILFFCITGGKHPYGESFER-----------------D-ANIVKDR--KDLFLVE------HIPE 609 (774)
Q Consensus 558 --~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~-----------------~-~~~~~~~--~~~~~~~------~~~~ 609 (774)
..++.++|||||||++|||++|+.+||...... . ....... ....+.. .+++
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 345678999999999999999866665432110 0 0111111 1111111 1236
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+.++|.+||+.||++|||++|+++
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcchHHHHH
Confidence 999999999999999999999963
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.83 Aligned_cols=242 Identities=24% Similarity=0.390 Sum_probs=184.8
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----------hHHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+ .++..++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV-FIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHH-HHHTTCCCTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHH-HHHHhCCCCCchhhheeecCCC
Confidence 46688999999999999999865 5789999999854321 2334455 4778889999999999998766
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
++|||||. +|+|.+.+.. ....+++..++.++.|++.||+
T Consensus 97 --~lv~e~~~----------~~~L~~~l~~----------------------------~~~~~~~~~~~~~~~~l~~~l~ 136 (287)
T 4f0f_A 97 --RMVMEFVP----------CGDLYHRLLD----------------------------KAHPIKWSVKLRLMLDIALGIE 136 (287)
T ss_dssp --EEEEECCT----------TCBHHHHHHC----------------------------TTSCCCHHHHHHHHHHHHHHHH
T ss_pred --eEEEEecC----------CCCHHHHHhc----------------------------ccCCccHHHHHHHHHHHHHHHH
Confidence 79999665 3444333321 1234677888999999999999
Q ss_pred HHHHcC--ccccccCCCCeeecCCC---CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh--cCCCCCcch
Q 004097 493 HLHEIG--LIHRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAID 565 (774)
Q Consensus 493 yLH~~~--ivHrDLkp~NILl~~~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sD 565 (774)
|||+.+ |+||||||+|||++.++ ...+||+|||+++..... .....||+.|+|||++. ...++.++|
T Consensus 137 ~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~D 210 (287)
T 4f0f_A 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKAD 210 (287)
T ss_dssp HHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHH
T ss_pred HHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhh
Confidence 999999 99999999999997644 234899999999754421 23456999999999984 445789999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHHH---H-HHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 566 LFSLGCILFFCITGGKHPYGESFERDA---N-IVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~~~---~-~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||||||++|||++| .+||........ . ... ......+...++++.++|.+||+.||.+|||++|+++
T Consensus 211 i~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 211 TYSFAMILYTILTG-EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHS-SCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHcC-CCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999997 778865432221 1 111 1122334456789999999999999999999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=355.66 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=182.4
Q ss_pred eEeecccCceEEEEEee---eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 350 NKEIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
.+.||+|+||+||++.. ..++.||||+++.... ....+|+. ++..++|||||+++++|.+ +..++|||||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 35899999999999844 2467899999975322 23445554 7788899999999999965 4589999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+|+|.+++.. ...+++..++.|+.||+.||+|||+.+|+|
T Consensus 452 ----------~~g~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 492 (635)
T 4fl3_A 452 ----------ELGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVH 492 (635)
T ss_dssp ----------TTEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----------CCCCHHHHHhh-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeC
Confidence 45555554422 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+++.+..............+|+.|+|||++....++.++|||||||++|||+++|.
T Consensus 493 rDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 493 RDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp SCCSGGGEEEEETTE--EEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999987764 899999999887644332233334457889999999999999999999999999999999448
Q ss_pred CCCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
.||....... .. +........+...++++.++|.+||+.||++||+++++++
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8887654433 22 2223333345566789999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.09 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=178.0
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
...|.+.+.||+|+||+||++.. .+|+.||||++.... . ....+|+ .++..++||||+++++++.+.+..|+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 35688999999999999999854 578999999986422 1 2234455 46788999999999999999999999
Q ss_pred eccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||+|.+ +|.+++ .... .....+++..++.++.||+.||+|||
T Consensus 110 v~e~~~~~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~l~~LH 153 (310)
T 2wqm_A 110 VLELADAGDLSRMI-----------KHFK-------------------------KQKRLIPERTVWKYFVQLCSALEHMH 153 (310)
T ss_dssp EEECCCSCBHHHHH-----------HHHH-------------------------HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCHHHHH-----------HHhc-------------------------ccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 9996663 555544 2111 11234677889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+||+++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 154 ~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 154 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HTTCCCCCCCGGGEEECTTSC--EEECCC---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred hCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 8999999998765321 11233468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHH---HHHHHh-hccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFER---DANIVK-DRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~---~~~~~~-~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++| ..||...... ....+. .... ......++++.++|.+||+.||.+|||+.+++++
T Consensus 229 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 229 MAAL-QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHS-SCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhC-CCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9997 5666543211 111111 1111 1123456789999999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.92 Aligned_cols=251 Identities=24% Similarity=0.412 Sum_probs=186.6
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCc--ee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~--~~ 414 (774)
..++.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+.+ ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE-VLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHH-HHHhcCCCCCCeEEEeeccCCCCee
Confidence 45678999999999999999998654 58999999996532 233445654 778889999999999988755 78
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++.... ....+++..++.++.||+.||+||
T Consensus 85 ~lv~e~~~----------~g~L~~~l~~~~--------------------------~~~~l~~~~~~~i~~qi~~aL~~L 128 (396)
T 4eut_A 85 VLIMEFCP----------CGSLYTVLEEPS--------------------------NAYGLPESEFLIVLRDVVGGMNHL 128 (396)
T ss_dssp EEEECCCT----------TEEHHHHTTSGG--------------------------GTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCC----------CCCHHHHHHhhh--------------------------cccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999664 444444433211 123378888999999999999999
Q ss_pred HHcCccccccCCCCeee--cCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc--------CCCCCcc
Q 004097 495 HEIGLIHRDLKPQNVLI--SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--------GRQTRAI 564 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl--~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~s 564 (774)
|+.+|+||||||+|||+ +.++...+||+|||+++...... ......||+.|+|||++.. ..++.++
T Consensus 129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (396)
T 4eut_A 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (396)
T ss_dssp HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHH
T ss_pred HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHH
Confidence 99999999999999998 22333469999999998765432 2234569999999999875 4677899
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCc------hHHHHHHHhhcccc------------------cc------ccCCHHHHHHH
Q 004097 565 DLFSLGCILFFCITGGKHPYGES------FERDANIVKDRKDL------------------FL------VEHIPEAVDLF 614 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~------~~~~~~~~~~~~~~------------------~~------~~~~~~~~dli 614 (774)
|||||||++|||++| ..||... ......++...... .+ ....+.+.++|
T Consensus 205 DiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll 283 (396)
T 4eut_A 205 DLWSIGVTFYHAATG-SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283 (396)
T ss_dssp HHHHHHHHHHHHHHS-SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHC-CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHH
Confidence 999999999999997 7787431 11122222221110 00 11124678999
Q ss_pred HHhcCCCCCCCcCHHHHHcC
Q 004097 615 TRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 615 ~~~L~~dP~~Rps~~elL~H 634 (774)
.+||+.||++||++.|++++
T Consensus 284 ~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 284 ANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCCTTTSCCHHHHHHH
T ss_pred HHhhccChhhhccHHHHHHH
Confidence 99999999999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.64 Aligned_cols=233 Identities=24% Similarity=0.370 Sum_probs=176.6
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEe
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLS 417 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV 417 (774)
+++.+...+.||+|+||+||++.. .+++.||||++... ....+|+..+....+||||+++++++.+ ....|+|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 344444558899999999999854 57899999999753 5567788777788899999999999876 7889999
Q ss_pred ccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 418 LERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 418 ~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
||||.+ +|.+++ ... ....+++..++.++.||+.||+|||+
T Consensus 94 ~e~~~~~~L~~~l-----------~~~---------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (299)
T 3m2w_A 94 MECLDGGELFSRI-----------QDR---------------------------GDQAFTEREASEIMKSIGEAIQYLHS 135 (299)
T ss_dssp ECCCCSCBHHHHH-----------HHC---------------------------TTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EeecCCCcHHHHH-----------Hhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 996653 555544 211 11246778899999999999999999
Q ss_pred cCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
.+|+||||||+|||++.++ ...+||+|||++..... ..++.++|||||||++||
T Consensus 136 ~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-------------------------~~~~~~~DiwslG~il~e 190 (299)
T 3m2w_A 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-------------------------EKYDKSCDMWSLGVIMYI 190 (299)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-------------------------CGGGGHHHHHHHHHHHHH
T ss_pred CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc-------------------------ccCCchhhHHHHHHHHHH
Confidence 9999999999999998632 23599999999865431 246779999999999999
Q ss_pred HHhCCCCCCCCchHHHHH-----HHhhccccc----cccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCcc
Q 004097 576 CITGGKHPYGESFERDAN-----IVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~ 641 (774)
|++| .+||......... ......... ....++++.++|.+||+.||.+|||++|+++||||....
T Consensus 191 l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 191 LLCG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHS-SCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHC-CCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 9997 7787654322110 000000011 134568999999999999999999999999999997643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.67 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=188.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcE--EEEEEeecCC----chHHHHHHHHHHHhC-CCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRS--VAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~--VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||+||++.. .+|.. ||||++.... .....+|+. ++..+ +||||+++++++.+.+..|+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHH-HHHhccCCCchhhhceeeeeCCceEE
Confidence 4577889999999999999854 45664 4999986432 223445655 56667 99999999999999999999
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||+|+ ++|.+++.... .+... . .. .........+++..++.++.||+.||+|||
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~---------~--~~------------~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSR-VLETD---------P--AF------------AIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp EECCCTTCBHHHHHHTTC-HHHHC---------H--HH------------HHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCHHHHHHhcc-ccccc---------c--cc------------cccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 999775 36666552111 00000 0 00 000011245788999999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+|||++.++. +||+|||+++..... .......+++.|+|||++.+..++.++|||||||++||
T Consensus 160 ~~~ivH~dlkp~NIl~~~~~~--~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (327)
T 1fvr_A 160 QKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233 (327)
T ss_dssp HTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred hCCccCCCCccceEEEcCCCe--EEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHH
Confidence 999999999999999977764 899999998744321 12233457889999999999889999999999999999
Q ss_pred HHhCCCCCCCCchHHHH-HHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 576 CITGGKHPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|++++.+||........ ..+.. .....+...++++.++|.+||+.||.+|||++++++|
T Consensus 234 llt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 234 IVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99844778866543322 22222 1222344556899999999999999999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.63 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=187.3
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHh-CCCCCeeEEeeeccCCc----eeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS-DQHPNIVRWYGVESDQD----FVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~-l~HpNIV~l~g~~~~~~----~~~ 415 (774)
..+.+.|.+.+.||+|+||+||++.. +|+.||||++.........+|...+... ++||||+++++++.+.+ ..|
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 34567789999999999999999754 6999999999766555566676544333 79999999999998876 899
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +|+|.+++.. ..+++..++.++.|++.||+|||
T Consensus 117 lv~e~~~----------~g~L~~~l~~------------------------------~~~~~~~~~~i~~~i~~~l~~lH 156 (342)
T 1b6c_B 117 LVSDYHE----------HGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLH 156 (342)
T ss_dssp EEECCCT----------TCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecC----------CCcHHHHHhc------------------------------cCccHHHHHHHHHHHHHHHHHHH
Confidence 9999665 3444443321 23567788999999999999999
Q ss_pred --------HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCC------C
Q 004097 496 --------EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------Q 560 (774)
Q Consensus 496 --------~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~------~ 560 (774)
+.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+.. +
T Consensus 157 ~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 234 (342)
T 1b6c_B 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234 (342)
T ss_dssp CCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred HHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccccc
Confidence 889999999999999987765 8999999998776432211 1224457999999999998753 3
Q ss_pred CCcchhHhHHHHHHHHHhCC---------CCCCCCch------HHHHHHHhh-ccc-cccc-----cCCHHHHHHHHHhc
Q 004097 561 TRAIDLFSLGCILFFCITGG---------KHPYGESF------ERDANIVKD-RKD-LFLV-----EHIPEAVDLFTRLL 618 (774)
Q Consensus 561 ~~~sDvwSlGvll~elltg~---------~~Pf~~~~------~~~~~~~~~-~~~-~~~~-----~~~~~~~dli~~~L 618 (774)
+.++|||||||++|||++|. ..||.... ......+.. ... ..+. ...+.+.++|.+||
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 314 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHC
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHh
Confidence 36899999999999999973 45665431 111122211 111 1111 11246889999999
Q ss_pred CCCCCCCcCHHHHHcC
Q 004097 619 DPNPDLRPKAQNVLNH 634 (774)
Q Consensus 619 ~~dP~~Rps~~elL~H 634 (774)
+.||++|||+.++++|
T Consensus 315 ~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 315 YANGAARLTALRIKKT 330 (342)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred ccChhhCCCHHHHHHH
Confidence 9999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.53 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=188.6
Q ss_pred ccceEEEeEeecccCceEEEEEe-----eeCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCc--
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQD-- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-----~~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-- 412 (774)
..+.|.+.+.||+|+||+||++. ..+|+.||||++...... ...+|+ .++..++||||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHH-HHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEEecCCC
Confidence 35668899999999999999986 346899999999754332 234455 4778889999999999987654
Q ss_pred eeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..++|||+|.+ +|.+++ ... ...+++..++.++.||+.||
T Consensus 118 ~~~lv~e~~~~~~L~~~l-----------~~~----------------------------~~~~~~~~~~~i~~qi~~aL 158 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYL-----------QKH----------------------------KERIDHIKLLQYTSQICKGM 158 (326)
T ss_dssp CCEEEECCCTTCBHHHHH-----------HHS----------------------------TTSSCHHHHHHHHHHHHHHH
T ss_pred ceEEEEECCCCCCHHHHH-----------Hhc----------------------------ccCCCHHHHHHHHHHHHHHH
Confidence 78999996653 555444 211 12356778899999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+|+||||||+|||++.++. +||+|||+++................++..|+|||++.+..++.++|||||||
T Consensus 159 ~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 236 (326)
T 2w1i_A 159 EYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236 (326)
T ss_dssp HHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred HHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHH
Confidence 9999999999999999999987764 89999999988765433222233445788899999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-----------------HHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFERD-----------------ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-----------------~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++| ..|+....... ...+. ......+...++++.++|.+||+.||.+|||+.|+++
T Consensus 237 il~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 237 VLYELFTY-IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHT-TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhc-CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999997 66665432111 01111 1112233456689999999999999999999999973
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.05 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=185.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeecc----CCceeE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVES----DQDFVY 415 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~----~~~~~~ 415 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+ .++..++||||+++++++. .....|
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA-DMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46799999999999999999854 6799999999865432 2233454 4778899999999999987 456789
Q ss_pred EeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 416 LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
+|||||.+ +|.+++ .... .....+++..++.++.||+.||+||
T Consensus 107 lv~e~~~~~~L~~~l-----------~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~L~~L 150 (317)
T 2buj_A 107 LLLPFFKRGTLWNEI-----------ERLK-------------------------DKGNFLTEDQILWLLLGICRGLEAI 150 (317)
T ss_dssp EEEECCTTCBHHHHH-----------HHHH-------------------------TTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHH-----------HHHH-------------------------hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99996653 554444 2211 1124578889999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc------cccccCcCCCCCCchhhhhcCC---CCCcch
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL------TQNATGYGSSGWQAPEQLLQGR---QTRAID 565 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~---~~~~sD 565 (774)
|+.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.... ++.++|
T Consensus 151 H~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 151 HAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp HHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred HhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 9999999999999999987765 8999999987654211100 0112235799999999987554 689999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHH---HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 566 LFSLGCILFFCITGGKHPYGESFER---DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 566 vwSlGvll~elltg~~~Pf~~~~~~---~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||||||++|||++| ..||...... ........ ........++++.++|.+||+.||.+|||++++++|
T Consensus 229 i~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 229 VWSLGCVLYAMMFG-EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHHHHS-SCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 99999999999997 7788532111 11111111 112223456899999999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.53 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=175.3
Q ss_pred ccccceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.....|.+.+.||+|+||+||++.. ...||||++..... ....+|+ .++..++||||+++++++ ..+..+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHH-HHHHhCCCCcEEEEEeec-cCCccE
Confidence 34456788999999999999999754 34699999864432 1233454 477889999999999975 456689
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||. +++|.+++... ...+++..++.++.||+.||+|||
T Consensus 96 lv~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~L~~lH 137 (289)
T 3og7_A 96 IVTQWCE----------GSSLYHHLHAS----------------------------ETKFEMKKLIDIARQTARGMDYLH 137 (289)
T ss_dssp EEEECCC----------EEEHHHHHTTC-------------------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecC----------CCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665 34444433211 123677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh---cCCCCCcchhHhHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCI 572 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSlGvl 572 (774)
+.+|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++. ...++.++|||||||+
T Consensus 138 ~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 214 (289)
T 3og7_A 138 AKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214 (289)
T ss_dssp HTTCCCSCCCGGGEEEETTTE--EEECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred hCCcccccCccceEEECCCCC--EEEccceeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence 999999999999999987764 89999999986543211 11223456999999999987 5668889999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhccc-----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 573 LFFCITGGKHPYGESFERD--ANIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+|+|++| ..||....... ...+..... ......++++.++|.+||+.||.+|||+.++++
T Consensus 215 l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 215 LYELMTG-QLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHS-SCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHC-CCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999996 77886543222 222222111 112245678999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.71 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=179.7
Q ss_pred cceEEEeEeecccCceEEEEEeee--CCc--EEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY--EGR--SVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~--~g~--~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 413 (774)
.+.|.+.+.||+|+||+||++... +++ .||||++.... .....+|+. ++..++||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHH-HHHhCCCCCcccEEEEEccCC-
Confidence 456889999999999999998643 233 69999986432 122344554 677889999999999998765
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.++|||+|. +|+|.+++... ...+++..+..++.||+.||+|
T Consensus 95 ~~~v~e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~ 136 (291)
T 1u46_A 95 MKMVTELAP----------LGSLLDRLRKH----------------------------QGHFLLGTLSRYAVQVAEGMGY 136 (291)
T ss_dssp CEEEEECCT----------TCBHHHHHHHH----------------------------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred ceeeEeccc----------CCCHHHHHHhc----------------------------cCCcCHHHHHHHHHHHHHHHHH
Confidence 899999665 34444433221 1235677889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+|+||||||+||+++.++. +||+|||+++................+|..|+|||++.+..++.++|||||||++
T Consensus 137 lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 137 LESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp HHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HHhCCcccCCCchheEEEcCCCC--EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 99999999999999999987764 8999999998776443322233344578899999999998899999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HHH-hhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFERDA-NIV-KDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-~~~-~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|+|++++.+||........ ..+ ... ....+...++++.++|.+||+.||.+|||+.+++++
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999944788866443322 222 211 122234556899999999999999999999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.05 Aligned_cols=242 Identities=25% Similarity=0.331 Sum_probs=180.7
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEeecCC------c-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH------H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~------~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
.+.||+|+||+||++.. +++.||||++.... . ....+|+ .++..++||||+++++++.+.+..|+|||+|.
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHH-HHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 47799999999999754 78999999986431 1 2233455 47788899999999999999999999999654
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+|+|.+++.... ....+++..++.++.||+.||+|||+.+|+||
T Consensus 114 ----------~~~L~~~l~~~~--------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 157 (307)
T 2nru_A 114 ----------NGSLLDRLSCLD--------------------------GTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157 (307)
T ss_dssp ----------TCBHHHHHHTGG--------------------------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ----------CCcHHHHHHhcc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence 444444432211 12346788889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||+++.++. +||+|||+++........ .......||+.|+|||++.+ .++.++|||||||++|+|++| .+
T Consensus 158 dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g-~~ 232 (307)
T 2nru_A 158 DIKSANILLDEAFT--AKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG-LP 232 (307)
T ss_dssp CCCGGGEEECTTCC--EEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC-CC
T ss_pred CCCHHHEEEcCCCc--EEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC-CC
Confidence 99999999987765 899999999876532211 12234569999999998865 588999999999999999997 77
Q ss_pred CCCCchHHH-----HHHHhhcc-----------ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 583 PYGESFERD-----ANIVKDRK-----------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 583 Pf~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||....... ........ ........+.+.+++.+||+.||.+|||+.+++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 886532111 11111100 00111123568899999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.27 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=190.4
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-chHHHHHHHHHHHhCCC-CCeeEEeeeccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-HDVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~H-pNIV~l~g~~~~~~~~~LV~ 418 (774)
.+++.|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+. ++..+.| ++|..+..++.+.+..||||
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-IYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHH-HHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHH-HHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 4567899999999999999999864 568999999886443 234556665 4455554 67777777788889999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.++|.+++... ...+++..++.|+.||+.||+|||+.+
T Consensus 83 e~~g~sL~~ll~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~g 123 (483)
T 3sv0_A 83 DLLGPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVEFVHSKS 123 (483)
T ss_dssp ECCCCBHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCCCCHHHHHHhh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 98877777766311 234677889999999999999999999
Q ss_pred ccccccCCCCeeec---CCCCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 499 LIHRDLKPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 499 ivHrDLkp~NILl~---~~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
|+||||||+|||++ .++ .+||+|||+++.+...... ........||+.|+|||++.+..++.++|||||||
T Consensus 124 IvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGv 201 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGY 201 (483)
T ss_dssp EECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHH
Confidence 99999999999994 454 4899999999877643221 11223567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchH----HH-HHHHhh----ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 572 ILFFCITGGKHPYGESFE----RD-ANIVKD----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~----~~-~~~~~~----~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
++|||++| ..||..... .. ..+... .........++++.++|.+||+.||++||++++|+
T Consensus 202 il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~ 270 (483)
T 3sv0_A 202 VLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK 270 (483)
T ss_dssp HHHHHHHS-SCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHhC-CCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 99999997 778865321 11 111111 11112245568999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=345.89 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=188.0
Q ss_pred ccceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
..+.|.+.+.||+|+||+||+|... .+..||||++...... ...+|+ .++..++|||||++++++.+ +..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEec-Cce
Confidence 3467899999999999999998553 3568999998654332 233444 47788999999999999854 568
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|+|||||. +|+|.+++... ...+++..++.++.||+.||+||
T Consensus 466 ~lv~E~~~----------~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~L 507 (656)
T 2j0j_A 466 WIIMELCT----------LGELRSFLQVR----------------------------KFSLDLASLILYAYQLSTALAYL 507 (656)
T ss_dssp EEEEECCT----------TCBHHHHHHHT----------------------------TTTCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCC----------CCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999655 44444443211 12366778899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 508 H~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 583 (656)
T 2j0j_A 508 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583 (656)
T ss_dssp HHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHH
Confidence 9999999999999999987764 89999999987654321 1222345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||++++.+||........ .+........+...++++.++|.+||+.||.+|||+.++++
T Consensus 584 ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 584 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999866888876543322 23333333345566789999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.46 Aligned_cols=251 Identities=16% Similarity=0.138 Sum_probs=178.2
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCC-CCee-------------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQH-PNIV------------- 402 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~H-pNIV------------- 402 (774)
.+.+...+.||+|+||+||++. ..+|+.||||++..... +...+|+. ++..+.| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL-RLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHH-GGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHH-HHHhhccCCCHHHHHHhcccccchh
Confidence 4557888999999999999986 55799999999873221 22334443 5556666 2211
Q ss_pred --E------EeeeccC-----CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHH
Q 004097 403 --R------WYGVESD-----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469 (774)
Q Consensus 403 --~------l~g~~~~-----~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 469 (774)
. +..++.. ....+++|+++.++|.+++.... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~--------~~~~------------------------ 203 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--------SHSS------------------------ 203 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHH--------HHTT------------------------
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhh--------cccc------------------------
Confidence 1 1111121 22468888888888877763210 0000
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCC
Q 004097 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 549 (774)
Q Consensus 470 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y 549 (774)
....+++..++.|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++..... ....+| +.|
T Consensus 204 -~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~~~~------~~~~~g-~~y 273 (413)
T 3dzo_A 204 -THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS------AVSPIG-RGF 273 (413)
T ss_dssp -TSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTEE------ECCCCC-TTT
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeecCCc------cccCCC-Cce
Confidence 0112345677899999999999999999999999999999988876 999999998865432 344567 999
Q ss_pred Cchhhh----------hcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcC
Q 004097 550 QAPEQL----------LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 550 ~aPE~l----------~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 619 (774)
+|||++ ....++.++|||||||++|||++| +.||........ .... .......++++.+||.+||+
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~~li~~~l~ 349 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-DLPNTDDAALGG--SEWI-FRSCKNIPQPVRALLEGFLR 349 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS-SCCCCTTGGGSC--SGGG-GSSCCCCCHHHHHHHHHHTC
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC-CCCCCCcchhhh--HHHH-HhhcccCCHHHHHHHHHHcc
Confidence 999999 444578899999999999999997 778865432211 0000 00112456899999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCcc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~~ 641 (774)
.||++||++.++++||||....
T Consensus 350 ~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 350 YPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp SSGGGSCCHHHHTTSHHHHHHH
T ss_pred CChhhCcCHHHHHhCHHHHHHH
Confidence 9999999999999999996543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.71 Aligned_cols=236 Identities=16% Similarity=0.136 Sum_probs=171.2
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhC---------CCCCeeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASD---------QHPNIVRW 404 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l---------~HpNIV~l 404 (774)
+.|.+.+.||+|+||+||++.. +|+.||||++..... ....+|+. ++..+ .|||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII-ISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHH-HHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHH-HHHHHHHhhccccccCCchhhh
Confidence 3355668899999999999865 889999999975431 44566765 33333 36666555
Q ss_pred eee-----------------ccC-------------CceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHH
Q 004097 405 YGV-----------------ESD-------------QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453 (774)
Q Consensus 405 ~g~-----------------~~~-------------~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~ 453 (774)
+++ +.+ .+..|||||||.+ ++.+.+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~------------------------ 153 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM------------------------ 153 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG------------------------
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH------------------------
Confidence 554 443 7889999997753 232222
Q ss_pred HHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccCCCCeeecCCC-----------------
Q 004097 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK----------------- 515 (774)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~----------------- 515 (774)
....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 154 -----------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~ 216 (336)
T 2vuw_A 154 -----------------RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216 (336)
T ss_dssp -----------------TTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEEC
T ss_pred -----------------HhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccC
Confidence 1123677888999999999999999 99999999999999998775
Q ss_pred -CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH-HHHHHhCCCCCCCCchH--HH
Q 004097 516 -SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI-LFFCITGGKHPYGESFE--RD 591 (774)
Q Consensus 516 -~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl-l~elltg~~~Pf~~~~~--~~ 591 (774)
...+||+|||+|+..... ..+||+.|+|||++.+.. +.++||||++++ .+++++| ..||..... ..
T Consensus 217 ~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g-~~p~~~~~~~~~~ 286 (336)
T 2vuw_A 217 CGLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGE-YHPYSNVLWLHYL 286 (336)
T ss_dssp TTEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTS-CCTHHHHHHHHHH
T ss_pred CCceEEEeeccccEecCCC--------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccc-cCCCcchhhhhHH
Confidence 236999999999876532 346999999999998766 889999998777 6667775 778754211 11
Q ss_pred H-HHHhhccc------cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH-cCCCCC
Q 004097 592 A-NIVKDRKD------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL-NHPFFW 638 (774)
Q Consensus 592 ~-~~~~~~~~------~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL-~HPff~ 638 (774)
. .+...... ......++++.+||.+||+.| |++|+| +||||.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 287 TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1 11111100 111234578999999999977 999999 999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=345.88 Aligned_cols=253 Identities=26% Similarity=0.325 Sum_probs=185.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC------Cce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD------QDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~~ 413 (774)
..|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+ .++..++||||+++++++.+ ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHH-HHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHH-HHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4577788999999999999854 56899999998654322 234455 47788899999999999766 678
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
.|+|||||. +|+|.+++.... ....+++..++.|+.||+.||+|
T Consensus 93 ~~LVmEy~~----------ggsL~~~L~~~~--------------------------~~~~lse~~i~~I~~QLl~aL~y 136 (676)
T 3qa8_A 93 PLLAMEYCE----------GGDLRKYLNQFE--------------------------NCCGLKEGPIRTLLSDISSALRY 136 (676)
T ss_dssp CCCEEECCS----------SCBHHHHHHSSS--------------------------CTTCCCSSHHHHHHHHHHHHHHH
T ss_pred EEEEEEeCC----------CCCHHHHHHhcc--------------------------cCCCCCHHHHHHHHHHHHHHHHH
Confidence 899999664 344444332211 11246777889999999999999
Q ss_pred HHHcCccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
||+.||+||||||+|||++.++ ...+||+|||++....... ......||+.|+|||++.+..++.++|||||||+
T Consensus 137 LHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212 (676)
T ss_dssp HHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHH
T ss_pred HHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHH
Confidence 9999999999999999998654 3458999999998765432 2234579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-----------HHHh-----h----ccc-----cccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 573 LFFCITGGKHPYGESFERDA-----------NIVK-----D----RKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~-----------~~~~-----~----~~~-----~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+|+|++| ..||........ .... . ... ......++++.++|.+||..||.+|||
T Consensus 213 LyeLltG-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 213 AFECITG-FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp HHHHHSS-CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred HHHHHHC-CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 9999997 667754321110 0000 0 000 001112367899999999999999999
Q ss_pred HHHHHcCCCCCC
Q 004097 628 AQNVLNHPFFWT 639 (774)
Q Consensus 628 ~~elL~HPff~~ 639 (774)
+.|+++||||..
T Consensus 292 a~elL~hp~F~~ 303 (676)
T 3qa8_A 292 DPQNPNVGCFQA 303 (676)
T ss_dssp CTTCCCCTTHHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999954
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.21 Aligned_cols=245 Identities=18% Similarity=0.208 Sum_probs=179.8
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++.... .||||++..... ....+|+. ++..++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVM-AYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGG-GGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHH-HHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4567888999999999999976533 499999864321 22334554 667889999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|. +++|.+++... ...+++..++.++.||+.||+|||+.+
T Consensus 109 e~~~----------~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (319)
T 2y4i_B 109 SLCK----------GRTLYSVVRDA----------------------------KIVLDVNKTRQIAQEIVKGMGYLHAKG 150 (319)
T ss_dssp BCCC----------SEEHHHHTTSS----------------------------CCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred eccc----------CCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9665 34444433211 123677888999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCc--cccccccCcCCCCCCchhhhhc---------CCCCCcchhH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQ---------GRQTRAIDLF 567 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~sDvw 567 (774)
|+||||||+|||++ ++ .+||+|||+++....... .........||+.|+|||++.. ..++.++|||
T Consensus 151 i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~ 227 (319)
T 2y4i_B 151 ILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227 (319)
T ss_dssp CCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred ccccCCChhhEEEe-CC--CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence 99999999999997 44 489999999876532111 1122233458999999999974 3478899999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHHH-HHH-hhcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 568 SLGCILFFCITGGKHPYGESFERDA-NIV-KDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 568 SlGvll~elltg~~~Pf~~~~~~~~-~~~-~~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||||++|||++| ..||........ ..+ .... .......++++.++|.+||+.||.+|||+.++++
T Consensus 228 slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 228 ALGTIWYELHAR-EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHS-SCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999997 778866443322 222 2211 1122245678999999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=346.24 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=183.9
Q ss_pred ccccceEEEeEeecccCceEEEEEeee--CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCce-
Q 004097 341 RRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF- 413 (774)
Q Consensus 341 ~~i~~~~~~~~~LG~GsfG~Vy~a~~~--~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~- 413 (774)
..+.+.|.+.+.||+|+||+||++... +|+.||||++...... ...+|+ .++..++|||||++++++.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER-QFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHH-HHHHhcCCCCcCeEeeeEeecCCC
Confidence 455678999999999999999998654 6899999998654332 223444 46788999999999999987665
Q ss_pred ----eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 414 ----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 414 ----~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
.|||||||. +++|.+++ ...+++..++.|+.||+.
T Consensus 155 ~~~~~~lv~E~~~----------g~~L~~~~-------------------------------~~~l~~~~~~~~~~qi~~ 193 (681)
T 2pzi_A 155 GDPVGYIVMEYVG----------GQSLKRSK-------------------------------GQKLPVAEAIAYLLEILP 193 (681)
T ss_dssp SCEEEEEEEECCC----------CEECC-----------------------------------CCCCHHHHHHHHHHHHH
T ss_pred CCceeEEEEEeCC----------CCcHHHHH-------------------------------hCCCCHHHHHHHHHHHHH
Confidence 799999665 34443321 124778889999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||+|||+.+|+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++|||||
T Consensus 194 aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~sl 262 (681)
T 2pzi_A 194 ALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTV 262 (681)
T ss_dssp HHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHH
T ss_pred HHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC-------CccCCCccccCHHHHcCCC-CCceehhhh
Confidence 9999999999999999999999764 4899999999876532 3456999999999997754 889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 570 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
||++|+|++| .+||........ ..........+.+.++|.+||+.||.+||+..+.+.|+|+
T Consensus 263 G~~l~~l~~g-~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 263 GRTLAALTLD-LPTRNGRYVDGL-----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHHHHHSC-CCEETTEECSSC-----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHhC-CCCCcccccccc-----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 9999999997 667654221100 0000111224688999999999999999998888888775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=293.97 Aligned_cols=215 Identities=13% Similarity=0.060 Sum_probs=163.2
Q ss_pred cccceEEEeEeecccCceEEEEEeee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
.++..|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. .+..++||||+++++++.+.+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL-RLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHH-HHhcCCCCCcceeeEEEEECCcE
Confidence 45567899999999999999998654 489999999975432 23445554 66889999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|+|||||. ++|.+++ .. +....++.+|+.||+.||+|
T Consensus 107 ~lv~e~~~g~~L~~~l-----------~~-------------------------------~~~~~~~~~i~~ql~~aL~~ 144 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVA-----------DT-------------------------------SPSPVGAIRAMQSLAAAADA 144 (286)
T ss_dssp EEEEECCCEEEHHHHH-----------TT-------------------------------CCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCCCHHHHH-----------hc-------------------------------CCChHHHHHHHHHHHHHHHH
Confidence 99999665 2454443 11 11233567899999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.||+||||||+|||++.++. +||+++| |++ .++.++|||||||++
T Consensus 145 lH~~givH~Dikp~NIll~~~g~--~kl~~~~-----------------------~~~-------~~~~~~Di~slG~il 192 (286)
T 3uqc_A 145 AHRAGVALSIDHPSRVRVSIDGD--VVLAYPA-----------------------TMP-------DANPQDDIRGIGASL 192 (286)
T ss_dssp HHHTTCCCCCCSGGGEEEETTSC--EEECSCC-----------------------CCT-------TCCHHHHHHHHHHHH
T ss_pred HHHCCCccCCCCcccEEEcCCCC--EEEEecc-----------------------ccC-------CCCchhHHHHHHHHH
Confidence 99999999999999999988876 7787443 333 368899999999999
Q ss_pred HHHHhCCCCCCCCchHHH-H----HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERD-A----NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~----~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|||++| .+||....... . ........ ......++++.++|.+||+.||.+| |+.|+++
T Consensus 193 ~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 193 YALLVN-RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHS-EECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHC-CCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 999997 77886533211 0 00111110 1223456889999999999999999 9999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-27 Score=278.58 Aligned_cols=224 Identities=14% Similarity=0.049 Sum_probs=134.6
Q ss_pred EeecccCceEEEEE-eeeCCcEEEEEEeecCCc-------------hHHHHHHHHHHHhC-CCCCeeEEeeeccCCceeE
Q 004097 351 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-------------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a-~~~~g~~VAVK~l~~~~~-------------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~ 415 (774)
..++.|++|.+..+ ..+.|+.||||++.+... ....+|+. ++..+ .|+||+++++++++++..|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIK-FLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHH-HHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEEECCEEE
Confidence 35677888877654 566799999999965421 12345555 55555 7999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
||||||+ +|+|.+.|... ..++. .+|+.||+.||+|||
T Consensus 319 LVMEyv~----------G~~L~d~i~~~-----------------------------~~l~~---~~I~~QIl~AL~ylH 356 (569)
T 4azs_A 319 LVMEKLP----------GRLLSDMLAAG-----------------------------EEIDR---EKILGSLLRSLAALE 356 (569)
T ss_dssp EEEECCC----------SEEHHHHHHTT-----------------------------CCCCH---HHHHHHHHHHHHHHH
T ss_pred EEEecCC----------CCcHHHHHHhC-----------------------------CCCCH---HHHHHHHHHHHHHHH
Confidence 9999665 44444443221 12332 368999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
++|||||||||+||||+.++. +||+|||+|+...... ....+.+||++|||||++.+ .+..++|+||+|+++++
T Consensus 357 ~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 357 KQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFN 430 (569)
T ss_dssp HTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC------CCSHHHHHHHHHHHHHHC------------------CC
T ss_pred HCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhh
Confidence 999999999999999988876 9999999998765432 23345679999999999975 46778999999999888
Q ss_pred HHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCC
Q 004097 576 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 636 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPf 636 (774)
+.++.. ++. ..+.. .. .. ...+.++...+...+|..||.......|+|
T Consensus 431 l~~~~~-~~~-------~~l~~-~~--~~--~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 478 (569)
T 4azs_A 431 LPQPWS-NWL-------YAVWQ-EP--VE--RWNFVLLLALFEKKAKLPSAEQQRGATEQW 478 (569)
T ss_dssp CCTTHH-HHH-------HHHHT-SC--GG--GCSHHHHHHHHHTGGGSCCGGGSSCCHHHH
T ss_pred hccccc-hhH-------HHhhc-CC--CC--CCcHHHHHHHHhCCCCCCCCChhhhccchh
Confidence 766421 110 00000 00 00 112455666666777777776655555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=242.62 Aligned_cols=182 Identities=18% Similarity=0.150 Sum_probs=131.7
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
..+.||+|+||+||++ ...++.+|+|+...... ....+|+. ++..++||||+++..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREAR-YLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHH-HHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHH-HHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999997 66788999998743221 11345554 67888999999666666677788999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||+ +|+|.+++.. ++.|+.|++.||+|||+.
T Consensus 418 mE~~~----------ggsL~~~l~~-------------------------------------~~~i~~qi~~aL~~LH~~ 450 (540)
T 3en9_A 418 MSYIN----------GKLAKDVIED-------------------------------------NLDIAYKIGEIVGKLHKN 450 (540)
T ss_dssp EECCC----------SEEHHHHSTT-------------------------------------CTHHHHHHHHHHHHHHHT
T ss_pred EECCC----------CCCHHHHHHH-------------------------------------HHHHHHHHHHHHHHHHHC
Confidence 99654 4444444321 257999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccc----cccccCcCCCCCCchhhhhc--CCCCCcchhHhHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGC 571 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSlGv 571 (774)
+|+||||||+|||++. .+||+|||+++......... ......+||+.|||||++.. ..|+..+|+||...
T Consensus 451 gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 451 DVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp TEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred cCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 9999999999999976 49999999999875421111 01234579999999999987 56888899999988
Q ss_pred HHHHHHhCCCCCC
Q 004097 572 ILFFCITGGKHPY 584 (774)
Q Consensus 572 ll~elltg~~~Pf 584 (774)
-..+.+.+ +.+|
T Consensus 527 ~~l~~v~~-r~rY 538 (540)
T 3en9_A 527 ELMKDVER-RARY 538 (540)
T ss_dssp HHHHHHHT-CSCC
T ss_pred HHHHHHHh-cccc
Confidence 88887774 4455
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-20 Score=199.97 Aligned_cols=154 Identities=19% Similarity=0.116 Sum_probs=111.7
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---------------------hHHHHHHHHHHHhCCCCCee
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------DVALKEIQNLIASDQHPNIV 402 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---------------------~~~~~Ei~~ll~~l~HpNIV 402 (774)
+..|.+.+.||+|+||.||++...+|+.||||.+..... ....+|+. ++..++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~-~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH-HHHhcc--C-C
Confidence 445677899999999999998776799999999864221 12446665 556666 4 5
Q ss_pred EEeeeccCCceeEEeccccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 403 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 403 ~l~g~~~~~~~~~LV~E~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
++++++ +.+..|+|||||++ +|.+ + .. ....
T Consensus 165 ~v~~~~-~~~~~~lvmE~~~g~~L~~-l-----------~~-----------------------------------~~~~ 196 (282)
T 1zar_A 165 AVPKVY-AWEGNAVLMELIDAKELYR-V-----------RV-----------------------------------ENPD 196 (282)
T ss_dssp SSCCEE-EEETTEEEEECCCCEEGGG-C-----------CC-----------------------------------SCHH
T ss_pred CcCeEE-eccceEEEEEecCCCcHHH-c-----------ch-----------------------------------hhHH
Confidence 566644 34667999996654 4443 1 00 1124
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc----
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---- 557 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---- 557 (774)
.++.|++.||+|||+.||+||||||+|||++ ++ .+||+|||+++. +..++|||++..
T Consensus 197 ~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~----------------~~~~~a~e~l~rdv~~ 257 (282)
T 1zar_A 197 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE----------------VGEEGWREILERDVRN 257 (282)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE----------------TTSTTHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE----------------CCCCCHHHHHHHHHHH
Confidence 7999999999999999999999999999998 65 499999999863 345789998854
Q ss_pred ------CCCCCcchhHh
Q 004097 558 ------GRQTRAIDLFS 568 (774)
Q Consensus 558 ------~~~~~~sDvwS 568 (774)
..|...+|+|.
T Consensus 258 i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 258 IITYFSRTYRTEKDINS 274 (282)
T ss_dssp HHHHHHHHHCCCCCHHH
T ss_pred HHHHHHHhcCCCCChHH
Confidence 34455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=172.72 Aligned_cols=139 Identities=19% Similarity=0.214 Sum_probs=95.8
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcE--EEEEEeecCCc---------------------------hHHHHHHHHHH
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRS--VAVKRLVKTHH---------------------------DVALKEIQNLI 393 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~--VAVK~l~~~~~---------------------------~~~~~Ei~~ll 393 (774)
+..+.+.+.||+|+||.||++.. .+|+. ||||+++.... ....+|+. .+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l 124 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR-NL 124 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH-HH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH-HH
Confidence 34577889999999999999876 68999 99998753210 12445655 44
Q ss_pred HhCCCCCe--eEEeeeccCCceeEEeccccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHH
Q 004097 394 ASDQHPNI--VRWYGVESDQDFVYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469 (774)
Q Consensus 394 ~~l~HpNI--V~l~g~~~~~~~~~LV~E~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 469 (774)
..+.|++| ...+++ +..+||||||.+ .+. .+|.+....
T Consensus 125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~-------~~L~~~~~~--------------------------- 166 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPA-------PTLVELGRE--------------------------- 166 (258)
T ss_dssp HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEEC-------CBHHHHGGG---------------------------
T ss_pred HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCcc-------ccHHHHhhc---------------------------
Confidence 55555543 233332 457899997742 110 122222110
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccCCCCeeecCCCCceEEEcccCccccc
Q 004097 470 WKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530 (774)
Q Consensus 470 ~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~ 530 (774)
.++..+..++.|++.||+||| +.||+||||||+|||++. .++|+|||+|...
T Consensus 167 -----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 167 -----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp -----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEET
T ss_pred -----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECcccccC
Confidence 012235789999999999999 999999999999999976 4899999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-15 Score=164.73 Aligned_cols=139 Identities=14% Similarity=0.153 Sum_probs=91.3
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----------------hHHHHHHHHHHHhCCCCCeeEEeee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------------DVALKEIQNLIASDQHPNIVRWYGV 407 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----------------~~~~~Ei~~ll~~l~HpNIV~l~g~ 407 (774)
..|.+...||+|++|.||+|...+|+.||||+++.... ....++ ..+.+...|+|+++++..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~-~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYL-SRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHH-HHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHH-HHHHHHHHHHHHHHHHhc
Confidence 34788999999999999999888999999998753210 011111 112222234444444432
Q ss_pred ccC------CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHH
Q 004097 408 ESD------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 481 (774)
Q Consensus 408 ~~~------~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 481 (774)
... ....+||||||++ +.+.... ..+...
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G----------~~L~~l~-----------------------------------~~~~~~ 208 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDA----------LPMRQVS-----------------------------------SVPDPA 208 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSC----------EEGGGCC-----------------------------------CCSCHH
T ss_pred CCCCCeeeeccCceEEEEecCC----------ccHhhhc-----------------------------------ccHHHH
Confidence 211 1223799997764 2222110 001235
Q ss_pred HHHHHHHHHHHHHHHcCccccccCCCCeeecCCCC--------ceEEEcccCcccc
Q 004097 482 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS--------FCAKLSDMGISKR 529 (774)
Q Consensus 482 ~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~--------~~~kl~DFGla~~ 529 (774)
.++.||+.+|.|||+.|||||||||.|||+++++. ..+.|+||+.+..
T Consensus 209 ~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 209 SLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 68899999999999999999999999999987652 2378999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=4.2e-09 Score=109.29 Aligned_cols=76 Identities=11% Similarity=-0.011 Sum_probs=55.5
Q ss_pred EEEeEeecccCceEEEEEeeeCCcEEEEEEeec---CCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK---THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~---~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
|.+...++.|+.+.||+... .+..+++|+... .......+|...+...-.|.++.++++++.+.+..|+|||+++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 45667788899999998653 468999999864 22334556665443333467788999998888899999997765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-08 Score=104.68 Aligned_cols=70 Identities=13% Similarity=-0.016 Sum_probs=48.4
Q ss_pred ecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCC--eeEEeeeccCCceeEEeccccCC
Q 004097 353 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN--IVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 353 LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN--IV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.+.|+.+.||+....+|+.++||+..........+|...+ ..+.+.+ +.+++++..+.+..|+|||+++|
T Consensus 28 ~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l-~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 28 TIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARL-SWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHH-HHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred ccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHH-HHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3466679999987667888999997654323345565533 3332223 55688888888889999998886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.49 E-value=3e-07 Score=100.05 Aligned_cols=136 Identities=13% Similarity=0.200 Sum_probs=87.5
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEee--cCC----chHHHHHHHHHHHhCC--CCCeeEEeeeccCC---ceeEEec
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTH----HDVALKEIQNLIASDQ--HPNIVRWYGVESDQ---DFVYLSL 418 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~--~~~----~~~~~~Ei~~ll~~l~--HpNIV~l~g~~~~~---~~~~LV~ 418 (774)
.+.|+.|.++.||+.... +..+++|+.. ... .....+|.. ++..+. +..+.++++++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~-~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYR-VMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHH-HHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHH-HHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 467899999999986554 4678888775 221 123445554 333333 45678888888776 4589999
Q ss_pred cccCCC-hhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-
Q 004097 419 ERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE- 496 (774)
Q Consensus 419 E~~~~s-L~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~- 496 (774)
|+++|. +.+.. + ..++..+...++.+++..|+.||.
T Consensus 121 e~v~G~~l~~~~----------------------------------------~--~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 121 EFVSGRVLWDQS----------------------------------------L--PGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp ECCCCBCCCCTT----------------------------------------C--TTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred EecCCeecCCCc----------------------------------------c--ccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 977752 21100 0 112334445666666666666665
Q ss_pred ---------------------------------------------------------cCccccccCCCCeeecCCCCceE
Q 004097 497 ---------------------------------------------------------IGLIHRDLKPQNVLISKDKSFCA 519 (774)
Q Consensus 497 ---------------------------------------------------------~~ivHrDLkp~NILl~~~~~~~~ 519 (774)
..++|+|+++.|||++.++.-.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~ 238 (359)
T 3dxp_A 159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL 238 (359)
T ss_dssp CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence 35899999999999987654346
Q ss_pred EEcccCcccc
Q 004097 520 KLSDMGISKR 529 (774)
Q Consensus 520 kl~DFGla~~ 529 (774)
.|+||+.+..
T Consensus 239 ~viDwe~a~~ 248 (359)
T 3dxp_A 239 AVLDWELSTL 248 (359)
T ss_dssp EECCCTTCEE
T ss_pred EEECcccccc
Confidence 8999998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3.3e-07 Score=110.21 Aligned_cols=79 Identities=8% Similarity=-0.075 Sum_probs=64.8
Q ss_pred cccCcccCCCCCcccccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC----CCCCCCCCCCCCCC
Q 004097 116 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP----GSSQNSLLGPVDRN 189 (774)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~----~~~~~sf~GN~~lc 189 (774)
|.+.+++.+|+. +.-..+|+.+.+.+|+|+|.|| .+.++ .|+.||||+|+|+|.||.. .++..+|.||+++|
T Consensus 664 s~N~l~g~ip~~--l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 664 GHNDISGSIPDE--VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp CSSCCCSCCCGG--GGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred cCCccCCCCChH--HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhc
Confidence 555666677776 5577899999999999999998 58888 5999999999999999943 46677889999999
Q ss_pred CCCCCCC
Q 004097 190 SPLFLPD 196 (774)
Q Consensus 190 g~~~~P~ 196 (774)
|++.++|
T Consensus 742 g~~l~~C 748 (768)
T 3rgz_A 742 GYPLPRC 748 (768)
T ss_dssp STTSCCC
T ss_pred CCCCcCC
Confidence 9765443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-06 Score=92.80 Aligned_cols=82 Identities=16% Similarity=0.142 Sum_probs=47.4
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-----CC---------CCCc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GR---------QTRA 563 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~---------~~~~ 563 (774)
.++|+|++|.||+++.+..-.+.|+||+.+.......+. ...... . .-..|+.... +. ....
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~--~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~ 267 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMED--D-EEYGMEFVSKILNHYKHKDIPTVLEKYRMK 267 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCT--T-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhh--c-cccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence 589999999999998742234789999987654321110 000000 0 0022332211 00 1123
Q ss_pred chhHhHHHHHHHHHhCCCCCC
Q 004097 564 IDLFSLGCILFFCITGGKHPY 584 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf 584 (774)
.+.|+++.++|.+.+| .++|
T Consensus 268 ~~~~~l~~~~~~~~~g-~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYG-YMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTT-CHHH
T ss_pred HHHHHHHHHHHHHHcC-CHHH
Confidence 6899999999999997 4443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00019 Score=74.13 Aligned_cols=75 Identities=11% Similarity=-0.060 Sum_probs=47.4
Q ss_pred ecccCce-EEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC-Chhh
Q 004097 353 IAKGSNG-TVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLND 427 (774)
Q Consensus 353 LG~GsfG-~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~-sL~~ 427 (774)
+..|..| +||+... .++..+.||+-.........+|...+...-.+--+-++++++.+.+..|+|||++++ ++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4455555 6887533 346789999865433333445555333333333466788888888999999998886 4443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00039 Score=73.73 Aligned_cols=72 Identities=15% Similarity=0.155 Sum_probs=43.5
Q ss_pred EeecccCceEEEEEeeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCC---CeeEEeeecc-CCceeEEeccccCC-C
Q 004097 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHP---NIVRWYGVES-DQDFVYLSLERCTC-S 424 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~Hp---NIV~l~g~~~-~~~~~~LV~E~~~~-s 424 (774)
+.++.|....||+. |..++||+-..... ....+|.. ++..+.+. .+.+.+.++. ..+..|+|||+++| +
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~-~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQ-LLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHH-HHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHH-HHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788999999985 56788887532211 23345554 44444331 2445555553 45567899999887 3
Q ss_pred hhh
Q 004097 425 LND 427 (774)
Q Consensus 425 L~~ 427 (774)
+.+
T Consensus 100 l~~ 102 (306)
T 3tdw_A 100 LGE 102 (306)
T ss_dssp CHH
T ss_pred Cch
Confidence 433
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0032 Score=66.88 Aligned_cols=43 Identities=19% Similarity=0.222 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHHH-------------cCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 484 TRDIVSGLSHLHE-------------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 484 ~~qia~gL~yLH~-------------~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
..++..++++|+. ..++|+|+++.|||++.++. +.|+||+.+.
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 3345556677753 47999999999999965544 7899999653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00049 Score=83.36 Aligned_cols=61 Identities=5% Similarity=-0.235 Sum_probs=40.4
Q ss_pred cccccCcccccccCccccchhhhhccCCchhhhhhccceeccccCCCCC--CCCCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSS--QNSLLGPVDRNS 190 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~l~~l~L~~Lnls~N~fsG~Ip~~~~~--~~sf~GN~~lcg 190 (774)
+....+|+.+.+.+|++++..+..-...|+.|||++|+++|.+|..... .-.+.||++.|.
T Consensus 500 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 500 FSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562 (844)
T ss_dssp SSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred ccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence 4456677777777777776554332245778888888888888754332 223449999985
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0011 Score=71.32 Aligned_cols=75 Identities=4% Similarity=0.022 Sum_probs=45.9
Q ss_pred EeEee-cccCceEEEEEeee-------CCcEEEEEEeecCC------chHHHHHHHHHHHhCCC--CCeeEEeeeccCC-
Q 004097 349 FNKEI-AKGSNGTVVLEGNY-------EGRSVAVKRLVKTH------HDVALKEIQNLIASDQH--PNIVRWYGVESDQ- 411 (774)
Q Consensus 349 ~~~~L-G~GsfG~Vy~a~~~-------~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~- 411 (774)
..+.| +.|....+|+.... ++..+++|+-.... .....+|...+...-.+ -.+.++++++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34668 88999999986544 26788999764322 12334555422211112 2456677776655
Q ss_pred --ceeEEeccccCC
Q 004097 412 --DFVYLSLERCTC 423 (774)
Q Consensus 412 --~~~~LV~E~~~~ 423 (774)
+..|+|||+++|
T Consensus 104 ~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 VLGTPFFLMDYVEG 117 (357)
T ss_dssp TTSSCEEEEECCCC
T ss_pred ccCCceEEEEecCC
Confidence 456899998886
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0002 Score=76.00 Aligned_cols=66 Identities=8% Similarity=-0.031 Sum_probs=51.8
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC----CCCCCCCCCCCCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP----GSSQNSLLGPVDRNSPLFLP 195 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~----~~~~~sf~GN~~lcg~~~~P 195 (774)
+....+|+.+.+.+|+++|.+| .+..+ .|+.|||++|+++|.||.. ......+.||+++||++.++
T Consensus 240 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~ 311 (313)
T 1ogq_A 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCC
Confidence 3456788999999999999998 47777 5999999999999999853 22344556999999965443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.004 Score=68.21 Aligned_cols=72 Identities=21% Similarity=0.168 Sum_probs=41.9
Q ss_pred eEeecccCceEEEEEee-eCCcEEEEEEeecC----------CchHHHHHHHHHHH--hCCCCCeeEEeeeccCCceeEE
Q 004097 350 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT----------HHDVALKEIQNLIA--SDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~----------~~~~~~~Ei~~ll~--~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.||.|..+.||++.. .+++.|+||..... ..+....|...+.. ......+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 36799999999999754 35688999975421 11223445543222 2212233455554 3445689
Q ss_pred eccccCC
Q 004097 417 SLERCTC 423 (774)
Q Consensus 417 V~E~~~~ 423 (774)
|||++.+
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999876
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0076 Score=66.63 Aligned_cols=71 Identities=10% Similarity=0.112 Sum_probs=44.0
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEee-------cC-----CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLV-------KT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~-------~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.||.|..+.||+... +++.++||... .. .......|+..++....+..+.+++++. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 36789999999998743 56789999421 11 1112233444444333334566666665 4567999
Q ss_pred cccc-CC
Q 004097 418 LERC-TC 423 (774)
Q Consensus 418 ~E~~-~~ 423 (774)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0013 Score=78.78 Aligned_cols=59 Identities=15% Similarity=0.027 Sum_probs=47.0
Q ss_pred cccCcccCCCCCcccccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCC
Q 004097 116 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPG 176 (774)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~ 176 (774)
|.+.+++.+|.. +.....|+.+.+.+|+|+|.|| .+.++ .|+.||||+|+|+|.||...
T Consensus 640 s~N~l~g~ip~~--l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l 700 (768)
T 3rgz_A 640 SYNMLSGYIPKE--IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700 (768)
T ss_dssp CSSCCBSCCCGG--GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGG
T ss_pred cCCcccccCCHH--HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHH
Confidence 445566666766 4467888899999999999998 58888 59999999999999998543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.049 Score=56.60 Aligned_cols=76 Identities=16% Similarity=0.034 Sum_probs=48.5
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCC--CCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~~~LV~ 418 (774)
|..+.-.+.+|.|..+.||+....+|+.|.||+-..... .....|...|...-.. --+.+.+++. .-++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 444556688999999999999989999999998653321 2334565533322222 1234445442 237889
Q ss_pred cccCC
Q 004097 419 ERCTC 423 (774)
Q Consensus 419 E~~~~ 423 (774)
|++.+
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 98774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.024 Score=60.16 Aligned_cols=74 Identities=23% Similarity=0.275 Sum_probs=51.5
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHH--HHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
.+.|+.|....+|+... ++..++||+...........|...+ +.......+.+.++++.+.+..|+|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999998654 5678899987654333344554432 33222356778888887778899999999863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.28 E-value=0.16 Score=50.61 Aligned_cols=115 Identities=15% Similarity=0.064 Sum_probs=71.4
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCC
Q 004097 470 WKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 548 (774)
Q Consensus 470 ~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 548 (774)
-...++.+++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|++ .+.+ +.+. .....
T Consensus 41 ~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V--~f~~-~~s~---------------~~~~~ 102 (229)
T 2yle_A 41 LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAV--TLAP-AADD---------------AGEPP 102 (229)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCE--EECC-C-----------------------
T ss_pred HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCce--eccc-cccc---------------ccccC
Confidence 345678999999999999999877622 111233345688999888873 3332 1110 01234
Q ss_pred CCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCC
Q 004097 549 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 620 (774)
Q Consensus 549 y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 620 (774)
+.+||... ...+.+.=|||||+++|.-+--+-++ ....+.++++..||..|...
T Consensus 103 ~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 103 PVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred CCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 56777653 34567888999999999887643322 13446778999999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.077 Score=55.46 Aligned_cols=28 Identities=21% Similarity=0.087 Sum_probs=22.5
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.++|+|+.+.||+. .++. +.++||..+.
T Consensus 174 ~l~HgDl~~~Nil~-~~~~--~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TGER--MWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEE-CSSC--EEECCCTTCE
T ss_pred eeeccCCCcCCEEE-CCCC--EEEEeccccc
Confidence 48999999999994 4444 6899998664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=94.91 E-value=0.014 Score=56.82 Aligned_cols=61 Identities=7% Similarity=-0.063 Sum_probs=38.9
Q ss_pred cccccCcccccccCccccchhhh-hccC-CchhhhhhccceeccccCCCCCCCCC-----CCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL-----LGPVDRNS 190 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf-----~GN~~lcg 190 (774)
+....+|+.+.+.+|++++..+. +.++ .|+.|||++|+++|.+|.......++ .||.+.|.
T Consensus 74 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 44566777788888888777764 6666 47778888888887776433322222 36665543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.73 E-value=0.1 Score=55.20 Aligned_cols=33 Identities=24% Similarity=0.323 Sum_probs=25.2
Q ss_pred cCccccccCCCCeeecCCC--CceEEEcccCcccc
Q 004097 497 IGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKR 529 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~~ 529 (774)
..++|+|+.+.||+++.+. .-.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3699999999999997641 12378999997753
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=94.45 E-value=0.027 Score=53.79 Aligned_cols=44 Identities=9% Similarity=-0.031 Sum_probs=27.0
Q ss_pred cccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|++++..+. +..+ .|+.|||++|+|++..+
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~ 95 (170)
T 3g39_A 50 FDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPR 95 (170)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCH
Confidence 34455666677777777755442 4555 46677777777776444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.24 E-value=0.12 Score=54.22 Aligned_cols=74 Identities=12% Similarity=-0.016 Sum_probs=37.6
Q ss_pred eEeecccCceEEEEEeeeCCcEEEEEEeecC-CchHHHHHHH--HHHHh--CCCCCeeEEe-e--eccCCceeEEecccc
Q 004097 350 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQ--NLIAS--DQHPNIVRWY-G--VESDQDFVYLSLERC 421 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~-~~~~~~~Ei~--~ll~~--l~HpNIV~l~-g--~~~~~~~~~LV~E~~ 421 (774)
.+.|+.|....+|+....+| .+++|+.... .......|.. ..+.. +.-|.++... | +....+..+++++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 45688898899998765555 6889987652 2222233333 22332 2223333211 1 011235678999998
Q ss_pred CCC
Q 004097 422 TCS 424 (774)
Q Consensus 422 ~~s 424 (774)
+|.
T Consensus 106 ~G~ 108 (322)
T 2ppq_A 106 EGM 108 (322)
T ss_dssp CCB
T ss_pred CCc
Confidence 873
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=94.19 E-value=0.025 Score=65.05 Aligned_cols=45 Identities=7% Similarity=-0.054 Sum_probs=25.1
Q ss_pred ccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 131 DLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
....+|+.+.+.+|++++..| .+.++ .|+.|||++|+++|.+|..
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 561 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 561 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSC
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHH
Confidence 344555566666666665554 34555 3666666666666655543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.17 E-value=0.17 Score=55.96 Aligned_cols=70 Identities=14% Similarity=0.030 Sum_probs=42.7
Q ss_pred eEeecccCceEEEEEeeeC--------CcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 350 NKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~~--------g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
.+.|+.|-...||+....+ ++.+.+|+...... .....|...+...-.+.-..++++.+.+ .+|+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 3568888889999876542 57899998744222 4445565533222122223566776543 288998
Q ss_pred cCC
Q 004097 421 CTC 423 (774)
Q Consensus 421 ~~~ 423 (774)
++|
T Consensus 154 l~G 156 (429)
T 1nw1_A 154 IPS 156 (429)
T ss_dssp CCE
T ss_pred eCC
Confidence 875
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.09 E-value=0.035 Score=39.06 Aligned_cols=29 Identities=17% Similarity=-0.144 Sum_probs=16.0
Q ss_pred cccccchhhHHHHHHHHHHHHHHHHhhhc
Q 004097 233 VEGFRSYIQSFIVLFIALCPIIGFLFYHS 261 (774)
Q Consensus 233 ~~~~~i~Iv~~v~~~lvll~~i~~~~~~~ 261 (774)
+.+.+..|++++++.+++++.+++++|+|
T Consensus 9 s~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 44556666666665555555555544443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.05 E-value=0.14 Score=54.00 Aligned_cols=70 Identities=16% Similarity=0.109 Sum_probs=39.8
Q ss_pred eecccCceEEEEEeeeCCcEEEEEEeecC-C-chHHHHHHH--HHHHhCCCCCeeEEeee-----ccCCceeEEeccccC
Q 004097 352 EIAKGSNGTVVLEGNYEGRSVAVKRLVKT-H-HDVALKEIQ--NLIASDQHPNIVRWYGV-----ESDQDFVYLSLERCT 422 (774)
Q Consensus 352 ~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~-~-~~~~~~Ei~--~ll~~l~HpNIV~l~g~-----~~~~~~~~LV~E~~~ 422 (774)
.|+ |....||+....+|+.+++|+.... . ......|.. ..+.... -.+.+.+.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g-~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcC-CeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 7788999876666778999998633 2 222333433 2222211 124444443 112345688999998
Q ss_pred C
Q 004097 423 C 423 (774)
Q Consensus 423 ~ 423 (774)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=93.68 E-value=0.045 Score=52.46 Aligned_cols=39 Identities=8% Similarity=-0.024 Sum_probs=19.1
Q ss_pred cccCcccccccCccccchhhh-hccC-Cchhhhhhccceec
Q 004097 132 LIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAG 170 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG 170 (774)
...+|+.+.+.+|+|++..+. +..+ .|+.|||++|++++
T Consensus 55 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~ 95 (174)
T 2r9u_A 55 HLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS 95 (174)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce
Confidence 344555555555555553332 3344 35555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.34 E-value=0.035 Score=55.36 Aligned_cols=42 Identities=5% Similarity=-0.062 Sum_probs=21.0
Q ss_pred cccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
...+|+.+.+.+|++++..| .+.++ .|+.|||++|++++.+|
T Consensus 103 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 34455555555555555443 24444 35555555555555444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=93.26 E-value=0.039 Score=58.76 Aligned_cols=42 Identities=5% Similarity=0.049 Sum_probs=28.5
Q ss_pred cccccCcccccccCccccchhh-hhccC-Cchhhhhhccceecc
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGW 171 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~ 171 (774)
+..+.+|+.+.|.+|+|+|..| .+.+| .|+.|||++|+|++-
T Consensus 52 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 95 (347)
T 2ifg_A 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL 95 (347)
T ss_dssp SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCC
T ss_pred hccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcccee
Confidence 3455667777777777777666 45666 477777777777753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.22 E-value=0.89 Score=48.30 Aligned_cols=69 Identities=12% Similarity=0.032 Sum_probs=39.9
Q ss_pred cccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeee------ccCCceeEEeccccCCC
Q 004097 354 AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ESDQDFVYLSLERCTCS 424 (774)
Q Consensus 354 G~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~------~~~~~~~~LV~E~~~~s 424 (774)
|.|....||+....+| .+++|+....... ...++...+....-|++.+.+.. ....+..+++|++++|.
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~~-~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHDE-INLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSCC-HHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccch-HHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 4444678998766666 8999987654422 12222233333222334454432 23356789999999863
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.94 E-value=0.19 Score=36.48 Aligned_cols=9 Identities=0% Similarity=0.165 Sum_probs=3.5
Q ss_pred HHhhhcccc
Q 004097 256 FLFYHSKQV 264 (774)
Q Consensus 256 ~~~~~~~~~ 264 (774)
+++|+|+++
T Consensus 31 ~~~~~RRr~ 39 (44)
T 2ks1_B 31 IGLFMRRRH 39 (44)
T ss_dssp HHHHHHTTT
T ss_pred HHHHhhhhH
Confidence 334444333
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=91.94 E-value=0.19 Score=54.59 Aligned_cols=31 Identities=23% Similarity=0.318 Sum_probs=24.3
Q ss_pred CccccccCCCCeeecCCC--CceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDK--SFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~--~~~~kl~DFGla~ 528 (774)
.++|+|+.+.||+++.+. .-.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 599999999999997651 1137899998764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=91.87 E-value=0.051 Score=62.56 Aligned_cols=42 Identities=10% Similarity=0.061 Sum_probs=27.2
Q ss_pred cccccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|+++ .|| .+..+ .|+.|||++|+++| ||
T Consensus 459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence 445566677777777776 665 45555 46677777777776 55
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.86 E-value=0.095 Score=51.01 Aligned_cols=44 Identities=5% Similarity=-0.103 Sum_probs=30.6
Q ss_pred cccccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|++++..+ .+.++ .|+.|+|++|++++-.+
T Consensus 74 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~ 119 (193)
T 2wfh_A 74 FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPE 119 (193)
T ss_dssp TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred ccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeCh
Confidence 4456677777888888877665 46666 47778888887775443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.78 E-value=0.14 Score=37.08 Aligned_cols=7 Identities=14% Similarity=0.074 Sum_probs=3.0
Q ss_pred hhHHHHH
Q 004097 240 IQSFIVL 246 (774)
Q Consensus 240 Iv~~v~~ 246 (774)
|++++++
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 4444443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.74 E-value=0.83 Score=50.89 Aligned_cols=69 Identities=7% Similarity=-0.112 Sum_probs=39.0
Q ss_pred EeecccCceEEEEEeeeC-CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 351 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~-g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+.|+.|-...+|+....+ +..+.+|+...... .....|...+...-.+.-..++++++.+ .+||||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 568888889999866544 47888987643211 1123555533222223223567777632 259999886
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.14 Score=54.76 Aligned_cols=90 Identities=18% Similarity=0.343 Sum_probs=55.9
Q ss_pred ccCCceeeeeeeeeEEEEEcccceeEeecccCCCCCCCCcCCCCCccccccCCcchhhcccccccCcchhhhheeeccee
Q 004097 5 SKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYV 84 (774)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (774)
|.||.|-.|++..+++-+|++||+++-.+...-....+. +..+....+ + ++ + .......|+|-|+||.
T Consensus 109 ~~~g~Vy~Gs~~g~l~ald~~tG~~~W~~~~~~~~~~~~-~~~e~~~~~--~---d~-~-----~d~~~~~v~ig~~~y~ 176 (339)
T 2be1_A 109 VEDEKVYTGSMRTIMYTINMLNGEIISAFGPGSKNGYFG-SQSVDCSPE--E---KI-K-----LQECENMIVIGKTIFE 176 (339)
T ss_dssp -CCEEEEECEEEEEEEEEETTTCCEEEEESTTCBCC--------------------------------CCEEEEEEEEEE
T ss_pred ccCCEEEEEecCCEEEEEECCCCcEEEEEecCCCccccc-ccccccccc--c---cc-c-----cccCCCeEEEecceEE
Confidence 589999999999999999999999998883322100000 000100000 0 00 0 0112346999999999
Q ss_pred ecccCCCccceeeeehhhhhhhhh
Q 004097 85 LQSTSQDSGEVLWNVAYADFKAEF 108 (774)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~ 108 (774)
+-..+. +|. .||+.+.++.+..
T Consensus 177 v~~~~~-sG~-~W~~~~s~~~~~~ 198 (339)
T 2be1_A 177 LGIHSY-DGA-SYNVTYSTWQQNV 198 (339)
T ss_dssp CEECCT-TSC-CCCCEEEEEECCT
T ss_pred EEEECC-CCC-eEEEecccccccc
Confidence 999985 587 8999888776543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=91.25 E-value=0.14 Score=51.28 Aligned_cols=42 Identities=10% Similarity=0.128 Sum_probs=23.5
Q ss_pred ccccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 131 DLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
....+|+.+.+.+|+++ .|| .+..+ .|+.|||++|++++..+
T Consensus 109 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 109 DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp TTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 34555666666666666 454 34444 36666666666665443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=90.99 E-value=0.12 Score=51.44 Aligned_cols=42 Identities=10% Similarity=-0.054 Sum_probs=23.8
Q ss_pred cccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
...+|+.+.+.+|++++..| .+.++ .|+.|||++|++++..+
T Consensus 102 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 102 GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 34555666666666666554 34454 36666666666665444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.45 E-value=0.15 Score=36.81 Aligned_cols=9 Identities=11% Similarity=0.091 Sum_probs=3.4
Q ss_pred HHHhhhccc
Q 004097 255 GFLFYHSKQ 263 (774)
Q Consensus 255 ~~~~~~~~~ 263 (774)
++++|.|||
T Consensus 30 ~~~~~~RRR 38 (44)
T 2jwa_A 30 VFGILIKRR 38 (44)
T ss_dssp HHHHHHHHH
T ss_pred HHHhheehh
Confidence 333444333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=90.38 E-value=0.14 Score=54.28 Aligned_cols=46 Identities=9% Similarity=-0.058 Sum_probs=39.3
Q ss_pred cccccCcccccccC-ccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 130 MDLIGDVESHLPCH-TQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 130 ~~~~~~~~~~~~~n-N~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
+....+|+.+.+.+ |+|++..+ .+.+| .|+.|||++|+|+|.+|..
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 45677899999996 99999886 58888 6999999999999987744
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=89.95 E-value=0.2 Score=50.54 Aligned_cols=43 Identities=9% Similarity=0.032 Sum_probs=23.7
Q ss_pred ccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 131 DLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
....+|+.+.+.+|++++..+. +..+ .|+.|++++|++++..+
T Consensus 104 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 104 DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 3445566666666666644442 3444 46666666666665444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=89.68 E-value=0.12 Score=54.87 Aligned_cols=53 Identities=8% Similarity=-0.101 Sum_probs=39.3
Q ss_pred cccccCcccccccCccccchhhh-hccC-CchhhhhhccceeccccCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 182 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf 182 (774)
+....+|+.+.+.+|+++|.+|. +..+ .|+.|++++|++.|.||.......++
T Consensus 225 l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 279 (328)
T 4fcg_A 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279 (328)
T ss_dssp GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence 55667888888888888888874 6666 58888888888888888554333333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=89.61 E-value=0.24 Score=47.00 Aligned_cols=41 Identities=7% Similarity=0.018 Sum_probs=24.0
Q ss_pred ccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecc
Q 004097 131 DLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGW 171 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~ 171 (774)
....+|+.+.+.+|++++..+. +..+ .|+.|++++|++++-
T Consensus 73 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 115 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSV 115 (177)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred cCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEe
Confidence 3445666666666666655543 4444 466666666666643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=89.57 E-value=0.089 Score=55.33 Aligned_cols=44 Identities=5% Similarity=-0.033 Sum_probs=27.2
Q ss_pred ccccCcccccccCccccchhhhhccC-CchhhhhhccceeccccC
Q 004097 131 DLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISL 174 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip~ 174 (774)
....+|+.+.+.+|+++|.+|.+..+ .|+.||+++|+++|.+|.
T Consensus 218 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 262 (313)
T 1ogq_A 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp CTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCG
T ss_pred hcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCCh
Confidence 34455666666666666666665555 366666666666666653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=89.37 E-value=0.11 Score=58.35 Aligned_cols=28 Identities=7% Similarity=-0.191 Sum_probs=21.9
Q ss_pred HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 384 VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 384 ~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
.+..|+ .++..++|+|||+++|||....
T Consensus 325 eF~~Ev-e~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 325 TERLEC-ERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp CHHHHH-HHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHH-HHHhcccccchhhHHHHhcChH
Confidence 344555 4788899999999999997653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=88.02 E-value=0.26 Score=47.66 Aligned_cols=46 Identities=9% Similarity=-0.053 Sum_probs=35.7
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
+....+|+.+.+.+|+++|.+| .+.++ .|+.|+|++|++++..|..
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 97 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSS
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHH
Confidence 4466788888888888888876 57777 5888888888888877643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=87.32 E-value=0.16 Score=59.08 Aligned_cols=51 Identities=10% Similarity=0.066 Sum_probs=44.1
Q ss_pred CCCCcccccccCcccccccCccccchhh-hhccC-Cchhhhhhccc-eec-cccC
Q 004097 124 SGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGK-VAG-WISL 174 (774)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~-fsG-~Ip~ 174 (774)
+|+..++....+|+.+.+.+|+++|.+| .+.++ .|+.||+++|+ |+| .||.
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~ 293 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHH
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchH
Confidence 7777555588999999999999999998 58888 69999999998 999 8874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=87.14 E-value=0.44 Score=48.67 Aligned_cols=42 Identities=10% Similarity=0.033 Sum_probs=24.7
Q ss_pred cccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 132 LIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
...+|+.+.+.+|++++..+. +..+ .|+.|++++|++++..|
T Consensus 131 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 131 KLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 445666666666666654442 4445 46666666666665444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.87 E-value=0.26 Score=54.32 Aligned_cols=38 Identities=11% Similarity=0.011 Sum_probs=17.7
Q ss_pred ccCcccccccCccccchhh-hhccC-Cchhhhhhccceec
Q 004097 133 IGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAG 170 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG 170 (774)
..+|+.+.+.+|++++..+ .+.++ .|+.|||++|++++
T Consensus 230 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 3344444444444444433 23344 35555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=86.84 E-value=0.25 Score=45.33 Aligned_cols=39 Identities=8% Similarity=0.067 Sum_probs=20.2
Q ss_pred cccCcccccccCccccchhhhh-ccC-Cchhhhhhccceec
Q 004097 132 LIGDVESHLPCHTQMTASVYRL-RDN-SLPEFLSVIGKVAG 170 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~~l-~~l-~L~~Lnls~N~fsG 170 (774)
...+|+.+.+.+|++++.+|.. ..+ .|+.||+++|++++
T Consensus 62 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~ 102 (149)
T 2je0_A 62 KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102 (149)
T ss_dssp CCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCS
T ss_pred cCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCC
Confidence 3445555555555555555432 223 35555555555555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=86.81 E-value=0.17 Score=58.89 Aligned_cols=58 Identities=7% Similarity=-0.035 Sum_probs=37.2
Q ss_pred CcccCCCCCcccccccCcccccccCccccch-----------------hh-hhc--cC-CchhhhhhccceeccccCCCC
Q 004097 119 GYHFNSGSELGMDLIGDVESHLPCHTQMTAS-----------------VY-RLR--DN-SLPEFLSVIGKVAGWISLPGS 177 (774)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~-----------------i~-~l~--~l-~L~~Lnls~N~fsG~Ip~~~~ 177 (774)
++.+ +|.. +.-..+|+.+.+.+|+|+|. || .+. ++ .|+.|++++|+++|.||....
T Consensus 194 ~l~~-ip~~--l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 194 NITF-VSKA--VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp EEEE-ECGG--GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred CCcc-CCHH--HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 4444 5554 44567777777777777775 66 354 55 477777777777777775443
Q ss_pred CC
Q 004097 178 SQ 179 (774)
Q Consensus 178 ~~ 179 (774)
..
T Consensus 271 ~l 272 (636)
T 4eco_A 271 AL 272 (636)
T ss_dssp TC
T ss_pred cC
Confidence 33
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.72 E-value=0.47 Score=45.96 Aligned_cols=46 Identities=2% Similarity=-0.041 Sum_probs=35.4
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
+....+|+.+.+.+|++++..+ .+.++ .|+.|+|++|++++-.|..
T Consensus 50 ~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~ 97 (193)
T 2wfh_A 50 LSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRT 97 (193)
T ss_dssp GGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred hhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHH
Confidence 5567788888888888887665 47777 5888888888888866643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=86.69 E-value=0.62 Score=49.94 Aligned_cols=28 Identities=25% Similarity=0.368 Sum_probs=22.8
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.++|+|+.+.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~---~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC---LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C---EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc---EEEEEecCCC
Confidence 599999999999996543 6799998664
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=86.66 E-value=0.28 Score=51.85 Aligned_cols=42 Identities=10% Similarity=-0.100 Sum_probs=19.5
Q ss_pred cccCcccccccCccccchhhhhccC-Cchhhhhhccceecccc
Q 004097 132 LIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
...+|+.+.+.+|+++|..+.+..+ .|+.|++++|++.|.+|
T Consensus 204 ~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p 246 (328)
T 4fcg_A 204 NLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYP 246 (328)
T ss_dssp GCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCC
T ss_pred CCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhH
Confidence 3344444555555554433334444 24455555555555444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=86.63 E-value=0.36 Score=50.06 Aligned_cols=44 Identities=7% Similarity=-0.093 Sum_probs=29.4
Q ss_pred cccccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|++++..| .+..+ .|+.||+++|++++..+
T Consensus 171 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 171 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred HhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 4455677777777777777655 45555 47777777777776543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=86.56 E-value=0.18 Score=60.92 Aligned_cols=52 Identities=12% Similarity=0.066 Sum_probs=45.0
Q ss_pred CCCCCcccccccCcccccccCccccchhh-hhccC-Cchhhhhhccc-eec-cccC
Q 004097 123 NSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGK-VAG-WISL 174 (774)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~-fsG-~Ip~ 174 (774)
.+|++.++.-..+|+.+.+.+|+++|.+| .+.++ .|+.|||++|+ |+| .||.
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~ 535 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHH
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchH
Confidence 37777666688999999999999999998 58888 59999999998 999 8873
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.38 E-value=0.59 Score=46.24 Aligned_cols=53 Identities=9% Similarity=0.023 Sum_probs=40.3
Q ss_pred cccccCcccccccCccccchhhh-hccC-CchhhhhhccceeccccCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 182 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf 182 (774)
+....+|+.+.+.+|++++..+. +.++ .|+.|++++|++++.+|.......++
T Consensus 77 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 131 (220)
T 2v70_A 77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131 (220)
T ss_dssp TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTC
T ss_pred hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccC
Confidence 45677888999999999888774 7777 59999999999998777544433333
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=86.04 E-value=0.24 Score=54.77 Aligned_cols=45 Identities=9% Similarity=-0.045 Sum_probs=27.3
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL 174 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~ 174 (774)
+....+|+.+.+.+|++++..| .+.++ .|+.|++++|++++..|.
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 3345566667777777766655 35555 466666666666665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=86.03 E-value=0.51 Score=48.91 Aligned_cols=43 Identities=7% Similarity=0.041 Sum_probs=32.0
Q ss_pred cccccCcccccccCccccchhh-hhccC-Cchhhhhhccceeccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWI 172 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~I 172 (774)
++...+|+.+.+.+|++++..+ .+..+ .|+.|++++|++++..
T Consensus 120 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 164 (290)
T 1p9a_G 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (290)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred HcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccC
Confidence 5567788888888888886554 35566 5888888888888543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=85.96 E-value=0.6 Score=45.38 Aligned_cols=43 Identities=7% Similarity=-0.001 Sum_probs=27.3
Q ss_pred ccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 131 DLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
....+|+.+.+.+|++++..+. +..+ .|+.|++++|++++..+
T Consensus 97 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 97 DKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 3455667777777777765543 4555 47777777777776444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=85.73 E-value=0.55 Score=44.67 Aligned_cols=41 Identities=12% Similarity=-0.011 Sum_probs=35.4
Q ss_pred ccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 133 IGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
..+|+.+.+.+|++++..| .+.++ .|+.|||++|+|++-.+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~ 74 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPT 74 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccCh
Confidence 3789999999999999987 57788 59999999999998444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.66 E-value=0.64 Score=33.67 Aligned_cols=31 Identities=6% Similarity=0.009 Sum_probs=15.5
Q ss_pred ccchhhHHHHHHHHHHHHHHHHhhhcccccc
Q 004097 236 FRSYIQSFIVLFIALCPIIGFLFYHSKQVKS 266 (774)
Q Consensus 236 ~~i~Iv~~v~~~lvll~~i~~~~~~~~~~k~ 266 (774)
++++.+++.++++++++++.++++++++.++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 3455555555555545555455555544433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.65 E-value=0.53 Score=34.12 Aligned_cols=28 Identities=14% Similarity=-0.141 Sum_probs=13.0
Q ss_pred hhHHHHHHHHHHHHHHHHhhhcccccccc
Q 004097 240 IQSFIVLFIALCPIIGFLFYHSKQVKSKK 268 (774)
Q Consensus 240 Iv~~v~~~lvll~~i~~~~~~~~~~k~~~ 268 (774)
|++++++++++++ ++...++...|+++.
T Consensus 13 IA~gVVgGv~~~~-ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLL-VVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHH-HHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHH-HHHHHHHHHhhhhHh
Confidence 4444444333333 223666666665543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=85.38 E-value=0.59 Score=44.17 Aligned_cols=42 Identities=7% Similarity=-0.163 Sum_probs=35.9
Q ss_pred ccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccC
Q 004097 133 IGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL 174 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~ 174 (774)
..+++.+.+.+|++++..| .+.++ .|+.|||++|++++-.|.
T Consensus 29 ~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 72 (170)
T 3g39_A 29 PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAG 72 (170)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChh
Confidence 4788899999999999987 57888 599999999999975553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=85.04 E-value=0.25 Score=55.87 Aligned_cols=38 Identities=3% Similarity=-0.102 Sum_probs=18.2
Q ss_pred CcccccccCccccchhhhhccC-Cchhhhhhccceecccc
Q 004097 135 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 135 ~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+|+.+.+.+|+++ .||....+ .|+.|||++|+++|.+|
T Consensus 452 ~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~ 490 (549)
T 2z81_A 452 RLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPD 490 (549)
T ss_dssp TCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCT
T ss_pred hhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCH
Confidence 4444444455444 44443333 35555555555555444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=85.03 E-value=0.42 Score=54.76 Aligned_cols=42 Identities=7% Similarity=-0.147 Sum_probs=22.9
Q ss_pred cccCcccccccCccccchhh-hhccC-Cchhhhhhccceecccc
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
...+|+.+.+.+|++++.+| .+..+ .|+.||+++|++++.+|
T Consensus 471 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 514 (606)
T 3vq2_A 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514 (606)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEG
T ss_pred cCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCH
Confidence 44555555566666655554 24444 35555555555555554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.97 E-value=0.22 Score=59.95 Aligned_cols=41 Identities=17% Similarity=-0.033 Sum_probs=34.2
Q ss_pred cCcccccccCccccchhhhhccCCchhhhhhccceeccccCC
Q 004097 134 GDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 134 ~~~~~~~~~nN~fsG~i~~l~~l~L~~Lnls~N~fsG~Ip~~ 175 (774)
.+|+.+.+.+|+++|.+|..- ..|+.|++++|.|.+..+..
T Consensus 526 ~~L~~L~Ls~N~l~~~~~~~~-~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 526 ANLEILDISRNQLLAPNPDVF-VSLSVLDITHNKFICECELS 566 (844)
T ss_dssp SCCCEEEEEEECCCCCCSCCC-SSCCEEEEEEECCCCSSSCC
T ss_pred ccccEEECCCCcCCCCChhHh-CCcCEEEecCCCcccccccH
Confidence 789999999999999998531 16888999999999977643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=84.70 E-value=0.3 Score=50.39 Aligned_cols=39 Identities=8% Similarity=-0.012 Sum_probs=30.7
Q ss_pred ccCcccccccCccccc--hhhh-hccC-Cchhhhhhccceecc
Q 004097 133 IGDVESHLPCHTQMTA--SVYR-LRDN-SLPEFLSVIGKVAGW 171 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG--~i~~-l~~l-~L~~Lnls~N~fsG~ 171 (774)
..+|+++.|++|+++| .||. +..+ .|+.|||++|+++++
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 3467889999999998 6663 4455 588899999999986
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=84.67 E-value=0.29 Score=57.94 Aligned_cols=39 Identities=5% Similarity=-0.120 Sum_probs=15.3
Q ss_pred ccCcccccccCccccchhh-hhccC-Cchhhhhhccceeccc
Q 004097 133 IGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWI 172 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~I 172 (774)
+.+|+.+.+.+|+|+ .|| .+.++ .|+.|||++|+|+|.+
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 332 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQF 332 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHH
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCC
Confidence 333444444444443 333 23333 2444444444444433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=84.38 E-value=0.21 Score=60.29 Aligned_cols=56 Identities=7% Similarity=-0.091 Sum_probs=43.3
Q ss_pred CcccCCCCCcccccccCcccccccCccccc-----------------hhhh-hc--cC-CchhhhhhccceeccccCCCC
Q 004097 119 GYHFNSGSELGMDLIGDVESHLPCHTQMTA-----------------SVYR-LR--DN-SLPEFLSVIGKVAGWISLPGS 177 (774)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG-----------------~i~~-l~--~l-~L~~Lnls~N~fsG~Ip~~~~ 177 (774)
++.+ +|.. +.-..+|+.+.+.+|+|+| .||. +. ++ .|+.|+|++|+++|.||....
T Consensus 436 ~L~~-IP~~--l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~ 512 (876)
T 4ecn_A 436 RITF-ISKA--IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512 (876)
T ss_dssp EEEE-ECGG--GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred cccc-hhHH--HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence 4444 6655 5578899999999999999 4874 54 67 599999999999999985443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=83.93 E-value=0.74 Score=46.96 Aligned_cols=44 Identities=9% Similarity=-0.073 Sum_probs=32.6
Q ss_pred cccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|+++|..+. +..+ .|+.|++++|.|+|.+|
T Consensus 177 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 177 FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 34567888888888888887663 5666 47778888887777765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=83.65 E-value=0.37 Score=45.17 Aligned_cols=39 Identities=10% Similarity=0.037 Sum_probs=17.3
Q ss_pred ccCcccccccCccccchhhhhccC-Cchhhhhhccceeccc
Q 004097 133 IGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWI 172 (774)
Q Consensus 133 ~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~I 172 (774)
..+|+.+.+.+|++++. +.+..+ .|+.||+++|++++.+
T Consensus 48 l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~ 87 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGL 87 (168)
T ss_dssp GGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCC
T ss_pred CCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHH
Confidence 34444444444444443 333333 2444444444444433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=82.52 E-value=0.39 Score=49.49 Aligned_cols=43 Identities=5% Similarity=0.012 Sum_probs=37.1
Q ss_pred ccccCcccccccCccccc--hhhhhccCCchhhhhhccceecccc
Q 004097 131 DLIGDVESHLPCHTQMTA--SVYRLRDNSLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG--~i~~l~~l~L~~Lnls~N~fsG~Ip 173 (774)
....+|+.+.|.+|++++ .+..+..+.|+.|+|++|.++|.+|
T Consensus 193 ~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 193 QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence 367899999999999999 4666777789999999999999765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=82.46 E-value=0.91 Score=46.16 Aligned_cols=44 Identities=9% Similarity=-0.041 Sum_probs=28.5
Q ss_pred cccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|++++..+. +..+ .|+.|++++|++++..+
T Consensus 129 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 129 FDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 34556777777777777764442 5555 47777777777776444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=82.08 E-value=1 Score=43.70 Aligned_cols=42 Identities=10% Similarity=-0.092 Sum_probs=22.1
Q ss_pred ccccCcccccccCccccchhhh-hccC-Cchhhhhhccceeccc
Q 004097 131 DLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWI 172 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~I 172 (774)
....+|+.+.+.+|++++..+. +..+ .|+.|++++|.++|..
T Consensus 121 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 121 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred ccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 3455666666666666654442 4444 3555555555544444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=81.64 E-value=0.61 Score=51.83 Aligned_cols=37 Identities=14% Similarity=0.096 Sum_probs=23.4
Q ss_pred cccCcccccccCccccchhhhhccC-Cchhhhhhccceec
Q 004097 132 LIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAG 170 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG 170 (774)
...+|+.+.+.+|+|+| ++ +..+ .|+.||+++|+|+|
T Consensus 316 ~~~~L~~L~L~~N~l~~-l~-l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 316 QNPKLVYLYLNNTELTE-LD-VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TCTTCCEEECTTCCCSC-CC-CTTCTTCSEEECCSSCCCB
T ss_pred hcccCCEEECCCCcccc-cc-cccCCcCcEEECCCCCCCC
Confidence 34566667777777777 34 4455 46666666666666
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=81.51 E-value=0.28 Score=56.32 Aligned_cols=46 Identities=4% Similarity=-0.004 Sum_probs=33.2
Q ss_pred ccccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccC
Q 004097 129 GMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL 174 (774)
Q Consensus 129 ~~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~ 174 (774)
.+....+|+.+.+.+|++++..| .+..+ .|+.||+++|+++|.+|.
T Consensus 471 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 518 (606)
T 3t6q_A 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518 (606)
T ss_dssp GGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred hhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence 35566777778888888887775 46666 477888888888877763
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.50 E-value=0.61 Score=52.77 Aligned_cols=53 Identities=9% Similarity=-0.048 Sum_probs=37.6
Q ss_pred cccccCcccccccCcccc-chhh-hhccC-CchhhhhhccceeccccCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMT-ASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 182 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fs-G~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf 182 (774)
+....+|+.+.+.+|+++ |.+| .+..+ .|+.||+++|++++.+|.......++
T Consensus 441 ~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 496 (570)
T 2z63_A 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496 (570)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence 445678888888888887 6776 46666 58888888888888777544333333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=81.13 E-value=0.75 Score=54.42 Aligned_cols=42 Identities=5% Similarity=-0.034 Sum_probs=28.0
Q ss_pred cccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
-..+|+.+.+.+|+|+ .|| .+.++ .|+.|||++|+|+ .||..
T Consensus 245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~ 288 (727)
T 4b8c_D 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE 288 (727)
T ss_dssp GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS
T ss_pred CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh
Confidence 4566777777777777 665 36666 4777777777777 66644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.79 E-value=0.88 Score=47.35 Aligned_cols=44 Identities=11% Similarity=-0.068 Sum_probs=31.6
Q ss_pred cccCcccccccCccccchhh-hhccC----CchhhhhhccceeccccCCC
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN----SLPEFLSVIGKVAGWISLPG 176 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l----~L~~Lnls~N~fsG~Ip~~~ 176 (774)
...+|+.+.+.+|++++.+| .+..+ .|+.||+++|+++ .||...
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh
Confidence 34678888888888888865 34443 5888888888888 666544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=80.28 E-value=0.49 Score=53.09 Aligned_cols=56 Identities=9% Similarity=-0.058 Sum_probs=39.0
Q ss_pred cccccCcccccccCccccchhhhhccC-CchhhhhhccceeccccCCCCCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLLGPV 186 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf~GN~ 186 (774)
+....+|+.+.+.+|+++|.+| +..+ .|+.|||++|++++..+......-.+.+|.
T Consensus 54 ~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~ 110 (487)
T 3oja_A 54 LAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNN 110 (487)
T ss_dssp GTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSC
T ss_pred HhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCc
Confidence 5566788888888888888777 6666 588888888888876654333333333443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=80.25 E-value=1.6 Score=41.15 Aligned_cols=43 Identities=9% Similarity=0.004 Sum_probs=28.2
Q ss_pred ccccCcccccccCccccchhhh-hccC-Cchhhhhhccceecccc
Q 004097 131 DLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~~-l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
....+|+.+.+.+|++++..+. +..+ .|+.||+++|++++..+
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 93 (177)
T 2o6r_A 49 DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPN 93 (177)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCH
Confidence 3456677777777777755543 4555 47777777777776554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 774 | ||||
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-45
Identities = 61/300 (20%), Positives = 102/300 (34%), Gaps = 34/300 (11%)
Query: 349 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQH 398
F K + G+ G V+ VAVK L + + E++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 399 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
NIV G + +YL E C L + + F E E L E + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
L LL + G+ L +HRDL +NVL+
Sbjct: 161 LTF-----------------EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGK 201
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
K+ D G+++ + D S W APE L +G T D++S G +L+
Sbjct: 202 VVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 578 TGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ G +PY ++++ + + E + + RP N+ +
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (397), Expect = 7e-43
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 55/297 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 406
+E+ G+ G V G + A K ++ H + KEIQ + + +HP +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM-SVLRHPTLVNLHD 90
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
D + + + E + L + + E
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------------------------- 124
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+ ++ R + GL H+HE +H DLKP+N++ + +S KL D G
Sbjct: 125 -------------EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
++ L S G++ + APE D++S+G + + ++ G P+
Sbjct: 172 LTAHLDPKQSVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFG 226
Query: 585 GESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
GE+ + VK + D +LL +P+ R L HP+
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVR 403
+ + KG G V L +A+K L K + +E++ + + +HPNI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILR 70
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
YG D VYL LE F+EQ
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------------------------ 106
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+ ++ + LS+ H +IHRD+KP+N+L+ + K++D
Sbjct: 107 ---------------RTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIAD 149
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G S T G+ + PE + +DL+SLG + + + G
Sbjct: 150 FGWSVHAPSSRRT-----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
+++ + + F A DL +RLL NP RP + VL HP+
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 6e-42
Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 57/296 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 406
++I +G++GTV G+ VA++++ ++ + EI ++ +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLD 84
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
D +++ +E SL D++
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT----------------------------------- 109
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 110 ------ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 585
++ + S + T G+ W APE + + +D++SLG + I G+ PY
Sbjct: 162 FCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYL 217
Query: 586 ESFERDA---NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
A +L E + D R LD + + R A+ +L H F
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 6e-42
Identities = 71/335 (21%), Positives = 125/335 (37%), Gaps = 64/335 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVR 403
+EI GS G V VA+K++ + +KE++ + +HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQ 79
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ G + +L +E C S +DL+ V +E
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------ 115
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 116 ---------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGD 158
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 580
G + + + G+ W APE +L +G+ +D++SLG
Sbjct: 159 FGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R 210
Query: 581 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
K P A +I ++ H + L P RP ++ +L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
Query: 638 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 672
+ + + D+ R + RE D+ R ++ I
Sbjct: 271 -LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 345 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALK-----EIQNLIASD 396
L + +KE+ G+ GTV + ++VAVK L +D ALK E ++
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQL 65
Query: 397 QHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 455
+P IVR G+ + + L +E LN +
Sbjct: 66 DNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-------------------------- 98
Query: 456 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 515
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 99 --------------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ- 143
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
AK+SD G+SK L+ D + G W APE + + + D++S G +++
Sbjct: 144 -HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 576 CITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV-- 631
+ G+ PY G +++ + + P E DL + + RP V
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 632 -LNHPFF 637
L + ++
Sbjct: 263 RLRNYYY 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 60/301 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYG 406
E+ G+ G V + A K + + + EI L AS HPNIV+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL-ASCDHPNIVKLLD 76
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
++ +++ +E C +++ ++ L E
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------------------------- 110
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
Q+ V + + L++LH+ +IHRDLK N+L + D KL+D G
Sbjct: 111 -------------QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFG 155
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGG 580
+S + + + G+ W APE ++ D++SLG L
Sbjct: 156 VSAKNTRTIQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-I 211
Query: 581 KHPYGESFERDA--NIVK-DRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
+ P+ E I K + L D + L+ N D R +L HPF
Sbjct: 212 EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 637 F 637
Sbjct: 272 V 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 57/295 (19%), Positives = 112/295 (37%), Gaps = 50/295 (16%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 406
+ + +G+ G V L +VAVK + + I+ + H N+V++YG
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ + YL LE Y G +++
Sbjct: 71 HRREGNIQYLFLE----------YCSGGELFDRIEPD----------------------- 97
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
G P + +++G+ +LH IG+ HRD+KP+N+L+ + K+SD G+
Sbjct: 98 ------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGL 149
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYG 585
+ + + N G+ + APE L + +D++S G +L + G
Sbjct: 150 ATVFRYNNRERLLN-KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 586 ES--FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
S + ++ + + L + I + L ++L NP R ++ ++
Sbjct: 209 PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 54/309 (17%)
Query: 345 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 398
L++ + E+ G+ G+V V + VA+K L + +E+ ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 399 PNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
P IVR GV + L +E L+ +
Sbjct: 69 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS------------------ 109
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ ++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------------NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--H 146
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
AK+SD G+SK L D S T + G W APE + + + D++S G ++ +
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206
Query: 578 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV---L 632
+ G+ PY ++ K + P E L + + RP V +
Sbjct: 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 633 NHPFFWTAD 641
++ A
Sbjct: 267 RACYYSLAS 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 64/310 (20%)
Query: 344 GKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQ 397
G+ + F+ EI +GS TV VA L + +E + ++ Q
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQ 66
Query: 398 HPNIVRWYGV----ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 453
HPNIVR+Y + + L E + SG+ + L
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYLK------------ 104
Query: 454 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 511
+ L R I+ GL LH +IHRDLK N+ I
Sbjct: 105 -----------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 512 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571
+ + K+ D+G++ + + G+ + APE + + ++D+++ G
Sbjct: 148 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEMY-EEKYDESVDVYAFGM 200
Query: 572 ILFFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK 627
+ T ++PY E + K + PE ++ + N D R
Sbjct: 201 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 628 AQNVLNHPFF 637
+++LNH FF
Sbjct: 260 IKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 55/300 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
I GS G +G+ + K L + + E+ L+ +HPNIVR+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRY 68
Query: 405 YGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
Y D+ +Y+ +E Y G + ++ L+E
Sbjct: 69 YDRIIDRTNTTLYIVME----------YCEGGDLASVITKGTKERQYLDE---------- 108
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQNVLISKDKSF 517
+L+V + L H ++HRDLKP NV + D
Sbjct: 109 ---------------EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQ 151
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
KL D G+++ L D S G+ + +PEQ+ + D++SLGC+L+
Sbjct: 152 NVKLGDFGLARILNHDTSFAK---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 578 TGGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 636
S + A +++ K + E ++ TR+L+ RP + +L +P
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 4e-40
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 29/295 (9%)
Query: 349 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHP 399
+ ++I +G+ G V VAVK L + + Q L+A +P
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
NIV+ GV + + L E Y+ G E L + + V
Sbjct: 77 NIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHT-----VCSLSHS 121
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+ + A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVV 179
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K++D G+S+ + + W PE + R T D+++ G +L+ +
Sbjct: 180 KIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 580 GKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 632
G PY G + E V+D L E+ P E +L P RP ++
Sbjct: 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 49/289 (16%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 408
+ I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV
Sbjct: 11 LLQTIGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 409 SDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
++ +Y+ E Y+ GS + L + + ++L
Sbjct: 70 VEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVLGG--------------- 102
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 527
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++
Sbjct: 103 ----------DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLT 150
Query: 528 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GE 586
K TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 151 KEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 587 SFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ V+ + + P ++ + +RP +
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 49/295 (16%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 406
+ + G G V + VAVK L + D L E L+ QH +VR Y
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYA 75
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V + + +Y+ E Y+ +GS + L
Sbjct: 76 VVTQEP-IYIITE----------YMENGSLVDFLKTP----------------------- 101
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+LL + I G++ + E IHRDL+ N+L+ + K++D G+
Sbjct: 102 ----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGL 155
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 585
++ ++ + + W APE + G T D++S G +L +T G+ PY G
Sbjct: 156 ARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 586 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFF 637
+ ++ + ++ P E L P+ RP + + FF
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (371), Expect = 2e-39
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 55/297 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 406
+E+ G+ G V GR K + + EI ++ HP ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHD 93
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
D+ + L LE + L D I E
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------------------------- 126
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
A+++ R GL H+HE ++H D+KP+N++ K+ K+ D G
Sbjct: 127 ------------AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
++ +L D AT + APE + + D++++G + + ++ G P+
Sbjct: 175 LATKLNPDEIVKVTTATAE----FAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFA 229
Query: 585 GESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
GE VK F + PEA D LL P R + L HP+
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 50/296 (16%), Positives = 106/296 (35%), Gaps = 54/296 (18%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGV 407
+++ +G G V ++ K + D L KEI L +H NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISIL-NIARHRNILHLHES 69
Query: 408 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ + + E + + + I + E+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNER--------------------------- 102
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+++ + L LH + H D++P+N++ +S K+ + G
Sbjct: 103 ------------EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 585
+++ + + + + APE + A D++SLG +++ ++ G +P+
Sbjct: 151 ARQ----LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLA 205
Query: 586 ESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
E+ ++ + + + F E EA+D RLL R A L HP+
Sbjct: 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 49/291 (16%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 406
F KE+ G G V VA+K + + D ++E + ++ + H +V+ YG
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQLYG 66
Query: 407 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
V + Q +++ E L + + + F+ Q
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-------------------------- 100
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
QLL++ +D+ + +L +HRDL +N L+ + K+SD G
Sbjct: 101 -------------QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFG 145
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 584
+S+ + D T + W PE L+ + + D+++ G +++ + GK PY
Sbjct: 146 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 585 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 634
+ A + L+ E V + D RP + +L++
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 7e-39
Identities = 57/290 (19%), Positives = 101/290 (34%), Gaps = 47/290 (16%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYG 406
F +EI G G V L VA+K + + ++E + ++ HP +V+ YG
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYG 67
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V +Q + L E D
Sbjct: 68 VCLEQAPICLVFEFMEHGCLS--------------------------------------D 89
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+ + LL + D+ G+++L E +IHRDL +N L+ ++ K+SD G+
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGM 147
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 585
++ + D T + W +PE R + D++S G +++ + GK PY
Sbjct: 148 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 586 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
S + L+ + P+ RP +L
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 42/302 (13%)
Query: 348 VFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALK----EIQNLIAS 395
V K + +G+ G VVL + VAVK L + L E++ +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 396 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 454
+H NI+ G + +Y+ +E + +L + + +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL------------------------Q 111
Query: 455 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 514
R P +E + + S L+ + G+ +L IHRDL +NVL+++D
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 515 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
K++D G+++ + G W APE L T D++S G +L+
Sbjct: 172 --NVMKIADFGLARDIHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 575 FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 632
T G PY G E ++K+ + + E + P RP + ++
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 633 NH 634
Sbjct: 289 ED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 37/297 (12%)
Query: 349 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQH 398
F K + G+ G VV + +VAVK L + H + + E++ L H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 399 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
NIV G + + E Y G L +++DS + ++ ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITE----------YCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
E D+E LL + + G++ L IHRDL +N+L++
Sbjct: 136 EDDELALDLE----------DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RI 183
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
K+ D G+++ ++ D S W APE + T D++S G L+ +
Sbjct: 184 TKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 579 GGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 632
G PY ++K+ + EH P E D+ D +P RP + ++
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 72/338 (21%), Positives = 121/338 (35%), Gaps = 60/338 (17%)
Query: 343 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 401
I V ++ + G NG V+ A+K L A +E++ + Q P+I
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHI 67
Query: 402 VRWYGV----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 456
VR V + + + + +E L I +++ E
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTEREAS 114
Query: 457 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 515
++ + I + +LH I + HRD+KP+N+L SK
Sbjct: 115 -------------------------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149
Query: 516 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575
+ KL+D G +K S T T Y + APE L + ++ D++SLG I++
Sbjct: 150 NAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 576 CITGGKHPYGESFERDANIVKDR--------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627
+ G Y + +K R + E E L LL P R
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265
Query: 628 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKL 665
+NHP+ T++ + RV ED+E +
Sbjct: 266 ITEFMNHPWI-MQSTKVPQTPLHTSRVLKEDKERWEDV 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 61/295 (20%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 349 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 400
K I G G V + VA+K L + + + ++ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
I+R GV S + + E D
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALD--------------------------------- 97
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
K QL+ + R I +G+ +L + +HRDL +N+L+ + + K
Sbjct: 98 -----KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCK 150
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
+SD G+S+ L+ D + G W APE + + T A D++S G +++ +T G
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 581 KHPYGESFERDA-NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 633
+ PY E + + D L P A+ L + RPK ++++
Sbjct: 211 ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 5e-38
Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 51/297 (17%)
Query: 349 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 401
+ I G G V VA+K L + + ++ + ++ HPN+
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ GV + V + E D
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLR------------------------------ 119
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+
Sbjct: 120 --------QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKV 169
Query: 522 SDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
SD G+S+ L+ D S T + W APE + + T A D++S G +++ ++
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 580 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 634
G+ PY + + N ++ L P A+ L + + RPK ++N
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 64/340 (18%), Positives = 108/340 (31%), Gaps = 95/340 (27%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 406
E+ G+ G V G +A K + +I ++ P IV +YG
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ + +E ++ GS ++ L
Sbjct: 72 AFYSDGEISICME----------HMDGGSLDQVL-------------------------- 95
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMG 525
KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D G
Sbjct: 96 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFG 150
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG------ 579
+S +L M+ + G+ + +PE+L + D++S+G L G
Sbjct: 151 VSGQLIDSMAN-----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 580 -------------------------------------GKHPYGESFERDANIVKDRKDLF 602
P FE IV +
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 603 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
E D + L NP R + ++ H F +D
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 69/329 (20%), Positives = 119/329 (36%), Gaps = 53/329 (16%)
Query: 351 KEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 402
K + G+ GTV EG VA+K L + A KEI + ++AS +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
R G+ ++ L D +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVR-------------------------------- 102
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
+ S LL I G+++L + L+HRDL +NVL+ K++
Sbjct: 103 -------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKIT 153
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G++K L + G W A E +L T D++S G ++ +T G
Sbjct: 154 DFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 583 PY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640
PY G ++I++ + L + + + + D RPK + ++
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
Query: 641 DTRLSFLRDVSDRVELEDRESDSKLLRAL 669
D + + +R+ L +DS RAL
Sbjct: 273 DPQRYLVIQGDERMHLPS-PTDSNFYRAL 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 38/295 (12%)
Query: 349 FNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNI 401
F I +G+ G V ++ + A+KR+ + + E++ L HPNI
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ G + ++YL++E NLL+ +R +
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHG-----------------------NLLDFLRKSRVLET 110
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ +++ AK+
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKI 168
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581
+D G+S+ + G W A E L T D++S G +L+ ++ G
Sbjct: 169 ADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 582 HPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
PY G + + L + E DL + P RP +L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 58/303 (19%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV 402
F K + +GS TVVL R A+K L K H + +++++ HP V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 403 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 462
+ Y D + +Y L Y +G + +
Sbjct: 72 KLYFTFQDDEKLYFGLS----------YAKNGELLKYI---------------------- 99
Query: 463 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 522
K T +IVS L +LH G+IHRDLKP+N+L+++D +++
Sbjct: 100 -------RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQIT 150
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G +K + S + + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 151 DFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLP 208
Query: 583 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ------NVLNH 634
P+ E I+K D F + P+A DL +LL + R + + H
Sbjct: 209 PFRAGNEYLIFQKIIKLEYD-FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
Query: 635 PFF 637
PFF
Sbjct: 268 PFF 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 67/306 (21%)
Query: 347 VVFNKEIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHHD-VALKEIQN---LIASDQHP 399
+ + I GS GTV Y+G+ VAVK L T L+ +N ++ +H
Sbjct: 10 ITVGQRIGSGSFGTV-----YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 400 NIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
NI+ + G + + + C SL ++++ FE
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI------------------- 104
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
+L+ + R G+ +LH +IHRDLK N+ + +D
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED--LT 142
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 575
K+ D G++ ++ S Q GS W APE + + + D+++ G +L+
Sbjct: 143 VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 576 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKA 628
+T G+ PY RD +V + + L L D RP
Sbjct: 202 LMT-GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260
Query: 629 QNVLNH 634
+L
Sbjct: 261 PQILAS 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 5e-37
Identities = 73/338 (21%), Positives = 136/338 (40%), Gaps = 57/338 (16%)
Query: 349 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRW 404
F + G+ V+L E + VA+K + K + ++N ++ +HPNIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 405 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+ +YL ++ + L D I
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIV--------------------------------- 99
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLS 522
+ + ++ ++ + +LH++G++HRDLKP+N+L S D+ +S
Sbjct: 100 -------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152
Query: 523 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582
D G+SK + +T G+ G+ APE L Q ++A+D +S+G I + + G
Sbjct: 153 DFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-YP 207
Query: 583 PYGESFERD--ANIVKDRKDLF--LVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
P+ + + I+K + + I A D L++ +P+ R + L HP+
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
Query: 638 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 675
DT L S +++ + SK +A A+V
Sbjct: 268 -AGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-37
Identities = 52/297 (17%), Positives = 105/297 (35%), Gaps = 51/297 (17%)
Query: 349 FNKEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 401
FN+ I +G G V +L+ + + AVK L + + + ++ HPN+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 402 VRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
+ G+ + + L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLR--------------------------------- 117
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
+ + + L+ + G+ L +HRDL +N ++ D+ F K
Sbjct: 118 -----NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVK 170
Query: 521 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
++D G+++ + N TG W A E L + T D++S G +L+ +T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 580 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 634
G PY + D + + L E+ P+ + ++ + P ++RP +++
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-37
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 348 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPN 400
+ +K + KGS G V L E + A+K L K + + E + L + +HP
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 401 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+ + ++ ++ +E L I Q + + R
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---------------QSCHKFDLSRAT--- 106
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+I+ GL LH G+++RDLK N+L+ KD
Sbjct: 107 ----------------------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHI 142
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K++D G+ K + T G+ + APE LL + ++D +S G +L+ + G
Sbjct: 143 KIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
Query: 580 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN-VLNHPFF 637
+G+ E + ++ + EA DL +L P+ R + + HP F
Sbjct: 200 QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 49/295 (16%)
Query: 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYG 406
++ +G G V + VA+K L L+E Q ++ +H +V+ Y
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYA 79
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
V S++ +Y+ E +
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFL------------------------------------ 102
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+ QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+
Sbjct: 103 -KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGL 159
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 585
++ ++ + Q W APE L GR T D++S G +L T G+ PY G
Sbjct: 160 ARLIEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 586 ESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN--HPFF 637
+ V+ + PE++ DL + P+ RP + + +F
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (338), Expect = 8e-36
Identities = 63/310 (20%), Positives = 106/310 (34%), Gaps = 68/310 (21%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------------ALKEIQNLIASDQ 397
+ + +G + V + AVK + T LKE+ L
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 398 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
HPNI++ F +L + + G + L K L+E R
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFD----------LMKKGELFDYLTEKVT----LSEKETR- 113
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
K+ R ++ + LH++ ++HRDLKP+N+L+ D +
Sbjct: 114 ------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDDMN- 148
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFSLGC 571
KL+D G S +L G+ + APE + + +D++S G
Sbjct: 149 -IKLTDFGFSCQLDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 572 ILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPK 627
I++ + G + ++ F DL +R L P R
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263
Query: 628 AQNVLNHPFF 637
A+ L HPFF
Sbjct: 264 AEEALAHPFF 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 40/300 (13%)
Query: 349 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH 398
K + +G+ G V+ + R+VAVK L + H + E++ LI H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 399 PNIVRWYGV-ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
N+V G + + +E C + NL +R +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFC-----------------------KFGNLSTYLRSKR 113
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
+ E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--N 171
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
K+ D G+++ + D + W APE + T D++S G +L+
Sbjct: 172 VVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 578 TGGKHPYGESFERD--ANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ G PY + +K+ + ++ PE P RP ++ H
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 59/308 (19%), Positives = 114/308 (37%), Gaps = 51/308 (16%)
Query: 348 VFNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 398
++E+ +GS G V + VA+K + + E N ++
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 399 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 457
++VR GV S + +E T L + L +
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL---------- 132
Query: 458 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 517
++++++ +I G+++L+ +HRDL +N ++++D F
Sbjct: 133 --------------------SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--F 170
Query: 518 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577
K+ D G+++ + + + G W +PE L G T D++S G +L+
Sbjct: 171 TVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 578 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN-- 633
T + PY G S E+ V + L ++ P +L NP +RP +++
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 634 ----HPFF 637
P F
Sbjct: 290 KEEMEPGF 297
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 135 bits (341), Expect = 3e-35
Identities = 70/318 (22%), Positives = 115/318 (36%), Gaps = 64/318 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNI 401
+ I +G G V G+ A+K L K +AL E +L+++ P I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
V D + L+ + G L+
Sbjct: 70 VCMSYAFHTPDKLSFILD----------LMNGGDLHYHLSQHGV---------------- 103
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
A + +I+ GL H+H +++RDLKP N+L+ D+ ++
Sbjct: 104 -------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRI 148
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 580
SD+G++ + G+ G+ APE L +G + D FSLGC+LF + G
Sbjct: 149 SDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
Query: 581 KHPYGESFERDANIVK--DRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK-----AQNVL 632
+ I + + L + PE L LL + + R AQ V
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 633 NHPFFWTADTRLSFLRDV 650
PFF + D ++ FL+
Sbjct: 264 ESPFFRSLDWQMVFLQKY 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 60/300 (20%), Positives = 101/300 (33%), Gaps = 64/300 (21%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---------THHDVALKEIQNLIA-SDQHP 399
+ G G+V + VA+K + K + E+ L S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
++R D L LER + ++ + L E R
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-------------TERGALQEELAR--- 113
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
++ + H H G++HRD+K +N+LI ++
Sbjct: 114 ----------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GEL 150
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 578
KL D G L+ + G+ + PE + R R+ ++SLG +L+ +
Sbjct: 151 KLIDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 579 GGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
G P FE D I+ R +F + + E L L P RP + + NHP+
Sbjct: 206 G-DIP----FEHDEEII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-35
Identities = 57/296 (19%), Positives = 105/296 (35%), Gaps = 54/296 (18%)
Query: 349 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 401
+ I +G G V +VA+K D ++ + HP+I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 402 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
V+ GV ++ + V++ +E CT L + V S +
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL---------------------- 107
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
A L+ + + L++L +HRD+ +NVL+ + C K
Sbjct: 108 -----------------ASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVK 148
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
L D G+S+ ++ G W APE + R T A D++ G ++ + G
Sbjct: 149 LGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 581 KHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
P+ G +++ + L + + P L T+ +P RP+ +
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 2e-34
Identities = 59/299 (19%), Positives = 112/299 (37%), Gaps = 60/299 (20%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 403
+ + GS G V L + GR A+K L K + E +++ HP I+R
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVTHPFIIR 68
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
+G D +++ ++ +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLL--------------------------------- 95
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
K+ P+ ++ L +LH +I+RDLKP+N+L+ DK+ K++D
Sbjct: 96 ------RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITD 147
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G +K + T G+ + APE + ++ID +S G +++ + G
Sbjct: 148 FGFAKYVPDVTY------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 637
Y + + + + + F + DL +RL+ + R ++V NHP+F
Sbjct: 202 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 58/297 (19%), Positives = 97/297 (32%), Gaps = 55/297 (18%)
Query: 351 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPN 400
+++ GS G V + + SVAVK L D ++E+ + S H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRN 72
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++R YGV ++ SL D + G F
Sbjct: 73 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL---------------------- 110
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 520
L + + G+ +L IHRDL +N+L+ K
Sbjct: 111 -----------------GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVK 151
Query: 521 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580
+ D G+ + L + W APE L + A D + G L+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 581 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
+ P+ I K+ + L E P + ++ + P+ RP + +
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 2e-34
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 57/318 (17%)
Query: 347 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 403
+ ++ G G V +VAVK L + +V LKE ++ +HPN+V+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQ 77
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
GV + + Y+ E T E
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------------------------- 112
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
+ LL + I S + +L + IHRDL +N L+ ++ K++D
Sbjct: 113 ------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVAD 158
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G+S+ + GD A W APE L + + D+++ G +L+ T G P
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 584 Y-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWT 639
Y G + +++ + E P + +L NP RP + F
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
Query: 640 ADTRLSFLRDVSDRVELE 657
+ +SD VE E
Sbjct: 277 S--------SISDEVEKE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 59/309 (19%), Positives = 108/309 (34%), Gaps = 60/309 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA---------LKEIQNLIASDQHPN 400
+E+ G V G A K + K + +E+ L QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL-KEIQHPN 74
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
++ + V ++ V L LE S E+
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--------------------- 113
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFC 518
+ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------------------EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
K+ D G++ ++ + +G+ + APE + D++S+G I + ++
Sbjct: 156 IKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 579 GGKHPYGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 634
G G++ + V F E+ A D RLL +P R Q+ L H
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 635 PFFWTADTR 643
P+ DT+
Sbjct: 272 PWIKPKDTQ 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-33
Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 57/299 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 403
K + KG+ G V+L GR A+K L K + E + L + +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTA 69
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
D + +E
Sbjct: 70 LKYAFQTHDRLCFVMEYANG---------------------------------------G 90
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
L + + +IVS L +LH +++RD+K +N+++ DK K++D
Sbjct: 91 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITD 148
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G+ K D + + G+ + APE L RA+D + LG +++ + G
Sbjct: 149 FGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
Query: 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 637
Y + ER ++ + F PEA L LL +P R A+ V+ H FF
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-32
Identities = 58/314 (18%), Positives = 99/314 (31%), Gaps = 57/314 (18%)
Query: 342 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 399
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
I ++ D+ + +E SL DL S F +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK-------------------- 103
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFC 518
+L + ++S + ++H IHRD+KP N L+ K
Sbjct: 104 -------------------TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144
Query: 519 AKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574
+ D G++K+ + + +N G++ + + L Q+R DL SLG +L
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 575 FCITGGKHPYGESFERDANIVKDRKDLFLVEHI--------PEAVDLFTRLLDPNPDLRP 626
+ G G + + + I E D +P
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 264
Query: 627 KAQ---NVLNHPFF 637
+ + F
Sbjct: 265 DYSYLRQLFRNLFH 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/324 (17%), Positives = 116/324 (35%), Gaps = 76/324 (23%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 406
I +G+ G V N VA+K++ H + ++ +H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 466
+ + +Y+++ +
Sbjct: 74 IIRAPTIEQM----------KDVYLVTH--------------------------LMGADL 97
Query: 467 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+L K + + I+ GL ++H ++HRDLKP N+L++ K+ D G+
Sbjct: 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGL 155
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY- 584
++ D + ++APE +L + T++ID++S+GCIL ++ + +
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFP 214
Query: 585 ---------------GESFERDANIVKDRKDLFLVEHIP----------------EAVDL 613
G + D N + + K + +P +A+DL
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFF 637
++L NP R + + L HP+
Sbjct: 275 LDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 71/335 (21%), Positives = 121/335 (36%), Gaps = 82/335 (24%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
++I +G+ G V G VA+K++ A++EI L+ HPNIV+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKL 66
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V ++ +YL E L +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFM----------------------------------- 91
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ G P + ++ GL+ H ++HRDLKPQN+LI+ + KL+D
Sbjct: 92 ---DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE--GAIKLADF 146
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 583
G+++ + T + ++APE LL + + A+D++SLGCI +T +
Sbjct: 147 GLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202
Query: 584 YGESFERD--ANIVKDRKDLFLVEHI----------------------------PEAVDL 613
+ E D I + V + L
Sbjct: 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 614 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 648
+++L +P+ R A+ L HPFF + LR
Sbjct: 263 LSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-32
Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 74/329 (22%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+I +G+ G V G+ VA+K+++ + AL+EI+ L +H N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-QLLKHENVVNL 74
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ + Y + + D +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDF-------------------------------CEHDL 103
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ +++ +V + +++GL ++H ++HRD+K NVLI++D KL+D
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161
Query: 525 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 582
G+++ S + + ++ PE LL R IDL+ GCI+ T
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 583 PYGESFERDANIVKD--------------------------------RKDLFLVEHIPEA 610
G + + ++ + L P A
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639
+DL +LL +P R + + LNH FFW+
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (307), Expect = 1e-31
Identities = 61/302 (20%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 403
+ + G V L R VAVK L + +E QN A+ HP IV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-AALNHPAIVA 71
Query: 404 WYGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
Y + Y+ +E I G +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-------------------- 111
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
+ ++V D L+ H+ G+IHRD+KP N++I +
Sbjct: 112 -------------------RAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAV 150
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
K+ D GI++ + + +TQ A G++ + +PEQ D++SLGC+L+ +T
Sbjct: 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT- 209
Query: 580 GKHPYGESFERDA--NIVKD--RKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 634
G+ P+ V++ E + + + + L NP+ R + +
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 635 PF 636
Sbjct: 270 DL 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 61/327 (18%), Positives = 104/327 (31%), Gaps = 83/327 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNI 401
+ +G TV + VA+K++ H + AL+EI+ L+ HPNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNI 62
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ + + L + L +I S
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS---------------------- 100
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 521
+ + GL +LH+ ++HRDLKP N+L+ ++ KL
Sbjct: 101 -----------------HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--GVLKL 141
Query: 522 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 580
+D G++K T + ++APE L R +D++++GCIL +
Sbjct: 142 ADFGLAKSFGSPNRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 581 KHPYGESFERDANIVKDRKDLFLVEHIP----------------------------EAVD 612
G+S + + E P + +D
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFFWT 639
L L NP R A L +F
Sbjct: 259 LIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (307), Expect = 2e-31
Identities = 46/308 (14%), Positives = 93/308 (30%), Gaps = 56/308 (18%)
Query: 343 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EIQNLIASDQHPN 400
+G + I +GS G + + VA+K + L+ E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 401 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 460
I Y + L ++ SL DL+ + F +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--------------------- 101
Query: 461 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---KSF 517
+ + +++ + +HE L++RD+KP N LI + +
Sbjct: 102 ------------------TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 518 CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573
+ D G+ K + ++ + G++ + + L Q+R DL +LG +
Sbjct: 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203
Query: 574 FFCITGGKHPYGESFERDANIVKDRKDLF-------LVEHIPEAV-DLFTRLLDPNPDLR 625
+ + G G + + + L PE + D
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
Query: 626 PKAQNVLN 633
P +
Sbjct: 264 PDYDYLQG 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 83/331 (25%)
Query: 351 KEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHD-----VALKEIQNL--IASDQHPNI 401
EI +G+ G V + GR VA+KR+ + ++E+ L + + +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 402 VRWYGVESDQDF---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 458
VR + V + L+L + Y
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY---------------------------- 104
Query: 459 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 518
++ G P+ + + ++ GL LH ++HRDLKPQN+L++
Sbjct: 105 --------LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI- 155
Query: 519 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 578
KL+D G+++ M+ + + ++APE LLQ +DL+S+GCI
Sbjct: 156 -KLADFGLARIYSFQMALTSV----VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210
Query: 579 GGKHPY--------------------------GESFERDANIVKDRKDL--FLVEHIPEA 610
K + + R A K + + F+ +
Sbjct: 211 -RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 611 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
DL + L NP R A + L+HP+F +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-30
Identities = 76/353 (21%), Positives = 124/353 (35%), Gaps = 81/353 (22%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 407
K I GS G V + G VA+K++++ +E+Q ++ H NIVR
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ-IMRKLDHCNIVRLRYFFY 83
Query: 408 --ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
+D VYL+L S +Q L + ++
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPVIYVK--------- 125
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+ L+++H G+ HRD+KPQN+L+ D + KL D G
Sbjct: 126 ----------------LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFG 168
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 584
+K+L ++ + Y ++APE + T +ID++S GC+L + G+ +
Sbjct: 169 SAKQLVRGEPNVSYICSRY----YRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIF 223
Query: 585 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 614
D I+K +F PEA+ L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF---WTADTRLSFLRDVSDRVELEDRESDSK 664
+RLL+ P R H FF + +L RD +E S
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 57/328 (17%), Positives = 104/328 (31%), Gaps = 77/328 (23%)
Query: 343 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNI 401
I + +V + I KG G V G + G VAVK +E + +H NI
Sbjct: 1 IARTIVLQESIGKGRFGEVWR-GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 402 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 461
+ + ++ + + L + Y GS + LN
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRY------------------ 95
Query: 462 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI--------GLIHRDLKPQNVLISK 513
++K+ SGL+HLH + HRDLK +N+L+
Sbjct: 96 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 141
Query: 514 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLL------QGRQTRAIDL 566
K+ ++D+G++ R + G+ + APE L + D+
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 567 FSLGCILFFCITG---------GKHPYGESFERDANIVKDRK-------------DLFLV 604
+++G + + + PY + D ++ + RK
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 605 EHIPEAVDLFTRLLDPNPDLRPKAQNVL 632
E + + N R A +
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (294), Expect = 8e-30
Identities = 63/323 (19%), Positives = 122/323 (37%), Gaps = 82/323 (25%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 405
++I +G+ G V N G + A+K++ D ++EI ++ +H NIV+ Y
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLY 66
Query: 406 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 465
V + + L E L L+ V G E
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-------------------------- 100
Query: 466 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 525
+++G+++ H+ ++HRDLKPQN+LI+++ K++D G
Sbjct: 101 -------------TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFG 145
Query: 526 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPY 584
+++ + + + ++AP+ L+ + + ID++S+GCI + G +
Sbjct: 146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLF 201
Query: 585 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 614
E D I + + FL +DL
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF 637
+++L +P+ R A+ L H +F
Sbjct: 262 SKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 66/323 (20%), Positives = 105/323 (32%), Gaps = 80/323 (24%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
++I +G+ GTV + VA+KR+ D AL+EI L +H NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL-KELKHKNIVRL 66
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
+ V + L E C L +G + +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE------------------------- 101
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ ++ GL H ++HRDLKPQN+LI+++ KL++
Sbjct: 102 --------------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANF 145
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
G+++ + C + + +ID++S GCI G+ +
Sbjct: 146 GLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 585 ----------------GESFERDANIVKDRKDLFLVEHIP--------------EAVDLF 614
G E + D P DL
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 615 TRLLDPNPDLRPKAQNVLNHPFF 637
LL NP R A+ L HP+F
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYF 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 4e-29
Identities = 59/330 (17%), Positives = 103/330 (31%), Gaps = 83/330 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 409
+++ +G V V VK L +EI+ L PNI+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100
Query: 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 469
D +L + D + L + IR
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT---------------LTDYDIR------------- 132
Query: 470 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 529
+I+ L + H +G++HRD+KP NV+I + +L D G+++
Sbjct: 133 ------------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL-RLIDWGLAEF 179
Query: 530 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 589
+ A+ Y + ++D++SLGC+L I + +
Sbjct: 180 YHPGQEYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 590 RD--ANIVKDRKDLFLVEHI------------------------------------PEAV 611
D I K L ++I PEA+
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 641
D +LL + R A+ + HP+F+T
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-29
Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 63/308 (20%)
Query: 351 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHP 399
K + G+ G V L G+ G+ A+K L K + E Q L Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 400 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 459
+V + + ++L L+
Sbjct: 90 FLVTLHYAFQTETKLHLILDYI-------------------------------------- 111
Query: 460 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 519
L + ++ +IV L HLH++G+I+RD+K +N+L+ +
Sbjct: 112 -NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHV 168
Query: 520 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579
L+D G+SK D + + G + +A+D +SLG +++ +T
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT- 227
Query: 580 GKHPYGESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPK-----AQ 629
G P+ E+++ R+ L P A DL RLL +P R A
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 630 NVLNHPFF 637
+ H FF
Sbjct: 288 EIKEHLFF 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 9e-28
Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 84/326 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ + G+ G V G VA+K+L + A +E++ L+ +H N++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 82
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + + + + L+ G+ +
Sbjct: 83 LDVFTPDETLDDFTDFY------LVMPFMGTDLGK------------------------- 111
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
L K ++ + ++ GL ++H G+IHRDLKP N+ +++D K+ D
Sbjct: 112 ----LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDF 165
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHP 583
G++++ +M+ + ++APE +L R T+ +D++S+GCI+ IT GK
Sbjct: 166 GLARQADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTL 218
Query: 584 YGESFERDA--------------------------------NIVKDRKDLFLVEHIPEAV 611
+ S D + K L P AV
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 612 DLFTRLLDPNPDLRPKAQNVLNHPFF 637
+L ++L + + R A L HP+F
Sbjct: 279 NLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 1e-27
Identities = 63/312 (20%), Positives = 110/312 (35%), Gaps = 60/312 (19%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 403
K + GS G V+L + G A+K L K + L E + ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVK 105
Query: 404 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 463
D +Y+ +E
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG---------------------------------------G 126
Query: 464 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 523
L + IV +LH + LI+RDLKP+N+LI + ++D
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ--VTD 184
Query: 524 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583
G +KR++G T G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTW------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 584 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFW 638
+ + + + K F + DL LL + +L+ ++ NH +F
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 639 TADTRLSFLRDV 650
T D + R V
Sbjct: 299 TTDWIAIYQRKV 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 57/325 (17%), Positives = 110/325 (33%), Gaps = 82/325 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 404
+ G+ G+V G VAVK+L + + +E++ L+ +H N++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 82
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + + + L+ +
Sbjct: 83 LDVFTPARSLE-----------------------------------EFNDVYLVTHLMGA 107
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
+ K + + I+ GL ++H +IHRDLKP N+ + ++ K+ D
Sbjct: 108 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDF 165
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 583
G+++ +M+ + ++APE +L + +D++S+GCI+ +TG
Sbjct: 166 GLARHTDDEMT------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 584 YGESFERDANIVKDRKDLFLVEHI-------------------------------PEAVD 612
G ++ E + P AVD
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 613 LFTRLLDPNPDLRPKAQNVLNHPFF 637
L ++L + D R A L H +F
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 3e-22
Identities = 61/370 (16%), Positives = 119/370 (32%), Gaps = 95/370 (25%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 404
K I G+ G V R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 81
Query: 405 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 464
V + Q + + + ++ + + +
Sbjct: 82 LNVFTPQKTLEEFQDVYLV-----MELMDANLCQVIQ----------------------- 113
Query: 465 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 524
++ + ++ G+ HLH G+IHRDLKP N+++ D + +
Sbjct: 114 --------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 525 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 584
+ M+ + ++APE +L +D++S+GCI+ + K +
Sbjct: 166 ARTAGTSFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILF 218
Query: 585 GESFERD---------------------------------------ANIVKDRKDLFLVE 605
D + D E
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 606 HI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--WTADTRLSFLRDVSDRVELEDR 659
H +A DL +++L +P R + L HP+ W + +L++R
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
Query: 660 ESDSKLLRAL 669
E + + L
Sbjct: 339 EHTIEEWKEL 348
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.7 bits (234), Expect = 2e-21
Identities = 56/340 (16%), Positives = 111/340 (32%), Gaps = 80/340 (23%)
Query: 351 KEIAKGSNGTVVL-EGNYEGRSVAVKRL--VKTHHDVALKEIQNLIASDQHPNIVRWYGV 407
+++ G TV L + VA+K + K + + A EI+ L+ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSM 77
Query: 408 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 467
++ L + N ++ V + + I
Sbjct: 78 GANHILKLLDHFN-----------------------HKGPNGVHVVMVFEVLGENLLALI 114
Query: 468 ELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 526
+ ++ G P + ++++ ++ GL ++H G+IH D+KP+NVL+ L + I
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKI 173
Query: 527 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-- 584
+ + +++PE LL D++S C++F ITG +
Sbjct: 174 ADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEP 231
Query: 585 --------------------GESFERDANIVKDRKDLFLVEHI----------------- 607
GE K + F +
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 608 ----------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637
E D + +L +P R A ++NHP+
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.2 bits (127), Expect = 1e-08
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 33/185 (17%)
Query: 351 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 410
K + +G V + + VK V+ D
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKV---------------GHTSFKKVKEKRDYGD 50
Query: 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 470
F L++ L + + + + N + +ME EL+
Sbjct: 51 LHFSVLAIRSARNEFRALQKLQGLAVPKVY---AWEGNAV---------LMELIDAKELY 98
Query: 471 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 530
+ ++L I+ ++ + G++H DL NVL+S+ + D S +
Sbjct: 99 RVRVENPDEVL---DMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVEV 152
Query: 531 QGDMS 535
+
Sbjct: 153 GEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.59 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 94.52 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 93.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 92.15 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 91.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 87.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 87.61 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 86.42 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 81.86 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 81.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 80.62 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=418.03 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=201.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+ .+++.++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHH-HHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 3588899999999999999865 568999999986421 22344565 478899999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||+ +|+|.+++. +...+++..++.|+.||+.||+|||+.
T Consensus 85 mEy~~----------~g~L~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~al~~lH~~ 125 (263)
T d2j4za1 85 LEYAP----------LGTVYRELQ-----------------------------KLSKFDEQRTATYITELANALSYCHSK 125 (263)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecC----------CCcHHHHHh-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99665 444444332 123478888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+|+..... ......||+.|||||++.+..++.++|||||||++|||+
T Consensus 126 ~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 126 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CeeeeeeccccceecCCCC--EeecccceeeecCCC-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence 9999999999999988876 899999999876532 223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 578 TGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 578 tg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+| .+||...... ....+.......+...++++.+||.+||+.||++|||++|+|+||||..
T Consensus 199 ~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 199 VG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred cC-CCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 97 7788654433 3333334444455567889999999999999999999999999999953
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=422.41 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=198.6
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++..... +...+|+. +++.++|||||++++++.+++..|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-INKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHH-HHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4688899999999999999864 5799999999865432 23456664 7889999999999999999999999999
Q ss_pred ccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 420 RCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 420 ~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||.+ +|.+++ . +...+++..++.|+.||+.||+|||+.|
T Consensus 84 y~~gg~L~~~l-----------~-----------------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~ 123 (271)
T d1nvra_ 84 YCSGGELFDRI-----------E-----------------------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG 123 (271)
T ss_dssp CCTTEEGGGGS-----------B-----------------------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCcHHHHH-----------h-----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 7663 554443 1 1234788889999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||+|+....... .......+||+.|||||++.+..+ +.++|||||||++|||+
T Consensus 124 IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (271)
T d1nvra_ 124 ITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200 (271)
T ss_dssp EECSCCCGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred CccCcccHHHEEECCCCC--EEEccchhheeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH
Confidence 999999999999988775 89999999987753321 122345679999999999988776 67899999999999999
Q ss_pred hCCCCCCCCchHHHH---HHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 578 TGGKHPYGESFERDA---NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~---~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+| .+||........ ...... ........++++.+||.+||+.||++|||++|+++||||..
T Consensus 201 ~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 201 AG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HS-SCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred hC-CCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 97 778865433221 111111 11223455789999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=420.99 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=200.9
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||+||+|. ..+|+.||||++.... .+...+|+. +++.++|||||++++++.+.+.+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHH-HHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357777899999999999985 4679999999986432 234566765 77889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++ ..+++++.+++.|+.||+.||+|||++||+
T Consensus 99 ~~----------gg~L~~~~------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ii 138 (293)
T d1yhwa1 99 LA----------GGSLTDVV------------------------------TETCMDEGQIAAVCRECLQALEFLHSNQVI 138 (293)
T ss_dssp CT----------TCBHHHHH------------------------------HHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cC----------CCcHHHHh------------------------------hccCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 65 44444332 123578888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+|||++.++. +||+|||+|+.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 139 HrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG- 212 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG- 212 (293)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS-
T ss_pred ccCCcHHHeEECCCCc--Eeeccchhheeecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhC-
Confidence 9999999999988876 8999999999875432 223456799999999999999999999999999999999997
Q ss_pred CCCCCCchHHH--HHHHhhcc--ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 581 KHPYGESFERD--ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 581 ~~Pf~~~~~~~--~~~~~~~~--~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
.+||....... ..+..... ...+...++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 77886544322 22222221 1234456789999999999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=413.67 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=189.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESD--QDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~L 416 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+. ++..++|||||++++++.+ ++.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHH-HTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHH-HHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4588899999999999999854 57999999999654321 2345554 7788999999999999865 466899
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|+|.+++.... .....+++..++.|+.||+.||+|||+
T Consensus 83 vmEy~~----------~g~L~~~i~~~~-------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 83 VMEYCE----------GGDLASVITKGT-------------------------KERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EEECCT----------TEEHHHHHHHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCC----------CCcHHHHHHhcc-------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999665 444444443221 123458889999999999999999999
Q ss_pred cC-----ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 497 IG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 497 ~~-----ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
.+ |+||||||+|||++.++. +||+|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||
T Consensus 128 ~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 202 (269)
T d2java1 128 RSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202 (269)
T ss_dssp HCC---------CCGGGEEECTTSC--EEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred hcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCH
Confidence 76 999999999999988875 8999999999876432 2234567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCC
Q 004097 572 ILFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 637 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff 637 (774)
++|||+|| .+||......+ . .+........+...++++.+||.+||+.||.+|||++|+++|||.
T Consensus 203 ilyel~tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 203 LLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHhhC-CCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999997 77886544332 2 333333334455678899999999999999999999999999994
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=409.74 Aligned_cols=246 Identities=28% Similarity=0.386 Sum_probs=192.3
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC----Cce
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDF 413 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~ 413 (774)
++.+.+.++||+|+||+||+|.. .+++.||||++..... ....+|+. +++.++|||||++++++.+ ++.
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeccccCCE
Confidence 45568889999999999999854 4688999999865431 12345554 7889999999999999864 466
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|||||+ +|+|.+++.. ...+++..++.|+.||+.||+|
T Consensus 87 ~~ivmE~~~----------~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 87 IVLVTELMT----------SGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp EEEEEECCC----------SCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCC----------CCcHHHHHhc-----------------------------cccccHHHHHHHHHHHHHHHHH
Confidence 899999665 4444444321 2347788889999999999999
Q ss_pred HHHcC--ccccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 494 LHEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 494 LH~~~--ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
||+++ |+||||||+|||++. ++. +||+|||+|+..... ...+.+||+.|||||++.+ .++.++||||||
T Consensus 128 LH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlG 199 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceeccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHH
Confidence 99998 999999999999964 444 899999999865432 2345679999999999865 699999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH--HHHHHh-hcc-ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCC
Q 004097 571 CILFFCITGGKHPYGESFER--DANIVK-DRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 638 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~--~~~~~~-~~~-~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~ 638 (774)
|++|||++| ++||.+.... ....+. ... .......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 200 vilyel~~g-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 200 MCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHC-CCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999997 7788653322 222222 222 223445678999999999999999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=414.71 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=201.0
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+. +++.++|||||++++++.+++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHH-HHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 4588999999999999999864 579999999986421 123455664 77889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++. ..+.+++..++.++.|++.||+|||+.
T Consensus 87 mEy~~----------gg~L~~~~~-----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~~ 127 (288)
T d1uu3a_ 87 LSYAK----------NGELLKYIR-----------------------------KIGSFDETCTRFYTAEIVSALEYLHGK 127 (288)
T ss_dssp ECCCT----------TEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEccC----------CCCHHHhhh-----------------------------ccCCCCHHHHHHHHHHHHHHHHhhccc
Confidence 99665 344443322 224578888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+|+.+..... .....+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 128 ~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 128 GIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp TEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred cEEcCcCCccccccCCCce--EEecccccceecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence 9999999999999988876 89999999987753321 12234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHH------HHcCCCCCCccc
Q 004097 578 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN------VLNHPFFWTADT 642 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~e------lL~HPff~~~~~ 642 (774)
+| .+||....... ...+......++...++++++||.+||+.||.+|||++| +++||||.+.++
T Consensus 205 ~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 205 AG-LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp HS-SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred hC-CCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 97 77886544332 222333333455667899999999999999999999988 588999976543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=413.95 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=199.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+. +++.++|||||++++++.+.+.+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3578889999999999999854 5789999999965432 34566775 67889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++.. ..+++++.+++.|+.||+.||+|||+++|+
T Consensus 91 ~~----------~g~L~~~~~~----------------------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 91 CA----------GGAVDAVMLE----------------------------LERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp CT----------TEEHHHHHHH----------------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCcHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 65 4444443321 123578888999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhh-----cCCCCCcchhHhHHHHHHH
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSlGvll~e 575 (774)
||||||+|||++.++. +||+|||+|+..... .....+..||+.|||||++. ...|+.++|||||||++||
T Consensus 133 HrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 133 HRDLKAGNILFTLDGD--IKLADFGVSAKNTRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp CCCCSGGGEEECTTSC--EEECCCTTCEECHHH---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred EeecChhheeECCCCC--EEEEechhhhccCCC---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 9999999999988876 899999999765432 12234567999999999984 4568899999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHHHhhccc--cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 576 CITGGKHPYGESFERD--ANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~--~~~~~~~~~--~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|++| .+||....... ..+...... ..+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 208 mltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 208 MAEI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHS-SCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HhhC-CCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9997 77886543322 233333221 2234567899999999999999999999999999999643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=416.66 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=206.6
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+. ......+|+. +++.++|||||++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHH-HHHhCCCCCEEEEEeeeccccccccc
Confidence 4588899999999999999854 67999999999643 2234456654 78899999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++. +.+.+++..++.++.||+.||+|||++
T Consensus 84 ~ey~~----------gg~L~~~~~-----------------------------~~~~~~e~~~~~~~~qil~al~ylH~~ 124 (337)
T d1o6la_ 84 MEYAN----------GGELFFHLS-----------------------------RERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeccC----------CCchhhhhh-----------------------------cccCCcHHHHHHHHHHHhhhhhhhhhc
Confidence 99554 455554432 234578888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
||+||||||+|||++.++. +||+|||+|+...... ....+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 125 ~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CccccccCHHHeEecCCCC--EEEeecccccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 9999999999999988876 8999999998765322 2234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccc
Q 004097 578 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 642 (774)
Q Consensus 578 tg~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~ 642 (774)
+| .+||... .......+......++...++++++||.+||+.||.+|++ ++|+++||||...++
T Consensus 200 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 200 CG-RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HC-CCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 97 6666544 3333344444445566678899999999999999999994 899999999977544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=409.68 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=203.1
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCCeeEEeeeccCC
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQ 411 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 411 (774)
.+.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .+...+|+. +++.++|||||++++++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEEC
Confidence 3567799999999999999999864 579999999996432 123456765 77889999999999999999
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+.+|||||||. +|+|.+++. ....+++..++.++.||+.||
T Consensus 86 ~~~~iv~E~~~----------gg~L~~~i~-----------------------------~~~~l~~~~~~~~~~qi~~al 126 (293)
T d1jksa_ 86 TDVILILELVA----------GGELFDFLA-----------------------------EKESLTEEEATEFLKQILNGV 126 (293)
T ss_dssp SEEEEEEECCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEcCC----------Cccccchhc-----------------------------cccccchhHHHHHHHHHHHHH
Confidence 99999999665 344444332 123578888999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCC--ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
+|||+.+|+||||||+|||++.++. ..+||+|||+++..... ....+..||+.|+|||++.+..++.++|||||
T Consensus 127 ~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSl 202 (293)
T d1jksa_ 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202 (293)
T ss_dssp HHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC----ccccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence 9999999999999999999987653 35899999999877543 22345679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCccc
Q 004097 570 GCILFFCITGGKHPYGESFERD-A-NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 642 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~-~-~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~~~ 642 (774)
||++|||++| .+||....... . .+...... ......++++++||++||+.||++|||++|+++||||+..+.
T Consensus 203 Gvilyell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 203 GVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred hHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 9999999997 77776543332 2 22222211 123456789999999999999999999999999999976443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=422.58 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=194.1
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||++.. .+|+.||||+++.... ....+|+. +++.++|||||+++++|.+.+.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGG-GGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45688899999999999999864 5789999999965432 23456665 778899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc-
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 497 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 497 (774)
|||. +|+|.+++. +...+++..++.++.||+.||+|||+.
T Consensus 84 Ey~~----------gg~L~~~l~-----------------------------~~~~l~~~~~~~~~~qil~aL~yLH~~~ 124 (322)
T d1s9ja_ 84 EHMD----------GGSLDQVLK-----------------------------KAGRIPEQILGKVSIAVIKGLTYLREKH 124 (322)
T ss_dssp ECCT----------TEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCC----------CCcHHHHHh-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 9665 444444332 123477888999999999999999975
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+|+..... ...+.+||+.|+|||++.+..|+.++||||+||++|||+
T Consensus 125 ~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 125 KIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred CEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999988876 899999999876532 234568999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHHHH--------------------------------------------Hhhcc-ccccccCCHHHHH
Q 004097 578 TGGKHPYGESFERDANI--------------------------------------------VKDRK-DLFLVEHIPEAVD 612 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~~~--------------------------------------------~~~~~-~~~~~~~~~~~~d 612 (774)
+| ++||.......... ..... .......++++.|
T Consensus 198 ~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 198 VG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HS-SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HC-CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHH
Confidence 97 77774322111000 00000 0011123578999
Q ss_pred HHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 613 LFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 613 li~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||.+||+.||.+|||++|+|+||||..
T Consensus 277 li~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 999999999999999999999999954
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=415.50 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=188.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. +++.++|||||++++++.+++.+||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA-VLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3456699999999999999999854 4689999999975432 22345664 7789999999999999999999999
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
|||||+ ++|.+++. ....+++..+..|+.||+.||+|||
T Consensus 85 vmE~~~gg~L~~~l~----------------------------------------~~~~l~e~~~~~~~~qi~~al~ylH 124 (307)
T d1a06a_ 85 IMQLVSGGELFDRIV----------------------------------------EKGFYTERDASRLIFQVLDAVKYLH 124 (307)
T ss_dssp EECCCCSCBHHHHHH----------------------------------------TCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEeccCCCcHHHhhh----------------------------------------cccCCCHHHHHHHHHHHHHHHHhhh
Confidence 999776 35555441 1235788899999999999999999
Q ss_pred HcCccccccCCCCeeecC-CCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||+.. +....+||+|||+|+..... ....+.+||+.|||||++.+..|+.++|||||||++|
T Consensus 125 ~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred hceeeeEEecccceeecccCCCceEEEeccceeEEccCC----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHH
Confidence 999999999999999964 22235899999999876532 2234567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH--HHHHhhcccc---ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 575 FCITGGKHPYGESFERD--ANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~--~~~~~~~~~~---~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||++| .+||....... ..+....... .....++++.+||.+||+.||++|||++|+++||||..
T Consensus 201 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 201 ILLCG-YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHS-SCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99997 77886644332 2333332221 22356789999999999999999999999999999965
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-47 Score=411.28 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=202.5
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC-----Cc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~-----~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+. .. ....+|+ .+++.++|||||++++++.+.+.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-LMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHH-HHHHhccCcChhheeeeEeeCCeeeeE
Confidence 3588899999999999999864 57999999998642 11 2334454 588999999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.+ |++...+. ....+++..++.++.||+.||+|||++
T Consensus 83 mE~~~g----------g~l~~~~~-----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~ 123 (316)
T d1fota_ 83 MDYIEG----------GELFSLLR-----------------------------KSQRFPNPVAKFYAAEVCLALEYLHSK 123 (316)
T ss_dssp ECCCCS----------CBHHHHHH-----------------------------HTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeecCC----------cccccccc-----------------------------ccccccccHHHHHHHHHHHhhhhhccC
Confidence 996653 34433322 123456677889999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 124 ~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml 195 (316)
T d1fota_ 124 DIIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195 (316)
T ss_dssp TEECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred cEEccccCchheeEcCCCC--EEEecCccceEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHH
Confidence 9999999999999988775 899999999876532 23567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
+| .+||...... ....+.......+...++++.++|.+||+.||.+|+ |++++++||||.+..+.
T Consensus 196 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 196 AG-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HS-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hC-CCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 97 7788654433 223333334445566788999999999999999996 89999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-48 Score=413.64 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=196.1
Q ss_pred ceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|...+.||+|+||+||+|. ..+|+.||||++..... ....+|+. ++..++|||||++++++.+++..|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHH-HHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 458888999999999999985 46789999999975432 12445665 77889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||.+++ +..++ ....++++..++.|+.||+.||+|||++
T Consensus 94 ~E~~~~g~----------l~~~~-----------------------------~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 94 MEYCLGSA----------SDLLE-----------------------------VHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp EECCSEEH----------HHHHH-----------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCCCc----------hHHHH-----------------------------HhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99776432 22211 1224578889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll~ 574 (774)
||+||||||+|||++.++. +||+|||+|+.... .....||+.|||||++.+ ..|+.++|||||||++|
T Consensus 135 ~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvily 205 (309)
T d1u5ra_ 135 NMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205 (309)
T ss_dssp TCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHH
T ss_pred CEeccCCCcceEEECCCCC--EEEeecccccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHH
Confidence 9999999999999987764 89999999986543 234579999999999864 45899999999999999
Q ss_pred HHHhCCCCCCCCchHHH--HHHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 575 FCITGGKHPYGESFERD--ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~--~~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||++| .+||.+..... ..+...... ......++++.+||.+||+.||.+|||++|+|+||||..
T Consensus 206 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 206 ELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 99997 66776543332 233333322 223345789999999999999999999999999999954
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-47 Score=417.34 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=201.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
++|.+.+.||+|+||+||+|.. .+|+.||||++...... ...+|+. ++..++|||||++++++.+++.+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHH-HHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4688999999999999999854 57999999999765432 2345664 77889999999999999999999999996
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|. +|+|.+++.. ....+++..++.|+.||+.||+|||++||+
T Consensus 105 ~~----------gg~L~~~l~~----------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii 146 (350)
T d1koaa2 105 MS----------GGELFEKVAD----------------------------EHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146 (350)
T ss_dssp CC----------SCBHHHHHTC----------------------------TTSCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCCHHHHHHh----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence 55 4454444321 123478889999999999999999999999
Q ss_pred ccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCC
Q 004097 501 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 501 HrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~ 580 (774)
||||||+|||++.+....+||+|||+++.+.... ...+..||+.|||||++.+..++.++|||||||++|||++|
T Consensus 147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G- 221 (350)
T d1koaa2 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG- 221 (350)
T ss_dssp CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS-
T ss_pred eeeechhHeeeccCCCCeEEEeecchheeccccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC-
Confidence 9999999999976544469999999998776432 23446799999999999999999999999999999999997
Q ss_pred CCCCCCchHH-HH-HHHhhcc---ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 581 KHPYGESFER-DA-NIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 581 ~~Pf~~~~~~-~~-~~~~~~~---~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||...... .. .+..... .......++++++||.+||+.||++|||++|+|+||||...
T Consensus 222 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 7788654332 22 2222221 11223467899999999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=412.00 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=205.1
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++.+. .......|+..+...++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 3588899999999999999854 47999999999642 2234566776666789999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.+++.. ...+++.+++.++.||+.||+|||++
T Consensus 82 mEy~~----------~g~L~~~i~~-----------------------------~~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 82 MEYLN----------GGDLMYHIQS-----------------------------CHKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp EECCT----------TCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecC----------CCcHHHHhhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99554 4555554422 23467888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 123 ~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml 197 (320)
T d1xjda_ 123 GIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197 (320)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CeeeccCcccceeecCCCc--eeccccchhhhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH
Confidence 9999999999999988776 8999999998765332 2223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCchH-HHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHH-HHHcCCCCCCcc
Q 004097 578 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 641 (774)
Q Consensus 578 tg~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~-elL~HPff~~~~ 641 (774)
+| ++||..... .....+.......+...++++.+||.+||+.||.+|||+. |+++||||++.+
T Consensus 198 tG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 198 IG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 97 777765433 3333344444455566789999999999999999999996 899999997643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.28 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=201.0
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||+||+|...+++.||||++.... .+...+|+. ++..++|||||+++|++.+ +..|+|||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~- 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYAVVTQ-EPIYIITEYM- 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEECC-
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHH-HHHhCCCCCEeEEEeeecc-CCeEEEEEeC-
Confidence 5688899999999999999988788899999997543 234556665 7788899999999998865 5679999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
++|+|.+++... ....+++..+++|+.||+.||+|||+.+|+||
T Consensus 90 ---------~~g~L~~~~~~~---------------------------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHr 133 (272)
T d1qpca_ 90 ---------ENGSLVDFLKTP---------------------------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133 (272)
T ss_dssp ---------TTCBHHHHTTSH---------------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ---------CCCcHHHHHhhc---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 455555543321 12347888999999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||||+.++. +||+|||+|+.+..... .......||+.|||||++....++.++|||||||++|||+||+.+
T Consensus 134 DiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 134 DLRAANILVSDTLS--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp CCSGGGEEECTTSC--EEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccchhheeeecccc--eeeccccceEEccCCcc--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCC
Confidence 99999999987765 89999999998764322 223345689999999999999999999999999999999998788
Q ss_pred CCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc--CCCCC
Q 004097 583 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFW 638 (774)
Q Consensus 583 Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~--HPff~ 638 (774)
|+....... ..+........+...++++.+||.+||+.||++|||++|+++ |+||.
T Consensus 210 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 210 PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 876654332 233333333445566789999999999999999999999987 77773
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-47 Score=414.56 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=202.2
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
-+.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+++.+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999999864 5799999999976543 23345664 7788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||+ +|+|.+.+.. ....+++.+++.|+.||+.||+|||+.||
T Consensus 107 ~~~----------gg~L~~~~~~----------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~i 148 (352)
T d1koba_ 107 FLS----------GGELFDRIAA----------------------------EDYKMSEAEVINYMRQACEGLKHMHEHSI 148 (352)
T ss_dssp CCC----------CCBHHHHTTC----------------------------TTCCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCC----------CChHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 665 4444443221 12347888999999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++......+||+|||+|+.+.... ...+..||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 149 iHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eecccccccccccccCCCeEEEeecccceecCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence 99999999999974433459999999998876432 23445799999999999999999999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHhhcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 580 GKHPYGESFERD-ANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~~~~~~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
.+||....... ...+...... .....++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 225 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 225 -LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 77886544332 2222222211 223467899999999999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=398.34 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=189.7
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||+||+|...+++.||||++..... +...+|+. ++..++|||||+++|+|.+++..|+|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~- 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYGVCLEQAPICLVFEFM- 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEECC-
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHH-HHHhcCCCCcccccceeccCCceEEEEEec-
Confidence 45788999999999999999888888999999975432 34456664 778899999999999999999999999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.+++... ...+++..++.|+.|||.||+|||+.+|+||
T Consensus 83 ---------~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr 125 (263)
T d1sm2a_ 83 ---------EHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125 (263)
T ss_dssp ---------TTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred ---------CCCcHHHHhhcc----------------------------ccCCCHHHHHHHHHHHHHHHHhhhccceeec
Confidence 455555544321 1346778889999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.+
T Consensus 126 DlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 126 DLAARNCLVGENQV--IKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp TCSGGGEEECGGGC--EEECSCC--------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchhheeecCCCC--eEecccchheeccCCCc--eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC
Confidence 99999999987764 99999999987754322 122335689999999999999999999999999999999998788
Q ss_pred CCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 583 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 583 Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||....... . .+........+...++++.++|.+||+.||++|||++|+++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 887654332 2 233333333445567899999999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-47 Score=412.61 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=204.8
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++|||||++++++.+.+..|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHH-HHHHcCCCcEeecccccccccccccc
Confidence 4688899999999999999854 579999999986421 234556765 77889999999999999999999999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||+|. +|++..++. +...+++..++.|+.||+.||+|||++
T Consensus 120 ~e~~~----------~g~l~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~aL~yLH~~ 160 (350)
T d1rdqe_ 120 MEYVA----------GGEMFSHLR-----------------------------RIGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccc----------ccchhhhHh-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99554 455544432 224578889999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+||||||||+|||++.++. +||+|||+|+.+... ..+..||+.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp TEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEecCcCCHHHcccCCCCC--EEeeeceeeeecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 9999999999999988875 899999999987532 23457999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHH-HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCccch
Q 004097 578 TGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 643 (774)
Q Consensus 578 tg~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~~~~ 643 (774)
|| .+||...... ....+.......+...++++.+||.+||+.||.+|+ |++++++||||.+.++.
T Consensus 233 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 233 AG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hC-CCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 97 6777654332 233333344445566789999999999999999994 99999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.2e-47 Score=413.56 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC------chHHHHHH--HHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEI--QNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|. ..+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 3488899999999999999864 569999999986432 12233333 24566778999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||+ +|+|.++|.. ...+++..++.|+.||+.||+|||
T Consensus 84 ivmE~~~----------gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~aL~ylH 124 (364)
T d1omwa3 84 FILDLMN----------GGDLHYHLSQ-----------------------------HGVFSEADMRFYAAEIILGLEHMH 124 (364)
T ss_dssp EEECCCC----------SCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecC----------CCcHHHHHHh-----------------------------cccccHHHHHHHHHHHHHHHHHHH
Confidence 9999665 4444444322 234677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 574 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ 574 (774)
+.+|+||||||+|||++.++. +||+|||+|+.+... .....+||+.|+|||++.. ..|+.++|||||||++|
T Consensus 125 ~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 125 NRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp HTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred HCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHH
Confidence 999999999999999988875 899999999876543 2345679999999999975 56899999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHH---HhhccccccccCCHHHHHHHHHhcCCCCCCCcC-----HHHHHcCCCCCCccchhh
Q 004097 575 FCITGGKHPYGESFERD-ANI---VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRLS 645 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~~~---~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps-----~~elL~HPff~~~~~~~~ 645 (774)
||+|| .+||....... ..+ ........+...++++.+||.+||+.||.+||| ++|+++||||++.++...
T Consensus 198 emltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 198 KLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp HHHHS-SCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 99997 77886543221 112 222233344567889999999999999999999 799999999988766544
Q ss_pred hhh
Q 004097 646 FLR 648 (774)
Q Consensus 646 ~l~ 648 (774)
+.+
T Consensus 277 ~~~ 279 (364)
T d1omwa3 277 FLQ 279 (364)
T ss_dssp HTT
T ss_pred hcC
Confidence 333
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=397.89 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=195.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhC--CCCCeeEEeeeccCC
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASD--QHPNIVRWYGVESDQ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l--~HpNIV~l~g~~~~~ 411 (774)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+. +++.+ .|||||++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-LLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHH-HHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHH-HHHHhccCCCCccEEEEEEeeC
Confidence 45689999999999999999854 579999999986432 122346776 44444 499999999999999
Q ss_pred ceeEEeccccCC--ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 412 ~~~~LV~E~~~~--sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
+..|+|||+|.+ ++.+++ .....+++.+++.++.||+.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~----------------------------------------~~~~~l~e~~~~~~~~qi~~ 121 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFI----------------------------------------TERGALQEELARSFFWQVLE 121 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHH----------------------------------------HHHCSCCHHHHHHHHHHHHH
T ss_pred CeEEEEEEeccCcchHHHHH----------------------------------------hccCCCCHHHHHHHHHHHHH
Confidence 999999998764 233322 12245788889999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCC-CCcchhHh
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 568 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwS 568 (774)
||+|||+.+|+||||||+|||++.+.. .+||+|||+|+..... ...+..||+.|+|||++.+..+ +.++||||
T Consensus 122 al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwS 195 (273)
T d1xwsa_ 122 AVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195 (273)
T ss_dssp HHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHH
T ss_pred HHHHHHHCCCccccCcccceEEecCCC-eEEECccccceecccc-----cccccccCCCcCCHHHHcCCCCCCccccccc
Confidence 999999999999999999999986542 5899999999865432 2245679999999999987765 67899999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 569 LGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|||++|||++| .+||.... .+.. .....+...++++++||.+||+.||++|||++|+++||||++.
T Consensus 196 lGvilyell~g-~~Pf~~~~----~i~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 196 LGILLYDMVCG-DIPFEHDE----EIIR-GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHS-SCSCCSHH----HHHH-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ceeeehhHhhC-CCCCCCch----HHhh-cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999997 78887633 2222 2333455678999999999999999999999999999999653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-46 Score=392.63 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=197.6
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc------------hHHHHHHHHHHHhC-CCCCeeEEeeeccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASD-QHPNIVRWYGVESD 410 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 410 (774)
++|.+.+.||+|+||+||++.. .+|+.||||++.+... +...+|+. +++.+ .|||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD-ILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHH-HHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHH-HHHHhcCCCCeEEEEeeccc
Confidence 5688999999999999999854 5799999999965421 13456765 45555 59999999999999
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
++.+|||||||+ +|+|.+++. ....+++..++.++.||+.|
T Consensus 82 ~~~~~ivmE~~~----------~g~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~a 122 (277)
T d1phka_ 82 NTFFFLVFDLMK----------KGELFDYLT-----------------------------EKVTLSEKETRKIMRALLEV 122 (277)
T ss_dssp SSEEEEEEECCT----------TCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHH
T ss_pred CcceEEEEEcCC----------CchHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 999999999665 444444432 12457888999999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc------CCCCCcc
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAI 564 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~s 564 (774)
|+|||+.||+||||||+|||++.++. +||+|||+++.+.... ......||+.|+|||++.+ ..++.++
T Consensus 123 l~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~ 196 (277)
T d1phka_ 123 ICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196 (277)
T ss_dssp HHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHH
T ss_pred HHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchh
Confidence 99999999999999999999987765 8999999998876432 2234579999999999864 3468899
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHHHH--HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~~~--~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
||||+||++|||++| .+||........ .+...... ......++++++||.+||+.||++|||++|+++||||+.
T Consensus 197 DiwslGvilyeml~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 197 DMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred eEcccchhhhhhccC-CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999999996 778876554332 23332221 122356789999999999999999999999999999953
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=405.43 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=202.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
-++|.+.+.||+|+||+||+|.. .+|+.||||++.....+ ...+|+. ++..++|||||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHH-HHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35688999999999999999854 57899999999765533 2346664 77899999999999999999999999997
Q ss_pred cCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 421 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 421 ~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
|.+ +|.+++ .. ....+++.+++.|+.||+.||+|||+.||
T Consensus 83 ~~gg~L~~~i-----------~~----------------------------~~~~l~e~~~~~i~~qi~~al~yLH~~~i 123 (321)
T d1tkia_ 83 ISGLDIFERI-----------NT----------------------------SAFELNEREIVSYVHQVCEALQFLHSHNI 123 (321)
T ss_dssp CCCCBHHHHH-----------TS----------------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCcHHHHH-----------Hh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 663 454444 21 11246788899999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhC
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 579 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg 579 (774)
+||||||+|||++.++...+||+|||+++..... ....+..||+.|+|||.+.+..|+.++|||||||++|+|++|
T Consensus 124 iHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~----~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CcccccccceeecCCCceEEEEcccchhhccccC----CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 9999999999998776667999999999876543 223445689999999999999999999999999999999997
Q ss_pred CCCCCCCchHHH-H-HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 580 GKHPYGESFERD-A-NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 580 ~~~Pf~~~~~~~-~-~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
.+||....... . .+...... ......++++++||.+||+.||.+|||++|+++||||..
T Consensus 200 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 200 -INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 77886654332 2 33332221 112356789999999999999999999999999999954
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=398.61 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=188.7
Q ss_pred EeecccCceEEEEEeee---CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 351 KEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
++||+|+||+||+|... .++.||||+++.... +...+|+. +++.++|||||+++|+|.+ +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHH-HHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHH-HHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 57999999999998543 357899999964322 23445664 7789999999999999865 45789999655
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
+|+|.+++.. ...+++..++.|+.||+.||+|||+.+|+||
T Consensus 91 ----------~g~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 91 ----------LGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp ----------TEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ----------CCcHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence 4444444321 2347888899999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++.+..............||+.|||||++.+..++.++|||||||++|||+|.|.+
T Consensus 132 DlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 132 DLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp CCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcchhhcccccCc--ccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence 99999999987764 8999999999876544433334455799999999999999999999999999999999996688
Q ss_pred CCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH---cCCCC
Q 004097 583 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL---NHPFF 637 (774)
Q Consensus 583 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL---~HPff 637 (774)
||......+ .. +........+...++++.+||.+||+.||++|||+++++ +|+|+
T Consensus 210 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 210 PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 997654333 22 233333344556778999999999999999999999984 56554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-46 Score=397.25 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=197.4
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||+++... .+...+|+. +++.++|||||+++|+|.+++..|+|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHH-HHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 4578889999999999999865 468999999997543 234566765 778899999999999999999999999955
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
. +|+|.+++... ....+++..++.|+.||+.||+|||+.+|+|
T Consensus 96 ~----------~g~l~~~l~~~---------------------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 138 (287)
T d1opja_ 96 T----------YGNLLDYLREC---------------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIH 138 (287)
T ss_dssp T----------TCBHHHHHHHS---------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred c----------CcchHHHhhhc---------------------------cccchHHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5 45555444321 1234678888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 581 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~ 581 (774)
|||||+|||++.++. +||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 139 rDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 139 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp SCCSGGGEEECGGGC--EEECCCCCTTTCCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccCeEEECCCCc--EEEccccceeecCCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 999999999987764 99999999987764322 12223458999999999999999999999999999999999877
Q ss_pred CCCCCchHHH-HHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 582 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 582 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
+||....... ...+... ....+...++++.+||.+||+.||++|||++|+++
T Consensus 215 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 7776544333 2333332 33344556789999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=397.03 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=189.6
Q ss_pred EeecccCceEEEEEee-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 351 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
+.||+|+||+||+|.. .+|+.||||++..... ....+|+. +++.++|||||++++++.+++.+|||||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHH-HHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 6799999999999864 5699999999864321 23556775 778899999999999999999999999987
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+++...+.. ....+++..+..+++||+.||+|||+++|+|
T Consensus 83 ~~~~~~~~~~---------------------------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 83 ETDLEVIIKD---------------------------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp SEEHHHHHTT---------------------------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred cchHHhhhhh---------------------------------------cccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 7644333211 1234667788999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+|||++.++. +||+|||+++...... ......+||+.|+|||++... .|+.++|||||||++|||++|
T Consensus 124 rDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g- 197 (299)
T d1ua2a_ 124 RDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR- 197 (299)
T ss_dssp CCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS-
T ss_pred ccCCcceEEecCCCc--cccccCccccccCCCc---ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC-
Confidence 999999999988775 8999999998765432 223456799999999998754 579999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhccc---------------------------cccccCCHHHHHHHHHhcCCCCCCCcCHHHH
Q 004097 581 KHPYGESFERDA--NIVKDRKD---------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 631 (774)
Q Consensus 581 ~~Pf~~~~~~~~--~~~~~~~~---------------------------~~~~~~~~~~~dli~~~L~~dP~~Rps~~el 631 (774)
.+||......+. .+...... ......++++.+||.+||+.||++|||++|+
T Consensus 198 ~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~ 277 (299)
T d1ua2a_ 198 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277 (299)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 778865433221 12111000 0012345789999999999999999999999
Q ss_pred HcCCCCCCc
Q 004097 632 LNHPFFWTA 640 (774)
Q Consensus 632 L~HPff~~~ 640 (774)
|+||||++.
T Consensus 278 L~Hp~f~~~ 286 (299)
T d1ua2a_ 278 LKMKYFSNR 286 (299)
T ss_dssp HTSGGGTSS
T ss_pred hCCHhhCCC
Confidence 999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=388.72 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=197.6
Q ss_pred eEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
.|.+.+.||+|+||+||+|...+++.||||++++.. .+...+|+ .++..++|||||+++|+|.+++.+|+|||||.
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev-~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~- 82 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA- 82 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHH-HHHHTCCCTTBCCEEEEECCSSSEEEEEECCT-
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHH-HHHHhcCCCceeeEEEEEeeCCceEEEEEccC-
Confidence 456778999999999999988788899999997643 23445565 47889999999999999999999999999665
Q ss_pred ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Q 004097 424 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 503 (774)
Q Consensus 424 sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 503 (774)
+|++..++... ...+++..+.+|+.||++||+|||+.+|+|||
T Consensus 83 ---------~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~d 125 (258)
T d1k2pa_ 83 ---------NGCLLNYLREM----------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125 (258)
T ss_dssp ---------TEEHHHHHHSG----------------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSC
T ss_pred ---------CCcHHHhhhcc----------------------------ccCCcHHHHHHHHHHHHHHHHHHhhcCccccc
Confidence 34444332211 12356778899999999999999999999999
Q ss_pred cCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCCC
Q 004097 504 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 583 (774)
Q Consensus 504 Lkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~P 583 (774)
|||+|||++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+++.|
T Consensus 126 lk~~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~P 201 (258)
T d1k2pa_ 126 LAARNCLVNDQGV--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201 (258)
T ss_dssp CSGGGEEECTTCC--EEECCCSSCCBCSSSSC--CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccceeEEEcCCCc--EEECcchhheeccCCCc--eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCC
Confidence 9999999987765 89999999987654322 2223456899999999999999999999999999999999966889
Q ss_pred CCCchHHHH--HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 584 YGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 584 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|......+. .+........+...++++.+||.+||+.||++|||++++++|
T Consensus 202 f~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 202 YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 976543332 233333334455566899999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=394.38 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=198.4
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
.|.+.+.||+|+||+||+|.. .+|+.||||++.... .....+|+. +++.++|||||++++++.+++.+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHH-HHHhCCCCcEEEeccccccccceeEEEe
Confidence 578889999999999999864 679999999985432 234556765 7788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||.+++.+++... ...++++..++.++.||+.||+|||+.+|
T Consensus 82 ~~~~~~~~~~~~~--------------------------------------~~~~l~e~~~~~~~~qil~~L~yLH~~~I 123 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--------------------------------------ALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123 (298)
T ss_dssp CCSEEHHHHHHHT--------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ecCCchhhhhhhh--------------------------------------cccCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9887665554221 12457888999999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~ellt 578 (774)
|||||||+|||++.++. +||+|||+|+...... .......||+.|+|||++.... ++.++|||||||++|+|++
T Consensus 124 iHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 124 LHRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp CCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred EccccCchheeecccCc--ceeccCCcceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 99999999999987765 8999999998775432 2234457999999999987766 5789999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhccc----------------------------cccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 579 GGKHPYGESFERDA--NIVKDRKD----------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
| ++||........ .+...... ......++++.+||.+||+.||++|||+
T Consensus 199 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~ 277 (298)
T d1gz8a_ 199 R-RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277 (298)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-CCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 7 788865433221 11110000 0011335789999999999999999999
Q ss_pred HHHHcCCCCCCccc
Q 004097 629 QNVLNHPFFWTADT 642 (774)
Q Consensus 629 ~elL~HPff~~~~~ 642 (774)
+|+++||||.+...
T Consensus 278 ~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 278 KAALAHPFFQDVTK 291 (298)
T ss_dssp HHHHTSGGGTTCCC
T ss_pred HHHhCCHhhccCCC
Confidence 99999999976543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=408.58 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=194.6
Q ss_pred eEEE-eEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC----CceeEEecc
Q 004097 346 LVVF-NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLE 419 (774)
Q Consensus 346 ~~~~-~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~E 419 (774)
.|.+ .+.||+|+||+||+|.. .+|+.||||++.+. ....+|+..++...+|||||++++++.+ ++.+|||||
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 4554 56799999999999954 67999999999753 5667888767777899999999999865 577999999
Q ss_pred ccCC-ChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 420 RCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 420 ~~~~-sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
||.+ +|.+++ ... ....+++.+++.|+.||+.||+|||+.|
T Consensus 90 y~~gg~L~~~i-----------~~~---------------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~ 131 (335)
T d2ozaa1 90 CLDGGELFSRI-----------QDR---------------------------GDQAFTEREASEIMKSIGEAIQYLHSIN 131 (335)
T ss_dssp CCCSEEHHHHH-----------HSC---------------------------SCCCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcHHHHH-----------Hhc---------------------------CCCCcCHHHHHHHHHHHHHHHHHHHHcC
Confidence 6653 555444 211 0134678889999999999999999999
Q ss_pred ccccccCCCCeeecCCC-CceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++ ...+||+|||+|+...... .....+||+.|||||++.+..|+.++|||||||++|+|+
T Consensus 132 iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred CccccccccccccccccccccccccccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence 99999999999997533 3458999999998776432 234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH--HHHHh---hcccc----ccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 578 TGGKHPYGESFERD--ANIVK---DRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 578 tg~~~Pf~~~~~~~--~~~~~---~~~~~----~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|| .+||....... ..+.. ..... .....++++.+||.+||+.||++|||+.|+++||||...
T Consensus 208 tg-~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 208 CG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TS-SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred hC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 97 77885432211 11111 11111 112457899999999999999999999999999999643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=394.67 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=194.8
Q ss_pred eEEEeE-eecccCceEEEEEee---eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEe
Q 004097 346 LVVFNK-EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 417 (774)
Q Consensus 346 ~~~~~~-~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 417 (774)
.+.+.+ +||+|+||+||+|.. .++..||||+++..... ...+|+. ++..++|||||+++|+|.+ +.+|||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHH-HHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 355666 599999999999843 34568999999754332 3445654 7788999999999999875 468999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||+ +|+|.+++... ...+++..+++|+.||+.||+|||++
T Consensus 87 mE~~~----------~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~gL~ylH~~ 128 (285)
T d1u59a_ 87 MEMAG----------GGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEEK 128 (285)
T ss_dssp EECCT----------TEEHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeCC----------CCcHHHHhhcc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99655 44444443211 13477888999999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ell 577 (774)
+|+||||||+|||++.++. +||+|||+++.+..............||+.|+|||++....++.++|||||||++|||+
T Consensus 129 ~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 129 NFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp TEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CeecCcCchhheeeccCCc--eeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence 9999999999999987764 99999999998765443333444567899999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHH---HcCCCC
Q 004097 578 TGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPFF 637 (774)
Q Consensus 578 tg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~el---L~HPff 637 (774)
|.|.+||......+ . .+........+...++++.+||.+||+.||++|||+.++ |+|+|+
T Consensus 207 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 96688997643322 2 333333444556677899999999999999999999987 566665
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=391.66 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=196.9
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~ 422 (774)
+.|.+.+.||+|+||+||+|...+++.||||++..... +...+|+ .++..++|||||+++|+|.+ +..|+|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~-~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~- 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEA-QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM- 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSCEEEECCC-
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHH-HHHHhcccCCEeEEEEEEec-CCeEEEEEec-
Confidence 45889999999999999999888888999999975543 3445565 47788999999999999865 5679999955
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|++...+... ....+++.+++.|+.||+.||+|||+.+|+||
T Consensus 94 ---------~~g~l~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~ 137 (285)
T d1fmka3 94 ---------SKGSLLDFLKGE---------------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 137 (285)
T ss_dssp ---------TTCBHHHHHSHH---------------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---------CCCchhhhhhhc---------------------------ccccchHHHHHHHHHHHHHHHHHHhhhheecc
Confidence 455555544332 12347889999999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+||||+.++. +||+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.+
T Consensus 138 DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 138 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSGGGEEECGGGC--EEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccceEEEECCCCc--EEEcccchhhhccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence 99999999987754 99999999987653321 222335689999999999999999999999999999999998788
Q ss_pred CCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc--CCCCCCc
Q 004097 583 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWTA 640 (774)
Q Consensus 583 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~--HPff~~~ 640 (774)
|+......+ .. +........+...++++.++|.+||+.||++|||+++|++ |+||.+.
T Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 214 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 776654432 22 2233333455566789999999999999999999999987 8888654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-46 Score=394.96 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=184.5
Q ss_pred cceEEEeEeecccCceEEEEEeee-CC---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
.+.|.+.+.||+|+||+||+|... +| ..||||++...... ...+|+. +++.++|||||+++|+|.+++.+|
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHH-HHHhCCCCCCccEEEEEeeCCEEE
Confidence 356888999999999999998653 33 36999998654332 3445654 778899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||||+ +|+|.+++.. ....+++.+++.|+.||+.||+|||
T Consensus 104 iv~Ey~~----------~g~L~~~~~~----------------------------~~~~l~~~~~~~i~~qia~gl~yLH 145 (299)
T d1jpaa_ 104 IITEFME----------NGSLDSFLRQ----------------------------NDGQFTVIQLVGMLRGIAAGMKYLA 145 (299)
T ss_dssp EEEECCT----------TEEHHHHHHT----------------------------TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecC----------CCcceeeecc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 9999555 4444443321 1234778889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCcccc--ccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
+.+|+||||||+||||+.++. +||+|||+++.+........ ......||+.|||||++.+..++.++|||||||++
T Consensus 146 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 146 DMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred hCCCccCccccceEEECCCCc--EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 999999999999999987765 99999999998764322211 12224589999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||+|+|.+||.+..... ...+ .......+...++++.+||.+||+.||.+|||+.|++++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999996688887654332 2223 333334455667899999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=399.24 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=196.7
Q ss_pred ceEEEeEeecccCceEEEEEeeeC------CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||+||+|.... ...||||++.... .....+|+..+....+|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 468899999999999999986543 2379999985432 234556776555556999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
|||||||+ ++|.+++....+.+........ .............+++..++.|+.||+.||+|
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYE-----------------NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC--------------------------------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhc-----------------cccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999766 3565555433222211100000 00000001223458899999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+++|+||||||+|||++.++. +||+|||+|+....... .....+..||+.|||||++.+..++.++|||||||++
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCeeeccCchhccccccCCe--EEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 99999999999999999987764 99999999987664322 1222345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchH--HHHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~--~~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||+|+|.+||..... ....++... ....+...++++.+||.+||+.||++|||++||++|
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999866889865332 223334333 223445667899999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=387.57 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=186.0
Q ss_pred ceEEEeEeecccCceEEEEEeeeCC-----cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEG-----RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 415 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g-----~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 415 (774)
..|...+.||+|+||+||+|..... ..||||++...... ...+|+ .++..++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHH-HHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577889999999999999865432 47999999654332 234566 4788899999999999999999999
Q ss_pred EeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 416 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 416 LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
+|||+|.+ |++.+.+.. ....+++.+++.|+.||+.||+|||
T Consensus 86 ~v~e~~~~----------~~l~~~~~~----------------------------~~~~~~~~~~~~i~~~i~~gl~~lH 127 (283)
T d1mqba_ 86 IITEYMEN----------GALDKFLRE----------------------------KDGEFSVLQLVGMLRGIAAGMKYLA 127 (283)
T ss_dssp EEEECCTT----------EEHHHHHHH----------------------------TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeccc----------Ccchhhhhc----------------------------ccccccHHHHHHHHHHHHHhhhhcc
Confidence 99996654 333332211 1234677888999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+.+|+||||||+||||+.++. +||+|||+++.+..............||+.|||||++.+..++.++|||||||++||
T Consensus 128 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 128 NMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred ccccccCccccceEEECCCCe--EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence 999999999999999987765 999999999887644322222334468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 576 CITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 576 lltg~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|++|+.+|+....... ...+ .......+...++++.+||.+||+.||++|||+.|+++
T Consensus 206 l~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 206 VMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9998777776543332 2223 23333344556688999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=387.53 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=195.7
Q ss_pred cceEEEeEeecccCceEEEEEee-eC-CcEEEEEEeecCC-----chHHHHHHHH--HHHhCCCCCeeEEeeecc-----
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGN-YE-GRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVES----- 409 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~-~~-g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~----- 409 (774)
.++|.+.+.||+|+||+||+|.. .+ ++.||||++.... .....+|+.. .++..+|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46789999999999999999864 34 6789999985421 2345677653 345568999999999985
Q ss_pred CCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 410 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 410 ~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
....+|++||+|.+++..+... .....+++..++.++.||+.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--------------------------------------VPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--------------------------------------SCTTCSCHHHHHHHHHHHHH
T ss_pred cCceEEEEEEeccCCchhhhhh--------------------------------------ccCCCCCHHHHHHHHHHHHH
Confidence 3467899999887654333211 12245788889999999999
Q ss_pred HHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhH
Q 004097 490 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 569 (774)
Q Consensus 490 gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSl 569 (774)
||+|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..|+.++||||+
T Consensus 128 aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 128 GLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhccc----ccCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 999999999999999999999987765 899999998765432 23345679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhhc--------------------------cccccccCCHHHHHHHHHhcCCC
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVKDR--------------------------KDLFLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~~~--------------------------~~~~~~~~~~~~~dli~~~L~~d 621 (774)
||++|||++| .+||......+. .+.... ........++++.+||.+||+.|
T Consensus 202 G~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 202 GCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC
Confidence 9999999997 778865433221 111100 00112234678999999999999
Q ss_pred CCCCcCHHHHHcCCCCCCcc
Q 004097 622 PDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 622 P~~Rps~~elL~HPff~~~~ 641 (774)
|++|||++|+|+||||++.+
T Consensus 281 P~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 281 PAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTTSCCHHHHHTSGGGTTCC
T ss_pred hhHCcCHHHHhcChhhcCch
Confidence 99999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-44 Score=383.50 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=194.8
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
++|.+.++||+|+||+||+|...+|+.||||++.... .....+|+. +++.++|||||++++++.+.+..|+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHH-HHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 3578889999999999999988889999999996532 234556665 6788999999999999999999999999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
+|.+++...+.. ..+.+++..++.|+.||+.||+|||+.+|
T Consensus 81 ~~~~~~~~~~~~---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~I 121 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---------------------------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (286)
T ss_dssp CCSEEHHHHHHT---------------------------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eehhhhHHHHHh---------------------------------------hcCCcchhhhHHHHHHHHHHHHHhccCcE
Confidence 887655444321 12457888999999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHh
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 578 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~ellt 578 (774)
+||||||+|||++.++. +|++|||++....... .......|++.|+|||.+.+. .++.++|||||||++|||++
T Consensus 122 vHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 122 LHRDLKPQNLLINREGE--LKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp CCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCceeeEcCCCC--EEecccccceecccCc---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH
Confidence 99999999999988876 8999999998765332 122344689999999999765 46899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcc----------------------------ccccccCCHHHHHHHHHhcCCCCCCCcCH
Q 004097 579 GGKHPYGESFERDA--NIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKA 628 (774)
Q Consensus 579 g~~~Pf~~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps~ 628 (774)
| ++||......+. .+..... .......++++.|||++||+.||++|||+
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 197 G-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-CCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 7 788875433221 1111000 01122345789999999999999999999
Q ss_pred HHHHcCCCCC
Q 004097 629 QNVLNHPFFW 638 (774)
Q Consensus 629 ~elL~HPff~ 638 (774)
+|+++||||+
T Consensus 276 ~ell~Hp~f~ 285 (286)
T d1ob3a_ 276 KQALEHAYFK 285 (286)
T ss_dssp HHHHTSGGGG
T ss_pred HHHhcCcccC
Confidence 9999999995
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=387.42 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=180.7
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 419 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 419 (774)
+.|.+.+.||+|+||+||+|... ..||||+++.... ....+|+ .++..++|||||+++|++.+ +.+|||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 34566788999999999998543 4699999864321 2233455 47788999999999999765 56899999
Q ss_pred ccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 004097 420 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 499 (774)
Q Consensus 420 ~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 499 (774)
||+ +|+|.++++.. ...+++..++.|+.||+.||+|||+.+|
T Consensus 84 y~~----------~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~i 125 (276)
T d1uwha_ 84 WCE----------GSSLYHHLHII----------------------------ETKFEMIKLIDIARQTAQGMDYLHAKSI 125 (276)
T ss_dssp CCC----------EEEHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCC----------CCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCE
Confidence 655 44444444321 1236778889999999999999999999
Q ss_pred cccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc---CCCCCcchhHhHHHHHHHH
Q 004097 500 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 500 vHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSlGvll~el 576 (774)
|||||||+|||++.++. +||+|||+|+....... .....+..||+.|||||++.. ..|+.++|||||||++|||
T Consensus 126 vHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 126 IHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp CCSCCCGGGEEEETTSS--EEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred eccccCHHHEEEcCCCC--EEEccccceeeccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHH
Confidence 99999999999987765 89999999987653322 122345579999999999974 3578999999999999999
Q ss_pred HhCCCCCCCCchHH--HHHHHhhccc-----cccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFER--DANIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+|| .+||...... ....+..... ......++++.+||.+||+.||.+|||++|+++|
T Consensus 203 ~tg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 203 MTG-QLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHS-SCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHC-CCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 996 7788654322 2222222211 1233456799999999999999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=380.88 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=187.5
Q ss_pred ceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCCeeEEeeeccC-CceeEEeccccC
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLERCT 422 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~LV~E~~~ 422 (774)
++|.+.+.||+|+||+||+|.. .|+.||||++++....+ ..+|+ .+++.++|||||+++|+|.+ .+.+|+|||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~- 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM- 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTH-HHHTTCCCTTBCCEEEEECCC--CCEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEecCCcEEEEEecc-
Confidence 3477889999999999999765 68899999997665444 44555 57889999999999999865 46789999954
Q ss_pred CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 004097 423 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 502 (774)
Q Consensus 423 ~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 502 (774)
.+|+|.++|.... ...+++..+++|+.||+.||+|||+.+|+||
T Consensus 84 ---------~~g~L~~~l~~~~---------------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~ 127 (262)
T d1byga_ 84 ---------AKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127 (262)
T ss_dssp ---------TTEEHHHHHHHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---------CCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence 5555555553321 1236788899999999999999999999999
Q ss_pred ccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHHHhCCCC
Q 004097 503 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 582 (774)
Q Consensus 503 DLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~elltg~~~ 582 (774)
||||+|||++.++. +||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+|++++
T Consensus 128 dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~ 199 (262)
T d1byga_ 128 DLAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199 (262)
T ss_dssp CCSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchHhheecCCCC--EeecccccceecCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCC
Confidence 99999999988875 899999999865432 2234589999999999999999999999999999999997788
Q ss_pred CCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 583 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 583 Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
||......+ . .+........+...++++.+||.+||+.||.+|||+.+++++
T Consensus 200 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 887654332 2 333333444556677899999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=385.88 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=188.6
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccC-Cce
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 413 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 413 (774)
+.|.+.+.||+|+||+||+|... +++.||||++..... ....+|+..+....+|+|||++++++.+ ++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 45889999999999999998543 357899999975432 2345566666777789999999998765 456
Q ss_pred eEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 414 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 414 ~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+|+|||||+ +|+|.++|+......... ...........+++..++.|+.||+.||+|
T Consensus 93 ~~iv~E~~~----------~g~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 93 LMVIVEFCK----------FGNLSTYLRSKRNEFVPY-------------KVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp CEEEEECCT----------TCBHHHHHHHTGGGBCC------------------------CBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEecC----------CCcHHHHHHhcccccccc-------------ccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence 899999665 344444443322110000 000000123457889999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+++|+||||||+|||++.++. +||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++
T Consensus 150 lH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCCcCCcCCccceeECCCCc--EEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHH
Confidence 99999999999999999987765 99999999987654322 1223445799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchH--HHHHHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 574 FFCITGGKHPYGESFE--RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~--~~~~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
|||+||+.+||..... .....+. ......+...++++.++|.+||+.||++|||++|+++|
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999988888865432 2222332 23333445567899999999999999999999999977
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=391.10 Aligned_cols=251 Identities=27% Similarity=0.360 Sum_probs=194.3
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC------CceeEEec
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD------QDFVYLSL 418 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~~~~LV~ 418 (774)
.|...++||+|+||+||+|.. .+|+.||||++.+.. ....+|+. ++..++|||||++++++.. ..++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHH-HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHH-HHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 477788999999999999865 469999999997643 22346775 6788999999999999843 34589999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||++++.+.+... ......+++.+++.|++||+.||+|||++|
T Consensus 99 Ey~~~~~~~~l~~~------------------------------------~~~~~~l~~~~~~~i~~qil~aL~yLH~~~ 142 (350)
T d1q5ka_ 99 DYVPETVYRVARHY------------------------------------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142 (350)
T ss_dssp ECCSEEHHHHHHHH------------------------------------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eccCCccHHHHHhh------------------------------------hhccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 98886654443110 022346888999999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. .+||+|||+++...... ...+.+||+.|+|||.+.+ ..++.++||||+||++|||+
T Consensus 143 IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 143 ICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp EECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcccCCCcceEEEecCCC-ceeEecccchhhccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence 999999999999987753 48999999998775432 2344679999999999875 46899999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhh------------c----------------cccccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 578 TGGKHPYGESFERDA--NIVKD------------R----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~--~~~~~------------~----------------~~~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+| .+||......+. .+.+. . ........++++.+||.+||+.||++|||
T Consensus 218 ~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 218 LG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HT-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 97 778865433221 11110 0 00111234679999999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 004097 628 AQNVLNHPFFWTA 640 (774)
Q Consensus 628 ~~elL~HPff~~~ 640 (774)
++|+|+||||...
T Consensus 297 a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 297 PLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHTSGGGGGG
T ss_pred HHHHhcCHhhccc
Confidence 9999999999653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-44 Score=386.09 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=193.7
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeEEeeeccC--CceeEEecccc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERC 421 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~E~~ 421 (774)
+.|.+.+.||+|+||+||+|.. .+|+.||||++++.......+|+..+.....||||+++++++.. ...+|+|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5699999999999999999854 57999999999877767777888755444469999999999864 46799999977
Q ss_pred CCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 004097 422 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 501 (774)
Q Consensus 422 ~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 501 (774)
.+ |+|... .+.+++..++.+++||+.||+|||++||+|
T Consensus 115 ~~----------~~L~~~--------------------------------~~~l~e~~i~~i~~qil~aL~~LH~~gIvH 152 (328)
T d3bqca1 115 NN----------TDFKQL--------------------------------YQTLTDYDIRFYMYEILKALDYCHSMGIMH 152 (328)
T ss_dssp CS----------CBGGGT--------------------------------TTSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CC----------CcHHHH--------------------------------hcCCCHHHHHHHHHHHHHHHHHHhhccccc
Confidence 64 232211 123677888999999999999999999999
Q ss_pred cccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhHHHHHHHHHhCC
Q 004097 502 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 580 (774)
Q Consensus 502 rDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSlGvll~elltg~ 580 (774)
|||||+|||++.++. .+||+|||+|+...... .....+||+.|+|||.+.+. .++.++||||+||++|||++|
T Consensus 153 rDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g- 226 (328)
T d3bqca1 153 RDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR- 226 (328)
T ss_dssp CCCSGGGEEEETTTT-EEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT-
T ss_pred ccccccceEEcCCCC-eeeecccccceeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC-
Confidence 999999999986654 58999999998776432 23455789999999998865 479999999999999999997
Q ss_pred CCCCCCchH-HH--HHHHh------------hc------------------------cccccccCCHHHHHHHHHhcCCC
Q 004097 581 KHPYGESFE-RD--ANIVK------------DR------------------------KDLFLVEHIPEAVDLFTRLLDPN 621 (774)
Q Consensus 581 ~~Pf~~~~~-~~--~~~~~------------~~------------------------~~~~~~~~~~~~~dli~~~L~~d 621 (774)
..||..... .. ..+.. .. ........++++.|||++||+.|
T Consensus 227 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 306 (328)
T d3bqca1 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306 (328)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS
T ss_pred CCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC
Confidence 666644321 11 00000 00 00011224578999999999999
Q ss_pred CCCCcCHHHHHcCCCCCCcc
Q 004097 622 PDLRPKAQNVLNHPFFWTAD 641 (774)
Q Consensus 622 P~~Rps~~elL~HPff~~~~ 641 (774)
|.+|||++|+|+||||++..
T Consensus 307 P~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 307 HQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGSCCHHHHHTSGGGTTSC
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=388.41 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=193.3
Q ss_pred ccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc-----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD----- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~----- 412 (774)
++.+|.+.+.||+|+||+||+|. ..+|+.||||++.+.... ...+|+. ++..++|||||++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHH-HHHHcCCCCCCcEEEEEeeccccccc
Confidence 45679999999999999999985 468999999999754432 3455665 678899999999999987653
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..||+++++.++|.+++. .+++++..++.++.||+.||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~-----------------------------------------~~~l~~~~i~~i~~qil~al~ 123 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLK-----------------------------------------TQHLSNDHICYFLYQILRGLK 123 (345)
T ss_dssp CEEEEEECCCEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeecCCchhhhhh-----------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 467776655556655542 234778889999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhc-CCCCCcchhHhHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 571 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSlGv 571 (774)
|||++|||||||||+|||++.++. +||+|||+++...............+||+.|+|||++.. ..++.++||||+||
T Consensus 124 yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 124 YIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp HHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred HHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999999999999999999987765 899999999877654333333455679999999999854 56789999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHH--HHh-----------------------hcc-------ccccccCCHHHHHHHHHhcC
Q 004097 572 ILFFCITGGKHPYGESFERDAN--IVK-----------------------DRK-------DLFLVEHIPEAVDLFTRLLD 619 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~~~--~~~-----------------------~~~-------~~~~~~~~~~~~dli~~~L~ 619 (774)
++|||++| .+||......+.. ... ... .......++++.+||.+||+
T Consensus 202 il~eml~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 280 (345)
T d1pmea_ 202 ILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280 (345)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSC
T ss_pred eehHHhhC-CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHcc
Confidence 99999997 7788654322110 000 000 00112345789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCc
Q 004097 620 PNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 620 ~dP~~Rps~~elL~HPff~~~ 640 (774)
.||.+|||++|+|+||||...
T Consensus 281 ~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 281 FNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp SSTTTSCCHHHHHTSGGGTTT
T ss_pred CChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-44 Score=381.27 Aligned_cols=269 Identities=21% Similarity=0.271 Sum_probs=197.3
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||+||+|... +++.||||++...... ...+|+. +++.++||||++++++|.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHH-HHHhcCCCCcccceeeeccCCce
Confidence 45788899999999999998643 4578999999754432 3445654 77899999999999999999999
Q ss_pred EEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 493 (774)
Q Consensus 415 ~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 493 (774)
+++||+|. ++|.++++............... .............+++..++.|+.||+.||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 155 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL----------------STRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC--------------------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCcccccccccccc----------------chhhhccccCCCCCCHHHHHHHHHHHHHHhhh
Confidence 99999765 45666554333221111100000 00000111223568899999999999999999
Q ss_pred HHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 494 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 494 LH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||+.+||||||||+|||++.++. +||+|||+|+....... .....+..||+.|+|||.+.+..++.++|||||||++
T Consensus 156 lH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 156 LSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 99999999999999999977654 99999999987654321 2223345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HH-HHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 574 FFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
|||++|+.+||......+ .. +........+...++++.+||.+||+.||++|||+.||++
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998778887654433 22 3333333345566789999999999999999999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=390.26 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=189.4
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCc----
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 412 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 412 (774)
+.++|.+.+.||+|+||+||+|.. .+|+.||||++.+... ....+|+. +++.++|||||+++++|.+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHH-HHHhcCCCCeeEEEEEeccCccccc
Confidence 356788999999999999999864 5699999999975432 23456765 678899999999999987654
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+|+|||||..+|..++ +...+++..++.+++||+.|
T Consensus 95 ~~~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~~~~qi~~a 133 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLM-----------------------------------------KHEKLGEDRIQFLVYQMLKG 133 (346)
T ss_dssp CCCCEEEEECCSEEHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_pred cceEEEEEecccccHHHHH-----------------------------------------HhccccHHHHHHHHHHHHHH
Confidence 57999998865554332 23457888899999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC-CCCCcchhHhH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 569 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSl 569 (774)
|+|||++||+||||||+|||++.++. +|++|||+|+..... .....||+.|+|||++.+. .++.++||||+
T Consensus 134 L~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 134 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHhCCCcccccCcchhhcccccc--cccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcc
Confidence 99999999999999999999988876 899999999876532 2345799999999999864 56899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHh-----------------------hcc-------ccccccCCHHHHHHHHHh
Q 004097 570 GCILFFCITGGKHPYGESFERDA--NIVK-----------------------DRK-------DLFLVEHIPEAVDLFTRL 617 (774)
Q Consensus 570 Gvll~elltg~~~Pf~~~~~~~~--~~~~-----------------------~~~-------~~~~~~~~~~~~dli~~~ 617 (774)
||++|||++| .+||........ .... ... .......++++.|||.+|
T Consensus 206 Gvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 206 GCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred hHHHHHHHHC-cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHH
Confidence 9999999997 778865432211 0000 000 001123468999999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 004097 618 LDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 618 L~~dP~~Rps~~elL~HPff~~~ 640 (774)
|+.||.+|||++|+|+||||+..
T Consensus 285 L~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 285 LVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CcCChhHCcCHHHHhcChhhCcC
Confidence 99999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=376.80 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=183.0
Q ss_pred ceEEEeEeecccCceEEEEEeee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||+||+|... .+..||||++.....+ ...+|+ .+++.++|||||+++|++.+ +.+|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 46889999999999999998543 2457999998654332 233455 47788999999999999864 67899
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||. +|++.+++.. ....+++..++.++.||+.||+|||+
T Consensus 85 v~E~~~----------~g~l~~~~~~----------------------------~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 85 IMELCT----------LGELRSFLQV----------------------------RKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp EEECCT----------TEEHHHHHHH----------------------------TTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecc----------CCcHHhhhhc----------------------------cCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence 999665 4444443221 12346788899999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+||+++.++. +||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 ~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp TTCCCSCCSGGGEEEEETTE--EEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred cCeeccccchhheeecCCCc--EEEccchhheeccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHH
Confidence 99999999999999987764 99999999987654322 223345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+++|.+||....... ..+........+...++++.+||.+||+.||++|||++|+++|
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 997788987654332 2333333444556677899999999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=381.45 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=190.9
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeEEeeeccC--------
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-------- 410 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-------- 410 (774)
.+|.+.+.||+|+||+||+|.. .+|+.||||++.... .....+|+. +++.++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHH-HHHHhcCCCccceEeeeeccccccccc
Confidence 5588899999999999999864 579999999985432 234567776 7788999999999998755
Q ss_pred CceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 411 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 411 ~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
.+.+|+|||+|.+.+..... .....+++..++.|++||+.|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---------------------------------------NVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---------------------------------------CTTCCCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEeccCCCccchhh---------------------------------------hcccccccHHHHHHHHHHHHH
Confidence 35689999988765443221 112346777889999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCc-cccccccCcCCCCCCchhhhhcC-CCCCcchhHh
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 568 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwS 568 (774)
|+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+||+.|+|||++.+. .++.++||||
T Consensus 130 l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS 207 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHccc
Confidence 99999999999999999999988875 89999999987653321 12233445799999999999765 6899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHH-HHHhh-cccc-------------------------------ccccCCHHHHHHHH
Q 004097 569 LGCILFFCITGGKHPYGESFERDA-NIVKD-RKDL-------------------------------FLVEHIPEAVDLFT 615 (774)
Q Consensus 569 lGvll~elltg~~~Pf~~~~~~~~-~~~~~-~~~~-------------------------------~~~~~~~~~~dli~ 615 (774)
|||++|||++| ++||........ ..+.. .... ......+++.|||.
T Consensus 208 lGvil~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 208 AGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred CCceeeeHhhC-CCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHH
Confidence 99999999997 778865433221 11111 0000 00112467889999
Q ss_pred HhcCCCCCCCcCHHHHHcCCCCCCc
Q 004097 616 RLLDPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 616 ~~L~~dP~~Rps~~elL~HPff~~~ 640 (774)
+||+.||++|||++|+|+||||+..
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHCcCChhHCcCHHHHHcChhhccC
Confidence 9999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=383.79 Aligned_cols=246 Identities=24% Similarity=0.287 Sum_probs=186.3
Q ss_pred eEEEeEeecccCceEEEEEee-eCCc----EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEE
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~----~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.|.+.+.||+|+||+||+|.. .+|+ .||||++..... ....+|+. ++..++|||||+++|+|.+++ .++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHH-HHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCC-eeE
Confidence 488889999999999999854 3443 689998864322 23455664 778899999999999998765 566
Q ss_pred eccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 495 (774)
Q Consensus 417 V~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 495 (774)
++|+|. ++|.+++ .. ....+++..+++|+.||+.||+|||
T Consensus 88 v~e~~~~~~l~~~~-----------~~----------------------------~~~~~~~~~~~~i~~qi~~gl~yLH 128 (317)
T d1xkka_ 88 ITQLMPFGCLLDYV-----------RE----------------------------HKDNIGSQYLLNWCVQIAKGMNYLE 128 (317)
T ss_dssp EEECCTTCBHHHHH-----------HH----------------------------TSSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeccCCcccccc-----------cc----------------------------cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 667443 4444433 21 2245778889999999999999999
Q ss_pred HcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHH
Q 004097 496 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 575 (774)
Q Consensus 496 ~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~e 575 (774)
+++|+||||||+|||++.++. +||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++||
T Consensus 129 ~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~e 205 (317)
T d1xkka_ 129 DRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 205 (317)
T ss_dssp HTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HcCcccCcchhhcceeCCCCC--eEeeccccceeccccccc-ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHH
Confidence 999999999999999987764 999999999987643221 12233468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHH-HHHHHhh-ccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCC
Q 004097 576 CITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 635 (774)
Q Consensus 576 lltg~~~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HP 635 (774)
|+|++.+||...... ....+.. .....+...++++.+||.+||+.||.+|||+.|+++|.
T Consensus 206 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 206 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999779999765433 2333333 33334455678999999999999999999999999883
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-44 Score=375.26 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=185.8
Q ss_pred cccceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeEEeeeccCCc--
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 412 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-- 412 (774)
.+.++|.+.+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. +++.++|||||++++++.+.+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ-NAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHH-HHHhcCCCCCCcccceeeeccCC
Confidence 356779999999999999999985 46799999999965432 12345654 678899999999999987653
Q ss_pred --eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 004097 413 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 490 (774)
Q Consensus 413 --~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 490 (774)
..|||||||+ +|+|.+++ ...+.+++.+++.|+.||+.|
T Consensus 83 ~~~~~lvmE~~~----------g~~L~~~~-----------------------------~~~~~l~~~~~~~i~~qi~~a 123 (277)
T d1o6ya_ 83 GPLPYIVMEYVD----------GVTLRDIV-----------------------------HTEGPMTPKRAIEVIADACQA 123 (277)
T ss_dssp SEEEEEEEECCC----------EEEHHHHH-----------------------------HHHCSCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEECCC----------CCEehhhh-----------------------------cccCCCCHHHHHHHHHHHHHH
Confidence 4899999666 34444332 122457888999999999999
Q ss_pred HHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHH
Q 004097 491 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 570 (774)
Q Consensus 491 L~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlG 570 (774)
|+|||+.||+||||||+|||++.++. .+++|||.++...............+||+.|+|||++.+..++.++||||||
T Consensus 124 l~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlG 201 (277)
T d1o6ya_ 124 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201 (277)
T ss_dssp HHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccch
Confidence 99999999999999999999988776 8999999988765443333444566799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhccc---cccccCCHHHHHHHHHhcCCCCCCCc-CHHHHHcCCC
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRP-KAQNVLNHPF 636 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~~---~~~~~~~~~~~dli~~~L~~dP~~Rp-s~~elL~HPf 636 (774)
|++|||+|| .+||........ .++..... ......++++.++|.+||+.||.+|| |+++++ |+|
T Consensus 202 vilyelltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l 271 (277)
T d1o6ya_ 202 CVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADL 271 (277)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred HHHHHHHhC-CCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence 999999997 788876543332 23332221 12234578999999999999999999 566554 554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=376.72 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=193.6
Q ss_pred ceEEEeEeecccCceEEEEEeeeC--------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 412 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~--------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 412 (774)
+.|.+.+.||+|+||.||+|.... +..||||++.+.... ...+|+..+....+|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 457888999999999999985432 357999999765432 33455555555568999999999999999
Q ss_pred eeEEeccccC-CChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 413 ~~~LV~E~~~-~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
..|+|||||. |+|.++|........... ..........+++..+++++.||+.||
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~------------------------~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYS------------------------YNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------------------------------CCCCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccc------------------------cccccCccccCCHHHHHHHHHHHHHHH
Confidence 9999999665 355555532211110000 000012235688999999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 571 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGv 571 (774)
+|||+.+||||||||+|||++.++. +||+|||+++........ .......||+.|+|||.+.++.|+.++|||||||
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHhhhCCEEeeeecccceeecCCCC--eEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence 9999999999999999999988875 899999999877643322 2334456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH-HHHh-hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 572 ILFFCITGGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 572 ll~elltg~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
++|||++++.+||........ ..+. ......+...++++.+||.+||+.||++|||+.||++
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999977889876544332 3333 3333445566789999999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=381.04 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=193.9
Q ss_pred ceEEEeEeecccCceEEEEEeee-CCc--EEEEEEeecCC----chHHHHHHHHHHHhC-CCCCeeEEeeeccCCceeEE
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~--~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~L 416 (774)
+.|.+.+.||+|+||+||+|... +|. .||||++.... .+...+|+. ++..+ +|||||+++|+|.+++.+|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHH-HHHhccCCCCEeeEEEEEecCCeeEE
Confidence 34677899999999999998654 444 57888875432 234567775 55665 79999999999999999999
Q ss_pred eccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH
Q 004097 417 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 496 (774)
Q Consensus 417 V~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 496 (774)
|||||+ +|+|.++|+.......... ..........+++..+++++.||+.||.|||+
T Consensus 89 V~ey~~----------~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 89 AIEYAP----------HGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp EECCCT----------TCBHHHHHHTTCHHHHCHH-------------HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecC----------CCcHHHHHhhccccccchh-------------hhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence 999665 4444444433211000000 00011234568999999999999999999999
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
.+|+||||||+|||++.++. +||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||
T Consensus 146 ~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp TTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCccccccccceEEEcCCCc--eEEcccccccccccc----ccccceecCCcccchHHhccCCCCccceeehhHHHHHHH
Confidence 99999999999999977754 999999999865432 122344689999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHHH-HHH-hhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
++|+.+||........ ..+ .......+...++++.+||.+||+.||++|||++|+++|
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9988888876543332 222 333333445567899999999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=374.98 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=198.3
Q ss_pred ceEEEeEeecccCceEEEEEeee------CCcEEEEEEeecCCchH----HHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||+||+|... +++.||||++++..... ..+|+. ++..++|||||+++|+|...+..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHH-HGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHH-HHHHcCCCCEeeeeeEEecCCce
Confidence 45778899999999999998542 36789999997544322 345654 67889999999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++||||| .+|+|.++++....... ..-....+++..+.+|+.|+++||.||
T Consensus 99 ~lv~e~~----------~~g~l~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 99 LVIMELM----------TRGDLKSYLRSLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp EEEEECC----------TTCBHHHHHHHHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEeec----------CCCCHHHHHHhcccccc-------------------cccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 44555554443221100 001123467788999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+.+|+||||||+|||++.++. +||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|
T Consensus 150 H~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCeeeceEcCCceeecCCce--EEEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 9999999999999999977754 99999999987754322 22234456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H-HHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||+||+.+||....... . .+........+...++++.++|.+||+.||.+|||+++|++
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999888887654433 2 23333333344566789999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=372.28 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=181.9
Q ss_pred ceEEEeEeecccCceEEEEEeeeC--C--cEEEEEEeecCC---c---hHHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTH---H---DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~~~--g--~~VAVK~l~~~~---~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
++|.+.+.||+|+||+||+|.... + ..||||++.+.. . +...+|+ .+++.++|||||+++|+|.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV-NAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEee-cch
Confidence 458899999999999999986432 2 379999986432 1 2345666 47888999999999999976 467
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
++|||||. +|++.+.+... ...+++..+++++.||+.||+||
T Consensus 86 ~lv~e~~~----------~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 86 KMVTELAP----------LGSLLDRLRKH----------------------------QGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp EEEEECCT----------TCBHHHHHHHH----------------------------GGGSCHHHHHHHHHHHHHHHHHH
T ss_pred heeeeeec----------Ccchhhhhhcc----------------------------cCCCCHHHHHHHHHHHHHHHHHh
Confidence 89999665 34444332211 12367788899999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+++|+||||||+|||++.++ .+||+|||+++.+..............||..|+|||++.+..++.++|||||||++|
T Consensus 128 H~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 128 ESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp HHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 999999999999999998776 499999999998765544333344456888999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H-HHHhhccc-cccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 575 FCITGGKHPYGESFERD-A-NIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 575 elltg~~~Pf~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
||+|+|.+||....... . .+...... ..+...++++.+||.+||+.||++|||++|++
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99996688996554333 2 23333222 23345678999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=369.56 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=193.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEec
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 418 (774)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.... ....+|+. +++.++|||||++++++.+.+..++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHH-HHHhcCcCCEEeeccccccccceeEEe
Confidence 3588899999999999999864 5789999999964432 23456665 678899999999999999999999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|+|.+.....+ + ...+.+++..++.++.|++.||+|||+++
T Consensus 81 ~~~~~~~l~~~----------~-----------------------------~~~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 81 EFCDQDLKKYF----------D-----------------------------SCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECCSEEHHHHH----------H-----------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeccccccccc----------c-----------------------------ccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 97765332222 1 11234667788999999999999999999
Q ss_pred ccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHHHHHHHHH
Q 004097 499 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 577 (774)
Q Consensus 499 ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlGvll~ell 577 (774)
|+||||||+|||++.++. +||+|||.++....... ......+++.|+|||++.... ++.++|||||||++|||+
T Consensus 122 IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred EeeecccCcccccccCCc--eeeeecchhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh
Confidence 999999999999987765 89999999987754322 223345788999999988765 689999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHhh-cc----------------------------ccccccCCHHHHHHHHHhcCCCCCCCcC
Q 004097 578 TGGKHPYGESFERDA-NIVKD-RK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPK 627 (774)
Q Consensus 578 tg~~~Pf~~~~~~~~-~~~~~-~~----------------------------~~~~~~~~~~~~dli~~~L~~dP~~Rps 627 (774)
+|+.|+|......+. ..+.. .. .......++++.+||.+||+.||.+|||
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence 987666654432221 11110 00 0011233578999999999999999999
Q ss_pred HHHHHcCCCCCC
Q 004097 628 AQNVLNHPFFWT 639 (774)
Q Consensus 628 ~~elL~HPff~~ 639 (774)
++|+|+||||.+
T Consensus 277 a~e~L~Hp~f~~ 288 (292)
T d1unla_ 277 AEEALQHPYFSD 288 (292)
T ss_dssp HHHHTTSGGGSS
T ss_pred HHHHhcChhhcC
Confidence 999999999964
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=372.75 Aligned_cols=247 Identities=20% Similarity=0.308 Sum_probs=188.9
Q ss_pred EEEeEeecccCceEEEEEeeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccC-CceeEEe
Q 004097 347 VVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLS 417 (774)
Q Consensus 347 ~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~LV 417 (774)
+.+.++||+|+||+||+|...+ ...||||++.+.... ...+|+ .++..++|||||+++|+|.+ ++..|+|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHH-HHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 4567899999999999986543 236999999654322 234555 47889999999999999875 5689999
Q ss_pred ccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 004097 418 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 497 (774)
Q Consensus 418 ~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 497 (774)
||||. +|+|.++++.. ....++..+++++.|++.||.|||+.
T Consensus 108 ~E~~~----------~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 108 LPYMK----------HGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp EECCT----------TCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEee----------cCchhhhhccc----------------------------cccchHHHHHHHHHHHHHhhhhhccc
Confidence 99555 45555443321 12345667789999999999999999
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHHHH
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 576 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~el 576 (774)
+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||.+....++.++|||||||++|||
T Consensus 150 ~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El 227 (311)
T d1r0pa_ 150 KFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227 (311)
T ss_dssp TCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CcccCCccHHhEeECCCCC--EEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHH
Confidence 9999999999999977654 9999999999876432221 222335689999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhccccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcC
Q 004097 577 ITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 634 (774)
Q Consensus 577 ltg~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~H 634 (774)
+||+.+|+......+ ..+........+...++++.+||.+||+.||++||++.||++|
T Consensus 228 ~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 228 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 998776665433221 2334444444455567899999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=371.23 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=196.3
Q ss_pred ceEEEeEeecccCceEEEEEee------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeEEeeeccCCcee
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 414 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 414 (774)
+.|.+.+.||+|+||.||+|.. .+++.||||+++..... ...+|+..+....+|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4678899999999999999854 34679999999764432 2345655444444899999999999999999
Q ss_pred EEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHH
Q 004097 415 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 494 (774)
Q Consensus 415 ~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 494 (774)
|||||||+ +|+|.++++........... ...........+++..+++|+.||+.||+||
T Consensus 103 ~lvmE~~~----------~g~l~~~l~~~~~~~~~~~~-----------~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 103 LVITEYCC----------YGDLLNFLRRKRDSFICSKT-----------SPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp EEEEECCT----------TEEHHHHHHHTTTTC-------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCC----------CCCHHHHHHhcccccccccc-----------ccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665 34444444332211100000 0000112335688899999999999999999
Q ss_pred HHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHHH
Q 004097 495 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 574 (774)
Q Consensus 495 H~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll~ 574 (774)
|+++|+||||||+|||++.++. +|++|||+++....... ........||+.|+|||++....++.++|||||||++|
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCCeeecccccccccccccCc--ccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 9999999999999999987764 89999999987764322 22334457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHH--HHHHHhhc-cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHc
Q 004097 575 FCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 633 (774)
Q Consensus 575 elltg~~~Pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~ 633 (774)
||+|++.+||...... ...++... ....+...++++.+||.+||+.||.+|||++|+++
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999778877654322 22333333 33334456789999999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=371.09 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=194.9
Q ss_pred ceEEEeEeecccCceEEEEEee----eCCcEEEEEEeecC-------CchHHHHHHHHHHHhCC-CCCeeEEeeeccCCc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKT-------HHDVALKEIQNLIASDQ-HPNIVRWYGVESDQD 412 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~-------~~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~ 412 (774)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+. ..+...+|+. ++..++ ||||+++++++.+.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~-il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHH-HHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHH-HHHhccCCCeEEEeeeeeccCC
Confidence 4588999999999999999853 35889999998532 1234456776 445554 489999999999999
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
..|++||||. +|+|.+++.. .+.+++..+..++.||+.||+
T Consensus 103 ~~~~v~e~~~----------~~~L~~~i~~-----------------------------~~~~~e~~~~~~~~Qi~~al~ 143 (322)
T d1vzoa_ 103 KLHLILDYIN----------GGELFTHLSQ-----------------------------RERFTEHEVQIYVGEIVLALE 143 (322)
T ss_dssp EEEEEECCCC----------SCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHH
T ss_pred ceeeeeeccc----------ccHHHHHHHh-----------------------------cccccHHHHHHHHHHHHHHHH
Confidence 9999999554 4555544322 234567778899999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcC--CCCCcchhHhHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLG 570 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSlG 570 (774)
|||+.+|+||||||+|||++.++. +||+|||+++.+..... ....+..|++.|+|||.+... .++.++||||||
T Consensus 144 ~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 144 HLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219 (322)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred HhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence 999999999999999999988765 89999999987654322 223455799999999999765 367899999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-----HHHHHhhccccccccCCHHHHHHHHHhcCCCCCCCc-----CHHHHHcCCCCCCc
Q 004097 571 CILFFCITGGKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTA 640 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~Rp-----s~~elL~HPff~~~ 640 (774)
|++|||++| .+||...... ............+...++++.+||.+||+.||++|| |++|+++||||...
T Consensus 220 ~iLyelltG-~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 220 VLMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999997 7788543211 112222223334456789999999999999999999 58999999999765
Q ss_pred cc
Q 004097 641 DT 642 (774)
Q Consensus 641 ~~ 642 (774)
++
T Consensus 299 ~~ 300 (322)
T d1vzoa_ 299 NW 300 (322)
T ss_dssp CH
T ss_pred CH
Confidence 43
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=376.03 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=182.2
Q ss_pred ceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccC------Cc
Q 004097 345 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD------QD 412 (774)
Q Consensus 345 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~ 412 (774)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+... ....+|+. +++.++|||||++++++.. .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEecccccccCc
Confidence 5688999999999999999854 4799999999975432 22445665 6788999999999999863 46
Q ss_pred eeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 004097 413 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 492 (774)
Q Consensus 413 ~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~ 492 (774)
.+|+|||||.+++.+.+ ...+++..++.+++||+.||+
T Consensus 96 ~~~iv~Ey~~~~l~~~~------------------------------------------~~~~~~~~i~~~~~qil~gl~ 133 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI------------------------------------------QMELDHERMSYLLYQMLCGIK 133 (355)
T ss_dssp EEEEEEECCSEEHHHHH------------------------------------------TSCCCHHHHHHHHHHHHHHHH
T ss_pred eeEEEEeccchHHHHhh------------------------------------------hcCCCHHHHHHHHHHHHHHHH
Confidence 88999998876654332 123677888999999999999
Q ss_pred HHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHH
Q 004097 493 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 572 (774)
Q Consensus 493 yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvl 572 (774)
|||+.||+||||||+|||++.++. +|++|||+++..... ......+||+.|+|||++.+..++.++||||+||+
T Consensus 134 ~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~ 207 (355)
T d2b1pa1 134 HLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207 (355)
T ss_dssp HHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred HhhhcccccccCCccccccccccc--eeeechhhhhccccc----cccccccccccccChhhhcCCCCCCCcccccccch
Confidence 999999999999999999988765 899999998866532 22344569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHH----------------------hhccc-------------c------ccccCCHH
Q 004097 573 LFFCITGGKHPYGESFERDA--NIV----------------------KDRKD-------------L------FLVEHIPE 609 (774)
Q Consensus 573 l~elltg~~~Pf~~~~~~~~--~~~----------------------~~~~~-------------~------~~~~~~~~ 609 (774)
+|||++| .+||........ .++ ..... . .....+++
T Consensus 208 l~ell~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 286 (355)
T d2b1pa1 208 MGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286 (355)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHH
T ss_pred HHHHhhC-CCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHH
Confidence 9999997 778854322211 111 00000 0 00011357
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 610 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 610 ~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
+.+||++||+.||++|||++|+|+||||..
T Consensus 287 ~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 287 ARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 899999999999999999999999999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=372.74 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=185.2
Q ss_pred cceEEEeEeecccCceEEEEEe-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeEEeeeccCC------
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ------ 411 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 411 (774)
.++|.+.+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. +++.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHH-HHHhcCCCCeeeEEEEEeeccccccC
Confidence 4668899999999999999985 46799999999975432 23456665 77889999999999987532
Q ss_pred ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 004097 412 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 491 (774)
Q Consensus 412 ~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 491 (774)
+..|++++++.++|.+++ ..+++++..++.|+.||+.||
T Consensus 96 ~~~~i~~~~~gg~L~~~~-----------------------------------------~~~~l~e~~~~~i~~qil~aL 134 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIV-----------------------------------------KCQKLTDDHVQFLIYQILRGL 134 (348)
T ss_dssp CCCEEEEECCSEEHHHHH-----------------------------------------TTCCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeecCCchhhhc-----------------------------------------ccccccHHHHHHHHHHHHHHH
Confidence 334555554444555443 123477888999999999999
Q ss_pred HHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCC-CCCcchhHhHH
Q 004097 492 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLG 570 (774)
Q Consensus 492 ~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSlG 570 (774)
+|||++||+||||||+|||++.++. +|++|||++..... ...+..||+.|+|||++.+.. ++.++||||||
T Consensus 135 ~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlG 206 (348)
T d2gfsa1 135 KYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206 (348)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHH
T ss_pred HHHHhCCCcccccCCcccccccccc--ccccccchhcccCc------ccccccccccccCchhhcCCccCCcccchhhhh
Confidence 9999999999999999999988876 89999999876542 234456899999999877654 68999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhccc------------------------------cccccCCHHHHHHHHHhc
Q 004097 571 CILFFCITGGKHPYGESFERDA--NIVKDRKD------------------------------LFLVEHIPEAVDLFTRLL 618 (774)
Q Consensus 571 vll~elltg~~~Pf~~~~~~~~--~~~~~~~~------------------------------~~~~~~~~~~~dli~~~L 618 (774)
|++|+|++| .+||........ .+...... ......++++.|||.+||
T Consensus 207 v~l~~ll~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 285 (348)
T d2gfsa1 207 CIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285 (348)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHC
Confidence 999999997 778865432211 11110000 001234678999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCCc
Q 004097 619 DPNPDLRPKAQNVLNHPFFWTA 640 (774)
Q Consensus 619 ~~dP~~Rps~~elL~HPff~~~ 640 (774)
+.||.+|||++|+|+||||...
T Consensus 286 ~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 286 VLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCChhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999999753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=368.05 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=181.4
Q ss_pred cceEEEeEeecccCceEEEEEeeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCCeeEEeeeccCCc----eeEEec
Q 004097 344 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSL 418 (774)
Q Consensus 344 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~l~g~~~~~~----~~~LV~ 418 (774)
.+.|.+.+.||+|+||+||+|. .+|+.||||++.........+|.+. .+..++|||||+++++|.+.+ .+|+||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~-~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEE-ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEE-ECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4668899999999999999976 5899999999976555555555432 234578999999999998654 689999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHH--
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-- 496 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-- 496 (774)
| |+.+|+|.++|+. .++++..+++++.|+|.||+|||+
T Consensus 81 E----------y~~~g~L~~~l~~------------------------------~~l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 81 D----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp E----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred e----------cccCCCHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 9 4555666655432 246778889999999999999997
Q ss_pred ------cCccccccCCCCeeecCCCCceEEEcccCccccccCCCccc-cccccCcCCCCCCchhhhhcCC------CCCc
Q 004097 497 ------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------QTRA 563 (774)
Q Consensus 497 ------~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~------~~~~ 563 (774)
.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+.. ++.+
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k 198 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhhccCCCeeccccCccceEEcCCCC--eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcc
Confidence 48999999999999987765 9999999999876433221 2234567999999999987643 5678
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCch----------------HHHHHHHhh-ccc-cccc-----cCCHHHHHHHHHhcCC
Q 004097 564 IDLFSLGCILFFCITGGKHPYGESF----------------ERDANIVKD-RKD-LFLV-----EHIPEAVDLFTRLLDP 620 (774)
Q Consensus 564 sDvwSlGvll~elltg~~~Pf~~~~----------------~~~~~~~~~-~~~-~~~~-----~~~~~~~dli~~~L~~ 620 (774)
+|||||||++|||+|| .+||.... ......... ... ..+. +...++.+|+.+||+.
T Consensus 199 ~Di~S~Gvvl~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 199 ADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHT-BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred hhhhhhHHHHHHHhhC-CCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence 9999999999999997 55543211 111111111 110 0111 1113588999999999
Q ss_pred CCCCCcCHHHHHcC
Q 004097 621 NPDLRPKAQNVLNH 634 (774)
Q Consensus 621 dP~~Rps~~elL~H 634 (774)
||++|||+.||+++
T Consensus 278 dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 278 NGAARLTALRIKKT 291 (303)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-41 Score=358.05 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=191.7
Q ss_pred cccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCC-eeEEeeeccCCceeEEec
Q 004097 342 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSL 418 (774)
Q Consensus 342 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~~~LV~ 418 (774)
++|++|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|++ ++..++|+| |+.+.+++.+.+..++||
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHH-HHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHH-HHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5677899999999999999999854 5689999999865433 34556665 566676665 555566667888999999
Q ss_pred cccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 004097 419 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 498 (774)
Q Consensus 419 E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 498 (774)
|||.++|.+.+.. ..+.+++..++.++.|++.||+|||+++
T Consensus 83 e~~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 83 ELLGPSLEDLFNF---------------------------------------CSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp ECCCCBHHHHHHH---------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCchhhhhhh---------------------------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 9988776655421 2245778889999999999999999999
Q ss_pred ccccccCCCCeeecC-CCCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 499 LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 499 ivHrDLkp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
|+||||||+|||++. +....+||+|||+|+.+...... .....+..||+.|||||++.+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 999999999999853 22346999999999987643221 1233456799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-----HHHh----hccccccccCCHHHHHHHHHhcCCCCCCCcCHHHH---HcCCC
Q 004097 574 FFCITGGKHPYGESFERDA-----NIVK----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPF 636 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~~~~-----~~~~----~~~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~el---L~HPf 636 (774)
|||++| .+||........ .... ..........++++.++|.+||+.||++||+++++ |+|+|
T Consensus 204 ~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 204 MYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHHHS-SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhC-CCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 999997 778865322211 1111 11111223456889999999999999999998754 56654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-40 Score=347.28 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=191.3
Q ss_pred ccceEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccc
Q 004097 343 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 420 (774)
Q Consensus 343 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 420 (774)
+++.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+..+....+|+||+.+++++.++...|+|||+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 567899999999999999999864 5789999999865432 34455665443344559999999999999999999999
Q ss_pred cCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 004097 421 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 500 (774)
Q Consensus 421 ~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 500 (774)
|.++|.+++... ...+++..+..++.|++.||+|||+.||+
T Consensus 83 ~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~i~~q~~~~l~~lH~~gii 123 (293)
T d1csna_ 83 LGPSLEDLLDLC---------------------------------------GRKFSVKTVAMAAKQMLARVQSIHEKSLV 123 (293)
T ss_dssp CCCBHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred cCCCHHHHHHhh---------------------------------------ccchhhHHHHHHHHHHHHHHHHHHHCCce
Confidence 888877765321 12366778899999999999999999999
Q ss_pred ccccCCCCeeecCC---CCceEEEcccCccccccCCCcc----ccccccCcCCCCCCchhhhhcCCCCCcchhHhHHHHH
Q 004097 501 HRDLKPQNVLISKD---KSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 573 (774)
Q Consensus 501 HrDLkp~NILl~~~---~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSlGvll 573 (774)
||||||+|||++.+ ....+||+|||+|+........ .......+||+.|||||++.+..++.++|||||||++
T Consensus 124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 99999999999642 1235899999999987543221 1233456799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchH----HH-HHHHhhcc----ccccccCCHHHHHHHHHhcCCCCCCCcCHHHHH
Q 004097 574 FFCITGGKHPYGESFE----RD-ANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 632 (774)
Q Consensus 574 ~elltg~~~Pf~~~~~----~~-~~~~~~~~----~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL 632 (774)
|||++| ..||..... .. ..+..... .......++++.+++..|+..+|+.||+++.+.
T Consensus 204 ~elltg-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 204 MYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHhC-CCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 999997 778853211 11 11111111 111234567899999999999999999987664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-38 Score=341.36 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=180.7
Q ss_pred eEEEeEeecccCceEEEEEee-eCCcEEEEEEeecCCc--hHHHHHHHHHHHh-----------CCCCCeeEEeeeccCC
Q 004097 346 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIAS-----------DQHPNIVRWYGVESDQ 411 (774)
Q Consensus 346 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~-----------l~HpNIV~l~g~~~~~ 411 (774)
+|.+.++||+|+||+||+|.. .+|+.||||++++... +...+|+. ++.. +.|+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~-~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHH-HHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 489999999999999999864 6799999999976532 33345554 2332 3478999999987654
Q ss_pred --ceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 004097 412 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 489 (774)
Q Consensus 412 --~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 489 (774)
...+++++++.+.-... ... .......+++..+..++.||+.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~---------~~~---------------------------~~~~~~~~~~~~i~~i~~qil~ 136 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLL---------ALI---------------------------KKYEHRGIPLIYVKQISKQLLL 136 (362)
T ss_dssp ETTEEEEEEEECCCCEEHH---------HHH---------------------------HHTTTSCCCHHHHHHHHHHHHH
T ss_pred cccceeeeeeecccccccc---------ccc---------------------------ccccccCCcHHHHHHHHHHHHH
Confidence 45666666554321100 000 0023355778889999999999
Q ss_pred HHHHHHH-cCccccccCCCCeeecCCCC----ceEEEcccCccccccCCCccccccccCcCCCCCCchhhhhcCCCCCcc
Q 004097 490 GLSHLHE-IGLIHRDLKPQNVLISKDKS----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 564 (774)
Q Consensus 490 gL~yLH~-~~ivHrDLkp~NILl~~~~~----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s 564 (774)
||+|||+ .||+||||||+|||++.++. ..++++|||.+..... .....+||+.|+|||++....++.++
T Consensus 137 al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~ 210 (362)
T d1q8ya_ 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGA 210 (362)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHH
T ss_pred HHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc------ccccccccccccChhhccccCCCccc
Confidence 9999998 89999999999999975543 3589999999876542 22446799999999999999999999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCchHH--------HHHHHh-----------hc---------------------------
Q 004097 565 DLFSLGCILFFCITGGKHPYGESFER--------DANIVK-----------DR--------------------------- 598 (774)
Q Consensus 565 DvwSlGvll~elltg~~~Pf~~~~~~--------~~~~~~-----------~~--------------------------- 598 (774)
||||+||++++|++| ++||...... ....+. ..
T Consensus 211 DiwSlG~il~el~~g-~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 211 DIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHS-SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred cccchHHHHHHHHHC-CCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence 999999999999997 7787532210 000000 00
Q ss_pred ---cccccccCCHHHHHHHHHhcCCCCCCCcCHHHHHcCCCCCC
Q 004097 599 ---KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 639 (774)
Q Consensus 599 ---~~~~~~~~~~~~~dli~~~L~~dP~~Rps~~elL~HPff~~ 639 (774)
........++++.|||.+||+.||.+|||++|+|+||||.+
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence 00001112357899999999999999999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=3e-21 Score=190.31 Aligned_cols=158 Identities=16% Similarity=0.078 Sum_probs=110.1
Q ss_pred EEeEeecccCceEEEEEeeeCCcEEEEEEeecCCc---------------------hHHHHHHHHHHHhCCCCCeeEEee
Q 004097 348 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------DVALKEIQNLIASDQHPNIVRWYG 406 (774)
Q Consensus 348 ~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---------------------~~~~~Ei~~ll~~l~HpNIV~l~g 406 (774)
.+++.||+|+||+||+|...+|+.||||+++.... ....+|.. .+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHH-HHHHccCCCcceEEE
Confidence 35789999999999999888899999998742110 01123333 556788999998887
Q ss_pred eccCCceeEEeccccCCChhhHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 004097 407 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 486 (774)
Q Consensus 407 ~~~~~~~~~LV~E~~~~sL~~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 486 (774)
+.. .+++||++++.. +.. ++...+..++.|
T Consensus 82 ~~~----~~lvme~~~~~~----------~~~------------------------------------l~~~~~~~i~~q 111 (191)
T d1zara2 82 WEG----NAVLMELIDAKE----------LYR------------------------------------VRVENPDEVLDM 111 (191)
T ss_dssp EET----TEEEEECCCCEE----------GGG------------------------------------CCCSCHHHHHHH
T ss_pred ecC----CEEEEEeecccc----------ccc------------------------------------hhhHHHHHHHHH
Confidence 632 379999776521 100 122234689999
Q ss_pred HHHHHHHHHHcCccccccCCCCeeecCCCCceEEEcccCccccccCCCccccccccCcCCCCCCch------hhhhcCCC
Q 004097 487 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP------EQLLQGRQ 560 (774)
Q Consensus 487 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~ 560 (774)
++.||+|||+.||+||||||+|||+++++ ++|+|||+|+........ .|... +. ..+.|
T Consensus 112 l~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~-f~r~y 176 (191)
T d1zara2 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGWR-----------EILERDVRNIITY-FSRTY 176 (191)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEETTSTTHH-----------HHHHHHHHHHHHH-HHHHH
T ss_pred HHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccCCCCCcH-----------HHHHHHHHHHHHH-HcCCC
Confidence 99999999999999999999999998553 789999998765422110 01110 11 13567
Q ss_pred CCcchhHhHHH
Q 004097 561 TRAIDLFSLGC 571 (774)
Q Consensus 561 ~~~sDvwSlGv 571 (774)
+.++|+||..-
T Consensus 177 ~~~~d~~s~~~ 187 (191)
T d1zara2 177 RTEKDINSAID 187 (191)
T ss_dssp CCCCCHHHHHH
T ss_pred CCcccHHHHHH
Confidence 88999999653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.84 E-value=1.7e-06 Score=89.35 Aligned_cols=67 Identities=7% Similarity=-0.040 Sum_probs=54.2
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccC----CCCCCCCCCCCCCCCCCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL----PGSSQNSLLGPVDRNSPLFLPD 196 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~----~~~~~~sf~GN~~lcg~~~~P~ 196 (774)
+....+++.+.+.+|+|+|.|| .+..+ .|+.|||++|+|+|.||. +......|.||..+||.+.|+|
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 4456788899999999999998 58888 499999999999999984 2334455679999999665544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.09 E-value=0.00075 Score=66.70 Aligned_cols=75 Identities=11% Similarity=-0.026 Sum_probs=45.8
Q ss_pred EeEeecccCceEEEEEeeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEeccccCCC
Q 004097 349 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 424 (774)
Q Consensus 349 ~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~s 424 (774)
..+..+.++...||+.. .+++.+.||+..... .....+|...+...-.+--+-+++.++.+++..|+||++.++.
T Consensus 18 ~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~ 95 (263)
T d1j7la_ 18 CVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccc
Confidence 33444445567899754 456678889875432 1233455543332223433556777777888899999988763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.62 E-value=0.0011 Score=65.11 Aligned_cols=70 Identities=13% Similarity=0.023 Sum_probs=46.7
Q ss_pred ecccCc-eEEEEEeeeCCcEEEEEEeecCCchHHHHHHHH--HHHhCCCCCeeEEeeeccCCceeEEeccccCC
Q 004097 353 IAKGSN-GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN--LIASDQHPNIVRWYGVESDQDFVYLSLERCTC 423 (774)
Q Consensus 353 LG~Gsf-G~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~~~ 423 (774)
+..|.. +.||+....++..+.||.-..........|... .+.. ..-.+.++++++.+.+..++||+++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~-~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLAT-TGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHT-TTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHh-cCCCCCceeeecccccceEEEEEeeec
Confidence 445543 678987777777889998765544344445442 2332 223366778888888899999999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.61 E-value=0.016 Score=60.96 Aligned_cols=72 Identities=18% Similarity=0.149 Sum_probs=42.8
Q ss_pred eEeecccCceEEEEEeee-CCcEEEEEEeec------C----CchHHHHHHHHH--HHhCCCCCeeEEeeeccCCceeEE
Q 004097 350 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVK------T----HHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYL 416 (774)
Q Consensus 350 ~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~------~----~~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~~~~~~L 416 (774)
.+.||.|....||+.... +++.|.||.-.. . ..+....|...+ +.......+.+++++. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 357999999999987544 467899996421 1 112344555433 2333234466666654 445678
Q ss_pred eccccCC
Q 004097 417 SLERCTC 423 (774)
Q Consensus 417 V~E~~~~ 423 (774)
|||++.+
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9998875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.59 E-value=0.0091 Score=61.06 Aligned_cols=162 Identities=14% Similarity=0.090 Sum_probs=74.9
Q ss_pred eEEEEEeeeCCcEEEEEEeecCC-c-hHHHHHHHHHHHhCC-----CCCeeEEee--eccCCceeEEeccccCCChh---
Q 004097 359 GTVVLEGNYEGRSVAVKRLVKTH-H-DVALKEIQNLIASDQ-----HPNIVRWYG--VESDQDFVYLSLERCTCSLN--- 426 (774)
Q Consensus 359 G~Vy~a~~~~g~~VAVK~l~~~~-~-~~~~~Ei~~ll~~l~-----HpNIV~l~g--~~~~~~~~~LV~E~~~~sL~--- 426 (774)
-.||+....+|..|++|+.+... . .+...|.. ++..+. .+..+..-+ .....+..+.+++++.|..-
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~-~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQ-FALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHH-HHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHH-HHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999888899999999986543 2 23334443 222221 121122111 12334667889998886211
Q ss_pred -hHHHHhcCChHHHhhhhhhcchhhHHHHHhhcccccchhh--HHHHhhCCCCHHHHHHHHHHHHHHHHHHHH-------
Q 004097 427 -DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD--IELWKANGHPSAQLLKVTRDIVSGLSHLHE------- 496 (774)
Q Consensus 427 -~~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~i~~qia~gL~yLH~------- 496 (774)
.-.+..-|.+--.+|........... ........... ...+....++......+...+...++.+..
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r---~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHR---PTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSS---CBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CHHHHHHHHHHHHHHHhhcccCCcccc---CCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11122233333334433221100000 00000000000 011112223332222233333333344432
Q ss_pred cCccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 497 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 497 ~~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
.++||+|+.+.|||++++ ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC----ceEEechhcc
Confidence 268999999999999633 3489999664
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=94.52 E-value=0.0047 Score=62.52 Aligned_cols=53 Identities=6% Similarity=-0.102 Sum_probs=43.5
Q ss_pred cccCcccCCCCCcccccccCcccccccCccccchhhhhccC-Cchhhhhhccc-eec
Q 004097 116 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGK-VAG 170 (774)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~-fsG 170 (774)
+.+.+.+.+|+. +.-..+|+.+.+.+|+|+|.||.+..+ .|+.|++++|+ +.|
T Consensus 252 s~N~l~g~iP~~--l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 252 RNNRIYGTLPQG--LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CSSCCEECCCGG--GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred ccCeecccCChH--HhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 445566667776 456789999999999999999988777 68999999998 566
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.54 E-value=0.023 Score=55.83 Aligned_cols=59 Identities=14% Similarity=-0.073 Sum_probs=46.6
Q ss_pred ccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCCCCCCCCC-----CCCCCCC
Q 004097 131 DLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL-----GPVDRNS 190 (774)
Q Consensus 131 ~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf~-----GN~~lcg 190 (774)
....+++.+.+.+|++++..+ .+..+ .|+.|||++|+++ .||...+...++. ||+|.|.
T Consensus 145 ~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 345678889999999998776 47777 5999999999999 8986666555443 9998886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.15 E-value=0.037 Score=49.92 Aligned_cols=60 Identities=12% Similarity=0.037 Sum_probs=39.6
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCCCCCCCCC-----CCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL-----GPVDRNS 190 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf~-----GN~~lcg 190 (774)
+....+|+.+.+.+|++++--+ .+..+ .|+.|||++|+++ .||...+...++. ||++.|.
T Consensus 52 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred hccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccCC
Confidence 3456678888888888877554 46666 5888888888887 4554433332332 7777664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=91.15 E-value=0.06 Score=49.98 Aligned_cols=61 Identities=7% Similarity=-0.087 Sum_probs=41.3
Q ss_pred cccccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCCCCCCCCCC-----CCCCCCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL-----GPVDRNS 190 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~sf~-----GN~~lcg 190 (774)
+.....|+.+.+.+|++++--+ .+.++ .|+.|+|++|++++-.|.......++. ||.+.|.
T Consensus 74 ~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 4456778888888998886655 47777 488889999988885554333333332 6665554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=87.93 E-value=0.56 Score=48.35 Aligned_cols=69 Identities=14% Similarity=0.043 Sum_probs=39.9
Q ss_pred EeecccCceEEEEEeeeC--------CcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeEEeeeccCCceeEEecccc
Q 004097 351 KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 421 (774)
Q Consensus 351 ~~LG~GsfG~Vy~a~~~~--------g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~~ 421 (774)
+.|+.|-.=.+|+....+ .+.|.+++.-.... ....+|...+...-.+.=..++++++.+ .+|+|+.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 568888888899875543 34566766543222 2334555433222223323477777754 5788987
Q ss_pred CC
Q 004097 422 TC 423 (774)
Q Consensus 422 ~~ 423 (774)
++
T Consensus 124 ~g 125 (395)
T d1nw1a_ 124 PS 125 (395)
T ss_dssp CE
T ss_pred cc
Confidence 75
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=87.61 E-value=0.48 Score=46.96 Aligned_cols=29 Identities=34% Similarity=0.450 Sum_probs=24.2
Q ss_pred CccccccCCCCeeecCCCCceEEEcccCccc
Q 004097 498 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 528 (774)
Q Consensus 498 ~ivHrDLkp~NILl~~~~~~~~kl~DFGla~ 528 (774)
|+||+|+.+.||+++.++ ..-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred ccccCCcchhhhhccccc--ceeEecccccc
Confidence 799999999999997654 35699999764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=86.42 E-value=0.2 Score=46.13 Aligned_cols=47 Identities=6% Similarity=-0.103 Sum_probs=34.5
Q ss_pred cCcccccccCccccchhh--hhccC-CchhhhhhccceeccccCCCCCCC
Q 004097 134 GDVESHLPCHTQMTASVY--RLRDN-SLPEFLSVIGKVAGWISLPGSSQN 180 (774)
Q Consensus 134 ~~~~~~~~~nN~fsG~i~--~l~~l-~L~~Lnls~N~fsG~Ip~~~~~~~ 180 (774)
.+++.+.+++|++++.++ .+.++ .|+.|++++|++++.++.......
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 78 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccc
Confidence 577788888888888774 46677 588888888888887764443333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=81.86 E-value=0.3 Score=49.47 Aligned_cols=45 Identities=7% Similarity=0.119 Sum_probs=29.6
Q ss_pred cccccCcccccccCccccchhhhhccC-CchhhhhhccceeccccCC
Q 004097 130 MDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
+....+|+.+.+++|++++ |+.+.++ .|+.||+++|+++|-+|+.
T Consensus 325 l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~l~ 370 (384)
T d2omza2 325 VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTPLA 370 (384)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGGGT
T ss_pred cccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChhhc
Confidence 3455667777777777764 5566666 3777777777777765543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.75 E-value=0.16 Score=49.83 Aligned_cols=44 Identities=16% Similarity=0.126 Sum_probs=26.0
Q ss_pred cccCcccccccCccccchhh-hhccC-CchhhhhhccceeccccCC
Q 004097 132 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 175 (774)
Q Consensus 132 ~~~~~~~~~~~nN~fsG~i~-~l~~l-~L~~Lnls~N~fsG~Ip~~ 175 (774)
....|+.+.+.+|++++-.+ .+.++ .|+.|++++|++++.+|..
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~ 196 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhH
Confidence 44556666666666665444 35555 4666666666666655543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=80.62 E-value=0.54 Score=44.11 Aligned_cols=43 Identities=7% Similarity=0.053 Sum_probs=28.9
Q ss_pred cccccCcccccccCccccchhhhhccC-Cchhhhhhccceecccc
Q 004097 130 MDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 173 (774)
Q Consensus 130 ~~~~~~~~~~~~~nN~fsG~i~~l~~l-~L~~Lnls~N~fsG~Ip 173 (774)
+....+|+.+.+.+|++++ |+.++.+ .|+.|||++|++++-.|
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBCGG
T ss_pred hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCCcc
Confidence 4455677777777777775 5556666 47777777777776333
|